<SEC-DOCUMENT>0001213900-23-081591.txt : 20231030
<SEC-HEADER>0001213900-23-081591.hdr.sgml : 20231030
<ACCEPTANCE-DATETIME>20231030172059
ACCESSION NUMBER:		0001213900-23-081591
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		143
CONFORMED PERIOD OF REPORT:	20230630
FILED AS OF DATE:		20231030
DATE AS OF CHANGE:		20231030

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Moolec Science SA
		CENTRAL INDEX KEY:			0001937737
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			N4
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41586
		FILM NUMBER:		231361526

	BUSINESS ADDRESS:	
		STREET 1:		17, BOULEVARD F.W. RAIFFEISAN
		CITY:			LUXEMBOURG
		STATE:			N4
		ZIP:			L-2411
		BUSINESS PHONE:		352 26 49 65 65

	MAIL ADDRESS:	
		STREET 1:		17, BOULEVARD F.W. RAIFFEISAN
		CITY:			LUXEMBOURG
		STATE:			N4
		ZIP:			L-2411
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>f20f2023_moolecsci.htm
<DESCRIPTION>ANNUAL REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Oct 30 21:05:21 UTC 2023 -->
<html xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:compsci="http://compsciresources.com" xmlns:mlec="http://www.moolecscience.com/20230630" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml">
<head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type" />
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNITED
STATES<br/>
SECURITIES AND EXCHANGE COMMISSION&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Washington,
D.C. 20549</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORM
<ix:nonNumeric contextRef="c0" name="dei:DocumentType">20-F</ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Mark
One)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentRegistrationStatement">&#9744;</ix:nonNumeric> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OR</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the fiscal year ended <ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate"><ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-en" name="dei:CurrentFiscalYearEndDate">June 30</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalYearFocus">2023</ix:nonNumeric></ix:nonNumeric></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OR</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">transition period from ________________ to ________________</span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OR</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentShellCompanyReport">&#9744;</ix:nonNumeric> SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Date of event requiring this shell company report: <span style="text-decoration:underline">__________</span></b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission
file number: <ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber">001-41586</ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName">Moolec
Science SA</ix:nonNumeric><br/>
</b><i>(Exact name of Registrant as specified in its charter)</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="c0" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode">Grand
Duchy of Luxembourg</ix:nonNumeric><br/>
</b><i>(Jurisdiction of incorporation)</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 21.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1">17,
Boulevard F. W.</ix:nonNumeric> <ix:nonNumeric contextRef="c0" continuedAt="_EntityAddressAddressLine2-c0_cont_1" name="dei:EntityAddressAddressLine2">Raiffeisen</ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 21.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:continuation id="_EntityAddressAddressLine2-c0_cont_1">L-2411
Luxembourg</ix:continuation>,</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grand
Duchy of Luxembourg</b></span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>R.C.S.
<ix:nonNumeric contextRef="c0" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry">Luxembourg</ix:nonNumeric>: <ix:nonNumeric contextRef="c1" name="dei:EntityAddressPostalZipCode"><ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode">B268440</ix:nonNumeric></ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 21.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>+352
26 49 65 65</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Address
of principal executive offices)</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><ix:nonNumeric contextRef="c1" name="dei:ContactPersonnelName"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Florencia
Bottero</b></span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal
Counsel</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 21.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="c1" name="dei:EntityAddressAddressLine1">17,
Boulevard F. W.</ix:nonNumeric> <ix:nonNumeric contextRef="c1" continuedAt="_EntityAddressAddressLine2-c1_cont_1" name="dei:EntityAddressAddressLine2">Raiffeisen</ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 21.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:continuation id="_EntityAddressAddressLine2-c1_cont_1">L-2411
Luxembourg</ix:continuation>,</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><b><ix:nonNumeric contextRef="c1" name="dei:EntityAddressCityOrTown"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grand
Duchy of <ix:nonNumeric contextRef="c1" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry">Luxembourg</ix:nonNumeric></span></ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><ix:nonNumeric contextRef="c1" name="dei:ContactPersonnelEmailAddress"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>legal@moolecscience.com</b></span></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="c1" name="dei:CityAreaCode">+54</ix:nonNumeric>
<ix:nonNumeric contextRef="c1" name="dei:LocalPhoneNumber">341 486 1100</ix:nonNumeric></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Name,
Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Copies
to:</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Matthew
S. Poulter</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pierre-Emmanuel
Perais</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Linklaters
LLP</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1290
Avenue of the Americas</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
York, NY 10104</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Phone:
(212) 903-9000</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fax:
(212) 903-9100</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered or to be registered pursuant to Section 12(b) of the Act:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of Each Class</span></td> <td style="width: 2%">&#160;</td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading Symbol</span></td> <td style="width: 2%">&#160;</td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of each exchange on which registered</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:Security12bTitle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary Shares, with nominal value of US$0.01 per share</span></ix:nonNumeric></td> <td>&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:TradingSymbol"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MLEC</span></ix:nonNumeric></td> <td>&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq Stock Market LLC</span></ix:nonNumeric></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered or to be registered pursuant to Section 12(g) of the Act:</span><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>None</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&#160;</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
for which there is a reporting obligation pursuant to Section 15(d) of the Act:&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ordinary
Shares</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
the number of outstanding shares of each of the issuer&#8217;s classes of capital stock or common stock as of the close of business covered
by the annual report. <ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitRef="shares">37,563,768</ix:nonFraction> ordinary shares were issued and outstanding as of June 30, 2023.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 21.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
Yes &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9746; <ix:nonNumeric contextRef="c0" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section
13 or 15(d) of the Securities Exchange Act of 1934.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
Yes &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9746; <ix:nonNumeric contextRef="c0" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;
<ix:nonNumeric contextRef="c0" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9744; No</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;
<ix:nonNumeric contextRef="c0" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9744; No</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth
company. See definition of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; and &#8220;emerging growth company&#8221;
in Rule 12b-2 of the Exchange Act.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated filer &#9744;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated filer &#9744;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric> &#9746;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging growth company <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards&#8224; provided
pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;The
term &#8220;new or revised financial accounting standard&#8221; refers to any update issued by the Financial Accounting Standards Board
to its Accounting Standards Codification after April 5, 2012.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report. <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:IcfrAuditorAttestationFlag">&#9744;</ix:nonNumeric></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant
included in the filing reflect the correction of an error to previously issued financial statements. <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentFinStmtErrorCorrectionFlag">&#9744;</ix:nonNumeric></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation
received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 33%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US GAAP &#9744;</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 34%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 21.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">International Financial Reporting</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 21.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Standards as issued by the</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">International Accounting Standards Board <span style="-sec-ix-hidden: hidden-fact-0">&#9746;</span></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 33%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other </span>&#9744;</td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
&#8220;Other&#8221; has been checked in response to the previous question indicate by check mark which financial statement item the registrant
has elected to follow.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
Item 17  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#9744; Item 18</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange
Act).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#9744;
Yes &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityShellCompany">&#9746;</ix:nonNumeric> No</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Table of Contents</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_001">ABOUT THIS ANNUAL REPORT</a></span></td>
    <td style="text-align: center">iii</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td colspan="2">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_002">PART I</a></span></td>
    <td style="width: 80%">&#160;</td>
    <td style="text-align: center; width: 10%">1</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_003">INTRODUCTORY NOTE AND PRESENTATION OF FINANCIAL AND OTHER INFORMATION</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 1.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_004">IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-left: -0.125in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_005">Directors and Senior Management</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_006">Advisors</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_007">Auditors</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 2.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_008">OFFER STATISTICS AND EXPECTED TIMETABLE</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_009">Offer Statistics</a></span></td>
    <td style="text-align: center">3</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_010">Method and Expected Timetable</a></span></td>
    <td style="text-align: center">3</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 3.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_011">KEY INFORMATION</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_012">[RESERVED]</a></span></td>
    <td style="text-align: center">4</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_013">Capitalization and Indebtedness</a></span></td>
    <td style="text-align: center">4</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_014">Reasons for the Offer and Use of Proceeds</a></span></td>
    <td style="text-align: center">4</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_015">Risk Factors</a></span></td>
    <td style="text-align: center">4</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 4.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_016">INFORMATION ON THE COMPANY</a></span></td>
    <td style="text-align: center">37</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_017">History and Development of the Company</a></span></td>
    <td style="text-align: center">37</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_018">Business Overview</a></span></td>
    <td style="text-align: center">42</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_019">Organizational Structure</a></span></td>
    <td style="text-align: center">50</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_020">Property, Plant and Equipment</a></span></td>
    <td style="text-align: center">50</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 4A.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_021">UNRESOLVED STAFF COMMENTS</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 5.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_022">OPERATING AND FINANCIAL REVIEW AND PROSPECTS</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_023">Operating Results</a></span></td>
    <td style="text-align: center">51</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_024">Liquidity and Capital Resources</a></span></td>
    <td style="text-align: center">55</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_025">Research and Development, Patents and Licenses, etc.</a></span></td>
    <td style="text-align: center">57</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_026">Trend Information</a></span></td>
    <td style="text-align: center">57</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_027">Critical Accounting Estimates</a></span></td>
    <td style="text-align: center">57</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 6.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_028">DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_029">Directors and Senior Management</a></span></td>
    <td style="text-align: center">58</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_030">Compensation</a></span></td>
    <td style="text-align: center">60</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_031">Board Practices</a></span></td>
    <td style="text-align: center">61</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_032">Employees</a></span></td>
    <td style="text-align: center">63</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_033">Share Ownership</a></span></td>
    <td style="text-align: center">63</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_034">Disclosure of a Registrant&#8217;s Action to Recover Erroneously Awarded Compensation</a></span></td>
    <td style="text-align: center">64</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 7.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_035">MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_036">Major Shareholders</a></span></td>
    <td style="text-align: center">65</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_037">Related Party Transactions</a></span></td>
    <td style="text-align: center">65</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_038">Interests of Experts and Counsel</a></span></td>
    <td style="text-align: center">65</td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 8.</span></td>
    <td style="width: 80%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_039">FINANCIAL INFORMATION</a></span></td>
    <td style="text-align: center; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_040">Consolidated Statements and Other Financial Information</a></span></td>
    <td style="text-align: center">66</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_041">Significant Changes</a></span></td>
    <td style="text-align: center">66</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 9.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_042">THE OFFER AND LISTING</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_043">Offer and Listing Details</a></span></td>
    <td style="text-align: center">66</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_044">Plan of Distribution</a></span></td>
    <td style="text-align: center">66</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_045">Markets</a></span></td>
    <td style="text-align: center">66</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_046">Selling Shareholders</a></span></td>
    <td style="text-align: center">66</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_047">Dilution</a></span></td>
    <td style="text-align: center">66</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_048">Expenses of the Issue</a></span></td>
    <td style="text-align: center">66</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 10.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_049">ADDITIONAL INFORMATION</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_050">Share Capital</a></span></td>
    <td style="text-align: center">67</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_051">Memorandum and Articles of Association</a></span></td>
    <td style="text-align: center">67</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_052">Material Contracts</a></span></td>
    <td style="text-align: center">70</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_053">Exchange Controls</a></span></td>
    <td style="text-align: center">73</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_054">Taxation</a></span></td>
    <td style="text-align: center">73</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_055">Dividends and Paying Agents</a></span></td>
    <td style="text-align: center">80</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_056">Statement by Experts</a></span></td>
    <td style="text-align: center">80</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_057">Documents on Display</a></span></td>
    <td style="text-align: center">80</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_058">Subsidiary Information</a></span></td>
    <td style="text-align: center">80</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">J.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_059">Annual Report to Security Holders</a></span></td>
    <td style="text-align: center">80</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 11.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_060">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 12.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_061">DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_062">Debt Securities</a></span></td>
    <td style="text-align: center">80</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_063">Warrants and Rights</a></span></td>
    <td style="text-align: center">80</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_064">Other Securities</a></span></td>
    <td style="text-align: center">80</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_065">American Depositary Shares</a></span></td>
    <td style="text-align: center">80</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_066">PART II</a></span></td>
    <td>&#160;</td>
    <td style="text-align: center">81</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 13.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_067">DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</a></span></td>
    <td style="text-align: center">81</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_068">Defaults</a></span></td>
    <td style="text-align: center">81</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_069">Arrears and Delinquencies</a></span></td>
    <td style="text-align: center">81</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 14.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_070">MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 15.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_071">CONTROLS AND PROCEDURES</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_072">Disclosure Controls and Procedures</a></span></td>
    <td style="text-align: center">81</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_073">Management&#8217;s Annual Report on Internal Control Over Financial Reporting</a></span></td>
    <td style="text-align: center">81</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center">C.</td>
    <td><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><a href="#a_092">Attestation Report of the Registered Public Accounting Firm</a></p></td>
    <td style="text-align: center">81</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_075">Changes in Internal Control Over Financial Reporting</a></span></td>
    <td style="text-align: center">81</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 16.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_076">Reserved</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_077">Audit Committee Financial Expert</a></span></td>
    <td style="text-align: center">82</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_078">Code of Ethics</a></span></td>
    <td style="text-align: center">82</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_079">Principal Accountant Fees and Services</a></span></td>
    <td style="text-align: center">82</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_080">Exemptions from the Listing Standards for Audit Committees</a></span></td>
    <td style="text-align: center">82</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_081">Purchases of Equity Securities by the Issuer and Affiliated Purchasers</a></span></td>
    <td style="text-align: center">82</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_082">Change in Registrant&#8217;s Certifying Accountant</a></span></td>
    <td style="text-align: center">83</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_083">Corporate Governance</a></span></td>
    <td style="text-align: center">83</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_084">Mine Safety Disclosure</a></span></td>
    <td style="text-align: center">83</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_085">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></td>
    <td style="text-align: center">83</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">J.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_086">Insider Trading Policies</a></span></td>
    <td style="text-align: center">83</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">K.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_087">Cybersecurity</a></span></td>
    <td style="text-align: center">83</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_088">PART III</a></span></td>
    <td>&#160;</td>
    <td style="text-align: center">84</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 17.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_089">FINANCIAL STATEMENTS</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 18.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_090">FINANCIAL STATEMENTS</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 19.</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_091">EXHIBITS</a></span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 4; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="a_001"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABOUT
THIS ANNUAL REPORT</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
the context otherwise requires, &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;the Company,&#8221; &#8220;Moolec&#8221;
and &#8220;Moolec Science&#8221; refers to Moolec Science SA and its subsidiaries. &#8220;Moolec Limited&#8221; refers to Moolec Science
Limited.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SELECTED
DEFINITIONS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following terms used in this Annual Report are defined below, unless where context otherwise requires:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>1915
Law</i>&#8221; means the Luxembourg law of August 10, 1915 on commercial companies, as amended.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Agreement
on Funds Flow</i>&#8221; means the Agreement on Funds Flow, dated as of December 30, 2022, among LightJump Acquisition Corporation, LightJump
One Founders, LLC, Moolec Limited, Moolec Acquisition, Inc. and Moolec.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Articles</i>&#8221;
means the articles of association of Moolec, as amended and restated from time to time.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Backstop
Agreement</i>&#8221; means the backstop agreement dated June 14, 2022 by and between UGVL, UG Holdings, LLC, Theo and the Sponsor, guaranteeing,
severally but not jointly, the funding of certain amounts as set forth therein and complemented by the memorandum of understanding dated
December 30, 2022 in connection thereto.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Bioceres</i>&#8221;
means Bioceres Crop Solutions Corp.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>BIOX
Supply Agreement</i>&#8221; means the HB4 soy supply agreement to be entered into by Moolec and Bioceres pursuant to the MOU dated October
15, 2023.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Business
Combination</i>&#8221; means the transactions contemplated by the Business Combination Agreement, including the Merger and the Exchange.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Business
Combination Closing</i>&#8221; means the time when the closing of the Business Combination occurred pursuant to the Business Combination
Agreement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Business
Combination Closing Date</i>&#8221; means December 30, 2022.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Business
Combination Proposal</i>&#8221; means the proposal to approve the adoption of the Business Combination Agreement and the Business Combination.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Certificate
of Merger</i>&#8221; means the certificate of merger that LightJump caused to be executed, acknowledged and filed with the Secretary
of State of the State of Delaware in accordance with the applicable provisions of the DGCL to effectuate the Merger.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Company
Core Shareholders</i>&#8221; means BG Farming Technologies Ltd., UGVL and Bioceres Crop Solutions Corp.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Continental</i>&#8221;
means Continental Stock Transfer &amp; Trust Company, transfer agent and warrant agent of Moolec.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>DGCL</i>&#8221;
means the Delaware General Corporation Law.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Earlybird</i>&#8221;
means EarlyBirdCapital, Inc.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Exchange</i>&#8221;
means the transactions contemplated in the Business Combination Agreement that occurred at the Exchange Effective Time, including the
contribution by each Moolec Limited Shareholder of its respective Moolec Limited Ordinary Shares to Moolec in exchange for an Ordinary
Share of Moolec.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Exchange
Agreements</i>&#8221; means those certain Contribution and Exchange Agreements dated as of June 14, 2022 and as amended or entered into
prior to the Business Combination Closing by and among the Company, Moolec and each of the Moolec Limited Shareholders.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 5; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Exchange
Effective Time</i>&#8221; means the time at which the issuance of the new Ordinary Shares pursuant to Moolec delegate resolutions was
effective on the Business Combination Closing, which was the effective time of the contribution and exchange of the Moolec Ordinary Shares
held by the Moolec Limited Shareholders and exchanged for Ordinary Shares, as applicable and as contemplated under the Exchange Agreements,
and which occurred immediately prior to the Merger Effective Time.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Exchange
Ratio</i>&#8221; has its meaning defined in the Business Combination Agreement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>FDA</i>&#8221;
means the U.S. Food and Drug Administration.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>GLA</i>&#8221;
means gamma-linoleic acid.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>GM</i>&#8221;
means genetically modified.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>GMOs</i>&#8221;
means genetically modified organisms.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>IFRS</i>&#8221;
means the International Financial Reporting Standards as issued by the International Accounting Standards Board (the &#8220;IASB&#8221;).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Insud</i>&#8221;
means Grupo Insud.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Insud
Convertible Note</i>&#8221; means the convertible note issued by Moolec to Insud pursuant to the note purchase agreement dated October
15, 2023.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>IPO</i>&#8221;
means LightJump&#8217;s initial public offering of units, consummated on January 12, 2021.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Key
Shareholders</i>&#8221; means BG Farming Technologies Limited, Union Group Ventures Ltd., Bioceres, Theo I SCSp, Jos&#233; Lopez Lecube,
LightJump One Founders, LLC, Serenity Traders Limited, UG Holdings, LLC, EarlyBirdCapital Inc. and its related parties.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Key
Staff Participation</i>&#8221; means the 232,523 Ordinary Shares that were freely allotted to Moolec&#8217;s CFO in order to satisfy
the Moolec&#8217;s obligations under the CFO Consulting Agreement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>LightJump</i>&#8221;
means LightJump Acquisition Corporation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>LightJump
Common Stock</i>&#8221; means LightJump&#8217;s common stock, par value US$0.0001 per share.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>LightJump
Warrant Agreement</i>&#8221; means the warrant agreement, between LightJump and Continental, dated as of January 12, 2021.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>LightJump
Warrants</i>&#8221; means the warrants to purchase LightJump Common Stock as contemplated under the LightJump Warrant Agreement, with
each warrant exercisable for the number of LightJump Common Stock stated in the applicable LightJump Warrant at an exercise price per
LightJump Common Stock of US$11.50.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Merger</i>&#8221;
means the merging of Merger Sub with and into LightJump, with LightJump surviving such merger and becoming a direct wholly-owned subsidiary
of Moolec.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Merger
Auditor Report</i>&#8221; has its meaning defined in the Business Combination Agreement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Merger
Effective Time</i>&#8221; means such time as the Certificate of Merger was duly filed with the Secretary of State of the State of Delaware
or at such later time as may have been agreed by Moolec and LightJump in writing and specified in the Certificate of Merger in accordance
with the DGCL.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Merger
Sub</i>&#8221; means Moolec Acquisition, Inc.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Moolec
Core Shareholders</i>&#8221; means BG Farming Technologies Ltd., UGVL and Bioceres.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Moolec
Limited SAFE</i>&#8221; means each of the simple agreement for future equity by and between Moolec and Moolec SAFE Holder named therein
(an &#8220;Original SAFE&#8221;) or any simple agreement for future equity between Moolec and that Moolec Limited SAFE Holder issued
in consideration for the contribution by the Moolec Limited SAFE Holder of its rights in the Original SAFE to Moolec (each a &#8220;Moolec
SAFE&#8221;) (in which case the Original SAFE ceased to be a &#8220;Moolec Limited SAFE&#8221;) with such adjustments required under
Luxembourg law.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Moolec
Limited SAFE Holder</i>&#8221; means each Person that has entered into a Moolec Limited SAFE.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 6; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Moolec
Limited Shareholders</i>&#8221; means the holders of all of the Moolec Ordinary Shares and all other shares being Equity Interest as
of immediately prior to the Exchange Effective Time.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Moolec
Requisite Approvals</i>&#8221; means HoldCo Requisite Approvals, as defined in the Business Combination Agreement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Moolec
SAFE</i>&#8221; means each of the simple agreement for future equity by and between Moolec and Moolec SAFE Holder named therein (an &#8220;Original
SAFE&#8221;) or any simple agreement for future equity between Moolec and that Moolec SAFE Holder issued in consideration for the contribution
by Moolec SAFE Holder of its rights in the Original SAFE to Moolec (in which case the Original SAFE ceased to be a &#8220;Moolec SAFE&#8221;)
with such adjustments required under Luxembourg law.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>MOU</i>&#8221;
means the binding memorandum of understanding dated October 15, 2023 by and between Moolec and Bioceres.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Nasdaq</i>&#8221;
means Nasdaq Stock Market LLC.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Nomura</i>&#8221;
means Nomura Securities International, Inc.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Nomura
Purchase Agreement</i>&#8221; means the share purchase agreement, dated as of April 14, 2023, by and between Moolec and Nomura.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Nomura
Registration Rights Agreement</i>&#8221; means the registration rights agreement, between Moolec and Nomura, dated as of April 14, 2023.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Ordinary
Shares</i>&#8221; means Moolec&#8217;s ordinary shares, each having a nominal value of US$0.01.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Piggy
Sooy</i>&#8221; means a brand registered by us, in the U.S. and Argentina.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Private
Warrants</i>&#8221; means the warrants to purchase LightJump Common Stock purchased in a private placement in connection with the IPO.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Share
Fee</i>&#8221; means a number of Moolec Limited Ordinary Shares equal to US$2,000,000 divided by the lesser of the volume weighted average
price of the Moolec Limited Ordinary Shares for the ten trading days preceding the six-month anniversary of the Business Combination
Closing Date, and US$10.00, up to a maximum of 600,000 shares, to be issued by Moolec Limited to EarlyBird.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Sponsor</i>&#8221;
means LightJump One Founders, LLC, a Delaware limited liability company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Theo</i>&#8221;
means THEO I SCSp.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>Trust
Account</i>&#8221; means the trust account that holds a portion of the proceeds of the IPO and the simultaneous sale of the Private Warrants.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>UGVL</i>&#8221;
means Union Group Ventures Limited.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>ValoraSoy</i>&#8221;
or &#8220;<i>ValoraSoy Food Ingredients</i>&#8221; means ValoraSoy S.A., a company incorporated in Argentina.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<i>ValoraSoy
Acquisition</i>&#8221; means our acquisition of ValoraSoy on April 24, 2023.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 7; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Annual Report contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that
relate to our current expectations and views of future events. We intend such forward-looking statements to be covered by the safe harbor
provisions for forward-looking statements as contained in Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-looking
statements include information concerning our possible or assumed future results of operations, including descriptions of our business
strategy. In some cases, you can identify forward-looking statements by terminology such as &#8220;believe,&#8221; &#8220;may,&#8221;
&#8220;might,&#8221; &#8220;will,&#8221; &#8220;consider,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221;
&#8220;intend,&#8221; &#8220;target,&#8221; &#8220;project,&#8221; &#8220;contemplate,&#8221; &#8220;should,&#8221; &#8220;plan,&#8221;
&#8220;expect,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; or the negative of these terms or other similar terms or expressions.
The statements we make regarding the following matters are forward-looking by their nature:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
impact of armed conflict in Israel and Gaza, in addition to the Ukraine, and any possible escalation of such conflicts or contagion to
neighboring countries or regions;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">general economic, financial, business and political conditions in Latin
America &#8212; including in Argentina, as a result of the presidential, provincial and congressional elections which will take place
on November 19, 2023;</p></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
financial performance;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
ability to maintain the listing of the Ordinary Shares or warrants on Nasdaq;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
in our strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
ability to develop and launch new products and services;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
ability to successfully and efficiently integrate future expansion plans and opportunities;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
availability of raw materials used in our products and our ability to source such raw materials;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
ability to grow our business in a cost-effective manner;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
product development timeline and expected research and development (&#8220;R&amp;D&#8221;);</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
ability to commercialize the products developed in our R&amp;D center, acquired as a result of the ValoraSoy Acquisition;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
implementation, market acceptance and success of our business model;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">developments
and projections relating to our competitors and industry;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
approach and goals with respect to technology;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
expectations regarding its ability to obtain and maintain intellectual property protection and not infringe on the rights of others;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
impact any global viral pandemic on our business;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
in applicable laws or regulations; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
outcome of any known and unknown litigation and regulatory proceedings; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">various
other factors, including without limitation those described under &#8220;<i>Item 3. Key Information &#8211; D. Risk Factors.</i>&#8221;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vi<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preceding list is not intended to be an exhaustive list of all of our forward-looking statements. The forward-looking statements are
based on our beliefs, assumptions and expectations of future performance, taking into account the information currently available to
us. These statements are only predictions based upon our current expectations and projections about future events. There are important
factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels
of activity, performance or achievements expressed or implied by the forward-looking statements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected
in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events
and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake
no obligation to update publicly any forward-looking statements for any reason after the date of this report or to conform these statements
to actual results or to changes in our expectations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MARKET
AND INDUSTRY DATA</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
annual report on Form 20-F industry data, information and statistics regarding the markets in which we compete as well as our analysis
of statistics, data and other information provided by third parties relating to markets, market sizes, market shares, market positions
and other industry data pertaining to our business and markets (collectively, &#8220;Industry Analysis&#8221;). Such information is supplemented
where necessary with our own internal estimates, taking into account publicly available information about other industry participants
and our management&#8217;s judgment where information is not publicly available.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industry
publications, tailormade industry reports, research, studies and forecasts generally state that the information they contain has been
obtained from sources believed to be reliable, but that the accuracy and completeness of such information is not guaranteed. Forecasts
and other forward-looking&#160;information obtained from these sources are subject to the same qualifications and uncertainties as the
other forward-looking&#160;statements in this annual report on Form 20-F. These forecasts and forward-looking&#160;information are subject
to uncertainty and risk due to a variety of factors, including those described under &#8220;<i>Risk Factors</i>.&#8221; These and other
factors could cause results to differ materially from those expressed in any forecasts or estimates.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TRADEMARKS,
SERVICE MARKS AND TRADE NAMES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
annual report on Form 20-F contains references to our trademarks and to trademarks belonging to other entities. Solely for convenience,
trademarks and trade names referred to in this annual report, including logos, artwork and other visual displays may appear without the
&#174; or TM symbols, but such references are not intended to indicate, in any way, that their respective owners will not assert, to the
fullest extent under applicable law, their rights thereto. We do not intend our use or display of other companies&#8217; trade names
or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other companies.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="a_002"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART
I</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_003"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INTRODUCTORY
NOTE AND PRESENTATION OF FINANCIAL AND OTHER INFORMATION</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Introductory
Note</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination.</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 30, 2022, the Business Combination Closing Date, we consummated the transactions contemplated by the Business Combination Agreement.
On or before the Business Combination Closing Date, pursuant to the Business Combination Agreement and related agreements:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
the issued Moolec Limited Ordinary Shares held by Moolec Limited Shareholders were transferred and for purposes of the 1915 Law, contributed
in kind to Moolec, free and clear of all Liens (other than the Moolec Limited Shareholders&#8217; Agreements Liens that have expired
on or prior to the Business Combination Closing Date), and Moolec Limited Shareholders subscribed for and, as consideration for the contribution,
were issued, in accordance with the Exchange Ratio (save that the Ordinary Shares to be were reduced by the number of Ordinary Shares
already held by Moolec Limited Shareholders immediately prior to the Exchange), being a total of 32,500,000&#160;Ordinary Shares. For
Luxembourg law purposes, a Luxembourg independent auditor (<i>r&#233;viseur d&#8217;entreprises</i>) of Moolec issued a report on the
contributions in kind relating to the contribution of the Moolec Ordinary Shares prepared in accordance with article&#160;420-10&#160;of
the 1915 Law;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
Moolec Limited SAFE Holder contributed all of its rights and obligations under each Original SAFE to Moolec in consideration for the
issuance by Moolec of a simple agreement for future equity on substantively identical terms (<i>mutatis mutandis</i>) with such adjustments
as required under Luxembourg law. For Luxembourg law purposes, a Luxembourg independent auditor (<i>r&#233;viseur d&#8217;entreprises</i>)
of Moolec issued a report on the contributions in kind relating to the contribution of the Original SAFEs prepared in accordance with
article&#160;420-10&#160;of the 1915 Law;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
Moolec Limited Shareholder ceased to be the beneficial holder of such Moolec Limited Ordinary Shares and subject to the submission of
all filings required under Law (including any filings required to pay stamp duties), Moolec was recorded as the registered holder of
all Moolec Limited Ordinary Shares so exchanged and transferred and is the legal and beneficial owner thereof;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">immediately
prior to the Merger Effective Time but after the Exchange Effective Time, each Moolec Limited SAFE Holder subscribed for, received and
became holder of Ordinary Shares, in accordance with the respective Moolec Limited SAFE, which included 262,260&#160;Ordinary Shares;
and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LightJump
caused the Certificate of Merger to be executed, acknowledged and filed with the Secretary of State of the State of Delaware in accordance
with the applicable provisions of the DGCL in order to effectuate the Merger. The Merger became effective on December&#160;30, 2022.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the Merger Effective Time, by virtue of the Merger and Moolec Requisite Approvals, subject to the Merger Auditor Report, and without
any further action on the part of LightJump, Merger Sub, Moolec or Moolec Limited or the holders thereunder:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
LightJump Common Stock issued and outstanding immediately prior to the Merger Effective Time, excluding those that had been redeemed
subject to any redemption rights, were exchanged with Moolec (which exchange, for purposes of the 1915 Law, included, for the avoidance
of doubt, a contribution-in-kind&#160;of each such shares of LightJump Common Stock from the holders of LightJump Common Stock to Moolec),
against the issue by Moolec of new Ordinary Shares (such issuance, the &#8220;Merger Issuance&#8221;), under the authorized share capital
of Moolec (pursuant to Moolec delegate merger resolutions) and subscribed by the contributing holders of LightJump Common Stock by virtue
of the Merger and in accordance with the 1915 Law for one validly issued and fully paid Ordinary Share, delivered by Moolec;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 10; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
a result of the Merger, all LightJump Common Stock ceased to be outstanding, was cancelled and ceased to exist;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
share of common stock, par value US$0.01, of Merger Sub issued and outstanding immediately prior to the Merger Effective Time was converted
and exchanged for one (1)&#160;validly issued, fully paid and nonassessable ordinary share, par value US$0.01 per share, of LightJump;
and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
LightJump Warrant that was outstanding immediately prior to the Merger Effective Time, pursuant to the LightJump Warrant Agreement, ceased
to represent a right to acquire one LightJump Common Stock and was converted in accordance with the terms of such LightJump Warrant Agreement,
at the Merger Effective Time, into a right to acquire one Ordinary Share on substantially the same terms as were in effect immediately
prior to the Merger Effective Time under the terms of the LightJump Warrant Agreement.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the Merger Effective Time:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moolec
Limited&#8217;s CFO was freely allotted the Key Staff Participation to satisfy the requirements under the Consulting Agreement dated
June 18, 2021, between Jose L&#243;pez Lecube and Moolec Limited.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the Business Combination Closing Date, on July&#160;8, 2022, LightJump held a special meeting of stockholders. At the meeting, LightJump&#8217;s
stockholders approved the Extension Amendment extending the date by which LightJump must consummate its initial business combination
from July&#160;12, 2022 to January&#160;12, 2023. Public stockholders of LightJump holding 11,032,790&#160;shares of LightJump Common
Stock exercised their right to redeem such shares for a&#160;<i>pro rata</i>&#160;portion of the funds in the Trust Account. As a result,
$110,507,220 (approximately US$10.02 per share) was removed from the Trust Account to pay such holders. Following redemptions, LightJump
had 2,767,210 public stockholders of LightJump Common Stock outstanding and the aggregate amount remaining in the Trust Account as of
September&#160;30, 2022 was $28,132,922 (which includes an additional US$276,721 contributed by the Sponsor in connection with the Extension).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the Business Combination Closing, on December&#160;27, 2022, in connection with the vote to approve the Business Combination Proposal
and the Adjournment Proposal at LightJump&#8217;s special meeting of stockholders, certain public holders of LightJump Common Stock exercised
their right to redeem 2,572,848&#160;shares of LightJump Common Stock for cash at a redemption price of approximately US$10.23 per share,
for an aggregate redemption amount of approximately US$26.3&#160;million. Accordingly, US$1,989,011 remained in the Trust Account, for
the benefit of Moolec, after considering the redemption amount to be paid to the redeeming public holders of LightJump Common Stock.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
pursuant to the Backstop Agreement, the Sponsor exercised the right to elect to concede Sponsor shares instead of contributing the requisite
cash amount under the Backstop Agreement by conceding a total of 200,276 Sponsor shares of LightJump Common Stock to each of UGVL and
Theo. UGVL and Theo each contributed US$4,005,520 to Moolec pursuant to the terms of the Backstop Agreement and in turn Moolec issued
400,552&#160;Ordinary Shares to each of UGVL and Theo.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
consummation of the Business Combination, Moolec Limited and LightJump became direct subsidiaries of Moolec.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRESENTATION
OF FINANCIAL AND OTHER INFORMATION</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moolec
Science SA, which we refer to in this annual report as &#8220;Moolec,&#8221; was incorporated on May 23, 2022 as a public limited liability
company (<i>societ&#233; anonyme</i>) governed by the laws of the Grand Duchy of Luxembourg. Moolec was formed in connection with the
Business Combination and to become the holding company of Moolec Science Limited, which we refer to in this annual report as &#8220;Moolec
Limited,&#8221; and Light Jump Acquisition Corporation. Until the closing of the Business Combination on December 30, 2022, Moolec had
not commenced its operations and had only nominal assets and liabilities and no material contingent liabilities or commitments. See &#8220;<i>Introductory
Note&#8212;The Business Combination.</i>&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
present in this annual report the audited consolidated financial statements of Moolec as of June 30, 2023 and 2022 and for the years
ended June 30, 2023 and 2022 and each of the periods from January 1, 2021 through June 30, 2021 and from August 21, 2020 through December
31, 2020 which were prepared in accordance with IFRS, as issued by the IASB.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The consolidated financial
information of Moolec contained in this annual report is derived from Moolec&#8217;s audited consolidated financial statements as of June
30, 2023 and 2022 and for the years ended June 30, 2023 and 2022 and each of the periods from January 1, 2021 through June 30, 2021 and
from August 21, 2020 through December 31, 2020, together with the notes thereto. All references herein to &#8220;our financial statements,&#8221;
&#8220;our audited consolidated financial information,&#8221; and &#8220;our audited consolidated financial statements&#8221; are to the
audited consolidated financial statements of Moolec included elsewhere in this annual report.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
financial information should be read in conjunction with &#8220;<i>Item 5. Operating and Financial Review and Prospects</i>&#8221; and
our audited consolidated financial statements, including the notes thereto, included elsewhere in this annual report.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
fiscal year ends on June 30<sup>th</sup>. References in this annual report to a fiscal year relate to our fiscal year ended June 30,
2023.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;1.
&#160;IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</b></span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_005"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
Directors and Senior Management</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_006"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
Advisors</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_007"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
Auditors</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_008"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;2.
OFFER STATISTICS AND EXPECTED TIMETABLE</b></span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_009"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
Offer Statistics</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_010"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
Method and Expected Timetable</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="a_011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;3. KEY INFORMATION</b></span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_012"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
 [RESERVED]</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_013"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
Capitalization and Indebtedness</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_014"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
Reasons for the Offer and Use of Proceeds</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_015"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.
Risk Factors</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following risk factors apply to our business and operations. The occurrence of one or more of the events or circumstances described in
these risk factors, alone or in combination with other events or circumstances, may have a material adverse effect on our business, projections,
cash flows, financial condition and results of operations. You should carefully consider the following risk factors in addition to the
other information included in this report, including matters addressed in the section titled &#8220;Cautionary Note Regarding Forward-Looking
statements.&#8221; We may face additional risks and uncertainties that are not presently known to us, or that we currently deem immaterial,
which may also impair our business or financial condition. </i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summary
Risk Factors</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should carefully consider all of the information in this annual report before making an investment in our ordinary shares. Below is a
summary of the principal risks and uncertainties we face, organized under relevant headings. These risks are discussed more fully below.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Relating to Our Business and Operations include:</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the following risks in respect of our business and our strategy:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
are an early-stage company with a history of losses and we may not achieve or maintain profitability;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
have a limited operating history, which makes it difficult to evaluate our current business and prospect and may increase the risk of
investment;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">price
increases and shortages of raw materials could adversely affect our results of operations;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
failure to accurately forecast and manage inventory could result in an unexpected shortfall or surplus of products which could harm our
business;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
expect that our future revenue depends on the success of our technologies, including our extrusion, fermentation, molecular farming and
other technologies, and we have limited data on the performance of such technologies to date. Accordingly, the development of our products
depends on assumptions we make in respect of the performance of such technologies, which are inherently uncertain;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
may face difficulty servicing our indebtedness, including the convertible note issued to Insud and the convertible note that we expect
to issue to Bioceres;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">conversion
of the convertible notes that we have issued and expect to issue would increase the number of ordinary shares and result in dilution
to shareholders;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
will likely require additional financing to achieve our goals, and failure to obtain necessary capital when needed on acceptable terms,
or at all, may force us to delay, limit, reduce or terminate our product manufacturing, development and other operations;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
may face difficulties implementing our inorganic growth strategy, including not identifying suitable targets and in respect of integrating
the operations of the business we have acquired or expect to acquire in the future;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
may acquire businesses or products, or form strategic alliances, in the future, and we may not realize the benefits of such acquisitions
or alliances;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
we fail to effectively utilize or expand our manufacturing and production capacity or commercialize or license our intellectual property,
our business and operating results and our brand reputation could be harmed;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
do not operate out of privately owned research facilities and our research capabilities are subject to lease and service agreements with
private companies and research universities;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
current operations could depend on third-party agreements for necessary supplies in order to develop and scale our production and increase
our stock of seed or raw materials required for our product development;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">currently,
we do not have a significant customer base for our molecular farming derived products, and our inability to expand such customer base
could negatively impact our sales and profitability;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
face significant competition and many of our competitors have substantially greater financial, technical and other resources than we
do;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
compete effectively, we must introduce existing and new products that achieve market acceptance and improve the output of our technology;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">collaboration
agreements we may seek to enter into with third parties may not be accomplished or successful;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
successful commercialization of our products depends significantly on our ability to produce high-quality products cost-effectively on
a large scale and to accurately forecast demand for our products. In addition, we also depend on regulatory approvals to successfully
market our products;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
products are subject to specific measures with regard to their maintenance in storage;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
successful commercialization of our products may face challenges from public perceptions of plant and strain engineered products (GMOs)
in addition to facing ethical, legal, environmental, health and social concerns;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">market
perception, consumer habits and preferences for our products are difficult to predict and may adversely affect our business;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">consumer
preferences for our products are difficult to predict and may change, and if we are unable to respond quickly to new trends, our business
may be adversely affected;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
business activities are currently conducted in a limited number of locations, which make us susceptible to damage or business disruptions
caused by natural disasters, climatic variations, disease or pests, or acts of vandalism, which could lower the expected yield and delay
the production and product candidates;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
our genetically engineered plants or strains do not express and produce a sufficient yield of an animal protein, or any animal protein
at all, we may not be able to market our products in a timely manner or successfully compete, or operate our business;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
we are unable to attract, train and retain employees, we may not be able to grow or successfully operate our business;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">food
safety and food-borne illness incidents or advertising or product mislabeling may materially and adversely affect our business by exposing
us to lawsuits, product recalls or regulatory enforcement actions, increasing our operating costs and reducing demand for our products;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
we are sued for defective products and if such lawsuits were determined adversely to us, we could be subject to substantial damages,
for which insurance coverage may not be available;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
brand has limited awareness among the general public;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
we fail to develop our technology or products and to develop our brand, our business prospects could adversely be affected;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
rely on information technology systems and any inadequacy, failure, interruption or security breaches of those systems may impair our
ability to operate our business effectively;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">disruptions
in the global economy, including high rates of inflation, the armed conflict in Israel and Palestine, Russia&#8217;s invasion of Ukraine
and the impact of pandemics, epidemics or disease outbreaks may adversely affect our business, results of operations and financial condition;
and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">economic
and political developments in Argentina, including regulations and restrictions, inflation and government controls may adversely affect
the economy and our financial condition and results of operations.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Relating to Our Industries</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the following risks in respect of our industries:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
overall agricultural, nutraceutical and food ingredient industries are susceptible to commodity price changes and we are exposed to market
risks from changes in commodity prices;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
are subject to industry-specific risks, which could adversely affect our operating results; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">climate
change and adverse weather conditions may negatively affect our business and operations.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Related to Our Intellectual Property</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the following risks in respect of our intellectual property rights:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">agreements
with our collaborators and third parties may not adequately prevent disclosure of trade secrets, know-how and other proprietary information,
which could materially adversely affect our technology and harm our business;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
and our customers depend on patents, copyrights, trademarks, know-how, trade secrets, and other forms of intellectual property protections,
but these protections may not be adequate;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">biotechnology
patents and patent applications involve highly complex legal and factual questions, which, if determined adversely to us, could negatively
impact our competitive position;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
will not seek to protect our intellectual property rights in all jurisdictions throughout the world and we may not be able to adequately
enforce our intellectual property rights even in the jurisdictions where we have sought protection;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
may be unsuccessful in developing, licensing or acquiring intellectual property rights that may be required to develop and commercialize
our future products; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
may infringe intellectual property unknowingly and unintentionally affecting our reputation and our future plans for our products and
competitiveness.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Relating to Laws and Regulation</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the following risks in respect of the relevant laws and regulation:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
regulatory environment in the United States for our current and potential future products is evolving and may change in the future, negatively
impacting the speed and cost to launch our potential future products;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
regulatory environment outside the United States varies greatly from jurisdiction to jurisdiction and there is less certainty how our
products will be regulated;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">government
policies and regulations, particularly those affecting the agricultural sector and related industries, could adversely affect our operations
and profitability;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
may use biological materials in our business and are subject to numerous environmental, health and safety laws and regulations. Compliance
with such laws and regulations and any claims relating to improper handling, storage or disposal of these materials could be time consuming
and costly;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax,
legislative or regulatory initiatives, new interpretations or developments concerning existing tax laws, or challenges to our tax positions
could adversely affect our results of operations and financial condition;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
are subject to governmental export and import controls that could impair our ability to compete in international markets and subject
us to liability if we are not in compliance with applicable laws;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
to comply with the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act 2010 and similar laws associated with our activities in other
jurisdictions could subject us to penalties and other adverse consequences;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
JOBS Act permits &#8220;emerging growth companies&#8221; like us to take advantage of certain exemptions from various reporting requirements
applicable to other public companies that are not emerging growth companies; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
are an early-stage multinational company, operating in several jurisdictions and we may omit any labor or civil registration law due
to lack of qualified personnel.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Relating to the Company</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the following risks in respect of our operating as a public company:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
will incur increased costs as a result of operating as a public company whose shares are listed on the Nasdaq, and its management will
devote substantial time to new compliance initiatives;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
management has limited experience in operating a public company;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
we became a publicly traded company by virtue of a Business Combination, as opposed to an underwritten initial public offering, the process
did not use the services of one or more underwriters which resulted in less diligence being conducted; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
resignation of Nomura as our exclusive financial advisor may indicate that it is unwilling to be associated with the disclosure in SEC
filings and the underlying business analysis related to the Business Combination.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
Risks Relating to Our Securities</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
shareholders are subject to the following risks:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales
of a substantial number of our securities in the public market by our existing securityholders, including the Key Shareholders, management
and Nomura (pursuant to the Nomura Purchase Agreement), could cause the price of our Ordinary Shares and warrants to decrease significantly;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">there
can be no assurance that we will be able to comply with the continued listing standards of the Nasdaq Global Select Market;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
price of our securities may be volatile, and their value may decline;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
warrants are exercisable for our Ordinary Shares, which will increase the number of shares eligible for future resale in the public market
and result in dilution to our shareholders;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
market for our securities may not continue, which would adversely affect the liquidity and price of its securities;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
securities or industry analysts cease publishing research or reports about us, our business, or our market, or if they change their recommendations
regarding Ordinary Shares adversely, then the price and trading volume of Ordinary Shares could decline; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
do not intend to pay dividends for the foreseeable future and, as a result, your ability to achieve a return on your investment will
depend on appreciation in the price of our Ordinary Shares.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Relating to Investment in a Luxembourg Company and Our Status as a Foreign Private Issuer</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
a &#8220;foreign private issuer,&#8221; we are exempt from a number of U.S. securities laws and rules promulgated thereunder and will
be permitted to publicly disclose less information than U.S. public companies must disclose. This may limit the information available
to holders of the Ordinary Shares;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
may lose our foreign private issuer status in the future, which could result in significant additional costs and expenses, and this would
subject us to GAAP reporting requirements which may be difficult for us to comply with;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
are organized under the laws of the Grand Duchy of Luxembourg and a substantial amount of our assets are not located in the United States,
and it may be difficult for you to obtain or enforce judgments or bring original actions against us or the members of our Board in the
United States;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Luxembourg
and European insolvency and bankruptcy laws are substantially different from U.S. insolvency and bankruptcy laws and may offer our shareholders
less protection than they would have under U.S. insolvency and bankruptcy laws;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
rights of our shareholders may differ from the rights they would have as shareholders of a United States corporation, which could adversely
impact trading in Ordinary Shares and our ability to conduct equity financings; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">non-Luxembourg
resident holders of Ordinary Shares could be subject to adverse income tax consequences in the Grand Duchy of Luxembourg.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Relating to U.S. Tax</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
believe we likely were a passive foreign investment company for U.S. federal income tax purposes for our taxable year ending June 30,
2023, and may be classified as a PFIC for our current taxable year or future taxable years which could subject U.S. holders of the Ordinary
Shares to adverse U.S. federal income tax consequences.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Related to Our Business and Operations</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
are an early-stage company with a history of losses and we may not achieve or maintain profitability. </b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
net losses for the year ended June 30, 2023 were US$51,788,880. As of June 30, 2023, we had an accumulated deficit of US$58,623,123.
We will need to generate significant revenues to achieve profitability, and we may not be able to achieve and maintain profitability
in the near future or at all. Our future success will depend, in part, on our ability to grow revenue associated with further R&amp;D,
production partnerships and direct sale to distributors and food producers. The net losses we incur may fluctuate significantly from
year-to-year such that a period-to-period comparison of our results of operations may not be a good indication of our future performance.
We cannot ensure that we will generate increased revenues, successfully commercialize products or generate revenue from licensing needed
to attain a level of profitable operations. Based on our history of losses we do not expect that we will be able to fund our longer-term
capital and liquidity needs through our cash balances and operating cash flow alone. Our current source of investment comes mainly from
our shareholders, BG Farming Technologies Ltd. and Union Group International Holdings Limited, and is related to our ability to obtain
third party funds. To fund our longer-term capital and liquidity needs, we expect we will need to secure additional capital. Our business
plan and financing needs are subject to change depending on, among other things, the success of our efforts to grow revenue and our efforts
to continue to effectively manage expenses.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
have a limited operating history, which makes it difficult to evaluate our current business and prospects and may increase the risk of
investment. </b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an early-stage food-technology company with a limited operating history that to date has been focused primarily on R&amp;D, conducting
scientific research to develop our products, field trials, pursuing initial commercialization efforts and building our management team.
Investment in food technology development is a highly speculative endeavor. It entails substantial upfront R&amp;D investment and there
is significant risk that we will not be able to insert the genes in a particular plant to express a desired trait, or, once modified,
we will not be able to replicate that trait across entire crops in order to commercialize the product candidate. Moreover, the regulatory
pathway for our product candidates can be uncertain and could add significant additional cost and time to development and may ultimately
be unsuccessful.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
limited operating history may make it difficult to evaluate our current business and our prospects. We have encountered, and will continue
to encounter, risks and difficulties frequently experienced by growing companies in rapidly developing and changing industries, including
challenges in forecasting accuracy, determining appropriate investments of our limited resources, gaining market acceptance of the products
made using our plant Molecular Farming, managing a complex regulatory landscape and developing new product candidates.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
respect to scientific research to develop our products, we may also face challenges in scaling our supply chain in a cost-effective manner,
as we will likely rely on contracting with third parties to bring our products to market. In addition, there is limited crushing and
processing capacity for our soybean-based and pea-based products which could restrict our ability to scale production of these products.
We may be required to adjust our current operating model in order to efficiently scale our operations. We may not be able to fully implement
or execute our business strategy or realize, in whole or in part within our expected time frames, the anticipated benefits of our growth
strategies.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price
increases and shortages of raw materials could adversely affect our results of operations.</b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
results of operations may be affected by the availability and pricing of raw materials, principally materials needed in our crushing
and ingredients development facility, such as soybean. Factors such as changes in the global or regional levels of supply and demand,
weather conditions, seasonal fluctuations, shortages or interruptions, changes in global climates and government regulations could substantially
impact the price of raw materials. To the extent we are unable to pass on increases in raw materials and energy prices to our customers,
a substantial increase in raw material prices or a continued interruption in supply could have a material adverse effect on our business,
financial condition and results of operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
failure to accurately forecast and manage inventory could result in an unexpected shortfall or surplus of products which could harm our
business.</b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are required to produce inventories of certain of our products (mainly seeds and biologicals) and we monitor our inventory levels based
on our own projections of future demand. Because of the significant time it takes to produce commercial quantities of seeds, production
decisions must be made well in advance of sales. An inaccurate forecast of demand for any seed variety can result in the unavailability
of seeds in high demand. Such unavailability may depress sales volumes and adversely affect customer relationships. Conversely, an inaccurate
forecast could also result in an over-supply of seeds which may increase costs, negatively impact cash flow, reduce the quality of inventory
and ultimately result in inventory write-offs, which could have a material adverse effect on our business, results of operations and
financial condition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
expect that our future revenue depends on the success of our technologies, including our extrusion, fermentation, molecular farming and
other technologies, and we have limited data on the performance of such technologies to date. Accordingly, the development of our products
depends on assumptions we make in respect of the performance of such technologies, which are inherently uncertain. </b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
for GLASO and SPC which are approved for cultivation and commercialization in certain jurisdictions, we do not currently have any products
or technologies approved for sale and we are still in the early stages of development. To date, we have limited data on the ability of
our technologies, which consist of developing a nuclear stable transformation of a crop to express an animal protein within the protein
bodies of the seed in order to produce a product consisting not only of the target protein but the plant protein as well, towards which
we have devoted substantial resources to date.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not be successful in developing our technologies in a manner sufficient to support our expected scale-ups and future growth, or at
all. We expect that a substantial portion of our efforts and expenditures over the next few years will be devoted to the development
of technologies designed to enable us to market industrial-scale manufacturing processes. We cannot guarantee that we will be successful
in developing these technologies on the timeline we expect, or at all, and we may not be able to achieve our anticipated growth, revenues
or profitability needed to continue our operations. If we are able to successfully develop our technologies, we cannot ensure that we
will obtain regulatory approval or that, following approval, upon commercialization our technologies will achieve market acceptance.
Any such delay or failure would materially and adversely affect our financial condition, results of operations and prospects. See &#8220;<i>Business&#8212;Products&#8212;Development
Timelines</i>.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may face difficulty servicing our indebtedness, including the convertible note issued to Insud and the convertible note that we expect
to issue to Bioceres.</b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to make scheduled payments of the principal of, to pay interest on, or to refinance our indebtedness depends on our future performance,
which is subject to many factors, including, economic, financial, competitive and other, beyond our control. We cannot assure you that
our business will generate sufficient cash flow from operations or that future borrowings will be available to us in an amount sufficient
to enable us to pay our indebtedness or to fund our other liquidity needs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may elect to make in-kind interest payments under the notes issued to Insud through its affiliate INVIM Corporativo S.L., and to be issued
to Bioceres, which will be capitalized, however, if we elect not to convert the notes the convertible notes into ordinary shares at maturity,
we will be required to pay the principal thereof in cash. Our ability to refinance the convertible notes will depend on the financial
markets and our financial condition at such time.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Conversion
of the convertible notes that we have issued and expect to issue would increase the number of ordinary shares and result in dilution
to shareholders.</b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 15, 2023, we issued to Insud an aggregate principal amount of US$10 million convertible notes, pursuant to a note purchase agreement
among us and Insud, the holders from time to time party thereto. In addition, on October 15, 2023, we entered into a binding memorandum
of understanding with Bioceres to issue a convertible note in an aggregate principal amount of equivalent to approximately 15,000 tons
of HB4&#174; soy option to upsize for an additional 15,000 tons.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
convertible notes we have issued to Insud and the convertible notes we expect to issue to Bioceres may be converted into our ordinary
shares. The issuance of a substantial number of additional ordinary shares upon conversion of the notes that we have issued and expect
to issue will result in dilution to the then existing holders of our ordinary shares and will increase the number of ordinary shares
in the public market. Sales of substantial numbers of such ordinary shares in the public market could adversely affect the market price
of our ordinary shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
will likely require additional financing to achieve our goals, and failure to obtain necessary capital when needed on acceptable terms,
or at all, may force us to delay, limit, reduce or terminate our product manufacturing, development and other operations.</b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that we will continue to expend substantial resources for the foreseeable future as we expand into additional markets we may
choose to pursue. These expenditures are expected to include costs associated with R&amp;D, the acquisition or expansion of manufacturing
and supply capabilities, as well as the marketing and selling of new products. In addition, other unanticipated costs may arise.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations may change because of factors that are currently unknown to us, and we may need to seek additional funds sooner than planned,
including through public equity or debt financings or other sources, such as the issuance of convertible notes or strategic collaborations.
Such financing may result in dilution to our existing shareholders, imposition of debt covenants and repayment obligations, or other
restrictions that may adversely affect our business. In addition, we may seek additional capital due to favorable market conditions or
strategic considerations even if we believe we have sufficient funds for our current or future operating plans.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future capital requirements depend on many factors, including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
number and characteristics of any additional products or manufacturing processes we develop or acquire to serve new or existing markets;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
expenses associated with our marketing initiatives;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">investment
in manufacturing to expand manufacturing and production capacity;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
costs required to fund domestic and international growth;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
scope, progress, results and costs of researching and developing future products or improvements to existing products or manufacturing
processes;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
lawsuits related to our products or team that may be commenced against us;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
expenses needed to attract and retain skilled personnel;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
costs associated with being a public company; and</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
timing, receipt and amount of sales of future products.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
funds may not be available when we need them, on terms that are acceptable to us, or at all. If adequate funds are not available on a
timely basis, we may be required to:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delay,
limit, reduce or terminate our manufacturing, research and development activities or growth and expansion plans; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delay,
limit, reduce or terminate the expansion of sales and marketing capabilities or other activities that may be necessary to generate revenue
and increase profitability.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may face difficulties implementing our inorganic growth strategy, including not identifying suitable targets and in respect of integrating
the operations of the business we have acquired or expect to acquire in the future. </b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, we may acquire businesses, assets, or securities of companies that we believe will provide a strategic fit with our business,
such as the ValoraSoy Acquisition. We integrate acquired businesses with our existing operations; our overall internal control over financial
reporting processes; and our financial, operations, and information systems. If the financial performance of our business, as supplemented
by the assets and businesses acquired, does not meet our expectations, our results of operations may fail to meet market expectations.
We may not effectively assimilate the business or product offerings of acquired companies into our business or within the anticipated
costs or timeframes. In addition, we may be unable to retain key customers and suppliers or key employees of acquired businesses, or
successfully implement our business plan for the combined business. Further, our final determinations and appraisals of the estimated
fair value of assets acquired and liabilities assumed in our acquisitions may vary materially from earlier estimates and we may fail
to realize fully anticipated cost savings, growth opportunities or other potential synergies. We cannot assure that the fair value of
acquired businesses or investments will remain constant.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
may acquire businesses or products, or form strategic alliances, in the future, and we may not realize the benefits of such acquisitions
or alliances. </b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
plan to selectively partner, in-license or acquire key enabling technologies and businesses across our value chain that we believe will
keep us on the cutting edge of our industry. We currently have one such licensing agreement with Arcadia Biosciences, Inc. for the commercialization
in the United States of GLA, which expires at the end of 2023 and which we expect to be extended for one year. However, we may not be
able to identify additional suitable targets or make acquisitions under satisfactory conditions, in particular on satisfactory price
conditions. In addition, we may be unable to obtain the financing for these acquisitions in the context of existing operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we acquire businesses within promising markets or which hold promising technologies, we may not be able to realize the benefit of acquiring
such businesses if we are unable to successfully integrate them with our existing operations and company culture. The integration process
of any newly acquired company may be complex, costly and time-consuming, and our failure to successfully complete this process could
have an adverse effect on our business, financial condition and operating results. The potential difficulties of integrating the operations
of an acquired business and realizing our expectations for an acquisition, including the benefits that may be realized, include, among
other things:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
of the business to perform as planned following the acquisition or achieve anticipated revenue or profitability targets;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays,
unexpected costs or difficulties in completing the integration of acquired companies or assets;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">higher
than expected costs, lower than expected cost savings or synergies and/or a need to allocate resources to manage unexpected operating
difficulties;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
assimilating the operations and personnel of acquired companies into our operations;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">diversion
of the attention and resources of management or other disruptions to current operations;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
impact on our or an acquired business&#8217; internal controls and compliance with legal requirements;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">retaining
key customers, suppliers and key personnel;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">retaining
and obtaining required regulatory approvals, licenses and permits;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">operating
risks inherent in the acquired business and our business;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">lower
than anticipated demand for product offerings by us or our licensees; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unanticipated
issues, expenses and liabilities.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may also encounter numerous difficulties in developing, manufacturing and marketing any new products resulting from a strategic alliance
or acquisition that delay or prevent us from realizing their expected benefits or enhancing our business. We cannot assure that, following
any such acquisition, we will achieve the expected synergies to justify the transaction, which could have a material adverse effect on
our business, financial conditions, earnings and prospects.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Completed
acquisitions may result in additional goodwill and/or an increase in other intangible assets on our balance sheet. We are required annually,
or if impairment indicators exist, to assess goodwill and other intangible assets to determine if impairment has occurred. If the testing
performed indicates that impairment has occurred, we are required to record a non-cash impairment charge for the difference between the
carrying value of the goodwill or other intangible assets and their recoverable amount in the period the determination is made. We cannot
accurately predict the amount and timing of any potential future impairment of assets. Should the value of goodwill or other intangible
assets become impaired, there could be a material adverse effect on our financial condition and results of operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
we fail to effectively utilize or expand our manufacturing and production capacity or the commercialize or license our intellectual property,
our business and operating results and our brand reputation could be harmed. </b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we do not have sufficient capacity to meet our customers&#8217; demands and to satisfy increased demand, we will need to expand our operations,
supply and manufacturing capabilities. However, there is risk in our ability to effectively scale production processes and effectively
manage our supply chain requirements. As we continue to scale our production, we must accurately forecast demand for our products in
order to ensure we have adequate available manufacturing capacity. We currently do not know what impact any current supply chain disruptions,
including but not limited to labor shortages, consumer demand, challenges related to Russia&#8217;s invasion of Ukraine, challenges related
to the conflict in Israel and Palestine, or export restrictions will have on our business. Our forecasts are based on multiple assumptions
which may cause our estimates to be inaccurate and affect our ability to obtain adequate manufacturing capacity (whether our own manufacturing
capacity or co-manufacturing capacity) in order to meet the demand for our products, which could prevent us from meeting increased customer
demand and harm our brand and our business and in some cases may result in penalties we must pay customers or distributors if we are
unable to fulfill orders placed by them in a timely manner or at all.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
if we overestimate our demand and overbuild our capacity, we may have significantly underutilized assets and may experience reduced margins.
If we do not accurately align our manufacturing capabilities with demand, if we experience disruptions or delays in our supply chain,
or if we cannot obtain raw materials of sufficient quantity and quality at reasonable prices and in a timely manner, our business, financial
condition and results of operations may be materially adversely affected.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"></p><div>

</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
do not operate out of privately owned research facilities and our research capabilities are subject to lease and service agreements with
private companies and research universities. </b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conduct our research by means of lease and service agreements and contracts with universities and private companies. We cannot guarantee
that these arrangements will be successful and yield the expected results, and that the engaged third parties will not make errors in
their research activities or breach their obligations to us.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
current operations could depend on third-party agreements for necessary supplies in order to develop and scale our production and increase
our stock of seed or raw materials required for our product development. </b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
our operations require an increase in the stock of our seeds and product development for our safflower platform, as well as R&amp;D of
soy and pea platforms since we have not yet reached the production stage. The seeds that we are developing in R&amp;D stages are the
primary raw materials necessary for the development of our portfolio. In addition, in the context of the convertible notes issued to
Insud, we will have access to Insud&#8217;s industrial processing facilities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our current operations require the use of chemical solvents, equipment, filters and other research materials in order to increase
our stock of viable seeds. The suppliers of these products manufacture their products at a limited number of facilities. A natural disaster,
fire, power interruption, work stoppage or other calamity affecting any of these facilities, or any interruption in their operations,
could negatively impact our ability to obtain required quantities of plant proteins in a timely manner, or at all, which could materially
reduce our net product sales and have a material adverse effect on our business and financial condition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
pursuant to a binding memorandum of understanding with Bioceres, we will pay for a premium in respect of HB4&#174; soy. We may not be
able to translate this cost relating to higher raw materials into end products, which would negatively impact our gross margins. Bioceres
may be affected by negative weather factors that may impact their capacity to deliver soy to us. If Bioceres is unable to deliver soy
to us pursuant to the soy purchase agreement, that could negatively impact our cash position. See &#8220;<i>Item 4. Information on the
Company&#8212;A. History and Development of the Company&#8212;Recent Developments.</i>&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Currently,
we do not have a significant customer base for our molecular farming derived products, and our inability to expand such customer base
could negatively impact our sales and profitability. </b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
customers do not perceive our product offerings to be of sufficient value, quality or innovation, or if we fail to offer innovative and
relevant product offerings, and if we fail to develop a suitable pricing strategy, we may not be able to attract customers to purchase
our products. We are focused on using animal DNA within plants to create animal proteins within the plants themselves. This is a technology
that has not been widely introduced to the market and will require sufficient education to show the difference between our technology
and other science-based food ingredients. In addition, our products could face difficulties in some jurisdictions due to regulatory requirements.
If producers face challenges in adopting our products, if we are unable to adequately educate our customers and develop commercial relationships
while emphasizing the difference in our technology, our sales and profitability may be negatively impacted.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
face significant competition and many of our competitors have substantially greater financial, technical and other resources than we
do. </b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
science-based food ingredient market is highly competitive, and we face significant direct and indirect competition in several aspects
of our business. Our main competitors are Motif FoodWorks, Impossible Foods Inc., Givaudan Group, International Flavors &amp; Fragrances,
Nobell Foods, Kyomei, DSM and Hansen, among others. Mergers and acquisitions in the plant science, specialty food ingredient and agricultural
biotechnology, and seed industries may result in even more resources being concentrated among a smaller number of our competitors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Most
of these competitors have substantially greater financial, technical, marketing, sales, distribution, supply chain infrastructure, larger
R&amp;D staff, more experienced marketing, manufacturing, and supply chain organizations and more well-established sales forces than
we do. As a result, we may be unable to compete successfully against our current or future competitors, which may result in price reductions,
reduced margins and the inability to achieve market acceptance for our products. We expect to continue to face significant competition
in the markets in which we intend to commercialize our products.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"></p><div>

</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
of our competitors engage in ongoing R&amp;D, and technological developments by our competitors could render our products less competitive
or obsolete, resulting in reduced sales compared to our expectations. Our ability to compete effectively and to achieve commercial success
depends, in part, on our ability to: control manufacturing and marketing costs; effectively price and market our products; successfully
develop an effective marketing program and an efficient supply chain; develop new products with properties which are attractive to customers;
and commercialize our products quickly without incurring significant regulatory costs. We may not be successful in achieving these factors
and any such failure may adversely affect our business, results of operations and financial condition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also anticipate increased competition in the future as new companies enter the market and new technologies become available, particularly
in the area of Molecular Farming, gene editing, fermentation (synthetic biology) and vertical farming. Our technology may be rendered
obsolete or uneconomical by technological advances or entirely different approaches developed by one or more of our competitors that
are more effective or that enable our competitors to develop and commercialize products more quickly or with lower expense than we are
able to. If for any reason our technology becomes obsolete or uneconomical relative to our competitors&#8217; technologies, this would
threaten or limit our ability to generate revenues from the commercialization of our products.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>To
compete effectively, we must introduce existing and new products that achieve market acceptance and improve the output of our technology.
</b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to become competitive and generate revenue, we must introduce new products from our pipeline of product candidates and prove that
our technology is economically feasible and accepted. If we fail to anticipate or respond to technological developments, market requirements,
or consumer preferences, or if we incur significant delays in developing and introducing products, we may not be able to generate revenue.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Development
of successful agricultural products using plant engineering and precision fermentation technologies requires significant levels of investment
in R&amp;D, including laboratory, greenhouse and field testing, to demonstrate product effectiveness and can take several years or more.
We must commit significant resources and may incur obligations (such as royalty obligations or milestone fees) to develop new products
before knowing whether our investments will result in products the market will accept and without knowing the levels of revenue, if any,
that may be derived from these products.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Development
of new or improved agricultural products involve risks of failure inherent in the development of products based on innovative and complex
technologies. These risks include the possibility that:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            may face challenges to scale up seed inventories, such as climate events impacting seed multiplication
                                            ramp up curves and higher than estimated industrial costs;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">farmers
                                            may choose to not adopt our seeds;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            products may not perform as expected in the field;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            products may not receive necessary regulatory permits and governmental clearances in the
                                            markets in which we intend to sell them;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            seed processing and production may not have the expected results;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">consumer
                                            preferences, which are unpredictable and can vary greatly, may change quickly, making our
                                            products no longer desirable;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            competitors may develop new products that taste better or have other more appealing characteristics
                                            than our products;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            products may be viewed as too expensive by our customers as compared to competitive products;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            products may be difficult to produce on a large scale or may not be economical to grow;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 23; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">intellectual
                                            property and other proprietary rights of third parties may prevent us or our collaborators
                                            from marketing and selling our products;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            may be unable to patent or otherwise obtain intellectual property protection for our discoveries
                                            in the necessary jurisdictions;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
                                            or our collaborators may be unable to fully develop or commercialize products in a timely
                                            manner or at all;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">third
                                            parties may develop superior or equivalent products; and</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.3in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">natural
                                            and climate risks may impact our business.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
if we experience any significant delays in the development or introduction of new products or if our new products do not achieve market
acceptance, our business, operating results and financial condition would be adversely affected. See &#8220;<i>Business &#8212; Products
&#8212; Development Timelines</i>.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Collaboration
agreements we may seek to enter into with third parties may not be accomplished or successful. </b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may seek to enter into collaboration arrangements with third parties for the development or commercialization of our products. We will
face, to the extent that we decide to enter collaboration arrangements, significant competition in seeking appropriate partners. Moreover,
collaboration arrangements are complex and time-consuming to negotiate, document, implement and maintain. We may not be successful in
our efforts to establish and implement collaboration or other alternative arrangements should we so chose to enter such arrangements.
The terms of any collaborations or other arrangements that we may establish may not be favorable to us. Any collaboration/marketing/wholesale/research
agreements that we may enter into in the future may not be successful, which could adversely affect our ability to develop and commercialize
our product candidates.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
successful commercialization of our products significantly depends mainly on our ability to produce high-quality products cost-effectively
on a large scale and to accurately forecast demand for our products. In addition, we also depend on regulatory approvals to successfully
market our products. </b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
production of commercial-scale quantities of seeds and products requires the multiplication of the plants or seeds through a succession
of plantings and seed harvests. The cost-effective production of high-quality, high-volume quantities of any product candidates we successfully
develop depends on our ability to scale our production processes to produce plants and seeds in enough quantity to meet demand. We cannot
assure that our existing or future seed production techniques will enable us to meet our large-scale production goals cost-effectively.
Even if we are successful in developing ways to minimize yield drag and enhance quality, we may not be able to do so cost-effectively
or on a timely basis, which could adversely affect our ability to achieve profitability. If we are unable to maintain or enhance the
quality of our plants and seeds as we increase our production capacity, including through the expected use of third parties to have access
to industrial availability for processing and purification, we may experience reductions in customer or farmer demand, higher costs and
increased inventory write-offs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, because of the length of time it takes to produce commercial quantities of marketable seeds, we will need to make seed production
decisions well in advance of product sales. The process that we may use to concentrate and isolate proteins is based on technologies
currently being used in the industry. We have access to a pilot plant where the wet-concentration process for protein recovery is being
validated. Our ability to accurately forecast supply can be adversely affected by several factors outside of our control, including unexpected
challenges in the process, changes in market conditions, environmental factors, such as pests and diseases, and adverse weather conditions.
A shortfall in the supply of our products may reduce product revenue, damage our reputation in the market and adversely affect relationships.
Any product surplus we have on hand may negatively impact cash flows, reduce the quality of our inventory and ultimately result in write-offs
of inventory. While we estimate that the potential size of our target markets for our products is significant, that estimate has not
been independently verified and is based on certain assumptions that may not prove to be accurate. Our ability to accurately forecast
demand is dependent on the timing of customer decisions, qualification cycles, and other factors outside of our control. As a result,
these estimates could differ materially from actual market sizes, which could result in decreased demand for our products and therefore
adversely impact our future business prospects, results of operation and financial condition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"></p><div>

</div><!-- Field: Page; Sequence: 24; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
products are subject to specific measures with regard to their maintenance in storage. </b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
products are subject to specific measures with regard to their maintenance in storage. The final product is stored in sealed plastic
bags to prevent changes in moisture that can lead to the acceleration of oxidation, formation of lumps, alterations of the characteristics
of the product. Sealed bags also prevent the powder from any contact with insects or odors, and delay oxidation. The temperature should
be kept below a specific temperature to prevent microbial growth and oxidation. Direct sunlight in the storage environment should be
avoided. Brown paper bags with a plastic layer inside are advised since they prevent the isolates from light. A change in any of these
conditions may affect the shelf life and the properties of the product significantly, which may consequently adversely affect our business.
See the section titled &#8220;<i>Business &#8212; Products</i>.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
successful commercialization of our products may face challenges from public perceptions of plant and strain engineered products (GMOs)
in addition to facing ethical, legal, environmental, health and social concerns. </b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
successful commercialization of our products depends, in part, on public acceptance of Molecular Farming/bio-engineered, and/or molecular
biology-derived products. The majority of our products are GMOs and negative social perception about GMOs or our technology may negatively
impact our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consumers
may not understand the nature of our technologies, which consist of the nuclear stable transformation of a crop or microorganism to express
an animal protein within the protein bodies of the seed or microorganism for the product to consist in an ingredient containing not only
the engineered protein but the plant or host protein as well. Consumers may also not understand the scientific distinction between our
molecular farming products and other plant-based protein or science-based food ingredients products. As a result, they may transfer negative
perceptions and attitudes regarding our products. A lack of understanding of our technologies may also make consumers more susceptible
to the influence of negative information provided by opponents of biotechnology. Some opponents of biotechnology actively seek to raise
public concern about gene editing or GMOs by claiming that plant or yeast products developed using biotechnology are unsafe for consumption
or their use poses a risk of causing damage to the environment, or creates legal, social and ethical dilemmas. The commercial success
of our products may be adversely affected by such claims, even if unsubstantiated. In addition, opponents of biotechnology have vandalized
the farmers&#8217; fields where biotech seeds were planted and facilities used by biotechnology companies. Any such acts of vandalism
targeting the fields of our farmers, our field-testing sites or our research, production or other facilities, could adversely affect
our sales and our costs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Negative
public perception about molecular farming and GMO products in general can also affect the regulatory environment in the jurisdictions
in which we target the sale of our products and the commercialization of our product candidates. Any increase in such negative perception
or any restrictive government regulations in response thereto, could have a negative effect on our business and may delay or impair the
sale of our products or the development or commercialization of our product candidates. Even in light of compliance with regulatory protocols
or following receipt of confirmation of non-regulated status in a jurisdiction, public pressure may lead to increased regulation of products
produced using biotechnology, further legislation regarding novel trait development technologies, or administrative litigation concerning
prior regulatory determinations, each of which could adversely affect our ability to sell our product or commercialize our product candidates.
In addition, labeling requirements could heighten public concerns and make consumers less likely to purchase food products containing
plant bioengineered/molecular farming and fermented ingredients.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
perception, habits and preferences for our products are difficult to predict and may adversely affect our business. </b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are currently many competitors in the plant-based protein market, however we expect that our products will be among the first to integrate
animal-proteins into plants. We expect to be the first to produce and commercialize an ingredient containing functional bovine and plant
proteins coming from a single source for the food market. There is a risk that our products will not be as in demand as more traditional
plant-based proteins or lab grown meat. A change in preferences for our products could reduce our sales or our market share and could
harm our business and financial condition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"></p><div>

</div><!-- Field: Page; Sequence: 25; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Consumer
preferences for our products are difficult to predict and may change, and if we are unable to respond quickly to new trends, our business
may be adversely affected. </b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is focused on the development, manufacturing, marketing, and distribution of science-based food ingredients which include animal
proteins produced using animal-free ingredients. Consumer demand could change based on a number of factors, including dietary habits
and nutritional values, concerns regarding the health effects of ingredients, and shifts in preference for various product attributes.
If consumer demand for our products decreases, our business and financial condition would suffer. In addition, sales of science-based
ingredients are subject to evolving consumer preferences to which we may not be able to accurately predict or respond. Consumer trends
that we believe favor sales of our products could change based on a number of possible factors, including economic factors and social
trends a more sustainable and healthy approach. Views towards healthy eating and plant-based products are trendy in nature, with constantly
changing consumer perceptions, however utilizing animal-proteins within plants has not been introduced into the market.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success will depend, in part, on our ability to anticipate the tastes and dietary habits of consumers and other consumer trends and to
offer products that appeal to their needs and preferences on a timely and affordable basis. A change in consumer discretionary spending,
due to economic downturn or other reasons, may also adversely affect our sales and business, financial condition and results of operations.
A significant shift in consumer demand away from our products could reduce sales or market share and the perception of our brand, which
would harm our business and financial condition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
business activities are currently conducted in a limited number of locations, which make us susceptible to damage or business disruptions
caused by natural disasters, climatic variations, disease or pests, or acts of vandalism, which could lower the expected yield and delay
the production and product candidates.</b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conduct our activities in geographic regions that are subject to climate disasters or other natural disasters that could negatively affect
our business and the development and increase of our operations. Natural disasters, such as hurricanes, droughts, fires, floods, tornados,
earthquakes, diseases or pests, or intentional or negligent acts, including acts of vandalism, could damage or destroy our equipment,
inventory, development projects, field trials or data, and could cause us to incur significant additional expenses to repair or replace
the damaged physical facilities, which in the case of seed production may be the result of years of development work that is not easily
or quickly reproduced, and increase the time required to development schedule for our pipeline of product candidates. If our early testing
of pipeline products is unsuccessful, we may be unable to complete the development of product candidates on a timely basis or at all.
Additionally, field trials, which may take years to be concluded, are costly, and any field trial failures that we may experience may
not be covered by insurance and, therefore, could result in increased costs, which may negatively impact our business and results of
operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we rely on early testing and research, including laboratory research, greenhouse activities and field trials, to demonstrate
the efficacy of product candidates that we develop and evaluate. Field trials allow us to test product candidates in the field as well
as to increase seed production, and to measure performance across multiple geographies and conditions. Successful completion of early
testing is critical to the success of our product development and scale-up efforts. Field trials for event selection and field trials
for gathering regulatory information are expected to begin in 2024 in the United States and Argentina. If our ongoing or future testing
is unsuccessful or produces inconsistent results or unanticipated adverse effects on the agronomic performance of our crops, or if the
testing does not produce reliable data, our product development efforts could be delayed, subject to additional regulatory review or
abandoned entirely. Further, in order to support our commercialization efforts, it is necessary to collect data across multiple growing
seasons and from different geographies. Even in cases where initial field trials are successful, we cannot be certain that additional
field trials conducted on a greater number of acres or in different geographies will also be successful.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
our genetically engineered plants or strains do not express and produce a sufficient yield of an animal protein, or any animal protein
at all, we may not be able to market our products in a timely manner or successfully compete, or operate our business. </b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely heavily on research and development of our products. Our molecular farming technology involves introducing DNA within a plant genome
in order to express animal proteins within the plant without using any animal products. This process requires significant research and
testing in order to have a product that produces a sufficient amount of the animal protein in order to be commercially viable. If the
tests of our products do not yield a sufficient amount of the animal protein within the plant, we may be required to begin the research
and development process anew for certain products or spend a significant amount of time and resources in order to achieve the targeted
outcome.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"></p><div>

</div><!-- Field: Page; Sequence: 26; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
research and testing to produce the expected result of animal protein yields within our molecular farmed plants can also be affected
by laboratory conditions, adverse climate conditions during planting and harvesting, or other conditions whereby the expected yield of
animal proteins within the plant are not what we would expect. Such conditions may delay our ability to take our products to market or
require additional time within our research and development stage in order to prepare a viable product. Such delays may have an adverse
effect on our business and operations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
we are unable to attract, train and retain employees, we may not be able to grow or successfully operate our business. </b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success depends in part on our ability to attract, train and retain a sufficient number of employees who understand and appreciate our
culture and business model, and can effectively represent our brand and establish credibility with potential business partners and customers.
The ability, expertise, motivation, judgment and discretion of our employees, including our technical team, are key for the development
of our business. In addition, our ability to manage our anticipated growth depends on our ability to recruit and retain qualified personnel
prepared to face major challenges with regard to technology and innovation. Our ability to retain our employees is influenced by the
economic environment and the fact that our operations are spread in different locations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Food
safety and food-borne illness incidents or advertising or product mislabeling may materially and adversely affect our business by exposing
us to lawsuits, product recalls or regulatory enforcement actions, increasing our operating costs and reducing demand for our products.
</b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
food for human consumption involves inherent legal and other risks, and there is increasing governmental scrutiny of and public awareness
regarding food safety. Unexpected side effects, illness, injury or death related to allergens, food-borne illnesses or other food safety
incidents caused by products we sell, or involving our suppliers, could result in the discontinuance of sales of these products or our
relationships with such suppliers, or otherwise result in increased operating costs, regulatory enforcement actions or harm to our reputation.
Shipment of adulterated or misbranded products, even if inadvertent, can result in criminal or civil liability. Such incidents could
also expose us to product liability and negligence claims or other lawsuits, including consumer class action lawsuits. Any claims brought
against us may exceed or be outside the scope of our future insurance policy coverage or limits. Any judgment against us that is more
than our policy limits or not covered by our policies or not subject to insurance would have to be paid from our cash reserves, which
would reduce our capital resources.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">The occurrence of food-borne
illnesses or other food safety incidents could also adversely affect the price and availability of affected ingredients, resulting in
higher costs, disruptions in supply and a reduction in our sales. Furthermore, any instances of food contamination or regulatory noncompliance,
whether or not caused by our actions, could compel us, our suppliers, our distributors or our customers, depending on the circumstances,
to conduct a recall in accordance with FDA regulations, and comparable state laws. Food recalls could result in significant losses due
to their costs, the destruction of product inventory, lost sales due to the unavailability of the product for a period of time and potential
loss of existing distributors or customers and a potential negative impact on our ability to attract new customers due to negative consumer
experiences or because of an adverse impact on our brand and reputation. The costs of a recall could exceed or be outside the scope of
our future insurance policy coverage or limits.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, food companies have been subject to targeted, large-scale tampering as well as to opportunistic, individual product tampering,
and we, like any food company, could be a target for product tampering. Forms of tampering could include the introduction of foreign
material, chemical contaminants and pathological organisms into consumer products as well as product substitution. Recently issued FDA
regulations will require companies like us to analyze, prepare and implement mitigation strategies specifically to address tampering
designed to inflict widespread public health harm. If we do not adequately address the possibility, or any actual instance, of product
tampering, we could face possible seizure or recall of our products and the imposition of civil or criminal sanctions, which could materially
adversely affect our business, financial condition and operating results.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"></p><div>

</div><!-- Field: Page; Sequence: 27; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
we are sued for defective products and if such lawsuits were determined adversely to us, we could be subject to substantial damages,
for which insurance coverage may not be available. </b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be held liable if any product we develop, or any product that uses or incorporates any of our technologies, is found unsuitable during
marketing, sale or consumption. For example, the detection of an unintended trait in a commercial seed variety or the crops and products
produced may result in governmental actions such as mandated crop destruction, product recalls or environmental cleanup or monitoring.
The costs of implementing these remedies could exceed or be outside the scope of our existing or future insurance policies. Concerns
about seed quality could also lead to additional regulations being imposed on our business, such as regulations related to testing procedures,
mandatory governmental reviews of biotechnology advances, or additional regulations relating to the integrity of the food supply chain
from the farm to the finished product.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Our
brand has limited awareness among the general public. </b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not conducted a dedicated and significant marketing campaign to educate consumers on our brand and it still has limited awareness
among the general public.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will need to dedicate significant resources in order to effectively plan, coordinate, and execute a marketing campaign and to add additional
sales and marketing staff. Substantial advertising and promotional expenditures may be required to improve our brand&#8217;s market position
or to introduce new products to the market. However, an increase in our marketing and advertising efforts may not enhance our reputation
or lead to an increase in brand awareness.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
we compete against other large, well-capitalized food ingredient companies who have significantly more resources than we do. Therefore,
we may have limited success, or none at all, in increasing awareness and reputation of our brand.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>If
we fail to develop our technology or products and to develop our brand, our business prospects could adversely be affected. </b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe our future growth could be affected by the perception of our brand and its value. Maintaining, promoting and positioning our
brand and its reputation will depend on, among other factors, the success of our science-based technology for the development of food
ingredients, food safety, quality assurance, marketing efforts, and our ability to provide a consistent, high-quality customer experience.
Any negative publicity, regardless of its accuracy, could adversely affect our business. Brand value is based on perceptions of subjective
qualities, and any incident that erodes the loyalty of customers or suppliers, including adverse publicity, product recall or a governmental
investigation or litigation, could significantly reduce the value of our brand and significantly damage our business, financial condition
and results of operation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
rely on information technology systems and any inadequacy, failure, interruption or security breaches of those systems may impair our
ability to operate our business effectively. </b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are increasingly dependent upon third-party information technology systems to operate our business. These systems may contain confidential
information (including personal data, trade secrets or other intellectual property, or proprietary business information). The nature
of digital systems, both internally and externally, makes them potentially vulnerable to disruption or damage from human error and/or
security breaches, which include, but are not limited to, ransomware, data theft, denial of service attacks, sabotage, industrial espionage,
and computer viruses. Such events may be difficult to detect, and once detected, their impact may be difficult to assess and address.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the information technology systems we use may be vulnerable to damage or interruption from circumstances beyond our control,
including fire, natural disasters, power outages, systems failures and viruses. If we are unable to execute our disaster recovery plans
or if our plans prove insufficient for a particular situation or take longer than expected to implement in a crisis situation, it could
have a material adverse effect on our business, financial condition and results of operations, and our business interruption insurance
may not adequately compensate us for losses that may occur.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also subject to numerous laws and regulations designed to protect personal data, such as the European national laws implementing
the General Data Protection Regulation as well as the UK General Data Protection Regulation. These data protection laws introduced more
stringent data protection requirements and significant potential fines, as well as increased our responsibility and potential liability
in relation to personal data that we process. We have put mechanisms in place to ensure compliance with applicable data protection laws
but there can be no guarantee of their effectiveness.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"></p><div>

</div><!-- Field: Page; Sequence: 28; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Disruptions in the global economy, including
high rates of inflation, the armed conflict in Israel and Palestine, Russia&#8217;s invasion of Ukraine and the impact of pandemics, epidemics
or disease outbreaks may adversely affect our business, results of operations and financial condition. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The global economy has been
negatively impacted by a variety of factors such as global high rates of inflation, economic crises including recessions and uncertainty
regarding protracted U.S. federal debt ceiling negotiations, actual or threatened war, terrorist activity, political unrest, civil strife,
the spread or fear of spread of contagious diseases (such as the recent COVID-19 pandemic) in locations where our products are sold, man-made
or natural disasters, and other geopolitical uncertainty. These economic conditions can arise suddenly and the full impact of such conditions
can be difficult to predict. As a result, we may experience price volatility and increases and supply disruptions, among other consequences.
In addition, geopolitical and domestic political developments, such as existing and potential trade wars and other events beyond our control,
such as the armed conflict in Israel and Palestine, in addition to the Ukraine, and a possible escalation of such conflicts or contagion
to neighboring regions, can increase levels of political and economic unpredictability globally and increase the volatility of global
financial markets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, our Argentine
operations could be affected by any general business restrictions imposed by the government due to its political and economic instability.
These adverse and uncertain economic conditions may impact distributor, retailer, foodservice and consumer demand for our products. In
addition, our ability to manage normal commercial relationships with our suppliers, distributors, customers and consumers and creditors
may suffer. Consumers may shift purchases to lower-priced or other perceived value offerings during economic downturns as a result of
various factors, including job losses, inflation, higher taxes, reduced access to credit, change in federal economic policy and international
trade disputes. A decrease in consumer discretionary spending may also result in consumers reducing the frequency and amount spent on
plant-based food. Distributors and customers may become more conservative in response to these conditions and seek to reduce their inventories.
Our results of operations depend upon, among other things, our ability to maintain and increase sales volume with our existing and future
customers and our ability to attract new consumers, the financial condition of consumers and our ability to provide products that appeal
to consumers at the right price. Decreases in demand for products without a corresponding decrease in costs would put downward pressure
on margins and would negatively impact our financial results. Prolonged unfavorable economic conditions or uncertainty may adversely affect
our sales and profitability and may result in consumers making changes to their discretionary spending behavior on a more long-lasting
or even permanent basis.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Economic and political developments
in Argentina, including regulations and restrictions, inflation and government controls may adversely affect the economy and our financial
condition and results of operations</b>.</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Presidential and federal
congressional elections in Argentina will be held in November 2023, and their impact on the future economic and political environment
is uncertain. No assurances can be made as to the policies that may be implemented by a new Argentine administration, or that political
developments in Argentina will not adversely affect the Argentine economy or our business, financial condition or results of operations.
In addition, we cannot assure you that future economic, regulatory, social and political developments in Argentina will not impair our
business, financial condition or results of operations, or cause the market value of our shares to decline.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In recent years, Argentina
has confronted inflationary pressures, including the depreciation of the Argentine Peso, evidenced by significantly higher fuel, energy,
and food prices, among other factors. Further, the Argentine government increased its direct intervention in the economy, including through
the implementation of regulation of market conditions, expropriations or nationalizations and price controls. Therefore, the inflation
rate in Argentina and the government&#8217;s intervention in the economy may adversely affect our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Further, according to data
published by the Argentine National Institute of Statistics and Census (<i>Instituto Nacional de Estad&#237;stica y Censos</i>), the
Consumer Price Index increased 80.2% from January through August 2023, 94.8% in 2022, 50.9% in 2021, 36.1% in 2020, 53.8% in 2019, 47.6%
in 2018 and 24.8% in 2017. If inflation remains high or continues to rise towards a hyperinflation, Argentina&#8217;s economy will continue
to be negatively impacted, and our results of operations could be materially adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 29; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Risks Related to Our Industries</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The overall agricultural, nutraceutical
and food ingredient industries are susceptible to commodity price changes and we are exposed to market risks from changes in commodity
prices. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Conditions in the United
States agricultural industry and the Argentine agricultural industry significantly impact our operating results. Changes in the prices
of commodities could result in higher overall cost along the agricultural and commercial supply chains, which may negatively affect our
ability to commercialize our products. We are susceptible to changes in costs in the agricultural industry as a result of factors beyond
our control, such as general economic conditions, seasonal fluctuations, weather conditions, demand, food safety concerns, product recalls
and government regulations. As a result, we may not be able to anticipate or react to changing costs by adjusting our practices, which
could cause our operating results to deteriorate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>We are subject to industry-specific
risks, which could adversely affect our operating results. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are subject to industry-specific
risks which include, but are not limited to, product safety and quality, launch of new products by other industries that can replace the
functionalities of our production; shifting consumer preferences, federal, state, and local regulations on manufacturing or labeling;
socially acceptable and sustainable farming practices; environmental, health, and safety regulations; and customer product liability claims.
The liability which could result from certain of these risks may not always be covered by, or could exceed the liability cap of, our insurance
for product liability and food safety matters. In addition, we may be unable to procure insurance on commercially reasonable terms or
may decide not to seek insurance for certain risks. Risks to our reputation may exist due to potential negative publicity caused by product
liability, food safety, occupational health and safety, workforce diversity, and environmental matters.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our products are used as
ingredients in food production. We are subject to risks associated with economic, product quality, food safety or other factors inherent
to the food industry, which may adversely affect us. In addition, as we increase our investment in flavors and ingredients businesses,
we are exposed to increased risks related to rapidly changing consumer preferences and the impacts these changes could have on the success
of certain of our customers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Climate change and adverse weather conditions
may negatively affect our business and operations. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The ability to grow our
products may be negatively affected by adverse weather conditions, including windstorms, floods, drought and extreme temperature, which
may be influenced and intensified by carbon dioxide and other greenhouse gases in the atmosphere. Unfavorable growing conditions and natural
disasters can reduce both crop size and crop quality, and in extreme cases may cause us to lose entire harvests in some geographic areas.
If such weather conditions and climate change negatively affects agricultural productivity, we may be subject to decreased availability
or less favorable pricing for certain commodities that are necessary for our products, such as our soy and pea plants, among others. Due
to climate change, we may also be subjected to decreased availability of water, deteriorated quality of water or less favorable pricing
for water, which could adversely impact manufacturing operations. In addition, the ability to grow our products may be negatively affected
by adverse weather conditions, including windstorms, floods, drought and extreme temperatures.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 30; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Risks Related to Our Intellectual Property</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Agreements with our collaborators and
third parties may not adequately prevent disclosure of trade secrets, know-how and other proprietary information, which could materially
adversely affect our technology and harm our business. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We rely on a combination
of intellectual property laws and agreements with our collaborators and third parties to protect and otherwise seek to control access
to, and distribution of, our proprietary information. These measures may not be sufficient to prevent disclosure, infringement, or misappropriation
of our confidential information. Our confidentiality and nondisclosure agreements or covenants may not be enforceable under applicable
law and, even if they are enforceable, may be breached, and we may not have adequate remedies for such a breach that would effectively
prevent the further dissemination of our confidential information. We also have limited control over the protection of trade secrets used
by our collaborators and could lose future trade secret protection if any unauthorized disclosure of such information occurs. Enforcement
of any claim that a party illegally disclosed confidential information or misappropriated a trade secret is difficult, expensive, and
time-consuming, and the outcome is unpredictable. In addition, others may independently discover our trade secrets and proprietary information,
and in such cases, we may not be able to assert any trade secret rights against such parties. Laws regarding trade secret rights in certain
markets where we operate may afford little or no protection of our trade secrets. If any of our trade secrets were to be disclosed to
or independently developed by a competitor (for example, by reverse engineering), or if we otherwise were to lose protection for our trade
secrets or proprietary know-how, the value of this information may be greatly reduced, and our business could be adversely impacted.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>We and our customers depend on patents,
copyrights, trademarks, know-how, trade secrets, and other forms of intellectual property protections, but these protections may not be
adequate. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We rely on a combination
of know-how, trade secrets, patents, copyrights, trademarks, and other intellectual property laws, nondisclosure and other contractual
arrangements, and technical measures to protect many of our products, services and intangible assets. These rights are important to our
ongoing operations. There can be no assurance that these protections will provide unique or meaningful competitive advantage in our offerings
or otherwise be commercially valuable. In addition, we may not be successful in obtaining additional intellectual property or enforcing
our intellectual property rights against unauthorized users. Our exclusive rights under certain of our products and services are protected
by patents, and when patents covering a product or service expire, loss of exclusivity may occur, which may force us to compete with third
parties, thereby negatively affecting our revenue and profitability.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our proprietary rights may
be invalidated, circumvented, or challenged. We may in the future be subject to proceedings seeking to oppose or limit the scope of our
patent applications or issued patents. In addition, in the future, we may need to take legal actions to enforce our intellectual property
rights, to protect our trade secrets, or to determine the validity or scope of the proprietary rights of others. Legal proceedings are
inherently uncertain, and the outcome of such proceedings may be unfavorable to us. Any legal action regardless of outcome might result
in substantial costs and diversion of resources and management attention. Although we use reasonable efforts to protect our proprietary
and confidential information, there can be no assurance that our confidentiality and non-disclosure agreements will not be breached, our
trade secrets will not otherwise become known by competitors, or that we will have adequate remedies in the event of unauthorized use
or disclosure of proprietary information. Even if the validity and enforceability of our intellectual property is upheld, an adjudicator
might construe our intellectual property not to cover the alleged infringement. In addition, intellectual property enforcement may be
unavailable or practically ineffective in some countries. There can be no assurance that our competitors will not independently develop
technologies that are substantially equivalent or superior to our technology or that third parties will not design around our intellectual
property claims to produce competitive offerings. The use of our technology or similar technology by others could reduce or eliminate
any competitive advantage we have developed, cause us to lose sales, or otherwise harm our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For example, Impossible
Foods filed a lawsuit against Motif FoodWorks, claiming that it infringed on at least one of Impossible Foods&#8217; patents and, subsequently,
Motif FoodWorks filed an administrative claim challenging certain of Impossible Foods&#8217; products. Although this proceeding is still
ongoing, similar cases can be brought against other parties that rely heavily on intellectual property rights within the science-based
food ingredients landscape, including us. While we are not party to such suits at this time, we may become subject to such litigation
in the future. Such cases could also adversely impact public perception and the demand for science-based food ingredients products, which
could subsequently result in decreased demand for our products and adversely affect our business and operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 31; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have patents granted
and patent applications, as owner or as licensee, in the United States, China, India, Canada, Germany, Spain, France, United Kingdom,
Brazil, Mexico, Australia, New Zealand, Japan, Hong Kong, Malaysia, and Argentina and trademarks and service marks in the United States,
Europe, Canada, the United Kingdom and Argentina, some of which have been registered or issued, and also claim common law rights in various
trademarks and service marks. There can be no assurance that third parties will not oppose our future applications to register intellectual
property. It is possible that in some cases we may be unable to obtain the registrations for trademarks, service marks, and patents for
which we have applied, and a failure to obtain trademark and patent registrations in the United States, the United Kingdom, the European
Union, and Argentina or other countries could limit our ability to protect our trademarks and proprietary technologies and our marketing
efforts in those jurisdictions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">License agreements with
third parties limit our rights to use certain patents, software, and information technology systems and proprietary technologies owned
by third parties, some of which are important to our business. Termination of these license agreements, for any reason, could result in
the loss of our rights to this intellectual property, causing an adverse change in our operations or the inability to commercialize certain
offerings.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Biotechnology patents and patent applications
involve highly complex legal and factual questions, which, if determined adversely to us, could negatively impact our competitive position.
</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The patent positions of
biotechnology companies and other actors in our fields of business can be highly uncertain and involve complex scientific, legal and factual
analyses. The interpretation and breadth of claims allowed in some patents covering biological compositions may be uncertain and difficult
to determine and are often affected materially by the facts and circumstances that pertain to the patented compositions and the related
patent claims. The issuance and scope of patents cannot be predicted with certainty. Patents, if issued, may be challenged, invalidated,
narrowed or circumvented. Challenges to our or our licensors&#8217; patents and patent applications, if successful, may result in the
denial of our or our licensors&#8217; patent applications or the loss or reduction in their scope. In addition, defending against such
challenges may be costly and involve the diversion of significant management time and our resources. Accordingly, rights under any of
our patents may not provide us with enough protection against competitive products or processes and any loss, denial or reduction in scope
of any of such patents and patent applications may have a material adverse effect on our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>We will not seek to protect our intellectual
property rights in all jurisdictions throughout the world and we may not be able to adequately enforce our intellectual property rights
even in the jurisdictions where we have sought protection. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our commercial success depends,
in part, on our ability to recognize intellectual property rights and protect our trade secrets for the technologies that we develop and
use. However, filing, prosecuting and defending patents in all countries and jurisdictions throughout the world would be prohibitively
expensive. Patent prosecution must be sought on a country-by-country basis, which is an expensive and time-consuming process with uncertain
outcomes. Our intellectual property rights in some countries outside the United States could be less extensive than those in the United
States, assuming that rights are obtained in the United States. In addition, the laws of some foreign countries do not protect intellectual
property rights to the same extent as federal and state laws in the United States. Consequently, we may not be able to prevent third parties
from using our inventions in countries outside the United States, or from selling or importing products made using our inventions in and
into the United States or other jurisdictions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Competitors may use our
technologies in jurisdictions where we or our licensors do not pursue and obtain patent protection. Further, competition may export products
that would otherwise infringe upon our intellectual property rights to territories where we or our licensors have patent protection, but
where the ability to enforce those patent rights is not as strong as in the United States. These products may compete with our products
and our intellectual property rights and such rights may not prevent such competition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, changes in,
or different interpretations of, patent laws in the United States and other countries may permit others to use our discoveries or to develop
and commercialize our technology and products without providing any notice or compensation to us or may limit the scope of patent protection
that we or our licensors are able to obtain. The laws of certain countries do not protect intellectual property rights to the same extent
as United States laws and those countries may lack adequate rules and procedures for defending our intellectual property rights.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 32; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Furthermore, proceedings
to enforce our patent rights and other intellectual property rights around the world could result in substantial costs and divert our
efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly,
could put our or our licensors&#8217; patent applications at risk of not issuing and could provoke third parties to assert claims against
us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded to us, if any, may not be commercially
meaningful, while the damages and other remedies we may be ordered to pay such third parties may be significant. Accordingly, our efforts
to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual
property that we develop or license.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, there is a
possibility that our technologies may be viewed by competitors as an infringement on their intellectual property rights, even in a case
where we believe they do not. This may lead to litigation that could create a significant cost for us and negatively impact our business
and operations as well as our public perception and goodwill.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>We may be unsuccessful in developing,
licensing or acquiring intellectual property rights that may be required to develop and commercialize our future products. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our programs may involve
additional product candidates that may require the use of intellectual property or proprietary rights held by third parties and the growth
of our business may depend in part on our ability to acquire, license or use these intellectual property and proprietary rights.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">However, we may be unable
to acquire or license any third-party intellectual property or proprietary rights that may be key to development. Even if we can acquire
or license such rights, we may be unable to do so on commercially reasonable terms. The licensing and acquisition of third-party intellectual
property and proprietary rights is highly competitive, and several more established companies are also pursuing strategies to license
or acquire third-party intellectual property and proprietary rights that we may consider attractive or necessary. These established companies
may have a competitive advantage over us due to their size, capital resources and agricultural development and commercialization capabilities.
We may also not be able to bypass or achieve &#8220;freedom to operate&#8221; status for the products in our pipeline to avoid liability
to third parties.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, companies that
perceive us to be a competitor may be unwilling to assign or license intellectual property and proprietary rights to us. We also may be
unable to license or acquire third-party intellectual property and proprietary rights on terms that would allow us to make an appropriate
return on our investment or at all. If a program, product or product candidate requires us to acquire or license third-party intellectual
property and proprietary rights or maintain our existing intellectual property and proprietary rights, and we are unable to do so, we
may have to cease development of such program, product or product candidate, which could have a material adverse effect on our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>We may infringe intellectual property
unknowingly and unintentionally affect our reputation and our future plans for our products and competitiveness.</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As the agricultural biotech
industry continues to develop, we, our collaborators or licensees may become party to, or be threatened with, litigation or other proceedings
regarding intellectual property or proprietary rights in our technology and processes. Third parties may assert claims based on existing
or future intellectual property rights and the outcome of any proceedings is subject to uncertainties that cannot be adequately quantified
in advance. Any litigation proceedings could be costly and time consuming. A negative outcome from an intellectual property infringement
suit could result in liability for monetary damages, require us to indemnify our licensees for damages arising from warranties we have
made in respect of the intellectual property rights we have licensed, which claims might not be subject to a cap, or treble damages and
attorneys&#8217; fees if we are found to have willfully infringed a patent. There is also no guarantee that we, our collaborators or licensees
would be able to obtain a license under such infringed intellectual property rights on commercially reasonable terms or at all. A finding
of infringement could prevent us, our collaborators or our licensees from developing, marketing or selling a product or force us to cease
some or all of our business operations. Even if we are successful in these proceedings, we may incur substantial costs and the time and
attention of our management and scientific personnel may be diverted as a result of these proceedings, which could have a material adverse
effect on our operations. In some cases, our agreements with our collaborators or licensees might oblige us to pay for the enforcement
of our licensed intellectual property rights, even though our collaborators or licensees may be responsible for commercializing the potentially
infringing products. Claims that we have misappropriated the confidential information or trade secrets of third parties could similarly
have a negative impact on our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 33; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Risks Relating to Laws and Regulation</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The regulatory environment in the United
States for our current and potential future products is evolving and may change in the future, negatively impacting the speed and cost
to launch our potential future products. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Changes in applicable regulatory
requirements could result in a substantial increase in the time and costs associated with developing our products and negatively impact
our operating results. While the USDA and FDA currently have petition processes that we have initiated, these processes and the manner
in which the USDA and FDA interpret their regulations may change in the future, negatively impacting the speed and cost with which we
launch our potential future products. We cannot predict whether advocacy groups will challenge existing regulations and USDA or FDA determinations
or whether the USDA or FDA will alter the manner in which it interprets its own regulations or institutes new regulations, or otherwise
modify regulations in a way that will subject our products to more burdensome standards, thereby substantially increasing the time and
costs associated with developing our product candidates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The regulatory environment outside the
United States varies greatly from jurisdiction to jurisdiction and there is less certainty how our products will be regulated. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The regulatory environment
around gene editing in plants, particularly in our case which includes the addition of animal-proteins without the use of animals, to
create food ingredients is greatly uncertain outside of the United States and varies greatly from jurisdiction to jurisdiction. Each jurisdiction
may have its own regulatory framework regarding genetically modified foods, which may include restrictions and regulations on planting
and growing genetically modified plants and in the consumption and labeling of genetically modified foods, and which may encapsulate our
products. To the extent regulatory frameworks outside of the United States are not receptive to our gene-editing technologies, this may
limit our ability to expand into other global markets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Complying with the regulatory
requirements outside the United States will be costly and time-consuming, and there is no guarantee we will be able to commercialize our
products in other jurisdictions apart from the United States and Argentina.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We cannot predict whether
or when any jurisdiction will change its regulations with respect to our products. Advocacy groups have engaged in publicity campaigns
and filed lawsuits in various countries against companies and regulatory agencies, seeking to halt regulatory approval or clearance activities
or influence public opinion against GMO products. In addition, governmental reaction to negative publicity concerning our products could
result in greater regulation of genetic research and derivative products or regulatory costs that render our products cost prohibitive.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The scale of the commodity
food and agricultural industry may make it difficult to monitor and control the distribution of our products. As a result, our products
may be sold inadvertently within jurisdictions where they are not approved for distribution. Such sales may lead to regulatory challenges
or lawsuits against us, which could result in significant expenses and management attention.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Government policies and regulations,
particularly those affecting the agricultural sector and related industries, could adversely affect our operations and profitability.
</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Agricultural production
and trade flows are subject to government policies and regulations. Governmental policies and approvals of technologies affecting the
agricultural industry, such as taxes, tariffs, duties, subsidies, incentives and import and export restrictions on agricultural commodities
and commodity products can influence the planting of certain crops, the location and size of crop production, and the volume and types
of imports and exports. In addition, as we grow our business, we may be required to secure additional permits and licenses. Finally, future
government policies in the United States or in other countries may discourage our customers from using our products or encourage the use
of products that are more advantageous to our competitors, which would put us at a commercial disadvantage and could negatively impact
our future revenues and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 34; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>We may use biological materials in our
business and are subject to numerous environmental, health and safety laws and regulations. Compliance with such laws and regulations
and any claims relating to improper handling, storage or disposal of these materials could be time consuming and costly. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are subject to numerous
federal, state, local and foreign environmental, health and safety laws and regulations, including those governing laboratory procedures,
the handling, use, storage, treatment, manufacture and disposal of hazardous materials and wastes, discharge of pollutants into the environment
and human health and safety matters. Our R&amp;D processes involve the controlled use of hazardous materials, including biological materials.
We may be sued for any injury or contamination that results from our use or the use by third parties of these materials, or may otherwise
be required to remediate such contamination, and our liability may exceed any insurance coverage and our total assets. Compliance with
environmental, health and safety laws and regulations may be expensive and may impair our R&amp;D efforts. If we fail to comply with these
requirements, we could incur substantial costs and liabilities, including civil or criminal fines and penalties, clean-up costs or capital
expenditures for control equipment or operational changes necessary to achieve and maintain compliance. In addition, we cannot predict
the impact on our business of new or amended environmental, health and safety laws or regulations or any changes in the way existing and
future laws and regulations are interpreted and enforced. These existing or future laws and regulations may impair our research, development
or production efforts or result in increased expense of compliance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Tax, legislative or regulatory initiatives,
new interpretations or developments concerning existing tax laws, or challenges to our tax positions could adversely affect our results
of operations and financial condition. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We currently have limited
operations; however, we have relationships with multiple jurisdictions throughout the world including the United Kingdom, the Grand Duchy
of Luxembourg, the United States, Argentina and the Netherlands. As such, we are subject to the tax laws and regulations of various jurisdictions,
including U.S. federal, state, and local governments and could be potentially subject to additional tax laws and regulations in additional
jurisdictions. From time to time, various legislative initiatives may be proposed that could adversely affect our tax positions, and existing
legislation, such as the 2017 U.S. Tax Cuts and Jobs Act, may be subject to additional regulatory changes or new interpretations. There
can be no assurance that our effective tax rate or tax payments will not be adversely affected by these initiatives.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, the tax laws
of several of the countries in which we operate, including Argentinian and U.S. federal, state and local tax laws and regulations, are
extremely complex and subject to varying interpretations. It is possible that the outcomes from examinations or interpretations by taxing
authorities or changes in laws, rules, regulations, or interpretations by taxing authorities could have a material adverse effect on our
financial condition or results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>We are subject to governmental export
and import controls that could impair our ability to compete in international markets and subject us to liability if we are not in compliance
with applicable laws. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our products are subject
to Export Control Laws and Import Control Laws and regulations of the jurisdictions in which we operate. Exports of our products must
be made in compliance with these laws and regulations. If we fail to comply with these laws and regulations, we and certain of our employees
could be subject to substantial civil or criminal penalties, including the possible loss of export or import privileges; fines, which
may be imposed on us and responsible employees or managers; and, in extreme cases, the incarceration of responsible employees or managers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, changes in
our products or changes in applicable export or import laws and regulations may create delays in the introduction, provision, or sale
of our products in international markets, prevent customers from using our products or, in some cases, prevent the export or import of
our products to certain countries, governments or persons altogether. Any limitation on our ability to export, provide, or sell our products
could adversely affect our business, financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 35; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Failure to comply with the U.S. Foreign
Corrupt Practices Act, the U.K. Bribery Act 2010 and similar laws associated with our activities in other jurisdictions could subject
us to penalties and other adverse consequences. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As we expect a substantial
portion of our future revenue to come from jurisdictions other than the United States, we face significant risks if we fail to comply
with the U.S. Foreign Corrupt Practices Act (&#8220;FCPA&#8221;), the U.K. Bribery Act 2010 (the &#8220;Bribery Act&#8221;) and other
laws that prohibit improper payments or offers of payment to governments and their officials and political parties by us and other business
entities for the purpose of obtaining or retaining business. In many countries, particularly in countries with developing economies, it
may be a local custom that businesses operating in such countries engage in business practices that are prohibited by the FCPA, the Bribery
Act or other laws and regulations. Although we have implemented company policy requiring employees and consultants to comply with the
FCPA, the Bribery Act and similar laws, such policy may not be effective at preventing all potential FCPA, Bribery Act or other violations.
In addition, we cannot guarantee the compliance by our partners, resellers, suppliers and agents with applicable laws, including the FCPA
and the Bribery Act. Therefore, there can be no assurance that none of our employees or agents will take actions in violation of our policies
or of applicable laws, for which we may be ultimately held responsible. Any violation of the FCPA or the Bribery Act and related policies
could result in severe criminal or civil sanctions, which could have a material and adverse effect on our reputation, business, financial
condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The JOBS Act permits &#8220;emerging
growth companies&#8221; like us to take advantage of certain exemptions from various reporting requirements applicable to other public
companies that are not emerging growth companies. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We currently qualify as
an &#8220;emerging growth company&#8221; as defined in Section 2(a)(19) of the Securities Act, as modified by the Jumpstart Our Business
Startups Act of 2012, which we refer to as the &#8220;JOBS Act.&#8221; As such, we take advantage of certain exemptions from various reporting
requirements applicable to other public companies that are not emerging growth companies for as long as we continue to be an emerging
growth company, including the exemption from the auditor attestation requirements with respect to internal control over financial reporting
under Section 404 of the Sarbanes-Oxley Act. As a result, our shareholders may not have access to certain information they deem important.
We expect to remain an emerging growth company for the foreseeable future. If we cease to be an &#8220;emerging growth company,&#8221;
as such term is defined in the JOBS Act, our independent registered public accounting firm must attest to and report on the effectiveness
of our internal control over financial reporting on an annual basis.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We cannot predict if investors
will find Ordinary Shares less attractive because we rely on these exemptions. If some investors find Ordinary Shares less attractive
as a result, there may be a less active trading market and share price for Ordinary Shares may be more volatile. When we no longer qualify
as an emerging growth company, we may incur increased legal, accounting and compliance costs associated with Section 404 of the Sarbanes-Oxley
Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>We are an early-stage multinational
company, operating in several jurisdictions and we may omit any labor or civil registration law due to lack of qualified personnel.</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As we are an early-stage
developing company operating in several jurisdictions, we may have difficulties facing compliance, including with respect to labor and
other regulatory matters in these jurisdictions, due to not having qualified personnel to address such issue.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 36; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Risks Relating to the Company</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>We will incur increased costs as a result
of operating as a public company whose shares are listed on the Nasdaq, and its management will devote substantial time to new compliance
initiatives. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We expect to incur significant
legal, accounting and other expenses that we did not incur as a private company, and these expenses may increase even more after we are
no longer an emerging growth company, as defined in Section 2(a) of the Securities Act. As a public company, we are subject to the reporting
requirements of the Exchange Act, the Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, as well as rules
adopted, and to be adopted, by the SEC and Nasdaq. Our management and other personnel will need to devote a substantial amount of time
to these compliance initiatives. Moreover, we expect these rules and regulations to substantially increase our legal and financial compliance
costs and to make some activities more time consuming and costly. The increased costs may increase our net loss. For example, these rules
and regulations could make it more difficult and more expensive for us to obtain director and officer liability insurance and as a result,
we may be forced to accept reduced policy limits or incur substantially higher costs to maintain the same or similar coverage. We cannot
predict or estimate the amount or timing of additional costs it may incur to respond to these requirements. The impact of these requirements
could also make it more difficult for us to attract and retain qualified persons to serve on our Board or as executive officers. Furthermore,
due to the increase in our shareholders base, costs related to shareholders&#8217; communication will increase as a result of the listing
of our shares on Nasdaq.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our management has limited experience
in operating a public company. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our executive officers have
limited experience in the management of a publicly traded company. Our management team may not successfully or effectively manage our
transition to a public company that will be subject to significant regulatory oversight and reporting obligations under federal securities
laws. Their limited experience in dealing with the increasingly complex laws pertaining to public companies could be a significant disadvantage
in that it is likely that an increasing amount of their time may be devoted to these activities which will result in less time being devoted
to our management and our growth. We may not have adequate personnel with the appropriate level of knowledge, experience, and training
in the accounting policies, practices or internal controls over financial reporting required of public companies in the United States.
The development and implementation of the standards and controls necessary for us to achieve the level of accounting standards required
of a public company in the United States may require costs greater than expected. It is likely that we will be required to expand our
employee base and hire additional employees to support our operations as a public company, which will increase our operating costs in
future periods.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>As we became a publicly traded company
by virtue of a Business Combination, as opposed to an underwritten initial public offering, the process did not use the services of one
or more underwriters which resulted in less diligence being conducted. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In an underwritten initial
public offering, underwriters typically conduct diligence on the company being taken public in order to establish a due diligence defense
against liability claims under federal securities laws. Because LightJump was already a publicly traded company, an underwriter was not
engaged in connection with the Business Combination. The Sponsor had an inherent conflict as their equity interests in LightJump were
worthless absent a business combination. While private investors and management in a business combination undertook a certain level of
due diligence, it was not necessarily the same level of due diligence undertaken by an underwriter in a traditional initial public offering
and, therefore, there could be a heightened risk of an incorrect valuation of the business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The resignation of Nomura as our exclusive
financial advisor may indicate that it is unwilling to be associated with the disclosure in SEC filings and the underlying business analysis
related to the Business Combination. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On June 29, 2022, Nomura
resigned from its role as our exclusive financial advisor, effective as of April 27, 2022, and waived its entitlement to the payment of
any fees or expense reimbursements. On March 30, 2022, prior to the resignation of Nomura, the SPAC Rule Proposals relating to, among
other items, disclosures in SEC filings and the treatment of investment banks in connection with business combination transactions involving
special purpose acquisition companies. The uncertainty related to the treatment of investment banks following the SPAC Rule Proposals
was the reason Nomura gave for its resignation. Nomura did not have a role in the negotiation of any materials related to or arising out
of the Business Combination and had no role in any subsequent preparation of the disclosure in SEC filings. Neither Moolec Science Ltd.
nor LightJump (our predecessor entities) relied on Nomura in the preparation and analysis of materials related to the Business Combination.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 37; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We note that Nomura was
provided with the disclosures in SEC filings pertaining to its roles and resignation, however we did not receive a response from Nomura
whether they agree with either the risks or the conclusions stated therein that are associated with its role and resignation. While Nomura
did not provide any additional detail in its resignation letters either to Moolec or to the SEC, such resignation may be an indication
by Nomura that it does not want to be associated with the disclosure in SEC filings, including any discussion related to reasons for its
withdrawal, or the underlying business analysis related to the Business Combination. Shareholders and investors should not place any reliance
on the fact that Nomura has been previously involved with the Business Combination solely as it was engaged as the exclusive financial
advisor to Moolec.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additional Risks Relating to Our Securities</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Sales of a substantial number of our
securities in the public market by our existing securityholders, including the Key Shareholders, management and Nomura (pursuant to the
Nomura Purchase Agreement), could cause the price of our Ordinary Shares and warrants to decrease significantly. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Sales of a substantial number
of Ordinary Shares in the public market by our existing securityholders, including the Key Shareholders, management, and Nomura pursuant
to the Nomura Purchase Agreement, or the perception that those sales might occur, could depress the market price of our Ordinary Shares
and warrants and could impair our ability to raise capital through the sale of additional equity securities. We are unable to predict
the effect that such sales may have on the prevailing market price of our Ordinary Shares and warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Certain Key Shareholders
acquired the Ordinary Shares at prices ranging from US$0.00 per share to US$7.63 per share, and the Sponsor acquired the Private Warrants
for a purchase price of US$1.00 per warrant. By comparison, the offering price to public shareholders in the SPAC&#8217;s initial public
offering was US$10.00 per unit, which consisted of one share and one-half of one warrant. Accordingly, certain Key Shareholders may realize
a positive rate of return on the sale of their shares even if the market price of Ordinary Share is below $10.00 per share. For example,
based on the closing price of our Ordinary Shares as of March 30, 2023, which was US$4.08, (i) BG Farming Technologies Limited may experience
a weighted average profit of US$3.92 per share, or approximately US$57.1 million in the aggregate for selling the 14,570,000 Ordinary
Shares it received, (ii) the UGVL may experience profit of US$3.66 per share, or approximately US$55.6 million in the aggregate for selling
the 15,170,828 Ordinary Shares it received, (iii) the Sponsor may experience a weighted average profit of US$4.08 per share, or approximately
US$7.8 million in the aggregate for selling the 1,902,767 Ordinary Shares it received and a loss of approximately US$35.4 million in the
aggregate for selling the 4,210,000 Ordinary Shares underlying Private Warrants if exercised at US$11.50 per share, (iv) Bioceres Crop
Solutions Corp. may experience a weighted average profit of US$2.47 per share, or approximately US$4.6 million in the aggregate for selling
the 1,860,000 Ordinary Shares it received, (v) Serenity Traders Limited may experience a weighted average loss of US$3.55 per share, or
approximately US$0.2 million in the aggregate for selling the 65,565 Ordinary Shares it received, (vi) UG Holdings, LLC may experience
a weighted average profit of US$4.08 per share, or approximately US$4.2 million in the aggregate for selling the 1,035,000 Ordinary Shares
it received, (vii) EarlyBird may experience a weighted average profit of US$2.18 per share, or approximately US$0.4 million in the aggregate
for selling the 184,079 Ordinary Shares it received, (viii) Company&#8217;s Chief Financial Officer may experience a weighted average
profit of US$4.08 per share, or approximately US$0.9 million in the aggregate for selling the 232,523 Ordinary Shares it received, and
(ix) Theo may experience a weighted average loss of US$2.82 per share, or approximately US$2.3 million in the aggregate for selling the
797,523 Ordinary Shares it received.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>There can be no assurance that we will
be able to comply with the continued listing standards of the Nasdaq Global Select Market.</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our Ordinary Shares are
currently listed on Nasdaq. Our continued eligibility for listing may depend on, among other things, the amount of &#8220;public float&#8221;
(equity held by non-affiliates). If Nasdaq delists our Ordinary Shares from trading on its exchange for failure to meet the listing standards,
our shareholders could face significant material adverse consequences including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">a
limited availability of market quotation for our Ordinary Shares;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">reduced
liquidity and inability to sell our Ordinary Shares;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">a
determination that our Ordinary Shares are a &#8220;penny stock&#8221; which will require brokers trading in our Ordinary Shares to adhere
to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our Ordinary Shares;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">a
limited amount of news and analyst coverage; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">a
decreased ability to issue additional Ordinary Shares or obtain additional financing in the future.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 38; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
National Securities Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the
sale of certain securities, which are referred to as &#8220;covered securities&#8221;. Because our ordinary shares are listed on Nasdaq
or another national securities exchange, they are covered securities. If our securities were no longer listed on Nasdaq, they would not
be covered securities and we would be subject to regulation in each state in which we offer securities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>The
price of our securities may be volatile, and their value may decline. </b></span></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">We
cannot predict the prices at which our securities, which include our Ordinary Shares and warrants, will trade. The market price of our
securities may fluctuate substantially and may be lower than the current market price. In addition, the trading price of our securities
is likely to be volatile and could be subject to fluctuations in response to various factors, some of which are beyond our control. These
fluctuations could cause you to lose all or part of your investment in our securities as you might be unable to sell your securities
at or above the price you paid. Factors that could cause fluctuations in the trading price of our securities include the following:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">actual
or anticipated fluctuations in our financial condition or results of operations;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">variance
in our financial performance from expectations of securities analysts;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">changes
in the pricing of our solutions;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">changes
in our projected operating and financial results;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">changes
in laws or regulations applicable to our business;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">announcements
by us or our competitors of significant business developments, acquisitions or new offerings;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">our
involvement in litigation;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">conditions
or developments affecting the science-based food ingredients industry;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">future
sales of our securities by us or our shareholders, as well as the anticipation of lock-up releases;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">changes
in senior management or key personnel;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the
trading volume of securities;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">changes
in the anticipated future size and growth rate of our markets;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">sales
and short-selling of our securities;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">publication
of research reports or news stories about us, our competitors or our industry, or positive or negative recommendations or withdrawal
of research coverage by securities analysts;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">general
economic and market conditions; and</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">other
events or factors, including those resulting from war (including the armed conflict in Israel and Palestine and ongoing war between Russia
and U</span>kraine), incidents of terrorism, global pandemics or responses to these events.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Broad market and industry
fluctuations, as well as general economic, political, regulatory and market conditions, may also negatively impact the market price of
our securities. In addition, technology stocks have historically experienced high levels of volatility. In the past, companies who have
experienced volatility in the market price of their securities have been subject to securities class action litigation. We may be the
target of this type of litigation in the future, which could result in substantial expenses and divert our management&#8217;s attention.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 39; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our warrants are exercisable for our
Ordinary Shares, which will increase the number of shares eligible for future resale in the public market and result in dilution to our
shareholders. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our warrants to purchase
an aggregate of 11,110,000 Ordinary Shares are exercisable in accordance with the terms of the Warrant Amendment governing those securities.
The exercise price of these warrants is US$11.50 per share. To the extent such warrants are exercised, additional Ordinary Shares will
be issued, which will result in dilution to the holders of our Ordinary Share and increase the number of shares eligible for resale in
the public market. Sales of substantial numbers of such shares in the public market or the fact that such warrants may be exercised could
adversely affect the market price of our Ordinary Shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Assuming the exercise of
all outstanding warrants for cash, we would receive aggregate proceeds of approximately US$127,765,000. However, we will only receive
such proceeds if all Warrant holders fully exercise their warrants. The exercise price of our warrants is US$11.50 per share, subject
to customary adjustment. We believe that the likelihood that warrant holders determine to exercise their warrants, and therefore the amount
of cash proceeds that we would receive, is dependent upon the market price of our Ordinary Shares. If the market price for our Ordinary
Shares is less than the exercise price of the warrants (on a per share basis), we believe that warrant holders will be very unlikely to
exercise any of their warrants, and accordingly, we will not receive any such proceeds. There is no assurance that the warrants will be
&#8220;in the money&#8221; prior to their expiration or that the warrant holders will exercise their warrants. As of October 30, 2023,
the closing price of our Ordinary Shares was US$2.80 per share. Warrant holders may exercise the warrants on a cashless basis at our option
in accordance with the Warrant Amendment. To the extent that any warrants are exercised on a cashless basis, the amount of cash we would
receive from the exercise of the warrants will decrease.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>A market for our securities may not
continue, which would adversely affect the liquidity and price of its securities. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The price of our securities
may fluctuate significantly due to the market&#8217;s reaction to general market and economic conditions. An active trading market for
our securities may never develop or, if developed, it may not be sustained. In addition, the price of our securities can vary due to general
economic conditions and forecasts, our general business condition and the release of our financial reports. Additionally, if our securities
are delisted from, Nasdaq for any reason, and are quoted on the OTC Bulletin Board, an inter-dealer automated quotation system for equity
securities that is not a national securities exchange, the liquidity and price of our securities may be more limited than if it were quoted
or listed on Nasdaq or another national securities exchange. You may be unable to sell your securities unless a market can be established
or sustained.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>If securities or industry analysts cease
publishing research or reports about us, our business, or our market, or if they change their recommendations regarding Ordinary Shares
adversely, then the price and trading volume of Ordinary Shares could decline. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The trading market for the
Ordinary Shares is influenced by the research and reports that industry or securities analysts may publish about us, our business, our
market, or our competitors. There is currently one publication that covers us. However, if no securities or industry analysts further
cover us, the price and trading volume of our ordinary shares would likely be negatively impacted. If any of the analysts who cover us
change their recommendation regarding our Ordinary Shares adversely, or provide more favorable relative recommendations about our competitors,
the price of the Ordinary Shares would likely decline. If any analyst who formerly covered LightJump were to cease coverage of us or fail
to regularly publish reports on us, we could lose visibility in the financial markets, which could cause Ordinary Share price or trading
volume to decline.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>We do not intend to pay dividends for
the foreseeable future and, as a result, your ability to achieve a return on your investment will depend on appreciation in the price
of our Ordinary Shares. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We do not intend to pay
any cash dividends in the foreseeable future, and any determination to pay dividends in the future will be at the discretion of our board
of directors. Accordingly, you may need to rely on sales of our Ordinary Shares after price appreciation, which may never occur, as the
only way to realize any future gains on your investment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 40; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Risks Relating to Investment in a Luxembourg
Company and Our Status as a Foreign Private Issuer</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>As a &#8220;foreign private issuer,&#8221;
we are exempt from a number of U.S. securities laws and rules promulgated thereunder and will be permitted to publicly disclose less information
than U.S. public companies must disclose. This may limit the information available to holders of the Ordinary Shares. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We qualify as a &#8220;foreign
private issuer,&#8221; as defined in the SEC&#8217;s rules and regulations, and, consequently, we are not subject to all of the disclosure
requirements applicable to public companies organized within the United States. For example, we are exempt from certain rules under the
Exchange Act that regulate disclosure obligations and procedural requirements related to the solicitation of proxies, consents or authorizations
applicable to a security registered under the Exchange Act. In addition, our officers and directors are exempt from the reporting and
&#8220;short-swing&#8221; profit recovery provisions of Section 16 of the Exchange Act and related rules with respect to their purchases
and sales of our securities. For example, some of our key executives may sell a significant number of Ordinary Shares and such sales will
not be required to be disclosed as promptly as public companies organized within the United States would have to disclose. Accordingly,
once such sales are eventually disclosed, the price of Ordinary Shares may decline significantly. Moreover, we will not be required to
file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. public companies. We are also not subject
to Regulation FD under the Exchange Act, which would prohibit us from selectively disclosing material nonpublic information to certain
persons without concurrently making a widespread public disclosure of such information. Accordingly, there may be less publicly available
information concerning us than there is for U.S. public companies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As a &#8220;foreign private
issuer,&#8221; we file an annual report on Form 20-F within four months of the close of each fiscal year ended June 30 and furnish reports
on Form 6-K relating to certain material events promptly after we publicly announce these events. However, because of the above exemptions
for foreign private issuers, which we intend to rely on, our shareholders will not be afforded the same information generally available
to investors holding shares in public companies that are not foreign private issuers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>We may lose our foreign private issuer
status in the future, which could result in significant additional costs and expenses. This would subject us to GAAP reporting requirements
which may be difficult for us to comply with. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As a &#8220;foreign private
issuer,&#8221; we are not required to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act
and related rules and regulations. Under those rules, the determination of foreign private issuer status is made annually on the last
business day of an issuer&#8217;s most recently completed second fiscal quarter, and, accordingly, the next determination will be made
with respect to us on December 31, 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In the future, we could
lose our foreign private issuer status if a majority of our ordinary shares are held by residents in the United States and we fail to
meet any one of the additional &#8220;business contacts&#8221; requirements. Although we intend to follow certain practices that are consistent
with U.S. regulatory provisions applicable to U.S. companies, our loss of foreign private issuer status would make such provisions mandatory.
The regulatory and compliance costs to us under U.S. securities laws if we are deemed a U.S. domestic issuer may be significantly higher.
If we are not a foreign private issuer, we will be required to file periodic reports and prospectuses on U.S. domestic issuer forms with
the SEC, which are more detailed and extensive than the forms available to a foreign private issuer. For example, we would become subject
to the Regulation FD, aimed at preventing issuers from making selective disclosures of material information. We also may be required to
modify certain policies to comply with good governance practices associated with U.S. domestic issuers. Such conversion and modifications
will involve additional costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, we may lose
our ability to rely upon exemptions from certain corporate governance requirements of Nasdaq that are available to foreign private issuers.
For example, Nasdaq&#8217;s corporate governance rules require listed companies to have, among other things, a majority of independent
board members and independent director oversight of executive compensation, nomination of directors, and corporate governance matters.
As a &#8220;foreign private issuer&#8221;, we are permitted to follow home country practice in lieu of the above requirements. We intend
to follow Luxembourg practice with respect to quorum requirements for shareholder meetings in lieu of the requirement under Nasdaq Listing
Rules that the quorum be not less than 33 1/3% of the outstanding voting shares. Under our articles of association, at an ordinary general
meeting, there is no quorum requirement and resolutions are adopted by a simple majority of validly cast votes. In addition, under our
articles of association, for any resolutions to be considered at an extraordinary general meeting of shareholders subject to the quorum
and majority requirements to amend our articles of association, the quorum shall be at least one half of our issued share capital unless
otherwise mandatorily required by law. As long as we rely on the foreign private issuer exemption to certain of Nasdaq&#8217;s corporate
governance standards, a majority of the directors on our Board are not required to be independent directors, our compensation committee
is not required to be comprised entirely of independent directors, and we will not be required to have a nominating committee. Also, we
would be required to change our basis of accounting from IFRS as issued by the IASB to GAAP, which may be difficult and costly for us
to comply with. If we lose our foreign private issuer status and fail to comply with U.S. securities laws applicable to U.S. domestic
issuers, we may have to de-list from Nasdaq and could be subject to investigation by the SEC, Nasdaq and other regulators, among other
materially adverse consequences.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 41; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>We are organized under the laws of the
Grand Duchy of Luxembourg and a substantial amount of our assets are not located in the United States. It may be difficult for you to
obtain or enforce judgments or bring original actions against us or the members of our Board in the United States. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are incorporated under
the laws of the Grand Duchy of Luxembourg. In addition, a substantial amount of our assets is located outside the United States. Furthermore,
some of the members of our Board and officers reside outside the United States. Investors may not be able to effect service of process
within the United States upon us or these persons or enforce judgments obtained against us or these persons in U.S. courts, including
judgments in actions predicated upon the civil liability provisions of the U.S. federal securities laws. Likewise, it also may be difficult
for an investor to enforce in U.S. courts judgments obtained against us or these persons in courts located in jurisdictions outside the
United States, including judgments predicated upon the civil liability provisions of the U.S. federal securities laws. Awards of punitive
damages in actions brought in the United States or elsewhere are generally not enforceable in the Grand Duchy of Luxembourg.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As there is no treaty in
force on the reciprocal recognition and enforcement of judgments in civil and commercial matters between the United States and the Grand
Duchy of Luxembourg, courts in the Grand Duchy of Luxembourg will not automatically recognize and enforce a final judgment rendered by
a U.S. court. However, a party who received such favorable judgment in a U.S. Court may initiate enforcement proceedings in the Grand
Duchy of Luxembourg (<i>exequatur</i>) by requesting the recognition and enforcement of the U.S. judgment by the District Court (<i>Tribunal
d&#8217;Arrondissement</i>) pursuant to Section 678 of the New Luxembourg Code of Civil Procedure. The District Court will authorize the
enforcement in Luxembourg of the U.S. judgment if it is satisfied that all of the following conditions are met:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the
U.S. judgment is enforceable (<i>ex&#233;cutoire</i>) in the United States;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the
U.S. court awarding the judgment had jurisdiction to adjudicate the applicable matter under applicable U.S. federal or state jurisdictions
rules, and the jurisdiction of the U.S. court is recognized by Luxembourg private international and local law;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the
U.S. court has applied the substantive law as designated by the Grand Duchy of Luxembourg conflict of laws rules according to certain
Luxembourg case law, it is admitted that the Grand Duchy of Luxembourg courts which are asked to grant an exequatur do not have to verify
whether the substantive law actually applied by the U.S. court awarding the judgment was the law which would have been applied;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the
U.S. judgment does not contravene international public policy or order as understood under the laws of the Grand Duchy of Luxembourg;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the
U.S. court has acted in accordance with its own procedural rules and laws;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the
U.S. judgment was granted following proceedings where the counterparty had the opportunity to appear, and if it appeared, to present
a defense; and</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#160;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the
U.S. ju</span>dgment was not granted pursuant to an evasion of Grand Duchy of Luxembourg law (<i>fraude &#224; la loi luxembourgeoise</i>).</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Please note that the Grand
Duchy of Luxembourg case law is constantly evolving. Some of the conditions of admissibility described above may change, and additional
conditions could be required to be fulfilled by the Grand Duchy of Luxembourg courts while other conditions may not be required by Luxembourg
courts in the future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Subject to the conditions
described above, courts of the Grand Duchy of Luxembourg tend not to review the merits of a foreign judgment, although such a review is
not statutorily prohibited.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 42; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If an original action is
brought in the Grand Duchy of Luxembourg, the Grand Duchy of Luxembourg courts may refuse to apply the law designated and applied in the
original action if (i) the choice of such law was not bona fide or if the foreign law was not pleaded or proved or if pleaded and proved,
the foreign law was contrary to the Grand Duchy of Luxembourg mandatory provisions (<i>lois imp&#233;ratives</i>) or incompatible with
the Grand Duchy of Luxembourg public policy rules, and (ii) its application is manifestly incompatible with the Grand Duchy of Luxembourg
international policy rules. In an action brought in the Grand Duchy of Luxembourg on the basis of U.S. federal or state securities laws,
the Grand Duchy of Luxembourg courts may not have the requisite power to grant the remedies sought. Also, an exequatur may be refused
if it involves punitive damages.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Litigation in the Grand
Duchy of Luxembourg is subject to rules of procedure that differ from the U.S. rules, including, with respect to the taking and admissibility
of evidence, the conduct of the proceedings and the allocation of costs. Proceedings in the Grand Duchy of Luxembourg would in principle
have to be conducted in French or German, and all documents submitted to the court would, in principle, have to be translated into French
or German (though the court does accept exhibits in English). For these reasons, it may be difficult for a U.S. investor to bring an original
action in a Grand Duchy of Luxembourg court predicated upon the civil liability provisions of the U.S. federal securities laws against
us, the members of our Board, our officers, or the experts named herein. In addition, even if a judgment against us, the non-U.S. members
of our Board, our officers, or the experts named in this annual report based on the civil liability provisions of the U.S. federal securities
laws is obtained, a U.S. investor may not be able to enforce it in U.S. or the Grand Duchy of Luxembourg courts.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Further, in the event of
any proceedings being brought in the Grand Duchy of Luxembourg court in respect of a monetary obligation expressed to be payable in a
currency other than the Euro, a Grand Duchy of Luxembourg court would have power to give judgment expressed as an order to pay a currency
other than the Euro. However, enforcement of the judgment against any party in the Grand Duchy of Luxembourg would be available only in
Euros and for such purposes all claims or debts would be converted into Euros.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our amended and restated
articles of association adopted in connection with the Business Combination contain specific indemnification provisions stating that every
person who is, or has been, a member of our Board or officer (<i>mandataire</i>) shall be indemnified by us to the fullest extent permitted
by Luxembourg law against liability and against all expenses reasonably incurred or paid by such director or officer in connection with
any claim, action, suit or proceeding in which such director or officer becomes involved as a party or otherwise by virtue of his or her
being or having been a director or officer and against amounts paid or incurred by him or her in the settlement thereof.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Luxembourg and European insolvency and
bankruptcy laws are substantially different from U.S. insolvency and bankruptcy laws and may offer our shareholders less protection than
they would have under U.S. insolvency and bankruptcy laws.</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As a company organized under
the laws of the Grand Duchy of Luxembourg and with our registered office in the Grand Duchy of Luxembourg, we are subject to the Grand
Duchy of Luxembourg insolvency and bankruptcy laws in the event any insolvency proceedings are initiated against us including, among other
things, Council and European Parliament Regulation (EU) 2015/848 of 20 May 2015 on insolvency proceedings (recast). Should courts in another
European country determine that the insolvency and bankruptcy laws of that country apply to us in accordance with and subject to such
EU regulations, the courts in that country could have jurisdiction over the insolvency proceedings initiated against us. Insolvency and
bankruptcy laws in the Grand Duchy of Luxembourg or the relevant other European country, if any, may offer our shareholders less protection
than they would have under U.S. insolvency and bankruptcy laws and make it more difficult for them to recover the amount they could expect
to recover in a liquidation under U.S. insolvency and bankruptcy laws.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 43; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The rights of our shareholders may differ
from the rights they would have as shareholders of a United States corporation, which could adversely impact trading in Ordinary Shares
and our ability to conduct equity financings. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our corporate affairs are
governed by our articles of association and the laws of the Grand Duchy of Luxembourg, including the Luxembourg Company Law (<i>loi du
10 ao&#251;t 1915 sur les soci&#233;t&#233;s commerciales, telle que modifi&#233;e</i>). The rights of our shareholders and the
responsibilities of our directors and officers under Luxembourg law are different from those applicable to a corporation incorporated
in the United States. For example, under Delaware law, the board of directors of a Delaware corporation bears the ultimate responsibility
for managing the business and affairs of a corporation. In discharging this function, directors of a Delaware corporation owe fiduciary
duties of care and loyalty to the corporation and its shareholders. Luxembourg law imposes a duty on directors of a Luxembourg company
to: (i) act in good faith with a view to the best interests of a company; and (ii) exercise the care, diligence, and skill that a reasonably
prudent person would exercise in a similar position and under comparable circumstances. Additionally, under Delaware law, a shareholder
may bring a derivative action on behalf of a company to enforce a company&#8217;s rights. Under Luxembourg law, the board of directors
has sole authority to decide whether to initiate legal action to enforce a company&#8217;s rights (other than, in certain circumstances,
an action against members of our Board, which may be initiated by the general meeting of the shareholders, or, subject to certain conditions,
by minority shareholders holding together at least 10% of the voting rights in the company). Further, under Luxembourg law, there may
be less publicly available information about us than is regularly published by or about U.S. issuers. In addition, Luxembourg laws governing
the securities of Luxembourg companies may not be as extensive as those in effect in the United States, and Luxembourg laws and regulations
in respect of corporate governance matters might not be as protective of minority shareholders as are state corporation laws in the United
States. Therefore, our shareholders may have more difficulty in protecting their interests in connection with actions taken by our directors,
officers or principal shareholders than they would as shareholders of a corporation incorporated in the United States. As a result of
these differences, our shareholders may have more difficulty protecting their interests than they would as shareholders of a U.S. issuer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Non-Luxembourg resident holders of Ordinary
Shares could be subject to adverse income tax consequences in the Grand Duchy of Luxembourg. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The tax position of the
holders of Ordinary Shares may vary according to their particular financial and tax situation. Our tax structuring and/or our investments
may not be tax-efficient for a particular prospective holder of Ordinary Shares. No assurances can be given that amounts distributed or
allocated to the holders of Ordinary Shares will have any particular characteristics or that any specific tax treatment will apply. Furthermore,
no assurances can be given that any particular investment structure in which we have a direct or indirect interest will be suitable for
all holders of Ordinary Shares and, in certain circumstances, such structures may lead to additional costs or reporting obligations for
some or all of the holders of Ordinary Shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Non-Luxembourg resident
holders of Ordinary Shares that have neither a permanent establishment nor a permanent representative in the Grand Duchy of Luxembourg
to which or whom the Ordinary Shares are attributable, are generally not subject to any income tax in the Grand Duchy of Luxembourg on
gains realized upon the sale, repurchase or redemption of the Ordinary Shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Non-Luxembourg resident
holders of Ordinary Shares will only be subject to the Grand Duchy of Luxembourg income tax on capital gains in the event they hold a
substantial participation in us (i.e. more than 10% of our issued shares, either alone or together with certain close relatives, at any
time during the five-year period preceding the disposition of Ordinary Shares) and (a) the disposition of Ordinary Shares (including liquidation)
takes place within six months after acquisition or (b) in case of a disposition of Ordinary Shares after six months or more, such holder
had been a Grand Duchy of Luxembourg resident taxpayer for more than fifteen years and has become a non-Luxembourg taxpayer less than
five years before the disposition of Ordinary Shares occurs. Nevertheless, holders should consult their own tax advisors to determine
which double tax treaties concluded by the Grand Duchy of Luxembourg, if any, apply in order to determine which state (residency state
or the Grand Duchy of Luxembourg) has the right to tax any such capital gains.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 44; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">U.S. Tax Risk Factors</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>We believe we likely were a passive
foreign investment company (&#8220;PFIC&#8221;) for U.S. federal income tax purposes for our taxable year ending June 30, 2023, and may
be classified as a PFIC for our current taxable year or future taxable years which could subject U.S. holders of the Ordinary Shares could
be subject to adverse U.S. federal income tax consequences. </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Because we constitute a
PFIC within the meaning of Section 1297 of the Code for any taxable year during which a U.S. holder (as defined under &#8220;<i>U.S. Federal
Income Tax Considerations</i>&#8221;) holds Ordinary Shares, certain adverse U.S. federal income tax consequences may apply to such U.S.
holder. The PFIC status of a company depends on the composition of such company&#8217;s income and assets and the fair market value of
its assets from time to time, as well as on the application of complex statutory and regulatory rules that are subject to potentially
varying or changing interpretations. We believe we likely were a PFIC for our taxable year ending June 30, 2023, and may be classified
as a PFIC in the current taxable year or in future taxable years. There can be no assurance that we will not be treated as a PFIC for
any taxable year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If we were treated as a
PFIC, a U.S. holder of the Ordinary Shares may be subject to adverse U.S. federal income tax consequences, such as taxation at the highest
marginal ordinary income tax rates on capital gains and on certain actual or deemed distributions, interest charges on certain taxes treated
as deferred, and additional reporting requirements. Certain elections (including a qualified electing fund (&#8220;QEF&#8221;) or a mark-to-market
election) may be available to U.S. holders of the Ordinary Shares to mitigate some of the adverse tax consequences resulting from the
PFIC treatment. However, there is no assurance that we will provide the information necessary for a U.S. holder to make a QEF election
with respect to the U.S. holder&#8217;s Ordinary Shares. U.S. holders should consult their own tax advisors regarding the likely application
of the PFIC rules and should read the discussion below under &#8220;<i>U.S. Federal Income Tax Considerations &#8211;&#8211; Passive Foreign
Investment Company Rules</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 45; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="a_016"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> ITEM&#160;4. INFORMATION ON THE COMPANY</p><div>



</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_017"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">A. History
and Development of the Company</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>General Overview</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are a science-based ingredient company, and we are a leader in the
use of molecular farming technology for developing food ingredients. Our mission is to create unique food ingredients by engineering plants
with animal protein genes. Our purpose is to redefine the way we produce animal-based food, for good and for all. Our technological approach
aims to have the cost structure of plant-based solutions with the organoleptic properties and functionality of animal-based ones. Moolec&#8217;s
technology has been under development for more than a decade and is known for pioneering the production of a bovine protein in a crop
for the food industry. During this period, our technology was developed by Bioceres S.A. from whom we were spun-out in 2020. Our product
portfolio and pipeline leverage the agronomic efficiency of broadly used target crops, like soy, pea, and safflower. Recently, we acquired
plant-based ingredient capabilities to consolidate our molecular farming technology. We also have a growing international patent portfolio
(26, both granted and pending) for our technology. We have a diverse team of Ph.Ds and food insiders and have operations in the United
States, Europe, and South America.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Molecular farming, which
can be defined as the production of recombinant proteins in plants with the express intention to utilize (and ultimately commercialize)
the protein itself rather than any trait or capability it confers on the plant. Molecular farming therefore differs from other genetic
engineering applications such as metabolic engineering (where the expressed protein has a catalytic activity in plants and the value-added
product is a particular metabolite) and agronomic engineering (where the expressed protein confers beneficial agronomic properties such
as pest or disease resistance, stress tolerance, or increased yields). Molecular farming enables the synthesis of animal proteins&#8217;
DNA in any seed crop, selecting each protein for its ability to add value in terms of a targeted functionality trait such as taste, texture,
or nutritional value. The resulting proteins can be used as ingredients in consumer food products providing better-tasting, more functional,
and affordable science-based ingredients. We believe that this technological platform has the ability to capitalize on science-based ingredients
scale that extensive agriculture entails to achieve affordability and that it is also cost-efficient due to the fact that it leverages
biology, using plants and their inputs&#160;&#8212;&#160;sun, water, and soil&#160;&#8212;&#160;as small factories to produce animal proteins.
Plants are grown through traditional farming practices that result in economies of scale through high productivity volume production.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">With the ingredients we develop, we expect to address the traditional
processed meat market, alternative proteins, nutritional lipids, and rennet market, which we estimate to be an approximately US$1 trillion
market. Our business model focuses on R&amp;D; manufacturing and farming; developing joint ventures and/or partnerships; technology licensing;
co-branding/co-development of consumer packaged goods products for food service; B2B strategy for selling of the ingredients; recipes
and other technological solutions to food producers and/or retailers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Molecular farming is a technological
platform that has the potential to combine, modify and enhance all sorts of crops with animal proteins, which could allow us to possibly
consider other market opportunities. Such possible market opportunities include milk, egg, chicken, and fish replacements, or other industries
such as alternative biomaterials and biocosmetics.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We hold a growing international patent portfolio for our technologies,
which is run by a diverse team of experts, such as Ph.Ds and food insiders who have a robust background in the traditional food and meat
industries. Research, development and innovation are core elements of our business strategy, and we believe they represent a critical
competitive advantage for us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On April 24, 2023, we acquired
ValoraSoy S.A. For more information see &#8220;<i>&#8212;B. Significant Transactions&#8212;ValoraSoy Acquisition</i>&#8221;.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are supported by Nasdaq-listed
Bioceres Crop Solutions Corp. (NASDAQ:&#160;BIOX), a fully integrated provider of crop productivity solutions enabling the transition
to a carbon neutral agriculture, Theo&#160;I, a life sciences venture capital enterprise, and Union Group, a private equity management
firm.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 46; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our History</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We were incorporated under
the laws of the Grand Duchy of Luxembourg on May 23, 2022, as a public limited liability company (<i>soci&#233;t&#233; anonyme</i>)
governed by the laws of the Grand Duchy of Luxembourg, having its registered office at 17, Boulevard F.W. Raiffeisen, L-2411 Luxembourg,
Grand Duchy of Luxembourg and registered with the Luxembourg Trade and Companies&#8217; Register (<i>Registre de Commerce et des Soci&#233;t&#233;s,
Luxembourg</i>) under number B268440. Our principal website address is www.moolecscience.com and our Investor Relations website address
is ir.moolecscience.com. The SEC also maintains a website at http://www.sec.gov which contains reports and other information regarding
registrants that file electronically with the SEC. We do not incorporate the information contained on, or accessible through, our websites
into this annual report on form 20-F, and you should not consider it a part of this annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On December 30, 2022, we
consummated the transactions contemplated by the Business Combination Agreement dated as of June 14, 2022, by and among LightJump, Moolec
Limited, Moolec Acquisition, Inc., and us, as amended by the Business Combination Agreement dated as of November 18, 2022. For more information
see &#8220;<i>Part I. Introductory Note and Presentation of Financial and Other Information&#8212;Introductory Note&#8212;The Business
Combination</i>&#8221;.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On April 24, 2023, we completed
the acquisition of ValoraSoy Food Ingredients from the sellers in accordance with the share purchase agreement. ValoraSoy Food Ingredients
specializes in the production of textured soy proteins and has a long history providing high-quality products and customized solutions
to clients in more than 14 countries on 3 different continents. Its products are manufactured using various extrusion processes obtaining
as a result vegetable proteins with texture and fibrousness similar to those of meat, with various applications such as hamburgers, sausages,
and other plant-based products. As a result of this acquisition, we acquired all of the issued and outstanding equity securities of ValoraSoy
Food Ingredients from the sellers, and ValoraSoy Food Ingredients became our wholly owned subsidiary for total aggregate consideration
of US$2.6 million, in a combination of cash and equity. For more information see &#8220;<i>&#8212;B. Significant Transactions&#8212;ValoraSoy
Acquisition</i>&#8221;.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Strengths and Competitive Positioning</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>Environmental Advantages.</i></b>
Our goal is to promote a sustainable business model. Plants are highly efficient metabolic factories which operate mainly on sunlight
and carbon dioxide. With regards to molecular farming and producing protein, if plants are used to make the protein of choice, instead
of a bioreactor, there will be no need to use another source of energy in the process. The technology has the potential to become carbon-fixing
instead of carbon emitting. Moreover, molecular farming allows for sustainable water handling and can benefit from Ag-space sustainable
technologies, techniques and approaches, such as regenerative agriculture, due to the compatibility of the spaces. It also allows raw
material and product traceability from farm-to-market and a cleaner label approach for food producers, ingredients and manufacturers.
Further, molecular farming will allow us to produce the traditional by-products that the market is used to obtain from crops (such as
sugars, fiber, and oil) promoting a circular production and business model, which has the potential to reduce waste generation. We believe
that this technology provides us with a competitive advantage when compared to the traditional protein industry, by producing products
in a way that will appeal to the environmentally conscious consumer and providing food with animal proteins, including their functionalities
and characteristics, without the negative impact of greenhouse gas emissions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>Shift in Consumer
Preferences.</i></b> Consumers&#8217; concern for health, sustainability, ethical sourcing, animal welfare and convenience are driving
food producers and retailers to reconsider their product offerings, which traditionally contain animal-derived products. In this scenario,
we intend to continue to develop our brand and products. We believe that we will be able to capitalize on this shift in consumers&#8217;
concern for health and animal welfare, which we believe puts us in an advantageous position when compared to the traditional protein industry.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>Industrial Shift.</i></b>
The food industry is going through a significant global protein shift and we are following this change. This shift is driven mainly by
five main pillars, which are supply chain, cost, compliance, operations and innovation, as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
                                            weaknesses and vulnerabilities in supply chains have been highlighted by the droughts, trade-sanctions,
                                            trade-wars, livestock diseases, Covid-19 pandemic, Suez Canal blockage and political instability
                                            and war in a major food exporting country, the Ukraine. When coupled with the increasing
                                            demand for local foods, this instability has led companies to reconsider their importing
                                            strategy. Moreover, certain ingredients have been difficult to source. Specifically, several
                                            animal-derived ingredients including milk-protein, pork and chicken have been difficult to
                                            procure due to a lack of exportable volumes (e.g., export ban of pork or chicken due to swine
                                            fever or bird flu, respectively).</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in"></p><div>

</div><!-- Field: Page; Sequence: 47; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
price of many essential ingredients such as milk-derivatives, pork and chicken derivatives have increased significantly which has put
pressure on low-cost high-volume markets in developing countries. Due to the functionality and ease of use of these ingredients, they
have been difficult to replace when the ingredient costs have been low. For example, considering that milk-derived protein prices have
reached an all-time high, many food formulators/producers have serious incentives to try and replace part, if not all, of the ingredients
in the final product. Assembled food products or food service offerings consisting of multiple protein sources like cheese sausages,
cheeseburgers, pastas, bakery products provide ample space for partial replacement of certain high-cost ingredients.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Compliance
requirements have increased the complexity of food production and its related supply chain. The pressure to responsibly source certain
ingredients is leading to a reduction of use of that specific ingredient whenever possible to limit the exposure to a market prone to
shortages in volumes.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
safety of certain food products is increasingly making daily operations complex due to the stricter control of cross-contamination of
specific product claims (e.g., organic, allergen-free, cruelty-free, GMO-free, etc.). This means that certain production lines are moving
to a system in which it can either process all of the above, or to a line in which it is not allowed to process specific ingredients
in order to maintain the &#8220;free-from&#8221; status.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Pressure
for i</span>nnovation to solve certain problems related to the previous pillars or demand-related issues is also generating opportunities
for plant-based proteins. Due to increased routes into higher volume applications of the traditional plant-proteins, other ingredient
suppliers have been developing a wider plant-based offering to find applications that other plant-based proteins have failed due to technical
or marketing concerns.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We believe that by addressing
the main concerns with supply chain issues, price and food safety concerns, our innovative molecular farming technology puts us at an
advantage when compared to the traditional protein industry and other alternative protein technologies. We will not be subject to certain
of the risks caused by supply chain issues, sourcing compliance, or rising cost of ingredients as our products would also use the native
proteins from the plant. Our technology also addresses the current challenges faced by the traditional science-based food ingredient and
meat industries by being animal free, green and reducing costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>Taste and Texture</i></b>.
Alternatives to animal-derived foods are edging closer to their targets whilst being acceptable to consumers who buy plant-based alternatives
with conviction. We are committed to prioritizing the growth of this acceptance. To make a global impact on sustainability and health,
wider adoption is needed which means that the mainstream consumer, which is not inherently attracted to plant-based alternatives, needs
to be drawn in. The prerequisites for a successful product which can be marketed towards committed vegans are significantly different
than flexitarian/reducetarian consumers. As a consequence, the plant-based products need to be a convincing alternative to the traditional
animal-based product in order to help a group of people to reduce their reliance on animal-derived protein. We believe that if the animal-alternatives
can survive for one or two generations, then a gradual shift can start taking place where the food systems are nudged towards products
which are perhaps less like meat but offer significant nutritional, cost and sustainability advantages over the initial generations of
meat alternatives. If successful, the introduction of animal proteins into plants could help increase the functionality of the bulk of
the animal-alternative recipes which are based on plants and seeds. These animal proteins have very specific functions in food where they
determine texture and overall behavior in application. In terms of taste, the industry has come a long way in boosting or replacing animal-based
flavors with plant or microbial derived ingredients. Using animal-inspired proteins and fats, we can also come closer to developing the
tastes more associated with the traditional animal-based products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We believe that our product
will appeal to the consumer that prefers the traditional taste and texture of traditional meat products, but shares our values. A challenge
for the science-based food ingredient industry has been the ability to create alternatives that mimic the taste and texture of meat. With
our technology the proteins that have a significant role and affect the taste and texture of meat products will be produced within the
plants themselves. This places us in an advantageous position when compared to competitors that use other methods to mimic the taste and
texture of meat products.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 48; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>Nutritional Values</i></b>.
We are a mission-driven business and nutritional value is among our priorities. More data is becoming available regarding general nutrition
of specific diets and the relationship with general health and wellbeing. Many foods which are attractive in terms of taste, cost and
convenience might not be considered part of a healthy diet. Replacing these foods and attracting the mainstream consumer can be difficult.
Animal proteins produced in plants by molecular farming will have the same protein sequence to the proteins which we have been eating
during the evolution of our species. By introducing these animal proteins in plants, we expect to increase the overall nutritional score
of the products we develop.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For the health-conscious
consumer, we expect to have a competitive advantage. We believe that our technology will produce a product that retains the benefits of
traditional meat, including certain animal-specific proteins, without the need to include less healthy ingredients needed to create a
suitable meat alternative. As discussed above, currently consumers are more health conscious when making decisions related to their food,
and we believe we are in a position to capitalize on this trend.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 18pt"><b><i>Scalability and Low Costs</i></b>.
We focus on molecular farming, as we believe through it we can compete with animal-based products in terms of costs. Considering that
our genetically modified seeds generally will not require significant downstream modifications, we expect operational costs to be in line
with the current farming methods and industrialization standards for existing soy, pea and safflower beans. With lower costs associated
with our ability to scale and produce our products, we believe we are at an advantage when compared to our competitors.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b><i>Management team and
Industry Expertise</i></b>. We are led by a proven and experienced executive management team consisting of Ph.Ds and agri-food insiders
with many&#160;years of industry experience. We believe this blend of talent gives us tremendous insights and capabilities to create demand
and fulfill it in a scalable, profitable and sustainable way and is one of our main strengths. See &#8220;<i>Item 6. Directors, Senior
Management and Employees</i>&#8221;.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Industry Overview</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We believe that consumer
awareness of the perceived negative health, environmental and animal-welfare impacts of animal-based meat consumption has resulted in
a surge in demand for viable plant-based protein alternatives. A key analogy for both the approach to and the scale of our opportunity
is the strategy by which the plant-based industry captured significant market share.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We expect the plant-based
industry to grow but we also recognize that a significant impact can be made on the world-wide food system by helping traditional animal-based
food producers minimize the amount of animal-derived ingredients they require for the production of nutritious, low cost and sustainable
foods. There is a trend indicating more interest from the traditional meat and dairy industry to accept next generation and alternative
ingredients which can reduce their dependence on animal proteins whilst maintaining a certain level of quality and preferably reduce costs
and increase supply chain stability. We believe working alongside the traditional food industry as a key opportunity to impact global
sustainability.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are currently operating
in a period of economic uncertainty and capital markets disruption, which has been significantly impacted by geopolitical instability,
including the armed conflict in Israel and Palestine, and ongoing military conflict between Russia and Ukraine. On February 24, 2022,
a full-scale military invasion of Ukraine by Russian troops began. Although the length and impact of the ongoing military conflict is
highly unpredictable, the conflict in Israel and Palestine and in the Ukraine have led to market disruptions, including significant volatility
in commodity prices, credit and capital markets, as well as supply chain disruptions. Our business, financial condition, and results of
operations may be adversely affected by the negative impact on the global economy resulting from the conflict in Israel and Palestine
and the Ukraine or any other geopolitical tensions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 49; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In recent years and months,
the food industry has experienced several major global events which have significantly disrupted the global supply chain. Beyond the conflict
in Ukraine, this includes several years of swine and avian flu in Europe, the current trade conflicts between the United States and China,
the COVID-19 pandemic, the Suez Canal blockage, severe climate events and drought in significant agricultural locations and the current
labor shortage. The relatively low cost of food, of which consumers have grown accustomed, requires production scale and efficient supply.
These developments and continuing pressure on the price of food and food products has reinforced the dependence on the global food supply
chain. For example, food recipes have frequently become complex so that if one ingredient cannot be sourced, the whole production line
is unable to produce. Due to strict labeling laws worldwide, replacement ingredients cannot always be used, which can cause major problems
which have been exacerbated by the aforementioned global events.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 18pt">The disruptions and demonstration
of the fragility of the global food supply chain has expedited the need for more localized sourcing, when possible, but more importantly
has increased the attractiveness of technological solutions to produce foods which cannot be produced locally. We believe that these technological
solutions, such as molecular farming, can play a major role to resolve the food security issue while also providing additional advantages
related to sustainability and cost reduction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In recent years, the general
acceptance of GMOs has increased. The most common GMO crops include soy, maize, cotton, canola, and alfalfa. In addition, several genetically
modified organisms (GMOs) have been approved by the EU commission recently. Since GMOs were first approved for commercial use and planted
in United States soil in 1996, their production has rapidly increased; helping to make farming methods significantly more efficient and
productive.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Recent Developments</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Convertible Note issued to Insud</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On October 15, 2023, we
entered into agreements with Insud to issue a convertible note for an aggregate principal amount of approximately US$21&#160;million (the
&#8220;Insud Convertible Note&#8221;). The convertible note was issued against a cash payment of US$10 million. In connection with this,
we entered into a binding contribution memorandum of understanding, pursuant to which Insud will contribute to us certain rights under
an industrial services agreement and its interest in Microo Foods Ingredients. Upon the effectiveness of such contributions, we will increase
the principal amount outstanding under the note by an amount equal to the value of the contributed assets. Valuation of the contribution
will be confirmed by an independent statutory auditor (<i>r&#233;viseur d&#8217;entreprises agr&#233;&#233;</i>) in accordance with
article 420-27 of the Luxembourg law of 10 August 1915 on commercial companies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The convertible note will
mature in 36 months after it is issued, will initially accrue interest at 10.0% p.a. and includes a &#8220;payment-in-kind&#8221; feature.
If the trading price of our ordinary shares exceeds the strike price of US$6.00 per ordinary share for 10 trading days, Insud will have
the option to exercise the early conversion option pursuant to which the principal amount outstanding under the note may be converted
into our ordinary shares at the strike price. At maturity, we have the option to convert the principal amount outstanding under the note
into ordinary shares. In connection with Insud&#8217;s early conversion option and our optional conversion at maturity, we may deliver
ordinary shares, cash, or a combination of cash and ordinary shares to Insud. The in-kind contributions to be made by Insud to us are
subject to the completion of an independent appraisal procedure in accordance with Luxembourg law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Binding Memorandum of Understanding with
Bioceres</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 18pt">On October 15, 2023, we entered
into an MOU with one of our affiliates, Bioceres. Pursuant to the MOU, we will enter into a note purchase agreement (the &#8220;Note Purchase
Agreement&#8221;) and a HB4&#174; soy supply agreement (the &#8220;BIOX Soy Supply Agreement&#8221;) with Bioceres. Under the BIOX Soy
Supply Agreement, Bioceres will supply us with an amount of HB4&#174; soy equivalent to US$9 million under our commitment. We have the
option to request additional deliveries of an amount of HB4&#174; soy equivalent to US$9 million and will issue additional notes in connection
with this option. Bioceres will engage with Generation HB4&#174; farmers to source and deliver to us soybeans with a sustainability-linked
premium, which are produced under regenerative agricultural practices, minimizing water, carbon and chemical footprints. The Generation
HB4&#174; program is an identity-preserving farming program that utilizes HB4&#174; drought-tolerance technology to enable soybean-wheat
crop rotations and improve agricultural sustainability. The BIOX Convertible Note is expected to be issued on substantially similar terms
as the Insud Convertible Note.</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 50; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Takeover Offers</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are not aware of any
public takeover offers by third parties in respect of our securities, and we have not made any public takeover offers in respect of any
other company&#8217;s securities, during the last or current financial year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="a_018"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">B. Business
Overview</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Significant Transactions</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ValoraSoy Acquisition</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">On
April 24, 2023, we completed the </span>acquisition <span style="font-family: Times New Roman, Times, Serif">of ValoraSoy Food Ingredients
from the sellers in accordance with the share purchase agreement. ValoraSoy Food Ingredients specializes in the production of textured
soy proteins and has a long history providing high-quality products and customized solutions to clients in more than 14 countries on 3
different continents. Its products are manufactured using various extrusion processes obtaining as a result vegetable proteins with texture
and fibrousness similar to those of meat, with various applications such as hamburgers, sausages, and other plant-based products. As a
result of this acquisition, we acquired all of the issued and outstanding equity securities of ValoraSoy Food Ingredients from the sellers,
and ValoraSoy Food Ingredients became our wholly owned subsidiary for total aggregate consideration of US$2.6 million, in a combination
of cash and equity. We expect that the ValoraSoy Acquisition will help to accelerate our growth in the food ingredients industry by expanding
our commercial network with a top-notch sales team and complementing our molecular farming Platform with industrial capacity and downstream
operations, in addition to adding a highly experienced team of professionals.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Grupo Insud</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On May&#160;24, 2022, we
formed Microo Food Ingredients as a joint arrangement with Insud, a global company focused on innovation, sustainability and developing
in different industries such as pharma, agribusiness and renewable energy, through its affiliate INVIM Corporativo S.L.&#160;Microo Food
Ingredients plans to use yeast, fungi and other microorganisms to produce animal-free ingredients that are expected to complement our
molecular farming and plant-based pipeline and enable us to have a unique set of science-based food ingredients formulations. The new
products that may result from Microo Food Ingredients are expected to represent an upgrade in nutritional value. We expect that combining
our respective technological platforms may improve our R&amp;D, since this partnership is expected to permit us to accelerate our scientific
research and developments and to scale-up our production expertise.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant to the binding contribution
memorandum of understanding, Insud has agreed to contribute to us their interest in Microo Food Ingredients. See &#8220;<i>&#8212;Recent
Developments</i>&#8221; above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Bioceres S.A. and Bioceres.</i></b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We were founded in 2020
as a spin-off from a privately owned entity, Bioceres S.A., which provided us with a scientific team and certain intellectual property.
In 2021, Bioceres transferred to us the GLA patents, as well as the trademarks relating to this technology.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Customers and Contracts</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As a result of the ValoraSoy
Acquisition, we have entered into contract with customers with clients in more than 14 countries on 3 different continents. Pursuant to
these agreements, we sold textured soy proteins for the year ended June 30, 2023. We did not have any contracts with customers for the
year ended June 30, 2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 51; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Segments and Key Products</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_001.jpg" style="width: 700px; height: 384px"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The table below sets forth
our pipeline. Our products are projects in various stages of R&amp;D and are not yet available to consumers. We currently have multiple
projects in development which will require us to confirm discovery, transformation, development and selection stages, prior to moving
from R&amp;D to operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; width: 14%">
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">Product</p></td>
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 17%; text-align: center; font-weight: bold">Category</td>
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-left: -0.125in; text-indent: -0.125in; width: 45%; text-align: center; font-weight: bold">Description</td>
    <td style="padding-bottom: 1.5pt; width: 1%; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-indent: 0.125in; padding-left: 0in; width: 21%; text-align: center; font-weight: bold">Market</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in"><b>SPC2</b></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: left">Food Ingredient</td>
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-left: 0in; text-align: left; text-indent: 0in">Plant-based chymosin. Chymosin is a key ingredient for the clotting step in cheese production. Our technology allows Chymosin to be produced in Safflower seeds turning this semi-arid crop into a bioreactor for industrial enzymes.</td>
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="text-indent: 0in; padding-left: 0in; text-align: left">Food, dairy (cheese industry)</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in"><b>GLASO </b></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: left">Nutritional Supplement</td>
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-left: 0in; text-align: left; text-indent: 0in">A safflower oil with high levels of GLA (up to 60% of total oil content).
Our technology allows a high concentration of GLA that can be up to three times as concentrated when compared with other standard sources
of GLA such as borage oil and evening primrose oil, whose concentrations vary between 20-22% and 9-12%, respectively.</td>
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="text-indent: 0in; padding-left: 0in; text-align: left">Dietary supplements, nutritional beverages and pet food <sup>(1)</sup></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in"><b>YEEA1</b></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: left">Nutritional Supplement or Food Ingredient</td>
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-left: 0in; text-align: left; text-indent: 0in">An extract derived from a novel yeast biomass with specific properties. The technology allows for replacement of specific animal-derived nutritional supplements and targets a market which might have religious, lifestyle or moral objections to the current products in the market. A secondary application is being studied where the same extract is used as a base for savory flavor generation.</td>
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="text-indent: 0in; padding-left: 0in; text-align: left">Nutritional supplement, food fortification, natural savory flavors</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in"><b>SOOY1</b></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: left">Meat Replacement</td>
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-left: 0in; text-align: left; text-indent: 0in">SOOY1 is a plant-based and animal meat free ingredient containing porcine proteins in soybeans. Our technology allows the enhancement of organoleptic properties and nutrition in traditional and alternative meat products by using a more sustainable and affordable approach when compared to traditional animal protein production.</td>
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="text-indent: 0in; padding-left: 0in; text-align: left">Traditional/ alternative/ cultivated meats, and non-meat products</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in"><b>SOOY2</b></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: left">Meat Replacement</td>
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-left: 0in; text-align: left; text-indent: 0in">SOOY2 is a plant-based and animal meat free ingredient containing animal proteins in soy. This technology allows the modulation of soy properties for meat replacement and for use in savory flavor generation when compared to traditional animal protein production.</td>
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="text-indent: 0in; padding-left: 0in; text-align: left">Traditional/ alternative/ cultivated meats, non-meat products and flavoring</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in"><b>SOOY3</b></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: left">Meat Replacement</td>
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-left: 0in; text-align: left; text-indent: 0in">SOOY3 is a plant-based and animal meat free ingredient containing animal proteins in soy. This version of the technology allows for an improved texture modulation in meats and meat replacement.</td>
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="text-indent: 0in; padding-left: 0in; text-align: left">Traditional/ alternative/ cultivated meats and non-meat products</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in"><b>PEEA1</b></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: left">Meat Replacement </td>
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-left: 0in; text-align: left; text-indent: 0in">PEEA1 is a plant-based and animal meat free ingredient containing porcine proteins in peas. Our technology allows the enhancement of organoleptic properties and nutrition in traditional and alternative meat products by using a more sustainable and affordable approach when compared to traditional animal protein production.</td>
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="text-indent: 0in; padding-left: 0in; text-align: left">Meat replacement, meat alternatives and nutritional/ functional foods</td></tr>
  </table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.3in"><i>Notes:-</i></td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in">(1)</td><td style="text-align: justify"><span style="font-size: 10pt">As <span style="font-family: Times New Roman, Times, Serif">of the date
of this annual report on form 20-F, the FDA has approved the GLA-containing safflower seed oil as a new ingredient in dietary supplements,
nutritional beverages, and medicinal foods for humans. The FDA has also approved the use of the seed oil as an ingredient in dog and cat
food and the use of the seed meal in cattle and poultry feeds. </span></span></td></tr></table><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 52; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Development Timeline and Process</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The seven projects included
in our product portfolio described above are each in different stages of product development. In order to commercialize our products and
for them to enter into markets, it is necessary for our products to go through multiple stages of development, including research and
development where we aim to locate proteins of interest found in traditional animal foods that can be effectively and efficiently expressed
within a plant or a microorganism, the development of a successful prototype, further research and testing to ensure that the prototype
can be efficiently scaled-up, production of the product and finally commercialization of the product. The stages of development for our
products consist of the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">(i)</td><td style="text-align: justify">Discovery: The first phase in the technology development
process is the discovery or identification of hosts, candidate genes or genetic systems, metabolites, or microorganisms potentially capable
of enhancing specified characteristics or enabling an agroindustrial biotech solution.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">(ii)</td><td style="text-align: justify">Proof of concept/Transformation: Upon successful validation of the
technologies in model systems (in vitro or in vivo), promising technologies graduate from discovery and are advanced to the transformation
phase after which it proceeds to the greenhouse or small bioreactor stage. The goal of this phase is to validate a technology within the
targeted organism before moving forward with technology escalation activities, extensive field validations or large-scale fermentations.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">(iii)</td><td style="text-align: justify">Early development/Development: In this phase, efficacy field trials
or pilot scale bioreactors are expanded to evaluate the expression level and phenological characteristics of the traits in multiple geographies
and growing cycles, as well as other characteristics in order to optimize the technology&#8217;s performance in the targeted organisms.
The goal of the development phase is to evaluate the technical feasibility by identifying the best candidate to scale up the seed stock
and to start the regulatory field trials for plants. For microbes, this stage aims to study the behavior of the organisms in production
settings and produce enough biomass to start downstream prototyping and safety assessments. We have held preliminary conversations with
regulatory agencies to permit solicitation and activities to obtain regulatory clearance for cultivation.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">(iv)</td><td style="text-align: justify">Advanced development/Selection: In this phase, extensive field tests
are used to fully demonstrate the effectiveness of the technology for its intended purpose. In the case of GM traits, the process of obtaining
regulatory approvals from regulatory agencies for products is started, and includes field trials for environmental, core and food safety
data generation. For solutions involving microbial fermentation, industrial-scale runs are conducted and data is collected for a more
precise techno economic assessment.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">(v)</td><td style="text-align: justify">Pre-launch/Scale-Up: This phase involves finalizing the regulatory
approval process and preparing for the launch and commercialization of the technology. The range of activities in this phase includes
seed increases, pre-commercial production, and product and solution testing with selected customers. Usually, a more detailed marketing
strategy and preparation of marketing materials occur during this phase. For solutions involving microbial fermentation, this phase is
where the gathered safety data is presented to the regulatory agencies for evaluation.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">(vi)</td><td style="text-align: justify">Product launch/Downstream: In general, this phase, which is the last
milestone of the research and development process, is carried out by the group. Here is where the novel seeds or novel microorganism biomass
are processed into the final products, ingredients for B2B activities.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">SPC2 is currently at the
&#8220;Scale-Up&#8221; stage, whereby we have already been able to successfully develop the prototype and our conducting further research
in greenhouses related to protein expression. GLASO is also at the scale-up stage, where we currently are increasing seed stock and crushing
processing trials. Our meat replacement products remain in the first developmental stages of research, including Discovery, Transformation
and Development.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 53; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The table below describes
the current projects that are within our pipeline. We believe that the projects below can continue to advance, becoming products, and
reach commercialization, subject to final regulatory approvals and success within each of the stages described above:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 15%; font-weight: bold; text-align: left">Project</td><td style="white-space: nowrap; text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 17%; font-weight: bold; text-align: center">Application</td><td style="white-space: nowrap; text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 16%; font-weight: bold; text-align: center">Plant/<br/> Microorganism <br/> Host</td><td style="white-space: nowrap; text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-left: 0in; text-indent: -0.125in; white-space: nowrap; width: 16%; font-weight: bold; text-align: center"><span style="font-size: 10pt">Function<span style="font-family: Times New Roman, Times, Serif"><sup>(1)</sup></span></span></td><td style="white-space: nowrap; text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 20%; font-weight: bold; text-align: center">Development Stage</td><td style="white-space: nowrap; text-align: center; width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="white-space: nowrap; padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: center">&#160;</td><td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 9%; font-weight: bold; text-align: center"><span style="font-size: 10pt">Planned<br/>
 Commercial<br/>
 Launch</span></td><td style="white-space: nowrap; width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">SPC2</td><td>&#160;</td>
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Food Ingredient</td><td>&#160;</td>
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Safflower</td><td>&#160;</td>
    <td style="text-align: left; text-indent: 0in; padding-left: 0in">Texture</td><td>&#160;</td>
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Scale-up</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">2025</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">GLASO</td><td>&#160;</td>
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Nutritional Oil</td><td>&#160;</td>
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Safflower</td><td>&#160;</td>
    <td style="text-align: left; text-indent: 0in; padding-left: 0in">Nutrition</td><td>&#160;</td>
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Scale-up</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">2025</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">YEEA1</td><td>&#160;</td>
    <td style="text-align: left">Nutritional Supplement or Food Ingredient</td><td>&#160;</td>
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Yeast</td><td>&#160;</td>
    <td style="text-align: left; text-indent: 0in; padding-left: 0in">Nutrition and Flavor</td><td>&#160;</td>
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">2025</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">SOOY1</td><td>&#160;</td>
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Meat replacement</td><td>&#160;</td>
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Soybean</td><td>&#160;</td>
    <td style="text-align: left; text-indent: 0in; padding-left: 0in">Sensory and Nutrition</td><td>&#160;</td>
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Development</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">2027</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">SOOY2</td><td>&#160;</td>
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Meat replacement</td><td>&#160;</td>
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Soybean</td><td>&#160;</td>
    <td style="text-align: left; text-indent: 0in; padding-left: 0in">Flavor and Nutrition</td><td>&#160;</td>
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Transformation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">2029</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">SOOY3</td><td>&#160;</td>
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Meat replacement</td><td>&#160;</td>
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Soybean</td><td>&#160;</td>
    <td style="text-align: left; text-indent: 0in; padding-left: 0in">Texture and Nutrition</td><td>&#160;</td>
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Transformation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">2029</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">PEEA1</td><td>&#160;</td>
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Meat replacement</td><td>&#160;</td>
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Pea</td><td>&#160;</td>
    <td style="text-align: left; text-indent: 0in; padding-left: 0in">Sensory and Nutrition</td><td>&#160;</td>
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Transformation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">2028</td><td style="text-align: left">&#160;</td></tr>
  </table><div>



</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.3in"><i>Notes:-</i></td><td style="text-align: justify"></td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in">(1)</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The function of our products
acts to create an experience within a product that is typical of the traditional meat market. This includes texture, sensory experience
and nutrition. Each of the projects described above will advance one or more of these functions within our products. Texture relates to
the feel and consistency of the product. Sensory implies an improved perception of the </span>product<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
especially with respect to meat replacements. Nutrition refers to increased digestibility of the expressed protein or an improvement of
the micronutrient content and bioavailability.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We believe, based on available
market research, that the Serviceable Available Market could reach US$37 billion by the end of 2025. In order to address this demand,
we must complete the necessary development activities in order to meet the planned commercial launches indicated above. However, delays
may occur as a result of the development process. See &#8220;<i>Item 3. Key Information&#8212;D. Risk Factors&#8212;Risks Related to our
Business and Operations&#8212;If our genetically engineered plants do not express a sufficient yield of an animal protein, we may not
be able to take our products to market in a timely manner or successfully operate our business.</i>&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Sales and Marketing</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">As
our product and focus on molecular farming may not be familiar to many potential consumers, we will be required to </span>educate <span style="font-family: Times New Roman, Times, Serif">potential
customers and consumers about our products and brand, respond quickly to concerns and consult on food trends. As we develop and grow our
brand, we expect to expand our sales and marketing team in the future by adding dedicated personnel to service new retail customers. In
the future we may also add sales representatives to expand our sales efforts to the extent necessary.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Competition</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have recognized three
clusters of competitors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
first category includes other molecular farming companies which are working on similar proteins in similar or different production systems.
In this category, our main competitors are Kyomei and IngredientWerks. Some molecular farming companies now potentially working on meat
proteins</span> next to their dairy core are Mozza, Nobbell Foods and such.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
second category includes companies which develop </span>science-based food ingredient <span style="font-family: Times New Roman, Times, Serif">technologies
which target the same molecules or molecules that have similar applications in the same target market. These technologies can include
precision fermentation, single cell protein, cultured meat and more. In this category, our main competitors include Motiff Food Works,
Impossible Foods, Paleo and Ginko Bioworks.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Finally, the third category
includes companies competing with traditional animal-based versions of our target proteins or companies making traditional alternatives
to target the same market. These companies classify as competitors in the loosest sense as they are more likely to be potential customers
or future users of the technology being developed. Givaudan Group, International Flavors&#160;&amp; Fragrances, DSM and Hansen could be
named, as examples, among others.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 54; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Intellectual Property</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Our
business model is focused on R&amp;D and the development of future IP and patents. Our IP strategy consists of </span>conducting <span style="font-family: Times New Roman, Times, Serif">research
and testing to rapidly acquire IP protection for all of our platforms.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The main jurisdictions in
which we seek patent protection, among others, are the United&#160;States, Canada, Brazil, Argentina, Australia, India, China, Hong&#160;Kong,
Japan, Malaysia, New Zealand, Mexico and countries in Europe.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">To date, we have identified
and sought patent protection in our capacity as either title holder or exclusive licensee for over 26 patents linked to our food ingredients,
nutritional supplements and meat replacements technology such as: (i) chymosin produced in safflower; (ii) GLA produced in safflower;
(iii) plant-based porcine and bovine proteins embedded within the matrix of native soy proteins to enhance meat products in terms of taste,
color and nutritional values and the&#160;molecular farming platform that enables production; (iv) plant-based animal myofibrillar proteins
to enhance meat products in terms of taste, texture and nutritional values; (v) methods for producing recombinant animal proteins within
yeast; and (vi) compositions and applications of novel microorganisms to improve the taste and nutritional properties of foods.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">These technologies are currently
protected through our 17 patents and 9 current patent applications as owner and or as exclusive licensee. Further, 10.5% of our patents
are proprietary while 89.5% of the patents listed below have been licensed from third parties. In addition, we own 22 trademarks across
five jurisdictions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research and Development</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our R&amp;D activities are
directed toward the ability to find proteins of interest that are found in traditional animal foods and express the desired proteins in
a host plant or microorganism. We undertake our R&amp;D activities through service agreements with institutions that specialize in the
research and development of technologies to increase crop yields, gene expression and biotechnology.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Service agreements with third parties</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
table below shows the service </span>agreements <span style="font-family: Times New Roman, Times, Serif">to which we are a party and through
which we develop our R&amp;D activities. These agreements are discussed in more detail below the table.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 49%">
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Counterparty Name</p></td>
    <td style="padding-bottom: 1.5pt; vertical-align: bottom; width: 1%; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 24%; text-align: center; font-weight: bold">Effective Date</td>
    <td style="padding-bottom: 1.5pt; vertical-align: top; width: 2%; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: top; width: 24%; text-align: center; font-weight: bold">End Date</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">Ingenier&#237;a Metab&#243;lica S.A. (INMET)</td>
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-left: 0.1in; text-align: center">October 22, 2020</td>
    <td style="padding-right: 5.4pt; padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 0.1in; text-align: center">July 2022</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">Instituto de Agrobiotecnolog&#237;a Rosario S.A.U. (INDEAR)</td>
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-left: 0.1in; text-align: center">January 18, 2021</td>
    <td style="padding-right: 5.4pt; padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 0.1in; text-align: center">December 2022</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">Washington State University (WSU) </td>
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-left: 0.1in; text-align: center">January 29, 2021</td>
    <td style="padding-right: 5.4pt; padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 0.1in; text-align: center">September 2023</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">Wisconsin Crop Innovation Center (WCIC)</td>
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-left: 0.1in; text-align: center">February 11, 2021</td>
    <td style="padding-right: 5.4pt; padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 0.1in; text-align: center">March 2023</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">Future Foods B.V.</td>
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-left: 0.1in; text-align: center">May&#160;1, 2021</td>
    <td style="padding-right: 5.4pt; padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 0.1in; text-align: center">December 2023</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">Instituto de Agrobiotecnolog&#237;a Rosario S.A.U. (INDEAR)</td>
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-left: 0.1in; text-align: center">September&#160;9, 2021</td>
    <td style="padding-right: 5.4pt; padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 0.1in; text-align: center">April 2023</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">Flavour Products B.V.</td>
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-left: 0.1in; text-align: center">December&#160;28, 2021</td>
    <td style="padding-right: 5.4pt; padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 0.1in; text-align: center">December 2023</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">Koompin Farms</td>
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-left: 0.1in; text-align: center">April 13, 2022</td>
    <td style="padding-right: 5.4pt; padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 0.1in; text-align: center">October 2022</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">Premas Biotech PVT Ltd. (Premas)</td>
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-left: 0.1in; text-align: center">May 16, 2022</td>
    <td style="padding-right: 5.4pt; padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 0.1in; text-align: center">October 2022</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">Instituto de Agrobiotecnolog&#237;a Rosario S.A.U. (INDEAR)</td>
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-left: 0.1in; text-align: center">June&#160;23, 2022</td>
    <td style="padding-right: 5.4pt; padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 0.1in; text-align: center">October 2023</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">The Curators of the University of Missouri</td>
    <td style="padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-left: 0.1in; text-align: center">November&#160;4, 2022</td>
    <td style="padding-right: 5.4pt; padding-left: 0.1in; text-align: left; text-indent: -0.1in">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 0.1in; text-align: center">November 2023</td></tr>
  </table><div>
</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 55; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ingenier&#237;a Metab&#243;lica S.A.
(INMET)</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">On
</span>October<span style="font-family: Times New Roman, Times, Serif">&#160;22, 2020, we entered into a service agreement with INMET
for a fermentation project consisting of strain construction and downstream processing of a bovine protein. This project ended in July&#160;2022
with inconclusive results.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Instituto de Agrobiotecnolog&#237;a Rosario
S.A.U. (INDEAR)</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On January&#160;18, 2021,
we entered into a service agreement with INDEAR for transformation services of transgenic events. This agreement expired in December&#160;2022,
and we are currently discussing an amendment agreement with INDEAR to extend the term of this agreement through completion of the project.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">On
September&#160;9, 2021, we entered into a service agreement with INDEAR for the development of the following: (a)&#160;seed multiplication
of GM safflower containing nutritional oil (GLA) and Chymosin, and (b)&#160;R&amp;D </span>activities <span style="font-family: Times New Roman, Times, Serif">related
to our safflower&#8217;s technologies. The seed multiplication service ended in February&#160;2022 and the R&amp;D activities were concluded
in April 2023.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On June&#160;23, 2022, we
entered into a service agreement with INDEAR for gene expression analysis and generation advancement services in order to select desirable
soybean transgenic lines.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Washington State University (WSU)</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">On
January 29, 2021, we entered into a sponsored research project agreement with WSU for the development of research related to bovine protein
</span>expression <span style="font-family: Times New Roman, Times, Serif">in pea plants. The agreement was amended on June 1, 2022, on
August 19, 2022, January 17, 2023, and September 22, 2023. The project was concluded in September 2023.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Wisconsin Crop Innovation Center (WCIC)</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On February 11, 2021, we
entered into a service agreement with WCIC for soybean transformation services. The scope of the project was expanded in December 2022,
and it was concluded in March 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Future Foods B.V. (Future Foods)</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">On
May&#160;1, 2021, we entered into a service agreement with Future Foods for food-product development services </span>and <span style="font-family: Times New Roman, Times, Serif">application
research. In December&#160;2022, this agreement was renewed for an additional twelve-month period. Future Foods is wholly-owned by our
Chief Product Officer, Henk Hoogenkamp.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Flavour Products BV (Flavour Products)</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">On
December&#160;28, 2021, we entered into a service agreement with Flavour Products for the development of flavor </span>profiles <span style="font-family: Times New Roman, Times, Serif">for
our products. This project is expected to be concluded by the end of 2023.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Koompin Farms</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">On
April&#160;13, 2022, we entered into a service agreement with Koompin Farms for the provision of seed multiplication </span>services<span style="font-family: Times New Roman, Times, Serif">.
The project ended with seed harvesting in October&#160;2022.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Premas Biotech PVT Ltd. (Premas)</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On May&#160;16, 2022, we
entered into a service agreement with Premas for a fermentation project consisting of the development of yeast-based production cell lines
for several bovine proteins. This agreement ended in October&#160;2022 after the completion of the project.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 56; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Curators of the University of Missouri
(University of Missouri)</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On November&#160;4, 2022,
we entered into a service agreement with the University of Missouri for the provision of expression analysis services in soybean transgenic
events.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Raw Materials and Material Sourcing</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The process of scaling up
our seed inventory and production is performed in the United&#160;States and Argentina. We have access to different growers in both countries
to outsource the production depending on agronomical conditions. Currently, we have safflower productions in American Falls (Idaho, USA)
and Monte del Rosario (C&#243;rdoba, Argentina).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For <span style="font-family: Times New Roman, Times, Serif">seed
transformation and seed scaling up at R&amp;D stage (soybean and pea), including greenhouses use, we currently work with three outsourced
service centers: WCIC, WSU and INDEAR.&#160;We are constantly evaluating the most suitable partners considering the scope of the new R&amp;D
programs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Government Regulation</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are, and will be, subject
to laws and regulations in which we operate. This includes laws and regulations governing <span style="font-family: Times New Roman, Times, Serif">biotechnology</span>
and food companies related to the development, approval, manufacturing, import, export, marketing and sale of our products. See &#8220;<i>Item
3. Key Information&#8212;D. Risk Factors&#8212;Risks Relating to Laws and Regulation</i>&#8221;.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Regulation of Plant Biotechnology Products</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">United&#160;States</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our main focus is the United&#160;States
market. In the United&#160;States, the main agencies with responsibility for regulation of plant biotechnology products are the USDA,
the Animal and APHIS, and the FDA.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On April 5, 2023, USDA-APHIS
issued a Regulatory Status Review with the conclusion that our GLA safflower plants pose no greater plant pest risk than non-genetically
engineered safflower plants according to regulation 7 CFR part 340. Accordingly, we are no longer required to obtain USDA-APHIS permits
for importation, interstate movement, and environmental release of GE plants.&#160;Moolec GLA safflower oil (GLASO) already has approvals
from the FDA for use of GLASO as an ingredient in dietary supplements, an ingredient in nutritional beverages and medical foods, and as
an ingredient in pet food. We also have FDA approval for use of the seed meal from GLA safflower plants in food for cattle and poultry.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Argentina</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our plants require approval
under the Ministry of Agriculture, Livestock and Fisheries (&#8220;MAGP&#8221;), since we plan to produce our crops in both Argentina
and the United&#160;States in order to have flexibility given the counter seasons of the two locations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Currently we have permits
from the MAGP for importation, movement and environmental release from some of our genetically modified plants. Our chymosin safflower
has been fully approved by MAGP for release and production in Argentina and no further permits are required for its production.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 57; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Regulation of Food and Ingredient Products</i></b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">United&#160;States</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are subject to laws and
regulations administered by various federal, state and local regulatory agencies in the United&#160;States, such as the FDA, the Federal
Trade Commission, the Environmental Protection Agency, the Occupational Safety and Health Administration, and the USDA, related to any
future processing, packaging, distribution, sale, marketing, labeling, quality, safety, and transportation of our products, as well as
our occupational safety and health practices.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Among other things, the
facilities where are products are grown in the United&#160;States may be required to register with the FDA, and comply with regulatory
schemes including the Food Safety Modernization Act. We would also be subject to state and local food and safety regulations in connection
with the sale of our future products. We are also subject to labor and employment laws, laws governing advertising, privacy laws, safety
regulations and other laws.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Other Regulatory Requirements</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are also subject to various
federal, state, local and national and transnational laws, regulations and requirements in the jurisdictions in which we operate, relating
to not only biotechnology and food and ingredient products. In the future as we continue to grow, we may be subject to other regulations
and requirements in the jurisdictions in which we operate relating to, among others, safe working conditions, laboratory and distribution
practices, transportation and disposal of hazardous or potentially hazardous substances. In addition, applicable import and export laws
will require us to abide by certain standards relating to the cross-border transit of finished goods and raw materials.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The costs associated with
our continued compliance with the various applicable federal, state, local, national and transnational regulations to which we are subject,
or could become subject could be significant, and the failure to comply with such legal requirements could have an adverse effect on our
results of operations and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Employees</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">As
of June 30, 2023, we had </span>45 <span style="font-family: Times New Roman, Times, Serif">full-time and temporary employees located
in the United&#160;States, Argentina, the Netherlands and the United Kingdom. We employ five Ph.Ds and other skilled scientists, biotechnologists
and engineers for our team. Our work environment is focused on technology, as it is our corporate purpose. We have never experienced a
labor-related work stoppage. </span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Legal Proceedings</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">From time to time, we may
become involved in legal proceedings arising in the ordinary course of our business. As of the date hereof, we are not party to any legal
proceeding.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 58; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_019"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">C. Organizational
Structure</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following diagram depicts
our current organizational structure:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_002.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">The following table identifies
our main subsidiaries and joint arrangements as of June 30, 2023:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Jurisdiction of Incorporation</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Ownership Interest</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Voting Interest</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -0.1in; padding-left: 0.1in">Moolec Science Limited <sup>(1)</sup>  <b>&#160;</b></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: center">England</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">LightJump Acquisition Corporation </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">Delaware</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Valorasoy S.A. <sup>(2)</sup> </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">Argentina</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">AG Biomolecules LLC </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">Delaware</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Microo Foods Ingredients S.L. <sup>(3)</sup>  </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">Spain</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50</td><td style="text-align: left">%</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.3in"><i>Notes:-</i></td><td style="text-align: justify"></td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in">(1)</td><td style="text-align: justify">Moolec Science Limited has a branch office in Argentina, Moolec Science Limited S.E.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in">(2)</td><td style="text-align: justify">Acquired pursuant to the ValoraSoy Acquisition, which closed on April 24, 2023.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in">(3)</td><td style="text-align: justify">During December 2022, we agreed to participate in a joint arrangement
with the 50% of participation of the newly created company named Microo Food Ingredients Sociedad Limitada. See &#8220;<i>Item 4. Information
on the Company&#8212;A. History and Development of the Company&#8212;Convertible Note issued to Insud.</i>&#8221;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><div><a id="a_020"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">D.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Property, Plant and Equipment</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Prior to the closing of
the ValoraSoy Acquisition, our assets mainly consisted of intangible assets, such as intellectual property rights. As a result of the
closing of the ValoraSoy Acquisition, we incorporated a processing facility located in the Argentine soybean corridor, which helps maximize
raw material origination, with an installed crushing capacity of 10 thousand tons of soybean per year. In our processing facility we specialize
in the production of textured soy proteins, providing high-quality products and customized solutions to clients in more than 14 countries
in 3 different continents.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In addition, we have entered
into a lease agreement with Excedr, Inc., pursuant to which we lease and operate a laboratory at Texas A&amp;M University and the equipment
therein, which has allowed us to continue to conduct our research.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"></p><div>

</div><!-- Field: Page; Sequence: 59; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><div><a id="a_021"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> ITEM 4A. UNRESOLVED STAFF COMMENTS</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">None.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><div><a id="a_022"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> ITEM&#160;5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><i>The following discussion
and analysis provide information which our management believes is relevant to an assessment and understanding of our operating results
and financial condition. This discussion and analysis should be read together with our audited consolidated financial statements and related
notes that are included elsewhere in this annual report, and with the financial information presented under the section entitled &#8220;Item
3. Key Information&#8212;A. Selected Financial Data.&#8221; In addition to historical financial information, this discussion and analysis
contains forward-looking statements based upon current expectations that involve risks, uncertainties and assumptions. See the section
entitled &#8220;Cautionary Note&#160;Regarding Forward-Looking Statements.&#8221; Actual results and timing of selected events may differ
materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under
&#8220;Item 3. Key Information&#8212;D. Risk Factors&#8221; or elsewhere in this annual report.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><div><a id="a_023"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">A.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Operating Results</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Factors Affecting our Operating Results</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our operating results have
been influenced and will continue to be influenced by the following factors:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Regulatory environment</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our operating results will
vary depending on the speed in which we are able to obtain regulatory approvals for our products and the cost and expense associated with
gaining such approvals. The degree of regulation to which we are subject varies by activity and country. Our ability to sell our technologies
and products depends on obtaining and maintaining necessary authorizations, permits and regulatory approvals in the markets in which we
operate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Product Development</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We have seven ongoing projects
which we expect to market and generate revenue in the near future. We expect to launch SPC2 in 2025 and GLASO in 2025, among others. SPC2
is currently at the scale-up stage, whereby we have already been able to successfully develop the prototype and are conducting further
research in greenhouses related to protein expression. GLASO is also at the scale-up stage, where we currently are increasing seed stock
and crushing processing trials. Our meat replacement products remain in the first developmental stages of research, including discovery,
transformation and development. See &#8220;<i>Item 4. Information on the Company&#8212;B. Business Overview&#8212;Research and Development</i>&#8221;.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We have made significant
progress in the research and development of our products, as well as in acquiring the necessary production facilities to scale-up production:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">On March 31, 2023, USDA-APHIS issued a Regulatory Status
Review with the conclusion that our GLA safflower plants pose no greater plant pest risk than non-genetically engineered safflower plants
according to regulation 7 CFR part 340. We also have FDA approval for use of the seed meal from GLA safflower plants in food for cattle
and poultry. See <i>&#8220;Item 4. Information on the Company <span style="font-family: Times New Roman, Times, Serif">&#8212;B. Business
Overview &#8212; Government Regulation.&#8221;</span></i></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">As a result of the closing of the ValoraSoy Acquisition,
we acquired a soy processing plant in Argentina which specializes in the production of textured soy proteins. Its products are manufactured
using various extrusion processes obtaining as a result vegetable proteins with texture and fibrousness similar to those of meat, with
various applications such as hamburgers, sausages, and other plant-based products. See <i>&#8220;Item 4. Information on the Company<span style="font-family: Times New Roman, Times, Serif">&#8212;B.
Business Overview &#8212; Significant Transactions &#8212; ValoraSoy Acquisition.&#8221;</span></i></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">We are striving to successfully
complete certain major research, development and production activities in order to meet our expected production dates.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"></p><div>

</div><!-- Field: Page; Sequence: 60; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our team of scientists,
technicians and staff is committed to achieving the milestones to meet our current production and commercialization timelines to enable
us to achieve our expected production dates. Achievement of these milestones are critical to our development timelines, though may be
subject to unanticipated delays outside of our control such as the ability to obtain sufficient capital to support production.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Capital Requirements</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">As a result of the closing
of the ValoraSoy Acquisition, we generate revenue from our operations from ValoraSoy&#8217;s pre-existing contracts. However, until we
can generate sufficient revenue, we are dependent on our ability to raise sufficient capital from third-party sources. We expect to finance
our future capital needs through private placements of our securities, public offerings of equity and/or equity-linked securities, debt
financings, collaborations, and licensing arrangements. See &#8220;<i>Item 4. Information on the Company&#8212;A. History and Development
of the Company&#8212;Recent Developments</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Macroeconomic conditions in Argentina</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We generate a significant
portion of our revenue in Argentina, an emerging market. Therefore, our operating result and financial condition are directly impacted
by macroeconomic and fiscal developments, including fluctuations in currency exchange rates, inflation and interest rate fluctuations,
in Argentina. See &#8220;<i>Item 3. Key Information&#8212;D. Risk Factors&#8212;Risks Relating to our Business and Operations&#8212;Economic
and political developments in Argentina, including inflation and government controls may adversely affect the economy and our financial
condition and results of operations</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operating Results</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We have based the following
discussion on our audited consolidated financial statements included elsewhere in this report. You should read it along with these financial
statements, and it is qualified in its entirety by reference to them.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Comparison of the Year Ended June&#160;30,
2023 and the Year Ended June 30, 2022</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
following table sets </span>forth <span style="font-family: Times New Roman, Times, Serif">our historical operating results for the periods
indicated:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Consolidated Statements of Comprehensive Loss</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the<br/> year&#160;ended<br/> June&#160;30,<br/> 2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the<br/> year&#160;ended<br/> June&#160;30,<br/> 2022</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Change</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Variation</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: normal; font-style: italic">&#160;</td>
    <td colspan="10" style="font-weight: normal; font-style: italic; text-align: center">(in United States Dollars)</td><td style="font-weight: normal; font-style: italic">&#160;</td><td style="font-weight: normal; font-style: italic">&#160;</td>
    <td colspan="2" style="font-weight: normal; font-style: italic; text-align: center">(%)</td><td style="font-weight: normal; font-style: italic">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">Continuing operations</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Revenue </td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">905,049</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#8212;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">905,049</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N.S.</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cost of sales </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,048,354</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,048,354</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N.S.</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Research and development expense </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,351,217</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(985,158</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(366,059</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37.2</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Marketing expense </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(256,421</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(105,060</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(151,361</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">144.1</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Administrative expense </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,808,655</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,523,230</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,285,425</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">90.6</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other operating expense </td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(94,207</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(38,985</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(55,222</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">141.6</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Loss from operations </td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(6,653,805</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(3,652,433</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(3,001,372</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">82.2</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Financial cost </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(160,035</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,130</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(157,905</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,413.4</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other financial results </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,030,525</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(872,342</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,902,867</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(218.1</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Transaction expenses </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,535,046</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,535,046</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N.S.</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Share based payment cost of listing shares </td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(42,705,061</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(42,705,061</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N.S.</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Net loss before Income tax </td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(52,023,422</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(4,526,905</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(47,496,517</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,049.2</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Income tax </td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">234,542</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Net loss for the year </td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(51,788,880</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(4,526,905</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(47,261,975</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,044.0</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Basic and diluted loss per share </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.50</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.15</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1.35</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">900.0</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Foreign exchange differences on translation of foreign operations </td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,112</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,112</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N.S.</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Total other comprehensive income/loss</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">18,112</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">18,112</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N.S.</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Total comprehensive loss for the year </td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(51,770,768</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(4,526,905</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(47,243,863</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,043.6</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.3in"><i>Notes:-</i></td><td style="text-align: justify"></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: 0in">&#8220;N.S.&#8221;:
not significant.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 61; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Revenue increased from nil
for the year ended June 30, 2022 to US$905,049 for the year ended June 30, 2023, primarily as a result of the acquisition and integration
of processing capabilities that are now being used as an R&amp;D center for product development, industrial process calibration for protein
treatment, and collaboration and innovation with customers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of sales</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Cost
of sales increased from nil for the year ended June 30, 2022 to </span>US<span style="font-family: Times New Roman, Times, Serif">$1,048,354
for the year ended June 30, 2023, as a </span>result <span style="font-family: Times New Roman, Times, Serif">of the acquisition and integration
of a processing plant that is now being used as a R&amp;D center for product development, industrial process calibration for protein treatment,
and collaboration and innovation with customers. </span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research and Development Expense</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">R&amp;D
expenses increased by </span>US<span style="font-family: Times New Roman, Times, Serif">$366,059 or 37.2% from </span>US<span style="font-family: Times New Roman, Times, Serif">$985,158
for the year ended June 30, 2022 to </span>US<span style="font-family: Times New Roman, Times, Serif">$1,351,217 for</span> the <span style="font-family: Times New Roman, Times, Serif">year
ended June&#160;30, 2023, primarily due to an increase in professional fees, mainly derived to the different stages and nature of the
projects.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Administrative Expense</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Administrative
expense increased by </span>US<span style="font-family: Times New Roman, Times, Serif">$2,285,425 or 90.6% from </span>US<span style="font-family: Times New Roman, Times, Serif">$2,523,230
for the year ended June 30, 2022 to $4,808,655 for the year ended June&#160;30, 2023, primarily due to an increase with audit, legal and
accountancy fees, which totaled </span>US<span style="font-family: Times New Roman, Times, Serif">$699,565, together with an increase
of </span>US<span style="font-family: Times New Roman, Times, Serif">$954,794 related to payroll and share based payments and to a lesser
extent, to the incorporation of the acquired processing capabilities. Included within our administrative expenses there is a significant
portion of non-cash items, mainly related to share-based payments, amortization and depreciation amounting to </span>US<span style="font-family: Times New Roman, Times, Serif">$1,263,680
in June 30, 2023 compared to </span>US<span style="font-family: Times New Roman, Times, Serif">$838,576 in June 30, 2022.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other Operating Expense</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Other
</span>operating <span style="font-family: Times New Roman, Times, Serif">expense increased by </span>US<span style="font-family: Times New Roman, Times, Serif">$55,222
from </span>US<span style="font-family: Times New Roman, Times, Serif">$38,985 for the year ended June 30, 2022 to </span>US<span style="font-family: Times New Roman, Times, Serif">$94,207
for the year ended June&#160;30, 2023, due to miscellaneous expenses.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial cost</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Financial
cost increased by </span>US<span style="font-family: Times New Roman, Times, Serif">$157,905 from $2,130 for the year ended June 30, 2022
to </span>US<span style="font-family: Times New Roman, Times, Serif">$160,035 for the year ended </span>June <span style="font-family: Times New Roman, Times, Serif">30,
2023, due to interest expenses related to loans.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"></p><div>

</div><!-- Field: Page; Sequence: 62; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other financial results</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Other
financial results increased by $1,902,867 from a loss of </span>US<span style="font-family: Times New Roman, Times, Serif">$872,342 for
the year ended June 30, 2022 to a gain of </span>US<span style="font-family: Times New Roman, Times, Serif">$1,030,525 for the year ended
June 30, 2023, mainly due to the effect of the warrants revaluation gain of </span>US<span style="font-family: Times New Roman, Times, Serif">$778,811,
investment gains of </span>US<span style="font-family: Times New Roman, Times, Serif">$1,009,318, interest gains of $693,027 and the gain
generated by the application of IAS 29 in our subsidiary in Argentina of </span>US<span style="font-family: Times New Roman, Times, Serif">$245,989,
partially offset by a loss of exchange rate differences of </span>US<span style="font-family: Times New Roman, Times, Serif">$1,386,599.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Transaction expenses</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Transaction
expenses increased from none for the year ended June 30, 2022 to </span>US<span style="font-family: Times New Roman, Times, Serif">$3,535,046
for the year ended June </span>30<span style="font-family: Times New Roman, Times, Serif">, 2023 due to one time transaction costs related
to the consummation of the Business Combination Agreement (excluding those that have been recognized in equity in accordance with IFRS-IASB).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Share based payment cost of listing shares</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">For
the year ended June 30, 2023 we recorded a charge for the cost relating to the listing of shares of </span>US<span style="font-family: Times New Roman, Times, Serif">$42,705,061,
accounted as a share based payment in accordance with IFRS 2</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Comparison of the Year Ended June 30,
2022 and the period from January 1, 2021 through June 30, 2021</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The <span style="font-family: Times New Roman, Times, Serif">following
table sets forth our historical operating results for the periods indicated. As a result of the difference in the length of time for each
period, the operating results for the year ended June 30, 2022 are not directly comparable with the results for the period from January
1, 2021 through June 30, 2021.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Consolidated Statements of Comprehensive Loss</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the<br/> year&#160;ended<br/> June&#160;30,<br/> 2022</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the period from<br/> January 1, 2021<br/> through<br/> June&#160;30,<br/> 2021</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Change</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Variation</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: normal; font-style: italic">&#160;</td>
    <td colspan="10" style="font-weight: normal; font-style: italic; text-align: center">(in United States Dollars)</td><td style="font-weight: normal; font-style: italic">&#160;</td><td style="font-weight: normal; font-style: italic">&#160;</td>
    <td colspan="2" style="font-weight: normal; font-style: italic; text-align: center">(%)</td><td style="font-weight: normal; font-style: italic">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">Continuing operations</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Research and development expense </td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(985,158</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(601,942</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(383,216</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">63.7</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Marketing expense </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(105,060</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(80,221</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(24,839</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31.0</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Administrative expense </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,523,230</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(820,946</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,702,284</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">207.4</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other operating expense </td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(38,985</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(93,252</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">54,267</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(58.2</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Loss from operations </td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(3,652,433</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(1,596,361</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(2,056,072</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">128.8</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Share of loss from associate </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(390,453</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">390,453</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(100.0</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Financial costs </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,130</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,130</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N.S.</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other financial results</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(872,342</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(872,342</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N.S.</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net loss before Income tax </td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(4,526,905</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(1,986,814</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(2,540,091</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">127.7</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Income tax </td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net loss for the year </td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(4,526,905</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(1,986,814</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(2,540,091</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">127.7</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Basic and diluted loss per share </td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.15</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.07</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.08</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">114.3</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: -0.125in; font-weight: bold; text-align: left">Total comprehensive loss for the year </td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(4,526,905</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(1,986,814</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(2,540,091</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">127.7</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td style="width: 0.25in"><i>Notes:-</i></td><td style="text-align: justify"></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify">&#8220;N.S.&#8221;: not significant.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 63; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Research and Development Expense</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">R&amp;D expenses increased
by US$383,216 or 63.7% from US$601,942 for the period of January 1, 2021 through June 30, 2021 to US$985,158 for the year ended June 30,
2022, primarily due to an increase in professional fees relating to advances in our R&amp;D pipeline.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Administrative Expense</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Administrative <span style="font-family: Times New Roman, Times, Serif">expense
increased by </span>US<span style="font-family: Times New Roman, Times, Serif">$1,702,284 or 207.4% from </span>US<span style="font-family: Times New Roman, Times, Serif">$820,946
for the period of January 1, 2021 through June 30, 2021 to </span>US<span style="font-family: Times New Roman, Times, Serif">$2,523,230
for the year ended June 30, 2022, primarily due to an increase with audit, legal and accountancy fees, and additional expenses including
share based payments, payroll expenses, insurance and amortization costs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other Operating Expense</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Other
operating expense decreased by </span>US<span style="font-family: Times New Roman, Times, Serif">$54,267 or 58.2% from US$93,252 for the
period of January 1, 2021 through June 30, 2021 to US$38,985 for the year ended June 30, 2022, primarily due to a reduction in non-recurrent
related party </span>expenses<span style="font-family: Times New Roman, Times, Serif">.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><div><a id="a_024"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">B.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Liquidity and Capital Resources</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Overview</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our principal source of
liquidity has been through shareholders funding, and which has historically been sufficient to meet our working capital and capital expenditure
requirements. As of June 30, 2023, June 30,&#160;2022, and June 30, 2021, we had cash and cash equivalents of US$2,527,673, US$1,081,808,
and US$980,527, respectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We believe that our current
level of liquidity is adequate for the expected needs of the Company for the next twelve&#160;months. As a growing business, we may, however,
in the future require additional cash resources due to changing business conditions, implementation of our strategies to expand our business,
or other investments or acquisitions we may decide to pursue. If we determine that our cash requirements exceed the amount of cash and
cash equivalents we have on hand at the time, we may seek to issue equity, debt or convertible securities or obtain credit facilities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">A decline in the market
price of our Ordinary Shares could adversely affect our ability to issue additional securities and our ability to raise additional capital
on acceptable terms at a time that we deem appropriate or at all in the future. In addition, issuance and sale of additional equity would
result in further dilution to our shareholders. The incurrence of indebtedness would result in increased fixed obligations and could result
in operating covenants that would restrict our operations. We cannot assure you that financing will be available in amounts or on terms
acceptable to us, if at all. See &#8220;<i>Item 3. Key Information&#8212;D.&#160;Risk Factors&#8212;Risks Relating to the Company</i>&#8221;&#160;and
&#8220;<i>Item 4. Information on the Company&#8212;A. History and Development of the Company&#8212;Recent Developments</i>&#8221; for
more details.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Equity Subscription Line</i></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">On April 14, 2023, we entered
into the Nomura Purchase Agreement and the Nomura Registration Rights Agreement with Nomura. Pursuant to the Nomura Purchase Agreement,
we have the right to sell to Nomura up to US$50 million in aggregate gross purchase price of our newly issued Ordinary Shares, from time
to time during the three-year term of the Nomura Purchase Agreement. The purchase price of our Ordinary Shares that we elect to sell Nomura
pursuant to the Nomura Purchase Agreement will generally be determined by reference to the VWAP during an applicable purchase period on
the day of the applicable purchase date for which we have timely delivered written notice to Nomura directing it to purchase Ordinary
Shares under the Nomura Purchase Agreement, less a fixed 5% discount to such VWAP. Sales of Ordinary Shares pursuant to the Nomura Purchase
Agreement, and the timing of any sales, are solely at our option, and we are under no obligation to sell any securities to Nomura under
the Nomura Purchase Agreement. We will determine the sales of our ordinary shares to Nomura from time to time in our sole discretion and
such sales will depend on a variety of factors, including, among other things, market conditions, the trading price of the ordinary shares
and our determinations regarding the use of proceeds from any sale.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"></p><div>

</div><!-- Field: Page; Sequence: 64; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consolidated Statements of Cash Flows</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The <span style="font-family: Times New Roman, Times, Serif">table</span>
below illustrate our statement of cash flows for the periods indicated:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the<br/> year&#160;ended<br/> June&#160;30,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the<br/> year&#160;ended<br/> June&#160;30,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the period from<br/> January
    1,<br/> 2021&#160;through<br/> June&#160;30,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: normal; font-style: italic">&#160;</td>
    <td colspan="10" style="font-weight: normal; font-style: italic; text-align: center">(in United States Dollars)</td><td style="font-weight: normal; font-style: italic">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -0.1in; padding-left: 0.1in">Net cash (used) in operating activities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(7,511,353</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(1,885,979</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">980,527</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Net cash used in investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,336,820</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.1in; padding-left: 0.1in">Net cash generated from financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,281,661</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,000,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Net increase in cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,433,488</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">114,021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">980,527</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.1in; padding-left: 0.1in">Cash and cash equivalents at the beginning of the year/period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,081,808</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">980,527</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -0.1in; padding-left: 0.1in">Effect of exchange rate changes on cash and equivalents</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">12,377</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(12,740</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">&#8212;</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; text-indent: -0.1in; padding-left: 0.1in">Cash and cash equivalents at end of the year/period</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,527,673</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,081,808</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">980,527</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Comparison of the Year Ended June&#160;30,
2023 and the Year Ended June 30, 2022</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net cash used in operating activities</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Net cash used in operating
activities increased by US$5,625,374 from US$1,885,979 <span style="font-family: Times New Roman, Times, Serif">for</span> the year ended
June&#160;30, 2022 to US$7,511,353 <span style="font-family: Times New Roman, Times, Serif">for</span> the year ended June 30, 2023, primarily
due to increases in one time transaction expenses paid for US$3,378,075 together with other working capital needs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net cash used from investing activities</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Cash flows used from financing
activities increased by US$2,336,820 from nil for the year ended June 30, 2022 to US$2,336,820 for the year ended June 30, 2023, primarily
due to the cash used by our Research and Development activities, which were capitalized as intangible assets, and a cash payment of US$1,930,883
(net of the cash acquired) in respect of the ValoraSoy Acquisition. In addition, the ValoraSoy Acquisition included customer relationships
which were recorded as an intangible asset.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net cash generated from financing activities</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Cash flows from financing
activities increased by US$9,281,661 from US$2,000,000 <span style="font-family: Times New Roman, Times, Serif">for</span> the year ended
June&#160;30, 2022 to US$11,281,661 <span style="font-family: Times New Roman, Times, Serif">for</span> the year ended June 30, 2023,
primarily due to an increase in proceeds relating to the issuance of share capital to UGVL, Theo and the SPAC public holders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Comparison of the Year Ended June&#160;30,
2022 and the period from January 1, 2021 through June&#160;30, 2021</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net cash used in operating activities</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Net cash used in operating
activities increased by US$2,866,506 from net cash generated of US$980,527 for the period of January 1, 2021 through June&#160;30, 2021
to net cash used of US$1,885,979 for the year ended June&#160;30, 2022, primarily due to increases in R&amp;D expenditures, payroll and
administrative expenses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 65; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net cash generated from financing activities</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Cash
</span>flows <span style="font-family: Times New Roman, Times, Serif">from financing activities increased from nil for the period of January
1, 2021 through June&#160;30, 2021 to US$2,000,000 for the year ended June&#160;30, 2022, primarily due to an increase in proceeds relating
to SAFE.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indebtedness</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">As of June 30, 2023, our total
outstanding borrowings, including interest accrued, were US$2,645,289, which consists of US$2,546,243 of current borrowings, and US$99,046
of non-current borrowings, consisting of long-term loans.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">As of June 30, 2023, our
borrowings denominated in US dollars totaled US$2,028,635, which bear a fixed weighted average interest rate of 0%. Our borrowings denominated
in Argentine pesos totaled US$616,654 that bear a fixed weighted average interest rate of 76%.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">As of June 30, 2023, our
total outstanding borrowings were unsecured.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Consideration of payment of acquisitions</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ValoraSoy Acquisition</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">On April 24, 2023, we completed
the acquisition of ValoraSoy from the sellers in accordance with the share purchase agreement. As a result of this acquisition, we acquired
all of the issued and outstanding equity securities of ValoraSoy from the sellers, and ValoraSoy became our wholly owned subsidiary for
total aggregate consideration of US$2.6 million, in a combination of cash and equity. For more information, see <i>&#8220;Item 4. Information
on the Company &#8212;B. Business Overview&#8212;Significant Transactions&#8212;ValoraSoy Acquisition.&#8221;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><div><a id="a_025"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">C.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Research and Development, Patents and Licenses, etc.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For a discussion of our R&amp;D
policy, see &#8220;<i>Item 4. Information on the Company&#8212;B. Business Overview&#8212;Research and Development</i>&#8221;. For a discussion
of patents and licenses, see &#8220;<i>Item 4. Information on the Company&#8212;B. Business Overview&#8212;Intellectual Property</i>.&#8221;</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><div><a id="a_026"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">D.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Trend Information</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">For a discussion of trend
information, see &#8220;<i>&#8212;A. Operating Results&#8212;Factors affecting our operating results</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><div><a id="a_027"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">E.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Critical Accounting Estimates</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our audited consolidated
financial statements are prepared in conformity with IFRS, as issued by the IASB. In preparing our audited consolidated financial statements,
we make judgments, estimates and assumptions about the application of our accounting policies which affect the reported amounts of assets,
liabilities, revenue and expenses. Our critical accounting judgements and sources of estimation uncertainty are described in Note 3 and
Note 4 to our audited consolidated financial statements, which are included elsewhere in this annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 66; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_028"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> ITEM&#160;6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><div><a id="a_029"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">A.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Directors and Senior Management</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Directors</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">As of June 30, 2023, the
following persons (with ages as of the date of this report) are members of our Board of Directors and senior management.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our Executive Officers and Directors</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Name</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Age</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Position</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 33%; text-align: left">Gast&#243;n Paladini</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 9%; text-align: center">42</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 54%; text-align: left">Chief Executive Officer and Director</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Jos&#233; L&#243;pez Lecube</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">40</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Chief Financial Officer and Director</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Amit Dhingra</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">52</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Chief Science Officer</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Henk Hoogenkamp</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">36</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Chief Product Officer</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Mart&#237;n Salinas</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">41</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Chief Technology Officer</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Catalina Jones</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">37</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Chief of Staff &amp; Sustainability</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Natalia Zang</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">47</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Director</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Kyle P. Bransfield</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">38</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Director</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Robert M. Bennett</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">58</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">Director</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Biographical information
for each member of our Board of Directors and senior management is set forth below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><b>Gast&#243;n Paladini</b>.
Mr. Paladini serves as our Chief Executive Officer and as one of our directors. Mr. Paladini is a Co-Founder, and has been the Chief Executive
Officer, since our inception in 2020. For the last ten years, Mr. Paladini has been a board member for Paladini Group, one of the largest
meat producers in Latin America where he committed to promoting innovation as a fundamental company value. Fully aware of the current
challenges the planet is facing and based on his knowledge and experience in the traditional meat industry, he began to explore the ecosystem
of alternative proteins. Before his role as a board member, Mr. Paladini worked at several advertising agencies, including Craverolanis
and Agulla &amp; Baccetti. He has an MBA from IAE Business School and an Advertising degree from the Universidad Abierta Interamericana.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><b>Jos&#233; L&#243;pez
Lecube</b>. Mr. L&#243;pez serves as our Chief Financial Officer and as one of our directors. Mr. L&#243;pez has served as our Chief
Financial Officer since July 2021. He has over 15 years of corporate development experience in strategic roles for multinational companies
with expertise in corporate strategy, finance, and high-impact partnerships. Most recently he worked for Uber Tech Inc. leading key growth
initiatives for the LatAm region during 2019 and 2020. Prior to that Mr. L&#243;pez served as a corporate development executive for
Lartirigoyen and Cia (a Glencore Agri joint venture) leading M&amp;A, financial planning and analysis and corporate strategy in 2017 and
2018. In 2015 and 2016 he was part of the corporate finance team of the Archer Daniel Midland Company in Chicago and S&#227;o Paulo.
Previously, Mr. L&#243;pez Lecube served as an executive for Schroders Asset Management for four years focusing on institutional markets.
He obtained his bachelor&#8217;s degree in business administration from the Universidad de San Andr&#233;s in Argentina in 2007 and
his MBA from the Kellogg School of Business at Northwestern University in the United States in 2015.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><b>Amit Dhingra</b>. Mr.
Dhingra serves as our Chief Science Officer. Mr. Dhingra has served as our Chief Science Officer since early 2021. In 2016, Mr. Dhingra
joined Washington State University (&#8220;WSU&#8221;) as an assistant professor, where he became a tenured professor and also served
as the Interim Chair and Professor of Genomics and Biotechnology in the Department of Horticulture. He also served as the Chair of the
Entrepreneurial Faculty Ambassadors Program, a presidential level task force. In September 2021, he moved his program to Texas A&amp;M
University where he is the Head of the Department of Horticultural Sciences and Professor of Genomics and Biotechnology. Mr. Dhingra is
a recipient of a national Biology Mentor award conferred by the Council on Undergraduate Research. He serves on the editorial board of
five internationally reputed plant science journals. He has been awarded three US and three international patents on regulating ripening
in fruits to reduce post-harvest wastage. His research has been featured in the New York Times, The Atlantic, BBC, The Times of London,
and several other news outlets. Before serving as our Chief Science Officer, Mr. Dhingra founded Phytelligence Inc., an agriculture biotechnology
spin-off out of his lab in 2011. Mr. Dhingra completed his B.Sc. in Botany (Hons) from Hindu College in 1991, New Delhi, India and his
M.Sc. in Botany (Hons) with specialization in Cytogenetics and Plant Breeding from Raja Balwant Singh College, Agra, India in 1993. He
then completed his Ph.D. at the University of Delhi, India and Rutgers University, New Jersey supported by fellowships from the University
Grants Commission and The Rockefeller Foundation, USA, respectively in 2000.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"></p><div>

</div><!-- Field: Page; Sequence: 67; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><b>Henk Hoogenkamp</b>.
Mr. Hoogenkamp serves as our Chief Product Officer. Mr. Hoogenkamp has acted as our Chief Product Officer since August 2020. In 2019,
Mr. Hoogenkamp started a contract research company active in the development of extruded plant-based ingredients whilst working for large
stock-listed multinational companies and many start-ups as a technical and strategic advisor. In 2016, Mr. Hoogenkamp resided in the UK
where he worked as a sales executive for the Brecks Food Company, a plant-based ingredient manufacturer and co-manufacturer of vegetarian
sausages. In 2015, Mr. Hoogenkamp joined Food Flow Inc., an ingredient company in the Philippines as a technical sales and innovation
manager regarding the application of animal and plant-based proteins in local food production until August 2016. Mr. Hoogenkamp has a
Bachelor&#8217;s degree in Biochemistry and a Master&#8217;s degree in Molecular Life Sciences from the HAN University of Applied Sciences
in the Netherlands. For his Ph.D. research, he raised funds from both public and private sectors to further research the use of animal
by-products for the design of biomedical materials in tissue engineering and regenerative medicine. He split his time between fundamental
research for the Radboud University Nijmegen Medical Centre and applied research for Marel Townsend Further Processing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><b>Mart&#237;n Salinas</b>.
Mr. Salinas has served as our Chief Technology Officer since August 2020. Mr. Salinas is a highly accomplished professional in the fields
of industrial biotechnology, biochemical engineering and business development. In 2010, Mr. Salinas&#8217; career commenced in the mining
industry, where he honed his skills as a process engineer. His transition to Bioceres in 2011 marked a transformative period, where he
dedicated over a decade to spearheading the industrialization of the molecular farming platform. Under his leadership, Bioceres achieved
a significant milestone by securing the first commercialization and regulatory approval for a product using this innovative technology.
In 2018, Mr. Salinas co-founded Phoenxt, a Germany-based company participating in the transition to a sustainable fashion industry through
the use of technology to recover fibers from textile waste and use it again for yarn production to fully close the loop. Mr. Salinas is
a Process and Chemical Engineer from the Universidad Nacional de Tucum&#225;n and holds a Ph.D in biology from the same university,
where he specialized in enzyme production and mathematical modeling while carrying out a secondment in Leibniz Universit&#228;t Hannover.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><b>Catalina Jones</b>. Ms.
Jones serves as Chief of Staff and Sustainability. Ms. Jones has acted as our Chief of Staff and Sustainability since January 2022. Ms.
Jones started her professional career in 2010 in the public sector where she worked in the Ministry of Education of Buenos Aires. After
that, in 2012, Ms. Jones moved her career to the private sector where she started her endeavors in corporate social responsibility, integration
of sustainability in business models, circular economy and accountability. During her time in Banco Galicia, one of the largest private
banks in Argentina, Ms. Jones worked in the implementation of social investment programs and coordinated the first green finance credit
line for ventures with high social and environmental impact. In 2016, Ms. Jones continued her professional career in Grupo Arcor carrying
out the integration of sustainability strategies in the Agribusiness, Consumer Food Products, and Packaging business units. In 2020, Ms.
Jones joined Moolec Science as Project and Communication Manager, a role she held until eventually assuming her current position. Ms.
Jones holds a degree in International Relations from the Pontificia Universidad Cat&#243;lica Argentina, and postgraduate training in
Business Sustainability from the Universidad de San Andr&#233;s and Project Management from Instituto Tecnol&#243;gico de Buenos Aires
in Argentina.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><b>Natalia Zang. </b>Ms.
Zang serves as one of our non-executive directors. Ms. Zang is a business leader with more than 25 years of experience in private equity
and corporate finance in Latin America, Europe and Australia. Ms. Zang serves as a Bioceres Crop Solutions Corp. non-executive director
and Chair of the Audit Committee. She is currently advisor of Jazzya Investments, CFO of Overture Life and member of the Investment Committee of MBV Fund.
Previously, Ms. Zang held C-level positions in several industries, including mining, retail and real estate. In late 2015, Ms. Zang joined
President Macri&#8217;s administration in Argentina, initially as Undersecretary for the Chief of Staff and then as Secretary (General
Coordinator of the G20). Ms. Zang is a sought-after lecturer on business and women&#8217;s leadership issues, and she is active in mentoring
programs for students and women entrepreneurs. Ms. Zang received a master&#8217;s degree in finance from the Universidad del CEMA and
a bachelor&#8217;s degree in Business Administration from the Universidad Torcuato Di Tella.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"></p><div>

</div><!-- Field: Page; Sequence: 68; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><b>Kyle P. Bransfield. </b>Mr.
Bransfield serves as one of our non-executive directors. Mr. Bransfield currently serves as the President, Chief Executive Officer and
a director of Union Finance Corp. since its inception in 2021, and as the Chief Executive Officer and a director of Union Acquisition
Corp. III since June 2020 and of Union Growth Capital since April 2021. He has also served as a director of Union Acquisition Corp. I
since November 2017 and as its Chief Executive Officer from December 2017 until it completed its merger with Bioceres, Inc. in March 2019,
and served as Chief Executive Officer and a director of Union Acquisition Corp. II since its inception until the closing of the business
combination with Procaps Group S.A. Mr. Bransfield currently serves on the boards of Procaps Group S.A. and Bioceres Crop Solutions Corp.,
and sits on our audit and compensation committees in addition to committees of Procaps Group S.A.. Mr. Bransfield is the Founder and CEO
of Union Acquisition Group, a private and public markets investment firm. Prior to Union Acquisition Group, Mr. Bransfield was a Partner
at Exos Technology Financial Partners where he established a SPAC Asset Management business through the formation of Exos SPAC Opportunities
I and the Morgan Cree-Exos SPAC+ Fund. Prior to Exos, Mr. Bransfield was a Partner of Atlantic-Pacific Capital and led the firm&#8217;s
global direct private placement and structured investment activities since 2015. Mr. Bransfield has over 13 years of experience in direct
equity and debt private markets principal investing, capital raising, and investment banking. Prior to joining Atlantic-Pacific, Mr. Bransfield
was an investment banker in Sagent Advisors&#8217; Private Financing Solutions Group from 2014 to 2015. Prior to Sagent, Mr. Bransfield
spent five years from 2009 to 2014 as a Principal and General Partner at CS Capital Partners, a Philadelphia-based multi-family office
focused on alternative investments. In his role there, he co-managed a portfolio of direct investments, served as an observer to several
boards of directors, and fulfilled operating roles within portfolio companies. In 2006, Mr. Bransfield began his career in the Mergers
&amp; Acquisitions Group at Stifel Nicolaus Weisel. Mr. Bransfield received a B.S. in Business Administration from American University.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><b>Robert M. Bennett</b>.
Mr. Bennet serves as one of our non-executive directors. Further, he is LightJump&#8217;s Chairman and Chief Executive Officer since July
2020 has over 30 years of private equity experience in technology, media and manufacturing businesses. Mr. Bennett has broad experience
in building proprietary deal sourcing, raising financing and closing acquisition transactions and then growing those businesses and selling
them to strategic acquirers. Since 1997, Mr. Bennett has served as Chief Executive Officer of the First Lexington organization, a private
equity sponsor group that has led many transactions. From 2014 to 2017, Mr. Bennett was Chief Executive Officer of ViewMarket, Inc., a
company he co-founded that acquired CultureMap, a digital media company. ViewMarket was subsequently sold to Gow Media, LLC in 2017. Since
2017, Mr. Bennett has also served as Chairman and Chief Executive Officer of Jon D. Williams Cotillions, Inc., a national social education
provider. From 1997 to 2019, Mr. Bennett was Chief Executive Officer of Long-Lok Fasteners Corporation, a next generation proprietary
aerospace fasteners company in which he purchased two additional &#8220;bulk up&#8221; businesses, Bernic Screw Corp and A&amp;W Screw
Corp. The company was sold to Novaria Group, LLC in December 2019. Since 2003, Mr. Bennett has also served as Vice Chairman of Modulant
Solutions, an IT services and software company that he co-founded and later acquired Product Data Integration Technologies, Inc. From
1999 to 2003, Mr. Bennett was Chairman of Springbow Solutions, Inc., a company he co-founded that acquired three IT service companies
and provided next generation IT, portal and web services. The company was sold to Soflink, Inc. in 2005. In the 1990s, Mr. Bennett acquired
and sold various media and manufacturing businesses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><div><a id="a_030"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">B.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Compensation</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Remuneration of Directors and Senior Management</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The aggregate compensation,
including benefits in kind, accrued or paid to our senior management with respect to the year ended June 30, 2023, for services in all
capacities was US$1.2&#160;million which includes restricted stock units that may be settled in cash or shares, at our election. In addition,
in the year ended June 30, 2023, we granted our senior management options to purchase 200,000 of our Ordinary Shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"></p><div>

</div><!-- Field: Page; Sequence: 69; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Moolec Share Option Plan</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The Moolec Limited Employee
Share Plan was adopted as our share option plan (the &#8220;Moolec Share Option Plan&#8221;) by our Board of Directors on December 20,
2023, which sets a limit of 5% of the ordinary share capital to be issued under the Moolec Share Option Plan. Previously Moolec Limited
had approved the Moolec Share Option Plan by their board of directors on August 23, 2021. In terms of eligibility, any of our current
or former employee, director or office holder or any of our subsidiaries may be designated by our Board of Directors as eligible to receive
an award under the Plan. Prior to the issuance or transfer of shares to the award holder, the award holder does not have voting rights,
the right to receive dividends, nor any other right of a shareholder.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Amount set aside for pension, retirement
or similar benefits</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The total amounts set aside
or accrued by us to provide pension, retirement or similar benefits for the fiscal year ended June 30, 2023 was not material.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Director Compensation</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our Board of Directors has
established a compensation program for executive and non-executive directors, which consists of an annual retainer, board fees in accordance
with their attendance at board meetings and committee fees for their service as members of a committee. We also reimburse our independent
directors for reasonable out of pocket expenses incurred in connection with the performance of their duties as directors, including, without
limitation, travel expenses in connection with their attendance in person at board and committee meetings.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><div><a id="a_031"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">C.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Board Practices</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our Articles provide that
the Board of Directors must comprise at least five members. Our board currently consists of five directors. Our Articles also provide
that each director will have a mandate that does not exceed one year, but is eligible for re-appointment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Audit Committee</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">As of the date of this report,
our audit committee consists of Natalia Zang, Kyle P. Bransfield and Robert M. Bennett, with Natalia Zang serving as the chair of the
audit committee. Each of Natalia Zang, Kyle P. Bransfield and Robert M. Bennett meets the applicable audit committee independence standards.
In addition, all of the audit committee members meet the requirements for financial literacy under applicable SEC and Nasdaq rules and
at least one of the members qualifies as an &#8220;audit committee financial expert,&#8221; as such term is defined in Item 407(d) of
Regulation S-K. Our Board adopted a new written charter for the audit committee, which is available on our Investor Relations website.
The reference to our websites in this annual report on Form 20-F does not include or incorporate by reference the information on our website
into this annual report on Form 20-F.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our audit committee is responsible
for, among other things:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">appointing, compensating, retaining, evaluating, terminating
and overseeing our independent registered public accounting firm;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">discussing with our independent registered public accounting
firm their independence from management;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">reviewing, with our independent registered public accounting
firm, the scope and results of their audit;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">approving all audit and permissible non-audit services to
be performed by our independent registered public accounting firm;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">overseeing the financial reporting process and discussing
with management and our independent registered public accounting firm the annual financial statements that we file with the SEC;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">overseeing our financial and accounting controls and compliance
with legal and regulatory requirements;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">reviewing our policies on risk assessment and risk management;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">reviewing related person transactions; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">establishing procedures for the confidential anonymous submission
of concerns regarding questionable accounting, internal controls or auditing matters.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 70; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Compensation Committee</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">As of the date of this report,
our compensation committee consists of Natalia Zang and Kyle P. Bransfield, with Natalia Zang serving as the chair of the compensation
committee. The members of our compensation committee were designated by our Board at the closing of the Business Combination, and each
qualifies as an independent director according to the rules and regulations of the SEC and Nasdaq with respect to compensation committee
membership, including the heightened independence standards for members of a compensation committee. Our Board adopted a new written charter
for the compensation committee, which is available on our Investor Relations website. The reference to our websites in this annual report
on Form 20-F does not include or incorporate by reference the information on our website into this annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our compensation committee
is responsible for, among other things:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">reviewing and approving the corporate goals and objectives,
evaluating the performance of and reviewing and approving, (either alone or, if directed by the Board, in conjunction with a majority
of the independent members of the Board) the compensation of our Chief Executive Officer;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">overseeing an evaluation of the performance of and reviewing
and setting or making recommendations to our Board regarding the compensation of our other executive officers;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">reviewing and approving or making recommendations to our
Board regarding our incentive compensation and equity-based plans, policies and programs;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">reviewing and approving all employment agreement and severance
arrangements for our executive officers;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">making recommendations to our Board regarding the compensation
of our directors; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">retaining and overseeing any compensation consultants.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Nominating Committee</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our nominating committee
consists of Natalia Zang and Robert M. Bennett, with Robert M. Bennett serving as the chair of the nominating committee. The members of
our nominating committee were designated by our Board at the closing of the Business Combination, and each qualifies as an independent
director according to the rules and regulations of the SEC and Nasdaq with respect to nominating committee membership, including the heightened
independence standards for members of a nominating committee. Our Board adopted a new written charter for the nominating committee, which
is available on our Investor Relations website. The reference to our websites in this annual report on Form 20-F does not include or incorporate
by reference the information on our website into this annual report on Form 20-F.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">Our nominating committee
is responsible for, among other things:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">identifying individuals qualified to become members of our
Board, consistent with criteria approved by our Board;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">overseeing succession planning for our Chief Executive Officer
and other executive officers;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">periodically reviewing our Board&#8217; leadership structure
and recommending any proposed changes to our Board;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">reviews developments in corporate governance practices;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">overseeing an annual evaluation of the effectiveness of our
Board and its committees; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#9679;</span></td><td style="text-align: justify">developing and recommending to our Board a set of corporate
governance guidelines.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Code of Ethics</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our Board adopted a Code
of Ethics applicable to our directors, executive officers and team members and such Code of Ethics complies with the rules and regulations
of Nasdaq and the SEC. The Code of Ethics is available on our Investor Relations website. In addition, we intend to post on the Corporate
Governance section of our website all disclosures that are required by law or Nasdaq listing standards concerning any amendments to, or
waivers from, any provision of the Code of Ethics. The reference to our websites in this annual report on Form 20-F does not include or
incorporate by reference the information on our website into this annual report.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 71; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><div><a id="a_032"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">D.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Employees</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The table below shows our
employees by role and location, as of the dates indicated, and does not include employees of our research collaborators or joint venture
partners.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of June 30,</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Management and administrative </td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">11</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Sales </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">OPEX and downstream </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">23</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Research and development services </td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; font-weight: bold; text-align: left">Total </td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">45</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">9</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">6</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_033"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">E.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Share Ownership</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The following table sets
forth information regarding the beneficial ownership of the Ordinary Shares as of June 30, 2023:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">each person known to by us to be the beneficial owner of
more than 5% of the Ordinary Shares;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">each of our directors and Executive Officers; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">all of our directors and members of Executive Management
as a group.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Beneficial ownership is
determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she
or it possesses sole or shared voting or investment power over that security, and includes shares underlying warrants, as applicable,
that are currently exercisable or convertible or exercisable or convertible within 60 days. Ordinary Shares that may be acquired within
60 days of October 31, 2023 pursuant to the exercise of warrants are deemed to be outstanding for the purpose of computing the percentage
ownership of such holder but are not deemed to be outstanding for computing the percentage ownership of any other person or entity shown
in the table.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Unless otherwise indicated,
we believe that all persons named in the table below have sole voting and investment power with respect to the Ordinary Shares beneficially
owned by them. They have the same voting rights as all other holders of ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Beneficial owners</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Number of<br/>
 shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">% &#160;owned</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gast&#243;n Paladini<sup>(1)(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jos&#233; L&#243;pez Lecube<sup>(3)(4)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">366,630</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amit Dhingra<sup>(5)(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">82,924</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Henk Hoogenkamp<sup>(7)(8)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">96,856</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Martin Salinas<sup>(9) (10)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">124,386</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Catalina Jones<sup>(11) (12)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">77,600</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Natalia Zang<sup>(13)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kyle P.&#160;Bransfield<sup>(14) (15)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,035,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.8</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert M.&#160;Bennett<sup>(16)(17)(18)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6,160,369</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12.7</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">All directors and executive officers as a group (nine individuals)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,943,764</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">16.3</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Five Percent or More Holders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BG Farming Technologies Ltd.<sup>(19)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,570,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">38.8</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THEO I SCSp<sup>(20)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,367,523</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40.9</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Bioceres Group PLC</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,367,523</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40.9</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Union Group Ventures Limited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,170,828</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40.4</td><td style="text-align: left">%</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-size: 10pt"><i>Notes:-</i></span><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>&#160;</i></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">Less than 1%.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.25in">1.</td><td style="text-align: justify">The business address of Mr.&#160;Paladini is Av. Jorge Newbery 8655, Country del Lago, lote 79, Rosario,
CP2000, Santa Fe, Argentina.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.25in">2.</td><td style="text-align: justify">Represents shares held by The Biotech Company LLC, an entity controlled
by Mr.&#160;Paladini and his spouse. Does not include approximately 79,032 vested and exercisable Restricted Stock Units, calculated using
a 25- day VWAP.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.25in">3.</td><td style="text-align: justify">The business address of Mr.&#160;L&#243;pez Lecube is Los Talas 301 (Ex. Av V50 s/n), BC Talar del Lago
2, lote 438, General Pacheco, Tigre, B1617 Provincia de Buenos Aires, Argentina.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p><div>

</div><!-- Field: Page; Sequence: 72; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.25in">4.</td><td style="text-align: justify">Includes 73,927 unissued Ordinary Shares and 60,180 vested and exercisable
options pursuant to the Moolec Employee Share Plan. Does not include approximately 43,004 vested and exercisable Restricted Stock Units,
calculated using a 25-day VWAP.&#160;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.25in">5.</td><td style="text-align: justify">The business address of Mr.&#160;Dhingra is 4302 Whitwick Pl, College Station, Texas 77845, United States.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.25in">6.</td><td style="text-align: justify">Includes 39,980 unissued Ordinary Shares and 42,944 vested and exercisable
options pursuant to the Moolec Employee Share Plan. Does not include approximately 19,424 vested and exercisable Restricted Stock Units,
calculated using a 25-day VWAP.&#160;&#160;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">7.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The business address of Mr.&#160;Hoogenkamp is
Hoeveveld 24B, 6584GG, </span>Molenhoek<span style="font-family: Times New Roman, Times, Serif">, The Netherlands.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.25in">8.</td><td style="text-align: justify">Includes 46,697 unissued Ordinary Shares and 50,159 vested and exercisable
options pursuant to the Moolec Employee Share Plan. Does not include approximately 32,447 vested and exercisable Restricted Stock Units,
calculated using a 25-day VWAP.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.25in">9.</td><td style="text-align: justify">The business address of Mr.&#160;Salinas is La Tradici&#243;n 3068, Funes, CP2132, Santa Fe, Argentina.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.25in">10.</td><td style="text-align: justify">Includes 59,972 unissued Ordinary Shares and 64,414 vested and exercisable
options pursuant to the Moolec Employee Share Plan. Does not include approximately 20,282 vested and exercisable Restricted Stock Units,
calculated using a 25-day VWAP.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in">11.</td><td style="text-align: justify">The business address of Ms.&#160;Jones is Rep&#250;blica de Italia 860, Adrogu&#233;, Almirante Brown,
CP1846, Provincia de Buenos Aires, Argentina.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.25in">12.</td><td style="text-align: justify">Includes 22,127 unissued Ordinary Shares and 55,473 vested and exercisable
options pursuant to the Moolec Employee Share Plan. Does not include approximately 26,921 vested and exercisable Restricted Stock Units,
calculated using a 25-day VWAP.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in">13.</td><td style="text-align: justify">The business address of Ms. Zang is Paseo de los Parques 6. Portal 4. 1d 28109 Alcobendas, Madrid, Spain.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in">14.</td><td style="text-align: justify">The business address of Mr.&#160;Bransfield is 714 Westview Ave Nashville, TN 37205, United States.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.25in">15.</td><td style="text-align: justify">Represents shares held by UG Holdings LLC, an entity controlled by Mr.&#160;Bransfield.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The business address of Mr.&#160;Bennett
is c/o LightJump One Founders, LLC 14755 Preston Road, Suite 520 Dallas, TX&#160;75254, United States. </span>&#160;&#160;&#160;&#160;&#160;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in">17.</td><td style="text-align: justify">Represents shares held by LightJump One Founders, LLC, an entity controlled by Mr.&#160;Bennett.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in">18.</td><td style="text-align: justify">Includes 4,210,000&#160;Ordinary Shares issuable in connection with the exercise of the Private Warrants.&#160;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in">19.</td><td style="text-align: justify">The Biotech Company LLC, an entity controlled by Mr. Paladini, Moolec&#8217;s Chief Executive Officer,
and Mr. Paladini&#8217;s spouse, is the beneficial owner of 20% of BG Farming Technologies Ltd. and Theo I SCSp is the beneficial owner
of 80% of BG Farming Technologies Ltd.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in">20.</td><td style="text-align: justify">Theo is a wholly owned subsidiary of Bioceres Group PLC. Consequently, Bioceres Group PLC may be deemed
the beneficial owner of the Shares of which Theo is deemed the beneficial owner and to share voting and dispositive control over such
shares.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">For more information on
our shares and share options owned by individual Directors see &#8220;<i>Item 6. Directors, Senior Management and Employees&#8212;B. Compensation&#8212;Moolec
Share Option Plan</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><div><a id="a_034"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">F.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Disclosure of a Registrant&#8217;s Action to Recover Erroneously Awarded Compensation</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"></p><div>

</div><!-- Field: Page; Sequence: 73; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><div><a id="a_035"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> ITEM&#160;7. &#160;MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><div><a id="a_036"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">A.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Major Shareholders</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">See &#8220;<i>Item 6. Directors,
Senior Management and Employees&#8212;E. Share Ownership</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Changes in Ownership</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">There has been no significant
change in the percentage ownership held by any major shareholder since its incorporation on May 23, 2022, except as described below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">On January 9, 2023, BG Farming Technologies Limited, Theo
and Bioceres Group PLC filed a Schedule 13D reporting beneficial ownership of 15,367,523 ordinary shares, representing 40.9% of our share
capital.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">On January 9, 2023, Union Group Ventures Limited, Union Group
International Holdings Limited and Juan Jos&#233; Sartori Pi&#241;eyro filed a Schedule 13D reporting beneficial ownership of 15,170,828
ordinary shares, representing 40.4% of our share capital.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Difference in Voting Rights</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">All of our ordinary shares
have the same voting rights and no major shareholder has different voting rights.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities Held in the Host Country</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">As of June 30, 2023, 37,563,768
ordinary shares were issued and outstanding, of which 1,854,840 Ordinary Shares, 4%, were held by one record holder in the United States,
Cede &amp; Co.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Arrangements for Change in Control</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We are not aware of any
arrangements that may, when in force, result in a change in control.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><div><a id="a_037"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">B.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Related Party Transactions</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Policy Concerning Related Party Transactions</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our Board of Directors has
adopted a written policy, for the review of any transaction, arrangement or relationship in which it is a participant, if the amount involved
exceeds US$120,000 and one of our executive officers, directors, director nominees or beneficial holders of more than 5% of our total
equity (or their immediate family members), each of whom we refer to as a related person, has a direct or indirect material interest.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">A copy of the related person
transaction approval policy is available on our Investor Relations website.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other Related Party Transactions</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The following are certain
other transactions with our directors, executive officers and shareholders. Omitted periods below signify that there were no transactions
in such period or the value of such transaction was a de minimis amount.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">See also &#8220;<i>Item
4. Information on the Company&#8212;B. Business Overview&#8212;Future Foods B.V. (Future Foods)</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Indemnification Agreement</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In connection with the consummation
of the business combination, we entered into indemnification agreements with each of our directors and executive officers. These agreements
provide that the director or officer will be indemnified by us to the fullest extent permitted by law against liability and against all
expenses reasonably incurred or paid by him or her in connection with any claim, action, suit or proceeding which he or she becomes involved
as a party or otherwise by virtue of his or her being or having been such a director or officer of and against amounts paid or incurred
by him or her in the resolution thereof. The agreements are subject to certain exceptions, including, among other exceptions, that no
indemnification will be provided to any director or officer against any liability to us or our shareholders (i) by reason of actual fraud,
dishonesty, actual fraudulent conduct, or gross negligence on the part of the director or officer; (ii) by reason of payment made under
an insurance policy or any third party that has no recourse against the indemnitee director or officer; or (iii) if contrary to applicable
law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><div><a id="a_038"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">C.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Interests of Experts and Counsel</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 74; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><div><a id="a_039"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> ITEM&#160;8. &#160;FINANCIAL INFORMATION</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><div><a id="a_040"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">A.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Consolidated Statements and Other Financial Information</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Financial Statements</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our financial statements
are set forth under &#8220;<i>Item 18. Financial Statements</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Legal Proceedings </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">From time to time, we may
become involved in legal proceedings arising in the ordinary course of our business. As of the date hereof, we are not party to any legal
proceeding</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Dividend Policy </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">From our annual net profits,
at least 5% shall each year be allocated to the reserve required by applicable laws (the &#8220;Legal Reserve&#8221;). That allocation
to the Legal Reserve will cease to be required as soon and as long as the Legal Reserve amounts to 10% of the amount of our share capital.
The general meeting of shareholders shall resolve how the remainder of the annual net profits, after allocation to the Legal Reserve,
will be disposed of by allocating the whole or part of the remainder to a reserve or to a provision, by carrying it forward to the next
following financial year or by distributing it, together with carried forward profits, distributable reserves or share premium to the
shareholders, each Ordinary Share entitling to the same proportion in such distributions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The Board may resolve that
we pay out an interim dividend to the shareholders, subject to the conditions of article 461-3 of the 1915 Law and our articles of association.
The Board shall set the amount and the date of payment of the interim dividend.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Any share premium, assimilated
premium or other distributable reserve may be freely distributed to the shareholders subject to the provisions of the 1915 Law and our
articles of association. In case of a dividend payment, each shareholder is entitled to receive a dividend right pro rata according to
his or her respective shareholding. The dividend entitlement lapses upon the expiration of a five-year prescription period from the date
of the dividend distribution. The unclaimed dividends return to our accounts.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><div><a id="a_041"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">B.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Significant Changes</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">No significant change has
occurred other than as described in this annual report on Form 20-F since the date of our most recent audited consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><div><a id="a_042"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> ITEM&#160;9. &#160;THE OFFER AND LISTING</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><div><a id="a_043"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">A.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Offer and Listing Details</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><div><a id="a_044"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">B.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Plan of Distribution</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><div><a id="a_045"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">C.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Markets</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The Nasdaq Global Select
Market.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><div><a id="a_046"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">D.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Selling Shareholders</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><div><a id="a_047"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">E.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Dilution</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><div><a id="a_048"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">F.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Expenses of the Issue</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"></p><div>

</div><!-- Field: Page; Sequence: 75; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><div><a id="a_049"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> ITEM&#160;10. &#160;ADDITIONAL INFORMATION</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><div><a id="a_050"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">A.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Share Capital</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">As
of June&#160;30, 2023, there were 37,563,768&#160;Ordinary Shares outstanding and issued. There were also 11,110,000 </span>warrants <span style="font-family: Times New Roman, Times, Serif">outstanding,
each entitling the holder to purchase one Ordinary Share at an exercise price of US$11.50 per share. We are authorized to issue five hundred
billion (500,000,000,000) Ordinary Shares, from which the shares already issued under the authorized capital shall be deducted.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><div><a id="a_051"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">B.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Memorandum and Articles of Association</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Registration Number</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our registration number
with the Luxembourg Trade and Companies&#8217; Register (<i>Registre de Commerce et des Soci&#233;t&#233;s</i>, <i>Luxembourg</i>)
is B268440.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Objects</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our Articles state that
the objects for which the Company is established the acquisition, holding and disposal of interests in Luxembourg and/or in foreign companies
and undertakings, as well as the administration, development and management of such interests. We may provide loans and financing in any
other kind or form or grant guarantees or security in any other kind or form, for the benefit of the companies and undertakings forming
part of the group of which we are a member. We may also invest in real estate, in intellectual property rights or any other movable or
immovable assets in any kind or form. We may borrow in any kind or form and issue bonds, notes or any other debt instruments as well as
warrants or other share subscription rights. In a general fashion, we may carry out any commercial, industrial or financial operation,
which we may deem useful in the accomplishment and development of our objects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Directors</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Luxembourg law and our Articles
restrict our directors&#8217; power to take part of any deliberation or vote in respect of any contract or transaction in which they have
a conflict of interest (as defined in our Articles), it being specified that the nature of the interest of any director in any such contract
or transaction shall be disclosed by them at or prior to its consideration and any vote thereon. There is no mandatory retirement age
for our directors and our directors are not required to own our securities in order to serve as directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Ordinary shares</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Pursuant
to Luxembourg law, the issuance of Ordinary Shares requires in principle approval by the extraordinary general meeting of shareholders
subject to necessary quorum and majority requirements. The extraordinary general meeting of shareholders of Company held prior to the
Business Combination Closing approved an </span>authorized <span style="font-family: Times New Roman, Times, Serif">capital and authorized
the Board to (i)&#160;realize for any reason whatsoever, including any issue in one or several successive tranches of (a)&#160;any subscription
and/or conversion rights, including warrants (which may be issued separately or linked to Ordinary Shares, bonds, notes or similar instruments
issued by us), convertible bonds, notes or similar instruments as well as (b)&#160;new Ordinary Shares, with or without share premium,
against payment in cash or in kind, by conversion of claims on us, by way of conversion of available reserves or in any other manner;
(ii)&#160;determine the place and date of the issue or the successive issues, the issue price, the terms and conditions of the subscription
of and paying up on the new Ordinary Shares, and (iii)&#160;remove or limit the preferential subscription right of the shareholders in
case of issue against payment in cash of Ordinary Shares, warrants (which may be separate or attached to Ordinary Shares, bonds, notes
or similar instruments), convertible bonds, notes or similar instruments, up to the maximum amount of such authorized capital for a maximum
period of five&#160;years from the date of incorporation or any subsequent resolutions to create, amend, renew, increase or extend the
authorized capital. The extraordinary general meeting of our shareholders may renew or increase such authorized capital and such authorization
to the Board to issue Ordinary Shares, each time for a period not exceeding five&#160;years.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"></p><div>

</div><!-- Field: Page; Sequence: 76; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">In
addition, upon adopting our amended and restated articles of association pursuant to the terms of the Business </span>Combination<span style="font-family: Times New Roman, Times, Serif">,
our shareholders authorized the Board of the Company to allocate our existing shares without consideration or to issue new shares (&#8220;Bonus
Shares&#8221;) paid-up out of distributable reserves (i)&#160;to our employees or to certain classes of such employees; (ii)&#160;to employees
of companies or economic interest groupings in which we hold directly or indirectly at least 50% of the share capital or of the voting
rights; (iii)&#160;to employees of companies or economic interest groupings in which at least 50% of the share capital or of the voting
rights are held, directly or indirectly, by a company holding itself, directly or indirectly, at 50% of our share capital; or (iv)&#160;to
members of our corporate bodies or any of the other companies or economic interest groupings referred to under items (ii)&#160;to (iii)&#160;above,
for a maximum period of five&#160;years from the date of incorporation or any subsequent resolutions to create, renew or increase the
authorization (such period restriction is only applicable in case of an allotment of newly issued shares). The preferential subscription
right of existing shareholders is, through their authorization to the Board of the Company, automatically waived in case of issuance of
Bonus Shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We recognize only one (1)&#160;holder
per Ordinary Share. In case an Ordinary Share is owned by several persons, they shall appoint a single representative who shall represent
them in respect of us. We have the right to suspend the exercise of all rights attached to that Ordinary Share, except for relevant information
rights, until such representative has been appointed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Upon
the consummation of the Business Combination, a delegate of the Board of the Company, who was granted powers pursuant to resolutions of
the Board of the Company, resolved on the issuance of Ordinary Shares out of the authorized capital to LightJump shareholders. When delegating
such powers to the delegate, the Board also resolved on the applicable procedures and timelines to which such issuance was subjected.
In the event a proposal of the Board to issue new Ordinary Shares exceeds the limits of our authorized share capital, the Board must then
convene the shareholders to an extraordinary general meeting to be held in front of a Luxembourg notary for the purpose of increasing
the issued share capital. Such meeting will be subject to the quorum and </span>majority <span style="font-family: Times New Roman, Times, Serif">requirements
required for amending the articles of association, it being understood that the articles of association may be amended by a majority of
at least two thirds (2/3) of the votes validly cast at such general meeting at which a quorum of more than half (1/2) of our share capital
is present or represented. If no quorum is reached in a meeting, a second meeting may be convened in accordance with the provisions of
Luxembourg law and our articles of association, which may deliberate regardless of the quorum and at which resolutions are adopted at
a majority of at least two thirds of the votes validly cast. Abstentions and nil votes shall not be taken into account. If the capital
call proposed by the Board consists of an increase in the shareholders&#8217; </span>commitments<span style="font-family: Times New Roman, Times, Serif">,
the Board must convene the shareholders to an extraordinary general meeting to be held in front of a Luxembourg notary for such purpose.
Such meeting will be subject to the unanimous consent of the shareholders.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Preferential Subscription Rights</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Under
Luxembourg law and in accordance with our articles of association, existing shareholders benefit from a </span>preferential <span style="font-family: Times New Roman, Times, Serif">subscription
right on the issuance of new Ordinary Shares for cash consideration. However, upon adopting our amended and restated articles of association
pursuant to the terms of the Business Combination, our shareholders have, in accordance with Luxembourg law, authorized the Board, within
the our limits of authorized share capital and within a period of five&#160;years, to remove or limit any pre-emptive subscription rights
of shareholders in case of issue against payment in cash of Ordinary Shares, warrants (which may be separate or linked to Ordinary Shares,
bonds, notes or similar instruments issued by us), convertible bonds, notes or similar instruments and we can limit or suppress, subject
to the quorum and majority for the amendment of the articles of association, such pre-emptive subscription rights. Such Ordinary Shares
may be issued above, at, or below market value, and, following a certain procedure, even below the accounting par value, if applicable,
per Ordinary Share. New Ordinary Shares also may be issued by way of incorporation of available reserves, including share premium.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"></p><div>

</div><!-- Field: Page; Sequence: 77; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Share Repurchases</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">We
</span>cannot <span style="font-family: Times New Roman, Times, Serif">subscribe for our own Ordinary Shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">We
</span>may<span style="font-family: Times New Roman, Times, Serif">, however, repurchase issued Ordinary Shares or have another person
acting in his, her or its own name, but on our behalf, repurchase issued Ordinary Shares, subject to the following conditions:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">prior authorization by a simple majority vote at an ordinary
general meeting of shareholders, which authorization sets forth:</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">(a)</td><td style="text-align: justify">the terms and conditions of the proposed repurchase and in
particular the maximum number of Ordinary Shares to be repurchased;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">(b)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the duration of the period for which the authorization
is given, which may not exceed </span>five<span style="font-family: Times New Roman, Times, Serif">&#160;years; and</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">(c)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">in </span>the <span style="font-family: Times New Roman, Times, Serif">case
of repurchase for consideration, the minimum and maximum consideration per share;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">redemptions,
including shares previously acquired by us and held by us in our portfolio and shares acquired by a person acting in his, her or its
own name, but on our behalf, may not result in the net assets as shown in the </span>annual <span style="font-family: Times New Roman, Times, Serif">accounts
falling below the amount of the subscribed capital, increased by the reserves which Luxembourg law or the articles of association do
not permit to distribute;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">only
fully </span>paid<span style="font-family: Times New Roman, Times, Serif">-up Ordinary Shares may be repurchased; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">(4)</td><td style="text-align: justify">the offer to repurchase must be made on the same terms to
all shareholders in the same situation except for repurchases which have been unanimously decided by a general meeting at which all shareholders
were present or represented; similarly, listed companies may purchase their own Ordinary Shares on the stock exchange without an offer
to acquire having to be made to its shareholders.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">On 29 December&#160;2022,
our shareholders have authorized the Board to repurchase, during a period of five&#160;years as from the date of such authorization, to
repurchase a maximum of 5,000,000 Ordinary Shares at a price no lower than the nominal value of the shares and not higher than 110% of
the volume weighted average price of the Ordinary Shares for the ten&#160;trading days preceding each individual acquisition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">When
the acquisition of our own Ordinary Shares is necessary to avoid serious and imminent harm to us, the prior authorization by a simple
majority vote at an ordinary general meeting of shareholders described in paragraph (1)&#160;above shall not apply. In such a case, the
Board must inform the shareholders at the following general meeting </span>of <span style="font-family: Times New Roman, Times, Serif">the
reasons for, and purpose of, the redemption, the number and nominal value, or failing that, such acquired Ordinary Share&#8217;s accounting
par value, the fraction of the subscribed capital such acquired Ordinary Shares represent, as well as the countervalue of such Ordinary
Shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
prior authorization by a simple majority vote at an ordinary general meeting of shareholders described in </span>paragraph <span style="font-family: Times New Roman, Times, Serif">(1)&#160;above
shall also not apply in the case of Ordinary Shares acquired either by us or by a person acting in his, her or its own name, but on our
behalf, for distribution to our employees or to the employees of one of our affiliates due to a control relationship (i.e., its subsidiaries
or controlling shareholder) or in any of the circumstances listed in article&#160;430-16 of the 1915 Law. The distribution of such Ordinary
Shares must be made within 12&#160;months of the acquisition of those shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
authorization will be valid for a period ending on the earlier of five&#160;years from the date of such shareholder </span>authorization
<span style="font-family: Times New Roman, Times, Serif">and the date of its renewal by a subsequent general meeting of shareholders.
Pursuant to such authorization, the Board is authorized to redeem all Ordinary Shares under the conditions set forth in article&#160;430-15
of the 1915 Law. Such purchases and sales may be carried out for any authorized purpose or any purpose that is authorized by the laws
and regulations in force. The purchase price per Ordinary Share to be determined by the Board or its delegate shall represent not more
than the fair market value of such Ordinary Shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The voting and dividend
rights attached to the repurchased Ordinary Shares will be suspended as long as such repurchased Ordinary Shares are held by us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Voting and Appointment of Directors
</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Voting Power</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Each
Ordinary Share entitles the holder thereof to one vote. Neither Luxembourg law nor our articles of association contain any restrictions
as to the voting of Ordinary Shares by non-Luxembourg residents. The 1915 Law </span>distinguishes <span style="font-family: Times New Roman, Times, Serif">general
meetings of shareholders and extraordinary general meetings of shareholders with respect to the quorum requirements and majority thresholds.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pre-emptive or Other Rights</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">There are no sinking fund
or redemption provisions applicable to our Ordinary Shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"></p><div>

</div><!-- Field: Page; Sequence: 78; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>General Meetings</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In accordance with the 1915
Law and our articles of association, there is no quorum requirement at an ordinary general meeting and resolutions are adopted by a simple
majority of validly cast votes of the shareholders present or represented for a given duly convened ordinary general meeting. Abstentions
and nil votes are not taken into account.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Annual General Meetings</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">An
annual general meeting of shareholders shall be held in the Grand Duchy of Luxembourg within six&#160;months of </span>the <span style="font-family: Times New Roman, Times, Serif">end
of the preceding financial year.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Extraordinary General Meetings</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Extraordinary resolutions
are required for any of the following matters, among others: (i)&#160;an increase or decrease of the authorized or issued capital (except
if made by the Board under the authorized capital), (ii)&#160;a limitation or exclusion of pre-emptive rights (except if made by the Board
under the authorized capital), (iii)&#160;approval of a statutory merger or de-merger (scission), (iv)&#160;our dissolution and liquidation,
(v)&#160;any and all amendments to our articles of association (except if made by the Board in accordance with our Articles), and (vi)&#160;change
of nationality. Pursuant to the 1915 Law and our articles of association, for any extraordinary resolutions to be considered at an extraordinary
general meeting of shareholders, the quorum shall be at least half (1/2) of our issued share capital at a first duly convened meeting,
unless otherwise mandatorily required by law. If the said quorum is not reached, a second meeting may be convened, for which the 1915
Law and our articles of association do not prescribe a quorum. Any extraordinary resolution shall be adopted at a quorate general meeting,
except otherwise provided by law, by at least a two-thirds (2/3) majority of the votes validly cast at such meeting by shareholders. Abstentions
and nil votes are not taken into account.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Rights of Non-Resident or Foreign Shareholders</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">There are no limitations
imposed by our articles of association on the rights of non-resident or foreign shareholders to hold or exercise voting rights on our
shares. In addition, there are no provisions in our articles of association governing the ownership threshold above which shareholder
ownership must be disclosed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><div><a id="a_052"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">C.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Material Contracts</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Agreements Relating to the Business
Combination</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Business Combination Agreement</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-size: 10pt">On
</span>June <span style="font-size: 10pt">14, 2022, we, Moolec Limited and Merger Sub entered into a Business Combination Agreement, pursuant
to which, among other things, (a)&#160;pursuant to the Exchange Agreements, each of the Moolec Limited Shareholders, effective on the
Exchange Effective Time, contributed its respective Moolec Limited Ordinary Shares to us in exchange for our Ordinary Shares to be subscribed
for by each such Moolec Limited Shareholder as part of the Exchange, (b)&#160;as a result of the Exchange, Moolec Limited became one of
our wholly-owned&#160;subsidiaries, (c)&#160;immediately prior to the consummation of the Merger but after the Exchange Effective Time,
each of the Moolec Limited SAFE Holders received and became holders of our issued and outstanding Ordinary Shares, in accordance with
the applicable Moolec Limited SAFE, (d)&#160;following the consummation of the Exchange, Merger Sub merged with and into Moolec Limited,
with Moolec Limited surviving such Merger and becoming one of our direct wholly-owned&#160;subsidiaries and, in the context of this Merger,
all Moolec Limited Common Stock outstanding were converted into the right to receive the Merger Consideration in the form of our Ordinary
Shares pursuant to our share capital increase, as set forth in this Agreement, and (e)&#160;in order to satisfy the Moolec Limited&#8217;s
obligations under that certain Consulting Agreement, dated June&#160;18, 2021, by and between Moolec Limited and Moolec Limited&#8217;s
CFO, Moolec Limited&#8217;s CFO was freely allotted an aggregate of&#160;232,523 Ordinary Shares. Capitalized terms used but not defined
herein shall have the respective meanings set forth in the Business Combination Agreement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Upon the terms and subject
to the conditions set forth in the Business Combination Agreement and the Exchange Agreements at the Exchange Effective Time, the Exchange
took place based on an exchange ratio of .66787343&#160;used to determine the number of our aggregate Shares valued at US$10.00&#160;per
Share for which the aggregate Moolec Limited Ordinary Shares have been exchanged. The valuation of the Moolec Limited Ordinary Shares
contributed to us by the Moolec Limited Shareholders against new Shares pursuant to the Exchange we deemed to be, as of the Exchange Effective
Time, the sum of US$325,000,000.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"></p><div>

</div><!-- Field: Page; Sequence: 79; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Pursuant to the Exchange
Agreements, each Moolec Limited Shareholder also agreed to not transfer any of its Moolec Limited Ordinary Shares before the earlier to
occur of the Exchange and the termination of the Business Combination Agreement pursuant to its terms.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Backstop Agreement</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Concurrently with the execution
of the Business Combination Agreement, UGVL, Theo, UG Holdings, LLC and the Sponsor entered into the Backstop Agreement, dated June&#160;14,
2022, pursuant to which, among other things, the Sponsor, UGVL and Theo agreed, on a several (and not joint) basis, to backstop an aggregate
amount equal to US$10,000,000, conditioned upon the Business Combination Closing on the terms and subject to the conditions set forth
in the Backstop Agreement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Registration Rights and&#160;Lock-Up&#160;Agreement</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In connection with the closing
of the Business Combination, the Sponsor, Moolec Limited, the CFO and the Company Core Shareholders and Moolec Limited SAFE Holders entered
into the Registration Rights and Lock-Up&#160;Agreement pursuant to which, among other things, the Sponsor, the CFO and the Company Core
Shareholders and Company SAFE Holders had customary demand and piggyback registration rights in connection with the Ordinary Shares issued
to them in the Merger or the Exchange. Additionally, the Ordinary Shares held by each party to the Registration Rights and Lock-Up&#160;Agreement
were subject to a lock-up&#160;until (i)&#160;the date that is 365&#160;days from the Business Combination Closing Date, and (ii)&#160;such
date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the shareholders
of the Company having the right to exchange their Ordinary Shares for cash, securities or other property, provided that if the share price
of the Ordinary Shares exceeds US$12.00 per Ordinary Share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations
and the like) for any 20&#160;trading days within any 30-day&#160;trading period, the parties to the Registration Rights and Lock-Up&#160;Agreement
could transfer up to 50% of the Ordinary Shares subject to the Registration Rights and Lock-Up&#160;Agreement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Moolec Limited Shareholder Contribution
and Exchange Agreements</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Concurrently with the execution
of the Business Combination Agreement, each <span style="font-family: Times New Roman, Times, Serif">Core Company Shareholder </span>entered
into an Exchange Agreement, dated as of June 14, 2022, with us and Moolec Limited pursuant to which, among other things, each Moolec Limited
Shareholder consented to the Exchange and all transaction contemplated under the Business Combination Agreement and the Transaction Documents
to which it is a party and, consequently, agreed to (i)&#160;contribute its Moolec Limited Ordinary Shares to us in exchange for our Ordinary
Shares, and (ii)&#160;not transfer any of its Moolec Limited Ordinary Shares before the earlier of (a)&#160;one year from June&#160;14,
2022 and (b)&#160;the implementation of the Exchange or termination of the Exchange Agreement. The Moolec Limited Shareholders who entered
or will enter into the Exchange Agreements collectively represent 100% of the issued and outstanding Moolec Limited Ordinary Shares. Pursuant
to the Amendment to the Business Combination Agreement, Moolec Limited issued an aggregate number of Moolec Limited Ordinary Shares equal
to 2,354,509 to at least 300 and up to 424 of the current individual shareholders of Bioceres&#160;S.A. and Bioceres Group PLC prior to
the Exchange Effective Time pursuant to Regulation S of the Securities Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Transaction Support Agreement</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Concurrently with the execution
of the Business Combination Agreement, we, Moolec Limited, LightJump, the Sponsor, certain Moolec Limited Shareholders and the Moolec
Limited SAFE Holders and the LightJump Holders entered into the Transaction Support Agreement pursuant to which, among other things, the
Sponsor and certain LightJump Holders agreed with us, LightJump, Moolec Limited and the certain Moolec Limited Shareholders to (i) waive
certain rights, and (ii) take certain actions to support the Transactions. Additionally, during the interim period (from June 14, 2022
until the earlier of (i) the Business Combination Closing or (ii) termination of the Business Combination Agreement), each LightJump Investor
agreed not to transfer any Sponsor shares that she, he or it Beneficially Owns (as defined under Rule 13d-3 of the Exchange Act) without
our prior written consent, with the exception of certain permitted transfers described in the Transaction Support Agreement. Each Moolec
Limited SAFE Holder agreed to execute all documentation and perform all necessary actions reasonably required by Moolec Limited and/or
us as may be necessary or desirable in connection with our issuance of our Ordinary Shares to each Moolec Limited SAFE Holder, substantially
in accordance with the respective Original SAFE, with such adjustments (if any) required under Luxembourg law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"></p><div>

</div><!-- Field: Page; Sequence: 80; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Warrant Agreement</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">On January 12, 2021, LightJump
and Continental entered into the LightJump Warrant Agreement, with each warrant exercisable for the number of LightJump Common Stock stated
in the applicable LightJump Warrant at an exercise price per LightJump Common Stock of US$11.50. At the Merger Effective Time, by virtue
of the Merger, each LightJump Warrant that was outstanding immediately prior to the Merger Effective Time, pursuant to the LightJump Warrant
Agreement, ceased to represent a right to acquire one LightJump Common Stock and was converted in accordance with the terms of such LightJump
Warrant Agreement, at the Merger Effective Time, into a right to acquire one Ordinary Share on substantially the same terms as were in
effect immediately prior to the Merger Effective Time under the terms of the LightJump Warrant Agreement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">First Amendment to the Business Combination
Agreement</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">On November 18, 2022, we,
Moolec Limited, LightJump and Merger Sub entered into the First Amendment to the Business Combination Agreement, pursuant to which our
number of directors after the Business Combination Closing was amended from seven to five and an additional provision was included to
ensure the satisfaction of the Nasdaq initial listing requirements. Pursuant to the First Amendment to the Business Combination Agreement,
(i) Moolec Limited issued an aggregate number of Moolec Limited Ordinary Shares equal to 2,354,609 to at least 300 and up to 424 of the
current individual shareholders of Bioceres S.A. and Bioceres Group PLC, and (ii) we and Moolec Limited amended any Exchange Agreement
as necessary in connection with such issuance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Agreement on Funds Flow</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Pursuant to the Agreement
on Funds Flow, dated as of December 30, 2022, by and among us, LightJump Acquisition Corporation, the Sponsor, Moolec Limited and Merger
Sub, during the Escrow Period, Moolec Limited had the right to acquire (with the right to thereafter dispose of and liquidate), for no
additional consideration, a number of Contingency Shares that was equal in monetary value to pay for (i) any actual or threatened litigation
between EarlyBird or any of its affiliates, on the one hand and the Moolec Limited or its subsidiaries (including LightJump) on the other
hand to the extent arising out of or relating to the Business Combination Marketing Agreement or the EarlyBird Amendment, including, attorneys&#8217;
fees and settlements and (ii) any payment due pursuant to the EarlyBird Cash Fee in excess of US$1,124,449.76.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Assignment, Assumption and Amendment to
Warrant Agreement</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">On the Business Combination
Closing Date, the Company entered into the Warrant Amendment to amend and assume LightJump&#8217;s obligations under the existing Warrant
Agreement to give effect to the conversion of SPAC warrants to warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Amendment to Business Combination Marketing
Agreement</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">On January&#160;8, 2021,
LightJump entered into the Business Combination Marketing Agreement with EarlyBird. It was a condition to the consummation of the transactions
contemplated by the Business Combination Agreement that LightJump and EarlyBird enter into an Amendment to the Business Combination Marketing
Agreement to provide for, among other things, a change in the compensation to be payable to EarlyBird upon the Business Combination Closing.
On June&#160;14, 2022, LightJump and EarlyBird executed the Amendment to the Business Combination Marketing Agreement whereby LightJump
paid to EarlyBird (A)&#160;a Cash Fee at the Business Combination Closing equal to (i)&#160;20% of the aggregate gross proceeds (up to
a maximum of US$3,830,000) held in the Trust Account (after redemptions on the redemption deadline, which was December&#160;22, 2022,
and reduction of all additional payments included in the Trust Account to accommodate all extensions) and received by LightJump in any
financing in connection with the Business Combination regardless of the source of such funds, plus (ii)&#160;US$1,000,000 and (B)&#160;in
consideration of EarlyBird introducing Moolec Limited to Registrant, Moolec Limited issued to EarlyBird a Share Fee constituting number
of Moolec Limited Ordinary Shares equal to US$2,000,000 divided by the lesser of (y)&#160;the volume weighted average price of the Moolec
Limited Ordinary Shares for the ten&#160;trading days preceding the six month anniversary of the Business Combination Closing and (z)&#160;US$10.00,
up to a maximum of 600,000&#160;shares. Pursuant to the Amendment to the Business Combination Marketing Agreement, the Share Fee was issued
to EarlyBird within five Business&#160;Days of the six-month&#160;anniversary of the Business Combination Closing, and Moolec Limited
registered the resale of the ordinary shares issued to EarlyBird as promptly as practicable after their issuance. EarlyBird&#8217;s Ordinary
Shares were registered for resale pursuant to this Registration Statement. In addition, pursuant to the Amendment to the Business Combination
Marketing Agreement, the Sponsor agreed to forfeit to Moolec Limited for cancellation the same number of shares of common stock payable
to EarlyBird under such Share Fee within five Business Days of the six-month&#160;anniversary of the Business Combination Closing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"></p><div>

</div><!-- Field: Page; Sequence: 81; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><div><a id="a_053"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">D.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Exchange Controls</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">There are no exchange controls
laws or currency regulations in the Grand Duchy of Luxembourg that would set out restrictions on the activities of the Company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><div><a id="a_054"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">E.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Taxation</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The following is a summary
of the material Luxembourg and U.S. tax consequences of acquiring, owning and disposing of securities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Material Luxembourg Tax Considerations</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The following is a general
description of certain Luxembourg tax considerations relating to the Company and the holders of Ordinary Shares and warrants. It does
not purport to be a complete analysis of all tax considerations in relation to the Ordinary Shares and the warrants. Prospective purchasers
should consult their own tax advisers as to which countries&#8217; tax laws could be relevant to acquiring, holding and disposing of the
securities and the consequences of such actions under the tax laws of those countries. This overview is based upon the law as in effect
on the date of this document and is subject to any change in law that may take effect after such date, even with retroactive effect.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The comments below are intended
as a basic overview of certain tax consequences in relation to the Company and the purchase, ownership and disposition of the Ordinary
Shares and Warrants under Luxembourg law. Persons who are in any doubt as to their tax position should consult a professional tax adviser.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Please be aware that the residence
concept used under the respective headings below applies for Luxembourg income tax assessment purposes only. Any reference in the present
section to a tax, duty, levy impost or other charge or withholding of a similar nature refers to Luxembourg tax law and/or concepts only.
Also, please note that a reference to Luxembourg income tax generally encompasses corporate income tax (<i>imp&#244;t sur le revenu des
collectivit&#233;s</i>), municipal business tax (imp&#244;t commercial communal), a solidarity surcharge (<i>contribution au fonds
pour l&#8217;emploi</i>) as well as personal income tax (<i>imp&#244;t sur le revenu des personnes physiques</i>). Corporate taxpayers
may further be subject to net wealth tax (<i>imp&#244;t sur la fortune</i>), as well as other duties, levies and taxes. Corporate income
tax, municipal business tax, net wealth tax and the solidarity surcharge invariably apply to most corporate taxpayers resident in Luxembourg
for tax purposes. Individual taxpayers are generally subject to personal income tax and solidarity surcharge. Under certain circumstances,
where individual taxpayers act in the course of the management of a professional or business undertaking, municipal business tax may apply
as well.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Taxation of the Company</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The Company is subject to Luxembourg
tax on its worldwide profits at the current combined ordinary rate of 24.94% for Luxembourg City, including the 17% corporate income tax,
a 6.75% municipal business tax (rate in the municipality of Luxembourg City in 2023) and a solidarity surcharge (together the &#8220;<b>Income
Tax</b>&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In principle, dividends and
capital gains realized by the Company are fully subject to Income Tax in Luxembourg.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">However, provided the conditions
of the Luxembourg participation exemption regime are met, dividends distributed by subsidiaries of the Company or capital gains realized
by the Company upon the disposal of shares in its subsidiaries are not taxable in Luxembourg.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"></p><div>

</div><!-- Field: Page; Sequence: 82; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Luxembourg net wealth tax (&#8220;NWT&#8221;)
will be due annually by the Company at the rate of 0.5% on its total net asset value below or equal to &#8364; 500 million. The tranche
above &#8364; 500 million will be taxed at a rate of 0.05%. Net worth is assessed based on the unitary value (<i>valeur unitaire</i>),
as determined on January 1st of each year. The unitary value is in principle calculated as the difference between (i) assets estimated
at their fair market value (<i>valeur estim&#233;e de r&#233;alisation</i>), and (ii) debt liabilities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Shareholdings qualifying for
the Luxembourg participation exemption regime are excluded from the NWT basis provided that the Company holds a direct shareholding in
a qualifying subsidiary representing at least 10% of the qualifying subsidiary&#8217;s share capital or having an acquisition cost (including
both share capital and share premium) of at least &#8364; 1.2 million; there is no minimum holding period requirement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Companies for which the sum
of fixed financial assets (i.e., financial assets notably including shares and loans, transferable securities and cash) exceeds 90% of
their total balance sheet and &#8364; 350,000 are liable to a minimum annual NWT of &#8364; 4,815. Other companies are liable to a minimum
progressive tax (in an amount up to &#8364; 32,100), depending on the total assets on their balance sheet.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Withholding taxation</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Any dividend distributed
by the Company to its shareholders will in principle be subject to a 15% withholding tax unless an exemption or a reduced treaty rate
applies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Luxembourg tax residence of the holders</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Holders will not be deemed
to be resident, domiciled or carrying on business in Luxembourg solely by reason of holding, execution, performance, delivery, exchange
and/or enforcement of the Ordinary Shares or warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Taxation of Luxembourg non-residents</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Holders who are non-residents
of Luxembourg and who do not have a permanent establishment, a permanent representative, or a fixed place of business in Luxembourg with
which the holding of the Ordinary Shares or warrants is connected, are not liable to any Luxembourg income tax, whether they receive payments
upon redemption or repurchase of the Ordinary Shares or warrants, or realize capital gains on the sale of any Ordinary Shares or warrants,
unless they sell a participation of more than 10% in the Company within 6&#160;months of its acquisition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Taxation of Luxembourg residents</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Holders
who are Luxembourg resident individuals will generally be subject to income tax on income derived from the Ordinary Shares and warrants.
Capital gains realized upon the disposal, sale or redemption of the Ordinary Shares and warrants by individual resident holders acting
in the course of the management of their </span>private <span style="font-family: Times New Roman, Times, Serif">wealth are in principle
not subject to income tax (except if the gain has been realized within 6&#160;months of the acquisition of the Ordinary Shares or warrants),
to the extent they do not hold a participation of more than 10% in the Company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Holders
who are Luxembourg resident companies (<i>soci&#233;t&#233;s de capitaux</i>) or foreign entities which have a permanent </span>establishment
<span style="font-family: Times New Roman, Times, Serif">or a permanent representative in Luxembourg with which the holding of the Ordinary
Shares or warrants is connected, must include in their taxable basis any income (including dividend) and the difference between the sale
or redemption price and the lower of the cost or book value of the Ordinary Shares and warrants sold or redeemed.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">A
holder who is a Luxembourg resident company benefiting from a special tax regime, such as (i)&#160;a specialized investment fund governed
by the amended law of February&#160;13, 2007, (ii)&#160;a family wealth management company governed by the amended law of May&#160;11,
2007, (iii)&#160;an undertaking for collective investment </span>governed <span style="font-family: Times New Roman, Times, Serif">by
the amended law of December&#160;17, 2010 or (iv)&#160;a reserved alternative investment fund treated as a specialized investment fund
for Luxembourg tax purposes governed by the amended law of July&#160;23, 2016 is exempt from income tax in Luxembourg and profits derived
from the Ordinary Shares and warrants are in principle not subject to Luxembourg Income Tax.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"></p><div>

</div><!-- Field: Page; Sequence: 83; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Net Wealth Tax</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">A
Luxembourg resident as well as a non-resident who has a permanent establishment or a permanent representative in Luxembourg to which the
Ordinary Shares or warrants are attributable, are subject to </span>Luxembourg <span style="font-family: Times New Roman, Times, Serif">NWT
on such Ordinary Shares or warrants, except if the holder is (i)&#160;a resident or non-resident individual taxpayer, (ii)&#160;a securitization
company governed by the amended law of March&#160;22, 2004 on securitization, (iii)&#160;a company governed by the amended law of June&#160;15,
2004 on venture capital vehicles, (iv)&#160;a professional pension institution governed by the amended law dated July&#160;13, 2005, (v)&#160;a
specialized investment fund governed by the amended law of February&#160;13, 2007, (vi)&#160;a family wealth management company governed
by the law of May&#160;11, 2007, (vii)&#160;an undertaking for collective investment governed by the amended law of December&#160;17,
2010 or (viii)&#160;a reserved alternative investment fund governed by the amended law of July&#160;23, 2016.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">However, (i)&#160;a securitization
company governed by the amended law of March&#160;22, 2004 on securitization, (ii)&#160;a company governed by the amended law of June&#160;15,
2004 on venture capital vehicles, (iii)&#160;a professional pension institution governed by the amended law dated July&#160;13, 2005 and
(iv)&#160;a reserved alternative investment fund treated as a venture capital vehicle governed by the amended law of July&#160;23, 2016
remain subject to minimum NWT.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The
minimum NWT tax is levied on companies having their statutory seat or central administration in Luxembourg. For entities for which the
sum of fixed financial assets, receivables against related companies, transferable </span>securities <span style="font-family: Times New Roman, Times, Serif">and
cash at bank exceeds 90% of their total gross assets and &#8364; 350,000, the minimum NWT is currently set at &#8364; 4,815. For all other
companies having their statutory seat or central administration in Luxembourg which do not fall within the scope of the &#8364; 4,815 minimum
NWT, the minimum NWT ranges from &#8364; 535 to &#8364; 32,100, depending on the company&#8217;s total gross assets.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Other Taxes</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">No stamp, value, issue,
registration, transfer or similar taxes or duties will be payable in Luxembourg by shareholders in connection with the issue of the Ordinary
Shares and warrants, nor will any of these taxes be payable as a consequence of a subsequent transfer, exchange or redemption of the Ordinary
Shares or warrants, unless the documents relating to the Ordinary Shares or warrants are (i)&#160;voluntarily registered in Luxembourg
or (ii)&#160;appended to a document that requires obligatory registration in Luxembourg.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">There
is </span>no <span style="font-family: Times New Roman, Times, Serif">Luxembourg value added tax payable in respect of payments in consideration
for the issuance of the Ordinary Shares or warrants or in respect of the payment under the Ordinary Shares or warrants or the transfer
of the Ordinary Shares or warrants. Luxembourg value added tax may, however, be payable in respect of fees charged for certain services
rendered to us if, for Luxembourg value added tax purposes, such services are rendered or are deemed to be rendered in Luxembourg and
an exemption from Luxembourg value added tax does not apply with respect to such services.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">No Luxembourg inheritance
tax is levied on the transfer of the Ordinary Shares or warrants upon the death of a holder in cases where the deceased was not a resident
of Luxembourg for inheritance tax purposes. Where a holder is a resident of Luxembourg for tax purposes at the time of his death, the
Ordinary Shares and warrants are included in such holder&#8217;s taxable estate for inheritance tax assessment purposes. No Luxembourg
gift tax will be levied on the transfer of Ordinary Shares or warrants by way of gift unless the gift is registered in Luxembourg.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"></p><div>

</div><!-- Field: Page; Sequence: 84; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Material U.S. Federal Income Tax Considerations</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>General </b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The following is a summary
of certain U.S.&#160;federal income tax consequences of the acquisition, ownership and disposition of the Ordinary Shares by a U.S.&#160;holder
(as defined below). This summary only applies to the Ordinary Shares held as capital assets for U.S.&#160;federal income tax purposes.
The discussion below does not cover all aspects of U.S.&#160;federal income taxation that may be relevant to, or the actual tax effect
that any of the matters described herein will have on, the acquisition, ownership or disposition of the Ordinary Shares by particular
investors (including consequences under the alternative minimum tax or net investment income tax), and does not address state, local,
non-U.S.&#160;or other tax laws (such as estate or gift tax laws). This summary also does not describe all of the tax consequences that
may be relevant to holders that own (directly, indirectly or by attribution) 10% or more of the Ordinary Shares by vote or value, nor
does this summary discuss all of the tax considerations that may be relevant to certain types of holders subject to special rules under
the U.S.&#160;federal income tax laws, such as:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">financial institutions or financial services entities;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">insurance
</span>companies<span style="font-family: Times New Roman, Times, Serif">;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">individual
</span>retirement <span style="font-family: Times New Roman, Times, Serif">accounts or other tax-deferred accounts;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">regulatory <span style="font-family: Times New Roman, Times, Serif">agencies
or instrumentalities thereof;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">regulated
</span>investment <span style="font-family: Times New Roman, Times, Serif">companies and real estate investment trusts;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">persons
that have ceased to be U.S.&#160;citizens or lawful permanent residents of the United&#160;States;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">U.S.&#160;</span>citizens
<span style="font-family: Times New Roman, Times, Serif">or lawful permanent residents living abroad;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">persons
</span>that <span style="font-family: Times New Roman, Times, Serif">acquired the Ordinary Shares pursuant to an exercise of employee
share options, in connection with employee share incentive plans or otherwise as compensation;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">dealers
or traders subject to a mark-to-market method of tax accounting with respect to the Ordinary Shares;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">persons
holding the Ordinary Shares as part of a &#8220;straddle,&#8221; constructive sale, hedging transactions, </span>integrated <span style="font-family: Times New Roman, Times, Serif">transactions
or similar transactions for U.S.&#160;federal income tax purposes;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">U.S</span>.<span style="font-family: Times New Roman, Times, Serif">&#160;holders
whose functional currency is not the U.S.&#160;dollar;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">holders
that are controlled foreign corporations or passive foreign investment companies; or</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">tax-</span>exempt
<span style="font-family: Times New Roman, Times, Serif">organizations.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">For purposes of this discussion,
the term &#8220;U.S.&#160;holder&#8221; means a beneficial owner of Ordinary Shares that is, for U.S.&#160;federal income tax purposes:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">an
individual citizen or resident of the United&#160;States;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">a
corporation created or organized in or under the laws of the United&#160;States, any state thereof or the District of Columbia;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">an
estate the income of which is subject to U.S.&#160;federal income tax regardless of its source; or;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">a
trust if (1)&#160;a U.S.&#160;court can exercise primary supervision over the trust&#8217;s administration and one or more U.S.&#160;persons
are authorized to control all substantial decisions of the trust; or (2)&#160;the trust has a valid election in effect under applicable
Treasury regulations to be treated as a domestic trust for U.S.&#160;federal income tax purposes.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The U.S.&#160;federal income
tax treatment of a partner in an entity or arrangement treated as a partnership for U.S.&#160;federal income tax purposes that holds the
Ordinary Shares will depend on the status of the partner and the activities of the partnership. Holders that are entities or arrangements
treated as partnerships for U.S.&#160;federal income tax purposes should consult their tax advisors concerning the U.S.&#160;federal income
tax consequences to them and their partners of the acquisition, ownership and disposition of the Ordinary Shares by the partnership.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">This
discussion is based on the tax laws of the United&#160;States, including the Code, its legislative history, existing and </span>proposed
<span style="font-family: Times New Roman, Times, Serif">Treasury regulations thereunder, published rulings and court decisions, all as
of the date hereof and all subject to change at any time, possibly with retroactive effect. No rulings have been requested from the U.S.&#160;Internal
Revenue Service (the &#8220;IRS&#8221;) and there can be no guarantee that the IRS would not challenge, possibly successfully, the treatment
described below.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>THE SUMMARY OF U.S.&#160;FEDERAL INCOME TAX
CONSEQUENCES SET OUT BELOW IS FOR GENERAL INFORMATION ONLY.&#160;ALL HOLDERS SHOULD CONSULT THEIR TAX ADVISORS AS TO THE PARTICULAR TAX
CONSEQUENCES TO THEM OF ACQUIRING, OWNING, AND DISPOSING OF THE ORDINARY SHARES, INCLUDING THE APPLICABILITY AND EFFECT OF STATE, LOCAL,
NON-U.S.&#160;AND OTHER TAX LAWS AND POSSIBLE CHANGES IN TAX LAW.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 85; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>U.S. Holders</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dividends</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Subject to the PFIC rules
discussed below, distributions paid by us out of current or accumulated earnings and <span style="font-family: Times New Roman, Times, Serif">profits</span>
(as determined for U.S. federal income tax purposes) generally will be taxable to a U.S. holder as dividend income, and will not be eligible
for the dividends received deduction allowed to corporations. Distributions in excess of current and accumulated earnings and profits
will be treated as a nontaxable return of capital to the extent of the U.S. holder&#8217;s basis in the Ordinary Shares, and thereafter
as capital gain. However, we cannot provide any assurance that we will maintain calculations of our earnings and profits in accordance
with U.S. federal income tax accounting principles. U.S. holders should therefore assume that any distribution by us with respect to ordinary
shares may be reported as ordinary dividend income. U.S. holders should consult their own tax advisers with respect to the appropriate
U.S. federal income tax treatment of any distribution received or treated as received from us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Dividends paid by us generally
will be taxable to a non-corporate U.S. holder at the reduced rate normally applicable to long-term capital gains, provided that (i) the
ordinary shares are readily tradable on an established securities market in the United States; (ii) certain holding period requirements
are satisfied; and (3) we are not classified as a PFIC for our taxable year during which the dividend is paid or the immediately preceding
taxable year. See &#8220;<i>&#8212;Passive Foreign Investment Company Considerations</i>&#8221; below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sale or Other Disposition</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Subject to the discussion
below under &#8220;&#8212;&#160;<i>Passive Foreign Investment Company Rules,</i>&#8221; a U.S.&#160;holder generally will recognize gain
or loss on any sale, exchange, redemption or other taxable disposition of the Ordinary Shares in an amount equal to the difference between
(i)&#160;the amount realized on the disposition and (ii)&#160;such U.S.&#160;holder&#8217;s adjusted tax basis in the Ordinary Shares.
Any gain or loss recognized by a U.S.&#160;holder on a sale, exchange, redemption or other taxable disposition of the Ordinary Shares
generally will be capital gain or loss and will be long-term&#160;capital gain or loss if the U.S.&#160;holder&#8217;s holding period
in such Ordinary Shares exceeds one year at the time of the disposition. Preferential tax rates may apply to long-term&#160;capital gains
of non-corporate&#160;U.S.&#160;holders (including individuals). The deductibility of capital losses is subject to limitations. Any gain
or loss recognized by a U.S.&#160;holder on the sale, exchange, redemption or other taxable disposition of the Ordinary Shares generally
will be treated as U.S.&#160;source gain or loss. U.S.&#160;holders should consult their tax advisors as to the foreign tax credit implications
of the sale, exchange, redemption of other taxable disposition of the Ordinary Shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Passive Foreign Investment Company Considerations</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">A non-U.S.&#160;corporation
will be a passive foreign investment company (&#8220;PFIC&#8221;) for U.S.&#160;federal income tax purposes in any taxable year in which,
after taking into account the income and assets of the corporation and certain subsidiaries pursuant to applicable &#8220;look-through
rules,&#8221; either (i)&#160;at least 75% of the corporation&#8217;s gross income is &#8220;passive income&#8221; or (ii)&#160;at least
50% of the value of the corporation&#8217;s assets (generally based on the quarterly average of the value of its assets during the taxable
year) is attributable to assets, including cash, that produce passive income or are held for the production of passive income. Passive
income generally includes dividends, interest, certain royalties and rents, annuities, net gains from the sale or exchange of property
producing such income and net foreign currency gains.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Based on the composition
of our income, we believe we likely were a PFIC for our taxable year ending June 30, 2023, and may be classified as a PFIC for our current
taxable year or future taxable years. However, since the tests for determining PFIC status are applied annually after the close of the
taxable year, and it is difficult to predict accurately future income and assets relevant to this determination, there can be no assurance
with respect to our PFIC status for our current taxable year or any future taxable year. Further, we provide no assurances that we will
make a determination as to our PFIC status in respect of any taxable year. The fair market value of our assets is expected to depend,
in part, upon (a)&#160;the market value of the Ordinary Shares, and (b)&#160;the composition of the our assets and income. Because we
may value our goodwill based on the market value of the Ordinary Shares, a decrease in the market value of the Ordinary Shares and/or
an increase in cash or other passive assets would increase the relative percentage of our passive assets. The application of the PFIC
rules is subject to uncertainty in several respects and, therefore, no assurances can be provided that the IRS will not assert that we
are a PFIC with respect to any taxable year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"></p><div>

</div><!-- Field: Page; Sequence: 86; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">If we are classified as
a PFIC in any year with respect to which a U.S. holder holds the Ordinary Shares, we generally will continue to be treated as a PFIC with
respect to such U.S. holder in all succeeding years during which the U.S. holder holds the Ordinary Shares (unless a purging election
is made), regardless of whether we continue to meet the tests described above for treatment as a PFIC in such succeeding years. Under
one form of purging election, a &#8220;deemed sale&#8221; election, a U.S. holder may be able to elect to be treated as having disposed
of the Ordinary Shares at their fair market value as of the last day of the last taxable year in which we are classified as a PFIC, triggering
gain that would be subject to tax under the excess distribution regime discussed below but terminating treatment of the Ordinary Shares
as stock of a PFIC with respect to such U.S. holder. As a result of the purging election, the U.S. holder would have a new basis and holding
period in the Ordinary Shares for purposes of the PFIC rules. U.S. holders should discuss the potential availability of a deemed sale
election and other purging elections with their own tax advisors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">If we are a PFIC in any
year during which a U.S.&#160;holder owns the Ordinary Shares, subject to the discussion below regarding the mark-to-market&#160;or qualified
electing fund (&#8220;QEF&#8221;) elections, a U.S.&#160;holder generally will be subject to special rules with respect to (i)&#160;any
&#8220;excess distribution&#8221; (generally, any distributions received by a U.S.&#160;holder on its Ordinary Shares in a taxable year
that are greater than 125% of the average annual distributions received by the U.S.&#160;holder in the three preceding taxable&#160;years
or, if shorter, the U.S.&#160;holder&#8217;s holding period for the Ordinary Shares) and (ii)&#160;any gain realized on the sale or other
disposition of Ordinary Shares. Under these rules (a)&#160;the excess distribution or gain will be allocated ratably over the U.S.&#160;holder&#8217;s
holding period, (b)&#160;the amount allocated to the current taxable year and any taxable year prior to the first taxable year in which
we became a PFIC will be taxed as ordinary income, and (c)&#160;the amount allocated to each of the other taxable&#160;years will be subject
to tax at the highest rate of tax in effect for the applicable class of taxpayer for that year, and an interest charge for the deemed
deferral benefit will be imposed with respect to the resulting tax attributable to each such other taxable year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">If we are a PFIC for any
taxable year, to the extent any of our subsidiaries are also PFICs, a U.S.&#160;holder will generally be deemed to own shares in such
lower-tier PFICs that are directly or indirectly owned by us in the proportion which the value of the Ordinary Shares owned by such U.S.&#160;holder
bears to the value of all of our equity interests, and such U.S.&#160;holder will generally be subject to the tax consequences described
above (and the IRS Form&#160;8621 reporting requirement described below) with respect to the shares of such lower-tier PFIC the U.S.&#160;holder
is deemed to own. As a result, if we receive a distribution from any lower-tier PFIC or sell shares in a lower-tier PFIC, a U.S.&#160;holder
will generally be subject to tax under the excess distribution rules described above in the same manner as if such U.S.&#160;holder had
held a proportionate share of the lower-tier PFIC stock directly, even if such amounts are not distributed to the U.S.&#160;holder. However,
if a U.S.&#160;holder is treated as receiving an excess distribution in respect of a lower-tier PFIC, such holder would increase its tax
basis in the Ordinary Shares by the amount of such distribution. In addition, if we were to distribute such amount to the U.S.&#160;holder
with respect to its Ordinary Shares, such U.S.&#160;holder would not include the distribution in income but would instead reduce its tax
basis in the Ordinary Shares by the amount of the distribution. The application of the PFIC rules to indirect ownership of any lower-tier
PFIC held by us is complex and uncertain, and U.S.&#160;holders should therefore consult their own tax advisors regarding the application
of such rules to their ownership of the Ordinary Shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt"></p><div>

</div><!-- Field: Page; Sequence: 87; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">A U.S.&#160;holder may be
able to avoid the interest charge and the other adverse impacts of the PFIC rules described above by making a mark-to-market election
with respect to the Ordinary Shares, provided that the Ordinary Shares are &#8220;marketable.&#8221; PFIC shares generally are marketable
if: (i)&#160;they are &#8220;regularly traded&#8221; on a national securities exchange that is registered with the SEC or on the national
market system established under Section&#160;11A of the Exchange&#160;Act; or (ii)&#160;they are &#8220;regularly traded&#8221; on any
exchange or market that the Treasury Department determines to have rules sufficient to ensure that the market price accurately represents
the fair market value of the stock. It is expected that the Ordinary Shares, which are listed on the Nasdaq, will qualify as marketable
shares for purposes of the PFIC rules, but there can be no assurance that the Ordinary Shares will be &#8220;regularly traded&#8221; for
purposes of these rules. Pursuant to the mark-to-market election, a U.S.&#160;holder would include in each year as ordinary income the
excess, if any, of the fair market value of the Ordinary Shares over their adjusted basis at the end of the taxable year. A U.S.&#160;holder
may treat as ordinary loss any excess of the adjusted basis of the Ordinary Shares over their fair market value at the end of the year,
but only to the extent of the net amount previously included in income as a result of the election in prior&#160;years. A U.S.&#160;holder&#8217;s
adjusted tax basis in the PFIC shares will be increased to reflect any amounts included in income, and decreased to reflect any amounts
deducted, as a result of a mark-to-market election. Any gain recognized on a disposition of the Ordinary Shares will be treated as ordinary
income and any loss will be treated as ordinary loss (but only to the extent of the net amount of income previously included as a result
of a mark-to-market election), and thereafter, as capital loss. A mark-to-market election only applies for the taxable year in which the
election was made, and for each subsequent taxable year, unless the PFIC shares cease to be marketable or the IRS consents to the revocation
of the election. U.S.&#160;holders should also be aware that the Code and the Treasury regulations do not allow a mark-to-market election
with respect to the stock of lower-tier PFICs that is non-marketable. There is also no provision in the Code, Treasury regulations or
other published authority that specifically provides that a mark-to-market election with respect to the stock of a publicly-traded holding
company (such as us) effectively exempts the stock of any lower-tier PFICs from the negative tax consequences arising from the general
PFIC rules and, as a result, a mark-to-market election may not mitigate the adverse implications of the excess distribution regime with
respect to an investment in the Ordinary Shares if we were classified as a PFIC as a result of owning interests in PFIC subsidiaries.
U.S.&#160;holders should consult their own tax advisors to determine whether the mark-to-market tax election is available to them and
the consequences resulting from such election.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In some cases, a shareholder
of a PFIC may be subject to alternative treatment by making a QEF election to be taxed currently on its share of the PFIC&#8217;s undistributed
income. To make a QEF election, we must provide U.S.&#160;holders with certain information compiled according to U.S.&#160;federal income
tax principles. There is no assurance that we will provide such information. There is also no assurance that we will have timely knowledge
of our status as a PFIC in the future or of the required information to be provided. In addition, if we hold an interest in a lower-tier
PFIC (including, without limitation, in any PFIC subsidiaries), U.S.&#160;holders will generally be subject to the PFIC rules described
above with respect to any such lower-tier PFICs. There can be no assurance that a portfolio company or subsidiary in which we hold an
interest will not qualify as a PFIC, or that a PFIC in which we hold an interest will provide the information necessary for a QEF election
to be made by a U.S.&#160;holder (in particular if we do not control that PFIC).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">A U.S.&#160;holder that
owns (or is deemed to own) shares in a PFIC during any taxable year of generally is required to file an IRS Form&#160;8621 (whether or
not a QEF or mark-to-market&#160;election is or has been made) with such U.S.&#160;holder&#8217;s U.S.&#160;federal income tax return
and provide such other information as may be required by the U.S.&#160;Treasury Department. Failure to file IRS Form&#160;8621 for each
applicable taxable year may result in substantial penalties and result in the U.S.&#160;holder&#8217;s taxable&#160;years being open to
audit by the IRS until such Forms are properly filed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">U.S.&#160;holders should
consult their own tax advisors concerning our likely PFIC status and the consequences to them, including potential reporting requirements,
if we are classified as a PFIC for any taxable year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Foreign Financial Asset Reporting</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">U.S. taxpayers that own
certain foreign financial assets, including equity of foreign entities, with an <span style="font-family: Times New Roman, Times, Serif">aggregate</span>
value in excess of US$50,000 at the end of the taxable year or US$75,000 at any time during the taxable year (or, for certain individuals
living outside the United States and married individuals filing joint returns, certain higher thresholds) may be required to file an information
report with respect to such assets with their tax returns. The Ordinary Shares are expected to constitute foreign financial assets subject
to these requirements unless such Ordinary Shares are held in an account at a financial institution (in which case the account may be
reportable if maintained by a foreign financial institution). U.S. holders should consult their tax advisers regarding the application
of the rules relating to foreign financial asset reporting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 21.55pt">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Non-U.S. Holders</b></p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Subject to the discussion
below under &#8220;<i>&#8212;Backup Withholding and Information Reporting</i>,&#8221; any proceeds of a sale or other disposition of the
Ordinary Shares, as well as dividends and other proceeds with respect to the Ordinary <span style="font-family: Times New Roman, Times, Serif">Shares</span>,
are not subject to U.S. federal income tax, including withholding taxes, if paid to a Non-U.S. holder.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 88; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Backup Withholding and Information Reporting</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Information reporting requirements
may apply to dividends received by U.S.&#160;holders of the Ordinary Shares, and the proceeds received on the disposition of the Ordinary
Shares effected within the United&#160;States (and, in certain cases, outside the United&#160;States), in each case, other than U.S.&#160;holders
that are exempt recipients (such as corporations). Backup withholding may apply to such amounts if the U.S.&#160;holder fails to provide
an accurate taxpayer identification number (generally on an IRS Form&#160;W-9&#160;provided to the paying agent of the U.S.&#160;holder&#8217;s
broker) or is otherwise subject to backup withholding. U.S.&#160;holders should consult their tax advisors regarding these rules and any
other reporting obligations that may apply to the ownership or disposition of the Ordinary Shares, including reporting obligations related
to the holding of certain foreign financial assets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Backup withholding is not
an additional tax. Any amounts withheld under the backup withholding rules may be allowed as a refund or credit against a U.S.&#160;holder&#8217;s
U.S.&#160;federal income tax liability, if any, provided the required information is timely furnished to the IRS.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_055"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">F.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Dividends and Paying Agents</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not <span style="font-family: Times New Roman, Times, Serif">applicable</span>.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_056"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">G.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Statement by Experts</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not <span style="font-family: Times New Roman, Times, Serif">applicable</span>.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_057"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">H.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Documents on Display</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are subject to the information
requirements of the Exchange Act, except that as a foreign issuer, we will not be <span style="font-family: Times New Roman, Times, Serif">subject</span>
to the proxy rules or the short-swing profit disclosure rules of the Exchange Act. In accordance with these statutory requirements, we
will file or furnish reports and other information with the SEC, which you may inspect and copy at the Public Reference Room at 100 F
Street, N.E., Washington, D.C. 20549. Information on the operation of the Public Reference Room may be obtained by calling the SEC at
1-800-SEC-0330. In addition, the SEC maintains an Internet website that contains reports and other information about issuers, like us,
that file electronically with the SEC. The address of that website is www.sec.gov. In addition, our security filings may be accessed at
our website, http://www.moolecscience.com. Such filings and other information on our website are not incorporated by reference in this
annual report on Form 20-F.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_058"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">I.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Subsidiary Information</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Please refer to &#8220;<i>Item
4. Information on the Company&#8212;C. Organizational Structure</i>.&#8221;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_059"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">J.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Annual Report to Security Holders</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If we are required to provide
an annual report to security holders in response to the requirements of Form 6-K, we will submit the annual report to security holders
in electronic format in accordance with the EDGAR Filer Manual.</p><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><div><a id="a_060"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> ITEM&#160;11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">We are exposed to market
risks in the ordinary course of our business. These risks primarily include credit risk, liquidity risk, market risk and fair value risk.
For more information about market risks to which we are exposed, see Note 29 to our audited consolidated financial statements included
elsewhere in this annual report.</p><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><div><a id="a_061"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> ITEM&#160;12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</p><div>



</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_062"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">A.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Debt Securities</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not <span style="font-family: Times New Roman, Times, Serif">applicable</span>.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_063"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">B.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Warrants and Rights</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_064"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">C.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Other Securities</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not <span style="font-family: Times New Roman, Times, Serif">applicable</span>.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_065"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">D.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>American Depositary Shares</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not <span style="font-family: Times New Roman, Times, Serif">applicable</span>.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>

</div><!-- Field: Page; Sequence: 89; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="a_066"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">PART II</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="a_067"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> ITEM&#160;13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</p><div>



</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_068"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">A.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Defaults</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not <span style="font-family: Times New Roman, Times, Serif">applicable</span>.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_069"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">B.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Arrears and Delinquencies</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="a_070"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> ITEM&#160;14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not <span style="font-family: Times New Roman, Times, Serif">applicable</span>.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="a_071"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> ITEM&#160;15. CONTROLS AND PROCEDURES</p><div>



</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_072"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">A.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Disclosure Controls and Procedures</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Under</span>
the supervision and with the participation of our management, including our chief executive officer and chief financial officer, we conducted
an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e)
and 15d-15(e) under the Exchange Act, as of June 30, 2023. Based on this evaluation, our chief executive officer and chief financial officer
concluded that our disclosure controls and procedures were effective as of June 30, 2023, the end of the period covered by this report,
at a reasonable assurance level and, accordingly, provide reasonable assurance that the information required to be disclosed by us in
reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s
rules and forms and that information required to be disclosed by us in the reports we file or submit under the Exchange Act is accumulated
and communicated to our management, including our chief executive officer and chief financial officer, or persons performing similar functions,
as appropriate to allow timely decisions regarding required disclosure.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">There are inherent limitations
to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention
or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable
assurance of achieving their control objectives.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_073"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">B.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Management&#8217;s Annual Report on Internal Control Over Financial Reporting</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This annual report does
not include a report of management&#8217;s assessment regarding internal control over financial reporting due to a transition period established
by the rules of the SEC for newly-public companies. We will include a management report on internal control over financial reporting beginning
with our Annual Report on Form 20-F for the fiscal year ending June 30, 2024.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_092"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">C.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Attestation Report of the Registered Public Accounting Firm</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This report does not include
an attestation report of internal controls from our independent registered public accounting firm due to our status as an emerging growth
company under the JOBS Act.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_075"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">D.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Changes in Internal Control Over Financial Reporting</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">During the period covered
by this annual report, there have not been any changes in our internal control over financial reporting that have materially affected
or are reasonably likely to materially affect, our internal control over financial reporting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 90; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="a_076"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> ITEM&#160;16. Reserved</p><div>



</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_077"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">A.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Audit Committee Financial Expert</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our board of directors has
determined that Natalia Zang is an &#8220;audit committee financial expert&#8221; as defined by the SEC item 16A of Form 20-F. All members
of the audit committee are independent directors as defined in the Nasdaq Global Select Market corporate governance standards and Rule
10A-3 under the Exchange Act.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_078"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">B.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Code of Ethics</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have adopted a Code of
Ethics applicable to our directors, executive officers and employees and to all board members, employees and officers of our controlled
companies. The Code of Ethics codifies the business and ethical principles that govern all aspects of our business. A copy of the Code
of Ethics will be filed with the SEC and will be provided without charge upon written request to us in writing at &#8198;legal@moolecscience.com.
We intend to disclose any amendments to or waivers of certain provisions of our Code of Ethics in a Current Report on Form 6-K (as required)
or on our website.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_079"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">C.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Principal Accountant Fees and Services</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Price Waterhouse &amp; Co.
S.R.L. (&#8220;PwC&#8221;) has acted as our principal accountants for the years ended June 30, 2023 and 2022 The following is a summary
of fees paid or to be paid to PwC for services rendered for each of the last two fiscal years.</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Audit Fees</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Audit fees consist of fees
billed for standard audit work that needs to be performed each year in order to issue opinions on our consolidated financial statements
and for services that are normally provided by PwC in connection with regulatory filings. The aggregate fees billed by PwC for professional
services rendered for the audit of our annual consolidated financial statements and review of the financial information included in our
required filings with the SEC for the year ended June 30, 2023 and 2022 totaled US$0.1 million and US$0.4 million, respectively.</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Audit-Related Fees</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Audit-related fees
billed consist of fees for services such as auditing of non-recurring transactions, reviews of semi-annual financial results,
consents and comfort letters and any other audit services required for SEC or other regulatory filings. The aggregate fees billed by
PwC for professional services rendered for audit-related services for the year ended June 30, 2023 totaled US$0.1 million. PwC did not bill
us for audit-related services for the years ended June 30, 2022.</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Tax Fees</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Tax services relate to the
aggregated fees for services on tax compliance. PwC did not bill us for tax fees for the years ended June 30, 2023 and 2022.</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>All Other Fees</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We did not pay PwC for other
services for the years ended June 30, 2023 and 2022.</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Pre-approval Policies</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our audit committee approves
all auditing services and permitted non-audit services performed for us by its independent auditor in advance of an engagement. All auditing
services and permitted non-audit services (including the fees and terms thereof) to be performed for us by our independent auditor must
be approved by the audit committee in advance, subject to the de minimis exceptions for non-audit services described in Section 10A(i)(1)(B)
of the Exchange Act which are approved by the committee prior to the completion of the audit.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_080"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">D.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Exemptions from the Listing Standards for Audit Committees</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">No exemptions from the listing
standards for our audit committee.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_081"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">E.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Purchases of Equity Securities by the Issuer and Affiliated Purchasers</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 91; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_082"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">F.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Change in Registrant&#8217;s Certifying Accountant</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_083"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">G.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Corporate Governance</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">See &#8220;<i>&#8212;Item
6. Directors, Senior Management and Employees&#8212;C. Board Practices</i>.&#8221;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_084"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">H.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Mine Safety Disclosure</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_085"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">I.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Not applicable.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_086"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">J.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Insider Trading Policies</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant to applicable SEC
transition guidance, the disclosure required by Item 16J will be applicable to us from the fiscal year ending June 30, 2024.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_087"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">K.<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Cybersecurity</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant to applicable SEC
transition guidance, the disclosure required by Item 16K will be applicable to us from the fiscal year ending June 30, 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 92; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="a_088"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">PART III</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="a_089"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> ITEM&#160;17. FINANCIAL STATEMENTS</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have responded to Item
18 in lieu of this item.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="a_090"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> ITEM&#160;18. FINANCIAL STATEMENTS</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Financial Statements are
filed as part of this report, see page F-1.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 93; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><div><a id="a_091"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in">ITEM&#160;19.</td><td style="text-align: justify">EXHIBITS</td></tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 9%; text-align: justify">1.1**</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 90%; text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1937737/000121390022074033/ff42022a1ex3-1_moolec.htm">Amended and Restated Articles of Association of the Company, dated as of December 29, 2022.</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">1.2**</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1937737/000121390022074033/ff42022a1ex4-1_moolec.htm">Specimen Ordinary Share Certificate of Moolec Science SA (incorporated by reference to Exhibit 4.1 to the Registration Statement on Form F-4/A filed December 1, 2022 (file no. 333-267912)).</a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">2.2**</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1825437/000121390022033124/ea161359ex10-4_lightjump.htm">Specimen Warrant Certificate of Moolec Science S.A. (included as Exhibit A to Exhibit 2.5).</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">2.3</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1825437/000121390021002945/ea133526ex4-1_lightjump.htm">Warrant Agreement, dated January 12, 2021, by and between LightJump Acquisition Corporation and Continental Stock Transfer &amp; Trust Company, as warrant agent (incorporated by reference to Exhibit 4.1 to LightJump Acquisition Corporation&#8217;s Form 8-K, File No. 001-39869, filed with the SEC on January 20, 2021).</a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">2.4</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1825437/000121390021002945/ea133526ex10-3_lightjump.htm">Subscription Agreement for Private Warrants by LightJump One Founders, LLC (incorporated by reference to Exhibit 10.3 to LightJump Acquisition Corporation&#8217;s Form 8-K, File No. 001-39869, filed with the SEC on January 20, 2021).</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">2.5**</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1825437/000121390022033124/ea161359ex10-4_lightjump.htm">Form of Assignment, Assumption and Amendment Agreement with respect to the Warrant Agreement between LightJump Acquisition Corporation, Moolec Science SA and Continental Stock Transfer &amp; Trust Company (incorporated by reference to Exhibit 10.4 to LightJump Acquisition Corporation&#8217;s Form 8-K, File No. 001-39869, filed with the SEC on June 15, 2022).</a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">2.6*</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="#a_051">Description of Registrant&#8217;s Securities: See &#8220;<i>Item 10. Additional Information&#8212;B.
    Memorandum and Articles of Association&#8212;Ordinary Shares</i>.&#8221;</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">4.1#</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1825437/000121390022033124/ea161359ex2-1_lightjump.htm">Business Combination Agreement, dated as of June 14, 2022, by and among LightJump Acquisition Corporation, Moolec Science Limited, Moolec Science SA and Moolec Acquisition, Inc. (incorporated by reference to Exhibit 2.1 to LightJump Acquisition Corporation&#8217;s Form 8-K, File No. 001-39869, filed with the SEC on June 15, 2022).</a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">4.2#</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1825437/000121390022074207/ea169063ex2-1_lightjump.htm">First Amendment to the Business Combination Agreement, by and among LightJump Acquisition Corporation, Moolec Science Limited, Moolec Science SA and Moolec Acquisition, Inc. (incorporated by reference to Exhibit 2.1 to LightJump Acquisition Corporation&#8217;s Form 8-K, File No. 001-39869, filed with the SEC on November 21, 2022).</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">4.3</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1825437/000121390022033124/ea161359ex10-1_lightjump.htm">Form of Exchange Agreement (incorporated by reference to Exhibit 10.1 to LightJump Acquisition Corporation&#8217;s Form 8-K, File No. 001-39869, filed with the SEC on June 15, 2022).</a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">4.4</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1825437/000121390022033124/ea161359ex10-3_lightjump.htm">Transaction Support Agreement, dated as of June 14, 2022, by and among LightJump Acquisition Corporation, LightJump One Founders, LLC, Moolec Science Limited, Moolec Science SA and others (incorporated by reference to Exhibit 10.3 to LightJump Acquisition Corporation&#8217;s Form 8-K, File No. 001-39869, filed with the SEC on June 15, 2022).</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">4.5</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1825437/000121390021002945/ea133526ex10-2_lightjump.htm">Registration Rights Agreement, dated as of January 12, 2021, by and between LightJump Acquisition Corporation and other investors (incorporated by reference to Exhibit 10.2 to LightJump Acquisition Corporation&#8217;s Form 8-K, File No. 001-39869, filed with the SEC on January 20, 2021).</a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">4.6**</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1937737/000121390023001441/f20f2022ex4-6_moolecsci.htm">Registration Right and Lock-Up Agreement, dated December 30, 2022, by and among, Moolec Science SA, LightJump One Founders, LLC, BG Farming Technologies Ltd., Union Group Ventures Ltd., Bioceres Crop Solutions Corp., THEO I SCSp, Serenity Traders LTD., UG Holdings, LLC, Robert M. Bennett and Jose L&#243;pez Lecube (incorporated by reference to Exhibit 4.6 to Company&#8217;s Form 20-F, File No. 001-41586, filed with the SEC on January 6, 2023).</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">4.7</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1825437/000121390022033124/ea161359ex10-2_lightjump.htm">Backstop Agreement (incorporated by reference to Exhibit 10.2 to LightJump Acquisition Corporation&#8217;s Form 8-K, File No. 001-39869, filed with the SEC on June 15, 2022).</a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">4.8**</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1937737/000121390023001441/f20f2022ex4-8_moolecsci.htm">Memorandum of Understanding on the Backstop Agreement, dated as of December 30, 2022, by and among LightJump Acquisition Corporation, Moolec Science Limited, Moolec Science SA, UG Holdings, LLC, Union Group Ventures Limited, THEO I SCSp and LightJump One Founders, LLC (incorporated by reference to Exhibit 4.8 to Company&#8217;s Form 20-F, File No. 001-41586, filed with the SEC on January 6, 2023).</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">4.9</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1825437/000121390022033124/ea161359ex10-6_lightjump.htm">Amendment to Business Combination Marketing Agreement, dated June 14, 2022 between LightJump Acquisition Corporation and EarlyBirdCapital, Inc. (incorporated by reference to Exhibit 10.6 to LightJump Acquisition Corporations&#8217;s Form 8-K, File No. 001-39869, filed with the SEC on June 15, 2022).</a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">8.1*</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="#a_019">List of subsidiaries of Moolec Science SA, as of June 30, 2021: See &#8220;<i>Item 4. Information on the Company&#8212;C. Organizational Structure</i>.&#8221;</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">10.11**</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1937737/000121390023028710/ea176777ex10-1_moolec.htm">Company Acceptance Letter, dated April 9, 2023, and Selling Shareholders Offer Letter, dated April 9, 2023, relating to the ValoraSoy SPA, between the Company and the Sellers (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Form 6-K, File No. 001-41586).</a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">12.1*</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="f20f2023ex12-1_moolec.htm">Rule 13a-14(a)/15d-14(a) - Section 302 - Certification of Chief Executive Officer</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">12.2*</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="f20f2023ex12-2_moolec.htm">Rule 13a-14(a)/15d-14(a) - Section 302 - Certification of Chief Financial Officer</a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify">13.1*</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="f20f2023ex13-1_moolec.htm">18 U.S.C. SECTION 1350 - Section 906 - Certification of Chief Executive Officer</a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify">13.2*</td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="f20f2023ex13-2_moolec.htm">18 U.S.C. SECTION 1350 - Section 906 - Certification of Chief Financial Officer</a></td></tr>

  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS*</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Instance Document </span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH*</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Schema Document.</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL*</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF*</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB*</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Label Linkbase Document.</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE*</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104*</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; text-align: justify">*</td>
    <td style="text-align: justify">Filed herewith.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">**</td>
    <td style="text-align: justify">Previously filed.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">#</td>
    <td style="text-align: justify">Certain schedules, annexes and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K, but will be furnished supplementally to the SEC upon request.</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: 0in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 94; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The registrant hereby certifies
that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this
registration statement on its behalf.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: October 30, 2023</span></td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%; text-align: justify">&#160;</td>
    <td style="width: 4%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 5%; text-align: justify">&#160;</td>
    <td style="width: 31%; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td colspan="3" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MOOLEC SCIENCE SA</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid">/s/ <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gast&#243;n Paladini</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gast&#243;n Paladini</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 95; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INDEX TO FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 91%; text-align: justify">MOOLEC SCIENCE SA</td>
    <td style="width: 9%; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><i>For the years ended June 2023 and 2022, and for the periods of January 1, 2021 through June 30, 2021 and from August 21, 2020 through December 31, 2020</i></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#f_001">Audited Consolidated Financial Statements</a></td>
    <td style="text-align: center">F-2</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#f_002">Audited consolidated statements of comprehensive loss</a></td>
    <td style="text-align: center">F-3</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#f_003">Audited consolidated statements of financial position</a></td>
    <td style="text-align: center">F-4</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; text-align: justify"><a href="#f_004">Audited consolidated statements of changes in equity</a></td>
    <td style="text-align: center">F-5</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#f_005">Audited statements of cash flow</a></td>
    <td style="text-align: center">&#8198;F-6</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#f_006">Notes to the Audited Consolidated Financial Statements</a></td>
    <td style="text-align: center">&#8198;F-8</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in"></p><div>

</div><!-- Field: Page; Sequence: 96 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">Consolidated Financial
Statements as of and for the years ended June 30, 2023 and 2022,</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">and for the periods of
January 1, 2021 through June 30, 2021 and from August 21, 2020 through December 31, 2020.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 97 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 90.3pt 0pt 87.6pt; text-align: center; background-color: white">Moolec
Science S.A.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Consolidated Financial
Statements as of and for the years ended June 30, 2023 and 2022, and for the<br/>
 periods of January 1, 2021 through June 30, 2021 and from
August 21, 2020 through December 31, 2020.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Table of Contents</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 8pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Contents</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>



</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0; width: 90%; text-align: left"><a href="#f_001">Report of Independent Registered Public Accounting Firm PCAOB ID: <ix:nonNumeric contextRef="c0" name="dei:AuditorFirmId">1349</ix:nonNumeric></a></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center">F-2</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_002">Consolidated statements of comprehensive loss</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-3</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_003">Consolidated statements of financial position</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-4</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_004">Consolidated statements of changes in equity</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-5</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_005">Consolidated statements of cash flow</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-6</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_006">Notes to the Consolidated financial statements</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-8</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_007">Note 1. General information</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-8</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_008">Note 2. Business combination</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-10</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_009">Note 3. Accounting standards and basis of preparation</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-11</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_010">Note 4. Summary of significant accounting policies</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-12</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_011">Note 5. Comparative Information</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-25</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_012">Note 6. Intangible Assets</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-25</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_013">Note 7. Fixed Assets</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-26</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_014">Note 8. Goodwill</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-27</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_015">Note 9. Right-of-use of assets</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-27</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_016">Note 10. Other non-current receivables</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-27</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_017">Note 11. Cash and cash equivalents</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-27</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_018">Note 12. Short-term investments</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-28</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_019">Note 13. Trade Receivable and Other current receivables</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-28</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_020">Note 14. Inventories</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-28</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_021">Note 15. Share capital and share premium</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-29</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_022">Note 16. Share based payment</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-30</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_023">Note 17. Accounts Payable and other current and non-current liabilities</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-31</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_024">Note 18. Financial debt</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-32</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_025">Note 19. Warrants liabilities</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-33</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_026">Note 20. Simple Agreement for Future Equity (&#8220;SAFE&#8221;)</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-33</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_027">Note 21. Deferred tax and income tax</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-34</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_028">Note 22. Financial income / expenses</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-36</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_029">Note 23. Other operating expense</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-36</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_030">Note 24. Administrative expenses</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-37</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_031">Note 25. Research and development expense</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-37</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_032">Note 26. Cost of sales</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-37</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_033">Note 27. Net loss per share</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-38</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_034">Note 28. Related parties</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-38</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_035">Note 29. Financial risk management</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-40</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_036">Note 30. Capital risk management</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-44</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><a href="#f_037">Note 31. Events after the reporting period</a></td> <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">F-44</td></tr>
</table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 98; Options: NewSection; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><div><a id="f_001"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Report of Independent
Registered Public Accounting Firm</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">To the board of directors
and shareholders of Moolec Science S.A.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><b><i>Opinion on the Financial
Statements</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We have audited the accompanying
consolidated statements of financial position of Moolec Science S.A. and its subsidiaries (the &#8220;Company&#8221;) as of June 30, 2023
and 2022, and the related consolidated statements of comprehensive loss, of changes in equity and of cash flows for the years ended June
30, 2023 and 2022 and for each of the periods from January 1, 2021 through June 30, 2021 and from August 21, 2020 through December 31,
2020, including the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the
consolidated financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2023
and 2022 and the results of its operations and its cash flows for the years ended June 30, 2023 and 2022 and for each of the periods from
January 1, 2021 through June 30, 2021 and from August 21, 2020 through December 31, 2020 in conformity with International Financial Reporting
Standards as issued by the International Accounting Standards Board.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>Basis for Opinion</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">These consolidated financial
statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s
consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight
Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We conducted our audits
of these consolidated financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform
the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether
due to error or fraud.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Our audits included performing
procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing
procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures
in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates
made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits
provide a reasonable basis for our opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; background-color: white"> <td style="width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Price Waterhouse &amp; Co. S.R.L.</span></td> <td style="width: 60%; text-align: left">&#160;</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Sebastian Azagra</span></td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="text-align: left"><ix:nonNumeric contextRef="c0" name="dei:AuditorName"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sebastian Azagra</span></ix:nonNumeric></td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Partner</span></td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="text-align: left"><ix:nonNumeric contextRef="c0" name="dei:AuditorLocation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rosario, Argentina</span></ix:nonNumeric></td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: top; background-color: white"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 30, 2023</span></td> <td style="text-align: left">&#160;</td></tr> </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">We have served as
the Company&#8217;s auditor since 2020.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 99; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="f_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Moolec Science S.A.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 5pt 0pt 0; text-align: center; background-color: white">Consolidated
statements of comprehensive loss</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">For the year ended June
30, 2023 and 2022 and for the periods of January 1, 2021 through June 30, 2021 and from August 21, 2020 through December 31, 2020.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.7pt 0pt 7.1pt; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">In USD [$]</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center"><b>Notes</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year<br/>
 ended on<br/>
 June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year<br/>
 ended on<br/>
 June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">From the<br/>
 period of<br/>
 January 1,<br/>
 2021<br/>
through<br/>
June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">From the<br/>
 period of<br/>
 August 21,<br/>
 2020<br/>
through<br/>
 December&#160;31,<br/>
 2020</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Continuing operations</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 40%; text-align: left">Revenue</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="font-style: normal; width: 1%; font-weight: normal; text-align: left"><b>$</b></td><td style="font-style: normal; width: 9%; font-weight: normal; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Revenue" scale="0" unitRef="usd">905,049</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left"><b>$</b></td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-1">-</div></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left"><b>$</b></td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-2">-</div></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left"><b>$</b></td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-3">-</div></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Cost of sales</td><td>&#160;</td>
    <td style="text-align: center">26</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd">1,048,354</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-4">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-5">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-6">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Research and development expense</td><td>&#160;</td>
    <td style="text-align: center">25</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="0" unitRef="usd">1,351,217</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="0" unitRef="usd">985,158</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="0" unitRef="usd">601,942</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="0" unitRef="usd">179,061</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Marketing expense</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SalesAndMarketingExpense" scale="0" unitRef="usd">256,421</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SalesAndMarketingExpense" scale="0" unitRef="usd">105,060</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SalesAndMarketingExpense" scale="0" unitRef="usd">80,221</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SalesAndMarketingExpense" scale="0" unitRef="usd">10,938</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Administrative expense</td><td>&#160;</td>
    <td style="text-align: center">24</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="0" unitRef="usd">4,808,655</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="0" unitRef="usd">2,523,230</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="0" unitRef="usd">820,946</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="0" unitRef="usd">127,886</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Other operating expense</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">23</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="0" sign="-" unitRef="usd">94,207</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="0" sign="-" unitRef="usd">38,985</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="0" sign="-" unitRef="usd">93,252</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherOperatingIncomeExpense" scale="0" sign="-" unitRef="usd">2,639</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Loss from operations</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossFromOperatingActivities" scale="0" sign="-" unitRef="usd">6,653,805</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossFromOperatingActivities" scale="0" sign="-" unitRef="usd">3,652,433</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossFromOperatingActivities" scale="0" sign="-" unitRef="usd">1,596,361</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossFromOperatingActivities" scale="0" sign="-" unitRef="usd">320,524</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Share of loss from associate</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-7">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-8">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" scale="0" sign="-" unitRef="usd">390,453</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-9">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Financial Cost</td><td>&#160;</td>
    <td style="text-align: center">22</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinanceCosts" scale="0" unitRef="usd">160,035</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinanceCosts" scale="0" unitRef="usd">2,130</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-10">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-11">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Other financial results</td><td>&#160;</td>
    <td style="text-align: center">22</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherFinanceIncomeCost" scale="0" unitRef="usd">1,030,525</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherFinanceIncomeCost" scale="0" sign="-" unitRef="usd">872,342</ix:nonFraction></td><td style="text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-12">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-13">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Transaction expenses</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:TransactionsExpenses" scale="0" unitRef="usd">3,535,046</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-14">-</div></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-15">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-16">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Share based payment cost of listing shares</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">1</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" scale="0" unitRef="usd">42,705,061</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-17">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-18">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-19">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Net loss before Income tax</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="0" sign="-" unitRef="usd">52,023,422</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="0" sign="-" unitRef="usd">4,526,905</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="0" sign="-" unitRef="usd">1,986,814</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossBeforeTax" scale="0" sign="-" unitRef="usd">320,524</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">&#160;Income tax benefit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">21</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="0" sign="-" unitRef="usd">234,542</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-20">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-21">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-22">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Net loss of the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd">51,788,880</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd">4,526,905</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd">1,986,814</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd">320,524</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"><div style="-sec-ix-hidden: hidden-fact-26; -sec-ix-hidden: hidden-fact-25; -sec-ix-hidden: hidden-fact-24; -sec-ix-hidden: hidden-fact-23">Basic and diluted loss per share</div></td><td>&#160;</td>
    <td style="text-align: center">27</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShare" scale="0" sign="-" unitRef="usdPershares">1.50</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShare" scale="0" sign="-" unitRef="usdPershares">0.15</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShare" scale="0" sign="-" unitRef="usdPershares">0.07</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShare" scale="0" sign="-" unitRef="usdPershares">0.01</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>

<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Other comprehensive income/loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; width: 40%; font-weight: bold; text-align: left">Net loss of the year</td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 11%; font-weight: bold; text-align: left"></td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd">51,788,880</ix:nonFraction></td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd">4,526,905</ix:nonFraction></td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd">1,986,814</ix:nonFraction></td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd">320,524</ix:nonFraction></td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Foreign exchange differences on translation of foreign operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" scale="0" unitRef="usd">18,112</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-27">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-28">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-29">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Total other comprehensive income/(loss)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncome" scale="0" unitRef="usd">18,112</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-30">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-31">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-32">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"><b>Total comprehensive loss for the
    year</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right"><b>(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="0" sign="-" unitRef="usd">51,770,768</ix:nonFraction></b></td><td style="font-weight: bold; text-align: left"><b>)</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right"><b>(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="0" sign="-" unitRef="usd">4,526,905</ix:nonFraction></b></td><td style="font-weight: bold; text-align: left"><b>)</b></td><td><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><b>$</b></td><td style="padding-bottom: 1.5pt; text-align: right"><b>(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="0" sign="-" unitRef="usd">1,986,814</ix:nonFraction></b></td><td style="text-align: left"><b>)</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><b>$</b></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right"><b>(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ComprehensiveIncome" scale="0" sign="-" unitRef="usd">320,524</ix:nonFraction></b></td><td style="font-weight: bold; text-align: left"><b>)</b></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">The accompanying notes are
an integral part of these consolidated financial statements.</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 100; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><div><a id="f_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Moolec Science S.A.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Consolidated statements
of financial position</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">As of June 30, 2023 and
2022</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">In USD [$]</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Notes</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">ASSET</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">Non- current assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Intangible Assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">6</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">8,519,098</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">4,598,930</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Fixed Assets</td><td>&#160;</td>
    <td style="text-align: center">7</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:FixedAssets" scale="0" unitRef="usd">1,142,082</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:FixedAssets" scale="0" unitRef="usd">8,918</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Goodwill</td><td>&#160;</td>
    <td style="text-align: center">8</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Goodwill" scale="0" unitRef="usd">251,440</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-33">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Right-of-use of assets</td><td>&#160;</td>
    <td style="text-align: center">9</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="0" unitRef="usd">43,806</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-34">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other Non-Current receivables</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">10</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentReceivables" scale="0" unitRef="usd">8,763,027</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-35">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Total non-current assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd">18,719,453</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentAssets" scale="0" unitRef="usd">4,607,848</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Current assets</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: center">11</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="0" unitRef="usd">2,527,673</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalents" scale="0" unitRef="usd">1,081,808</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Short-term investments</td><td>&#160;</td>
    <td style="text-align: center">12</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:ShorttermInvestmentsCurrent" scale="0" unitRef="usd">306,034</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-36">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Trade receivables</td><td>&#160;</td>
    <td style="text-align: center">13</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentTradeReceivables" scale="0" unitRef="usd">361,097</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-37">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other receivables</td><td>&#160;</td>
    <td style="text-align: center">13</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherReceivables" scale="0" unitRef="usd">1,330,177</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-38">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Prepayments</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPrepayments" scale="0" unitRef="usd">341,107</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentPrepayments" scale="0" unitRef="usd">2,061</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Inventories</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">14</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Inventories" scale="0" unitRef="usd">465,748</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-39">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">Total current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="0" unitRef="usd">5,331,836</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="0" unitRef="usd">1,083,869</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">TOTAL ASSETS</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Assets" scale="0" unitRef="usd">24,051,289</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Assets" scale="0" unitRef="usd">5,691,717</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">LIABILITIES AND EQUITY</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Equity</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Share capital</td><td>&#160;</td>
    <td style="text-align: center">15</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IssuedCapital" scale="0" unitRef="usd">375,641</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IssuedCapital" scale="0" unitRef="usd">310,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Share premium</td><td>&#160;</td>
    <td style="text-align: center">15</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SharePremium" scale="0" unitRef="usd">66,996,982</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SharePremium" scale="0" unitRef="usd">7,290,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Shares to be issued</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:ShareToBeIssuedAmount" scale="0" unitRef="usd">3,068</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-40">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Equity settled share-based payment</td><td>&#160;</td>
    <td style="text-align: center">16</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:EquitySettledShareBasedPayments" scale="0" unitRef="usd">1,335,253</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:EquitySettledShareBasedPayments" scale="0" unitRef="usd">838,576</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cumulative translation adjustment</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="0" unitRef="usd">18,112</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-41">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accumulated deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RetainedEarnings" scale="0" sign="-" unitRef="usd">58,623,123</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RetainedEarnings" scale="0" sign="-" unitRef="usd">6,834,243</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Total equity</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">10,105,933</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">1,604,333</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Liabilities</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current liabilities</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: center">17</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="0" unitRef="usd">7,479,614</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayables" scale="0" unitRef="usd">1,226,213</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Financial debts</td><td>&#160;</td>
    <td style="text-align: center">18</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentFinancialLiabilities" scale="0" unitRef="usd">2,546,243</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-42">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other current liabilities</td><td>&#160;</td>
    <td style="text-align: center">17</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentLiabilities" scale="0" unitRef="usd">1,685,645</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentLiabilities" scale="0" unitRef="usd">1,171</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Warrants liabilities</td><td>&#160;</td>
    <td style="text-align: center">19</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:WarrantLiability" scale="0" unitRef="usd">887,689</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-43">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Simply Agreement for Future Equity (&#8220;SAFE&#8221;)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">20</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-44">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:SimplyAgreementForFutureEquitySAFE" scale="0" unitRef="usd">2,860,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Total current liabilities</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="0" unitRef="usd">12,599,191</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentLiabilities" scale="0" unitRef="usd">4,087,384</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Non-current liabilities</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Financial debt</td><td>&#160;</td>
    <td style="text-align: center">18</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentFinancialLiabilities" scale="0" unitRef="usd">99,046</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-45">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other non-current liabilities</td><td>&#160;</td>
    <td style="text-align: center">17</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentPayables" scale="0" unitRef="usd">175,312</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-46">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Deferred Tax Liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">21</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxLiabilities" scale="0" unitRef="usd">1,071,807</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-47">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">Total non-current liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentLiabilities" scale="0" unitRef="usd">1,346,165</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-48">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">TOTAL LIABILITIES</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Liabilities" scale="0" unitRef="usd">13,945,356</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Liabilities" scale="0" unitRef="usd">4,087,384</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">TOTAL LIABILITIES AND EQUITY</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:EquityAndLiabilities" scale="0" unitRef="usd">24,051,289</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:EquityAndLiabilities" scale="0" unitRef="usd">5,691,717</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">The accompanying
notes are an integral part of these consolidated financial statement</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5pt 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5pt 0pt 0; text-align: left; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 101; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5pt 0pt 0; text-align: left; background-color: white">&#160;</p><div>




</div><div><a id="f_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Moolec Science S.A.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Consolidated statements
of changes in equity</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">For the year ended June
30, 2023 and 2022 and for the periods of January 1, 2021 through June 30, 2021 and from August 21, 2020 through December 31, 2020.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">In USD [$]</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Share Capital</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Cumulative</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Equity<br/>
 settled<br/>
share</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Notes</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares<br/>
 issued</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares to<br/>
 be issued</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Share<br/>
 Premium</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">translation<br/>
 adjustment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> based<br/>
 payment</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Retained<br/>
 (deficit)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total Equity</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="font-style: normal; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal">
    <td style="font-style: normal; font-weight: normal; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"><b>Balance
    as of August 21, 2020</b></td><td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal"><b>&#160;</b></td>
    <td style="font-style: normal; text-align: center; padding-bottom: 1.5pt; font-weight: normal"><b>&#160;</b></td><td style="font-style: normal; font-weight: normal; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; font-style: normal; font-weight: normal; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; font-style: normal; font-weight: normal; text-align: right"><div style="-sec-ix-hidden: hidden-fact-49">-<b>&#160;</b></div></td><td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal; text-align: left"><b>&#160;</b></td><td style="font-style: normal; font-weight: normal; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; font-style: normal; font-weight: normal; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; font-style: normal; font-weight: normal; text-align: right"><div style="-sec-ix-hidden: hidden-fact-50">-<b>&#160;</b></div></td><td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal; text-align: left"><b>&#160;</b></td><td style="font-style: normal; font-weight: normal; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; font-style: normal; font-weight: normal; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; font-style: normal; font-weight: normal; text-align: right"><div style="-sec-ix-hidden: hidden-fact-51">-<b>&#160;</b></div></td><td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal; text-align: left"><b>&#160;</b></td><td style="font-style: normal; font-weight: normal; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; font-style: normal; padding-bottom: 1.5pt; font-weight: normal; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; font-style: normal; padding-bottom: 1.5pt; font-weight: normal; text-align: right"><div style="-sec-ix-hidden: hidden-fact-52">-<b>&#160;</b></div></td><td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal; text-align: left"><b>&#160;</b></td><td style="font-style: normal; font-weight: normal; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; font-style: normal; font-weight: normal; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; font-style: normal; font-weight: normal; text-align: right"><div style="-sec-ix-hidden: hidden-fact-53">-<b>&#160;</b></div></td><td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal; text-align: left"><b>&#160;</b></td><td style="font-style: normal; font-weight: normal; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; font-style: normal; font-weight: normal; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; font-style: normal; font-weight: normal; text-align: right"><div style="-sec-ix-hidden: hidden-fact-54">-<b>&#160;</b></div></td><td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal; text-align: left"><b>&#160;</b></td><td style="font-style: normal; font-weight: normal; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; font-style: normal; font-weight: normal; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; font-style: normal; font-weight: normal; text-align: right"><div style="-sec-ix-hidden: hidden-fact-55">-<b>&#160;</b></div></td><td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal; text-align: left"><b>&#160;</b></td></tr>
  <tr style="font-style: normal; vertical-align: bottom; background-color: White; font-weight: normal">
    <td style="font-style: normal; width: 30%; font-weight: normal; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Issue
    of share capital</td><td style="font-style: normal; width: 1%; font-weight: normal">&#160;</td>
    <td style="font-style: normal; width: 6%; text-align: center; font-weight: normal">&#160;</td><td style="font-style: normal; width: 1%; font-weight: normal">&#160;</td>
    <td style="font-style: normal; width: 1%; font-weight: normal; text-align: left"></td><td style="font-style: normal; width: 6%; font-weight: normal; text-align: right"><ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="mlec:IssueOfShareCapital" scale="0" unitRef="usd">291,400</ix:nonFraction></td><td style="font-style: normal; width: 1%; font-weight: normal; text-align: left">&#160;</td><td style="font-style: normal; width: 1%; font-weight: normal">&#160;</td>
    <td style="font-style: normal; width: 1%; font-weight: normal; text-align: left"></td><td style="font-style: normal; width: 6%; font-weight: normal; text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">-</div></td><td style="font-style: normal; width: 1%; font-weight: normal; text-align: left">&#160;</td><td style="font-style: normal; width: 1%; font-weight: normal">&#160;</td>
    <td style="font-style: normal; width: 1%; font-weight: normal; text-align: left"></td><td style="font-style: normal; width: 6%; font-weight: normal; text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="mlec:IssueOfShareCapital" scale="0" unitRef="usd">4,308,600</ix:nonFraction></td><td style="font-style: normal; width: 1%; font-weight: normal; text-align: left">&#160;</td><td style="font-style: normal; width: 1%; font-weight: normal">&#160;</td>
    <td style="font-style: normal; width: 1%; font-weight: normal; text-align: left"></td><td style="font-style: normal; width: 6%; font-weight: normal; text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">-</div></td><td style="font-style: normal; width: 1%; font-weight: normal; text-align: left">&#160;</td><td style="font-style: normal; width: 1%; font-weight: normal">&#160;</td>
    <td style="font-style: normal; width: 1%; font-weight: normal; text-align: left"></td><td style="font-style: normal; width: 6%; font-weight: normal; text-align: right"><div style="-sec-ix-hidden: hidden-fact-58">-</div></td><td style="font-style: normal; width: 1%; font-weight: normal; text-align: left">&#160;</td><td style="font-style: normal; width: 1%; font-weight: normal">&#160;</td>
    <td style="font-style: normal; width: 1%; font-weight: normal; text-align: left"></td><td style="font-style: normal; width: 6%; font-weight: normal; text-align: right"><div style="-sec-ix-hidden: hidden-fact-59">-</div></td><td style="font-style: normal; width: 1%; font-weight: normal; text-align: left">&#160;</td><td style="font-style: normal; width: 1%; font-weight: normal">&#160;</td>
    <td style="font-style: normal; width: 1%; font-weight: normal; text-align: left"></td><td style="font-style: normal; width: 6%; font-weight: normal; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:IssueOfShareCapital" scale="0" unitRef="usd">4,600,000</ix:nonFraction></td><td style="font-style: normal; width: 1%; font-weight: normal; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Total comprehensive (loss)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-60">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-61">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-62">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-63">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-64">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" scale="0" sign="-" unitRef="usd">320,524</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" scale="0" sign="-" unitRef="usd">320,524</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Balance as of December 31, 2020</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="font-style: normal; text-align: right; font-weight: normal"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">291,400</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-65">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c22" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">4,308,600</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-66">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-67">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c25" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd">320,524</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c26" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">4,279,476</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Issue of share capital</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="mlec:IssueOfShareCapital" scale="0" unitRef="usd">18,600</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-68">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c29" decimals="0" format="ixt:num-dot-decimal" name="mlec:IssueOfShareCapital" scale="0" unitRef="usd">2,981,400</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-69">&#160;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-70">&#160;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-71">&#160;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:IssueOfShareCapital" scale="0" unitRef="usd">3,000,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Total comprehensive (loss)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-72">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-73">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-75">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-76">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c32" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" scale="0" sign="-" unitRef="usd">1,986,814</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" scale="0" sign="-" unitRef="usd">1,986,814</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Balance as of June 30, 2021</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c33" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">310,000</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-77">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c35" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">7,290,000</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-78">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-79">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c38" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd">2,307,338</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c39" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">5,292,662</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Equity settled share-based payment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-80">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-81">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-83">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c44" decimals="0" format="ixt:num-dot-decimal" name="mlec:EquitySettledShareBasedPayment" scale="0" unitRef="usd">838,576</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-84">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="mlec:EquitySettledShareBasedPayment" scale="0" unitRef="usd">838,576</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Total comprehensive (loss)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-85">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-86">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-87">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-88">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-89">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c45" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" scale="0" sign="-" unitRef="usd">4,526,905</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" scale="0" sign="-" unitRef="usd">4,526,905</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Balance as of June 30, 2022</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c46" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">310,000</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-90">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c48" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">7,290,000</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-91">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c50" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">838,576</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c51" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd">6,834,243</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">1,604,333</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Issue of share capital (Moolec Science shares)</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center">15</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right"><ix:nonFraction contextRef="c52" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IssueOfEquity" scale="0" unitRef="usd">15,000</ix:nonFraction></td><td style="vertical-align: top; text-align: right">&#160;</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right"><div style="-sec-ix-hidden: hidden-fact-92">-</div></td><td style="vertical-align: top; text-align: right">&#160;</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right"><ix:nonFraction contextRef="c54" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IssueOfEquity" scale="0" unitRef="usd">8,105,000</ix:nonFraction></td><td style="vertical-align: top; text-align: right">&#160;</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right"><div style="-sec-ix-hidden: hidden-fact-93">-</div></td><td style="vertical-align: top; text-align: right">&#160;</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right"><div style="-sec-ix-hidden: hidden-fact-94">-</div></td><td style="vertical-align: top; text-align: right">&#160;</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right"><div style="-sec-ix-hidden: hidden-fact-95">-</div></td><td style="vertical-align: top; text-align: right">&#160;</td><td style="text-align: right; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: right">&#160;</td><td style="vertical-align: top; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IssueOfEquity" scale="0" unitRef="usd">8,120,000</ix:nonFraction></td><td style="vertical-align: top; text-align: right">&#160;</td></tr>

<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 30%; text-align: left">Issue of share capital (SAFE shares)</td><td style="width: 1%">&#160;</td>
    <td style="width: 6%; text-align: center">20</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="c52" decimals="0" format="ixt:num-dot-decimal" name="mlec:IssueOfShareCapitalSAFEShares" scale="0" unitRef="usd">2,623</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-96">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="c54" decimals="0" format="ixt:num-dot-decimal" name="mlec:IssueOfShareCapitalSAFEShares" scale="0" unitRef="usd">3,170,723</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-97">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-98">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-99">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:IssueOfShareCapitalSAFEShares" scale="0" unitRef="usd">3,173,346</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Issue of share capital (LightJump shares)</td><td>&#160;</td>
    <td style="text-align: center">1</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c52" decimals="0" format="ixt:num-dot-decimal" name="mlec:IssueOfShareCapitalLightJumpShares" scale="0" unitRef="usd">33,639</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-100">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c54" decimals="0" format="ixt:num-dot-decimal" name="mlec:IssueOfShareCapitalLightJumpShares" scale="0" unitRef="usd">39,610,630</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-101">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-102">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-103">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:IssueOfShareCapitalLightJumpShares" scale="0" unitRef="usd">39,644,269</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Issue of share capital (Backstop shares)</td><td>&#160;</td>
    <td style="text-align: center">1</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c52" decimals="0" format="ixt:num-dot-decimal" name="mlec:IssueOfShareCapitalBackstopShares" scale="0" unitRef="usd">12,017</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-104">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c54" decimals="0" format="ixt:num-dot-decimal" name="mlec:IssueOfShareCapitalBackstopShares" scale="0" unitRef="usd">7,999,023</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-105">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-106">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-107">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:IssueOfShareCapitalBackstopShares" scale="0" unitRef="usd">8,011,040</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Issue of share capital</td><td>&#160;</td>
    <td style="text-align: center">15</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c52" decimals="0" format="ixt:num-dot-decimal" name="mlec:IssueOfShareCapital" scale="0" unitRef="usd">36</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-108">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c54" decimals="0" format="ixt:num-dot-decimal" name="mlec:IssueOfShareCapital" scale="0" unitRef="usd">10,647</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-109">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-110">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-111">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:IssueOfShareCapital" scale="0" unitRef="usd">10,683</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Equity settled share-based payment</td><td>&#160;</td>
    <td style="text-align: center">16</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c52" decimals="0" format="ixt:num-dot-decimal" name="mlec:EquitySettledShareBasedPayment" scale="0" unitRef="usd">2,326</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c53" decimals="0" format="ixt:num-dot-decimal" name="mlec:EquitySettledShareBasedPayment" scale="0" unitRef="usd">2,427</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c54" decimals="0" format="ixt:num-dot-decimal" name="mlec:EquitySettledShareBasedPayment" scale="0" unitRef="usd">593,684</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-112">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c56" decimals="0" format="ixt:num-dot-decimal" name="mlec:EquitySettledShareBasedPayment" scale="0" unitRef="usd">496,677</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-113">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:EquitySettledShareBasedPayment" scale="0" unitRef="usd">1,095,114</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Exchange differences on translation of foreign operations</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-114">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-115">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-116">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c55" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" scale="0" unitRef="usd">18,112</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-117">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-118">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" scale="0" unitRef="usd">18,112</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Business combination</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-119">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c53" decimals="0" format="ixt:num-dot-decimal" name="mlec:BusinessCombination" scale="0" unitRef="usd">641</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c54" decimals="0" format="ixt:num-dot-decimal" name="mlec:BusinessCombination" scale="0" unitRef="usd">217,275</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-120">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-121">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-122">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:BusinessCombination" scale="0" unitRef="usd">217,916</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Net loss of the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-123">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-124">&#160;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-125">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-126">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-127">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c57" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd">51,788,880</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd">51,788,880</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"><b>Balance as of June 30, 2023</b></td><td><b>&#160;</b></td>
    <td style="text-align: center"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right"><b><ix:nonFraction contextRef="c58" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">375,641</ix:nonFraction></b></td><td style="font-weight: bold; text-align: left"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right"><b><ix:nonFraction contextRef="c59" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">3,068</ix:nonFraction></b></td><td style="font-weight: bold; text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b><ix:nonFraction contextRef="c60" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">66,996,982</ix:nonFraction></b></td><td style="text-align: left"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right"><b><ix:nonFraction contextRef="c61" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">18,112</ix:nonFraction></b></td><td style="font-weight: bold; text-align: left"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right"><b><ix:nonFraction contextRef="c62" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">1,335,253</ix:nonFraction></b></td><td style="font-weight: bold; text-align: left"><b>&#160;</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right"><b>(<ix:nonFraction contextRef="c63" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" sign="-" unitRef="usd">58,623,123</ix:nonFraction></b></td><td style="font-weight: bold; text-align: left"><b>)</b></td><td style="font-weight: bold"><b>&#160;</b></td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right"><b><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Equity" scale="0" unitRef="usd">10,105,933</ix:nonFraction></b></td><td style="font-weight: bold; text-align: left"><b>&#160;</b></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">The accompanying notes are
an integral part of these consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 102; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>




</div><div><a id="f_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Moolec Science S.A.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Consolidated statements
of cash flows</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">For the year ended June
30, 2023 and 2022 and for the periods of January 1, 2021 through June 30, 2021 and from August 21, 2020 through December 31, 2020.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">In USD [$]</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the&#160;year<br/>
 ended on<br/>
 June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year<br/>
 ended on<br/>
 June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the<br/>
 period of<br/>
 January 1,<br/>
 2021<br/>
through <br/>
June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the<br/>
 period of<br/>
 August 21,<br/>
 2020<br/>
through<br/>
 December&#160;31,<br/>
 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Cash flows from operating activities</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 52%; font-weight: bold; text-align: left">Loss for the year</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd">51,788,880</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd">4,526,905</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd">1,986,814</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLoss" scale="0" sign="-" unitRef="usd">320,524</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Adjustments to reconcile loss for the year to net cash flows</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Deferred income tax</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncomeTaxExpense" scale="0" sign="-" unitRef="usd">234,542</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-128">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-129">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-130">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" scale="0" unitRef="usd">122,022</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" scale="0" unitRef="usd">1,699</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-131">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-132">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Employee share-based payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="0" unitRef="usd">1,095,114</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForSharebasedPayments" scale="0" unitRef="usd">838,576</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-133">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-134">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Share of loss from associate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-135">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-136">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" scale="0" sign="-" unitRef="usd">390,453</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-137">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Change in fair value of Simply Agreement for Future Equity (&#8220;SAFE&#8221;)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss" scale="0" sign="-" unitRef="usd">313,346</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss" scale="0" sign="-" unitRef="usd">860,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-138">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-139">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Share based payment cost of listing shares (non-cash item)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:ShareBasedPaymentCostOfListingSharesnoncashItem" scale="0" unitRef="usd">42,705,061</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-140">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-141">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-142">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Financial income / expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinanceIncomeCost" scale="0" unitRef="usd">1,452,876</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinanceIncomeCost" scale="0" sign="-" unitRef="usd">14,472</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-143">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-144">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Changes in working capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" scale="0" sign="-" unitRef="usd">44,126</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-145">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-146">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-147">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" scale="0" sign="-" unitRef="usd">276,292</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-148">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-149">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-150">&#160;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Receivables from related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-151">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-152">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" scale="0" unitRef="usd">2,009,220</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" scale="0" sign="-" unitRef="usd">2,299,108</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Prepayment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses" scale="0" sign="-" unitRef="usd">339,046</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses" scale="0" sign="-" unitRef="usd">1,703</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses" scale="0" sign="-" unitRef="usd">358</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-153">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Inventories</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" scale="0" unitRef="usd">66,484</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-154">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-155">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-156">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Accounts Payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" scale="0" unitRef="usd">1,485,151</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" scale="0" unitRef="usd">926,711</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" scale="0" unitRef="usd">568,026</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" scale="0" unitRef="usd">19,632</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Other liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherLiabilitie" scale="0" sign="-" unitRef="usd">837,231</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherLiabilitie" scale="0" sign="-" unitRef="usd">1,171</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-157">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-158">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash (used in) / generated by operating activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" scale="0" sign="-" unitRef="usd">7,511,353</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" scale="0" sign="-" unitRef="usd">1,885,979</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" scale="0" unitRef="usd">980,527</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" scale="0" sign="-" unitRef="usd">2,600,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>

<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Cash flows from investing activities</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left">Additions of fixed assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="0" unitRef="usd">14,824</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-159">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-160">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-161">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Cash paid for acquisition of ValoraSoy net of the cash acquired</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" scale="0" unitRef="usd">1,930,883</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-162">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-163">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-164">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Additions of Intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="0" unitRef="usd">164,362</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-165">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-166">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-167">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Short term investment subscriptions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" scale="0" sign="-" unitRef="usd">2,572,783</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-168">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-169">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-170">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Short-term investments withdrawals</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities" scale="0" unitRef="usd">2,346,032</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-171">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-172">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-173">-</div></td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash used in investing activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="0" sign="-" unitRef="usd">2,336,820</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-174">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-175">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-176">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Cash flows from financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Proceeds from issuance of share capital to UGVL and Theo (Backstop)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromIssuingOtherEquityInstruments" scale="0" unitRef="usd">8,011,040</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-177">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-178">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-179">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Proceeds from issuance of share capital to SPAC public holders (Trust)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:Proceedsfromissuanceofsharecapital" scale="0" unitRef="usd">1,988,975</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-180">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-181">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-182">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Proceeds from financial debts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromCurrentBorrowings" scale="0" unitRef="usd">2,171,830</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-183">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-184">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-185">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Payment of loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" scale="0" unitRef="usd">876,769</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-186">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-187">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-188">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Payment of loan interests</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="0" unitRef="usd">24,098</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-189">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-190">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-191">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Proceeds from the SAFE</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-192">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="mlec:ProceedsFromSAFE" scale="0" unitRef="usd">2,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-193">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-194">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Proceeds from of issue of shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromIssuingShares" scale="0" unitRef="usd">10,683</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-195">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-196">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-197">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Proceeds from issue of share capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-198">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-199">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-200">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:ProceedsFromIssueOfShareCapital" scale="0" unitRef="usd">600,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Proceeds from additional issue of ordinary shares</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-201">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-202">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-203">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" scale="0" unitRef="usd">2,000,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Net cash generated from financing activities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="0" unitRef="usd">11,281,661</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="0" unitRef="usd">2,000,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-204">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="0" unitRef="usd">2,600,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Net increase in cash and cash equivalents</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" scale="0" unitRef="usd">1,433,488</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" scale="0" unitRef="usd">114,021</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" scale="0" unitRef="usd">980,527</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-205">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Cash and cash equivalents at beginning of the year/period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" scale="0" unitRef="usd">1,081,808</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c39" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" scale="0" unitRef="usd">980,527</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-206">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-207">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Effect of exchange rate changes on cash and equivalents</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="0" unitRef="usd">12,377</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" scale="0" sign="-" unitRef="usd">12,740</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-208">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-209">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Cash and cash equivalents at end of the year/period</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" scale="0" unitRef="usd">2,527,673</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" scale="0" unitRef="usd">1,081,808</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c39" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" scale="0" unitRef="usd">980,527</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-210">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 103; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Moolec Science S.A.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Consolidated statements
of cash flows (Contd.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">For the year ended June
30, 2023 and 2022 and for the periods of January 1, 2021 through June 30, 2021 and from August 21, 2020 through December 31, 2020.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">In USD [$]</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year<br/>
 ended on<br/>
 June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the year<br/>
 ended on<br/>
 June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the<br/>
 period of<br/>
 January 1,<br/>
 2021<br/>
through<br/>
 June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the<br/>
 period of<br/>
 August 21,<br/>
 2020<br/>
through<br/>
 December&#160;31, <br/>
2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Non-cash financing activities</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left">Issue of Share Capital and Share Premium of New Shareholders through other non current receivables</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left"><b>$</b></td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei" scale="0" unitRef="usd">8,120,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-211">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-212">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left"><b>$</b></td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-213">-</div></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Relief of SAFE financial liabilities through the issue of Share Capital and Share Premium</td><td>&#160;</td>
    <td style="text-align: left"><b>$</b></td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium" scale="0" unitRef="usd">3,173,346</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-214">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-215">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-216">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Capitalization of transaction expenses through Accounts Payable</td><td>&#160;</td>
    <td style="text-align: left"><b>$</b></td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:CapitalizationOfTransactionExpensesThroughAccountsPayable" scale="0" unitRef="usd">1,057,833</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-217">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-218">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-219">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net liabilities acquired through issuance of share capital</td><td>&#160;</td>
    <td style="text-align: left"><b>$</b></td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:NetLiabilitiesAcquiredThroughIssuanceOfShareCapital" scale="0" unitRef="usd">3,991,935</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-220">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-221">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-222">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Acquisition of Business Combination trough deferred payment</td><td>&#160;</td>
    <td style="text-align: left"><b>$</b></td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:AcquisitionOfBusinessCombinationTroughDeferredPayment" scale="0" unitRef="usd">488,431</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-223">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-224">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-225">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Acquisition of Business Combination trough deferred payment in kind</td><td>&#160;</td>
    <td style="text-align: left"><b>$</b></td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind" scale="0" unitRef="usd">217,916</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-226">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-227">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-228">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Acquisition of non-current assets by the issuance of ordinary shares</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-229">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-230">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>$</b></td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares" scale="0" unitRef="usd">3,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left"><b>$</b></td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares" scale="0" unitRef="usd">2,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">The accompanying notes are
an integral part of these consolidated financial statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 104; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><div><a id="f_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">Moolec Science S.A.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">Notes to the Consolidated
financial statements</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">For the year ended June
30, 2023 and 2022 and for the periods of January 1, 2021 through June 30, 2021 and<br/>
 from August 21, 2020 through December 31, 2020</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">In USD [$]</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; background-color: white">&#160;</p><div>

</div><div><a id="f_007"></a></div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 1. General information</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Moolec Science SA (&#8220;the
Company&#8217;&#8217;, &#8220;the Group&#8221; or &#8220;Moolec Science&#8217;&#8217;) is a public limited liability company (soci&#233;t&#233; anonyme) incorporated
under the laws of the Grand Duchy of Luxembourg on May 23, 2022 (&#8220;date of incorporation&#8221;), created to develop affordable alternative
proteins using molecular farming technology. The Company is registered with the Luxembourg Trade and Companies&#8217; Register (Registre
de Commerce et des Soci&#233;t&#233;s, Luxembourg) under number B268440. Its registered address is 17, Boulevard F.W. Raiffeisen,
L-2411 Luxembourg, Grand Duchy of Luxembourg.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Company Reorganization</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On December 30, 2022
(the &#8220;Closing Date&#8221;), the Company consummated the transactions contemplated by the Business Combination Agreement dated as
of June 14, 2022, by and among LightJump Acquisition Corporation (&#8220;LightJump&#8221; or &#8220;SPAC&#8221;, a Delaware corporation),
Moolec Science Limited (&#8220;Moolec&#8221; or &#8220;Moolec Science Limited&#8221;, a private limited company incorporated under the
laws of England and Wales), the Company, and Moolec Acquisition, Inc. (&#8220;Merger Sub&#8221;, a Delaware corporation) (referred together
with Moolec Science SA as &#8220;the Group&#8221;), as amended by the Business Combination Agreement dated as of November 18, 2022. Pursuant
to the Business Combination Agreement and related agreements:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">all the issued Moolec Ordinary Shares held by Moolec Shareholders were transferred and contributed in
kind to the Company, and were issued, in accordance with the Exchange Ratio (1:0.6370485) (except that the Ordinary Shares to be reduced
by the number of Ordinary Shares already held by Moolec Shareholders immediately prior to the transactions contemplated in the Business
Combination Agreement (&#8220;Exchange&#8221;), being a total of <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" scale="0" unitRef="shares">32,500,000</ix:nonFraction> Ordinary Shares;</td></tr> </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">each Moolec SAFE Holder contributed all of its rights and obligations under each Original SAFE to the
Company in consideration for the issuance by the Company of a simple agreement for future equity on substantially identical terms (mutatis
mutandis) with such adjustments as required under Luxembourg law;</td></tr>
                                                                           </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">each Moolec Shareholder ceased to be the beneficial holder of such Moolec Ordinary Shares and subject
to the submission of all filings required under Law (including any filings required to pay stamp duties), the Company was recorded as
the registered holder of all Ordinary Shares so exchanged and transferred and is the legal and beneficial owner thereof;</td></tr>
                                                                                                                                  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">immediately prior to the Merger but after the Exchange, each Moolec SAFE Holder subscribed for, received
and became holder of Ordinary Shares, in accordance with the respective Moolec SAFE, which included <ix:nonFraction contextRef="c64" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" scale="0" unitRef="shares">262,260</ix:nonFraction> Ordinary Shares; and</td></tr> </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">SPAC caused the Certificate of Merger to be executed, acknowledged and filed with the Secretary of State
of the State of Delaware in accordance with the applicable provisions of the DGCL in order to effectuate the Merger. The Merger became
effective on December 30, 2022.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">At the Merger and without
any further action on the part of SPAC, Merger Sub, the Company or Moolec or the holders thereunder:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">each SPAC Common Stock issued and outstanding immediately prior to the Merger, excluding those that had
been redeemed subject to any redemption rights, were exchanged with the Company, against the issue by the Company of new Ordinary Shares,
under the authorized share capital of the Company and subscribed by the contributing holders of SPAC Common Stock for one validly issued
and fully paid Ordinary Share, delivered by the Company;</td></tr></table><p style="margin: 0">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><!-- Field: Page; Sequence: 105; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>


</div><ix:continuation id="_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">as a result of the Merger, all SPAC Common Stock ceased to be outstanding, was canceled and ceased to
exist;</td></tr>
                </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">each share of common stock, par value $<ix:nonFraction contextRef="c65" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ParValuePerShare" scale="0" unitRef="usdPershares">0.01</ix:nonFraction> of Merger Sub issued and outstanding immediately prior to
the Merger Effective Time was converted and exchanged for one (1) validly issued, fully paid and nonassessable ordinary share, par value
$<ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ParValuePerShare" scale="0" unitRef="usdPershares">0.01</ix:nonFraction> per share of the Company; and</td></tr> </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">each SPAC Warrant that was outstanding immediately prior to the Merger, pursuant to the SPAC Warrant Agreement,
ceased to represent a right to acquire one SPAC Common Stock and was converted in accordance with the terms of such SPAC Warrant Agreement,
at the Merger, into a right to acquire one Ordinary Share of the Company on substantially the same terms as were in effect immediately
prior to the Time under the terms of the SPAC Warrant Agreement.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Following the Merger:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Moolec&#8217;s CFO was freely allotted the shares to satisfy the requirements under the CFO Consulting
Agreement.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Prior to the Closing,
on December 27, 2022, in connection with the vote to approve the adoption of the Business Combination Agreement at LightJump&#8217;s special
meeting of stockholders, certain public holders of SPAC Common Stock exercised their right to redeem <ix:nonFraction contextRef="c66" decimals="0" format="ixt:num-dot-decimal" name="mlec:CommonStockExercised" scale="0" unitRef="shares">2,572,848</ix:nonFraction> shares of SPAC Common Stock
for cash at a redemption price of approximately $<ix:nonFraction contextRef="c67" decimals="2" format="ixt:num-dot-decimal" name="mlec:RedemptionPrice" scale="0" unitRef="usdPershares">10.23</ix:nonFraction> per share, for an aggregate redemption amount of approximately $ <ix:nonFraction contextRef="c66" decimals="-5" format="ixt:num-dot-decimal" name="mlec:AggregateRedemption" scale="6" unitRef="usd">26.3</ix:nonFraction> million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Accordingly, $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:TrustAccount" scale="0" unitRef="usd">1,988,975</ix:nonFraction>
remained in the Trust Account, for the benefit of the Company, after considering the redemption amount to be paid to the redeeming public
holders of SPAC Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Additionally, pursuant
to the Backstop Agreement, the Sponsor exercised the right to elect to concede Sponsor shares instead of contributing the requisite cash
amount under the Backstop Agreement by conceding a total of <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:SponsorShares" scale="0" unitRef="shares">200,276</ix:nonFraction> Sponsor shares of SPAC Common Stock to each of Union Group Ventures
Limited (&#8220;UGVL&#8221;) and THEO I SCSp. (&#8220;Theo&#8221;). UGVL and Theo each contributed $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets" scale="0" unitRef="usd">4,005,520</ix:nonFraction> to the Company pursuant
to the terms of the Backstop Agreement and in turn the Company issued <ix:nonFraction contextRef="c68" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" scale="0" unitRef="shares">400,552</ix:nonFraction> Ordinary Shares to each of UGVL and Theo.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As a result of the Exchange
and following the consummation of the Transaction, Moolec and SPAC had become direct wholly-owned subsidiaries of the Company and Moolec
shareholders and SPAC shareholders became holders of issued Company Ordinary Shares of Moolec Science S.A.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In accordance with IFRS
2, for the excess of the fair value of shares deemed to have been issued by Moolec over the fair value of LightJump&#8217;s identifiable
net assets at the date of the Company Reorganization, the Company recognized $ <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:ShareBasedPaymentCost" scale="0" unitRef="usd">42,705,061</ix:nonFraction> as listing costs included in line item &#8220;Share
based payment cost of listing shares&#8221; as an expense in the Statements of Operations, being a non-cash item.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Negative working capital</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As of June 30, 2023, the
Company has a negative working capital of $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:NegativeWorkingCapital" scale="0" unitRef="usd">7,427,356</ix:nonFraction> increased mainly by reorganization expenses pending to be paid and a temporary mismatch
between account payables together with financial debt and account receivables. However, as part of the continuous efforts of management
to strengthen the financial situation of the Company, as of October 15, 2023, the Company has entered into an agreement to issue a convertible
note due 2026 to Grupo Insud (&#8220;Insud&#8221;). As a consequence of the cash inflow related to the convertible note, the Group concludes
it will, for the foreseeable future, be able to realize its assets and discharge its liabilities in the normal course of operations. See
note 31. Events after the reporting period.</p></ix:continuation><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 106; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><div><a id="f_008"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfBusinessCombinationsExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 2. Business combination</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Summary of ValoraSoy
acquisition</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On April 24, 2023 (the
&#8220;Closing Date&#8221;), the Company completed the acquisition of ValoraSoy S.A. (&#8220;ValoraSoy Food Ingredients&#8221;) from the
sellers in accordance with the share purchase agreement (&#8220;ValoraSoy SPA&#8221;) by and among the Company and the sellers (the &#8220;ValoraSoy
Acquisition&#8221;). As a result of the ValoraSoy Acquisition, the Company acquired all of the issued and outstanding equity securities
of ValoraSoy Food Ingredients from the sellers, and ValoraSoy Food Ingredients became a wholly owned subsidiary of the Company for total
aggregate consideration of $<ix:nonFraction contextRef="c69" decimals="-5" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" scale="6" unitRef="usd">2.6</ix:nonFraction> million, in a combination of cash ($<ix:nonFraction contextRef="c69" decimals="-5" format="ixt:num-dot-decimal" name="ifrs-full:CashTransferred" scale="6" unitRef="usd">2.4</ix:nonFraction> million of which $<ix:nonFraction contextRef="c70" decimals="-5" format="ixt:num-dot-decimal" name="ifrs-full:IssueCostsNotRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" scale="6" unitRef="usd">1.9</ix:nonFraction> million were an immediate cash payment and
$<ix:nonFraction contextRef="c69" decimals="-5" format="ixt:num-dot-decimal" name="mlec:CashPayment" scale="6" unitRef="usd">0.5</ix:nonFraction> million will be paid in 6 months from the Closing Date) and equity (<ix:nonFraction contextRef="c69" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" scale="0" unitRef="shares">64,093</ix:nonFraction> shares equivalent to $<ix:nonFraction contextRef="c2" decimals="-5" format="ixt:num-dot-decimal" name="ifrs-full:CashTransferred" scale="6" unitRef="usd">0.2</ix:nonFraction> million which will be transferred
in 12 months from the Closing Date). The acquisition agreement also included a contingent payment in a fixed amount of equity amounting
to <ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" scale="0" unitRef="shares">384,558</ix:nonFraction> shares equivalent to $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="mlec:ShareEquivalent" scale="6" unitRef="usd">1.7</ix:nonFraction> million, which was determined to be a remuneration agreement for future services (the &#8220;earn-out&#8221;)
and consequently it was excluded from the consideration and will be recognized as an expense over the required service period. The contingent
payment is payable in shares over a three-year period from 2024 to 2026 and subject to the achievement of certain EBITDA targets, as defined
in the ValoraSoy SPA. Such payment is automatically forfeited on termination of employment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">ValoraSoy Food Ingredients
has more than <ix:nonNumeric contextRef="c2" format="ixt-sec:duryear" name="mlec:ExperienceDate">10</ix:nonNumeric> years of experience, specializes in the production of textured soy proteins and has a long history providing high-quality
products and customized solutions to clients in more than 14 countries in 3 different continents. Its products are manufactured using
various extrusion processes obtaining as a result vegetable proteins with texture and fibrousness similar to those of meat with various
applications such as hamburgers, sausages and other meat extenders and plant-based products. This demo center is a state-of-the-art processing
facility located in the Argentine soybean corridor, which helps maximize raw material origination, with an installed crushing capacity
of 10 thousand tons of soybean per year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><ix:nonNumeric contextRef="c0" continuedAt="mlec_ScheduleOfNetAssetsAcquiredAndGoodwill-c0_cont_1" escape="true" name="mlec:ScheduleOfNetAssetsAcquiredAndGoodwill">Details of the purchase
consideration, the net assets acquired and goodwill are as follows:</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="mlec_ScheduleOfNetAssetsAcquiredAndGoodwill-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">Purchase consideration:</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: justify; text-indent: 0pt; padding-left: 0.125in">Cash paid</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:CashPaid" scale="0" unitRef="usd">1,931,112</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: 0pt; padding-left: 0.125in">Deferred Payment after 6 months</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:DeferredPaymentAfter6Months" scale="0" unitRef="usd">488,431</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: justify; text-indent: 0pt; padding-left: 0.125in">Payment in kind after 12 months</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherPayables" scale="0" unitRef="usd">217,916</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify; text-indent: 0pt; padding-left: 0.125in">Total purchase consideration</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:ConsiderationPaid" scale="0" unitRef="usd">2,637,458</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfCondensedBalanceSheetTableTextBlock-c0_cont_1" escape="true" name="srt:ScheduleOfCondensedBalanceSheetTableTextBlock">The assets and liabilities
recognised as a result of the acquisition are as follows:</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="_ScheduleOfCondensedBalanceSheetTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0pt; text-align: justify; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; width: 88%; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Cash and Banks</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c71" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:BalancesWithBanks" scale="0" unitRef="usd">228</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Accounts Receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c71" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherReceivables" scale="0" unitRef="usd">316,972</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Other Receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c71" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentReceivables" scale="0" unitRef="usd">1,044,808</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c71" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherInventories" scale="0" unitRef="usd">532,231</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Property, Plant, and Equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c71" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" scale="0" unitRef="usd">1,138,026</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Intangible Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c71" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherIntangibleAssets" scale="0" unitRef="usd">3,824,054</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Right-of-use of assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c72" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsToRightofuseAssets" scale="0" unitRef="usd">43,507</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Accounts Payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c71" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentPayables" scale="0" unitRef="usd">1,384,980</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Current Financial Debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c71" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentFinancialLiabilities" scale="0" unitRef="usd">1,176,089</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Current Other Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c71" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherLiabilities" scale="0" unitRef="usd">356,757</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Non-current Financial Debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c71" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialLiabilities" scale="0" unitRef="usd">119,464</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Non-current Other Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c71" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentLiabilities" scale="0" unitRef="usd">177,367</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 1.5pt; text-align: justify; text-indent: 0pt">Deferred Tax Liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c71" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxLiabilities" scale="0" sign="-" unitRef="usd">1,297,436</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 1.5pt; font-weight: bold; text-align: justify; text-indent: 0pt">Net identifiable assets acquired</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c71" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed" scale="0" unitRef="usd">2,387,733</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 1.5pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif">Goodwill recognized <span style="font-size: 10pt">(i)</span></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c71" decimals="0" format="ixt:num-dot-decimal" id="ix_0_fact" name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" scale="0" unitRef="usd">249,725</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; font-weight: bold; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Net assets acquired</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c71" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetAssetsLiabilities" scale="0" unitRef="usd">2,637,458</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(i)</span></td><td style="text-align: justify">The goodwill is attributable to the expected future synergies
from combining operations as well as an assembled workforce, which does not qualify for separate recognition. The Company expects that
the ValoraSoy Acquisition will help to accelerate its growth in the food ingredients industry by expanding its commercial network with
a top-notch sales team and complementing its Molecular Farming Platform with industrial capacity and downstream operations, in addition
to adding a highly experienced team of professionals. It will not be deductible for tax purposes.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The pro-forma revenue
of the combined entity for the year ended June 30, 2023 as though the date for the merger had been as of the beginning of the reporting
period amounts to $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionsProFormaRevenue" scale="0" unitRef="usd">5,043,956</ix:nonFraction>.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>


</div><!-- Field: Page; Sequence: 107; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><div><a id="f_009"></a></div><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 3. Accounting
standards and basis of preparation</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><b>Note 3.1. Compliance
with IFRS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">These Consolidated Financial
Statements of the Group have been prepared in accordance with International Financial Reporting Standards (IFRS) and interpretations issued
by the IFRS Interpretations Committee (IFRS IC) applicable to companies reporting under IFRS. The financial statements comply with IFRS
as issued by the International Accounting Standards Board (IASB).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The consolidated financial
statements of the Group as of June 30, 2023, and June 30, 2022 and for the year ended June 30, 2023 and 2022 were authorized by the Board
of Directors of Moolec Science S.A. on October 30, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 3.2. Basis of
measurement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The consolidated financial
statements have been prepared on the historical cost basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The significant accounting
policies set out in Note 3 have been applied in preparing the consolidated financial statements as of June 30, 2023 and 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Due to the activities
of the Group, costs and expenses presented in the consolidated statements of Comprehensive loss are classified according to their function.
The consolidated statements of Financial Position has been prepared based on the nature of the transactions, distinguishing: (a) current
assets from non-current assets, where current assets are intended as the assets that should be realized, sold or used during the normal
operating cycle, or the assets owned with the aim of being sold in the short-term (within 12 months); (b) current liabilities from non-current
liabilities, where current liabilities are intended as the liabilities that should be paid during the normal operating cycle or over the
12-month period subsequent to the reporting date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 3.3. Functional
and presentation currency</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Items included in the
Consolidated Financial Statements are measured using the currency of the primary economic market in which the Company operates (&#8220;the
functional currency&#8221;). These Consolidated Financial Statements are presented in US Dollars, which is the Company&#8217;s functional
currency.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group has applied
IAS 29 for its newly acquired subsidiary in Argentina. IAS 29 &#8220;Financial reporting in hyperinflationary economies&#8221; requires
that the financial statements of an entity whose functional currency is the currency of a hyperinflationary economy, whether these are
based on the historical cost method or the current cost method, be stated in terms of the measuring unit current at the closing date of
the reporting period. For such purpose, the inflation produced since the acquisition date or the revaluation date, as applicable, must
be computed in non-monetary items. The standard details a series of factors to be considered for concluding whether an economy is hyperinflationary,
including, but not limited to, a cumulative inflation rate over a three-year period that approaches or exceeds <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="mlec:CumulativeInflationRate" scale="-2" unitRef="pure">100</ix:nonFraction>%. Inflation accumulated
in <span style="-sec-ix-hidden: hidden-fact-231">three</span>&#160;years, as of June&#160;30, 2018, was over <ix:nonFraction contextRef="c73" decimals="2" format="ixt:num-dot-decimal" name="mlec:InflationAccumulated" scale="-2" unitRef="pure">100</ix:nonFraction>%. It was for this reason that, in accordance with IAS 29, the Argentine economy
had to be considered as hyperinflationary since July&#160;1, 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In an inflationary period,
any entity that maintains an excess of monetary assets over monetary liabilities, will lose purchasing power, and any entity that maintains
an excess of monetary liabilities over monetary assets, will gain purchasing power, provided that such items are not subject to an adjustment
mechanism.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Briefly, the restatement
mechanism of IAS 29 establishes that monetary assets and liabilities will not be restated because they are already expressed in a current
unit of measurement at the end of the reporting period. Assets and liabilities subject to adjustments based on specific agreements, will
be adjusted according to those agreements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 108; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><ix:continuation id="_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Non-monetary items measured at their current values at the end of the reporting period, such
as the net realizable value or others, do not need to be restated. The remaining non-monetary assets and liabilities will be restated
according to a general price index. The loss or gain for the net monetary position will be included in the net result of the reporting
period, revealing this information in a separate line item.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The inflation adjustment
to the initial balances was calculated by means of a conversion factor derived from the Argentine price indexes published by the National
Institute of Statistics.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The index as of June
30, 2023 and as of April 30, 2023 was&#160;<ix:nonFraction contextRef="c74" decimals="4" format="ixt:num-dot-decimal" name="mlec:ArgentinePriceIndexes" scale="0" unitRef="usd">1,709.6115</ix:nonFraction> and&#160;<ix:nonFraction contextRef="c75" decimals="4" format="ixt:num-dot-decimal" name="mlec:ArgentinePriceIndexes" scale="0" unitRef="usd">1,497.2147</ix:nonFraction>, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group started with
the application of IAS 29, since the ValoraSoy acquisition, as such no comparative figures were presented using IAS 29. However, in the
future the comparative figures in the consolidated financial statements presented in a stable currency will not be adjusted for subsequent
changes in the price levels or exchange rates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 3.4. Use of estimates
and judgements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The preparation of the
Consolidated Financial Statements requires Management to make judgements, estimates and assumptions that affect the application of accounting
policies and the reporting amounts as presented in the Consolidated Financial Statements for all periods presented.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Estimates and underlying
assumptions are reviewed on an ongoing basis. Refer to Note 4 &#8211; Summary of significant accounting policies for further discussion
on accounting treatments applied in preparation of the financial results of the Group as of the reporting period in compliance with IFRS.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 3.5. Going concern</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Management has evaluated
whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Group&#8217;s ability to
continue as a going concern after the accompanying Consolidated Financial Statements are issued. The accompanying Consolidated Financial
Statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities that
might be necessary if the Group is unable to continue as a going concern. The Group concludes it will, for the foreseeable future, be
able to realize its assets and discharge its liabilities in the normal course of operations.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><div><a id="f_010"></a></div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Note 4. Summary
of significant accounting policies</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock-c0_cont_1" escape="true" name="mlec:DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.1. Basis of
consolidation of subsidiary</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:continuation id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Subsidiaries are entities
controlled by the Company. The financial statements of the Company&#8217;s subsidiaries are included in the Consolidated Financial Statements
from the date that control commences after the acquisition date. The accounting policies of subsidiaries have been changed when necessary
to align them with the policies adopted by the Company.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="mlec_DescriptionOfAccountingPolicyForForeignCurrencyTextBlock-c0_cont_1" escape="true" name="mlec:DescriptionOfAccountingPolicyForForeignCurrencyTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.2. Foreign
currency</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:continuation id="mlec_DescriptionOfAccountingPolicyForForeignCurrencyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Transactions entered
into by the Group in a currency other than their functional currency are recorded at the relevant exchange rates as of the date upon which
such transactions occur. Foreign currency monetary assets and liabilities are translated at the prevailing exchange rates as of the final
day of each reporting period. Non-monetary assets and liabilities that are measured at fair value in a foreign currency are translated
into the functional currency at the exchange rate when the fair value was determined. Non-monetary items that are measured based on historical
cost in a foreign currency are translated at the exchange rate at the date of the transaction. Exchange differences arising on the retranslation
of unsettled monetary assets and liabilities are recognized immediately through other comprehensive income in the consolidated statements
of operations and are accumulated in equity (attributed to the non-controlling interests when appropriate).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p></ix:continuation></ix:nonNumeric><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 109; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_2" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_1"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.3. Intangible
assets</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Intangible assets include
projects in-progress (mainly related to internally developing products), software, licenses and other rights, and the purchase value of
customer relationships. The accounting policies regarding the recognition and measurement of such intangible assets are described below.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration:underline">Internally Generated
Intangible Assets</span></i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Expenditure&#160;on&#160;internally&#160;developed&#160;products&#160;is&#160;capitalized&#160;if&#160;it&#160;can&#160;be&#160;demonstrated&#160;that:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_4"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">It&#160;is&#160;technically&#160;feasible&#160;to&#160;develop&#160;the&#160;product&#160;for&#160;it&#160;to&#160;be&#160;sold;</span></td>
</tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_6" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_5"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Adequate&#160;resources&#160;are&#160;available&#160;to&#160;complete&#160;the&#160;development;</span></td></tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_7" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_6"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">There&#160;is&#160;an&#160;intention&#160;to&#160;complete&#160;and&#160;sell&#160;the&#160;product;</span></td></tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_8" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_7"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The&#160;Group&#160;is&#160;able&#160;to&#160;sell&#160;the&#160;product;</span></td></tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_9" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_8"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Sale&#160;of&#160;the&#160;product&#160;will&#160;generate&#160;future&#160;economic&#160;benefits;&#160;and</span></td></tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_10" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_9"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Expenditure&#160;on&#160;the&#160;project&#160;can&#160;be&#160;measured&#160;reliably.</span></td></tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_11" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Development expenditure
not satisfying the above criteria and expenditure on the research phase of internal projects are recognized in the consolidated statements
of operations as incurred.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_12" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Capitalized development
costs are amortized using the straight-line method over the periods the Group expects to benefit from selling the products developed.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_13" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Useful&#160;lives&#160;and&#160;amortization&#160;methods&#160;are&#160;reviewed&#160;every&#160;year&#160;as&#160;required&#160;by&#160;IAS&#160;38.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_14" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The research and development
process can be divided into several discrete steps or phases, which generally begin with discovery, validation and development and end
with regulatory approval and commercial launch. The process for developing seed traits is relatively similar for both GM and non-GM traits.
However, the two differ significantly in later phases of development. For example, obtaining regulatory approval for GM seeds is a far
more comprehensive and lengthy process than for non-GM seeds. Although breeding programs and industrial biotechnology solutions may have
shorter or simpler phases than those described below, the Group has used the industry consensus for seed-trait development phases to characterize
its technology portfolios, which is generally divided into the following six phases:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_15" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_14"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">i)</td><td style="text-align: justify">Discovery: The first phase in the technology development
process is the discovery or identification of candidate genes or genetic systems, metabolites, or microorganisms potentially capable
of enhancing specified plant characteristics or enabling an agro-industrial biotech solution.</td>
</tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_16" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_15"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">ii)</td><td style="text-align: justify">Proof of concept: Upon successful validation of the technologies in model systems (in vitro or in vivo),
promising technologies graduate from discovery and are advanced to the proof of concept phase. The goal of this phase is to validate a
technology within the targeted organism before moving forward with technology escalation activities or extensive field validation.</td></tr>
                                                                                                                                            </table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_17" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_16"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">iii)</td><td style="text-align: justify">Early development: In this phase, efficacy field trials are expanded to evaluate the expression level
and phenological characteristics of the traits in multiple geographies and growing cycles, as well as other characteristics in order to
optimize the technology&#8217;s performance in the targeted organisms. The goal of the early development phase is to evaluate the technical
feasibility by identifying the best candidate to scale up the seed stock and to start the regulatory field trials.</td></tr>
                                                                                                                            </table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_18" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_17"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">iv)</td><td style="text-align: justify">Advanced development and deregulation: In this phase, extensive field tests are used to fully demonstrate
the effectiveness of the technology for its intended purpose. In the case of GM traits, the process of obtaining regulatory approvals
from the government agencies is started, and includes field trials for environmental, core and food safety data generation. For solutions
involving microbial fermentation, industrial-scale runs are conducted.</td></tr></table><p style="margin: 0">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 110; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>


</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_3" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_2"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_19" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_18"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">v)</td><td style="text-align: justify">Pre-launch: This phase involves finalizing the regulatory approval process and preparing for the launch
and commercialization of the technology. The range of activities in this phase includes seed increases, pre-commercial production, and
product and solution testing with selected customers. Usually, a more detailed marketing strategy and preparation of marketing materials
occur during this phase.</td></tr>
                                  </table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_20" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_19"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">vi)</td><td style="text-align: justify">Product launch: In general, this phase, which is the last milestone of the research and development process,
is carried out by the Group.</td></tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_21" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_20"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We determined that the
Research &amp; Development is more likely than not (&#8220;probable&#8221;) to become a commercialized product and reach compliance with
IAS 38 criteria items at the end of the phase iii &#8220;Early Development&#8221;, when efficacy field trials are performed to determine
the technical feasibility of the project by measuring parameters like expression level and phenological characteristics. The obtention
of desired values for this set of data represents the strongest and clearest indication that the technical feasibility has been proved.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_22" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_21"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Impairment testing of
intangible assets not yet available for use requires the use of significant assumptions for the estimation of future cash flows and the
determination of discount rates. The significant assumptions and the determination of discount rates for the impairment testing of goodwill
are further explained below.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_23" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_22"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Management&#8217;s estimations
about the demonstrability of the recognition criteria for these assets and the subsequent recoverability represent the best estimate that
can be made based on all the available evidence, existing facts and circumstances and using reasonable and supportable assumptions in
cash flow projections. Therefore, the Consolidated financial statements do not include any adjustments that would result if the Group
were unable to recover the carrying amount of the above-mentioned assets through the generation of enough future economic benefits.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_24" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_23"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Management has made the
estimates considering the cash flow projections projected. The key assumptions utilized are the following:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_25" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_24"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="border-bottom: Black 1.5pt solid; width: 30%"><span style="font-family: Times New Roman, Times, Serif"><b>Key assumption</b></span></td> <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 69%"><span style="font-family: Times New Roman, Times, Serif"><b>Management&#8217;s approach</b></span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Discount rate</span></td> <td>&#160;</td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The discount rate used ranges between <ix:nonFraction contextRef="c76" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets" scale="-2" unitRef="pure">10</ix:nonFraction>% and <ix:nonFraction contextRef="c77" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets" scale="-2" unitRef="pure">20</ix:nonFraction>%</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: middle"><p style="margin-top: 0; margin-bottom: 0"></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Budgeted market share</span></p></td> <td>&#160;</td> <td style="text-align: justify"> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The projected revenue from the products has been estimated by the management based on market penetration data for comparable products and technologies and on future expectations of foreseen economic and market conditions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The value assigned is consistent with external sources of information.</p></td></tr> <tr style="vertical-align: top; background-color: White"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Budgeted product prices</span></td> <td>&#160;</td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The prices estimated in the revenue projections are based on current and projected market prices for the products.</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Budgeted gross margin</span></td> <td>&#160;</td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Based on past performance and management&#8217;s expectations for the future.</span></td></tr> </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_26" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_25"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration:underline">Intangible Assets
Acquired in a Business Combination </span></i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_27" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_26"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Intangible assets acquired
in a business combination are identified and recognized separately regarding goodwill when they meet the definition of intangible assets
and their fair value can be measured reliably. Such intangible assets are recognized at fair value at acquisition date.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_28" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_27"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">After the initial recognition,
intangible assets acquired in a business combination are valued at cost, net of accumulated amortization, based on the expected attrition
over the respective estimated periods for which the intangible assets will provide economic benefit to the Company.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_29" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_28"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Intangible assets acquisitions
from ValoraSoy were restated by applying the corresponding adjustment coefficients (as mentioned in Note 3.3) since the date of the business
combination and are translated at the exchange rate at the closing date of the financial statements.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_30" id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_29"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration:underline">Software</span></i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory-c0_cont_30"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Software licenses are
valued at cost, restated as mentioned in Note 3.3, net of the corresponding accumulated amortization and impairment losses. Amortization
is calculated on a straight-line basis over the estimated useful life of the intangible assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 111; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_4" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_3"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.4. Property,
plant and equipment, net </b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Property, plant and equipment
assets are measured at historical cost less accumulated depreciation and any impairment loss, except for those acquired in a business
combination, which are then recorded at fair value; assets under construction and land are not depreciated. The cost of the property,
plant and equipment is the fair value of the consideration initially provided to acquire or construct the item and prepare it for use.
Subsequent costs incurred for repair and maintenance, are expensed in the consolidated statements of comprehensive income unless these
costs meet the criteria for capitalization (i.e. extension of the useful life). Depreciation commences when the assets are ready for use.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Property, plant and equipment
is depreciated based on the straight-line method over estimated useful lives.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">An item of property,
plant and equipment will be derecognized upon disposal or when future economic benefits from the continued use of the asset are no longer
expected. The gain or loss arising from the derecognition is measured as the difference between the gain on sale and the carrying amount
of the asset and is recognized through profit or loss.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory">The useful lives of property,
plant and equipment are:</ix:nonNumeric></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory-c0_cont_1"><ix:continuation id="_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory-c0_cont_5"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Storage</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="white-space: nowrap; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="c79" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">20</ix:nonNumeric> years</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Machinery and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="c80" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">10</ix:nonNumeric> - <ix:nonNumeric contextRef="c81" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">20</ix:nonNumeric> years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Vehicles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="c82" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">5</ix:nonNumeric> years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Furniture</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="c83" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">10</ix:nonNumeric> years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Computer equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="c84" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">3</ix:nonNumeric> - <ix:nonNumeric contextRef="c85" format="ixt-sec:duryear" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">5</ix:nonNumeric> years</span></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForGoodwillExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForGoodwillExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.5. Goodwill</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForGoodwillExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForGoodwillExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Goodwill arising from
the acquisition of a business is recorded at cost at the acquisition date, less accumulated impairment losses, if any.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForGoodwillExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForGoodwillExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The acquisitions related
to a foreign operation are considered to be expressed in the functional currency of the foreign operation and are translated at the exchange
rate at the reporting date.&#160;</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForGoodwillExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForGoodwillExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Goodwill acquisition
related to the acquisition of ValoraSoy are recorded at cost, restated by applying the corresponding adjustment coefficients (as mentioned
in Note 3.3) since the date of the business combination and are translated at the exchange rate at the closing date of the financial statements.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForGoodwillExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForGoodwillExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Note 4.5.1 Goodwill
impairment</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForGoodwillExplanatory-c0_cont_6" id="_DescriptionOfAccountingPolicyForGoodwillExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Goodwill is tested for
impairment annually at the cash-generating unit level, which is the level at which the assets generate largely independent cash inflows
and are monitored for internal management purposes. An impairment loss is recognized whenever the carrying amount of an asset or the related
cash-generating unit exceeds its recoverable amount. Impairment losses are recognized in the consolidated statements of profit or loss.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="_DescriptionOfAccountingPolicyForGoodwillExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Impairment losses recognized
for cash-generating units first reduce allocated goodwill and then the carrying amounts of the other assets in the unit on a pro rata
basis.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForMeasuringInventories-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.6. Inventories,
net </b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForMeasuringInventories-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Inventories are presented
at the lower of acquisition cost or net realizable value. Cost is determined by the weighted average method. The net realizable value
represents the estimated sale price less all the estimated termination and selling costs. The cost of finished products and products in
progress includes the costs of raw materials, direct labor, other direct costs and the respective direct production expenses (based on
normal operating capacity), excluding borrowing costs. Inventories are presented net of the allowances for obsolescence and, in consolidation,
net of eliminations of unrealized profit on inventories.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 112; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_5" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_4"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.7. Cash and
cash equivalents</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">For the purposes of the
statements of financial position and statements of cash flows, cash and cash equivalents include cash on hand and in banks and short-term
highly liquid investments. Investments can be readily convertible to known amounts of cash and they are subject to insignificant risk
of changes in value in the consolidated statements of financial position.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.8. Trade receivables
and other receivables</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Trade receivables represent
amounts owing for goods supplied by the Company prior to the end of the financial period which remain unpaid. They arise from transactions
in the normal operating activities of the Company.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Trade receivables are
carried at amortized cost, net of expected credit losses.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company derecognizes
a financial asset when the contractual rights to the cash flows from the asset expire, or when it transfers the financial asset and substantially
all the risks and rewards of ownership of the asset to another party. If the Company neither transfers nor retains substantially all the
risks and rewards of ownership and continues to control the transferred asset, the Company recognizes its retained interest in the asset
and an associated liability for amounts it may have to pay. If the Company retains substantially all the risks and rewards of ownership
of a transferred financial asset, the Company continues to recognize the financial asset and also recognizes a collateralized borrowing
for the proceeds received.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock-c0_cont_1" escape="true" name="mlec:DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.9. Right-of-use
of assets</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock-c0_cont_2" id="mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Due to the acquisition
of ValoraSoy, the Group acquired rights to use a parcel of land, as part of the acquisition agreement. At the acquisition date, right-of-use
of assets are initially recognized at fair value using a third-party valuation.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock-c0_cont_3" id="mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The ownership of the
parcel of land is held by one of the sellers of ValoraSoy, who has entered into an agreement with the Company whereby he granted the right-of-use
of the property to the Company until the effective fulfillment of his obligation to lift encumbrances, subdivide and assign the property
to the Company within a period of twelve months or longer, if required by the proceedings, from the acquisition date.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock-c0_cont_4" id="mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The right-of-use of land
shall not be depreciated due to the imminent transfer of ownership of the underlying asset to the Group which has an indefinite useful
life.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The right-of-use of assets
are presented in a single line in the consolidated statements of financial position.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock-c0_cont_1" escape="true" name="mlec:DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.10. Share capital
and reserves</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock-c0_cont_2" id="mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Ordinary shares</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock-c0_cont_3" id="mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Ordinary shares are classified
as equity. Incremental costs directly attributable to the issue of ordinary shares and share options are recognized as a deduction from
equity, net of any tax effects.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock-c0_cont_4" id="mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Foreign currency translation
adjustment</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:continuation id="mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The foreign currency
translation reserve is used to record exchange differences arising from the translation of the financial statements from the functional
currency of Argentine Peso into the presentation currency of US dollar.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 113; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_6" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_5"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.11. Share-based
payment arrangements</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Share-based compensation
benefits are provided to certain key employees under the Company Compensation Plan. Under this agreement, some employees and members of
the executive management team as defined by the Board of Directors, were granted share options and restricted stock units (&#8220;RSU&#8221;)
in return for their services to the Group.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group receives services
in exchange for its own equity instruments and does not have any obligation to settle the obligation with cash, so the plan is classified
as equity settled. The only condition to be met is the delivery of service by the employee during a certain period as defined in the Agreements.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The fair value of options
granted under the plan is measured at grant date and recognized in accordance with the requirements of IFRS 2, as an employee benefits
expense, with a corresponding increase in equity.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The total expense is
recognized over the vesting period, which is the period over which all of the specified vesting conditions are to be satisfied.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_6" id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">When the options are
exercised, the Company issues the shares to the employee and members to the executive team. The proceeds received, net of any directly
attributable transaction costs, are credited directly to equity.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The ValoraSoy acquisition
agreement also included a contingent payment in a fixed amount of equity amounting to <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:NumberOfSharesToBeIssuedOfContingentPayment" scale="0" unitRef="shares">384,558</ix:nonFraction> shares equivalent to $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="ifrs-full:ShareIssueRelatedCost" scale="6" unitRef="usd">1.7</ix:nonFraction> million, which
was determined to be a remuneration agreement for future services (the &#8220;earn-out&#8221;) and consequently it was excluded from the
consideration and will be recognized as an expense over the required service period. The contingent payment is payable in shares over
a three-year period from 2024 to 2026 and subject to the achievement of certain EBITDA targets, as defined in the ValoraSoy SPA. Such
payment is automatically forfeited on termination of employment.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" continuedAt="mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock-c0_cont_1" escape="true" name="mlec:DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.12. Accounts
payable and other liabilities</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock-c0_cont_2" id="mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Trade and other payables
are recognized when the Group has a legal or a constructive obligation, as a result of a past event, and it is probable that there may
be an outflow of resources embodying economic benefits to settle the obligation and the obligation can be measured reliably. These amounts
represent liabilities for goods and services provided to the Group prior to the end of financial year which are unpaid.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock-c0_cont_3" id="mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company derecognizes
financial liabilities when, and only when, the Company&#8217;s obligations are discharged, canceled or have expired. The difference between
the carrying amount of the financial liability derecognized and the consideration paid and payable is recognized in profit or loss.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Other payables correspond
mainly to employment obligations and provisions.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.13. Taxes</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration:underline">Current income
tax</span></i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Current income tax assets
and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws
used to compute the amount are those that are enacted or substantively enacted at the reporting date in the country where the Group operates
and generates taxable income.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Current income tax relating
to items recognized directly in equity is recognized in equity and not in the consolidated statements of operations. Management periodically
evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation
and establishes provisions where appropriate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 114; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_7" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_6"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration:underline">Deferred tax</span></i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_6" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Deferred tax is provided
using the liability method on temporary differences between the tax bases of assets and liabilities and their carrying amounts for financial
reporting purposes at the reporting date.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_7" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Deferred tax liabilities
are recognized for all taxable temporary differences, except:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_8" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_7"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">When
the deferred tax liability arises from the initial recognition of goodwill or an asset or liability in a transaction that is not a business
combination and, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss, and</span></td>
</tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_9" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_8"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In respect of taxable temporary differences affiliated
with investments in subsidiaries, associates, and interests in joint arrangements, when the timing of the reversal of the temporary differences
can be controlled and it is probable that the temporary differences will not reverse in the foreseeable future.</span></td></tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_10" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Deferred tax assets are
recognized for all deductible temporary differences, the carry forward of unused tax credits and any unused tax losses. Deferred tax assets
are recognized to the extent that it is probable that taxable profit will be available against which the deductible temporary differences,
and the carry forward of unused tax credits and unused tax losses can be utilized, except:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_11" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_10"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">When the deferred tax asset relating to the deductible
temporary difference arises from the initial recognition of an asset or liability in a transaction that is not a business combination
and, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss, and</span></td></tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_12" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_11"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In respect of deductible temporary differences
affiliated with investments in subsidiaries, associates and interests in joint arrangements, deferred tax assets are recognized only to
the extent that it is probable that the temporary differences will reverse in the foreseeable future and taxable profit will be available
against which the temporary differences can be utilized.</span></td></tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_13" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The carrying amount of
deferred tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable
profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are re-assessed
at each reporting date and are recognized to the extent that it has become probable that future taxable profits will allow the deferred
tax asset to be recovered.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_14" id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Deferred tax assets and
liabilities are measured at the tax rates that are expected to apply in the year when the asset is realized or the liability is settled,
based on tax rates that have been enacted or substantively enacted at the reporting date.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="_DescriptionOfAccountingPolicyForIncomeTaxExplanatory-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Deferred tax relating
to items recognized outside profit or loss is recognized outside profit or loss. Deferred tax items are recognized in correlation to the
underlying transaction either in OCI or directly in equity.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock-c0_cont_1" escape="true" name="mlec:DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.14. Subsidiaries
and joint arrangements</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock-c0_cont_2" id="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Where the Company holds
a controlling interest in an entity, such entity is classified as a subsidiary. The Company exercises control over such an entity if all
three of the following elements are present: (i) the Company has the power to direct or cause the direction of the management and policies
of the entity, (ii) the Company is exposed to the variable returns of such entity; and (iii) the Company has power to affect the variability
of such returns. Control is reassessed whenever facts and circumstances indicate that there may be a change in any of these elements of
control.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock-c0_cont_3" id="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">De-facto control exists
in situations where the Company has the practical ability to direct the relevant activities of an entity without holding the majority
of the voting rights. In determining whether de facto control exists, the Company considers all relevant facts and circumstances, including:
(i) the relative share of the Company&#8217;s voting rights with respect to both the size and dispersion of other parties who hold voting
rights; (ii) substantive potential voting rights held by the Company and by other parties, (iii) other contractual arrangements; and (iv)
historic patterns in voting attendance. As of the issuance of these Financial Statements, there is no de-facto control over any entity.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 115; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_8" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_7"><ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock-c0_cont_4" id="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company is a party
to a joint arrangement when there is a contractual arrangement that confers joint control over the relevant activities of the arrangement
to the Group and at least one other party. Joint control is assessed under the same principles as control over subsidiaries.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock-c0_cont_5" id="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory">The subsidiaries and
joint arrangements of the Company, of which their financial results have been included in the Consolidated Financial Statements, and holds
a majority share of the voting rights as of June 30, 2023 are as follows:</ix:nonNumeric></p></ix:continuation>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory-c0_cont_2" id="_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory-c0_cont_1"><ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock-c0_cont_6" id="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock-c0_cont_5"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Principal activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Country of incorporation and<br/> principal place of business</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% Equity <br/> interest as of<br/> June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: left">Moolec Science Limited (i)</td><td style="width: 1%">&#160;</td>
    <td style="width: 28%; text-align: center"><ix:nonNumeric contextRef="c86" id="ix_1_fact" name="ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary">Investment in subsidiaries</ix:nonNumeric></td><td style="width: 1%">&#160;</td>
    <td style="width: 28%; text-align: center"><ix:nonNumeric contextRef="c86" id="ix_2_fact" name="ifrs-full:CountryOfIncorporation">United Kingdom</ix:nonNumeric></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c86" decimals="2" format="ixt:num-dot-decimal" id="ix_3_fact" name="ifrs-full:ProportionOfVotingPowerHeldInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">LightJump Acquisition Corporation</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c87" name="ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary">Investment in subsidiaries</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c87" name="ifrs-full:CountryOfIncorporation">USA</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c87" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfVotingPowerHeldInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">ValoraSoy S.A. (ii)</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c88" id="ix_4_fact" name="ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary">Investment in subsidiaries</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c88" id="ix_5_fact" name="ifrs-full:CountryOfIncorporation">Argentina</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c88" decimals="2" format="ixt:num-dot-decimal" id="ix_6_fact" name="ifrs-full:ProportionOfVotingPowerHeldInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">AG Biomolecules LLC (DE)</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c89" name="ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary">Investment in subsidiaries</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c89" name="ifrs-full:CountryOfIncorporation">USA</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c89" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ProportionOfVotingPowerHeldInSubsidiary" scale="-2" unitRef="pure">100</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Microo Foods Ingredients S.L. (iii)</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c90" id="ix_7_fact" name="ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary">Investment in joint arrangements</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c90" id="ix_8_fact" name="ifrs-full:CountryOfIncorporation">Spain</ix:nonNumeric></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c90" decimals="2" format="ixt:num-dot-decimal" id="ix_9_fact" name="ifrs-full:ProportionOfVotingPowerHeldInSubsidiary" scale="-2" unitRef="pure">50</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table></ix:continuation></ix:continuation>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory-c0_cont_3" id="_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory-c0_cont_2"><ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock-c0_cont_7" id="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock-c0_cont_6"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(i)</td><td style="text-align: justify"><ix:footnote id="ix_1_footnote" xml:lang="en-US">Moolec Science Limited has a branch office in Argentina,
Moolec Science Limited S.E.</ix:footnote></td>
</tr></table></ix:continuation></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory-c0_cont_4" id="_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory-c0_cont_3"><ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock-c0_cont_8" id="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock-c0_cont_7"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(ii)</td><td style="text-align: justify"><ix:footnote id="ix_2_footnote" xml:lang="en-US">Incorporated through the acquisition on April 24, 2023.</ix:footnote></td>
</tr></table></ix:continuation></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation id="_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory-c0_cont_4"><ix:continuation id="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock-c0_cont_8"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(iii)</td><td style="text-align: justify"><ix:footnote id="ix_3_footnote" xml:lang="en-US">During December 2022, the Company agreed to participate in
a joint arrangement with the <ix:nonFraction contextRef="c78" decimals="2" format="ixt:num-dot-decimal" name="mlec:JointArrangementParticipationPercentage" scale="-2" unitRef="pure">50</ix:nonFraction>% of participation of the newly created company named Microo Food Ingredients Sociedad Limitada.</ix:footnote></td>
</tr></table></ix:continuation></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.15. Financial
instruments </b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Financial assets and
liabilities are recognized when an entity of the Group becomes party to the contractual provisions of an instrument.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Financial assets and
liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issue of financial
assets and liabilities (other than those designated at fair value through profit or loss) are added to or deducted from the fair value
of the financial assets or liabilities, when appropriate, at initial recognition. Transaction costs directly attributable to the acquisition
of financial assets or liabilities designated at fair value through profit or loss are recognized immediately through profit or loss.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company applies a
hierarchy to classify valuation methods used to measure financial instruments carried at fair value. Levels 1 to 3 are defined based on
the degree to which fair value inputs are observable and have a significant effect on the recorded fair value, as follows:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory-c0_cont_4"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Level 1: Quoted prices (unadjusted) in active markets for
identical assets or liabilities;</td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory-c0_cont_6" id="_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory-c0_cont_5"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Level 2: Valuation techniques use significant observable
inputs, either directly (i.e., as prices) or indirectly (i.e., derived from prices), or valuations are based on quoted prices for similar
instruments; and</td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory-c0_cont_6"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Level 3: Valuation techniques use significant inputs that
are not based on observable market data (unobservable inputs).</td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.15.1. Financial
assets</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Classification of
financial assets </i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">If and when applicable
the Company follows the framework and requirements outlined in IFRS 9 to classify financial assets based on whether:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_3"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">The financial asset is held within a business model whose
objective is to collect contractual cash flows or whose objective is achieved through the collection of contractual cash flows and the
sale of financial assets; and</td>
</tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_4"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify">The contractual terms give rise to cash flows that are only
payments of principal and interest.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 116; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_9" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_8"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_6" id="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">By default, all other
financial assets are subsequently measured at fair value through profit or loss.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_7" id="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Trade receivables are
amounts due from customers for goods sold or services performed in the ordinary course of business. They are generally due for settlement
within 30 days and are therefore all classified as current. Trade receivables are recognized initially at the amount of consideration
that is unconditional, unless they contain significant financing components, when they are recognized at fair value. The Group holds the
trade receivables with the objective of collecting the contractual cash flows and therefore measures them subsequently at amortized cost
using the effective interest method.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_8" id="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Gains and losses in
foreign currency</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_9" id="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Trade receivables denominated
in a currency other than the subsidiaries&#8217; functional currency is determined in that foreign currency and converted to the subsidiaries&#8217;
functional currency at the end of each reporting period using the then prevailing spot rate. Exchange differences are recognized through
profit or loss and are classified within financial income / expenses.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_10" id="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Derecognition of financial
assets</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_11" id="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group derecognizes
a financial asset only when the contractual rights to the asset&#8217;s cash flows expire, or when it transfers the financial asset and
substantially all the risks and rewards of ownership of the asset to another party. If the Group does not transfer or retain substantially
all risks and rewards of ownership and continues to control the transferred asset, the Group recognizes its interest retained in the asset
and an associated liability for the amounts to be paid. If the Group retains substantially all the risks and rewards of ownership of a
transferred financial asset, the Group continues to recognize the financial asset and also recognizes a loan secured by the revenue received.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_12" id="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Upon derecognition of
a financial asset measured at amortized cost, the difference between the carrying amount of the asset and the sum of the consideration
received and receivable is recognized through profit or loss.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group also derecognizes
a financial asset when there is information which indicates that the counterparty is in serious financial difficulty and there is no realistic
prospect of recovery. The derecognized financial assets may still be subject to compliance activities in accordance with the Group&#8217;s
recovery procedures, taking into account legal advice when appropriate. Any recovery is recognized through profit or loss.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.15.2. Financial
liabilities and equity instruments </b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Classification as
debt or equity</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Debt and equity instruments
are classified as financial liabilities or equity in accordance with the substance of the contractual agreement and definitions of financial
liability and equity instrument.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Equity instruments</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">An equity instrument
consists of any contract that evidences a residual interest in the assets of an entity, after deducting all of its liabilities. Equity
instruments issued by a Group entity are recognized for income received, net of direct issue costs.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_6" id="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The repurchase of equity
instruments of the Group is recognized and deducted directly in equity. No gain or loss is recognized through profit or loss, arising
from the purchase, sale, issue or cancellation of the equity instruments of the Group. During the fiscal year ended June 30, 2023 no repurchase
of equity instruments took place.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_7" id="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Financial liabilities</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_8" id="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Financial liabilities
are classified at their inception at fair value through profit or loss or at amortized cost, using the effective interest amortization
method.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 117; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_10" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_9"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_9" id="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Warrant liabilities</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_10" id="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As part of the reorganization,
the Group acquired public warrants (&#8220;Public warrants&#8221;). The warrants are initially recognized at fair value on the date a
derivative contract is entered into, and they are subsequently remeasured to their fair value at the end of each reporting period. Gains
and losses will be recorded in profit or loss.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">These instruments are
measured at Level 1 fair value based on its quoted price.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_1" escape="true" name="mlec:DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.16. New standards,
amendments and interpretations of IFRS</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_2" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="text-decoration:underline">Standards and IFRICs
newly applicable for companies with 30 June 2023 year ends are set out below.</span></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_3" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">A number of narrow-scope
amendments to IFRS 3, IAS 16, IAS 37 and some annual improvements on IFRS 1, IFRS 9, IAS 41 and IFRS 16</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_4" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Amendments to IFRS 3,
&#8216;Business combinations&#8217; update a reference in IFRS 3 to the Conceptual Framework for Financial Reporting without changing
the accounting requirements for business combinations.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_5" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Amendments to IAS 16,
&#8216;Property, plant and equipment&#8217; prohibit a company from deducting from the cost of property, plant and equipment amounts received
from selling items produced while the company is preparing the asset for its intended use. Instead, a company will recognise such sales
proceeds and related costs in profit or loss.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_6" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Amendments to IAS 37,
&#8216;Provisions, contingent liabilities and contingent assets&#8217; specify which costs a company includes when assessing whether a
contract will be loss-making.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_7" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Annual improvements make
minor amendments to IFRS 1, &#8216;First-time Adoption of IFRS&#8217;, IFRS 9, &#8216;Financial instruments&#8217;, IAS 41, &#8216;Agriculture&#8217;
and the Illustrative Examples accompanying IFRS 16, &#8216;Leases&#8217;.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_8" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The amendments listed
above did not have any impact on the amounts recognised in the Consolidated Financial Statements.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_9" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><span style="text-decoration:underline">New standards and
interpretations not yet adopted</span></b></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_10" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Certain new accounting
standards and interpretations have been published that are not mandatory for June 30, 2023 reporting period and have not been early adopted
by the Group. These standards are not expected to have a material impact on the Group in the current or future reporting periods and on
foreseeable future transactions:</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_11" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Amendment to IAS 12-
deferred tax related to assets and liabilities arising from a single transaction</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_12" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">These amendments require
companies to recognise deferred tax on transactions that, on initial recognition, give rise to equal amounts of taxable and deductible
temporary differences.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_13" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Effective date Annual
periods beginning on or after January 1, 2023<b>. </b></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_14" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Narrow scope amendments
to IAS 1, Practice statement 2 and IAS 8</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_15" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The amendments aim to
improve accounting policy disclosures and to help users of the financial statements to distinguish between changes in accounting estimates
and changes in accounting policies.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_16" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Effective date Annual
periods beginning on or after January 1, 2023<b>. </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 118; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_11" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_10"><ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_17" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_16"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Amendments to IFRS
16, Lease Liability in a Sale and Leaseback </i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_18" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_17"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The&#160;amendments&#160;include
requirements for sale and leaseback transactions in IFRS 16 to explain how an entity accounts for a sale and leaseback after the date
of the transaction. Sale and leaseback transactions where some or all the lease payments are variable lease payments that do not depend
on an index or rate are most likely to be impacted.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_19" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_18"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Effective date Annual
periods beginning on or after January 1, 2024.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_20" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_19"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">These amendments are
not applicable to the Group.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_21" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_20"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Amendments to IAS
1, &#8216;Presentation of financial statements&#8217;, on classification of liabilities </i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_22" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_21"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">These narrow-scope amendments
to IAS 1, &#8216;Presentation of financial statements&#8217;, clarify that liabilities are classified as either current or noncurrent,
depending on the rights that exist at the end of the reporting period.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_23" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_22"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Classification is unaffected
by the expectations of the entity or events after the reporting date (for example, the receipt of a waiver or a breach of covenant).</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_24" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_23"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The amendment also clarifies
what IAS 1 means when it refers to the &#8216;settlement&#8217; of a liability.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_25" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_24"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Effective date Annual
periods beginning on or after January 1, 2024.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_26" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_25"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Amendments to IAS
7 and IFRS 7, Supplier Finance Arrangements</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_27" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_26"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">These&#160;amendments&#160;require
disclosures to enhance the transparency of supplier finance arrangements and their effects on a company&#8217;s liabilities, cash flows
and exposure to liquidity risk. The disclosure requirements are the IASB&#8217;s response to investors&#8217; concerns that some companies&#8217;
supplier finance arrangements are not sufficiently visible, hindering investors&#8217; analysis.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_28" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_27"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Effective date Annual
periods beginning on or after January 1, 2024.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_29" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_28"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Amendments to IFRS
10 and IAS 28, Sale or Contribution of Assets between an Investor and its Associate or Joint Venture </i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_30" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_29"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The amendments clarify
the accounting treatment for sales or contributions of assets between an investor and its associates or joint ventures. They confirm that
the accounting treatment depends on whether the non-monetary assets sold or contributed to an associate or joint venture constitute a
&#8216;business&#8217; (as defined in IFRS 3 Business Combinations).</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_31" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_30"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Where the non-monetary
assets constitute a business, the investor will recognize the full gain or loss on the sale or contribution of assets. If the assets do
not meet the definition of a business, the gain or loss is recognized by the investor only to the extent of the other investor&#8217;s
interests in the associate or joint venture. The amendments apply prospectively.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:continuation id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock-c0_cont_31"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The effective date of
the amendment has not yet been set by the IASB; however, early application of the amendments is permitted.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" continuedAt="mlec_DescriptionOfAccountingPolicyForLossPerShareTextBlock-c0_cont_1" escape="true" name="mlec:DescriptionOfAccountingPolicyForLossPerShareTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.17. Loss per
share</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:continuation continuedAt="mlec_DescriptionOfAccountingPolicyForLossPerShareTextBlock-c0_cont_2" id="mlec_DescriptionOfAccountingPolicyForLossPerShareTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group presents basic
and diluted earnings per share (EPS) data for its ordinary shares. Basic EPS is calculated by dividing the profit and loss attributable
to ordinary shareholders of the Group by the weighted average number of ordinary shares outstanding during the period. Diluted EPS is
determined by adjusting the profit or loss attributed to ordinary shareholders and the weighted average number of ordinary shares outstanding
for the effects of all dilutive potential ordinary shares.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 119; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_12" id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_11"><ix:continuation id="mlec_DescriptionOfAccountingPolicyForLossPerShareTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As of June 30, 2023 and
2022, Basic EPS and Diluted EPS are the same, employee share based payments are considered dilutive instruments properly included in the
profit and loss account, however they do not impact in EPS diluted calculation because the Group has generated net loss to ordinary shareholders
(See Note 27).</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForRecognitionOfRevenue-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.18. Revenue
</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForRecognitionOfRevenue-c0_cont_2" id="_DescriptionOfAccountingPolicyForRecognitionOfRevenue-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The group identifies
contracts with customers and evaluates the goods and services committed therein to determine performance obligations and their classification
between performance obligations that are satisfied at a given time or over time.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForRecognitionOfRevenue-c0_cont_3" id="_DescriptionOfAccountingPolicyForRecognitionOfRevenue-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Revenue from satisfaction
of performance obligations at a given time is recognized when the client obtains control of the committed asset or service considering
whether there is a right to collection, if the client has the physical possession, if the client has the legal right and if they have
transferred the risks and benefits.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForRecognitionOfRevenue-c0_cont_4" id="_DescriptionOfAccountingPolicyForRecognitionOfRevenue-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Revenue from sales is
recognized when performance obligations are met, which consists of transforming the significant risks and benefits of ownership of the
goods are transferred to the purchaser, usually when the products are delivered to the purchaser at the determined location, according
to the agreed sales terms.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForRecognitionOfRevenue-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group had no revenues
during 2022 and 2023 until ValoraSoy Acquisition on April 24, 2023.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForExpensesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForExpensesExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.19. Expenses</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForExpensesExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForExpensesExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Research and development
costs</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForExpensesExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForExpensesExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Research costs are expensed
in the period in which these costs are incurred. Development costs are expensed in the period in which these costs are incurred if they
do not meet the criteria for capitalization.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForExpensesExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForExpensesExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Sales and marketing,
administrative and other operating expenses</i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<ix:continuation id="_DescriptionOfAccountingPolicyForExpensesExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group recognizes
expenses in the period in which these costs are incurred and are presented by function on the consolidated statements of operations. Sales
and marketing expenses primarily relate to marketing materials and research of the Group to increase brand awareness in the marketplace.
Administrative expenses primarily comprise professional fees (mainly related to consultancy, accountancy and legal expenses), payroll
and share based compensation to certain executives. Other operating expenses relate to those that do not depend on general business operations
or relate to the other expense categories.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForSegmentReportingExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.20. Segment
reporting</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSegmentReportingExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForSegmentReportingExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group operates in
a single operating segment, which is &#8220;science-based food ingredients&#8221;. Operating segments are defined as components of an
enterprise for which separate financial information is regularly evaluated by the chief operating decision maker, who in the Group&#8217;s
case is the Executive Team, in deciding how to allocate resources and assess performance. The Executive Team is composed of the Chief
Executive Officer (&#8220;CEO&#8221;), the Chief Financial Officer (&#8220;CFO&#8221;), the Chief Product Officer (&#8220;CPO&#8221;),
the Chief Technology Officer (&#8220;CTO&#8221;) and the Chief Science Officer (&#8220;CSO&#8221;).</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSegmentReportingExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForSegmentReportingExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Executive Team evaluates
the Group&#8217;s financial information and resources and assess the financial performance of these resources on a consolidated basis
on the basis of Net revenue/loss for the period.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSegmentReportingExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForSegmentReportingExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group&#8217;s revenue,
results and assets for this one reportable segment can be determined by reference to the Consolidated Statement of Comprehensive Income
and Consolidated Statement of Financial Position.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 120; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><ix:continuation id="_DisclosureOfChangesInAccountingPoliciesExplanatory-c0_cont_12"><ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSegmentReportingExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForSegmentReportingExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group acquired ValoraSoy
on April 24, 2023. Because of the short-period of time since the acquisition, most of the required disclosures by IFRS 8 Operating Segments,
relating to entity-wide disclosures are not significant to disclose.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSegmentReportingExplanatory-c0_cont_6" id="_DescriptionOfAccountingPolicyForSegmentReportingExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As required by IFRS 8
Operating Segments, below are presented applicable entity-wide disclosures related to Moolec Science&#8217;s revenues.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSegmentReportingExplanatory-c0_cont_7" id="_DescriptionOfAccountingPolicyForSegmentReportingExplanatory-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration:underline">Revenues breakdown:</span></i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSegmentReportingExplanatory-c0_cont_8" id="_DescriptionOfAccountingPolicyForSegmentReportingExplanatory-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company&#8217;s revenues
arise from operations in Argentina. During the periods covered by these consolidated financial statements the Company had no revenues
from customers attributed to the entity&#8217;s country of domicile.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSegmentReportingExplanatory-c0_cont_9" id="_DescriptionOfAccountingPolicyForSegmentReportingExplanatory-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration:underline">Non-current assets
other than financial instruments</span></i></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForSegmentReportingExplanatory-c0_cont_10" id="_DescriptionOfAccountingPolicyForSegmentReportingExplanatory-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><ix:nonNumeric contextRef="c0" continuedAt="mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock-c0_cont_1" escape="true" name="mlec:ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock">Non-current assets other
than financial instruments are located in the following countries:</ix:nonNumeric></p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock-c0_cont_1"><ix:continuation id="_DescriptionOfAccountingPolicyForSegmentReportingExplanatory-c0_cont_10"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>As of <br/>
June 30,<br/>
 2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>As of <br/>
June 30,<br/>
 2022</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left">Lux</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c91" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherNonCurrentAssetsOtherThanFinancialAssets" scale="0" unitRef="usd">251,440</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">United Kingdom</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c92" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherNonCurrentAssetsOtherThanFinancialAssets" scale="0" unitRef="usd">4,774,320</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c93" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherNonCurrentAssetsOtherThanFinancialAssets" scale="0" unitRef="usd">4,607,848</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Argentina</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c94" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherNonCurrentAssetsOtherThanFinancialAssets" scale="0" unitRef="usd">4,930,666</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Total non-current assets other than financial instruments</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherNonCurrentAssetsOtherThanFinancialAssets" scale="0" unitRef="usd">9,956,426</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherNonCurrentAssetsOtherThanFinancialAssets" scale="0" unitRef="usd">4,607,848</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.21 Business
combinations</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group applies the
acquisition method to account for business combinations. The acquisition cost is measured as the aggregate of the consideration transferred
for the acquisition of a subsidiary, which is measured at fair value at the acquisition date, and the amount of any non-controlling interest
in such subsidiary. The Group recognizes any non-controlling interest in a subsidiary at the non-controlling interest&#8217;s proportionate
share of the recognized amounts of subsidiary&#8217;s identifiable net assets. The acquisition related costs are expensed as incurred.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory-c0_cont_3" id="_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Any contingent consideration
to be transferred by the Group is recognized at fair value at the acquisition date. The contingent consideration is classified as an asset
or liability that is a financial instrument under IFRS 9 is measured at fair value through profit or loss.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory-c0_cont_4" id="_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Goodwill is initially
measured at cost, which is the excess of the aggregate of the consideration transferred and the amount of the non-controlling interest
and any previous interest carried over the net identifiable assets acquired, and liabilities assumed.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory-c0_cont_5" id="_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">After initial recognition,
goodwill is measured at cost less any accumulated impairment losses. For impairment testing, goodwill acquired in a business combination
is, as of the acquisition date, allocated to each of the cash-generating units of the Group that is expected to benefit from the synergies
of the combination, without considering whether other assets or liabilities of the subsidiary are allocated to those units.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Any impairment in the
carrying value is recognized in the consolidated statement of comprehensive income. In the case of acquisitions in stages, prior to the
write-off of the previously held equity interest in the subsidiary, said interest is re-measured at fair value as of the date of acquisition
of control over the subsidiary. The result of the re-measurement at fair value is recognized in profit or loss.</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.22 Critical
accounting judgements and estimates</b></p></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_2" id="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group makes certain
estimates and assumptions regarding the future. Estimates and judgments are continually evaluated based on historical experience and other
factors, including expectations of future events that are believed to be reasonable under the circumstances. In the future, actual experience
may differ from these estimates and assumptions. The estimates and assumptions that have a significant risk of causing a material adjustment
to the carrying amounts of assets and liabilities within the next financial year are listed below.</p></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_3" id="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Critical estimates</p></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_4" id="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_3"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Identification and fair value of identifiable intangible
assets arising in acquisitions (Note 4.3).</td>
</tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="_DisclosureOfAccountingJudgementsAndEstimatesExplanatory-c0_cont_4"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Impairment of intangible assets not yet available for use
(Notes 4.3).</td>
</tr></table></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><!-- Field: Page; Sequence: 121; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><div><a id="f_011"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfAdditionalInformationExplanatory"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note
5. Comparative Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The information as of
June 30, 2022 and for the year ended June 30, 2022 and for the periods of January 1, 2021 through June 30, 2021 and from August 21, 2020
through December 31, 2020 disclosed for comparative purposes arises from the consolidated financial statements of Moolec as of those dates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Certain amounts in the
prior year financial statements have been reclassified to conform to the current year presentation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The exchange of shares
related to the Capital Reorganization contemplated by the Business Combination Agreement, explained in Note 2, has been given a retrospective
effect in the share capital of the statement of changes in equity and in Net loss per share purposes in Note 27.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><div><a id="f_012"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfIntangibleAssetsExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 6. <ix:nonNumeric contextRef="c0" continuedAt="mlec_DisclosureOfIntangibleAssetsExplanatoryTableTextBlock-c0_cont_1" escape="true" name="mlec:DisclosureOfIntangibleAssetsExplanatoryTableTextBlock">Intangible
Assets</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_DisclosureOfIntangibleAssetsExplanatoryTableTextBlock-c0_cont_2" id="mlec_DisclosureOfIntangibleAssetsExplanatoryTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; font-weight: bold; text-align: left"></td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Gamma<br/>
 Linolenic<br/>
 Acid (&#8220;GLA&#8217;)<br/>
 assets and<br/>
 licensing<br/>
 rights to<br/>
 Arachidonic <br/>
Acid<br/>
 (&#8220;ARA&#8221;)</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">SPC&#174;<br/>
 technology</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Customer<br/>
 relationship</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Software<br/>
 License</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Total<br/>
 Intangible<br/>
 Assets</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; font-weight: bold; text-align: left">As of December 31, 2020</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-232">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-233">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-234">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-235">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-236">&#160;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated Amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-237">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-238">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-239">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-240">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-241">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net book amount</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-242">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-243">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-244">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-245">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-246">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Year ended June 30, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Opening net book amount</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-247">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-248">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-249">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-250">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-251">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 40%; text-align: left; padding-bottom: 1.5pt">Additions</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c109" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">3,000,000</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c110" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">1,598,930</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-252">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-253">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c113" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">4,598,930</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Closing net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c114" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">3,000,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c115" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">1,598,930</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-254">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-255">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c39" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">4,598,930</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">As of June 30, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c109" decimals="0" format="ixt:num-dot-decimal" name="mlec:Cost" scale="0" unitRef="usd">3,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c110" decimals="0" format="ixt:num-dot-decimal" name="mlec:Cost" scale="0" unitRef="usd">1,598,930</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-256">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-257">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c113" decimals="0" format="ixt:num-dot-decimal" name="mlec:Cost" scale="0" unitRef="usd">4,598,930</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Accumulated Amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-258">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-259">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-260">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-261">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-262">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Net book amount</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c114" decimals="0" format="ixt:num-dot-decimal" name="mlec:NetBookAmount" scale="0" unitRef="usd">3,000,000</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c115" decimals="0" format="ixt:num-dot-decimal" name="mlec:NetBookAmount" scale="0" unitRef="usd">1,598,930</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-263">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-264">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c39" decimals="0" format="ixt:num-dot-decimal" name="mlec:NetBookAmount" scale="0" unitRef="usd">4,598,930</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
ended June 30, 2022</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Opening net book amount</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c114" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">3,000,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c115" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">1,598,930</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-265">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-266">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c39" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">4,598,930</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Closing net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c118" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">3,000,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c119" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">1,598,930</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-267">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-268">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">4,598,930</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">As of June 30, 2022</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c122" decimals="0" format="ixt:num-dot-decimal" name="mlec:Cost" scale="0" unitRef="usd">3,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c123" decimals="0" format="ixt:num-dot-decimal" name="mlec:Cost" scale="0" unitRef="usd">1,598,930</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-269">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-270">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="mlec:Cost" scale="0" unitRef="usd">4,598,930</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated Amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-271">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-272">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-273">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-274">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-275">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Net book amount</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c118" decimals="0" format="ixt:num-dot-decimal" name="mlec:NetBookAmount" scale="0" unitRef="usd">3,000,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c119" decimals="0" format="ixt:num-dot-decimal" name="mlec:NetBookAmount" scale="0" unitRef="usd">1,598,930</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-276">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-277">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:NetBookAmount" scale="0" unitRef="usd">4,598,930</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Year ended June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Opening net book amount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c118" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">3,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c119" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">1,598,930</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-278">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-279">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">4,598,930</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c126" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">101,033</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">63,329</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-280">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-281">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">164,362</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Acquisitions through business combinations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-282">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-283">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c128" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" scale="0" unitRef="usd">3,819,009</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c129" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" scale="0" unitRef="usd">5,045</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" scale="0" unitRef="usd">3,824,054</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Effect of changes in foreign exchange rates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-284">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-285">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c128" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">26,235</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c129" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">34</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">26,269</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Amortization (i)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-286">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-287">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c128" decimals="0" format="ixt:num-dot-decimal" id="ix_10_fact" name="mlec:Amortization" scale="0" unitRef="usd">93,247</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c129" decimals="0" format="ixt:num-dot-decimal" id="ix_11_fact" name="mlec:Amortization" scale="0" unitRef="usd">1,270</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" id="ix_12_fact" name="mlec:Amortization" scale="0" unitRef="usd">94,517</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Closing net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c130" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">3,101,033</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">1,662,259</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c132" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">3,751,997</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c133" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">3,809</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">8,519,098</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">As of June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c126" decimals="0" format="ixt:num-dot-decimal" name="mlec:Cost" scale="0" unitRef="usd">3,101,033</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c127" decimals="0" format="ixt:num-dot-decimal" name="mlec:Cost" scale="0" unitRef="usd">1,662,259</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c128" decimals="0" format="ixt:num-dot-decimal" name="mlec:Cost" scale="0" unitRef="usd">3,845,244</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c129" decimals="0" format="ixt:num-dot-decimal" name="mlec:Cost" scale="0" unitRef="usd">5,079</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:Cost" scale="0" unitRef="usd">8,613,615</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated Amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-288">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-289">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c128" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">93,247</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c129" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">1,270</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" scale="0" unitRef="usd">94,517</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c130" decimals="0" format="ixt:num-dot-decimal" name="mlec:NetBookAmount" scale="0" unitRef="usd">3,101,033</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c131" decimals="0" format="ixt:num-dot-decimal" name="mlec:NetBookAmount" scale="0" unitRef="usd">1,662,259</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c132" decimals="0" format="ixt:num-dot-decimal" name="mlec:NetBookAmount" scale="0" unitRef="usd">3,751,997</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c133" decimals="0" format="ixt:num-dot-decimal" name="mlec:NetBookAmount" scale="0" unitRef="usd">3,809</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:NetBookAmount" scale="0" unitRef="usd">8,519,098</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left; background-color: white">&#160;</p>

<ix:continuation id="mlec_DisclosureOfIntangibleAssetsExplanatoryTableTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(i)</td><td style="text-align: justify"><ix:footnote id="ix_4_footnote" xml:lang="en-US">The charge of the amortization is included in Administrative
expenses and Research and development expenses (see notes 24 and 25).</ix:footnote></td>
</tr></table></ix:continuation></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 122; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><div><a id="f_013"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 7. Fixed Assets</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="mlec_ScheduleOfFixedAssetstextBlock-c0_cont_1" escape="true" name="mlec:ScheduleOfFixedAssetstextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap; text-align: left; font-weight: bold"></td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Chymosin<br/>
 osmosis<br/>
 equipment</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Vehicles</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Furniture</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Storage</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Computer<br/>
 equipment</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Machinery</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Total <br/>
Fixed<br/>
Assets</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap; text-align: left; font-weight: bold">As of December 31, 2020</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Cost</td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b style="-sec-ix-hidden: hidden-fact-290">-</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b style="-sec-ix-hidden: hidden-fact-291">-</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b style="-sec-ix-hidden: hidden-fact-292">-</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b style="-sec-ix-hidden: hidden-fact-293">-</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b style="-sec-ix-hidden: hidden-fact-294">-</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b style="-sec-ix-hidden: hidden-fact-295">-</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b style="-sec-ix-hidden: hidden-fact-296">-</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-style: normal; font-weight: normal">Accumulated
    Depreciation</span></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-297">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-298">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-299">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-300">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-301">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-302">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-303">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Net book amount</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-304">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-305">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-306">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-307">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-308">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-309">-</div></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-310">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">Year ended June 30, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Opening net book amount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-311">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-312">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-313">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-314">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-315">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-316">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-317">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 30%">Additions</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction contextRef="c161" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd">10,617</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-318">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-319">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-320">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-321">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-322">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction contextRef="c113" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd">10,617</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Closing net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c167" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">10,617</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-323">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-324">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-325">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-326">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-327">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c39" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">10,617</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">As of June 30, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt">Cost</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c173" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">10,617</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-328">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-329">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-330">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-331">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-332">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c179" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">10,617</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated Depreciation</td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-333">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-334">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-335">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-336">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-337">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-338">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-339">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c187" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">10,617</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-340">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-341">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-342">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-343">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-344">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c193" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">10,617</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
ended June 30, 2022</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; text-align: left">Opening net book amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c167" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">10,617</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-345">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-346">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-347">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-348">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-349">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c39" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">10,617</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Depreciation (i)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c194" decimals="0" format="ixt:num-dot-decimal" id="ix_13_fact" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd">1,699</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-350">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-351">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-352">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-353">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-354">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" id="ix_14_fact" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd">1,699</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Closing net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c200" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">8,918</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-355">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-356">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-357">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-358">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-359">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">8,918</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">As of June 30, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; font-size: 10pt; padding-left: 0.125in; text-indent: -0.125in; font-weight: normal; font-style: normal">Cost</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c206" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">10,617</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-360">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-361">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-362">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-363">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-364">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c212" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">10,617</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated Depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c213" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" sign="-" unitRef="usd">1,699</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-365">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-366">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-367">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-368">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-369">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c219" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" sign="-" unitRef="usd">1,699</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c220" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">8,918</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-370">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-371">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-372">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-373">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-374">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c226" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">8,918</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">Year ended June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Opening net book amount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c200" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">8,918</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-375">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-376">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-377">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-378">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-379">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">8,918</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Acquisitions through business combinations, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-380">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c82" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd">25,464</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c83" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd">5,154</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c79" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd">49,281</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c228" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd">2,633</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c229" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd">1,055,494</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd">1,138,026</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Effect of changes in foreign exchange rates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-381">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c82" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="0" unitRef="usd">176</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c83" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="0" unitRef="usd">35</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c79" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="0" unitRef="usd">340</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c228" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="0" sign="-" unitRef="usd">9</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c229" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="0" unitRef="usd">7,277</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="0" unitRef="usd">7,819</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-382">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-383">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-384">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c79" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd">9,143</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c228" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd">5,681</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-385">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="0" unitRef="usd">14,824</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Depreciation (i)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c227" decimals="0" format="ixt:num-dot-decimal" id="ix_15_fact" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd">1,699</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c82" decimals="0" format="ixt:num-dot-decimal" id="ix_16_fact" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd">1,603</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c83" decimals="0" format="ixt:num-dot-decimal" id="ix_17_fact" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd">106</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c79" decimals="0" format="ixt:num-dot-decimal" id="ix_18_fact" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd">1,160</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c228" decimals="0" format="ixt:num-dot-decimal" id="ix_19_fact" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd">699</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c229" decimals="0" format="ixt:num-dot-decimal" id="ix_20_fact" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd">22,238</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" id="ix_21_fact" name="ifrs-full:DepreciationPropertyPlantAndEquipment" scale="0" unitRef="usd">27,505</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Closing net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c230" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">7,219</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c231" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">24,037</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c232" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">5,083</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c233" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">57,604</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c234" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">7,606</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c235" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">1,040,533</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">1,142,082</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">As of June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c236" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">10,617</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c237" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">25,640</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c238" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">5,189</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c239" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">58,764</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c240" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">8,305</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c241" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">1,062,771</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c242" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">1,171,286</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated Depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c243" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" sign="-" unitRef="usd">3,398</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c244" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" sign="-" unitRef="usd">1,603</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c245" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" sign="-" unitRef="usd">106</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c246" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" sign="-" unitRef="usd">1,160</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c247" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" sign="-" unitRef="usd">699</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c248" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" sign="-" unitRef="usd">22,238</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c249" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" sign="-" unitRef="usd">29,204</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c250" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">7,219</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c251" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">24,037</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c252" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">5,083</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c253" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">57,604</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c254" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">7,606</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c255" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">1,040,533</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c256" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PropertyPlantAndEquipment" scale="0" unitRef="usd">1,142,082</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<ix:continuation id="mlec_ScheduleOfFixedAssetstextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(i)</td><td style="text-align: justify"><ix:footnote id="ix_5_footnote" xml:lang="en-US">The depreciation charge is included in Administrative expenses
and Cost of sales (see notes 24 and 26).</ix:footnote></td>
</tr></table></ix:continuation></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 123; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><div><a id="f_014"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfGoodwillExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 8. Goodwill</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: center; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt">Goodwill</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Goodwill" scale="0" unitRef="usd">251,440</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-386">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Goodwill</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:TotalGoodwill" scale="0" unitRef="usd">251,440</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-387">&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">As of June 30, 2023, no
goodwill impairment losses were recognized.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><div><a id="f_015"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 9. <ix:nonNumeric contextRef="c0" continuedAt="mlec_ScheduleOfRightofuseOfAssetsTableTextBlock-c0_cont_1" escape="true" name="mlec:ScheduleOfRightofuseOfAssetsTableTextBlock">Right-of-use
of assets</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_ScheduleOfRightofuseOfAssetsTableTextBlock-c0_cont_2" id="mlec_ScheduleOfRightofuseOfAssetsTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: center">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Land</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">As of June 30, 2022</td><td>&#160;</td>
    <td style="text-align: left"><b>$</b></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-388">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 88%; text-align: left">Acquisitions through business combinations (i)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" id="ix_22_fact" name="mlec:AcquisitionsThroughBusinessCombinationsi" scale="0" unitRef="usd">43,507</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Effect of changes in foreign exchange rates</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:EffectOfChangesInForeignExchangeRates" scale="0" unitRef="usd">299</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">As of June 30, 2023</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RightofuseAssets" scale="0" unitRef="usd">43,806</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<ix:continuation id="mlec_ScheduleOfRightofuseOfAssetsTableTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.25in">(i)</td><td style="text-align: left"><ix:footnote id="ix_6_footnote" xml:lang="en-US">Through the ValoraSoy acquisition, the Group acquired a parcel of land for an original amount of $ <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:OriginalAmount" scale="0" unitRef="usd">43,507</ix:nonFraction>.</ix:footnote></td></tr></table></ix:continuation></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><div><a id="f_016"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 10. Other non-current
receivables</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="mlec:ScheduleOfOtherNoncurrentReceivableTableTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30, <br/>
2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt">Receivables with shareholders</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentReceivables" scale="0" unitRef="usd">8,763,027</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">-</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Other Non-Current receivables</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentReceivables" scale="0" unitRef="usd">8,763,027</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Moolec Science Limited
issued an aggregate number of Moolec Science Limited ordinary shares equal to <ix:nonFraction contextRef="c257" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" scale="0" unitRef="shares">2,354,069</ix:nonFraction> (or <ix:nonFraction contextRef="c258" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" scale="0" unitRef="shares">1,500,000</ix:nonFraction> of Moolec Science SA shares after
the transaction) to current individual shareholders of Bioceres S.A., and Bioceres Group PLC, (&#8220;New shareholders&#8221;) Moolec
and the new shareholders entered into a subscription agreement (the &#8220;shareholders&#8217; subscription agreement&#8221;) prior to
the transaction pursuant to which Moolec Science Limited agreed to issue <ix:nonFraction contextRef="c86" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued" scale="0" unitRef="shares">2,354,069</ix:nonFraction> of Moolec Science Limited ordinary shares. The new
shareholders agreed to pay an aggregate purchase price of $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:AggregatePurchasePrice" scale="0" unitRef="usd">15,000,000</ix:nonFraction> within <ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="mlec:PurchasePaymentTerms">5</ix:nonNumeric> years from the date of such subscription agreement. Such
shareholders&#8217; subscription agreement accrues an internal rate of return of <ix:nonFraction contextRef="c2" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:BorrowingsInterestRate" scale="-2" unitRef="pure">13.20</ix:nonFraction>%.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><div><a id="f_017"></a></div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfCashAndCashEquivalentsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 11. Cash and cash
equivalents</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">For the purposes of preparing
the Consolidated Statements of Financial Position and Statement of Cash Flows, the item &#8220;Cash and Cash Equivalents&#8221; includes
cash on hand and in banks and short-term highly liquid investments that can be readily convertible to known amounts of cash and they are
subject to insignificant risk of changes in value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Bank overdrafts are classified
as &#8220;Financial Debt&#8221; in the Consolidated Statement of Financial Position.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 124; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><ix:continuation id="_DisclosureOfCashAndCashEquivalentsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfRestrictedCashAndCashEquivalentsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfRestrictedCashAndCashEquivalentsExplanatory">Cash and cash equivalents
at each year-end, as disclosed in the Consolidated Statement of Cash Flows, may be reconciled against the items related to the Consolidated
Statement of Financial Position as follows:</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="_DisclosureOfRestrictedCashAndCashEquivalentsExplanatory-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30, <br/>
2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30, <br/>
2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Cash</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Cash" scale="0" unitRef="usd">2,443</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Bank accounts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepositsFromBanks" scale="0" unitRef="usd">2,061,636</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepositsFromBanks" scale="0" unitRef="usd">1,081,808</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Short-term investments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents" scale="0" unitRef="usd">463,594</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total cash and cash equivalents</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCashAndCashEquivalents" scale="0" unitRef="usd">2,527,673</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCashAndCashEquivalents" scale="0" unitRef="usd">1,081,808</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><div><a id="f_018"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 12. Short-term
investments</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="mlec:DisclosureOfShortTermInvestmentsTableTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">As of<br/>
 June 30,<br/>
</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt">Mutual funds</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:MutualFunds" scale="0" unitRef="usd">306,034</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-389">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Short-term investments</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:TotalMutualFunds" scale="0" unitRef="usd">306,034</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-390">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><div><a id="f_019"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 13. Trade Receivable
and Other current receivables</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="mlec:ScheduleOfTradeReceivableTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30, <br/>
2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt">Accounts receivable</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeReceivables" scale="0" unitRef="usd">361,097</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-391">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Trade receivable</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherReceivables" scale="0" unitRef="usd">361,097</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-392">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="mlec:ScheduleOfOtherCurrentReceivablesTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30, <br/>
2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left">Taxes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentValueAddedTaxReceivables" scale="0" unitRef="usd">952,953</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-393">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentReceivables" scale="0" unitRef="usd">377,224</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-394">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Other current receivables</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentReceivables" scale="0" unitRef="usd">1,330,177</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-395">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The book value is reasonably
approximate to the fair value given its short-term nature.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><div><a id="f_020"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfInventoriesExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 14. Inventories</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="mlec:DisclosureOfInventoriesTableTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30, <br/>
2023</td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left">Raw materials</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RawMaterials" scale="0" unitRef="usd">179,368</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-396">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Finished goods</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinishedGoods" scale="0" unitRef="usd">286,380</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-397">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Inventories</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InventoriesTotal" scale="0" unitRef="usd">465,748</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-398">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 125; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><div><a id="f_021"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 15. Share capital
and share premium</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">As of June 30, 2023, the
share capital stock and share premium amounts to $ <ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:ShareCapitalStockAndSharePremiumAmounts" scale="0" unitRef="usd">66,996,982</ix:nonFraction>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><ix:nonNumeric contextRef="c0" continuedAt="mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock-c0_cont_1" escape="true" name="mlec:ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock"><i>Reconciliation of share
capital and share premium</i></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><i>&#160;</i></p>

<ix:continuation id="mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Number <br/>
of<br/>
 shares</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Shares<br/>
 issued<br/>
 amount</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Shares<br/>
 to be <br/>
issued<br/>
 amount</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Share <br/>
Premium</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Opening Balance as of August, 2020</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-399">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-400">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-401">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-402">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; width: 52%; text-align: left; padding-bottom: 1.5pt">Issue of share capital</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="mlec:NumberOfSharesIssueOfShareCapitalinShares" scale="0" unitRef="shares">29,140,000</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsForShareIssueCosts" scale="0" unitRef="usd">291,400</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-403">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharePremiumIssueOfShareCapital" scale="0" unitRef="usd">4,308,600</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>Balance as of December, 2020</b></span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c26" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares">29,140,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c26" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharesIssuedAmount" scale="0" unitRef="usd">291,400</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-404">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c26" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SharePremium" scale="0" unitRef="usd">4,308,600</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Issue of share capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="mlec:NumberOfSharesIssueOfShareCapitalinShares" scale="0" unitRef="shares">1,860,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsForShareIssueCosts" scale="0" unitRef="usd">18,600</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-405">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharePremiumIssueOfShareCapital" scale="0" unitRef="usd">2,981,400</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Balance as of June 30, 2021</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c39" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares">31,000,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c39" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharesIssuedAmount" scale="0" unitRef="usd">310,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-406">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c39" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SharePremium" scale="0" unitRef="usd">7,290,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Issue of share capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-407">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-408">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-409">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-410">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Balance as of&#160;&#160;June 30, 2022</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares">31,000,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharesIssuedAmount" scale="0" unitRef="usd">310,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-411">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SharePremium" scale="0" unitRef="usd">7,290,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Issue of share capital (Moolec Science shares)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c260" decimals="INF" format="ixt:num-dot-decimal" name="mlec:NumberOfSharesIssueOfShareCapitalinShares" scale="0" unitRef="shares">1,500,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c260" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsForShareIssueCosts" scale="0" unitRef="usd">15,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-412">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c260" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharePremiumIssueOfShareCapital" scale="0" unitRef="usd">8,105,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Issue of share capital (SAFE shares)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-413; font-family: Times New Roman, Times, Serif">&#160;262, 260</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsForShareIssueCosts" scale="0" unitRef="usd">2,623</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-414">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c262" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharePremiumIssueOfShareCapital" scale="0" unitRef="usd">3,170,723</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Issue of share capital (LightJump shares)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c264" decimals="INF" format="ixt:num-dot-decimal" name="mlec:NumberOfSharesIssueOfShareCapitalinShares" scale="0" unitRef="shares">3,363,810</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c264" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsForShareIssueCosts" scale="0" unitRef="usd">33,639</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-415">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c264" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharePremiumIssueOfShareCapital" scale="0" unitRef="usd">39,610,630</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Issue of share capital (Backstop shares)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c266" decimals="INF" format="ixt:num-dot-decimal" name="mlec:NumberOfSharesIssueOfShareCapitalinShares" scale="0" unitRef="shares">1,201,656</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c266" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsForShareIssueCosts" scale="0" unitRef="usd">12,017</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-416">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c266" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharePremiumIssueOfShareCapital" scale="0" unitRef="usd">7,999,023</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Issue of share capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="mlec:NumberOfSharesIssueOfShareCapitalinShares" scale="0" unitRef="shares">3,519</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PaymentsForShareIssueCosts" scale="0" unitRef="usd">36</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-417">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharePremiumIssueOfShareCapital" scale="0" unitRef="usd">10,647</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">From business acquisition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-418">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-419">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharesToBeIssuedAmountFromBusinessAcquisition" scale="0" unitRef="usd">641</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharePremiumFromBusinessAcquisition" scale="0" unitRef="usd">217,275</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Equity settled share based payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="mlec:NumberOfShareEquitySettledShareBasedPayment" scale="0" unitRef="shares">232,523</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharesIssuedAmountEquitySettledShareBasedPayment" scale="0" unitRef="usd">2,326</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharesToBeIssuedAmountEquitySettledShareBasedPayment" scale="0" unitRef="usd">2,427</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharePremiumEquitySettledShareBasedPayment" scale="0" unitRef="usd">593,684</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Balance as of June 30, 2023</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:NumberOfSharesIssued" scale="0" unitRef="shares">37,563,768</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharesIssuedAmount" scale="0" unitRef="usd">375,641</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:ShareToBeIssuedAmount" scale="0" unitRef="usd">3,068</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SharePremium" scale="0" unitRef="usd">66,996,982</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="text-decoration:underline">Share Purchase Agreement
</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On April 14, the Company
entered into a Share Purchase Agreement with Nomura Securities International, Inc (&#8220;Nomura&#8221;). The Agreement provides for a
committed equity financing facility under which the Company has the option, but not the obligation, to sell up to the equivalent of $<ix:nonFraction contextRef="c259" decimals="-6" format="ixt:num-dot-decimal" name="mlec:Equivalent" scale="6" unitRef="usd">50</ix:nonFraction>
million in aggregate gross purchase price of its ordinary shares to Nomura over a <ix:nonNumeric contextRef="c259" format="ixt-sec:durmonth" name="mlec:SharePurchaseAgreementOverPeriod">36</ix:nonNumeric>-month period, subject to the terms of the Agreement.
The Company intends to use the proceeds from any future sales of securities under the financing facility, if it is utilized, for general
corporate purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Sales of ordinary shares
to Nomura, and the timing of any such sales, will be determined by the Company from time to time in its sole discretion and will depend
on a variety of factors, including, among other things, market conditions, the trading price of the ordinary shares and determinations
by the Company regarding the use of proceeds from any sale.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As of June 30, 2023 only
<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:UnderIssuedSharePurchaseAgreement" scale="0" unitRef="shares">3,600</ix:nonFraction> shares (equivalent to $<ix:nonFraction contextRef="c74" decimals="0" format="ixt:num-dot-decimal" name="mlec:SharePurchaseAgreement" scale="0" unitRef="usd">10,647</ix:nonFraction>) were issued under the Share Purchase Agreement.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 126; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><div><a id="f_022"></a></div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfSharebasedPaymentArrangementsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 16. Share based
payment</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Under the share-based
compensation plan, some employees and members of the executive management team as defined by the Board of Directors, were granted share
options or restricted stock units (&#8220;RSU&#8221;) in return for their services to the Group.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">As of June 30, 2023, Moolec
had the following shared-based payment arrangements:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Share option plan for
executives and senior management:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Group 1 granted up to <ix:nonFraction contextRef="c268" decimals="0" format="ixt:num-dot-decimal" name="mlec:OrdinaryShares" scale="0" unitRef="shares">579,078</ix:nonFraction> underlying ordinary shares.
The options have an exercise price of $<ix:nonFraction contextRef="c268" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" scale="0" unitRef="usdPershares">1.52</ix:nonFraction> and expire in December 2030 (except one case in June 2031).</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Group 2 granted up to <ix:nonFraction contextRef="c269" decimals="0" format="ixt:num-dot-decimal" name="mlec:OrdinaryShares" scale="0" unitRef="shares">346,555</ix:nonFraction> underlying ordinary shares.
The options have an exercise price of $<ix:nonFraction contextRef="c269" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" scale="0" unitRef="usdPershares">8.00</ix:nonFraction> and expire in December 2030.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Group 3 granted up to <ix:nonFraction contextRef="c270" decimals="0" format="ixt:num-dot-decimal" name="mlec:OrdinaryShares" scale="0" unitRef="shares">700,000</ix:nonFraction> underlying ordinary shares.
The options have an exercise price of $<ix:nonFraction contextRef="c270" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" scale="0" unitRef="usdPershares">4.25</ix:nonFraction>. Five of them expire in January 2033 and the other two in March 2033.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The fair value is defined
as the actuarial expected value of the future benefits under the Plan calculated at the date in which benefits are granted and it is estimated
using the option valuation method known as &#8216;binomial trees&#8217;. The estimate considers the effects of rotation, the vesting schedule
and the possible dilutive effect of the future exercise of options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-indent: 0in; font-weight: bold; text-align: left">Factor</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Group 1</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Group 2</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Group 3</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; width: 64%; text-align: left">Fair value of shares</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c271" decimals="2" format="ixt:num-dot-decimal" name="mlec:FairValueOfSharesinShares" scale="0" unitRef="usdPershares">1.00</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c272" decimals="2" format="ixt:num-dot-decimal" name="mlec:FairValueOfSharesinShares" scale="0" unitRef="usdPershares">1.00</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c273" decimals="2" format="ixt:num-dot-decimal" name="mlec:FairValueOfSharesinShares" scale="0" unitRef="usdPershares">2.97</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left">Exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-420">1.52</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-421">8.00</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-422">4.25</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c271" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" unitRef="pure">70</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c272" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" unitRef="pure">70</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c273" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" unitRef="pure">70</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left">Dividend rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-423">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-424">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-425">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left">Reference risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c271" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" unitRef="pure">3.00</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c272" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" unitRef="pure">3.00</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c273" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" unitRef="pure">4.25</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left">Plan duration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="c271" format="ixt-sec:duryear" name="mlec:PlanDuration">10</ix:nonNumeric> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="c272" format="ixt-sec:duryear" name="mlec:PlanDuration">10</ix:nonNumeric> years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="c273" format="ixt-sec:duryear" name="mlec:PlanDuration">10</ix:nonNumeric> years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left">Fair value of stock options at measurement date</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonNumeric contextRef="c271" format="ixt-sec:duryear" name="mlec:FairValueOfStockOptionsAtMeasurementDate">9.11</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonNumeric contextRef="c272" format="ixt-sec:duryear" name="mlec:FairValueOfStockOptionsAtMeasurementDate">7.25</ix:nonNumeric></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonNumeric contextRef="c273" format="ixt-sec:duryear" name="mlec:FairValueOfStockOptionsAtMeasurementDate">2.04</ix:nonNumeric></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">There are no market-related
performance conditions or non-vesting conditions that should be considered for determining the fair value of options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Moolec Science estimates
an expected rotation of <ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="mlec:ConstantValuePercentage" scale="-2" unitRef="pure">2.00</ix:nonFraction>% annually at constant value, taking into account historical patterns of executives maintaining their jobs
and the probability of exercising the options. This estimate is reviewed at the end of each annual or interim period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 127; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><ix:continuation id="_DisclosureOfSharebasedPaymentArrangementsExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The following table shows
the amount and exercise price and the movements of the stock options of executives and managers of the Group for the period ended June
30, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; white-space: nowrap; text-indent: 0in; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">June 30, 2023</td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; text-indent: 0in; padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Group 1</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Group 2</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Group 3</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; text-indent: 0in; padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Number<br/>
 of<br/>
 options</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Exercise <br/>
price</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Number <br/>
of<br/>
 options</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Exercise <br/>
price</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Number <br/>
of<br/>
 options</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Exercise <br/>
price</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: 0in">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left">At the beginning</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-426">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-427">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-428">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-429">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-430">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-431">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; width: 28%; text-align: left">Granted during the period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c271" decimals="INF" format="ixt:num-dot-decimal" name="mlec:NumberOfOptionsGrantedDuringThePeriod" scale="0" unitRef="shares">579,078</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c271" decimals="2" format="ixt:num-dot-decimal" name="mlec:ExercisePriceGrantedDuringThePeriod" scale="0" unitRef="usdPershares">1.52</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c272" decimals="INF" format="ixt:num-dot-decimal" name="mlec:NumberOfOptionsGrantedDuringThePeriod" scale="0" unitRef="shares">346,555</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c272" decimals="2" format="ixt:num-dot-decimal" name="mlec:ExercisePriceGrantedDuringThePeriod" scale="0" unitRef="usdPershares">8.00</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c273" decimals="INF" format="ixt:num-dot-decimal" name="mlec:NumberOfOptionsGrantedDuringThePeriod" scale="0" unitRef="shares">700,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c273" decimals="2" format="ixt:num-dot-decimal" name="mlec:ExercisePriceGrantedDuringThePeriod" scale="0" unitRef="usdPershares">4.25</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left">Forfeited during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-432">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-433">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-434">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-435">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-436">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-437">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left">Exercised during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c271" decimals="INF" format="ixt:num-dot-decimal" name="mlec:NumberOfOptionsExercisedDuringThePeriod" scale="0" unitRef="shares">253,252</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c271" decimals="2" format="ixt:num-dot-decimal" name="mlec:ExercisePriceExercisedDuringThePeriod" scale="0" unitRef="usdPershares">1.52</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c272" decimals="INF" format="ixt:num-dot-decimal" name="mlec:NumberOfOptionsExercisedDuringThePeriod" scale="0" unitRef="shares">139,957</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c272" decimals="2" format="ixt:num-dot-decimal" name="mlec:ExercisePriceExercisedDuringThePeriod" scale="0" unitRef="usdPershares">8.00</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-438">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-439">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left">Expired during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-440">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-441">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-442">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-443">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-444">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-445">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in">At the ending</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c271" decimals="INF" format="ixt:num-dot-decimal" name="mlec:NumberOfOptionsAtTheEnding" scale="0" unitRef="shares">325,826</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c271" decimals="2" format="ixt:num-dot-decimal" name="mlec:ExercisePriceAtTheEnding" scale="0" unitRef="usdPershares">1.52</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c272" decimals="INF" format="ixt:num-dot-decimal" name="mlec:NumberOfOptionsAtTheEnding" scale="0" unitRef="shares">206,598</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c272" decimals="2" format="ixt:num-dot-decimal" name="mlec:ExercisePriceAtTheEnding" scale="0" unitRef="usdPershares">8.00</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c273" decimals="INF" format="ixt:num-dot-decimal" name="mlec:NumberOfOptionsAtTheEnding" scale="0" unitRef="shares">700,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction contextRef="c273" decimals="2" format="ixt:num-dot-decimal" name="mlec:ExercisePriceAtTheEnding" scale="0" unitRef="usdPershares">4.25</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">The charge of the plans
based on options recognized during the period was $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:OptionsRecognizedAmount" scale="0" unitRef="usd">508,149</ix:nonFraction>.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><div><a id="f_023"></a></div><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 17. Accounts Payable
and other current and non-current liabilities</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="mlec_ScheduleOfAccountsPayable-c0_cont_1" escape="true" name="mlec:ScheduleOfAccountsPayable"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Transaction expenses payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities" scale="0" unitRef="usd">3,579,057</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities" scale="0" unitRef="usd">485,735</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties" scale="0" unitRef="usd">774,460</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties" scale="0" unitRef="usd">385,508</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AccrualsClassifiedAsNoncurrent" scale="0" unitRef="usd">787,010</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AccrualsClassifiedAsNoncurrent" scale="0" unitRef="usd">190,843</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Trade payables</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" scale="0" unitRef="usd">2,339,087</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" scale="0" unitRef="usd">164,127</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Accounts payable</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayables" scale="0" unitRef="usd">7,479,614</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayables" scale="0" unitRef="usd">1,226,213</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_ScheduleOfAccountsPayable-c0_cont_2" id="mlec_ScheduleOfAccountsPayable-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30, <br/>
2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left">Related parties</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentPayablesToRelatedParties" scale="0" unitRef="usd">677,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-446">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Deferred payment related to Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:DeferredPaymentRelatedToBusinessCombination" scale="0" unitRef="usd">492,799</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-447">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Wages</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:Wages" scale="0" unitRef="usd">221,141</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-448">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:Taxes" scale="0" unitRef="usd">21,783</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-449">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Pay As You Earn (PAYE)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:PayAsYouEarnPAYE" scale="0" unitRef="usd">1,551</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:PayAsYouEarnPAYE" scale="0" unitRef="usd">1,171</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentNonfinancialLiabilities" scale="0" unitRef="usd">271,371</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-450">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Other current liabilities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentLiabilities" scale="0" unitRef="usd">1,685,645</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentLiabilities" scale="0" unitRef="usd">1,171</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p></ix:continuation></ix:nonNumeric><div>
</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 128; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><ix:continuation id="_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The book value is reasonably
approximate to the fair value given its short-term nature.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<ix:continuation id="mlec_ScheduleOfAccountsPayable-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30, <br/>
2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30, <br/>
2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt">Others</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentNonfinancialLiabilities" scale="0" unitRef="usd">175,312</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-451">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Other non-current liabilities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentLiabilities" scale="0" unitRef="usd">175,312</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-452">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><div><a id="f_024"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfDebtSecuritiesExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 18. Financial
debt</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfFinancialAssetsExplanatory"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left">Financial Debt denominated in Argentine Pesos</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c274" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentFinancialAssetsAtAmortisedCost" scale="0" unitRef="usd">517,743</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-453">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Financial Debt denominated in US Dollars</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c276" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentFinancialAssetsAtAmortisedCost" scale="0" unitRef="usd">2,028,500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-454">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Current Financial Debt</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentFinancialAssetsAtAmortisedCost" scale="0" unitRef="usd">2,546,243</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-455">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><ix:nonNumeric contextRef="c0" continuedAt="_AnalysisOfAgeOfFinancialAssetsThatArePastDueButNotImpaired-c0_cont_1" escape="true" name="ifrs-full:AnalysisOfAgeOfFinancialAssetsThatArePastDueButNotImpaired">The book value is reasonably
approximate to the fair value given its short-term nature.</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="_AnalysisOfAgeOfFinancialAssetsThatArePastDueButNotImpaired-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30, <br/>
2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt">Financial Debt denominated in Argentine Pesos</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c274" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssets" scale="0" unitRef="usd">99,046</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-456">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Non-current Financial Debt</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NoncurrentFinancialAssets" scale="0" unitRef="usd">99,046</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-457">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfFinancialLiabilitiesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory">The terms and conditions
of outstanding loans are as follows:</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DisclosureOfFinancialLiabilitiesExplanatory-c0_cont_2" id="_DisclosureOfFinancialLiabilitiesExplanatory-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Bank entity</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Currency of<br/>
 denomination</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nominal<br/>
 value<br/>
 (equivalent<br/>
 in USD)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nominal<br/>
 interest<br/>
 rate</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Date of<br/>
 maturity</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 28%; text-align: left; padding-bottom: 1.5pt">Banco Macro - pre-financing of exports</td><td style="width: 0.5%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 8%; text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c278" name="mlec:BorrowingOriginalCurrency">ARS</ix:nonNumeric></td><td style="width: 0.5%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 8%; text-align: right"><ix:nonFraction contextRef="c278" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk" scale="0" unitRef="usd">147,874</ix:nonFraction></td><td style="width: 0.5%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 0.5%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c279" decimals="2" format="ixt:num-dot-decimal" id="ix_23_fact" name="mlec:NominalInterestRate" scale="-2" unitRef="pure">67</ix:nonFraction>% - <ix:nonFraction contextRef="c280" decimals="2" format="ixt:num-dot-decimal" id="ix_24_fact" name="mlec:NominalInterestRate" scale="-2" unitRef="pure">88</ix:nonFraction> </span></td><td style="white-space: nowrap; width: 0.5%; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="width: 0.5%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 25%; text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c279" name="mlec:BorrowingMaturity">07/17/2023</ix:nonNumeric>-<ix:nonNumeric contextRef="c280" name="mlec:BorrowingMaturity">12/27/2023</ix:nonNumeric></td><td style="width: 0.5%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 8%; text-align: right"><ix:nonFraction contextRef="c278" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="0" unitRef="usd">173,236</ix:nonFraction></td><td style="width: 0.5%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 0.5%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 8%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-458">-</div></td><td style="width: 0.5%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Banco Naci&#243;n - pre-financing of exports</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c282" name="mlec:BorrowingOriginalCurrency">USD</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c282" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk" scale="0" unitRef="usd">28,500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c283" decimals="2" format="ixt:num-dot-decimal" name="mlec:NominalInterestRate" scale="-2" unitRef="pure"><ix:nonFraction contextRef="c284" decimals="2" format="ixt:num-dot-decimal" name="mlec:NominalInterestRate" scale="-2" unitRef="pure">2</ix:nonFraction></ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c282" name="mlec:BorrowingMaturity">10/6/2023</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c282" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="0" unitRef="usd">28,635</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-459">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Banco C&#243;rdoba - pre-financing of exports</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c286" name="mlec:BorrowingOriginalCurrency">ARS</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c286" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk" scale="0" unitRef="usd">142,567</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c287" decimals="2" format="ixt:num-dot-decimal" id="ix_25_fact" name="mlec:NominalInterestRate" scale="-2" unitRef="pure">55</ix:nonFraction>% - <ix:nonFraction contextRef="c288" decimals="2" format="ixt:num-dot-decimal" id="ix_26_fact" name="mlec:NominalInterestRate" scale="-2" unitRef="pure">88</ix:nonFraction> </span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c287" name="mlec:BorrowingMaturity">01/11/2023 </ix:nonNumeric>-<ix:nonNumeric contextRef="c288" name="mlec:BorrowingMaturity"> 06/26/2023</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c286" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="0" unitRef="usd">156,057</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-460">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Banco Galicia - bank overdrafts</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c290" name="mlec:BorrowingOriginalCurrency">ARS</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c290" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk" scale="0" unitRef="usd">18,849</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c291" decimals="2" format="ixt:num-dot-decimal" id="ix_27_fact" name="mlec:NominalInterestRate" scale="-2" unitRef="pure"><ix:nonFraction contextRef="c292" decimals="2" format="ixt:num-dot-decimal" id="ix_28_fact" name="mlec:NominalInterestRate" scale="-2" unitRef="pure">144</ix:nonFraction></ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c290" name="mlec:BorrowingMaturity">06/30/2023</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c290" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="0" unitRef="usd">18,849</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-461">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">HSBC Bank - bank overdrafts</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c294" name="mlec:BorrowingOriginalCurrency">ARS</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c294" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk" scale="0" unitRef="usd">4,625</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c295" decimals="2" format="ixt:num-dot-decimal" id="ix_29_fact" name="mlec:NominalInterestRate" scale="-2" unitRef="pure"><ix:nonFraction contextRef="c296" decimals="2" format="ixt:num-dot-decimal" id="ix_30_fact" name="mlec:NominalInterestRate" scale="-2" unitRef="pure">108</ix:nonFraction></ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c294" name="mlec:BorrowingMaturity">06/30/2023</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c294" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="0" unitRef="usd">4,625</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-462">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Banco Santander - bank overdrafts</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c298" name="mlec:BorrowingOriginalCurrency">ARS</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c298" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk" scale="0" unitRef="usd">41,325</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c299" decimals="2" format="ixt:num-dot-decimal" id="ix_31_fact" name="mlec:NominalInterestRate" scale="-2" unitRef="pure"><ix:nonFraction contextRef="c300" decimals="2" format="ixt:num-dot-decimal" id="ix_32_fact" name="mlec:NominalInterestRate" scale="-2" unitRef="pure">161</ix:nonFraction></ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c298" name="mlec:BorrowingMaturity">06/30/2023</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c298" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="0" unitRef="usd">44,446</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-463">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Banco Galicia - loans</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c302" name="mlec:BorrowingOriginalCurrency">ARS</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c302" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk" scale="0" unitRef="usd">99,643</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c303" decimals="2" format="ixt:num-dot-decimal" id="ix_33_fact" name="mlec:NominalInterestRate" scale="-2" unitRef="pure">35</ix:nonFraction>%
- <ix:nonFraction contextRef="c304" decimals="2" format="ixt:num-dot-decimal" id="ix_34_fact" name="mlec:NominalInterestRate" scale="-2" unitRef="pure">85</ix:nonFraction> </span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c303" name="mlec:BorrowingMaturity">08/21/2023 </ix:nonNumeric>-<ix:nonNumeric contextRef="c304" name="mlec:BorrowingMaturity"> 01/25/2024</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c302" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="0" unitRef="usd">33,728</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-464">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">HSBC Bank - loans</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c306" name="mlec:BorrowingOriginalCurrency">ARS</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c306" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk" scale="0" unitRef="usd">19,508</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c307" decimals="2" format="ixt:num-dot-decimal" id="ix_35_fact" name="mlec:NominalInterestRate" scale="-2" unitRef="pure"><ix:nonFraction contextRef="c308" decimals="2" format="ixt:num-dot-decimal" id="ix_36_fact" name="mlec:NominalInterestRate" scale="-2" unitRef="pure">64</ix:nonFraction></ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c306" name="mlec:BorrowingMaturity">07/27/2023</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c306" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="0" unitRef="usd">14,940</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-465">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Banco Santander - loans</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c310" name="mlec:BorrowingOriginalCurrency">ARS</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c310" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk" scale="0" unitRef="usd">119,001</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c311" decimals="2" format="ixt:num-dot-decimal" id="ix_37_fact" name="mlec:NominalInterestRate" scale="-2" unitRef="pure">50</ix:nonFraction>%
- <ix:nonFraction contextRef="c312" decimals="2" format="ixt:num-dot-decimal" id="ix_38_fact" name="mlec:NominalInterestRate" scale="-2" unitRef="pure">57</ix:nonFraction> </span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c311" name="mlec:BorrowingMaturity">09/03/2026 </ix:nonNumeric>-<ix:nonNumeric contextRef="c312" name="mlec:BorrowingMaturity"> 03/04/2027</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c310" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="0" unitRef="usd">118,185</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-466">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Banco Macro - loans</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c314" name="mlec:BorrowingOriginalCurrency">ARS</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c314" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk" scale="0" unitRef="usd">11,705</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c315" decimals="2" format="ixt:num-dot-decimal" id="ix_39_fact" name="mlec:NominalInterestRate" scale="-2" unitRef="pure"><ix:nonFraction contextRef="c316" decimals="2" format="ixt:num-dot-decimal" id="ix_40_fact" name="mlec:NominalInterestRate" scale="-2" unitRef="pure">54</ix:nonFraction></ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c314" name="mlec:BorrowingMaturity">7/12/2023</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c314" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="0" unitRef="usd">1,257</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-467">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Promissory notes</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c318" name="mlec:BorrowingOriginalCurrency">USD</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c318" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk" scale="0" unitRef="usd">2,000,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c319" decimals="2" format="ixt:num-dot-decimal" name="mlec:NominalInterestRate" scale="-2" unitRef="pure"><ix:nonFraction contextRef="c320" decimals="2" format="ixt:num-dot-decimal" name="mlec:NominalInterestRate" scale="-2" unitRef="pure">0</ix:nonFraction></ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c319" name="mlec:BorrowingMaturity">05/22/2024 </ix:nonNumeric>-<ix:nonNumeric contextRef="c320" name="mlec:BorrowingMaturity"> 06/25/2024</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c318" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="0" unitRef="usd">2,000,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-468">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Asociaci&#243;n mutual AMA &#8211; loans</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c322" name="mlec:BorrowingOriginalCurrency">ARS</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c322" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk" scale="0" unitRef="usd">42,316</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c323" decimals="2" format="ixt:num-dot-decimal" id="ix_41_fact" name="mlec:NominalInterestRate" scale="-2" unitRef="pure"><ix:nonFraction contextRef="c324" decimals="2" format="ixt:num-dot-decimal" id="ix_42_fact" name="mlec:NominalInterestRate" scale="-2" unitRef="pure">53</ix:nonFraction></ix:nonFraction></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt"><ix:nonNumeric contextRef="c323" name="mlec:BorrowingMaturity">07/10/2023 </ix:nonNumeric>-<ix:nonNumeric contextRef="c324" name="mlec:BorrowingMaturity"> 04/10/2024</ix:nonNumeric></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c322" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Borrowings" scale="0" unitRef="usd">51,331</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-469">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="_DisclosureOfFinancialLiabilitiesExplanatory-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify"><ix:footnote id="ix_7_footnote" xml:lang="en-US">Interest rates of our outstanding loans in ARS, correspond
to market rates in the country of incorporation of our newly acquired subsidiary, which deems to be a hyperinflationary economy.</ix:footnote></td>
</tr></table></ix:continuation></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 129; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><div><a id="f_025"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 19. Warrants liabilities</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Each of the Warrants
to purchase an aggregate of <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:AggregateShares" scale="0" unitRef="shares">11,110,000</ix:nonFraction> Ordinary Shares are exercisable to purchase one Ordinary Share and only whole warrants are exercisable.
The exercise price of the Warrants is $<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:ExercisePriceShareOptionsGranted2019" scale="0" unitRef="usdPershares">11.50</ix:nonFraction> per share. A Warrant may be exercised only during the period commencing on the date of the
consummation of the transactions contemplated by the Business Combination Agreement and terminating on the earlier to occur of: the date
that is five (5) years after the date on which the Business Combination is completed or the liquidation of the Company. Redemptions of
warrants for cash once the public warrants become exercisable, may be redeemed (i) in whole and not in part, (ii) at a price of $<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="mlec:PricePerWarrant" scale="0" unitRef="usdPershares">0.01</ix:nonFraction>
per warrant, (iii) upon not less than 30 days&#8217; prior written notice of redemption to each warrant holder, and (iv) if, and only
if, the reported last sale price of the Ordinary Shares equals or exceeds $<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="mlec:ExercisePricePerShare" scale="0" unitRef="usdPershares">18.00</ix:nonFraction> per share for any 20 trading days within a 30-trading
day period ending three business days before sending the notice of redemption to each warrant holder. If the public warrants are called
for redemption for cash, management will have the option to require all holders that wish to exercise the public warrants to do so on
a &#8220;cashless basis&#8221;. The private warrants will be treated identical to the public warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory">Considering that the
fair value as of June 2023 is $<ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="ifrs-full:DividendsPaidOrdinarySharesPerShare" scale="0" unitRef="usdPershares">0.0799</ix:nonFraction> per Ordinary Share, the valuation of warrants is the following:</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">As of June 30, 2022</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-470">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 88%; text-align: left">Issued by the SPAC</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c327" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementEntitysOwnEquityInstruments" scale="0" unitRef="usd">1,666,500</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Fair value remeasurement (Gain)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c327" decimals="0" format="ixt:num-dot-decimal" name="mlec:FairValueAdjustmentOfWarrant" scale="0" sign="-" unitRef="usd">778,811</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">As of June 30, 2023</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c328" decimals="0" format="ixt:num-dot-decimal" name="mlec:WarrantAndRightsOutstanding" scale="0" unitRef="usd">887,689</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">There were no other warrants
outstanding prior to the ones issued by the SPAC.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><div><a id="f_026"></a></div><ix:nonNumeric contextRef="c0" continuedAt="mlec_SimpleAgreementForFutureEquitySAFETextBlock-c0_cont_1" escape="true" name="mlec:SimpleAgreementForFutureEquitySAFETextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 20. Simple Agreement
for Future Equity (&#8220;SAFE&#8221;)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company signed two
simple agreements for future equity (referred to as &#8220;SAFE&#8221; or &#8220;SAFEs&#8221; in plural), in exchange for the payment
by certain investors of the amounts detailed below on or about December 28, 2021. Both SAFEs were signed with two different investors
and for the following amounts:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">One SAFE was signed with
THEO 1 SCSp for the amount of $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NotionalAmount" scale="0" unitRef="usd">1,500,000</ix:nonFraction>, from which $<ix:nonFraction contextRef="c329" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentReceivablesFromSaleOfProperties" scale="0" unitRef="usd">1,000,000</ix:nonFraction> was received on January 5, 2022 and $<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentReceivablesFromSaleOfProperties" scale="0" unitRef="usd">500,000</ix:nonFraction> were received on June 30,
2022.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The other SAFE was signed
with SERENITY TRADERS LDT, for the amount of $<ix:nonFraction contextRef="c330" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentReceivablesFromSaleOfProperties" scale="0" unitRef="usd">500,000</ix:nonFraction>, fully received on January 6, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Both SAFEs give the investors,
in exchange for the payment of the mentioned amounts, the right to a variable number of shares on the Company&#8217;s Share Capital&#160;subject
to the occurrence of a qualified event or a twelve months maturity, whatever happens before, and in the case of a qualified event, specifically
the shares of the series of equity securities issued to the investors investing new money in the Company in connection with the closing.&#160;These
qualified events are defined as Equity Financing of not less than $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" scale="0" unitRef="usd">20,000,000</ix:nonFraction>, Change&#160;of Control, a Direct Listing, an Initial Public
Offering or a De-SPAC Transaction.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 130; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><ix:continuation id="mlec_SimpleAgreementForFutureEquitySAFETextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The De-SPAC transaction
occurred on December 30, 2022 and defined as a qualified event pursuant the agreement, converted the SAFE in <ix:nonFraction contextRef="c331" decimals="0" format="ixt:num-dot-decimal" name="mlec:ConvertedShares" scale="0" unitRef="shares">262,260</ix:nonFraction> shares of the Company
at a purchase price on $ <ix:nonFraction contextRef="c331" decimals="2" format="ixt:num-dot-decimal" name="mlec:PurchasePricePerShare" scale="0" unitRef="usdPershares">12.10</ix:nonFraction> for a total of $<ix:nonFraction contextRef="c331" decimals="0" format="ixt:num-dot-decimal" name="mlec:PurchasePrice" scale="0" unitRef="usd">3,173,346</ix:nonFraction>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfFinancialInstrumentsExplanatory">The following table presents
the changes in Level 3 financial instruments as of June 30 of each year:</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_2" id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-weight: bold; text-align: left; padding-bottom: 1.5pt">At the beginning</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue" scale="0" unitRef="usd">2,860,000</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-471">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-472">&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-473">&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additions</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-474">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:Additions" scale="0" unitRef="usd">2,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-475">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-476">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Results on the change of Fair Value of the SAFE (i)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" id="ix_43_fact" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="0" unitRef="usd">313,346</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" id="ix_44_fact" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="0" unitRef="usd">860,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-477">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-478">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">SAFE Capitalization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:SAFECapitalization" scale="0" sign="-" unitRef="usd">3,173,346</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-479">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-480">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-481">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">At the end</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-482">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue" scale="0" unitRef="usd">2,860,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-483">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-484">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<ix:continuation id="_DisclosureOfFinancialInstrumentsExplanatory-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(i)</td><td style="text-align: justify"><ix:footnote id="ix_8_footnote" xml:lang="en-US">The result due to the change in the fair value of the SAFE
was included in &#8220;Other financial Results&#8221;.</ix:footnote></td>
</tr></table></ix:continuation></ix:continuation><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><div><a id="f_027"></a></div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfIncomeTaxExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfIncomeTaxExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 21. Deferred tax
and income tax</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfDeferredTaxesExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfDeferredTaxesExplanatory">The roll forward of net
deferred tax as of June 30, 2023, 2022, 2021 and 2020 is as follows:</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="_DisclosureOfDeferredTaxesExplanatory-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2022</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2021</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2020</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Balance at beginning of year</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-485">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-486">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-487">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-488">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: justify">Incorporated through the business combination</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncorporatedThroughTheBusinessCombination" scale="0" unitRef="usd">1,297,436</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-489">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-490">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-491">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Credited to profit &amp; loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss" scale="0" unitRef="usd">234,542</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-492">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-493">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-494">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Charged to Other Comprehensive Income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:ChargedToOtherComprehensiveIncome" scale="0" unitRef="usd">8,913</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-495">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-496">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-497">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Balance at year end</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxLiabilities" scale="0" unitRef="usd">1,071,807</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-498">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-499">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-500">-</div></td><td style="text-align: left">&#160;</td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><ix:nonNumeric contextRef="c0" continuedAt="mlec_DisclosureOfStatutoryTaxesInCountriesTableTextBlock-c0_cont_1" escape="true" name="mlec:DisclosureOfStatutoryTaxesInCountriesTableTextBlock">Principal statutory taxes
rates in the countries where the Group operates for all the years presented are:</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<ix:continuation id="mlec_DisclosureOfStatutoryTaxesInCountriesTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold"></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Income tax rate</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>Tax Jurisdiction</b></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Argentina</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c337" decimals="2" format="ixt:num-dot-decimal" name="mlec:TaxJurisdiction" scale="-2" unitRef="pure">25</ix:nonFraction>%-<ix:nonFraction contextRef="c338" decimals="2" format="ixt:num-dot-decimal" name="mlec:TaxJurisdiction" scale="-2" unitRef="pure">35</ix:nonFraction></span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-501">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-502">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-503">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%">Luxembourg</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c332" decimals="2" format="ixt:num-dot-decimal" name="mlec:TaxJurisdiction" scale="-2" unitRef="pure">15</ix:nonFraction></td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-504">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-505">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-506">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">United Kingdom</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c345" decimals="2" format="ixt:num-dot-decimal" name="mlec:TaxJurisdiction" scale="-2" unitRef="pure">19</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c346" decimals="2" format="ixt:num-dot-decimal" name="mlec:TaxJurisdiction" scale="-2" unitRef="pure">19</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c347" decimals="2" format="ixt:num-dot-decimal" name="mlec:TaxJurisdiction" scale="-2" unitRef="pure">19</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c348" decimals="2" format="ixt:num-dot-decimal" name="mlec:TaxJurisdiction" scale="-2" unitRef="pure">19</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">United States of America</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c349" decimals="2" format="ixt:num-dot-decimal" name="mlec:TaxJurisdiction" scale="-2" unitRef="pure">21</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c350" decimals="2" format="ixt:num-dot-decimal" name="mlec:TaxJurisdiction" scale="-2" unitRef="pure">21</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c351" decimals="2" format="ixt:num-dot-decimal" name="mlec:TaxJurisdiction" scale="-2" unitRef="pure">21</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c352" decimals="2" format="ixt:num-dot-decimal" name="mlec:TaxJurisdiction" scale="-2" unitRef="pure">21</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><i>&#160;</i></p></ix:continuation></ix:nonNumeric><div>


</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 131; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><i>&#160;</i></p><div>

</div><ix:continuation continuedAt="_DisclosureOfIncomeTaxExplanatory-c0_cont_2" id="_DisclosureOfIncomeTaxExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration:underline">Reconciliation
of effective tax rate</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group&#8217;s reconciliation
of the effective tax rate is based on its domestic tax rate, with a reconciling item in respect of tax rates applied by Group companies
in other jurisdictions.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The tax rate used for
2023 represents the corporate tax rate of <ix:nonFraction contextRef="c332" decimals="2" format="ixt:num-dot-decimal" name="mlec:IncomeTaxRate" scale="-2" unitRef="pure">15</ix:nonFraction>% from Luxembourg on the taxable income payable by the Group, in accordance with the tax laws
of said jurisdiction. <ix:nonNumeric contextRef="c0" continuedAt="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock-c0_cont_1" escape="true" name="mlec:ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock">Income tax for other jurisdictions is calculated based on the substantially enacted nominal tax rates prevailing
in the respective jurisdictions.</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock-c0_cont_2" id="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December&#160;30, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left; padding-bottom: 1.5pt">Loss before tax</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"><span style="font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"><span style="font-style: normal; font-weight: normal">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:LossBeforeTax" scale="0" unitRef="usd">52,023,422</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-style: normal; font-weight: normal">)</span></td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:LossBeforeTax" scale="0" unitRef="usd">4,526,905</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(<ix:nonFraction contextRef="c39" decimals="0" format="ixt:num-dot-decimal" name="mlec:LossBeforeTax" scale="0" unitRef="usd">1,986,814</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(<ix:nonFraction contextRef="c353" decimals="0" format="ixt:num-dot-decimal" name="mlec:LossBeforeTax" scale="0" unitRef="usd">320,524</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Corporate tax rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="mlec:CorporateTaxRate" scale="-2" unitRef="pure">15</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="2" format="ixt:num-dot-decimal" name="mlec:CorporateTaxRate" scale="-2" unitRef="pure">19</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c39" decimals="2" format="ixt:num-dot-decimal" name="mlec:CorporateTaxRate" scale="-2" unitRef="pure">19</ix:nonFraction></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c353" decimals="2" format="ixt:num-dot-decimal" name="mlec:CorporateTaxRate" scale="-2" unitRef="pure">19</ix:nonFraction></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Income tax (benefit)/expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AccruedIncomeOtherThanContractAssets" scale="0" unitRef="usd">7,803,513</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AccruedIncomeOtherThanContractAssets" scale="0" unitRef="usd">860,112</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c39" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AccruedIncomeOtherThanContractAssets" scale="0" unitRef="usd">377,495</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c353" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AccruedIncomeOtherThanContractAssets" scale="0" unitRef="usd">60,900</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Effect of difference tax rates subsidiaries operating in other jurisdictions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions" scale="0" unitRef="usd">428,506</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-507">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-508">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-509">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Tax losses (i)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" id="ix_45_fact" name="mlec:TaxLosses" scale="0" unitRef="usd">1,631,947</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" id="ix_46_fact" name="mlec:TaxLosses" scale="0" unitRef="usd">860,112</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c39" decimals="0" format="ixt:num-dot-decimal" id="ix_47_fact" name="mlec:TaxLosses" scale="0" unitRef="usd">377,495</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c353" decimals="0" format="ixt:num-dot-decimal" id="ix_48_fact" name="mlec:TaxLosses" scale="0" unitRef="usd">60,900</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Non-deductible expenses - listing cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:NondeductibleExpensesListingCost" scale="0" unitRef="usd">6,405,759</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-510">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-511">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-512">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net gain on inflation effect on monetary items</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:NetGainOnInflationEffectOnMonetaryItems" scale="0" unitRef="usd">52,914</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-513">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-514">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-515">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Income tax inflation adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncomeTaxInflationAdjustment" scale="0" unitRef="usd">35,826</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-516">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-517">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-518">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c74" decimals="0" format="ixt:num-dot-decimal" name="mlec:Others" scale="0" unitRef="usd">23,141</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-519">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-520">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-521">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Tax benefit for the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:TaxBenefitForTheYear" scale="0" sign="-" unitRef="usd">234,542</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-522">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-523">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-524">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 17.85pt">(i)</td><td style="text-align: justify"><ix:footnote id="ix_9_footnote" xml:lang="en-US">Deferred tax assets have not been recognized, because it is not probable that future taxable profit will
be available against which the Group can use the benefits therefrom.</ix:footnote></td></tr></table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration:underline">Deferred tax</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Deferred tax assets and
liabilities are recognized when the carrying amount of an asset or liability in the Consolidated statement of financial position differs
from its tax base, except for differences arising on the initial recognition of goodwill.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><ix:nonNumeric contextRef="c0" continuedAt="mlec_ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock-c0_cont_1" escape="true" name="mlec:ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock">Net deferred tax liabilities
are comprised of the following amounts:</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<ix:continuation id="mlec_ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">Deferred tax asset</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify; padding-bottom: 1.5pt">Tax loss carry-forward</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c357" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" scale="0" unitRef="usd">292,267</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-525">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total other receivables</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c357" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherCurrentReceivables" scale="0" unitRef="usd">292,267</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-526">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">Deferred tax liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Customer relationship</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c357" decimals="0" format="ixt:num-dot-decimal" name="mlec:CustomerRelationship" scale="0" unitRef="usd">1,346,374</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-527">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Other tax liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c357" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherLiabilities" scale="0" unitRef="usd">17,700</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total deferred tax liability</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c357" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxLiabilityAsset" scale="0" unitRef="usd">1,364,074</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-528">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">&#160;Net deferred tax liability</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c357" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:NetDeferredTaxLiabilities" scale="0" unitRef="usd">1,071,807</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-529">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><ix:nonNumeric contextRef="c0" continuedAt="mlec_ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock-c0_cont_1" escape="true" name="mlec:ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock">The following table shows
the expiration date of the recognized accumulated tax loss carryforwards pursuant to statutes of limitations:</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="mlec_ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Fiscal year</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tax-loss<br/>
 carry<br/> forward</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Deferred <br/> tax asset</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Expiration<br/> date</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tax<br/> jurisdiction</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c359" decimals="0" format="ixt:num-dot-decimal" name="mlec:TaxlossCarryForward" scale="0" unitRef="usd">10,980</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c359" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxAssets" scale="0" unitRef="usd">3,843</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: center"><ix:nonNumeric contextRef="c360" name="ifrs-full:DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits">2027</ix:nonNumeric></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center; padding-left: 5.4pt"><ix:nonNumeric contextRef="c360" name="ifrs-full:DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory">Argentina</ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">2023</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c361" decimals="0" format="ixt:num-dot-decimal" name="mlec:TaxlossCarryForward" scale="0" unitRef="usd">824,069</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c361" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxAssets" scale="0" unitRef="usd">288,424</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center"><ix:nonNumeric contextRef="c362" name="ifrs-full:DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits">2028</ix:nonNumeric></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt"><ix:nonNumeric contextRef="c362" name="ifrs-full:DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory">Argentina</ix:nonNumeric></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:TaxlossCarryForward" scale="0" unitRef="usd">835,049</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxAssets" scale="0" unitRef="usd">292,267</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt; text-align: center">&#160;</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="text-align: right; padding-bottom: 4pt; padding-left: 5.4pt">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p></ix:continuation></ix:continuation><div>



</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 132; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>&#160;</i></b></p><div>

</div><ix:continuation id="_DisclosureOfIncomeTaxExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>Unrecognized deferred
tax assets </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">As
of June 30, 2023 and 2022 deferred tax assets relating to the operating company in the UK, Luxembourg, Argentina (Moolec Science S.E.)
and United States of America aren&#8217;t recognized because it is not probable that future taxable amounts will be available to utilize those
temporary differences and losses. Therefore, in the present Consolidated Financial Statements, the Company decided not to recognize deferred
income tax assets generated by the tax loss carry forward for the periods ended on June 30, 2023 and 2022 for the amounts of </span>$<span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction contextRef="c333" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncome" scale="0" unitRef="usd">1,631,947</ix:nonFraction>
and $ <ix:nonFraction contextRef="c334" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DeferredTaxExpenseIncome" scale="0" unitRef="usd">860,112</ix:nonFraction> respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><ix:nonNumeric contextRef="c0" continuedAt="mlec_ScheduleOfEstimatedFutureTaxableProfitTableTextBlock-c0_cont_1" escape="true" name="mlec:ScheduleOfEstimatedFutureTaxableProfitTableTextBlock">Deferred tax assets have
not been recognized in respect of the following items, because it is not probable that future taxable profit will be available against
which the Group can use the benefits therefrom:</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="mlec_ScheduleOfEstimatedFutureTaxableProfitTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Tax losses per country</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tax effect</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tax effect</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tax effect</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tax effect</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 20%; text-align: justify; padding-bottom: 1.5pt">United Kingdom</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction contextRef="c345" decimals="0" format="ixt:num-dot-decimal" name="mlec:DeferredTaxAssetsGrossAmount" scale="0" unitRef="usd">3,641,516</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction contextRef="c345" decimals="0" format="ixt:num-dot-decimal" name="mlec:DeferredTaxAssetsTaxEffect" scale="0" unitRef="usd">691,888</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction contextRef="c346" decimals="0" format="ixt:num-dot-decimal" name="mlec:DeferredTaxAssetsGrossAmount" scale="0" unitRef="usd">4,526,905</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction contextRef="c346" decimals="0" format="ixt:num-dot-decimal" name="mlec:DeferredTaxAssetsTaxEffect" scale="0" unitRef="usd">860,112</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction contextRef="c347" decimals="0" format="ixt:num-dot-decimal" name="mlec:DeferredTaxAssetsGrossAmount" scale="0" unitRef="usd">1,986,814</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction contextRef="c347" decimals="0" format="ixt:num-dot-decimal" name="mlec:DeferredTaxAssetsTaxEffect" scale="0" unitRef="usd">377,495</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction contextRef="c348" decimals="0" format="ixt:num-dot-decimal" name="mlec:DeferredTaxAssetsGrossAmount" scale="0" unitRef="usd">320,524</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction contextRef="c348" decimals="0" format="ixt:num-dot-decimal" name="mlec:DeferredTaxAssetsTaxEffect" scale="0" unitRef="usd">60,900</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Luxembourg</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c332" decimals="0" format="ixt:num-dot-decimal" name="mlec:DeferredTaxAssetsGrossAmount" scale="0" unitRef="usd">3,267,560</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c332" decimals="0" format="ixt:num-dot-decimal" name="mlec:DeferredTaxAssetsTaxEffect" scale="0" unitRef="usd">620,837</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Argentina</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c363" decimals="0" format="ixt:num-dot-decimal" name="mlec:DeferredTaxAssetsGrossAmount" scale="0" unitRef="usd">1,484,790</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c363" decimals="0" format="ixt:num-dot-decimal" name="mlec:DeferredTaxAssetsTaxEffect" scale="0" unitRef="usd">282,110</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">United States of America</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c349" decimals="0" format="ixt:num-dot-decimal" name="mlec:DeferredTaxAssetsGrossAmount" scale="0" unitRef="usd">195,328</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c349" decimals="0" format="ixt:num-dot-decimal" name="mlec:DeferredTaxAssetsTaxEffect" scale="0" unitRef="usd">37,112</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:DeferredTaxAssetsGrossAmount" scale="0" unitRef="usd">8,589,194</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:DeferredTaxAssetsTaxEffect" scale="0" unitRef="usd">1,631,947</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:DeferredTaxAssetsGrossAmount" scale="0" unitRef="usd">4,526,905</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:DeferredTaxAssetsTaxEffect" scale="0" unitRef="usd">860,112</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c39" decimals="0" format="ixt:num-dot-decimal" name="mlec:DeferredTaxAssetsGrossAmount" scale="0" unitRef="usd">1,986,814</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c39" decimals="0" format="ixt:num-dot-decimal" name="mlec:DeferredTaxAssetsTaxEffect" scale="0" unitRef="usd">377,495</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c108" decimals="0" format="ixt:num-dot-decimal" name="mlec:DeferredTaxAssetsGrossAmount" scale="0" unitRef="usd">320,524</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c108" decimals="0" format="ixt:num-dot-decimal" name="mlec:DeferredTaxAssetsTaxEffect" scale="0" unitRef="usd">60,900</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:continuation></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><div><a id="f_028"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">Note
22. Financial income / expenses</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfFinanceIncomeExplanatory"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 December&#160;30,<br/>
 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">Financial Costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Interest expense</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:InterestExpenses" scale="0" unitRef="usd">160,035</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:InterestExpenses" scale="0" unitRef="usd">2,130</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-530">&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-531">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Financial Costs</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:TotalFinancialCosts" scale="0" unitRef="usd">160,035</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:TotalFinancialCosts" scale="0" unitRef="usd">2,130</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-532">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-533">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Other financial results</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Exchange rate difference</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:ExchangeRateDifference" scale="0" unitRef="usd">1,386,599</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:ExchangeRateDifference" scale="0" unitRef="usd">12,342</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-534">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-535">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of Simply Agreement for Future Equity (&#8220;SAFE&#8221;) - Loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss" scale="0" unitRef="usd">313,346</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss" scale="0" unitRef="usd">860,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-536">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-537">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Investment gain related to money market funds</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:InvestmentGainRelatedToMoneyMarketFunds" scale="0" unitRef="usd">1,009,318</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-538">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-539">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-540">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:ChangeInWarrants" scale="0" unitRef="usd">778,811</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-541">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-542">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-543">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Interest gain (Shareholders loan)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:LoansAndReceivables" scale="0" unitRef="usd">693,027</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-544">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-545">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-546">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Inflation adjustment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:InflationAdjustment" scale="0" unitRef="usd">245,989</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-547">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-548">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-549">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherFinancialResults" scale="0" sign="-" unitRef="usd">3,325</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-550">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-551">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-552">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Other financial results</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:TotalOtherFinancialResults" scale="0" sign="-" unitRef="usd">1,030,525</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:TotalOtherFinancialResults" scale="0" unitRef="usd">872,342</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-553">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-554">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total net financial income / expenses</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:NetFinancialIncomeExpenses" scale="0" unitRef="usd">870,490</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:NetFinancialIncomeExpenses" scale="0" sign="-" unitRef="usd">874,472</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-555">-</div></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-556">-</div></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><div><a id="f_029"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Note 23. Other operating
expense</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="mlec:ScheduleOfOtherOperatingExpensesTableTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 December&#160;31,<br/>
 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Taxes, duties and penalties</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:TaxesDutiesAndPenalties" scale="0" sign="-" unitRef="usd">62,263</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-557">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-558">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-559">-</div></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Miscellaneous expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c74" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="0" unitRef="usd">31,944</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c354" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="0" unitRef="usd">38,985</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c355" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="0" unitRef="usd">93,252</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c99" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:MiscellaneousOtherOperatingExpense" scale="0" unitRef="usd">2,639</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total other operating expense</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherOperatingExpense" scale="0" unitRef="usd">94,207</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherOperatingExpense" scale="0" unitRef="usd">38,985</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c39" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherOperatingExpense" scale="0" unitRef="usd">93,252</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c26" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherOperatingExpense" scale="0" unitRef="usd">2,639</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 133; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><div><a id="f_030"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Note 24. Administrative
expenses</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="mlec:DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 December&#160;31,<br/>
 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Audit. legal and accountancy fees</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:AuditLegalAndAccountancyFee" scale="0" unitRef="usd">2,024,611</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="mlec:AuditLegalAndAccountancyFee" scale="0" unitRef="usd">1,355,046</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:AuditLegalAndAccountancyFee" scale="0" unitRef="usd">635,173</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:AuditLegalAndAccountancyFee" scale="0" unitRef="usd">125,867</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Employee Stock Option Plan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:EmployeeBenefitsExpense" scale="0" unitRef="usd">1,166,755</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:EmployeeBenefitsExpense" scale="0" unitRef="usd">838,576</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-560">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-561">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Payroll Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:PayrollExpenses" scale="0" unitRef="usd">880,830</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="mlec:PayrollExpenses" scale="0" unitRef="usd">254,215</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:PayrollExpenses" scale="0" unitRef="usd">10,544</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-562">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:InsuranceExpense" scale="0" unitRef="usd">428,947</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-563">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-564">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-565">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Travel Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TravelExpense" scale="0" unitRef="usd">102,305</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TravelExpense" scale="0" unitRef="usd">52,532</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TravelExpense" scale="0" unitRef="usd">332</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-566">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:AmortizationExpense" scale="0" unitRef="usd">92,818</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-567">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-568">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-569">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationExpense" scale="0" unitRef="usd">4,107</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-570">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-571">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-572">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other office and admin expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd">108,282</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd">22,861</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd">174,897</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:SellingGeneralAndAdministrativeExpense" scale="0" unitRef="usd">2,019</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">Total Administrative expenses</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="0" unitRef="usd">4,808,655</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="0" unitRef="usd">2,523,230</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="0" unitRef="usd">820,946</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AdministrativeExpense" scale="0" unitRef="usd">127,886</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><div><a id="f_031"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Note 25. Research
and development expense</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 December&#160;31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Professional fees</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfessionalFeesExpense" scale="0" unitRef="usd">886,628</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfessionalFeesExpense" scale="0" unitRef="usd">373,259</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfessionalFeesExpense" scale="0" unitRef="usd">75,189</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-573">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Laboratories&#8217; related expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:LaboratoriesRelatedExpenses" scale="0" unitRef="usd">434,551</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="mlec:LaboratoriesRelatedExpenses" scale="0" unitRef="usd">449,442</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="mlec:LaboratoriesRelatedExpenses" scale="0" unitRef="usd">526,753</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-574">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AmortisationExpense" scale="0" unitRef="usd">1,699</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:AmortisationExpense" scale="0" unitRef="usd">1,699</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-575">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-576">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other research and development expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherResearchAndDevelopmentExpenses" scale="0" unitRef="usd">28,339</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherResearchAndDevelopmentExpenses" scale="0" unitRef="usd">160,758</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-577">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherResearchAndDevelopmentExpenses" scale="0" unitRef="usd">179,061</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">Total Research and development expenses</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="0" unitRef="usd">1,351,217</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="0" unitRef="usd">985,158</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="0" unitRef="usd">601,942</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ResearchAndDevelopmentExpense" scale="0" unitRef="usd">179,061</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><div><a id="f_032"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfCostOfSalesExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 26. Cost of sales</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="mlec:ScheduleOfCostOfSalesTableTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 December&#160;31,<br/>
 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Inventories at beginning</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-578">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-579">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-580">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-581">&#160;&#160;&#160;&#160;&#160;-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left">Inventories incorporated through the business combination</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:InventoriesIncorporatedThroughTheBusinessCombination" scale="0" unitRef="usd">532,231</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-582">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-583">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-584">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Purchases</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:PurchasesFairValueMeasurementAssets" scale="0" unitRef="usd">788,751</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-585">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-586">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-587">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Production costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; font-style: italic; text-align: left">Payroll and and professional fees</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:PayrollAndAndProfessionalFees" scale="0" unitRef="usd">121,285</ix:nonFraction></td><td style="font-style: italic; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-588">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-589">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-590">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; font-style: italic; text-align: left">Maintenance, energy and fuel related to fixed assets</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RepairsAndMaintenanceExpense" scale="0" unitRef="usd">77,495</ix:nonFraction></td><td style="font-style: italic; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-591">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-592">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-593">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; font-style: italic; text-align: left">Amortization and depreciation</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:DepreciationAndAmortisationExpense" scale="0" unitRef="usd">23,398</ix:nonFraction></td><td style="font-style: italic; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-594">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-595">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-596">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; font-style: italic; text-align: left">Other production costs</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherProductionCosts" scale="0" sign="-" unitRef="usd">31,050</ix:nonFraction></td><td style="font-style: italic; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-597">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-598">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-599">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; font-style: italic; text-align: left">Sub-total Production costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:RawMaterialsAndConsumablesUsed" scale="0" unitRef="usd">253,228</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-600">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-601">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-602">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency translation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" scale="0" unitRef="usd">60,108</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-603">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-604">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-605">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Sub-total</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:TotalOtherProductionCost" scale="0" sign="-" unitRef="usd">1,514,102</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-606">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-607">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-608">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Inventories as of the end</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:Inventories" scale="0" unitRef="usd">465,748</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-609">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-610">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-611">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Cost of sales</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CostOfSales" scale="0" unitRef="usd">1,048,354</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-612">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-613">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-614">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 134; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><div><a id="f_033"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfEarningsPerShareExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 27. Net loss per
share</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Basic loss per share
is computed using the weighted-average number of ordinary shares outstanding during the year. Diluted net loss per share is computed using
the weighted-average number of ordinary shares and potentially dilutive, ordinary share equivalents outstanding during the year. The Group&#8217;s
basic and diluted loss per ordinary share are the same because the Group has generated net loss to ordinary shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The following table presents
the calculation of basic and diluted loss per ordinary share for the year ended on June 30, 2023 and June 30, 2022 as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Loss attributable to ordinary shareholders (basic and diluted)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_EarningsPerShareExplanatory-c0_cont_1" escape="true" name="ifrs-full:EarningsPerShareExplanatory"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Numerator</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31,<br/>
 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left">Loss for the year, attributable to the owners of the Group</td><td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" scale="0" sign="-" unitRef="usd">51,788,880</ix:nonFraction></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left">)</td><td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" scale="0" sign="-" unitRef="usd">4,526,905</ix:nonFraction></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left">)</td><td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" scale="0" sign="-" unitRef="usd">1,986,814</ix:nonFraction></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left">)</td><td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" scale="0" sign="-" unitRef="usd">320,524</ix:nonFraction></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 4pt; padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Loss attributable to the ordinary shareholders</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" scale="0" sign="-" unitRef="usd">51,788,880</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" scale="0" sign="-" unitRef="usd">4,526,905</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" scale="0" sign="-" unitRef="usd">1,986,814</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" scale="0" sign="-" unitRef="usd">320,524</ix:nonFraction></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td></tr>
</table></ix:nonNumeric>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"><b>Weighted-average number of ordinary shares (basic and diluted)</b></p>

<p style="margin: 0">&#160;</p>

<ix:continuation continuedAt="_EarningsPerShareExplanatory-c0_cont_2" id="_EarningsPerShareExplanatory-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Denominator</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31,<br/>
 2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Weighted-average number of ordinary shares</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:AdjustedWeightedAverageShares" scale="0" unitRef="shares">34,466,258</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:AdjustedWeightedAverageShares" scale="0" unitRef="shares">31,000,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:AdjustedWeightedAverageShares" scale="0" unitRef="shares">30,239,558</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="ifrs-full:AdjustedWeightedAverageShares" scale="0" unitRef="shares">29,140,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
</table></ix:continuation>

<p style="margin: 0">&#160;</p>

<ix:continuation id="_EarningsPerShareExplanatory-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Net loss attributable to ordinary shareholders per share</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31,<br/>
 2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -0.125in; padding-left: 0.125in"><div style="-sec-ix-hidden: hidden-fact-618; -sec-ix-hidden: hidden-fact-617; -sec-ix-hidden: hidden-fact-616; -sec-ix-hidden: hidden-fact-615">Basic and Diluted</div></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations" scale="0" sign="-" unitRef="usdPershares">1.50</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations" scale="0" sign="-" unitRef="usdPershares">0.15</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations" scale="0" sign="-" unitRef="usdPershares">0.07</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations" scale="0" sign="-" unitRef="usdPershares">0.01</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  </table></ix:continuation></ix:nonNumeric><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><div><a id="f_034"></a></div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfRelatedPartyExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfRelatedPartyExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 28. Related parties</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Balances and transactions
between the Group entities, which are related parties, have been eliminated on consolidation and are not disclosed in this note. Transactions
between the Group and its directors and/or executive board members and the Company and the Parent are disclosed below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Transactions with
key management personnel </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Key management personnel
compensation comprised:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Other Related Party
Transactions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" escape="true" name="mlec:ScheduleOfOtherRelatedPartyTransactions"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-style: italic; text-align: left">In USD ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31,<br/>
 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Short-term employee benefits</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermEmployeeBenefitsExpense" scale="0" unitRef="usd">39,250</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermEmployeeBenefitsExpense" scale="0" unitRef="usd">96,437</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermEmployeeBenefitsExpense" scale="0" unitRef="usd">109,205</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermEmployeeBenefitsExpense" scale="0" unitRef="usd">38,355</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Share based payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermEmployeeBenefitsAccruals" scale="0" unitRef="usd">904,861</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ShorttermEmployeeBenefitsAccruals" scale="0" unitRef="usd">838,576</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-619">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-620">-</div></td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p></ix:nonNumeric></ix:nonNumeric><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 135; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfRelatedPartyExplanatory-c0_cont_2" id="_DisclosureOfRelatedPartyExplanatory-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Other Related Party
Transactions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<ix:nonNumeric contextRef="c0" continuedAt="mlec_ScheduleOfShareBasedPayment-c0_cont_1" escape="true" name="mlec:ScheduleOfShareBasedPayment"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>In USD ($)</i></b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note</b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended<br/>
June 30,<br/>
2023</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended <br/>
June 30,<br/>
2022</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>From the period<br/>
of January 1,<br/>
2021 through<br/>
June 30,<br/>
2021</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>From the period of August 21, 2020 through December&#160;31,<br/>
2020</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share based payment</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 40%; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key management</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensation" scale="0" unitRef="usd">904,861</ix:nonFraction></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:KeyManagementPersonnelCompensation" scale="0" unitRef="usd">838,576</ix:nonFraction></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-621; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-622; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CFO Shares Alloted</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" id="ix_73_fact" name="mlec:CFOSharesAlloted" scale="0" unitRef="usd">364,014</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-623; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-624; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-625; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issue of Additional Shares</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue of share capital</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:IssueOfSharesCapital" scale="0" unitRef="usd">15,000</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-626; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-627; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-628; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue of share premium</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:IssueOfSharePremium" scale="0" unitRef="usd">39,610,630</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-629; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-630; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-631; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent of the Company &#8211; Bioceres Crop Solutions Corp</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-632; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-633; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c366" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" scale="0" unitRef="usd">3,000,000</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-634; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent of the Company &#8211; Union Group Ventures</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-635; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-636; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-637; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c371" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" scale="0" unitRef="usd">2,000,000</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent of the Company &#8211; BG Farming Technologies</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-638; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-639; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-640; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c375" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" scale="0" unitRef="usd">2,000,000</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Company&#8217;s Cash Balance in Other&#8217;s Accounts</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent of BF Farming Technologies &#8211; Bioceres S.A.</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-641; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-642; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-643; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c379" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashEquivalents" scale="0" unitRef="usd">300,000</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="mlec:SubsidiaryPercentage" scale="-2" unitRef="pure">100</ix:nonFraction>% Subsidiary of Bioceres S.A. &#8211; Bioceres LLC</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-644; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-645; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c382" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashEquivalents" scale="0" unitRef="usd">500,000</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c383" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CashEquivalents" scale="0" unitRef="usd">300,000</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expenses Paid on Behalf of the Company</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent of BG Farming Technologies - Bioceres S.A.</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-646; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c385" decimals="0" format="ixt:num-dot-decimal" id="ix_49_fact" name="mlec:ExpensesPaid" scale="0" unitRef="usd">265,810</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c386" decimals="0" format="ixt:num-dot-decimal" id="ix_50_fact" name="mlec:ExpensesPaid" scale="0" unitRef="usd">509,628</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c387" decimals="0" format="ixt:num-dot-decimal" id="ix_51_fact" name="mlec:ExpensesPaid" scale="0" unitRef="usd">244,029</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c388" decimals="2" format="ixt:num-dot-decimal" id="ix_56_fact" name="mlec:SubsidiaryPercentage" scale="-2" unitRef="pure">100</ix:nonFraction>% Subsidiary of Bioceres S.A. - Bioceres LLC</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c388" decimals="0" format="ixt:num-dot-decimal" id="ix_52_fact" name="mlec:ExpensesPaid" scale="0" unitRef="usd">238,121</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c389" decimals="0" format="ixt:num-dot-decimal" id="ix_53_fact" name="mlec:ExpensesPaid" scale="0" unitRef="usd">156,760</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c390" decimals="0" format="ixt:num-dot-decimal" id="ix_54_fact" name="mlec:ExpensesPaid" scale="0" unitRef="usd">453,282</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c391" decimals="0" format="ixt:num-dot-decimal" id="ix_55_fact" name="mlec:ExpensesPaid" scale="0" unitRef="usd">56,863</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Services Provided by Other Companies</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c392" decimals="2" format="ixt:num-dot-decimal" id="ix_61_fact" name="mlec:OwnedPercentage" scale="-2" unitRef="pure">30</ix:nonFraction>% owned by Bioceres S.A. - INMET S.A.- Ingenieria Metabolica S.A</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c392" decimals="0" format="ixt:num-dot-decimal" id="ix_57_fact" name="mlec:ServicesProvidedByOtherCompanies" scale="0" unitRef="usd">286</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c393" decimals="0" format="ixt:num-dot-decimal" id="ix_58_fact" name="mlec:ServicesProvidedByOtherCompanies" scale="0" unitRef="usd">252</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c394" decimals="0" format="ixt:num-dot-decimal" id="ix_59_fact" name="mlec:ServicesProvidedByOtherCompanies" scale="0" unitRef="usd">144,530</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c395" decimals="0" format="ixt:num-dot-decimal" id="ix_60_fact" name="mlec:ServicesProvidedByOtherCompanies" scale="0" unitRef="usd">160,390</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c396" decimals="3" format="ixt:num-dot-decimal" id="ix_66_fact" name="mlec:OwnedPercentage" scale="-2" unitRef="pure">98.6</ix:nonFraction>% owned by Bioceres S.A. - INDEAR S.A.- Instituto de Agrobiotecnolog&#237;a Rosario</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c396" decimals="0" format="ixt:num-dot-decimal" id="ix_62_fact" name="mlec:ServicesProvidedByOtherCompanies" scale="0" unitRef="usd">258,279</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c397" decimals="0" format="ixt:num-dot-decimal" id="ix_63_fact" name="mlec:ServicesProvidedByOtherCompanies" scale="0" unitRef="usd">57,047</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c398" decimals="0" format="ixt:num-dot-decimal" id="ix_64_fact" name="mlec:ServicesProvidedByOtherCompanies" scale="0" unitRef="usd">129,695</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c399" decimals="0" format="ixt:num-dot-decimal" id="ix_65_fact" name="mlec:ServicesProvidedByOtherCompanies" scale="0" unitRef="usd">2,540</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned by Bioceres S.A. - Agrality Inc.</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c400" decimals="0" format="ixt:num-dot-decimal" id="ix_67_fact" name="mlec:ServicesProvidedByOtherCompanies" scale="0" unitRef="usd">5,000</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c401" decimals="0" format="ixt:num-dot-decimal" id="ix_68_fact" name="mlec:ServicesProvidedByOtherCompanies" scale="0" unitRef="usd">85,435</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-647; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-648; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Founded and operated by the Company&#8217;s CPO - Future Foods B.V.</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c404" decimals="0" format="ixt:num-dot-decimal" id="ix_69_fact" name="mlec:ServicesProvidedByOtherCompanies" scale="0" unitRef="usd">85,880</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c405" decimals="0" format="ixt:num-dot-decimal" id="ix_70_fact" name="mlec:ServicesProvidedByOtherCompanies" scale="0" unitRef="usd">94,857</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c406" decimals="0" format="ixt:num-dot-decimal" id="ix_71_fact" name="mlec:ServicesProvidedByOtherCompanies" scale="0" unitRef="usd">35,958</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c407" decimals="0" format="ixt:num-dot-decimal" id="ix_72_fact" name="mlec:ServicesProvidedByOtherCompanies" scale="0" unitRef="usd">17,801</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moolec Science S.A. Shareholders</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c408" decimals="0" format="ixt:num-dot-decimal" id="ix_74_fact" name="mlec:ServicesProvidedByOtherCompanies" scale="0" unitRef="usd">693,027</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-649; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-650; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-651; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THEO I SCSp</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-652; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c413" decimals="0" format="ixt:num-dot-decimal" name="mlec:ServicesProvidedByOtherCompanies" scale="0" unitRef="usd">1,500,000</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-653; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-654; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="mlec_ScheduleOfShareBasedPayment-c0_cont_2" id="mlec_ScheduleOfShareBasedPayment-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.35in">(i)</td><td style="text-align: justify"><ix:footnote id="ix_10_footnote" xml:lang="en-US">Expenses paid by Bioceres LLC on behalf of the Company.</ix:footnote></td></tr></table></ix:continuation>

<ix:continuation continuedAt="mlec_ScheduleOfShareBasedPayment-c0_cont_3" id="mlec_ScheduleOfShareBasedPayment-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.35in">(ii)</td><td style="text-align: justify"><ix:footnote id="ix_11_footnote" xml:lang="en-US">The Company entered into an agreement with INMET S.A.- Ingenieria Metabolica S,A through which it would
receive research services in exchange for payment.</ix:footnote></td></tr></table></ix:continuation>

<ix:continuation continuedAt="mlec_ScheduleOfShareBasedPayment-c0_cont_4" id="mlec_ScheduleOfShareBasedPayment-c0_cont_3"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.35in">(iii)</td><td style="text-align: justify"><ix:footnote id="ix_12_footnote" xml:lang="en-US">The Company entered into an agreement with INDEAR S.A.- Instituto de Agrobiotecnologia Rosario where it
would receive research services in exchange for payment.</ix:footnote></td></tr></table></ix:continuation>

<ix:continuation continuedAt="mlec_ScheduleOfShareBasedPayment-c0_cont_5" id="mlec_ScheduleOfShareBasedPayment-c0_cont_4"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.35in">(iv)</td><td style="text-align: justify"><ix:footnote id="ix_13_footnote" xml:lang="en-US">The Company entered into an agreement with Agrality Inc, for the provision of services.</ix:footnote></td></tr></table></ix:continuation>

<ix:continuation continuedAt="mlec_ScheduleOfShareBasedPayment-c0_cont_6" id="mlec_ScheduleOfShareBasedPayment-c0_cont_5"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.35in">(v)</td><td style="text-align: justify"><ix:footnote id="ix_14_footnote" xml:lang="en-US">The Company entered into an agreement with Future Foods B.V. for the provision of services.</ix:footnote></td></tr></table></ix:continuation>

<ix:continuation continuedAt="mlec_ScheduleOfShareBasedPayment-c0_cont_7" id="mlec_ScheduleOfShareBasedPayment-c0_cont_6"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.35in">(vi)</td><td style="text-align: justify"><ix:footnote id="ix_15_footnote" xml:lang="en-US">Shares issue related to share based payment already vested.</ix:footnote></td></tr></table></ix:continuation>

<ix:continuation id="mlec_ScheduleOfShareBasedPayment-c0_cont_7"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.35in">(vii)</td><td style="text-align: justify"><ix:footnote id="ix_16_footnote" xml:lang="en-US">The Company entered into an agreement with shareholders which accrues an internal rate of return.</ix:footnote></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 136; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p><div>

</div><ix:continuation id="_DisclosureOfRelatedPartyExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Other Related Party
Balances</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<ix:nonNumeric contextRef="c0" escape="true" name="mlec:ScheduleOfOtherRelatedPartyBalances"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">In USD ($)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Balance<br/> outstanding<br/> as of<br/> June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Balance<br/> outstanding<br/> as of<br/> June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt"><ix:nonFraction contextRef="c418" decimals="2" format="ixt:num-dot-decimal" name="mlec:SubsidiaryPercentage" scale="-2" unitRef="pure">100</ix:nonFraction>% Subsidiary of Bioceres S.A. <span style="-sec-ix-hidden: hidden-fact-655">-</span> Bioceres LLC</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c416" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherRelatedPartyBalances" scale="0" sign="-" unitRef="usd">623,629</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c417" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherRelatedPartyBalances" scale="0" sign="-" unitRef="usd">385,508</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Moolec S.A. Shareholders</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c420" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherRelatedPartyBalances" scale="0" unitRef="usd">8,763,027</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-656">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Union Group Ventures Limited</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c422" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherRelatedPartyBalances" scale="0" sign="-" unitRef="usd">677,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-657">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">INDEAR S.A.</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c424" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherRelatedPartyBalances" scale="0" sign="-" unitRef="usd">72,494</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-658">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Future Foods B.V</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c426" decimals="0" format="ixt:num-dot-decimal" name="mlec:OtherRelatedPartyBalances" scale="0" sign="-" unitRef="usd">78,337</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-659">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><div>

</div><div><a id="f_035"></a></div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfFinancialRiskManagementExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 29. Financial risk
management</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group&#8217;s activities
are subject to several financial risks: market risk (including the exchange rate risk, the interest rate risk and price risk), credit
risk and liquidity risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The following matters
have been considered by Management in determining the appropriateness of the going concern basis of preparation of the accompanying Consolidated
Financial Statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><b>a)</b></td><td style="text-align: justify"><b>Credit risk</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Credit risk is the risk
of financial loss to the Group if the counterparty to a financial instrument fails to meet its contractual obligations. Financial instruments
held by the Group that are potentially subject to concentration of credit risk are primarily cash and receivables, the latter held as
a result of ValoraSoy Acquisition. Management believes that the credit risk concentrating with respect to cash and amounts receivable
is remote.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfTradingIncomeExpenseExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfTradingIncomeExpenseExplanatory">The following table sets
forth details of the age of trade and other receivables:</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="_DisclosureOfTradingIncomeExpenseExplanatory-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">As at</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">To due become</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt">Up to 3 months</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction contextRef="c431" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherReceivables" scale="0" unitRef="usd">450,728</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-660">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><b>b)</b></td><td style="text-align: left"><b>Liquidity risk</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Liquidity risk is the
risk that the Group will encounter difficulty in meeting the obligations affiliated with its financial liabilities that are settled by
delivering cash or another financial asset. The Group&#8217;s approach to managing liquidity is to ensure, as far as possible, that it
will always have sufficient liquidity to meet its liabilities when due, under both normal and stressed conditions, without incurring unacceptable
losses or risking damage to the Group&#8217; s reputation. Given the Group&#8217;s financial position as of June 30, 2023, total current
financial assets $<ix:nonFraction contextRef="c428" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentFinancialAssets" scale="0" unitRef="usd">4,524,972</ix:nonFraction> as compared to total financial liabilities of $<ix:nonFraction contextRef="c428" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd">11,985,860</ix:nonFraction> management expects that the Group will be able to
provide the capital needed to keep the Group liquid and able to fulfill its short-term obligations. Group&#8217;s financial position as
of June 30, 2022, total current financial assets $<ix:nonFraction contextRef="c429" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentFinancialAssets" scale="0" unitRef="usd">1,081,808</ix:nonFraction> as compared to total financial liabilities of $<ix:nonFraction contextRef="c429" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd">1,227,384</ix:nonFraction>, which comprised
the SAFE agreement convertible in future Equity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company continuously
monitors and reviews its actual and forecasted cash flows and manages liquidity risk by maintaining adequate cash and cash equivalents,
by utilizing term loans and by monitoring developments in the capital markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><ix:nonNumeric contextRef="c0" continuedAt="_MaturityAnalysisForDerivativeFinancialLiabilities-c0_cont_1" escape="true" name="ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities">The table below analyzes
the Company&#8217;s financial liabilities into relevant maturity groupings based on the remaining period at the balance sheet to the contractual
maturity date.</ix:nonNumeric></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p></ix:nonNumeric><div>

</div><div>


</div><!-- Field: Page; Sequence: 137; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_2" id="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_1"><ix:continuation id="_MaturityAnalysisForDerivativeFinancialLiabilities-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Maturity date</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Within 1<br/>
 year or on<br/>
 demand</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Between 1<br/>
 and 2 years</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Between 2<br/>
 and 5 years</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">More than <br/>
5 years</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Without any<br/>
 established<br/>
 term</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">June 30, 2023</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 28%; text-align: left">Trade Payables</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c433" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayables" scale="0" unitRef="usd">7,479,614</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-661">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-662">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-663">&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-664">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayables" scale="0" unitRef="usd">7,479,614</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Other liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c433" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherLiabilities" scale="0" unitRef="usd">1,776,438</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c434" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherLiabilities" scale="0" unitRef="usd">180,197</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-665">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-666">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherLiabilities" scale="0" unitRef="usd">1,956,635</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: left">Financial debts</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c433" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd">2,578,100</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c434" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd">72,831</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c435" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd">108,638</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-667">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-668">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd">2,759,569</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left">Subtotal</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c433" decimals="0" format="ixt:num-dot-decimal" name="mlec:SubtotalNonDerivatesLiabilities" scale="0" unitRef="usd">11,834,152</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c434" decimals="0" format="ixt:num-dot-decimal" name="mlec:SubtotalNonDerivatesLiabilities" scale="0" unitRef="usd">253,028</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c435" decimals="0" format="ixt:num-dot-decimal" name="mlec:SubtotalNonDerivatesLiabilities" scale="0" unitRef="usd">108,638</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-669">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-670">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:SubtotalNonDerivatesLiabilities" scale="0" unitRef="usd">12,195,818</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Warrant</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c433" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:WarrantLiability" scale="0" unitRef="usd">887,689</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-671">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-672">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-673">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-674">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:WarrantLiability" scale="0" unitRef="usd">887,689</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left">Subtotal</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c433" decimals="0" format="ixt:num-dot-decimal" name="mlec:SubtotalDerivatesLiabilities" scale="0" unitRef="usd">887,689</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-675">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-676">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-677">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-678">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:SubtotalDerivatesLiabilities" scale="0" unitRef="usd">887,689</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c433" decimals="0" format="ixt:num-dot-decimal" name="mlec:TotalLiabilities" scale="0" unitRef="usd">12,721,841</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c434" decimals="0" format="ixt:num-dot-decimal" name="mlec:TotalLiabilities" scale="0" unitRef="usd">253,028</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c435" decimals="0" format="ixt:num-dot-decimal" name="mlec:TotalLiabilities" scale="0" unitRef="usd">108,638</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-679">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-680">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="mlec:TotalLiabilities" scale="0" unitRef="usd">13,083,507</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">June 30, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Trade Payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c438" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayables" scale="0" unitRef="usd">1,226,213</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-681">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-682">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-683">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-684">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:TradeAndOtherPayables" scale="0" unitRef="usd">1,226,213</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Other liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c438" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherLiabilities" scale="0" unitRef="usd">1,171</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-685">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-686">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-687">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-688">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherLiabilities" scale="0" unitRef="usd">1,171</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: left">Simply Agreement for Future Equity (&#8220;SAFE&#8221;)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c438" decimals="0" format="ixt:num-dot-decimal" name="mlec:SimplyAgreementForFutureEquitySAFE" scale="0" unitRef="usd">2,860,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-689">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-690">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-691">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-692">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:SimplyAgreementForFutureEquitySAFE" scale="0" unitRef="usd">2,860,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left">Subtotal</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c438" decimals="0" format="ixt:num-dot-decimal" name="mlec:SubtotalNonDerivatesLiabilities" scale="0" unitRef="usd">4,087,384</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-693">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-694">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-695">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-696">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:SubtotalNonDerivatesLiabilities" scale="0" unitRef="usd">4,087,384</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c438" decimals="0" format="ixt:num-dot-decimal" name="mlec:TotalLiabilities" scale="0" unitRef="usd">4,087,384</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-697">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-698">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-699">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="mlec:TotalLiabilities" scale="0" unitRef="usd">4,087,384</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"></td></tr>
  </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><b>c)</b></td><td style="text-align: left"><b>Market risk</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Market risk is the risk
that changes in market prices -e.g. foreign exchange rates, interest rates and equity prices -will affect the Group&#8217;s income or
the value of its holdings of financial instruments including commodity prices and foreign currency exchange rates. The objective of market
risk management is to manage and control market risk exposures within acceptable parameters, while optimizing the return.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><span style="text-decoration:underline">Commodity risk</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In the normal course
of its business, the Company is exposed to risk resulting from fluctuations in the market prices of commodities. The Company does not
engage in transactional hedging of its commodity price risk.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b><i>&#160;</i></b></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 138; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b><i>&#160;</i></b></p><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_3" id="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="text-decoration:underline">Foreign currency exchange
risk</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company is exposed
to foreign exchange risk as a result of transactions being conducted in currencies other than the functional currency of each of the Company
and its subsidiaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company has not entered
into transactions that seek to hedge or mitigate its exposure to exchange rate fluctuations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><ix:nonNumeric contextRef="c0" continuedAt="_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory-c0_cont_1" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory">The carrying amounts
of the Group&#8217;s foreign currency denominated monetary assets and monetary liabilities at the reporting date are as follows:</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory-c0_cont_2" id="_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Assets</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Currency</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Argentine pesos</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="mlec:ForeignCurrencyExchangeRiskAssets" scale="0" unitRef="usd">765,690</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-700">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c443" decimals="0" format="ixt:num-dot-decimal" name="mlec:ForeignCurrencyExchangeRiskLiabilities" scale="0" unitRef="usd">50,073</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-701">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">U.S. Dollar</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="mlec:ForeignCurrencyExchangeRiskAssets" scale="0" unitRef="usd">368,186</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-702">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c445" decimals="0" format="ixt:num-dot-decimal" name="mlec:ForeignCurrencyExchangeRiskLiabilities" scale="0" unitRef="usd">2,227,751</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-703">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Pound sterling</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c447" decimals="0" format="ixt:num-dot-decimal" name="mlec:ForeignCurrencyExchangeRiskAssets" scale="0" unitRef="usd">22,062</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c448" decimals="0" format="ixt:num-dot-decimal" name="mlec:ForeignCurrencyExchangeRiskAssets" scale="0" unitRef="usd">8,025</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-704">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-705">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The following table details
sensitivity to a <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageOfFunctionalCurrency" scale="-2" unitRef="pure">10</ix:nonFraction>% increase and decrease in the functional currency of each of the companies against the relevant foreign currencies.
The sensitivity analysis includes only the outstanding monetary items denominated in foreign currency and adjusts its conversion at the
end of the period for a <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ifrs-full:TaxRateEffectOfForeignTaxRates" scale="-2" unitRef="pure">10</ix:nonFraction>% change in exchange rates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(+10%) Impact to profit or loss before tax</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(-10%) Impact to profit or loss before tax</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Assets</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Currency</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Argentine pesos</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c449" decimals="0" format="ixt:num-dot-decimal" name="mlec:ForeignCurrencyExchangeRiskAssets" scale="0" unitRef="usd">76,569</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-706">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c451" decimals="0" format="ixt:num-dot-decimal" name="mlec:ForeignCurrencyExchangeRiskLiabilities" scale="0" sign="-" unitRef="usd">5,007</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-707">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">U.S. Dollar</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c453" decimals="0" format="ixt:num-dot-decimal" name="mlec:ForeignCurrencyExchangeRiskAssets" scale="0" unitRef="usd">36,819</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-708">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c455" decimals="0" format="ixt:num-dot-decimal" name="mlec:ForeignCurrencyExchangeRiskLiabilities" scale="0" sign="-" unitRef="usd">222,775</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-709">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Pound sterling</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c457" decimals="0" format="ixt:num-dot-decimal" name="mlec:ForeignCurrencyExchangeRiskAssets" scale="0" unitRef="usd">2,206</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c458" decimals="0" format="ixt:num-dot-decimal" name="mlec:ForeignCurrencyExchangeRiskAssets" scale="0" unitRef="usd">803</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-710">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-711">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 139; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><ix:continuation continuedAt="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_4" id="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_3"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><b>d)</b></td><td style="text-align: left"><b>Fair value risk</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfFairValueOfFinancialInstrumentsExplanatory-c0_cont_1" escape="true" name="ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory"><b>Fair value and carrying
value of financial instruments:</b></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The following represents
the carrying value and fair value of the Company&#8217;s financial instruments and non-financial derivatives:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DisclosureOfFairValueOfFinancialInstrumentsExplanatory-c0_cont_2" id="_DisclosureOfFairValueOfFinancialInstrumentsExplanatory-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Recurring measurements</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Note</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">Financial Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Amortized costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Cash and cash equivalents</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 11%; text-align: center; padding-bottom: 1.5pt">(i)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c461" decimals="0" format="ixt:num-dot-decimal" id="ix_75_fact" name="ifrs-full:CashAndCashEquivalents" scale="0" unitRef="usd">2,064,079</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c462" decimals="0" format="ixt:num-dot-decimal" id="ix_76_fact" name="ifrs-full:CashAndCashEquivalents" scale="0" unitRef="usd">1,081,808</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Trade and other receivables</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">(i)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c461" decimals="0" format="ixt:num-dot-decimal" id="ix_77_fact" name="ifrs-full:TradeAndOtherCurrentReceivables" scale="0" unitRef="usd">10,454,301</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c462" decimals="0" format="ixt:num-dot-decimal" id="ix_78_fact" name="ifrs-full:TradeAndOtherCurrentReceivables" scale="0" unitRef="usd">2,061</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Fair value through profit or loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Cash and cash equivalents</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">(ii)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c461" decimals="0" format="ixt:num-dot-decimal" id="ix_82_fact" name="ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents" scale="0" unitRef="usd">463,594</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-712">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Short-term investments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">(ii)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c461" decimals="0" format="ixt:num-dot-decimal" id="ix_83_fact" name="mlec:ShorttermInvestmentsCurrent" scale="0" unitRef="usd">306,034</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-713">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total financial assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c461" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="0" unitRef="usd">13,288,008</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c462" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssets" scale="0" unitRef="usd">1,083,869</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>

<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><b>Financial Liabilities</b></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Amortized costs</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Trade and other payables</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">(i)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c461" decimals="0" format="ixt:num-dot-decimal" id="ix_79_fact" name="ifrs-full:TradeAndOtherCurrentPayables" scale="0" unitRef="usd">9,340,571</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c462" decimals="0" format="ixt:num-dot-decimal" id="ix_80_fact" name="ifrs-full:TradeAndOtherCurrentPayables" scale="0" unitRef="usd">1,227,384</ix:nonFraction></td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Financial debt</td>
    <td>&#160;</td>
    <td style="text-align: center">(i)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c461" decimals="0" format="ixt:num-dot-decimal" id="ix_81_fact" name="mlec:FinancialDebts" scale="0" unitRef="usd">2,645,289</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-714">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Fair value through profit or loss</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Simply Agreement for Future Equity (&#8220;SAFE&#8221;)</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-715">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><ix:nonFraction contextRef="c462" decimals="0" format="ixt:num-dot-decimal" name="mlec:SimplyAgreementForFutureEquitySAFE" scale="0" unitRef="usd">2,860,000</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Warrant liabilities</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">(ii)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c461" decimals="0" format="ixt:num-dot-decimal" id="ix_84_fact" name="ifrs-full:WarrantLiability" scale="0" unitRef="usd">887,689</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-716">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total financial liabilities</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c461" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd">12,873,549</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c462" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:FinancialLiabilities" scale="0" unitRef="usd">4,087,384</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net financial asset /(liability)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction contextRef="c461" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssetsLiabilities" scale="0" unitRef="usd">414,459</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction contextRef="c462" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:CurrentAssetsLiabilities" scale="0" sign="-" unitRef="usd">3,003,515</ix:nonFraction></td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table></ix:continuation>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation continuedAt="_DisclosureOfFairValueOfFinancialInstrumentsExplanatory-c0_cont_3" id="_DisclosureOfFairValueOfFinancialInstrumentsExplanatory-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-size: 10pt">(i)</span></td><td style="text-align: justify"><ix:footnote id="ix_17_footnote" xml:lang="en-US">Cash, short-term investments, trade and other receivables, prepayments, trade and other payables, and
loans payable are recorded at carrying value, which approximates fair value due to their short-term nature and generally negligible credit
losses.</ix:footnote></td></tr></table></ix:continuation>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:continuation id="_DisclosureOfFairValueOfFinancialInstrumentsExplanatory-c0_cont_3"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(ii)</span></td><td style="text-align: justify"><ix:footnote id="ix_18_footnote" xml:lang="en-US">Fair value of short-term investment and warrants has been
determined using the quoted market price at the year end (level 1).</ix:footnote></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 140; Value: 1 --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><ix:continuation id="_DisclosureOfFinancialRiskManagementExplanatory-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>e) Interest rate risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group&#8217;s financing
costs may be affected by interest rate volatility. Borrowings under the Group&#8217;s interest rate management policy may be fixed or
floating rate. The Group maintains adequate committed borrowing facilities and holds most of its financial assets primarily in cash or
short-term investments that are readily convertible into known amounts of cash.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group&#8217;s interest
rate risk arises from long-term borrowings. Borrowings issued at floating rates expose the Group to cash flow interest rate risk. Borrowings
issued at fixed rates expose the Group to fair value interest rate risk. <ix:nonNumeric contextRef="c0" continuedAt="mlec_DisclosureOfFixedRateInstruments-c0_cont_1" escape="true" name="mlec:DisclosureOfFixedRateInstruments">The Group has not entered into derivative contracts to hedge
this exposure.</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<ix:continuation id="mlec_DisclosureOfFixedRateInstruments-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Fixed-rate instruments</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Current financial liabilities</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherCurrentFinancialLiabilities" scale="0" unitRef="usd">2,546,243</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-717">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-718">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Non-current financial liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ifrs-full:OtherNoncurrentFinancialLiabilities" scale="0" unitRef="usd">99,046</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-719">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-720">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table></ix:continuation>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Holding all other variables
constant, including levels of our external indebtedness, as of June 30, 2023 a <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="mlec:PercentageOfInterestRates" scale="-2" unitRef="pure">10</ix:nonFraction>% increase/(decrease) in interest rates would increase/(decrease)
interest payable by <ix:nonFraction contextRef="c430" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncreasedecreaseInterestPayable" scale="0" unitRef="usd">11,428</ix:nonFraction>/(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="mlec:IncreasedecreaseInterestPayable" scale="0" sign="-" unitRef="usd">11,428</ix:nonFraction>).</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white">&#160;</p><div>

</div><div><a id="f_036"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="mlec:DisclosureOfCapitalRiskManagementTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 30. Capital risk
management</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company includes
as its capital its share capital and accumulated deficit and has no externally imposed capital requirements. The Company&#8217;s objectives
in managing capital are to safeguard cash as well as maintain financial liquidity and flexibility in order to preserve its ability to
meet financial obligations, deploy capital to develop its mining properties and to maintain investor, creditor and market confidence to
sustain the future development of the business. The Company manages its capital structure and makes adjustments as needed, in order to
have funds available to support its activities. Management reviews its capital management approach on an ongoing basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company&#8217;s financial
strategy is designed to maintain a capital structure consistent with the objective stated above and to respond to business growth opportunities
and changes in economic conditions, In order to maintain or adjust its capital structure, the Company may, from time to time, issue new
shares, acquire or dispose of assets or adjust its capital spending to manage its ability to continue as a going concern. (Note 15).</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>

</div><div><a id="f_037"></a></div><ix:nonNumeric contextRef="c0" escape="true" name="ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 31. Events after
the reporting period</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Management has considered
subsequent events through the date these consolidated financial statements were issued.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As of October 15,
2023, the Company has entered into an agreement to issue a convertible note due 2026 to Grupo Insud (&#8220;Insud&#8221;) in a
principal amount of approximately $<ix:nonFraction contextRef="c463" decimals="-6" format="ixt:num-dot-decimal" name="ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk" scale="6" unitRef="usd">21</ix:nonFraction> million (the &#8220;Insud Convertible Note&#8221;) with a strike price of US $<ix:nonFraction contextRef="c464" decimals="2" format="ixt:num-dot-decimal" name="mlec:StrikePricePerShare" scale="0" unitRef="usdPershares">6.00</ix:nonFraction> per share.
The Insud Convertible Note will be issued against a cash payment of US $<ix:nonFraction contextRef="c464" decimals="-6" format="ixt:num-dot-decimal" name="ifrs-full:CashRepaymentsOfAdvancesAndLoansFromRelatedParties" scale="6" unitRef="usd">10</ix:nonFraction> million and in-kind contributions to be made by Insud to
Moolec Science. In-kind contributions include credits to access Insud&#8217;s state-of-the-art industrial capabilities, operational
services, and the incorporation of joint agreement participation, started with the Company in the past. At maturity, Moolec Science
will hold the option to deliver ordinary shares, cash, or a combination of cash and ordinary shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The agreement signed
with Insud, follows Moolec Science&#8217;s previous announcement that it entered into a Memorandum of Understanding with Bioceres Crop
Solutions &#8220;BIOX&#8221;) that secures the supply of approximately <ix:nonFraction contextRef="c464" decimals="0" format="ixt:num-dot-decimal" name="mlec:NumberOfStockInventories" scale="0" unitRef="pure">15,000</ix:nonFraction> tons of HB4&#174; soybeans (the &#8220;BIOX Supply Agreement&#8221;)
that may be upsized for a similar volume. The BIOX Supply Agreement will be paid through the issuance of a convertible note (the&#160;&#8220;BIOX
Convertible Note&#8217;&#8217;and together with the Insud Convertible Note, the&#160;&#8220;Convertible Notes&#8221;) on arms-length terms to
the Insud Convertible Note.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Together,
the Convertible Notes total approximately US $<ix:nonFraction contextRef="c464" decimals="-6" format="ixt:num-dot-decimal" name="mlec:CashPaidInKindInterest" scale="6" unitRef="usd">30</ix:nonFraction> million of cash and in-kind contributions that include soybean inventories, operational
services, and the acquisition of joint arrangement participation</span>.</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"></p><div>

</div><!-- Field: Page; Sequence: 141; Options: Last --><div>
    </div><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>








</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" id="hidden-fact-0" name="dei:DocumentAccountingStandard">International Financial Reporting Standards</ix:nonNumeric>
<ix:nonFraction contextRef="c3" id="hidden-fact-1" name="ifrs-full:Revenue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-2" name="ifrs-full:Revenue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-3" name="ifrs-full:Revenue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-4" name="ifrs-full:CostOfSales" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-5" name="ifrs-full:CostOfSales" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-6" name="ifrs-full:CostOfSales" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-7" name="ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-8" name="ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-9" name="ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-10" name="ifrs-full:FinanceCosts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-11" name="ifrs-full:FinanceCosts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-12" name="ifrs-full:OtherFinanceIncomeCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-13" name="ifrs-full:OtherFinanceIncomeCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-14" name="mlec:TransactionsExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-15" name="mlec:TransactionsExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-16" name="mlec:TransactionsExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-17" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-18" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-19" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-20" name="ifrs-full:IncomeTaxExpenseContinuingOperations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-21" name="ifrs-full:IncomeTaxExpenseContinuingOperations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-22" name="ifrs-full:IncomeTaxExpenseContinuingOperations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" decimals="2" id="hidden-fact-23" name="ifrs-full:DilutedEarningsLossPerShare" sign="-" unitRef="usdPershares">0.01</ix:nonFraction>
<ix:nonFraction contextRef="c4" decimals="2" id="hidden-fact-24" name="ifrs-full:DilutedEarningsLossPerShare" sign="-" unitRef="usdPershares">0.07</ix:nonFraction>
<ix:nonFraction contextRef="c3" decimals="2" id="hidden-fact-25" name="ifrs-full:DilutedEarningsLossPerShare" sign="-" unitRef="usdPershares">0.15</ix:nonFraction>
<ix:nonFraction contextRef="c0" decimals="2" id="hidden-fact-26" name="ifrs-full:DilutedEarningsLossPerShare" sign="-" unitRef="usdPershares">1.50</ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-27" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-28" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-29" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-30" name="ifrs-full:OtherComprehensiveIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-31" name="ifrs-full:OtherComprehensiveIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-32" name="ifrs-full:OtherComprehensiveIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-33" name="ifrs-full:Goodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-34" name="ifrs-full:RightofuseAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-35" name="ifrs-full:NoncurrentReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-36" name="mlec:ShorttermInvestmentsCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-37" name="ifrs-full:CurrentTradeReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-38" name="ifrs-full:OtherReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-39" name="ifrs-full:Inventories" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-40" name="mlec:ShareToBeIssuedAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-41" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-42" name="ifrs-full:OtherCurrentFinancialLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-43" name="ifrs-full:WarrantLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-44" name="mlec:SimplyAgreementForFutureEquitySAFE" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-45" name="ifrs-full:OtherNoncurrentFinancialLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-46" name="ifrs-full:OtherNoncurrentPayables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-47" name="ifrs-full:DeferredTaxLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-48" name="ifrs-full:NoncurrentLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c7" id="hidden-fact-49" name="ifrs-full:Equity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c8" id="hidden-fact-50" name="ifrs-full:Equity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c9" id="hidden-fact-51" name="ifrs-full:Equity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c10" id="hidden-fact-52" name="ifrs-full:Equity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c11" id="hidden-fact-53" name="ifrs-full:Equity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c12" id="hidden-fact-54" name="ifrs-full:Equity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-55" name="ifrs-full:Equity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-56" name="mlec:IssueOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-57" name="mlec:IssueOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-58" name="mlec:IssueOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-59" name="mlec:IssueOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-60" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c15" id="hidden-fact-61" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c16" id="hidden-fact-62" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-63" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-64" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-65" name="ifrs-full:Equity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-66" name="ifrs-full:Equity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c24" id="hidden-fact-67" name="ifrs-full:Equity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-68" name="mlec:IssueOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-69" name="mlec:IssueOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c31" id="hidden-fact-70" name="mlec:IssueOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c32" id="hidden-fact-71" name="mlec:IssueOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-72" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-73" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-74" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-75" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c31" id="hidden-fact-76" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c34" id="hidden-fact-77" name="ifrs-full:Equity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c36" id="hidden-fact-78" name="ifrs-full:Equity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c37" id="hidden-fact-79" name="ifrs-full:Equity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c40" id="hidden-fact-80" name="mlec:EquitySettledShareBasedPayment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c41" id="hidden-fact-81" name="mlec:EquitySettledShareBasedPayment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c42" id="hidden-fact-82" name="mlec:EquitySettledShareBasedPayment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c43" id="hidden-fact-83" name="mlec:EquitySettledShareBasedPayment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c45" id="hidden-fact-84" name="mlec:EquitySettledShareBasedPayment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c40" id="hidden-fact-85" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c41" id="hidden-fact-86" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c42" id="hidden-fact-87" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c43" id="hidden-fact-88" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c44" id="hidden-fact-89" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c47" id="hidden-fact-90" name="ifrs-full:Equity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c49" id="hidden-fact-91" name="ifrs-full:Equity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c53" id="hidden-fact-92" name="ifrs-full:IssueOfEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c55" id="hidden-fact-93" name="ifrs-full:IssueOfEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c56" id="hidden-fact-94" name="ifrs-full:IssueOfEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c57" id="hidden-fact-95" name="ifrs-full:IssueOfEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c53" id="hidden-fact-96" name="mlec:IssueOfShareCapitalSAFEShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c55" id="hidden-fact-97" name="mlec:IssueOfShareCapitalSAFEShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c56" id="hidden-fact-98" name="mlec:IssueOfShareCapitalSAFEShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c57" id="hidden-fact-99" name="mlec:IssueOfShareCapitalSAFEShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c53" id="hidden-fact-100" name="mlec:IssueOfShareCapitalLightJumpShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c55" id="hidden-fact-101" name="mlec:IssueOfShareCapitalLightJumpShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c56" id="hidden-fact-102" name="mlec:IssueOfShareCapitalLightJumpShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c57" id="hidden-fact-103" name="mlec:IssueOfShareCapitalLightJumpShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c53" id="hidden-fact-104" name="mlec:IssueOfShareCapitalBackstopShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c55" id="hidden-fact-105" name="mlec:IssueOfShareCapitalBackstopShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c56" id="hidden-fact-106" name="mlec:IssueOfShareCapitalBackstopShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c57" id="hidden-fact-107" name="mlec:IssueOfShareCapitalBackstopShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c53" id="hidden-fact-108" name="mlec:IssueOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c55" id="hidden-fact-109" name="mlec:IssueOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c56" id="hidden-fact-110" name="mlec:IssueOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c57" id="hidden-fact-111" name="mlec:IssueOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c55" id="hidden-fact-112" name="mlec:EquitySettledShareBasedPayment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c57" id="hidden-fact-113" name="mlec:EquitySettledShareBasedPayment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c52" id="hidden-fact-114" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c53" id="hidden-fact-115" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c54" id="hidden-fact-116" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c56" id="hidden-fact-117" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c57" id="hidden-fact-118" name="ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c52" id="hidden-fact-119" name="mlec:BusinessCombination" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c55" id="hidden-fact-120" name="mlec:BusinessCombination" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c56" id="hidden-fact-121" name="mlec:BusinessCombination" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c57" id="hidden-fact-122" name="mlec:BusinessCombination" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c52" id="hidden-fact-123" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c53" id="hidden-fact-124" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c54" id="hidden-fact-125" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c55" id="hidden-fact-126" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c56" id="hidden-fact-127" name="ifrs-full:ProfitLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-128" name="ifrs-full:AdjustmentsForIncomeTaxExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-129" name="ifrs-full:AdjustmentsForIncomeTaxExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-130" name="ifrs-full:AdjustmentsForIncomeTaxExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-131" name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-132" name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-133" name="ifrs-full:AdjustmentsForSharebasedPayments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-134" name="ifrs-full:AdjustmentsForSharebasedPayments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-135" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-136" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-137" name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-138" name="ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-139" name="ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-140" name="mlec:ShareBasedPaymentCostOfListingSharesnoncashItem" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-141" name="mlec:ShareBasedPaymentCostOfListingSharesnoncashItem" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-142" name="mlec:ShareBasedPaymentCostOfListingSharesnoncashItem" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-143" name="ifrs-full:FinanceIncomeCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-144" name="ifrs-full:FinanceIncomeCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-145" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-146" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-147" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-148" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-149" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-150" name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-151" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-152" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-153" name="ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-154" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-155" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-156" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-157" name="mlec:OtherLiabilitie" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-158" name="mlec:OtherLiabilitie" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-159" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-160" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-161" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-162" name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-163" name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-164" name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-165" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-166" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-167" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-168" name="ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-169" name="ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-170" name="ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-171" name="ifrs-full:ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-172" name="ifrs-full:ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-173" name="ifrs-full:ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-174" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-175" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-176" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-177" name="ifrs-full:ProceedsFromIssuingOtherEquityInstruments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-178" name="ifrs-full:ProceedsFromIssuingOtherEquityInstruments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-179" name="ifrs-full:ProceedsFromIssuingOtherEquityInstruments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-180" name="mlec:Proceedsfromissuanceofsharecapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-181" name="mlec:Proceedsfromissuanceofsharecapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-182" name="mlec:Proceedsfromissuanceofsharecapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-183" name="ifrs-full:ProceedsFromCurrentBorrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-184" name="ifrs-full:ProceedsFromCurrentBorrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-185" name="ifrs-full:ProceedsFromCurrentBorrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-186" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-187" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-188" name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-189" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-190" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-191" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-192" name="mlec:ProceedsFromSAFE" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-193" name="mlec:ProceedsFromSAFE" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-194" name="mlec:ProceedsFromSAFE" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-195" name="ifrs-full:ProceedsFromIssuingShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-196" name="ifrs-full:ProceedsFromIssuingShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-197" name="ifrs-full:ProceedsFromIssuingShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-198" name="mlec:ProceedsFromIssueOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-199" name="mlec:ProceedsFromIssueOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-200" name="mlec:ProceedsFromIssueOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-201" name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-202" name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-203" name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-204" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-205" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-206" name="ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-207" name="ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-208" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-209" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-210" name="ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-211" name="mlec:IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-212" name="mlec:IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-213" name="mlec:IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-214" name="mlec:ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-215" name="mlec:ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-216" name="mlec:ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-217" name="mlec:CapitalizationOfTransactionExpensesThroughAccountsPayable" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-218" name="mlec:CapitalizationOfTransactionExpensesThroughAccountsPayable" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-219" name="mlec:CapitalizationOfTransactionExpensesThroughAccountsPayable" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-220" name="mlec:NetLiabilitiesAcquiredThroughIssuanceOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-221" name="mlec:NetLiabilitiesAcquiredThroughIssuanceOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-222" name="mlec:NetLiabilitiesAcquiredThroughIssuanceOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-223" name="mlec:AcquisitionOfBusinessCombinationTroughDeferredPayment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-224" name="mlec:AcquisitionOfBusinessCombinationTroughDeferredPayment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-225" name="mlec:AcquisitionOfBusinessCombinationTroughDeferredPayment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-226" name="mlec:AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-227" name="mlec:AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-228" name="mlec:AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-229" name="mlec:AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-230" name="mlec:AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:footnote id="ix_0_footnote" xml:lang="en-US">The goodwill is attributable to the expected future synergies from combining operations as well as an assembled workforce, which does not qualify for separate recognition. The Company expects that the ValoraSoy Acquisition will help to accelerate its growth in the food ingredients industry by expanding its commercial network with a top-notch sales team and complementing its Molecular Farming Platform with industrial capacity and downstream operations, in addition to adding a highly experienced team of professionals. It will not be deductible for tax purposes.</ix:footnote><!--Text not found in footnote sections assigned to Schedule of Assets and Liabilities Recognised-->
<ix:nonNumeric contextRef="c73" id="hidden-fact-231" name="mlec:Accumulated">P3Y</ix:nonNumeric>
<ix:nonFraction contextRef="c95" id="hidden-fact-232" name="mlec:Cost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c96" id="hidden-fact-233" name="mlec:Cost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c97" id="hidden-fact-234" name="mlec:Cost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c98" id="hidden-fact-235" name="mlec:Cost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c99" id="hidden-fact-236" name="mlec:Cost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c95" id="hidden-fact-237" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c96" id="hidden-fact-238" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c97" id="hidden-fact-239" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c98" id="hidden-fact-240" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c99" id="hidden-fact-241" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c100" id="hidden-fact-242" name="mlec:NetBookAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c101" id="hidden-fact-243" name="mlec:NetBookAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c102" id="hidden-fact-244" name="mlec:NetBookAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c103" id="hidden-fact-245" name="mlec:NetBookAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-246" name="mlec:NetBookAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c104" id="hidden-fact-247" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c105" id="hidden-fact-248" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c106" id="hidden-fact-249" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c107" id="hidden-fact-250" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c108" id="hidden-fact-251" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c111" id="hidden-fact-252" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c112" id="hidden-fact-253" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c116" id="hidden-fact-254" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c117" id="hidden-fact-255" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c111" id="hidden-fact-256" name="mlec:Cost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c112" id="hidden-fact-257" name="mlec:Cost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c109" id="hidden-fact-258" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c110" id="hidden-fact-259" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c111" id="hidden-fact-260" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c112" id="hidden-fact-261" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c113" id="hidden-fact-262" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c116" id="hidden-fact-263" name="mlec:NetBookAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c117" id="hidden-fact-264" name="mlec:NetBookAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c116" id="hidden-fact-265" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c117" id="hidden-fact-266" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c120" id="hidden-fact-267" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c121" id="hidden-fact-268" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c124" id="hidden-fact-269" name="mlec:Cost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c125" id="hidden-fact-270" name="mlec:Cost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c122" id="hidden-fact-271" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c123" id="hidden-fact-272" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c124" id="hidden-fact-273" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c125" id="hidden-fact-274" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-275" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c120" id="hidden-fact-276" name="mlec:NetBookAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c121" id="hidden-fact-277" name="mlec:NetBookAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c120" id="hidden-fact-278" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c121" id="hidden-fact-279" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c128" id="hidden-fact-280" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c129" id="hidden-fact-281" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c126" id="hidden-fact-282" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c127" id="hidden-fact-283" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c126" id="hidden-fact-284" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c127" id="hidden-fact-285" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c126" id="hidden-fact-286" name="mlec:Amortization" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c127" id="hidden-fact-287" name="mlec:Amortization" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c126" id="hidden-fact-288" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c127" id="hidden-fact-289" name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c134" id="hidden-fact-290" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c135" id="hidden-fact-291" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c136" id="hidden-fact-292" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c137" id="hidden-fact-293" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c138" id="hidden-fact-294" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c139" id="hidden-fact-295" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c140" id="hidden-fact-296" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c141" id="hidden-fact-297" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c142" id="hidden-fact-298" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c143" id="hidden-fact-299" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c144" id="hidden-fact-300" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c145" id="hidden-fact-301" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c146" id="hidden-fact-302" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c147" id="hidden-fact-303" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c148" id="hidden-fact-304" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c149" id="hidden-fact-305" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c150" id="hidden-fact-306" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c151" id="hidden-fact-307" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c152" id="hidden-fact-308" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c153" id="hidden-fact-309" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c154" id="hidden-fact-310" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c155" id="hidden-fact-311" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c156" id="hidden-fact-312" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c157" id="hidden-fact-313" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c158" id="hidden-fact-314" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c159" id="hidden-fact-315" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c160" id="hidden-fact-316" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c108" id="hidden-fact-317" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c162" id="hidden-fact-318" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c163" id="hidden-fact-319" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c164" id="hidden-fact-320" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c165" id="hidden-fact-321" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c166" id="hidden-fact-322" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c168" id="hidden-fact-323" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c169" id="hidden-fact-324" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c170" id="hidden-fact-325" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c171" id="hidden-fact-326" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c172" id="hidden-fact-327" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c174" id="hidden-fact-328" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c175" id="hidden-fact-329" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c176" id="hidden-fact-330" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c177" id="hidden-fact-331" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c178" id="hidden-fact-332" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c180" id="hidden-fact-333" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c181" id="hidden-fact-334" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c182" id="hidden-fact-335" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c183" id="hidden-fact-336" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c184" id="hidden-fact-337" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c185" id="hidden-fact-338" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c186" id="hidden-fact-339" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c188" id="hidden-fact-340" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c189" id="hidden-fact-341" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c190" id="hidden-fact-342" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c191" id="hidden-fact-343" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c192" id="hidden-fact-344" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c168" id="hidden-fact-345" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c169" id="hidden-fact-346" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c170" id="hidden-fact-347" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c171" id="hidden-fact-348" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c172" id="hidden-fact-349" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c195" id="hidden-fact-350" name="ifrs-full:DepreciationPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c196" id="hidden-fact-351" name="ifrs-full:DepreciationPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c197" id="hidden-fact-352" name="ifrs-full:DepreciationPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c198" id="hidden-fact-353" name="ifrs-full:DepreciationPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c199" id="hidden-fact-354" name="ifrs-full:DepreciationPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c201" id="hidden-fact-355" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c202" id="hidden-fact-356" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c203" id="hidden-fact-357" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c204" id="hidden-fact-358" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c205" id="hidden-fact-359" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c207" id="hidden-fact-360" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c208" id="hidden-fact-361" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c209" id="hidden-fact-362" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c210" id="hidden-fact-363" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c211" id="hidden-fact-364" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c214" id="hidden-fact-365" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c215" id="hidden-fact-366" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c216" id="hidden-fact-367" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c217" id="hidden-fact-368" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c218" id="hidden-fact-369" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c221" id="hidden-fact-370" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c222" id="hidden-fact-371" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c223" id="hidden-fact-372" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c224" id="hidden-fact-373" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c225" id="hidden-fact-374" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c201" id="hidden-fact-375" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c202" id="hidden-fact-376" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c203" id="hidden-fact-377" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c204" id="hidden-fact-378" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c205" id="hidden-fact-379" name="ifrs-full:PropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c227" id="hidden-fact-380" name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c227" id="hidden-fact-381" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c227" id="hidden-fact-382" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c82" id="hidden-fact-383" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c83" id="hidden-fact-384" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c229" id="hidden-fact-385" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-386" name="ifrs-full:Goodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-387" name="mlec:TotalGoodwill" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-388" name="ifrs-full:RightofuseAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-389" name="mlec:MutualFunds" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-390" name="mlec:TotalMutualFunds" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-391" name="ifrs-full:TradeReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-392" name="ifrs-full:TradeAndOtherReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-393" name="ifrs-full:CurrentValueAddedTaxReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-394" name="ifrs-full:OtherCurrentReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-395" name="ifrs-full:TradeAndOtherCurrentReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-396" name="ifrs-full:RawMaterials" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-397" name="ifrs-full:FinishedGoods" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-398" name="ifrs-full:InventoriesTotal" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-399" name="ifrs-full:NumberOfSharesIssued" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-400" name="mlec:SharesIssuedAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-401" name="mlec:ShareToBeIssuedAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-402" name="ifrs-full:SharePremium" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-403" name="mlec:SharesToBeIssuedAmountIssueOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-404" name="mlec:ShareToBeIssuedAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-405" name="mlec:SharesToBeIssuedAmountIssueOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-406" name="mlec:ShareToBeIssuedAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-407" name="mlec:NumberOfSharesIssueOfShareCapitalinShares" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-408" name="ifrs-full:PaymentsForShareIssueCosts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-409" name="mlec:SharesToBeIssuedAmountIssueOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-410" name="mlec:SharePremiumIssueOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-411" name="mlec:ShareToBeIssuedAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c261" id="hidden-fact-412" name="mlec:SharesToBeIssuedAmountIssueOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c262" decimals="INF" id="hidden-fact-413" name="mlec:NumberOfSharesIssueOfShareCapitalinShares" unitRef="shares">262260</ix:nonFraction>
<ix:nonFraction contextRef="c263" id="hidden-fact-414" name="mlec:SharesToBeIssuedAmountIssueOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c265" id="hidden-fact-415" name="mlec:SharesToBeIssuedAmountIssueOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c267" id="hidden-fact-416" name="mlec:SharesToBeIssuedAmountIssueOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-417" name="mlec:SharesToBeIssuedAmountIssueOfShareCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-418" name="mlec:NumberOfSharesFromBusinessAcquisition" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-419" name="mlec:SharesIssuedAmountFromBusinessAcquisition" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c271" id="hidden-fact-420" name="mlec:ExercisePrice">$1.52</ix:nonNumeric>
<ix:nonNumeric contextRef="c272" id="hidden-fact-421" name="mlec:ExercisePrice">$8.00</ix:nonNumeric>
<ix:nonNumeric contextRef="c273" id="hidden-fact-422" name="mlec:ExercisePrice">$4.25</ix:nonNumeric>
<ix:nonFraction contextRef="c271" id="hidden-fact-423" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c272" id="hidden-fact-424" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c273" id="hidden-fact-425" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c271" id="hidden-fact-426" name="mlec:NumberOfOptionsAtTheBeginning" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c271" id="hidden-fact-427" name="mlec:ExercisePriceAtTheBeginning" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c272" id="hidden-fact-428" name="mlec:NumberOfOptionsAtTheBeginning" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c272" id="hidden-fact-429" name="mlec:ExercisePriceAtTheBeginning" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c273" id="hidden-fact-430" name="mlec:NumberOfOptionsAtTheBeginning" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c273" id="hidden-fact-431" name="mlec:ExercisePriceAtTheBeginning" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c271" id="hidden-fact-432" name="mlec:NumberOfOptionsForfeitedDuringThePeriod" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c271" id="hidden-fact-433" name="mlec:ExercisePriceForfeitedDuringThePeriod" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c272" id="hidden-fact-434" name="mlec:NumberOfOptionsForfeitedDuringThePeriod" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c272" id="hidden-fact-435" name="mlec:ExercisePriceForfeitedDuringThePeriod" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c273" id="hidden-fact-436" name="mlec:NumberOfOptionsForfeitedDuringThePeriod" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c273" id="hidden-fact-437" name="mlec:ExercisePriceForfeitedDuringThePeriod" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c273" id="hidden-fact-438" name="mlec:NumberOfOptionsExercisedDuringThePeriod" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c273" id="hidden-fact-439" name="mlec:ExercisePriceExercisedDuringThePeriod" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c271" id="hidden-fact-440" name="mlec:NumberOfOptionsExpiredDuringThePeriod" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c271" id="hidden-fact-441" name="mlec:ExercisePriceExpiredDuringThePeriod" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c272" id="hidden-fact-442" name="mlec:NumberOfOptionsExpiredDuringThePeriod" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c272" id="hidden-fact-443" name="mlec:ExercisePriceExpiredDuringThePeriod" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c273" id="hidden-fact-444" name="mlec:NumberOfOptionsExpiredDuringThePeriod" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c273" id="hidden-fact-445" name="mlec:ExercisePriceExpiredDuringThePeriod" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-446" name="ifrs-full:NoncurrentPayablesToRelatedParties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-447" name="mlec:DeferredPaymentRelatedToBusinessCombination" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-448" name="mlec:Wages" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-449" name="mlec:Taxes" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-450" name="ifrs-full:OtherCurrentNonfinancialLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-451" name="ifrs-full:OtherNoncurrentNonfinancialLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-452" name="ifrs-full:OtherNoncurrentLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c275" id="hidden-fact-453" name="ifrs-full:CurrentFinancialAssetsAtAmortisedCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c277" id="hidden-fact-454" name="ifrs-full:CurrentFinancialAssetsAtAmortisedCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-455" name="ifrs-full:CurrentFinancialAssetsAtAmortisedCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c275" id="hidden-fact-456" name="ifrs-full:NoncurrentFinancialAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-457" name="ifrs-full:NoncurrentFinancialAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c281" id="hidden-fact-458" name="ifrs-full:Borrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c285" id="hidden-fact-459" name="ifrs-full:Borrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c289" id="hidden-fact-460" name="ifrs-full:Borrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c293" id="hidden-fact-461" name="ifrs-full:Borrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c297" id="hidden-fact-462" name="ifrs-full:Borrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c301" id="hidden-fact-463" name="ifrs-full:Borrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c305" id="hidden-fact-464" name="ifrs-full:Borrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c309" id="hidden-fact-465" name="ifrs-full:Borrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c313" id="hidden-fact-466" name="ifrs-full:Borrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c317" id="hidden-fact-467" name="ifrs-full:Borrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c321" id="hidden-fact-468" name="ifrs-full:Borrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c325" id="hidden-fact-469" name="ifrs-full:Borrowings" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c326" id="hidden-fact-470" name="mlec:WarrantAndRightsOutstanding" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-471" name="mlec:FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-472" name="mlec:FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c108" id="hidden-fact-473" name="mlec:FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-474" name="mlec:Additions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-475" name="mlec:Additions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c108" id="hidden-fact-476" name="mlec:Additions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-477" name="ifrs-full:FinancialLiabilitiesAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c108" id="hidden-fact-478" name="ifrs-full:FinancialLiabilitiesAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-479" name="mlec:SAFECapitalization" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-480" name="mlec:SAFECapitalization" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c108" id="hidden-fact-481" name="mlec:SAFECapitalization" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-482" name="mlec:ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-483" name="mlec:ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c108" id="hidden-fact-484" name="mlec:ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-485" name="ifrs-full:DeferredTaxLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-486" name="ifrs-full:DeferredTaxLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c108" id="hidden-fact-487" name="ifrs-full:DeferredTaxLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c335" id="hidden-fact-488" name="ifrs-full:DeferredTaxLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-489" name="mlec:IncorporatedThroughTheBusinessCombination" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c113" id="hidden-fact-490" name="mlec:IncorporatedThroughTheBusinessCombination" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c336" id="hidden-fact-491" name="mlec:IncorporatedThroughTheBusinessCombination" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-492" name="mlec:DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c113" id="hidden-fact-493" name="mlec:DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c336" id="hidden-fact-494" name="mlec:DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-495" name="mlec:ChargedToOtherComprehensiveIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c113" id="hidden-fact-496" name="mlec:ChargedToOtherComprehensiveIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c336" id="hidden-fact-497" name="mlec:ChargedToOtherComprehensiveIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-498" name="ifrs-full:DeferredTaxLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-499" name="ifrs-full:DeferredTaxLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c108" id="hidden-fact-500" name="ifrs-full:DeferredTaxLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c339" id="hidden-fact-501" name="mlec:TaxJurisdiction" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c340" id="hidden-fact-502" name="mlec:TaxJurisdiction" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c341" id="hidden-fact-503" name="mlec:TaxJurisdiction" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c342" id="hidden-fact-504" name="mlec:TaxJurisdiction" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c343" id="hidden-fact-505" name="mlec:TaxJurisdiction" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c344" id="hidden-fact-506" name="mlec:TaxJurisdiction" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-507" name="mlec:EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-508" name="mlec:EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c353" id="hidden-fact-509" name="mlec:EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-510" name="mlec:NondeductibleExpensesListingCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-511" name="mlec:NondeductibleExpensesListingCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c353" id="hidden-fact-512" name="mlec:NondeductibleExpensesListingCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-513" name="mlec:NetGainOnInflationEffectOnMonetaryItems" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-514" name="mlec:NetGainOnInflationEffectOnMonetaryItems" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c353" id="hidden-fact-515" name="mlec:NetGainOnInflationEffectOnMonetaryItems" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-516" name="mlec:IncomeTaxInflationAdjustment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-517" name="mlec:IncomeTaxInflationAdjustment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c353" id="hidden-fact-518" name="mlec:IncomeTaxInflationAdjustment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c354" id="hidden-fact-519" name="mlec:Others" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c355" id="hidden-fact-520" name="mlec:Others" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c356" id="hidden-fact-521" name="mlec:Others" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-522" name="mlec:TaxBenefitForTheYear" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-523" name="mlec:TaxBenefitForTheYear" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c353" id="hidden-fact-524" name="mlec:TaxBenefitForTheYear" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c358" id="hidden-fact-525" name="ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c358" id="hidden-fact-526" name="ifrs-full:TradeAndOtherCurrentReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c358" id="hidden-fact-527" name="mlec:CustomerRelationship" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c358" id="hidden-fact-528" name="ifrs-full:DeferredTaxLiabilityAsset" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c358" id="hidden-fact-529" name="ifrs-full:NetDeferredTaxLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-530" name="mlec:InterestExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-531" name="mlec:InterestExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-532" name="mlec:TotalFinancialCosts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-533" name="mlec:TotalFinancialCosts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-534" name="mlec:ExchangeRateDifference" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-535" name="mlec:ExchangeRateDifference" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-536" name="mlec:ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-537" name="mlec:ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-538" name="mlec:InvestmentGainRelatedToMoneyMarketFunds" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-539" name="mlec:InvestmentGainRelatedToMoneyMarketFunds" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-540" name="mlec:InvestmentGainRelatedToMoneyMarketFunds" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-541" name="mlec:ChangeInWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-542" name="mlec:ChangeInWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-543" name="mlec:ChangeInWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-544" name="ifrs-full:LoansAndReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-545" name="ifrs-full:LoansAndReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-546" name="ifrs-full:LoansAndReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-547" name="mlec:InflationAdjustment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-548" name="mlec:InflationAdjustment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-549" name="mlec:InflationAdjustment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-550" name="mlec:OtherFinancialResults" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-551" name="mlec:OtherFinancialResults" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-552" name="mlec:OtherFinancialResults" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-553" name="mlec:TotalOtherFinancialResults" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-554" name="mlec:TotalOtherFinancialResults" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-555" name="mlec:NetFinancialIncomeExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-556" name="mlec:NetFinancialIncomeExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-557" name="mlec:TaxesDutiesAndPenalties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-558" name="mlec:TaxesDutiesAndPenalties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-559" name="mlec:TaxesDutiesAndPenalties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-560" name="ifrs-full:EmployeeBenefitsExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-561" name="ifrs-full:EmployeeBenefitsExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-562" name="mlec:PayrollExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-563" name="ifrs-full:InsuranceExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-564" name="ifrs-full:InsuranceExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-565" name="ifrs-full:InsuranceExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-566" name="ifrs-full:TravelExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-567" name="mlec:AmortizationExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-568" name="mlec:AmortizationExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-569" name="mlec:AmortizationExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-570" name="ifrs-full:DepreciationExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-571" name="ifrs-full:DepreciationExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-572" name="ifrs-full:DepreciationExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-573" name="ifrs-full:ProfessionalFeesExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-574" name="mlec:LaboratoriesRelatedExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-575" name="ifrs-full:AmortisationExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-576" name="ifrs-full:AmortisationExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-577" name="mlec:OtherResearchAndDevelopmentExpenses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-578" name="ifrs-full:Inventories" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-579" name="ifrs-full:Inventories" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-580" name="ifrs-full:Inventories" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-581" name="ifrs-full:Inventories" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-582" name="mlec:InventoriesIncorporatedThroughTheBusinessCombination" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-583" name="mlec:InventoriesIncorporatedThroughTheBusinessCombination" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-584" name="mlec:InventoriesIncorporatedThroughTheBusinessCombination" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-585" name="ifrs-full:PurchasesFairValueMeasurementAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-586" name="ifrs-full:PurchasesFairValueMeasurementAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-587" name="ifrs-full:PurchasesFairValueMeasurementAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-588" name="mlec:PayrollAndAndProfessionalFees" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-589" name="mlec:PayrollAndAndProfessionalFees" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-590" name="mlec:PayrollAndAndProfessionalFees" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-591" name="ifrs-full:RepairsAndMaintenanceExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-592" name="ifrs-full:RepairsAndMaintenanceExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-593" name="ifrs-full:RepairsAndMaintenanceExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-594" name="ifrs-full:DepreciationAndAmortisationExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-595" name="ifrs-full:DepreciationAndAmortisationExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-596" name="ifrs-full:DepreciationAndAmortisationExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-597" name="mlec:OtherProductionCosts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-598" name="mlec:OtherProductionCosts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-599" name="mlec:OtherProductionCosts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-600" name="ifrs-full:RawMaterialsAndConsumablesUsed" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-601" name="ifrs-full:RawMaterialsAndConsumablesUsed" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-602" name="ifrs-full:RawMaterialsAndConsumablesUsed" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-603" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-604" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-605" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-606" name="mlec:TotalOtherProductionCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-607" name="mlec:TotalOtherProductionCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-608" name="mlec:TotalOtherProductionCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-609" name="ifrs-full:Inventories" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-610" name="ifrs-full:Inventories" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-611" name="ifrs-full:Inventories" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-612" name="ifrs-full:CostOfSales" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-613" name="ifrs-full:CostOfSales" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-614" name="ifrs-full:CostOfSales" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" decimals="2" id="hidden-fact-615" name="ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations" sign="-" unitRef="usdPershares">0.01</ix:nonFraction>
<ix:nonFraction contextRef="c4" decimals="2" id="hidden-fact-616" name="ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations" sign="-" unitRef="usdPershares">0.07</ix:nonFraction>
<ix:nonFraction contextRef="c3" decimals="2" id="hidden-fact-617" name="ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations" sign="-" unitRef="usdPershares">0.15</ix:nonFraction>
<ix:nonFraction contextRef="c0" decimals="2" id="hidden-fact-618" name="ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations" sign="-" unitRef="usdPershares">1.50</ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-619" name="ifrs-full:ShorttermEmployeeBenefitsAccruals" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-620" name="ifrs-full:ShorttermEmployeeBenefitsAccruals" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-621" name="ifrs-full:KeyManagementPersonnelCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-622" name="ifrs-full:KeyManagementPersonnelCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-623" name="mlec:CFOSharesAlloted" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-624" name="mlec:CFOSharesAlloted" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-625" name="mlec:CFOSharesAlloted" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-626" name="mlec:IssueOfSharesCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-627" name="mlec:IssueOfSharesCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-628" name="mlec:IssueOfSharesCapital" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-629" name="mlec:IssueOfSharePremium" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-630" name="mlec:IssueOfSharePremium" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-631" name="mlec:IssueOfSharePremium" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c364" id="hidden-fact-632" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c365" id="hidden-fact-633" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c367" id="hidden-fact-634" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c368" id="hidden-fact-635" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c369" id="hidden-fact-636" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c370" id="hidden-fact-637" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c372" id="hidden-fact-638" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c373" id="hidden-fact-639" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c374" id="hidden-fact-640" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c376" id="hidden-fact-641" name="ifrs-full:CashEquivalents" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c377" id="hidden-fact-642" name="ifrs-full:CashEquivalents" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c378" id="hidden-fact-643" name="ifrs-full:CashEquivalents" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c380" id="hidden-fact-644" name="ifrs-full:CashEquivalents" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c381" id="hidden-fact-645" name="ifrs-full:CashEquivalents" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c384" id="hidden-fact-646" name="mlec:ExpensesPaid" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c402" id="hidden-fact-647" name="mlec:ServicesProvidedByOtherCompanies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c403" id="hidden-fact-648" name="mlec:ServicesProvidedByOtherCompanies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c409" id="hidden-fact-649" name="mlec:ServicesProvidedByOtherCompanies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c410" id="hidden-fact-650" name="mlec:ServicesProvidedByOtherCompanies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c411" id="hidden-fact-651" name="mlec:ServicesProvidedByOtherCompanies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c412" id="hidden-fact-652" name="mlec:ServicesProvidedByOtherCompanies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c414" id="hidden-fact-653" name="mlec:ServicesProvidedByOtherCompanies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c415" id="hidden-fact-654" name="mlec:ServicesProvidedByOtherCompanies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c419" id="hidden-fact-655" name="mlec:SubsidiaryPercentage" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c421" id="hidden-fact-656" name="mlec:OtherRelatedPartyBalances" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c423" id="hidden-fact-657" name="mlec:OtherRelatedPartyBalances" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c425" id="hidden-fact-658" name="mlec:OtherRelatedPartyBalances" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c427" id="hidden-fact-659" name="mlec:OtherRelatedPartyBalances" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c432" id="hidden-fact-660" name="ifrs-full:TradeAndOtherReceivables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c434" id="hidden-fact-661" name="ifrs-full:NoncurrentPayables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c435" id="hidden-fact-662" name="ifrs-full:NoncurrentPayables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c436" id="hidden-fact-663" name="ifrs-full:NoncurrentPayables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c437" id="hidden-fact-664" name="ifrs-full:NoncurrentPayables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c435" id="hidden-fact-665" name="ifrs-full:OtherLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c436" id="hidden-fact-666" name="ifrs-full:OtherLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c436" id="hidden-fact-667" name="ifrs-full:FinancialLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c437" id="hidden-fact-668" name="ifrs-full:FinancialLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c436" id="hidden-fact-669" name="mlec:SubtotalNonDerivatesLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c437" id="hidden-fact-670" name="mlec:SubtotalNonDerivatesLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c434" id="hidden-fact-671" name="ifrs-full:WarrantLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c435" id="hidden-fact-672" name="ifrs-full:WarrantLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c436" id="hidden-fact-673" name="ifrs-full:WarrantLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c437" id="hidden-fact-674" name="ifrs-full:WarrantLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c434" id="hidden-fact-675" name="mlec:SubtotalDerivatesLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c435" id="hidden-fact-676" name="mlec:SubtotalDerivatesLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c436" id="hidden-fact-677" name="mlec:SubtotalDerivatesLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c437" id="hidden-fact-678" name="mlec:SubtotalDerivatesLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c436" id="hidden-fact-679" name="mlec:TotalLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c437" id="hidden-fact-680" name="mlec:TotalLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c439" id="hidden-fact-681" name="ifrs-full:NoncurrentPayables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c440" id="hidden-fact-682" name="ifrs-full:NoncurrentPayables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c441" id="hidden-fact-683" name="ifrs-full:NoncurrentPayables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c442" id="hidden-fact-684" name="ifrs-full:NoncurrentPayables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c439" id="hidden-fact-685" name="ifrs-full:OtherLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c440" id="hidden-fact-686" name="ifrs-full:OtherLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c441" id="hidden-fact-687" name="ifrs-full:OtherLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c442" id="hidden-fact-688" name="ifrs-full:OtherLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c439" id="hidden-fact-689" name="mlec:SimplyAgreementForFutureEquitySAFE" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c440" id="hidden-fact-690" name="mlec:SimplyAgreementForFutureEquitySAFE" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c441" id="hidden-fact-691" name="mlec:SimplyAgreementForFutureEquitySAFE" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c442" id="hidden-fact-692" name="mlec:SimplyAgreementForFutureEquitySAFE" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c439" id="hidden-fact-693" name="mlec:SubtotalNonDerivatesLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c440" id="hidden-fact-694" name="mlec:SubtotalNonDerivatesLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c441" id="hidden-fact-695" name="mlec:SubtotalNonDerivatesLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c442" id="hidden-fact-696" name="mlec:SubtotalNonDerivatesLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c439" id="hidden-fact-697" name="mlec:TotalLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c440" id="hidden-fact-698" name="mlec:TotalLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c441" id="hidden-fact-699" name="mlec:TotalLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c444" id="hidden-fact-700" name="mlec:ForeignCurrencyExchangeRiskAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c444" id="hidden-fact-701" name="mlec:ForeignCurrencyExchangeRiskLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c446" id="hidden-fact-702" name="mlec:ForeignCurrencyExchangeRiskAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c446" id="hidden-fact-703" name="mlec:ForeignCurrencyExchangeRiskLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c447" id="hidden-fact-704" name="mlec:ForeignCurrencyExchangeRiskLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c448" id="hidden-fact-705" name="mlec:ForeignCurrencyExchangeRiskLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c450" id="hidden-fact-706" name="mlec:ForeignCurrencyExchangeRiskAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c452" id="hidden-fact-707" name="mlec:ForeignCurrencyExchangeRiskLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c454" id="hidden-fact-708" name="mlec:ForeignCurrencyExchangeRiskAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c456" id="hidden-fact-709" name="mlec:ForeignCurrencyExchangeRiskLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c459" id="hidden-fact-710" name="mlec:ForeignCurrencyExchangeRiskLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c460" id="hidden-fact-711" name="mlec:ForeignCurrencyExchangeRiskLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c462" id="hidden-fact-712" name="ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c462" id="hidden-fact-713" name="mlec:ShorttermInvestmentsCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c462" id="hidden-fact-714" name="mlec:FinancialDebts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c461" id="hidden-fact-715" name="mlec:SimplyAgreementForFutureEquitySAFE" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c462" id="hidden-fact-716" name="ifrs-full:WarrantLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-717" name="ifrs-full:OtherCurrentFinancialLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-718" name="ifrs-full:OtherCurrentFinancialLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-719" name="ifrs-full:OtherNoncurrentFinancialLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-720" name="ifrs-full:OtherNoncurrentFinancialLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey">0001937737</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="mlec-20230630.xsd" xlink:type="simple"></link:schemaRef></ix:references>
<ix:resources><ix:relationship fromRefs="ix_0_fact" toRefs="ix_0_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_1_fact ix_2_fact ix_3_fact" toRefs="ix_1_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_4_fact ix_5_fact ix_6_fact" toRefs="ix_2_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_7_fact ix_8_fact ix_9_fact" toRefs="ix_3_footnote"></ix:relationship>
<ix:relationship fromRefs="hidden-fact-286 hidden-fact-287 ix_10_fact ix_11_fact ix_12_fact" toRefs="ix_4_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_13_fact hidden-fact-350 hidden-fact-351 hidden-fact-352 hidden-fact-353 hidden-fact-354 ix_14_fact ix_15_fact ix_16_fact ix_17_fact ix_18_fact ix_19_fact ix_20_fact ix_21_fact" toRefs="ix_5_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_22_fact" toRefs="ix_6_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_23_fact ix_24_fact ix_25_fact ix_26_fact ix_27_fact ix_28_fact ix_29_fact ix_30_fact ix_31_fact ix_32_fact ix_33_fact ix_34_fact ix_35_fact ix_36_fact ix_37_fact ix_38_fact ix_39_fact ix_40_fact ix_41_fact ix_42_fact" toRefs="ix_7_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_43_fact ix_44_fact hidden-fact-477 hidden-fact-478" toRefs="ix_8_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_45_fact ix_46_fact ix_47_fact ix_48_fact" toRefs="ix_9_footnote"></ix:relationship>
<ix:relationship fromRefs="hidden-fact-646 ix_49_fact ix_50_fact ix_51_fact ix_52_fact ix_53_fact ix_54_fact ix_55_fact ix_56_fact" toRefs="ix_10_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_57_fact ix_58_fact ix_59_fact ix_60_fact ix_61_fact" toRefs="ix_11_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_62_fact ix_63_fact ix_64_fact ix_65_fact ix_66_fact" toRefs="ix_12_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_67_fact ix_68_fact hidden-fact-647 hidden-fact-648" toRefs="ix_13_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_69_fact ix_70_fact ix_71_fact ix_72_fact" toRefs="ix_14_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_73_fact hidden-fact-623 hidden-fact-624 hidden-fact-625" toRefs="ix_15_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_74_fact hidden-fact-649 hidden-fact-650 hidden-fact-651" toRefs="ix_16_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_75_fact ix_76_fact ix_77_fact ix_78_fact ix_79_fact ix_80_fact ix_81_fact hidden-fact-714" toRefs="ix_17_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_82_fact hidden-fact-712 ix_83_fact hidden-fact-713 ix_84_fact hidden-fact-716" toRefs="ix_18_footnote"></ix:relationship>
<xbrli:context id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-08-21</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-08-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-08-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-08-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:CumulativeTranslationAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-08-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:EquitySettledShareBasedPaymentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-08-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-08-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-08-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-08-21</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-08-21</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-08-21</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:CumulativeTranslationAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-08-21</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:EquitySettledShareBasedPaymentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-08-21</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-08-21</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:CumulativeTranslationAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:EquitySettledShareBasedPaymentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:CumulativeTranslationAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:EquitySettledShareBasedPaymentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c35">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:CumulativeTranslationAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:EquitySettledShareBasedPaymentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c40">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c41">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c42">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c43">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:CumulativeTranslationAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c44">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:EquitySettledShareBasedPaymentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c45">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c46">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c47">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c48">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c49">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:CumulativeTranslationAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c50">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:EquitySettledShareBasedPaymentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c51">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c52">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c53">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c54">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c55">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:CumulativeTranslationAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c56">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:EquitySettledShareBasedPaymentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c57">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c58">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c59">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c60">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c61">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:CumulativeTranslationAdjustmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c62">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:EquitySettledShareBasedPaymentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c63">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c64">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:MoolecSAFEMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c65">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:MoolecSAFEMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c66">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-12-27</xbrli:startDate>
    <xbrli:endDate>2022-12-27</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c67">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-27</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c68">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:UGVLAndTheoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c69">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-04-24</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c70">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-04-24</xbrli:startDate>
    <xbrli:endDate>2023-04-24</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c71">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c72">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c73">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2018-06-30</xbrli:startDate>
    <xbrli:endDate>2018-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c74">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-06-30</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c75">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-04-30</xbrli:startDate>
    <xbrli:endDate>2023-04-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c76">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c77">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c78">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c79">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c80">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c81">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c82">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c83">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c84">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c85">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c86">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:MoolecScienceLimitedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c87">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:LightJumpAcquisitionCorporationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c88">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ValoraSoySAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c89">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:AGBiomoleculesLLCDEMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c90">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:MicrooFoodsIngredientsSLMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c91">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:LuxMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c92">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">country:GB</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c93">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">country:GB</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c94">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">country:AR</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c95">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-12-31</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c96">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SPCTechnologyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-12-31</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c97">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:CustomerRelationshipMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-12-31</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c98">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SoftwareLicenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-12-31</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c99">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-12-31</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c100">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c101">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SPCTechnologyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c102">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:CustomerRelationshipMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c103">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SoftwareLicenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c104">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c105">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SPCTechnologyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c106">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:CustomerRelationshipMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c107">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SoftwareLicenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c108">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c109">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-07-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c110">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SPCTechnologyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-07-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c111">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:CustomerRelationshipMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-07-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c112">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SoftwareLicenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-07-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c113">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-07-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c114">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c115">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SPCTechnologyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c116">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:CustomerRelationshipMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c117">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SoftwareLicenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c118">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c119">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SPCTechnologyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c120">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:CustomerRelationshipMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c121">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SoftwareLicenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c122">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c123">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SPCTechnologyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c124">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:CustomerRelationshipMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c125">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SoftwareLicenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c126">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c127">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SPCTechnologyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c128">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:CustomerRelationshipMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c129">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SoftwareLicenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c130">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c131">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SPCTechnologyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c132">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:CustomerRelationshipMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c133">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SoftwareLicenseMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c134">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c135">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c136">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c137">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c138">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c139">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c140">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c141">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c142">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c143">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c144">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c145">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c146">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c147">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c148">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c149">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c150">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c151">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c152">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c153">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c154">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c155">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c156">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c157">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c158">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c159">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c160">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c161">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-07-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c162">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-07-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c163">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-07-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c164">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-07-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c165">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-07-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c166">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-07-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c167">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c168">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c169">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c170">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c171">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c172">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c173">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c174">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c175">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c176">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c177">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c178">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c179">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c180">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c181">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c182">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c183">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c184">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c185">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c186">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c187">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c188">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c189">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c190">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c191">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c192">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c193">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c194">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c195">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c196">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c197">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c198">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrbCcuxiEw7DaKnp03QCb9S1ssLhKhQhPI9/LGJ51TgzssCI1ODtwCrgkN0a+ZUXnMF8I/KcADyvbmI99H904sqIF1YM5bLcN+DbpeVS5vMyNXq7Gcc0AsRuAtIzhrDpAdkHW0SbRbM9JtED/NKe0AzzApdc0Kim8/GgaIUDBDfI2qGJJ00w0l4cyr5wsTQ1gfbdPx5SFDRXgQ==] CSR-->
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c199">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c200">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c201">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c202">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c203">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c204">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c205">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c206">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c207">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c208">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c209">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c210">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c211">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c212">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c213">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c214">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c215">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c216">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c217">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c218">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c219">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c220">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c221">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c222">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c223">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c224">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c225">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c226">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c227">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c228">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c229">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c230">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c231">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c232">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c233">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c234">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c235">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c236">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c237">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c238">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c239">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c240">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c241">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c242">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c243">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c244">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c245">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c246">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c247">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c248">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c249">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c250">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c251">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c252">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c253">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c254">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c255">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c256">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c257">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c258">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c259">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-04-14</xbrli:startDate>
    <xbrli:endDate>2023-04-14</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c260">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:MoolecScienceSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c261">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:MoolecScienceSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c262">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:SAFESharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c263">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:SAFESharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c264">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:LightJumpSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c265">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:LightJumpSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c266">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:BackstopSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c267">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:BackstopSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c268">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:Group1GrantedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c269">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:Group2GrantedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c270">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:Group3GrantedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c271">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">mlec:Group1Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c272">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">mlec:Group2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c273">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">mlec:Group3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c274">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">currency:ARS</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c275">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">currency:ARS</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c276">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c277">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c278">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoMacroPreFinancingOfExportsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c279">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoMacroPreFinancingOfExportsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c280">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoMacroPreFinancingOfExportsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c281">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoMacroPreFinancingOfExportsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c282">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoNacinPreFinancingOfExportsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c283">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoNacinPreFinancingOfExportsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c284">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoNacinPreFinancingOfExportsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c285">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoNacinPreFinancingOfExportsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c286">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoCrdobaPreFinancingOfExportsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c287">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoCrdobaPreFinancingOfExportsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c288">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoCrdobaPreFinancingOfExportsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c289">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoCrdobaPreFinancingOfExportsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c290">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoGaliciaBankOverdraftsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c291">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoGaliciaBankOverdraftsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c292">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoGaliciaBankOverdraftsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c293">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoGaliciaBankOverdraftsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c294">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:HSBCBankBankOverdraftsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c295">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:HSBCBankBankOverdraftsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c296">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:HSBCBankBankOverdraftsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c297">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:HSBCBankBankOverdraftsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c298">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoSantanderBankOverdraftsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c299">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoSantanderBankOverdraftsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c300">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoSantanderBankOverdraftsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c301">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoSantanderBankOverdraftsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c302">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoGaliciaLoansMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c303">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoGaliciaLoansMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c304">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoGaliciaLoansMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c305">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoGaliciaLoansMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c306">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:HSBCBankLoansMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c307">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:HSBCBankLoansMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c308">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:HSBCBankLoansMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c309">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:HSBCBankLoansMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c310">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoSantanderLoansMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c311">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoSantanderLoansMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c312">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoSantanderLoansMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c313">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoSantanderLoansMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c314">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoMacroLoansMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c315">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoMacroLoansMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c316">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoMacroLoansMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c317">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoMacroLoansMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c318">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:PromissoryNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c319">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:PromissoryNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c320">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:PromissoryNotesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c321">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:PromissoryNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c322">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:AsociacinMutualAMALoansMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c323">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:AsociacinMutualAMALoansMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c324">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:AsociacinMutualAMALoansMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c325">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:AsociacinMutualAMALoansMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c326">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantReserveMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c327">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantReserveMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c328">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantReserveMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c329">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-01-05</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c330">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-01-06</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c331">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c332">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:LU</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c333">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:LU</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c334">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:LU</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c335">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c336">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2019-07-01</xbrli:startDate>
    <xbrli:endDate>2020-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c337">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c338">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c339">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c340">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c341">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c342">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:LU</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c343">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:LU</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c344">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:LU</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c345">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c346">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c347">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c348">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c349">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">currency:USD</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c350">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">currency:USD</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c351">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">currency:USD</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c352">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">currency:USD</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c353">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c354">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-06-30</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c355">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-30</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c356">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-12-30</xbrli:startDate>
    <xbrli:endDate>2020-12-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c357">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:NetDeferredTaxLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c358">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:NetDeferredTaxLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c359">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">mlec:TwoThousandTwentyTwoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c360">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">mlec:TwoThousandTwentyTwoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c361">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">mlec:TwoThousandTwentyThreeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c362">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">mlec:TwoThousandTwentyThreeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c363">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c364">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c365">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c366">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c367">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-08-21</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c368">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:UnionGroupVenturesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c369">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:UnionGroupVenturesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c370">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:UnionGroupVenturesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c371">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:UnionGroupVenturesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-08-21</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c372">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BGFarmingTechnologiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c373">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BGFarmingTechnologiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c374">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BGFarmingTechnologiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c375">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BGFarmingTechnologiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-08-21</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c376">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c377">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c378">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c379">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c380">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresLLCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c381">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresLLCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c382">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresLLCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c383">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresLLCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c384">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c385">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c386">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c387">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-08-21</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c388">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresLLCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c389">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresLLCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c390">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresLLCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c391">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresLLCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-08-21</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c392">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAINMETSAIngenieriaMetabolicaSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c393">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAINMETSAIngenieriaMetabolicaSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c394">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAINMETSAIngenieriaMetabolicaSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c395">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAINMETSAIngenieriaMetabolicaSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-08-21</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c396">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c397">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c398">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c399">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-08-21</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c400">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAAgralityIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c401">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAAgralityIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c402">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAAgralityIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c403">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAAgralityIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-08-21</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c404">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:FutureFoodsBVMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c405">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:FutureFoodsBVMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c406">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:FutureFoodsBVMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c407">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:FutureFoodsBVMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-08-21</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c408">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:MoolecScienceSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c409">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:MoolecScienceSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c410">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:MoolecScienceSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c411">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:MoolecScienceSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-08-21</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c412">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:THEOISCSpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c413">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:THEOISCSpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c414">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:THEOISCSpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c415">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:THEOISCSpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-08-21</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c416">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSABioceresLLCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c417">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSABioceresLLCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c418">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSABioceresLLCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c419">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSABioceresLLCMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2022-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c420">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:MoolecSAShareholdersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c421">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:MoolecSAShareholdersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c422">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:UnionGroupVenturesLimitedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c423">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:UnionGroupVenturesLimitedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c424">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:INDEARSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c425">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:INDEARSAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c426">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:FutureFoodsBVMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c427">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:FutureFoodsBVMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c428">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c429">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c430">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-01</xbrli:startDate>
    <xbrli:endDate>2023-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c431">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:UpToThreeMonthsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c432">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:UpToThreeMonthsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c433">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:WithinOneYearOrOnDemandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c434">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:BetweenOneAndTwoYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c435">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:BetweenTwoAndFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c436">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:MoreThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c437">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:WithoutAnyEstablishedTermMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c438">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:WithinOneYearOrOnDemandMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c439">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:BetweenOneAndTwoYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c440">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:BetweenTwoAndFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c441">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:MoreThanFiveYearsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c442">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:WithoutAnyEstablishedTermMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c443">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:ArgentinePesosMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c444">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:ArgentinePesosMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c445">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:USDollarMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c446">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:USDollarMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c447">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:PoundSterlingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c448">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:PoundSterlingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c449">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ImpactToProfitOrLossBeforeTaxAssetsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:ArgentinePesosMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c450">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ImpactToProfitOrLossBeforeTaxAssetsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:ArgentinePesosMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c451">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ImpactToProfitOrLossBeforeTaxLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:ArgentinePesosMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c452">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ImpactToProfitOrLossBeforeTaxLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:ArgentinePesosMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c453">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ImpactToProfitOrLossBeforeTaxAssetsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:USDollarMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c454">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ImpactToProfitOrLossBeforeTaxAssetsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:USDollarMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c455">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ImpactToProfitOrLossBeforeTaxLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:USDollarMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c456">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ImpactToProfitOrLossBeforeTaxLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:USDollarMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c457">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ImpactToProfitOrLossBeforeTaxAssetsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:PoundSterlingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c458">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ImpactToProfitOrLossBeforeTaxAssetsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:PoundSterlingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c459">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ImpactToProfitOrLossBeforeTaxLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:PoundSterlingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c460">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ImpactToProfitOrLossBeforeTaxLiabilitiesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:PoundSterlingMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c461">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:ClassesOfFinancialInstrumentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c462">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:ClassesOfFinancialInstrumentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c463">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-10-15</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c464">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001937737</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-10-15</xbrli:startDate>
    <xbrli:endDate>2023-10-15</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>2
<FILENAME>f20f2023ex12-1_moolec.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 12.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO RULES 13a-14(a) AND
15d-14(a)<BR>
UNDER THE SECURITIES EXCHANGE ACT OF 1934<BR>
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, Gast&oacute;n Paladini, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: justify">I have reviewed this annual report on Form&nbsp;20-F of Moolec
Science SA;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: justify">Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under
which such statements were made, not misleading with respect to the period covered by this report;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">3.</TD><TD STYLE="text-align: justify">Based on my knowledge, the financial statements, and other
financial information included in this report, fairly present in all material respects the financial condition, results of operations
and cash flows of the company as of, and for, the periods presented in this report;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">4.</TD><TD STYLE="text-align: justify">The company&rsquo;s other certifying officer and I are responsible
for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">Designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company,
including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which
this report is being prepared;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">Designed such internal control over financial reporting,
or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding
the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: justify">Evaluated the effectiveness of the company&rsquo;s disclosure
controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures,
as of the end of the period covered by this report based on such evaluation; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(d)</TD><TD STYLE="text-align: justify">Disclosed in this report any change in the company&rsquo;s
internal control over financial reporting that occurred during the period covered by the annual report that has materially affected,
or is reasonably likely to materially affect, the company&rsquo;s internal control over financial reporting; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">5.</TD><TD STYLE="text-align: justify">The company&rsquo;s other certifying officer and I have disclosed,
based on our most recent evaluation of internal control over financial reporting, to the company&rsquo;s auditors and the audit committee
of the company&rsquo;s board of directors (or persons performing the equivalent functions):</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">All significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&rsquo;s
ability to record, process, summarize and report financial information; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">Any fraud, whether or not material, that involves management
or other employees who have a significant role in the company&rsquo;s internal control over financial reporting.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>[Signature page follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: October 30, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 50%">/s/ Gast&oacute;n Paladini</TD>
    <TD STYLE="width: 50%; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Gast&oacute;n Paladini, Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>[Signature Page to Exhibit
12.1]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>3
<FILENAME>f20f2023ex12-2_moolec.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 12.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO RULES 13a-14(a) AND
15d-14(a)<BR>
UNDER THE SECURITIES EXCHANGE ACT OF 1934<BR>
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, Jos&eacute; L&oacute;pez Lecube, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: justify">I have reviewed this annual report on Form&nbsp;20-F of Moolec
Science SA;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: justify">Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under
which such statements were made, not misleading with respect to the period covered by this report;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">3.</TD><TD STYLE="text-align: justify">Based on my knowledge, the financial statements, and other
financial information included in this report, fairly present in all material respects the financial condition, results of operations
and cash flows of the company as of, and for, the periods presented in this report;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">4.</TD><TD STYLE="text-align: justify">The company&rsquo;s other certifying officer and I are responsible
for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">Designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company,
including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which
this report is being prepared;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">Designed such internal control over financial reporting,
or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding
the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: justify">Evaluated the effectiveness of the company&rsquo;s disclosure
controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures,
as of the end of the period covered by this report based on such evaluation; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(d)</TD><TD STYLE="text-align: justify">Disclosed in this report any change in the company&rsquo;s
internal control over financial reporting that occurred during the period covered by the annual report that has materially affected,
or is reasonably likely to materially affect, the company&rsquo;s internal control over financial reporting; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">5.</TD><TD STYLE="text-align: justify">The company&rsquo;s other certifying officer and I have disclosed,
based on our most recent evaluation of internal control over financial reporting, to the company&rsquo;s auditors and the audit committee
of the company&rsquo;s board of directors (or persons performing the equivalent functions):</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">All significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&rsquo;s
ability to record, process, summarize and report financial information; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">Any fraud, whether or not material, that involves management
or other employees who have a significant role in the company&rsquo;s internal control over financial reporting.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>[Signature page follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date: October 30, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%">/s/ Jos&eacute; L&oacute;pez Lecube</TD>
    <TD STYLE="width: 60%; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 3pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Jos&eacute; L&oacute;pez Lecube, Chief Financial Officer</FONT></TD>
    <TD STYLE="padding-top: 3pt; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>[Signature Page to Exhibit
12.2]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>4
<FILENAME>f20f2023ex13-1_moolec.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 13.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO<BR>
18 U.S.C. SECTION 1350,<BR>
AS ADOPTED PURSUANT TO<BR>
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In connection with the Annual
Report of Moolec Science SA (the &ldquo;Company&rdquo;) on Form 20-F for the year ended June 30, 2023, as filed with the Securities and
Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of our knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Date: October 30, 2023</FONT></TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 36%">/s/ Gast&oacute;n Paladini</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Gast&oacute;n Paladini</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>5
<FILENAME>f20f2023ex13-2_moolec.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 13.2</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO<BR>
18 U.S.C. SECTION 1350,<BR>
AS ADOPTED PURSUANT TO<BR>
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In connection with the Annual
Report of Moolec Science SA (the &ldquo;Company&rdquo;) on Form 20-F for the year ended June 30, 2023, as filed with the Securities and
Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of our knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Date: October 30, 2023</FONT></TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 36%">/s/ Jos&eacute; L&oacute;pez Lecube</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Jos&eacute; L&oacute;pez Lecube</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>mlec-20230630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Oct 30 21:05:19 UTC 2023 -->
<xs:schema elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:mlec="http://www.moolecscience.com/20230630" targetNamespace="http://www.moolecscience.com/20230630" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="mlec-20230630_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="mlec-20230630_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="mlec-20230630_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="mlec-20230630_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome" id="mlec_r_ConsolidatedComprehensiveIncome">
        <link:definition>001 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ConsolidatedComprehensiveIncomeAlt0" id="mlec_r_ConsolidatedComprehensiveIncomeAlt0">
        <link:definition>001 - Statement - Consolidated Statements of Comprehensive Loss Alternate 0</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome_Parentheticals" id="mlec_r_ConsolidatedComprehensiveIncome_Parentheticals">
        <link:definition>002 - Statement - Consolidated Statements of Comprehensive Loss (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ConsolidatedBalanceSheet" id="mlec_r_ConsolidatedBalanceSheet">
        <link:definition>003 - Statement - Consolidated Statements of Financial Position</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ShareholdersEquityType2or3" id="mlec_r_ShareholdersEquityType2or3">
        <link:definition>004 - Statement - Consolidated Statements of Changes in Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ConsolidatedCashFlow" id="mlec_r_ConsolidatedCashFlow">
        <link:definition>005 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/GeneralInformation" id="mlec_r_GeneralInformation">
        <link:definition>006 - Disclosure - General Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/BusinessCombination" id="mlec_r_BusinessCombination">
        <link:definition>007 - Disclosure - Business Combination</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparation" id="mlec_r_AccountingStandardsandBasisofPreparation">
        <link:definition>008 - Disclosure - Accounting Standards and Basis of Preparation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/SummaryofSignificantAccountingPolicies" id="mlec_r_SummaryofSignificantAccountingPolicies">
        <link:definition>009 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ComparativeInformation" id="mlec_r_ComparativeInformation">
        <link:definition>010 - Disclosure - Comparative Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/IntangibleAssets" id="mlec_r_IntangibleAssets">
        <link:definition>011 - Disclosure - Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/FixedAssets" id="mlec_r_FixedAssets">
        <link:definition>012 - Disclosure - Fixed Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/Goodwill" id="mlec_r_Goodwill">
        <link:definition>013 - Disclosure - Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/RightofUseofAssets" id="mlec_r_RightofUseofAssets">
        <link:definition>014 - Disclosure - Right of Use of Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/OtherNonCurrentReceivables" id="mlec_r_OtherNonCurrentReceivables">
        <link:definition>015 - Disclosure - Other Non-Current Receivables</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/CashandCashEquivalents" id="mlec_r_CashandCashEquivalents">
        <link:definition>016 - Disclosure - Cash and Cash Equivalents</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ShortTermInvestments" id="mlec_r_ShortTermInvestments">
        <link:definition>017 - Disclosure - Short Term Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/TradeReceivableandOtherCurrentReceivables" id="mlec_r_TradeReceivableandOtherCurrentReceivables">
        <link:definition>018 - Disclosure - Trade Receivable and Other Current Receivables</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/Inventories" id="mlec_r_Inventories">
        <link:definition>019 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ShareCapitalandSharePremium" id="mlec_r_ShareCapitalandSharePremium">
        <link:definition>020 - Disclosure - Share Capital and Share Premium</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ShareBasedPayment" id="mlec_r_ShareBasedPayment">
        <link:definition>021 - Disclosure - Share Based Payment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/AccountsPayableandOtherCurrentandNonCurrentLiabilities" id="mlec_r_AccountsPayableandOtherCurrentandNonCurrentLiabilities">
        <link:definition>022 - Disclosure - Accounts Payable and Other Current and Non-Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/FinancialDebt" id="mlec_r_FinancialDebt">
        <link:definition>023 - Disclosure - Financial Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/WarrantsLiabilities" id="mlec_r_WarrantsLiabilities">
        <link:definition>024 - Disclosure - Warrants Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFE" id="mlec_r_SimpleAgreementforFutureEquitySAFE">
        <link:definition>025 - Disclosure - Simple Agreement for Future Equity (&#8220;SAFE&#8221;)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/DeferredTaxandIncomeTax" id="mlec_r_DeferredTaxandIncomeTax">
        <link:definition>026 - Disclosure - Deferred Tax and Income Tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/FinancialIncomeExpenses" id="mlec_r_FinancialIncomeExpenses">
        <link:definition>027 - Disclosure - Financial Income / Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/OtherOperatingExpense" id="mlec_r_OtherOperatingExpense">
        <link:definition>028 - Disclosure - Other Operating Expense</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/AdministrativeExpenses" id="mlec_r_AdministrativeExpenses">
        <link:definition>029 - Disclosure - Administrative Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ResearchandDevelopmentExpense" id="mlec_r_ResearchandDevelopmentExpense">
        <link:definition>030 - Disclosure - Research and Development Expense</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/Costofsales" id="mlec_r_Costofsales">
        <link:definition>031 - Disclosure - Cost of sales</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/NetLossperShare" id="mlec_r_NetLossperShare">
        <link:definition>032 - Disclosure - Net Loss per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/RelatedParties" id="mlec_r_RelatedParties">
        <link:definition>033 - Disclosure - Related Parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/FinancialRiskManagement" id="mlec_r_FinancialRiskManagement">
        <link:definition>034 - Disclosure - Financial Risk Management</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/CapitalRiskManagement" id="mlec_r_CapitalRiskManagement">
        <link:definition>035 - Disclosure - Capital Risk Management</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/EventsaftertheReportingPeriod" id="mlec_r_EventsaftertheReportingPeriod">
        <link:definition>036 - Disclosure - Events after the Reporting Period</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/AccountingPoliciesByPolicy" id="mlec_r_AccountingPoliciesByPolicy">
        <link:definition>037 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/BusinessCombinationTables" id="mlec_r_BusinessCombinationTables">
        <link:definition>038 - Disclosure - Business Combination (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesTables" id="mlec_r_SummaryofSignificantAccountingPoliciesTables">
        <link:definition>039 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/IntangibleAssetsTables" id="mlec_r_IntangibleAssetsTables">
        <link:definition>040 - Disclosure - Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/FixedAssetsTables" id="mlec_r_FixedAssetsTables">
        <link:definition>041 - Disclosure - Fixed Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/GoodwillTables" id="mlec_r_GoodwillTables">
        <link:definition>042 - Disclosure - Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/RightofUseofAssetsTables" id="mlec_r_RightofUseofAssetsTables">
        <link:definition>043 - Disclosure - Right of Use of Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/OtherNonCurrentReceivablesTables" id="mlec_r_OtherNonCurrentReceivablesTables">
        <link:definition>044 - Disclosure - Other Non-Current Receivables (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/CashandCashEquivalentsTables" id="mlec_r_CashandCashEquivalentsTables">
        <link:definition>045 - Disclosure - Cash and Cash Equivalents (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ShortTermInvestmentsTables" id="mlec_r_ShortTermInvestmentsTables">
        <link:definition>046 - Disclosure - Short Term Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/TradeReceivableandOtherCurrentReceivablesTables" id="mlec_r_TradeReceivableandOtherCurrentReceivablesTables">
        <link:definition>047 - Disclosure - Trade Receivable and Other Current Receivables (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/InventoriesTables" id="mlec_r_InventoriesTables">
        <link:definition>048 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ShareCapitalandSharePremiumTables" id="mlec_r_ShareCapitalandSharePremiumTables">
        <link:definition>049 - Disclosure - Share Capital and Share Premium (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ShareBasedPaymentTables" id="mlec_r_ShareBasedPaymentTables">
        <link:definition>050 - Disclosure - Share Based Payment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTables" id="mlec_r_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTables">
        <link:definition>051 - Disclosure - Accounts Payable and Other Current and Non-Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/FinancialDebtTables" id="mlec_r_FinancialDebtTables">
        <link:definition>052 - Disclosure - Financial Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/WarrantsLiabilitiesTables" id="mlec_r_WarrantsLiabilitiesTables">
        <link:definition>053 - Disclosure - Warrants Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFETables" id="mlec_r_SimpleAgreementforFutureEquitySAFETables">
        <link:definition>054 - Disclosure - Simple Agreement for Future Equity (&#8220;SAFE&#8221;) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/DeferredTaxandIncomeTaxTables" id="mlec_r_DeferredTaxandIncomeTaxTables">
        <link:definition>055 - Disclosure - Deferred Tax and Income Tax (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/FinancialIncomeExpensesTables" id="mlec_r_FinancialIncomeExpensesTables">
        <link:definition>056 - Disclosure - Financial Income / Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/OtherOperatingExpenseTables" id="mlec_r_OtherOperatingExpenseTables">
        <link:definition>057 - Disclosure - Other Operating Expense (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/AdministrativeExpensesTables" id="mlec_r_AdministrativeExpensesTables">
        <link:definition>058 - Disclosure - Administrative Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ResearchandDevelopmentExpenseTables" id="mlec_r_ResearchandDevelopmentExpenseTables">
        <link:definition>059 - Disclosure - Research and Development Expense (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/CostofsalesTables" id="mlec_r_CostofsalesTables">
        <link:definition>060 - Disclosure - Cost of sales (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/NetLossperShareTables" id="mlec_r_NetLossperShareTables">
        <link:definition>061 - Disclosure - Net Loss per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/RelatedPartiesTables" id="mlec_r_RelatedPartiesTables">
        <link:definition>062 - Disclosure - Related Parties (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/FinancialRiskManagementTables" id="mlec_r_FinancialRiskManagementTables">
        <link:definition>063 - Disclosure - Financial Risk Management (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/GeneralInformationDetails" id="mlec_r_GeneralInformationDetails">
        <link:definition>064 - Disclosure - General Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/BusinessCombinationDetails" id="mlec_r_BusinessCombinationDetails">
        <link:definition>065 - Disclosure - Business Combination (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofNetAssetsAcquiredandGoodwillTable" id="mlec_r_ScheduleofNetAssetsAcquiredandGoodwillTable">
        <link:definition>066 - Disclosure - Business Combination (Details) - Schedule of Net Assets Acquired and Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable" id="mlec_r_ScheduleofAssetsandLiabilitiesRecognisedTable">
        <link:definition>067 - Disclosure - Business Combination (Details) - Schedule of Assets and Liabilities Recognised</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails" id="mlec_r_AccountingStandardsandBasisofPreparationDetails">
        <link:definition>068 - Disclosure - Accounting Standards and Basis of Preparation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails" id="mlec_r_SummaryofSignificantAccountingPoliciesDetails">
        <link:definition>069 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofUsefulLivesofPropertyPlantandEquipmentTable" id="mlec_r_ScheduleofUsefulLivesofPropertyPlantandEquipmentTable">
        <link:definition>070 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Useful Lives of Property, Plant and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofConsolidatedFinancialStatementsTable" id="mlec_r_ScheduleofConsolidatedFinancialStatementsTable">
        <link:definition>071 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Consolidated Financial Statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable" id="mlec_r_ScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable">
        <link:definition>072 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Non-Current Assets Other than Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable" id="mlec_r_ScheduleofIntangibleAssetsTable">
        <link:definition>073 - Disclosure - Intangible Assets (Details) - Schedule of Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofFixedAssetsTable" id="mlec_r_ScheduleofFixedAssetsTable">
        <link:definition>074 - Disclosure - Fixed Assets (Details) - Schedule of Fixed Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofGoodwillTable" id="mlec_r_ScheduleofGoodwillTable">
        <link:definition>075 - Disclosure - Goodwill (Details) - Schedule of Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/RightofUseofAssetsDetails" id="mlec_r_RightofUseofAssetsDetails">
        <link:definition>076 - Disclosure - Right of Use of Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofRightofUseofAssetsTable" id="mlec_r_ScheduleofRightofUseofAssetsTable">
        <link:definition>077 - Disclosure - Right of Use of Assets (Details) - Schedule of Right of Use of Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/OtherNonCurrentReceivablesDetails" id="mlec_r_OtherNonCurrentReceivablesDetails">
        <link:definition>078 - Disclosure - Other Non-Current Receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofOtherNonCurrentReceivablesTable" id="mlec_r_ScheduleofOtherNonCurrentReceivablesTable">
        <link:definition>079 - Disclosure - Other Non-Current Receivables (Details) - Schedule of Other Non-Current Receivables</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable" id="mlec_r_ScheduleofCashandCashEquivalentsTable">
        <link:definition>080 - Disclosure - Cash and Cash Equivalents (Details) - Schedule of Cash and Cash Equivalents</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofShortTermInvestmentsTable" id="mlec_r_ScheduleofShortTermInvestmentsTable">
        <link:definition>081 - Disclosure - Short Term Investments (Details) - Schedule of Short Term Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofTradeReceivableTable" id="mlec_r_ScheduleofTradeReceivableTable">
        <link:definition>082 - Disclosure - Trade Receivable and Other Current Receivables (Details) - Schedule of Trade Receivable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofOtherCurrentReceivablesTable" id="mlec_r_ScheduleofOtherCurrentReceivablesTable">
        <link:definition>083 - Disclosure - Trade Receivable and Other Current Receivables (Details) - Schedule of Other Current Receivables</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofInventoriesTable" id="mlec_r_ScheduleofInventoriesTable">
        <link:definition>084 - Disclosure - Inventories (Details) - Schedule of Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ShareCapitalandSharePremiumDetails" id="mlec_r_ShareCapitalandSharePremiumDetails">
        <link:definition>085 - Disclosure - Share Capital and Share Premium (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable" id="mlec_r_ScheduleofReconciliationofShareCapitalandSharePremiumTable">
        <link:definition>086 - Disclosure - Share Capital and Share Premium (Details) - Schedule of Reconciliation of Share Capital and Share Premium</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ShareBasedPaymentDetails" id="mlec_r_ShareBasedPaymentDetails">
        <link:definition>087 - Disclosure - Share Based Payment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable" id="mlec_r_ScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable">
        <link:definition>088 - Disclosure - Share Based Payment (Details) - Schedule and the Possible Dilutive Effect of the Future Exercise of Options</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable" id="mlec_r_ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable">
        <link:definition>089 - Disclosure - Share Based Payment (Details) - Schedule of Amount and Exercise Price and the Movements of the Stock Options of Executives and Managers</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofAccountsPayableTable" id="mlec_r_ScheduleofAccountsPayableTable">
        <link:definition>090 - Disclosure - Accounts Payable and Other Current and Non-Current Liabilities (Details) - Schedule of Accounts Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofFinancialDebtTable" id="mlec_r_ScheduleofFinancialDebtTable">
        <link:definition>091 - Disclosure - Financial Debt (Details) - Schedule of Financial Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable" id="mlec_r_ScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable">
        <link:definition>092 - Disclosure - Financial Debt (Details) - Schedule of Book Value is Reasonably Approximate to the Fair Value given its Short-Term Nature</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable" id="mlec_r_ScheduleofTermsandConditionsofOutstandingLoansTable">
        <link:definition>093 - Disclosure - Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/WarrantsLiabilitiesDetails" id="mlec_r_WarrantsLiabilitiesDetails">
        <link:definition>094 - Disclosure - Warrants Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofFairValueOrdinaryShareofWarrantsTable" id="mlec_r_ScheduleofFairValueOrdinaryShareofWarrantsTable">
        <link:definition>095 - Disclosure - Warrants Liabilities (Details) - Schedule of Fair Value Ordinary Share of Warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFEDetails" id="mlec_r_SimpleAgreementforFutureEquitySAFEDetails">
        <link:definition>096 - Disclosure - Simple Agreement for Future Equity (&#8220;SAFE&#8221;) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofFinancialInstrumentsTable" id="mlec_r_ScheduleofFinancialInstrumentsTable">
        <link:definition>097 - Disclosure - Simple Agreement for Future Equity (&#8220;SAFE&#8221;) (Details) - Schedule of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/DeferredTaxandIncomeTaxDetails" id="mlec_r_DeferredTaxandIncomeTaxDetails">
        <link:definition>098 - Disclosure - Deferred Tax and Income Tax (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofRollForwardofNetDeferredTaxTable" id="mlec_r_ScheduleofRollForwardofNetDeferredTaxTable">
        <link:definition>099 - Disclosure -  Deferred Tax and Income Tax (Details) - Schedule of Roll Forward of Net Deferred Tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable" id="mlec_r_ScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable">
        <link:definition>100 - Disclosure -  Deferred Tax and Income Tax (Details) - Schedule of Principal Statutory Taxes Rates in the Countries</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofIncomeTaxforOtherJurisdictionsTable" id="mlec_r_ScheduleofIncomeTaxforOtherJurisdictionsTable">
        <link:definition>101 - Disclosure -  Deferred Tax and Income Tax (Details) - Schedule of Income Tax for Other Jurisdictions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable" id="mlec_r_ScheduleofNetDeferredTaxLiabilitiesTable">
        <link:definition>102 - Disclosure -  Deferred Tax and Income Tax (Details) - Schedule of Net Deferred Tax Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrbCcuxiEw7DaKnp03QCb9S1ssLhKhQhPI9/LGJ51TgzssCI1ODtwCrgkN0a+ZUXnMF8I/KcADyvbmI99H904sqIF1YM5bLcN+DbpeVS5vMyNXq7Gcc0AsRuAtIzhrDpAdkHW0SbRbM9JtED/NKe0AzzApdc0Kim8/GgaIUDBDfI2qGJJ00w0l4c7ckiU55mxDXlrjGWyRRjAg==] CSR-->
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofAccumulatedTaxLossCarryforwardsTable" id="mlec_r_ScheduleofAccumulatedTaxLossCarryforwardsTable">
        <link:definition>103 - Disclosure -  Deferred Tax and Income Tax (Details) - Schedule of Accumulated Tax Loss Carryforwards</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofEstimatedFutureTaxableProfitTable" id="mlec_r_ScheduleofEstimatedFutureTaxableProfitTable">
        <link:definition>104 - Disclosure -  Deferred Tax and Income Tax (Details) - Schedule of Estimated Future Taxable Profit.</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofFinancialIncomeExpensesTable" id="mlec_r_ScheduleofFinancialIncomeExpensesTable">
        <link:definition>105 - Disclosure - Financial Income / Expenses (Details) - Schedule of Financial Income Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofOtherOperatingExpenseTable" id="mlec_r_ScheduleofOtherOperatingExpenseTable">
        <link:definition>106 - Disclosure - Other Operating Expense (Details) - Schedule of Other Operating Expense</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable" id="mlec_r_ScheduleofAdministrativeExpensesTable">
        <link:definition>107 - Disclosure - Administrative Expenses (Details) - Schedule of Administrative Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofResearchandDevelopmentExpenseTable" id="mlec_r_ScheduleofResearchandDevelopmentExpenseTable">
        <link:definition>108 - Disclosure - Research and Development Expense (Details) - Schedule of Research and Development Expense</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofCostofsalesTable" id="mlec_r_ScheduleofCostofsalesTable">
        <link:definition>109 - Disclosure - Cost of sales (Details) - Schedule of Cost of sales</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable" id="mlec_r_ScheduleofNetLossPerShareTable">
        <link:definition>110 - Disclosure - Net Loss per Share (Details) - Schedule of Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable_Parentheticals" id="mlec_r_ScheduleofNetLossPerShareTable_Parentheticals">
        <link:definition>111 - Disclosure - Net Loss per Share (Details) - Schedule of Net Loss Per Share (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofOtherRelatedPartyTransactionsTable" id="mlec_r_ScheduleofOtherRelatedPartyTransactionsTable">
        <link:definition>112 - Disclosure - Related Parties (Details) - Schedule of Other Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable" id="mlec_r_ScheduleofShareBasedPaymentTable">
        <link:definition>113 - Disclosure - Related Parties (Details) - Schedule of Share Based Payment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable_Parentheticals" id="mlec_r_ScheduleofShareBasedPaymentTable_Parentheticals">
        <link:definition>114 - Disclosure - Related Parties (Details) - Schedule of Share Based Payment (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable" id="mlec_r_ScheduleofotherrelatedpartybalancesTable">
        <link:definition>115 - Disclosure - Related Parties (Details) - Schedule of other related party balances</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable_Parentheticals" id="mlec_r_ScheduleofotherrelatedpartybalancesTable_Parentheticals">
        <link:definition>116 - Disclosure - Related Parties (Details) - Schedule of other related party balances (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/FinancialRiskManagementDetails" id="mlec_r_FinancialRiskManagementDetails">
        <link:definition>117 - Disclosure - Financial Risk Management (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofTradeandOtherReceivablesTable" id="mlec_r_ScheduleofTradeandOtherReceivablesTable">
        <link:definition>118 - Disclosure - Financial Risk Management (Details) - Schedule of Trade and Other Receivables</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable" id="mlec_r_ScheduleofContractualMaturityDateTable">
        <link:definition>119 - Disclosure - Financial Risk Management (Details) - Schedule of Contractual Maturity Date</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTableAlt0" id="mlec_r_ScheduleofContractualMaturityDateTableAlt0">
        <link:definition>119 - Disclosure - Financial Risk Management (Details) - Schedule of Contractual Maturity Date Alternate 0</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofForeignCurrencyExchangeRiskTable" id="mlec_r_ScheduleofForeignCurrencyExchangeRiskTable">
        <link:definition>120 - Disclosure - Financial Risk Management (Details) - Schedule of Foreign Currency Exchange Risk</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable" id="mlec_r_ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable">
        <link:definition>121 - Disclosure - Financial Risk Management (Details) - Schedule of Fair Value and Carrying Value of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/ScheduleofFixedRateInstrumentsTable" id="mlec_r_ScheduleofFixedRateInstrumentsTable">
        <link:definition>122 - Disclosure - Financial Risk Management (Details) - Schedule of Fixed-Rate Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/EventsaftertheReportingPeriodDetails" id="mlec_r_EventsaftertheReportingPeriodDetails">
        <link:definition>123 - Disclosure - Events after the Reporting Period (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.moolecscience.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd"/>
  <xs:element name="ConsolidatedStatementsOfChangesInEquityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ConsolidatedStatementsOfChangesInEquityAbstract"/>
  <xs:element name="ScheduleOfNetAssetsAcquiredAndGoodwillAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfNetAssetsAcquiredAndGoodwillAbstract"/>
  <xs:element name="ScheduleOfAssetsAndLiabilitiesRecognisedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfAssetsAndLiabilitiesRecognisedAbstract"/>
  <xs:element name="ScheduleOfUsefulLivesOfPropertyPlantAndEquipmentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfUsefulLivesOfPropertyPlantAndEquipmentAbstract"/>
  <xs:element name="ScheduleOfConsolidatedFinancialStatementsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfConsolidatedFinancialStatementsAbstract"/>
  <xs:element name="ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsAbstract"/>
  <xs:element name="DisclosureOfAdditionalInformationTextBlockAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfAdditionalInformationTextBlockAbstract"/>
  <xs:element name="ScheduleOfIntangibleAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfIntangibleAssetsAbstract"/>
  <xs:element name="ScheduleOfFixedAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfFixedAssetsAbstract"/>
  <xs:element name="ScheduleOfGoodwillAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfGoodwillAbstract"/>
  <xs:element name="ScheduleOfRightOfUseOfAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfRightOfUseOfAssetsAbstract"/>
  <xs:element name="ScheduleOfOtherNonCurrentReceivablesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfOtherNonCurrentReceivablesAbstract"/>
  <xs:element name="ScheduleOfCashAndCashEquivalentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfCashAndCashEquivalentsAbstract"/>
  <xs:element name="ScheduleOfShortTermInvestmentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfShortTermInvestmentsAbstract"/>
  <xs:element name="ScheduleOfTradeReceivableAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfTradeReceivableAbstract"/>
  <xs:element name="ScheduleOfOtherCurrentReceivablesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfOtherCurrentReceivablesAbstract"/>
  <xs:element name="ScheduleOfInventoriesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfInventoriesAbstract"/>
  <xs:element name="ScheduleOfReconciliationOfShareCapitalAndSharePremiumAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumAbstract"/>
  <xs:element name="ScheduleAndThePossibleDilutiveEffectOfTheFutureExerciseOfOptionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleAndThePossibleDilutiveEffectOfTheFutureExerciseOfOptionsAbstract"/>
  <xs:element name="ScheduleOfAmountAndExercisePriceAndTheMovementsOfTheStockOptionsOfExecutivesAndManagersAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfAmountAndExercisePriceAndTheMovementsOfTheStockOptionsOfExecutivesAndManagersAbstract"/>
  <xs:element name="ScheduleOfAccountsPayableAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfAccountsPayableAbstract"/>
  <xs:element name="ScheduleOfFinancialDebtAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfFinancialDebtAbstract"/>
  <xs:element name="ScheduleOfTermsAndConditionsOfOutstandingLoansAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfTermsAndConditionsOfOutstandingLoansAbstract"/>
  <xs:element name="ScheduleOfFairValueOrdinaryShareOfWarrantsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfFairValueOrdinaryShareOfWarrantsAbstract"/>
  <xs:element name="SimpleAgreementForFutureEquitySafeAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SimpleAgreementForFutureEquitySafeAbstract"/>
  <xs:element name="ScheduleOfFinancialInstrumentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfFinancialInstrumentsAbstract"/>
  <xs:element name="ScheduleOfRollForwardOfNetDeferredTaxAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfRollForwardOfNetDeferredTaxAbstract"/>
  <xs:element name="ScheduleOfPrincipalStatutoryTaxesRatesInTheCountriesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfPrincipalStatutoryTaxesRatesInTheCountriesAbstract"/>
  <xs:element name="ScheduleOfIncomeTaxForOtherJurisdictionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsAbstract"/>
  <xs:element name="ScheduleOfNetDeferredTaxLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfNetDeferredTaxLiabilitiesAbstract"/>
  <xs:element name="ScheduleOfAccumulatedTaxLossCarryforwardsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfAccumulatedTaxLossCarryforwardsAbstract"/>
  <xs:element name="ScheduleOfEstimatedFutureTaxableProfitAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfEstimatedFutureTaxableProfitAbstract"/>
  <xs:element name="ScheduleOfFinancialIncomeExpensesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfFinancialIncomeExpensesAbstract"/>
  <xs:element name="ScheduleOfOtherOperatingExpenseAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfOtherOperatingExpenseAbstract"/>
  <xs:element name="ScheduleOfAdministrativeExpensesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfAdministrativeExpensesAbstract"/>
  <xs:element name="ScheduleOfResearchAndDevelopmentExpenseAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfResearchAndDevelopmentExpenseAbstract"/>
  <xs:element name="ScheduleOfCostOfSalesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfCostOfSalesAbstract"/>
  <xs:element name="ScheduleOfNetLossPerShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfNetLossPerShareAbstract"/>
  <xs:element name="ScheduleOfOtherRelatedPartyTransactionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfOtherRelatedPartyTransactionsAbstract"/>
  <xs:element name="ScheduleOfShareBasedPaymentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfShareBasedPaymentAbstract"/>
  <xs:element name="ScheduleOfOtherRelatedPartyBalancesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfOtherRelatedPartyBalancesAbstract"/>
  <xs:element name="ScheduleOfTradeAndOtherReceivablesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfTradeAndOtherReceivablesAbstract"/>
  <xs:element name="ScheduleOfContractualMaturityDateAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfContractualMaturityDateAbstract"/>
  <xs:element name="ScheduleOfForeignCurrencyExchangeRiskAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfForeignCurrencyExchangeRiskAbstract"/>
  <xs:element name="ScheduleOfFairValueAndCarryingValueOfFinancialInstrumentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfFairValueAndCarryingValueOfFinancialInstrumentsAbstract"/>
  <xs:element name="ScheduleOfFixedRateInstrumentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfFixedRateInstrumentsAbstract"/>
  <xs:element name="ContinuingOperationsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ContinuingOperationsAbstract"/>
  <xs:element name="UnlabeledAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract"/>
  <xs:element name="UnlabeledAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract0"/>
  <xs:element name="UnlabeledAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract1"/>
  <xs:element name="AssetAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AssetAbstract"/>
  <xs:element name="NonCurrentAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NonCurrentAssetsAbstract"/>
  <xs:element name="LiabilitiesAndEquityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_LiabilitiesAndEquityAbstract"/>
  <xs:element name="NonCurrentLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NonCurrentLiabilitiesAbstract"/>
  <xs:element name="PurchaseConsiderationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PurchaseConsiderationAbstract"/>
  <xs:element name="UnlabeledAbstract2" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract2"/>
  <xs:element name="YearEndedJune302021Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_YearEndedJune302021Abstract"/>
  <xs:element name="UnlabeledAbstract3" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract3"/>
  <xs:element name="AsOfJune302021Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AsOfJune302021Abstract"/>
  <xs:element name="UnlabeledAbstract4" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract4"/>
  <xs:element name="YearEndedJune302022Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_YearEndedJune302022Abstract"/>
  <xs:element name="UnlabeledAbstract5" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract5"/>
  <xs:element name="AsOfJune302022Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AsOfJune302022Abstract"/>
  <xs:element name="UnlabeledAbstract6" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract6"/>
  <xs:element name="YearEndedJune302023Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_YearEndedJune302023Abstract"/>
  <xs:element name="UnlabeledAbstract7" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract7"/>
  <xs:element name="AsOfJune302023Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AsOfJune302023Abstract"/>
  <xs:element name="UnlabeledAbstract8" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract8"/>
  <xs:element name="YearEndedJune302021Abstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_YearEndedJune302021Abstract0"/>
  <xs:element name="UnlabeledAbstract9" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract9"/>
  <xs:element name="AsOfJune302021Abstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AsOfJune302021Abstract0"/>
  <xs:element name="UnlabeledAbstract10" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract10"/>
  <xs:element name="YearEndedJune302022Abstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_YearEndedJune302022Abstract0"/>
  <xs:element name="UnlabeledAbstract11" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract11"/>
  <xs:element name="AsOfJune302022Abstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AsOfJune302022Abstract0"/>
  <xs:element name="UnlabeledAbstract12" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract12"/>
  <xs:element name="YearEndedJune302023Abstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_YearEndedJune302023Abstract0"/>
  <xs:element name="UnlabeledAbstract13" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract13"/>
  <xs:element name="AsOfJune302023Abstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AsOfJune302023Abstract0"/>
  <xs:element name="DeferredTaxAssetAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DeferredTaxAssetAbstract"/>
  <xs:element name="UnlabeledAbstract14" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract14"/>
  <xs:element name="DeferredTaxLiabilityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DeferredTaxLiabilityAbstract"/>
  <xs:element name="FinancialCostsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FinancialCostsAbstract"/>
  <xs:element name="OtherFinancialResultsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OtherFinancialResultsAbstract"/>
  <xs:element name="ProductionCostsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ProductionCostsAbstract"/>
  <xs:element name="ShareBasedPaymentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ShareBasedPaymentAbstract"/>
  <xs:element name="IssueOfAdditionalSharesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_IssueOfAdditionalSharesAbstract"/>
  <xs:element name="CompanySCashBalanceInOtherSAccountsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CompanySCashBalanceInOtherSAccountsAbstract"/>
  <xs:element name="ExpensesPaidOnBehalfOfTheCompanyAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ExpensesPaidOnBehalfOfTheCompanyAbstract"/>
  <xs:element name="ServicesProvidedByOtherCompaniesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ServicesProvidedByOtherCompaniesAbstract"/>
  <xs:element name="ToDueBecomeAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ToDueBecomeAbstract"/>
  <xs:element name="UnlabeledAbstract15" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract15"/>
  <xs:element name="UnlabeledAbstract16" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract16"/>
  <xs:element name="June302022Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_June302022Abstract"/>
  <xs:element name="FinancialAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FinancialAssetsAbstract"/>
  <xs:element name="AmortizedCostsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AmortizedCostsAbstract"/>
  <xs:element name="UnlabeledAbstract17" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract17"/>
  <xs:element name="FairValueThroughProfitOrLossAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FairValueThroughProfitOrLossAbstract"/>
  <xs:element name="UnlabeledAbstract18" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnlabeledAbstract18"/>
  <xs:element name="FinancialLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FinancialLiabilitiesAbstract"/>
  <xs:element name="AmortizedCostsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AmortizedCostsAbstract0"/>
  <xs:element name="FairValueThroughProfitOrLossAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FairValueThroughProfitOrLossAbstract0"/>
  <xs:element name="TransactionsExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_TransactionsExpenses"/>
  <xs:element name="FixedAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_FixedAssets"/>
  <xs:element name="ShorttermInvestmentsCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ShorttermInvestmentsCurrent"/>
  <xs:element name="ShareToBeIssuedAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ShareToBeIssuedAmount"/>
  <xs:element name="EquitySettledShareBasedPayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_EquitySettledShareBasedPayments"/>
  <xs:element name="SimplyAgreementForFutureEquitySAFE" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_SimplyAgreementForFutureEquitySAFE"/>
  <xs:element name="IssueOfShareCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_IssueOfShareCapital"/>
  <xs:element name="EquitySettledShareBasedPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_EquitySettledShareBasedPayment"/>
  <xs:element name="IssueOfShareCapitalSAFEShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_IssueOfShareCapitalSAFEShares"/>
  <xs:element name="IssueOfShareCapitalLightJumpShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_IssueOfShareCapitalLightJumpShares"/>
  <xs:element name="IssueOfShareCapitalBackstopShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_IssueOfShareCapitalBackstopShares"/>
  <xs:element name="BusinessCombination" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_BusinessCombination"/>
  <xs:element name="ShareBasedPaymentCostOfListingSharesnoncashItem" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ShareBasedPaymentCostOfListingSharesnoncashItem"/>
  <xs:element name="OtherLiabilitie" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_OtherLiabilitie"/>
  <xs:element name="Proceedsfromissuanceofsharecapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_Proceedsfromissuanceofsharecapital"/>
  <xs:element name="ProceedsFromSAFE" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ProceedsFromSAFE"/>
  <xs:element name="ProceedsFromIssueOfShareCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ProceedsFromIssueOfShareCapital"/>
  <xs:element name="IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei"/>
  <xs:element name="ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium"/>
  <xs:element name="CapitalizationOfTransactionExpensesThroughAccountsPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_CapitalizationOfTransactionExpensesThroughAccountsPayable"/>
  <xs:element name="NetLiabilitiesAcquiredThroughIssuanceOfShareCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_NetLiabilitiesAcquiredThroughIssuanceOfShareCapital"/>
  <xs:element name="AcquisitionOfBusinessCombinationTroughDeferredPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AcquisitionOfBusinessCombinationTroughDeferredPayment"/>
  <xs:element name="AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind"/>
  <xs:element name="AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares"/>
  <xs:element name="ComparativeInformationTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_ComparativeInformationTable"/>
  <xs:element name="ComparativeInformationLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ComparativeInformationLineItems"/>
  <xs:element name="AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTable"/>
  <xs:element name="AccountsPayableandOtherCurrentandNonCurrentLiabilitiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesLineItems"/>
  <xs:element name="SimpleAgreementForFutureEquitySAFETextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SimpleAgreementForFutureEquitySAFETextBlock"/>
  <xs:element name="DeferredTaxandIncomeTaxTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_DeferredTaxandIncomeTaxTable"/>
  <xs:element name="DeferredTaxandIncomeTaxLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DeferredTaxandIncomeTaxLineItems"/>
  <xs:element name="OtherOperatingExpenseTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_OtherOperatingExpenseTable"/>
  <xs:element name="OtherOperatingExpenseLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OtherOperatingExpenseLineItems"/>
  <xs:element name="ResearchandDevelopmentExpenseTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_ResearchandDevelopmentExpenseTable"/>
  <xs:element name="ResearchandDevelopmentExpenseLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ResearchandDevelopmentExpenseLineItems"/>
  <xs:element name="NetLossperShareTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_NetLossperShareTable"/>
  <xs:element name="NetLossperShareLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NetLossperShareLineItems"/>
  <xs:element name="RelatedPartiesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_RelatedPartiesTable"/>
  <xs:element name="RelatedPartiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_RelatedPartiesLineItems"/>
  <xs:element name="DisclosureOfCapitalRiskManagementTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfCapitalRiskManagementTextBlock"/>
  <xs:element name="EventsaftertheReportingPeriodTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_EventsaftertheReportingPeriodTable"/>
  <xs:element name="EventsaftertheReportingPeriodLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_EventsaftertheReportingPeriodLineItems"/>
  <xs:element name="DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock"/>
  <xs:element name="DescriptionOfAccountingPolicyForForeignCurrencyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DescriptionOfAccountingPolicyForForeignCurrencyTextBlock"/>
  <xs:element name="DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock"/>
  <xs:element name="DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock"/>
  <xs:element name="DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock"/>
  <xs:element name="DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock"/>
  <xs:element name="DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock"/>
  <xs:element name="DescriptionOfAccountingPolicyForLossPerShareTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DescriptionOfAccountingPolicyForLossPerShareTextBlock"/>
  <xs:element name="ScheduleOfNetAssetsAcquiredAndGoodwill" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfNetAssetsAcquiredAndGoodwill"/>
  <xs:element name="ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock"/>
  <xs:element name="DisclosureOfIntangibleAssetsExplanatoryTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfIntangibleAssetsExplanatoryTableTextBlock"/>
  <xs:element name="ScheduleOfFixedAssetstextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfFixedAssetstextBlock"/>
  <xs:element name="ScheduleOfRightofuseOfAssetsTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfRightofuseOfAssetsTableTextBlock"/>
  <xs:element name="ScheduleOfOtherNoncurrentReceivableTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfOtherNoncurrentReceivableTableTextBlock"/>
  <xs:element name="CashandCashEquivalentsTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_CashandCashEquivalentsTablesTable"/>
  <xs:element name="CashandCashEquivalentsTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CashandCashEquivalentsTablesLineItems"/>
  <xs:element name="DisclosureOfShortTermInvestmentsTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfShortTermInvestmentsTableTextBlock"/>
  <xs:element name="ScheduleOfTradeReceivableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfTradeReceivableTextBlock"/>
  <xs:element name="ScheduleOfOtherCurrentReceivablesTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfOtherCurrentReceivablesTextBlock"/>
  <xs:element name="DisclosureOfInventoriesTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfInventoriesTableTextBlock"/>
  <xs:element name="ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock"/>
  <xs:element name="ScheduleOfAccountsPayable" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfAccountsPayable"/>
  <xs:element name="AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesTable"/>
  <xs:element name="AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesLineItems"/>
  <xs:element name="DisclosureOfStatutoryTaxesInCountriesTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfStatutoryTaxesInCountriesTableTextBlock"/>
  <xs:element name="ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock"/>
  <xs:element name="ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock"/>
  <xs:element name="ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock"/>
  <xs:element name="ScheduleOfEstimatedFutureTaxableProfitTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfEstimatedFutureTaxableProfitTableTextBlock"/>
  <xs:element name="ScheduleOfOtherOperatingExpensesTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfOtherOperatingExpensesTableTextBlock"/>
  <xs:element name="OtherOperatingExpenseTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_OtherOperatingExpenseTablesTable"/>
  <xs:element name="OtherOperatingExpenseTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OtherOperatingExpenseTablesLineItems"/>
  <xs:element name="DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock"/>
  <xs:element name="ResearchandDevelopmentExpenseTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_ResearchandDevelopmentExpenseTablesTable"/>
  <xs:element name="ResearchandDevelopmentExpenseTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ResearchandDevelopmentExpenseTablesLineItems"/>
  <xs:element name="ScheduleOfCostOfSalesTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfCostOfSalesTableTextBlock"/>
  <xs:element name="NetLossperShareTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_NetLossperShareTablesTable"/>
  <xs:element name="NetLossperShareTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NetLossperShareTablesLineItems"/>
  <xs:element name="ScheduleOfOtherRelatedPartyTransactions" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfOtherRelatedPartyTransactions"/>
  <xs:element name="ScheduleOfShareBasedPayment" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfShareBasedPayment"/>
  <xs:element name="ScheduleOfOtherRelatedPartyBalances" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ScheduleOfOtherRelatedPartyBalances"/>
  <xs:element name="RelatedPartiesTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_RelatedPartiesTablesTable"/>
  <xs:element name="RelatedPartiesTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_RelatedPartiesTablesLineItems"/>
  <xs:element name="DisclosureOfFixedRateInstruments" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DisclosureOfFixedRateInstruments"/>
  <xs:element name="CashPaid" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_CashPaid"/>
  <xs:element name="DeferredPaymentAfter6Months" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_DeferredPaymentAfter6Months"/>
  <xs:element name="ConsiderationPaid" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ConsiderationPaid"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentTable"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsTable"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsLineItems"/>
  <xs:element name="OtherNonCurrentAssetsOtherThanFinancialAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_OtherNonCurrentAssetsOtherThanFinancialAssets"/>
  <xs:element name="IntangibleAssetsDetailsScheduleofIntangibleAssetsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsTable"/>
  <xs:element name="IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems"/>
  <xs:element name="Cost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_Cost"/>
  <xs:element name="NetBookAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_NetBookAmount"/>
  <xs:element name="Amortization" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_Amortization"/>
  <xs:element name="FixedAssetsDetailsScheduleofFixedAssetsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_FixedAssetsDetailsScheduleofFixedAssetsTable"/>
  <xs:element name="FixedAssetsDetailsScheduleofFixedAssetsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems"/>
  <xs:element name="TotalGoodwill" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_TotalGoodwill"/>
  <xs:element name="AcquisitionsThroughBusinessCombinationsi" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AcquisitionsThroughBusinessCombinationsi"/>
  <xs:element name="EffectOfChangesInForeignExchangeRates" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_EffectOfChangesInForeignExchangeRates"/>
  <xs:element name="CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsTable"/>
  <xs:element name="CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems"/>
  <xs:element name="MutualFunds" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_MutualFunds"/>
  <xs:element name="TotalMutualFunds" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_TotalMutualFunds"/>
  <xs:element name="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumTable"/>
  <xs:element name="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems"/>
  <xs:element name="SharesIssuedAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_SharesIssuedAmount"/>
  <xs:element name="NumberOfSharesIssueOfShareCapitalinShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NumberOfSharesIssueOfShareCapitalinShares"/>
  <xs:element name="SharesToBeIssuedAmountIssueOfShareCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_SharesToBeIssuedAmountIssueOfShareCapital"/>
  <xs:element name="SharePremiumIssueOfShareCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_SharePremiumIssueOfShareCapital"/>
  <xs:element name="NumberOfSharesFromBusinessAcquisition" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NumberOfSharesFromBusinessAcquisition"/>
  <xs:element name="SharesIssuedAmountFromBusinessAcquisition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_SharesIssuedAmountFromBusinessAcquisition"/>
  <xs:element name="SharesToBeIssuedAmountFromBusinessAcquisition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_SharesToBeIssuedAmountFromBusinessAcquisition"/>
  <xs:element name="SharePremiumFromBusinessAcquisition" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_SharePremiumFromBusinessAcquisition"/>
  <xs:element name="NumberOfShareEquitySettledShareBasedPayment" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NumberOfShareEquitySettledShareBasedPayment"/>
  <xs:element name="SharesIssuedAmountEquitySettledShareBasedPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_SharesIssuedAmountEquitySettledShareBasedPayment"/>
  <xs:element name="SharesToBeIssuedAmountEquitySettledShareBasedPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_SharesToBeIssuedAmountEquitySettledShareBasedPayment"/>
  <xs:element name="SharePremiumEquitySettledShareBasedPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_SharePremiumEquitySettledShareBasedPayment"/>
  <xs:element name="ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable"/>
  <xs:element name="ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems"/>
  <xs:element name="FairValueOfSharesinShares" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FairValueOfSharesinShares"/>
  <xs:element name="ExercisePrice" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ExercisePrice"/>
  <xs:element name="PlanDuration" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PlanDuration"/>
  <xs:element name="FairValueOfStockOptionsAtMeasurementDate" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FairValueOfStockOptionsAtMeasurementDate"/>
  <xs:element name="ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable"/>
  <xs:element name="ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems"/>
  <xs:element name="NumberOfOptionsAtTheBeginning" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NumberOfOptionsAtTheBeginning"/>
  <xs:element name="ExercisePriceAtTheBeginning" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ExercisePriceAtTheBeginning"/>
  <xs:element name="NumberOfOptionsGrantedDuringThePeriod" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NumberOfOptionsGrantedDuringThePeriod"/>
  <xs:element name="ExercisePriceGrantedDuringThePeriod" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ExercisePriceGrantedDuringThePeriod"/>
  <xs:element name="NumberOfOptionsForfeitedDuringThePeriod" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NumberOfOptionsForfeitedDuringThePeriod"/>
  <xs:element name="ExercisePriceForfeitedDuringThePeriod" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ExercisePriceForfeitedDuringThePeriod"/>
  <xs:element name="NumberOfOptionsExercisedDuringThePeriod" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NumberOfOptionsExercisedDuringThePeriod"/>
  <xs:element name="ExercisePriceExercisedDuringThePeriod" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ExercisePriceExercisedDuringThePeriod"/>
  <xs:element name="NumberOfOptionsExpiredDuringThePeriod" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NumberOfOptionsExpiredDuringThePeriod"/>
  <xs:element name="ExercisePriceExpiredDuringThePeriod" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ExercisePriceExpiredDuringThePeriod"/>
  <xs:element name="NumberOfOptionsAtTheEnding" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NumberOfOptionsAtTheEnding"/>
  <xs:element name="ExercisePriceAtTheEnding" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ExercisePriceAtTheEnding"/>
  <xs:element name="DeferredPaymentRelatedToBusinessCombination" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_DeferredPaymentRelatedToBusinessCombination"/>
  <xs:element name="Wages" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_Wages"/>
  <xs:element name="Taxes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_Taxes"/>
  <xs:element name="PayAsYouEarnPAYE" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_PayAsYouEarnPAYE"/>
  <xs:element name="FinancialDebtDetailsScheduleofFinancialDebtTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_FinancialDebtDetailsScheduleofFinancialDebtTable"/>
  <xs:element name="FinancialDebtDetailsScheduleofFinancialDebtLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FinancialDebtDetailsScheduleofFinancialDebtLineItems"/>
  <xs:element name="FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable"/>
  <xs:element name="FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureLineItems"/>
  <xs:element name="FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansTable"/>
  <xs:element name="FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems"/>
  <xs:element name="BorrowingOriginalCurrency" type="xbrli:stringItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_BorrowingOriginalCurrency"/>
  <xs:element name="NominalInterestRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_NominalInterestRate"/>
  <xs:element name="BorrowingMaturity" type="xbrli:stringItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_BorrowingMaturity"/>
  <xs:element name="WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsTable"/>
  <xs:element name="WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsLineItems"/>
  <xs:element name="WarrantAndRightsOutstanding" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_WarrantAndRightsOutstanding"/>
  <xs:element name="FairValueAdjustmentOfWarrant" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_FairValueAdjustmentOfWarrant"/>
  <xs:element name="FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue"/>
  <xs:element name="Additions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_Additions"/>
  <xs:element name="SAFECapitalization" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_SAFECapitalization"/>
  <xs:element name="ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue"/>
  <xs:element name="IncorporatedThroughTheBusinessCombination" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_IncorporatedThroughTheBusinessCombination"/>
  <xs:element name="DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss"/>
  <xs:element name="ChargedToOtherComprehensiveIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ChargedToOtherComprehensiveIncome"/>
  <xs:element name="DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable"/>
  <xs:element name="DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesLineItems"/>
  <xs:element name="TaxJurisdiction" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_TaxJurisdiction"/>
  <xs:element name="LossBeforeTax" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_LossBeforeTax"/>
  <xs:element name="CorporateTaxRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_CorporateTaxRate"/>
  <xs:element name="EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions"/>
  <xs:element name="TaxLosses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_TaxLosses"/>
  <xs:element name="NondeductibleExpensesListingCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_NondeductibleExpensesListingCost"/>
  <xs:element name="NetGainOnInflationEffectOnMonetaryItems" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_NetGainOnInflationEffectOnMonetaryItems"/>
  <xs:element name="IncomeTaxInflationAdjustment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_IncomeTaxInflationAdjustment"/>
  <xs:element name="Others" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_Others"/>
  <xs:element name="TaxBenefitForTheYear" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_TaxBenefitForTheYear"/>
  <xs:element name="DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesTable"/>
  <xs:element name="DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesLineItems"/>
  <xs:element name="CustomerRelationship" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_CustomerRelationship"/>
  <xs:element name="DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsTable"/>
  <xs:element name="DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems"/>
  <xs:element name="TaxlossCarryForward" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_TaxlossCarryForward"/>
  <xs:element name="DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitTable"/>
  <xs:element name="DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems"/>
  <xs:element name="DeferredTaxAssetsGrossAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_DeferredTaxAssetsGrossAmount"/>
  <xs:element name="DeferredTaxAssetsTaxEffect" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_DeferredTaxAssetsTaxEffect"/>
  <xs:element name="InterestExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_InterestExpenses"/>
  <xs:element name="TotalFinancialCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_TotalFinancialCosts"/>
  <xs:element name="ExchangeRateDifference" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ExchangeRateDifference"/>
  <xs:element name="ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss"/>
  <xs:element name="InvestmentGainRelatedToMoneyMarketFunds" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_InvestmentGainRelatedToMoneyMarketFunds"/>
  <xs:element name="ChangeInWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ChangeInWarrants"/>
  <xs:element name="InflationAdjustment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_InflationAdjustment"/>
  <xs:element name="OtherFinancialResults" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_OtherFinancialResults"/>
  <xs:element name="TotalOtherFinancialResults" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_TotalOtherFinancialResults"/>
  <xs:element name="NetFinancialIncomeExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_NetFinancialIncomeExpenses"/>
  <xs:element name="TaxesDutiesAndPenalties" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_TaxesDutiesAndPenalties"/>
  <xs:element name="OtherOperatingExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_OtherOperatingExpense"/>
  <xs:element name="AuditLegalAndAccountancyFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AuditLegalAndAccountancyFee"/>
  <xs:element name="PayrollExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_PayrollExpenses"/>
  <xs:element name="AmortizationExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AmortizationExpense"/>
  <xs:element name="ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseTable"/>
  <xs:element name="ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems"/>
  <xs:element name="LaboratoriesRelatedExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_LaboratoriesRelatedExpenses"/>
  <xs:element name="OtherResearchAndDevelopmentExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_OtherResearchAndDevelopmentExpenses"/>
  <xs:element name="CostofsalesDetailsScheduleofCostofsalesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_CostofsalesDetailsScheduleofCostofsalesTable"/>
  <xs:element name="CostofsalesDetailsScheduleofCostofsalesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CostofsalesDetailsScheduleofCostofsalesLineItems"/>
  <xs:element name="InventoriesIncorporatedThroughTheBusinessCombination" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_InventoriesIncorporatedThroughTheBusinessCombination"/>
  <xs:element name="PayrollAndAndProfessionalFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_PayrollAndAndProfessionalFees"/>
  <xs:element name="OtherProductionCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_OtherProductionCosts"/>
  <xs:element name="TotalOtherProductionCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_TotalOtherProductionCost"/>
  <xs:element name="NetLossperShareDetailsScheduleofNetLossPerShareTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_NetLossperShareDetailsScheduleofNetLossPerShareTable"/>
  <xs:element name="NetLossperShareDetailsScheduleofNetLossPerShareLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NetLossperShareDetailsScheduleofNetLossPerShareLineItems"/>
  <xs:element name="NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsTable"/>
  <xs:element name="NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsLineItems"/>
  <xs:element name="RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsTable"/>
  <xs:element name="RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsLineItems"/>
  <xs:element name="RelatedPartiesDetailsScheduleofShareBasedPaymentTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentTable"/>
  <xs:element name="RelatedPartiesDetailsScheduleofShareBasedPaymentLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentLineItems"/>
  <xs:element name="CFOSharesAlloted" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_CFOSharesAlloted"/>
  <xs:element name="IssueOfSharesCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_IssueOfSharesCapital"/>
  <xs:element name="IssueOfSharePremium" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_IssueOfSharePremium"/>
  <xs:element name="ExpensesPaid" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ExpensesPaid"/>
  <xs:element name="ServicesProvidedByOtherCompanies" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ServicesProvidedByOtherCompanies"/>
  <xs:element name="RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsTable"/>
  <xs:element name="RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsLineItems"/>
  <xs:element name="SubsidiaryPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SubsidiaryPercentage"/>
  <xs:element name="OwnedPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OwnedPercentage"/>
  <xs:element name="RelatedPartiesDetailsScheduleofotherrelatedpartybalancesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesTable"/>
  <xs:element name="RelatedPartiesDetailsScheduleofotherrelatedpartybalancesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesLineItems"/>
  <xs:element name="OtherRelatedPartyBalances" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_OtherRelatedPartyBalances"/>
  <xs:element name="RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsTable"/>
  <xs:element name="RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsLineItems"/>
  <xs:element name="FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesTable"/>
  <xs:element name="FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesLineItems"/>
  <xs:element name="FinancialRiskManagementDetailsScheduleofContractualMaturityDateTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateTable"/>
  <xs:element name="FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems"/>
  <xs:element name="SubtotalNonDerivatesLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_SubtotalNonDerivatesLiabilities"/>
  <xs:element name="SubtotalDerivatesLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_SubtotalDerivatesLiabilities"/>
  <xs:element name="TotalLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_TotalLiabilities"/>
  <xs:element name="FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskTable"/>
  <xs:element name="FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems"/>
  <xs:element name="ForeignCurrencyExchangeRiskAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ForeignCurrencyExchangeRiskAssets"/>
  <xs:element name="ForeignCurrencyExchangeRiskLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ForeignCurrencyExchangeRiskLiabilities"/>
  <xs:element name="FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsTable"/>
  <xs:element name="FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems"/>
  <xs:element name="FinancialDebts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_FinancialDebts"/>
  <xs:element name="GeneralInformationDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_GeneralInformationDetailsTable"/>
  <xs:element name="GeneralInformationDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_GeneralInformationDetailsLineItems"/>
  <xs:element name="CommonStockExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CommonStockExercised"/>
  <xs:element name="RedemptionPrice" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_RedemptionPrice"/>
  <xs:element name="AggregateRedemption" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AggregateRedemption"/>
  <xs:element name="TrustAccount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_TrustAccount"/>
  <xs:element name="SponsorShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SponsorShares"/>
  <xs:element name="ShareBasedPaymentCost" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ShareBasedPaymentCost"/>
  <xs:element name="NegativeWorkingCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_NegativeWorkingCapital"/>
  <xs:element name="CashPayment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_CashPayment"/>
  <xs:element name="ShareEquivalent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ShareEquivalent"/>
  <xs:element name="ExperienceDate" type="xbrli:durationItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_ExperienceDate"/>
  <xs:element name="CumulativeInflationRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CumulativeInflationRate"/>
  <xs:element name="Accumulated" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_Accumulated"/>
  <xs:element name="InflationAccumulated" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_InflationAccumulated"/>
  <xs:element name="ArgentinePriceIndexes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ArgentinePriceIndexes"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_SummaryofSignificantAccountingPoliciesDetailsTable"/>
  <xs:element name="SummaryofSignificantAccountingPoliciesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SummaryofSignificantAccountingPoliciesDetailsLineItems"/>
  <xs:element name="NumberOfSharesToBeIssuedOfContingentPayment" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NumberOfSharesToBeIssuedOfContingentPayment"/>
  <xs:element name="JointArrangementParticipationPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_JointArrangementParticipationPercentage"/>
  <xs:element name="OriginalAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_OriginalAmount"/>
  <xs:element name="OtherNonCurrentReceivablesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_OtherNonCurrentReceivablesDetailsTable"/>
  <xs:element name="OtherNonCurrentReceivablesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OtherNonCurrentReceivablesDetailsLineItems"/>
  <xs:element name="AggregatePurchasePrice" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_AggregatePurchasePrice"/>
  <xs:element name="PurchasePaymentTerms" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PurchasePaymentTerms"/>
  <xs:element name="ShareCapitalStockAndSharePremiumAmounts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_ShareCapitalStockAndSharePremiumAmounts"/>
  <xs:element name="Equivalent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_Equivalent"/>
  <xs:element name="SharePurchaseAgreementOverPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SharePurchaseAgreementOverPeriod"/>
  <xs:element name="UnderIssuedSharePurchaseAgreement" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnderIssuedSharePurchaseAgreement"/>
  <xs:element name="SharePurchaseAgreement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_SharePurchaseAgreement"/>
  <xs:element name="ShareBasedPaymentDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_ShareBasedPaymentDetailsTable"/>
  <xs:element name="ShareBasedPaymentDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ShareBasedPaymentDetailsLineItems"/>
  <xs:element name="OrdinaryShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_OrdinaryShares"/>
  <xs:element name="ConstantValuePercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ConstantValuePercentage"/>
  <xs:element name="OptionsRecognizedAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="mlec_OptionsRecognizedAmount"/>
  <xs:element name="AggregateShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AggregateShares"/>
  <xs:element name="PricePerWarrant" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PricePerWarrant"/>
  <xs:element name="ExercisePricePerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ExercisePricePerShare"/>
  <xs:element name="ConvertedShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_ConvertedShares"/>
  <xs:element name="PurchasePricePerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_PurchasePricePerShare"/>
  <xs:element name="PurchasePrice" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_PurchasePrice"/>
  <xs:element name="DeferredTaxandIncomeTaxDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_DeferredTaxandIncomeTaxDetailsTable"/>
  <xs:element name="DeferredTaxandIncomeTaxDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DeferredTaxandIncomeTaxDetailsLineItems"/>
  <xs:element name="IncomeTaxRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="mlec_IncomeTaxRate"/>
  <xs:element name="FinancialRiskManagementDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_FinancialRiskManagementDetailsTable"/>
  <xs:element name="FinancialRiskManagementDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FinancialRiskManagementDetailsLineItems"/>
  <xs:element name="PercentageOfFunctionalCurrency" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PercentageOfFunctionalCurrency"/>
  <xs:element name="PercentageOfInterestRates" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PercentageOfInterestRates"/>
  <xs:element name="IncreasedecreaseInterestPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_IncreasedecreaseInterestPayable"/>
  <xs:element name="EventsaftertheReportingPeriodDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="mlec_EventsaftertheReportingPeriodDetailsTable"/>
  <xs:element name="EventsaftertheReportingPeriodDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_EventsaftertheReportingPeriodDetailsLineItems"/>
  <xs:element name="StrikePricePerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_StrikePricePerShare"/>
  <xs:element name="NumberOfStockInventories" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NumberOfStockInventories"/>
  <xs:element name="CashPaidInKindInterest" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="mlec_CashPaidInKindInterest"/>
  <xs:element name="AGBiomoleculesLLCDEMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AGBiomoleculesLLCDEMember"/>
  <xs:element name="ArgentinePesosMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ArgentinePesosMember"/>
  <xs:element name="AsociacinMutualAMALoansMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_AsociacinMutualAMALoansMember"/>
  <xs:element name="BGFarmingTechnologiesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BGFarmingTechnologiesMember"/>
  <xs:element name="BackstopSharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BackstopSharesMember"/>
  <xs:element name="BancoCrdobaPreFinancingOfExportsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BancoCrdobaPreFinancingOfExportsMember"/>
  <xs:element name="BancoGaliciaBankOverdraftsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BancoGaliciaBankOverdraftsMember"/>
  <xs:element name="BancoGaliciaLoansMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BancoGaliciaLoansMember"/>
  <xs:element name="BancoMacroLoansMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BancoMacroLoansMember"/>
  <xs:element name="BancoMacroPreFinancingOfExportsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BancoMacroPreFinancingOfExportsMember"/>
  <xs:element name="BancoNacinPreFinancingOfExportsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BancoNacinPreFinancingOfExportsMember"/>
  <xs:element name="BancoSantanderBankOverdraftsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BancoSantanderBankOverdraftsMember"/>
  <xs:element name="BancoSantanderLoansMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BancoSantanderLoansMember"/>
  <xs:element name="BetweenOneAndTwoYearsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BetweenOneAndTwoYearsMember"/>
  <xs:element name="BetweenTwoAndFiveYearsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BetweenTwoAndFiveYearsMember"/>
  <xs:element name="BioceresCropSolutionsCorpMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BioceresCropSolutionsCorpMember"/>
  <xs:element name="BioceresLLCMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BioceresLLCMember"/>
  <xs:element name="BioceresSAAgralityIncMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BioceresSAAgralityIncMember"/>
  <xs:element name="BioceresSABioceresLLCMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BioceresSABioceresLLCMember"/>
  <xs:element name="BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember"/>
  <xs:element name="BioceresSAINMETSAIngenieriaMetabolicaSAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BioceresSAINMETSAIngenieriaMetabolicaSAMember"/>
  <xs:element name="BioceresSAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BioceresSAMember"/>
  <xs:element name="ChymosinOsmosisEquipmentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ChymosinOsmosisEquipmentMember"/>
  <xs:element name="CumulativeTranslationAdjustmentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CumulativeTranslationAdjustmentMember"/>
  <xs:element name="CustomerRelationshipMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CustomerRelationshipMember"/>
  <xs:element name="EquitySettledShareBasedPaymentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_EquitySettledShareBasedPaymentMember"/>
  <xs:element name="FurnitureMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FurnitureMember"/>
  <xs:element name="FutureFoodsBVMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_FutureFoodsBVMember"/>
  <xs:element name="GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember"/>
  <xs:element name="Group1GrantedMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_Group1GrantedMember"/>
  <xs:element name="Group1Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_Group1Member"/>
  <xs:element name="Group2GrantedMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_Group2GrantedMember"/>
  <xs:element name="Group2Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_Group2Member"/>
  <xs:element name="Group3GrantedMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_Group3GrantedMember"/>
  <xs:element name="Group3Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_Group3Member"/>
  <xs:element name="HSBCBankBankOverdraftsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_HSBCBankBankOverdraftsMember"/>
  <xs:element name="HSBCBankLoansMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_HSBCBankLoansMember"/>
  <xs:element name="INDEARSAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_INDEARSAMember"/>
  <xs:element name="ImpactToProfitOrLossBeforeTaxAssetsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ImpactToProfitOrLossBeforeTaxAssetsMember"/>
  <xs:element name="ImpactToProfitOrLossBeforeTaxLiabilitiesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ImpactToProfitOrLossBeforeTaxLiabilitiesMember"/>
  <xs:element name="LightJumpAcquisitionCorporationMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_LightJumpAcquisitionCorporationMember"/>
  <xs:element name="LightJumpSharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_LightJumpSharesMember"/>
  <xs:element name="LuxMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_LuxMember"/>
  <xs:element name="MicrooFoodsIngredientsSLMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MicrooFoodsIngredientsSLMember"/>
  <xs:element name="MoolecSAFEMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MoolecSAFEMember"/>
  <xs:element name="MoolecSAShareholdersMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MoolecSAShareholdersMember"/>
  <xs:element name="MoolecScienceLimitedMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MoolecScienceLimitedMember"/>
  <xs:element name="MoolecScienceSAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MoolecScienceSAMember"/>
  <xs:element name="MoolecScienceSharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MoolecScienceSharesMember"/>
  <xs:element name="MoreThanFiveYearsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_MoreThanFiveYearsMember"/>
  <xs:element name="NetBookAmountMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NetBookAmountMember"/>
  <xs:element name="NetDeferredTaxLiabilitiesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NetDeferredTaxLiabilitiesMember"/>
  <xs:element name="PoundSterlingMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PoundSterlingMember"/>
  <xs:element name="PromissoryNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_PromissoryNotesMember"/>
  <xs:element name="SAFESharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SAFESharesMember"/>
  <xs:element name="SPCTechnologyMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SPCTechnologyMember"/>
  <xs:element name="SoftwareLicenseMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_SoftwareLicenseMember"/>
  <xs:element name="StorageMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_StorageMember"/>
  <xs:element name="THEOISCSpMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_THEOISCSpMember"/>
  <xs:element name="TwoThousandTwentyThreeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_TwoThousandTwentyThreeMember"/>
  <xs:element name="TwoThousandTwentyTwoMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_TwoThousandTwentyTwoMember"/>
  <xs:element name="UGVLAndTheoMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UGVLAndTheoMember"/>
  <xs:element name="USDollarMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_USDollarMember"/>
  <xs:element name="UnionGroupVenturesLimitedMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnionGroupVenturesLimitedMember"/>
  <xs:element name="UnionGroupVenturesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UnionGroupVenturesMember"/>
  <xs:element name="UpToThreeMonthsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_UpToThreeMonthsMember"/>
  <xs:element name="ValoraSoySAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ValoraSoySAMember"/>
  <xs:element name="WithinOneYearOrOnDemandMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_WithinOneYearOrOnDemandMember"/>
  <xs:element name="WithoutAnyEstablishedTermMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_WithoutAnyEstablishedTermMember"/>
  <xs:element name="BusinessCombinationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_BusinessCombinationAbstract"/>
  <xs:element name="CapitalRiskManagementAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CapitalRiskManagementAbstract"/>
  <xs:element name="ChangesInWorkingCapitalAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ChangesInWorkingCapitalAbstract"/>
  <xs:element name="CostOfSalesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_CostOfSalesAbstract"/>
  <xs:element name="EventsAfterTheReportingPeriodAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_EventsAfterTheReportingPeriodAbstract"/>
  <xs:element name="NonCashFinancingActivitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_NonCashFinancingActivitiesAbstract"/>
  <xs:element name="RightofUseOfAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_RightofUseOfAssetsAbstract"/>
  <xs:element name="ShareCapitalAndSharePremiumAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ShareCapitalAndSharePremiumAbstract"/>
  <xs:element name="ShortTermInvestmentAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_ShortTermInvestmentAbstract"/>
  <xs:element name="WarrantsLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_WarrantsLiabilitiesAbstract"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="mlec_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>mlec-20230630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Oct 30 21:05:19 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ConsolidatedComprehensiveIncome" roleURI="http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ConsolidatedBalanceSheet" roleURI="http://www.moolecscience.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ConsolidatedCashFlow" roleURI="http://www.moolecscience.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofGoodwillTable" roleURI="http://www.moolecscience.com/role/ScheduleofGoodwillTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofOtherNonCurrentReceivablesTable" roleURI="http://www.moolecscience.com/role/ScheduleofOtherNonCurrentReceivablesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofTradeReceivableTable" roleURI="http://www.moolecscience.com/role/ScheduleofTradeReceivableTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofInventoriesTable" roleURI="http://www.moolecscience.com/role/ScheduleofInventoriesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofNetDeferredTaxLiabilitiesTable" roleURI="http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofAdministrativeExpensesTable" roleURI="http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofResearchandDevelopmentExpenseTable" roleURI="http://www.moolecscience.com/role/ScheduleofResearchandDevelopmentExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofContractualMaturityDateTable" roleURI="http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable" roleURI="http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome">
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Revenue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_Revenue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherOperatingIncomeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_OtherOperatingIncomeExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CostOfSales"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_CostOfSales" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SalesAndMarketingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SalesAndMarketingExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_SalesAndMarketingExpense" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_AdministrativeExpense" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossFromOperatingActivities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherFinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherFinanceIncomeCost"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_OtherFinanceIncomeCost" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_FinanceCosts" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="mlec_TransactionsExpenses" xlink:href="mlec-20230630.xsd#mlec_TransactionsExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="mlec_TransactionsExpenses" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLossBeforeTax" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_OtherComprehensiveIncome" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComprehensiveIncome"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ProfitLoss" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentAssets"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_FixedAssets" xlink:href="mlec-20230630.xsd#mlec_FixedAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="mlec_FixedAssets" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Goodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Goodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_Goodwill" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_RightofuseAssets" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentReceivables" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssets"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CashAndCashEquivalents" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_ShorttermInvestmentsCurrent" xlink:href="mlec-20230630.xsd#mlec_ShorttermInvestmentsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="mlec_ShorttermInvestmentsCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTradeReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentTradeReceivables" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_OtherReceivables" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPrepayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentPrepayments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentPrepayments" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Inventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Inventories"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_Inventories" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_NoncurrentAssets" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_CurrentAssets" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_IssuedCapital" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremium" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharePremium"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_SharePremium" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareToBeIssuedAmount" xlink:href="mlec-20230630.xsd#mlec_ShareToBeIssuedAmount"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity" xlink:to="mlec_ShareToBeIssuedAmount" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_EquitySettledShareBasedPayments" xlink:href="mlec-20230630.xsd#mlec_EquitySettledShareBasedPayments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity" xlink:to="mlec_EquitySettledShareBasedPayments" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarnings" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarnings"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_RetainedEarnings" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_TradeAndOtherCurrentPayables" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentFinancialLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_OtherCurrentFinancialLiabilities" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_OtherCurrentLiabilities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WarrantLiability" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WarrantLiability"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_WarrantLiability" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_SimplyAgreementForFutureEquitySAFE" xlink:href="mlec-20230630.xsd#mlec_SimplyAgreementForFutureEquitySAFE"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="mlec_SimplyAgreementForFutureEquitySAFE" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_OtherNoncurrentFinancialLiabilities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentPayables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_OtherNoncurrentPayables" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_DeferredTaxLiabilities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Liabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_CurrentLiabilities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_NoncurrentLiabilities" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAndLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAndLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_Equity" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_Liabilities" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_ProfitLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncomeTaxExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForIncomeTaxExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentCostOfListingSharesnoncashItem" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentCostOfListingSharesnoncashItem"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="mlec_ShareBasedPaymentCostOfListingSharesnoncashItem" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" order="10" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrbCcuxiEw7DaKnp03QCb9S1ssLhKhQhPI9/LGJ51TgzssCI1ODtwCrgkN0a+ZUXnMF8I/KcADyvbmI99H904sqIF1YM5bLcN+DbpeVS5vMyNXq7Gcc0AsRuAtIzhrDpAdkHW0SbRbM9JtED/NKe0AzzApdc0Kim8/GgaIUDBDfI2qGJJ00w0l4cJfwQUe2ZfctNa8zn/B7omw==] CSR-->
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" order="11" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" order="12" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss" order="13" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncomeCost"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_FinanceIncomeCost" order="14" weight="-1"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherLiabilitie" xlink:href="mlec-20230630.xsd#mlec_OtherLiabilitie"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="mlec_OtherLiabilitie" order="15" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromIssuingOtherEquityInstruments" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromIssuingOtherEquityInstruments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_ProceedsFromIssuingOtherEquityInstruments" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_Proceedsfromissuanceofsharecapital" xlink:href="mlec-20230630.xsd#mlec_Proceedsfromissuanceofsharecapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="mlec_Proceedsfromissuanceofsharecapital" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromCurrentBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromCurrentBorrowings"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_ProceedsFromCurrentBorrowings" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_ProceedsFromSAFE" xlink:href="mlec-20230630.xsd#mlec_ProceedsFromSAFE"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="mlec_ProceedsFromSAFE" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromIssuingShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_ProceedsFromIssuingShares" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_ProceedsFromIssueOfShareCapital" xlink:href="mlec-20230630.xsd#mlec_ProceedsFromIssueOfShareCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="mlec_ProceedsFromIssueOfShareCapital" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities" order="9" weight="-1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofGoodwillTable">
    <loc xlink:type="locator" xlink:label="mlec_TotalGoodwill" xlink:href="mlec-20230630.xsd#mlec_TotalGoodwill"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Goodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Goodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mlec_TotalGoodwill" xlink:to="ifrs-full_Goodwill" order="1" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofOtherNonCurrentReceivablesTable">
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentReceivables"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NoncurrentReceivables" xlink:to="ifrs-full_OtherNoncurrentReceivables" order="1" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofTradeReceivableTable">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherReceivables"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_TradeAndOtherReceivables" xlink:to="ifrs-full_TradeReceivables" order="1" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofInventoriesTable">
    <loc xlink:type="locator" xlink:label="ifrs-full_InventoriesTotal" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InventoriesTotal"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RawMaterials" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RawMaterials"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_InventoriesTotal" xlink:to="ifrs-full_RawMaterials" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinishedGoods" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinishedGoods"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_InventoriesTotal" xlink:to="ifrs-full_FinishedGoods" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_TradeAndOtherCurrentReceivables" xlink:to="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <loc xlink:type="locator" xlink:label="mlec_CustomerRelationship" xlink:href="mlec-20230630.xsd#mlec_CustomerRelationship"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_DeferredTaxLiabilityAsset" xlink:to="mlec_CustomerRelationship" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_DeferredTaxLiabilityAsset" xlink:to="ifrs-full_OtherLiabilities" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetDeferredTaxLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NetDeferredTaxLiabilities" xlink:to="ifrs-full_DeferredTaxLiabilityAsset" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_NetDeferredTaxLiabilities" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable">
    <loc xlink:type="locator" xlink:label="ifrs-full_AdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdministrativeExpense"/>
    <loc xlink:type="locator" xlink:label="mlec_AuditLegalAndAccountancyFee" xlink:href="mlec-20230630.xsd#mlec_AuditLegalAndAccountancyFee"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_AdministrativeExpense" xlink:to="mlec_AuditLegalAndAccountancyFee" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EmployeeBenefitsExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EmployeeBenefitsExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_AdministrativeExpense" xlink:to="ifrs-full_EmployeeBenefitsExpense" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_PayrollExpenses" xlink:href="mlec-20230630.xsd#mlec_PayrollExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_AdministrativeExpense" xlink:to="mlec_PayrollExpenses" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InsuranceExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InsuranceExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_AdministrativeExpense" xlink:to="ifrs-full_InsuranceExpense" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TravelExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TravelExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_AdministrativeExpense" xlink:to="ifrs-full_TravelExpense" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_AmortizationExpense" xlink:href="mlec-20230630.xsd#mlec_AmortizationExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_AdministrativeExpense" xlink:to="mlec_AmortizationExpense" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_AdministrativeExpense" xlink:to="ifrs-full_DepreciationExpense" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_AdministrativeExpense" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense" order="8" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofResearchandDevelopmentExpenseTable">
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfessionalFeesExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfessionalFeesExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_ProfessionalFeesExpense" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_LaboratoriesRelatedExpenses" xlink:href="mlec-20230630.xsd#mlec_LaboratoriesRelatedExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="mlec_LaboratoriesRelatedExpenses" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AmortisationExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_AmortisationExpense" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherResearchAndDevelopmentExpenses" xlink:href="mlec-20230630.xsd#mlec_OtherResearchAndDevelopmentExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="mlec_OtherResearchAndDevelopmentExpenses" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable">
    <loc xlink:type="locator" xlink:label="mlec_SubtotalNonDerivatesLiabilities" xlink:href="mlec-20230630.xsd#mlec_SubtotalNonDerivatesLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mlec_SubtotalNonDerivatesLiabilities" xlink:to="ifrs-full_TradeAndOtherPayables" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mlec_SubtotalNonDerivatesLiabilities" xlink:to="ifrs-full_OtherLiabilities" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mlec_SubtotalNonDerivatesLiabilities" xlink:to="ifrs-full_FinancialLiabilities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_SimplyAgreementForFutureEquitySAFE" xlink:href="mlec-20230630.xsd#mlec_SimplyAgreementForFutureEquitySAFE"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mlec_SubtotalNonDerivatesLiabilities" xlink:to="mlec_SimplyAgreementForFutureEquitySAFE" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_SubtotalDerivatesLiabilities" xlink:href="mlec-20230630.xsd#mlec_SubtotalDerivatesLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WarrantLiability" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WarrantLiability"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mlec_SubtotalDerivatesLiabilities" xlink:to="ifrs-full_WarrantLiability" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_TotalLiabilities" xlink:href="mlec-20230630.xsd#mlec_TotalLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mlec_TotalLiabilities" xlink:to="mlec_SubtotalNonDerivatesLiabilities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="mlec_TotalLiabilities" xlink:to="mlec_SubtotalDerivatesLiabilities" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable">
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_TradeAndOtherCurrentPayables" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialDebts" xlink:href="mlec-20230630.xsd#mlec_FinancialDebts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="mlec_FinancialDebts" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="mlec_SimplyAgreementForFutureEquitySAFE" xlink:href="mlec-20230630.xsd#mlec_SimplyAgreementForFutureEquitySAFE"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="mlec_SimplyAgreementForFutureEquitySAFE" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WarrantLiability" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WarrantLiability"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_WarrantLiability" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssetsLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssetsLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssetsLiabilities" xlink:to="ifrs-full_CurrentAssets" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ifrs-full_CurrentAssetsLiabilities" xlink:to="ifrs-full_FinancialLiabilities" order="2" weight="-1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>mlec-20230630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Oct 30 21:05:19 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ConsolidatedComprehensiveIncome" roleURI="http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ConsolidatedComprehensiveIncome_Parentheticals" roleURI="http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ConsolidatedBalanceSheet" roleURI="http://www.moolecscience.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ShareholdersEquityType2or3" roleURI="http://www.moolecscience.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ConsolidatedCashFlow" roleURI="http://www.moolecscience.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_GeneralInformation" roleURI="http://www.moolecscience.com/role/GeneralInformation"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_BusinessCombination" roleURI="http://www.moolecscience.com/role/BusinessCombination"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_AccountingStandardsandBasisofPreparation" roleURI="http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparation"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_SummaryofSignificantAccountingPolicies" roleURI="http://www.moolecscience.com/role/SummaryofSignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ComparativeInformation" roleURI="http://www.moolecscience.com/role/ComparativeInformation"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_IntangibleAssets" roleURI="http://www.moolecscience.com/role/IntangibleAssets"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_FixedAssets" roleURI="http://www.moolecscience.com/role/FixedAssets"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_Goodwill" roleURI="http://www.moolecscience.com/role/Goodwill"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_RightofUseofAssets" roleURI="http://www.moolecscience.com/role/RightofUseofAssets"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_OtherNonCurrentReceivables" roleURI="http://www.moolecscience.com/role/OtherNonCurrentReceivables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_CashandCashEquivalents" roleURI="http://www.moolecscience.com/role/CashandCashEquivalents"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ShortTermInvestments" roleURI="http://www.moolecscience.com/role/ShortTermInvestments"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_TradeReceivableandOtherCurrentReceivables" roleURI="http://www.moolecscience.com/role/TradeReceivableandOtherCurrentReceivables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_Inventories" roleURI="http://www.moolecscience.com/role/Inventories"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ShareCapitalandSharePremium" roleURI="http://www.moolecscience.com/role/ShareCapitalandSharePremium"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ShareBasedPayment" roleURI="http://www.moolecscience.com/role/ShareBasedPayment"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_AccountsPayableandOtherCurrentandNonCurrentLiabilities" roleURI="http://www.moolecscience.com/role/AccountsPayableandOtherCurrentandNonCurrentLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_FinancialDebt" roleURI="http://www.moolecscience.com/role/FinancialDebt"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_WarrantsLiabilities" roleURI="http://www.moolecscience.com/role/WarrantsLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_SimpleAgreementforFutureEquitySAFE" roleURI="http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFE"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_DeferredTaxandIncomeTax" roleURI="http://www.moolecscience.com/role/DeferredTaxandIncomeTax"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_FinancialIncomeExpenses" roleURI="http://www.moolecscience.com/role/FinancialIncomeExpenses"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_OtherOperatingExpense" roleURI="http://www.moolecscience.com/role/OtherOperatingExpense"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_AdministrativeExpenses" roleURI="http://www.moolecscience.com/role/AdministrativeExpenses"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ResearchandDevelopmentExpense" roleURI="http://www.moolecscience.com/role/ResearchandDevelopmentExpense"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_Costofsales" roleURI="http://www.moolecscience.com/role/Costofsales"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_NetLossperShare" roleURI="http://www.moolecscience.com/role/NetLossperShare"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_RelatedParties" roleURI="http://www.moolecscience.com/role/RelatedParties"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_FinancialRiskManagement" roleURI="http://www.moolecscience.com/role/FinancialRiskManagement"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_CapitalRiskManagement" roleURI="http://www.moolecscience.com/role/CapitalRiskManagement"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_EventsaftertheReportingPeriod" roleURI="http://www.moolecscience.com/role/EventsaftertheReportingPeriod"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_AccountingPoliciesByPolicy" roleURI="http://www.moolecscience.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_BusinessCombinationTables" roleURI="http://www.moolecscience.com/role/BusinessCombinationTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_IntangibleAssetsTables" roleURI="http://www.moolecscience.com/role/IntangibleAssetsTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_FixedAssetsTables" roleURI="http://www.moolecscience.com/role/FixedAssetsTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_GoodwillTables" roleURI="http://www.moolecscience.com/role/GoodwillTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_RightofUseofAssetsTables" roleURI="http://www.moolecscience.com/role/RightofUseofAssetsTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_OtherNonCurrentReceivablesTables" roleURI="http://www.moolecscience.com/role/OtherNonCurrentReceivablesTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_CashandCashEquivalentsTables" roleURI="http://www.moolecscience.com/role/CashandCashEquivalentsTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ShortTermInvestmentsTables" roleURI="http://www.moolecscience.com/role/ShortTermInvestmentsTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_TradeReceivableandOtherCurrentReceivablesTables" roleURI="http://www.moolecscience.com/role/TradeReceivableandOtherCurrentReceivablesTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_InventoriesTables" roleURI="http://www.moolecscience.com/role/InventoriesTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ShareCapitalandSharePremiumTables" roleURI="http://www.moolecscience.com/role/ShareCapitalandSharePremiumTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ShareBasedPaymentTables" roleURI="http://www.moolecscience.com/role/ShareBasedPaymentTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTables" roleURI="http://www.moolecscience.com/role/AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_FinancialDebtTables" roleURI="http://www.moolecscience.com/role/FinancialDebtTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_WarrantsLiabilitiesTables" roleURI="http://www.moolecscience.com/role/WarrantsLiabilitiesTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_SimpleAgreementforFutureEquitySAFETables" roleURI="http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFETables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_DeferredTaxandIncomeTaxTables" roleURI="http://www.moolecscience.com/role/DeferredTaxandIncomeTaxTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_FinancialIncomeExpensesTables" roleURI="http://www.moolecscience.com/role/FinancialIncomeExpensesTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_OtherOperatingExpenseTables" roleURI="http://www.moolecscience.com/role/OtherOperatingExpenseTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_AdministrativeExpensesTables" roleURI="http://www.moolecscience.com/role/AdministrativeExpensesTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ResearchandDevelopmentExpenseTables" roleURI="http://www.moolecscience.com/role/ResearchandDevelopmentExpenseTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_CostofsalesTables" roleURI="http://www.moolecscience.com/role/CostofsalesTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_NetLossperShareTables" roleURI="http://www.moolecscience.com/role/NetLossperShareTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_RelatedPartiesTables" roleURI="http://www.moolecscience.com/role/RelatedPartiesTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_FinancialRiskManagementTables" roleURI="http://www.moolecscience.com/role/FinancialRiskManagementTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofNetAssetsAcquiredandGoodwillTable" roleURI="http://www.moolecscience.com/role/ScheduleofNetAssetsAcquiredandGoodwillTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofAssetsandLiabilitiesRecognisedTable" roleURI="http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofUsefulLivesofPropertyPlantandEquipmentTable" roleURI="http://www.moolecscience.com/role/ScheduleofUsefulLivesofPropertyPlantandEquipmentTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofConsolidatedFinancialStatementsTable" roleURI="http://www.moolecscience.com/role/ScheduleofConsolidatedFinancialStatementsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable" roleURI="http://www.moolecscience.com/role/ScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofIntangibleAssetsTable" roleURI="http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofFixedAssetsTable" roleURI="http://www.moolecscience.com/role/ScheduleofFixedAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofGoodwillTable" roleURI="http://www.moolecscience.com/role/ScheduleofGoodwillTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofRightofUseofAssetsTable" roleURI="http://www.moolecscience.com/role/ScheduleofRightofUseofAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofOtherNonCurrentReceivablesTable" roleURI="http://www.moolecscience.com/role/ScheduleofOtherNonCurrentReceivablesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofCashandCashEquivalentsTable" roleURI="http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofShortTermInvestmentsTable" roleURI="http://www.moolecscience.com/role/ScheduleofShortTermInvestmentsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofTradeReceivableTable" roleURI="http://www.moolecscience.com/role/ScheduleofTradeReceivableTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofOtherCurrentReceivablesTable" roleURI="http://www.moolecscience.com/role/ScheduleofOtherCurrentReceivablesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofInventoriesTable" roleURI="http://www.moolecscience.com/role/ScheduleofInventoriesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofReconciliationofShareCapitalandSharePremiumTable" roleURI="http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable" roleURI="http://www.moolecscience.com/role/ScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable" roleURI="http://www.moolecscience.com/role/ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofAccountsPayableTable" roleURI="http://www.moolecscience.com/role/ScheduleofAccountsPayableTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofFinancialDebtTable" roleURI="http://www.moolecscience.com/role/ScheduleofFinancialDebtTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable" roleURI="http://www.moolecscience.com/role/ScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofTermsandConditionsofOutstandingLoansTable" roleURI="http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofFairValueOrdinaryShareofWarrantsTable" roleURI="http://www.moolecscience.com/role/ScheduleofFairValueOrdinaryShareofWarrantsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofFinancialInstrumentsTable" roleURI="http://www.moolecscience.com/role/ScheduleofFinancialInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofRollForwardofNetDeferredTaxTable" roleURI="http://www.moolecscience.com/role/ScheduleofRollForwardofNetDeferredTaxTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable" roleURI="http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofIncomeTaxforOtherJurisdictionsTable" roleURI="http://www.moolecscience.com/role/ScheduleofIncomeTaxforOtherJurisdictionsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofNetDeferredTaxLiabilitiesTable" roleURI="http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofAccumulatedTaxLossCarryforwardsTable" roleURI="http://www.moolecscience.com/role/ScheduleofAccumulatedTaxLossCarryforwardsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofEstimatedFutureTaxableProfitTable" roleURI="http://www.moolecscience.com/role/ScheduleofEstimatedFutureTaxableProfitTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofFinancialIncomeExpensesTable" roleURI="http://www.moolecscience.com/role/ScheduleofFinancialIncomeExpensesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofOtherOperatingExpenseTable" roleURI="http://www.moolecscience.com/role/ScheduleofOtherOperatingExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofAdministrativeExpensesTable" roleURI="http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofResearchandDevelopmentExpenseTable" roleURI="http://www.moolecscience.com/role/ScheduleofResearchandDevelopmentExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofCostofsalesTable" roleURI="http://www.moolecscience.com/role/ScheduleofCostofsalesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofNetLossPerShareTable" roleURI="http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofNetLossPerShareTable_Parentheticals" roleURI="http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofOtherRelatedPartyTransactionsTable" roleURI="http://www.moolecscience.com/role/ScheduleofOtherRelatedPartyTransactionsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofShareBasedPaymentTable" roleURI="http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofShareBasedPaymentTable_Parentheticals" roleURI="http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofotherrelatedpartybalancesTable" roleURI="http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofotherrelatedpartybalancesTable_Parentheticals" roleURI="http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofTradeandOtherReceivablesTable" roleURI="http://www.moolecscience.com/role/ScheduleofTradeandOtherReceivablesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofContractualMaturityDateTable" roleURI="http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofForeignCurrencyExchangeRiskTable" roleURI="http://www.moolecscience.com/role/ScheduleofForeignCurrencyExchangeRiskTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable" roleURI="http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofFixedRateInstrumentsTable" roleURI="http://www.moolecscience.com/role/ScheduleofFixedRateInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_GeneralInformationDetails" roleURI="http://www.moolecscience.com/role/GeneralInformationDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_BusinessCombinationDetails" roleURI="http://www.moolecscience.com/role/BusinessCombinationDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_AccountingStandardsandBasisofPreparationDetails" roleURI="http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_SummaryofSignificantAccountingPoliciesDetails" roleURI="http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_RightofUseofAssetsDetails" roleURI="http://www.moolecscience.com/role/RightofUseofAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_OtherNonCurrentReceivablesDetails" roleURI="http://www.moolecscience.com/role/OtherNonCurrentReceivablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ShareCapitalandSharePremiumDetails" roleURI="http://www.moolecscience.com/role/ShareCapitalandSharePremiumDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ShareBasedPaymentDetails" roleURI="http://www.moolecscience.com/role/ShareBasedPaymentDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_WarrantsLiabilitiesDetails" roleURI="http://www.moolecscience.com/role/WarrantsLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_SimpleAgreementforFutureEquitySAFEDetails" roleURI="http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFEDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_DeferredTaxandIncomeTaxDetails" roleURI="http://www.moolecscience.com/role/DeferredTaxandIncomeTaxDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_FinancialRiskManagementDetails" roleURI="http://www.moolecscience.com/role/FinancialRiskManagementDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_EventsaftertheReportingPeriodDetails" roleURI="http://www.moolecscience.com/role/EventsaftertheReportingPeriodDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#DocumentAndEntityInformation" roleURI="http://www.moolecscience.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome">
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeStatementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_ContinuingOperationsAbstract" xlink:href="mlec-20230630.xsd#mlec_ContinuingOperationsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="mlec_ContinuingOperationsAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Revenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ContinuingOperationsAbstract" xlink:to="ifrs-full_Revenue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CostOfSales"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ContinuingOperationsAbstract" xlink:to="ifrs-full_CostOfSales" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ContinuingOperationsAbstract" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SalesAndMarketingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SalesAndMarketingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ContinuingOperationsAbstract" xlink:to="ifrs-full_SalesAndMarketingExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ContinuingOperationsAbstract" xlink:to="ifrs-full_AdministrativeExpense" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherOperatingIncomeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ContinuingOperationsAbstract" xlink:to="ifrs-full_OtherOperatingIncomeExpense" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ContinuingOperationsAbstract" xlink:to="ifrs-full_ProfitLossFromOperatingActivities" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_FinanceCosts" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherFinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherFinanceIncomeCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_OtherFinanceIncomeCost" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TransactionsExpenses" xlink:href="mlec-20230630.xsd#mlec_TransactionsExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="mlec_TransactionsExpenses" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLossBeforeTax" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLoss" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_BasicEarningsLossPerShare" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncomeAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_OtherComprehensiveIncomeAbstract" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="ifrs-full_OtherComprehensiveIncome" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComprehensiveIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="ifrs-full_ComprehensiveIncome" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome_Parentheticals">
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeStatementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_DilutedEarningsLossPerShare" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_NonCurrentAssetsAbstract" xlink:href="mlec-20230630.xsd#mlec_NonCurrentAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="mlec_NonCurrentAssetsAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_NonCurrentAssetsAbstract" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_FixedAssets" xlink:href="mlec-20230630.xsd#mlec_FixedAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_NonCurrentAssetsAbstract" xlink:to="mlec_FixedAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Goodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Goodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_NonCurrentAssetsAbstract" xlink:to="ifrs-full_Goodwill" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_NonCurrentAssetsAbstract" xlink:to="ifrs-full_RightofuseAssets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_NonCurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentReceivables" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NoncurrentAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentAssetsAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CashAndCashEquivalents" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ShorttermInvestmentsCurrent" xlink:href="mlec-20230630.xsd#mlec_ShorttermInvestmentsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="mlec_ShorttermInvestmentsCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTradeReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentTradeReceivables" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_OtherReceivables" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPrepayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentPrepayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentPrepayments" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Inventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Inventories"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_Inventories" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentAssets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Assets" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_EquityAbstract" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_IssuedCapital" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremium" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharePremium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_SharePremium" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareToBeIssuedAmount" xlink:href="mlec-20230630.xsd#mlec_ShareToBeIssuedAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EquityAbstract" xlink:to="mlec_ShareToBeIssuedAmount" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_EquitySettledShareBasedPayments" xlink:href="mlec-20230630.xsd#mlec_EquitySettledShareBasedPayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EquityAbstract" xlink:to="mlec_EquitySettledShareBasedPayments" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarnings" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarnings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_RetainedEarnings" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Equity" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentLiabilitiesAbstract" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayables" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentFinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_OtherCurrentFinancialLiabilities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_OtherCurrentLiabilities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WarrantLiability" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WarrantLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_WarrantLiability" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SimplyAgreementForFutureEquitySAFE" xlink:href="mlec-20230630.xsd#mlec_SimplyAgreementForFutureEquitySAFE"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="mlec_SimplyAgreementForFutureEquitySAFE" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentLiabilities" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NonCurrentLiabilitiesAbstract" xlink:href="mlec-20230630.xsd#mlec_NonCurrentLiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="mlec_NonCurrentLiabilitiesAbstract" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_NonCurrentLiabilitiesAbstract" xlink:to="ifrs-full_OtherNoncurrentFinancialLiabilities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_NonCurrentLiabilitiesAbstract" xlink:to="ifrs-full_OtherNoncurrentPayables" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_NonCurrentLiabilitiesAbstract" xlink:to="ifrs-full_DeferredTaxLiabilities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NoncurrentLiabilities" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Liabilities" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAndLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAndLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_EquityAndLiabilities" order="12" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_StatementOfChangesInEquityTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_EquityMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_EquityMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_ClassesOfShareCapitalMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_IssuedCapitalMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremiumMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharePremiumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_SharePremiumMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CumulativeTranslationAdjustmentMember" xlink:href="mlec-20230630.xsd#mlec_CumulativeTranslationAdjustmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EquityMember" xlink:to="mlec_CumulativeTranslationAdjustmentMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_EquitySettledShareBasedPaymentMember" xlink:href="mlec-20230630.xsd#mlec_EquitySettledShareBasedPaymentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EquityMember" xlink:to="mlec_EquitySettledShareBasedPaymentMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarningsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_RetainedEarningsMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_Equity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IssueOfShareCapital" xlink:href="mlec-20230630.xsd#mlec_IssueOfShareCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="mlec_IssueOfShareCapital" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_EquitySettledShareBasedPayment" xlink:href="mlec-20230630.xsd#mlec_EquitySettledShareBasedPayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="mlec_EquitySettledShareBasedPayment" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssueOfEquity" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssueOfEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IssueOfEquity" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IssueOfShareCapitalSAFEShares" xlink:href="mlec-20230630.xsd#mlec_IssueOfShareCapitalSAFEShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IssueOfEquity" xlink:to="mlec_IssueOfShareCapitalSAFEShares" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IssueOfShareCapitalLightJumpShares" xlink:href="mlec-20230630.xsd#mlec_IssueOfShareCapitalLightJumpShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IssueOfEquity" xlink:to="mlec_IssueOfShareCapitalLightJumpShares" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IssueOfShareCapitalBackstopShares" xlink:href="mlec-20230630.xsd#mlec_IssueOfShareCapitalBackstopShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IssueOfEquity" xlink:to="mlec_IssueOfShareCapitalBackstopShares" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IssueOfEquity" xlink:to="ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BusinessCombination" xlink:href="mlec-20230630.xsd#mlec_BusinessCombination"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IssueOfEquity" xlink:to="mlec_BusinessCombination" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IssueOfEquity" xlink:to="ifrs-full_ProfitLoss" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_ProfitLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncomeTaxExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForIncomeTaxExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentCostOfListingSharesnoncashItem" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentCostOfListingSharesnoncashItem"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="mlec_ShareBasedPaymentCostOfListingSharesnoncashItem" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncomeCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_FinanceIncomeCost" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ChangesInWorkingCapitalAbstract" xlink:href="mlec-20230630.xsd#mlec_ChangesInWorkingCapitalAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="mlec_ChangesInWorkingCapitalAbstract" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ChangesInWorkingCapitalAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ChangesInWorkingCapitalAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ChangesInWorkingCapitalAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ChangesInWorkingCapitalAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ChangesInWorkingCapitalAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ChangesInWorkingCapitalAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherLiabilitie" xlink:href="mlec-20230630.xsd#mlec_OtherLiabilitie"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ChangesInWorkingCapitalAbstract" xlink:to="mlec_OtherLiabilitie" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ChangesInWorkingCapitalAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromIssuingOtherEquityInstruments" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromIssuingOtherEquityInstruments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromIssuingOtherEquityInstruments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_Proceedsfromissuanceofsharecapital" xlink:href="mlec-20230630.xsd#mlec_Proceedsfromissuanceofsharecapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="mlec_Proceedsfromissuanceofsharecapital" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromCurrentBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromCurrentBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromCurrentBorrowings" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ProceedsFromSAFE" xlink:href="mlec-20230630.xsd#mlec_ProceedsFromSAFE"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="mlec_ProceedsFromSAFE" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromIssuingShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromIssuingShares" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ProceedsFromIssueOfShareCapital" xlink:href="mlec-20230630.xsd#mlec_ProceedsFromIssueOfShareCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="mlec_ProceedsFromIssueOfShareCapital" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NonCashFinancingActivitiesAbstract" xlink:href="mlec-20230630.xsd#mlec_NonCashFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="mlec_NonCashFinancingActivitiesAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei" xlink:href="mlec-20230630.xsd#mlec_IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_NonCashFinancingActivitiesAbstract" xlink:to="mlec_IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium" xlink:href="mlec-20230630.xsd#mlec_ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_NonCashFinancingActivitiesAbstract" xlink:to="mlec_ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CapitalizationOfTransactionExpensesThroughAccountsPayable" xlink:href="mlec-20230630.xsd#mlec_CapitalizationOfTransactionExpensesThroughAccountsPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_NonCashFinancingActivitiesAbstract" xlink:to="mlec_CapitalizationOfTransactionExpensesThroughAccountsPayable" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NetLiabilitiesAcquiredThroughIssuanceOfShareCapital" xlink:href="mlec-20230630.xsd#mlec_NetLiabilitiesAcquiredThroughIssuanceOfShareCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_NonCashFinancingActivitiesAbstract" xlink:to="mlec_NetLiabilitiesAcquiredThroughIssuanceOfShareCapital" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AcquisitionOfBusinessCombinationTroughDeferredPayment" xlink:href="mlec-20230630.xsd#mlec_AcquisitionOfBusinessCombinationTroughDeferredPayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_NonCashFinancingActivitiesAbstract" xlink:to="mlec_AcquisitionOfBusinessCombinationTroughDeferredPayment" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind" xlink:href="mlec-20230630.xsd#mlec_AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_NonCashFinancingActivitiesAbstract" xlink:to="mlec_AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares" xlink:href="mlec-20230630.xsd#mlec_AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_NonCashFinancingActivitiesAbstract" xlink:to="mlec_AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/GeneralInformation">
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/BusinessCombination">
    <loc xlink:type="locator" xlink:label="mlec_BusinessCombinationAbstract" xlink:href="mlec-20230630.xsd#mlec_BusinessCombinationAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfBusinessCombinationsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_BusinessCombinationAbstract" xlink:to="ifrs-full_DisclosureOfBusinessCombinationsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparation">
    <loc xlink:type="locator" xlink:label="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/SummaryofSignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ComparativeInformation">
    <loc xlink:type="locator" xlink:label="mlec_ComparativeInformationLineItems" xlink:href="mlec-20230630.xsd#mlec_ComparativeInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_ComparativeInformationTable" xlink:href="mlec-20230630.xsd#mlec_ComparativeInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_ComparativeInformationLineItems" xlink:to="mlec_ComparativeInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAdditionalInformationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfAdditionalInformationExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ComparativeInformationLineItems" xlink:to="ifrs-full_DisclosureOfAdditionalInformationExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/IntangibleAssets">
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/FixedAssets">
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/Goodwill">
    <loc xlink:type="locator" xlink:label="ifrs-full_ChangesInGoodwillAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ChangesInGoodwillAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfGoodwillExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ChangesInGoodwillAbstract" xlink:to="ifrs-full_DisclosureOfGoodwillExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/RightofUseofAssets">
    <loc xlink:type="locator" xlink:label="mlec_RightofUseOfAssetsAbstract" xlink:href="mlec-20230630.xsd#mlec_RightofUseOfAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_RightofUseOfAssetsAbstract" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/OtherNonCurrentReceivables">
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentReceivablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NoncurrentReceivablesAbstract" xlink:to="ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/CashandCashEquivalents">
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CashAndCashEquivalentsAbstract" xlink:to="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ShortTermInvestments">
    <loc xlink:type="locator" xlink:label="mlec_ShortTermInvestmentAbstract" xlink:href="mlec-20230630.xsd#mlec_ShortTermInvestmentAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShortTermInvestmentAbstract" xlink:to="ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/TradeReceivableandOtherCurrentReceivables">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:to="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/Inventories">
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfInventoriesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfInventoriesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInventoriesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInventoriesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfInventoriesAbstract" xlink:to="ifrs-full_DisclosureOfInventoriesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ShareCapitalandSharePremium">
    <loc xlink:type="locator" xlink:label="mlec_ShareCapitalAndSharePremiumAbstract" xlink:href="mlec-20230630.xsd#mlec_ShareCapitalAndSharePremiumAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareCapitalAndSharePremiumAbstract" xlink:to="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ShareBasedPayment">
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentAbstract" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentAbstract" xlink:to="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/AccountsPayableandOtherCurrentandNonCurrentLiabilities">
    <loc xlink:type="locator" xlink:label="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesLineItems" xlink:href="mlec-20230630.xsd#mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTable" xlink:href="mlec-20230630.xsd#mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesLineItems" xlink:to="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesLineItems" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/FinancialDebt">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDebtSecuritiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDebtSecuritiesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:to="ifrs-full_DisclosureOfDebtSecuritiesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/WarrantsLiabilities">
    <loc xlink:type="locator" xlink:label="mlec_WarrantsLiabilitiesAbstract" xlink:href="mlec-20230630.xsd#mlec_WarrantsLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_WarrantsLiabilitiesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFE">
    <loc xlink:type="locator" xlink:label="mlec_SimpleAgreementForFutureEquitySafeAbstract" xlink:href="mlec-20230630.xsd#mlec_SimpleAgreementForFutureEquitySafeAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_SimpleAgreementForFutureEquitySAFETextBlock" xlink:href="mlec-20230630.xsd#mlec_SimpleAgreementForFutureEquitySAFETextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_SimpleAgreementForFutureEquitySafeAbstract" xlink:to="mlec_SimpleAgreementForFutureEquitySAFETextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/DeferredTaxandIncomeTax">
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxandIncomeTaxLineItems" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxandIncomeTaxTable" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_DeferredTaxandIncomeTaxLineItems" xlink:to="mlec_DeferredTaxandIncomeTaxTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DeferredTaxandIncomeTaxLineItems" xlink:to="ifrs-full_DisclosureOfIncomeTaxExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/FinancialIncomeExpenses">
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeExpenseGainsOrLossesOfFinancialInstrumentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeExpenseGainsOrLossesOfFinancialInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeExpenseGainsOrLossesOfFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/OtherOperatingExpense">
    <loc xlink:type="locator" xlink:label="mlec_OtherOperatingExpenseLineItems" xlink:href="mlec-20230630.xsd#mlec_OtherOperatingExpenseLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherOperatingExpenseTable" xlink:href="mlec-20230630.xsd#mlec_OtherOperatingExpenseTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_OtherOperatingExpenseLineItems" xlink:to="mlec_OtherOperatingExpenseTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_OtherOperatingExpenseLineItems" xlink:to="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/AdministrativeExpenses">
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract" xlink:to="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ResearchandDevelopmentExpense">
    <loc xlink:type="locator" xlink:label="mlec_ResearchandDevelopmentExpenseLineItems" xlink:href="mlec-20230630.xsd#mlec_ResearchandDevelopmentExpenseLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_ResearchandDevelopmentExpenseTable" xlink:href="mlec-20230630.xsd#mlec_ResearchandDevelopmentExpenseTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_ResearchandDevelopmentExpenseLineItems" xlink:to="mlec_ResearchandDevelopmentExpenseTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchandDevelopmentExpenseLineItems" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/Costofsales">
    <loc xlink:type="locator" xlink:label="mlec_CostOfSalesAbstract" xlink:href="mlec-20230630.xsd#mlec_CostOfSalesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCostOfSalesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfCostOfSalesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CostOfSalesAbstract" xlink:to="ifrs-full_DisclosureOfCostOfSalesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/NetLossperShare">
    <loc xlink:type="locator" xlink:label="mlec_NetLossperShareLineItems" xlink:href="mlec-20230630.xsd#mlec_NetLossperShareLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_NetLossperShareTable" xlink:href="mlec-20230630.xsd#mlec_NetLossperShareTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_NetLossperShareLineItems" xlink:to="mlec_NetLossperShareTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_NetLossperShareLineItems" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/RelatedParties">
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesLineItems" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesTable" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_RelatedPartiesLineItems" xlink:to="mlec_RelatedPartiesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_RelatedPartiesLineItems" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/FinancialRiskManagement">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialRiskManagementExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:to="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/CapitalRiskManagement">
    <loc xlink:type="locator" xlink:label="mlec_CapitalRiskManagementAbstract" xlink:href="mlec-20230630.xsd#mlec_CapitalRiskManagementAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfCapitalRiskManagementTextBlock" xlink:href="mlec-20230630.xsd#mlec_DisclosureOfCapitalRiskManagementTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CapitalRiskManagementAbstract" xlink:to="mlec_DisclosureOfCapitalRiskManagementTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/EventsaftertheReportingPeriod">
    <loc xlink:type="locator" xlink:label="mlec_EventsaftertheReportingPeriodLineItems" xlink:href="mlec-20230630.xsd#mlec_EventsaftertheReportingPeriodLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_EventsaftertheReportingPeriodTable" xlink:href="mlec-20230630.xsd#mlec_EventsaftertheReportingPeriodTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_EventsaftertheReportingPeriodLineItems" xlink:to="mlec_EventsaftertheReportingPeriodTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_EventsaftertheReportingPeriodLineItems" xlink:to="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock" xlink:href="mlec-20230630.xsd#mlec_DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DescriptionOfAccountingPolicyForForeignCurrencyTextBlock" xlink:href="mlec-20230630.xsd#mlec_DescriptionOfAccountingPolicyForForeignCurrencyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mlec_DescriptionOfAccountingPolicyForForeignCurrencyTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock" xlink:href="mlec-20230630.xsd#mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock" xlink:href="mlec-20230630.xsd#mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock" xlink:href="mlec-20230630.xsd#mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock" xlink:href="mlec-20230630.xsd#mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock" xlink:href="mlec-20230630.xsd#mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DescriptionOfAccountingPolicyForLossPerShareTextBlock" xlink:href="mlec-20230630.xsd#mlec_DescriptionOfAccountingPolicyForLossPerShareTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mlec_DescriptionOfAccountingPolicyForLossPerShareTextBlock" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" order="23" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/BusinessCombinationTables">
    <loc xlink:type="locator" xlink:label="mlec_BusinessCombinationAbstract" xlink:href="mlec-20230630.xsd#mlec_BusinessCombinationAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfNetAssetsAcquiredAndGoodwill" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfNetAssetsAcquiredAndGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_BusinessCombinationAbstract" xlink:to="mlec_ScheduleOfNetAssetsAcquiredAndGoodwill" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_BusinessCombinationAbstract" xlink:to="srt_ScheduleOfCondensedBalanceSheetTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/IntangibleAssetsTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfIntangibleAssetsExplanatoryTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_DisclosureOfIntangibleAssetsExplanatoryTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:to="mlec_DisclosureOfIntangibleAssetsExplanatoryTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/FixedAssetsTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfFixedAssetstextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfFixedAssetstextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:to="mlec_ScheduleOfFixedAssetstextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/GoodwillTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_ChangesInGoodwillAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ChangesInGoodwillAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ChangesInGoodwillAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/RightofUseofAssetsTables">
    <loc xlink:type="locator" xlink:label="mlec_RightofUseOfAssetsAbstract" xlink:href="mlec-20230630.xsd#mlec_RightofUseOfAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfRightofuseOfAssetsTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfRightofuseOfAssetsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_RightofUseOfAssetsAbstract" xlink:to="mlec_ScheduleOfRightofuseOfAssetsTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/OtherNonCurrentReceivablesTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentReceivablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOtherNoncurrentReceivableTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherNoncurrentReceivableTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NoncurrentReceivablesAbstract" xlink:to="mlec_ScheduleOfOtherNoncurrentReceivableTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/CashandCashEquivalentsTables">
    <loc xlink:type="locator" xlink:label="mlec_CashandCashEquivalentsTablesLineItems" xlink:href="mlec-20230630.xsd#mlec_CashandCashEquivalentsTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_CashandCashEquivalentsTablesTable" xlink:href="mlec-20230630.xsd#mlec_CashandCashEquivalentsTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_CashandCashEquivalentsTablesLineItems" xlink:to="mlec_CashandCashEquivalentsTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRestrictedCashAndCashEquivalentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRestrictedCashAndCashEquivalentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CashandCashEquivalentsTablesLineItems" xlink:to="ifrs-full_DisclosureOfRestrictedCashAndCashEquivalentsExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ShortTermInvestmentsTables">
    <loc xlink:type="locator" xlink:label="mlec_ShortTermInvestmentAbstract" xlink:href="mlec-20230630.xsd#mlec_ShortTermInvestmentAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfShortTermInvestmentsTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_DisclosureOfShortTermInvestmentsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShortTermInvestmentAbstract" xlink:to="mlec_DisclosureOfShortTermInvestmentsTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/TradeReceivableandOtherCurrentReceivablesTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfTradeReceivableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfTradeReceivableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:to="mlec_ScheduleOfTradeReceivableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOtherCurrentReceivablesTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherCurrentReceivablesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:to="mlec_ScheduleOfOtherCurrentReceivablesTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/InventoriesTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfInventoriesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfInventoriesAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfInventoriesTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_DisclosureOfInventoriesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfInventoriesAbstract" xlink:to="mlec_DisclosureOfInventoriesTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ShareCapitalandSharePremiumTables">
    <loc xlink:type="locator" xlink:label="mlec_ShareCapitalAndSharePremiumAbstract" xlink:href="mlec-20230630.xsd#mlec_ShareCapitalAndSharePremiumAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareCapitalAndSharePremiumAbstract" xlink:to="mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ShareBasedPaymentTables">
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentAbstract" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentAbstract" xlink:to="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentAbstract" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTables">
    <loc xlink:type="locator" xlink:label="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesLineItems" xlink:href="mlec-20230630.xsd#mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesTable" xlink:href="mlec-20230630.xsd#mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesLineItems" xlink:to="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfAccountsPayable" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfAccountsPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesLineItems" xlink:to="mlec_ScheduleOfAccountsPayable" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/FinancialDebtTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:to="ifrs-full_DisclosureOfFinancialAssetsExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AnalysisOfAgeOfFinancialAssetsThatArePastDueButNotImpaired" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AnalysisOfAgeOfFinancialAssetsThatArePastDueButNotImpaired"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:to="ifrs-full_AnalysisOfAgeOfFinancialAssetsThatArePastDueButNotImpaired" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:to="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/WarrantsLiabilitiesTables">
    <loc xlink:type="locator" xlink:label="mlec_WarrantsLiabilitiesAbstract" xlink:href="mlec-20230630.xsd#mlec_WarrantsLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_WarrantsLiabilitiesAbstract" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFETables">
    <loc xlink:type="locator" xlink:label="mlec_SimpleAgreementForFutureEquitySafeAbstract" xlink:href="mlec-20230630.xsd#mlec_SimpleAgreementForFutureEquitySafeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_SimpleAgreementForFutureEquitySafeAbstract" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/DeferredTaxandIncomeTaxTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="ifrs-full_DisclosureOfDeferredTaxesExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfStatutoryTaxesInCountriesTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_DisclosureOfStatutoryTaxesInCountriesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="mlec_DisclosureOfStatutoryTaxesInCountriesTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="mlec_ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="mlec_ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfEstimatedFutureTaxableProfitTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfEstimatedFutureTaxableProfitTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="mlec_ScheduleOfEstimatedFutureTaxableProfitTableTextBlock" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/FinancialIncomeExpensesTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeExpenseGainsOrLossesOfFinancialInstrumentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeExpenseGainsOrLossesOfFinancialInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinanceIncomeExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IncomeExpenseGainsOrLossesOfFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfFinanceIncomeExplanatory" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/OtherOperatingExpenseTables">
    <loc xlink:type="locator" xlink:label="mlec_OtherOperatingExpenseTablesLineItems" xlink:href="mlec-20230630.xsd#mlec_OtherOperatingExpenseTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherOperatingExpenseTablesTable" xlink:href="mlec-20230630.xsd#mlec_OtherOperatingExpenseTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_OtherOperatingExpenseTablesLineItems" xlink:to="mlec_OtherOperatingExpenseTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOtherOperatingExpensesTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherOperatingExpensesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_OtherOperatingExpenseTablesLineItems" xlink:to="mlec_ScheduleOfOtherOperatingExpensesTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/AdministrativeExpensesTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract" xlink:to="mlec_DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ResearchandDevelopmentExpenseTables">
    <loc xlink:type="locator" xlink:label="mlec_ResearchandDevelopmentExpenseTablesLineItems" xlink:href="mlec-20230630.xsd#mlec_ResearchandDevelopmentExpenseTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_ResearchandDevelopmentExpenseTablesTable" xlink:href="mlec-20230630.xsd#mlec_ResearchandDevelopmentExpenseTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_ResearchandDevelopmentExpenseTablesLineItems" xlink:to="mlec_ResearchandDevelopmentExpenseTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchandDevelopmentExpenseTablesLineItems" xlink:to="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/CostofsalesTables">
    <loc xlink:type="locator" xlink:label="mlec_CostOfSalesAbstract" xlink:href="mlec-20230630.xsd#mlec_CostOfSalesAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfCostOfSalesTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfCostOfSalesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CostOfSalesAbstract" xlink:to="mlec_ScheduleOfCostOfSalesTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/NetLossperShareTables">
    <loc xlink:type="locator" xlink:label="mlec_NetLossperShareTablesLineItems" xlink:href="mlec-20230630.xsd#mlec_NetLossperShareTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_NetLossperShareTablesTable" xlink:href="mlec-20230630.xsd#mlec_NetLossperShareTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_NetLossperShareTablesLineItems" xlink:to="mlec_NetLossperShareTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EarningsPerShareExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_NetLossperShareTablesLineItems" xlink:to="ifrs-full_EarningsPerShareExplanatory" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/RelatedPartiesTables">
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesTablesLineItems" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesTablesTable" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_RelatedPartiesTablesLineItems" xlink:to="mlec_RelatedPartiesTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOtherRelatedPartyTransactions" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherRelatedPartyTransactions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_RelatedPartiesTablesLineItems" xlink:to="mlec_ScheduleOfOtherRelatedPartyTransactions" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfShareBasedPayment" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfShareBasedPayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_RelatedPartiesTablesLineItems" xlink:to="mlec_ScheduleOfShareBasedPayment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOtherRelatedPartyBalances" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherRelatedPartyBalances"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_RelatedPartiesTablesLineItems" xlink:to="mlec_ScheduleOfOtherRelatedPartyBalances" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/FinancialRiskManagementTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTradingIncomeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTradingIncomeExpenseExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:to="ifrs-full_DisclosureOfTradingIncomeExpenseExplanatory" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:to="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:to="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfFixedRateInstruments" xlink:href="mlec-20230630.xsd#mlec_DisclosureOfFixedRateInstruments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:to="mlec_DisclosureOfFixedRateInstruments" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofNetAssetsAcquiredandGoodwillTable">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfNetAssetsAcquiredAndGoodwillAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfNetAssetsAcquiredAndGoodwillAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_PurchaseConsiderationAbstract" xlink:href="mlec-20230630.xsd#mlec_PurchaseConsiderationAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfNetAssetsAcquiredAndGoodwillAbstract" xlink:to="mlec_PurchaseConsiderationAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CashPaid" xlink:href="mlec-20230630.xsd#mlec_CashPaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_PurchaseConsiderationAbstract" xlink:to="mlec_CashPaid" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredPaymentAfter6Months" xlink:href="mlec-20230630.xsd#mlec_DeferredPaymentAfter6Months"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_PurchaseConsiderationAbstract" xlink:to="mlec_DeferredPaymentAfter6Months" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_PurchaseConsiderationAbstract" xlink:to="ifrs-full_OtherPayables" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ConsiderationPaid" xlink:href="mlec-20230630.xsd#mlec_ConsiderationPaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_PurchaseConsiderationAbstract" xlink:to="mlec_ConsiderationPaid" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable">
    <loc xlink:type="locator" xlink:label="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedBalanceSheetStatementsCaptionsLineItems"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedBalanceSheetStatementTable" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedBalanceSheetStatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="srt_CondensedBalanceSheetStatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MeasurementAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MeasurementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="srt_CondensedBalanceSheetStatementTable" xlink:to="ifrs-full_MeasurementAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AggregatedMeasurementMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_MeasurementAxis" xlink:to="ifrs-full_AggregatedMeasurementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AggregatedMeasurementMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_MeasurementAxis" xlink:to="ifrs-full_AggregatedMeasurementMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AtFairValueMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AtFairValueMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AggregatedMeasurementMember" xlink:to="ifrs-full_AtFairValueMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BalancesWithBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BalancesWithBanks"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_BalancesWithBanks" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_TradeAndOtherReceivables" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_OtherCurrentReceivables" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherInventories"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_OtherInventories" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherIntangibleAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_OtherIntangibleAssets" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsToRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsToRightofuseAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_AdditionsToRightofuseAssets" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_NoncurrentPayables" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentFinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_CurrentFinancialLiabilities" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_OtherLiabilities" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentFinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_NoncurrentFinancialLiabilities" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_OtherNoncurrentLiabilities" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetDeferredTaxLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_NetDeferredTaxLiabilities" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:to="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetAssetsLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetAssetsLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_NetAssetsLiabilities" order="15" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofUsefulLivesofPropertyPlantandEquipmentTable">
    <loc xlink:type="locator" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems" xlink:href="mlec-20230630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentTable" xlink:href="mlec-20230630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems" xlink:to="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentTable" xlink:to="ifrs-full_RangeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_StorageMember" xlink:href="mlec-20230630.xsd#mlec_StorageMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="mlec_StorageMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MachineryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MachineryMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_MachineryMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_VehiclesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_VehiclesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_VehiclesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_FurnitureMember" xlink:href="mlec-20230630.xsd#mlec_FurnitureMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="mlec_FurnitureMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComputerEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComputerEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_ComputerEquipmentMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofConsolidatedFinancialStatementsTable">
    <loc xlink:type="locator" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems" xlink:href="mlec-20230630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsTable" xlink:href="mlec-20230630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems" xlink:to="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MoolecScienceLimitedMember" xlink:href="mlec-20230630.xsd#mlec_MoolecScienceLimitedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_MoolecScienceLimitedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_LightJumpAcquisitionCorporationMember" xlink:href="mlec-20230630.xsd#mlec_LightJumpAcquisitionCorporationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_LightJumpAcquisitionCorporationMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ValoraSoySAMember" xlink:href="mlec-20230630.xsd#mlec_ValoraSoySAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_ValoraSoySAMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AGBiomoleculesLLCDEMember" xlink:href="mlec-20230630.xsd#mlec_AGBiomoleculesLLCDEMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_AGBiomoleculesLLCDEMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MicrooFoodsIngredientsSLMember" xlink:href="mlec-20230630.xsd#mlec_MicrooFoodsIngredientsSLMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_MicrooFoodsIngredientsSLMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems" xlink:to="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CountryOfIncorporation" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CountryOfIncorporation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems" xlink:to="ifrs-full_CountryOfIncorporation" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfVotingPowerHeldInSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProportionOfVotingPowerHeldInSubsidiary"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems" xlink:to="ifrs-full_ProportionOfVotingPowerHeldInSubsidiary" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable">
    <loc xlink:type="locator" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsLineItems" xlink:href="mlec-20230630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable" xlink:href="mlec-20230630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsLineItems" xlink:to="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable" xlink:to="ifrs-full_ClassesOfFinancialAssetsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_FinancialAssetsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssetsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_FinancialAssetsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_LuxMember" xlink:href="mlec-20230630.xsd#mlec_LuxMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_FinancialAssetsMember" xlink:to="mlec_LuxMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_GB" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_FinancialAssetsMember" xlink:to="country_GB" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_AR" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_AR"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_FinancialAssetsMember" xlink:to="country_AR" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherNonCurrentAssetsOtherThanFinancialAssets" xlink:href="mlec-20230630.xsd#mlec_OtherNonCurrentAssetsOtherThanFinancialAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsLineItems" xlink:to="mlec_OtherNonCurrentAssetsOtherThanFinancialAssets" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable">
    <loc xlink:type="locator" xlink:label="mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems" xlink:href="mlec-20230630.xsd#mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsTable" xlink:href="mlec-20230630.xsd#mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems" xlink:to="mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsTable" xlink:to="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="ifrs-full_IntangibleAssetsAndGoodwillMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsAndGoodwillMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="ifrs-full_IntangibleAssetsAndGoodwillMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember" xlink:href="mlec-20230630.xsd#mlec_GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:to="mlec_GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SPCTechnologyMember" xlink:href="mlec-20230630.xsd#mlec_SPCTechnologyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:to="mlec_SPCTechnologyMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CustomerRelationshipMember" xlink:href="mlec-20230630.xsd#mlec_CustomerRelationshipMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:to="mlec_CustomerRelationshipMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SoftwareLicenseMember" xlink:href="mlec-20230630.xsd#mlec_SoftwareLicenseMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:to="mlec_SoftwareLicenseMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_Cost" xlink:href="mlec-20230630.xsd#mlec_Cost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems" xlink:to="mlec_Cost" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_Cost" xlink:to="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NetBookAmount" xlink:href="mlec-20230630.xsd#mlec_NetBookAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_Cost" xlink:to="mlec_NetBookAmount" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_YearEndedJune302021Abstract" xlink:href="mlec-20230630.xsd#mlec_YearEndedJune302021Abstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems" xlink:to="mlec_YearEndedJune302021Abstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_YearEndedJune302021Abstract" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_YearEndedJune302021Abstract" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_YearEndedJune302021Abstract" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_YearEndedJune302021Abstract" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_Amortization" xlink:href="mlec-20230630.xsd#mlec_Amortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_YearEndedJune302021Abstract" xlink:to="mlec_Amortization" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AsOfJune302023Abstract" xlink:href="mlec-20230630.xsd#mlec_AsOfJune302023Abstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems" xlink:to="mlec_AsOfJune302023Abstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AsOfJune302022Abstract" xlink:href="mlec-20230630.xsd#mlec_AsOfJune302022Abstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems" xlink:to="mlec_AsOfJune302022Abstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AsOfJune302021Abstract" xlink:href="mlec-20230630.xsd#mlec_AsOfJune302021Abstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems" xlink:to="mlec_AsOfJune302021Abstract" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofFixedAssetsTable">
    <loc xlink:type="locator" xlink:label="mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems" xlink:href="mlec-20230630.xsd#mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_FixedAssetsDetailsScheduleofFixedAssetsTable" xlink:href="mlec-20230630.xsd#mlec_FixedAssetsDetailsScheduleofFixedAssetsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems" xlink:to="mlec_FixedAssetsDetailsScheduleofFixedAssetsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_FixedAssetsDetailsScheduleofFixedAssetsTable" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_FixedAssetsDetailsScheduleofFixedAssetsTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossCarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NetBookAmountMember" xlink:href="mlec-20230630.xsd#mlec_NetBookAmountMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="mlec_NetBookAmountMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ChymosinOsmosisEquipmentMember" xlink:href="mlec-20230630.xsd#mlec_ChymosinOsmosisEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="mlec_ChymosinOsmosisEquipmentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_VehiclesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_VehiclesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_VehiclesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_FurnitureMember" xlink:href="mlec-20230630.xsd#mlec_FurnitureMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="mlec_FurnitureMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_StorageMember" xlink:href="mlec-20230630.xsd#mlec_StorageMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="mlec_StorageMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComputerEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComputerEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_ComputerEquipmentMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MachineryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MachineryMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_MachineryMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems" xlink:to="ifrs-full_PropertyPlantAndEquipment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_YearEndedJune302021Abstract0" xlink:href="mlec-20230630.xsd#mlec_YearEndedJune302021Abstract0"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems" xlink:to="mlec_YearEndedJune302021Abstract0" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_YearEndedJune302021Abstract0" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_YearEndedJune302021Abstract0" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_YearEndedJune302021Abstract0" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_YearEndedJune302021Abstract0" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AsOfJune302023Abstract0" xlink:href="mlec-20230630.xsd#mlec_AsOfJune302023Abstract0"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems" xlink:to="mlec_AsOfJune302023Abstract0" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AsOfJune302022Abstract0" xlink:href="mlec-20230630.xsd#mlec_AsOfJune302022Abstract0"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems" xlink:to="mlec_AsOfJune302022Abstract0" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AsOfJune302021Abstract0" xlink:href="mlec-20230630.xsd#mlec_AsOfJune302021Abstract0"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems" xlink:to="mlec_AsOfJune302021Abstract0" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofGoodwillTable">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfGoodwillAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfGoodwillAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Goodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Goodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfGoodwillAbstract" xlink:to="ifrs-full_Goodwill" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TotalGoodwill" xlink:href="mlec-20230630.xsd#mlec_TotalGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfGoodwillAbstract" xlink:to="mlec_TotalGoodwill" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofRightofUseofAssetsTable">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfRightOfUseOfAssetsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfRightOfUseOfAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfRightOfUseOfAssetsAbstract" xlink:to="ifrs-full_RightofuseAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AcquisitionsThroughBusinessCombinationsi" xlink:href="mlec-20230630.xsd#mlec_AcquisitionsThroughBusinessCombinationsi"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfRightOfUseOfAssetsAbstract" xlink:to="mlec_AcquisitionsThroughBusinessCombinationsi" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_EffectOfChangesInForeignExchangeRates" xlink:href="mlec-20230630.xsd#mlec_EffectOfChangesInForeignExchangeRates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfRightOfUseOfAssetsAbstract" xlink:to="mlec_EffectOfChangesInForeignExchangeRates" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofOtherNonCurrentReceivablesTable">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOtherNonCurrentReceivablesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherNonCurrentReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfOtherNonCurrentReceivablesAbstract" xlink:to="ifrs-full_OtherNoncurrentReceivables" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfOtherNonCurrentReceivablesAbstract" xlink:to="ifrs-full_NoncurrentReceivables" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable">
    <loc xlink:type="locator" xlink:label="mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems" xlink:href="mlec-20230630.xsd#mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsTable" xlink:href="mlec-20230630.xsd#mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems" xlink:to="mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsTable" xlink:to="ifrs-full_SegmentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Cash" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Cash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems" xlink:to="ifrs-full_Cash" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepositsFromBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepositsFromBanks"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems" xlink:to="ifrs-full_DepositsFromBanks" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems" xlink:to="ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems" xlink:to="ifrs-full_OtherCashAndCashEquivalents" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofShortTermInvestmentsTable">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfShortTermInvestmentsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfShortTermInvestmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_MutualFunds" xlink:href="mlec-20230630.xsd#mlec_MutualFunds"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfShortTermInvestmentsAbstract" xlink:to="mlec_MutualFunds" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TotalMutualFunds" xlink:href="mlec-20230630.xsd#mlec_TotalMutualFunds"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfShortTermInvestmentsAbstract" xlink:to="mlec_TotalMutualFunds" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofTradeReceivableTable">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfTradeReceivableAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfTradeReceivableAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfTradeReceivableAbstract" xlink:to="ifrs-full_TradeReceivables" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfTradeReceivableAbstract" xlink:to="ifrs-full_TradeAndOtherReceivables" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofOtherCurrentReceivablesTable">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOtherCurrentReceivablesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherCurrentReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentValueAddedTaxReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentValueAddedTaxReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfOtherCurrentReceivablesAbstract" xlink:to="ifrs-full_CurrentValueAddedTaxReceivables" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfOtherCurrentReceivablesAbstract" xlink:to="ifrs-full_OtherCurrentReceivables" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfOtherCurrentReceivablesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofInventoriesTable">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfInventoriesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfInventoriesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RawMaterials" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RawMaterials"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfInventoriesAbstract" xlink:to="ifrs-full_RawMaterials" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinishedGoods" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinishedGoods"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfInventoriesAbstract" xlink:to="ifrs-full_FinishedGoods" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InventoriesTotal" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InventoriesTotal"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfInventoriesAbstract" xlink:to="ifrs-full_InventoriesTotal" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable">
    <loc xlink:type="locator" xlink:label="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:href="mlec-20230630.xsd#mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumTable" xlink:href="mlec-20230630.xsd#mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MoolecScienceSharesMember" xlink:href="mlec-20230630.xsd#mlec_MoolecScienceSharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="mlec_MoolecScienceSharesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SAFESharesMember" xlink:href="mlec-20230630.xsd#mlec_SAFESharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="mlec_SAFESharesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_LightJumpSharesMember" xlink:href="mlec-20230630.xsd#mlec_LightJumpSharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="mlec_LightJumpSharesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BackstopSharesMember" xlink:href="mlec-20230630.xsd#mlec_BackstopSharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="mlec_BackstopSharesMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SharesIssuedAmount" xlink:href="mlec-20230630.xsd#mlec_SharesIssuedAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="mlec_SharesIssuedAmount" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareToBeIssuedAmount" xlink:href="mlec-20230630.xsd#mlec_ShareToBeIssuedAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="mlec_ShareToBeIssuedAmount" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremium" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharePremium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="ifrs-full_SharePremium" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfSharesIssueOfShareCapitalinShares" xlink:href="mlec-20230630.xsd#mlec_NumberOfSharesIssueOfShareCapitalinShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="mlec_NumberOfSharesIssueOfShareCapitalinShares" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsForShareIssueCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PaymentsForShareIssueCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="ifrs-full_PaymentsForShareIssueCosts" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SharesToBeIssuedAmountIssueOfShareCapital" xlink:href="mlec-20230630.xsd#mlec_SharesToBeIssuedAmountIssueOfShareCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="mlec_SharesToBeIssuedAmountIssueOfShareCapital" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SharePremiumIssueOfShareCapital" xlink:href="mlec-20230630.xsd#mlec_SharePremiumIssueOfShareCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="mlec_SharePremiumIssueOfShareCapital" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfSharesFromBusinessAcquisition" xlink:href="mlec-20230630.xsd#mlec_NumberOfSharesFromBusinessAcquisition"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrbCcuxiEw7DaKnp03QCb9S1ssLhKhQhPI9/LGJ51TgzssCI1ODtwCrgkN0a+ZUXnMF8I/KcADyvbmI99H904sqIF1YM5bLcN+DbpeVS5vMyNXq7Gcc0AsRuAtIzhrDpAdkHW0SbRbM9JtED/NKe0AzzApdc0Kim8/GgaIUDBDfI2qGJJ00w0l4c4VP9fPx/GbEQjRq8/J2XAQ==] CSR-->
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="mlec_NumberOfSharesFromBusinessAcquisition" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SharesIssuedAmountFromBusinessAcquisition" xlink:href="mlec-20230630.xsd#mlec_SharesIssuedAmountFromBusinessAcquisition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="mlec_SharesIssuedAmountFromBusinessAcquisition" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SharesToBeIssuedAmountFromBusinessAcquisition" xlink:href="mlec-20230630.xsd#mlec_SharesToBeIssuedAmountFromBusinessAcquisition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="mlec_SharesToBeIssuedAmountFromBusinessAcquisition" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SharePremiumFromBusinessAcquisition" xlink:href="mlec-20230630.xsd#mlec_SharePremiumFromBusinessAcquisition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="mlec_SharePremiumFromBusinessAcquisition" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfShareEquitySettledShareBasedPayment" xlink:href="mlec-20230630.xsd#mlec_NumberOfShareEquitySettledShareBasedPayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="mlec_NumberOfShareEquitySettledShareBasedPayment" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SharesIssuedAmountEquitySettledShareBasedPayment" xlink:href="mlec-20230630.xsd#mlec_SharesIssuedAmountEquitySettledShareBasedPayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="mlec_SharesIssuedAmountEquitySettledShareBasedPayment" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SharesToBeIssuedAmountEquitySettledShareBasedPayment" xlink:href="mlec-20230630.xsd#mlec_SharesToBeIssuedAmountEquitySettledShareBasedPayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="mlec_SharesToBeIssuedAmountEquitySettledShareBasedPayment" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SharePremiumEquitySettledShareBasedPayment" xlink:href="mlec-20230630.xsd#mlec_SharePremiumEquitySettledShareBasedPayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="mlec_SharePremiumEquitySettledShareBasedPayment" order="16" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable">
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems" xlink:to="mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CreationDateAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CreationDateAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable" xlink:to="ifrs-full_CreationDateAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DefaultFinancialStatementsDateMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefaultFinancialStatementsDateMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CreationDateAxis" xlink:to="ifrs-full_DefaultFinancialStatementsDateMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DefaultFinancialStatementsDateMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefaultFinancialStatementsDateMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CreationDateAxis" xlink:to="ifrs-full_DefaultFinancialStatementsDateMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_Group1Member" xlink:href="mlec-20230630.xsd#mlec_Group1Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DefaultFinancialStatementsDateMember" xlink:to="mlec_Group1Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_Group2Member" xlink:href="mlec-20230630.xsd#mlec_Group2Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DefaultFinancialStatementsDateMember" xlink:to="mlec_Group2Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_Group3Member" xlink:href="mlec-20230630.xsd#mlec_Group3Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DefaultFinancialStatementsDateMember" xlink:to="mlec_Group3Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_FairValueOfSharesinShares" xlink:href="mlec-20230630.xsd#mlec_FairValueOfSharesinShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems" xlink:to="mlec_FairValueOfSharesinShares" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ExercisePrice" xlink:href="mlec-20230630.xsd#mlec_ExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems" xlink:to="mlec_ExercisePrice" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PlanDuration" xlink:href="mlec-20230630.xsd#mlec_PlanDuration"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems" xlink:to="mlec_PlanDuration" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_FairValueOfStockOptionsAtMeasurementDate" xlink:href="mlec-20230630.xsd#mlec_FairValueOfStockOptionsAtMeasurementDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems" xlink:to="mlec_FairValueOfStockOptionsAtMeasurementDate" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable">
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CreationDateAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CreationDateAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable" xlink:to="ifrs-full_CreationDateAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DefaultFinancialStatementsDateMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefaultFinancialStatementsDateMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CreationDateAxis" xlink:to="ifrs-full_DefaultFinancialStatementsDateMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DefaultFinancialStatementsDateMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefaultFinancialStatementsDateMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CreationDateAxis" xlink:to="ifrs-full_DefaultFinancialStatementsDateMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_Group1Member" xlink:href="mlec-20230630.xsd#mlec_Group1Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DefaultFinancialStatementsDateMember" xlink:to="mlec_Group1Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_Group2Member" xlink:href="mlec-20230630.xsd#mlec_Group2Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DefaultFinancialStatementsDateMember" xlink:to="mlec_Group2Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_Group3Member" xlink:href="mlec-20230630.xsd#mlec_Group3Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DefaultFinancialStatementsDateMember" xlink:to="mlec_Group3Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfOptionsAtTheBeginning" xlink:href="mlec-20230630.xsd#mlec_NumberOfOptionsAtTheBeginning"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="mlec_NumberOfOptionsAtTheBeginning" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ExercisePriceAtTheBeginning" xlink:href="mlec-20230630.xsd#mlec_ExercisePriceAtTheBeginning"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="mlec_ExercisePriceAtTheBeginning" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfOptionsGrantedDuringThePeriod" xlink:href="mlec-20230630.xsd#mlec_NumberOfOptionsGrantedDuringThePeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="mlec_NumberOfOptionsGrantedDuringThePeriod" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ExercisePriceGrantedDuringThePeriod" xlink:href="mlec-20230630.xsd#mlec_ExercisePriceGrantedDuringThePeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="mlec_ExercisePriceGrantedDuringThePeriod" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfOptionsForfeitedDuringThePeriod" xlink:href="mlec-20230630.xsd#mlec_NumberOfOptionsForfeitedDuringThePeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="mlec_NumberOfOptionsForfeitedDuringThePeriod" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ExercisePriceForfeitedDuringThePeriod" xlink:href="mlec-20230630.xsd#mlec_ExercisePriceForfeitedDuringThePeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="mlec_ExercisePriceForfeitedDuringThePeriod" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfOptionsExercisedDuringThePeriod" xlink:href="mlec-20230630.xsd#mlec_NumberOfOptionsExercisedDuringThePeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="mlec_NumberOfOptionsExercisedDuringThePeriod" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ExercisePriceExercisedDuringThePeriod" xlink:href="mlec-20230630.xsd#mlec_ExercisePriceExercisedDuringThePeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="mlec_ExercisePriceExercisedDuringThePeriod" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfOptionsExpiredDuringThePeriod" xlink:href="mlec-20230630.xsd#mlec_NumberOfOptionsExpiredDuringThePeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="mlec_NumberOfOptionsExpiredDuringThePeriod" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ExercisePriceExpiredDuringThePeriod" xlink:href="mlec-20230630.xsd#mlec_ExercisePriceExpiredDuringThePeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="mlec_ExercisePriceExpiredDuringThePeriod" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfOptionsAtTheEnding" xlink:href="mlec-20230630.xsd#mlec_NumberOfOptionsAtTheEnding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="mlec_NumberOfOptionsAtTheEnding" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ExercisePriceAtTheEnding" xlink:href="mlec-20230630.xsd#mlec_ExercisePriceAtTheEnding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="mlec_ExercisePriceAtTheEnding" order="12" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofAccountsPayableTable">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfAccountsPayableAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfAccountsPayableAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfAccountsPayableAbstract" xlink:to="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfAccountsPayableAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccrualsClassifiedAsNoncurrent" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccrualsClassifiedAsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfAccountsPayableAbstract" xlink:to="ifrs-full_AccrualsClassifiedAsNoncurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfAccountsPayableAbstract" xlink:to="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfAccountsPayableAbstract" xlink:to="ifrs-full_TradeAndOtherPayables" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentPayablesToRelatedParties" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentPayablesToRelatedParties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfAccountsPayableAbstract" xlink:to="ifrs-full_NoncurrentPayablesToRelatedParties" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredPaymentRelatedToBusinessCombination" xlink:href="mlec-20230630.xsd#mlec_DeferredPaymentRelatedToBusinessCombination"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfAccountsPayableAbstract" xlink:to="mlec_DeferredPaymentRelatedToBusinessCombination" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_Wages" xlink:href="mlec-20230630.xsd#mlec_Wages"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfAccountsPayableAbstract" xlink:to="mlec_Wages" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_Taxes" xlink:href="mlec-20230630.xsd#mlec_Taxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfAccountsPayableAbstract" xlink:to="mlec_Taxes" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PayAsYouEarnPAYE" xlink:href="mlec-20230630.xsd#mlec_PayAsYouEarnPAYE"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfAccountsPayableAbstract" xlink:to="mlec_PayAsYouEarnPAYE" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentNonfinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentNonfinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfAccountsPayableAbstract" xlink:to="ifrs-full_OtherCurrentNonfinancialLiabilities" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfAccountsPayableAbstract" xlink:to="ifrs-full_OtherCurrentLiabilities" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentNonfinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentNonfinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfAccountsPayableAbstract" xlink:to="ifrs-full_OtherNoncurrentNonfinancialLiabilities" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfAccountsPayableAbstract" xlink:to="ifrs-full_OtherNoncurrentLiabilities" order="13" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofFinancialDebtTable">
    <loc xlink:type="locator" xlink:label="mlec_FinancialDebtDetailsScheduleofFinancialDebtLineItems" xlink:href="mlec-20230630.xsd#mlec_FinancialDebtDetailsScheduleofFinancialDebtLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialDebtDetailsScheduleofFinancialDebtTable" xlink:href="mlec-20230630.xsd#mlec_FinancialDebtDetailsScheduleofFinancialDebtTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_FinancialDebtDetailsScheduleofFinancialDebtLineItems" xlink:to="mlec_FinancialDebtDetailsScheduleofFinancialDebtTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CounterpartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_FinancialDebtDetailsScheduleofFinancialDebtTable" xlink:to="ifrs-full_CounterpartiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CounterpartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CounterpartiesAxis" xlink:to="ifrs-full_CounterpartiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CounterpartiesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CounterpartiesAxis" xlink:to="ifrs-full_CounterpartiesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="currency_ARS" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_ARS"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CounterpartiesMember" xlink:to="currency_ARS" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CounterpartiesMember" xlink:to="country_US" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentFinancialAssetsAtAmortisedCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentFinancialAssetsAtAmortisedCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialDebtDetailsScheduleofFinancialDebtLineItems" xlink:to="ifrs-full_CurrentFinancialAssetsAtAmortisedCost" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable">
    <loc xlink:type="locator" xlink:label="mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureLineItems" xlink:href="mlec-20230630.xsd#mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable" xlink:href="mlec-20230630.xsd#mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureLineItems" xlink:to="mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CounterpartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable" xlink:to="ifrs-full_CounterpartiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CounterpartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CounterpartiesAxis" xlink:to="ifrs-full_CounterpartiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CounterpartiesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CounterpartiesAxis" xlink:to="ifrs-full_CounterpartiesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="currency_ARS" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_ARS"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CounterpartiesMember" xlink:to="currency_ARS" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentFinancialAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureLineItems" xlink:to="ifrs-full_NoncurrentFinancialAssets" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable">
    <loc xlink:type="locator" xlink:label="mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems" xlink:href="mlec-20230630.xsd#mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansTable" xlink:href="mlec-20230630.xsd#mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems" xlink:to="mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansTable" xlink:to="ifrs-full_BorrowingsByNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsByNameMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsByNameMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansTable" xlink:to="ifrs-full_RangeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BancoMacroPreFinancingOfExportsMember" xlink:href="mlec-20230630.xsd#mlec_BancoMacroPreFinancingOfExportsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameMember" xlink:to="mlec_BancoMacroPreFinancingOfExportsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BancoNacinPreFinancingOfExportsMember" xlink:href="mlec-20230630.xsd#mlec_BancoNacinPreFinancingOfExportsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameMember" xlink:to="mlec_BancoNacinPreFinancingOfExportsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BancoCrdobaPreFinancingOfExportsMember" xlink:href="mlec-20230630.xsd#mlec_BancoCrdobaPreFinancingOfExportsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameMember" xlink:to="mlec_BancoCrdobaPreFinancingOfExportsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BancoGaliciaBankOverdraftsMember" xlink:href="mlec-20230630.xsd#mlec_BancoGaliciaBankOverdraftsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameMember" xlink:to="mlec_BancoGaliciaBankOverdraftsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_HSBCBankBankOverdraftsMember" xlink:href="mlec-20230630.xsd#mlec_HSBCBankBankOverdraftsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameMember" xlink:to="mlec_HSBCBankBankOverdraftsMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BancoSantanderBankOverdraftsMember" xlink:href="mlec-20230630.xsd#mlec_BancoSantanderBankOverdraftsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameMember" xlink:to="mlec_BancoSantanderBankOverdraftsMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BancoGaliciaLoansMember" xlink:href="mlec-20230630.xsd#mlec_BancoGaliciaLoansMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameMember" xlink:to="mlec_BancoGaliciaLoansMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_HSBCBankLoansMember" xlink:href="mlec-20230630.xsd#mlec_HSBCBankLoansMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameMember" xlink:to="mlec_HSBCBankLoansMember" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BancoSantanderLoansMember" xlink:href="mlec-20230630.xsd#mlec_BancoSantanderLoansMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameMember" xlink:to="mlec_BancoSantanderLoansMember" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BancoMacroLoansMember" xlink:href="mlec-20230630.xsd#mlec_BancoMacroLoansMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameMember" xlink:to="mlec_BancoMacroLoansMember" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PromissoryNotesMember" xlink:href="mlec-20230630.xsd#mlec_PromissoryNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameMember" xlink:to="mlec_PromissoryNotesMember" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AsociacinMutualAMALoansMember" xlink:href="mlec-20230630.xsd#mlec_AsociacinMutualAMALoansMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_BorrowingsByNameMember" xlink:to="mlec_AsociacinMutualAMALoansMember" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BorrowingOriginalCurrency" xlink:href="mlec-20230630.xsd#mlec_BorrowingOriginalCurrency"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems" xlink:to="mlec_BorrowingOriginalCurrency" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems" xlink:to="ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NominalInterestRate" xlink:href="mlec-20230630.xsd#mlec_NominalInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems" xlink:to="mlec_NominalInterestRate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BorrowingMaturity" xlink:href="mlec-20230630.xsd#mlec_BorrowingMaturity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems" xlink:to="mlec_BorrowingMaturity" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Borrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Borrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems" xlink:to="ifrs-full_Borrowings" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofFairValueOrdinaryShareofWarrantsTable">
    <loc xlink:type="locator" xlink:label="mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsLineItems" xlink:href="mlec-20230630.xsd#mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsTable" xlink:href="mlec-20230630.xsd#mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsLineItems" xlink:to="mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_EquityMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_EquityMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WarrantReserveMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WarrantReserveMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_WarrantReserveMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_WarrantAndRightsOutstanding" xlink:href="mlec-20230630.xsd#mlec_WarrantAndRightsOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsLineItems" xlink:to="mlec_WarrantAndRightsOutstanding" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementEntitysOwnEquityInstruments" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementEntitysOwnEquityInstruments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsLineItems" xlink:to="ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementEntitysOwnEquityInstruments" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_FairValueAdjustmentOfWarrant" xlink:href="mlec-20230630.xsd#mlec_FairValueAdjustmentOfWarrant"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsLineItems" xlink:to="mlec_FairValueAdjustmentOfWarrant" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofFinancialInstrumentsTable">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfFinancialInstrumentsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfFinancialInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue" xlink:href="mlec-20230630.xsd#mlec_FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfFinancialInstrumentsAbstract" xlink:to="mlec_FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_Additions" xlink:href="mlec-20230630.xsd#mlec_Additions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue" xlink:to="mlec_Additions" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue" xlink:to="ifrs-full_FinancialLiabilitiesAtFairValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SAFECapitalization" xlink:href="mlec-20230630.xsd#mlec_SAFECapitalization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue" xlink:to="mlec_SAFECapitalization" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue" xlink:href="mlec-20230630.xsd#mlec_ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue" xlink:to="mlec_ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofRollForwardofNetDeferredTaxTable">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfRollForwardOfNetDeferredTaxAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfRollForwardOfNetDeferredTaxAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfRollForwardOfNetDeferredTaxAbstract" xlink:to="ifrs-full_DeferredTaxLiabilities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IncorporatedThroughTheBusinessCombination" xlink:href="mlec-20230630.xsd#mlec_IncorporatedThroughTheBusinessCombination"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfRollForwardOfNetDeferredTaxAbstract" xlink:to="mlec_IncorporatedThroughTheBusinessCombination" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfRollForwardOfNetDeferredTaxAbstract" xlink:to="mlec_DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ChargedToOtherComprehensiveIncome" xlink:href="mlec-20230630.xsd#mlec_ChargedToOtherComprehensiveIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfRollForwardOfNetDeferredTaxAbstract" xlink:to="mlec_ChargedToOtherComprehensiveIncome" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable">
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesLineItems" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesLineItems" xlink:to="mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable" xlink:to="ifrs-full_GeographicalAreasAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable" xlink:to="ifrs-full_RangeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_AR" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_AR"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="country_AR" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_LU" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_LU"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="country_LU" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_GB" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="country_GB" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="currency_USD" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_USD"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="currency_USD" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxJurisdiction" xlink:href="mlec-20230630.xsd#mlec_TaxJurisdiction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesLineItems" xlink:to="mlec_TaxJurisdiction" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofIncomeTaxforOtherJurisdictionsTable">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfIncomeTaxForOtherJurisdictionsAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_LossBeforeTax" xlink:href="mlec-20230630.xsd#mlec_LossBeforeTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsAbstract" xlink:to="mlec_LossBeforeTax" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CorporateTaxRate" xlink:href="mlec-20230630.xsd#mlec_CorporateTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsAbstract" xlink:to="mlec_CorporateTaxRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccruedIncomeOtherThanContractAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccruedIncomeOtherThanContractAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CorporateTaxRate" xlink:to="ifrs-full_AccruedIncomeOtherThanContractAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions" xlink:href="mlec-20230630.xsd#mlec_EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CorporateTaxRate" xlink:to="mlec_EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxLosses" xlink:href="mlec-20230630.xsd#mlec_TaxLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CorporateTaxRate" xlink:to="mlec_TaxLosses" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NondeductibleExpensesListingCost" xlink:href="mlec-20230630.xsd#mlec_NondeductibleExpensesListingCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CorporateTaxRate" xlink:to="mlec_NondeductibleExpensesListingCost" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NetGainOnInflationEffectOnMonetaryItems" xlink:href="mlec-20230630.xsd#mlec_NetGainOnInflationEffectOnMonetaryItems"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CorporateTaxRate" xlink:to="mlec_NetGainOnInflationEffectOnMonetaryItems" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IncomeTaxInflationAdjustment" xlink:href="mlec-20230630.xsd#mlec_IncomeTaxInflationAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CorporateTaxRate" xlink:to="mlec_IncomeTaxInflationAdjustment" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_Others" xlink:href="mlec-20230630.xsd#mlec_Others"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CorporateTaxRate" xlink:to="mlec_Others" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxBenefitForTheYear" xlink:href="mlec-20230630.xsd#mlec_TaxBenefitForTheYear"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsAbstract" xlink:to="mlec_TaxBenefitForTheYear" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable">
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesLineItems" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesTable" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesLineItems" xlink:to="mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NetDeferredTaxLiabilitiesMember" xlink:href="mlec-20230630.xsd#mlec_NetDeferredTaxLiabilitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_NetDeferredTaxLiabilitiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxAssetAbstract" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxAssetAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesLineItems" xlink:to="mlec_DeferredTaxAssetAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DeferredTaxAssetAbstract" xlink:to="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesLineItems" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxLiabilityAbstract" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxLiabilityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesLineItems" xlink:to="mlec_DeferredTaxLiabilityAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CustomerRelationship" xlink:href="mlec-20230630.xsd#mlec_CustomerRelationship"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DeferredTaxLiabilityAbstract" xlink:to="mlec_CustomerRelationship" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DeferredTaxLiabilityAbstract" xlink:to="ifrs-full_OtherLiabilities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesLineItems" xlink:to="ifrs-full_DeferredTaxLiabilityAsset" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetDeferredTaxLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesLineItems" xlink:to="ifrs-full_NetDeferredTaxLiabilities" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofAccumulatedTaxLossCarryforwardsTable">
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsTable" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems" xlink:to="mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CreationDateAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CreationDateAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsTable" xlink:to="ifrs-full_CreationDateAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DefaultFinancialStatementsDateMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefaultFinancialStatementsDateMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CreationDateAxis" xlink:to="ifrs-full_DefaultFinancialStatementsDateMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DefaultFinancialStatementsDateMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefaultFinancialStatementsDateMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CreationDateAxis" xlink:to="ifrs-full_DefaultFinancialStatementsDateMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TwoThousandTwentyTwoMember" xlink:href="mlec-20230630.xsd#mlec_TwoThousandTwentyTwoMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DefaultFinancialStatementsDateMember" xlink:to="mlec_TwoThousandTwentyTwoMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TwoThousandTwentyThreeMember" xlink:href="mlec-20230630.xsd#mlec_TwoThousandTwentyThreeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_DefaultFinancialStatementsDateMember" xlink:to="mlec_TwoThousandTwentyThreeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxlossCarryForward" xlink:href="mlec-20230630.xsd#mlec_TaxlossCarryForward"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems" xlink:to="mlec_TaxlossCarryForward" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems" xlink:to="ifrs-full_DeferredTaxAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems" xlink:to="ifrs-full_DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems" xlink:to="ifrs-full_DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofEstimatedFutureTaxableProfitTable">
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitTable" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems" xlink:to="mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitTable" xlink:to="ifrs-full_GeographicalAreasAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_GB" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="country_GB" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_LU" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_LU"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="country_LU" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_AR" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_AR"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="country_AR" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="currency_USD" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_USD"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="currency_USD" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxAssetsGrossAmount" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxAssetsGrossAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems" xlink:to="mlec_DeferredTaxAssetsGrossAmount" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxAssetsTaxEffect" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxAssetsTaxEffect"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems" xlink:to="mlec_DeferredTaxAssetsTaxEffect" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofFinancialIncomeExpensesTable">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfFinancialIncomeExpensesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfFinancialIncomeExpensesAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialCostsAbstract" xlink:href="mlec-20230630.xsd#mlec_FinancialCostsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfFinancialIncomeExpensesAbstract" xlink:to="mlec_FinancialCostsAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InterestExpenses" xlink:href="mlec-20230630.xsd#mlec_InterestExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialCostsAbstract" xlink:to="mlec_InterestExpenses" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TotalFinancialCosts" xlink:href="mlec-20230630.xsd#mlec_TotalFinancialCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfFinancialIncomeExpensesAbstract" xlink:to="mlec_TotalFinancialCosts" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherFinancialResultsAbstract" xlink:href="mlec-20230630.xsd#mlec_OtherFinancialResultsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfFinancialIncomeExpensesAbstract" xlink:to="mlec_OtherFinancialResultsAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ExchangeRateDifference" xlink:href="mlec-20230630.xsd#mlec_ExchangeRateDifference"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_OtherFinancialResultsAbstract" xlink:to="mlec_ExchangeRateDifference" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss" xlink:href="mlec-20230630.xsd#mlec_ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_OtherFinancialResultsAbstract" xlink:to="mlec_ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InvestmentGainRelatedToMoneyMarketFunds" xlink:href="mlec-20230630.xsd#mlec_InvestmentGainRelatedToMoneyMarketFunds"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_OtherFinancialResultsAbstract" xlink:to="mlec_InvestmentGainRelatedToMoneyMarketFunds" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ChangeInWarrants" xlink:href="mlec-20230630.xsd#mlec_ChangeInWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_OtherFinancialResultsAbstract" xlink:to="mlec_ChangeInWarrants" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LoansAndReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LoansAndReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_OtherFinancialResultsAbstract" xlink:to="ifrs-full_LoansAndReceivables" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InflationAdjustment" xlink:href="mlec-20230630.xsd#mlec_InflationAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_OtherFinancialResultsAbstract" xlink:to="mlec_InflationAdjustment" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherFinancialResults" xlink:href="mlec-20230630.xsd#mlec_OtherFinancialResults"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_OtherFinancialResultsAbstract" xlink:to="mlec_OtherFinancialResults" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TotalOtherFinancialResults" xlink:href="mlec-20230630.xsd#mlec_TotalOtherFinancialResults"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfFinancialIncomeExpensesAbstract" xlink:to="mlec_TotalOtherFinancialResults" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NetFinancialIncomeExpenses" xlink:href="mlec-20230630.xsd#mlec_NetFinancialIncomeExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfFinancialIncomeExpensesAbstract" xlink:to="mlec_NetFinancialIncomeExpenses" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofOtherOperatingExpenseTable">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOtherOperatingExpenseAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherOperatingExpenseAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxesDutiesAndPenalties" xlink:href="mlec-20230630.xsd#mlec_TaxesDutiesAndPenalties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfOtherOperatingExpenseAbstract" xlink:to="mlec_TaxesDutiesAndPenalties" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MiscellaneousOtherOperatingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfOtherOperatingExpenseAbstract" xlink:to="ifrs-full_MiscellaneousOtherOperatingExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherOperatingExpense" xlink:href="mlec-20230630.xsd#mlec_OtherOperatingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfOtherOperatingExpenseAbstract" xlink:to="mlec_OtherOperatingExpense" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfAdministrativeExpensesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfAdministrativeExpensesAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_AuditLegalAndAccountancyFee" xlink:href="mlec-20230630.xsd#mlec_AuditLegalAndAccountancyFee"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfAdministrativeExpensesAbstract" xlink:to="mlec_AuditLegalAndAccountancyFee" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EmployeeBenefitsExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EmployeeBenefitsExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfAdministrativeExpensesAbstract" xlink:to="ifrs-full_EmployeeBenefitsExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PayrollExpenses" xlink:href="mlec-20230630.xsd#mlec_PayrollExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfAdministrativeExpensesAbstract" xlink:to="mlec_PayrollExpenses" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InsuranceExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InsuranceExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfAdministrativeExpensesAbstract" xlink:to="ifrs-full_InsuranceExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TravelExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TravelExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfAdministrativeExpensesAbstract" xlink:to="ifrs-full_TravelExpense" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AmortizationExpense" xlink:href="mlec-20230630.xsd#mlec_AmortizationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfAdministrativeExpensesAbstract" xlink:to="mlec_AmortizationExpense" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfAdministrativeExpensesAbstract" xlink:to="ifrs-full_DepreciationExpense" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfAdministrativeExpensesAbstract" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfAdministrativeExpensesAbstract" xlink:to="ifrs-full_AdministrativeExpense" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofResearchandDevelopmentExpenseTable">
    <loc xlink:type="locator" xlink:label="mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems" xlink:href="mlec-20230630.xsd#mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseTable" xlink:href="mlec-20230630.xsd#mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems" xlink:to="mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseTable" xlink:to="ifrs-full_SegmentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfessionalFeesExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfessionalFeesExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems" xlink:to="ifrs-full_ProfessionalFeesExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_LaboratoriesRelatedExpenses" xlink:href="mlec-20230630.xsd#mlec_LaboratoriesRelatedExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems" xlink:to="mlec_LaboratoriesRelatedExpenses" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AmortisationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems" xlink:to="ifrs-full_AmortisationExpense" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherResearchAndDevelopmentExpenses" xlink:href="mlec-20230630.xsd#mlec_OtherResearchAndDevelopmentExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems" xlink:to="mlec_OtherResearchAndDevelopmentExpenses" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofCostofsalesTable">
    <loc xlink:type="locator" xlink:label="mlec_CostofsalesDetailsScheduleofCostofsalesLineItems" xlink:href="mlec-20230630.xsd#mlec_CostofsalesDetailsScheduleofCostofsalesLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_CostofsalesDetailsScheduleofCostofsalesTable" xlink:href="mlec-20230630.xsd#mlec_CostofsalesDetailsScheduleofCostofsalesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_CostofsalesDetailsScheduleofCostofsalesLineItems" xlink:to="mlec_CostofsalesDetailsScheduleofCostofsalesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_CostofsalesDetailsScheduleofCostofsalesTable" xlink:to="ifrs-full_SegmentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Inventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Inventories"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CostofsalesDetailsScheduleofCostofsalesLineItems" xlink:to="ifrs-full_Inventories" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InventoriesIncorporatedThroughTheBusinessCombination" xlink:href="mlec-20230630.xsd#mlec_InventoriesIncorporatedThroughTheBusinessCombination"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CostofsalesDetailsScheduleofCostofsalesLineItems" xlink:to="mlec_InventoriesIncorporatedThroughTheBusinessCombination" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchasesFairValueMeasurementAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchasesFairValueMeasurementAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CostofsalesDetailsScheduleofCostofsalesLineItems" xlink:to="ifrs-full_PurchasesFairValueMeasurementAssets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ProductionCostsAbstract" xlink:href="mlec-20230630.xsd#mlec_ProductionCostsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CostofsalesDetailsScheduleofCostofsalesLineItems" xlink:to="mlec_ProductionCostsAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PayrollAndAndProfessionalFees" xlink:href="mlec-20230630.xsd#mlec_PayrollAndAndProfessionalFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ProductionCostsAbstract" xlink:to="mlec_PayrollAndAndProfessionalFees" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepairsAndMaintenanceExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RepairsAndMaintenanceExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ProductionCostsAbstract" xlink:to="ifrs-full_RepairsAndMaintenanceExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationAndAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationAndAmortisationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ProductionCostsAbstract" xlink:to="ifrs-full_DepreciationAndAmortisationExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherProductionCosts" xlink:href="mlec-20230630.xsd#mlec_OtherProductionCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ProductionCostsAbstract" xlink:to="mlec_OtherProductionCosts" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RawMaterialsAndConsumablesUsed" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RawMaterialsAndConsumablesUsed"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ProductionCostsAbstract" xlink:to="ifrs-full_RawMaterialsAndConsumablesUsed" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CostofsalesDetailsScheduleofCostofsalesLineItems" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TotalOtherProductionCost" xlink:href="mlec-20230630.xsd#mlec_TotalOtherProductionCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CostofsalesDetailsScheduleofCostofsalesLineItems" xlink:to="mlec_TotalOtherProductionCost" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CostOfSales"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CostofsalesDetailsScheduleofCostofsalesLineItems" xlink:to="ifrs-full_CostOfSales" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable">
    <loc xlink:type="locator" xlink:label="mlec_NetLossperShareDetailsScheduleofNetLossPerShareLineItems" xlink:href="mlec-20230630.xsd#mlec_NetLossperShareDetailsScheduleofNetLossPerShareLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_NetLossperShareDetailsScheduleofNetLossPerShareTable" xlink:href="mlec-20230630.xsd#mlec_NetLossperShareDetailsScheduleofNetLossPerShareTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_NetLossperShareDetailsScheduleofNetLossPerShareLineItems" xlink:to="mlec_NetLossperShareDetailsScheduleofNetLossPerShareTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_NetLossperShareDetailsScheduleofNetLossPerShareTable" xlink:to="ifrs-full_SegmentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_NetLossperShareDetailsScheduleofNetLossPerShareLineItems" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustedWeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_NetLossperShareDetailsScheduleofNetLossPerShareLineItems" xlink:to="ifrs-full_AdjustedWeightedAverageShares" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_NetLossperShareDetailsScheduleofNetLossPerShareLineItems" xlink:to="ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable_Parentheticals">
    <loc xlink:type="locator" xlink:label="mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsLineItems" xlink:href="mlec-20230630.xsd#mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsTable" xlink:href="mlec-20230630.xsd#mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsLineItems" xlink:to="mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsTable" xlink:to="ifrs-full_SegmentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsLineItems" xlink:to="ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofOtherRelatedPartyTransactionsTable">
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsLineItems" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsTable" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsLineItems" xlink:to="mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsTable" xlink:to="ifrs-full_SegmentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermEmployeeBenefitsExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsLineItems" xlink:to="ifrs-full_ShorttermEmployeeBenefitsExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsLineItems" xlink:to="ifrs-full_ShorttermEmployeeBenefitsAccruals" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable">
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentLineItems" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentTable" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentLineItems" xlink:to="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresCropSolutionsCorpMember" xlink:href="mlec-20230630.xsd#mlec_BioceresCropSolutionsCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_BioceresCropSolutionsCorpMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_UnionGroupVenturesMember" xlink:href="mlec-20230630.xsd#mlec_UnionGroupVenturesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_UnionGroupVenturesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BGFarmingTechnologiesMember" xlink:href="mlec-20230630.xsd#mlec_BGFarmingTechnologiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_BGFarmingTechnologiesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresSAMember" xlink:href="mlec-20230630.xsd#mlec_BioceresSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_BioceresSAMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresLLCMember" xlink:href="mlec-20230630.xsd#mlec_BioceresLLCMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_BioceresLLCMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresSAINMETSAIngenieriaMetabolicaSAMember" xlink:href="mlec-20230630.xsd#mlec_BioceresSAINMETSAIngenieriaMetabolicaSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_BioceresSAINMETSAIngenieriaMetabolicaSAMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember" xlink:href="mlec-20230630.xsd#mlec_BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresSAAgralityIncMember" xlink:href="mlec-20230630.xsd#mlec_BioceresSAAgralityIncMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_BioceresSAAgralityIncMember" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_FutureFoodsBVMember" xlink:href="mlec-20230630.xsd#mlec_FutureFoodsBVMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_FutureFoodsBVMember" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MoolecScienceSAMember" xlink:href="mlec-20230630.xsd#mlec_MoolecScienceSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_MoolecScienceSAMember" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_THEOISCSpMember" xlink:href="mlec-20230630.xsd#mlec_THEOISCSpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_THEOISCSpMember" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentAbstract" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentLineItems" xlink:to="mlec_ShareBasedPaymentAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensation" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensation" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CFOSharesAlloted" xlink:href="mlec-20230630.xsd#mlec_CFOSharesAlloted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentAbstract" xlink:to="mlec_CFOSharesAlloted" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IssueOfAdditionalSharesAbstract" xlink:href="mlec-20230630.xsd#mlec_IssueOfAdditionalSharesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentLineItems" xlink:to="mlec_IssueOfAdditionalSharesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IssueOfSharesCapital" xlink:href="mlec-20230630.xsd#mlec_IssueOfSharesCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_IssueOfAdditionalSharesAbstract" xlink:to="mlec_IssueOfSharesCapital" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IssueOfSharePremium" xlink:href="mlec-20230630.xsd#mlec_IssueOfSharePremium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_IssueOfAdditionalSharesAbstract" xlink:to="mlec_IssueOfSharePremium" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_IssueOfAdditionalSharesAbstract" xlink:to="ifrs-full_ProfitLossAttributableToOwnersOfParent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CompanySCashBalanceInOtherSAccountsAbstract" xlink:href="mlec-20230630.xsd#mlec_CompanySCashBalanceInOtherSAccountsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentLineItems" xlink:to="mlec_CompanySCashBalanceInOtherSAccountsAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_CompanySCashBalanceInOtherSAccountsAbstract" xlink:to="ifrs-full_CashEquivalents" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ExpensesPaidOnBehalfOfTheCompanyAbstract" xlink:href="mlec-20230630.xsd#mlec_ExpensesPaidOnBehalfOfTheCompanyAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentLineItems" xlink:to="mlec_ExpensesPaidOnBehalfOfTheCompanyAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ExpensesPaid" xlink:href="mlec-20230630.xsd#mlec_ExpensesPaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ExpensesPaidOnBehalfOfTheCompanyAbstract" xlink:to="mlec_ExpensesPaid" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ServicesProvidedByOtherCompaniesAbstract" xlink:href="mlec-20230630.xsd#mlec_ServicesProvidedByOtherCompaniesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentLineItems" xlink:to="mlec_ServicesProvidedByOtherCompaniesAbstract" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ServicesProvidedByOtherCompanies" xlink:href="mlec-20230630.xsd#mlec_ServicesProvidedByOtherCompanies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ServicesProvidedByOtherCompaniesAbstract" xlink:to="mlec_ServicesProvidedByOtherCompanies" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable_Parentheticals">
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsLineItems" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsTable" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsLineItems" xlink:to="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresLLCMember" xlink:href="mlec-20230630.xsd#mlec_BioceresLLCMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_BioceresLLCMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresSAINMETSAIngenieriaMetabolicaSAMember" xlink:href="mlec-20230630.xsd#mlec_BioceresSAINMETSAIngenieriaMetabolicaSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_BioceresSAINMETSAIngenieriaMetabolicaSAMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember" xlink:href="mlec-20230630.xsd#mlec_BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SubsidiaryPercentage" xlink:href="mlec-20230630.xsd#mlec_SubsidiaryPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsLineItems" xlink:to="mlec_SubsidiaryPercentage" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OwnedPercentage" xlink:href="mlec-20230630.xsd#mlec_OwnedPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsLineItems" xlink:to="mlec_OwnedPercentage" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable">
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesLineItems" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesTable" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesLineItems" xlink:to="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresSABioceresLLCMember" xlink:href="mlec-20230630.xsd#mlec_BioceresSABioceresLLCMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_BioceresSABioceresLLCMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MoolecSAShareholdersMember" xlink:href="mlec-20230630.xsd#mlec_MoolecSAShareholdersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_MoolecSAShareholdersMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_UnionGroupVenturesLimitedMember" xlink:href="mlec-20230630.xsd#mlec_UnionGroupVenturesLimitedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_UnionGroupVenturesLimitedMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_INDEARSAMember" xlink:href="mlec-20230630.xsd#mlec_INDEARSAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_INDEARSAMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_FutureFoodsBVMember" xlink:href="mlec-20230630.xsd#mlec_FutureFoodsBVMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_FutureFoodsBVMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherRelatedPartyBalances" xlink:href="mlec-20230630.xsd#mlec_OtherRelatedPartyBalances"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesLineItems" xlink:to="mlec_OtherRelatedPartyBalances" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable_Parentheticals">
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsLineItems" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsTable" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsLineItems" xlink:to="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresSABioceresLLCMember" xlink:href="mlec-20230630.xsd#mlec_BioceresSABioceresLLCMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_BioceresSABioceresLLCMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SubsidiaryPercentage" xlink:href="mlec-20230630.xsd#mlec_SubsidiaryPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsLineItems" xlink:to="mlec_SubsidiaryPercentage" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofTradeandOtherReceivablesTable">
    <loc xlink:type="locator" xlink:label="mlec_FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesLineItems" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesTable" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesLineItems" xlink:to="mlec_FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesTable" xlink:to="ifrs-full_MaturityAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AggregatedTimeBandsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_AggregatedTimeBandsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AggregatedTimeBandsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_AggregatedTimeBandsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_UpToThreeMonthsMember" xlink:href="mlec-20230630.xsd#mlec_UpToThreeMonthsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="mlec_UpToThreeMonthsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ToDueBecomeAbstract" xlink:href="mlec-20230630.xsd#mlec_ToDueBecomeAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesLineItems" xlink:to="mlec_ToDueBecomeAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ToDueBecomeAbstract" xlink:to="ifrs-full_TradeAndOtherReceivables" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable">
    <loc xlink:type="locator" xlink:label="mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateTable" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems" xlink:to="mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateTable" xlink:to="ifrs-full_MaturityAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AggregatedTimeBandsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_AggregatedTimeBandsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AggregatedTimeBandsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_AggregatedTimeBandsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_WithinOneYearOrOnDemandMember" xlink:href="mlec-20230630.xsd#mlec_WithinOneYearOrOnDemandMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="mlec_WithinOneYearOrOnDemandMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BetweenOneAndTwoYearsMember" xlink:href="mlec-20230630.xsd#mlec_BetweenOneAndTwoYearsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="mlec_BetweenOneAndTwoYearsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_BetweenTwoAndFiveYearsMember" xlink:href="mlec-20230630.xsd#mlec_BetweenTwoAndFiveYearsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="mlec_BetweenTwoAndFiveYearsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MoreThanFiveYearsMember" xlink:href="mlec-20230630.xsd#mlec_MoreThanFiveYearsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="mlec_MoreThanFiveYearsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_WithoutAnyEstablishedTermMember" xlink:href="mlec-20230630.xsd#mlec_WithoutAnyEstablishedTermMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="mlec_WithoutAnyEstablishedTermMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems" xlink:to="ifrs-full_TradeAndOtherPayables" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems" xlink:to="ifrs-full_NoncurrentPayables" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NoncurrentPayables" xlink:to="ifrs-full_OtherLiabilities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SimplyAgreementForFutureEquitySAFE" xlink:href="mlec-20230630.xsd#mlec_SimplyAgreementForFutureEquitySAFE"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NoncurrentPayables" xlink:to="mlec_SimplyAgreementForFutureEquitySAFE" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NoncurrentPayables" xlink:to="ifrs-full_FinancialLiabilities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SubtotalNonDerivatesLiabilities" xlink:href="mlec-20230630.xsd#mlec_SubtotalNonDerivatesLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_NoncurrentPayables" xlink:to="mlec_SubtotalNonDerivatesLiabilities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WarrantLiability" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WarrantLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems" xlink:to="ifrs-full_WarrantLiability" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SubtotalDerivatesLiabilities" xlink:href="mlec-20230630.xsd#mlec_SubtotalDerivatesLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems" xlink:to="mlec_SubtotalDerivatesLiabilities" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TotalLiabilities" xlink:href="mlec-20230630.xsd#mlec_TotalLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems" xlink:to="mlec_TotalLiabilities" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofForeignCurrencyExchangeRiskTable">
    <loc xlink:type="locator" xlink:label="mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskTable" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems" xlink:to="mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskTable" xlink:to="ifrs-full_TypesOfRisksAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ArgentinePesosMember" xlink:href="mlec-20230630.xsd#mlec_ArgentinePesosMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfRisksMember" xlink:to="mlec_ArgentinePesosMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_USDollarMember" xlink:href="mlec-20230630.xsd#mlec_USDollarMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfRisksMember" xlink:to="mlec_USDollarMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PoundSterlingMember" xlink:href="mlec-20230630.xsd#mlec_PoundSterlingMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfRisksMember" xlink:to="mlec_PoundSterlingMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ImpactToProfitOrLossBeforeTaxAssetsMember" xlink:href="mlec-20230630.xsd#mlec_ImpactToProfitOrLossBeforeTaxAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_ImpactToProfitOrLossBeforeTaxAssetsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ImpactToProfitOrLossBeforeTaxLiabilitiesMember" xlink:href="mlec-20230630.xsd#mlec_ImpactToProfitOrLossBeforeTaxLiabilitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_ImpactToProfitOrLossBeforeTaxLiabilitiesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ForeignCurrencyExchangeRiskAssets" xlink:href="mlec-20230630.xsd#mlec_ForeignCurrencyExchangeRiskAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems" xlink:to="mlec_ForeignCurrencyExchangeRiskAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ForeignCurrencyExchangeRiskLiabilities" xlink:href="mlec-20230630.xsd#mlec_ForeignCurrencyExchangeRiskLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems" xlink:to="mlec_ForeignCurrencyExchangeRiskLiabilities" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable">
    <loc xlink:type="locator" xlink:label="mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsTable" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems" xlink:to="mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsTable" xlink:to="ifrs-full_ClassesOfFinancialAssetsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_FinancialAssetsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssetsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_FinancialAssetsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_FinancialAssetsMember" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialAssetsAbstract" xlink:href="mlec-20230630.xsd#mlec_FinancialAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems" xlink:to="mlec_FinancialAssetsAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AmortizedCostsAbstract" xlink:href="mlec-20230630.xsd#mlec_AmortizedCostsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialAssetsAbstract" xlink:to="mlec_AmortizedCostsAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AmortizedCostsAbstract" xlink:to="ifrs-full_CashAndCashEquivalents" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_AmortizedCostsAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_FairValueThroughProfitOrLossAbstract" xlink:href="mlec-20230630.xsd#mlec_FairValueThroughProfitOrLossAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems" xlink:to="mlec_FairValueThroughProfitOrLossAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FairValueThroughProfitOrLossAbstract" xlink:to="ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ShorttermInvestmentsCurrent" xlink:href="mlec-20230630.xsd#mlec_ShorttermInvestmentsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FairValueThroughProfitOrLossAbstract" xlink:to="mlec_ShorttermInvestmentsCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FairValueThroughProfitOrLossAbstract" xlink:to="ifrs-full_CurrentAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialLiabilitiesAbstract" xlink:href="mlec-20230630.xsd#mlec_FinancialLiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems" xlink:to="mlec_FinancialLiabilitiesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialLiabilitiesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayables" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialDebts" xlink:href="mlec-20230630.xsd#mlec_FinancialDebts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialLiabilitiesAbstract" xlink:to="mlec_FinancialDebts" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_FairValueThroughProfitOrLossAbstract0" xlink:href="mlec-20230630.xsd#mlec_FairValueThroughProfitOrLossAbstract0"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems" xlink:to="mlec_FairValueThroughProfitOrLossAbstract0" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SimplyAgreementForFutureEquitySAFE" xlink:href="mlec-20230630.xsd#mlec_SimplyAgreementForFutureEquitySAFE"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FairValueThroughProfitOrLossAbstract0" xlink:to="mlec_SimplyAgreementForFutureEquitySAFE" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WarrantLiability" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WarrantLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FairValueThroughProfitOrLossAbstract0" xlink:to="ifrs-full_WarrantLiability" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems" xlink:to="ifrs-full_FinancialLiabilities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssetsLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssetsLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems" xlink:to="ifrs-full_CurrentAssetsLiabilities" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofFixedRateInstrumentsTable">
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfFixedRateInstrumentsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfFixedRateInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentFinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfFixedRateInstrumentsAbstract" xlink:to="ifrs-full_OtherCurrentFinancialLiabilities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ScheduleOfFixedRateInstrumentsAbstract" xlink:to="ifrs-full_OtherNoncurrentFinancialLiabilities" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/GeneralInformationDetails">
    <loc xlink:type="locator" xlink:label="mlec_GeneralInformationDetailsLineItems" xlink:href="mlec-20230630.xsd#mlec_GeneralInformationDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_GeneralInformationDetailsTable" xlink:href="mlec-20230630.xsd#mlec_GeneralInformationDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_GeneralInformationDetailsLineItems" xlink:to="mlec_GeneralInformationDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_GeneralInformationDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MoolecSAFEMember" xlink:href="mlec-20230630.xsd#mlec_MoolecSAFEMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_MoolecSAFEMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_UGVLAndTheoMember" xlink:href="mlec-20230630.xsd#mlec_UGVLAndTheoMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_UGVLAndTheoMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_GeneralInformationDetailsLineItems" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ParValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_GeneralInformationDetailsLineItems" xlink:to="ifrs-full_ParValuePerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CommonStockExercised" xlink:href="mlec-20230630.xsd#mlec_CommonStockExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_GeneralInformationDetailsLineItems" xlink:to="mlec_CommonStockExercised" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_RedemptionPrice" xlink:href="mlec-20230630.xsd#mlec_RedemptionPrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_GeneralInformationDetailsLineItems" xlink:to="mlec_RedemptionPrice" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AggregateRedemption" xlink:href="mlec-20230630.xsd#mlec_AggregateRedemption"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_GeneralInformationDetailsLineItems" xlink:to="mlec_AggregateRedemption" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_TrustAccount" xlink:href="mlec-20230630.xsd#mlec_TrustAccount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_GeneralInformationDetailsLineItems" xlink:to="mlec_TrustAccount" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SponsorShares" xlink:href="mlec-20230630.xsd#mlec_SponsorShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_GeneralInformationDetailsLineItems" xlink:to="mlec_SponsorShares" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_GeneralInformationDetailsLineItems" xlink:to="ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentCost" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_GeneralInformationDetailsLineItems" xlink:to="mlec_ShareBasedPaymentCost" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NegativeWorkingCapital" xlink:href="mlec-20230630.xsd#mlec_NegativeWorkingCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_GeneralInformationDetailsLineItems" xlink:to="mlec_NegativeWorkingCapital" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/BusinessCombinationDetails">
    <loc xlink:type="locator" xlink:label="mlec_BusinessCombinationAbstract" xlink:href="mlec-20230630.xsd#mlec_BusinessCombinationAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_BusinessCombinationAbstract" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashTransferred"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_BusinessCombinationAbstract" xlink:to="ifrs-full_CashTransferred" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssueCostsNotRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssueCostsNotRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_BusinessCombinationAbstract" xlink:to="ifrs-full_IssueCostsNotRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CashPayment" xlink:href="mlec-20230630.xsd#mlec_CashPayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_BusinessCombinationAbstract" xlink:to="mlec_CashPayment" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_BusinessCombinationAbstract" xlink:to="ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareEquivalent" xlink:href="mlec-20230630.xsd#mlec_ShareEquivalent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_BusinessCombinationAbstract" xlink:to="mlec_ShareEquivalent" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ExperienceDate" xlink:href="mlec-20230630.xsd#mlec_ExperienceDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_BusinessCombinationAbstract" xlink:to="mlec_ExperienceDate" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_BusinessCombinationAbstract" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails">
    <loc xlink:type="locator" xlink:label="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_CumulativeInflationRate" xlink:href="mlec-20230630.xsd#mlec_CumulativeInflationRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:to="mlec_CumulativeInflationRate" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_Accumulated" xlink:href="mlec-20230630.xsd#mlec_Accumulated"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:to="mlec_Accumulated" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_InflationAccumulated" xlink:href="mlec-20230630.xsd#mlec_InflationAccumulated"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:to="mlec_InflationAccumulated" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ArgentinePriceIndexes" xlink:href="mlec-20230630.xsd#mlec_ArgentinePriceIndexes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:to="mlec_ArgentinePriceIndexes" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:href="mlec-20230630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:href="mlec-20230630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="mlec_SummaryofSignificantAccountingPoliciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="ifrs-full_RangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfSharesToBeIssuedOfContingentPayment" xlink:href="mlec-20230630.xsd#mlec_NumberOfSharesToBeIssuedOfContingentPayment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="mlec_NumberOfSharesToBeIssuedOfContingentPayment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareIssueRelatedCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareIssueRelatedCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="ifrs-full_ShareIssueRelatedCost" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_JointArrangementParticipationPercentage" xlink:href="mlec-20230630.xsd#mlec_JointArrangementParticipationPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="mlec_JointArrangementParticipationPercentage" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/RightofUseofAssetsDetails">
    <loc xlink:type="locator" xlink:label="mlec_RightofUseOfAssetsAbstract" xlink:href="mlec-20230630.xsd#mlec_RightofUseOfAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_OriginalAmount" xlink:href="mlec-20230630.xsd#mlec_OriginalAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_RightofUseOfAssetsAbstract" xlink:to="mlec_OriginalAmount" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/OtherNonCurrentReceivablesDetails">
    <loc xlink:type="locator" xlink:label="mlec_OtherNonCurrentReceivablesDetailsLineItems" xlink:href="mlec-20230630.xsd#mlec_OtherNonCurrentReceivablesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherNonCurrentReceivablesDetailsTable" xlink:href="mlec-20230630.xsd#mlec_OtherNonCurrentReceivablesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_OtherNonCurrentReceivablesDetailsLineItems" xlink:to="mlec_OtherNonCurrentReceivablesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_OtherNonCurrentReceivablesDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_OtherNonCurrentReceivablesDetailsTable" xlink:to="ifrs-full_RangeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_TopOfRangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_BottomOfRangeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_MoolecScienceLimitedMember" xlink:href="mlec-20230630.xsd#mlec_MoolecScienceLimitedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="mlec_MoolecScienceLimitedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_OtherNonCurrentReceivablesDetailsLineItems" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_AggregatePurchasePrice" xlink:href="mlec-20230630.xsd#mlec_AggregatePurchasePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_OtherNonCurrentReceivablesDetailsLineItems" xlink:to="mlec_AggregatePurchasePrice" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PurchasePaymentTerms" xlink:href="mlec-20230630.xsd#mlec_PurchasePaymentTerms"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_OtherNonCurrentReceivablesDetailsLineItems" xlink:to="mlec_PurchasePaymentTerms" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsInterestRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_OtherNonCurrentReceivablesDetailsLineItems" xlink:to="ifrs-full_BorrowingsInterestRate" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ShareCapitalandSharePremiumDetails">
    <loc xlink:type="locator" xlink:label="mlec_ShareCapitalAndSharePremiumAbstract" xlink:href="mlec-20230630.xsd#mlec_ShareCapitalAndSharePremiumAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareCapitalStockAndSharePremiumAmounts" xlink:href="mlec-20230630.xsd#mlec_ShareCapitalStockAndSharePremiumAmounts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareCapitalAndSharePremiumAbstract" xlink:to="mlec_ShareCapitalStockAndSharePremiumAmounts" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_Equivalent" xlink:href="mlec-20230630.xsd#mlec_Equivalent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareCapitalAndSharePremiumAbstract" xlink:to="mlec_Equivalent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SharePurchaseAgreementOverPeriod" xlink:href="mlec-20230630.xsd#mlec_SharePurchaseAgreementOverPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareCapitalAndSharePremiumAbstract" xlink:to="mlec_SharePurchaseAgreementOverPeriod" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_UnderIssuedSharePurchaseAgreement" xlink:href="mlec-20230630.xsd#mlec_UnderIssuedSharePurchaseAgreement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareCapitalAndSharePremiumAbstract" xlink:to="mlec_UnderIssuedSharePurchaseAgreement" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_SharePurchaseAgreement" xlink:href="mlec-20230630.xsd#mlec_SharePurchaseAgreement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareCapitalAndSharePremiumAbstract" xlink:to="mlec_SharePurchaseAgreement" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ShareBasedPaymentDetails">
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentDetailsLineItems" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentDetailsTable" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_ShareBasedPaymentDetailsLineItems" xlink:to="mlec_ShareBasedPaymentDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_ShareBasedPaymentDetailsTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_Group1GrantedMember" xlink:href="mlec-20230630.xsd#mlec_Group1GrantedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="mlec_Group1GrantedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_Group2GrantedMember" xlink:href="mlec-20230630.xsd#mlec_Group2GrantedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="mlec_Group2GrantedMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_Group3GrantedMember" xlink:href="mlec-20230630.xsd#mlec_Group3GrantedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="mlec_Group3GrantedMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OrdinaryShares" xlink:href="mlec-20230630.xsd#mlec_OrdinaryShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentDetailsLineItems" xlink:to="mlec_OrdinaryShares" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentDetailsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ConstantValuePercentage" xlink:href="mlec-20230630.xsd#mlec_ConstantValuePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentDetailsLineItems" xlink:to="mlec_ConstantValuePercentage" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_OptionsRecognizedAmount" xlink:href="mlec-20230630.xsd#mlec_OptionsRecognizedAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_ShareBasedPaymentDetailsLineItems" xlink:to="mlec_OptionsRecognizedAmount" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/WarrantsLiabilitiesDetails">
    <loc xlink:type="locator" xlink:label="mlec_WarrantsLiabilitiesAbstract" xlink:href="mlec-20230630.xsd#mlec_WarrantsLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="mlec_AggregateShares" xlink:href="mlec-20230630.xsd#mlec_AggregateShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_WarrantsLiabilitiesAbstract" xlink:to="mlec_AggregateShares" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_WarrantsLiabilitiesAbstract" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PricePerWarrant" xlink:href="mlec-20230630.xsd#mlec_PricePerWarrant"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_WarrantsLiabilitiesAbstract" xlink:to="mlec_PricePerWarrant" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ExercisePricePerShare" xlink:href="mlec-20230630.xsd#mlec_ExercisePricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_WarrantsLiabilitiesAbstract" xlink:to="mlec_ExercisePricePerShare" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DividendsPaidOrdinarySharesPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DividendsPaidOrdinarySharesPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_WarrantsLiabilitiesAbstract" xlink:to="ifrs-full_DividendsPaidOrdinarySharesPerShare" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFEDetails">
    <loc xlink:type="locator" xlink:label="mlec_SimpleAgreementForFutureEquitySafeAbstract" xlink:href="mlec-20230630.xsd#mlec_SimpleAgreementForFutureEquitySafeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NotionalAmount" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotionalAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_SimpleAgreementForFutureEquitySafeAbstract" xlink:to="ifrs-full_NotionalAmount" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentReceivablesFromSaleOfProperties" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentReceivablesFromSaleOfProperties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_SimpleAgreementForFutureEquitySafeAbstract" xlink:to="ifrs-full_CurrentReceivablesFromSaleOfProperties" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_SimpleAgreementForFutureEquitySafeAbstract" xlink:to="ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_ConvertedShares" xlink:href="mlec-20230630.xsd#mlec_ConvertedShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_SimpleAgreementForFutureEquitySafeAbstract" xlink:to="mlec_ConvertedShares" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PurchasePricePerShare" xlink:href="mlec-20230630.xsd#mlec_PurchasePricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_SimpleAgreementForFutureEquitySafeAbstract" xlink:to="mlec_PurchasePricePerShare" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PurchasePrice" xlink:href="mlec-20230630.xsd#mlec_PurchasePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_SimpleAgreementForFutureEquitySafeAbstract" xlink:to="mlec_PurchasePrice" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/DeferredTaxandIncomeTaxDetails">
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsLineItems" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsTable" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsLineItems" xlink:to="mlec_DeferredTaxandIncomeTaxDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsTable" xlink:to="ifrs-full_GeographicalAreasAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_LU" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_LU"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="country_LU" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IncomeTaxRate" xlink:href="mlec-20230630.xsd#mlec_IncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsLineItems" xlink:to="mlec_IncomeTaxRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxExpenseIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsLineItems" xlink:to="ifrs-full_DeferredTaxExpenseIncome" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/FinancialRiskManagementDetails">
    <loc xlink:type="locator" xlink:label="mlec_FinancialRiskManagementDetailsLineItems" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialRiskManagementDetailsTable" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_FinancialRiskManagementDetailsLineItems" xlink:to="mlec_FinancialRiskManagementDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_FinancialRiskManagementDetailsTable" xlink:to="ifrs-full_TypesOfRisksAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksMember_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiquidityRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiquidityRiskMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfRisksMember" xlink:to="ifrs-full_LiquidityRiskMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestRateRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestRateRiskMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ifrs-full_TypesOfRisksMember" xlink:to="ifrs-full_InterestRateRiskMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentFinancialAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialRiskManagementDetailsLineItems" xlink:to="ifrs-full_CurrentFinancialAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialRiskManagementDetailsLineItems" xlink:to="ifrs-full_FinancialLiabilities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfFunctionalCurrency" xlink:href="mlec-20230630.xsd#mlec_PercentageOfFunctionalCurrency"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialRiskManagementDetailsLineItems" xlink:to="mlec_PercentageOfFunctionalCurrency" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxRateEffectOfForeignTaxRates" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TaxRateEffectOfForeignTaxRates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialRiskManagementDetailsLineItems" xlink:to="ifrs-full_TaxRateEffectOfForeignTaxRates" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfInterestRates" xlink:href="mlec-20230630.xsd#mlec_PercentageOfInterestRates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialRiskManagementDetailsLineItems" xlink:to="mlec_PercentageOfInterestRates" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_IncreasedecreaseInterestPayable" xlink:href="mlec-20230630.xsd#mlec_IncreasedecreaseInterestPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_FinancialRiskManagementDetailsLineItems" xlink:to="mlec_IncreasedecreaseInterestPayable" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/EventsaftertheReportingPeriodDetails">
    <loc xlink:type="locator" xlink:label="mlec_EventsaftertheReportingPeriodDetailsLineItems" xlink:href="mlec-20230630.xsd#mlec_EventsaftertheReportingPeriodDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="mlec_EventsaftertheReportingPeriodDetailsTable" xlink:href="mlec-20230630.xsd#mlec_EventsaftertheReportingPeriodDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="mlec_EventsaftertheReportingPeriodDetailsLineItems" xlink:to="mlec_EventsaftertheReportingPeriodDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="mlec_EventsaftertheReportingPeriodDetailsTable" xlink:to="srt_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_EventsaftertheReportingPeriodDetailsLineItems" xlink:to="ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_StrikePricePerShare" xlink:href="mlec-20230630.xsd#mlec_StrikePricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_EventsaftertheReportingPeriodDetailsLineItems" xlink:to="mlec_StrikePricePerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_EventsaftertheReportingPeriodDetailsLineItems" xlink:to="ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfStockInventories" xlink:href="mlec-20230630.xsd#mlec_NumberOfStockInventories"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_EventsaftertheReportingPeriodDetailsLineItems" xlink:to="mlec_NumberOfStockInventories" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="mlec_CashPaidInKindInterest" xlink:href="mlec-20230630.xsd#mlec_CashPaidInKindInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="mlec_EventsaftertheReportingPeriodDetailsLineItems" xlink:to="mlec_CashPaidInKindInterest" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain_0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_AddressTypeDomain" xlink:to="dei_BusinessContactMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentRegistrationStatement" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentShellCompanyReport" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCountry" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelName" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelEmailAddress" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelEmailAddress"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelEmailAddress" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" order="37" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAccountingStandard" order="38" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="39" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="40" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="41" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>mlec-20230630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Oct 30 21:05:19 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US">Entity Addresses, Address Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_lbl" xml:lang="en-US">Loss from operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLossBeforeTax_lbl" xml:lang="en-US">Net loss before Income tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossBeforeTax_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLoss_lbl" xml:lang="en-US">Net loss of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLoss_lbl0" xml:lang="en-US">Net loss of the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProfitLoss_lbl1" xml:lang="en-US">Loss for the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_OtherComprehensiveIncome_lbl" xml:lang="en-US">Total other comprehensive income/(loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncome" xlink:to="ifrs-full_OtherComprehensiveIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComprehensiveIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ComprehensiveIncome_lbl" xml:lang="en-US">Total comprehensive loss for the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NoncurrentAssets_lbl" xml:lang="en-US">Total non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentAssets_lbl" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentAssets_lbl0" xml:lang="en-US">Total financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Equity_lbl" xml:lang="en-US">Total equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_Equity_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_Equity_lbl1" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentLiabilities_lbl" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NoncurrentLiabilities_lbl" xml:lang="en-US">Total non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Liabilities_lbl" xml:lang="en-US">TOTAL LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_Liabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAndLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAndLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_EquityAndLiabilities_lbl" xml:lang="en-US">TOTAL LIABILITIES AND EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_EquityAndLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComponentsOfEquityAxis_lbl" xml:lang="en-US">Components of equity [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ComponentsOfEquityAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash (used in) / generated by operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash generated from financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl" xml:lang="en-US">Net increase in cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_lbl" xml:lang="en-US">Cash and cash equivalents at beginning of the year/period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" xlink:to="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_lbl0" xml:lang="en-US">Cash and cash equivalents at end of the year/period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" xlink:to="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract_lbl" xml:lang="en-US">General Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="ifrs-full_NotesAndOtherExplanatoryInformationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BusinessCombinationAbstract" xlink:href="mlec-20230630.xsd#mlec_BusinessCombinationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BusinessCombinationAbstract_lbl" xml:lang="en-US">Business Combination [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BusinessCombinationAbstract" xlink:to="mlec_BusinessCombinationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MeasurementAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MeasurementAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MeasurementAxis_lbl" xml:lang="en-US">Measurement [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MeasurementAxis" xlink:to="ifrs-full_MeasurementAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_lbl" xml:lang="en-US">Accounting standards and Basis of preparation [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:to="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Summary of Significant Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_lbl" xml:lang="en-US">Classes of property, plant and equipment [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangeAxis_lbl" xml:lang="en-US">Range [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis_lbl" xml:lang="en-US">Categories of related parties [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis_lbl" xml:lang="en-US">Classes of financial assets [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_ClassesOfFinancialAssetsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsAndGoodwillAbstract_lbl" xml:lang="en-US">Intangible Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:to="ifrs-full_IntangibleAssetsAndGoodwillAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Opening net book amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl0" xml:lang="en-US">Closing net book amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl1" xml:lang="en-US">Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_lbl" xml:lang="en-US">Classes of intangible assets and goodwill [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Fixed Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_PropertyPlantAndEquipmentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_lbl" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl" xml:lang="en-US">Opening net book amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl0" xml:lang="en-US">Closing net book amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl1" xml:lang="en-US">Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl2" xml:lang="en-US">Accumulated Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl3" xml:lang="en-US">Net book amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_lbl3"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ChangesInGoodwillAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ChangesInGoodwillAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ChangesInGoodwillAbstract_lbl" xml:lang="en-US">Goodwill [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ChangesInGoodwillAbstract" xlink:to="ifrs-full_ChangesInGoodwillAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfGoodwillAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfGoodwillAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfGoodwillAbstract_lbl" xml:lang="en-US">Schedule of Goodwill [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfGoodwillAbstract" xlink:to="mlec_ScheduleOfGoodwillAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TotalGoodwill" xlink:href="mlec-20230630.xsd#mlec_TotalGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="mlec_TotalGoodwill_lbl" xml:lang="en-US">Total Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalGoodwill" xlink:to="mlec_TotalGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RightofUseOfAssetsAbstract" xlink:href="mlec-20230630.xsd#mlec_RightofUseOfAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RightofUseOfAssetsAbstract_lbl" xml:lang="en-US">Right-of-Use of Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RightofUseOfAssetsAbstract" xlink:to="mlec_RightofUseOfAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfRightOfUseOfAssetsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfRightOfUseOfAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfRightOfUseOfAssetsAbstract_lbl" xml:lang="en-US">Schedule of Right-of-Use of Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfRightOfUseOfAssetsAbstract" xlink:to="mlec_ScheduleOfRightOfUseOfAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_RightofuseAssets_lbl" xml:lang="en-US">As of June 30, 2022</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_RightofuseAssets_lbl0" xml:lang="en-US">As of June 30, 2023</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RightofuseAssets_lbl1" xml:lang="en-US">Right-of-use of assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentReceivablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentReceivablesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentReceivablesAbstract_lbl" xml:lang="en-US">Other Non-Current Receivables [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentReceivablesAbstract" xlink:to="ifrs-full_NoncurrentReceivablesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOtherNonCurrentReceivablesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherNonCurrentReceivablesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfOtherNonCurrentReceivablesAbstract_lbl" xml:lang="en-US">Schedule Of Other Non Current Receivables [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfOtherNonCurrentReceivablesAbstract" xlink:to="mlec_ScheduleOfOtherNonCurrentReceivablesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NoncurrentReceivables_lbl" xml:lang="en-US">Total Other Non-Current receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentReceivables" xlink:to="ifrs-full_NoncurrentReceivables_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentReceivables_lbl0" xml:lang="en-US">Other Non-Current receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentReceivables" xlink:to="ifrs-full_NoncurrentReceivables_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAndCashEquivalentsAbstract_lbl" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalentsAbstract" xlink:to="ifrs-full_CashAndCashEquivalentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShortTermInvestmentAbstract" xlink:href="mlec-20230630.xsd#mlec_ShortTermInvestmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShortTermInvestmentAbstract_lbl" xml:lang="en-US">Short-Term Investments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShortTermInvestmentAbstract" xlink:to="mlec_ShortTermInvestmentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfShortTermInvestmentsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfShortTermInvestmentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfShortTermInvestmentsAbstract_lbl" xml:lang="en-US">Schedule of Short Term Investments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfShortTermInvestmentsAbstract" xlink:to="mlec_ScheduleOfShortTermInvestmentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentReceivablesAbstract_lbl" xml:lang="en-US">Trade Receivable and Other Current Receivables [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentReceivablesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_TradeAndOtherReceivables_lbl" xml:lang="en-US">Total Trade receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherReceivables" xlink:to="ifrs-full_TradeAndOtherReceivables_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeAndOtherReceivables_lbl0" xml:lang="en-US">Accounts Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherReceivables" xlink:to="ifrs-full_TradeAndOtherReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TradeAndOtherReceivables_lbl1" xml:lang="en-US">Up to 3 months</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherReceivables" xlink:to="ifrs-full_TradeAndOtherReceivables_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOtherCurrentReceivablesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherCurrentReceivablesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfOtherCurrentReceivablesAbstract_lbl" xml:lang="en-US">Schedule of Other Current Receivables [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfOtherCurrentReceivablesAbstract" xlink:to="mlec_ScheduleOfOtherCurrentReceivablesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfInventoriesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfInventoriesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfInventoriesAbstract_lbl" xml:lang="en-US">Inventories [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfInventoriesAbstract" xlink:to="ifrs-full_ClassesOfInventoriesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfInventoriesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfInventoriesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfInventoriesAbstract_lbl" xml:lang="en-US">Schedule of Inventories [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfInventoriesAbstract" xlink:to="mlec_ScheduleOfInventoriesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InventoriesTotal" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InventoriesTotal"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_InventoriesTotal_lbl" xml:lang="en-US">Total Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InventoriesTotal" xlink:to="ifrs-full_InventoriesTotal_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareCapitalAndSharePremiumAbstract" xlink:href="mlec-20230630.xsd#mlec_ShareCapitalAndSharePremiumAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareCapitalAndSharePremiumAbstract_lbl" xml:lang="en-US">Share Capital and Share Premium [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareCapitalAndSharePremiumAbstract" xlink:to="mlec_ShareCapitalAndSharePremiumAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NumberOfSharesIssued_lbl" xml:lang="en-US">Number of shares,Opening balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NumberOfSharesIssued_lbl0" xml:lang="en-US">Number of shares, Ending balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_SharesIssuedAmount" xlink:href="mlec-20230630.xsd#mlec_SharesIssuedAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="mlec_SharesIssuedAmount_lbl" xml:lang="en-US">Shares issued amount,Opening balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesIssuedAmount" xlink:to="mlec_SharesIssuedAmount_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="mlec_SharesIssuedAmount_lbl0" xml:lang="en-US">Shares issued amount, Ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesIssuedAmount" xlink:to="mlec_SharesIssuedAmount_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareToBeIssuedAmount" xlink:href="mlec-20230630.xsd#mlec_ShareToBeIssuedAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="mlec_ShareToBeIssuedAmount_lbl" xml:lang="en-US">Shares to be issued amount,Opening balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareToBeIssuedAmount" xlink:to="mlec_ShareToBeIssuedAmount_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="mlec_ShareToBeIssuedAmount_lbl0" xml:lang="en-US">Shares to be issued amount, Ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareToBeIssuedAmount" xlink:to="mlec_ShareToBeIssuedAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ShareToBeIssuedAmount_lbl1" xml:lang="en-US">Shares to be issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareToBeIssuedAmount" xlink:to="mlec_ShareToBeIssuedAmount_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremium" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharePremium"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_SharePremium_lbl" xml:lang="en-US">Share Premium,Opening balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharePremium" xlink:to="ifrs-full_SharePremium_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_SharePremium_lbl0" xml:lang="en-US">Share Premium, Ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharePremium" xlink:to="ifrs-full_SharePremium_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_SharePremium_lbl1" xml:lang="en-US">Share premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharePremium" xlink:to="ifrs-full_SharePremium_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_lbl" xml:lang="en-US">Classes of share capital [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentAbstract" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareBasedPaymentAbstract_lbl" xml:lang="en-US">Share Based Payment [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentAbstract" xlink:to="mlec_ShareBasedPaymentAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ShareBasedPaymentAbstract_lbl0" xml:lang="en-US">Share based payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentAbstract" xlink:to="mlec_ShareBasedPaymentAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CreationDateAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CreationDateAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CreationDateAxis_lbl" xml:lang="en-US">Creation date [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CreationDateAxis" xlink:to="ifrs-full_CreationDateAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfAccountsPayableAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfAccountsPayableAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfAccountsPayableAbstract_lbl" xml:lang="en-US">Schedule of Accounts Payable [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfAccountsPayableAbstract" xlink:to="mlec_ScheduleOfAccountsPayableAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialAssetsAbstract_lbl" xml:lang="en-US">Financial Debt [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:to="ifrs-full_DisclosureOfFinancialAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CounterpartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CounterpartiesAxis_lbl" xml:lang="en-US">Counterparties [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CounterpartiesAxis" xlink:to="ifrs-full_CounterpartiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeAbstract_lbl" xml:lang="en-US">Schedule of Book Value is Reasonably Approximate to the Fair Value given its Short-Term Nature [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeAbstract" xlink:to="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsByNameAxis_lbl" xml:lang="en-US">Borrowings by name [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_WarrantsLiabilitiesAbstract" xlink:href="mlec-20230630.xsd#mlec_WarrantsLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_WarrantsLiabilitiesAbstract_lbl" xml:lang="en-US">Warrants Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_WarrantsLiabilitiesAbstract" xlink:to="mlec_WarrantsLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_WarrantAndRightsOutstanding" xlink:href="mlec-20230630.xsd#mlec_WarrantAndRightsOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="mlec_WarrantAndRightsOutstanding_lbl" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_WarrantAndRightsOutstanding" xlink:to="mlec_WarrantAndRightsOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="mlec_WarrantAndRightsOutstanding_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_WarrantAndRightsOutstanding" xlink:to="mlec_WarrantAndRightsOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_SimpleAgreementForFutureEquitySafeAbstract" xlink:href="mlec-20230630.xsd#mlec_SimpleAgreementForFutureEquitySafeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SimpleAgreementForFutureEquitySafeAbstract_lbl" xml:lang="en-US">Simple Agreement for Future Equity Safe [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SimpleAgreementForFutureEquitySafeAbstract" xlink:to="mlec_SimpleAgreementForFutureEquitySafeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfFinancialInstrumentsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfFinancialInstrumentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfFinancialInstrumentsAbstract_lbl" xml:lang="en-US">Schedule of Financial Instruments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfFinancialInstrumentsAbstract" xlink:to="mlec_ScheduleOfFinancialInstrumentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfRollForwardOfNetDeferredTaxAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfRollForwardOfNetDeferredTaxAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfRollForwardOfNetDeferredTaxAbstract_lbl" xml:lang="en-US">Schedule of Roll Forward of Net Deferred Tax [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfRollForwardOfNetDeferredTaxAbstract" xlink:to="mlec_ScheduleOfRollForwardOfNetDeferredTaxAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_DeferredTaxLiabilities_lbl" xml:lang="en-US">Balance at beginning of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxLiabilities" xlink:to="ifrs-full_DeferredTaxLiabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_DeferredTaxLiabilities_lbl0" xml:lang="en-US">Balance at year end</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxLiabilities" xlink:to="ifrs-full_DeferredTaxLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DeferredTaxLiabilities_lbl1" xml:lang="en-US">Deferred Tax Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxLiabilities" xlink:to="ifrs-full_DeferredTaxLiabilities_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GeographicalAreasAxis_lbl" xml:lang="en-US">Geographical areas [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfIncomeTaxForOtherJurisdictionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsAbstract_lbl" xml:lang="en-US">Schedule of Income Tax For Other Jurisdictions [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsAbstract" xlink:to="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables_lbl" xml:lang="en-US">Total other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentReceivables" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables_lbl0" xml:lang="en-US">Total Other current receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentReceivables" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables_lbl1" xml:lang="en-US">Trade and other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentReceivables" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_DeferredTaxLiabilityAsset_lbl" xml:lang="en-US">Total deferred tax liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxLiabilityAsset" xlink:to="ifrs-full_DeferredTaxLiabilityAsset_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetDeferredTaxLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NetDeferredTaxLiabilities_lbl" xml:lang="en-US">Net deferred tax liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDeferredTaxLiabilities" xlink:to="ifrs-full_NetDeferredTaxLiabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NetDeferredTaxLiabilities_lbl0" xml:lang="en-US">Deferred Tax Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDeferredTaxLiabilities" xlink:to="ifrs-full_NetDeferredTaxLiabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeExpenseGainsOrLossesOfFinancialInstrumentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeExpenseGainsOrLossesOfFinancialInstrumentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeExpenseGainsOrLossesOfFinancialInstrumentsAbstract_lbl" xml:lang="en-US">Financial income / expenses [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeExpenseGainsOrLossesOfFinancialInstrumentsAbstract" xlink:to="ifrs-full_IncomeExpenseGainsOrLossesOfFinancialInstrumentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOtherOperatingExpenseAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherOperatingExpenseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfOtherOperatingExpenseAbstract_lbl" xml:lang="en-US">Schedule of Other Operating Expense [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfOtherOperatingExpenseAbstract" xlink:to="mlec_ScheduleOfOtherOperatingExpenseAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_lbl" xml:lang="en-US">Administrative Expenses [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfAdministrativeExpensesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfAdministrativeExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfAdministrativeExpensesAbstract_lbl" xml:lang="en-US">Schedule of Administrative Expenses [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfAdministrativeExpensesAbstract" xlink:to="mlec_ScheduleOfAdministrativeExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="ifrs-full_AdministrativeExpense_lbl" xml:lang="en-US">Total Administrative expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdministrativeExpense" xlink:to="ifrs-full_AdministrativeExpense_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AdministrativeExpense_lbl0" xml:lang="en-US">Administrative expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdministrativeExpense" xlink:to="ifrs-full_AdministrativeExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Total Research and development expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_lbl0" xml:lang="en-US">Research and development expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_CostOfSalesAbstract" xlink:href="mlec-20230630.xsd#mlec_CostOfSalesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CostOfSalesAbstract_lbl" xml:lang="en-US">Cost of Sales [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CostOfSalesAbstract" xlink:to="mlec_CostOfSalesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Inventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Inventories"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_Inventories_lbl" xml:lang="en-US">Inventories at beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Inventories" xlink:to="ifrs-full_Inventories_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_Inventories_lbl0" xml:lang="en-US">Inventories as of the end</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Inventories" xlink:to="ifrs-full_Inventories_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Inventories_lbl1" xml:lang="en-US">Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Inventories" xlink:to="ifrs-full_Inventories_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfNetLossPerShareAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfNetLossPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfNetLossPerShareAbstract_lbl" xml:lang="en-US">Schedule Of Net Loss Per Share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfNetLossPerShareAbstract" xlink:to="mlec_ScheduleOfNetLossPerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract_lbl" xml:lang="en-US">Financial Risk Management [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:to="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MaturityAxis_lbl" xml:lang="en-US">Maturity [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SubtotalNonDerivatesLiabilities" xlink:href="mlec-20230630.xsd#mlec_SubtotalNonDerivatesLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="mlec_SubtotalNonDerivatesLiabilities_lbl" xml:lang="en-US">Subtotal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SubtotalNonDerivatesLiabilities" xlink:to="mlec_SubtotalNonDerivatesLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SubtotalDerivatesLiabilities" xlink:href="mlec-20230630.xsd#mlec_SubtotalDerivatesLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="mlec_SubtotalDerivatesLiabilities_lbl" xml:lang="en-US">Subtotal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SubtotalDerivatesLiabilities" xlink:to="mlec_SubtotalDerivatesLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TotalLiabilities" xlink:href="mlec-20230630.xsd#mlec_TotalLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="mlec_TotalLiabilities_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalLiabilities" xlink:to="mlec_TotalLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfRisksAxis_lbl" xml:lang="en-US">Types of risks [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_FinancialLiabilities_lbl" xml:lang="en-US">Total financial liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_FinancialLiabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FinancialLiabilities_lbl0" xml:lang="en-US">Financial debts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_FinancialLiabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssetsLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssetsLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentAssetsLiabilities_lbl" xml:lang="en-US">Net financial asset /(liability)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssetsLiabilities" xlink:to="ifrs-full_CurrentAssetsLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfFixedRateInstrumentsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfFixedRateInstrumentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfFixedRateInstrumentsAbstract_lbl" xml:lang="en-US">Schedule of Fixed Rate Instruments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfFixedRateInstrumentsAbstract" xlink:to="mlec_ScheduleOfFixedRateInstrumentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CapitalRiskManagementAbstract" xlink:href="mlec-20230630.xsd#mlec_CapitalRiskManagementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CapitalRiskManagementAbstract_lbl" xml:lang="en-US">Capital Risk Management [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CapitalRiskManagementAbstract" xlink:to="mlec_CapitalRiskManagementAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_ContactPersonnelName_lbl" xml:lang="en-US">Contact Personnel Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelEmailAddress" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelEmailAddress"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_ContactPersonnelEmailAddress_lbl" xml:lang="en-US">Contact Personnel Email Address</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelEmailAddress" xlink:to="dei_ContactPersonnelEmailAddress_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ContinuingOperationsAbstract" xlink:href="mlec-20230630.xsd#mlec_ContinuingOperationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ContinuingOperationsAbstract_lbl" xml:lang="en-US">Continuing operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ContinuingOperationsAbstract" xlink:to="mlec_ContinuingOperationsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Revenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Revenue_lbl" xml:lang="en-US">Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_Revenue_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherOperatingIncomeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherOperatingIncomeExpense_lbl" xml:lang="en-US">Other operating expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_OtherOperatingIncomeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract" xlink:href="mlec-20230630.xsd#mlec_UnlabeledAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract" xlink:to="mlec_UnlabeledAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax_lbl" xml:lang="en-US">Share of loss from associate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherFinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherFinanceIncomeCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherFinanceIncomeCost_lbl" xml:lang="en-US">Other financial results</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherFinanceIncomeCost" xlink:to="ifrs-full_OtherFinanceIncomeCost_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract0" xlink:href="mlec-20230630.xsd#mlec_UnlabeledAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract0_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract0" xlink:to="mlec_UnlabeledAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BasicEarningsLossPerShare_lbl" xml:lang="en-US">Basic and diluted loss per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShare" xlink:to="ifrs-full_BasicEarningsLossPerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DilutedEarningsLossPerShare_lbl" xml:lang="en-US">Diluted loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerShare" xlink:to="ifrs-full_DilutedEarningsLossPerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract1" xlink:href="mlec-20230630.xsd#mlec_UnlabeledAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract1_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract1" xlink:to="mlec_UnlabeledAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncomeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeAbstract_lbl" xml:lang="en-US">Other comprehensive income/loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="ifrs-full_OtherComprehensiveIncomeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax_lbl" xml:lang="en-US">Foreign exchange differences on translation of foreign operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AssetAbstract" xlink:href="mlec-20230630.xsd#mlec_AssetAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AssetAbstract_lbl" xml:lang="en-US">ASSET</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AssetAbstract" xlink:to="mlec_AssetAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NonCurrentAssetsAbstract" xlink:href="mlec-20230630.xsd#mlec_NonCurrentAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NonCurrentAssetsAbstract_lbl" xml:lang="en-US">Non- current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NonCurrentAssetsAbstract" xlink:to="mlec_NonCurrentAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FixedAssets" xlink:href="mlec-20230630.xsd#mlec_FixedAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FixedAssets_lbl" xml:lang="en-US">Fixed Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FixedAssets" xlink:to="mlec_FixedAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Goodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Goodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Goodwill_lbl" xml:lang="en-US">Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Goodwill" xlink:to="ifrs-full_Goodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentAssetsAbstract_lbl" xml:lang="en-US">Current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashAndCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShorttermInvestmentsCurrent" xlink:href="mlec-20230630.xsd#mlec_ShorttermInvestmentsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ShorttermInvestmentsCurrent_lbl" xml:lang="en-US">Short-term investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShorttermInvestmentsCurrent" xlink:to="mlec_ShorttermInvestmentsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTradeReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentTradeReceivables_lbl" xml:lang="en-US">Trade receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTradeReceivables" xlink:to="ifrs-full_CurrentTradeReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherReceivables_lbl" xml:lang="en-US">Other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherReceivables" xlink:to="ifrs-full_OtherReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPrepayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentPrepayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentPrepayments_lbl" xml:lang="en-US">Prepayments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentPrepayments" xlink:to="ifrs-full_CurrentPrepayments_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_LiabilitiesAndEquityAbstract" xlink:href="mlec-20230630.xsd#mlec_LiabilitiesAndEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_LiabilitiesAndEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LiabilitiesAndEquityAbstract" xlink:to="mlec_LiabilitiesAndEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EquityAbstract_lbl" xml:lang="en-US">Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_EquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IssuedCapital_lbl" xml:lang="en-US">Share capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapital" xlink:to="ifrs-full_IssuedCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_EquitySettledShareBasedPayments" xlink:href="mlec-20230630.xsd#mlec_EquitySettledShareBasedPayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_EquitySettledShareBasedPayments_lbl" xml:lang="en-US">Equity settled share-based payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EquitySettledShareBasedPayments" xlink:to="mlec_EquitySettledShareBasedPayments_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_lbl" xml:lang="en-US">Cumulative translation adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarnings" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarnings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RetainedEarnings_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarnings" xlink:to="ifrs-full_RetainedEarnings_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LiabilitiesAbstract_lbl" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesAbstract" xlink:to="ifrs-full_LiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentLiabilitiesAbstract_lbl" xml:lang="en-US">Current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_lbl" xml:lang="en-US">Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayables" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_lbl0" xml:lang="en-US">Trade and other payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayables" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentFinancialLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherCurrentFinancialLiabilities_lbl" xml:lang="en-US">Financial debts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentFinancialLiabilities" xlink:to="ifrs-full_OtherCurrentFinancialLiabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_OtherCurrentFinancialLiabilities_lbl0" xml:lang="en-US">Current financial liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentFinancialLiabilities" xlink:to="ifrs-full_OtherCurrentFinancialLiabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherCurrentLiabilities_lbl" xml:lang="en-US">Other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentLiabilities" xlink:to="ifrs-full_OtherCurrentLiabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherCurrentLiabilities_lbl0" xml:lang="en-US">Total Other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentLiabilities" xlink:to="ifrs-full_OtherCurrentLiabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WarrantLiability" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WarrantLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WarrantLiability_lbl" xml:lang="en-US">Warrants liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WarrantLiability" xlink:to="ifrs-full_WarrantLiability_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_WarrantLiability_lbl0" xml:lang="en-US">Warrant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WarrantLiability" xlink:to="ifrs-full_WarrantLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_WarrantLiability_lbl1" xml:lang="en-US">Warrant liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WarrantLiability" xlink:to="ifrs-full_WarrantLiability_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_SimplyAgreementForFutureEquitySAFE" xlink:href="mlec-20230630.xsd#mlec_SimplyAgreementForFutureEquitySAFE"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SimplyAgreementForFutureEquitySAFE_lbl" xml:lang="en-US">Simply Agreement for Future Equity (&#8220;SAFE&#8221;)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SimplyAgreementForFutureEquitySAFE" xlink:to="mlec_SimplyAgreementForFutureEquitySAFE_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NonCurrentLiabilitiesAbstract" xlink:href="mlec-20230630.xsd#mlec_NonCurrentLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NonCurrentLiabilitiesAbstract_lbl" xml:lang="en-US">Non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NonCurrentLiabilitiesAbstract" xlink:to="mlec_NonCurrentLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherNoncurrentFinancialLiabilities_lbl" xml:lang="en-US">Financial debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:to="ifrs-full_OtherNoncurrentFinancialLiabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_OtherNoncurrentFinancialLiabilities_lbl0" xml:lang="en-US">Non-current financial liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:to="ifrs-full_OtherNoncurrentFinancialLiabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentPayables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherNoncurrentPayables_lbl" xml:lang="en-US">Other non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentPayables" xlink:to="ifrs-full_OtherNoncurrentPayables_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IssueOfShareCapital" xlink:href="mlec-20230630.xsd#mlec_IssueOfShareCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IssueOfShareCapital_lbl" xml:lang="en-US">Issue of share capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssueOfShareCapital" xlink:to="mlec_IssueOfShareCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax_lbl" xml:lang="en-US">Total comprehensive (loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" xlink:to="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_EquitySettledShareBasedPayment" xlink:href="mlec-20230630.xsd#mlec_EquitySettledShareBasedPayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_EquitySettledShareBasedPayment_lbl" xml:lang="en-US">Equity settled share-based payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EquitySettledShareBasedPayment" xlink:to="mlec_EquitySettledShareBasedPayment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssueOfEquity" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssueOfEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IssueOfEquity_lbl" xml:lang="en-US">Issue of share capital (Moolec Science shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssueOfEquity" xlink:to="ifrs-full_IssueOfEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IssueOfShareCapitalSAFEShares" xlink:href="mlec-20230630.xsd#mlec_IssueOfShareCapitalSAFEShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IssueOfShareCapitalSAFEShares_lbl" xml:lang="en-US">Issue of share capital (SAFE shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssueOfShareCapitalSAFEShares" xlink:to="mlec_IssueOfShareCapitalSAFEShares_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IssueOfShareCapitalLightJumpShares" xlink:href="mlec-20230630.xsd#mlec_IssueOfShareCapitalLightJumpShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IssueOfShareCapitalLightJumpShares_lbl" xml:lang="en-US">Issue of share capital (LightJump shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssueOfShareCapitalLightJumpShares" xlink:to="mlec_IssueOfShareCapitalLightJumpShares_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IssueOfShareCapitalBackstopShares" xlink:href="mlec-20230630.xsd#mlec_IssueOfShareCapitalBackstopShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IssueOfShareCapitalBackstopShares_lbl" xml:lang="en-US">Issue of share capital (Backstop shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssueOfShareCapitalBackstopShares" xlink:to="mlec_IssueOfShareCapitalBackstopShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax_lbl" xml:lang="en-US">Exchange differences on translation of foreign operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" xlink:to="ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BusinessCombination" xlink:href="mlec-20230630.xsd#mlec_BusinessCombination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BusinessCombination_lbl" xml:lang="en-US">Business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BusinessCombination" xlink:to="mlec_BusinessCombination_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_lbl" xml:lang="en-US">Adjustments to reconcile loss for the year to net cash flows</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncomeTaxExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForIncomeTaxExpense_lbl" xml:lang="en-US">Deferred income tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:to="ifrs-full_AdjustmentsForIncomeTaxExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_lbl" xml:lang="en-US">Depreciation and amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:to="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments_lbl" xml:lang="en-US">Employee share-based payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForSharebasedPayments" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentCostOfListingSharesnoncashItem" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentCostOfListingSharesnoncashItem"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ShareBasedPaymentCostOfListingSharesnoncashItem_lbl" xml:lang="en-US">Share based payment cost of listing shares (non-cash item)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentCostOfListingSharesnoncashItem" xlink:to="mlec_ShareBasedPaymentCostOfListingSharesnoncashItem_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ChangesInWorkingCapitalAbstract" xlink:href="mlec-20230630.xsd#mlec_ChangesInWorkingCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ChangesInWorkingCapitalAbstract_lbl" xml:lang="en-US">Changes in working capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChangesInWorkingCapitalAbstract" xlink:to="mlec_ChangesInWorkingCapitalAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_lbl" xml:lang="en-US">Trade receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_lbl" xml:lang="en-US">Other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_lbl" xml:lang="en-US">Receivables from related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_lbl" xml:lang="en-US">Prepayment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_lbl" xml:lang="en-US">Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl" xml:lang="en-US">Accounts Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_lbl" xml:lang="en-US">Short term investment subscriptions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:to="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Short-term investments withdrawals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities" xlink:to="ifrs-full_ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromIssuingOtherEquityInstruments" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromIssuingOtherEquityInstruments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromIssuingOtherEquityInstruments_lbl" xml:lang="en-US">Proceeds from issuance of share capital to UGVL and Theo (Backstop)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromIssuingOtherEquityInstruments" xlink:to="ifrs-full_ProceedsFromIssuingOtherEquityInstruments_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_Proceedsfromissuanceofsharecapital" xlink:href="mlec-20230630.xsd#mlec_Proceedsfromissuanceofsharecapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_Proceedsfromissuanceofsharecapital_lbl" xml:lang="en-US">Proceeds from issuance of share capital to SPAC public holders (Trust)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Proceedsfromissuanceofsharecapital" xlink:to="mlec_Proceedsfromissuanceofsharecapital_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromCurrentBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromCurrentBorrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromCurrentBorrowings_lbl" xml:lang="en-US">Proceeds from financial debts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromCurrentBorrowings" xlink:to="ifrs-full_ProceedsFromCurrentBorrowings_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ProceedsFromSAFE" xlink:href="mlec-20230630.xsd#mlec_ProceedsFromSAFE"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ProceedsFromSAFE_lbl" xml:lang="en-US">Proceeds from the SAFE</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProceedsFromSAFE" xlink:to="mlec_ProceedsFromSAFE_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromIssuingShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromIssuingShares_lbl" xml:lang="en-US">Proceeds from of issue of shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromIssuingShares" xlink:to="ifrs-full_ProceedsFromIssuingShares_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ProceedsFromIssueOfShareCapital" xlink:href="mlec-20230630.xsd#mlec_ProceedsFromIssueOfShareCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ProceedsFromIssueOfShareCapital_lbl" xml:lang="en-US">Proceeds from issue of share capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProceedsFromIssueOfShareCapital" xlink:to="mlec_ProceedsFromIssueOfShareCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares_lbl" xml:lang="en-US">Proceeds from additional issue of ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl" xml:lang="en-US">Effect of exchange rate changes on cash and equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NonCashFinancingActivitiesAbstract" xlink:href="mlec-20230630.xsd#mlec_NonCashFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NonCashFinancingActivitiesAbstract_lbl" xml:lang="en-US">Non-cash financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NonCashFinancingActivitiesAbstract" xlink:to="mlec_NonCashFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei" xlink:href="mlec-20230630.xsd#mlec_IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei_lbl" xml:lang="en-US">Issue of Share Capital and Share Premium of New Shareholders through other non current receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei" xlink:to="mlec_IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium" xlink:href="mlec-20230630.xsd#mlec_ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium_lbl" xml:lang="en-US">Relief of SAFE financial liabilities through the issue of Share Capital and Share Premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium" xlink:to="mlec_ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CapitalizationOfTransactionExpensesThroughAccountsPayable" xlink:href="mlec-20230630.xsd#mlec_CapitalizationOfTransactionExpensesThroughAccountsPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CapitalizationOfTransactionExpensesThroughAccountsPayable_lbl" xml:lang="en-US">Capitalization of transaction expenses through Accounts Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CapitalizationOfTransactionExpensesThroughAccountsPayable" xlink:to="mlec_CapitalizationOfTransactionExpensesThroughAccountsPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NetLiabilitiesAcquiredThroughIssuanceOfShareCapital" xlink:href="mlec-20230630.xsd#mlec_NetLiabilitiesAcquiredThroughIssuanceOfShareCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NetLiabilitiesAcquiredThroughIssuanceOfShareCapital_lbl" xml:lang="en-US">Net liabilities acquired through issuance of share capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetLiabilitiesAcquiredThroughIssuanceOfShareCapital" xlink:to="mlec_NetLiabilitiesAcquiredThroughIssuanceOfShareCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AcquisitionOfBusinessCombinationTroughDeferredPayment" xlink:href="mlec-20230630.xsd#mlec_AcquisitionOfBusinessCombinationTroughDeferredPayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AcquisitionOfBusinessCombinationTroughDeferredPayment_lbl" xml:lang="en-US">Acquisition of Business Combination trough deferred payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AcquisitionOfBusinessCombinationTroughDeferredPayment" xlink:to="mlec_AcquisitionOfBusinessCombinationTroughDeferredPayment_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind" xlink:href="mlec-20230630.xsd#mlec_AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind_lbl" xml:lang="en-US">Acquisition of Business Combination trough deferred payment in kind</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind" xlink:to="mlec_AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares" xlink:href="mlec-20230630.xsd#mlec_AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares_lbl" xml:lang="en-US">Acquisition of non-current assets by the issuance of ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares" xlink:to="mlec_AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CostOfSales"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_CostOfSales_lbl" xml:lang="en-US">Cost of sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CostOfSales" xlink:to="ifrs-full_CostOfSales_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_CostOfSales_lbl0" xml:lang="en-US">Cost of sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CostOfSales" xlink:to="ifrs-full_CostOfSales_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SalesAndMarketingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SalesAndMarketingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_SalesAndMarketingExpense_lbl" xml:lang="en-US">Marketing expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SalesAndMarketingExpense" xlink:to="ifrs-full_SalesAndMarketingExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_FinanceCosts_lbl" xml:lang="en-US">Financial Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceCosts" xlink:to="ifrs-full_FinanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TransactionsExpenses" xlink:href="mlec-20230630.xsd#mlec_TransactionsExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_TransactionsExpenses_lbl" xml:lang="en-US">Transaction expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TransactionsExpenses" xlink:to="mlec_TransactionsExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl" xml:lang="en-US">Share based payment cost of listing shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl" xml:lang="en-US">Income tax benefit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl" xml:lang="en-US">Share of loss from associate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss_lbl" xml:lang="en-US">Change in fair value of Simply Agreement for Future Equity (&#8220;SAFE&#8221;)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncomeCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_FinanceIncomeCost_lbl" xml:lang="en-US">Financial income / expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncomeCost" xlink:to="ifrs-full_FinanceIncomeCost_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherLiabilitie" xlink:href="mlec-20230630.xsd#mlec_OtherLiabilitie"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_OtherLiabilitie_lbl" xml:lang="en-US">Other liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherLiabilitie" xlink:to="mlec_OtherLiabilitie_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Additions of fixed assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Cash paid for acquisition of ValoraSoy net of the cash acquired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:to="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Additions of Intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Payment of loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Payment of loan interests</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US">Business Contact [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="dei_BusinessContactMember_lbl0" xml:lang="en-US">Business Contact</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ClassesOfShareCapitalMember_lbl" xml:lang="en-US">Capital shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="ifrs-full_ClassesOfShareCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IssuedCapitalMember_lbl" xml:lang="en-US">Capital shares to be issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapitalMember" xlink:to="ifrs-full_IssuedCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremiumMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharePremiumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_SharePremiumMember_lbl" xml:lang="en-US">Share Premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharePremiumMember" xlink:to="ifrs-full_SharePremiumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CumulativeTranslationAdjustmentMember" xlink:href="mlec-20230630.xsd#mlec_CumulativeTranslationAdjustmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CumulativeTranslationAdjustmentMember_lbl" xml:lang="en-US">Cumulative translation adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CumulativeTranslationAdjustmentMember" xlink:to="mlec_CumulativeTranslationAdjustmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_EquitySettledShareBasedPaymentMember" xlink:href="mlec-20230630.xsd#mlec_EquitySettledShareBasedPaymentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_EquitySettledShareBasedPaymentMember_lbl" xml:lang="en-US">Equity settled share based payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EquitySettledShareBasedPaymentMember" xlink:to="mlec_EquitySettledShareBasedPaymentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarningsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RetainedEarningsMember_lbl" xml:lang="en-US">Retained (deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarningsMember" xlink:to="ifrs-full_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_lbl" xml:lang="en-US">General information</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:to="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfBusinessCombinationsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsExplanatory_lbl" xml:lang="en-US">Business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:to="ifrs-full_DisclosureOfBusinessCombinationsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfNetAssetsAcquiredAndGoodwill" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfNetAssetsAcquiredAndGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ScheduleOfNetAssetsAcquiredAndGoodwill_lbl" xml:lang="en-US">Schedule of Net Assets Acquired and Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfNetAssetsAcquiredAndGoodwill" xlink:to="mlec_ScheduleOfNetAssetsAcquiredAndGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PurchaseConsiderationAbstract" xlink:href="mlec-20230630.xsd#mlec_PurchaseConsiderationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PurchaseConsiderationAbstract_lbl" xml:lang="en-US">Purchase consideration:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PurchaseConsiderationAbstract" xlink:to="mlec_PurchaseConsiderationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CashPaid" xlink:href="mlec-20230630.xsd#mlec_CashPaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CashPaid_lbl" xml:lang="en-US">Cash paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CashPaid" xlink:to="mlec_CashPaid_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredPaymentAfter6Months" xlink:href="mlec-20230630.xsd#mlec_DeferredPaymentAfter6Months"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DeferredPaymentAfter6Months_lbl" xml:lang="en-US">Deferred Payment after 6 months</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredPaymentAfter6Months" xlink:to="mlec_DeferredPaymentAfter6Months_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherPayables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherPayables_lbl" xml:lang="en-US">Payment in kind after 12 months</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherPayables" xlink:to="ifrs-full_OtherPayables_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ConsiderationPaid" xlink:href="mlec-20230630.xsd#mlec_ConsiderationPaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ConsiderationPaid_lbl" xml:lang="en-US">Total purchase consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsiderationPaid" xlink:to="mlec_ConsiderationPaid_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScheduleOfCondensedBalanceSheetTableTextBlock_lbl" xml:lang="en-US">Schedule of Assets and Liabilities Recognised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:to="srt_ScheduleOfCondensedBalanceSheetTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BalancesWithBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BalancesWithBanks"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BalancesWithBanks_lbl" xml:lang="en-US">Cash and Banks</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BalancesWithBanks" xlink:to="ifrs-full_BalancesWithBanks_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherCurrentReceivables_lbl" xml:lang="en-US">Other Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentReceivables" xlink:to="ifrs-full_OtherCurrentReceivables_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherCurrentReceivables_lbl0" xml:lang="en-US">Others</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentReceivables" xlink:to="ifrs-full_OtherCurrentReceivables_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherInventories"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherInventories_lbl" xml:lang="en-US">Inventory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherInventories" xlink:to="ifrs-full_OtherInventories_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherIntangibleAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherIntangibleAssets_lbl" xml:lang="en-US">Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherIntangibleAssets" xlink:to="ifrs-full_OtherIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsToRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsToRightofuseAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdditionsToRightofuseAssets_lbl" xml:lang="en-US">Right-of-use of assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsToRightofuseAssets" xlink:to="ifrs-full_AdditionsToRightofuseAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_lbl" xml:lang="en-US">Net identifiable assets acquired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:to="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Goodwill recognized (i)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetAssetsLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetAssetsLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NetAssetsLiabilities_lbl" xml:lang="en-US">Net assets acquired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetAssetsLiabilities" xlink:to="ifrs-full_NetAssetsLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory_lbl" xml:lang="en-US">Accounting standards and Basis of preparation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory_lbl" xml:lang="en-US">Summary of significant accounting policies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory" xlink:to="ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US">Schedule of Useful Lives of Property, Plant and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_lbl" xml:lang="en-US">Property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_lbl" xml:lang="en-US">Schedule of Consolidated Financial Statements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary_lbl" xml:lang="en-US">Principal activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary" xlink:to="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CountryOfIncorporation" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CountryOfIncorporation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CountryOfIncorporation_lbl" xml:lang="en-US">Country of incorporation and principal place of business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CountryOfIncorporation" xlink:to="ifrs-full_CountryOfIncorporation_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfVotingPowerHeldInSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProportionOfVotingPowerHeldInSubsidiary"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProportionOfVotingPowerHeldInSubsidiary_lbl" xml:lang="en-US">% Equity interest as of June 30, 2023</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfVotingPowerHeldInSubsidiary" xlink:to="ifrs-full_ProportionOfVotingPowerHeldInSubsidiary_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock_lbl" xml:lang="en-US">Schedule of Non-Current Assets Other than Financial Instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock" xlink:to="mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherNonCurrentAssetsOtherThanFinancialAssets" xlink:href="mlec-20230630.xsd#mlec_OtherNonCurrentAssetsOtherThanFinancialAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OtherNonCurrentAssetsOtherThanFinancialAssets_lbl" xml:lang="en-US">Total non-current assets other than financial instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherNonCurrentAssetsOtherThanFinancialAssets" xlink:to="mlec_OtherNonCurrentAssetsOtherThanFinancialAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAdditionalInformationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfAdditionalInformationExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfAdditionalInformationExplanatory_lbl" xml:lang="en-US">Comparative Information</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAdditionalInformationExplanatory" xlink:to="ifrs-full_DisclosureOfAdditionalInformationExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_lbl" xml:lang="en-US">Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfIntangibleAssetsExplanatoryTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_DisclosureOfIntangibleAssetsExplanatoryTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfIntangibleAssetsExplanatoryTableTextBlock_lbl" xml:lang="en-US">Schedule of Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfIntangibleAssetsExplanatoryTableTextBlock" xlink:to="mlec_DisclosureOfIntangibleAssetsExplanatoryTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_Cost" xlink:href="mlec-20230630.xsd#mlec_Cost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_Cost_lbl" xml:lang="en-US">Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Cost" xlink:to="mlec_Cost_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NetBookAmount" xlink:href="mlec-20230630.xsd#mlec_NetBookAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NetBookAmount_lbl" xml:lang="en-US">Net book amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetBookAmount" xlink:to="mlec_NetBookAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract2" xlink:href="mlec-20230630.xsd#mlec_UnlabeledAbstract2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract2_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract2" xlink:to="mlec_UnlabeledAbstract2_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_YearEndedJune302021Abstract" xlink:href="mlec-20230630.xsd#mlec_YearEndedJune302021Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_YearEndedJune302021Abstract_lbl" xml:lang="en-US">Year ended June 30, 2021</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_YearEndedJune302021Abstract" xlink:to="mlec_YearEndedJune302021Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Additions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract3" xlink:href="mlec-20230630.xsd#mlec_UnlabeledAbstract3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract3_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract3" xlink:to="mlec_UnlabeledAbstract3_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AsOfJune302021Abstract" xlink:href="mlec-20230630.xsd#mlec_AsOfJune302021Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AsOfJune302021Abstract_lbl" xml:lang="en-US">As of June 30, 2021</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AsOfJune302021Abstract" xlink:to="mlec_AsOfJune302021Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract4" xlink:href="mlec-20230630.xsd#mlec_UnlabeledAbstract4"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract4_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract4" xlink:to="mlec_UnlabeledAbstract4_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_YearEndedJune302022Abstract" xlink:href="mlec-20230630.xsd#mlec_YearEndedJune302022Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_YearEndedJune302022Abstract_lbl" xml:lang="en-US">Year ended June 30, 2022</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_YearEndedJune302022Abstract" xlink:to="mlec_YearEndedJune302022Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract5" xlink:href="mlec-20230630.xsd#mlec_UnlabeledAbstract5"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract5_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract5" xlink:to="mlec_UnlabeledAbstract5_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AsOfJune302022Abstract" xlink:href="mlec-20230630.xsd#mlec_AsOfJune302022Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AsOfJune302022Abstract_lbl" xml:lang="en-US">As of June 30, 2022</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AsOfJune302022Abstract" xlink:to="mlec_AsOfJune302022Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract6" xlink:href="mlec-20230630.xsd#mlec_UnlabeledAbstract6"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract6_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract6" xlink:to="mlec_UnlabeledAbstract6_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_YearEndedJune302023Abstract" xlink:href="mlec-20230630.xsd#mlec_YearEndedJune302023Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_YearEndedJune302023Abstract_lbl" xml:lang="en-US">Year ended June 30, 2023</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_YearEndedJune302023Abstract" xlink:to="mlec_YearEndedJune302023Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_lbl" xml:lang="en-US">Acquisitions through business combinations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Effect of changes in foreign exchange rates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract7" xlink:href="mlec-20230630.xsd#mlec_UnlabeledAbstract7"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract7_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract7" xlink:to="mlec_UnlabeledAbstract7_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AsOfJune302023Abstract" xlink:href="mlec-20230630.xsd#mlec_AsOfJune302023Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AsOfJune302023Abstract_lbl" xml:lang="en-US">As of June 30, 2023</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AsOfJune302023Abstract" xlink:to="mlec_AsOfJune302023Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US">Fixed Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfFixedAssetstextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfFixedAssetstextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ScheduleOfFixedAssetstextBlock_lbl" xml:lang="en-US">Schedule of Fixed Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfFixedAssetstextBlock" xlink:to="mlec_ScheduleOfFixedAssetstextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract8" xlink:href="mlec-20230630.xsd#mlec_UnlabeledAbstract8"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract8_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract8" xlink:to="mlec_UnlabeledAbstract8_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_YearEndedJune302021Abstract0" xlink:href="mlec-20230630.xsd#mlec_YearEndedJune302021Abstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_YearEndedJune302021Abstract0_lbl" xml:lang="en-US">Year ended June 30, 2021</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_YearEndedJune302021Abstract0" xlink:to="mlec_YearEndedJune302021Abstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Additions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract9" xlink:href="mlec-20230630.xsd#mlec_UnlabeledAbstract9"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract9_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract9" xlink:to="mlec_UnlabeledAbstract9_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AsOfJune302021Abstract0" xlink:href="mlec-20230630.xsd#mlec_AsOfJune302021Abstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AsOfJune302021Abstract0_lbl" xml:lang="en-US">As of June 30, 2021</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AsOfJune302021Abstract0" xlink:to="mlec_AsOfJune302021Abstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract10" xlink:href="mlec-20230630.xsd#mlec_UnlabeledAbstract10"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract10_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract10" xlink:to="mlec_UnlabeledAbstract10_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_YearEndedJune302022Abstract0" xlink:href="mlec-20230630.xsd#mlec_YearEndedJune302022Abstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_YearEndedJune302022Abstract0_lbl" xml:lang="en-US">Year ended June 30, 2022</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_YearEndedJune302022Abstract0" xlink:to="mlec_YearEndedJune302022Abstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract11" xlink:href="mlec-20230630.xsd#mlec_UnlabeledAbstract11"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract11_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract11" xlink:to="mlec_UnlabeledAbstract11_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AsOfJune302022Abstract0" xlink:href="mlec-20230630.xsd#mlec_AsOfJune302022Abstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AsOfJune302022Abstract0_lbl" xml:lang="en-US">As of June 30, 2022</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AsOfJune302022Abstract0" xlink:to="mlec_AsOfJune302022Abstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract12" xlink:href="mlec-20230630.xsd#mlec_UnlabeledAbstract12"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract12_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract12" xlink:to="mlec_UnlabeledAbstract12_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_YearEndedJune302023Abstract0" xlink:href="mlec-20230630.xsd#mlec_YearEndedJune302023Abstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_YearEndedJune302023Abstract0_lbl" xml:lang="en-US">Year ended June 30, 2023</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_YearEndedJune302023Abstract0" xlink:to="mlec_YearEndedJune302023Abstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Acquisitions through business combinations, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_lbl" xml:lang="en-US">Effect of changes in foreign exchange rates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract13" xlink:href="mlec-20230630.xsd#mlec_UnlabeledAbstract13"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract13_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract13" xlink:to="mlec_UnlabeledAbstract13_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AsOfJune302023Abstract0" xlink:href="mlec-20230630.xsd#mlec_AsOfJune302023Abstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AsOfJune302023Abstract0_lbl" xml:lang="en-US">As of June 30, 2023</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AsOfJune302023Abstract0" xlink:to="mlec_AsOfJune302023Abstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfGoodwillExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfGoodwillExplanatory_lbl" xml:lang="en-US">Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGoodwillExplanatory" xlink:to="ifrs-full_DisclosureOfGoodwillExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl" xml:lang="en-US">Schedule of Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl" xml:lang="en-US">Right-of-use of assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfRightofuseOfAssetsTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfRightofuseOfAssetsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ScheduleOfRightofuseOfAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of Right of Use of Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfRightofuseOfAssetsTableTextBlock" xlink:to="mlec_ScheduleOfRightofuseOfAssetsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AcquisitionsThroughBusinessCombinationsi" xlink:href="mlec-20230630.xsd#mlec_AcquisitionsThroughBusinessCombinationsi"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AcquisitionsThroughBusinessCombinationsi_lbl" xml:lang="en-US">Acquisitions through business combinations (i)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AcquisitionsThroughBusinessCombinationsi" xlink:to="mlec_AcquisitionsThroughBusinessCombinationsi_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_EffectOfChangesInForeignExchangeRates" xlink:href="mlec-20230630.xsd#mlec_EffectOfChangesInForeignExchangeRates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_EffectOfChangesInForeignExchangeRates_lbl" xml:lang="en-US">Effect of changes in foreign exchange rates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EffectOfChangesInForeignExchangeRates" xlink:to="mlec_EffectOfChangesInForeignExchangeRates_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory_lbl" xml:lang="en-US">Other non-current receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOtherNoncurrentReceivableTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherNoncurrentReceivableTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ScheduleOfOtherNoncurrentReceivableTableTextBlock_lbl" xml:lang="en-US">Schedule of Other Non-Current Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfOtherNoncurrentReceivableTableTextBlock" xlink:to="mlec_ScheduleOfOtherNoncurrentReceivableTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherNoncurrentReceivables_lbl" xml:lang="en-US">Receivables with shareholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentReceivables" xlink:to="ifrs-full_OtherNoncurrentReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:to="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRestrictedCashAndCashEquivalentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRestrictedCashAndCashEquivalentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfRestrictedCashAndCashEquivalentsExplanatory_lbl" xml:lang="en-US">Schedule of Cash and Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRestrictedCashAndCashEquivalentsExplanatory" xlink:to="ifrs-full_DisclosureOfRestrictedCashAndCashEquivalentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Cash" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Cash"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Cash_lbl" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Cash" xlink:to="ifrs-full_Cash_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepositsFromBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepositsFromBanks"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DepositsFromBanks_lbl" xml:lang="en-US">Bank accounts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepositsFromBanks" xlink:to="ifrs-full_DepositsFromBanks_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_lbl" xml:lang="en-US">Short-term investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:to="ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherCashAndCashEquivalents_lbl" xml:lang="en-US">Total cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCashAndCashEquivalents" xlink:to="ifrs-full_OtherCashAndCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory_lbl" xml:lang="en-US">Short term investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:to="ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfShortTermInvestmentsTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_DisclosureOfShortTermInvestmentsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfShortTermInvestmentsTableTextBlock_lbl" xml:lang="en-US">Schedule of Short Term Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfShortTermInvestmentsTableTextBlock" xlink:to="mlec_DisclosureOfShortTermInvestmentsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MutualFunds" xlink:href="mlec-20230630.xsd#mlec_MutualFunds"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MutualFunds_lbl" xml:lang="en-US">Mutual funds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MutualFunds" xlink:to="mlec_MutualFunds_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TotalMutualFunds" xlink:href="mlec-20230630.xsd#mlec_TotalMutualFunds"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_TotalMutualFunds_lbl" xml:lang="en-US">Total Short-term investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalMutualFunds" xlink:to="mlec_TotalMutualFunds_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_lbl" xml:lang="en-US">Trade Receivable and Other current receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:to="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfTradeReceivableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfTradeReceivableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ScheduleOfTradeReceivableTextBlock_lbl" xml:lang="en-US">Schedule of Trade Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfTradeReceivableTextBlock" xlink:to="mlec_ScheduleOfTradeReceivableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeReceivables_lbl" xml:lang="en-US">Accounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeReceivables" xlink:to="ifrs-full_TradeReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOtherCurrentReceivablesTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherCurrentReceivablesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ScheduleOfOtherCurrentReceivablesTextBlock_lbl" xml:lang="en-US">Schedule of Other Current Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfOtherCurrentReceivablesTextBlock" xlink:to="mlec_ScheduleOfOtherCurrentReceivablesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentValueAddedTaxReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentValueAddedTaxReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentValueAddedTaxReceivables_lbl" xml:lang="en-US">Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentValueAddedTaxReceivables" xlink:to="ifrs-full_CurrentValueAddedTaxReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInventoriesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInventoriesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfInventoriesExplanatory_lbl" xml:lang="en-US">Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInventoriesExplanatory" xlink:to="ifrs-full_DisclosureOfInventoriesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfInventoriesTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_DisclosureOfInventoriesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfInventoriesTableTextBlock_lbl" xml:lang="en-US">Schedule of Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfInventoriesTableTextBlock" xlink:to="mlec_DisclosureOfInventoriesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RawMaterials" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RawMaterials"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_RawMaterials_lbl" xml:lang="en-US">Raw materials</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RawMaterials" xlink:to="ifrs-full_RawMaterials_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinishedGoods" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinishedGoods"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FinishedGoods_lbl" xml:lang="en-US">Finished goods</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinishedGoods" xlink:to="ifrs-full_FinishedGoods_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl" xml:lang="en-US">Share capital and share premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:to="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock_lbl" xml:lang="en-US">Schedule of Reconciliation of Share Capital and Share Premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock" xlink:to="mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfSharesIssueOfShareCapitalinShares" xlink:href="mlec-20230630.xsd#mlec_NumberOfSharesIssueOfShareCapitalinShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NumberOfSharesIssueOfShareCapitalinShares_lbl" xml:lang="en-US">Number of shares, Issue of share capital (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfSharesIssueOfShareCapitalinShares" xlink:to="mlec_NumberOfSharesIssueOfShareCapitalinShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsForShareIssueCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PaymentsForShareIssueCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PaymentsForShareIssueCosts_lbl" xml:lang="en-US">Shares issued amount, Issue of share capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsForShareIssueCosts" xlink:to="ifrs-full_PaymentsForShareIssueCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SharesToBeIssuedAmountIssueOfShareCapital" xlink:href="mlec-20230630.xsd#mlec_SharesToBeIssuedAmountIssueOfShareCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SharesToBeIssuedAmountIssueOfShareCapital_lbl" xml:lang="en-US">Shares to be issued amount, Issue of share capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesToBeIssuedAmountIssueOfShareCapital" xlink:to="mlec_SharesToBeIssuedAmountIssueOfShareCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SharePremiumIssueOfShareCapital" xlink:href="mlec-20230630.xsd#mlec_SharePremiumIssueOfShareCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SharePremiumIssueOfShareCapital_lbl" xml:lang="en-US">Share Premium, Issue of share capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharePremiumIssueOfShareCapital" xlink:to="mlec_SharePremiumIssueOfShareCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfSharesFromBusinessAcquisition" xlink:href="mlec-20230630.xsd#mlec_NumberOfSharesFromBusinessAcquisition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NumberOfSharesFromBusinessAcquisition_lbl" xml:lang="en-US">Number of shares, From business acquisition (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfSharesFromBusinessAcquisition" xlink:to="mlec_NumberOfSharesFromBusinessAcquisition_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SharesIssuedAmountFromBusinessAcquisition" xlink:href="mlec-20230630.xsd#mlec_SharesIssuedAmountFromBusinessAcquisition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SharesIssuedAmountFromBusinessAcquisition_lbl" xml:lang="en-US">Shares issued amount, From business acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesIssuedAmountFromBusinessAcquisition" xlink:to="mlec_SharesIssuedAmountFromBusinessAcquisition_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SharesToBeIssuedAmountFromBusinessAcquisition" xlink:href="mlec-20230630.xsd#mlec_SharesToBeIssuedAmountFromBusinessAcquisition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SharesToBeIssuedAmountFromBusinessAcquisition_lbl" xml:lang="en-US">Shares to be issued amount, From business acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesToBeIssuedAmountFromBusinessAcquisition" xlink:to="mlec_SharesToBeIssuedAmountFromBusinessAcquisition_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SharePremiumFromBusinessAcquisition" xlink:href="mlec-20230630.xsd#mlec_SharePremiumFromBusinessAcquisition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SharePremiumFromBusinessAcquisition_lbl" xml:lang="en-US">Share Premium, From business acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharePremiumFromBusinessAcquisition" xlink:to="mlec_SharePremiumFromBusinessAcquisition_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfShareEquitySettledShareBasedPayment" xlink:href="mlec-20230630.xsd#mlec_NumberOfShareEquitySettledShareBasedPayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NumberOfShareEquitySettledShareBasedPayment_lbl" xml:lang="en-US">Number of shares, Equity settled share based payment (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfShareEquitySettledShareBasedPayment" xlink:to="mlec_NumberOfShareEquitySettledShareBasedPayment_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SharesIssuedAmountEquitySettledShareBasedPayment" xlink:href="mlec-20230630.xsd#mlec_SharesIssuedAmountEquitySettledShareBasedPayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SharesIssuedAmountEquitySettledShareBasedPayment_lbl" xml:lang="en-US">Shares issued amount, Equity settled share based payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesIssuedAmountEquitySettledShareBasedPayment" xlink:to="mlec_SharesIssuedAmountEquitySettledShareBasedPayment_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SharesToBeIssuedAmountEquitySettledShareBasedPayment" xlink:href="mlec-20230630.xsd#mlec_SharesToBeIssuedAmountEquitySettledShareBasedPayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SharesToBeIssuedAmountEquitySettledShareBasedPayment_lbl" xml:lang="en-US">Shares to be issued amount, Equity settled share based payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesToBeIssuedAmountEquitySettledShareBasedPayment" xlink:to="mlec_SharesToBeIssuedAmountEquitySettledShareBasedPayment_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SharePremiumEquitySettledShareBasedPayment" xlink:href="mlec-20230630.xsd#mlec_SharePremiumEquitySettledShareBasedPayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SharePremiumEquitySettledShareBasedPayment_lbl" xml:lang="en-US">Share Premium, Equity settled share based payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharePremiumEquitySettledShareBasedPayment" xlink:to="mlec_SharePremiumEquitySettledShareBasedPayment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_lbl" xml:lang="en-US">Share Based Payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:to="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_lbl" xml:lang="en-US">Schedule and the Possible Dilutive Effect of the Future Exercise of Options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FairValueOfSharesinShares" xlink:href="mlec-20230630.xsd#mlec_FairValueOfSharesinShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FairValueOfSharesinShares_lbl" xml:lang="en-US">Fair value of shares (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FairValueOfSharesinShares" xlink:to="mlec_FairValueOfSharesinShares_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ExercisePrice" xlink:href="mlec-20230630.xsd#mlec_ExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ExercisePrice_lbl" xml:lang="en-US">Exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExercisePrice" xlink:to="mlec_ExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl" xml:lang="en-US">Expected volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl" xml:lang="en-US">Dividend rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl" xml:lang="en-US">Reference risk-free interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PlanDuration" xlink:href="mlec-20230630.xsd#mlec_PlanDuration"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PlanDuration_lbl" xml:lang="en-US">Plan duration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PlanDuration" xlink:to="mlec_PlanDuration_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FairValueOfStockOptionsAtMeasurementDate" xlink:href="mlec-20230630.xsd#mlec_FairValueOfStockOptionsAtMeasurementDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FairValueOfStockOptionsAtMeasurementDate_lbl" xml:lang="en-US">Fair value of stock options at measurement date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FairValueOfStockOptionsAtMeasurementDate" xlink:to="mlec_FairValueOfStockOptionsAtMeasurementDate_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_lbl" xml:lang="en-US">Schedule of Amount and Exercise Price and the Movements of the Stock Options of Executives and Managers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfOptionsAtTheBeginning" xlink:href="mlec-20230630.xsd#mlec_NumberOfOptionsAtTheBeginning"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NumberOfOptionsAtTheBeginning_lbl" xml:lang="en-US">Number of options, At the beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfOptionsAtTheBeginning" xlink:to="mlec_NumberOfOptionsAtTheBeginning_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ExercisePriceAtTheBeginning" xlink:href="mlec-20230630.xsd#mlec_ExercisePriceAtTheBeginning"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ExercisePriceAtTheBeginning_lbl" xml:lang="en-US">Exercise price, At the beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExercisePriceAtTheBeginning" xlink:to="mlec_ExercisePriceAtTheBeginning_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfOptionsGrantedDuringThePeriod" xlink:href="mlec-20230630.xsd#mlec_NumberOfOptionsGrantedDuringThePeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NumberOfOptionsGrantedDuringThePeriod_lbl" xml:lang="en-US">Number of options, Granted during the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfOptionsGrantedDuringThePeriod" xlink:to="mlec_NumberOfOptionsGrantedDuringThePeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ExercisePriceGrantedDuringThePeriod" xlink:href="mlec-20230630.xsd#mlec_ExercisePriceGrantedDuringThePeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ExercisePriceGrantedDuringThePeriod_lbl" xml:lang="en-US">Exercise price, Granted during the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExercisePriceGrantedDuringThePeriod" xlink:to="mlec_ExercisePriceGrantedDuringThePeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfOptionsForfeitedDuringThePeriod" xlink:href="mlec-20230630.xsd#mlec_NumberOfOptionsForfeitedDuringThePeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NumberOfOptionsForfeitedDuringThePeriod_lbl" xml:lang="en-US">Number of options, Forfeited during the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfOptionsForfeitedDuringThePeriod" xlink:to="mlec_NumberOfOptionsForfeitedDuringThePeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ExercisePriceForfeitedDuringThePeriod" xlink:href="mlec-20230630.xsd#mlec_ExercisePriceForfeitedDuringThePeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ExercisePriceForfeitedDuringThePeriod_lbl" xml:lang="en-US">Exercise price, Forfeited during the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExercisePriceForfeitedDuringThePeriod" xlink:to="mlec_ExercisePriceForfeitedDuringThePeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfOptionsExercisedDuringThePeriod" xlink:href="mlec-20230630.xsd#mlec_NumberOfOptionsExercisedDuringThePeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NumberOfOptionsExercisedDuringThePeriod_lbl" xml:lang="en-US">Number of options, Exercised during the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfOptionsExercisedDuringThePeriod" xlink:to="mlec_NumberOfOptionsExercisedDuringThePeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ExercisePriceExercisedDuringThePeriod" xlink:href="mlec-20230630.xsd#mlec_ExercisePriceExercisedDuringThePeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ExercisePriceExercisedDuringThePeriod_lbl" xml:lang="en-US">Exercise price, Exercised during the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExercisePriceExercisedDuringThePeriod" xlink:to="mlec_ExercisePriceExercisedDuringThePeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfOptionsExpiredDuringThePeriod" xlink:href="mlec-20230630.xsd#mlec_NumberOfOptionsExpiredDuringThePeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NumberOfOptionsExpiredDuringThePeriod_lbl" xml:lang="en-US">Number of options, Expired during the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfOptionsExpiredDuringThePeriod" xlink:to="mlec_NumberOfOptionsExpiredDuringThePeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ExercisePriceExpiredDuringThePeriod" xlink:href="mlec-20230630.xsd#mlec_ExercisePriceExpiredDuringThePeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ExercisePriceExpiredDuringThePeriod_lbl" xml:lang="en-US">Exercise price, Expired during the period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExercisePriceExpiredDuringThePeriod" xlink:to="mlec_ExercisePriceExpiredDuringThePeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfOptionsAtTheEnding" xlink:href="mlec-20230630.xsd#mlec_NumberOfOptionsAtTheEnding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NumberOfOptionsAtTheEnding_lbl" xml:lang="en-US">Number of options,At the ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfOptionsAtTheEnding" xlink:to="mlec_NumberOfOptionsAtTheEnding_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ExercisePriceAtTheEnding" xlink:href="mlec-20230630.xsd#mlec_ExercisePriceAtTheEnding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ExercisePriceAtTheEnding_lbl" xml:lang="en-US">Exercise price, At the ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExercisePriceAtTheEnding" xlink:to="mlec_ExercisePriceAtTheEnding_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory_lbl" xml:lang="en-US">Accounts Payable and other current and non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfAccountsPayable" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfAccountsPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ScheduleOfAccountsPayable_lbl" xml:lang="en-US">Schedule of Accounts Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfAccountsPayable" xlink:to="mlec_ScheduleOfAccountsPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_lbl" xml:lang="en-US">Transaction expenses payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:to="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_lbl" xml:lang="en-US">Related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccrualsClassifiedAsNoncurrent" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccrualsClassifiedAsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AccrualsClassifiedAsNoncurrent_lbl" xml:lang="en-US">Accruals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccrualsClassifiedAsNoncurrent" xlink:to="ifrs-full_AccrualsClassifiedAsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeAndOtherPayablesToTradeSuppliers_lbl" xml:lang="en-US">Trade payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:to="ifrs-full_TradeAndOtherPayablesToTradeSuppliers_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TradeAndOtherPayables_lbl" xml:lang="en-US">Total Accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayables" xlink:to="ifrs-full_TradeAndOtherPayables_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TradeAndOtherPayables_lbl0" xml:lang="en-US">Trade Payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayables" xlink:to="ifrs-full_TradeAndOtherPayables_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentPayablesToRelatedParties" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentPayablesToRelatedParties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentPayablesToRelatedParties_lbl" xml:lang="en-US">Related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentPayablesToRelatedParties" xlink:to="ifrs-full_NoncurrentPayablesToRelatedParties_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredPaymentRelatedToBusinessCombination" xlink:href="mlec-20230630.xsd#mlec_DeferredPaymentRelatedToBusinessCombination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DeferredPaymentRelatedToBusinessCombination_lbl" xml:lang="en-US">Deferred payment related to Business Combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredPaymentRelatedToBusinessCombination" xlink:to="mlec_DeferredPaymentRelatedToBusinessCombination_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_Wages" xlink:href="mlec-20230630.xsd#mlec_Wages"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_Wages_lbl" xml:lang="en-US">Wages</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Wages" xlink:to="mlec_Wages_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_Taxes" xlink:href="mlec-20230630.xsd#mlec_Taxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_Taxes_lbl" xml:lang="en-US">Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Taxes" xlink:to="mlec_Taxes_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PayAsYouEarnPAYE" xlink:href="mlec-20230630.xsd#mlec_PayAsYouEarnPAYE"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PayAsYouEarnPAYE_lbl" xml:lang="en-US">Pay As You Earn (PAYE)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PayAsYouEarnPAYE" xlink:to="mlec_PayAsYouEarnPAYE_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentNonfinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentNonfinancialLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherCurrentNonfinancialLiabilities_lbl" xml:lang="en-US">Others</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentNonfinancialLiabilities" xlink:to="ifrs-full_OtherCurrentNonfinancialLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentNonfinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentNonfinancialLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherNoncurrentNonfinancialLiabilities_lbl" xml:lang="en-US">Others</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentNonfinancialLiabilities" xlink:to="ifrs-full_OtherNoncurrentNonfinancialLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherNoncurrentLiabilities_lbl" xml:lang="en-US">Other non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentLiabilities" xlink:to="ifrs-full_OtherNoncurrentLiabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_OtherNoncurrentLiabilities_lbl0" xml:lang="en-US">Non-current Other Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentLiabilities" xlink:to="ifrs-full_OtherNoncurrentLiabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDebtSecuritiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDebtSecuritiesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDebtSecuritiesExplanatory_lbl" xml:lang="en-US">Financial debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDebtSecuritiesExplanatory" xlink:to="ifrs-full_DisclosureOfDebtSecuritiesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFinancialAssetsExplanatory_lbl" xml:lang="en-US">Schedule of Financial Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentFinancialAssetsAtAmortisedCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentFinancialAssetsAtAmortisedCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentFinancialAssetsAtAmortisedCost_lbl" xml:lang="en-US">Total Current Financial Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialAssetsAtAmortisedCost" xlink:to="ifrs-full_CurrentFinancialAssetsAtAmortisedCost_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AnalysisOfAgeOfFinancialAssetsThatArePastDueButNotImpaired" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AnalysisOfAgeOfFinancialAssetsThatArePastDueButNotImpaired"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AnalysisOfAgeOfFinancialAssetsThatArePastDueButNotImpaired_lbl" xml:lang="en-US">Schedule of Book Value is Reasonably Approximate to the Fair Value given its Short-Term Nature</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AnalysisOfAgeOfFinancialAssetsThatArePastDueButNotImpaired" xlink:to="ifrs-full_AnalysisOfAgeOfFinancialAssetsThatArePastDueButNotImpaired_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentFinancialAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentFinancialAssets_lbl" xml:lang="en-US">Total Non-current Financial Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialAssets" xlink:to="ifrs-full_NoncurrentFinancialAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory_lbl" xml:lang="en-US">Schedule of Terms and Conditions of Outstanding Loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BorrowingOriginalCurrency" xlink:href="mlec-20230630.xsd#mlec_BorrowingOriginalCurrency"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BorrowingOriginalCurrency_lbl" xml:lang="en-US">Currency of denomination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BorrowingOriginalCurrency" xlink:to="mlec_BorrowingOriginalCurrency_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk_lbl" xml:lang="en-US">Nominal value (equivalent in USD)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk" xlink:to="ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk_lbl0" xml:lang="en-US">Principal amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk" xlink:to="ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_NominalInterestRate" xlink:href="mlec-20230630.xsd#mlec_NominalInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NominalInterestRate_lbl" xml:lang="en-US">Nominal interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NominalInterestRate" xlink:to="mlec_NominalInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BorrowingMaturity" xlink:href="mlec-20230630.xsd#mlec_BorrowingMaturity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BorrowingMaturity_lbl" xml:lang="en-US">Date of maturity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BorrowingMaturity" xlink:to="mlec_BorrowingMaturity_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Borrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Borrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_Borrowings_lbl" xml:lang="en-US">Outstanding loans balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Borrowings" xlink:to="ifrs-full_Borrowings_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory_lbl" xml:lang="en-US">Warrants liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory_lbl" xml:lang="en-US">Schedule of Fair Value Ordinary Share of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementEntitysOwnEquityInstruments" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementEntitysOwnEquityInstruments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementEntitysOwnEquityInstruments_lbl" xml:lang="en-US">Issued by the SPAC</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementEntitysOwnEquityInstruments" xlink:to="ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementEntitysOwnEquityInstruments_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FairValueAdjustmentOfWarrant" xlink:href="mlec-20230630.xsd#mlec_FairValueAdjustmentOfWarrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FairValueAdjustmentOfWarrant_lbl" xml:lang="en-US">Fair value remeasurement (Gain)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FairValueAdjustmentOfWarrant" xlink:to="mlec_FairValueAdjustmentOfWarrant_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SimpleAgreementForFutureEquitySAFETextBlock" xlink:href="mlec-20230630.xsd#mlec_SimpleAgreementForFutureEquitySAFETextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SimpleAgreementForFutureEquitySAFETextBlock_lbl" xml:lang="en-US">Simple Agreement for Future Equity (&#8220;SAFE&#8221;)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SimpleAgreementForFutureEquitySAFETextBlock" xlink:to="mlec_SimpleAgreementForFutureEquitySAFETextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_lbl" xml:lang="en-US">Schedule of Financial Instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue" xlink:href="mlec-20230630.xsd#mlec_FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue_lbl" xml:lang="en-US">At the beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue" xlink:to="mlec_FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_Additions" xlink:href="mlec-20230630.xsd#mlec_Additions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_Additions_lbl" xml:lang="en-US">Additions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Additions" xlink:to="mlec_Additions_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValue_lbl" xml:lang="en-US">Results on the change of Fair Value of the SAFE</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesAtFairValue" xlink:to="ifrs-full_FinancialLiabilitiesAtFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SAFECapitalization" xlink:href="mlec-20230630.xsd#mlec_SAFECapitalization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SAFECapitalization_lbl" xml:lang="en-US">SAFE Capitalization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SAFECapitalization" xlink:to="mlec_SAFECapitalization_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue" xlink:href="mlec-20230630.xsd#mlec_ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue_lbl" xml:lang="en-US">At the end</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue" xlink:to="mlec_ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl" xml:lang="en-US">Deferred tax and income tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:to="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfDeferredTaxesExplanatory_lbl" xml:lang="en-US">Schedule of Net Deferred Tax Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:to="ifrs-full_DisclosureOfDeferredTaxesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IncorporatedThroughTheBusinessCombination" xlink:href="mlec-20230630.xsd#mlec_IncorporatedThroughTheBusinessCombination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IncorporatedThroughTheBusinessCombination_lbl" xml:lang="en-US">Incorporated through the business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncorporatedThroughTheBusinessCombination" xlink:to="mlec_IncorporatedThroughTheBusinessCombination_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ChargedToOtherComprehensiveIncome" xlink:href="mlec-20230630.xsd#mlec_ChargedToOtherComprehensiveIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ChargedToOtherComprehensiveIncome_lbl" xml:lang="en-US">Charged to Other Comprehensive Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChargedToOtherComprehensiveIncome" xlink:to="mlec_ChargedToOtherComprehensiveIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfStatutoryTaxesInCountriesTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_DisclosureOfStatutoryTaxesInCountriesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfStatutoryTaxesInCountriesTableTextBlock_lbl" xml:lang="en-US">Schedule of Principal Statutory Taxes Rates in the Countries</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfStatutoryTaxesInCountriesTableTextBlock" xlink:to="mlec_DisclosureOfStatutoryTaxesInCountriesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxJurisdiction" xlink:href="mlec-20230630.xsd#mlec_TaxJurisdiction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_TaxJurisdiction_lbl" xml:lang="en-US">Income tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxJurisdiction" xlink:to="mlec_TaxJurisdiction_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Income Tax for Other Jurisdictions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock" xlink:to="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CorporateTaxRate" xlink:href="mlec-20230630.xsd#mlec_CorporateTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CorporateTaxRate_lbl" xml:lang="en-US">Corporate tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CorporateTaxRate" xlink:to="mlec_CorporateTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccruedIncomeOtherThanContractAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccruedIncomeOtherThanContractAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AccruedIncomeOtherThanContractAssets_lbl" xml:lang="en-US">Income tax (benefit)/expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccruedIncomeOtherThanContractAssets" xlink:to="ifrs-full_AccruedIncomeOtherThanContractAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions" xlink:href="mlec-20230630.xsd#mlec_EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions_lbl" xml:lang="en-US">Effect of difference tax rates subsidiaries operating in other jurisdictions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions" xlink:to="mlec_EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NetGainOnInflationEffectOnMonetaryItems" xlink:href="mlec-20230630.xsd#mlec_NetGainOnInflationEffectOnMonetaryItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NetGainOnInflationEffectOnMonetaryItems_lbl" xml:lang="en-US">Net gain on inflation effect on monetary items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetGainOnInflationEffectOnMonetaryItems" xlink:to="mlec_NetGainOnInflationEffectOnMonetaryItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_Others" xlink:href="mlec-20230630.xsd#mlec_Others"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_Others_lbl" xml:lang="en-US">Others</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Others" xlink:to="mlec_Others_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Net Deferred Tax Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock" xlink:to="mlec_ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxAssetAbstract" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxAssetAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DeferredTaxAssetAbstract_lbl" xml:lang="en-US">Deferred tax asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxAssetAbstract" xlink:to="mlec_DeferredTaxAssetAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_lbl" xml:lang="en-US">Tax loss carry-forward</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:to="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract14" xlink:href="mlec-20230630.xsd#mlec_UnlabeledAbstract14"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract14_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract14" xlink:to="mlec_UnlabeledAbstract14_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxLiabilityAbstract" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxLiabilityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DeferredTaxLiabilityAbstract_lbl" xml:lang="en-US">Deferred tax liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxLiabilityAbstract" xlink:to="mlec_DeferredTaxLiabilityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CustomerRelationship" xlink:href="mlec-20230630.xsd#mlec_CustomerRelationship"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CustomerRelationship_lbl" xml:lang="en-US">Customer relationship</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CustomerRelationship" xlink:to="mlec_CustomerRelationship_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherLiabilities_lbl" xml:lang="en-US">Other tax liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherLiabilities" xlink:to="ifrs-full_OtherLiabilities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherLiabilities_lbl0" xml:lang="en-US">Other liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherLiabilities" xlink:to="ifrs-full_OtherLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_OtherLiabilities_lbl1" xml:lang="en-US">Current Other Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherLiabilities" xlink:to="ifrs-full_OtherLiabilities_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock_lbl" xml:lang="en-US">Schedule of Accumulated Tax Loss Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock" xlink:to="mlec_ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxlossCarryForward" xlink:href="mlec-20230630.xsd#mlec_TaxlossCarryForward"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_TaxlossCarryForward_lbl" xml:lang="en-US">Tax-loss carry forward</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxlossCarryForward" xlink:to="mlec_TaxlossCarryForward_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DeferredTaxAssets_lbl" xml:lang="en-US">Deferred tax asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxAssets" xlink:to="ifrs-full_DeferredTaxAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits_lbl" xml:lang="en-US">Expiration date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits" xlink:to="ifrs-full_DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory_lbl" xml:lang="en-US">Tax jurisdiction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfEstimatedFutureTaxableProfitTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfEstimatedFutureTaxableProfitTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ScheduleOfEstimatedFutureTaxableProfitTableTextBlock_lbl" xml:lang="en-US">Schedule of Estimated Future Taxable Profit.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfEstimatedFutureTaxableProfitTableTextBlock" xlink:to="mlec_ScheduleOfEstimatedFutureTaxableProfitTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxAssetsGrossAmount" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxAssetsGrossAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DeferredTaxAssetsGrossAmount_lbl" xml:lang="en-US">Deferred tax assets, Gross amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxAssetsGrossAmount" xlink:to="mlec_DeferredTaxAssetsGrossAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxAssetsTaxEffect" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxAssetsTaxEffect"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DeferredTaxAssetsTaxEffect_lbl" xml:lang="en-US">Deferred tax assets, Tax effect</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxAssetsTaxEffect" xlink:to="mlec_DeferredTaxAssetsTaxEffect_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_lbl" xml:lang="en-US">Financial income / expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinanceIncomeExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExplanatory_lbl" xml:lang="en-US">Schedule of Financial Income Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinanceIncomeExplanatory" xlink:to="ifrs-full_DisclosureOfFinanceIncomeExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialCostsAbstract" xlink:href="mlec-20230630.xsd#mlec_FinancialCostsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FinancialCostsAbstract_lbl" xml:lang="en-US">Financial Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialCostsAbstract" xlink:to="mlec_FinancialCostsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherFinancialResultsAbstract" xlink:href="mlec-20230630.xsd#mlec_OtherFinancialResultsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OtherFinancialResultsAbstract_lbl" xml:lang="en-US">Other financial results</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherFinancialResultsAbstract" xlink:to="mlec_OtherFinancialResultsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InvestmentGainRelatedToMoneyMarketFunds" xlink:href="mlec-20230630.xsd#mlec_InvestmentGainRelatedToMoneyMarketFunds"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InvestmentGainRelatedToMoneyMarketFunds_lbl" xml:lang="en-US">Investment gain related to money market funds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InvestmentGainRelatedToMoneyMarketFunds" xlink:to="mlec_InvestmentGainRelatedToMoneyMarketFunds_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ChangeInWarrants" xlink:href="mlec-20230630.xsd#mlec_ChangeInWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ChangeInWarrants_lbl" xml:lang="en-US">Change in warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChangeInWarrants" xlink:to="mlec_ChangeInWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LoansAndReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LoansAndReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LoansAndReceivables_lbl" xml:lang="en-US">Interest gain (Shareholders loan)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LoansAndReceivables" xlink:to="ifrs-full_LoansAndReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InflationAdjustment" xlink:href="mlec-20230630.xsd#mlec_InflationAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InflationAdjustment_lbl" xml:lang="en-US">Inflation adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InflationAdjustment" xlink:to="mlec_InflationAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NetFinancialIncomeExpenses" xlink:href="mlec-20230630.xsd#mlec_NetFinancialIncomeExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NetFinancialIncomeExpenses_lbl" xml:lang="en-US">Total net financial income / expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetFinancialIncomeExpenses" xlink:to="mlec_NetFinancialIncomeExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_lbl" xml:lang="en-US">Other operating expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOtherOperatingExpensesTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherOperatingExpensesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ScheduleOfOtherOperatingExpensesTableTextBlock_lbl" xml:lang="en-US">Schedule of Other Operating Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfOtherOperatingExpensesTableTextBlock" xlink:to="mlec_ScheduleOfOtherOperatingExpensesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxesDutiesAndPenalties" xlink:href="mlec-20230630.xsd#mlec_TaxesDutiesAndPenalties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_TaxesDutiesAndPenalties_lbl" xml:lang="en-US">Taxes, duties and penalties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxesDutiesAndPenalties" xlink:to="mlec_TaxesDutiesAndPenalties_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_lbl" xml:lang="en-US">Administrative Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock_lbl" xml:lang="en-US">Schedule of Administrative Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock" xlink:to="mlec_DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_lbl" xml:lang="en-US">Research and development expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_lbl" xml:lang="en-US">Schedule of Research and Development Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCostOfSalesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfCostOfSalesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfCostOfSalesExplanatory_lbl" xml:lang="en-US">Cost of sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCostOfSalesExplanatory" xlink:to="ifrs-full_DisclosureOfCostOfSalesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfCostOfSalesTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfCostOfSalesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ScheduleOfCostOfSalesTableTextBlock_lbl" xml:lang="en-US">Schedule of Cost of Sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfCostOfSalesTableTextBlock" xlink:to="mlec_ScheduleOfCostOfSalesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ProductionCostsAbstract" xlink:href="mlec-20230630.xsd#mlec_ProductionCostsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ProductionCostsAbstract_lbl" xml:lang="en-US">Production costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProductionCostsAbstract" xlink:to="mlec_ProductionCostsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherProductionCosts" xlink:href="mlec-20230630.xsd#mlec_OtherProductionCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OtherProductionCosts_lbl" xml:lang="en-US">Other production costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherProductionCosts" xlink:to="mlec_OtherProductionCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations_lbl" xml:lang="en-US">Foreign currency translation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TotalOtherProductionCost" xlink:href="mlec-20230630.xsd#mlec_TotalOtherProductionCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_TotalOtherProductionCost_lbl" xml:lang="en-US">Sub-total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalOtherProductionCost" xlink:to="mlec_TotalOtherProductionCost_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl" xml:lang="en-US">Net loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EarningsPerShareExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_EarningsPerShareExplanatory_lbl" xml:lang="en-US">Schedule of Net Loss Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EarningsPerShareExplanatory" xlink:to="ifrs-full_EarningsPerShareExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_lbl" xml:lang="en-US">Loss for the year, attributable to the owners of the Group</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_lbl0" xml:lang="en-US">Loss attributable to the ordinary shareholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustedWeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AdjustedWeightedAverageShares_lbl" xml:lang="en-US">Weighted-average number of ordinary shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustedWeightedAverageShares" xlink:to="ifrs-full_AdjustedWeightedAverageShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_lbl" xml:lang="en-US">Basic (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:to="ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_lbl" xml:lang="en-US">Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:to="ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl" xml:lang="en-US">Related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOtherRelatedPartyTransactions" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherRelatedPartyTransactions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ScheduleOfOtherRelatedPartyTransactions_lbl" xml:lang="en-US">Schedule of Other Related Party Transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfOtherRelatedPartyTransactions" xlink:to="mlec_ScheduleOfOtherRelatedPartyTransactions_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermEmployeeBenefitsExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ShorttermEmployeeBenefitsExpense_lbl" xml:lang="en-US">Short-term employee benefits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:to="ifrs-full_ShorttermEmployeeBenefitsExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ShorttermEmployeeBenefitsAccruals_lbl" xml:lang="en-US">Share based payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:to="ifrs-full_ShorttermEmployeeBenefitsAccruals_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfShareBasedPayment" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfShareBasedPayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ScheduleOfShareBasedPayment_lbl" xml:lang="en-US">Schedule of Share Based Payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfShareBasedPayment" xlink:to="mlec_ScheduleOfShareBasedPayment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensation" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_KeyManagementPersonnelCompensation_lbl" xml:lang="en-US">Key management</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CFOSharesAlloted" xlink:href="mlec-20230630.xsd#mlec_CFOSharesAlloted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CFOSharesAlloted_lbl" xml:lang="en-US">CFO Shares Alloted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CFOSharesAlloted" xlink:to="mlec_CFOSharesAlloted_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IssueOfAdditionalSharesAbstract" xlink:href="mlec-20230630.xsd#mlec_IssueOfAdditionalSharesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IssueOfAdditionalSharesAbstract_lbl" xml:lang="en-US">Issue of Additional Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssueOfAdditionalSharesAbstract" xlink:to="mlec_IssueOfAdditionalSharesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IssueOfSharesCapital" xlink:href="mlec-20230630.xsd#mlec_IssueOfSharesCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IssueOfSharesCapital_lbl" xml:lang="en-US">Issue of share capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssueOfSharesCapital" xlink:to="mlec_IssueOfSharesCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IssueOfSharePremium" xlink:href="mlec-20230630.xsd#mlec_IssueOfSharePremium"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IssueOfSharePremium_lbl" xml:lang="en-US">Issue of share premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssueOfSharePremium" xlink:to="mlec_IssueOfSharePremium_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent_lbl" xml:lang="en-US">Parent of the Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:to="ifrs-full_ProfitLossAttributableToOwnersOfParent_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CompanySCashBalanceInOtherSAccountsAbstract" xlink:href="mlec-20230630.xsd#mlec_CompanySCashBalanceInOtherSAccountsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CompanySCashBalanceInOtherSAccountsAbstract_lbl" xml:lang="en-US">Company&#8217;s Cash Balance in Other&#8217;s Accounts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CompanySCashBalanceInOtherSAccountsAbstract" xlink:to="mlec_CompanySCashBalanceInOtherSAccountsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashEquivalents_lbl" xml:lang="en-US">Company&#8217;s Cash Balance in Other&#8217;s Accounts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashEquivalents" xlink:to="ifrs-full_CashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SubsidiaryPercentage" xlink:href="mlec-20230630.xsd#mlec_SubsidiaryPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SubsidiaryPercentage_lbl" xml:lang="en-US">Subsidiary percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SubsidiaryPercentage" xlink:to="mlec_SubsidiaryPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ExpensesPaidOnBehalfOfTheCompanyAbstract" xlink:href="mlec-20230630.xsd#mlec_ExpensesPaidOnBehalfOfTheCompanyAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ExpensesPaidOnBehalfOfTheCompanyAbstract_lbl" xml:lang="en-US">Expenses Paid on Behalf of the Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExpensesPaidOnBehalfOfTheCompanyAbstract" xlink:to="mlec_ExpensesPaidOnBehalfOfTheCompanyAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ExpensesPaid" xlink:href="mlec-20230630.xsd#mlec_ExpensesPaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ExpensesPaid_lbl" xml:lang="en-US">Expenses Paid on Behalf of the Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExpensesPaid" xlink:to="mlec_ExpensesPaid_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ServicesProvidedByOtherCompaniesAbstract" xlink:href="mlec-20230630.xsd#mlec_ServicesProvidedByOtherCompaniesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ServicesProvidedByOtherCompaniesAbstract_lbl" xml:lang="en-US">Services Provided by Other Companies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ServicesProvidedByOtherCompaniesAbstract" xlink:to="mlec_ServicesProvidedByOtherCompaniesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ServicesProvidedByOtherCompanies" xlink:href="mlec-20230630.xsd#mlec_ServicesProvidedByOtherCompanies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ServicesProvidedByOtherCompanies_lbl" xml:lang="en-US">Services Provided by Other Companies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ServicesProvidedByOtherCompanies" xlink:to="mlec_ServicesProvidedByOtherCompanies_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OwnedPercentage" xlink:href="mlec-20230630.xsd#mlec_OwnedPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OwnedPercentage_lbl" xml:lang="en-US">Owned percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OwnedPercentage" xlink:to="mlec_OwnedPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOtherRelatedPartyBalances" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherRelatedPartyBalances"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ScheduleOfOtherRelatedPartyBalances_lbl" xml:lang="en-US">Schedule of other related party balances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfOtherRelatedPartyBalances" xlink:to="mlec_ScheduleOfOtherRelatedPartyBalances_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherRelatedPartyBalances" xlink:href="mlec-20230630.xsd#mlec_OtherRelatedPartyBalances"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OtherRelatedPartyBalances_lbl" xml:lang="en-US">Other related party balances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherRelatedPartyBalances" xlink:to="mlec_OtherRelatedPartyBalances_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialRiskManagementExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_lbl" xml:lang="en-US">Financial risk management</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTradingIncomeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTradingIncomeExpenseExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfTradingIncomeExpenseExplanatory_lbl" xml:lang="en-US">Schedule of Trade and Other Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTradingIncomeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfTradingIncomeExpenseExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ToDueBecomeAbstract" xlink:href="mlec-20230630.xsd#mlec_ToDueBecomeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ToDueBecomeAbstract_lbl" xml:lang="en-US">To due become</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ToDueBecomeAbstract" xlink:to="mlec_ToDueBecomeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_lbl" xml:lang="en-US">Schedule of Contractual Maturity Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:to="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentPayables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NoncurrentPayables_lbl" xml:lang="en-US">Trade Payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentPayables" xlink:to="ifrs-full_NoncurrentPayables_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NoncurrentPayables_lbl0" xml:lang="en-US">Accounts Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentPayables" xlink:to="ifrs-full_NoncurrentPayables_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract15" xlink:href="mlec-20230630.xsd#mlec_UnlabeledAbstract15"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract15_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract15" xlink:to="mlec_UnlabeledAbstract15_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract16" xlink:href="mlec-20230630.xsd#mlec_UnlabeledAbstract16"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract16_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract16" xlink:to="mlec_UnlabeledAbstract16_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_June302022Abstract" xlink:href="mlec-20230630.xsd#mlec_June302022Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_June302022Abstract_lbl" xml:lang="en-US">June 30, 2022</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_June302022Abstract" xlink:to="mlec_June302022Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_lbl" xml:lang="en-US">Schedule of Foreign Currency Exchange Risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ForeignCurrencyExchangeRiskAssets" xlink:href="mlec-20230630.xsd#mlec_ForeignCurrencyExchangeRiskAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ForeignCurrencyExchangeRiskAssets_lbl" xml:lang="en-US">Foreign currency exchange risk assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ForeignCurrencyExchangeRiskAssets" xlink:to="mlec_ForeignCurrencyExchangeRiskAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ForeignCurrencyExchangeRiskLiabilities" xlink:href="mlec-20230630.xsd#mlec_ForeignCurrencyExchangeRiskLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ForeignCurrencyExchangeRiskLiabilities_lbl" xml:lang="en-US">Foreign currency exchange risk liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ForeignCurrencyExchangeRiskLiabilities" xlink:to="mlec_ForeignCurrencyExchangeRiskLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory_lbl" xml:lang="en-US">Schedule of Fair Value and Carrying Value of Financial Instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialAssetsAbstract" xlink:href="mlec-20230630.xsd#mlec_FinancialAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FinancialAssetsAbstract_lbl" xml:lang="en-US">Financial Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialAssetsAbstract" xlink:to="mlec_FinancialAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AmortizedCostsAbstract" xlink:href="mlec-20230630.xsd#mlec_AmortizedCostsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AmortizedCostsAbstract_lbl" xml:lang="en-US">Amortized costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AmortizedCostsAbstract" xlink:to="mlec_AmortizedCostsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract17" xlink:href="mlec-20230630.xsd#mlec_UnlabeledAbstract17"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract17_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract17" xlink:to="mlec_UnlabeledAbstract17_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FairValueThroughProfitOrLossAbstract" xlink:href="mlec-20230630.xsd#mlec_FairValueThroughProfitOrLossAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FairValueThroughProfitOrLossAbstract_lbl" xml:lang="en-US">Fair value through profit or loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FairValueThroughProfitOrLossAbstract" xlink:to="mlec_FairValueThroughProfitOrLossAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents" xlink:to="ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnlabeledAbstract18" xlink:href="mlec-20230630.xsd#mlec_UnlabeledAbstract18"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnlabeledAbstract18_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract18" xlink:to="mlec_UnlabeledAbstract18_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialLiabilitiesAbstract" xlink:href="mlec-20230630.xsd#mlec_FinancialLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FinancialLiabilitiesAbstract_lbl" xml:lang="en-US">Financial Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialLiabilitiesAbstract" xlink:to="mlec_FinancialLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AmortizedCostsAbstract0" xlink:href="mlec-20230630.xsd#mlec_AmortizedCostsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AmortizedCostsAbstract0_lbl" xml:lang="en-US">Amortized costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AmortizedCostsAbstract0" xlink:to="mlec_AmortizedCostsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialDebts" xlink:href="mlec-20230630.xsd#mlec_FinancialDebts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FinancialDebts_lbl" xml:lang="en-US">Financial debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialDebts" xlink:to="mlec_FinancialDebts_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FairValueThroughProfitOrLossAbstract0" xlink:href="mlec-20230630.xsd#mlec_FairValueThroughProfitOrLossAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FairValueThroughProfitOrLossAbstract0_lbl" xml:lang="en-US">Fair value through profit or loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FairValueThroughProfitOrLossAbstract0" xlink:to="mlec_FairValueThroughProfitOrLossAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfFixedRateInstruments" xlink:href="mlec-20230630.xsd#mlec_DisclosureOfFixedRateInstruments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfFixedRateInstruments_lbl" xml:lang="en-US">Schedule of Fixed-Rate Instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfFixedRateInstruments" xlink:to="mlec_DisclosureOfFixedRateInstruments_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfCapitalRiskManagementTextBlock" xlink:href="mlec-20230630.xsd#mlec_DisclosureOfCapitalRiskManagementTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DisclosureOfCapitalRiskManagementTextBlock_lbl" xml:lang="en-US">Capital Risk Management</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfCapitalRiskManagementTextBlock" xlink:to="mlec_DisclosureOfCapitalRiskManagementTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl" xml:lang="en-US">Events after the reporting period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentFinancialLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_CurrentFinancialLiabilities_lbl" xml:lang="en-US">Current Financial Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialLiabilities" xlink:to="ifrs-full_CurrentFinancialLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentFinancialLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_NoncurrentFinancialLiabilities_lbl" xml:lang="en-US">Non-current Financial Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialLiabilities" xlink:to="ifrs-full_NoncurrentFinancialLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Accumulated Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_Amortization" xlink:href="mlec-20230630.xsd#mlec_Amortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_Amortization_lbl" xml:lang="en-US">Amortization (i)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Amortization" xlink:to="mlec_Amortization_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss_lbl" xml:lang="en-US">Credited to profit &amp; loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss" xlink:to="mlec_DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_LossBeforeTax" xlink:href="mlec-20230630.xsd#mlec_LossBeforeTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_LossBeforeTax_lbl" xml:lang="en-US">Loss before tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LossBeforeTax" xlink:to="mlec_LossBeforeTax_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxLosses" xlink:href="mlec-20230630.xsd#mlec_TaxLosses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_TaxLosses_lbl" xml:lang="en-US">Tax losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxLosses" xlink:to="mlec_TaxLosses_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NondeductibleExpensesListingCost" xlink:href="mlec-20230630.xsd#mlec_NondeductibleExpensesListingCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_NondeductibleExpensesListingCost_lbl" xml:lang="en-US">Non-deductible expenses - listing cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NondeductibleExpensesListingCost" xlink:to="mlec_NondeductibleExpensesListingCost_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IncomeTaxInflationAdjustment" xlink:href="mlec-20230630.xsd#mlec_IncomeTaxInflationAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_IncomeTaxInflationAdjustment_lbl" xml:lang="en-US">Income tax inflation adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncomeTaxInflationAdjustment" xlink:to="mlec_IncomeTaxInflationAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TaxBenefitForTheYear" xlink:href="mlec-20230630.xsd#mlec_TaxBenefitForTheYear"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_TaxBenefitForTheYear_lbl" xml:lang="en-US">Tax benefit for the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxBenefitForTheYear" xlink:to="mlec_TaxBenefitForTheYear_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InterestExpenses" xlink:href="mlec-20230630.xsd#mlec_InterestExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_InterestExpenses_lbl" xml:lang="en-US">Interest expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InterestExpenses" xlink:to="mlec_InterestExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TotalFinancialCosts" xlink:href="mlec-20230630.xsd#mlec_TotalFinancialCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_TotalFinancialCosts_lbl" xml:lang="en-US">Total Financial Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalFinancialCosts" xlink:to="mlec_TotalFinancialCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ExchangeRateDifference" xlink:href="mlec-20230630.xsd#mlec_ExchangeRateDifference"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_ExchangeRateDifference_lbl" xml:lang="en-US">Exchange rate difference</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExchangeRateDifference" xlink:to="mlec_ExchangeRateDifference_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss" xlink:href="mlec-20230630.xsd#mlec_ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss_lbl" xml:lang="en-US">Change in fair value of Simply Agreement for Future Equity (&#8220;SAFE&#8221;) - Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss" xlink:to="mlec_ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherFinancialResults" xlink:href="mlec-20230630.xsd#mlec_OtherFinancialResults"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_OtherFinancialResults_lbl" xml:lang="en-US">Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherFinancialResults" xlink:to="mlec_OtherFinancialResults_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TotalOtherFinancialResults" xlink:href="mlec-20230630.xsd#mlec_TotalOtherFinancialResults"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_TotalOtherFinancialResults_lbl" xml:lang="en-US">Total Other financial results</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalOtherFinancialResults" xlink:to="mlec_TotalOtherFinancialResults_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MiscellaneousOtherOperatingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_MiscellaneousOtherOperatingExpense_lbl" xml:lang="en-US">Miscellaneous expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MiscellaneousOtherOperatingExpense" xlink:to="ifrs-full_MiscellaneousOtherOperatingExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherOperatingExpense" xlink:href="mlec-20230630.xsd#mlec_OtherOperatingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_OtherOperatingExpense_lbl" xml:lang="en-US">Total other operating expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherOperatingExpense" xlink:to="mlec_OtherOperatingExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AuditLegalAndAccountancyFee" xlink:href="mlec-20230630.xsd#mlec_AuditLegalAndAccountancyFee"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_AuditLegalAndAccountancyFee_lbl" xml:lang="en-US">Audit. legal and accountancy fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AuditLegalAndAccountancyFee" xlink:to="mlec_AuditLegalAndAccountancyFee_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EmployeeBenefitsExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EmployeeBenefitsExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_EmployeeBenefitsExpense_lbl" xml:lang="en-US">Employee Stock Option Plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EmployeeBenefitsExpense" xlink:to="ifrs-full_EmployeeBenefitsExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PayrollExpenses" xlink:href="mlec-20230630.xsd#mlec_PayrollExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_PayrollExpenses_lbl" xml:lang="en-US">Payroll Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PayrollExpenses" xlink:to="mlec_PayrollExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InsuranceExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InsuranceExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_InsuranceExpense_lbl" xml:lang="en-US">Insurance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InsuranceExpense" xlink:to="ifrs-full_InsuranceExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TravelExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TravelExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_TravelExpense_lbl" xml:lang="en-US">Travel Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TravelExpense" xlink:to="ifrs-full_TravelExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AmortizationExpense" xlink:href="mlec-20230630.xsd#mlec_AmortizationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_AmortizationExpense_lbl" xml:lang="en-US">Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AmortizationExpense" xlink:to="mlec_AmortizationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DepreciationExpense_lbl" xml:lang="en-US">Depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationExpense" xlink:to="ifrs-full_DepreciationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Other office and admin expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfessionalFeesExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfessionalFeesExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_ProfessionalFeesExpense_lbl" xml:lang="en-US">Professional fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfessionalFeesExpense" xlink:to="ifrs-full_ProfessionalFeesExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_LaboratoriesRelatedExpenses" xlink:href="mlec-20230630.xsd#mlec_LaboratoriesRelatedExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_LaboratoriesRelatedExpenses_lbl" xml:lang="en-US">Laboratories&#8217; related expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LaboratoriesRelatedExpenses" xlink:to="mlec_LaboratoriesRelatedExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AmortisationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AmortisationExpense_lbl" xml:lang="en-US">Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmortisationExpense" xlink:to="ifrs-full_AmortisationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherResearchAndDevelopmentExpenses" xlink:href="mlec-20230630.xsd#mlec_OtherResearchAndDevelopmentExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_OtherResearchAndDevelopmentExpenses_lbl" xml:lang="en-US">Other research and development expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherResearchAndDevelopmentExpenses" xlink:to="mlec_OtherResearchAndDevelopmentExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InventoriesIncorporatedThroughTheBusinessCombination" xlink:href="mlec-20230630.xsd#mlec_InventoriesIncorporatedThroughTheBusinessCombination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_InventoriesIncorporatedThroughTheBusinessCombination_lbl" xml:lang="en-US">Inventories incorporated through the business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoriesIncorporatedThroughTheBusinessCombination" xlink:to="mlec_InventoriesIncorporatedThroughTheBusinessCombination_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchasesFairValueMeasurementAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchasesFairValueMeasurementAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PurchasesFairValueMeasurementAssets_lbl" xml:lang="en-US">Purchases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchasesFairValueMeasurementAssets" xlink:to="ifrs-full_PurchasesFairValueMeasurementAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PayrollAndAndProfessionalFees" xlink:href="mlec-20230630.xsd#mlec_PayrollAndAndProfessionalFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="mlec_PayrollAndAndProfessionalFees_lbl" xml:lang="en-US">Payroll and and professional fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PayrollAndAndProfessionalFees" xlink:to="mlec_PayrollAndAndProfessionalFees_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepairsAndMaintenanceExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RepairsAndMaintenanceExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_RepairsAndMaintenanceExpense_lbl" xml:lang="en-US">Maintenance, energy and fuel related to fixed assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RepairsAndMaintenanceExpense" xlink:to="ifrs-full_RepairsAndMaintenanceExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationAndAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationAndAmortisationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DepreciationAndAmortisationExpense_lbl" xml:lang="en-US">Amortization and depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationAndAmortisationExpense" xlink:to="ifrs-full_DepreciationAndAmortisationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RawMaterialsAndConsumablesUsed" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RawMaterialsAndConsumablesUsed"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_RawMaterialsAndConsumablesUsed_lbl" xml:lang="en-US">Sub-total Production costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RawMaterialsAndConsumablesUsed" xlink:to="ifrs-full_RawMaterialsAndConsumablesUsed_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AtFairValueMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AtFairValueMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AtFairValueMember_lbl" xml:lang="en-US">Fair Value [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AtFairValueMember" xlink:to="ifrs-full_AtFairValueMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_StorageMember" xlink:href="mlec-20230630.xsd#mlec_StorageMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_StorageMember_lbl" xml:lang="en-US">Storage [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_StorageMember" xlink:to="mlec_StorageMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MachineryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MachineryMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_MachineryMember_lbl" xml:lang="en-US">Machinery and equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MachineryMember" xlink:to="ifrs-full_MachineryMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_MachineryMember_lbl0" xml:lang="en-US">Machinery [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MachineryMember" xlink:to="ifrs-full_MachineryMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_VehiclesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_VehiclesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_VehiclesMember_lbl" xml:lang="en-US">Vehicles [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_VehiclesMember" xlink:to="ifrs-full_VehiclesMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_VehiclesMember_lbl0" xml:lang="en-US">Vehicles [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_VehiclesMember" xlink:to="ifrs-full_VehiclesMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_FurnitureMember" xlink:href="mlec-20230630.xsd#mlec_FurnitureMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FurnitureMember_lbl" xml:lang="en-US">Furniture [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FurnitureMember" xlink:to="mlec_FurnitureMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComputerEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComputerEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ComputerEquipmentMember_lbl" xml:lang="en-US">Computer equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComputerEquipmentMember" xlink:to="ifrs-full_ComputerEquipmentMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ComputerEquipmentMember_lbl0" xml:lang="en-US">Computer equipment [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComputerEquipmentMember" xlink:to="ifrs-full_ComputerEquipmentMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BottomOfRangeMember_lbl" xml:lang="en-US">Bottom of range [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BottomOfRangeMember" xlink:to="ifrs-full_BottomOfRangeMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_BottomOfRangeMember_lbl0" xml:lang="en-US">Bottom of Range [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BottomOfRangeMember" xlink:to="ifrs-full_BottomOfRangeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_BottomOfRangeMember_lbl1" xml:lang="en-US">Bottom of range [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BottomOfRangeMember" xlink:to="ifrs-full_BottomOfRangeMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TopOfRangeMember_lbl" xml:lang="en-US">Top of range [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TopOfRangeMember" xlink:to="ifrs-full_TopOfRangeMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TopOfRangeMember_lbl0" xml:lang="en-US">Top of Range [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TopOfRangeMember" xlink:to="ifrs-full_TopOfRangeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="ifrs-full_TopOfRangeMember_lbl1" xml:lang="en-US">Top of range [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TopOfRangeMember" xlink:to="ifrs-full_TopOfRangeMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_MoolecScienceLimitedMember" xlink:href="mlec-20230630.xsd#mlec_MoolecScienceLimitedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MoolecScienceLimitedMember_lbl" xml:lang="en-US">Moolec Science Limited [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MoolecScienceLimitedMember" xlink:to="mlec_MoolecScienceLimitedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_LightJumpAcquisitionCorporationMember" xlink:href="mlec-20230630.xsd#mlec_LightJumpAcquisitionCorporationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_LightJumpAcquisitionCorporationMember_lbl" xml:lang="en-US">LightJump Acquisition Corporation [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LightJumpAcquisitionCorporationMember" xlink:to="mlec_LightJumpAcquisitionCorporationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ValoraSoySAMember" xlink:href="mlec-20230630.xsd#mlec_ValoraSoySAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ValoraSoySAMember_lbl" xml:lang="en-US">ValoraSoy S.A. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ValoraSoySAMember" xlink:to="mlec_ValoraSoySAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AGBiomoleculesLLCDEMember" xlink:href="mlec-20230630.xsd#mlec_AGBiomoleculesLLCDEMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AGBiomoleculesLLCDEMember_lbl" xml:lang="en-US">AG Biomolecules LLC (DE) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AGBiomoleculesLLCDEMember" xlink:to="mlec_AGBiomoleculesLLCDEMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MicrooFoodsIngredientsSLMember" xlink:href="mlec-20230630.xsd#mlec_MicrooFoodsIngredientsSLMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MicrooFoodsIngredientsSLMember_lbl" xml:lang="en-US">Microo Foods Ingredients S.L. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MicrooFoodsIngredientsSLMember" xlink:to="mlec_MicrooFoodsIngredientsSLMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_LuxMember" xlink:href="mlec-20230630.xsd#mlec_LuxMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_LuxMember_lbl" xml:lang="en-US">Lux [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LuxMember" xlink:to="mlec_LuxMember_lbl"/>
    <loc xlink:type="locator" xlink:label="country_GB" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_GB_lbl" xml:lang="en-US">United Kingdom [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_GB" xlink:to="country_GB_lbl"/>
    <loc xlink:type="locator" xlink:label="country_AR" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_AR"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_AR_lbl" xml:lang="en-US">Argentina [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_AR" xlink:to="country_AR_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember" xlink:href="mlec-20230630.xsd#mlec_GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember_lbl" xml:lang="en-US">Gamma Linolenic Acid (&#8220;GLA&#8217;) assets and licensing rights to Arachidonic Acid (&#8220;ARA&#8221;) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember" xlink:to="mlec_GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SPCTechnologyMember" xlink:href="mlec-20230630.xsd#mlec_SPCTechnologyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SPCTechnologyMember_lbl" xml:lang="en-US">SPC&#174; technology [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SPCTechnologyMember" xlink:to="mlec_SPCTechnologyMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CustomerRelationshipMember" xlink:href="mlec-20230630.xsd#mlec_CustomerRelationshipMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CustomerRelationshipMember_lbl" xml:lang="en-US">Customer relationship [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CustomerRelationshipMember" xlink:to="mlec_CustomerRelationshipMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SoftwareLicenseMember" xlink:href="mlec-20230630.xsd#mlec_SoftwareLicenseMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SoftwareLicenseMember_lbl" xml:lang="en-US">Software License [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SoftwareLicenseMember" xlink:to="mlec_SoftwareLicenseMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossCarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_GrossCarryingAmountMember_lbl" xml:lang="en-US">Cost [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossCarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl" xml:lang="en-US">Accumulated Depreciation [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NetBookAmountMember" xlink:href="mlec-20230630.xsd#mlec_NetBookAmountMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NetBookAmountMember_lbl" xml:lang="en-US">Net book amount [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetBookAmountMember" xlink:to="mlec_NetBookAmountMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ChymosinOsmosisEquipmentMember" xlink:href="mlec-20230630.xsd#mlec_ChymosinOsmosisEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ChymosinOsmosisEquipmentMember_lbl" xml:lang="en-US">Chymosin osmosis equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChymosinOsmosisEquipmentMember" xlink:to="mlec_ChymosinOsmosisEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MoolecScienceSharesMember" xlink:href="mlec-20230630.xsd#mlec_MoolecScienceSharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MoolecScienceSharesMember_lbl" xml:lang="en-US">Issue of share capital (Moolec Science shares) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MoolecScienceSharesMember" xlink:to="mlec_MoolecScienceSharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SAFESharesMember" xlink:href="mlec-20230630.xsd#mlec_SAFESharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SAFESharesMember_lbl" xml:lang="en-US">Issue of share capital (SAFE shares) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SAFESharesMember" xlink:to="mlec_SAFESharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_LightJumpSharesMember" xlink:href="mlec-20230630.xsd#mlec_LightJumpSharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_LightJumpSharesMember_lbl" xml:lang="en-US">Issue of share capital (LightJump shares) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LightJumpSharesMember" xlink:to="mlec_LightJumpSharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BackstopSharesMember" xlink:href="mlec-20230630.xsd#mlec_BackstopSharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BackstopSharesMember_lbl" xml:lang="en-US">Issue of share capital (Backstop shares) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BackstopSharesMember" xlink:to="mlec_BackstopSharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_Group1Member" xlink:href="mlec-20230630.xsd#mlec_Group1Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_Group1Member_lbl" xml:lang="en-US">Group 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Group1Member" xlink:to="mlec_Group1Member_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_Group2Member" xlink:href="mlec-20230630.xsd#mlec_Group2Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_Group2Member_lbl" xml:lang="en-US">Group 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Group2Member" xlink:to="mlec_Group2Member_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_Group3Member" xlink:href="mlec-20230630.xsd#mlec_Group3Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_Group3Member_lbl" xml:lang="en-US">Group 3 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Group3Member" xlink:to="mlec_Group3Member_lbl"/>
    <loc xlink:type="locator" xlink:label="currency_ARS" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_ARS"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="currency_ARS_lbl" xml:lang="en-US">Financial Debt denominated in Argentine Pesos [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_ARS" xlink:to="currency_ARS_lbl"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_US_lbl" xml:lang="en-US">Financial Debt denominated in US Dollars [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BancoMacroPreFinancingOfExportsMember" xlink:href="mlec-20230630.xsd#mlec_BancoMacroPreFinancingOfExportsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BancoMacroPreFinancingOfExportsMember_lbl" xml:lang="en-US">Banco Macro - Pre-Financing of Exports [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BancoMacroPreFinancingOfExportsMember" xlink:to="mlec_BancoMacroPreFinancingOfExportsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BancoNacinPreFinancingOfExportsMember" xlink:href="mlec-20230630.xsd#mlec_BancoNacinPreFinancingOfExportsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BancoNacinPreFinancingOfExportsMember_lbl" xml:lang="en-US">Banco Naci&#243;n - Pre-Financing of Exports [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BancoNacinPreFinancingOfExportsMember" xlink:to="mlec_BancoNacinPreFinancingOfExportsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BancoCrdobaPreFinancingOfExportsMember" xlink:href="mlec-20230630.xsd#mlec_BancoCrdobaPreFinancingOfExportsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BancoCrdobaPreFinancingOfExportsMember_lbl" xml:lang="en-US">Banco C&#243;rdoba - Pre-Financing of Exports [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BancoCrdobaPreFinancingOfExportsMember" xlink:to="mlec_BancoCrdobaPreFinancingOfExportsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BancoGaliciaBankOverdraftsMember" xlink:href="mlec-20230630.xsd#mlec_BancoGaliciaBankOverdraftsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BancoGaliciaBankOverdraftsMember_lbl" xml:lang="en-US">Banco Galicia - Bank Overdrafts [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BancoGaliciaBankOverdraftsMember" xlink:to="mlec_BancoGaliciaBankOverdraftsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_HSBCBankBankOverdraftsMember" xlink:href="mlec-20230630.xsd#mlec_HSBCBankBankOverdraftsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_HSBCBankBankOverdraftsMember_lbl" xml:lang="en-US">HSBC Bank - Bank Overdrafts [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_HSBCBankBankOverdraftsMember" xlink:to="mlec_HSBCBankBankOverdraftsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BancoSantanderBankOverdraftsMember" xlink:href="mlec-20230630.xsd#mlec_BancoSantanderBankOverdraftsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BancoSantanderBankOverdraftsMember_lbl" xml:lang="en-US">Banco Santander - Bank Overdrafts [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BancoSantanderBankOverdraftsMember" xlink:to="mlec_BancoSantanderBankOverdraftsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BancoGaliciaLoansMember" xlink:href="mlec-20230630.xsd#mlec_BancoGaliciaLoansMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BancoGaliciaLoansMember_lbl" xml:lang="en-US">Banco Galicia - Loans [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BancoGaliciaLoansMember" xlink:to="mlec_BancoGaliciaLoansMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_HSBCBankLoansMember" xlink:href="mlec-20230630.xsd#mlec_HSBCBankLoansMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_HSBCBankLoansMember_lbl" xml:lang="en-US">HSBC Bank - Loans [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_HSBCBankLoansMember" xlink:to="mlec_HSBCBankLoansMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BancoSantanderLoansMember" xlink:href="mlec-20230630.xsd#mlec_BancoSantanderLoansMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BancoSantanderLoansMember_lbl" xml:lang="en-US">Banco Santander - Loans [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BancoSantanderLoansMember" xlink:to="mlec_BancoSantanderLoansMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BancoMacroLoansMember" xlink:href="mlec-20230630.xsd#mlec_BancoMacroLoansMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BancoMacroLoansMember_lbl" xml:lang="en-US">Banco Macro - Loans [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BancoMacroLoansMember" xlink:to="mlec_BancoMacroLoansMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PromissoryNotesMember" xlink:href="mlec-20230630.xsd#mlec_PromissoryNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PromissoryNotesMember_lbl" xml:lang="en-US">Promissory Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PromissoryNotesMember" xlink:to="mlec_PromissoryNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AsociacinMutualAMALoansMember" xlink:href="mlec-20230630.xsd#mlec_AsociacinMutualAMALoansMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AsociacinMutualAMALoansMember_lbl" xml:lang="en-US">Asociaci&#243;n Mutual AMA &#8211; Loans [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AsociacinMutualAMALoansMember" xlink:to="mlec_AsociacinMutualAMALoansMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WarrantReserveMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WarrantReserveMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WarrantReserveMember_lbl" xml:lang="en-US">Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WarrantReserveMember" xlink:to="ifrs-full_WarrantReserveMember_lbl"/>
    <loc xlink:type="locator" xlink:label="country_LU" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_LU"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_LU_lbl" xml:lang="en-US">Luxembourg [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_LU" xlink:to="country_LU_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="country_LU_lbl0" xml:lang="en-US">LUXEMBOURG</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_LU" xlink:to="country_LU_lbl0"/>
    <loc xlink:type="locator" xlink:label="currency_USD" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_USD"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="currency_USD_lbl" xml:lang="en-US">United States of America [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_USD" xlink:to="currency_USD_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NetDeferredTaxLiabilitiesMember" xlink:href="mlec-20230630.xsd#mlec_NetDeferredTaxLiabilitiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NetDeferredTaxLiabilitiesMember_lbl" xml:lang="en-US">Net deferred tax liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetDeferredTaxLiabilitiesMember" xlink:to="mlec_NetDeferredTaxLiabilitiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TwoThousandTwentyTwoMember" xlink:href="mlec-20230630.xsd#mlec_TwoThousandTwentyTwoMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_TwoThousandTwentyTwoMember_lbl" xml:lang="en-US">2022 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TwoThousandTwentyTwoMember" xlink:to="mlec_TwoThousandTwentyTwoMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TwoThousandTwentyThreeMember" xlink:href="mlec-20230630.xsd#mlec_TwoThousandTwentyThreeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_TwoThousandTwentyThreeMember_lbl" xml:lang="en-US">2023 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TwoThousandTwentyThreeMember" xlink:to="mlec_TwoThousandTwentyThreeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresCropSolutionsCorpMember" xlink:href="mlec-20230630.xsd#mlec_BioceresCropSolutionsCorpMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BioceresCropSolutionsCorpMember_lbl" xml:lang="en-US">Bioceres Crop Solutions Corp [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresCropSolutionsCorpMember" xlink:to="mlec_BioceresCropSolutionsCorpMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnionGroupVenturesMember" xlink:href="mlec-20230630.xsd#mlec_UnionGroupVenturesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnionGroupVenturesMember_lbl" xml:lang="en-US">Union Group Ventures [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnionGroupVenturesMember" xlink:to="mlec_UnionGroupVenturesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BGFarmingTechnologiesMember" xlink:href="mlec-20230630.xsd#mlec_BGFarmingTechnologiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BGFarmingTechnologiesMember_lbl" xml:lang="en-US">BG Farming Technologies [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BGFarmingTechnologiesMember" xlink:to="mlec_BGFarmingTechnologiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresSAMember" xlink:href="mlec-20230630.xsd#mlec_BioceresSAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BioceresSAMember_lbl" xml:lang="en-US">Bioceres S.A. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresSAMember" xlink:to="mlec_BioceresSAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresLLCMember" xlink:href="mlec-20230630.xsd#mlec_BioceresLLCMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BioceresLLCMember_lbl" xml:lang="en-US">Bioceres LLC [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresLLCMember" xlink:to="mlec_BioceresLLCMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresSAINMETSAIngenieriaMetabolicaSAMember" xlink:href="mlec-20230630.xsd#mlec_BioceresSAINMETSAIngenieriaMetabolicaSAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BioceresSAINMETSAIngenieriaMetabolicaSAMember_lbl" xml:lang="en-US">30% owned by Bioceres S.A. - INMET S.A.- Ingenieria Metabolica S.A [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresSAINMETSAIngenieriaMetabolicaSAMember" xlink:to="mlec_BioceresSAINMETSAIngenieriaMetabolicaSAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember" xlink:href="mlec-20230630.xsd#mlec_BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember_lbl" xml:lang="en-US">98.6% owned by Bioceres S.A. - INDEAR S.A.- Instituto de Agrobiotecnolog&#237;a Rosario [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember" xlink:to="mlec_BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresSAAgralityIncMember" xlink:href="mlec-20230630.xsd#mlec_BioceresSAAgralityIncMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BioceresSAAgralityIncMember_lbl" xml:lang="en-US">Bioceres S.A. - Agrality Inc.[Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresSAAgralityIncMember" xlink:to="mlec_BioceresSAAgralityIncMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FutureFoodsBVMember" xlink:href="mlec-20230630.xsd#mlec_FutureFoodsBVMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_FutureFoodsBVMember_lbl" xml:lang="en-US">Future Foods B.V. Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FutureFoodsBVMember" xlink:to="mlec_FutureFoodsBVMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="mlec_FutureFoodsBVMember_lbl0" xml:lang="en-US">Future Foods B.V [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FutureFoodsBVMember" xlink:to="mlec_FutureFoodsBVMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_MoolecScienceSAMember" xlink:href="mlec-20230630.xsd#mlec_MoolecScienceSAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MoolecScienceSAMember_lbl" xml:lang="en-US">Moolec Science S.A. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MoolecScienceSAMember" xlink:to="mlec_MoolecScienceSAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_THEOISCSpMember" xlink:href="mlec-20230630.xsd#mlec_THEOISCSpMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_THEOISCSpMember_lbl" xml:lang="en-US">THEO I SCSp [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_THEOISCSpMember" xlink:to="mlec_THEOISCSpMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BioceresSABioceresLLCMember" xlink:href="mlec-20230630.xsd#mlec_BioceresSABioceresLLCMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BioceresSABioceresLLCMember_lbl" xml:lang="en-US">100% Subsidiary of Bioceres S.A. - Bioceres LLC	[Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresSABioceresLLCMember" xlink:to="mlec_BioceresSABioceresLLCMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MoolecSAShareholdersMember" xlink:href="mlec-20230630.xsd#mlec_MoolecSAShareholdersMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MoolecSAShareholdersMember_lbl" xml:lang="en-US">Moolec S.A. Shareholders [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MoolecSAShareholdersMember" xlink:to="mlec_MoolecSAShareholdersMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnionGroupVenturesLimitedMember" xlink:href="mlec-20230630.xsd#mlec_UnionGroupVenturesLimitedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnionGroupVenturesLimitedMember_lbl" xml:lang="en-US">Union Group Ventures Limited [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnionGroupVenturesLimitedMember" xlink:to="mlec_UnionGroupVenturesLimitedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_INDEARSAMember" xlink:href="mlec-20230630.xsd#mlec_INDEARSAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_INDEARSAMember_lbl" xml:lang="en-US">INDEAR S.A. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_INDEARSAMember" xlink:to="mlec_INDEARSAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UpToThreeMonthsMember" xlink:href="mlec-20230630.xsd#mlec_UpToThreeMonthsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UpToThreeMonthsMember_lbl" xml:lang="en-US">Up to 3 months [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UpToThreeMonthsMember" xlink:to="mlec_UpToThreeMonthsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_WithinOneYearOrOnDemandMember" xlink:href="mlec-20230630.xsd#mlec_WithinOneYearOrOnDemandMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_WithinOneYearOrOnDemandMember_lbl" xml:lang="en-US">Within 1 year or on demand [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_WithinOneYearOrOnDemandMember" xlink:to="mlec_WithinOneYearOrOnDemandMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BetweenOneAndTwoYearsMember" xlink:href="mlec-20230630.xsd#mlec_BetweenOneAndTwoYearsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BetweenOneAndTwoYearsMember_lbl" xml:lang="en-US">Between 1 and 2 years [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BetweenOneAndTwoYearsMember" xlink:to="mlec_BetweenOneAndTwoYearsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_BetweenTwoAndFiveYearsMember" xlink:href="mlec-20230630.xsd#mlec_BetweenTwoAndFiveYearsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_BetweenTwoAndFiveYearsMember_lbl" xml:lang="en-US">Between 2 and 5 years [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BetweenTwoAndFiveYearsMember" xlink:to="mlec_BetweenTwoAndFiveYearsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MoreThanFiveYearsMember" xlink:href="mlec-20230630.xsd#mlec_MoreThanFiveYearsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MoreThanFiveYearsMember_lbl" xml:lang="en-US">More than 5 years [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MoreThanFiveYearsMember" xlink:to="mlec_MoreThanFiveYearsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_WithoutAnyEstablishedTermMember" xlink:href="mlec-20230630.xsd#mlec_WithoutAnyEstablishedTermMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_WithoutAnyEstablishedTermMember_lbl" xml:lang="en-US">Without any established term [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_WithoutAnyEstablishedTermMember" xlink:to="mlec_WithoutAnyEstablishedTermMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ArgentinePesosMember" xlink:href="mlec-20230630.xsd#mlec_ArgentinePesosMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ArgentinePesosMember_lbl" xml:lang="en-US">Argentine pesos [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ArgentinePesosMember" xlink:to="mlec_ArgentinePesosMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_USDollarMember" xlink:href="mlec-20230630.xsd#mlec_USDollarMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_USDollarMember_lbl" xml:lang="en-US">U.S. Dollar [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_USDollarMember" xlink:to="mlec_USDollarMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PoundSterlingMember" xlink:href="mlec-20230630.xsd#mlec_PoundSterlingMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PoundSterlingMember_lbl" xml:lang="en-US">Pound sterling [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PoundSterlingMember" xlink:to="mlec_PoundSterlingMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ImpactToProfitOrLossBeforeTaxAssetsMember" xlink:href="mlec-20230630.xsd#mlec_ImpactToProfitOrLossBeforeTaxAssetsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ImpactToProfitOrLossBeforeTaxAssetsMember_lbl" xml:lang="en-US">(+10%) Impact to profit or loss before tax assets [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ImpactToProfitOrLossBeforeTaxAssetsMember" xlink:to="mlec_ImpactToProfitOrLossBeforeTaxAssetsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ImpactToProfitOrLossBeforeTaxLiabilitiesMember" xlink:href="mlec-20230630.xsd#mlec_ImpactToProfitOrLossBeforeTaxLiabilitiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ImpactToProfitOrLossBeforeTaxLiabilitiesMember_lbl" xml:lang="en-US">(-10%) Impact to profit or loss before tax liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ImpactToProfitOrLossBeforeTaxLiabilitiesMember" xlink:to="mlec_ImpactToProfitOrLossBeforeTaxLiabilitiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsMember_lbl" xml:lang="en-US">Financial instruments, class [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_lbl" xml:lang="en-US">Types of share-based payment arrangements [axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_lbl" xml:lang="en-US">Ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_lbl0" xml:lang="en-US">Ordinary shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ParValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ParValuePerShare_lbl" xml:lang="en-US">Price per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ParValuePerShare" xlink:to="ifrs-full_ParValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CommonStockExercised" xlink:href="mlec-20230630.xsd#mlec_CommonStockExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CommonStockExercised_lbl" xml:lang="en-US">Common stock exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CommonStockExercised" xlink:to="mlec_CommonStockExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RedemptionPrice" xlink:href="mlec-20230630.xsd#mlec_RedemptionPrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_RedemptionPrice_lbl" xml:lang="en-US">Redemption price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RedemptionPrice" xlink:to="mlec_RedemptionPrice_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AggregateRedemption" xlink:href="mlec-20230630.xsd#mlec_AggregateRedemption"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AggregateRedemption_lbl" xml:lang="en-US">Aggregate redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AggregateRedemption" xlink:to="mlec_AggregateRedemption_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_TrustAccount" xlink:href="mlec-20230630.xsd#mlec_TrustAccount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_TrustAccount_lbl" xml:lang="en-US">Trust account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TrustAccount" xlink:to="mlec_TrustAccount_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SponsorShares" xlink:href="mlec-20230630.xsd#mlec_SponsorShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SponsorShares_lbl" xml:lang="en-US">Sponsor shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SponsorShares" xlink:to="mlec_SponsorShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets_lbl" xml:lang="en-US">Contributed amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets" xlink:to="ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentCost" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ShareBasedPaymentCost_lbl" xml:lang="en-US">Share based payment cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentCost" xlink:to="mlec_ShareBasedPaymentCost_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NegativeWorkingCapital" xlink:href="mlec-20230630.xsd#mlec_NegativeWorkingCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NegativeWorkingCapital_lbl" xml:lang="en-US">Negative Working Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NegativeWorkingCapital" xlink:to="mlec_NegativeWorkingCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl" xml:lang="en-US">Total aggregate amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashTransferred"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashTransferred_lbl" xml:lang="en-US">Combination of cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashTransferred" xlink:to="ifrs-full_CashTransferred_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssueCostsNotRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssueCostsNotRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IssueCostsNotRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_lbl" xml:lang="en-US">Cash payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssueCostsNotRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:to="ifrs-full_IssueCostsNotRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CashPayment" xlink:href="mlec-20230630.xsd#mlec_CashPayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CashPayment_lbl" xml:lang="en-US">Cash payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CashPayment" xlink:to="mlec_CashPayment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_lbl" xml:lang="en-US">Equity (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" xlink:to="ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareEquivalent" xlink:href="mlec-20230630.xsd#mlec_ShareEquivalent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ShareEquivalent_lbl" xml:lang="en-US">Shares equivalent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareEquivalent" xlink:to="mlec_ShareEquivalent_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ExperienceDate" xlink:href="mlec-20230630.xsd#mlec_ExperienceDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ExperienceDate_lbl" xml:lang="en-US">Experience years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExperienceDate" xlink:to="mlec_ExperienceDate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xml:lang="en-US">Pro-forma revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CumulativeInflationRate" xlink:href="mlec-20230630.xsd#mlec_CumulativeInflationRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CumulativeInflationRate_lbl" xml:lang="en-US">Cumulative inflation rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CumulativeInflationRate" xlink:to="mlec_CumulativeInflationRate_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_Accumulated" xlink:href="mlec-20230630.xsd#mlec_Accumulated"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_Accumulated_lbl" xml:lang="en-US">Accumulated</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Accumulated" xlink:to="mlec_Accumulated_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_InflationAccumulated" xlink:href="mlec-20230630.xsd#mlec_InflationAccumulated"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_InflationAccumulated_lbl" xml:lang="en-US">Inflation accumulated</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InflationAccumulated" xlink:to="mlec_InflationAccumulated_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ArgentinePriceIndexes" xlink:href="mlec-20230630.xsd#mlec_ArgentinePriceIndexes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ArgentinePriceIndexes_lbl" xml:lang="en-US">Argentine price indexes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ArgentinePriceIndexes" xlink:to="mlec_ArgentinePriceIndexes_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets_lbl" xml:lang="en-US">Discount rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets" xlink:to="ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfSharesToBeIssuedOfContingentPayment" xlink:href="mlec-20230630.xsd#mlec_NumberOfSharesToBeIssuedOfContingentPayment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NumberOfSharesToBeIssuedOfContingentPayment_lbl" xml:lang="en-US">Number of shares to be issued of contingent payment (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfSharesToBeIssuedOfContingentPayment" xlink:to="mlec_NumberOfSharesToBeIssuedOfContingentPayment_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareIssueRelatedCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareIssueRelatedCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ShareIssueRelatedCost_lbl" xml:lang="en-US">Shares equivalent amount (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareIssueRelatedCost" xlink:to="ifrs-full_ShareIssueRelatedCost_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_JointArrangementParticipationPercentage" xlink:href="mlec-20230630.xsd#mlec_JointArrangementParticipationPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_JointArrangementParticipationPercentage_lbl" xml:lang="en-US">Participation percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_JointArrangementParticipationPercentage" xlink:to="mlec_JointArrangementParticipationPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OriginalAmount" xlink:href="mlec-20230630.xsd#mlec_OriginalAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OriginalAmount_lbl" xml:lang="en-US">Original amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OriginalAmount" xlink:to="mlec_OriginalAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AggregatePurchasePrice" xlink:href="mlec-20230630.xsd#mlec_AggregatePurchasePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AggregatePurchasePrice_lbl" xml:lang="en-US">Aggregate purchase price (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AggregatePurchasePrice" xlink:to="mlec_AggregatePurchasePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PurchasePaymentTerms" xlink:href="mlec-20230630.xsd#mlec_PurchasePaymentTerms"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PurchasePaymentTerms_lbl" xml:lang="en-US">Purchase payment term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PurchasePaymentTerms" xlink:to="mlec_PurchasePaymentTerms_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsInterestRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_BorrowingsInterestRate_lbl" xml:lang="en-US">Internal rate percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsInterestRate" xlink:to="ifrs-full_BorrowingsInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareCapitalStockAndSharePremiumAmounts" xlink:href="mlec-20230630.xsd#mlec_ShareCapitalStockAndSharePremiumAmounts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ShareCapitalStockAndSharePremiumAmounts_lbl" xml:lang="en-US">Share capital stock and share premium amounts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareCapitalStockAndSharePremiumAmounts" xlink:to="mlec_ShareCapitalStockAndSharePremiumAmounts_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_Equivalent" xlink:href="mlec-20230630.xsd#mlec_Equivalent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_Equivalent_lbl" xml:lang="en-US">Equivalent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Equivalent" xlink:to="mlec_Equivalent_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SharePurchaseAgreementOverPeriod" xlink:href="mlec-20230630.xsd#mlec_SharePurchaseAgreementOverPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SharePurchaseAgreementOverPeriod_lbl" xml:lang="en-US">Share purchase Agreement over period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharePurchaseAgreementOverPeriod" xlink:to="mlec_SharePurchaseAgreementOverPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UnderIssuedSharePurchaseAgreement" xlink:href="mlec-20230630.xsd#mlec_UnderIssuedSharePurchaseAgreement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UnderIssuedSharePurchaseAgreement_lbl" xml:lang="en-US">Shares issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnderIssuedSharePurchaseAgreement" xlink:to="mlec_UnderIssuedSharePurchaseAgreement_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SharePurchaseAgreement" xlink:href="mlec-20230630.xsd#mlec_SharePurchaseAgreement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_SharePurchaseAgreement_lbl" xml:lang="en-US">Share Purchase Agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharePurchaseAgreement" xlink:to="mlec_SharePurchaseAgreement_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OrdinaryShares" xlink:href="mlec-20230630.xsd#mlec_OrdinaryShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OrdinaryShares_lbl" xml:lang="en-US">Ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OrdinaryShares" xlink:to="mlec_OrdinaryShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ConstantValuePercentage" xlink:href="mlec-20230630.xsd#mlec_ConstantValuePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ConstantValuePercentage_lbl" xml:lang="en-US">Constant value percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConstantValuePercentage" xlink:to="mlec_ConstantValuePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OptionsRecognizedAmount" xlink:href="mlec-20230630.xsd#mlec_OptionsRecognizedAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OptionsRecognizedAmount_lbl" xml:lang="en-US">Options recognized amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OptionsRecognizedAmount" xlink:to="mlec_OptionsRecognizedAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AggregateShares" xlink:href="mlec-20230630.xsd#mlec_AggregateShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AggregateShares_lbl" xml:lang="en-US">Aggregate shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AggregateShares" xlink:to="mlec_AggregateShares_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl" xml:lang="en-US">Exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PricePerWarrant" xlink:href="mlec-20230630.xsd#mlec_PricePerWarrant"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PricePerWarrant_lbl" xml:lang="en-US">Price per warrant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PricePerWarrant" xlink:to="mlec_PricePerWarrant_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ExercisePricePerShare" xlink:href="mlec-20230630.xsd#mlec_ExercisePricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ExercisePricePerShare_lbl" xml:lang="en-US">Exercise price per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExercisePricePerShare" xlink:to="mlec_ExercisePricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DividendsPaidOrdinarySharesPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DividendsPaidOrdinarySharesPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DividendsPaidOrdinarySharesPerShare_lbl" xml:lang="en-US">Ordinary shares per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPaidOrdinarySharesPerShare" xlink:to="ifrs-full_DividendsPaidOrdinarySharesPerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NotionalAmount" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotionalAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_NotionalAmount_lbl" xml:lang="en-US">Signed amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotionalAmount" xlink:to="ifrs-full_NotionalAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentReceivablesFromSaleOfProperties" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentReceivablesFromSaleOfProperties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentReceivablesFromSaleOfProperties_lbl" xml:lang="en-US">Amount received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentReceivablesFromSaleOfProperties" xlink:to="ifrs-full_CurrentReceivablesFromSaleOfProperties_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Equity financing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:to="ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ConvertedShares" xlink:href="mlec-20230630.xsd#mlec_ConvertedShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ConvertedShares_lbl" xml:lang="en-US">Converted shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConvertedShares" xlink:to="mlec_ConvertedShares_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PurchasePricePerShare" xlink:href="mlec-20230630.xsd#mlec_PurchasePricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PurchasePricePerShare_lbl" xml:lang="en-US">Purchase price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PurchasePricePerShare" xlink:to="mlec_PurchasePricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PurchasePrice" xlink:href="mlec-20230630.xsd#mlec_PurchasePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PurchasePrice_lbl" xml:lang="en-US">Total purchase price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PurchasePrice" xlink:to="mlec_PurchasePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IncomeTaxRate" xlink:href="mlec-20230630.xsd#mlec_IncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IncomeTaxRate_lbl" xml:lang="en-US">Income tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncomeTaxRate" xlink:to="mlec_IncomeTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxExpenseIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DeferredTaxExpenseIncome_lbl" xml:lang="en-US">Deferred income tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxExpenseIncome" xlink:to="ifrs-full_DeferredTaxExpenseIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentFinancialAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CurrentFinancialAssets_lbl" xml:lang="en-US">Total current financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialAssets" xlink:to="ifrs-full_CurrentFinancialAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfFunctionalCurrency" xlink:href="mlec-20230630.xsd#mlec_PercentageOfFunctionalCurrency"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PercentageOfFunctionalCurrency_lbl" xml:lang="en-US">Percentage of functional currency</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfFunctionalCurrency" xlink:to="mlec_PercentageOfFunctionalCurrency_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxRateEffectOfForeignTaxRates" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TaxRateEffectOfForeignTaxRates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_TaxRateEffectOfForeignTaxRates_lbl" xml:lang="en-US">Percentage of exchange rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxRateEffectOfForeignTaxRates" xlink:to="ifrs-full_TaxRateEffectOfForeignTaxRates_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_PercentageOfInterestRates" xlink:href="mlec-20230630.xsd#mlec_PercentageOfInterestRates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_PercentageOfInterestRates_lbl" xml:lang="en-US">Percentage of interest rates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfInterestRates" xlink:to="mlec_PercentageOfInterestRates_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IncreasedecreaseInterestPayable" xlink:href="mlec-20230630.xsd#mlec_IncreasedecreaseInterestPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_IncreasedecreaseInterestPayable_lbl" xml:lang="en-US">Interest payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncreasedecreaseInterestPayable" xlink:to="mlec_IncreasedecreaseInterestPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_StrikePricePerShare" xlink:href="mlec-20230630.xsd#mlec_StrikePricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_StrikePricePerShare_lbl" xml:lang="en-US">Strike price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_StrikePricePerShare" xlink:to="mlec_StrikePricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_lbl" xml:lang="en-US">Cash payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties" xlink:to="ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NumberOfStockInventories" xlink:href="mlec-20230630.xsd#mlec_NumberOfStockInventories"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NumberOfStockInventories_lbl" xml:lang="en-US">Secures the supply of tons</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfStockInventories" xlink:to="mlec_NumberOfStockInventories_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CashPaidInKindInterest" xlink:href="mlec-20230630.xsd#mlec_CashPaidInKindInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CashPaidInKindInterest_lbl" xml:lang="en-US">Cash and in kind</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CashPaidInKindInterest" xlink:to="mlec_CashPaidInKindInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock" xlink:href="mlec-20230630.xsd#mlec_DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock_lbl" xml:lang="en-US">Basis of consolidation of subsidiary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DescriptionOfAccountingPolicyForForeignCurrencyTextBlock" xlink:href="mlec-20230630.xsd#mlec_DescriptionOfAccountingPolicyForForeignCurrencyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DescriptionOfAccountingPolicyForForeignCurrencyTextBlock_lbl" xml:lang="en-US">Foreign currency</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForForeignCurrencyTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForForeignCurrencyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_lbl" xml:lang="en-US">Intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US">Property, plant and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_lbl" xml:lang="en-US">Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_lbl" xml:lang="en-US">Inventories, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_lbl" xml:lang="en-US">Trade receivables and other receivables</label>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrbCcuxiEw7DaKnp03QCb9S1ssLhKhQhPI9/LGJ51TgzssCI1ODtwCrgkN0a+ZUXnMF8I/KcADyvbmI99H904sqIF1YM5bLcN+DbpeVS5vMyNXq7Gcc0AsRuAtIzhrDpAdkHW0SbRbM9JtED/NKe0AzzApdc0Kim8/GgaIUDBDfI2qGJJ00w0l4cvI/ZAFTbPkBR/+gxaWNDsQ==] CSR-->
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock" xlink:href="mlec-20230630.xsd#mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock_lbl" xml:lang="en-US">Right-of-use of assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock" xlink:href="mlec-20230630.xsd#mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock_lbl" xml:lang="en-US">Share capital and reserves</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_lbl" xml:lang="en-US">Share-based payment arrangements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock" xlink:href="mlec-20230630.xsd#mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock_lbl" xml:lang="en-US">Accounts payable and other liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl" xml:lang="en-US">Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock" xlink:href="mlec-20230630.xsd#mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock_lbl" xml:lang="en-US">Subsidiaries and joint arrangements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_lbl" xml:lang="en-US">Financial instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_lbl" xml:lang="en-US">Financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_lbl" xml:lang="en-US">Financial liabilities and equity instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock" xlink:href="mlec-20230630.xsd#mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock_lbl" xml:lang="en-US">New standards, amendments and interpretations of IFRS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DescriptionOfAccountingPolicyForLossPerShareTextBlock" xlink:href="mlec-20230630.xsd#mlec_DescriptionOfAccountingPolicyForLossPerShareTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_DescriptionOfAccountingPolicyForLossPerShareTextBlock_lbl" xml:lang="en-US">Loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForLossPerShareTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForLossPerShareTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_lbl" xml:lang="en-US">Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory_lbl" xml:lang="en-US">Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_lbl" xml:lang="en-US">Segment reporting</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_lbl" xml:lang="en-US">Business combinations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_lbl" xml:lang="en-US">Critical accounting judgements and estimates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:to="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_MoolecSAFEMember" xlink:href="mlec-20230630.xsd#mlec_MoolecSAFEMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_MoolecSAFEMember_lbl" xml:lang="en-US">Moolec SAFE [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MoolecSAFEMember" xlink:to="mlec_MoolecSAFEMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_UGVLAndTheoMember" xlink:href="mlec-20230630.xsd#mlec_UGVLAndTheoMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_UGVLAndTheoMember_lbl" xml:lang="en-US">UGVL and Theo [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UGVLAndTheoMember" xlink:to="mlec_UGVLAndTheoMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_Group1GrantedMember" xlink:href="mlec-20230630.xsd#mlec_Group1GrantedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_Group1GrantedMember_lbl" xml:lang="en-US">Group 1 Granted [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Group1GrantedMember" xlink:to="mlec_Group1GrantedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_Group2GrantedMember" xlink:href="mlec-20230630.xsd#mlec_Group2GrantedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_Group2GrantedMember_lbl" xml:lang="en-US">Group 2 Granted [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Group2GrantedMember" xlink:to="mlec_Group2GrantedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_Group3GrantedMember" xlink:href="mlec-20230630.xsd#mlec_Group3GrantedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_Group3GrantedMember_lbl" xml:lang="en-US">Group 3 Granted [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Group3GrantedMember" xlink:to="mlec_Group3GrantedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiquidityRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiquidityRiskMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_LiquidityRiskMember_lbl" xml:lang="en-US">Liquidity Risk [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiquidityRiskMember" xlink:to="ifrs-full_LiquidityRiskMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestRateRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestRateRiskMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_InterestRateRiskMember_lbl" xml:lang="en-US">Interest Rate Risk [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestRateRiskMember" xlink:to="ifrs-full_InterestRateRiskMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScenarioForecastMember_lbl" xml:lang="en-US">Forecast [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityMember_lbl" xml:lang="en-US">Equity [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityMember" xlink:to="ifrs-full_EquityMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfChangesInEquityTable_lbl" xml:lang="en-US">Statement of changes in equity [table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_StatementOfChangesInEquityTable_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems_lbl" xml:lang="en-US">Statement of changes in equity [line items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_StatementOfChangesInEquityLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ComparativeInformationTable" xlink:href="mlec-20230630.xsd#mlec_ComparativeInformationTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ComparativeInformationTable_lbl" xml:lang="en-US">Comparative Information [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ComparativeInformationTable" xlink:to="mlec_ComparativeInformationTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ComparativeInformationLineItems" xlink:href="mlec-20230630.xsd#mlec_ComparativeInformationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ComparativeInformationLineItems_lbl" xml:lang="en-US">Comparative Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ComparativeInformationLineItems" xlink:to="mlec_ComparativeInformationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTable" xlink:href="mlec-20230630.xsd#mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTable_lbl" xml:lang="en-US">Accounts Payable and Other Current and Non-Current Liabilities [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTable" xlink:to="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesLineItems" xlink:href="mlec-20230630.xsd#mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesLineItems_lbl" xml:lang="en-US">Accounts Payable and Other Current and Non-Current Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesLineItems" xlink:to="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxandIncomeTaxTable" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeferredTaxandIncomeTaxTable_lbl" xml:lang="en-US">Deferred Tax and Income Tax [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxandIncomeTaxTable" xlink:to="mlec_DeferredTaxandIncomeTaxTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxandIncomeTaxLineItems" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeferredTaxandIncomeTaxLineItems_lbl" xml:lang="en-US">Deferred Tax and Income Tax [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxandIncomeTaxLineItems" xlink:to="mlec_DeferredTaxandIncomeTaxLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherOperatingExpenseTable" xlink:href="mlec-20230630.xsd#mlec_OtherOperatingExpenseTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherOperatingExpenseTable_lbl" xml:lang="en-US">Other Operating Expense [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherOperatingExpenseTable" xlink:to="mlec_OtherOperatingExpenseTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherOperatingExpenseLineItems" xlink:href="mlec-20230630.xsd#mlec_OtherOperatingExpenseLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherOperatingExpenseLineItems_lbl" xml:lang="en-US">Other Operating Expense [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherOperatingExpenseLineItems" xlink:to="mlec_OtherOperatingExpenseLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ResearchandDevelopmentExpenseTable" xlink:href="mlec-20230630.xsd#mlec_ResearchandDevelopmentExpenseTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ResearchandDevelopmentExpenseTable_lbl" xml:lang="en-US">Research and Development Expense [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ResearchandDevelopmentExpenseTable" xlink:to="mlec_ResearchandDevelopmentExpenseTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ResearchandDevelopmentExpenseLineItems" xlink:href="mlec-20230630.xsd#mlec_ResearchandDevelopmentExpenseLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ResearchandDevelopmentExpenseLineItems_lbl" xml:lang="en-US">Research and Development Expense [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ResearchandDevelopmentExpenseLineItems" xlink:to="mlec_ResearchandDevelopmentExpenseLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NetLossperShareTable" xlink:href="mlec-20230630.xsd#mlec_NetLossperShareTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NetLossperShareTable_lbl" xml:lang="en-US">Net Loss per Share [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetLossperShareTable" xlink:to="mlec_NetLossperShareTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NetLossperShareLineItems" xlink:href="mlec-20230630.xsd#mlec_NetLossperShareLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NetLossperShareLineItems_lbl" xml:lang="en-US">Net Loss per Share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetLossperShareLineItems" xlink:to="mlec_NetLossperShareLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesTable" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RelatedPartiesTable_lbl" xml:lang="en-US">Related Parties [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RelatedPartiesTable" xlink:to="mlec_RelatedPartiesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesLineItems" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RelatedPartiesLineItems_lbl" xml:lang="en-US">Related Parties [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RelatedPartiesLineItems" xlink:to="mlec_RelatedPartiesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_EventsaftertheReportingPeriodTable" xlink:href="mlec-20230630.xsd#mlec_EventsaftertheReportingPeriodTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_EventsaftertheReportingPeriodTable_lbl" xml:lang="en-US">Events after the Reporting Period [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EventsaftertheReportingPeriodTable" xlink:to="mlec_EventsaftertheReportingPeriodTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_EventsaftertheReportingPeriodLineItems" xlink:href="mlec-20230630.xsd#mlec_EventsaftertheReportingPeriodLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_EventsaftertheReportingPeriodLineItems_lbl" xml:lang="en-US">Events after the Reporting Period [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EventsaftertheReportingPeriodLineItems" xlink:to="mlec_EventsaftertheReportingPeriodLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CashandCashEquivalentsTablesTable" xlink:href="mlec-20230630.xsd#mlec_CashandCashEquivalentsTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CashandCashEquivalentsTablesTable_lbl" xml:lang="en-US">Cash and Cash Equivalents (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CashandCashEquivalentsTablesTable" xlink:to="mlec_CashandCashEquivalentsTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CashandCashEquivalentsTablesLineItems" xlink:href="mlec-20230630.xsd#mlec_CashandCashEquivalentsTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_CashandCashEquivalentsTablesLineItems_lbl" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CashandCashEquivalentsTablesLineItems" xlink:to="mlec_CashandCashEquivalentsTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesTable" xlink:href="mlec-20230630.xsd#mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesTable_lbl" xml:lang="en-US">Accounts Payable and Other Current and Non-Current Liabilities (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesTable" xlink:to="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesLineItems" xlink:href="mlec-20230630.xsd#mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesLineItems_lbl" xml:lang="en-US">Accounts Payable and Other Current and Non-Current Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesLineItems" xlink:to="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherOperatingExpenseTablesTable" xlink:href="mlec-20230630.xsd#mlec_OtherOperatingExpenseTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherOperatingExpenseTablesTable_lbl" xml:lang="en-US">Other Operating Expense (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherOperatingExpenseTablesTable" xlink:to="mlec_OtherOperatingExpenseTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherOperatingExpenseTablesLineItems" xlink:href="mlec-20230630.xsd#mlec_OtherOperatingExpenseTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_OtherOperatingExpenseTablesLineItems_lbl" xml:lang="en-US">Other Operating Expense [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherOperatingExpenseTablesLineItems" xlink:to="mlec_OtherOperatingExpenseTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ResearchandDevelopmentExpenseTablesTable" xlink:href="mlec-20230630.xsd#mlec_ResearchandDevelopmentExpenseTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ResearchandDevelopmentExpenseTablesTable_lbl" xml:lang="en-US">Research and Development Expense (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ResearchandDevelopmentExpenseTablesTable" xlink:to="mlec_ResearchandDevelopmentExpenseTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ResearchandDevelopmentExpenseTablesLineItems" xlink:href="mlec-20230630.xsd#mlec_ResearchandDevelopmentExpenseTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_ResearchandDevelopmentExpenseTablesLineItems_lbl" xml:lang="en-US">Research and Development Expense [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ResearchandDevelopmentExpenseTablesLineItems" xlink:to="mlec_ResearchandDevelopmentExpenseTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NetLossperShareTablesTable" xlink:href="mlec-20230630.xsd#mlec_NetLossperShareTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NetLossperShareTablesTable_lbl" xml:lang="en-US">Net Loss per Share (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetLossperShareTablesTable" xlink:to="mlec_NetLossperShareTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NetLossperShareTablesLineItems" xlink:href="mlec-20230630.xsd#mlec_NetLossperShareTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NetLossperShareTablesLineItems_lbl" xml:lang="en-US">Net Loss per Share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetLossperShareTablesLineItems" xlink:to="mlec_NetLossperShareTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesTablesTable" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RelatedPartiesTablesTable_lbl" xml:lang="en-US">Related Parties (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RelatedPartiesTablesTable" xlink:to="mlec_RelatedPartiesTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesTablesLineItems" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_RelatedPartiesTablesLineItems_lbl" xml:lang="en-US">Related Parties [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RelatedPartiesTablesLineItems" xlink:to="mlec_RelatedPartiesTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AggregatedMeasurementMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedMeasurementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AggregatedMeasurementMember_lbl" xml:lang="en-US">Aggregated measurement [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AggregatedMeasurementMember" xlink:to="ifrs-full_AggregatedMeasurementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedBalanceSheetStatementTable" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedBalanceSheetStatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedBalanceSheetStatementTable_lbl" xml:lang="en-US">Condensed Balance Sheet Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedBalanceSheetStatementTable" xlink:to="srt_CondensedBalanceSheetStatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedBalanceSheetStatementsCaptionsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedBalanceSheetStatementsCaptionsLineItems_lbl" xml:lang="en-US">Condensed Balance Sheet Statements, Captions [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="srt_CondensedBalanceSheetStatementsCaptionsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember_lbl" xml:lang="en-US">Property, plant and equipment [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentMember" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangesMember_lbl" xml:lang="en-US">Ranges [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangesMember" xlink:to="ifrs-full_RangesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentTable" xlink:href="mlec-20230630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentTable_lbl" xml:lang="en-US">Summary of Significant Accounting Policies (Details) - Schedule of Useful Lives of Property, Plant and Equipment [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentTable" xlink:to="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems" xlink:href="mlec-20230630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems_lbl" xml:lang="en-US">Summary of Significant Accounting Policies (Details) - Schedule of Useful Lives of Property, Plant and Equipment [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems" xlink:to="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember_lbl" xml:lang="en-US">Entity&apos;s total for related parties [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsTable" xlink:href="mlec-20230630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsTable_lbl" xml:lang="en-US">Summary of Significant Accounting Policies (Details) - Schedule of Consolidated Financial Statements [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsTable" xlink:to="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems" xlink:href="mlec-20230630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems_lbl" xml:lang="en-US">Summary of Significant Accounting Policies (Details) - Schedule of Consolidated Financial Statements [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems" xlink:to="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssetsMember_lbl" xml:lang="en-US">Financial assets, class [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsMember" xlink:to="ifrs-full_FinancialAssetsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable" xlink:href="mlec-20230630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable_lbl" xml:lang="en-US">Summary of Significant Accounting Policies (Details) - Schedule of Non-Current Assets Other than Financial Instruments [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable" xlink:to="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsLineItems" xlink:href="mlec-20230630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsLineItems_lbl" xml:lang="en-US">Summary of Significant Accounting Policies (Details) - Schedule of Non-Current Assets Other than Financial Instruments [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsLineItems" xlink:to="mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsAndGoodwillMember_lbl" xml:lang="en-US">Intangible assets and goodwill [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:to="ifrs-full_IntangibleAssetsAndGoodwillMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsTable" xlink:href="mlec-20230630.xsd#mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsTable_lbl" xml:lang="en-US">Intangible Assets (Details) - Schedule of Intangible Assets [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsTable" xlink:to="mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems" xlink:href="mlec-20230630.xsd#mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems_lbl" xml:lang="en-US">Intangible Assets (Details) - Schedule of Intangible Assets [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems" xlink:to="mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CarryingAmountMember_lbl" xml:lang="en-US">Carrying amount [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CarryingAmountMember" xlink:to="ifrs-full_CarryingAmountMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FixedAssetsDetailsScheduleofFixedAssetsTable" xlink:href="mlec-20230630.xsd#mlec_FixedAssetsDetailsScheduleofFixedAssetsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FixedAssetsDetailsScheduleofFixedAssetsTable_lbl" xml:lang="en-US">Fixed Assets (Details) - Schedule of Fixed Assets [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FixedAssetsDetailsScheduleofFixedAssetsTable" xlink:to="mlec_FixedAssetsDetailsScheduleofFixedAssetsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems" xlink:href="mlec-20230630.xsd#mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems_lbl" xml:lang="en-US">Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems" xlink:to="mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsTable" xlink:href="mlec-20230630.xsd#mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsTable_lbl" xml:lang="en-US">Cash and Cash Equivalents (Details) - Schedule of Cash and Cash Equivalents [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsTable" xlink:to="mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems" xlink:href="mlec-20230630.xsd#mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems_lbl" xml:lang="en-US">Schedule of cash and cash equivalents [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems" xlink:to="mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfShareCapitalMember_lbl0" xml:lang="en-US">Share capital [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfShareCapitalMember" xlink:to="ifrs-full_ClassesOfShareCapitalMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumTable" xlink:href="mlec-20230630.xsd#mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumTable_lbl" xml:lang="en-US">Share Capital and Share Premium (Details) - Schedule of Reconciliation of Share Capital and Share Premium [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumTable" xlink:to="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:href="mlec-20230630.xsd#mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems_lbl" xml:lang="en-US">Share Capital and Share Premium (Details) - Schedule of Reconciliation of Share Capital and Share Premium [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DefaultFinancialStatementsDateMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefaultFinancialStatementsDateMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DefaultFinancialStatementsDateMember_lbl" xml:lang="en-US">Default financial statements date [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DefaultFinancialStatementsDateMember" xlink:to="ifrs-full_DefaultFinancialStatementsDateMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable_lbl" xml:lang="en-US">Share Based Payment (Details) - Schedule and the Possible Dilutive Effect of the Future Exercise of Options [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable" xlink:to="mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems_lbl" xml:lang="en-US">Share Based Payment (Details) - Schedule and the Possible Dilutive Effect of the Future Exercise of Options [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems" xlink:to="mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable_lbl" xml:lang="en-US">Share Based Payment (Details) - Schedule of Amount and Exercise Price and the Movements of the Stock Options of Executives and Managers [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable" xlink:to="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems_lbl" xml:lang="en-US">Share Based Payment (Details) - Schedule of Amount and Exercise Price and the Movements of the Stock Options of Executives and Managers [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CounterpartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CounterpartiesMember_lbl" xml:lang="en-US">Counterparties [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CounterpartiesMember" xlink:to="ifrs-full_CounterpartiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialDebtDetailsScheduleofFinancialDebtTable" xlink:href="mlec-20230630.xsd#mlec_FinancialDebtDetailsScheduleofFinancialDebtTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialDebtDetailsScheduleofFinancialDebtTable_lbl" xml:lang="en-US">Financial Debt (Details) - Schedule of Financial Debt [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialDebtDetailsScheduleofFinancialDebtTable" xlink:to="mlec_FinancialDebtDetailsScheduleofFinancialDebtTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialDebtDetailsScheduleofFinancialDebtLineItems" xlink:href="mlec-20230630.xsd#mlec_FinancialDebtDetailsScheduleofFinancialDebtLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialDebtDetailsScheduleofFinancialDebtLineItems_lbl" xml:lang="en-US">Financial Debt (Details) - Schedule of Financial Debt [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialDebtDetailsScheduleofFinancialDebtLineItems" xlink:to="mlec_FinancialDebtDetailsScheduleofFinancialDebtLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable" xlink:href="mlec-20230630.xsd#mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable_lbl" xml:lang="en-US">Financial Debt (Details) - Schedule of Book Value is Reasonably Approximate to the Fair Value given its Short-Term Nature [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable" xlink:to="mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureLineItems" xlink:href="mlec-20230630.xsd#mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureLineItems_lbl" xml:lang="en-US">Financial Debt (Details) - Schedule of Book Value is Reasonably Approximate to the Fair Value given its Short-Term Nature [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureLineItems" xlink:to="mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsByNameMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsByNameMember_lbl" xml:lang="en-US">Borrowings by name [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsByNameMember" xlink:to="ifrs-full_BorrowingsByNameMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansTable" xlink:href="mlec-20230630.xsd#mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansTable_lbl" xml:lang="en-US">Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansTable" xlink:to="mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems" xlink:href="mlec-20230630.xsd#mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems_lbl" xml:lang="en-US">Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems" xlink:to="mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsTable" xlink:href="mlec-20230630.xsd#mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsTable_lbl" xml:lang="en-US">Warrants Liabilities (Details) - Schedule of Fair Value Ordinary Share of Warrants [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsTable" xlink:to="mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsLineItems" xlink:href="mlec-20230630.xsd#mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsLineItems_lbl" xml:lang="en-US">Warrants Liabilities (Details) - Schedule of Fair Value Ordinary Share of Warrants [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsLineItems" xlink:to="mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GeographicalAreasMember_lbl" xml:lang="en-US">Geographical areas [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeographicalAreasMember" xlink:to="ifrs-full_GeographicalAreasMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable_lbl" xml:lang="en-US">Deferred Tax and Income Tax (Details) - Schedule of Principal Statutory Taxes Rates in the Countries [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable" xlink:to="mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesLineItems" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesLineItems_lbl" xml:lang="en-US">Deferred Tax and Income Tax (Details) - Schedule of Principal Statutory Taxes Rates in the Countries [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesLineItems" xlink:to="mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesTable" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesTable_lbl" xml:lang="en-US">Deferred Tax and Income Tax (Details) - Schedule of Net Deferred Tax Liabilities [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesTable" xlink:to="mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesLineItems" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesLineItems_lbl" xml:lang="en-US">Deferred Tax and Income Tax (Details) - Schedule of Net Deferred Tax Liabilities [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesLineItems" xlink:to="mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsTable" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsTable_lbl" xml:lang="en-US">Deferred Tax and Income Tax (Details) - Schedule of Accumulated Tax Loss Carryforwards [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsTable" xlink:to="mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems_lbl" xml:lang="en-US">Deferred Tax and Income Tax (Details) - Schedule of Accumulated Tax Loss Carryforwards [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems" xlink:to="mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitTable" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitTable_lbl" xml:lang="en-US">Deferred Tax and Income Tax (Details) - Schedule of Estimated Future Taxable Profit. [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitTable" xlink:to="mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems_lbl" xml:lang="en-US">Deferred Tax and Income Tax (Details) - Schedule of Estimated Future Taxable Profit. [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems" xlink:to="mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseTable" xlink:href="mlec-20230630.xsd#mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseTable_lbl" xml:lang="en-US">Research and Development Expense (Details) - Schedule of Research and Development Expense [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseTable" xlink:to="mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems" xlink:href="mlec-20230630.xsd#mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems_lbl" xml:lang="en-US">Schedule of Research and Development Expense [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems" xlink:to="mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CostofsalesDetailsScheduleofCostofsalesTable" xlink:href="mlec-20230630.xsd#mlec_CostofsalesDetailsScheduleofCostofsalesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CostofsalesDetailsScheduleofCostofsalesTable_lbl" xml:lang="en-US">Cost of sales (Details) - Schedule of Cost of sales [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CostofsalesDetailsScheduleofCostofsalesTable" xlink:to="mlec_CostofsalesDetailsScheduleofCostofsalesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_CostofsalesDetailsScheduleofCostofsalesLineItems" xlink:href="mlec-20230630.xsd#mlec_CostofsalesDetailsScheduleofCostofsalesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CostofsalesDetailsScheduleofCostofsalesLineItems_lbl" xml:lang="en-US">Schedule of Cost Sales [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CostofsalesDetailsScheduleofCostofsalesLineItems" xlink:to="mlec_CostofsalesDetailsScheduleofCostofsalesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NetLossperShareDetailsScheduleofNetLossPerShareTable" xlink:href="mlec-20230630.xsd#mlec_NetLossperShareDetailsScheduleofNetLossPerShareTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NetLossperShareDetailsScheduleofNetLossPerShareTable_lbl" xml:lang="en-US">Net Loss per Share (Details) - Schedule of Net Loss Per Share [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetLossperShareDetailsScheduleofNetLossPerShareTable" xlink:to="mlec_NetLossperShareDetailsScheduleofNetLossPerShareTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NetLossperShareDetailsScheduleofNetLossPerShareLineItems" xlink:href="mlec-20230630.xsd#mlec_NetLossperShareDetailsScheduleofNetLossPerShareLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NetLossperShareDetailsScheduleofNetLossPerShareLineItems_lbl" xml:lang="en-US">Schedule of net loss per share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetLossperShareDetailsScheduleofNetLossPerShareLineItems" xlink:to="mlec_NetLossperShareDetailsScheduleofNetLossPerShareLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsTable" xlink:href="mlec-20230630.xsd#mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsTable_lbl" xml:lang="en-US">Net Loss per Share (Details) - Schedule of Net Loss Per Share (Parentheticals) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsTable" xlink:to="mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsLineItems" xlink:href="mlec-20230630.xsd#mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsLineItems_lbl" xml:lang="en-US">Schedule of net loss per share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsLineItems" xlink:to="mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsTable" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsTable_lbl" xml:lang="en-US">Related Parties (Details) - Schedule of Other Related Party Transactions [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsTable" xlink:to="mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsLineItems" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsLineItems_lbl" xml:lang="en-US">Schedule of other related party transactions [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsLineItems" xlink:to="mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentTable" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentTable_lbl" xml:lang="en-US">Related Parties (Details) - Schedule of Share Based Payment [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentTable" xlink:to="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentLineItems" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentLineItems_lbl" xml:lang="en-US">Related Parties (Details) - Schedule of Share Based Payment [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentLineItems" xlink:to="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsTable" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsTable_lbl" xml:lang="en-US">Related Parties (Details) - Schedule of Share Based Payment (Parentheticals) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsTable" xlink:to="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsLineItems" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsLineItems_lbl" xml:lang="en-US">Related Parties (Details) - Schedule of Share Based Payment (Parentheticals) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsLineItems" xlink:to="mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesTable" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesTable_lbl" xml:lang="en-US">Related Parties (Details) - Schedule of other related party balances [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesTable" xlink:to="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesLineItems" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesLineItems_lbl" xml:lang="en-US">Related Parties (Details) - Schedule of other related party balances [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesLineItems" xlink:to="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsTable" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsTable_lbl" xml:lang="en-US">Related Parties (Details) - Schedule of other related party balances (Parentheticals) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsTable" xlink:to="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsLineItems" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsLineItems_lbl" xml:lang="en-US">Related Parties (Details) - Schedule of other related party balances (Parentheticals) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsLineItems" xlink:to="mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AggregatedTimeBandsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AggregatedTimeBandsMember_lbl" xml:lang="en-US">Aggregated time bands [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AggregatedTimeBandsMember" xlink:to="ifrs-full_AggregatedTimeBandsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesTable" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesTable_lbl" xml:lang="en-US">Financial Risk Management (Details) - Schedule of Trade and Other Receivables [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesTable" xlink:to="mlec_FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesLineItems" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesLineItems_lbl" xml:lang="en-US">Financial Risk Management (Details) - Schedule of Trade and Other Receivables [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesLineItems" xlink:to="mlec_FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateTable" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateTable_lbl" xml:lang="en-US">Financial Risk Management (Details) - Schedule of Contractual Maturity Date [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateTable" xlink:to="mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems_lbl" xml:lang="en-US">Financial Risk Management (Details) - Schedule of Contractual Maturity Date [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems" xlink:to="mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfRisksMember_lbl" xml:lang="en-US">Risks [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfRisksMember" xlink:to="ifrs-full_TypesOfRisksMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskTable" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskTable_lbl" xml:lang="en-US">Financial Risk Management (Details) - Schedule of Foreign Currency Exchange Risk [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskTable" xlink:to="mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems_lbl" xml:lang="en-US">Financial Risk Management (Details) - Schedule of Foreign Currency Exchange Risk [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems" xlink:to="mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsTable" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsTable_lbl" xml:lang="en-US">Financial Risk Management (Details) - Schedule of Fair Value and Carrying Value of Financial Instruments [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsTable" xlink:to="mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems_lbl" xml:lang="en-US">Financial Risk Management (Details) - Schedule of Fair Value and Carrying Value of Financial Instruments [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems" xlink:to="mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_GeneralInformationDetailsTable" xlink:href="mlec-20230630.xsd#mlec_GeneralInformationDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_GeneralInformationDetailsTable_lbl" xml:lang="en-US">General Information (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GeneralInformationDetailsTable" xlink:to="mlec_GeneralInformationDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_GeneralInformationDetailsLineItems" xlink:href="mlec-20230630.xsd#mlec_GeneralInformationDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_GeneralInformationDetailsLineItems_lbl" xml:lang="en-US">General Information (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GeneralInformationDetailsLineItems" xlink:to="mlec_GeneralInformationDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:href="mlec-20230630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsTable_lbl" xml:lang="en-US">Summary of Significant Accounting Policies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="mlec_SummaryofSignificantAccountingPoliciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:href="mlec-20230630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SummaryofSignificantAccountingPoliciesDetailsLineItems_lbl" xml:lang="en-US">Summary of Significant Accounting Policies (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="mlec_SummaryofSignificantAccountingPoliciesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherNonCurrentReceivablesDetailsTable" xlink:href="mlec-20230630.xsd#mlec_OtherNonCurrentReceivablesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherNonCurrentReceivablesDetailsTable_lbl" xml:lang="en-US">Other Non-Current Receivables (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherNonCurrentReceivablesDetailsTable" xlink:to="mlec_OtherNonCurrentReceivablesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_OtherNonCurrentReceivablesDetailsLineItems" xlink:href="mlec-20230630.xsd#mlec_OtherNonCurrentReceivablesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherNonCurrentReceivablesDetailsLineItems_lbl" xml:lang="en-US">Other Non-Current Receivables (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherNonCurrentReceivablesDetailsLineItems" xlink:to="mlec_OtherNonCurrentReceivablesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember_lbl" xml:lang="en-US">Share-based payment arrangements [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharebasedPaymentArrangementsMember" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentDetailsTable" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareBasedPaymentDetailsTable_lbl" xml:lang="en-US">Share Based Payment (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentDetailsTable" xlink:to="mlec_ShareBasedPaymentDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_ShareBasedPaymentDetailsLineItems" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareBasedPaymentDetailsLineItems_lbl" xml:lang="en-US">Share Based Payment (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentDetailsLineItems" xlink:to="mlec_ShareBasedPaymentDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsTable" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsTable_lbl" xml:lang="en-US">Deferred Tax and Income Tax (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsTable" xlink:to="mlec_DeferredTaxandIncomeTaxDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsLineItems" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeferredTaxandIncomeTaxDetailsLineItems_lbl" xml:lang="en-US">Deferred Tax and Income Tax (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxandIncomeTaxDetailsLineItems" xlink:to="mlec_DeferredTaxandIncomeTaxDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialRiskManagementDetailsTable" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialRiskManagementDetailsTable_lbl" xml:lang="en-US">Financial Risk Management (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialRiskManagementDetailsTable" xlink:to="mlec_FinancialRiskManagementDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_FinancialRiskManagementDetailsLineItems" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialRiskManagementDetailsLineItems_lbl" xml:lang="en-US">Financial Risk Management (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialRiskManagementDetailsLineItems" xlink:to="mlec_FinancialRiskManagementDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US">Scenario [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_EventsaftertheReportingPeriodDetailsTable" xlink:href="mlec-20230630.xsd#mlec_EventsaftertheReportingPeriodDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_EventsaftertheReportingPeriodDetailsTable_lbl" xml:lang="en-US">Events after the Reporting Period (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EventsaftertheReportingPeriodDetailsTable" xlink:to="mlec_EventsaftertheReportingPeriodDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="mlec_EventsaftertheReportingPeriodDetailsLineItems" xlink:href="mlec-20230630.xsd#mlec_EventsaftertheReportingPeriodDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_EventsaftertheReportingPeriodDetailsLineItems_lbl" xml:lang="en-US">Events after the Reporting Period (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EventsaftertheReportingPeriodDetailsLineItems" xlink:to="mlec_EventsaftertheReportingPeriodDetailsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_Accumulated_lbl0" xml:lang="en-US">Accumulated.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Accumulated" xlink:to="mlec_Accumulated_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AcquisitionOfBusinessCombinationTroughDeferredPayment_lbl0" xml:lang="en-US">Amount of acquisition of business combination trough deferred payment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AcquisitionOfBusinessCombinationTroughDeferredPayment" xlink:to="mlec_AcquisitionOfBusinessCombinationTroughDeferredPayment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind_lbl0" xml:lang="en-US">Amount of acquisition of business combination trough deferred payment in kind.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind" xlink:to="mlec_AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares_lbl0" xml:lang="en-US">Amount of acquisition of non-current assets by the issuance of ordinary shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares" xlink:to="mlec_AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AcquisitionsThroughBusinessCombinationsi_lbl0" xml:lang="en-US">Acquisitions through business combinations.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AcquisitionsThroughBusinessCombinationsi" xlink:to="mlec_AcquisitionsThroughBusinessCombinationsi_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AggregatePurchasePrice_lbl0" xml:lang="en-US">Aggregate purchase price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AggregatePurchasePrice" xlink:to="mlec_AggregatePurchasePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AggregateShares_lbl0" xml:lang="en-US">Aggregate shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AggregateShares" xlink:to="mlec_AggregateShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_Amortization_lbl0" xml:lang="en-US">Amortization.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Amortization" xlink:to="mlec_Amortization_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_AmortizationExpense_lbl0" xml:lang="en-US">Amortization expense.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AmortizationExpense" xlink:to="mlec_AmortizationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ArgentinePriceIndexes_lbl0" xml:lang="en-US">Argentine price indexes.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ArgentinePriceIndexes" xlink:to="mlec_ArgentinePriceIndexes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_BorrowingOriginalCurrency_lbl0" xml:lang="en-US">Currency of denomination.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BorrowingOriginalCurrency" xlink:to="mlec_BorrowingOriginalCurrency_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_BusinessCombination_lbl0" xml:lang="en-US">Amount of business combination consideration.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BusinessCombination" xlink:to="mlec_BusinessCombination_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_CFOSharesAlloted_lbl0" xml:lang="en-US">CFO Shares Alloted.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CFOSharesAlloted" xlink:to="mlec_CFOSharesAlloted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_CapitalizationOfTransactionExpensesThroughAccountsPayable_lbl0" xml:lang="en-US">Capitalization of transaction expenses through accounts payable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CapitalizationOfTransactionExpensesThroughAccountsPayable" xlink:to="mlec_CapitalizationOfTransactionExpensesThroughAccountsPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_CashPaid_lbl0" xml:lang="en-US">The amount of cash paid.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CashPaid" xlink:to="mlec_CashPaid_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_CashPaidInKindInterest_lbl0" xml:lang="en-US">Represent the amount of cash paid in kind interest.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CashPaidInKindInterest" xlink:to="mlec_CashPaidInKindInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_CashPayment_lbl0" xml:lang="en-US">The amount of cash payment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CashPayment" xlink:to="mlec_CashPayment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ChangeInWarrants_lbl0" xml:lang="en-US">Amount of change in warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChangeInWarrants" xlink:to="mlec_ChangeInWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ChargedToOtherComprehensiveIncome_lbl0" xml:lang="en-US">Charged to Other Comprehensive Income.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChargedToOtherComprehensiveIncome" xlink:to="mlec_ChargedToOtherComprehensiveIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ConsiderationPaid_lbl0" xml:lang="en-US">The amount of consideration paid in respect of both obtaining and losing control of subsidiaries or other businesses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsiderationPaid" xlink:to="mlec_ConsiderationPaid_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ConstantValuePercentage_lbl0" xml:lang="en-US">Percentage of constant value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConstantValuePercentage" xlink:to="mlec_ConstantValuePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ConvertedShares_lbl0" xml:lang="en-US">Number of converted shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConvertedShares" xlink:to="mlec_ConvertedShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_Cost_lbl0" xml:lang="en-US">Cost.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Cost" xlink:to="mlec_Cost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_CumulativeInflationRate_lbl0" xml:lang="en-US">Cumulative inflation rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CumulativeInflationRate" xlink:to="mlec_CumulativeInflationRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_CustomerRelationship_lbl0" xml:lang="en-US">Customer relationship.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CustomerRelationship" xlink:to="mlec_CustomerRelationship_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DeferredPaymentAfter6Months_lbl0" xml:lang="en-US">The amount of deferred payment after 6 months.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredPaymentAfter6Months" xlink:to="mlec_DeferredPaymentAfter6Months_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DeferredPaymentRelatedToBusinessCombination_lbl0" xml:lang="en-US">The amount of deferred payments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredPaymentRelatedToBusinessCombination" xlink:to="mlec_DeferredPaymentRelatedToBusinessCombination_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DeferredTaxAssetsGrossAmount_lbl0" xml:lang="en-US">Deferred tax assets, gross amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxAssetsGrossAmount" xlink:to="mlec_DeferredTaxAssetsGrossAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss_lbl0" xml:lang="en-US">Deferred tax expense income recognized in profit or loss.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss" xlink:to="mlec_DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock_lbl0" xml:lang="en-US">The description of accounting policy for accounts payable and other liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock_lbl0" xml:lang="en-US">The description of accounting policy for basis of consolidation of subsidiary.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DescriptionOfAccountingPolicyForForeignCurrencyTextBlock_lbl0" xml:lang="en-US">The description of accounting policy for foreign currency.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForForeignCurrencyTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForForeignCurrencyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DescriptionOfAccountingPolicyForLossPerShareTextBlock_lbl0" xml:lang="en-US">The description of accounting policy for loss per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForLossPerShareTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForLossPerShareTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock_lbl0" xml:lang="en-US">The description of accounting policy for new standards, amendments and interpretations of IFRS.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock_lbl0" xml:lang="en-US">The description of accounting policy for right-of-use of assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock_lbl0" xml:lang="en-US">The description of accounting policy for share capital and reserves.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock_lbl0" xml:lang="en-US">The description of accounting policy for subsidiaries and joint arrangements.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosureOfCapitalRiskManagementTextBlock_lbl0" xml:lang="en-US">The entire disclosure of capital risk management.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfCapitalRiskManagementTextBlock" xlink:to="mlec_DisclosureOfCapitalRiskManagementTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosureOfFixedRateInstruments_lbl0" xml:lang="en-US">The disclosure of fixed rate instruments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfFixedRateInstruments" xlink:to="mlec_DisclosureOfFixedRateInstruments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock_lbl0" xml:lang="en-US">The tabular disclosure of general and administrative expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock" xlink:to="mlec_DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosureOfInventoriesTableTextBlock_lbl0" xml:lang="en-US">The table disclosue of inventories.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfInventoriesTableTextBlock" xlink:to="mlec_DisclosureOfInventoriesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosureOfShortTermInvestmentsTableTextBlock_lbl0" xml:lang="en-US">The disclosure of Short-Term Investments Table Text Block.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfShortTermInvestmentsTableTextBlock" xlink:to="mlec_DisclosureOfShortTermInvestmentsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_DisclosureOfStatutoryTaxesInCountriesTableTextBlock_lbl0" xml:lang="en-US">Disclosure of statutory taxes in countries.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfStatutoryTaxesInCountriesTableTextBlock" xlink:to="mlec_DisclosureOfStatutoryTaxesInCountriesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_EffectOfChangesInForeignExchangeRates_lbl0" xml:lang="en-US">Effect of changes in foreign exchange rates.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EffectOfChangesInForeignExchangeRates" xlink:to="mlec_EffectOfChangesInForeignExchangeRates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_EquitySettledShareBasedPayment_lbl0" xml:lang="en-US">The amount of equity settled share based payment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EquitySettledShareBasedPayment" xlink:to="mlec_EquitySettledShareBasedPayment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_EquitySettledShareBasedPayments_lbl0" xml:lang="en-US">Equity settled share based payment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EquitySettledShareBasedPayments" xlink:to="mlec_EquitySettledShareBasedPayments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_Equivalent_lbl0" xml:lang="en-US">The Amount Equivalent.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Equivalent" xlink:to="mlec_Equivalent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ExchangeRateDifference_lbl0" xml:lang="en-US">Amount of exchange rate difference.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExchangeRateDifference" xlink:to="mlec_ExchangeRateDifference_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ExercisePrice_lbl0" xml:lang="en-US">Exercise price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExercisePrice" xlink:to="mlec_ExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ExercisePriceAtTheBeginning_lbl0" xml:lang="en-US">Exercise price per share balance at beginning.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExercisePriceAtTheBeginning" xlink:to="mlec_ExercisePriceAtTheBeginning_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ExercisePriceAtTheEnding_lbl0" xml:lang="en-US">Exercise price per share balance at the ending.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExercisePriceAtTheEnding" xlink:to="mlec_ExercisePriceAtTheEnding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ExercisePriceExercisedDuringThePeriod_lbl0" xml:lang="en-US">Exercise price, exercised during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExercisePriceExercisedDuringThePeriod" xlink:to="mlec_ExercisePriceExercisedDuringThePeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ExercisePriceExpiredDuringThePeriod_lbl0" xml:lang="en-US">Exercise price, expired during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExercisePriceExpiredDuringThePeriod" xlink:to="mlec_ExercisePriceExpiredDuringThePeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ExercisePriceForfeitedDuringThePeriod_lbl0" xml:lang="en-US">Exercise price, forfeited during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExercisePriceForfeitedDuringThePeriod" xlink:to="mlec_ExercisePriceForfeitedDuringThePeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ExercisePriceGrantedDuringThePeriod_lbl0" xml:lang="en-US">Exercise price, granted during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExercisePriceGrantedDuringThePeriod" xlink:to="mlec_ExercisePriceGrantedDuringThePeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ExercisePricePerShare_lbl0" xml:lang="en-US">Exercise price per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExercisePricePerShare" xlink:to="mlec_ExercisePricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ExpensesPaid_lbl0" xml:lang="en-US">Expenses paid.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExpensesPaid" xlink:to="mlec_ExpensesPaid_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ExperienceDate_lbl0" xml:lang="en-US">Experience date.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExperienceDate" xlink:to="mlec_ExperienceDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_FairValueAdjustmentOfWarrant_lbl0" xml:lang="en-US">Amount of expense (income) related to adjustment to fair value of warrant liability.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FairValueAdjustmentOfWarrant" xlink:to="mlec_FairValueAdjustmentOfWarrant_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_FairValueOfSharesinShares_lbl0" xml:lang="en-US">Fair value of shares price per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FairValueOfSharesinShares" xlink:to="mlec_FairValueOfSharesinShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_FairValueOfStockOptionsAtMeasurementDate_lbl0" xml:lang="en-US">Fair value of stock options at measurement date.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FairValueOfStockOptionsAtMeasurementDate" xlink:to="mlec_FairValueOfStockOptionsAtMeasurementDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_FinancialDebts_lbl0" xml:lang="en-US">Amount of financial debt.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialDebts" xlink:to="mlec_FinancialDebts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_FixedAssets_lbl0" xml:lang="en-US">Fixed Assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FixedAssets" xlink:to="mlec_FixedAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ForeignCurrencyExchangeRiskAssets_lbl0" xml:lang="en-US">Foreign currency exchange risk assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ForeignCurrencyExchangeRiskAssets" xlink:to="mlec_ForeignCurrencyExchangeRiskAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ForeignCurrencyExchangeRiskLiabilities_lbl0" xml:lang="en-US">Foreign currency exchange risk liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ForeignCurrencyExchangeRiskLiabilities" xlink:to="mlec_ForeignCurrencyExchangeRiskLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_IncomeTaxRate_lbl0" xml:lang="en-US">Income tax rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncomeTaxRate" xlink:to="mlec_IncomeTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_IncorporatedThroughTheBusinessCombination_lbl0" xml:lang="en-US">IncorporatedThroughTheBusinessCombination.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncorporatedThroughTheBusinessCombination" xlink:to="mlec_IncorporatedThroughTheBusinessCombination_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_IncreasedecreaseInterestPayable_lbl0" xml:lang="en-US">Amount of increase/(decrease) interest payable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncreasedecreaseInterestPayable" xlink:to="mlec_IncreasedecreaseInterestPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_InflationAccumulated_lbl0" xml:lang="en-US">Inflation accumulated.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InflationAccumulated" xlink:to="mlec_InflationAccumulated_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_InflationAdjustment_lbl0" xml:lang="en-US">Amount of inflation adjustment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InflationAdjustment" xlink:to="mlec_InflationAdjustment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_InterestExpenses_lbl0" xml:lang="en-US">Interest expense.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InterestExpenses" xlink:to="mlec_InterestExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_InventoriesIncorporatedThroughTheBusinessCombination_lbl0" xml:lang="en-US">The amount of inventories incorporated through the business combination.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoriesIncorporatedThroughTheBusinessCombination" xlink:to="mlec_InventoriesIncorporatedThroughTheBusinessCombination_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_IssueOfShareCapital_lbl0" xml:lang="en-US">The amount of issue of share capital.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssueOfShareCapital" xlink:to="mlec_IssueOfShareCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_IssueOfShareCapitalBackstopShares_lbl0" xml:lang="en-US">The amount of issue of share capital (Backstop shares).</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssueOfShareCapitalBackstopShares" xlink:to="mlec_IssueOfShareCapitalBackstopShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_IssueOfShareCapitalLightJumpShares_lbl0" xml:lang="en-US">The amount of issue of share capital (LightJump shares).</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssueOfShareCapitalLightJumpShares" xlink:to="mlec_IssueOfShareCapitalLightJumpShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_IssueOfShareCapitalSAFEShares_lbl0" xml:lang="en-US">The amount of issue of share capital (SAFE shares).</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssueOfShareCapitalSAFEShares" xlink:to="mlec_IssueOfShareCapitalSAFEShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_IssueOfSharePremium_lbl0" xml:lang="en-US">Issue of share premium.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssueOfSharePremium" xlink:to="mlec_IssueOfSharePremium_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_IssueOfSharesCapital_lbl0" xml:lang="en-US">The nominal value of capital arising from issuing ordinary shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssueOfSharesCapital" xlink:to="mlec_IssueOfSharesCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_JointArrangementParticipationPercentage_lbl0" xml:lang="en-US">Joint arrangement participation percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_JointArrangementParticipationPercentage" xlink:to="mlec_JointArrangementParticipationPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_LaboratoriesRelatedExpenses_lbl0" xml:lang="en-US">Amount of labor-related expenses classified as other.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LaboratoriesRelatedExpenses" xlink:to="mlec_LaboratoriesRelatedExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_MutualFunds_lbl0" xml:lang="en-US">The amount of short term mutual funds.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MutualFunds" xlink:to="mlec_MutualFunds_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NegativeWorkingCapital_lbl0" xml:lang="en-US">Negative working capital.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NegativeWorkingCapital" xlink:to="mlec_NegativeWorkingCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NetBookAmount_lbl0" xml:lang="en-US">Net book amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetBookAmount" xlink:to="mlec_NetBookAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NetFinancialIncomeExpenses_lbl0" xml:lang="en-US">Total net financial income / expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetFinancialIncomeExpenses" xlink:to="mlec_NetFinancialIncomeExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NetGainOnInflationEffectOnMonetaryItems_lbl0" xml:lang="en-US">Net gain on inflation effect on monetary items.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetGainOnInflationEffectOnMonetaryItems" xlink:to="mlec_NetGainOnInflationEffectOnMonetaryItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NominalInterestRate_lbl0" xml:lang="en-US">Nominal interest rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NominalInterestRate" xlink:to="mlec_NominalInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NumberOfOptionsAtTheBeginning_lbl0" xml:lang="en-US">Number of options outstanding shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfOptionsAtTheBeginning" xlink:to="mlec_NumberOfOptionsAtTheBeginning_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NumberOfOptionsAtTheEnding_lbl0" xml:lang="en-US">Number of options, at the ending.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfOptionsAtTheEnding" xlink:to="mlec_NumberOfOptionsAtTheEnding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NumberOfOptionsExercisedDuringThePeriod_lbl0" xml:lang="en-US">Number of options shares exercised during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfOptionsExercisedDuringThePeriod" xlink:to="mlec_NumberOfOptionsExercisedDuringThePeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NumberOfOptionsExpiredDuringThePeriod_lbl0" xml:lang="en-US">Number of options shares expired during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfOptionsExpiredDuringThePeriod" xlink:to="mlec_NumberOfOptionsExpiredDuringThePeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NumberOfOptionsForfeitedDuringThePeriod_lbl0" xml:lang="en-US">Number of options shares forfeited during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfOptionsForfeitedDuringThePeriod" xlink:to="mlec_NumberOfOptionsForfeitedDuringThePeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NumberOfOptionsGrantedDuringThePeriod_lbl0" xml:lang="en-US">Number of option granted shares during the period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfOptionsGrantedDuringThePeriod" xlink:to="mlec_NumberOfOptionsGrantedDuringThePeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NumberOfShareEquitySettledShareBasedPayment_lbl0" xml:lang="en-US">A share-based payment is a transaction in which the entity receives goods or services either as consideration for its equity instruments or by incurring liabilities for amounts based on the price of the entity&apos;s shares or other equity instruments of the entity.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfShareEquitySettledShareBasedPayment" xlink:to="mlec_NumberOfShareEquitySettledShareBasedPayment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NumberOfSharesFromBusinessAcquisition_lbl0" xml:lang="en-US">Acquisition occurs when one company buys the shares of another company in an effort to gain control over that company. In simple terms you can say that acquisition is an act of one company taking over or acquiring another company&apos;s controlling interest.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfSharesFromBusinessAcquisition" xlink:to="mlec_NumberOfSharesFromBusinessAcquisition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NumberOfSharesIssueOfShareCapitalinShares_lbl0" xml:lang="en-US">Number of shares issue of share capital.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfSharesIssueOfShareCapitalinShares" xlink:to="mlec_NumberOfSharesIssueOfShareCapitalinShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NumberOfSharesToBeIssuedOfContingentPayment_lbl0" xml:lang="en-US">Number of shares to be issued of contingent payment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfSharesToBeIssuedOfContingentPayment" xlink:to="mlec_NumberOfSharesToBeIssuedOfContingentPayment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_NumberOfStockInventories_lbl0" xml:lang="en-US">Represents the number of soybean inventories.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfStockInventories" xlink:to="mlec_NumberOfStockInventories_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_OptionsRecognizedAmount_lbl0" xml:lang="en-US">The amount of options recognized.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OptionsRecognizedAmount" xlink:to="mlec_OptionsRecognizedAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_OrdinaryShares_lbl0" xml:lang="en-US">Number of ordinary shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OrdinaryShares" xlink:to="mlec_OrdinaryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_OriginalAmount_lbl0" xml:lang="en-US">Original amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OriginalAmount" xlink:to="mlec_OriginalAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_OtherLiabilitie_lbl0" xml:lang="en-US">Amount of other liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherLiabilitie" xlink:to="mlec_OtherLiabilitie_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_OtherNonCurrentAssetsOtherThanFinancialAssets_lbl0" xml:lang="en-US">Other non current assets other than financial assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherNonCurrentAssetsOtherThanFinancialAssets" xlink:to="mlec_OtherNonCurrentAssetsOtherThanFinancialAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_OtherOperatingExpense_lbl0" xml:lang="en-US">The amount of total other operating expense.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherOperatingExpense" xlink:to="mlec_OtherOperatingExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_OtherProductionCosts_lbl0" xml:lang="en-US">Amount of other production costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherProductionCosts" xlink:to="mlec_OtherProductionCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_OtherResearchAndDevelopmentExpenses_lbl0" xml:lang="en-US">Amount of other research and development expense.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherResearchAndDevelopmentExpenses" xlink:to="mlec_OtherResearchAndDevelopmentExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_Others_lbl0" xml:lang="en-US">Others.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Others" xlink:to="mlec_Others_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_OwnedPercentage_lbl0" xml:lang="en-US">Owned percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OwnedPercentage" xlink:to="mlec_OwnedPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PayAsYouEarnPAYE_lbl0" xml:lang="en-US">Pay as you earn.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PayAsYouEarnPAYE" xlink:to="mlec_PayAsYouEarnPAYE_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PayrollAndAndProfessionalFees_lbl0" xml:lang="en-US">The amount of fees paid payroll and and professional fees.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PayrollAndAndProfessionalFees" xlink:to="mlec_PayrollAndAndProfessionalFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PayrollExpenses_lbl0" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity&apos;s matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PayrollExpenses" xlink:to="mlec_PayrollExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PercentageOfFunctionalCurrency_lbl0" xml:lang="en-US">Percentage of functional currency.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfFunctionalCurrency" xlink:to="mlec_PercentageOfFunctionalCurrency_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PercentageOfInterestRates_lbl0" xml:lang="en-US">Percentage of interest rates.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfInterestRates" xlink:to="mlec_PercentageOfInterestRates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PlanDuration_lbl0" xml:lang="en-US">The duration of plan.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PlanDuration" xlink:to="mlec_PlanDuration_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PricePerWarrant_lbl0" xml:lang="en-US">Price per warrant.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PricePerWarrant" xlink:to="mlec_PricePerWarrant_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ProceedsFromIssueOfShareCapital_lbl0" xml:lang="en-US">The cash inflow from the issuing of share capital.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProceedsFromIssueOfShareCapital" xlink:to="mlec_ProceedsFromIssueOfShareCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ProceedsFromSAFE_lbl0" xml:lang="en-US">The cash inflow from the SAFE.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProceedsFromSAFE" xlink:to="mlec_ProceedsFromSAFE_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_Proceedsfromissuanceofsharecapital_lbl0" xml:lang="en-US">The amount of proceeds from issuance of share capital.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Proceedsfromissuanceofsharecapital" xlink:to="mlec_Proceedsfromissuanceofsharecapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PurchasePaymentTerms_lbl0" xml:lang="en-US">Term of purchase payment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PurchasePaymentTerms" xlink:to="mlec_PurchasePaymentTerms_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PurchasePrice_lbl0" xml:lang="en-US">Purchase price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PurchasePrice" xlink:to="mlec_PurchasePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_PurchasePricePerShare_lbl0" xml:lang="en-US">The price per share of purchase.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PurchasePricePerShare" xlink:to="mlec_PurchasePricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SAFECapitalization_lbl0" xml:lang="en-US">Safe capitalization.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SAFECapitalization" xlink:to="mlec_SAFECapitalization_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock_lbl0" xml:lang="en-US">Schedule of accumulated tax loss carryforwards.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock" xlink:to="mlec_ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ScheduleOfEstimatedFutureTaxableProfitTableTextBlock_lbl0" xml:lang="en-US">Schedule of estimated future taxable profit.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfEstimatedFutureTaxableProfitTableTextBlock" xlink:to="mlec_ScheduleOfEstimatedFutureTaxableProfitTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock_lbl0" xml:lang="en-US">Schedule of income tax for other jurisdictions.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock" xlink:to="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ScheduleOfOtherCurrentReceivablesTextBlock_lbl0" xml:lang="en-US">Schedule of Other Current Receivables Text Block.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfOtherCurrentReceivablesTextBlock" xlink:to="mlec_ScheduleOfOtherCurrentReceivablesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ScheduleOfOtherNoncurrentReceivableTableTextBlock_lbl0" xml:lang="en-US">The tabular disclosure of schedule of other non-current receivables.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfOtherNoncurrentReceivableTableTextBlock" xlink:to="mlec_ScheduleOfOtherNoncurrentReceivableTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock_lbl0" xml:lang="en-US">The entire disclosure of Reconciliation of Share Capital and Share Premium.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock" xlink:to="mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ScheduleOfRightofuseOfAssetsTableTextBlock_lbl0" xml:lang="en-US">The entire disclosure of Schedule of Right-of-use of Assets Table Text Block.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfRightofuseOfAssetsTableTextBlock" xlink:to="mlec_ScheduleOfRightofuseOfAssetsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ScheduleOfTradeReceivableTextBlock_lbl0" xml:lang="en-US">Schedule of Trade Receivable Text Block.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfTradeReceivableTextBlock" xlink:to="mlec_ScheduleOfTradeReceivableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ServicesProvidedByOtherCompanies_lbl0" xml:lang="en-US">Services provided by other companies.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ServicesProvidedByOtherCompanies" xlink:to="mlec_ServicesProvidedByOtherCompanies_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ShareEquivalent_lbl0" xml:lang="en-US">Share equivalent.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareEquivalent" xlink:to="mlec_ShareEquivalent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SharePremiumEquitySettledShareBasedPayment_lbl0" xml:lang="en-US">The amount of share premium equity settled share based payment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharePremiumEquitySettledShareBasedPayment" xlink:to="mlec_SharePremiumEquitySettledShareBasedPayment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SharePremiumFromBusinessAcquisition_lbl0" xml:lang="en-US">The amount of share premium from business acquisition.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharePremiumFromBusinessAcquisition" xlink:to="mlec_SharePremiumFromBusinessAcquisition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SharePremiumIssueOfShareCapital_lbl0" xml:lang="en-US">The amount of share premium issue of share capital.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharePremiumIssueOfShareCapital" xlink:to="mlec_SharePremiumIssueOfShareCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SharePurchaseAgreement_lbl0" xml:lang="en-US">Share Purchase Agreement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharePurchaseAgreement" xlink:to="mlec_SharePurchaseAgreement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SharePurchaseAgreementOverPeriod_lbl0" xml:lang="en-US">Share purchase Agreement over period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharePurchaseAgreementOverPeriod" xlink:to="mlec_SharePurchaseAgreementOverPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ShareToBeIssuedAmount_lbl2" xml:lang="en-US">The amount of shares to be issued.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareToBeIssuedAmount" xlink:to="mlec_ShareToBeIssuedAmount_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SharesIssuedAmount_lbl1" xml:lang="en-US">The amount of shares issued.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesIssuedAmount" xlink:to="mlec_SharesIssuedAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SharesIssuedAmountEquitySettledShareBasedPayment_lbl0" xml:lang="en-US">The amount of shares issued amount equity settled share based payment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesIssuedAmountEquitySettledShareBasedPayment" xlink:to="mlec_SharesIssuedAmountEquitySettledShareBasedPayment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SharesIssuedAmountFromBusinessAcquisition_lbl0" xml:lang="en-US">The amount of shares issued amount from business acquisition.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesIssuedAmountFromBusinessAcquisition" xlink:to="mlec_SharesIssuedAmountFromBusinessAcquisition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SharesToBeIssuedAmountEquitySettledShareBasedPayment_lbl0" xml:lang="en-US">The amount of shares to be issued equity settled share based payment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesToBeIssuedAmountEquitySettledShareBasedPayment" xlink:to="mlec_SharesToBeIssuedAmountEquitySettledShareBasedPayment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SharesToBeIssuedAmountFromBusinessAcquisition_lbl0" xml:lang="en-US">The amount of shares to be issued from business acquisition.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesToBeIssuedAmountFromBusinessAcquisition" xlink:to="mlec_SharesToBeIssuedAmountFromBusinessAcquisition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SharesToBeIssuedAmountIssueOfShareCapital_lbl0" xml:lang="en-US">The amount of shares to be issued amount issue of share capital.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesToBeIssuedAmountIssueOfShareCapital" xlink:to="mlec_SharesToBeIssuedAmountIssueOfShareCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_ShorttermInvestmentsCurrent_lbl0" xml:lang="en-US">Amount of short-term investments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShorttermInvestmentsCurrent" xlink:to="mlec_ShorttermInvestmentsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SimplyAgreementForFutureEquitySAFE_lbl0" xml:lang="en-US">Simply Agreement for Future Equity (&#8220;SAFE&#8221;).</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SimplyAgreementForFutureEquitySAFE" xlink:to="mlec_SimplyAgreementForFutureEquitySAFE_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_StrikePricePerShare_lbl0" xml:lang="en-US">Strike price per share.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_StrikePricePerShare" xlink:to="mlec_StrikePricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SubsidiaryPercentage_lbl0" xml:lang="en-US">Subsidiary percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SubsidiaryPercentage" xlink:to="mlec_SubsidiaryPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SubtotalDerivatesLiabilities_lbl0" xml:lang="en-US">Subtotal of derivates liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SubtotalDerivatesLiabilities" xlink:to="mlec_SubtotalDerivatesLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_SubtotalNonDerivatesLiabilities_lbl0" xml:lang="en-US">Subtotal of non-derivates liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SubtotalNonDerivatesLiabilities" xlink:to="mlec_SubtotalNonDerivatesLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_TaxJurisdiction_lbl0" xml:lang="en-US">Income tax rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxJurisdiction" xlink:to="mlec_TaxJurisdiction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_Taxes_lbl0" xml:lang="en-US">The amount of taxes.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Taxes" xlink:to="mlec_Taxes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_TaxesDutiesAndPenalties_lbl0" xml:lang="en-US">The amount of taxes, duties and penalties.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxesDutiesAndPenalties" xlink:to="mlec_TaxesDutiesAndPenalties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_TaxlossCarryForward_lbl0" xml:lang="en-US">The amount of tax-loss carry forward.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxlossCarryForward" xlink:to="mlec_TaxlossCarryForward_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_TotalGoodwill_lbl0" xml:lang="en-US">The total amount of goodwill.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalGoodwill" xlink:to="mlec_TotalGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_TotalLiabilities_lbl0" xml:lang="en-US">Total liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalLiabilities" xlink:to="mlec_TotalLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_TotalMutualFunds_lbl0" xml:lang="en-US">The amount of total short-term investments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalMutualFunds" xlink:to="mlec_TotalMutualFunds_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_TotalOtherFinancialResults_lbl0" xml:lang="en-US">Represents the amount of total other financial results.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalOtherFinancialResults" xlink:to="mlec_TotalOtherFinancialResults_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_TotalOtherProductionCost_lbl0" xml:lang="en-US">Other cost of sales.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalOtherProductionCost" xlink:to="mlec_TotalOtherProductionCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_TransactionsExpenses_lbl0" xml:lang="en-US">Transaction expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TransactionsExpenses" xlink:to="mlec_TransactionsExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_UnderIssuedSharePurchaseAgreement_lbl0" xml:lang="en-US">The amount of under share issued agreement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnderIssuedSharePurchaseAgreement" xlink:to="mlec_UnderIssuedSharePurchaseAgreement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_Wages_lbl0" xml:lang="en-US">The amount of wages.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Wages" xlink:to="mlec_Wages_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="mlec_WarrantAndRightsOutstanding_lbl1" xml:lang="en-US">Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_WarrantAndRightsOutstanding" xlink:to="mlec_WarrantAndRightsOutstanding_lbl1"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AddressTypeDomain_lbl" xml:lang="en-US">Address Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AddressTypeDomain" xlink:to="dei_AddressTypeDomain_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Liabilities_lbl0" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_Liabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for financial assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl0" xml:lang="en-US">Adjustments for increase (decrease) in trade accounts payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NumberOfOptionsGrantedDuringThePeriod_lbl1" xml:lang="en-US">Number Of Options Granted During The Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfOptionsGrantedDuringThePeriod" xlink:to="mlec_NumberOfOptionsGrantedDuringThePeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NetFinancialIncomeExpenses_lbl1" xml:lang="en-US">Net Financial Income Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetFinancialIncomeExpenses" xlink:to="mlec_NetFinancialIncomeExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentFinancialAssets_lbl0" xml:lang="en-US">Non-current financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialAssets" xlink:to="ifrs-full_NoncurrentFinancialAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetAssetsLiabilities_lbl0" xml:lang="en-US">Assets (liabilities)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetAssetsLiabilities" xlink:to="ifrs-full_NetAssetsLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock_lbl1" xml:lang="en-US">Description Of Accounting Policy For Share Capital And Reserves Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssueOfEquity_lbl0" xml:lang="en-US">Issue of equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssueOfEquity" xlink:to="ifrs-full_IssueOfEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl0" xml:lang="en-US">Disclosure of events after reporting period [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SubsidiaryPercentage_lbl1" xml:lang="en-US">Subsidiary Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SubsidiaryPercentage" xlink:to="mlec_SubsidiaryPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxLiabilityAsset_lbl0" xml:lang="en-US">Deferred tax liability (asset)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxLiabilityAsset" xlink:to="ifrs-full_DeferredTaxLiabilityAsset_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl0" xml:lang="en-US">Auditor Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl0" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl0" xml:lang="en-US">Exercise price, share options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuedCapitalMember_lbl0" xml:lang="en-US">Issued capital [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapitalMember" xlink:to="ifrs-full_IssuedCapitalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfOtherRelatedPartyBalances_lbl0" xml:lang="en-US">Schedule Of Other Related Party Balances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfOtherRelatedPartyBalances" xlink:to="mlec_ScheduleOfOtherRelatedPartyBalances_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TaxLosses_lbl0" xml:lang="en-US">Tax Losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxLosses" xlink:to="mlec_TaxLosses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_lbl0" xml:lang="en-US">Disclosure of accounting judgements and estimates [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:to="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AcquisitionsThroughBusinessCombinationsi_lbl1" xml:lang="en-US">Acquisitions Through Business Combinationsi</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AcquisitionsThroughBusinessCombinationsi" xlink:to="mlec_AcquisitionsThroughBusinessCombinationsi_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SoftwareLicenseMember_lbl0" xml:lang="en-US">Software License Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SoftwareLicenseMember" xlink:to="mlec_SoftwareLicenseMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_Amortization_lbl1" xml:lang="en-US">Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Amortization" xlink:to="mlec_Amortization_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InterestExpenses_lbl1" xml:lang="en-US">Interest Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InterestExpenses" xlink:to="mlec_InterestExpenses_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfResearchAndDevelopmentExpenseAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfResearchAndDevelopmentExpenseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfResearchAndDevelopmentExpenseAbstract_lbl" xml:lang="en-US">Schedule Of Research And Development Expense Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfResearchAndDevelopmentExpenseAbstract" xlink:to="mlec_ScheduleOfResearchAndDevelopmentExpenseAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_Assets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl2" xml:lang="en-US">Intangible assets other than goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_THEOISCSpMember_lbl0" xml:lang="en-US">THEOISCSp Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_THEOISCSpMember" xlink:to="mlec_THEOISCSpMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl0" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_YearEndedJune302021Abstract0_lbl0" xml:lang="en-US">Year Ended June302021 Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_YearEndedJune302021Abstract0" xlink:to="mlec_YearEndedJune302021Abstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_lbl0" xml:lang="en-US">Useful life measured as period of time, property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RawMaterialsAndConsumablesUsed_lbl0" xml:lang="en-US">Raw materials and consumables used</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RawMaterialsAndConsumablesUsed" xlink:to="ifrs-full_RawMaterialsAndConsumablesUsed_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NonCurrentLiabilitiesAbstract_lbl0" xml:lang="en-US">Non Current Liabilities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NonCurrentLiabilitiesAbstract" xlink:to="mlec_NonCurrentLiabilitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfFinancialIncomeExpensesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfFinancialIncomeExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfFinancialIncomeExpensesAbstract_lbl" xml:lang="en-US">Schedule Of Financial Income Expenses Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfFinancialIncomeExpensesAbstract" xlink:to="mlec_ScheduleOfFinancialIncomeExpensesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PurchasePaymentTerms_lbl1" xml:lang="en-US">Purchase Payment Terms</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PurchasePaymentTerms" xlink:to="mlec_PurchasePaymentTerms_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for intangible assets and goodwill [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_lbl0" xml:lang="en-US">Adjustments for depreciation and amortisation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:to="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl0" xml:lang="en-US">Document Registration Statement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfFixedAssetstextBlock_lbl0" xml:lang="en-US">Schedule Of Fixed Assetstext Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfFixedAssetstextBlock" xlink:to="mlec_ScheduleOfFixedAssetstextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SponsorShares_lbl0" xml:lang="en-US">Sponsor Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SponsorShares" xlink:to="mlec_SponsorShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PoundSterlingMember_lbl0" xml:lang="en-US">Pound Sterling Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PoundSterlingMember" xlink:to="mlec_PoundSterlingMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OwnedPercentage_lbl1" xml:lang="en-US">Owned Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OwnedPercentage" xlink:to="mlec_OwnedPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock_lbl1" xml:lang="en-US">Description Of Accounting Policy For New Standards Amendments And Interpretations Of IFRSText Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentPrepayments_lbl0" xml:lang="en-US">Current prepayments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentPrepayments" xlink:to="ifrs-full_CurrentPrepayments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CorporateTaxRate_lbl0" xml:lang="en-US">Corporate Tax Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CorporateTaxRate" xlink:to="mlec_CorporateTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IncorporatedThroughTheBusinessCombination_lbl1" xml:lang="en-US">Incorporated Through The Business Combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncorporatedThroughTheBusinessCombination" xlink:to="mlec_IncorporatedThroughTheBusinessCombination_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FurnitureMember_lbl0" xml:lang="en-US">Furniture Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FurnitureMember" xlink:to="mlec_FurnitureMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AmortizedCostsAbstract0_lbl0" xml:lang="en-US">Amortized Costs Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AmortizedCostsAbstract0" xlink:to="mlec_AmortizedCostsAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DividendsPaidOrdinarySharesPerShare_lbl0" xml:lang="en-US">Dividends paid, ordinary shares per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPaidOrdinarySharesPerShare" xlink:to="ifrs-full_DividendsPaidOrdinarySharesPerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDeferredTaxesExplanatory_lbl0" xml:lang="en-US">Disclosure of deferred taxes [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:to="ifrs-full_DisclosureOfDeferredTaxesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock_lbl0" xml:lang="en-US">Schedule Of Non Current Assets Other Than Financial Instruments Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock" xlink:to="mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_lbl0" xml:lang="en-US">Adjustments for decrease (increase) in inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinishedGoods_lbl0" xml:lang="en-US">Current finished goods</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinishedGoods" xlink:to="ifrs-full_FinishedGoods_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromIssuingShares_lbl0" xml:lang="en-US">Proceeds from issuing shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromIssuingShares" xlink:to="ifrs-full_ProceedsFromIssuingShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BancoSantanderLoansMember_lbl0" xml:lang="en-US">Banco Santander Loans Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BancoSantanderLoansMember" xlink:to="mlec_BancoSantanderLoansMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl0" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl0" xml:lang="en-US">Entity Address, Address Line Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InsuranceExpense_lbl0" xml:lang="en-US">Insurance expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InsuranceExpense" xlink:to="ifrs-full_InsuranceExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl0" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfFixedAssetsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfFixedAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfFixedAssetsAbstract_lbl" xml:lang="en-US">Schedule Of Fixed Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfFixedAssetsAbstract" xlink:to="mlec_ScheduleOfFixedAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember_lbl0" xml:lang="en-US">Gamma Linolenic Acid GLAAssets And Licensing Rights To Arachidonic Acid ARAMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember" xlink:to="mlec_GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_lbl0" xml:lang="en-US">Disclosure of intangible assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ExercisePricePerShare_lbl1" xml:lang="en-US">Exercise Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExercisePricePerShare" xlink:to="mlec_ExercisePricePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsToRightofuseAssets_lbl0" xml:lang="en-US">Additions to right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsToRightofuseAssets" xlink:to="ifrs-full_AdditionsToRightofuseAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfCashAndCashEquivalentsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfCashAndCashEquivalentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfCashAndCashEquivalentsAbstract_lbl" xml:lang="en-US">Schedule Of Cash And Cash Equivalents Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfCashAndCashEquivalentsAbstract" xlink:to="mlec_ScheduleOfCashAndCashEquivalentsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl0" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SalesAndMarketingExpense_lbl0" xml:lang="en-US">Sales and marketing expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SalesAndMarketingExpense" xlink:to="ifrs-full_SalesAndMarketingExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsForShareIssueCosts_lbl0" xml:lang="en-US">Payments for share issue costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsForShareIssueCosts" xlink:to="ifrs-full_PaymentsForShareIssueCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_Wages_lbl1" xml:lang="en-US">Wages</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Wages" xlink:to="mlec_Wages_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_lbl0" xml:lang="en-US">Disclosure of share-based payment arrangements [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:to="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfRightofuseOfAssetsTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Rightofuse Of Assets Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfRightofuseOfAssetsTableTextBlock" xlink:to="mlec_ScheduleOfRightofuseOfAssetsTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares_lbl1" xml:lang="en-US">Acquisition Of Noncurrent Assets By The Issuance Of Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares" xlink:to="mlec_AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherPayablesToTradeSuppliers_lbl0" xml:lang="en-US">Trade payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:to="ifrs-full_TradeAndOtherPayablesToTradeSuppliers_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_LuxMember_lbl0" xml:lang="en-US">Lux Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LuxMember" xlink:to="mlec_LuxMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for functional currency [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BGFarmingTechnologiesMember_lbl0" xml:lang="en-US">BGFarming Technologies Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BGFarmingTechnologiesMember" xlink:to="mlec_BGFarmingTechnologiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelName_lbl0" xml:lang="en-US">Contact Personnel Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RedemptionPrice_lbl0" xml:lang="en-US">Redemption Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RedemptionPrice" xlink:to="mlec_RedemptionPrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TotalOtherFinancialResults_lbl1" xml:lang="en-US">Total Other Financial Results</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalOtherFinancialResults" xlink:to="mlec_TotalOtherFinancialResults_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_lbl0" xml:lang="en-US">Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock_lbl1" xml:lang="en-US">Description Of Accounting Policy For Rightofuse Of Assets Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_lbl0" xml:lang="en-US">Cash repayments of advances and loans from related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties" xlink:to="ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfOtherNoncurrentReceivableTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Other Noncurrent Receivable Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfOtherNoncurrentReceivableTableTextBlock" xlink:to="mlec_ScheduleOfOtherNoncurrentReceivableTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InflationAdjustment_lbl1" xml:lang="en-US">Inflation Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InflationAdjustment" xlink:to="mlec_InflationAdjustment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShorttermEmployeeBenefitsExpense_lbl0" xml:lang="en-US">Short-term employee benefits expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:to="ifrs-full_ShorttermEmployeeBenefitsExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BancoMacroPreFinancingOfExportsMember_lbl0" xml:lang="en-US">Banco Macro Pre Financing Of Exports Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BancoMacroPreFinancingOfExportsMember" xlink:to="mlec_BancoMacroPreFinancingOfExportsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl0" xml:lang="en-US">Document Shell Company Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl0" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfShareBasedPayment_lbl0" xml:lang="en-US">Schedule Of Share Based Payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfShareBasedPayment" xlink:to="mlec_ScheduleOfShareBasedPayment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilities_lbl1" xml:lang="en-US">Financial liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_FinancialLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_lbl0" xml:lang="en-US">Adjustments for decrease (increase) in other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TwoThousandTwentyThreeMember_lbl0" xml:lang="en-US">Two Thousand Twenty Three Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TwoThousandTwentyThreeMember" xlink:to="mlec_TwoThousandTwentyThreeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxExpenseIncome_lbl0" xml:lang="en-US">Deferred tax expense (income)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxExpenseIncome" xlink:to="ifrs-full_DeferredTaxExpenseIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_USDollarMember_lbl0" xml:lang="en-US">USDollar Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_USDollarMember" xlink:to="mlec_USDollarMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiquidityRiskMember_lbl0" xml:lang="en-US">Liquidity risk [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiquidityRiskMember" xlink:to="ifrs-full_LiquidityRiskMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ImpactToProfitOrLossBeforeTaxLiabilitiesMember_lbl0" xml:lang="en-US">Impact To Profit Or Loss Before Tax Liabilities Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ImpactToProfitOrLossBeforeTaxLiabilitiesMember" xlink:to="mlec_ImpactToProfitOrLossBeforeTaxLiabilitiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SharePremiumEquitySettledShareBasedPayment_lbl1" xml:lang="en-US">Share Premium Equity Settled Share Based Payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharePremiumEquitySettledShareBasedPayment" xlink:to="mlec_SharePremiumEquitySettledShareBasedPayment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ProductionCostsAbstract_lbl0" xml:lang="en-US">Production Costs Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProductionCostsAbstract" xlink:to="mlec_ProductionCostsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BancoGaliciaLoansMember_lbl0" xml:lang="en-US">Banco Galicia Loans Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BancoGaliciaLoansMember" xlink:to="mlec_BancoGaliciaLoansMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_June302022Abstract_lbl0" xml:lang="en-US">June302022 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_June302022Abstract" xlink:to="mlec_June302022Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for financial instruments [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfFairValueAndCarryingValueOfFinancialInstrumentsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfFairValueAndCarryingValueOfFinancialInstrumentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfFairValueAndCarryingValueOfFinancialInstrumentsAbstract_lbl" xml:lang="en-US">Schedule Of Fair Value And Carrying Value Of Financial Instruments Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfFairValueAndCarryingValueOfFinancialInstrumentsAbstract" xlink:to="mlec_ScheduleOfFairValueAndCarryingValueOfFinancialInstrumentsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfFixedRateInstruments_lbl1" xml:lang="en-US">Disclosure Of Fixed Rate Instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfFixedRateInstruments" xlink:to="mlec_DisclosureOfFixedRateInstruments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfessionalFeesExpense_lbl0" xml:lang="en-US">Professional fees expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfessionalFeesExpense" xlink:to="ifrs-full_ProfessionalFeesExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OrdinaryShares_lbl1" xml:lang="en-US">Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OrdinaryShares" xlink:to="mlec_OrdinaryShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_LiabilitiesAndEquityAbstract_lbl0" xml:lang="en-US">Liabilities And Equity Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LiabilitiesAndEquityAbstract" xlink:to="mlec_LiabilitiesAndEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RightofuseAssets_lbl2" xml:lang="en-US">Right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TotalLiabilities_lbl1" xml:lang="en-US">Total Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalLiabilities" xlink:to="mlec_TotalLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialCostsAbstract_lbl0" xml:lang="en-US">Financial Costs Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialCostsAbstract" xlink:to="mlec_FinancialCostsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl0" xml:lang="en-US">Risk free interest rate, share options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationAndAmortisationExpense_lbl0" xml:lang="en-US">Depreciation and amortisation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationAndAmortisationExpense" xlink:to="ifrs-full_DepreciationAndAmortisationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl0" xml:lang="en-US">Purchase of property, plant and equipment, classified as investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl0" xml:lang="en-US">Disclosure of related party [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_Group3Member_lbl0" xml:lang="en-US">Group3 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Group3Member" xlink:to="mlec_Group3Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_Taxes_lbl1" xml:lang="en-US">Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Taxes" xlink:to="mlec_Taxes_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_StrikePricePerShare_lbl1" xml:lang="en-US">Strike Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_StrikePricePerShare" xlink:to="mlec_StrikePricePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SharePremiumFromBusinessAcquisition_lbl1" xml:lang="en-US">Share Premium From Business Acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharePremiumFromBusinessAcquisition" xlink:to="mlec_SharePremiumFromBusinessAcquisition_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_lbl1" xml:lang="en-US">Trade and other current payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayables" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherFinancialResults_lbl0" xml:lang="en-US">Other Financial Results</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherFinancialResults" xlink:to="mlec_OtherFinancialResults_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_lbl0" xml:lang="en-US">Disclosure of cash and cash equivalents [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:to="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherNonCurrentAssetsOtherThanFinancialAssets_lbl1" xml:lang="en-US">Other Non Current Assets Other Than Financial Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherNonCurrentAssetsOtherThanFinancialAssets" xlink:to="mlec_OtherNonCurrentAssetsOtherThanFinancialAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PercentageOfInterestRates_lbl1" xml:lang="en-US">Percentage Of Interest Rates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfInterestRates" xlink:to="mlec_PercentageOfInterestRates_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium_lbl0" xml:lang="en-US">Relief Of SAFEFinancial Liabilities Through The Issue Of Share Capital And Share Premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium" xlink:to="mlec_ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PayrollExpenses_lbl1" xml:lang="en-US">Payroll Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PayrollExpenses" xlink:to="mlec_PayrollExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShorttermEmployeeBenefitsAccruals_lbl0" xml:lang="en-US">Short-term employee benefits accruals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:to="ifrs-full_ShorttermEmployeeBenefitsAccruals_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_lbl0" xml:lang="en-US">Disclosure of research and development expense [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FairValueAdjustmentOfWarrant_lbl1" xml:lang="en-US">Fair Value Adjustment Of Warrant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FairValueAdjustmentOfWarrant" xlink:to="mlec_FairValueAdjustmentOfWarrant_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BioceresSAINMETSAIngenieriaMetabolicaSAMember_lbl0" xml:lang="en-US">Bioceres SAINMETSAIngenieria Metabolica SAMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresSAINMETSAIngenieriaMetabolicaSAMember" xlink:to="mlec_BioceresSAINMETSAIngenieriaMetabolicaSAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfCapitalRiskManagementTextBlock_lbl1" xml:lang="en-US">Disclosure Of Capital Risk Management Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfCapitalRiskManagementTextBlock" xlink:to="mlec_DisclosureOfCapitalRiskManagementTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AccrualsClassifiedAsNoncurrent_lbl0" xml:lang="en-US">Accruals classified as non-current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccrualsClassifiedAsNoncurrent" xlink:to="ifrs-full_AccrualsClassifiedAsNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentFinancialLiabilities_lbl0" xml:lang="en-US">Non-current financial liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialLiabilities" xlink:to="ifrs-full_NoncurrentFinancialLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_INDEARSAMember_lbl0" xml:lang="en-US">INDEARSAMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_INDEARSAMember" xlink:to="mlec_INDEARSAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CashPaid_lbl1" xml:lang="en-US">Cash Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CashPaid" xlink:to="mlec_CashPaid_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsAbstract_lbl" xml:lang="en-US">Schedule Of Non Current Assets Other Than Financial Instruments Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsAbstract" xlink:to="mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepositsFromBanks_lbl0" xml:lang="en-US">Deposits from banks</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepositsFromBanks" xlink:to="ifrs-full_DepositsFromBanks_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_lbl0" xml:lang="en-US">Disclosure of financial risk management [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_EffectOfChangesInForeignExchangeRates_lbl1" xml:lang="en-US">Effect Of Changes In Foreign Exchange Rates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EffectOfChangesInForeignExchangeRates" xlink:to="mlec_EffectOfChangesInForeignExchangeRates_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfAdditionalInformationExplanatory_lbl0" xml:lang="en-US">Disclosure of additional information [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAdditionalInformationExplanatory" xlink:to="ifrs-full_DisclosureOfAdditionalInformationExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl0" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ServicesProvidedByOtherCompanies_lbl1" xml:lang="en-US">Services Provided By Other Companies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ServicesProvidedByOtherCompanies" xlink:to="mlec_ServicesProvidedByOtherCompanies_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_lbl0" xml:lang="en-US">Adjustments for decrease (increase) in prepaid expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentFinancialAssetsAtAmortisedCost_lbl0" xml:lang="en-US">Current financial assets at amortised cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialAssetsAtAmortisedCost" xlink:to="ifrs-full_CurrentFinancialAssetsAtAmortisedCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCurrentLiabilities_lbl1" xml:lang="en-US">Other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentLiabilities" xlink:to="ifrs-full_OtherCurrentLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for trade and other payables [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherProductionCosts_lbl1" xml:lang="en-US">Other Production Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherProductionCosts" xlink:to="mlec_OtherProductionCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl0" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl0" xml:lang="en-US">Tax expense (income)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_LightJumpAcquisitionCorporationMember_lbl0" xml:lang="en-US">Light Jump Acquisition Corporation Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LightJumpAcquisitionCorporationMember" xlink:to="mlec_LightJumpAcquisitionCorporationMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_lbl0" xml:lang="en-US">Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:to="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MoolecScienceLimitedMember_lbl0" xml:lang="en-US">Moolec Science Limited Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MoolecScienceLimitedMember" xlink:to="mlec_MoolecScienceLimitedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_LaboratoriesRelatedExpenses_lbl1" xml:lang="en-US">Laboratories Related Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LaboratoriesRelatedExpenses" xlink:to="mlec_LaboratoriesRelatedExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BioceresSAAgralityIncMember_lbl0" xml:lang="en-US">Bioceres SAAgrality Inc Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresSAAgralityIncMember" xlink:to="mlec_BioceresSAAgralityIncMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLiabilities_lbl0" xml:lang="en-US">Non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_lbl0" xml:lang="en-US">Disclosure of general information about financial statements [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:to="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeReceivables_lbl0" xml:lang="en-US">Trade receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeReceivables" xlink:to="ifrs-full_TradeReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ServicesProvidedByOtherCompaniesAbstract_lbl0" xml:lang="en-US">Services Provided By Other Companies Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ServicesProvidedByOtherCompaniesAbstract" xlink:to="mlec_ServicesProvidedByOtherCompaniesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory_lbl0" xml:lang="en-US">Disclosure of investments accounted for using equity method [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:to="ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_YearEndedJune302021Abstract_lbl0" xml:lang="en-US">Year Ended June302021 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_YearEndedJune302021Abstract" xlink:to="mlec_YearEndedJune302021Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCurrentFinancialLiabilities_lbl1" xml:lang="en-US">Other current financial liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentFinancialLiabilities" xlink:to="ifrs-full_OtherCurrentFinancialLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits_lbl0" xml:lang="en-US">Description of expiry date of deductible temporary differences, unused tax losses and unused tax credits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits" xlink:to="ifrs-full_DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_lbl0" xml:lang="en-US">Disclosure of financial instruments [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_Additions_lbl0" xml:lang="en-US">Additions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Additions" xlink:to="mlec_Additions_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfIntangibleAssetsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfIntangibleAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfIntangibleAssetsAbstract_lbl" xml:lang="en-US">Schedule Of Intangible Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfIntangibleAssetsAbstract" xlink:to="mlec_ScheduleOfIntangibleAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BancoCrdobaPreFinancingOfExportsMember_lbl0" xml:lang="en-US">Banco Crdoba Pre Financing Of Exports Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BancoCrdobaPreFinancingOfExportsMember" xlink:to="mlec_BancoCrdobaPreFinancingOfExportsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_ARS_lbl0" xml:lang="en-US">Argentina, Pesos</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_ARS" xlink:to="currency_ARS_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfOtherRelatedPartyTransactions_lbl0" xml:lang="en-US">Schedule Of Other Related Party Transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfOtherRelatedPartyTransactions" xlink:to="mlec_ScheduleOfOtherRelatedPartyTransactions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShorttermInvestmentsCurrent_lbl1" xml:lang="en-US">Shortterm Investments Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShorttermInvestmentsCurrent" xlink:to="mlec_ShorttermInvestmentsCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl0" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OriginalAmount_lbl1" xml:lang="en-US">Original Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OriginalAmount" xlink:to="mlec_OriginalAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock_lbl1" xml:lang="en-US">Description Of Accounting Policy For Basis Of Consolidation Of Subsidiary Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MiscellaneousOtherOperatingExpense_lbl0" xml:lang="en-US">Miscellaneous other operating expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MiscellaneousOtherOperatingExpense" xlink:to="ifrs-full_MiscellaneousOtherOperatingExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProportionOfVotingPowerHeldInSubsidiary_lbl0" xml:lang="en-US">Proportion of voting rights held in subsidiary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfVotingPowerHeldInSubsidiary" xlink:to="ifrs-full_ProportionOfVotingPowerHeldInSubsidiary_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss_lbl1" xml:lang="en-US">Deferred Taxes Expense Income Recognised In Profit Or Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss" xlink:to="mlec_DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_lbl0" xml:lang="en-US">Property, plant and equipment recognised as of acquisition date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax_lbl0" xml:lang="en-US">Other comprehensive income that will be reclassified to profit or loss, before tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" xlink:to="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CumulativeTranslationAdjustmentMember_lbl0" xml:lang="en-US">Cumulative Translation Adjustment Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CumulativeTranslationAdjustmentMember" xlink:to="mlec_CumulativeTranslationAdjustmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl0" xml:lang="en-US">Amortisation, intangible assets other than goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl0" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_lbl0" xml:lang="en-US">Short-term investments, classified as cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents" xlink:to="ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BasicEarningsLossPerShare_lbl0" xml:lang="en-US">Basic earnings (loss) per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShare" xlink:to="ifrs-full_BasicEarningsLossPerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_lbl0" xml:lang="en-US">Identifiable assets acquired (liabilities assumed)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:to="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Additions other than through business combinations, property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CFOSharesAlloted_lbl1" xml:lang="en-US">CFOShares Alloted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CFOSharesAlloted" xlink:to="mlec_CFOSharesAlloted_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ForeignCurrencyExchangeRiskAssets_lbl1" xml:lang="en-US">Foreign Currency Exchange Risk Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ForeignCurrencyExchangeRiskAssets" xlink:to="mlec_ForeignCurrencyExchangeRiskAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PercentageOfFunctionalCurrency_lbl1" xml:lang="en-US">Percentage Of Functional Currency</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PercentageOfFunctionalCurrency" xlink:to="mlec_PercentageOfFunctionalCurrency_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssets_lbl1" xml:lang="en-US">Current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NumberOfOptionsExercisedDuringThePeriod_lbl1" xml:lang="en-US">Number Of Options Exercised During The Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfOptionsExercisedDuringThePeriod" xlink:to="mlec_NumberOfOptionsExercisedDuringThePeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AmortisationExpense_lbl0" xml:lang="en-US">Amortisation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmortisationExpense" xlink:to="ifrs-full_AmortisationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MoolecScienceSAMember_lbl0" xml:lang="en-US">Moolec Science SAMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MoolecScienceSAMember" xlink:to="mlec_MoolecScienceSAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PlanDuration_lbl1" xml:lang="en-US">Plan Duration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PlanDuration" xlink:to="mlec_PlanDuration_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestRateRiskMember_lbl0" xml:lang="en-US">Interest rate risk [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestRateRiskMember" xlink:to="ifrs-full_InterestRateRiskMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentReceivables_lbl1" xml:lang="en-US">Trade and other non-current receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentReceivables" xlink:to="ifrs-full_NoncurrentReceivables_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InventoriesTotal_lbl0" xml:lang="en-US">Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InventoriesTotal" xlink:to="ifrs-full_InventoriesTotal_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_HSBCBankLoansMember_lbl0" xml:lang="en-US">HSBCBank Loans Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_HSBCBankLoansMember" xlink:to="mlec_HSBCBankLoansMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MoreThanFiveYearsMember_lbl0" xml:lang="en-US">More Than Five Years Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MoreThanFiveYearsMember" xlink:to="mlec_MoreThanFiveYearsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AsOfJune302023Abstract0_lbl0" xml:lang="en-US">As Of June302023 Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AsOfJune302023Abstract0" xlink:to="mlec_AsOfJune302023Abstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl0" xml:lang="en-US">Disclosure of income tax [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:to="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_YearEndedJune302023Abstract_lbl0" xml:lang="en-US">Year Ended June302023 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_YearEndedJune302023Abstract" xlink:to="mlec_YearEndedJune302023Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareCapitalStockAndSharePremiumAmounts_lbl0" xml:lang="en-US">Share Capital Stock And Share Premium Amounts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareCapitalStockAndSharePremiumAmounts" xlink:to="mlec_ShareCapitalStockAndSharePremiumAmounts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_lbl0" xml:lang="en-US">Description of accounting policy for measuring inventories [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnderIssuedSharePurchaseAgreement_lbl1" xml:lang="en-US">Under Issued Share Purchase Agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnderIssuedSharePurchaseAgreement" xlink:to="mlec_UnderIssuedSharePurchaseAgreement_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfOtherCurrentReceivablesTextBlock_lbl1" xml:lang="en-US">Schedule Of Other Current Receivables Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfOtherCurrentReceivablesTextBlock" xlink:to="mlec_ScheduleOfOtherCurrentReceivablesTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BancoSantanderBankOverdraftsMember_lbl0" xml:lang="en-US">Banco Santander Bank Overdrafts Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BancoSantanderBankOverdraftsMember" xlink:to="mlec_BancoSantanderBankOverdraftsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CapitalizationOfTransactionExpensesThroughAccountsPayable_lbl1" xml:lang="en-US">Capitalization Of Transaction Expenses Through Accounts Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CapitalizationOfTransactionExpensesThroughAccountsPayable" xlink:to="mlec_CapitalizationOfTransactionExpensesThroughAccountsPayable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TopOfRangeMember_lbl2" xml:lang="en-US">Top of range [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TopOfRangeMember" xlink:to="ifrs-full_TopOfRangeMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_LossBeforeTax_lbl0" xml:lang="en-US">Loss Before Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LossBeforeTax" xlink:to="mlec_LossBeforeTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssueCostsNotRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_lbl0" xml:lang="en-US">Issue costs not recognised as expense for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssueCostsNotRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:to="ifrs-full_IssueCostsNotRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_lbl0" xml:lang="en-US">Weighted average exercise price of share options expired in share-based payment arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RetainedEarningsMember_lbl0" xml:lang="en-US">Retained earnings [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarningsMember" xlink:to="ifrs-full_RetainedEarningsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InventoriesIncorporatedThroughTheBusinessCombination_lbl1" xml:lang="en-US">Inventories Incorporated Through The Business Combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InventoriesIncorporatedThroughTheBusinessCombination" xlink:to="mlec_InventoriesIncorporatedThroughTheBusinessCombination_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfAccumulatedTaxLossCarryforwardsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfAccumulatedTaxLossCarryforwardsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfAccumulatedTaxLossCarryforwardsAbstract_lbl" xml:lang="en-US">Schedule Of Accumulated Tax Loss Carryforwards Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfAccumulatedTaxLossCarryforwardsAbstract" xlink:to="mlec_ScheduleOfAccumulatedTaxLossCarryforwardsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_lbl0" xml:lang="en-US">Disclosure of other operating income (expense) [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CashPaidInKindInterest_lbl1" xml:lang="en-US">Cash Paid In Kind Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CashPaidInKindInterest" xlink:to="mlec_CashPaidInKindInterest_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BioceresSABioceresLLCMember_lbl0" xml:lang="en-US">Bioceres SABioceres LLCMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresSABioceresLLCMember" xlink:to="mlec_BioceresSABioceresLLCMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeferredPaymentRelatedToBusinessCombination_lbl1" xml:lang="en-US">Deferred Payment Related To Business Combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredPaymentRelatedToBusinessCombination" xlink:to="mlec_DeferredPaymentRelatedToBusinessCombination_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentAssets_lbl0" xml:lang="en-US">Non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ConsolidatedStatementsOfChangesInEquityAbstract" xlink:href="mlec-20230630.xsd#mlec_ConsolidatedStatementsOfChangesInEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ConsolidatedStatementsOfChangesInEquityAbstract_lbl" xml:lang="en-US">Consolidated Statements Of Changes In Equity Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsolidatedStatementsOfChangesInEquityAbstract" xlink:to="mlec_ConsolidatedStatementsOfChangesInEquityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl0" xml:lang="en-US">Expected dividend as percentage, share options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Income Tax For Other Jurisdictions Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock" xlink:to="mlec_ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EarningsPerShareExplanatory_lbl0" xml:lang="en-US">Earnings per share [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EarningsPerShareExplanatory" xlink:to="ifrs-full_EarningsPerShareExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExplanatory_lbl0" xml:lang="en-US">Disclosure of finance income [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinanceIncomeExplanatory" xlink:to="ifrs-full_DisclosureOfFinanceIncomeExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_lbl0" xml:lang="en-US">Disclosure of finance income (cost) [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_lbl0" xml:lang="en-US">Number of shares reserved for issue under options and contracts for sale of shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" xlink:to="ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl0" xml:lang="en-US">Increase (decrease) in cash and cash equivalents after effect of exchange rate changes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ProceedsFromSAFE_lbl1" xml:lang="en-US">Proceeds From SAFE</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProceedsFromSAFE" xlink:to="mlec_ProceedsFromSAFE_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IssueOfShareCapitalLightJumpShares_lbl1" xml:lang="en-US">Issue Of Share Capital Light Jump Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssueOfShareCapitalLightJumpShares" xlink:to="mlec_IssueOfShareCapitalLightJumpShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareBasedPaymentCostOfListingSharesnoncashItem_lbl0" xml:lang="en-US">Share Based Payment Cost Of Listing Sharesnoncash Item</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentCostOfListingSharesnoncashItem" xlink:to="mlec_ShareBasedPaymentCostOfListingSharesnoncashItem_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NumberOfSharesIssueOfShareCapitalinShares_lbl1" xml:lang="en-US">Number Of Shares Issue Of Share Capitalin Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfSharesIssueOfShareCapitalinShares" xlink:to="mlec_NumberOfSharesIssueOfShareCapitalinShares_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfEstimatedFutureTaxableProfitAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfEstimatedFutureTaxableProfitAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfEstimatedFutureTaxableProfitAbstract_lbl" xml:lang="en-US">Schedule Of Estimated Future Taxable Profit Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfEstimatedFutureTaxableProfitAbstract" xlink:to="mlec_ScheduleOfEstimatedFutureTaxableProfitAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxRateEffectOfForeignTaxRates_lbl0" xml:lang="en-US">Tax rate effect of foreign tax rates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxRateEffectOfForeignTaxRates" xlink:to="ifrs-full_TaxRateEffectOfForeignTaxRates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl0" xml:lang="en-US">Expected volatility, share options granted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CashandCashEquivalentsTablesLineItems_lbl0" xml:lang="en-US">Cashand Cash Equivalents Tables Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CashandCashEquivalentsTablesLineItems" xlink:to="mlec_CashandCashEquivalentsTablesLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfNetAssetsAcquiredAndGoodwillAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfNetAssetsAcquiredAndGoodwillAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfNetAssetsAcquiredAndGoodwillAbstract_lbl" xml:lang="en-US">Schedule Of Net Assets Acquired And Goodwill Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfNetAssetsAcquiredAndGoodwillAbstract" xlink:to="mlec_ScheduleOfNetAssetsAcquiredAndGoodwillAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfIntangibleAssetsExplanatoryTableTextBlock_lbl0" xml:lang="en-US">Disclosure Of Intangible Assets Explanatory Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfIntangibleAssetsExplanatoryTableTextBlock" xlink:to="mlec_DisclosureOfIntangibleAssetsExplanatoryTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeferredTaxLiabilityAbstract_lbl0" xml:lang="en-US">Deferred Tax Liability Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxLiabilityAbstract" xlink:to="mlec_DeferredTaxLiabilityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationExpense_lbl0" xml:lang="en-US">Depreciation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationExpense" xlink:to="ifrs-full_DepreciationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DescriptionOfAccountingPolicyForForeignCurrencyTextBlock_lbl1" xml:lang="en-US">Description Of Accounting Policy For Foreign Currency Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForForeignCurrencyTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForForeignCurrencyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_StorageMember_lbl0" xml:lang="en-US">Storage Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_StorageMember" xlink:to="mlec_StorageMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TotalGoodwill_lbl1" xml:lang="en-US">Total Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalGoodwill" xlink:to="mlec_TotalGoodwill_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IssueOfAdditionalSharesAbstract_lbl0" xml:lang="en-US">Issue Of Additional Shares Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssueOfAdditionalSharesAbstract" xlink:to="mlec_IssueOfAdditionalSharesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComputerEquipmentMember_lbl1" xml:lang="en-US">Computer equipment [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComputerEquipmentMember" xlink:to="ifrs-full_ComputerEquipmentMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeferredPaymentAfter6Months_lbl1" xml:lang="en-US">Deferred Payment After6 Months</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredPaymentAfter6Months" xlink:to="mlec_DeferredPaymentAfter6Months_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumAbstract_lbl" xml:lang="en-US">Schedule Of Reconciliation Of Share Capital And Share Premium Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumAbstract" xlink:to="mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ExercisePriceAtTheBeginning_lbl1" xml:lang="en-US">Exercise Price At The Beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExercisePriceAtTheBeginning" xlink:to="mlec_ExercisePriceAtTheBeginning_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_Others_lbl1" xml:lang="en-US">Others</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Others" xlink:to="mlec_Others_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl0" xml:lang="en-US">Auditor Location</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FutureFoodsBVMember_lbl1" xml:lang="en-US">Future Foods BVMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FutureFoodsBVMember" xlink:to="mlec_FutureFoodsBVMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_Proceedsfromissuanceofsharecapital_lbl1" xml:lang="en-US">Proceedsfromissuanceofsharecapital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Proceedsfromissuanceofsharecapital" xlink:to="mlec_Proceedsfromissuanceofsharecapital_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_WarrantAndRightsOutstanding_lbl2" xml:lang="en-US">Warrant And Rights Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_WarrantAndRightsOutstanding" xlink:to="mlec_WarrantAndRightsOutstanding_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FairValueOfSharesinShares_lbl1" xml:lang="en-US">Fair Value Of Sharesin Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FairValueOfSharesinShares" xlink:to="mlec_FairValueOfSharesinShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl0" xml:lang="en-US">Repayments of borrowings, classified as financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NonCurrentAssetsAbstract_lbl0" xml:lang="en-US">Non Current Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NonCurrentAssetsAbstract" xlink:to="mlec_NonCurrentAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AsOfJune302021Abstract_lbl0" xml:lang="en-US">As Of June302021 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AsOfJune302021Abstract" xlink:to="mlec_AsOfJune302021Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock_lbl0" xml:lang="en-US">Schedule Of Net Deferred Tax Liabilities Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock" xlink:to="mlec_ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for expenses [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareBasedPaymentCost_lbl0" xml:lang="en-US">Share Based Payment Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareBasedPaymentCost" xlink:to="mlec_ShareBasedPaymentCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UGVLAndTheoMember_lbl0" xml:lang="en-US">UGVLAnd Theo Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UGVLAndTheoMember" xlink:to="mlec_UGVLAndTheoMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities_lbl0" xml:lang="en-US">Interest paid, classified as financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OptionsRecognizedAmount_lbl1" xml:lang="en-US">Options Recognized Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OptionsRecognizedAmount" xlink:to="mlec_OptionsRecognizedAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for warrants [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCashAndCashEquivalents_lbl0" xml:lang="en-US">Other cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCashAndCashEquivalents" xlink:to="ifrs-full_OtherCashAndCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeferredTaxAssetAbstract_lbl0" xml:lang="en-US">Deferred Tax Asset Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxAssetAbstract" xlink:to="mlec_DeferredTaxAssetAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl0" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfCostOfSalesTableTextBlock_lbl0" xml:lang="en-US">Schedule Of Cost Of Sales Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfCostOfSalesTableTextBlock" xlink:to="mlec_ScheduleOfCostOfSalesTableTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfTradeAndOtherReceivablesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfTradeAndOtherReceivablesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfTradeAndOtherReceivablesAbstract_lbl" xml:lang="en-US">Schedule Of Trade And Other Receivables Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfTradeAndOtherReceivablesAbstract" xlink:to="mlec_ScheduleOfTradeAndOtherReceivablesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AGBiomoleculesLLCDEMember_lbl0" xml:lang="en-US">AGBiomolecules LLCDEMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AGBiomoleculesLLCDEMember" xlink:to="mlec_AGBiomoleculesLLCDEMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxLiabilities_lbl2" xml:lang="en-US">Deferred tax liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxLiabilities" xlink:to="ifrs-full_DeferredTaxLiabilities_lbl2"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfTradeReceivableAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfTradeReceivableAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfTradeReceivableAbstract_lbl" xml:lang="en-US">Schedule Of Trade Receivable Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfTradeReceivableAbstract" xlink:to="mlec_ScheduleOfTradeReceivableAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherLiabilities_lbl2" xml:lang="en-US">Other liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherLiabilities" xlink:to="ifrs-full_OtherLiabilities_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CompanySCashBalanceInOtherSAccountsAbstract_lbl0" xml:lang="en-US">Company SCash Balance In Other SAccounts Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CompanySCashBalanceInOtherSAccountsAbstract" xlink:to="mlec_CompanySCashBalanceInOtherSAccountsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl0" xml:lang="en-US">Entity Address, Country</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SharesIssuedAmountEquitySettledShareBasedPayment_lbl1" xml:lang="en-US">Shares Issued Amount Equity Settled Share Based Payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesIssuedAmountEquitySettledShareBasedPayment" xlink:to="mlec_SharesIssuedAmountEquitySettledShareBasedPayment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherNoncurrentReceivables_lbl0" xml:lang="en-US">Other non-current receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentReceivables" xlink:to="ifrs-full_OtherNoncurrentReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue_lbl0" xml:lang="en-US">Financial Instruments Designated As Hedging Instrument At Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue" xlink:to="mlec_FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherOperatingExpense_lbl1" xml:lang="en-US">Other Operating Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherOperatingExpense" xlink:to="mlec_OtherOperatingExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BioceresSAMember_lbl0" xml:lang="en-US">Bioceres SAMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresSAMember" xlink:to="mlec_BioceresSAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Increase (decrease) through net exchange differences, property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfGoodwillExplanatory_lbl0" xml:lang="en-US">Disclosure of goodwill [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGoodwillExplanatory" xlink:to="ifrs-full_DisclosureOfGoodwillExplanatory_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfFinancialDebtAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfFinancialDebtAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfFinancialDebtAbstract_lbl" xml:lang="en-US">Schedule Of Financial Debt Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfFinancialDebtAbstract" xlink:to="mlec_ScheduleOfFinancialDebtAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory_lbl0" xml:lang="en-US">Disclosure of fair value measurement of liabilities [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValue_lbl0" xml:lang="en-US">Financial liabilities, at fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesAtFairValue" xlink:to="ifrs-full_FinancialLiabilitiesAtFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PurchasePrice_lbl1" xml:lang="en-US">Purchase Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PurchasePrice" xlink:to="mlec_PurchasePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfNetAssetsAcquiredAndGoodwill_lbl0" xml:lang="en-US">Schedule Of Net Assets Acquired And Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfNetAssetsAcquiredAndGoodwill" xlink:to="mlec_ScheduleOfNetAssetsAcquiredAndGoodwill_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfConsolidatedFinancialStatementsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfConsolidatedFinancialStatementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfConsolidatedFinancialStatementsAbstract_lbl" xml:lang="en-US">Schedule Of Consolidated Financial Statements Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfConsolidatedFinancialStatementsAbstract" xlink:to="mlec_ScheduleOfConsolidatedFinancialStatementsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_VehiclesMember_lbl1" xml:lang="en-US">Vehicles [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_VehiclesMember" xlink:to="ifrs-full_VehiclesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsExplanatory_lbl0" xml:lang="en-US">Disclosure of business combinations [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:to="ifrs-full_DisclosureOfBusinessCombinationsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares_lbl0" xml:lang="en-US">Proceeds from issue of ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfStatutoryTaxesInCountriesTableTextBlock_lbl1" xml:lang="en-US">Disclosure Of Statutory Taxes In Countries Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfStatutoryTaxesInCountriesTableTextBlock" xlink:to="mlec_DisclosureOfStatutoryTaxesInCountriesTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NumberOfOptionsExpiredDuringThePeriod_lbl1" xml:lang="en-US">Number Of Options Expired During The Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfOptionsExpiredDuringThePeriod" xlink:to="mlec_NumberOfOptionsExpiredDuringThePeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AsociacinMutualAMALoansMember_lbl0" xml:lang="en-US">Asociacin Mutual AMALoans Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AsociacinMutualAMALoansMember" xlink:to="mlec_AsociacinMutualAMALoansMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities_lbl0" xml:lang="en-US">Dividends paid to equity holders of parent, classified as financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:to="ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialDebts_lbl1" xml:lang="en-US">Financial Debts</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialDebts" xlink:to="mlec_FinancialDebts_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfForeignCurrencyExchangeRiskAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfForeignCurrencyExchangeRiskAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfForeignCurrencyExchangeRiskAbstract_lbl" xml:lang="en-US">Schedule Of Foreign Currency Exchange Risk Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfForeignCurrencyExchangeRiskAbstract" xlink:to="mlec_ScheduleOfForeignCurrencyExchangeRiskAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ExercisePriceExpiredDuringThePeriod_lbl1" xml:lang="en-US">Exercise Price Expired During The Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExercisePriceExpiredDuringThePeriod" xlink:to="mlec_ExercisePriceExpiredDuringThePeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_Group3GrantedMember_lbl0" xml:lang="en-US">Group3 Granted Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Group3GrantedMember" xlink:to="mlec_Group3GrantedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherFinanceIncomeCost_lbl0" xml:lang="en-US">Other finance income (cost)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherFinanceIncomeCost" xlink:to="ifrs-full_OtherFinanceIncomeCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareToBeIssuedAmount_lbl3" xml:lang="en-US">Share To Be Issued Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareToBeIssuedAmount" xlink:to="mlec_ShareToBeIssuedAmount_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_Group1GrantedMember_lbl0" xml:lang="en-US">Group1 Granted Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Group1GrantedMember" xlink:to="mlec_Group1GrantedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NumberOfSharesToBeIssuedOfContingentPayment_lbl1" xml:lang="en-US">Number Of Shares To Be Issued Of Contingent Payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfSharesToBeIssuedOfContingentPayment" xlink:to="mlec_NumberOfSharesToBeIssuedOfContingentPayment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IncreasedecreaseInterestPayable_lbl1" xml:lang="en-US">Increasedecrease Interest Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncreasedecreaseInterestPayable" xlink:to="mlec_IncreasedecreaseInterestPayable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfInventoriesTableTextBlock_lbl1" xml:lang="en-US">Disclosure Of Inventories Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfInventoriesTableTextBlock" xlink:to="mlec_DisclosureOfInventoriesTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CountryOfIncorporation_lbl0" xml:lang="en-US">Country of incorporation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CountryOfIncorporation" xlink:to="ifrs-full_CountryOfIncorporation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl0" xml:lang="en-US">Description of accounting policy for determining components of cash and cash equivalents [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ExpensesPaidOnBehalfOfTheCompanyAbstract_lbl0" xml:lang="en-US">Expenses Paid On Behalf Of The Company Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExpensesPaidOnBehalfOfTheCompanyAbstract" xlink:to="mlec_ExpensesPaidOnBehalfOfTheCompanyAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl0" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncomeAbstract_lbl0" xml:lang="en-US">Other comprehensive income [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="ifrs-full_OtherComprehensiveIncomeAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for financial liabilities [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelEmailAddress_lbl0" xml:lang="en-US">Contact Personnel Email Address</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelEmailAddress" xlink:to="dei_ContactPersonnelEmailAddress_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfCostOfSalesExplanatory_lbl0" xml:lang="en-US">Disclosure of cost of sales [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCostOfSalesExplanatory" xlink:to="ifrs-full_DisclosureOfCostOfSalesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Borrowings_lbl0" xml:lang="en-US">Borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Borrowings" xlink:to="ifrs-full_Borrowings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock_lbl1" xml:lang="en-US">Description Of Accounting Policy For Accounts Payable And Other Liabilities Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PurchasePricePerShare_lbl1" xml:lang="en-US">Purchase Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PurchasePricePerShare" xlink:to="mlec_PurchasePricePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ExercisePriceExercisedDuringThePeriod_lbl1" xml:lang="en-US">Exercise Price Exercised During The Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExercisePriceExercisedDuringThePeriod" xlink:to="mlec_ExercisePriceExercisedDuringThePeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ResearchandDevelopmentExpenseTablesLineItems_lbl0" xml:lang="en-US">Researchand Development Expense Tables Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ResearchandDevelopmentExpenseTablesLineItems" xlink:to="mlec_ResearchandDevelopmentExpenseTablesLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of financial position [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_StatementOfFinancialPositionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AnalysisOfAgeOfFinancialAssetsThatArePastDueButNotImpaired_lbl0" xml:lang="en-US">Analysis of age of financial assets that are past due but not impaired [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AnalysisOfAgeOfFinancialAssetsThatArePastDueButNotImpaired" xlink:to="ifrs-full_AnalysisOfAgeOfFinancialAssetsThatArePastDueButNotImpaired_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_Equivalent_lbl1" xml:lang="en-US">Equivalent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Equivalent" xlink:to="mlec_Equivalent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashEquivalents_lbl0" xml:lang="en-US">Cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashEquivalents" xlink:to="ifrs-full_CashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl0" xml:lang="en-US">Cash flows from (used in) investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRestrictedCashAndCashEquivalentsExplanatory_lbl0" xml:lang="en-US">Disclosure of restricted cash and cash equivalents [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRestrictedCashAndCashEquivalentsExplanatory" xlink:to="ifrs-full_DisclosureOfRestrictedCashAndCashEquivalentsExplanatory_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfShareBasedPaymentAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfShareBasedPaymentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfShareBasedPaymentAbstract_lbl" xml:lang="en-US">Schedule Of Share Based Payment Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfShareBasedPaymentAbstract" xlink:to="mlec_ScheduleOfShareBasedPaymentAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsMember_lbl0" xml:lang="en-US">Financial instruments, class [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AmortizationExpense_lbl1" xml:lang="en-US">Amortization Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AmortizationExpense" xlink:to="mlec_AmortizationExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Reconciliation Of Share Capital And Share Premium Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock" xlink:to="mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssetsLiabilities_lbl0" xml:lang="en-US">Current assets (liabilities)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssetsLiabilities" xlink:to="ifrs-full_CurrentAssetsLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TaxBenefitForTheYear_lbl0" xml:lang="en-US">Tax Benefit For The Year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxBenefitForTheYear" xlink:to="mlec_TaxBenefitForTheYear_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_YearEndedJune302023Abstract0_lbl0" xml:lang="en-US">Year Ended June302023 Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_YearEndedJune302023Abstract0" xlink:to="mlec_YearEndedJune302023Abstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherPayables_lbl0" xml:lang="en-US">Other payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherPayables" xlink:to="ifrs-full_OtherPayables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCurrentNonfinancialLiabilities_lbl0" xml:lang="en-US">Other current non-financial liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentNonfinancialLiabilities" xlink:to="ifrs-full_OtherCurrentNonfinancialLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BioceresCropSolutionsCorpMember_lbl0" xml:lang="en-US">Bioceres Crop Solutions Corp Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresCropSolutionsCorpMember" xlink:to="mlec_BioceresCropSolutionsCorpMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl0" xml:lang="en-US">Auditor Firm ID</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssetsAbstract_lbl0" xml:lang="en-US">Current assets [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_lbl0" xml:lang="en-US">Disclosure of trade and other receivables [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:to="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax_lbl0" xml:lang="en-US">Share of other comprehensive income of associates and joint ventures accounted for using equity method that will be reclassified to profit or loss, net of tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_HSBCBankBankOverdraftsMember_lbl0" xml:lang="en-US">HSBCBank Bank Overdrafts Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_HSBCBankBankOverdraftsMember" xlink:to="mlec_HSBCBankBankOverdraftsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncomeTaxExpense_lbl0" xml:lang="en-US">Adjustments for income tax expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:to="ifrs-full_AdjustmentsForIncomeTaxExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashTransferred_lbl0" xml:lang="en-US">Cash transferred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashTransferred" xlink:to="ifrs-full_CashTransferred_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherOperatingExpenseTablesLineItems_lbl0" xml:lang="en-US">Other Operating Expense Tables Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherOperatingExpenseTablesLineItems" xlink:to="mlec_OtherOperatingExpenseTablesLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_lbl0" xml:lang="en-US">Unused tax losses for which no deferred tax asset recognised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:to="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FixedAssets_lbl1" xml:lang="en-US">Fixed Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FixedAssets" xlink:to="mlec_FixedAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei_lbl0" xml:lang="en-US">Issue Of Share Capital And Share Premium Of New Shareholders Through Other Non Current Recei</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei" xlink:to="mlec_IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ArgentinePriceIndexes_lbl1" xml:lang="en-US">Argentine Price Indexes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ArgentinePriceIndexes" xlink:to="mlec_ArgentinePriceIndexes_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_EventsAfterTheReportingPeriodAbstract" xlink:href="mlec-20230630.xsd#mlec_EventsAfterTheReportingPeriodAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_EventsAfterTheReportingPeriodAbstract_lbl" xml:lang="en-US">Events After The Reporting Period Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EventsAfterTheReportingPeriodAbstract" xlink:to="mlec_EventsAfterTheReportingPeriodAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdministrativeExpense_lbl1" xml:lang="en-US">Administrative expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdministrativeExpense" xlink:to="ifrs-full_AdministrativeExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_EquitySettledShareBasedPayment_lbl1" xml:lang="en-US">Equity Settled Share Based Payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EquitySettledShareBasedPayment" xlink:to="mlec_EquitySettledShareBasedPayment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SAFECapitalization_lbl1" xml:lang="en-US">SAFECapitalization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SAFECapitalization" xlink:to="mlec_SAFECapitalization_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ResearchAndDevelopmentExpense_lbl1" xml:lang="en-US">Research and development expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ResearchAndDevelopmentExpense" xlink:to="ifrs-full_ResearchAndDevelopmentExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AcquisitionOfBusinessCombinationTroughDeferredPayment_lbl1" xml:lang="en-US">Acquisition Of Business Combination Trough Deferred Payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AcquisitionOfBusinessCombinationTroughDeferredPayment" xlink:to="mlec_AcquisitionOfBusinessCombinationTroughDeferredPayment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TwoThousandTwentyTwoMember_lbl0" xml:lang="en-US">Two Thousand Twenty Two Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TwoThousandTwentyTwoMember" xlink:to="mlec_TwoThousandTwentyTwoMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl0" xml:lang="en-US">Expense from share-based payment transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CostOfSales_lbl1" xml:lang="en-US">Cost of sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CostOfSales" xlink:to="ifrs-full_CostOfSales_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl0" xml:lang="en-US">Consideration transferred, acquisition-date fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_lbl0" xml:lang="en-US">Disclosure of maturity analysis for derivative financial liabilities [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:to="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_WithoutAnyEstablishedTermMember_lbl0" xml:lang="en-US">Without Any Established Term Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_WithoutAnyEstablishedTermMember" xlink:to="mlec_WithoutAnyEstablishedTermMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory_lbl0" xml:lang="en-US">Disclosure of financial liabilities [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioForecastMember_lbl0" xml:lang="en-US">Forecast [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind_lbl1" xml:lang="en-US">Acquisition Of Business Combination Trough Deferred Payment In Kind</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind" xlink:to="mlec_AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LoansAndReceivables_lbl0" xml:lang="en-US">Loans and receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LoansAndReceivables" xlink:to="ifrs-full_LoansAndReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MicrooFoodsIngredientsSLMember_lbl0" xml:lang="en-US">Microo Foods Ingredients SLMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MicrooFoodsIngredientsSLMember" xlink:to="mlec_MicrooFoodsIngredientsSLMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_lbl0" xml:lang="en-US">Disclosure of general and administrative expense [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl0" xml:lang="en-US">Document Accounting Standard</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialAssetsExplanatory_lbl0" xml:lang="en-US">Disclosure of financial assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl0" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceIncomeCost_lbl0" xml:lang="en-US">Finance income (cost)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncomeCost" xlink:to="ifrs-full_FinanceIncomeCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BorrowingMaturity_lbl0" xml:lang="en-US">Borrowing Maturity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BorrowingMaturity" xlink:to="mlec_BorrowingMaturity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromIssuingOtherEquityInstruments_lbl0" xml:lang="en-US">Proceeds from issuing other equity instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromIssuingOtherEquityInstruments" xlink:to="ifrs-full_ProceedsFromIssuingOtherEquityInstruments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for goodwill [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_Cost_lbl1" xml:lang="en-US">Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Cost" xlink:to="mlec_Cost_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RawMaterials_lbl0" xml:lang="en-US">Current raw materials</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RawMaterials" xlink:to="ifrs-full_RawMaterials_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ExperienceDate_lbl1" xml:lang="en-US">Experience Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExperienceDate" xlink:to="mlec_ExperienceDate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentPayablesToRelatedParties_lbl0" xml:lang="en-US">Non-current payables to related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentPayablesToRelatedParties" xlink:to="ifrs-full_NoncurrentPayablesToRelatedParties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SimpleAgreementForFutureEquitySAFETextBlock_lbl0" xml:lang="en-US">Simple Agreement For Future Equity SAFEText Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SimpleAgreementForFutureEquitySAFETextBlock" xlink:to="mlec_SimpleAgreementForFutureEquitySAFETextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock_lbl1" xml:lang="en-US">Disclosure Of General And Administrative Expenses Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock" xlink:to="mlec_DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl0" xml:lang="en-US">Share of profit (loss) of associates and joint ventures accounted for using equity method</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FairValueThroughProfitOrLossAbstract0_lbl0" xml:lang="en-US">Fair Value Through Profit Or Loss Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FairValueThroughProfitOrLossAbstract0" xlink:to="mlec_FairValueThroughProfitOrLossAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MutualFunds_lbl1" xml:lang="en-US">Mutual Funds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MutualFunds" xlink:to="mlec_MutualFunds_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember_lbl0" xml:lang="en-US">Bioceres SAINDEARSAInstituto De Agrobiotecnologa Rosario Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember" xlink:to="mlec_BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLoss_lbl2" xml:lang="en-US">Profit (loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ContinuingOperationsAbstract_lbl0" xml:lang="en-US">Continuing Operations Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ContinuingOperationsAbstract" xlink:to="mlec_ContinuingOperationsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AsOfJune302023Abstract_lbl0" xml:lang="en-US">As Of June302023 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AsOfJune302023Abstract" xlink:to="mlec_AsOfJune302023Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BancoNacinPreFinancingOfExportsMember_lbl0" xml:lang="en-US">Banco Nacin Pre Financing Of Exports Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BancoNacinPreFinancingOfExportsMember" xlink:to="mlec_BancoNacinPreFinancingOfExportsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_US_lbl0" xml:lang="en-US">UNITED STATES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl0" xml:lang="en-US">Disclosure of detailed information about intangible assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Equity_lbl2" xml:lang="en-US">Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl0" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherRelatedPartyBalances_lbl0" xml:lang="en-US">Other Related Party Balances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherRelatedPartyBalances" xlink:to="mlec_OtherRelatedPartyBalances_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeStatementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeStatementAbstract_lbl" xml:lang="en-US">Profit or loss [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_IncomeStatementAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossBeforeTax_lbl0" xml:lang="en-US">Profit (loss) before tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossBeforeTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for business combinations [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeferredTaxAssetsGrossAmount_lbl1" xml:lang="en-US">Deferred Tax Assets Gross Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxAssetsGrossAmount" xlink:to="mlec_DeferredTaxAssetsGrossAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CumulativeInflationRate_lbl1" xml:lang="en-US">Cumulative Inflation Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CumulativeInflationRate" xlink:to="mlec_CumulativeInflationRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_lbl0" xml:lang="en-US">Current payables to related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SharesToBeIssuedAmountFromBusinessAcquisition_lbl1" xml:lang="en-US">Shares To Be Issued Amount From Business Acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesToBeIssuedAmountFromBusinessAcquisition" xlink:to="mlec_SharesToBeIssuedAmountFromBusinessAcquisition_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherReceivables_lbl0" xml:lang="en-US">Other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherReceivables" xlink:to="ifrs-full_OtherReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ChargedToOtherComprehensiveIncome_lbl1" xml:lang="en-US">Charged To Other Comprehensive Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChargedToOtherComprehensiveIncome" xlink:to="mlec_ChargedToOtherComprehensiveIncome_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_lbl0" xml:lang="en-US">Acquisitions through business combinations, intangible assets and goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract18_lbl0" xml:lang="en-US">Unlabeled Abstract18</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract18" xlink:to="mlec_UnlabeledAbstract18_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary_lbl0" xml:lang="en-US">Country of incorporation of subsidiary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary" xlink:to="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnionGroupVenturesLimitedMember_lbl0" xml:lang="en-US">Union Group Ventures Limited Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnionGroupVenturesLimitedMember" xlink:to="mlec_UnionGroupVenturesLimitedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract16_lbl0" xml:lang="en-US">Unlabeled Abstract16</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract16" xlink:to="mlec_UnlabeledAbstract16_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract17_lbl0" xml:lang="en-US">Unlabeled Abstract17</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract17" xlink:to="mlec_UnlabeledAbstract17_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SharesIssuedAmount_lbl2" xml:lang="en-US">Shares Issued Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesIssuedAmount" xlink:to="mlec_SharesIssuedAmount_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AsOfJune302021Abstract0_lbl0" xml:lang="en-US">As Of June302021 Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AsOfJune302021Abstract0" xlink:to="mlec_AsOfJune302021Abstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UpToThreeMonthsMember_lbl0" xml:lang="en-US">Up To Three Months Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UpToThreeMonthsMember" xlink:to="mlec_UpToThreeMonthsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl0" xml:lang="en-US">Additions other than through business combinations, intangible assets other than goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for share-based payment transactions [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BalancesWithBanks_lbl0" xml:lang="en-US">Balances with banks</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BalancesWithBanks" xlink:to="ifrs-full_BalancesWithBanks_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ArgentinePesosMember_lbl0" xml:lang="en-US">Argentine Pesos Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ArgentinePesosMember" xlink:to="mlec_ArgentinePesosMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities_lbl0" xml:lang="en-US">Proceeds from sales or maturity of financial instruments, classified as investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities" xlink:to="ifrs-full_ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BancoGaliciaBankOverdraftsMember_lbl0" xml:lang="en-US">Banco Galicia Bank Overdrafts Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BancoGaliciaBankOverdraftsMember" xlink:to="mlec_BancoGaliciaBankOverdraftsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TaxesDutiesAndPenalties_lbl1" xml:lang="en-US">Taxes Duties And Penalties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxesDutiesAndPenalties" xlink:to="mlec_TaxesDutiesAndPenalties_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_lbl0" xml:lang="en-US">Short-term deposits, classified as cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:to="ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NetBookAmountMember_lbl0" xml:lang="en-US">Net Book Amount Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetBookAmountMember" xlink:to="mlec_NetBookAmountMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherNoncurrentLiabilities_lbl1" xml:lang="en-US">Other non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentLiabilities" xlink:to="ifrs-full_OtherNoncurrentLiabilities_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfPrincipalStatutoryTaxesRatesInTheCountriesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfPrincipalStatutoryTaxesRatesInTheCountriesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfPrincipalStatutoryTaxesRatesInTheCountriesAbstract_lbl" xml:lang="en-US">Schedule Of Principal Statutory Taxes Rates In The Countries Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfPrincipalStatutoryTaxesRatesInTheCountriesAbstract" xlink:to="mlec_ScheduleOfPrincipalStatutoryTaxesRatesInTheCountriesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_YearEndedJune302022Abstract0_lbl0" xml:lang="en-US">Year Ended June302022 Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_YearEndedJune302022Abstract0" xlink:to="mlec_YearEndedJune302022Abstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAndCashEquivalents_lbl0" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentPayables_lbl1" xml:lang="en-US">Trade and other non-current payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentPayables" xlink:to="ifrs-full_NoncurrentPayables_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PurchaseConsiderationAbstract_lbl0" xml:lang="en-US">Purchase Consideration Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PurchaseConsiderationAbstract" xlink:to="mlec_PurchaseConsiderationAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfOtherOperatingExpensesTableTextBlock_lbl0" xml:lang="en-US">Schedule Of Other Operating Expenses Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfOtherOperatingExpensesTableTextBlock" xlink:to="mlec_ScheduleOfOtherOperatingExpensesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentFinancialLiabilities_lbl0" xml:lang="en-US">Current financial liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialLiabilities" xlink:to="ifrs-full_CurrentFinancialLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialLiabilitiesAbstract_lbl0" xml:lang="en-US">Financial Liabilities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialLiabilitiesAbstract" xlink:to="mlec_FinancialLiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentReceivablesFromSaleOfProperties_lbl0" xml:lang="en-US">Current receivables from sale of properties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentReceivablesFromSaleOfProperties" xlink:to="ifrs-full_CurrentReceivablesFromSaleOfProperties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherNoncurrentFinancialLiabilities_lbl1" xml:lang="en-US">Other non-current financial liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:to="ifrs-full_OtherNoncurrentFinancialLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for derivative financial instruments and hedging [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations_lbl0" xml:lang="en-US">Other comprehensive income, net of tax, hedges of net investments in foreign operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NetLossperShareTablesLineItems_lbl0" xml:lang="en-US">Net Lossper Share Tables Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetLossperShareTablesLineItems" xlink:to="mlec_NetLossperShareTablesLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TaxJurisdiction_lbl1" xml:lang="en-US">Tax Jurisdiction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxJurisdiction" xlink:to="mlec_TaxJurisdiction_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherInventories_lbl0" xml:lang="en-US">Other current inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherInventories" xlink:to="ifrs-full_OtherInventories_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for research and development expense [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ForeignCurrencyExchangeRiskLiabilities_lbl1" xml:lang="en-US">Foreign Currency Exchange Risk Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ForeignCurrencyExchangeRiskLiabilities" xlink:to="mlec_ForeignCurrencyExchangeRiskLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DeferredTaxAssetsTaxEffect_lbl0" xml:lang="en-US">Deferred Tax Assets Tax Effect</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DeferredTaxAssetsTaxEffect" xlink:to="mlec_DeferredTaxAssetsTaxEffect_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfTradeReceivableTextBlock_lbl1" xml:lang="en-US">Schedule Of Trade Receivable Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfTradeReceivableTextBlock" xlink:to="mlec_ScheduleOfTradeReceivableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_lbl1" xml:lang="en-US">Cash and cash equivalents if different from statement of financial position</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" xlink:to="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NumberOfSharesFromBusinessAcquisition_lbl1" xml:lang="en-US">Number Of Shares From Business Acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfSharesFromBusinessAcquisition" xlink:to="mlec_NumberOfSharesFromBusinessAcquisition_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromCurrentBorrowings_lbl0" xml:lang="en-US">Proceeds from current borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromCurrentBorrowings" xlink:to="ifrs-full_ProceedsFromCurrentBorrowings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl4" xml:lang="en-US">Property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_lbl4"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DilutedEarningsLossPerShare_lbl0" xml:lang="en-US">Diluted earnings (loss) per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerShare" xlink:to="ifrs-full_DilutedEarningsLossPerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract10_lbl0" xml:lang="en-US">Unlabeled Abstract10</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract10" xlink:to="mlec_UnlabeledAbstract10_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract11_lbl0" xml:lang="en-US">Unlabeled Abstract11</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract11" xlink:to="mlec_UnlabeledAbstract11_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract14_lbl0" xml:lang="en-US">Unlabeled Abstract14</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract14" xlink:to="mlec_UnlabeledAbstract14_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherFinancialResultsAbstract_lbl0" xml:lang="en-US">Other Financial Results Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherFinancialResultsAbstract" xlink:to="mlec_OtherFinancialResultsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract15_lbl0" xml:lang="en-US">Unlabeled Abstract15</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract15" xlink:to="mlec_UnlabeledAbstract15_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract12_lbl0" xml:lang="en-US">Unlabeled Abstract12</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract12" xlink:to="mlec_UnlabeledAbstract12_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsLineItems_lbl0" xml:lang="en-US">Net Lossper Share Details Scheduleof Net Loss Per Share Parentheticals Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsLineItems" xlink:to="mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract13_lbl0" xml:lang="en-US">Unlabeled Abstract13</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract13" xlink:to="mlec_UnlabeledAbstract13_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SharePurchaseAgreementOverPeriod_lbl1" xml:lang="en-US">Share Purchase Agreement Over Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharePurchaseAgreementOverPeriod" xlink:to="mlec_SharePurchaseAgreementOverPeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustedWeightedAverageShares_lbl0" xml:lang="en-US">Weighted average number of ordinary shares used in calculating diluted earnings per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustedWeightedAverageShares" xlink:to="ifrs-full_AdjustedWeightedAverageShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SharesIssuedAmountFromBusinessAcquisition_lbl1" xml:lang="en-US">Shares Issued Amount From Business Acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesIssuedAmountFromBusinessAcquisition" xlink:to="mlec_SharesIssuedAmountFromBusinessAcquisition_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuedCapital_lbl0" xml:lang="en-US">Issued capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapital" xlink:to="ifrs-full_IssuedCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NondeductibleExpensesListingCost_lbl0" xml:lang="en-US">Nondeductible Expenses Listing Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NondeductibleExpensesListingCost" xlink:to="mlec_NondeductibleExpensesListingCost_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfNetDeferredTaxLiabilitiesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfNetDeferredTaxLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfNetDeferredTaxLiabilitiesAbstract_lbl" xml:lang="en-US">Schedule Of Net Deferred Tax Liabilities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfNetDeferredTaxLiabilitiesAbstract" xlink:to="mlec_ScheduleOfNetDeferredTaxLiabilitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAndLiabilities_lbl0" xml:lang="en-US">Equity and liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_EquityAndLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_YearEndedJune302022Abstract_lbl0" xml:lang="en-US">Year Ended June302022 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_YearEndedJune302022Abstract" xlink:to="mlec_YearEndedJune302022Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SharesToBeIssuedAmountIssueOfShareCapital_lbl1" xml:lang="en-US">Shares To Be Issued Amount Issue Of Share Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesToBeIssuedAmountIssueOfShareCapital" xlink:to="mlec_SharesToBeIssuedAmountIssueOfShareCapital_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsInterestRate_lbl0" xml:lang="en-US">Borrowings, interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsInterestRate" xlink:to="ifrs-full_BorrowingsInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfAccountsPayable_lbl0" xml:lang="en-US">Schedule Of Accounts Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfAccountsPayable" xlink:to="mlec_ScheduleOfAccountsPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Accumulated Tax Loss Carryforwards Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock" xlink:to="mlec_ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract2_lbl0" xml:lang="en-US">Unlabeled Abstract2</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract2" xlink:to="mlec_UnlabeledAbstract2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract1_lbl0" xml:lang="en-US">Unlabeled Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract1" xlink:to="mlec_UnlabeledAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract4_lbl0" xml:lang="en-US">Unlabeled Abstract4</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract4" xlink:to="mlec_UnlabeledAbstract4_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract3_lbl0" xml:lang="en-US">Unlabeled Abstract3</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract3" xlink:to="mlec_UnlabeledAbstract3_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_lbl0" xml:lang="en-US">Increase (decrease) through net exchange differences, intangible assets other than goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NominalInterestRate_lbl1" xml:lang="en-US">Nominal Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NominalInterestRate" xlink:to="mlec_NominalInterestRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract0_lbl0" xml:lang="en-US">Unlabeled Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract0" xlink:to="mlec_UnlabeledAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BioceresLLCMember_lbl0" xml:lang="en-US">Bioceres LLCMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BioceresLLCMember" xlink:to="mlec_BioceresLLCMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock_lbl1" xml:lang="en-US">Description Of Accounting Policy For Subsidiaries And Joint Arrangements Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PayrollAndAndProfessionalFees_lbl1" xml:lang="en-US">Payroll And And Professional Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PayrollAndAndProfessionalFees" xlink:to="mlec_PayrollAndAndProfessionalFees_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract9_lbl0" xml:lang="en-US">Unlabeled Abstract9</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract9" xlink:to="mlec_UnlabeledAbstract9_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract6_lbl0" xml:lang="en-US">Unlabeled Abstract6</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract6" xlink:to="mlec_UnlabeledAbstract6_lbl0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of cash flows [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_StatementOfCashFlowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract5_lbl0" xml:lang="en-US">Unlabeled Abstract5</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract5" xlink:to="mlec_UnlabeledAbstract5_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IssueOfShareCapital_lbl1" xml:lang="en-US">Issue Of Share Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssueOfShareCapital" xlink:to="mlec_IssueOfShareCapital_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract8_lbl0" xml:lang="en-US">Unlabeled Abstract8</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract8" xlink:to="mlec_UnlabeledAbstract8_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract7_lbl0" xml:lang="en-US">Unlabeled Abstract7</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract7" xlink:to="mlec_UnlabeledAbstract7_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AuditLegalAndAccountancyFee_lbl0" xml:lang="en-US">Audit Legal And Accountancy Fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AuditLegalAndAccountancyFee" xlink:to="mlec_AuditLegalAndAccountancyFee_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherLiabilitie_lbl1" xml:lang="en-US">Other Liabilitie</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherLiabilitie" xlink:to="mlec_OtherLiabilitie_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense_lbl0" xml:lang="en-US">Selling, general and administrative expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTradeReceivables_lbl0" xml:lang="en-US">Current trade receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTradeReceivables" xlink:to="ifrs-full_CurrentTradeReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for trade and other receivables [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_lbl1" xml:lang="en-US">Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating diluted earnings per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RepairsAndMaintenanceExpense_lbl0" xml:lang="en-US">Repairs and maintenance expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RepairsAndMaintenanceExpense" xlink:to="ifrs-full_RepairsAndMaintenanceExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NetGainOnInflationEffectOnMonetaryItems_lbl1" xml:lang="en-US">Net Gain On Inflation Effect On Monetary Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetGainOnInflationEffectOnMonetaryItems" xlink:to="mlec_NetGainOnInflationEffectOnMonetaryItems_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SharePremiumMember_lbl0" xml:lang="en-US">Share premium [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharePremiumMember" xlink:to="ifrs-full_SharePremiumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SAFESharesMember_lbl0" xml:lang="en-US">SAFEShares Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SAFESharesMember" xlink:to="mlec_SAFESharesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_BusinessContactMember_lbl1" xml:lang="en-US">Business Contact [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax_lbl0" xml:lang="en-US">Reclassification adjustments on exchange differences on translation of foreign operations, net of tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" xlink:to="ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MoolecSAShareholdersMember_lbl0" xml:lang="en-US">Moolec SAShareholders Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MoolecSAShareholdersMember" xlink:to="mlec_MoolecSAShareholdersMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NumberOfStockInventories_lbl1" xml:lang="en-US">Number Of Stock Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfStockInventories" xlink:to="mlec_NumberOfStockInventories_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCurrentReceivables_lbl1" xml:lang="en-US">Other current receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentReceivables" xlink:to="ifrs-full_OtherCurrentReceivables_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnlabeledAbstract_lbl0" xml:lang="en-US">Unlabeled Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnlabeledAbstract" xlink:to="mlec_UnlabeledAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BancoMacroLoansMember_lbl0" xml:lang="en-US">Banco Macro Loans Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BancoMacroLoansMember" xlink:to="mlec_BancoMacroLoansMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncome_lbl0" xml:lang="en-US">Other comprehensive income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncome" xlink:to="ifrs-full_OtherComprehensiveIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLiabilities_lbl0" xml:lang="en-US">Current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CashPayment_lbl1" xml:lang="en-US">Cash Payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CashPayment" xlink:to="mlec_CashPayment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IssueOfShareCapitalSAFEShares_lbl1" xml:lang="en-US">Issue Of Share Capital SAFEShares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssueOfShareCapitalSAFEShares" xlink:to="mlec_IssueOfShareCapitalSAFEShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_lbl0" xml:lang="en-US">Adjustments for decrease (increase) in trade and other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_lbl1" xml:lang="en-US">Increase (decrease) in number of ordinary shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfContractualMaturityDateAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfContractualMaturityDateAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfContractualMaturityDateAbstract_lbl" xml:lang="en-US">Schedule Of Contractual Maturity Date Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfContractualMaturityDateAbstract" xlink:to="mlec_ScheduleOfContractualMaturityDateAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SharePurchaseAgreement_lbl1" xml:lang="en-US">Share Purchase Agreement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharePurchaseAgreement" xlink:to="mlec_SharePurchaseAgreement_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CommonStockExercised_lbl0" xml:lang="en-US">Common Stock Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CommonStockExercised" xlink:to="mlec_CommonStockExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NumberOfOptionsAtTheEnding_lbl1" xml:lang="en-US">Number Of Options At The Ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfOptionsAtTheEnding" xlink:to="mlec_NumberOfOptionsAtTheEnding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DescriptionOfAccountingPolicyForLossPerShareTextBlock_lbl1" xml:lang="en-US">Description Of Accounting Policy For Loss Per Share Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DescriptionOfAccountingPolicyForLossPerShareTextBlock" xlink:to="mlec_DescriptionOfAccountingPolicyForLossPerShareTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Depreciation, property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_lbl0" xml:lang="en-US">Current accrued expenses and other current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:to="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets_lbl0" xml:lang="en-US">Percentage of reasonably possible increase in unobservable input, assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets" xlink:to="ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_Group2Member_lbl0" xml:lang="en-US">Group2 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Group2Member" xlink:to="mlec_Group2Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory_lbl0" xml:lang="en-US">Disclosure of fair value of financial instruments [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FairValueThroughProfitOrLossAbstract_lbl0" xml:lang="en-US">Fair Value Through Profit Or Loss Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FairValueThroughProfitOrLossAbstract" xlink:to="mlec_FairValueThroughProfitOrLossAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentValueAddedTaxReceivables_lbl0" xml:lang="en-US">Current value added tax receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentValueAddedTaxReceivables" xlink:to="ifrs-full_CurrentValueAddedTaxReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments_lbl0" xml:lang="en-US">Adjustments for share-based payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForSharebasedPayments" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfCostOfSalesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfCostOfSalesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfCostOfSalesAbstract_lbl" xml:lang="en-US">Schedule Of Cost Of Sales Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfCostOfSalesAbstract" xlink:to="mlec_ScheduleOfCostOfSalesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Revenue_lbl0" xml:lang="en-US">Revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_Revenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_lbl0" xml:lang="en-US">Diluted earnings (loss) per share from discontinued operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:to="ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for property, plant and equipment [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfCondensedBalanceSheetTableTextBlock_lbl0" xml:lang="en-US">Condensed Balance Sheet [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:to="srt_ScheduleOfCondensedBalanceSheetTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl0" xml:lang="en-US">Cash flows from (used in) investing activities [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Acquisitions through business combinations, property, plant and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IssueOfShareCapitalBackstopShares_lbl1" xml:lang="en-US">Issue Of Share Capital Backstop Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssueOfShareCapitalBackstopShares" xlink:to="mlec_IssueOfShareCapitalBackstopShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WarrantLiability_lbl2" xml:lang="en-US">Warrant liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WarrantLiability" xlink:to="ifrs-full_WarrantLiability_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for income tax [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl0" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Cash_lbl0" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Cash" xlink:to="ifrs-full_Cash_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceCosts_lbl0" xml:lang="en-US">Finance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceCosts" xlink:to="ifrs-full_FinanceCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NetLiabilitiesAcquiredThroughIssuanceOfShareCapital_lbl0" xml:lang="en-US">Net Liabilities Acquired Through Issuance Of Share Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetLiabilitiesAcquiredThroughIssuanceOfShareCapital" xlink:to="mlec_NetLiabilitiesAcquiredThroughIssuanceOfShareCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SPCTechnologyMember_lbl0" xml:lang="en-US">SPCTechnology Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SPCTechnologyMember" xlink:to="mlec_SPCTechnologyMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_lbl0" xml:lang="en-US">Profit (loss) from operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_Accumulated_lbl1" xml:lang="en-US">Accumulated</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Accumulated" xlink:to="mlec_Accumulated_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl0" xml:lang="en-US">Cash flows from (used in) financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl0" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentFinancialAssets_lbl0" xml:lang="en-US">Current financial assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialAssets" xlink:to="ifrs-full_CurrentFinancialAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AggregateShares_lbl1" xml:lang="en-US">Aggregate Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AggregateShares" xlink:to="mlec_AggregateShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl0" xml:lang="en-US">Accumulated depreciation and amortisation [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory_lbl0" xml:lang="en-US">Disclosure of changes in accounting policies [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory" xlink:to="ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_Group1Member_lbl0" xml:lang="en-US">Group1 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Group1Member" xlink:to="mlec_Group1Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TaxlossCarryForward_lbl1" xml:lang="en-US">Taxloss Carry Forward</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TaxlossCarryForward" xlink:to="mlec_TaxlossCarryForward_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetDeferredTaxLiabilities_lbl1" xml:lang="en-US">Net deferred tax liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDeferredTaxLiabilities" xlink:to="ifrs-full_NetDeferredTaxLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ExercisePriceGrantedDuringThePeriod_lbl1" xml:lang="en-US">Exercise Price Granted During The Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExercisePriceGrantedDuringThePeriod" xlink:to="mlec_ExercisePriceGrantedDuringThePeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BusinessCombination_lbl1" xml:lang="en-US">Business Combination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BusinessCombination" xlink:to="mlec_BusinessCombination_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_lbl0" xml:lang="en-US">Adjustments to reconcile profit (loss) [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PricePerWarrant_lbl1" xml:lang="en-US">Price Per Warrant</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PricePerWarrant" xlink:to="mlec_PricePerWarrant_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TransactionsExpenses_lbl1" xml:lang="en-US">Transactions Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TransactionsExpenses" xlink:to="mlec_TransactionsExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions_lbl0" xml:lang="en-US">Effect Of Difference Tax Rates Subsidiaries Operating In Other Jurisdictions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions" xlink:to="mlec_EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IssueOfSharePremium_lbl1" xml:lang="en-US">Issue Of Share Premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssueOfSharePremium" xlink:to="mlec_IssueOfSharePremium_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NumberOfOptionsAtTheBeginning_lbl1" xml:lang="en-US">Number Of Options At The Beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfOptionsAtTheBeginning" xlink:to="mlec_NumberOfOptionsAtTheBeginning_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_GB_lbl0" xml:lang="en-US">UNITED KINGDOM</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_GB" xlink:to="country_GB_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl0" xml:lang="en-US">Document Annual Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NumberOfShareEquitySettledShareBasedPayment_lbl1" xml:lang="en-US">Number Of Share Equity Settled Share Based Payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfShareEquitySettledShareBasedPayment" xlink:to="mlec_NumberOfShareEquitySettledShareBasedPayment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RetainedEarnings_lbl0" xml:lang="en-US">Retained earnings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarnings" xlink:to="ifrs-full_RetainedEarnings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl0" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherIntangibleAssets_lbl0" xml:lang="en-US">Other intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherIntangibleAssets" xlink:to="ifrs-full_OtherIntangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ExchangeRateDifference_lbl1" xml:lang="en-US">Exchange Rate Difference</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExchangeRateDifference" xlink:to="mlec_ExchangeRateDifference_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComprehensiveIncome_lbl0" xml:lang="en-US">Comprehensive income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncome_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOtherRelatedPartyBalancesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherRelatedPartyBalancesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfOtherRelatedPartyBalancesAbstract_lbl" xml:lang="en-US">Schedule Of Other Related Party Balances Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfOtherRelatedPartyBalancesAbstract" xlink:to="mlec_ScheduleOfOtherRelatedPartyBalancesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss_lbl0" xml:lang="en-US">Change In Fair Value Of Simply Agreement For Future Equity SAFELoss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss" xlink:to="mlec_ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfAmountAndExercisePriceAndTheMovementsOfTheStockOptionsOfExecutivesAndManagersAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfAmountAndExercisePriceAndTheMovementsOfTheStockOptionsOfExecutivesAndManagersAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfAmountAndExercisePriceAndTheMovementsOfTheStockOptionsOfExecutivesAndManagersAbstract_lbl" xml:lang="en-US">Schedule Of Amount And Exercise Price And The Movements Of The Stock Options Of Executives And Managers Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfAmountAndExercisePriceAndTheMovementsOfTheStockOptionsOfExecutivesAndManagersAbstract" xlink:to="mlec_ScheduleOfAmountAndExercisePriceAndTheMovementsOfTheStockOptionsOfExecutivesAndManagersAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl0" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl0" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ToDueBecomeAbstract_lbl0" xml:lang="en-US">To Due Become Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ToDueBecomeAbstract" xlink:to="mlec_ToDueBecomeAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherNoncurrentNonfinancialLiabilities_lbl0" xml:lang="en-US">Other non-current non-financial liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentNonfinancialLiabilities" xlink:to="ifrs-full_OtherNoncurrentNonfinancialLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_lbl0" xml:lang="en-US">Disclosure of subsidiaries [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherOperatingIncomeExpense_lbl0" xml:lang="en-US">Other operating income (expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherOperatingIncomeExpense" xlink:to="ifrs-full_OtherOperatingIncomeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_lbl0" xml:lang="en-US">Cash flows from (used in) decrease (increase) in short-term deposits and investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:to="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InflationAccumulated_lbl1" xml:lang="en-US">Inflation Accumulated</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InflationAccumulated" xlink:to="mlec_InflationAccumulated_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue_lbl0" xml:lang="en-US">ifrs-full_ Financial Instrument Designated As Hedging Instruments At Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue" xlink:to="mlec_ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BorrowingOriginalCurrency_lbl1" xml:lang="en-US">Borrowing Original Currency</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BorrowingOriginalCurrency" xlink:to="mlec_BorrowingOriginalCurrency_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ConsiderationPaid_lbl1" xml:lang="en-US">Consideration Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConsiderationPaid" xlink:to="mlec_ConsiderationPaid_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SubtotalDerivatesLiabilities_lbl1" xml:lang="en-US">Subtotal Derivates Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SubtotalDerivatesLiabilities" xlink:to="mlec_SubtotalDerivatesLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SharePremiumIssueOfShareCapital_lbl1" xml:lang="en-US">Share Premium Issue Of Share Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharePremiumIssueOfShareCapital" xlink:to="mlec_SharePremiumIssueOfShareCapital_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl0" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ChymosinOsmosisEquipmentMember_lbl0" xml:lang="en-US">Chymosin Osmosis Equipment Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChymosinOsmosisEquipmentMember" xlink:to="mlec_ChymosinOsmosisEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesIssued_lbl1" xml:lang="en-US">Number of shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TotalFinancialCosts_lbl0" xml:lang="en-US">Total Financial Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalFinancialCosts" xlink:to="mlec_TotalFinancialCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MoolecSAFEMember_lbl0" xml:lang="en-US">Moolec SAFEMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MoolecSAFEMember" xlink:to="mlec_MoolecSAFEMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesLineItems_lbl0" xml:lang="en-US">Accounts Payableand Other Currentand Non Current Liabilities Tables Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesLineItems" xlink:to="mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl0" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ParValuePerShare_lbl0" xml:lang="en-US">Par value per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ParValuePerShare" xlink:to="ifrs-full_ParValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl0" xml:lang="en-US">Disclosure of earnings per share [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NonCashFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Non Cash Financing Activities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NonCashFinancingActivitiesAbstract" xlink:to="mlec_NonCashFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NegativeWorkingCapital_lbl1" xml:lang="en-US">Negative Working Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NegativeWorkingCapital" xlink:to="mlec_NegativeWorkingCapital_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory_lbl0" xml:lang="en-US">Disclosure of other non-current assets [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FairValueOfStockOptionsAtMeasurementDate_lbl1" xml:lang="en-US">Fair Value Of Stock Options At Measurement Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FairValueOfStockOptionsAtMeasurementDate" xlink:to="mlec_FairValueOfStockOptionsAtMeasurementDate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BetweenOneAndTwoYearsMember_lbl0" xml:lang="en-US">Between One And Two Years Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BetweenOneAndTwoYearsMember" xlink:to="mlec_BetweenOneAndTwoYearsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SubtotalNonDerivatesLiabilities_lbl1" xml:lang="en-US">Subtotal Non Derivates Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SubtotalNonDerivatesLiabilities" xlink:to="mlec_SubtotalNonDerivatesLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AccruedIncomeOtherThanContractAssets_lbl0" xml:lang="en-US">Accrued income other than contract assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccruedIncomeOtherThanContractAssets" xlink:to="ifrs-full_AccruedIncomeOtherThanContractAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_lbl0" xml:lang="en-US">Description of accounting policy for recognition of revenue [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_RelatedPartiesTablesLineItems_lbl0" xml:lang="en-US">Related Parties Tables Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_RelatedPartiesTablesLineItems" xlink:to="mlec_RelatedPartiesTablesLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfShortTermInvestmentsTableTextBlock_lbl1" xml:lang="en-US">Disclosure Of Short Term Investments Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfShortTermInvestmentsTableTextBlock" xlink:to="mlec_DisclosureOfShortTermInvestmentsTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AtFairValueMember_lbl0" xml:lang="en-US">At fair value [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AtFairValueMember" xlink:to="ifrs-full_AtFairValueMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Cash flows from (used in) financing activities [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Goodwill_lbl0" xml:lang="en-US">Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Goodwill" xlink:to="ifrs-full_Goodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_lbl0" xml:lang="en-US">Adjustments for decrease (increase) in trade accounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WarrantReserveMember_lbl0" xml:lang="en-US">Warrant reserve [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WarrantReserveMember" xlink:to="ifrs-full_WarrantReserveMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent_lbl0" xml:lang="en-US">Profit (loss), attributable to owners of parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:to="ifrs-full_ProfitLossAttributableToOwnersOfParent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BottomOfRangeMember_lbl2" xml:lang="en-US">Bottom of range [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BottomOfRangeMember" xlink:to="ifrs-full_BottomOfRangeMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_USD_lbl0" xml:lang="en-US">United States of America, Dollars</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_USD" xlink:to="currency_USD_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AssetAbstract_lbl0" xml:lang="en-US">Asset Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AssetAbstract" xlink:to="mlec_AssetAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl0" xml:lang="en-US">Disclosure of share capital, reserves and other equity interest [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:to="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ConstantValuePercentage_lbl1" xml:lang="en-US">Constant Value Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConstantValuePercentage" xlink:to="mlec_ConstantValuePercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherNoncurrentPayables_lbl0" xml:lang="en-US">Other non-current payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentPayables" xlink:to="ifrs-full_OtherNoncurrentPayables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TravelExpense_lbl0" xml:lang="en-US">Travel expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TravelExpense" xlink:to="ifrs-full_TravelExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SharePremium_lbl2" xml:lang="en-US">Share premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharePremium" xlink:to="ifrs-full_SharePremium_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_EquitySettledShareBasedPayments_lbl1" xml:lang="en-US">Equity Settled Share Based Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EquitySettledShareBasedPayments" xlink:to="mlec_EquitySettledShareBasedPayments_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfUsefulLivesOfPropertyPlantAndEquipmentAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfUsefulLivesOfPropertyPlantAndEquipmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfUsefulLivesOfPropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Schedule Of Useful Lives Of Property Plant And Equipment Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfUsefulLivesOfPropertyPlantAndEquipmentAbstract" xlink:to="mlec_ScheduleOfUsefulLivesOfPropertyPlantAndEquipmentAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_AR_lbl0" xml:lang="en-US">ARGENTINA</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_AR" xlink:to="country_AR_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GrossCarryingAmountMember_lbl0" xml:lang="en-US">Gross carrying amount [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossCarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfFairValueOrdinaryShareOfWarrantsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfFairValueOrdinaryShareOfWarrantsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfFairValueOrdinaryShareOfWarrantsAbstract_lbl" xml:lang="en-US">Schedule Of Fair Value Ordinary Share Of Warrants Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfFairValueOrdinaryShareOfWarrantsAbstract" xlink:to="mlec_ScheduleOfFairValueOrdinaryShareOfWarrantsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IncomeTaxInflationAdjustment_lbl0" xml:lang="en-US">Income Tax Inflation Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncomeTaxInflationAdjustment" xlink:to="mlec_IncomeTaxInflationAdjustment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ExpensesPaid_lbl1" xml:lang="en-US">Expenses Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExpensesPaid" xlink:to="mlec_ExpensesPaid_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AggregatePurchasePrice_lbl1" xml:lang="en-US">Aggregate Purchase Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AggregatePurchasePrice" xlink:to="mlec_AggregatePurchasePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TotalMutualFunds_lbl1" xml:lang="en-US">Total Mutual Funds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalMutualFunds" xlink:to="mlec_TotalMutualFunds_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_lbl0" xml:lang="en-US">Reserve of exchange differences on translation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MachineryMember_lbl1" xml:lang="en-US">Machinery [member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MachineryMember" xlink:to="ifrs-full_MachineryMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ChangesInWorkingCapitalAbstract_lbl0" xml:lang="en-US">Changes In Working Capital Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChangesInWorkingCapitalAbstract" xlink:to="mlec_ChangesInWorkingCapitalAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_InvestmentGainRelatedToMoneyMarketFunds_lbl0" xml:lang="en-US">Investment Gain Related To Money Market Funds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_InvestmentGainRelatedToMoneyMarketFunds" xlink:to="mlec_InvestmentGainRelatedToMoneyMarketFunds_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilitiesAbstract_lbl0" xml:lang="en-US">Liabilities [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesAbstract" xlink:to="ifrs-full_LiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_Group2GrantedMember_lbl0" xml:lang="en-US">Group2 Granted Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_Group2GrantedMember" xlink:to="mlec_Group2GrantedMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfTermsAndConditionsOfOutstandingLoansAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfTermsAndConditionsOfOutstandingLoansAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfTermsAndConditionsOfOutstandingLoansAbstract_lbl" xml:lang="en-US">Schedule Of Terms And Conditions Of Outstanding Loans Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfTermsAndConditionsOfOutstandingLoansAbstract" xlink:to="mlec_ScheduleOfTermsAndConditionsOfOutstandingLoansAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Inventories_lbl2" xml:lang="en-US">Current inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Inventories" xlink:to="ifrs-full_Inventories_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShareIssueRelatedCost_lbl0" xml:lang="en-US">Share issue related cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareIssueRelatedCost" xlink:to="ifrs-full_ShareIssueRelatedCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CustomerRelationship_lbl1" xml:lang="en-US">Customer Relationship</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CustomerRelationship" xlink:to="mlec_CustomerRelationship_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ImpactToProfitOrLossBeforeTaxAssetsMember_lbl0" xml:lang="en-US">Impact To Profit Or Loss Before Tax Assets Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ImpactToProfitOrLossBeforeTaxAssetsMember" xlink:to="mlec_ImpactToProfitOrLossBeforeTaxAssetsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AsOfJune302022Abstract_lbl0" xml:lang="en-US">As Of June302022 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AsOfJune302022Abstract" xlink:to="mlec_AsOfJune302022Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NetBookAmount_lbl1" xml:lang="en-US">Net Book Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetBookAmount" xlink:to="mlec_NetBookAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_EquitySettledShareBasedPaymentMember_lbl0" xml:lang="en-US">Equity Settled Share Based Payment Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_EquitySettledShareBasedPaymentMember" xlink:to="mlec_EquitySettledShareBasedPaymentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EmployeeBenefitsExpense_lbl0" xml:lang="en-US">Employee benefits expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EmployeeBenefitsExpense" xlink:to="ifrs-full_EmployeeBenefitsExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_WithinOneYearOrOnDemandMember_lbl0" xml:lang="en-US">Within One Year Or On Demand Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_WithinOneYearOrOnDemandMember" xlink:to="mlec_WithinOneYearOrOnDemandMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IssueOfSharesCapital_lbl1" xml:lang="en-US">Issue Of Shares Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IssueOfSharesCapital" xlink:to="mlec_IssueOfSharesCapital_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BackstopSharesMember_lbl0" xml:lang="en-US">Backstop Shares Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BackstopSharesMember" xlink:to="mlec_BackstopSharesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ChangeInWarrants_lbl1" xml:lang="en-US">Change In Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ChangeInWarrants" xlink:to="mlec_ChangeInWarrants_lbl1"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfAssetsAndLiabilitiesRecognisedAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfAssetsAndLiabilitiesRecognisedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfAssetsAndLiabilitiesRecognisedAbstract_lbl" xml:lang="en-US">Schedule Of Assets And Liabilities Recognised Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfAssetsAndLiabilitiesRecognisedAbstract" xlink:to="mlec_ScheduleOfAssetsAndLiabilitiesRecognisedAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets_lbl0" xml:lang="en-US">Real estate, amount contributed to fair value of plan assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets" xlink:to="ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ProceedsFromIssueOfShareCapital_lbl1" xml:lang="en-US">Proceeds From Issue Of Share Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ProceedsFromIssueOfShareCapital" xlink:to="mlec_ProceedsFromIssueOfShareCapital_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Cash flows from (used in) operating activities [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PromissoryNotesMember_lbl0" xml:lang="en-US">Promissory Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PromissoryNotesMember" xlink:to="mlec_PromissoryNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfEstimatedFutureTaxableProfitTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Estimated Future Taxable Profit Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfEstimatedFutureTaxableProfitTableTextBlock" xlink:to="mlec_ScheduleOfEstimatedFutureTaxableProfitTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxAssets_lbl0" xml:lang="en-US">Deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxAssets" xlink:to="ifrs-full_DeferredTaxAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_lbl0" xml:lang="en-US">Description of accounting policy for segment reporting [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_lbl0" xml:lang="en-US">Disclosure of number and weighted average exercise prices of share options [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_LU_lbl1" xml:lang="en-US">LUXEMBOURG</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_LU" xlink:to="country_LU_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_PayAsYouEarnPAYE_lbl1" xml:lang="en-US">Pay As You Earn PAYE</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_PayAsYouEarnPAYE" xlink:to="mlec_PayAsYouEarnPAYE_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_lbl0" xml:lang="en-US">Basic earnings (loss) per share from discontinued operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:to="ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_lbl0" xml:lang="en-US">Goodwill recognised as of acquisition date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TotalOtherProductionCost_lbl1" xml:lang="en-US">Total Other Production Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TotalOtherProductionCost" xlink:to="mlec_TotalOtherProductionCost_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AggregateRedemption_lbl0" xml:lang="en-US">Aggregate Redemption</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AggregateRedemption" xlink:to="mlec_AggregateRedemption_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_FinancialAssetsAbstract_lbl0" xml:lang="en-US">Financial Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_FinancialAssetsAbstract" xlink:to="mlec_FinancialAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl0" xml:lang="en-US">ICFR Auditor Attestation Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_CustomerRelationshipMember_lbl0" xml:lang="en-US">Customer Relationship Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_CustomerRelationshipMember" xlink:to="mlec_CustomerRelationshipMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk_lbl1" xml:lang="en-US">Nominal or principal amount of financial instrument on discontinuation of measurement at fair value through profit or loss because credit derivative is used to manage credit risk</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk" xlink:to="ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory_lbl0" xml:lang="en-US">Description of evidence supporting recognition of deferred tax asset when utilisation is dependent on future taxable profits in excess of profits from reversal of taxable temporary differences and entity has suffered loss in jurisdiction to which deferred tax asset relates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInventoriesExplanatory_lbl0" xml:lang="en-US">Disclosure of inventories [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInventoriesExplanatory" xlink:to="ifrs-full_DisclosureOfInventoriesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ValoraSoySAMember_lbl0" xml:lang="en-US">Valora Soy SAMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ValoraSoySAMember" xlink:to="mlec_ValoraSoySAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTradingIncomeExpenseExplanatory_lbl0" xml:lang="en-US">Disclosure of trading income (expense) [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTradingIncomeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfTradingIncomeExpenseExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_TrustAccount_lbl0" xml:lang="en-US">Trust Account</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_TrustAccount" xlink:to="mlec_TrustAccount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_MoolecScienceSharesMember_lbl0" xml:lang="en-US">Moolec Science Shares Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_MoolecScienceSharesMember" xlink:to="mlec_MoolecScienceSharesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherReceivables_lbl2" xml:lang="en-US">Trade and other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherReceivables" xlink:to="ifrs-full_TradeAndOtherReceivables_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_lbl0" xml:lang="en-US">Purchase of intangible assets, classified as investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NetDeferredTaxLiabilitiesMember_lbl0" xml:lang="en-US">Net Deferred Tax Liabilities Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NetDeferredTaxLiabilitiesMember" xlink:to="mlec_NetDeferredTaxLiabilitiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SharesToBeIssuedAmountEquitySettledShareBasedPayment_lbl1" xml:lang="en-US">Shares To Be Issued Amount Equity Settled Share Based Payment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SharesToBeIssuedAmountEquitySettledShareBasedPayment" xlink:to="mlec_SharesToBeIssuedAmountEquitySettledShareBasedPayment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_IncomeTaxRate_lbl1" xml:lang="en-US">Income Tax Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_IncomeTaxRate" xlink:to="mlec_IncomeTaxRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_NumberOfOptionsForfeitedDuringThePeriod_lbl1" xml:lang="en-US">Number Of Options Forfeited During The Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_NumberOfOptionsForfeitedDuringThePeriod" xlink:to="mlec_NumberOfOptionsForfeitedDuringThePeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherPayables_lbl1" xml:lang="en-US">Trade and other payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayables" xlink:to="ifrs-full_TradeAndOtherPayables_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDebtSecuritiesExplanatory_lbl0" xml:lang="en-US">Disclosure of debt instruments [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDebtSecuritiesExplanatory" xlink:to="ifrs-full_DisclosureOfDebtSecuritiesExplanatory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ExercisePriceAtTheEnding_lbl1" xml:lang="en-US">Exercise Price At The Ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExercisePriceAtTheEnding" xlink:to="mlec_ExercisePriceAtTheEnding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl0" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLiabilitiesAbstract_lbl0" xml:lang="en-US">Current liabilities [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ConvertedShares_lbl1" xml:lang="en-US">Converted Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ConvertedShares" xlink:to="mlec_ConvertedShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AmortizedCostsAbstract_lbl0" xml:lang="en-US">Amortized Costs Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AmortizedCostsAbstract" xlink:to="mlec_AmortizedCostsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleOfOtherRelatedPartyTransactionsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherRelatedPartyTransactionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleOfOtherRelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Schedule Of Other Related Party Transactions Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleOfOtherRelatedPartyTransactionsAbstract" xlink:to="mlec_ScheduleOfOtherRelatedPartyTransactionsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_AsOfJune302022Abstract0_lbl0" xml:lang="en-US">As Of June302022 Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_AsOfJune302022Abstract0" xlink:to="mlec_AsOfJune302022Abstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_LightJumpSharesMember_lbl0" xml:lang="en-US">Light Jump Shares Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_LightJumpSharesMember" xlink:to="mlec_LightJumpSharesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_OtherResearchAndDevelopmentExpenses_lbl1" xml:lang="en-US">Other Research And Development Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_OtherResearchAndDevelopmentExpenses" xlink:to="mlec_OtherResearchAndDevelopmentExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementEntitysOwnEquityInstruments_lbl0" xml:lang="en-US">Gains (losses) recognised in profit or loss excluding exchange differences, fair value measurement, entity&apos;s own equity instruments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementEntitysOwnEquityInstruments" xlink:to="ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementEntitysOwnEquityInstruments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax_lbl0" xml:lang="en-US">Gains (losses) on exchange differences on translation of foreign operations, net of tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_SimplyAgreementForFutureEquitySAFE_lbl1" xml:lang="en-US">Simply Agreement For Future Equity SAFE</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_SimplyAgreementForFutureEquitySAFE" xlink:to="mlec_SimplyAgreementForFutureEquitySAFE_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NotionalAmount_lbl0" xml:lang="en-US">Notional amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotionalAmount" xlink:to="ifrs-full_NotionalAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensation_lbl0" xml:lang="en-US">Key management personnel compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables_lbl2" xml:lang="en-US">Trade and other current receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentReceivables" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ExercisePriceForfeitedDuringThePeriod_lbl1" xml:lang="en-US">Exercise Price Forfeited During The Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExercisePriceForfeitedDuringThePeriod" xlink:to="mlec_ExercisePriceForfeitedDuringThePeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ShareEquivalent_lbl1" xml:lang="en-US">Share Equivalent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ShareEquivalent" xlink:to="mlec_ShareEquivalent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_BetweenTwoAndFiveYearsMember_lbl0" xml:lang="en-US">Between Two And Five Years Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_BetweenTwoAndFiveYearsMember" xlink:to="mlec_BetweenTwoAndFiveYearsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl0" xml:lang="en-US">Cash flows from (used in) operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_JointArrangementParticipationPercentage_lbl1" xml:lang="en-US">Joint Arrangement Participation Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_JointArrangementParticipationPercentage" xlink:to="mlec_JointArrangementParticipationPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PurchasesFairValueMeasurementAssets_lbl0" xml:lang="en-US">Purchases, fair value measurement, assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchasesFairValueMeasurementAssets" xlink:to="ifrs-full_PurchasesFairValueMeasurementAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ExercisePrice_lbl1" xml:lang="en-US">Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ExercisePrice" xlink:to="mlec_ExercisePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAbstract_lbl0" xml:lang="en-US">Equity [abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_EquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss_lbl0" xml:lang="en-US">Gains (losses) on financial assets at fair value through profit or loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:to="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl0" xml:lang="en-US">Disclosure of property, plant and equipment [text block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_DisclosureOfAdditionalInformationTextBlockAbstract" xlink:href="mlec-20230630.xsd#mlec_DisclosureOfAdditionalInformationTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_DisclosureOfAdditionalInformationTextBlockAbstract_lbl" xml:lang="en-US">Disclosure Of Additional Information Text Block Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_DisclosureOfAdditionalInformationTextBlockAbstract" xlink:to="mlec_DisclosureOfAdditionalInformationTextBlockAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_UnionGroupVenturesMember_lbl0" xml:lang="en-US">Union Group Ventures Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_UnionGroupVenturesMember" xlink:to="mlec_UnionGroupVenturesMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="mlec_ScheduleAndThePossibleDilutiveEffectOfTheFutureExerciseOfOptionsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleAndThePossibleDilutiveEffectOfTheFutureExerciseOfOptionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="mlec_ScheduleAndThePossibleDilutiveEffectOfTheFutureExerciseOfOptionsAbstract_lbl" xml:lang="en-US">Schedule And The Possible Dilutive Effect Of The Future Exercise Of Options Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="mlec_ScheduleAndThePossibleDilutiveEffectOfTheFutureExerciseOfOptionsAbstract" xlink:to="mlec_ScheduleAndThePossibleDilutiveEffectOfTheFutureExerciseOfOptionsAbstract_lbl"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>mlec-20230630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Oct 30 21:05:19 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ConsolidatedComprehensiveIncome" roleURI="http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ConsolidatedComprehensiveIncome_Parentheticals" roleURI="http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ConsolidatedBalanceSheet" roleURI="http://www.moolecscience.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ShareholdersEquityType2or3" roleURI="http://www.moolecscience.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ConsolidatedCashFlow" roleURI="http://www.moolecscience.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_GeneralInformation" roleURI="http://www.moolecscience.com/role/GeneralInformation"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_BusinessCombination" roleURI="http://www.moolecscience.com/role/BusinessCombination"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_AccountingStandardsandBasisofPreparation" roleURI="http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparation"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_SummaryofSignificantAccountingPolicies" roleURI="http://www.moolecscience.com/role/SummaryofSignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ComparativeInformation" roleURI="http://www.moolecscience.com/role/ComparativeInformation"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_IntangibleAssets" roleURI="http://www.moolecscience.com/role/IntangibleAssets"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_FixedAssets" roleURI="http://www.moolecscience.com/role/FixedAssets"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_Goodwill" roleURI="http://www.moolecscience.com/role/Goodwill"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_RightofUseofAssets" roleURI="http://www.moolecscience.com/role/RightofUseofAssets"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_OtherNonCurrentReceivables" roleURI="http://www.moolecscience.com/role/OtherNonCurrentReceivables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_CashandCashEquivalents" roleURI="http://www.moolecscience.com/role/CashandCashEquivalents"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ShortTermInvestments" roleURI="http://www.moolecscience.com/role/ShortTermInvestments"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_TradeReceivableandOtherCurrentReceivables" roleURI="http://www.moolecscience.com/role/TradeReceivableandOtherCurrentReceivables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_Inventories" roleURI="http://www.moolecscience.com/role/Inventories"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ShareCapitalandSharePremium" roleURI="http://www.moolecscience.com/role/ShareCapitalandSharePremium"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ShareBasedPayment" roleURI="http://www.moolecscience.com/role/ShareBasedPayment"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_AccountsPayableandOtherCurrentandNonCurrentLiabilities" roleURI="http://www.moolecscience.com/role/AccountsPayableandOtherCurrentandNonCurrentLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_FinancialDebt" roleURI="http://www.moolecscience.com/role/FinancialDebt"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_WarrantsLiabilities" roleURI="http://www.moolecscience.com/role/WarrantsLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_SimpleAgreementforFutureEquitySAFE" roleURI="http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFE"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_DeferredTaxandIncomeTax" roleURI="http://www.moolecscience.com/role/DeferredTaxandIncomeTax"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_FinancialIncomeExpenses" roleURI="http://www.moolecscience.com/role/FinancialIncomeExpenses"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_OtherOperatingExpense" roleURI="http://www.moolecscience.com/role/OtherOperatingExpense"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_AdministrativeExpenses" roleURI="http://www.moolecscience.com/role/AdministrativeExpenses"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ResearchandDevelopmentExpense" roleURI="http://www.moolecscience.com/role/ResearchandDevelopmentExpense"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_Costofsales" roleURI="http://www.moolecscience.com/role/Costofsales"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_NetLossperShare" roleURI="http://www.moolecscience.com/role/NetLossperShare"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_RelatedParties" roleURI="http://www.moolecscience.com/role/RelatedParties"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_FinancialRiskManagement" roleURI="http://www.moolecscience.com/role/FinancialRiskManagement"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_CapitalRiskManagement" roleURI="http://www.moolecscience.com/role/CapitalRiskManagement"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_EventsaftertheReportingPeriod" roleURI="http://www.moolecscience.com/role/EventsaftertheReportingPeriod"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_AccountingPoliciesByPolicy" roleURI="http://www.moolecscience.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_BusinessCombinationTables" roleURI="http://www.moolecscience.com/role/BusinessCombinationTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_IntangibleAssetsTables" roleURI="http://www.moolecscience.com/role/IntangibleAssetsTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_FixedAssetsTables" roleURI="http://www.moolecscience.com/role/FixedAssetsTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_GoodwillTables" roleURI="http://www.moolecscience.com/role/GoodwillTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_RightofUseofAssetsTables" roleURI="http://www.moolecscience.com/role/RightofUseofAssetsTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_OtherNonCurrentReceivablesTables" roleURI="http://www.moolecscience.com/role/OtherNonCurrentReceivablesTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_CashandCashEquivalentsTables" roleURI="http://www.moolecscience.com/role/CashandCashEquivalentsTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ShortTermInvestmentsTables" roleURI="http://www.moolecscience.com/role/ShortTermInvestmentsTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_TradeReceivableandOtherCurrentReceivablesTables" roleURI="http://www.moolecscience.com/role/TradeReceivableandOtherCurrentReceivablesTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_InventoriesTables" roleURI="http://www.moolecscience.com/role/InventoriesTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ShareCapitalandSharePremiumTables" roleURI="http://www.moolecscience.com/role/ShareCapitalandSharePremiumTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ShareBasedPaymentTables" roleURI="http://www.moolecscience.com/role/ShareBasedPaymentTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTables" roleURI="http://www.moolecscience.com/role/AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_FinancialDebtTables" roleURI="http://www.moolecscience.com/role/FinancialDebtTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_WarrantsLiabilitiesTables" roleURI="http://www.moolecscience.com/role/WarrantsLiabilitiesTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_SimpleAgreementforFutureEquitySAFETables" roleURI="http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFETables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_DeferredTaxandIncomeTaxTables" roleURI="http://www.moolecscience.com/role/DeferredTaxandIncomeTaxTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_FinancialIncomeExpensesTables" roleURI="http://www.moolecscience.com/role/FinancialIncomeExpensesTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_OtherOperatingExpenseTables" roleURI="http://www.moolecscience.com/role/OtherOperatingExpenseTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_AdministrativeExpensesTables" roleURI="http://www.moolecscience.com/role/AdministrativeExpensesTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ResearchandDevelopmentExpenseTables" roleURI="http://www.moolecscience.com/role/ResearchandDevelopmentExpenseTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_CostofsalesTables" roleURI="http://www.moolecscience.com/role/CostofsalesTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_NetLossperShareTables" roleURI="http://www.moolecscience.com/role/NetLossperShareTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_RelatedPartiesTables" roleURI="http://www.moolecscience.com/role/RelatedPartiesTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_FinancialRiskManagementTables" roleURI="http://www.moolecscience.com/role/FinancialRiskManagementTables"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofNetAssetsAcquiredandGoodwillTable" roleURI="http://www.moolecscience.com/role/ScheduleofNetAssetsAcquiredandGoodwillTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofAssetsandLiabilitiesRecognisedTable" roleURI="http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofUsefulLivesofPropertyPlantandEquipmentTable" roleURI="http://www.moolecscience.com/role/ScheduleofUsefulLivesofPropertyPlantandEquipmentTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofConsolidatedFinancialStatementsTable" roleURI="http://www.moolecscience.com/role/ScheduleofConsolidatedFinancialStatementsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable" roleURI="http://www.moolecscience.com/role/ScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofIntangibleAssetsTable" roleURI="http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofFixedAssetsTable" roleURI="http://www.moolecscience.com/role/ScheduleofFixedAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofGoodwillTable" roleURI="http://www.moolecscience.com/role/ScheduleofGoodwillTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofRightofUseofAssetsTable" roleURI="http://www.moolecscience.com/role/ScheduleofRightofUseofAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofOtherNonCurrentReceivablesTable" roleURI="http://www.moolecscience.com/role/ScheduleofOtherNonCurrentReceivablesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofCashandCashEquivalentsTable" roleURI="http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofShortTermInvestmentsTable" roleURI="http://www.moolecscience.com/role/ScheduleofShortTermInvestmentsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofTradeReceivableTable" roleURI="http://www.moolecscience.com/role/ScheduleofTradeReceivableTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofOtherCurrentReceivablesTable" roleURI="http://www.moolecscience.com/role/ScheduleofOtherCurrentReceivablesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofInventoriesTable" roleURI="http://www.moolecscience.com/role/ScheduleofInventoriesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofReconciliationofShareCapitalandSharePremiumTable" roleURI="http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable" roleURI="http://www.moolecscience.com/role/ScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable" roleURI="http://www.moolecscience.com/role/ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofAccountsPayableTable" roleURI="http://www.moolecscience.com/role/ScheduleofAccountsPayableTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofFinancialDebtTable" roleURI="http://www.moolecscience.com/role/ScheduleofFinancialDebtTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable" roleURI="http://www.moolecscience.com/role/ScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofTermsandConditionsofOutstandingLoansTable" roleURI="http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofFairValueOrdinaryShareofWarrantsTable" roleURI="http://www.moolecscience.com/role/ScheduleofFairValueOrdinaryShareofWarrantsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofFinancialInstrumentsTable" roleURI="http://www.moolecscience.com/role/ScheduleofFinancialInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofRollForwardofNetDeferredTaxTable" roleURI="http://www.moolecscience.com/role/ScheduleofRollForwardofNetDeferredTaxTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable" roleURI="http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofIncomeTaxforOtherJurisdictionsTable" roleURI="http://www.moolecscience.com/role/ScheduleofIncomeTaxforOtherJurisdictionsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofNetDeferredTaxLiabilitiesTable" roleURI="http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofAccumulatedTaxLossCarryforwardsTable" roleURI="http://www.moolecscience.com/role/ScheduleofAccumulatedTaxLossCarryforwardsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofEstimatedFutureTaxableProfitTable" roleURI="http://www.moolecscience.com/role/ScheduleofEstimatedFutureTaxableProfitTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofFinancialIncomeExpensesTable" roleURI="http://www.moolecscience.com/role/ScheduleofFinancialIncomeExpensesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofOtherOperatingExpenseTable" roleURI="http://www.moolecscience.com/role/ScheduleofOtherOperatingExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofAdministrativeExpensesTable" roleURI="http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofResearchandDevelopmentExpenseTable" roleURI="http://www.moolecscience.com/role/ScheduleofResearchandDevelopmentExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofCostofsalesTable" roleURI="http://www.moolecscience.com/role/ScheduleofCostofsalesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofNetLossPerShareTable" roleURI="http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofNetLossPerShareTable_Parentheticals" roleURI="http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofOtherRelatedPartyTransactionsTable" roleURI="http://www.moolecscience.com/role/ScheduleofOtherRelatedPartyTransactionsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofShareBasedPaymentTable" roleURI="http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofShareBasedPaymentTable_Parentheticals" roleURI="http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofotherrelatedpartybalancesTable" roleURI="http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofotherrelatedpartybalancesTable_Parentheticals" roleURI="http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofTradeandOtherReceivablesTable" roleURI="http://www.moolecscience.com/role/ScheduleofTradeandOtherReceivablesTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofContractualMaturityDateTable" roleURI="http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofForeignCurrencyExchangeRiskTable" roleURI="http://www.moolecscience.com/role/ScheduleofForeignCurrencyExchangeRiskTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable" roleURI="http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ScheduleofFixedRateInstrumentsTable" roleURI="http://www.moolecscience.com/role/ScheduleofFixedRateInstrumentsTable"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_GeneralInformationDetails" roleURI="http://www.moolecscience.com/role/GeneralInformationDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_BusinessCombinationDetails" roleURI="http://www.moolecscience.com/role/BusinessCombinationDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_AccountingStandardsandBasisofPreparationDetails" roleURI="http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_SummaryofSignificantAccountingPoliciesDetails" roleURI="http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_RightofUseofAssetsDetails" roleURI="http://www.moolecscience.com/role/RightofUseofAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_OtherNonCurrentReceivablesDetails" roleURI="http://www.moolecscience.com/role/OtherNonCurrentReceivablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ShareCapitalandSharePremiumDetails" roleURI="http://www.moolecscience.com/role/ShareCapitalandSharePremiumDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_ShareBasedPaymentDetails" roleURI="http://www.moolecscience.com/role/ShareBasedPaymentDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_WarrantsLiabilitiesDetails" roleURI="http://www.moolecscience.com/role/WarrantsLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_SimpleAgreementforFutureEquitySAFEDetails" roleURI="http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFEDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_DeferredTaxandIncomeTaxDetails" roleURI="http://www.moolecscience.com/role/DeferredTaxandIncomeTaxDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_FinancialRiskManagementDetails" roleURI="http://www.moolecscience.com/role/FinancialRiskManagementDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#mlec_r_EventsaftertheReportingPeriodDetails" roleURI="http://www.moolecscience.com/role/EventsaftertheReportingPeriodDetails"/>
  <roleRef xlink:type="simple" xlink:href="mlec-20230630.xsd#DocumentAndEntityInformation" roleURI="http://www.moolecscience.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome">
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeStatementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="ContinuingOperationsAbstract" xlink:href="mlec-20230630.xsd#mlec_ContinuingOperationsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ContinuingOperationsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Revenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContinuingOperationsAbstract" xlink:to="ifrs-full_Revenue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CostOfSales"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContinuingOperationsAbstract" xlink:to="ifrs-full_CostOfSales" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContinuingOperationsAbstract" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SalesAndMarketingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SalesAndMarketingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContinuingOperationsAbstract" xlink:to="ifrs-full_SalesAndMarketingExpense" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContinuingOperationsAbstract" xlink:to="ifrs-full_AdministrativeExpense" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherOperatingIncomeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContinuingOperationsAbstract" xlink:to="ifrs-full_OtherOperatingIncomeExpense" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContinuingOperationsAbstract" xlink:to="ifrs-full_ProfitLossFromOperatingActivities" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_FinanceCosts" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherFinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherFinanceIncomeCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_OtherFinanceIncomeCost" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TransactionsExpenses" xlink:href="mlec-20230630.xsd#mlec_TransactionsExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="TransactionsExpenses" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLossBeforeTax" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_ProfitLoss" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_BasicEarningsLossPerShare" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncomeAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_OtherComprehensiveIncomeAbstract" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="ifrs-full_ProfitLoss_0" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="ifrs-full_OtherComprehensiveIncome" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComprehensiveIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="ifrs-full_ComprehensiveIncome" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome_Parentheticals">
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeStatementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_DilutedEarningsLossPerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="NonCurrentAssetsAbstract" xlink:href="mlec-20230630.xsd#mlec_NonCurrentAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="NonCurrentAssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FixedAssets" xlink:href="mlec-20230630.xsd#mlec_FixedAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="FixedAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Goodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Goodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="ifrs-full_Goodwill" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="ifrs-full_RightofuseAssets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentReceivables" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NoncurrentAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentAssetsAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CashAndCashEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShorttermInvestmentsCurrent" xlink:href="mlec-20230630.xsd#mlec_ShorttermInvestmentsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ShorttermInvestmentsCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentTradeReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentTradeReceivables" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_OtherReceivables" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPrepayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentPrepayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentPrepayments" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Inventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Inventories"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_Inventories" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentAssets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Assets" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_EquityAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_IssuedCapital" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremium" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharePremium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_SharePremium" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareToBeIssuedAmount" xlink:href="mlec-20230630.xsd#mlec_ShareToBeIssuedAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ShareToBeIssuedAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EquitySettledShareBasedPayments" xlink:href="mlec-20230630.xsd#mlec_EquitySettledShareBasedPayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="EquitySettledShareBasedPayments" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_ReserveOfExchangeDifferencesOnTranslation" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarnings" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarnings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_RetainedEarnings" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Equity" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentLiabilitiesAbstract" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentFinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_OtherCurrentFinancialLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_OtherCurrentLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WarrantLiability" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WarrantLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_WarrantLiability" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SimplyAgreementForFutureEquitySAFE" xlink:href="mlec-20230630.xsd#mlec_SimplyAgreementForFutureEquitySAFE"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="SimplyAgreementForFutureEquitySAFE" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_CurrentLiabilities" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="NonCurrentLiabilitiesAbstract" xlink:href="mlec-20230630.xsd#mlec_NonCurrentLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="NonCurrentLiabilitiesAbstract" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentLiabilitiesAbstract" xlink:to="ifrs-full_OtherNoncurrentFinancialLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentLiabilitiesAbstract" xlink:to="ifrs-full_OtherNoncurrentPayables" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentLiabilitiesAbstract" xlink:to="ifrs-full_DeferredTaxLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_NoncurrentLiabilities" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_Liabilities" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAndLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityAndLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_EquityAndLiabilities" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="ConsolidatedStatementsOfChangesInEquityAbstract" xlink:href="mlec-20230630.xsd#mlec_ConsolidatedStatementsOfChangesInEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConsolidatedStatementsOfChangesInEquityAbstract" xlink:to="ifrs-full_StatementOfChangesInEquityTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ClassesOfShareCapitalMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapitalMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssuedCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_IssuedCapitalMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremiumMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharePremiumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_SharePremiumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CumulativeTranslationAdjustmentMember" xlink:href="mlec-20230630.xsd#mlec_CumulativeTranslationAdjustmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="CumulativeTranslationAdjustmentMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EquitySettledShareBasedPaymentMember" xlink:href="mlec-20230630.xsd#mlec_EquitySettledShareBasedPaymentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="EquitySettledShareBasedPaymentMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarningsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_RetainedEarningsMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EquityMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_EquityMember" order="6.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_StatementOfChangesInEquityLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_Equity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="IssueOfShareCapital" xlink:href="mlec-20230630.xsd#mlec_IssueOfShareCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="IssueOfShareCapital" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EquitySettledShareBasedPayment" xlink:href="mlec-20230630.xsd#mlec_EquitySettledShareBasedPayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="EquitySettledShareBasedPayment" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssueOfEquity" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssueOfEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_IssueOfEquity" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssueOfShareCapitalSAFEShares" xlink:href="mlec-20230630.xsd#mlec_IssueOfShareCapitalSAFEShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IssueOfEquity" xlink:to="IssueOfShareCapitalSAFEShares" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssueOfShareCapitalLightJumpShares" xlink:href="mlec-20230630.xsd#mlec_IssueOfShareCapitalLightJumpShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IssueOfEquity" xlink:to="IssueOfShareCapitalLightJumpShares" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssueOfShareCapitalBackstopShares" xlink:href="mlec-20230630.xsd#mlec_IssueOfShareCapitalBackstopShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IssueOfEquity" xlink:to="IssueOfShareCapitalBackstopShares" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IssueOfEquity" xlink:to="ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BusinessCombination" xlink:href="mlec-20230630.xsd#mlec_BusinessCombination"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IssueOfEquity" xlink:to="BusinessCombination" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IssueOfEquity" xlink:to="ifrs-full_ProfitLoss" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Equity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="ifrs-full_Equity_0" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_ProfitLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncomeTaxExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForIncomeTaxExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentCostOfListingSharesnoncashItem" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentCostOfListingSharesnoncashItem"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ShareBasedPaymentCostOfListingSharesnoncashItem" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinanceIncomeCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_FinanceIncomeCost" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ChangesInWorkingCapitalAbstract" xlink:href="mlec-20230630.xsd#mlec_ChangesInWorkingCapitalAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ChangesInWorkingCapitalAbstract" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInWorkingCapitalAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInWorkingCapitalAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInWorkingCapitalAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInWorkingCapitalAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInWorkingCapitalAbstract" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInWorkingCapitalAbstract" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherLiabilitie" xlink:href="mlec-20230630.xsd#mlec_OtherLiabilitie"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInWorkingCapitalAbstract" xlink:to="OtherLiabilitie" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChangesInWorkingCapitalAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromIssuingOtherEquityInstruments" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromIssuingOtherEquityInstruments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromIssuingOtherEquityInstruments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Proceedsfromissuanceofsharecapital" xlink:href="mlec-20230630.xsd#mlec_Proceedsfromissuanceofsharecapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="Proceedsfromissuanceofsharecapital" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromCurrentBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromCurrentBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromCurrentBorrowings" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromSAFE" xlink:href="mlec-20230630.xsd#mlec_ProceedsFromSAFE"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromSAFE" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromIssuingShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromIssuingShares" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromIssueOfShareCapital" xlink:href="mlec-20230630.xsd#mlec_ProceedsFromIssueOfShareCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromIssueOfShareCapital" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_0" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="NonCashFinancingActivitiesAbstract" xlink:href="mlec-20230630.xsd#mlec_NonCashFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="NonCashFinancingActivitiesAbstract" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei" xlink:href="mlec-20230630.xsd#mlec_IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCashFinancingActivitiesAbstract" xlink:to="IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium" xlink:href="mlec-20230630.xsd#mlec_ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCashFinancingActivitiesAbstract" xlink:to="ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CapitalizationOfTransactionExpensesThroughAccountsPayable" xlink:href="mlec-20230630.xsd#mlec_CapitalizationOfTransactionExpensesThroughAccountsPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCashFinancingActivitiesAbstract" xlink:to="CapitalizationOfTransactionExpensesThroughAccountsPayable" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetLiabilitiesAcquiredThroughIssuanceOfShareCapital" xlink:href="mlec-20230630.xsd#mlec_NetLiabilitiesAcquiredThroughIssuanceOfShareCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCashFinancingActivitiesAbstract" xlink:to="NetLiabilitiesAcquiredThroughIssuanceOfShareCapital" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AcquisitionOfBusinessCombinationTroughDeferredPayment" xlink:href="mlec-20230630.xsd#mlec_AcquisitionOfBusinessCombinationTroughDeferredPayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCashFinancingActivitiesAbstract" xlink:to="AcquisitionOfBusinessCombinationTroughDeferredPayment" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind" xlink:href="mlec-20230630.xsd#mlec_AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCashFinancingActivitiesAbstract" xlink:to="AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares" xlink:href="mlec-20230630.xsd#mlec_AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCashFinancingActivitiesAbstract" xlink:to="AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/GeneralInformation">
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/BusinessCombination">
    <loc xlink:type="locator" xlink:label="BusinessCombinationAbstract" xlink:href="mlec-20230630.xsd#mlec_BusinessCombinationAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfBusinessCombinationsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationAbstract" xlink:to="ifrs-full_DisclosureOfBusinessCombinationsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparation">
    <loc xlink:type="locator" xlink:label="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/SummaryofSignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ComparativeInformation">
    <loc xlink:type="locator" xlink:label="DisclosureOfAdditionalInformationTextBlockAbstract" xlink:href="mlec-20230630.xsd#mlec_DisclosureOfAdditionalInformationTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="ComparativeInformationTable" xlink:href="mlec-20230630.xsd#mlec_ComparativeInformationTable"/>
    <loc xlink:type="locator" xlink:label="ComparativeInformationLineItems" xlink:href="mlec-20230630.xsd#mlec_ComparativeInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfAdditionalInformationTextBlockAbstract" xlink:to="ComparativeInformationTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComparativeInformationTable" xlink:to="ComparativeInformationLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAdditionalInformationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfAdditionalInformationExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComparativeInformationLineItems" xlink:to="ifrs-full_DisclosureOfAdditionalInformationExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/IntangibleAssets">
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/FixedAssets">
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/Goodwill">
    <loc xlink:type="locator" xlink:label="ifrs-full_ChangesInGoodwillAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ChangesInGoodwillAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfGoodwillExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInGoodwillAbstract" xlink:to="ifrs-full_DisclosureOfGoodwillExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/RightofUseofAssets">
    <loc xlink:type="locator" xlink:label="RightofUseOfAssetsAbstract" xlink:href="mlec-20230630.xsd#mlec_RightofUseOfAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofUseOfAssetsAbstract" xlink:to="ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/OtherNonCurrentReceivables">
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentReceivablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentReceivablesAbstract" xlink:to="ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/CashandCashEquivalents">
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashAndCashEquivalentsAbstract" xlink:to="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ShortTermInvestments">
    <loc xlink:type="locator" xlink:label="ShortTermInvestmentAbstract" xlink:href="mlec-20230630.xsd#mlec_ShortTermInvestmentAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShortTermInvestmentAbstract" xlink:to="ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/TradeReceivableandOtherCurrentReceivables">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:to="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/Inventories">
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfInventoriesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfInventoriesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfInventoriesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfInventoriesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfInventoriesAbstract" xlink:to="ifrs-full_DisclosureOfInventoriesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ShareCapitalandSharePremium">
    <loc xlink:type="locator" xlink:label="ShareCapitalAndSharePremiumAbstract" xlink:href="mlec-20230630.xsd#mlec_ShareCapitalAndSharePremiumAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalAndSharePremiumAbstract" xlink:to="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ShareBasedPayment">
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentAbstract" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentAbstract" xlink:to="ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/AccountsPayableandOtherCurrentandNonCurrentLiabilities">
    <loc xlink:type="locator" xlink:label="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <loc xlink:type="locator" xlink:label="AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTable" xlink:href="mlec-20230630.xsd#mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTable"/>
    <loc xlink:type="locator" xlink:label="AccountsPayableandOtherCurrentandNonCurrentLiabilitiesLineItems" xlink:href="mlec-20230630.xsd#mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:to="AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTable" xlink:to="AccountsPayableandOtherCurrentandNonCurrentLiabilitiesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableandOtherCurrentandNonCurrentLiabilitiesLineItems" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/FinancialDebt">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDebtSecuritiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDebtSecuritiesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:to="ifrs-full_DisclosureOfDebtSecuritiesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/WarrantsLiabilities">
    <loc xlink:type="locator" xlink:label="WarrantsLiabilitiesAbstract" xlink:href="mlec-20230630.xsd#mlec_WarrantsLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFE">
    <loc xlink:type="locator" xlink:label="SimpleAgreementForFutureEquitySafeAbstract" xlink:href="mlec-20230630.xsd#mlec_SimpleAgreementForFutureEquitySafeAbstract"/>
    <loc xlink:type="locator" xlink:label="SimpleAgreementForFutureEquitySAFETextBlock" xlink:href="mlec-20230630.xsd#mlec_SimpleAgreementForFutureEquitySAFETextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SimpleAgreementForFutureEquitySafeAbstract" xlink:to="SimpleAgreementForFutureEquitySAFETextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/DeferredTaxandIncomeTax">
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxandIncomeTaxTable" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxTable"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxandIncomeTaxLineItems" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="DeferredTaxandIncomeTaxTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxTable" xlink:to="DeferredTaxandIncomeTaxLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxLineItems" xlink:to="ifrs-full_DisclosureOfIncomeTaxExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/FinancialIncomeExpenses">
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeExpenseGainsOrLossesOfFinancialInstrumentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeExpenseGainsOrLossesOfFinancialInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeExpenseGainsOrLossesOfFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/OtherOperatingExpense">
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="OtherOperatingExpenseTable" xlink:href="mlec-20230630.xsd#mlec_OtherOperatingExpenseTable"/>
    <loc xlink:type="locator" xlink:label="OtherOperatingExpenseLineItems" xlink:href="mlec-20230630.xsd#mlec_OtherOperatingExpenseLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="OtherOperatingExpenseTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherOperatingExpenseTable" xlink:to="OtherOperatingExpenseLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherOperatingExpenseLineItems" xlink:to="ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/AdministrativeExpenses">
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract" xlink:to="ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ResearchandDevelopmentExpense">
    <loc xlink:type="locator" xlink:label="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <loc xlink:type="locator" xlink:label="ResearchandDevelopmentExpenseTable" xlink:href="mlec-20230630.xsd#mlec_ResearchandDevelopmentExpenseTable"/>
    <loc xlink:type="locator" xlink:label="ResearchandDevelopmentExpenseLineItems" xlink:href="mlec-20230630.xsd#mlec_ResearchandDevelopmentExpenseLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:to="ResearchandDevelopmentExpenseTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchandDevelopmentExpenseTable" xlink:to="ResearchandDevelopmentExpenseLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchandDevelopmentExpenseLineItems" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/Costofsales">
    <loc xlink:type="locator" xlink:label="CostOfSalesAbstract" xlink:href="mlec-20230630.xsd#mlec_CostOfSalesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfCostOfSalesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfCostOfSalesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostOfSalesAbstract" xlink:to="ifrs-full_DisclosureOfCostOfSalesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/NetLossperShare">
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="NetLossperShareTable" xlink:href="mlec-20230630.xsd#mlec_NetLossperShareTable"/>
    <loc xlink:type="locator" xlink:label="NetLossperShareLineItems" xlink:href="mlec-20230630.xsd#mlec_NetLossperShareLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="NetLossperShareTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetLossperShareTable" xlink:to="NetLossperShareLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetLossperShareLineItems" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/RelatedParties">
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="RelatedPartiesTable" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesTable"/>
    <loc xlink:type="locator" xlink:label="RelatedPartiesLineItems" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="RelatedPartiesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesTable" xlink:to="RelatedPartiesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesLineItems" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/FinancialRiskManagement">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialRiskManagementExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:to="ifrs-full_DisclosureOfFinancialRiskManagementExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/CapitalRiskManagement">
    <loc xlink:type="locator" xlink:label="CapitalRiskManagementAbstract" xlink:href="mlec-20230630.xsd#mlec_CapitalRiskManagementAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfCapitalRiskManagementTextBlock" xlink:href="mlec-20230630.xsd#mlec_DisclosureOfCapitalRiskManagementTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalRiskManagementAbstract" xlink:to="DisclosureOfCapitalRiskManagementTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/EventsaftertheReportingPeriod">
    <loc xlink:type="locator" xlink:label="EventsAfterTheReportingPeriodAbstract" xlink:href="mlec-20230630.xsd#mlec_EventsAfterTheReportingPeriodAbstract"/>
    <loc xlink:type="locator" xlink:label="EventsaftertheReportingPeriodTable" xlink:href="mlec-20230630.xsd#mlec_EventsaftertheReportingPeriodTable"/>
    <loc xlink:type="locator" xlink:label="EventsaftertheReportingPeriodLineItems" xlink:href="mlec-20230630.xsd#mlec_EventsaftertheReportingPeriodLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsAfterTheReportingPeriodAbstract" xlink:to="EventsaftertheReportingPeriodTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsaftertheReportingPeriodTable" xlink:to="EventsaftertheReportingPeriodLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsaftertheReportingPeriodLineItems" xlink:to="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock" xlink:href="mlec-20230630.xsd#mlec_DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForForeignCurrencyTextBlock" xlink:href="mlec-20230630.xsd#mlec_DescriptionOfAccountingPolicyForForeignCurrencyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForForeignCurrencyTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock" xlink:href="mlec-20230630.xsd#mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock" xlink:href="mlec-20230630.xsd#mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock" xlink:href="mlec-20230630.xsd#mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock" xlink:href="mlec-20230630.xsd#mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock" xlink:href="mlec-20230630.xsd#mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DescriptionOfAccountingPolicyForLossPerShareTextBlock" xlink:href="mlec-20230630.xsd#mlec_DescriptionOfAccountingPolicyForLossPerShareTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DescriptionOfAccountingPolicyForLossPerShareTextBlock" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/BusinessCombinationTables">
    <loc xlink:type="locator" xlink:label="BusinessCombinationAbstract" xlink:href="mlec-20230630.xsd#mlec_BusinessCombinationAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfNetAssetsAcquiredAndGoodwill" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfNetAssetsAcquiredAndGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationAbstract" xlink:to="ScheduleOfNetAssetsAcquiredAndGoodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationAbstract" xlink:to="srt_ScheduleOfCondensedBalanceSheetTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/IntangibleAssetsTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfIntangibleAssetsExplanatoryTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_DisclosureOfIntangibleAssetsExplanatoryTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:to="DisclosureOfIntangibleAssetsExplanatoryTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/FixedAssetsTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfFixedAssetstextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfFixedAssetstextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:to="ScheduleOfFixedAssetstextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/GoodwillTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_ChangesInGoodwillAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ChangesInGoodwillAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ChangesInGoodwillAbstract" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/RightofUseofAssetsTables">
    <loc xlink:type="locator" xlink:label="RightofUseOfAssetsAbstract" xlink:href="mlec-20230630.xsd#mlec_RightofUseOfAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfRightofuseOfAssetsTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfRightofuseOfAssetsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofUseOfAssetsAbstract" xlink:to="ScheduleOfRightofuseOfAssetsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/OtherNonCurrentReceivablesTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentReceivablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherNoncurrentReceivableTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherNoncurrentReceivableTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentReceivablesAbstract" xlink:to="ScheduleOfOtherNoncurrentReceivableTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/CashandCashEquivalentsTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalentsAbstract"/>
    <loc xlink:type="locator" xlink:label="CashandCashEquivalentsTablesTable" xlink:href="mlec-20230630.xsd#mlec_CashandCashEquivalentsTablesTable"/>
    <loc xlink:type="locator" xlink:label="CashandCashEquivalentsTablesLineItems" xlink:href="mlec-20230630.xsd#mlec_CashandCashEquivalentsTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CashAndCashEquivalentsAbstract" xlink:to="CashandCashEquivalentsTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashandCashEquivalentsTablesTable" xlink:to="CashandCashEquivalentsTablesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRestrictedCashAndCashEquivalentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRestrictedCashAndCashEquivalentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashandCashEquivalentsTablesLineItems" xlink:to="ifrs-full_DisclosureOfRestrictedCashAndCashEquivalentsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ShortTermInvestmentsTables">
    <loc xlink:type="locator" xlink:label="ShortTermInvestmentAbstract" xlink:href="mlec-20230630.xsd#mlec_ShortTermInvestmentAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfShortTermInvestmentsTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_DisclosureOfShortTermInvestmentsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShortTermInvestmentAbstract" xlink:to="DisclosureOfShortTermInvestmentsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/TradeReceivableandOtherCurrentReceivablesTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfTradeReceivableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfTradeReceivableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:to="ScheduleOfTradeReceivableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherCurrentReceivablesTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherCurrentReceivablesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TradeAndOtherCurrentReceivablesAbstract" xlink:to="ScheduleOfOtherCurrentReceivablesTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/InventoriesTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfInventoriesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfInventoriesAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfInventoriesTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_DisclosureOfInventoriesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfInventoriesAbstract" xlink:to="DisclosureOfInventoriesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ShareCapitalandSharePremiumTables">
    <loc xlink:type="locator" xlink:label="ShareCapitalAndSharePremiumAbstract" xlink:href="mlec-20230630.xsd#mlec_ShareCapitalAndSharePremiumAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalAndSharePremiumAbstract" xlink:to="ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ShareBasedPaymentTables">
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentAbstract" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentAbstract" xlink:to="ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentAbstract" xlink:to="ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <loc xlink:type="locator" xlink:label="AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesTable" xlink:href="mlec-20230630.xsd#mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesTable"/>
    <loc xlink:type="locator" xlink:label="AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesLineItems" xlink:href="mlec-20230630.xsd#mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:to="AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesTable" xlink:to="AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfAccountsPayable" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfAccountsPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesLineItems" xlink:to="ScheduleOfAccountsPayable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/FinancialDebtTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialAssetsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:to="ifrs-full_DisclosureOfFinancialAssetsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AnalysisOfAgeOfFinancialAssetsThatArePastDueButNotImpaired" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AnalysisOfAgeOfFinancialAssetsThatArePastDueButNotImpaired"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:to="ifrs-full_AnalysisOfAgeOfFinancialAssetsThatArePastDueButNotImpaired" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfFinancialAssetsAbstract" xlink:to="ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/WarrantsLiabilitiesTables">
    <loc xlink:type="locator" xlink:label="WarrantsLiabilitiesAbstract" xlink:href="mlec-20230630.xsd#mlec_WarrantsLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesAbstract" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFETables">
    <loc xlink:type="locator" xlink:label="SimpleAgreementForFutureEquitySafeAbstract" xlink:href="mlec-20230630.xsd#mlec_SimpleAgreementForFutureEquitySafeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SimpleAgreementForFutureEquitySafeAbstract" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/DeferredTaxandIncomeTaxTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfDeferredTaxesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfDeferredTaxesExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="ifrs-full_DisclosureOfDeferredTaxesExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfStatutoryTaxesInCountriesTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_DisclosureOfStatutoryTaxesInCountriesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="DisclosureOfStatutoryTaxesInCountriesTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfEstimatedFutureTaxableProfitTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfEstimatedFutureTaxableProfitTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="ScheduleOfEstimatedFutureTaxableProfitTableTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/FinancialIncomeExpensesTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeExpenseGainsOrLossesOfFinancialInstrumentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncomeExpenseGainsOrLossesOfFinancialInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFinanceIncomeExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IncomeExpenseGainsOrLossesOfFinancialInstrumentsAbstract" xlink:to="ifrs-full_DisclosureOfFinanceIncomeExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/OtherOperatingExpenseTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="OtherOperatingExpenseTablesTable" xlink:href="mlec-20230630.xsd#mlec_OtherOperatingExpenseTablesTable"/>
    <loc xlink:type="locator" xlink:label="OtherOperatingExpenseTablesLineItems" xlink:href="mlec-20230630.xsd#mlec_OtherOperatingExpenseTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="OtherOperatingExpenseTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherOperatingExpenseTablesTable" xlink:to="OtherOperatingExpenseTablesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherOperatingExpensesTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherOperatingExpensesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherOperatingExpenseTablesLineItems" xlink:to="ScheduleOfOtherOperatingExpensesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/AdministrativeExpensesTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract" xlink:to="DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ResearchandDevelopmentExpenseTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <loc xlink:type="locator" xlink:label="ResearchandDevelopmentExpenseTablesTable" xlink:href="mlec-20230630.xsd#mlec_ResearchandDevelopmentExpenseTablesTable"/>
    <loc xlink:type="locator" xlink:label="ResearchandDevelopmentExpenseTablesLineItems" xlink:href="mlec-20230630.xsd#mlec_ResearchandDevelopmentExpenseTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:to="ResearchandDevelopmentExpenseTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchandDevelopmentExpenseTablesTable" xlink:to="ResearchandDevelopmentExpenseTablesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchandDevelopmentExpenseTablesLineItems" xlink:to="ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/CostofsalesTables">
    <loc xlink:type="locator" xlink:label="CostOfSalesAbstract" xlink:href="mlec-20230630.xsd#mlec_CostOfSalesAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfCostOfSalesTableTextBlock" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfCostOfSalesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostOfSalesAbstract" xlink:to="ScheduleOfCostOfSalesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/NetLossperShareTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="NetLossperShareTablesTable" xlink:href="mlec-20230630.xsd#mlec_NetLossperShareTablesTable"/>
    <loc xlink:type="locator" xlink:label="NetLossperShareTablesLineItems" xlink:href="mlec-20230630.xsd#mlec_NetLossperShareTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="NetLossperShareTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetLossperShareTablesTable" xlink:to="NetLossperShareTablesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EarningsPerShareExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetLossperShareTablesLineItems" xlink:to="ifrs-full_EarningsPerShareExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/RelatedPartiesTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="RelatedPartiesTablesTable" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesTablesTable"/>
    <loc xlink:type="locator" xlink:label="RelatedPartiesTablesLineItems" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="RelatedPartiesTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesTablesTable" xlink:to="RelatedPartiesTablesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherRelatedPartyTransactions" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherRelatedPartyTransactions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesTablesLineItems" xlink:to="ScheduleOfOtherRelatedPartyTransactions" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfShareBasedPayment" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfShareBasedPayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesTablesLineItems" xlink:to="ScheduleOfShareBasedPayment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherRelatedPartyBalances" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherRelatedPartyBalances"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesTablesLineItems" xlink:to="ScheduleOfOtherRelatedPartyBalances" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/FinancialRiskManagementTables">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfTradingIncomeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfTradingIncomeExpenseExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:to="ifrs-full_DisclosureOfTradingIncomeExpenseExplanatory" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:to="ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:to="ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfFixedRateInstruments" xlink:href="mlec-20230630.xsd#mlec_DisclosureOfFixedRateInstruments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:to="DisclosureOfFixedRateInstruments" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofNetAssetsAcquiredandGoodwillTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfNetAssetsAcquiredAndGoodwillAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfNetAssetsAcquiredAndGoodwillAbstract"/>
    <loc xlink:type="locator" xlink:label="PurchaseConsiderationAbstract" xlink:href="mlec-20230630.xsd#mlec_PurchaseConsiderationAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNetAssetsAcquiredAndGoodwillAbstract" xlink:to="PurchaseConsiderationAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CashPaid" xlink:href="mlec-20230630.xsd#mlec_CashPaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PurchaseConsiderationAbstract" xlink:to="CashPaid" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredPaymentAfter6Months" xlink:href="mlec-20230630.xsd#mlec_DeferredPaymentAfter6Months"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PurchaseConsiderationAbstract" xlink:to="DeferredPaymentAfter6Months" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PurchaseConsiderationAbstract" xlink:to="ifrs-full_OtherPayables" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConsiderationPaid" xlink:href="mlec-20230630.xsd#mlec_ConsiderationPaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PurchaseConsiderationAbstract" xlink:to="ConsiderationPaid" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfAssetsAndLiabilitiesRecognisedAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfAssetsAndLiabilitiesRecognisedAbstract"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedBalanceSheetStatementTable" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedBalanceSheetStatementTable"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedBalanceSheetStatementsCaptionsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAssetsAndLiabilitiesRecognisedAbstract" xlink:to="srt_CondensedBalanceSheetStatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MeasurementAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MeasurementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementTable" xlink:to="ifrs-full_MeasurementAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AtFairValueMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AtFairValueMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MeasurementAxis" xlink:to="ifrs-full_AtFairValueMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementTable" xlink:to="srt_CondensedBalanceSheetStatementsCaptionsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BalancesWithBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BalancesWithBanks"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_BalancesWithBanks" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_TradeAndOtherReceivables" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_OtherCurrentReceivables" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherInventories"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_OtherInventories" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherIntangibleAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_OtherIntangibleAssets" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsToRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsToRightofuseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_AdditionsToRightofuseAssets" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_NoncurrentPayables" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentFinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_CurrentFinancialLiabilities" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_OtherLiabilities" order="9.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentFinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_NoncurrentFinancialLiabilities" order="10.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_OtherNoncurrentLiabilities" order="11.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetDeferredTaxLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_NetDeferredTaxLiabilities" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed" xlink:to="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetAssetsLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetAssetsLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedBalanceSheetStatementsCaptionsLineItems" xlink:to="ifrs-full_NetAssetsLiabilities" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofUsefulLivesofPropertyPlantandEquipmentTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfUsefulLivesOfPropertyPlantAndEquipmentAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfUsefulLivesOfPropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentTable" xlink:href="mlec-20230630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentTable"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems" xlink:href="mlec-20230630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfUsefulLivesOfPropertyPlantAndEquipmentAbstract" xlink:to="SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="StorageMember" xlink:href="mlec-20230630.xsd#mlec_StorageMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="StorageMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MachineryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MachineryMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_MachineryMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_VehiclesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_VehiclesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_VehiclesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FurnitureMember" xlink:href="mlec-20230630.xsd#mlec_FurnitureMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="FurnitureMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComputerEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComputerEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ComputerEquipmentMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentTable" xlink:to="ifrs-full_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_BottomOfRangeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_TopOfRangeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentTable" xlink:to="SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofConsolidatedFinancialStatementsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfConsolidatedFinancialStatementsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfConsolidatedFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsTable" xlink:href="mlec-20230630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsTable"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems" xlink:href="mlec-20230630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfConsolidatedFinancialStatementsAbstract" xlink:to="SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="MoolecScienceLimitedMember" xlink:href="mlec-20230630.xsd#mlec_MoolecScienceLimitedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="MoolecScienceLimitedMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LightJumpAcquisitionCorporationMember" xlink:href="mlec-20230630.xsd#mlec_LightJumpAcquisitionCorporationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="LightJumpAcquisitionCorporationMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ValoraSoySAMember" xlink:href="mlec-20230630.xsd#mlec_ValoraSoySAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ValoraSoySAMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AGBiomoleculesLLCDEMember" xlink:href="mlec-20230630.xsd#mlec_AGBiomoleculesLLCDEMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="AGBiomoleculesLLCDEMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MicrooFoodsIngredientsSLMember" xlink:href="mlec-20230630.xsd#mlec_MicrooFoodsIngredientsSLMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="MicrooFoodsIngredientsSLMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsTable" xlink:to="SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems" xlink:to="ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CountryOfIncorporation" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CountryOfIncorporation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems" xlink:to="ifrs-full_CountryOfIncorporation" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProportionOfVotingPowerHeldInSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProportionOfVotingPowerHeldInSubsidiary"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems" xlink:to="ifrs-full_ProportionOfVotingPowerHeldInSubsidiary" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable" xlink:href="mlec-20230630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsLineItems" xlink:href="mlec-20230630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsAbstract" xlink:to="SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable" xlink:to="ifrs-full_ClassesOfFinancialAssetsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_FinancialAssetsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="LuxMember" xlink:href="mlec-20230630.xsd#mlec_LuxMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="LuxMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_GB" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="country_GB" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_AR" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_AR"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="country_AR" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable" xlink:to="SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OtherNonCurrentAssetsOtherThanFinancialAssets" xlink:href="mlec-20230630.xsd#mlec_OtherNonCurrentAssetsOtherThanFinancialAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsLineItems" xlink:to="OtherNonCurrentAssetsOtherThanFinancialAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfIntangibleAssetsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfIntangibleAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="IntangibleAssetsDetailsScheduleofIntangibleAssetsTable" xlink:href="mlec-20230630.xsd#mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsTable"/>
    <loc xlink:type="locator" xlink:label="IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems" xlink:href="mlec-20230630.xsd#mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIntangibleAssetsAbstract" xlink:to="IntangibleAssetsDetailsScheduleofIntangibleAssetsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsDetailsScheduleofIntangibleAssetsTable" xlink:to="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="ifrs-full_IntangibleAssetsAndGoodwillMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember" xlink:href="mlec-20230630.xsd#mlec_GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SPCTechnologyMember" xlink:href="mlec-20230630.xsd#mlec_SPCTechnologyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="SPCTechnologyMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CustomerRelationshipMember" xlink:href="mlec-20230630.xsd#mlec_CustomerRelationshipMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="CustomerRelationshipMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SoftwareLicenseMember" xlink:href="mlec-20230630.xsd#mlec_SoftwareLicenseMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="SoftwareLicenseMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsDetailsScheduleofIntangibleAssetsTable" xlink:to="IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="Cost" xlink:href="mlec-20230630.xsd#mlec_Cost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems" xlink:to="Cost" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Cost" xlink:to="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="NetBookAmount" xlink:href="mlec-20230630.xsd#mlec_NetBookAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="Cost" xlink:to="NetBookAmount" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="YearEndedJune302021Abstract" xlink:href="mlec-20230630.xsd#mlec_YearEndedJune302021Abstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems" xlink:to="YearEndedJune302021Abstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="YearEndedJune302021Abstract" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="YearEndedJune302021Abstract" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="YearEndedJune302021Abstract" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="YearEndedJune302021Abstract" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Amortization" xlink:href="mlec-20230630.xsd#mlec_Amortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="YearEndedJune302021Abstract" xlink:to="Amortization" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="YearEndedJune302021Abstract" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_0" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="AsOfJune302023Abstract" xlink:href="mlec-20230630.xsd#mlec_AsOfJune302023Abstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems" xlink:to="AsOfJune302023Abstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AsOfJune302022Abstract" xlink:href="mlec-20230630.xsd#mlec_AsOfJune302022Abstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems" xlink:to="AsOfJune302022Abstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AsOfJune302021Abstract" xlink:href="mlec-20230630.xsd#mlec_AsOfJune302021Abstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems" xlink:to="AsOfJune302021Abstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofFixedAssetsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFixedAssetsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfFixedAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="FixedAssetsDetailsScheduleofFixedAssetsTable" xlink:href="mlec-20230630.xsd#mlec_FixedAssetsDetailsScheduleofFixedAssetsTable"/>
    <loc xlink:type="locator" xlink:label="FixedAssetsDetailsScheduleofFixedAssetsLineItems" xlink:href="mlec-20230630.xsd#mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFixedAssetsAbstract" xlink:to="FixedAssetsDetailsScheduleofFixedAssetsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FixedAssetsDetailsScheduleofFixedAssetsTable" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CarryingAmountMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GrossCarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_GrossCarryingAmountMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetBookAmountMember" xlink:href="mlec-20230630.xsd#mlec_NetBookAmountMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="NetBookAmountMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FixedAssetsDetailsScheduleofFixedAssetsTable" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_PropertyPlantAndEquipmentMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ChymosinOsmosisEquipmentMember" xlink:href="mlec-20230630.xsd#mlec_ChymosinOsmosisEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ChymosinOsmosisEquipmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_VehiclesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_VehiclesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_VehiclesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="FurnitureMember" xlink:href="mlec-20230630.xsd#mlec_FurnitureMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="FurnitureMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StorageMember" xlink:href="mlec-20230630.xsd#mlec_StorageMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="StorageMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComputerEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComputerEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ComputerEquipmentMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MachineryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MachineryMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_MachineryMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FixedAssetsDetailsScheduleofFixedAssetsTable" xlink:to="FixedAssetsDetailsScheduleofFixedAssetsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FixedAssetsDetailsScheduleofFixedAssetsLineItems" xlink:to="ifrs-full_PropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FixedAssetsDetailsScheduleofFixedAssetsLineItems" xlink:to="ifrs-full_PropertyPlantAndEquipment_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment_1" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FixedAssetsDetailsScheduleofFixedAssetsLineItems" xlink:to="ifrs-full_PropertyPlantAndEquipment_1" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="YearEndedJune302021Abstract0" xlink:href="mlec-20230630.xsd#mlec_YearEndedJune302021Abstract0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FixedAssetsDetailsScheduleofFixedAssetsLineItems" xlink:to="YearEndedJune302021Abstract0" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment_2" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="YearEndedJune302021Abstract0" xlink:to="ifrs-full_PropertyPlantAndEquipment_2" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="YearEndedJune302021Abstract0" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="YearEndedJune302021Abstract0" xlink:to="ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="YearEndedJune302021Abstract0" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="YearEndedJune302021Abstract0" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyPlantAndEquipment_3" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FixedAssetsDetailsScheduleofFixedAssetsLineItems" xlink:to="ifrs-full_PropertyPlantAndEquipment_3" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="AsOfJune302023Abstract0" xlink:href="mlec-20230630.xsd#mlec_AsOfJune302023Abstract0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FixedAssetsDetailsScheduleofFixedAssetsLineItems" xlink:to="AsOfJune302023Abstract0" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AsOfJune302022Abstract0" xlink:href="mlec-20230630.xsd#mlec_AsOfJune302022Abstract0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FixedAssetsDetailsScheduleofFixedAssetsLineItems" xlink:to="AsOfJune302022Abstract0" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AsOfJune302021Abstract0" xlink:href="mlec-20230630.xsd#mlec_AsOfJune302021Abstract0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FixedAssetsDetailsScheduleofFixedAssetsLineItems" xlink:to="AsOfJune302021Abstract0" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofGoodwillTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfGoodwillAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfGoodwillAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Goodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Goodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGoodwillAbstract" xlink:to="ifrs-full_Goodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalGoodwill" xlink:href="mlec-20230630.xsd#mlec_TotalGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGoodwillAbstract" xlink:to="TotalGoodwill" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofRightofUseofAssetsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfRightOfUseOfAssetsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfRightOfUseOfAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRightOfUseOfAssetsAbstract" xlink:to="ifrs-full_RightofuseAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="AcquisitionsThroughBusinessCombinationsi" xlink:href="mlec-20230630.xsd#mlec_AcquisitionsThroughBusinessCombinationsi"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRightOfUseOfAssetsAbstract" xlink:to="AcquisitionsThroughBusinessCombinationsi" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EffectOfChangesInForeignExchangeRates" xlink:href="mlec-20230630.xsd#mlec_EffectOfChangesInForeignExchangeRates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRightOfUseOfAssetsAbstract" xlink:to="EffectOfChangesInForeignExchangeRates" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RightofuseAssets_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RightofuseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRightOfUseOfAssetsAbstract" xlink:to="ifrs-full_RightofuseAssets_0" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofOtherNonCurrentReceivablesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherNonCurrentReceivablesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherNonCurrentReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherNonCurrentReceivablesAbstract" xlink:to="ifrs-full_OtherNoncurrentReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherNonCurrentReceivablesAbstract" xlink:to="ifrs-full_NoncurrentReceivables" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfCashAndCashEquivalentsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfCashAndCashEquivalentsAbstract"/>
    <loc xlink:type="locator" xlink:label="CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsTable" xlink:href="mlec-20230630.xsd#mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsTable"/>
    <loc xlink:type="locator" xlink:label="CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems" xlink:href="mlec-20230630.xsd#mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCashAndCashEquivalentsAbstract" xlink:to="CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsTable" xlink:to="ifrs-full_SegmentsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsTable" xlink:to="CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Cash" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Cash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems" xlink:to="ifrs-full_Cash" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepositsFromBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepositsFromBanks"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems" xlink:to="ifrs-full_DepositsFromBanks" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems" xlink:to="ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems" xlink:to="ifrs-full_OtherCashAndCashEquivalents" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofShortTermInvestmentsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfShortTermInvestmentsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfShortTermInvestmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="MutualFunds" xlink:href="mlec-20230630.xsd#mlec_MutualFunds"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShortTermInvestmentsAbstract" xlink:to="MutualFunds" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalMutualFunds" xlink:href="mlec-20230630.xsd#mlec_TotalMutualFunds"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShortTermInvestmentsAbstract" xlink:to="TotalMutualFunds" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofTradeReceivableTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfTradeReceivableAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfTradeReceivableAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTradeReceivableAbstract" xlink:to="ifrs-full_TradeReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTradeReceivableAbstract" xlink:to="ifrs-full_TradeAndOtherReceivables" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofOtherCurrentReceivablesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherCurrentReceivablesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherCurrentReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentValueAddedTaxReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentValueAddedTaxReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherCurrentReceivablesAbstract" xlink:to="ifrs-full_CurrentValueAddedTaxReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherCurrentReceivablesAbstract" xlink:to="ifrs-full_OtherCurrentReceivables" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherCurrentReceivablesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofInventoriesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfInventoriesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfInventoriesAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RawMaterials" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RawMaterials"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInventoriesAbstract" xlink:to="ifrs-full_RawMaterials" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinishedGoods" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinishedGoods"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInventoriesAbstract" xlink:to="ifrs-full_FinishedGoods" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InventoriesTotal" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InventoriesTotal"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInventoriesAbstract" xlink:to="ifrs-full_InventoriesTotal" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfReconciliationOfShareCapitalAndSharePremiumAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumTable" xlink:href="mlec-20230630.xsd#mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumTable"/>
    <loc xlink:type="locator" xlink:label="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:href="mlec-20230630.xsd#mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationOfShareCapitalAndSharePremiumAbstract" xlink:to="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumTable" xlink:to="ifrs-full_ClassesOfShareCapitalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfShareCapitalMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfShareCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="MoolecScienceSharesMember" xlink:href="mlec-20230630.xsd#mlec_MoolecScienceSharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="MoolecScienceSharesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SAFESharesMember" xlink:href="mlec-20230630.xsd#mlec_SAFESharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="SAFESharesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LightJumpSharesMember" xlink:href="mlec-20230630.xsd#mlec_LightJumpSharesMember"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrbCcuxiEw7DaKnp03QCb9S1ssLhKhQhPI9/LGJ51TgzssCI1ODtwCrgkN0a+ZUXnMF8I/KcADyvbmI99H904sqIF1YM5bLcN+DbpeVS5vMyNXq7Gcc0AsRuAtIzhrDpAdkHW0SbRbM9JtED/NKe0AzzApdc0Kim8/GgaIUDBDfI2qGJJ00w0l4c/QomHyUqlqAjOvjGNLto/w==] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="LightJumpSharesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BackstopSharesMember" xlink:href="mlec-20230630.xsd#mlec_BackstopSharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="BackstopSharesMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumTable" xlink:to="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="ifrs-full_NumberOfSharesIssued" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="SharesIssuedAmount" xlink:href="mlec-20230630.xsd#mlec_SharesIssuedAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="SharesIssuedAmount" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ShareToBeIssuedAmount" xlink:href="mlec-20230630.xsd#mlec_ShareToBeIssuedAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="ShareToBeIssuedAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremium" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharePremium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="ifrs-full_SharePremium" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfSharesIssueOfShareCapitalinShares" xlink:href="mlec-20230630.xsd#mlec_NumberOfSharesIssueOfShareCapitalinShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="NumberOfSharesIssueOfShareCapitalinShares" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsForShareIssueCosts" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PaymentsForShareIssueCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="ifrs-full_PaymentsForShareIssueCosts" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharesToBeIssuedAmountIssueOfShareCapital" xlink:href="mlec-20230630.xsd#mlec_SharesToBeIssuedAmountIssueOfShareCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="SharesToBeIssuedAmountIssueOfShareCapital" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharePremiumIssueOfShareCapital" xlink:href="mlec-20230630.xsd#mlec_SharePremiumIssueOfShareCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="SharePremiumIssueOfShareCapital" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfSharesFromBusinessAcquisition" xlink:href="mlec-20230630.xsd#mlec_NumberOfSharesFromBusinessAcquisition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="NumberOfSharesFromBusinessAcquisition" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharesIssuedAmountFromBusinessAcquisition" xlink:href="mlec-20230630.xsd#mlec_SharesIssuedAmountFromBusinessAcquisition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="SharesIssuedAmountFromBusinessAcquisition" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharesToBeIssuedAmountFromBusinessAcquisition" xlink:href="mlec-20230630.xsd#mlec_SharesToBeIssuedAmountFromBusinessAcquisition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="SharesToBeIssuedAmountFromBusinessAcquisition" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharePremiumFromBusinessAcquisition" xlink:href="mlec-20230630.xsd#mlec_SharePremiumFromBusinessAcquisition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="SharePremiumFromBusinessAcquisition" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfShareEquitySettledShareBasedPayment" xlink:href="mlec-20230630.xsd#mlec_NumberOfShareEquitySettledShareBasedPayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="NumberOfShareEquitySettledShareBasedPayment" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharesIssuedAmountEquitySettledShareBasedPayment" xlink:href="mlec-20230630.xsd#mlec_SharesIssuedAmountEquitySettledShareBasedPayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="SharesIssuedAmountEquitySettledShareBasedPayment" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharesToBeIssuedAmountEquitySettledShareBasedPayment" xlink:href="mlec-20230630.xsd#mlec_SharesToBeIssuedAmountEquitySettledShareBasedPayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="SharesToBeIssuedAmountEquitySettledShareBasedPayment" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharePremiumEquitySettledShareBasedPayment" xlink:href="mlec-20230630.xsd#mlec_SharePremiumEquitySettledShareBasedPayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="SharePremiumEquitySettledShareBasedPayment" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NumberOfSharesIssued_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NumberOfSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="ifrs-full_NumberOfSharesIssued_0" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="SharesIssuedAmount_0" xlink:href="mlec-20230630.xsd#mlec_SharesIssuedAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="SharesIssuedAmount_0" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ShareToBeIssuedAmount_0" xlink:href="mlec-20230630.xsd#mlec_ShareToBeIssuedAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="ShareToBeIssuedAmount_0" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremium_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharePremium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems" xlink:to="ifrs-full_SharePremium_0" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable">
    <loc xlink:type="locator" xlink:label="ScheduleAndThePossibleDilutiveEffectOfTheFutureExerciseOfOptionsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleAndThePossibleDilutiveEffectOfTheFutureExerciseOfOptionsAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable"/>
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleAndThePossibleDilutiveEffectOfTheFutureExerciseOfOptionsAbstract" xlink:to="ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CreationDateAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CreationDateAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable" xlink:to="ifrs-full_CreationDateAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="Group1Member" xlink:href="mlec-20230630.xsd#mlec_Group1Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CreationDateAxis" xlink:to="Group1Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Group2Member" xlink:href="mlec-20230630.xsd#mlec_Group2Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CreationDateAxis" xlink:to="Group2Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Group3Member" xlink:href="mlec-20230630.xsd#mlec_Group3Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CreationDateAxis" xlink:to="Group3Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable" xlink:to="ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="FairValueOfSharesinShares" xlink:href="mlec-20230630.xsd#mlec_FairValueOfSharesinShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems" xlink:to="FairValueOfSharesinShares" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisePrice" xlink:href="mlec-20230630.xsd#mlec_ExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems" xlink:to="ExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PlanDuration" xlink:href="mlec-20230630.xsd#mlec_PlanDuration"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems" xlink:to="PlanDuration" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueOfStockOptionsAtMeasurementDate" xlink:href="mlec-20230630.xsd#mlec_FairValueOfStockOptionsAtMeasurementDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems" xlink:to="FairValueOfStockOptionsAtMeasurementDate" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfAmountAndExercisePriceAndTheMovementsOfTheStockOptionsOfExecutivesAndManagersAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfAmountAndExercisePriceAndTheMovementsOfTheStockOptionsOfExecutivesAndManagersAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable"/>
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAmountAndExercisePriceAndTheMovementsOfTheStockOptionsOfExecutivesAndManagersAbstract" xlink:to="ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CreationDateAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CreationDateAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable" xlink:to="ifrs-full_CreationDateAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="Group1Member" xlink:href="mlec-20230630.xsd#mlec_Group1Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CreationDateAxis" xlink:to="Group1Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Group2Member" xlink:href="mlec-20230630.xsd#mlec_Group2Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CreationDateAxis" xlink:to="Group2Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Group3Member" xlink:href="mlec-20230630.xsd#mlec_Group3Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CreationDateAxis" xlink:to="Group3Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable" xlink:to="ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NumberOfOptionsAtTheBeginning" xlink:href="mlec-20230630.xsd#mlec_NumberOfOptionsAtTheBeginning"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="NumberOfOptionsAtTheBeginning" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisePriceAtTheBeginning" xlink:href="mlec-20230630.xsd#mlec_ExercisePriceAtTheBeginning"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="ExercisePriceAtTheBeginning" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfOptionsGrantedDuringThePeriod" xlink:href="mlec-20230630.xsd#mlec_NumberOfOptionsGrantedDuringThePeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="NumberOfOptionsGrantedDuringThePeriod" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisePriceGrantedDuringThePeriod" xlink:href="mlec-20230630.xsd#mlec_ExercisePriceGrantedDuringThePeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="ExercisePriceGrantedDuringThePeriod" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfOptionsForfeitedDuringThePeriod" xlink:href="mlec-20230630.xsd#mlec_NumberOfOptionsForfeitedDuringThePeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="NumberOfOptionsForfeitedDuringThePeriod" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisePriceForfeitedDuringThePeriod" xlink:href="mlec-20230630.xsd#mlec_ExercisePriceForfeitedDuringThePeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="ExercisePriceForfeitedDuringThePeriod" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfOptionsExercisedDuringThePeriod" xlink:href="mlec-20230630.xsd#mlec_NumberOfOptionsExercisedDuringThePeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="NumberOfOptionsExercisedDuringThePeriod" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisePriceExercisedDuringThePeriod" xlink:href="mlec-20230630.xsd#mlec_ExercisePriceExercisedDuringThePeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="ExercisePriceExercisedDuringThePeriod" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfOptionsExpiredDuringThePeriod" xlink:href="mlec-20230630.xsd#mlec_NumberOfOptionsExpiredDuringThePeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="NumberOfOptionsExpiredDuringThePeriod" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisePriceExpiredDuringThePeriod" xlink:href="mlec-20230630.xsd#mlec_ExercisePriceExpiredDuringThePeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="ExercisePriceExpiredDuringThePeriod" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfOptionsAtTheEnding" xlink:href="mlec-20230630.xsd#mlec_NumberOfOptionsAtTheEnding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="NumberOfOptionsAtTheEnding" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisePriceAtTheEnding" xlink:href="mlec-20230630.xsd#mlec_ExercisePriceAtTheEnding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems" xlink:to="ExercisePriceAtTheEnding" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofAccountsPayableTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfAccountsPayableAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfAccountsPayableAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccountsPayableAbstract" xlink:to="ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccountsPayableAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccrualsClassifiedAsNoncurrent" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccrualsClassifiedAsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccountsPayableAbstract" xlink:to="ifrs-full_AccrualsClassifiedAsNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccountsPayableAbstract" xlink:to="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccountsPayableAbstract" xlink:to="ifrs-full_TradeAndOtherPayables" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentPayablesToRelatedParties" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentPayablesToRelatedParties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccountsPayableAbstract" xlink:to="ifrs-full_NoncurrentPayablesToRelatedParties" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredPaymentRelatedToBusinessCombination" xlink:href="mlec-20230630.xsd#mlec_DeferredPaymentRelatedToBusinessCombination"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccountsPayableAbstract" xlink:to="DeferredPaymentRelatedToBusinessCombination" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Wages" xlink:href="mlec-20230630.xsd#mlec_Wages"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccountsPayableAbstract" xlink:to="Wages" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Taxes" xlink:href="mlec-20230630.xsd#mlec_Taxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccountsPayableAbstract" xlink:to="Taxes" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PayAsYouEarnPAYE" xlink:href="mlec-20230630.xsd#mlec_PayAsYouEarnPAYE"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccountsPayableAbstract" xlink:to="PayAsYouEarnPAYE" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentNonfinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentNonfinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccountsPayableAbstract" xlink:to="ifrs-full_OtherCurrentNonfinancialLiabilities" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccountsPayableAbstract" xlink:to="ifrs-full_OtherCurrentLiabilities" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentNonfinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentNonfinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccountsPayableAbstract" xlink:to="ifrs-full_OtherNoncurrentNonfinancialLiabilities" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccountsPayableAbstract" xlink:to="ifrs-full_OtherNoncurrentLiabilities" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofFinancialDebtTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFinancialDebtAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfFinancialDebtAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialDebtDetailsScheduleofFinancialDebtTable" xlink:href="mlec-20230630.xsd#mlec_FinancialDebtDetailsScheduleofFinancialDebtTable"/>
    <loc xlink:type="locator" xlink:label="FinancialDebtDetailsScheduleofFinancialDebtLineItems" xlink:href="mlec-20230630.xsd#mlec_FinancialDebtDetailsScheduleofFinancialDebtLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinancialDebtAbstract" xlink:to="FinancialDebtDetailsScheduleofFinancialDebtTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CounterpartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialDebtDetailsScheduleofFinancialDebtTable" xlink:to="ifrs-full_CounterpartiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CounterpartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CounterpartiesAxis" xlink:to="ifrs-full_CounterpartiesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="currency_ARS" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_ARS"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CounterpartiesAxis" xlink:to="currency_ARS" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CounterpartiesAxis" xlink:to="country_US" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialDebtDetailsScheduleofFinancialDebtTable" xlink:to="FinancialDebtDetailsScheduleofFinancialDebtLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentFinancialAssetsAtAmortisedCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentFinancialAssetsAtAmortisedCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialDebtDetailsScheduleofFinancialDebtLineItems" xlink:to="ifrs-full_CurrentFinancialAssetsAtAmortisedCost" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable">
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable" xlink:href="mlec-20230630.xsd#mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable"/>
    <loc xlink:type="locator" xlink:label="FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureLineItems" xlink:href="mlec-20230630.xsd#mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeAbstract" xlink:to="FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CounterpartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable" xlink:to="ifrs-full_CounterpartiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CounterpartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CounterpartiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CounterpartiesAxis" xlink:to="ifrs-full_CounterpartiesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="currency_ARS" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_ARS"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CounterpartiesAxis" xlink:to="currency_ARS" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable" xlink:to="FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentFinancialAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureLineItems" xlink:to="ifrs-full_NoncurrentFinancialAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfTermsAndConditionsOfOutstandingLoansAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfTermsAndConditionsOfOutstandingLoansAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansTable" xlink:href="mlec-20230630.xsd#mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansTable"/>
    <loc xlink:type="locator" xlink:label="FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems" xlink:href="mlec-20230630.xsd#mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTermsAndConditionsOfOutstandingLoansAbstract" xlink:to="FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansTable" xlink:to="ifrs-full_BorrowingsByNameAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="BancoMacroPreFinancingOfExportsMember" xlink:href="mlec-20230630.xsd#mlec_BancoMacroPreFinancingOfExportsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="BancoMacroPreFinancingOfExportsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BancoNacinPreFinancingOfExportsMember" xlink:href="mlec-20230630.xsd#mlec_BancoNacinPreFinancingOfExportsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="BancoNacinPreFinancingOfExportsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BancoCrdobaPreFinancingOfExportsMember" xlink:href="mlec-20230630.xsd#mlec_BancoCrdobaPreFinancingOfExportsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="BancoCrdobaPreFinancingOfExportsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BancoGaliciaBankOverdraftsMember" xlink:href="mlec-20230630.xsd#mlec_BancoGaliciaBankOverdraftsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="BancoGaliciaBankOverdraftsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="HSBCBankBankOverdraftsMember" xlink:href="mlec-20230630.xsd#mlec_HSBCBankBankOverdraftsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="HSBCBankBankOverdraftsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BancoSantanderBankOverdraftsMember" xlink:href="mlec-20230630.xsd#mlec_BancoSantanderBankOverdraftsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="BancoSantanderBankOverdraftsMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BancoGaliciaLoansMember" xlink:href="mlec-20230630.xsd#mlec_BancoGaliciaLoansMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="BancoGaliciaLoansMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="HSBCBankLoansMember" xlink:href="mlec-20230630.xsd#mlec_HSBCBankLoansMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="HSBCBankLoansMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BancoSantanderLoansMember" xlink:href="mlec-20230630.xsd#mlec_BancoSantanderLoansMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="BancoSantanderLoansMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BancoMacroLoansMember" xlink:href="mlec-20230630.xsd#mlec_BancoMacroLoansMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="BancoMacroLoansMember" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PromissoryNotesMember" xlink:href="mlec-20230630.xsd#mlec_PromissoryNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="PromissoryNotesMember" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AsociacinMutualAMALoansMember" xlink:href="mlec-20230630.xsd#mlec_AsociacinMutualAMALoansMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="AsociacinMutualAMALoansMember" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansTable" xlink:to="ifrs-full_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_BottomOfRangeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_TopOfRangeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansTable" xlink:to="FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="BorrowingOriginalCurrency" xlink:href="mlec-20230630.xsd#mlec_BorrowingOriginalCurrency"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems" xlink:to="BorrowingOriginalCurrency" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems" xlink:to="ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NominalInterestRate" xlink:href="mlec-20230630.xsd#mlec_NominalInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems" xlink:to="NominalInterestRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BorrowingMaturity" xlink:href="mlec-20230630.xsd#mlec_BorrowingMaturity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems" xlink:to="BorrowingMaturity" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Borrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Borrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems" xlink:to="ifrs-full_Borrowings" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofFairValueOrdinaryShareofWarrantsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFairValueOrdinaryShareOfWarrantsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfFairValueOrdinaryShareOfWarrantsAbstract"/>
    <loc xlink:type="locator" xlink:label="WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsTable" xlink:href="mlec-20230630.xsd#mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsTable"/>
    <loc xlink:type="locator" xlink:label="WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsLineItems" xlink:href="mlec-20230630.xsd#mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueOrdinaryShareOfWarrantsAbstract" xlink:to="WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsTable" xlink:to="ifrs-full_ComponentsOfEquityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WarrantReserveMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WarrantReserveMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_WarrantReserveMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsTable" xlink:to="WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="WarrantAndRightsOutstanding" xlink:href="mlec-20230630.xsd#mlec_WarrantAndRightsOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsLineItems" xlink:to="WarrantAndRightsOutstanding" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementEntitysOwnEquityInstruments" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementEntitysOwnEquityInstruments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsLineItems" xlink:to="ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementEntitysOwnEquityInstruments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueAdjustmentOfWarrant" xlink:href="mlec-20230630.xsd#mlec_FairValueAdjustmentOfWarrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsLineItems" xlink:to="FairValueAdjustmentOfWarrant" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WarrantAndRightsOutstanding_0" xlink:href="mlec-20230630.xsd#mlec_WarrantAndRightsOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsLineItems" xlink:to="WarrantAndRightsOutstanding_0" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofFinancialInstrumentsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFinancialInstrumentsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfFinancialInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue" xlink:href="mlec-20230630.xsd#mlec_FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinancialInstrumentsAbstract" xlink:to="FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Additions" xlink:href="mlec-20230630.xsd#mlec_Additions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue" xlink:to="Additions" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue" xlink:to="ifrs-full_FinancialLiabilitiesAtFairValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SAFECapitalization" xlink:href="mlec-20230630.xsd#mlec_SAFECapitalization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue" xlink:to="SAFECapitalization" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue" xlink:href="mlec-20230630.xsd#mlec_ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue" xlink:to="ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofRollForwardofNetDeferredTaxTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfRollForwardOfNetDeferredTaxAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfRollForwardOfNetDeferredTaxAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRollForwardOfNetDeferredTaxAbstract" xlink:to="ifrs-full_DeferredTaxLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="IncorporatedThroughTheBusinessCombination" xlink:href="mlec-20230630.xsd#mlec_IncorporatedThroughTheBusinessCombination"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRollForwardOfNetDeferredTaxAbstract" xlink:to="IncorporatedThroughTheBusinessCombination" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRollForwardOfNetDeferredTaxAbstract" xlink:to="DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ChargedToOtherComprehensiveIncome" xlink:href="mlec-20230630.xsd#mlec_ChargedToOtherComprehensiveIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRollForwardOfNetDeferredTaxAbstract" xlink:to="ChargedToOtherComprehensiveIncome" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilities_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ChargedToOtherComprehensiveIncome" xlink:to="ifrs-full_DeferredTaxLiabilities_0" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfPrincipalStatutoryTaxesRatesInTheCountriesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfPrincipalStatutoryTaxesRatesInTheCountriesAbstract"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesLineItems" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPrincipalStatutoryTaxesRatesInTheCountriesAbstract" xlink:to="DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable" xlink:to="ifrs-full_GeographicalAreasAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="country_AR" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_AR"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="country_AR" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_LU" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_LU"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="country_LU" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_GB" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="country_GB" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="currency_USD" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_USD"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="currency_USD" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable" xlink:to="ifrs-full_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_BottomOfRangeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_TopOfRangeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable" xlink:to="DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="TaxJurisdiction" xlink:href="mlec-20230630.xsd#mlec_TaxJurisdiction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesLineItems" xlink:to="TaxJurisdiction" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofIncomeTaxforOtherJurisdictionsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfIncomeTaxForOtherJurisdictionsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfIncomeTaxForOtherJurisdictionsAbstract"/>
    <loc xlink:type="locator" xlink:label="LossBeforeTax" xlink:href="mlec-20230630.xsd#mlec_LossBeforeTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxForOtherJurisdictionsAbstract" xlink:to="LossBeforeTax" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="CorporateTaxRate" xlink:href="mlec-20230630.xsd#mlec_CorporateTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxForOtherJurisdictionsAbstract" xlink:to="CorporateTaxRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AccruedIncomeOtherThanContractAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AccruedIncomeOtherThanContractAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CorporateTaxRate" xlink:to="ifrs-full_AccruedIncomeOtherThanContractAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions" xlink:href="mlec-20230630.xsd#mlec_EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CorporateTaxRate" xlink:to="EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TaxLosses" xlink:href="mlec-20230630.xsd#mlec_TaxLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CorporateTaxRate" xlink:to="TaxLosses" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="NondeductibleExpensesListingCost" xlink:href="mlec-20230630.xsd#mlec_NondeductibleExpensesListingCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CorporateTaxRate" xlink:to="NondeductibleExpensesListingCost" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="NetGainOnInflationEffectOnMonetaryItems" xlink:href="mlec-20230630.xsd#mlec_NetGainOnInflationEffectOnMonetaryItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CorporateTaxRate" xlink:to="NetGainOnInflationEffectOnMonetaryItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxInflationAdjustment" xlink:href="mlec-20230630.xsd#mlec_IncomeTaxInflationAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CorporateTaxRate" xlink:to="IncomeTaxInflationAdjustment" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="Others" xlink:href="mlec-20230630.xsd#mlec_Others"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CorporateTaxRate" xlink:to="Others" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TaxBenefitForTheYear" xlink:href="mlec-20230630.xsd#mlec_TaxBenefitForTheYear"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxForOtherJurisdictionsAbstract" xlink:to="TaxBenefitForTheYear" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfNetDeferredTaxLiabilitiesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfNetDeferredTaxLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesTable" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesTable"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesLineItems" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNetDeferredTaxLiabilitiesAbstract" xlink:to="DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NetDeferredTaxLiabilitiesMember" xlink:href="mlec-20230630.xsd#mlec_NetDeferredTaxLiabilitiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="NetDeferredTaxLiabilitiesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesTable" xlink:to="DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetAbstract" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxAssetAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesLineItems" xlink:to="DeferredTaxAssetAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetAbstract" xlink:to="ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesLineItems" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxLiabilityAbstract" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxLiabilityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesLineItems" xlink:to="DeferredTaxLiabilityAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CustomerRelationship" xlink:href="mlec-20230630.xsd#mlec_CustomerRelationship"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLiabilityAbstract" xlink:to="CustomerRelationship" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLiabilityAbstract" xlink:to="ifrs-full_OtherLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesLineItems" xlink:to="ifrs-full_DeferredTaxLiabilityAsset" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NetDeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NetDeferredTaxLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesLineItems" xlink:to="ifrs-full_NetDeferredTaxLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofAccumulatedTaxLossCarryforwardsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfAccumulatedTaxLossCarryforwardsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfAccumulatedTaxLossCarryforwardsAbstract"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsTable" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsTable"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccumulatedTaxLossCarryforwardsAbstract" xlink:to="DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CreationDateAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CreationDateAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsTable" xlink:to="ifrs-full_CreationDateAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DefaultFinancialStatementsDateMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DefaultFinancialStatementsDateMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CreationDateAxis" xlink:to="ifrs-full_DefaultFinancialStatementsDateMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TwoThousandTwentyTwoMember" xlink:href="mlec-20230630.xsd#mlec_TwoThousandTwentyTwoMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CreationDateAxis" xlink:to="TwoThousandTwentyTwoMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoThousandTwentyThreeMember" xlink:href="mlec-20230630.xsd#mlec_TwoThousandTwentyThreeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CreationDateAxis" xlink:to="TwoThousandTwentyThreeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsTable" xlink:to="DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="TaxlossCarryForward" xlink:href="mlec-20230630.xsd#mlec_TaxlossCarryForward"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems" xlink:to="TaxlossCarryForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems" xlink:to="ifrs-full_DeferredTaxAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems" xlink:to="ifrs-full_DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems" xlink:to="ifrs-full_DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofEstimatedFutureTaxableProfitTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfEstimatedFutureTaxableProfitAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfEstimatedFutureTaxableProfitAbstract"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitTable" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitTable"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEstimatedFutureTaxableProfitAbstract" xlink:to="DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitTable" xlink:to="ifrs-full_GeographicalAreasAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="ifrs-full_GeographicalAreasMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="country_GB" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_GB"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="country_GB" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_LU" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_LU"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="country_LU" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_AR" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_AR"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="country_AR" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="currency_USD" xlink:href="https://xbrl.sec.gov/currency/2023/currency-2023.xsd#currency_USD"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="currency_USD" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitTable" xlink:to="DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetsGrossAmount" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxAssetsGrossAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems" xlink:to="DeferredTaxAssetsGrossAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetsTaxEffect" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxAssetsTaxEffect"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems" xlink:to="DeferredTaxAssetsTaxEffect" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofFinancialIncomeExpensesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFinancialIncomeExpensesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfFinancialIncomeExpensesAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialCostsAbstract" xlink:href="mlec-20230630.xsd#mlec_FinancialCostsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinancialIncomeExpensesAbstract" xlink:to="FinancialCostsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InterestExpenses" xlink:href="mlec-20230630.xsd#mlec_InterestExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialCostsAbstract" xlink:to="InterestExpenses" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="TotalFinancialCosts" xlink:href="mlec-20230630.xsd#mlec_TotalFinancialCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinancialIncomeExpensesAbstract" xlink:to="TotalFinancialCosts" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="OtherFinancialResultsAbstract" xlink:href="mlec-20230630.xsd#mlec_OtherFinancialResultsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinancialIncomeExpensesAbstract" xlink:to="OtherFinancialResultsAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExchangeRateDifference" xlink:href="mlec-20230630.xsd#mlec_ExchangeRateDifference"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherFinancialResultsAbstract" xlink:to="ExchangeRateDifference" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss" xlink:href="mlec-20230630.xsd#mlec_ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherFinancialResultsAbstract" xlink:to="ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="InvestmentGainRelatedToMoneyMarketFunds" xlink:href="mlec-20230630.xsd#mlec_InvestmentGainRelatedToMoneyMarketFunds"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherFinancialResultsAbstract" xlink:to="InvestmentGainRelatedToMoneyMarketFunds" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInWarrants" xlink:href="mlec-20230630.xsd#mlec_ChangeInWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherFinancialResultsAbstract" xlink:to="ChangeInWarrants" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LoansAndReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LoansAndReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherFinancialResultsAbstract" xlink:to="ifrs-full_LoansAndReceivables" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InflationAdjustment" xlink:href="mlec-20230630.xsd#mlec_InflationAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherFinancialResultsAbstract" xlink:to="InflationAdjustment" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherFinancialResults" xlink:href="mlec-20230630.xsd#mlec_OtherFinancialResults"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherFinancialResultsAbstract" xlink:to="OtherFinancialResults" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="TotalOtherFinancialResults" xlink:href="mlec-20230630.xsd#mlec_TotalOtherFinancialResults"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinancialIncomeExpensesAbstract" xlink:to="TotalOtherFinancialResults" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="NetFinancialIncomeExpenses" xlink:href="mlec-20230630.xsd#mlec_NetFinancialIncomeExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinancialIncomeExpensesAbstract" xlink:to="NetFinancialIncomeExpenses" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofOtherOperatingExpenseTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherOperatingExpenseAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherOperatingExpenseAbstract"/>
    <loc xlink:type="locator" xlink:label="TaxesDutiesAndPenalties" xlink:href="mlec-20230630.xsd#mlec_TaxesDutiesAndPenalties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherOperatingExpenseAbstract" xlink:to="TaxesDutiesAndPenalties" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MiscellaneousOtherOperatingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MiscellaneousOtherOperatingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherOperatingExpenseAbstract" xlink:to="ifrs-full_MiscellaneousOtherOperatingExpense" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="OtherOperatingExpense" xlink:href="mlec-20230630.xsd#mlec_OtherOperatingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherOperatingExpenseAbstract" xlink:to="OtherOperatingExpense" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfAdministrativeExpensesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfAdministrativeExpensesAbstract"/>
    <loc xlink:type="locator" xlink:label="AuditLegalAndAccountancyFee" xlink:href="mlec-20230630.xsd#mlec_AuditLegalAndAccountancyFee"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAdministrativeExpensesAbstract" xlink:to="AuditLegalAndAccountancyFee" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EmployeeBenefitsExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EmployeeBenefitsExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAdministrativeExpensesAbstract" xlink:to="ifrs-full_EmployeeBenefitsExpense" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="PayrollExpenses" xlink:href="mlec-20230630.xsd#mlec_PayrollExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAdministrativeExpensesAbstract" xlink:to="PayrollExpenses" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InsuranceExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InsuranceExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAdministrativeExpensesAbstract" xlink:to="ifrs-full_InsuranceExpense" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TravelExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TravelExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAdministrativeExpensesAbstract" xlink:to="ifrs-full_TravelExpense" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="AmortizationExpense" xlink:href="mlec-20230630.xsd#mlec_AmortizationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAdministrativeExpensesAbstract" xlink:to="AmortizationExpense" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAdministrativeExpensesAbstract" xlink:to="ifrs-full_DepreciationExpense" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAdministrativeExpensesAbstract" xlink:to="ifrs-full_SellingGeneralAndAdministrativeExpense" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAdministrativeExpensesAbstract" xlink:to="ifrs-full_AdministrativeExpense" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofResearchandDevelopmentExpenseTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfResearchAndDevelopmentExpenseAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfResearchAndDevelopmentExpenseAbstract"/>
    <loc xlink:type="locator" xlink:label="ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseTable" xlink:href="mlec-20230630.xsd#mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseTable"/>
    <loc xlink:type="locator" xlink:label="ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems" xlink:href="mlec-20230630.xsd#mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfResearchAndDevelopmentExpenseAbstract" xlink:to="ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseTable" xlink:to="ifrs-full_SegmentsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseTable" xlink:to="ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfessionalFeesExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfessionalFeesExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems" xlink:to="ifrs-full_ProfessionalFeesExpense" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="LaboratoriesRelatedExpenses" xlink:href="mlec-20230630.xsd#mlec_LaboratoriesRelatedExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems" xlink:to="LaboratoriesRelatedExpenses" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AmortisationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems" xlink:to="ifrs-full_AmortisationExpense" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="OtherResearchAndDevelopmentExpenses" xlink:href="mlec-20230630.xsd#mlec_OtherResearchAndDevelopmentExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems" xlink:to="OtherResearchAndDevelopmentExpenses" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofCostofsalesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfCostOfSalesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfCostOfSalesAbstract"/>
    <loc xlink:type="locator" xlink:label="CostofsalesDetailsScheduleofCostofsalesTable" xlink:href="mlec-20230630.xsd#mlec_CostofsalesDetailsScheduleofCostofsalesTable"/>
    <loc xlink:type="locator" xlink:label="CostofsalesDetailsScheduleofCostofsalesLineItems" xlink:href="mlec-20230630.xsd#mlec_CostofsalesDetailsScheduleofCostofsalesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfCostOfSalesAbstract" xlink:to="CostofsalesDetailsScheduleofCostofsalesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostofsalesDetailsScheduleofCostofsalesTable" xlink:to="ifrs-full_SegmentsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostofsalesDetailsScheduleofCostofsalesTable" xlink:to="CostofsalesDetailsScheduleofCostofsalesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Inventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Inventories"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostofsalesDetailsScheduleofCostofsalesLineItems" xlink:to="ifrs-full_Inventories" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="InventoriesIncorporatedThroughTheBusinessCombination" xlink:href="mlec-20230630.xsd#mlec_InventoriesIncorporatedThroughTheBusinessCombination"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostofsalesDetailsScheduleofCostofsalesLineItems" xlink:to="InventoriesIncorporatedThroughTheBusinessCombination" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchasesFairValueMeasurementAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PurchasesFairValueMeasurementAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostofsalesDetailsScheduleofCostofsalesLineItems" xlink:to="ifrs-full_PurchasesFairValueMeasurementAssets" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ProductionCostsAbstract" xlink:href="mlec-20230630.xsd#mlec_ProductionCostsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostofsalesDetailsScheduleofCostofsalesLineItems" xlink:to="ProductionCostsAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PayrollAndAndProfessionalFees" xlink:href="mlec-20230630.xsd#mlec_PayrollAndAndProfessionalFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductionCostsAbstract" xlink:to="PayrollAndAndProfessionalFees" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepairsAndMaintenanceExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RepairsAndMaintenanceExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductionCostsAbstract" xlink:to="ifrs-full_RepairsAndMaintenanceExpense" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DepreciationAndAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DepreciationAndAmortisationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductionCostsAbstract" xlink:to="ifrs-full_DepreciationAndAmortisationExpense" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="OtherProductionCosts" xlink:href="mlec-20230630.xsd#mlec_OtherProductionCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductionCostsAbstract" xlink:to="OtherProductionCosts" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RawMaterialsAndConsumablesUsed" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RawMaterialsAndConsumablesUsed"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProductionCostsAbstract" xlink:to="ifrs-full_RawMaterialsAndConsumablesUsed" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostofsalesDetailsScheduleofCostofsalesLineItems" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalOtherProductionCost" xlink:href="mlec-20230630.xsd#mlec_TotalOtherProductionCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostofsalesDetailsScheduleofCostofsalesLineItems" xlink:to="TotalOtherProductionCost" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Inventories_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_Inventories"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TotalOtherProductionCost" xlink:to="ifrs-full_Inventories_0" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CostOfSales"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CostofsalesDetailsScheduleofCostofsalesLineItems" xlink:to="ifrs-full_CostOfSales" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfNetLossPerShareAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfNetLossPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="NetLossperShareDetailsScheduleofNetLossPerShareTable" xlink:href="mlec-20230630.xsd#mlec_NetLossperShareDetailsScheduleofNetLossPerShareTable"/>
    <loc xlink:type="locator" xlink:label="NetLossperShareDetailsScheduleofNetLossPerShareLineItems" xlink:href="mlec-20230630.xsd#mlec_NetLossperShareDetailsScheduleofNetLossPerShareLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNetLossPerShareAbstract" xlink:to="NetLossperShareDetailsScheduleofNetLossPerShareTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetLossperShareDetailsScheduleofNetLossPerShareTable" xlink:to="ifrs-full_SegmentsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetLossperShareDetailsScheduleofNetLossPerShareTable" xlink:to="NetLossperShareDetailsScheduleofNetLossPerShareLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetLossperShareDetailsScheduleofNetLossPerShareLineItems" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetLossperShareDetailsScheduleofNetLossPerShareLineItems" xlink:to="ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustedWeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetLossperShareDetailsScheduleofNetLossPerShareLineItems" xlink:to="ifrs-full_AdjustedWeightedAverageShares" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetLossperShareDetailsScheduleofNetLossPerShareLineItems" xlink:to="ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable_Parentheticals">
    <loc xlink:type="locator" xlink:label="ScheduleOfNetLossPerShareAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfNetLossPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsTable" xlink:href="mlec-20230630.xsd#mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsTable"/>
    <loc xlink:type="locator" xlink:label="NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsLineItems" xlink:href="mlec-20230630.xsd#mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfNetLossPerShareAbstract" xlink:to="NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsTable" xlink:to="ifrs-full_SegmentsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsTable" xlink:to="NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsLineItems" xlink:to="ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofOtherRelatedPartyTransactionsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherRelatedPartyTransactionsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherRelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsTable" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsTable"/>
    <loc xlink:type="locator" xlink:label="RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsLineItems" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherRelatedPartyTransactionsAbstract" xlink:to="RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsTable" xlink:to="ifrs-full_SegmentsAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SegmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SegmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsMember" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsTable" xlink:to="RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermEmployeeBenefitsExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermEmployeeBenefitsExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsLineItems" xlink:to="ifrs-full_ShorttermEmployeeBenefitsExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermEmployeeBenefitsAccruals" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermEmployeeBenefitsAccruals"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsLineItems" xlink:to="ifrs-full_ShorttermEmployeeBenefitsAccruals" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfShareBasedPaymentAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfShareBasedPaymentAbstract"/>
    <loc xlink:type="locator" xlink:label="RelatedPartiesDetailsScheduleofShareBasedPaymentTable" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentTable"/>
    <loc xlink:type="locator" xlink:label="RelatedPartiesDetailsScheduleofShareBasedPaymentLineItems" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedPaymentAbstract" xlink:to="RelatedPartiesDetailsScheduleofShareBasedPaymentTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsScheduleofShareBasedPaymentTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="BioceresCropSolutionsCorpMember" xlink:href="mlec-20230630.xsd#mlec_BioceresCropSolutionsCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="BioceresCropSolutionsCorpMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnionGroupVenturesMember" xlink:href="mlec-20230630.xsd#mlec_UnionGroupVenturesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="UnionGroupVenturesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BGFarmingTechnologiesMember" xlink:href="mlec-20230630.xsd#mlec_BGFarmingTechnologiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="BGFarmingTechnologiesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BioceresSAMember" xlink:href="mlec-20230630.xsd#mlec_BioceresSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="BioceresSAMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BioceresLLCMember" xlink:href="mlec-20230630.xsd#mlec_BioceresLLCMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="BioceresLLCMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BioceresSAINMETSAIngenieriaMetabolicaSAMember" xlink:href="mlec-20230630.xsd#mlec_BioceresSAINMETSAIngenieriaMetabolicaSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="BioceresSAINMETSAIngenieriaMetabolicaSAMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember" xlink:href="mlec-20230630.xsd#mlec_BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BioceresSAAgralityIncMember" xlink:href="mlec-20230630.xsd#mlec_BioceresSAAgralityIncMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="BioceresSAAgralityIncMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FutureFoodsBVMember" xlink:href="mlec-20230630.xsd#mlec_FutureFoodsBVMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="FutureFoodsBVMember" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MoolecScienceSAMember" xlink:href="mlec-20230630.xsd#mlec_MoolecScienceSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="MoolecScienceSAMember" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="THEOISCSpMember" xlink:href="mlec-20230630.xsd#mlec_THEOISCSpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="THEOISCSpMember" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsScheduleofShareBasedPaymentTable" xlink:to="RelatedPartiesDetailsScheduleofShareBasedPaymentLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentAbstract" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsScheduleofShareBasedPaymentLineItems" xlink:to="ShareBasedPaymentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_KeyManagementPersonnelCompensation" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentAbstract" xlink:to="ifrs-full_KeyManagementPersonnelCompensation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CFOSharesAlloted" xlink:href="mlec-20230630.xsd#mlec_CFOSharesAlloted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentAbstract" xlink:to="CFOSharesAlloted" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssueOfAdditionalSharesAbstract" xlink:href="mlec-20230630.xsd#mlec_IssueOfAdditionalSharesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsScheduleofShareBasedPaymentLineItems" xlink:to="IssueOfAdditionalSharesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssueOfSharesCapital" xlink:href="mlec-20230630.xsd#mlec_IssueOfSharesCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IssueOfAdditionalSharesAbstract" xlink:to="IssueOfSharesCapital" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssueOfSharePremium" xlink:href="mlec-20230630.xsd#mlec_IssueOfSharePremium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IssueOfAdditionalSharesAbstract" xlink:to="IssueOfSharePremium" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IssueOfAdditionalSharesAbstract" xlink:to="ifrs-full_ProfitLossAttributableToOwnersOfParent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CompanySCashBalanceInOtherSAccountsAbstract" xlink:href="mlec-20230630.xsd#mlec_CompanySCashBalanceInOtherSAccountsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsScheduleofShareBasedPaymentLineItems" xlink:to="CompanySCashBalanceInOtherSAccountsAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CompanySCashBalanceInOtherSAccountsAbstract" xlink:to="ifrs-full_CashEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExpensesPaidOnBehalfOfTheCompanyAbstract" xlink:href="mlec-20230630.xsd#mlec_ExpensesPaidOnBehalfOfTheCompanyAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsScheduleofShareBasedPaymentLineItems" xlink:to="ExpensesPaidOnBehalfOfTheCompanyAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExpensesPaid" xlink:href="mlec-20230630.xsd#mlec_ExpensesPaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ExpensesPaidOnBehalfOfTheCompanyAbstract" xlink:to="ExpensesPaid" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ServicesProvidedByOtherCompaniesAbstract" xlink:href="mlec-20230630.xsd#mlec_ServicesProvidedByOtherCompaniesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsScheduleofShareBasedPaymentLineItems" xlink:to="ServicesProvidedByOtherCompaniesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ServicesProvidedByOtherCompanies" xlink:href="mlec-20230630.xsd#mlec_ServicesProvidedByOtherCompanies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ServicesProvidedByOtherCompaniesAbstract" xlink:to="ServicesProvidedByOtherCompanies" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable_Parentheticals">
    <loc xlink:type="locator" xlink:label="ScheduleOfShareBasedPaymentAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfShareBasedPaymentAbstract"/>
    <loc xlink:type="locator" xlink:label="RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsTable" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsTable"/>
    <loc xlink:type="locator" xlink:label="RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsLineItems" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedPaymentAbstract" xlink:to="RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="BioceresLLCMember" xlink:href="mlec-20230630.xsd#mlec_BioceresLLCMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="BioceresLLCMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BioceresSAINMETSAIngenieriaMetabolicaSAMember" xlink:href="mlec-20230630.xsd#mlec_BioceresSAINMETSAIngenieriaMetabolicaSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="BioceresSAINMETSAIngenieriaMetabolicaSAMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember" xlink:href="mlec-20230630.xsd#mlec_BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsTable" xlink:to="RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SubsidiaryPercentage" xlink:href="mlec-20230630.xsd#mlec_SubsidiaryPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsLineItems" xlink:to="SubsidiaryPercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OwnedPercentage" xlink:href="mlec-20230630.xsd#mlec_OwnedPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsLineItems" xlink:to="OwnedPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherRelatedPartyBalancesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherRelatedPartyBalancesAbstract"/>
    <loc xlink:type="locator" xlink:label="RelatedPartiesDetailsScheduleofotherrelatedpartybalancesTable" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesTable"/>
    <loc xlink:type="locator" xlink:label="RelatedPartiesDetailsScheduleofotherrelatedpartybalancesLineItems" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherRelatedPartyBalancesAbstract" xlink:to="RelatedPartiesDetailsScheduleofotherrelatedpartybalancesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsScheduleofotherrelatedpartybalancesTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="BioceresSABioceresLLCMember" xlink:href="mlec-20230630.xsd#mlec_BioceresSABioceresLLCMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="BioceresSABioceresLLCMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MoolecSAShareholdersMember" xlink:href="mlec-20230630.xsd#mlec_MoolecSAShareholdersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="MoolecSAShareholdersMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnionGroupVenturesLimitedMember" xlink:href="mlec-20230630.xsd#mlec_UnionGroupVenturesLimitedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="UnionGroupVenturesLimitedMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="INDEARSAMember" xlink:href="mlec-20230630.xsd#mlec_INDEARSAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="INDEARSAMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FutureFoodsBVMember" xlink:href="mlec-20230630.xsd#mlec_FutureFoodsBVMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="FutureFoodsBVMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsScheduleofotherrelatedpartybalancesTable" xlink:to="RelatedPartiesDetailsScheduleofotherrelatedpartybalancesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OtherRelatedPartyBalances" xlink:href="mlec-20230630.xsd#mlec_OtherRelatedPartyBalances"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsScheduleofotherrelatedpartybalancesLineItems" xlink:to="OtherRelatedPartyBalances" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable_Parentheticals">
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherRelatedPartyBalancesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfOtherRelatedPartyBalancesAbstract"/>
    <loc xlink:type="locator" xlink:label="RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsTable" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsTable"/>
    <loc xlink:type="locator" xlink:label="RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsLineItems" xlink:href="mlec-20230630.xsd#mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherRelatedPartyBalancesAbstract" xlink:to="RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="BioceresSABioceresLLCMember" xlink:href="mlec-20230630.xsd#mlec_BioceresSABioceresLLCMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="BioceresSABioceresLLCMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsTable" xlink:to="RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SubsidiaryPercentage" xlink:href="mlec-20230630.xsd#mlec_SubsidiaryPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsLineItems" xlink:to="SubsidiaryPercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofTradeandOtherReceivablesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfTradeAndOtherReceivablesAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfTradeAndOtherReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesTable" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesTable"/>
    <loc xlink:type="locator" xlink:label="FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesLineItems" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTradeAndOtherReceivablesAbstract" xlink:to="FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesTable" xlink:to="ifrs-full_MaturityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="UpToThreeMonthsMember" xlink:href="mlec-20230630.xsd#mlec_UpToThreeMonthsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="UpToThreeMonthsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesTable" xlink:to="FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ToDueBecomeAbstract" xlink:href="mlec-20230630.xsd#mlec_ToDueBecomeAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesLineItems" xlink:to="ToDueBecomeAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ToDueBecomeAbstract" xlink:to="ifrs-full_TradeAndOtherReceivables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfContractualMaturityDateAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfContractualMaturityDateAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialRiskManagementDetailsScheduleofContractualMaturityDateTable" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateTable"/>
    <loc xlink:type="locator" xlink:label="FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfContractualMaturityDateAbstract" xlink:to="FinancialRiskManagementDetailsScheduleofContractualMaturityDateTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_MaturityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_MaturityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsScheduleofContractualMaturityDateTable" xlink:to="ifrs-full_MaturityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AggregatedTimeBandsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AggregatedTimeBandsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_AggregatedTimeBandsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="WithinOneYearOrOnDemandMember" xlink:href="mlec-20230630.xsd#mlec_WithinOneYearOrOnDemandMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="WithinOneYearOrOnDemandMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BetweenOneAndTwoYearsMember" xlink:href="mlec-20230630.xsd#mlec_BetweenOneAndTwoYearsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="BetweenOneAndTwoYearsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BetweenTwoAndFiveYearsMember" xlink:href="mlec-20230630.xsd#mlec_BetweenTwoAndFiveYearsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="BetweenTwoAndFiveYearsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MoreThanFiveYearsMember" xlink:href="mlec-20230630.xsd#mlec_MoreThanFiveYearsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="MoreThanFiveYearsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WithoutAnyEstablishedTermMember" xlink:href="mlec-20230630.xsd#mlec_WithoutAnyEstablishedTermMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_MaturityAxis" xlink:to="WithoutAnyEstablishedTermMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsScheduleofContractualMaturityDateTable" xlink:to="FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems" xlink:to="ifrs-full_TradeAndOtherPayables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems" xlink:to="ifrs-full_NoncurrentPayables" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentPayables" xlink:to="ifrs-full_OtherLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherLiabilities_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherLiabilities"/>
    <loc xlink:type="locator" xlink:label="SimplyAgreementForFutureEquitySAFE" xlink:href="mlec-20230630.xsd#mlec_SimplyAgreementForFutureEquitySAFE"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentPayables" xlink:to="SimplyAgreementForFutureEquitySAFE" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SimplyAgreementForFutureEquitySAFE_0" xlink:href="mlec-20230630.xsd#mlec_SimplyAgreementForFutureEquitySAFE"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentPayables" xlink:to="ifrs-full_FinancialLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilities_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilities"/>
    <loc xlink:type="locator" xlink:label="SubtotalNonDerivatesLiabilities" xlink:href="mlec-20230630.xsd#mlec_SubtotalNonDerivatesLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentPayables" xlink:to="SubtotalNonDerivatesLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="SubtotalNonDerivatesLiabilities_0" xlink:href="mlec-20230630.xsd#mlec_SubtotalNonDerivatesLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WarrantLiability" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WarrantLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems" xlink:to="ifrs-full_WarrantLiability" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WarrantLiability_0" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WarrantLiability"/>
    <loc xlink:type="locator" xlink:label="SubtotalDerivatesLiabilities" xlink:href="mlec-20230630.xsd#mlec_SubtotalDerivatesLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems" xlink:to="SubtotalDerivatesLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="SubtotalDerivatesLiabilities_0" xlink:href="mlec-20230630.xsd#mlec_SubtotalDerivatesLiabilities"/>
    <loc xlink:type="locator" xlink:label="TotalLiabilities" xlink:href="mlec-20230630.xsd#mlec_TotalLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems" xlink:to="TotalLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="TotalLiabilities_0" xlink:href="mlec-20230630.xsd#mlec_TotalLiabilities"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofForeignCurrencyExchangeRiskTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfForeignCurrencyExchangeRiskAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfForeignCurrencyExchangeRiskAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskTable" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskTable"/>
    <loc xlink:type="locator" xlink:label="FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfForeignCurrencyExchangeRiskAbstract" xlink:to="FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskTable" xlink:to="ifrs-full_TypesOfRisksAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ArgentinePesosMember" xlink:href="mlec-20230630.xsd#mlec_ArgentinePesosMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ArgentinePesosMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="USDollarMember" xlink:href="mlec-20230630.xsd#mlec_USDollarMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="USDollarMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PoundSterlingMember" xlink:href="mlec-20230630.xsd#mlec_PoundSterlingMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="PoundSterlingMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ImpactToProfitOrLossBeforeTaxAssetsMember" xlink:href="mlec-20230630.xsd#mlec_ImpactToProfitOrLossBeforeTaxAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ImpactToProfitOrLossBeforeTaxAssetsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ImpactToProfitOrLossBeforeTaxLiabilitiesMember" xlink:href="mlec-20230630.xsd#mlec_ImpactToProfitOrLossBeforeTaxLiabilitiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ImpactToProfitOrLossBeforeTaxLiabilitiesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskTable" xlink:to="FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ForeignCurrencyExchangeRiskAssets" xlink:href="mlec-20230630.xsd#mlec_ForeignCurrencyExchangeRiskAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems" xlink:to="ForeignCurrencyExchangeRiskAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ForeignCurrencyExchangeRiskLiabilities" xlink:href="mlec-20230630.xsd#mlec_ForeignCurrencyExchangeRiskLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems" xlink:to="ForeignCurrencyExchangeRiskLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFairValueAndCarryingValueOfFinancialInstrumentsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfFairValueAndCarryingValueOfFinancialInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsTable" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsTable"/>
    <loc xlink:type="locator" xlink:label="FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueAndCarryingValueOfFinancialInstrumentsAbstract" xlink:to="FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsTable" xlink:to="ifrs-full_ClassesOfFinancialAssetsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ClassesOfFinancialInstrumentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ClassesOfFinancialInstrumentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_ClassesOfFinancialInstrumentsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsTable" xlink:to="FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="FinancialAssetsAbstract" xlink:href="mlec-20230630.xsd#mlec_FinancialAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems" xlink:to="FinancialAssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AmortizedCostsAbstract" xlink:href="mlec-20230630.xsd#mlec_AmortizedCostsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialAssetsAbstract" xlink:to="AmortizedCostsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashAndCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AmortizedCostsAbstract" xlink:to="ifrs-full_CashAndCashEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AmortizedCostsAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentReceivables" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueThroughProfitOrLossAbstract" xlink:href="mlec-20230630.xsd#mlec_FairValueThroughProfitOrLossAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems" xlink:to="FairValueThroughProfitOrLossAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueThroughProfitOrLossAbstract" xlink:to="ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShorttermInvestmentsCurrent" xlink:href="mlec-20230630.xsd#mlec_ShorttermInvestmentsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueThroughProfitOrLossAbstract" xlink:to="ShorttermInvestmentsCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueThroughProfitOrLossAbstract" xlink:to="ifrs-full_CurrentAssets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FinancialLiabilitiesAbstract" xlink:href="mlec-20230630.xsd#mlec_FinancialLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems" xlink:to="FinancialLiabilitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialLiabilitiesAbstract" xlink:to="ifrs-full_TradeAndOtherCurrentPayables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="FinancialDebts" xlink:href="mlec-20230630.xsd#mlec_FinancialDebts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialLiabilitiesAbstract" xlink:to="FinancialDebts" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueThroughProfitOrLossAbstract0" xlink:href="mlec-20230630.xsd#mlec_FairValueThroughProfitOrLossAbstract0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems" xlink:to="FairValueThroughProfitOrLossAbstract0" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SimplyAgreementForFutureEquitySAFE" xlink:href="mlec-20230630.xsd#mlec_SimplyAgreementForFutureEquitySAFE"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueThroughProfitOrLossAbstract0" xlink:to="SimplyAgreementForFutureEquitySAFE" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WarrantLiability" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WarrantLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueThroughProfitOrLossAbstract0" xlink:to="ifrs-full_WarrantLiability" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems" xlink:to="ifrs-full_FinancialLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssetsLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentAssetsLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems" xlink:to="ifrs-full_CurrentAssetsLiabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ScheduleofFixedRateInstrumentsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFixedRateInstrumentsAbstract" xlink:href="mlec-20230630.xsd#mlec_ScheduleOfFixedRateInstrumentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherCurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherCurrentFinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFixedRateInstrumentsAbstract" xlink:to="ifrs-full_OtherCurrentFinancialLiabilities" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFixedRateInstrumentsAbstract" xlink:to="ifrs-full_OtherNoncurrentFinancialLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/GeneralInformationDetails">
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="GeneralInformationDetailsTable" xlink:href="mlec-20230630.xsd#mlec_GeneralInformationDetailsTable"/>
    <loc xlink:type="locator" xlink:label="GeneralInformationDetailsLineItems" xlink:href="mlec-20230630.xsd#mlec_GeneralInformationDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="GeneralInformationDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="MoolecSAFEMember" xlink:href="mlec-20230630.xsd#mlec_MoolecSAFEMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="MoolecSAFEMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UGVLAndTheoMember" xlink:href="mlec-20230630.xsd#mlec_UGVLAndTheoMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="UGVLAndTheoMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsTable" xlink:to="GeneralInformationDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ParValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="ifrs-full_ParValuePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CommonStockExercised" xlink:href="mlec-20230630.xsd#mlec_CommonStockExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="CommonStockExercised" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RedemptionPrice" xlink:href="mlec-20230630.xsd#mlec_RedemptionPrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="RedemptionPrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AggregateRedemption" xlink:href="mlec-20230630.xsd#mlec_AggregateRedemption"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="AggregateRedemption" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TrustAccount" xlink:href="mlec-20230630.xsd#mlec_TrustAccount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="TrustAccount" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SponsorShares" xlink:href="mlec-20230630.xsd#mlec_SponsorShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="SponsorShares" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentCost" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="ShareBasedPaymentCost" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NegativeWorkingCapital" xlink:href="mlec-20230630.xsd#mlec_NegativeWorkingCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="NegativeWorkingCapital" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/BusinessCombinationDetails">
    <loc xlink:type="locator" xlink:label="BusinessCombinationAbstract" xlink:href="mlec-20230630.xsd#mlec_BusinessCombinationAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationAbstract" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashTransferred" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashTransferred"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationAbstract" xlink:to="ifrs-full_CashTransferred" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssueCostsNotRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IssueCostsNotRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationAbstract" xlink:to="ifrs-full_IssueCostsNotRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CashPayment" xlink:href="mlec-20230630.xsd#mlec_CashPayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationAbstract" xlink:to="CashPayment" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationAbstract" xlink:to="ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareEquivalent" xlink:href="mlec-20230630.xsd#mlec_ShareEquivalent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationAbstract" xlink:to="ShareEquivalent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExperienceDate" xlink:href="mlec-20230630.xsd#mlec_ExperienceDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationAbstract" xlink:to="ExperienceDate" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessCombinationAbstract" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails">
    <loc xlink:type="locator" xlink:label="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract"/>
    <loc xlink:type="locator" xlink:label="CumulativeInflationRate" xlink:href="mlec-20230630.xsd#mlec_CumulativeInflationRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:to="CumulativeInflationRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Accumulated" xlink:href="mlec-20230630.xsd#mlec_Accumulated"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:to="Accumulated" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InflationAccumulated" xlink:href="mlec-20230630.xsd#mlec_InflationAccumulated"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:to="InflationAccumulated" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ArgentinePriceIndexes" xlink:href="mlec-20230630.xsd#mlec_ArgentinePriceIndexes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:to="ArgentinePriceIndexes" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:href="mlec-20230630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:href="mlec-20230630.xsd#mlec_SummaryofSignificantAccountingPoliciesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SummaryofSignificantAccountingPoliciesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="ifrs-full_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_BottomOfRangeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_TopOfRangeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsTable" xlink:to="SummaryofSignificantAccountingPoliciesDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfSharesToBeIssuedOfContingentPayment" xlink:href="mlec-20230630.xsd#mlec_NumberOfSharesToBeIssuedOfContingentPayment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="NumberOfSharesToBeIssuedOfContingentPayment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ShareIssueRelatedCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ShareIssueRelatedCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="ifrs-full_ShareIssueRelatedCost" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="JointArrangementParticipationPercentage" xlink:href="mlec-20230630.xsd#mlec_JointArrangementParticipationPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SummaryofSignificantAccountingPoliciesDetailsLineItems" xlink:to="JointArrangementParticipationPercentage" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/RightofUseofAssetsDetails">
    <loc xlink:type="locator" xlink:label="RightofUseOfAssetsAbstract" xlink:href="mlec-20230630.xsd#mlec_RightofUseOfAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="OriginalAmount" xlink:href="mlec-20230630.xsd#mlec_OriginalAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RightofUseOfAssetsAbstract" xlink:to="OriginalAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/OtherNonCurrentReceivablesDetails">
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentReceivablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NoncurrentReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="OtherNonCurrentReceivablesDetailsTable" xlink:href="mlec-20230630.xsd#mlec_OtherNonCurrentReceivablesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="OtherNonCurrentReceivablesDetailsLineItems" xlink:href="mlec-20230630.xsd#mlec_OtherNonCurrentReceivablesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NoncurrentReceivablesAbstract" xlink:to="OtherNonCurrentReceivablesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonCurrentReceivablesDetailsTable" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_EntitysTotalForRelatedPartiesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="MoolecScienceLimitedMember" xlink:href="mlec-20230630.xsd#mlec_MoolecScienceLimitedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="MoolecScienceLimitedMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonCurrentReceivablesDetailsTable" xlink:to="ifrs-full_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RangesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_RangesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangesMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TopOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_TopOfRangeMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BottomOfRangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_BottomOfRangeMember" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonCurrentReceivablesDetailsTable" xlink:to="OtherNonCurrentReceivablesDetailsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonCurrentReceivablesDetailsLineItems" xlink:to="ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="AggregatePurchasePrice" xlink:href="mlec-20230630.xsd#mlec_AggregatePurchasePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonCurrentReceivablesDetailsLineItems" xlink:to="AggregatePurchasePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchasePaymentTerms" xlink:href="mlec-20230630.xsd#mlec_PurchasePaymentTerms"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonCurrentReceivablesDetailsLineItems" xlink:to="PurchasePaymentTerms" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_BorrowingsInterestRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_BorrowingsInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherNonCurrentReceivablesDetailsLineItems" xlink:to="ifrs-full_BorrowingsInterestRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ShareCapitalandSharePremiumDetails">
    <loc xlink:type="locator" xlink:label="ShareCapitalAndSharePremiumAbstract" xlink:href="mlec-20230630.xsd#mlec_ShareCapitalAndSharePremiumAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareCapitalStockAndSharePremiumAmounts" xlink:href="mlec-20230630.xsd#mlec_ShareCapitalStockAndSharePremiumAmounts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalAndSharePremiumAbstract" xlink:to="ShareCapitalStockAndSharePremiumAmounts" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Equivalent" xlink:href="mlec-20230630.xsd#mlec_Equivalent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalAndSharePremiumAbstract" xlink:to="Equivalent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharePurchaseAgreementOverPeriod" xlink:href="mlec-20230630.xsd#mlec_SharePurchaseAgreementOverPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalAndSharePremiumAbstract" xlink:to="SharePurchaseAgreementOverPeriod" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnderIssuedSharePurchaseAgreement" xlink:href="mlec-20230630.xsd#mlec_UnderIssuedSharePurchaseAgreement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalAndSharePremiumAbstract" xlink:to="UnderIssuedSharePurchaseAgreement" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharePurchaseAgreement" xlink:href="mlec-20230630.xsd#mlec_SharePurchaseAgreement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalAndSharePremiumAbstract" xlink:to="SharePurchaseAgreement" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/ShareBasedPaymentDetails">
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentAbstract" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentDetailsTable" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ShareBasedPaymentDetailsLineItems" xlink:href="mlec-20230630.xsd#mlec_ShareBasedPaymentDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentAbstract" xlink:to="ShareBasedPaymentDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsTable" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharebasedPaymentArrangementsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_SharebasedPaymentArrangementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_SharebasedPaymentArrangementsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="Group1GrantedMember" xlink:href="mlec-20230630.xsd#mlec_Group1GrantedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="Group1GrantedMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Group2GrantedMember" xlink:href="mlec-20230630.xsd#mlec_Group2GrantedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="Group2GrantedMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Group3GrantedMember" xlink:href="mlec-20230630.xsd#mlec_Group3GrantedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="Group3GrantedMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsTable" xlink:to="ShareBasedPaymentDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OrdinaryShares" xlink:href="mlec-20230630.xsd#mlec_OrdinaryShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsLineItems" xlink:to="OrdinaryShares" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsLineItems" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConstantValuePercentage" xlink:href="mlec-20230630.xsd#mlec_ConstantValuePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsLineItems" xlink:to="ConstantValuePercentage" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OptionsRecognizedAmount" xlink:href="mlec-20230630.xsd#mlec_OptionsRecognizedAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedPaymentDetailsLineItems" xlink:to="OptionsRecognizedAmount" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/WarrantsLiabilitiesDetails">
    <loc xlink:type="locator" xlink:label="WarrantsLiabilitiesAbstract" xlink:href="mlec-20230630.xsd#mlec_WarrantsLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="AggregateShares" xlink:href="mlec-20230630.xsd#mlec_AggregateShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesAbstract" xlink:to="AggregateShares" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ExercisePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_ExercisePriceShareOptionsGranted2019"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesAbstract" xlink:to="ifrs-full_ExercisePriceShareOptionsGranted2019" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PricePerWarrant" xlink:href="mlec-20230630.xsd#mlec_PricePerWarrant"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesAbstract" xlink:to="PricePerWarrant" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisePricePerShare" xlink:href="mlec-20230630.xsd#mlec_ExercisePricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesAbstract" xlink:to="ExercisePricePerShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DividendsPaidOrdinarySharesPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DividendsPaidOrdinarySharesPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsLiabilitiesAbstract" xlink:to="ifrs-full_DividendsPaidOrdinarySharesPerShare" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFEDetails">
    <loc xlink:type="locator" xlink:label="SimpleAgreementForFutureEquitySafeAbstract" xlink:href="mlec-20230630.xsd#mlec_SimpleAgreementForFutureEquitySafeAbstract"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NotionalAmount" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotionalAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SimpleAgreementForFutureEquitySafeAbstract" xlink:to="ifrs-full_NotionalAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentReceivablesFromSaleOfProperties" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentReceivablesFromSaleOfProperties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SimpleAgreementForFutureEquitySafeAbstract" xlink:to="ifrs-full_CurrentReceivablesFromSaleOfProperties" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SimpleAgreementForFutureEquitySafeAbstract" xlink:to="ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertedShares" xlink:href="mlec-20230630.xsd#mlec_ConvertedShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SimpleAgreementForFutureEquitySafeAbstract" xlink:to="ConvertedShares" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchasePricePerShare" xlink:href="mlec-20230630.xsd#mlec_PurchasePricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SimpleAgreementForFutureEquitySafeAbstract" xlink:to="PurchasePricePerShare" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchasePrice" xlink:href="mlec-20230630.xsd#mlec_PurchasePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SimpleAgreementForFutureEquitySafeAbstract" xlink:to="PurchasePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/DeferredTaxandIncomeTaxDetails">
    <loc xlink:type="locator" xlink:label="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NotesAndOtherExplanatoryInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxandIncomeTaxDetailsTable" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsTable"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxandIncomeTaxDetailsLineItems" xlink:href="mlec-20230630.xsd#mlec_DeferredTaxandIncomeTaxDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_NotesAndOtherExplanatoryInformationAbstract" xlink:to="DeferredTaxandIncomeTaxDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeographicalAreasAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_GeographicalAreasAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxDetailsTable" xlink:to="ifrs-full_GeographicalAreasAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="country_LU" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_LU"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_GeographicalAreasAxis" xlink:to="country_LU" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxDetailsTable" xlink:to="DeferredTaxandIncomeTaxDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxRate" xlink:href="mlec-20230630.xsd#mlec_IncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxDetailsLineItems" xlink:to="IncomeTaxRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_DeferredTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DeferredTaxExpenseIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxandIncomeTaxDetailsLineItems" xlink:to="ifrs-full_DeferredTaxExpenseIncome" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/FinancialRiskManagementDetails">
    <loc xlink:type="locator" xlink:label="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialRiskManagementDetailsTable" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsTable"/>
    <loc xlink:type="locator" xlink:label="FinancialRiskManagementDetailsLineItems" xlink:href="mlec-20230630.xsd#mlec_FinancialRiskManagementDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract" xlink:to="FinancialRiskManagementDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsTable" xlink:to="ifrs-full_TypesOfRisksAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TypesOfRisksMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TypesOfRisksMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_LiquidityRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_LiquidityRiskMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_LiquidityRiskMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestRateRiskMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_InterestRateRiskMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_InterestRateRiskMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsTable" xlink:to="FinancialRiskManagementDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CurrentFinancialAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsLineItems" xlink:to="ifrs-full_CurrentFinancialAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_FinancialLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsLineItems" xlink:to="ifrs-full_FinancialLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfFunctionalCurrency" xlink:href="mlec-20230630.xsd#mlec_PercentageOfFunctionalCurrency"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsLineItems" xlink:to="PercentageOfFunctionalCurrency" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TaxRateEffectOfForeignTaxRates" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_TaxRateEffectOfForeignTaxRates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsLineItems" xlink:to="ifrs-full_TaxRateEffectOfForeignTaxRates" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfInterestRates" xlink:href="mlec-20230630.xsd#mlec_PercentageOfInterestRates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsLineItems" xlink:to="PercentageOfInterestRates" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncreasedecreaseInterestPayable" xlink:href="mlec-20230630.xsd#mlec_IncreasedecreaseInterestPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialRiskManagementDetailsLineItems" xlink:to="IncreasedecreaseInterestPayable" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/EventsaftertheReportingPeriodDetails">
    <loc xlink:type="locator" xlink:label="EventsAfterTheReportingPeriodAbstract" xlink:href="mlec-20230630.xsd#mlec_EventsAfterTheReportingPeriodAbstract"/>
    <loc xlink:type="locator" xlink:label="EventsaftertheReportingPeriodDetailsTable" xlink:href="mlec-20230630.xsd#mlec_EventsaftertheReportingPeriodDetailsTable"/>
    <loc xlink:type="locator" xlink:label="EventsaftertheReportingPeriodDetailsLineItems" xlink:href="mlec-20230630.xsd#mlec_EventsaftertheReportingPeriodDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsAfterTheReportingPeriodAbstract" xlink:to="EventsaftertheReportingPeriodDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsaftertheReportingPeriodDetailsTable" xlink:to="srt_StatementScenarioAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioForecastMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsaftertheReportingPeriodDetailsTable" xlink:to="EventsaftertheReportingPeriodDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsaftertheReportingPeriodDetailsLineItems" xlink:to="ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="StrikePricePerShare" xlink:href="mlec-20230630.xsd#mlec_StrikePricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsaftertheReportingPeriodDetailsLineItems" xlink:to="StrikePricePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties" xlink:href="https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd#ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsaftertheReportingPeriodDetailsLineItems" xlink:to="ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfStockInventories" xlink:href="mlec-20230630.xsd#mlec_NumberOfStockInventories"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsaftertheReportingPeriodDetailsLineItems" xlink:to="NumberOfStockInventories" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CashPaidInKindInterest" xlink:href="mlec-20230630.xsd#mlec_CashPaidInKindInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EventsaftertheReportingPeriodDetailsLineItems" xlink:to="CashPaidInKindInterest" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.moolecscience.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="mlec-20230630.xsd#mlec_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_BusinessContactMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentRegistrationStatement" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentShellCompanyReport" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCountry" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelName" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelEmailAddress" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelEmailAddress"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelEmailAddress" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="33.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="34.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="35.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" order="36.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAccountingStandard" order="37.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="38.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="39.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="40.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" )/!#,# 2(  A$! Q$!_\0
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MG@SPO9LR[T2XU[Q'>Z;I<;N PC1KH/(Z21H&DC=5^&?^"JW_  4:^%7_  3
M_9)\7?M+?$>V'B#5[:ZB\+?"_P  P%TO_B#\1]4M[B?0?#T=S"'DTK2[5[)]
M=U[6IE2RM-.TB6R^T)JVHZ1;W7^0]^W3_P %#?VKO^"AOQ:U'XL_M,_%;6/&
MU_->71\->#;6YNK;X>>!])N9HKBUT+P+X-F T[2;!3+&T\[PRZG?RHKW;/\
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MP+7XFS7*\!QMDU6OPAG& QU+#PR'-H4L-.4*]6DJC=.HJ-:52+Y8*#:?#_\
M!/;_ (([?'K]B#_@G+_P5D_;'_;.O!IW[5/[3G[$?[3/AR'P5>:YINO^*/!?
MA;7/ GBSQ5XHU7QUKFFWMWIMSXV^(/BBWT[4K_3]/O-0M]&MK"TAGOFO[F[M
M['Y>_P""-!2#_@V/_P""P=J+F&&]EU+]HB[0)(K7<21? 3X:6QQ"#EA'%'<,
MAVD7/GM'!YDD<JI[I\?M.\6>._V>_CKX&T*;5+_Q#XO^$_Q'\-:19#5]4E6^
MNM;\(ZMI-A8*^H:G8VEQ/J-S>QQ%-1D95/,9""5J_'K]G?X/_%_X"_\ !*W]
ML'PS\5/#NN>![O5[7XIZ['X<U"\GANI])F^'-CISWE]IL>HVMI''<C2IX8I'
M6ZGO#;(;>)O+0RWEWB%5S#+,=B'E4<+5KO*,FIY?4S'#.O/"_P!JX'EKPY/=
ME4IRE><.5.:A+EC"\;?1^'_TZ^$^.>$\+G<.&:&49S2\;^"N":/#.-XPR;%9
MYG^2\=1PN3XGB?(<+3PN'JU,)DV8YC3P]23HXC#RE"=*KB*3<JD?W6_X,_?V
M&_V;[W]E3XH?MC^-/!'A#QU\<->^-FO?"[PYJGB?0M/\27_PU\&^!_#_ (3U
MLP>&;74H;Z#2=2\1ZSXEO#J^LVMG;ZG)9Z?:6UEJ=O;K=)-Y%_P>#?L?_ +X
M3>&OV6_VVO@SX:\,?"OXX:C\9KKX8>+=4\!V>G^&[OQ=9Q^&KWQ]X9\7WL&E
M_888?%W@C7/"MQ#8ZZL,5_=)XC:/6M2NH[?34B_G+_8&^(7[<_P ^!6H?%CX
M > HOC/\%_$_C+7]$\6_#G3I_$\FJ:/X@T2#3U?7K33]#O+74TN]5L]3@*W.
MB1:G+/'IJ1WD43QQ1UZ9XF^'G[=?_!4'XN?#N#XZ_#[7/@W\$O!.IRR+INN:
M;XAT'1=%L-0%C!K5S9:5XHU&;Q3X@\3:A9Z:(6U3^R(X]/4D,\0OU6;Z7'<1
M2HXVM&I@X87!8'"RK2Q;S3"5JL;4OAEAHQA4?.O=C=4[2J+GDW3FC]JS+QTA
MPKQ1Q?3XCP?A_E_AYPG//Z><\85/%_AF?$D,QRW+ZV)PO#V#\-5@5Q+C.)/K
MJHT*^ P[JX&OAY>WP68N4XT5]F?\%K_VI_%O[2O[;7_!*#1/V@/!?Q"^-GPO
MT3]BS]C3XR>+_@5\.BT_BOXI>+_B]:KXJ^+NG:5X=FCN8[[Q/XR.B)X46."Q
MFU1M/L;*"Q^SO)*[?K)^V%_P53^'?[4_['WQ3_8_UC_@@3^W9X8\%:Q\-?$'
MA;P':V?P(ATVU^$FOQ:/<GX?>+/#NEZ/X1L9M M_"GBJWTW69$T]K.W*66IQ
MO/J$L]Q;C\J/^"@/[%'Q#^(W_"H_C9^S-J%]I7QF_9^T70?#?A#2I-< U74/
M!O@ZX2Y\*6VB:QJ+1M'K7A:='9+=[JTLIK2[DM[2=Y1Y3>2R?\%%/^"H%[X;
MM/ ^G_L<^,(OB3'&^G-XWET/XAQZ VH2KY&H:K;Z+]HL]$CNKRZN)=4\ZZ\9
M-HYN6G:[M[N P*OD9?QE@\TP<<1EM7!8N2K\M:C4Q$<+73I24N:E4K35/E<X
MJ4W*,[4U."M446?G_#?TN\+XA<)</<6^%W#'"6>RS#'9CEG%W#O&7C'PEX;9
MIP(J?MJ&#S'$_P!MX2=/B/*L52=/,,5B\IY7E=WEDZ&+QUC[G_8X\-?M6?#S
M_@V _P""KWPL_:0^''Q*^&GAKPQXET2]^"6D_%3PMK7@S69M'\2>*/A9>^-+
M;0M*\2VVEZH?#,/B>W74K"0:7#9/J&O:DME=WQ,J6WJW[,S1P?\ !F9^TC:S
M20I=#Q!\26$3R(7*C]IWPL=T>&*N?E91L)RX,8RXVU\Y?$;P5^V)\4?^";_Q
M3\"_&>_O?'_[0WBSP9<?;]%TK49Y99[6+Q3H.MZ5H-T\.HV.BG5+'3]&4O:V
MNE&"-RL$.J:E*2MM\X>!?V>?CY;?\$B?&/P&G\&:]9?$C6K7Q'J\/P]CN)8[
MZYMY_'&G^(XW>SAUDV)NKB&Q@G-L]K]J#ED8"7-54XXA5H5U6RV$<57S'+\L
M=*GFF$DI4ZN-P\*V*A[MW3A3D^6]I\ZBW%J3@O(R7Z;?#%7*<LQ&/R_A2GF>
M6>/6$\*,QIY9XB9/F&3X;*L;@,7.OQO@\?5P&$Q6,R7#.#DZF+P65X64%.^/
MA&/M#[<TJ2.'_@RVU*!MAN(/BU.#;A0[&67]K^V>"3&TJ_E>?%.&7>BL"&;>
MC ?N5_P;._L8?LL>'O\ @DI\$OB?JGPB^&_B[XA_M 2_$;QE\4O%WC;P;H/B
M74=5.G_$KQEX,T+1)+C5;&_6UT/2O#&@VME96:2PQRW<NIW:V\QN96/\GR?L
MW_'S_AS\_P #QX*U\_$?^T7\1O\ #>.[9;XQ2?$-]<>Y:P.MBQ:]2R==66T%
MF;HW$(A -R54_HE^P#X0^(7PE_8^^!G@#QYI^L>'?$V@:%K)U7PS=3WXN-$&
MJ^(_$VHVJS+;ZC+!;O=0W%C>R110;DFO9$G!GMYEBQS/CNA1P'$^,GETH5Z6
M.E0HQ6/P]5.IE>62C@I^R48SE#$U(4Z56*G&=Y.2]G'1>)QQ].OACA+A#,^(
M<EX;R[BO%<-^*O%WAWAN'LMX\R*GC\\R/ X#$YM3XYPTUA:TEE>(Q%-TJ4:6
M'Q6"E#FC0S;%XATX/"_X)S?#3P=^R'_P=:_M1_"[X.Z=/X<^$^A:%^TW#H?A
M32+N>WTY?#6K_#32?B7%X41X6:6VT&Q\5W-H=+A"$V,VE:2;4$P0*_YT?\$@
MOVY[?P#^V]^US^W)\=OV%/VA_P#@H+^T!XWU:Y\2>'-2^%O@2'XA0?"7Q'XU
M\4ZQKWB3Q%X@T-K#4EL]4O[:WT71O"UXMQ8OX5L-'U>UTZ"4RO/I_IWPO^ /
MQXT#_@KC\5_CMJWA#7K+X>:_IGB._A\<R7S65OJ*:QX3T?2;1;:[M+BVOTDD
MO+&Y6[BDA,;6\*)<,J7,9D\=\0?!/]KO_@GM^T+XZ^,_[)?A'4/B?\(/B=>R
MWOB?P;HRRRVWV.XNKR]72?$.DZ=?QZV;O29=4U'_ (1?4M-CNXECGO(WAW ,
ME8#CS UL9EU&E15;$XCA;#9FX.M"G2_M.N[8K#>TD[4J-'#.I*-.;=;VL$IU
M%%\LONJ7TO. LYS+%<-9+CN"UG^8>'G O'_#5'//$C(\HR3,\?GF5XO-,Z\/
M\5Q)]4JX#+^*,/7P+PF6U<5[#!RQ-2&'QM*FINO'ZB_X+<?'[Q;_ ,%/-;^!
MGQ2_9[_X)$_MW_LX?M,_"GQ?);:E\6M4^!OB&*_\5>"0L&I:+;7-UX.\,VM[
M=>+_  5XP.EZEX2U>_N+@Z/9ZEK0N[^W6XB*_P"C;^R_XB^(OBO]GGX&^(?C
M#I;:'\7=:^#?PPU?XJ:(Z1QMHWQ'U'P?IEQXWTEDA>2 -IOB@ZK9,()98<P'
MRY)$VNW^:1X?_:__ ."J'[2_Q%\):3\._@WXH_9O\#6'B"TU3Q=XC\5Q^*@J
MV=A+!%<?:-?\:0:7//:O;"XCM-(T2QN79;EE:XE*Q%/[_O\ @E(UW-^S)<W-
M]>7-Y<2?$+Q*F;V66YN84BATTM$;JY1+F:W:ZDNI[42;XXXYML3D^8J>ME?$
M=;%8O^SZV6PHRQ'/65:GF.&Q/L>2,I.$Z=)-N4[))1D^5-2DU\*^AX%\>\VX
MI\4>'_#7B;ACAGA[/LVX%SSC>>5\-^(F1\>XKA_!9=4R&C@\'Q!C\DHK*7B\
M='-J]2G#*\9BYQA2I3K4:%/GE/\ 3.BBBOIC^GPHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J.5BJ.P4L41G"_P!XH,A<
M] 2<8Y'3ZU)4<A?*[%+8923N  &]5;()&?W;.XQW3')*@@'^<E_P>T?&;Q+=
M_M,_L=?L^"XG3P=X3^!_B3XR2633,MIJ7B/Q_P#$+7?!ZSRVZL!+)I.G?#SR
MH'=24CU*X"':[Y_B%59 'C):1<%GC3[_ )D%O<&*38X63RH8SN=MH786Y) Q
M_?Q_P>L?LF>)[Z\_9$_;6T72[N^\)Z-H^O\ [.'Q(U..V\VUT*6ZUN?QK\.)
M;^[&4L5UJ35/'L%O/<&*V^TV202W$=Q-:P7/\ Y78'6X+1RHIMVC<R1S),LD
MC9FC:-B4B"+$Z.48%TV;C%(J ']U'QW_ .""7PF_:D_X(Q?L!?%']ASX8>%]
M"_;W3X#_  V^+'C+PGX?OVTOQ1^T9X'\8CP?H_Q \0:E!JFH2FXNO WB76="
MURQU5(K>.TM;O5+)R\^L:<ESQ7_!87_@BG^SM^RW_P $]?\ @G'\$?V4O 7A
M#XD?MJ^-/VK/"_[,OQ-^,'A+4M2NM:^*7Q-\8>'/&!\8>$?$5W%JT>F6OA_1
M_B1%9:+IIU/1OMGA;1M"MM.?^S7&MH?S$^./_!=/Q/X<^%G_  2FF_8:\1?$
M;X+?';]AG]DWQ]^S_P#%/Q)KGA3P?>>$/%K^-!X!T<Z-9Z=<7FOVOB/P^]A\
M/H?$BGQ!I(ATO6U\-36-I+J-K?7FEH__  6WTS0_V"/^"<?POT*Q\=>+?VQ?
MV-OV]_%_[8_C[QU\1(=/U;P)\1)-0\=?$OQO8VUYKT/B:76[J]\8#XDOH'B2
MUDT73X["PT5[675+JSU&R.E 'T/J_P#P;+:+=ZOX\_9X^#W_  4Q_9X^+7_!
M1OX5^!)_''C+]C?2/"VNZ%+YMOH\5[<>&_#OQ3N/$0T^XUBQMM0TR.YMG\/6
MR6F9KG7AI.FV[RVWR;^R9_P0Y\*_$7]E#P'^V-^W5^W#\+O^">OPE^-?C36/
MA_\ L]V'Q$\$ZGXU\9?%C7_#M]+X?O-2FT#3];\+1^'/#,>NVFLPV^NN_B"Z
MGTNQN==U*TTC1WTJ^US]./\ A]C_ ,$=/A#^T5\6O^"JW[/7[/'[6)_X*0_%
MKPEX@LH/A/X\UCP5-^S7X/\ B5XPT5=/\0^-+KQ+8W\?BB^TS4[H0WM\+.UE
MDU.:'4I;6QTK^T6,'R#\&O\ @J/_ ,$T_P!J_P#84^ W[&/_  5_^'?[3/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ7_&CS(_^>B?]]+_ (US/]H>)O\ H6HO_!]#_P#&:/[0\3?]"U%_X/H?_C-
M'3>9'_ST3_OI?\:/,C_YZ)_WTO\ C7,_VAXF_P"A:B_\'T/_ ,9H_M#Q-_T+
M47_@^A_^,T =-YD?_/1/^^E_QH\R/_GHG_?2_P"-<S_:'B;_ *%J+_P?0_\
MQFC^T/$W_0M1?^#Z'_XS0!TWF1_\]$_[Z7_&CS(_^>B?]]+_ (US/]H>)O\
MH6HO_!]#_P#&:/[0\3?]"U%_X/H?_C- '3>9'_ST3_OI?\:/,C_YZ)_WTO\
MC7,_VAXF_P"A:B_\'T/_ ,9H_M#Q-_T+47_@^A_^,T =-YD?_/1/^^E_QH\R
M/_GHG_?2_P"-<S_:'B;_ *%J+_P?0_\ QFC^T/$W_0M1?^#Z'_XS0!TWF1_\
M]$_[Z7_&CS(_^>B?]]+_ (US/]H>)O\ H6HO_!]#_P#&:/[0\3?]"U%_X/H?
M_C- '3>9'_ST3_OI?\:/,C_YZ)_WTO\ C7,_VAXF_P"A:B_\'T/_ ,9H_M#Q
M-_T+47_@^A_^,T =-YD?_/1/^^E_QH\R/_GHG_?2_P"-<S_:'B;_ *%J+_P?
M0_\ QFH+K6]=L;>6ZN_#B)!"C222+KD3;$12S$JMNSMA02 BD\$8)(H%)V39
MUOF1_P#/1/\ OI?\:/,C_P">B?\ ?2_XUS/]I>(VX7PR@QUW:];GN1QMA[%3
MG/MBC^T/$W_0M1?^#Z'_ .,T$1FVTM#IO,C_ .>B?]]+_C1YD?\ ST3_ +Z7
M_&N9_M#Q-_T+47_@^A_^,T?VAXF_Z%J+_P 'T/\ \9H-#IO,C_YZ)_WTO^-'
MF1_\]$_[Z7_&N9_M#Q-_T+47_@^A_P#C-']H>)O^A:B_\'T/_P 9H Z;S(_^
M>B?]]+_C1YD?_/1/^^E_QKF?[0\3?]"U%_X/H?\ XS1_:'B;_H6HO_!]#_\
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M7_@^A_\ C- '3>9'_P ]$_[Z7_&CS(_^>B?]]+_C7,_VAXF_Z%J+_P 'T/\
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M7_@^A_\ C- '3>9'_P ]$_[Z7_&CS(_^>B?]]+_C7,_VAXF_Z%J+_P 'T/\
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M 'TO^-'F1_\ /1/^^E_QKF?[0\3?]"U%_P"#Z'_XS1_:'B;_ *%J+_P?0_\
MQF@#IO,C_P">B?\ ?2_XT>9'_P ]$_[Z7_&N9_M#Q-_T+47_ (/H?_C-']H>
M)O\ H6HO_!]#_P#&: .F\R/_ )Z)_P!]+_C1YD?_ #T3_OI?\:YG^T/$W_0M
M1?\ @^A_^,T?VAXF_P"A:B_\'T/_ ,9H Z<.IZ,&Y ^7YL9Z9VYP/<X'O2@@
MYQG@D'*LO(]-P&1Z,,J>Q-<I)JOB"".26?PXJ)%')+N75[:8#RE+G<&$;#Y
MQ&P.6P1P<!N@L9GN;:&Y=!$T\,4IC#EPID0/C)&!\K+]W\>10!<HHHH 8_;Z
MK_Z&E<[X=_UGB#_L8;__ - @KHG[?5?_ $-*YWP[_K/$'_8PW_\ Z!!0!TM%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %<_P"*?^0!JG_7G<_^B)*Z"N?\4_\ ( U3_KSN?_1$
ME FKJQN)]YOQ_P#1DE25&GWF_'_T9)4E E!)WU"BBB@H**** "BBB@ HHHH
M****!-75B*;_ %3_ .Y)_P"BVKF](_Y&7Q=_OZ%_Z;#723?ZI_\ <D_]%M7-
MZ1_R,OB[_?T+_P!-AH$H).^IU-%%%!04444 %%%% !1110 4444 8.I?\AKP
MY_UVU/\ ]-TM;$'^K3_KG%_Z *Q]2_Y#7AS_ *[:G_Z;I:V(/]6G_7.+_P!
M% $U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S_BG_D
M:I_UYW/_ *(DKH*Y_P 4_P#( U3_ *\[G_T1)0!N)]YOQ_\ 1DE25&GWF_'_
M -&25)0 4444 %%%% !1110 4444 %%%% $4W^J?_<D_]%M7-Z1_R,OB[_?T
M+_TV&NDF_P!4_P#N2?\ HMJYO2/^1E\7?[^A?^FPT =31110 4444 %%%% !
M1110 4444 8.I?\ (:\.?]=M3_\ 3=+6Q!_JT_ZYQ?\ H K'U+_D->'/^NVI
M_P#INEK8@_U:?]<XO_0!0!-1110 4444 %%%% !1110 4444 %%%% !1110
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M- %^BBB@!C]OJO\ Z&E<[X=_UGB#_L8;_P#] @KHG[?5?_0TKG?#O^L\0?\
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M\8>.?%'Q@LO$>B>'Y]'^+G@?4E@T"R\ :/<BS\.:+XKU^%=:BN$T6-(@U_\
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M-6T[PAKKQSQ1:C);E(]2AMNZ^)__  1)^!?QGT_Q)X?^)7QV_:@\3>#?BO\
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M^&/PFTKX@#4;CP%X8N?B%XN\/^);WQ#\5O&NG:/J&H^'_!ND:&]A_9EC)?\
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M]W_QX4H)/48_'-+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6?JO_(.OO^O.\_\
M26:M"L_5?^0=??\ 7I=#DXY:WE1>OJS >@SDX&30 NE_\@^R_P"O2T_])8:O
MU1TT8L+-3U%I:YP0?^7>->HR#RK#@]O0BKU !1110 4444 %-;=QM]\]*=10
M #..>O>BBB@5M;W?IT"BBB@84444 %%%% !1110 4444 %%%% !1110!0U3_
M )!][_UZ7?\ Z2S4:7_R#[+_ *]+3_TEAI=3!.GWH'_/I==2!UMI1U.!U(_G
MTI-+_P"0?9?]>EI_Z2PT 7Z*** &/V^J_P#H:5SOAW_6>(/^QAO_ /T""NB?
MM]5_]#2N=\._ZSQ!_P!C#?\ _H$% '2T444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S_BG_D :
MI_UYW/\ Z(DKH*Y_Q3_R -4_Z\[G_P!$24 ;B?>;\?\ T9)4E1I]YOQ_]&25
M)0 4444 %%%% !1110 4444 %%%% $4W^J?_ ')/_1;5S>D?\C+XN_W]"_\
M38:Z2;_5/_N2?^BVKF](_P"1E\7?[^A?^FPT =31110 4444 %%%% !1110
M4444 <OK<D\6L>&V@M6NG\[5>%EBB*_\2V3O*Z [L]CQMYQD9GAO]6"+_P 2
M&4_NH3E;W3P2?*7=G-SV;('L._4OU+_D->'/^NVI_P#INEK8@_U:?]<XO_0!
M0!E?VAJW_0!G_P# [3O_ ))H_M#5O^@#/_X':=_\DUMT4 8G]H:M_P! &?\
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MO^@#/_X':=_\DT?VAJW_ $ 9_P#P.T[_ .2:VZ* ,3^T-6_Z ,__ (':=_\
M)-']H:M_T 9__ [3O_DFMNB@#$_M#5O^@#/_ .!VG?\ R31_:&K?] &?_P #
MM._^2:VZ* ,3^T-6_P"@#/\ ^!VG?_)-']H:M_T 9_\ P.T[_P"2:VZ* ,3^
MT-6_Z ,__@=IW_R31_:&K?\ 0!G_ / [3O\ Y)K;HH Q/[0U;_H S_\ @=IW
M_P DU6FUC4(I;:"30KCS;IY([=1>V!WO%$\\@W"YVKB*-VRY4';M!+$ ])6)
MJ/\ R%?#W_7W?_\ IJNZ &)J&JG)&@7 Z=;[3N<C(Z71[$?G]</_ +0U;_H
MS_\ @=IW_P DUKQ_=/\ P'_T6E24 8G]H:M_T 9__ [3O_DFC^T-6_Z ,_\
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MW_0!G_\  [3O_DFC^T-6_P"@#/\ ^!VG?_)-;=% &)_:&K?] &?_ ,#M._\
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M#M._^2:/[0U;_H S_P#@=IW_ ,DUMT4 8G]H:M_T 9__  .T[_Y)H_M#5O\
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M>)#X7T3QMXAEO7^(TOPCL-5U#X4?&#0_!>N_$BWUO6/#5WX1\+?$/7/ 6G>
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MJ=KX=U"TU$6=Y-J"WB6%O=QZ;J4EI]))(DF=AW!2RD@';N1WC==V,%D>-E8
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MZ'_"G44#YX]_P8W>OK^A_P *-Z^OZ'_"G44!SQ[_ (,;O7U_0_X4;U]?T/\
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MK^A_PHWKZ_H?\*=10'/'O^#&[U]?T/\ A1O7U_0_X4ZB@.>/?\&-WKZ_H?\
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M=Z/\Z_\  X?YASUO^?,/_!DR_P"='_M_]^I?_B*/.C_V_P#OU+_\15#SH/\
MGE_Y!?\ ^-T>=!_SR_\ (+__ !NB]'^=?^!P_P PYZW_ #YA_P"#)E_SH_\
M;_[]2_\ Q%'G1_[?_?J7_P"(JAYT'_/+_P @O_\ &Z/.@_YY?^07_P#C=%Z/
M\Z_\#A_F'/6_Y\P_\&3+_G1_[?\ WZE_^(H\Z/\ V_\ OU+_ /$50\Z#_GE_
MY!?_ .-T>=!_SR_\@O\ _&Z+T?YU_P"!P_S#GK?\^8?^#)E_SH_]O_OU+_\
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M\Z#_ )Y?^07_ /C=3>C_ #K_ ,#A_F7SUO\ GS#_ ,&3+_G1_P"W_P!^I?\
MXBCSH_\ ;_[]2_\ Q%4/.@_YY?\ D%__ (W1YT'_ #R_\@O_ /&Z+T?YU_X'
M#_,.>M_SYA_X,F7_ #H_]O\ []2__$4>='_M_P#?J7_XBJ'G0?\ /+_R"_\
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M</\ ,.>M_P ^8?\ @R9?\Z/_ &_^_4O_ ,11YT?^W_WZE_\ B*H>=!_SR_\
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M07_^-T7H_P Z_P# X?YASUO^?,/_  9,O^='_M_]^I?_ (BCSH_]O_OU+_\
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MQ<EI?X(^T3_\&*RUUM9Y.C?\A'Q'_P!?^G_^F'2JZ&N>T;_D(^(_^O\ T_\
M],.E5T-(L**** "BBB@ HHHH **** "BBB@"AJG_ "#[W_KTN_\ TEFHTO\
MY!]E_P!>EI_Z2PT:I_R#[W_KTN__ $EFHTO_ )!]E_UZ6G_I+#0!?HHHH A8
M$A5/ 'SYXX9'1E'X\^P[]J^5_%]_>V_B?78X;N[@0ZE+)Y5O.\(5GCARS[3A
MB^T8Y.W!Z9KZK?I^!_FM?)/C7_D;=>_Z_?\ VDE5%7=OZV;.'%5)):6T:_-F
M/_:NI?\ 00U/_P #I/\ &C^U=2_Z"&I_^!TG^-4**OD7=_A_D<7MI^7W%_\
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M_P")%Q#_ //T](/QA^*;=?B9\25Q_P!3WXM.<_\ <P>U)_PM[XI_]%.^)/\
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M[V/0?^%O?%/_ **=\2?_  NO%O\ \T%.3XN?%5F 7XH?$E1R6)\<^+.@&?\
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MSXDKC_J>_%ISG_N8/:O-Z*+U/^?]?_P8P_UHXF_Z*3B/_P 2+B'_ .?IZ/\
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M\4_^BG?$G_PNO%O_ ,T%'_"WOBG_ -%.^)/_ (77BW_YH*\XHHO4_P"?]?\
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MI1\8?BFO3XF?$EL_]3WXM&,?]S![UYO147J?\_Z__@QGQ7^M/$W_ $4G$?\
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M_P#HIWQ)_P#"Z\6__-!1_P +>^*?_13OB3_X77BW_P":"O.**+U/^?\ 7_\
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MJU>,ET2BYR7*MT[K6[>A_P C&*_B5K_]!N/_ /3U4CHHHKH.4**** "BBB@
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M,0T$,N]2'3<Z;T(:/?&<.F]<IO3*LR9W".2*0CRYHF< 6BBB@ HHHH ****
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M5_\ !E(/^*?WTK?^C7+_ ,3+@[_YXGX;>8G]X5ZGX,/F?#WXRA/F(\/^$5.
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MPP].E0]G&CR0Y>:+I4Z<:4$I*"I+EY-%8HHHJ2PHHHH **** "BBB@ HHHH
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M>^%M27P[IN@7?AE'B,"3WE[:QSL&9.6^(_\ P33^-/Q2^(VK?M':Y^T/\/\
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MJ_!7X?\ [.?PB'PM^$VL^$?"GAKP3X,_:!^&/QU\4>-O%_AS5_&_BW6O&/Q
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MJ&CD 4G=%(,^7,N8I"LBH[-'(%6@/(ZKYA)V-,H>27]Z_F7$UTS?9HX_LMO
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MQ^'X]J^*:*/[2S/_ *&6,_\ !D?_ )$/^)@_'7_H[_B-Z_ZVYM_\M_0^UO\
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M9_\ 0RQG_@R/_P B9?\ $P?CK_T>#Q'_ /$MS;_Y:?:W_#PW]KS_ *+#>?\
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M5U&[8N=C^A@<^Q%%PI5YJ5%R4-4U*+G)*+NK.:YK74W9-\RE'E49?V%]&O\
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MVD?M'?%GQ'^SU\(?$T/@GX:?"V]UC5]"7XI_$?P]?>(]8U3P'X-OKC1=?9]
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MSOVL5A^;!1C&O*K4C"ZG.3Y6KM%%%:'[.%%%% !1110 4444 %%%% %#5/\
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MYLX/H?R-&#Z'\C7Z8?\ #K3]J;_H&?#+_P +6\_^96C_ (=:?M3?] SX9?\
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MVUW\:OB;8RZ7"L,DGAKX?VD^G7-\X+F6UU'Q!>Q_:XK4#RU:&RMB+U'F6::
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M_P"&_(__ )UG[A_\/R?CG_T23X3?^##QG_\ 'J/^'Y/QS_Z))\)O_!AXS_\
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MOP\HI>QC_=_\%4?_ )6?,?\ $WOTCO\ HZ&;?^&_(_\ YUG[A_\ #\GXY_\
M1)/A-_X,/&?_ ,>H_P"'Y/QS_P"B2?";_P &'C/_ ./5^'E%'L8_W?\ P51_
M^5A_Q-[]([_HZ&;?^&_(_P#YUG[A_P##\GXY_P#1)/A-_P"##QG_ /'J/^'Y
M/QS_ .B2?";_ ,&'C/\ ^/5^'E%'L8_W?_!5'_Y6'_$WOTCO^CH9M_X;\C_^
M=9^X?_#\GXY_]$D^$W_@P\9__'J/^'Y/QS'_ #2+X2M];_QD<?G,*_#RBCV,
M?+_P717Y4T./TO\ Z1\6FO%#-KKOEV1-=O\ H5G[?O\ \%QOC:Y5Y/@W\))'
MC/[O%UXJ9E#$;]LDTS>63A>51MV/F^Z,^K> /^"Y<]QJEE;?%#X&*FES2Q17
M&H^ /$S7%Y9*Q;S9WTG7M/TZVO(E4*PB&M6TH".$6=FPG\]5(R>8NTF155TD
MW1-M<.A.P<_+M.YMVXC(X&<FIE244Y0?++924*=UT_D[.W=[71Z& ^F1](VA
MBZ%:KXBU\;3I2<Y8;,LLRFI@:BC%NU>EA\+A:U2,7:<:=&O2J5)J,$Y-\K_N
MJ^ ?[37P@_:3\/'7_@_XSTW6XX%#:GHC6XT_7]&9V*&/4=(NI(K^+9*KQ-=I
M$]C+*A,-Q(,$^UWFZ74=#7#;C<73 B1<,K:9>D,ICNI2$.TD-E-PW!=XR*_A
M'^#?Q@\<_ GQSHWQ)^%NN3>'O%FASB\G$+26]CXFL$DC:\\-ZO;P$P7-OJL6
MZ/?.H6$HQW#>0W]F7[,/[1GAG]J'X7?#GXJ^'0;.74YKW3O$&CLC[M"\3V.B
MW7]K:67*['@BD.;:8%HY4)V2.5(7/G<DT]7"UXRA%-ZJTG9-R3W5W=:*VA_I
MS]&+Z4. \>\OQ'#_ !#A*&2^('#]"GB,SPL<+2H8'.L%>,(YIE<*M65:CS5.
M3V^7SKUJU%2=7VDJ;T^FUM9B"6V8!&"DMP"/E4C.9O?H!Q4J1SKG #9Q]R2?
M(Z_>+W"CZ;2>^<<9MPN&0$#(95=>",J47'!&02!T(SZ@4^-LEAC&,>O?/K2Y
M[I^Y3LK:<J5OU/Z]]E0A+E5&A&<U:+A1C96U;5ZC6J6OJ5=MQ_<;_OX__P E
MT%)SUC8_61__ )+J]14\RZ0@GW45=?@5[*/:'_@J'_R90\N?_GF?^_C_ /R5
M1Y<__/,_]_'_ /DJK]%'-+O^$?\ (/91[0_\%0_^3*'ES_\ /,_]_'_^2J79
M..D;#_MH_P#\EU>HHYGULUV:5G^ >RCVA_X*A_\ )E';<?W&_P"_C_\ R71M
MN/[C?]_'_P#DNKU%'-'_ )]T_P#P$/91[0_\$T__ ),H[;C^XW_?Q_\ Y+JA
MJ<4QL;MF&T):7><R2ECFWD)P!<.I&%.X,.1C ;D5NUGZK_R#K[_KSO/_ $EF
MHYE_S[I]5\/=6_43HP::E&G)--6=&%KVT>E1:Q=FM=TKZ%#3[>9K.T=-N/LM
MM_K)9]W-O&05$<NT#!^4$# (!48P+JP3H6)0$MC.)93TSR=UPN,Y[9Z<XXR_
M2_\ D'V7_7I:?^DL-7Z;J.UE&"T2NHJ]E;KKV[ J%&,8J-*BG'[2I1YF]G)_
MO6N9K1^3*'ES_P#/,_\ ?Q__ )*I=DXZ1L/^VC__ "75ZBES/K9KLTK/\!^R
MCVA_X*A_\F4=MQ_<;_OX_P#\ET%)SUC8_61__DNKU%',ND()]U%77X![*/:'
M_@J'_P F4/+G_P">9_[^/_\ )5+LG'2-A_VT?_Y+J]11S/K9KLTK/\ ]E'M#
M_P %0_\ DRCMN/[C?]_'_P#DND,,[LI(V[<\D+(W./N-)-(4Z<[2N[C.<#%^
MBCF72$$^ZBKA[&+\O.G'V4O15*=132>TDG[T6XO1LIQP!7#F,[N,NS@GW. >
MY[<@>XZJL0C+,$"EY(<D'EL.>O)Z;O;))JW4<G1?^ND?_H8IN<FK-]$MWLG=
M+>V_E;LD.-*G37+2BJ46[SA3TC4?>I=MS:>J;=[J]S"T?/\ :'B/')^WZ?C_
M ,$.E5OC=SN]L=*P-&_Y"/B/_K_T_P#],.E5T-3?2UEZ]1J"333>E].FOR_4
M****184444 %%%% !1110 4444 4-4_Y!][_ ->EW_Z2S4:7_P @^R_Z]+3_
M -)8:-4_Y!][_P!>EW_Z2S4:7_R#[+_KTM/_ $EAH OT444 ,?I^!_FM?)/C
M7_D;=>_Z_?\ VDE?6S]/P/\ -:^2?&O_ "-NO?\ 7[_[22KANO7]&>=B]GZ_
MJSF****U. **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ K"\4_\ (L>)?^Q<U_\ ],][6[6%XI_Y%CQ+
M_P!BYK__ *9[VJA\2^?Y''F'^YXC_KSB/_4'-#^,%O\ 50?]>T'_ *+CJ,]?
MP7^0J1O]5!_U[0?^BXZC/7\%_D*UC\*_KJS_ )E*OQXC_K_C/_3TA*O61B1I
M;BXP(+>.621F*,C*UM<1FWD@E(26.X5V0N,RQ,%\H$N:HT^,%G"$1M&S1,Z2
MJ6C;R;F"Y&0O)R(&C],2G) J*O-[.7+:^F_:ZOU6MEIK;O=:$4%3E.<:J;HR
MH8B-9Q:52-%T9NI.DW=1K148^RDXR49R;<9/EY?BF]^/?Q.L/$.I? -?#.C7
M/[1TWC$6>AO)IEW<^ &^%EY+'<I\6FU"18X(%T;0K6/1+O3VF_M"TOFA\[3D
MEO+1+KU70OVGOAEKWBS3?"FG6>L7%CKOB+4O!_AOQL^B(? WB#QIX=MYK?6/
M"VA7$TT&IMJ+:EI>I)IC7D$5AJ<I>&PN;IX9]GHDWPZTV[^,5G\9&OKS^VK+
MX;ZC\,CIXBC:TNM-U'Q9IGB9[KSA+;W5N UG#!,\-W%<F&Q6,07"RQI7B.B?
MLD^%=!\27]WIVOQ6&@2WOBG4;/3(? _@BZ\3:7?^*[2^N=0FL?B&^BZ?XV+V
M^M:MJ#Z.5UVR&FP2RQN]Y%.K1<7M,5[B?(WO/1*R:3>T[M7NKI\ZY874DW?^
MG,)G'@5Q#1C#B++ZN3U*'!V$SG,%E#Q5&A+C'/:]*GQ-@**@IXF&595/*.&)
M<.X6564\/#.>)HXO&XOVV$6"M:A^U_\ #C2?^$K7Q/X6\;^$]5\,^'AXA&D^
M)= TJVU7Q#H\FLVOA_[1I4=C?S:796\&J7VGV^I#6[JTNM.34;&>\AA@D>5:
MNH_M,ZE!\0_@YX3LOA/XXBLOB=8^*Y9[FXC\,Z3JVB'PZ= $%[9RR:R^DZEH
MT1U6X+:A!<-;ZC&%.C2WK1W*QX&D_L;Z3H%Q]OL?'MU;:BW@&\^'$;6?P^^'
M]MIUWHVI:OHFMR3^,=,GL=2LO&&R[T94U676+?4-2U7=;L+I!"V[J_#/[,,7
M@F?X=:KX<^(>KZ)KO@OQ5XP\1/<Z;HNF6VB7MOXY_L9?$FD6WAN%QIVD:?,O
MA[3!9VNGP16UN)IUC@B"*%5*>*<H>TA%*7-S<KAS;Q:6LY1;LYQ>B7+#F3YW
M%'7&/T8, L)B<MJXW,<;6P>=T*^#S&6?U,#&K/(LYH82I"-5KV488Z.7XFF\
M3]8E]8K>RC!4:;J+ZIN6::&";@(T:[0N,29+#[66?;<&2Y*XD21%1#"#$65B
M:J'&U<')RQ(YXZ8[?R)I[R HD4:"*%2[)"F6CCWNQ(#L?,9B?F=2/*0E1$Q!
M8*P@!5/&3NS^F/\ /3]:]"*Y4EHM79+9*[LOZLO+O_+#3IX6%)^Y3>,Q%3#T
MXO14GS\KGS<TG[O*E[UVU=N6EFTX?<;_ 'E_D]-IP^XW^\O\GJG^J(I?QJ'_
M &$4/_3L1K$;XQZHV/P4U]-_%4$?LY_LIY'_ "[_ !T_]6E/7S&X/F1'T1\_
MBAKZ>^*Y!_9S_93P?^7?XZ?^K2GI=?DOS9^@<*_\DUXF?]D1E7_KPN'CYBIZ
MXPQ*AM@\U1T8R(0$"G@ '<2V2 < 'M3*53@GT*$?B2N._P!?PS4U')0;A;F3
M5KZKXDGU71OJ?GBM>*;:3G!2:T:BZE-3L];/D<[:,\W\:_&#PI\,]?T;3O&-
MU)H&CZ[9ZQ=V/C#4Y;8Z%<W>CV"7NL^&KB)B\UOJ,^ERSW.B^<D/]H76GRV>
MG&[O)88&\>L_VF/$^K:[#X>\-?!;Q7JNHV7A_P -Z]?PZYXP\'^$;_3H?%UY
MJT?A&_AL->UG2[R^M-0TK38M0C2V@FGM9GGM;M+>ZAEA3V;XK_#33?BIX,MO
M#&J#3_)B\3>&?$D+ZC8KJ,"7GA7Q%IVOP(;5E(:/4(]/GT:[(="=/U6\CVNK
ML!Y%XV_9QNM>^,&M_%#2K[X<7+:II'@724T[QW\)++QG?:9%X+,[6W]B:E_P
ME6EQZ=+=PZM<K,TD=S%]JT\M&B1O"]SPRJXI-M*$TI/ECR)/E4XQ:<O:)V@D
MVK6<G)7M&.O]"\&Q\%<1E%/#\0T:>#S>6"XOG5S/'XO,5@:5?)L[R/#9!>GE
M4L)CO:YQE..S1XF-+%PI_6L)AIT5&A/$8:IU'@SXY:YXU\6ZOX>TKX2:C;^%
M?#OC+Q3X/U/Q9=^/?"TC6=UX*>^COM1;PTNJCQ#>L-3L/L,-M;:7)/<QK)<V
M:3V:2SI-X?\ V@?"_C/5?BMH_A;PYK.I:K\,H[FYB&G1V%JGCRTAU.;0M4U'
MPCJD]XVD:GIUCXGL]1T6_P!0>Y6UCFAM)+>::&Z#CSCPW^S3XE\$^*?%OB#0
MO%7P]M[SQ+XA\9^(D\1R_":S_P"$_P!/N?%ZW+SOIWBQ?$+M9RVE]?--I*QV
M*C3X(;X>>\LUK')TGA+]ECPI\.-<\#^*?"WB;QF^J^'-$UWPOJJZWXFUGQ/I
MVL^'_$5JTFNVNFZ7K>H-::#:W7C!HO&]M;VD-J999;V&^)N8;&,E.IB'.TH)
M)R<8RB[/EY;*48RG.,G&[G9I)QA:\I-H]O-<!]'ZA+/:V"QDJKQ&78:MP1/"
MXOBFK2JYA0H4<5FU#/Y9CCL1AW0K3ABLNP[HT*5:E4Q%*<7"5*%=>U^ /%EE
M\1?!7A+QSI%I>6NG^+M)M=2L8-2*#4(DN/N6USL"VP,0=-K1GK(ZR[63 ZUT
M*#D8(9T;D'#IMW#CTW#GH<\$XXXGX7>"$^&OP_\  _@"VOSJB>$M&L-(34#:
MBT^W/:P0?:+S8)'?%Q=BYD D".J;21SA>U8LPR><NYS_ +1VEOZ5W0<[14FF
M^6/-HDW+1/X?=W4OA5KWY?=LC\"XFP^40SC-I9'B(U,KHYGFD,O7-*<YY?'/
M\TP>53E.2C*<YY3AL)B*DI14I5)RFU&[BF4].K?[C_R-,IZ=6_W'_D:M[,^=
MC]K_  2_]L/</ '_ "1GX_\ _7E\,/\ U.XZ\1G_ -?<?]=W_P#04KV[P!_R
M1GX__P#7E\,/_4[CKQ&?_7W'_7=__04I?:_[=_\ ;F?;<5?\BG@?_LF,S_\
M6RS@BHHHIGQ 4444 %%%% !1110 4Y>W^\O]:;3E[?[R_P!:!K=?/_TF9[1^
MSW_R6SX4?]E&\*_^G2"O%VZ1?]<4_P#0Y*]H_9[_ .2V?"C_ +*-X5_].D%>
M+MTB_P"N*?\ H<E2M_\ MZ7Y1/L,5_R0^5?]E7Q+_P"J+A8;1115'QP4444
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M[_KSO/\ TEFH 72_^0?9?]>EI_Z2PU?JAI?_ "#[+_KTM/\ TEAJ_0 4444
M%%%% !1110 4444 %1R=%_ZZ1_\ H8J2HY.B_P#72/\ ]#% &%HW_(1\1_\
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M  !N?_C= <D_+[O_ +8Q:*VO^$<\0?\ 0%U3_P  ;G_XW1_PCGB#_H"ZI_X
MW/\ \;H#DGY?=_\ ;&+16U_PCGB#_H"ZI_X W/\ \;H_X1SQ!_T!=4_\ ;G_
M .-T!R3\ON_^V,6BMK_A'/$'_0%U3_P!N?\ XW1_PCGB#_H"ZI_X W/_ ,;H
M#DGY?=_]L8M%;7_".>(/^@+JG_@#<_\ QNC_ (1SQ!_T!=4_\ ;G_P"-T!R3
M\ON_^V,6BMK_ (1SQ!_T!=4_\ ;G_P"-T?\ ".>(/^@+JG_@#<__ !N@.2?E
M]W_VQBT5M?\ ".>(/^@+JG_@#<__ !NC_A'/$'_0%U3_ , ;G_XW0')/R^[_
M .V,6BMK_A'/$'_0%U3_ , ;G_XW1_PCGB#_ * NJ?\ @#<__&Z Y)^7W?\
MVQBT5M?\(YX@_P"@+JG_ ( W/_QNC_A'/$'_ $!=4_\  &Y_^-T!R3\ON_\
MMC%HK:_X1SQ!_P! 75/_  !N?_C='_".>(/^@+JG_@#<_P#QN@.2?E]W_P!L
M8M%;7_".>(/^@+JG_@#<_P#QNC_A'/$'_0%U3_P!N?\ XW0')/R^[_[8Q:*V
MO^$<\0?] 75/_ &Y_P#C='_".>(/^@+JG_@#<_\ QN@.2?E]W_VQBT5M?\(Y
MX@_Z NJ?^ -S_P#&Z/\ A'/$'_0%U3_P!N?_ (W0')/R^[_[8Q:PO%/_ "+'
MB7_L7-?_ /3/>UV__".>(/\ H"ZI_P" -S_\;K!\4>'=?_X1KQ&G]C:GOD\/
M:XD:?8KC?*\NFW%O''$GE[I)'FGB18T#.2V0NU6(J,HQ:<K\JWMOM9='U./,
M:>(_L[,94:$L37IY=F-6C0IV4ZM:GEV8NG!)MN=Y2UIQM.I90@U*29_%2!OB
M@VE3_HT75U'*(FX?,1@C:>.IQQGBD:)PB2D#9)N5#N7),84."N[<N-R_> SG
M*Y%>_0?LI_M'M;PLWP"^-8W0*ZLGPR\72QNS* FQTTD@JY'!ST(.<$&F+^RK
M^TQC:W[/?QKR"6POPS\8<!L#)!T?C.W&>^/;AJM1V2JKE>MX-73YGH[)/5K7
M9+I[RM_SA5N!.*Y_794.&N+Y5*..=.="IP?GD'*&*K9E[]*L\(J=7E^J4G%Q
M3C.,JDD[*)X!@^WYC_&I4""*4E@)0T8C7U4[_,.1P-N$ZD$[N <''O9_94_:
M6'_-O7QN_P##9>,#_+1Z/^&5/VEC_P V]?&[\?AEXP'\]'I^WH_]/=T]ET=[
M;;/9^1R?ZA\9W3_U0XO:4HR:_P!5LXM)1DFX2MA4W&=N6233<6U=;G@:,4)Y
M&"#W'7''KWX_&D(W LSKOST)Z],'(!'KU]*]]_X94_:6_P"C>OC;_P"&R\7_
M /RGH_X94_:6_P"C>OC;_P"&R\7_ /RGI^WH;\LT]-;=C9<%<:QG*I3X-XLI
M59*FI5(<*9PVU#FYKQGA9P?M6XNJG!ING3<5"SOX"J ]75?8Y)_0$?K28(R,
MJ<XYR.WUP:]__P"&5/VEO^C>OC;_ .&R\7__ "GH_P"&5/VEO^C>OC;_ .&R
M\7__ "GH]O1UTJ?<M/Z\RI\&\=U%.-3A/BZ<:G+>+X1S**7+*,ERN&7PE"[B
MK\LE=73NF> !1SD@>G(_QI,'V_,?XU] ?\,J?M+?]&]?&W_PV7B__P"4]'_#
M*G[2W_1O7QM_\-EXO_\ E/1[>CVJ?<C+_4?C7]XGP?Q=+G22YN%<Y?LK23O2
M_P!E]UM+E=[WBVM]3Y_P?;\Q_C2]%(XR64]0> &ST^HKW_\ X94_:6_Z-Z^-
MO_ALO%__ ,IZDC_95_:2!/F_L\_&]E_V?AGXO!'7_J$ ?_JI.O12O:J[=$E<
MF/ O&E-JHN#.,JKI-55"'"V<)OV7OW;^I3]V-N:=HM\J=FMU\_)&\TBB, E8
MW9LLJX"J<G+E0<>@R3VS7TQ\558?LY_LJ<'_ (]_CITY_P":I3^E8)_96_:6
M20D_L^?&L*R21H/^%:^+E<F10BY!TD97<RAF&53(+D9!KZ(^(G[.WQXU;X#?
MLV:+IWP9^*VH:QX>M_C)_;NEZ9X!\27VH:-_:OQ*N[G31JUG#8&XT\W]O%+-
M9"ZCC-RD4QBW>3)@]M2O)VJ6M%1T>^K>J3NU=:*UNM]S[_AC@KBR.1>)=%\*
M<74ZE?A#(:."PL^%,]J8G$*KQED6-K6CA\#*;=*-*<TZ=*=Z46YQ@DY+\^L'
MT/Y&C!]#^1KZ%_X92_:5_P"C?OCE_P"&M\7_ /RNH_X92_:5_P"C?OCE_P"&
MM\7_ /RNH^L4?Y:G_@,O\CX=>'O'"_YHCC5Z-:\&<6]4U_T)NE[KS2/G[<Q&
MW!VCE1@\$=#^/O\ XY,ML?);<S1\8/*@/DDXQ\IV@<YY.,\U] _\,I?M*_\
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M<7%2C)GRS@^A_(T8/H?R-?4O_#%7[6G_ $;U\8O_  B-7_\ B:/^&*OVM/\
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M2-6]_P#9H?\ 8I_:U.,?L\_&+O\ \R1JWM_LT>VI?RU/_ 9?_(A_Q#'Q O\
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M^@+??^!%O1_PM_3O^@+??^!%O7@]% ?6)?RP_P#)O_DCWC_A;^G?] 6^_P#
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M:*?]CX/M4_\  E_D'_$Z/C]_T4>2_P#B*Y)_\J/ZD?\ B(#^$O\ T;W\1_\
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M%^$W_1OGQ-_\*OPO7\MU%']CX/M4_P# H_\ R(?\3K_2 _Z*+)/_ !%LF_\
MD3^I'_B(%^$W_1OGQ-_\*OPO1_Q$"_";_HWSXF_^%7X7K^6ZBC^Q\'VJ?^!1
M_P#D0_XG7^D!_P!%%DG_ (BV3?\ R)_4C_Q$"_";_HWSXF_^%7X7IC?\%_\
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M_"]'_$0+\)O^C?/B;_X5?A>OY;J*/['P?:I_X%'_ .1#_B=?Z0'_ $462?\
MB+9-_P#(G]2/_$0+\)O^C?/B;_X5?A>C_B(%^$W_ $;Y\3?_  J_"]?RW44?
MV/@^U3_P*/\ \B'_ !.O](#_ **+)/\ Q%LF_P#D3^I'_B(%^$W_ $;Y\3?_
M  J_"]'_ !$!_"8\_P##/GQ.X]/%GA;OZ@@YZ5_+=3A]UO\ @/\ .C^Q\&_^
M?BT>TH]%?K!ETOIK?2 E4IQ?$62VE.$';A;)KVE.,7;W=[2=O.U[K0_J/?\
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M0)\)?^C>OB7_ .%3X5_PH_XB!?A+_P!&]_$P?3Q5X6'\L5_+=11_8^#[5/\
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M!0U3_D'WO_7I=_\ I+-1I?\ R#[+_KTM/_26&C5/^0?>_P#7I=_^DLU&E_\
M(/LO^O2T_P#26&@"_1110!&_4?[K?^A)7R7XT_Y&K7?^PA)_Z+BKZT?J/]UO
M_0DKY+\:?\C5KO\ V$)/_1<5:1Z?XG_Z2>=B]GZ_JSEZ***T. **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ KG?&/\ R)WC#_L4_$G_ *9KVNBKG?&/_(G>,/\ L4_$G_IFO:TI?Q(?
MXD<V+_W>K_UZQ'_J%FA_#!-_RQ_Z\K3_ - 6HWZK_N)_(5)-_P L?^O*T_\
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M\HW=1Q2:;L_WRBY7_OG_ -%I4E11<+^"?^BTJ6OCS_8T**** "BBB@ HHHH
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M_P#1<5:1Z?XG_P"DGG8O9^OZLY>BBBM#@"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YWQC_R)WC#_
M +%/Q)_Z9KVNBKG?&/\ R)WC#_L4_$G_ *9KVM*7\2'^)'-B_P#=ZO\ UZQ'
M_J%FA_#!-_RQ_P"O*T_] 6HWZK_N)_(5)-_RQ_Z\K3_T!:C?JO\ N)_(5]M1
M_@X;_ _R9_SI3_AU/^OV)_\ 3C&44H!/0$_0' ^IZ#\<4$$=01]0<'Z'H?PS
M6QRB44A(&,]^E.((QGOTH 2BBB@ HHHH *4*6S@9P"QZ=!U//_ZZ2I(CC?\
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M,P_^8C,V-Z?J/\:-C>GZC_&M3^QM6_Z!^I?^ %Y_\9H_L;5O^@?J7_@!>?\
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M"BBB@ HHHH **** "BBB@ K/U7_D'7W_ %YWG_I+-6A6?JO_ "#K[_KSO/\
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M((/0TM']ET_^@C$_^!4__D _XGJ\8/\ H0>&/_B&Q_\ FX_LU_X?"?\ !/\
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M2C3Y-$I<TFVY.3DVS^RX_P#!8/\ 8 XQ\2O$'_AI?&/_ ,SJ_P!:!_P6#_8
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M?QF_&]]H8MX>8$J.Z]<Y)Z*G\GW[-O\ R73X1?\ 92_"?_ITMZ\2O/\ 6_\
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M%3_^1#_B>KQ@_P"A!X8_^(;#_P";C^S7_A\)_P $_P#_ **5K_\ X:7QC_\
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MZ'*.,I(ISPZ,R$Y 8D''YI_L7_MF_&;]IOX__MN?#?Q=\%[/0OAI^S_\;IO
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MIIMF07$,;E 06 !!I*GCDVQ31A 9,QW%M-M#/;7EMO\ (GB(>.0R@2R*J;A
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M:?\ I+#5^J&E_P#(/LO^O2T_])8:OT %%%% !1110 4444 %%%% !4<G1?\
MKI'_ .ABI*CDZ+_UTC_]#% &%HW_ "$?$?\ U_Z?_P"F'2JZ&N>T;_D(^(_^
MO_3_ /TPZ570T %%%% !1110 4444 %%%% !1110!0U3_D'WO_7I=_\ I+-1
MI?\ R#[+_KTM/_26&C5/^0?>_P#7I=_^DLU&E_\ (/LO^O2T_P#26&@"_111
M0!&_4?[K?^A)7R7XT_Y&K7?^PA)_Z+BKZT?J/]UO_0DKY+\:?\C5KO\ V$)/
M_1<5:1Z?XG_Z2>=B]GZ_JSEZ***T. ****  )YDD$7!$T\4!_<&=HUG;R7N
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MG>?^DLU "Z7_ ,@^R_Z]+3_TEAJ_5#2_^0?9?]>EI_Z2PU?H **** "BBB@
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MOBEJ/BO]K_XE_M;VO@>S^(_Q(\)?!2^\3>)_%DWC7P#)XY^"^E>*;;P'XO\
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M?^^+?_Y54?V3B?\ GY4_\&/_ .0#_B<["?\ 1A_"K_P7BO\ Z#S^UG_A ?\
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M'>@CL/V)=I1]Q_M?X6A0X>$KN#:F7.4\T+LX!^_SL(_BLW/_ ,_$/_?%O_\
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M ,M*_BFW/_S\0_\ ?%O_ /*JC<__ #\0_P#?%O\ _*JC^R<3_P _*G_@Q_\
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MO1_]\M_\14-%'*_YY_>'-_<I_P#@"_\ DR;>?[T?_?+?_$4;S_>C_P"^6_\
MB*AHHY7_ #S^\.;^Y3_\ 7_R9-O/]Z/_ +Y;_P"(HWG^]'_WRW_Q%0T4<K_G
MG]X<W]RG_P" +_Y,FWG^]'_WRW_Q%!8D#F,_,O\ "??KE1QZXYZ8J&G+V_WE
M_K4R3C%M2EIW?_!*B[R2Y8+?:%OLR_OGNW[-I/\ PO/X1_<'_%S/"?"K@_\
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MZ7?_ *2S4:7_ ,@^R_Z]+3_TEAHU3_D'WO\ UZ7?_I+-1I?_ "#[+_KTM/\
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M_P#M@^IU_P#H!Q?W+_Y,K459_<>MS^2?XT?N/6Y_)/\ &B[[_A_]L'U.O_T
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M/[OZK_C1Y4G]W]5_QJ3%I_SUD_[YC_\ CE&+3_GK)_WS'_\ '*.9_P R_P#
M)?\ R0?5J?\ S^K_ /ANQ'_S01^5)_=_5?\ &G>5(J%RN%5T#'(X+;L< Y.=
MIZ#MSVIV+3_GK)_WS'_\<J3;;?9Y2LLFX2P  A I!6;<3A\9 'RY([CN2)DV
MTDY*SE%?!);OOS:>O0N&&I^TI)UL0U.K3@[9=B&[3<HMQ7UC623NEU>A[9^S
M:"/CK\)%/5?B5X3)&1P#JMN ?Q/I7B=RC/)E1D $=0.0[ CDBO:?V;Q /C]\
M'U25V:7XE>$H(0P4*S-J<4I\UPQ6+"0RMYDA2,!2"P+ 'Q &V=Y',Q*N[.K)
MY;*0[%@ WF8^X4)'#*6(8*>*4:?+:2FKIMVY7?WHQ3TO?I??NNA]'5H^TX1P
M:=:JH4^),SG&V68J[EBLCR1U+S^L\K470IJ$5%-)RDW)3BHM\J3^[^J_XT>5
M)_=_5?\ &I,6G_/63_OF/_XY1BT_YZR?]\Q__'*OF?\ ,O\ P"7_ ,D?,_5J
M?_/ZO_X;L1_\T$?E2?W?U7_&CRI/[OZK_C4F+3_GK)_WS'_\<HQ:?\]9/^^8
M_P#XY1S/^9?^ 2_^2#ZM3_Y_5_\ PW8C_P":"/RI/[OZK_C1Y4G]W]5_QJ3%
MI_SUD_[YC_\ CE&+3_GK)_WS'_\ '*.9_P R_P# )?\ R0?5J?\ S^K_ /AN
MQ'_S01^5)_=_5?\ &E$$ASPHQ_>DC3\MSC/X9QQGJ*?BT_YZR?\ ?,?_ ,<I
M0MO_  F63Z&-<>G1FSG\.G?/#4M=9)+J^6WXRFHKYO\ $F="G"+DZU>RM?\
MV"I#K;XJN)C!?]O-7V5W9$?DOZQ?]_X?_CE#*(AARH9F#(%='R$^\/D+?-\Z
M[4X9_FV*VUL2%$ R(9]H^\W55Z\NX4J@.."Y .#SQ73^!?!?BOXB>*-+\'^
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M]Y\1O&D]I>V,EXT5Q;W43:Z0ZR"0*% (^8[N!FO$I?C_ /'5Q&)?C9\7A(J
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MZ7?_ *2S4:7_ ,@^R_Z]+3_TEAHU3_D'WO\ UZ7?_I+-1I?_ "#[+_KTM/\
MTEAH OT444 %>9?%#1#J.A&\@B:2YTYS< *5!$3&/SC@D$X"*<#)P#P<8KTV
MH+B-9$*.N^.16B=>,%)1M;(/7C((YR">*J.DE_70RK0YZ<HZZVVWT:?Z'Q&C
M[RQVXR0X/]X,.OURIR#\P[@9%/KJ/%WA^7P[J]Q:;6-G++)-9S, /,20JS)P
M3CRMR#!P#N^7(YKF"".H(^O%;'CU*<H2M;3K?<2BBB@@**** "BBB@ HHHH
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MBA_\K)&;=C$@XSUW^W^S2[AY+ID,S2Q$?>X"K,#U ')=?RJ(@CJ*5>W^\O\
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M_P#TU7=;=8FH_P#(5\/?]?=__P"FJ[H UX_NG_@/_HM*DJ./[I_X#_Z+2I*
M"BBB@ HHHH **** "BBB@ K/U7_D'7W_ %YWG_I+-6A6?JO_ "#K[_KSO/\
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MVM_<?_OAO\*-K?W'_P"^&_PH'R3\ON_^V$HI=K?W'_[X;_"C:W]Q_P#OAO\
M"@.2?E]W_P!L)12[6_N/_P!\-_A1M;^X_P#WPW^% <D_+[O_ +82BEVM_<?_
M +X;_"C:W]Q_^^&_PH#DGY?=_P#;"44NUO[C_P#?#?X4;6_N/_WPW^% <D_+
M[O\ [82BEVM_<?\ [X;_  HVM_<?_OAO\* Y)^7W?_;"44NUO[C_ /?#?X4;
M6_N/_P!\-_A0')/R^[_[82BEVM_<?_OAO\*-K?W'_P"^&_PH#DGY?=_]L)12
M[6_N/_WPW^%&UO[C_P#?#?X4!R3\ON_^V$HI=K?W'_[X;_"C:W]Q_P#OAO\
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M:*3(]_R/^%&1[_D?\* %HI,CW_(_X49'O^1_PH 6BDR/?\C_ (49'O\ D?\
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MF1[_ )'_  HR/?\ (_X4 +129'O^1_PHR/?\C_A0 M%)D>_Y'_"C(]_R/^%
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M (27AC_Y95_2)11_K%G'_0=6_P# G_F'_$L_@=_T0&7_ /A?G/\ \\C^;O\
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M .65'_$.G\,/^CD/B1_X27AC_P"65?TB44?ZQ9Q_T'5O_ G_ )A_Q+/X'?\
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M (27AC_Y95_2)11_K%G'_0=6_P# G_F'_$L_@=_T0&7_ /A?G/\ \\C^;O\
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M .)KHJ* .=V^*?[^B_E=_P#Q-&WQ3_?T7\KO_P")KHJ* .=V^*?[^B_E=_\
MQ-&WQ3_?T7\KO_XFNBHH YJ6W\27,4UO.VB^7-#)$Q N]P$@VG;\N.F<Y]B.
F16W90-;6L$#A-T,,<68V8J?+&T8#@$#T^I'  JU10 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %' EH# 2(  A$! Q$!_\0
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MMQ;12-"LP1[B+/WU!C_X2'0?^@UI7_@RL>O_ ($?K^E?RU_\%N/AKX"^+?\
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M/_R57\6G_#OO]BG_ *-Q\"?^!'BC_P":"C_AWW^Q3_T;CX$_\"/%'_S04?\
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MJ-E>2WLGW1+YC(KQ$I)'+',(DN3'.GV,I:S0^=;2NE^UI.&E;_1C&L#E+O\
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M.G_8V_\ 6G/A%7U37RM^V#_R33X?_P#9T_[&W_K3GPBKGSS_ )%&<?,TPO\
MO?R_R/[4:***_C\_5PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV_@.PN=/\4W7B^^U;PIHNGW, U#3[Y[TWFEP"[E>UMP-*_U8EW)]IP6$5O\
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MFNEJB#G<WW:RZ*_0EA<,J7.J$%7_ )5&*U;;;NDHW;;=[WNV[W;;\"TO^?\
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M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_,'_P5U_Y2J?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5C^VE\!KEM+\+^'-(EU[7;Z.WAT\_:9M.TJ"XN9+7S8B3"\9D0@D8/P1U_\
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M **** "BBB@"#R!G@A1O5R44J[%"A =]YWAL2!PRG<K@<,A9Y/+7T'_?*_\
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MM<6]PUI#;K<G]XRIG8/Z!?+]_P!/_KU_/_\ \$*5SXV_X+,<X_XW%?M1=O\
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M/[(O_AT_BS_\R%'_  U1_P %!O\ HE/[(O\ X=/XL_\ S(4?\1G\&O\ HZO
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MI$-XC.TRJ#*#@[,8PP!:O1AX@T@Q^'/%4%W9C7/',GARRU^(N&2U;3,_VQ=
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MO%MK!M8K\V=^=/D>2+^TX],O7TT2#B%OM7V)2;:8\"X\H*I_A:JOGS_\]?\
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M44EB,4_J=L;7?U[D]A:MCGR^T^#ZU:K_ +%?K]<]AR_:L'ML5_/0_P#!2_\
MD0R__/2;_P "KS_Y)HR__/2;_P "KS_Y)HHJG6Q2G6IO'S4\/_%7UO%^Y^]A
M1W]O:7[ZI"E[K?[SFA\4)*-*IBY;2H?^"XK\XH,O_P ])O\ P*O/_DFC+_\
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MXZK5.3FRVE'EDJDN2?+SU(\)T^%$G>,U[.U/^U)1MS.M*48SIN4YRR61I?\
M,3+:RT=TMWUWULGLEK9M(ZK_ ()7_'#Q=%XQTC]F'2M$\%1_#S2/A_\ %3QM
MXGTO3M'U6Q^*'PG\8>$_C(?!<<OQI\2:OJ]W:^,?B#\61)/\2]4U"/3])O-+
MU&>7[/'J%@(3'_0'7\]MI_P4J_X*5:9>7MYH_P#P;[?M&VUUJ=U'>:IJ5O\
MM.?LTZ?>ZO<1PM:B?59;6YSJ$WV0JB27,S^7.BW 3*I&NU_P]/\ ^"HN,?\
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MI[=8I-J,]O/HW@.98)X;Y(1O6S:"9P[E#]H:-P!&6?\ H-K^8_PI_P $QO\
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M?\8_?%8_^63K==64*^;Y2EO]8H?C5HK?8Y\5_N]3T?\ [<?%WP\_Y)_\/_\
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MJ3]:_ S_ (6;_P '*_\ T;!_P2<_\/A^T)_\I*/^%F_\'*__ $;!_P $G/\
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MWK]H?L803V7['O[*-K<1[)[7]FWX'6]PA/,;P?##PTC9XY)9<$<8SWQ7PO\
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ME_G'B>$H\2YHFE=3ULXOKY-E^BBBOU\^<"BBB@ HHHH **** "BBB@ HHHH
M**** (<\#V)_I7S;^UUX1UOXB_LL_M$^!_#=L;K7?%GP2^)NAZ+;C.^ZU?4?
M!NJ0:;9*F 2UY<SK &!RC$$*Y.T?2@CP ,]/;V ]?:H6MV8Y,@Q^\^41X4[F
M/E@C?SY:'8?[_P![Y>E+#3J8>M@J\5:I0DI2U7NN+C)=7?WH]+]S+$0<Z,H1
M5Y/I=+NMWIUN?B=\ O&.B?$+X)?"/QCX?NDN=/UWX<>&)H+>-M]W%=6>B:=;
MZU82+(((C-H^L6/_  CUU.LOV2+6Y?L5[/8E-[^NX7^]_P".FN<^)7[%7QG^
M#_CCQ'X^_8TO_ ^N> OB!XEU'QMXW_9D^(^HWWAGPYI'C36[M=1\1^/?@CXX
ML].\1CP-)XJO#_:/C#P-=^%]3\)ZMK++J5A'I186M>?7+_MU6\P@3]@/6KPD
M;A=V?[2?P';3L<\F>XUJVO!TS@Z>.*_S:X\^BAXF8+BK,,3P#0H\0Y-B:"I4
MJU?-<ERUO)K7?#[HYKF&#JK%1_Z#.3V+Z5K/3]PR?Q"R6ME66T\UQ7U3&X?^
M+36%Q=7EW^W0H5(2OY29[)M_VE_.C;_M+^=>*^=^W1_TCY\2?^))? /_ .7]
M'G?MT?\ 2/GQ)_XDE\ __E_7QG_$KOCE_P!$72_\2?A+_P"?AZ7_ !$+A'_H
M:R_\-^9?_,A[5M_VE_.NX\,KY_@SXA6,<@>Y?3] U&(*K>=+8V6K%M85DP68
M6\*F1CD[U8J0G4_+OG?MT?\ 2/GQ)_XDE\ __E_5^PUG]O?2Y[JYL/V!?%D,
MUWIUYIDI?]I7X 21FWOK(6\X,?\ ;B@DS@72\C!_=\_ZROH.%OHZ>.&19Y]<
MJ<$49X:W$Z]H^)N$I?\ (QX8XGR[">XL\<[U<9F.#I+W?<=7VE3DIPJ2CPYG
MQOPAB<'[&EFLG44J<TOJ&915Z=2%3E;>#VDHN+\FO5?8MUIMOXMMOA;J=GJ^
M@VUKX>TG3-*UM-1U*VMK[3&TR\%YY_V422"?S@/+\IIK<1C,GG2<K5^R\=Z?
MILGQ.\26(AN;34_%/A\6L$I\O59-*OENUU*ZLU.^2UE7[<S6[;9OLXB;))=2
MGPR7_;H(;/\ P3\\3.\G^MED_:._9V:23@_>(U15//JI'MGFOF_XY?M9?M"?
ML]_$3]G3X9?$[]A;QOI_C']J;XE7OPD^$$&E_'KX%:C9:KXRMM(O=<ATK6]2
MC\1PIHL::39B\%W+;W"$2-&%WJGF_;87PX^D)E^*PF-R?PPPV#X@Q/O9IGU?
MBK@VOAH./ATO#52>$CGTJT^7 Q6;>Y3FG47*_P!ZW \EY[P9)3C/B"HX2=HQ
M66YG'E@^)'F,HR?U9\_-A7*KS6BU=4^5U$D_U0T/3[+P]XEUN2PO+/4_#]MX
M*UK6;6>*X=)H]/U338XX$U>8I/Y<]_JR2PQQ'S&B,1E'F'*#S1)=B(N%.P8S
MOQGG/3:<?F:\8M-6_;VL;:_L[7]@+Q+%!J(LDNU'[1_P W7$-A=M?6]O<.=>
M)E@%R[,T:B,,C%.AJIYW[='_ $CY\2?^))? /_Y?U\GGGT?_ !HQ^%RRGE/A
MU_9T\/\ ZSNM&MQ9PA6Y/[1XG688-)_V_-257!I5?=;</X=3EJ>Z^_"<:<*4
MI3E4S:4G*-**?]GYBFU3C-.4E'"<JE*4VWRVC9*R3;2]J==[[]RCD'&<]/?C
M^5&W_:7\Z\5\[]NC_I'SXD_\22^ ?_R_H\[]NC_I'SXD_P#$DO@'_P#+^OE?
M^)7?'+_HBZ7_ (D_"7_S\/5_XB%PC_T-9?\ AOS+_P"9#VK;_M+^=&W_ &E_
M.O%?._;H_P"D?/B3_P 22^ ?_P OZ/._;H_Z1\^)/_$DO@'_ /+^C_B5WQR_
MZ(NE_P")/PE_\_ _XB%PC_T-9?\ AOS+_P"9#VLQL"N5<JPWLZA6AA@_Y^9K
ML/\ 8A#_ +$%U/<_].]<]^PM;/XC_:U_;9^(VF/)/H&A:-^S[\ I[H*L=J?'
MWPVTOQOXL\7Z-9O Z6T\GA6#XEZ5I^MK'YHM]0DD@\UFC=1P]M\(?V_/BX8/
M#MI\/_AU^R9X;U5?(USXC^*?B%H?QH^(FG687/VKP%X(\!PVO@P>)R/NZ]J?
MBFWMN>=&/;]._P!G[]G?P%^S9\*= ^$OPW2^71=$^W7=UK&M3+J7B?Q+X@U:
MX>\USQ5XGUDK#/K'B'7;QS/J>H7 ,DR+#;J4AAB"_P!2?1O\$>+O#/,>(N*^
M,94LLSO'\/O@;"Y;2Q6 S*%7):2X<FLY=?+,1B\/3JSJ99B*2HSJ1Q2E#FG2
MC%Q<_B..^*\-G%#+<ERUK$9=AE>KCW3J49I]O9UHPK/SM%KS9[MY0_O/_P!_
M)O\ X[1Y0_O/_P!_)O\ X[4M%?UJ?G)%Y0_O/_W\F_\ CM?SD?\ !$A!)^VI
M_P %^(P61?\ AY%J;@J0'223P[KD$LL)4*D4KLN\2"-B =A#_?K^CROYQ?\
M@B'_ ,GK?\%^?^TD&H_^F77J /Z.J*** "BBBDVEO^3?Y %%5_.;^XOYS?\
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MV/\ W6_[Y/\ A72?\.]OB5_T?+\<O_#>? '_ .=I1_P[V^)7_1\OQR_\-Y\
M?_G:4?\ $EWB!_T77 /_ (#Q9_\ ,8?\1/RW_H!XG_\ #AA/_EYS>Q_[K?\
M?)_PHV/_ '6_[Y/^%=)_P[V^)7_1\OQR_P##>? '_P"=I1_P[V^)7_1\OQR_
M\-Y\ ?\ YVE'_$EWB!_T77 /_@/%G_S&'_$3\M_Z >)__#AA/_EYS>Q_[K?]
M\G_"C8_]UO\ OD_X5TG_  [V^)7_ $?+\<O_  WGP!_^=I1_P[V^)7_1\OQR
M_P##>? '_P"=I1_Q)=X@?]%UP#_X#Q9_\QA_Q$_+?^@'B?\ \.&$_P#EYS>Q
M_P"ZW_?)_P *-C_W6_[Y/^%=)_P[V^)7_1\OQR_\-Y\ ?_G:4?\ #O;XE?\
M1\OQR_\ #>? '_YVE'_$EWB!_P!%UP#_ . \6?\ S&'_ !$_+?\ H!XG_P##
MAA/_ )><WL?^ZW_?)_PHV/\ W6_[Y/\ A72?\.]OB5_T?+\<O_#>? '_ .=I
M1_P[V^)7_1\OQR_\-Y\ ?_G:4?\ $EWB!_T77 /_ (#Q9_\ ,8?\1/RW_H!X
MG_\ #AA/_EYS>Q_[K?\ ?)_PI&"HKR-(BPK:B\6:7?9QM ?^6[MJ26(@M?\
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MH?VA?_GCU_/\?I9^!DZGLD^.54ZQ_P!5:27WRXM4?34^I?AKQM=VI<*Z=?\
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M=.9I+.UNKVWUJ&>>UAE8LEM*[6T89UAAB+EA\&G_ (-ZO^",/_1@'P:''/\
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MM9VE!-75TKDQESS]G",Y2[QIU)0^511<'_X$?0]%?/G_  UE^S!_T<7\"/\
MP[W@#_Y?4?\ #67[,'_1Q?P(_P##O> /_E]1['$_] >._P#"+%?_ "HS^L8?
M_G_2_P#!D3Z#HKY\_P"&LOV8/^CB_@1_X=[P!_\ +ZC_ (:R_9@_Z.+^!'_A
MWO '_P OJ/8XG_H#QW_A%BO_ )4'UC#_ //^E_X,B?0=?@5_P5^_Y/9_X(0_
M]I"]9_\ 5-^(:_7'_AK+]E_./^&B_@3]?^%N^ ,?G_;_ /D\>]?AC_P5?_:!
M^ WB?]LC_@B)JV@?&OX3ZQIOA/\ ;WU;6_$.I:7\1O!=_IFB:0_P>\40?VEK
M-];ZX\>E60NXX;7[3>K% 9;A4$AE"126L-BWM@L<_<E4_P!SQ"]V,7*6LHP5
MU&+?+S<SV2;:3N52E%7=6FE_U\@_PC*3_ _I2HKYY_X:R_9D[_M$_ 3_ ,/%
MX"/_ +FA2-^UI^S&N/\ C(CX#GUV_&#P$<?EK7Z4WA<7?EA@L;6;Z4,'B:[^
MZE1DU]QD\7@UI]=P/_A9A?\ Y<?0]%?/G_#67[,'_1Q?P(_\.]X _P#E]1_P
MUE^S!_T<7\"/_#O> /\ Y?5G['$_] >._P#"+%?_ "HKZQA_^?\ 2_\ !D3Z
M#HKY\_X:R_9@_P"CB_@1_P"'>\ ?_+ZC_AK+]F#_ *.+^!'_ (=[P!_\OJ/8
MXG_H#QW_ (18K_Y4'UC#_P#/^E_X,B?0=%>:^"_C#\+_ (DQW<WPY^(O@#Q_
M#8H&OI?!GC7PWXH2Q<X'EWIT'4=1^S/S_P M %XQGFN^%V6R!&"P0, ),J6Q
MRI;9P.N&VG/]T9K&I4A2475E[-3Q"PL7-.%Z[;BJ?O)6NTTI.T6]+ZHUO[_L
MVI*?52A.*7>[E%1TOJ[V74N44458PHHHH **** ,1O\ VA'_ .AU^#/['W_)
M&KC_ ++#^T9_ZNCQ]7[TRQNH<J"^V&,#'&[# GUQC.".>A]*_!C]CW8?@WJB
M!MDVG?&O]HZSOXI5\M[.>+XT_$!;C[0,L8X[66*;3[AF :+6/LVG%,7*W"?R
M]]+>I"7@NUS*/M./>%\-'VG[M*I2R'BS U'-U.54J,,5B\/2>(J.&'7M8S]K
M[-.2^[\-X/\ UC>RYL@K8)7E%7Q4G3<:6KTNOMNT%LY7T/I^BBBO\R+/M_Y-
M3_\ EY^Z7\I?^ 2_R"BBBBS[?^34_P#Y>5RR_EE_X"_\@KZ EL;;_A:'C+Q/
MJ4\%GIO@^VM-5BNC ;A4O;O11IFCRV]IYL(GAMV\V[6%)55Y66'>G^M/S_6[
MKGB"^UZ6TFNG>%XM)M]-O1;2&./4I+,EK*ZN8PN#]G8D^2QDW$G]ZM?H'!_%
MF%X>R[,J&(P<,16K\8\,\6T:<U3DIPR["<99'B\K;]K**IT,/Q;3SM*4HTYU
M<JI0I\V)]E%>)FV55\QQ:J0E.C3=.=.4E%W492IR=H]7.,9TW=-+F4FI*\7[
M?:VNGZ_JOPTU^#4K?Q0+/48_"VO7[Z=<1/<W]E8->6=Y+!<;L1V\@927=E8R
M!Q(/NFUX0N-1\3:?XFU../1]%U&T\5P:#9RZ5X=MM3*:+:E#_8_D0(P:1\MF
M^\W8F1BS  %?.*75S&JK'<W<:HV]4AOKZ!%E^Q?8_/"Q7*8N/^6GG [NJ8_C
MKJM"\6II.DW^B7>CVVI:=?:D=58I>ZCI-\MZ>3*;W3+BW9SD \1)TYS7W^2^
M*&1X['4GQ!E5# X?,, \PXNP[I4\1@\[S[_4W@_A%4<-FV&=7/L/)3X3J9HJ
MTJ<*2JYK5O4=5U6_$Q?#F/CA^7#5*E6:Y81A_#Y:?MI59*\IQIM6:C91BVHI
M)JUCM);Z2_U'XOW)L)-'M9O"SK':W-M'82+$)Y;;PV6M$,^VX: -<K-N5B"L
M8B7 :O&:[/5_&VHZO%XC5[:TM9_$MWI3WUU;*ZSC3M)LA;0:<C.S]9@;G[1E
M=I9H_(;/F#C*_/N.,\RS.<;EG]F24L+A_P#7/VTXT_8\O^MW%'$^8P]RI.$G
M_96#S#!UJ2C%I>V]G2_>4ZD8>]DF"Q.#YGB*4J=U25E+VME3HTZ=W):R;:=Y
M-<TK7>]D4445\#9]O_)J?_R\]CEE_++_ ,!?^044445+TI^SFFI]HNG/\85I
M+\2;^4O_  "7^1Y'9_\ )_?["7_8'_:S_P#5:Z!7[;'[H_#^;U^(MDSM^WW^
MPR(XFG:TT7]K.6[^S_O4A@7X7^$C)+N #,$OM1MM-7**KW)90X=3%7[<*VX$
M$8P 1WSR>G'O[]*_UG^CS*W@9X<P:G&52EG\X1G"<)../XGXIQ^%;C*,7'VN
M$QV%JVDDX>UY*G+4A4A'^>N-].,<WC=-J2ORM26ZZJZ_$L4445^XGRH4444
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M_P#RGI?\27<"?]%IQC_X;."?_G*;?\11S3_H!A_X% _)G_AHG]GW_HNGP?\
M_#D>$?\ Y;4?\-$_L^_]%T^#_P#X<CPC_P#+:OUF_P"%"?!+_HD'PK_\-UX/
M_P#E/1_PH3X)?]$@^%?_ (;KP?\ _*>C_B2[@3_HM.,?_#9P3_\ .4/^(HYI
M_P! ,/\ P*!^3/\ PT3^S[_T73X/_P#AR/"/_P MJ/\ AHG]GW_HNGP?_P##
MD>$?_EM7ZS?\*$^"7_1(/A7_ .&Z\'__ "GH_P"%"?!+_HD'PK_\-UX/_P#E
M/1_Q)=P)_P!%IQC_ .&S@G_YRA_Q%'-/^@&'_@4#\F?^&B?V??\ HNGP?_\
M#D>$?_EM1_PT3^S[_P!%T^#_ /X<CPC_ /+:OUF_X4)\$O\ HD'PK_\ #=>#
M_P#Y3T?\*$^"7_1(/A7_ .&Z\'__ "GH_P")+N!/^BTXQ_\ #9P3_P#.4/\
MB*.:?] ,/_ H'Y,_\-$_L^_]%T^#_P#X<CPC_P#+:C_AHG]GW_HNGP?_ /#D
M>$?_ );5^LW_  H3X)?]$@^%?_ANO!__ ,IZ/^%"?!+_ *)!\*__  W7@_\
M^4]'_$EW G_1:<8_^&S@G_YRA_Q%'-/^@&'_ (% _)G_ (:)_9]_Z+I\'_\
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M/BGQO:0O]GT[Q[\1M4M-,N+K1X%N9_#^G:<+*35-8CNDGB_5$Y9L#A0 #V[
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MBX_"LEUHVGOIMH]_?R^,+GPS!J:WK1M/=VS,QT^6R\AQ;V[P+YQNS<RA /\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.H\<L [SES2QRE3FJ4FH13:=*'O65/EC9MIMOTFZ\:^'M1&JZ5=G4[;3M?\
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M?)TTJ1HN$D[)Z2E;\%]*45\T?\-2>%O^B2?M2_\ B,?Q@_\ F:H_X:D\+?\
M1)/VI?\ Q&/XP?\ S-5\5_Q 7QJ_Z-;QO_X8J_\ \TGK?ZRY%_T,J'_D_P#\
MB?<_A73[S4_AKX[@TBRN]0F36_!<D<5KY;,Z6QC:Z"+-+ )U*J_F9*XR#@X.
M;>K^&==O?AEX1M8=)U6:XLO$GC*:_ABM79K*.X:8VOVM21]D0!HQ&1YH)''W
M@%^%(OVKM MQ_HOPR_:UM>'RMO\ LW?&2&)V(_<M+%%X902>3V!(W=,K4L?[
M6VDQ*=GPY_:ZC=Y8YK@Q_L[_ !S2&\8<2_;8#HSI/YOU3;Z-7Z/A/#+Q&_L9
M9/B?!CQ:B_\ 5[_4)XQ9=P]*?]B?ZX_ZV_VVK8!S]KR?\)7LG_M/L=/9^S/G
M99CEOUJ56&;83D_UF_M.#G[:ZP]N7VD^66L&M>2*59/[#6I]V>-_#>L>)F\'
M:KX<TZ;7=+_X1'3-+S!!ICIHMWIDA.IP26\KVW]FW+ A3<!KAE8;%B(4"LCX
M:V[Q^++R!I2FIP^'_%5K9RAS(4U1;58(/+8;?,N6(:X2<;2&/EXZR'XHA_:Q
MT*W22&W^&7[6EO;S3?:)H;?]G#XTP)<2S?\ '\UR(O#J"47?]T!!%_TTJSHW
M[7/A_0M3LM6L/A-^U*+NQNA=1-+^S)\89-[,"+A9L^&AYBS@D-G[OHU:R\,O
M$C%\=Y)QQ6\'_%G#2H<2<-YAQ7E\LMR.I3S7#9?@7D.)K<+^RP#SG+8T:/+G
M<J?$F?9I6J3O3HQ>*Y4LX8_+(9-F>3?VKAG&NG]6Q2YH5)MRG+WY7;5^9*_)
M'7FF[MM'VK:Z'J>N?"KPK;:1I5YJ5S!XPO[N806D%VL3!Y<W$SZK:2,BC(R#
M'C)&6Z9],M/(N=9UW3'M$\27VD_!IM&UJW@F$TFIWC;A_9Z:AO4O=28;_2OL
M[O\ -D0JQX_-I_VN-$#W9M?A?^UA9PWMW<W<MG;_ +.?QTBL@UQVCMX=(B"%
M.I8-\YYVK5:V_:K\-V<S3V7PK_:OT^4C"RZ?^S9\9K69AZ7,O_"-R-<K[,$&
M*]S*.%/%O(U@%2\(_%3&^RP?!N0X[FRK(8^QPW"/#G&6%GG7#WM,N_V:KFN/
MXNA6JPXC_MG$/&952RJI#^P%3K'-BEDN,>8REG>'H^VE4GATE5;DZKI.2DXM
M6LH.*MR)MJ3TBHO[H\%V3V/Q!LUC\--X4LY-#UV>[TM[>YDF%FNF()VN9Y8-
MIAU&\P1;M&HMW3AYV.*\HKP6S_;'TNQ35BOPM_:JO+K5M.33);_4_P!FSXWW
MMY#;"\:YF2*7^QHMHEA8V^%"E<"4EL>6<+_AJ3PM_P!$D_:E_P#$8_C!_P#,
MU7QG$/A%XNXO*LLP6"\+>-E/#\9<3\75</2X>Q5&E"GF/^K"P>56R>MD&12I
M55EV+TAD;I0]E^\Y>>GS>OEV=93A\9*M6S##QBZ=*%U.4E[BJ-O7FJ:RJ67.
MW*T5=ZGTO17S1_PU)X6_Z))^U+_XC'\8/_F:H_X:D\+?]$D_:E_\1C^,'_S-
M5\5_Q 7QJ_Z-;QO_ .&*O_\ -)['^LN1?]#*A_Y/_P#(GTJ6PS1XW3&(S+;J
MR^;&G]V[+LD-K,?^>/G2GWK#_8BB-W^VS^VGXALBEWIND?#/]E[X>W\L>\?9
M_$^CV'Q8\87VFMNC"FZ_L7QAX<U"VM]V9M.U$7<C0.@MI/%XOB-\?/BLEIX?
M_9T_9;^+6H:UJPM9K7X@_'GP;>_!SX)^&!<\GQ)JU[XH4^+/&XC'70?!OAS5
M]W_026OTQ_90_9IM?V:?A>_A:[\2W'C;QUXG\0ZU\1/BOX_U&S%MJ?C;Q_XC
MD\S4M5-NMY>/8:3IUO#8:)X7T?[;?)H/A_2K/2XKNZ :X/\ 57T8/!SB;@?.
MN+>/.)L%4RVMB<HP>0</X5XO!8EU\NQM/AV>=S=+!XBO4P\*-3+:\.6O"E*M
M.$714U*+E^=<=\59=G6"RW"9;46(AA_XW[JM1Y/3VU.G?_MVY]:T445_:A^8
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 9_DX;<KNIV;<J(@2V"HDR$#-(
M > Y:+@'RB0#2/$.,E^>N7)S@=BS.0.3P<_UHHKFJX2A[*7/3A.SM\"I>6OU
M66$[F%:<X3M"4H:;Q=NK\GV^?4E\A_[[?]]/_P#':/(?^^W_ 'T__P =HHI<
MJ_EI?^":7^8_84_[_P#X,J?YAY#_ -]O^^G_ /CM'D/_ 'V_[Z?_ ..T44<J
M_EI?^":7^8>PI_W_ /P94_S#R'_OM_WT_P#\=H\A_P"^W_?3_P#QVBBCE7\M
M+_P32_S#V%/^_P#^#*G^8>0_]]O^^G_^.T>0_P#?;_OI_P#X[111RK^6E_X)
MI?YA["G_ '__  94_P P\A_[[?\ ?3__ !VCR'_OM_WT_P#\=HHHY5_+2_\
M!-+_ ##V%/\ O_\ @RI_F'D/_?;_ +Z?_P".T>0_]]O^^G_^.T44<J_EI?\
M@FE_F'L*?]__ ,&5/\QD5OAW=G+R.8F+-'"C 1-D1AX(XG:,\_+*TNW)'*DK
M5@H0 #M Z *NW"XQM8EFWCU& /8\&BBNE^[4M&T8V:Y(I1ATUY8I*_HD=$M)
M/U_R)Z***9(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
510 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539422531216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Moolec
Science SA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MLEC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">37,563,768<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001937737<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41586<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">N4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">17,
Boulevard F. W.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">RaiffeisenL-2411
Luxembourg<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Grand
Duchy of Luxembourg<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">LU<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">B268440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary Shares, with nominal value of US$0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">International Financial Reporting Standards<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Sebastian Azagra<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Rosario, Argentina<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">17,
Boulevard F. W.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">RaiffeisenL-2411
Luxembourg<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Grand
Duchy of Luxembourg<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">LU<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">B268440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Florencia
Bottero<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelEmailAddress', window );">Contact Personnel Email Address</a></td>
<td class="text">legal@moolecscience.com<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">+54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">341 486 1100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelEmailAddress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Email address of contact personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelEmailAddress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539416685872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ContinuingOperationsAbstract', window );"><strong>Continuing operations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 905,049<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,048,354)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="num">(179,061)<span></span>
</td>
<td class="num">(601,942)<span></span>
</td>
<td class="num">(1,351,217)<span></span>
</td>
<td class="num">(985,158)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SalesAndMarketingExpense', window );">Marketing expense</a></td>
<td class="num">(10,938)<span></span>
</td>
<td class="num">(80,221)<span></span>
</td>
<td class="num">(256,421)<span></span>
</td>
<td class="num">(105,060)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdministrativeExpense', window );">Administrative expense</a></td>
<td class="num">(127,886)<span></span>
</td>
<td class="num">(820,946)<span></span>
</td>
<td class="num">(4,808,655)<span></span>
</td>
<td class="num">(2,523,230)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Other operating expense</a></td>
<td class="num">(2,639)<span></span>
</td>
<td class="num">(93,252)<span></span>
</td>
<td class="num">(94,207)<span></span>
</td>
<td class="num">(38,985)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Loss from operations</a></td>
<td class="num">(320,524)<span></span>
</td>
<td class="num">(1,596,361)<span></span>
</td>
<td class="num">(6,653,805)<span></span>
</td>
<td class="num">(3,652,433)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Share of loss from associate</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(390,453)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Financial Cost</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(160,035)<span></span>
</td>
<td class="num">(2,130)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherFinanceIncomeCost', window );">Other financial results</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,030,525<span></span>
</td>
<td class="num">(872,342)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TransactionsExpenses', window );">Transaction expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(3,535,046)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Share based payment cost of listing shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(42,705,061)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Net loss before Income tax</a></td>
<td class="num">(320,524)<span></span>
</td>
<td class="num">(1,986,814)<span></span>
</td>
<td class="num">(52,023,422)<span></span>
</td>
<td class="num">(4,526,905)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax benefit</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">234,542<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss of the year</a></td>
<td class="num">$ (320,524)<span></span>
</td>
<td class="num">$ (1,986,814)<span></span>
</td>
<td class="num">$ (51,788,880)<span></span>
</td>
<td class="num">$ (4,526,905)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic and diluted loss per share (in Dollars per share)</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (1.5)<span></span>
</td>
<td class="num">$ (0.15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeAbstract', window );"><strong>Other comprehensive income/loss</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss of the year</a></td>
<td class="num">$ (320,524)<span></span>
</td>
<td class="num">$ (1,986,814)<span></span>
</td>
<td class="num">$ (51,788,880)<span></span>
</td>
<td class="num">$ (4,526,905)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax', window );">Foreign exchange differences on translation of foreign operations</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">18,112<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Total other comprehensive income/(loss)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">18,112<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss for the year</a></td>
<td class="num">$ (320,524)<span></span>
</td>
<td class="num">$ (1,986,814)<span></span>
</td>
<td class="num">$ (51,770,768)<span></span>
</td>
<td class="num">$ (4,526,905)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses that the entity classifies as being administrative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2023-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35_b_vi&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 51<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_51_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2023-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherFinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of finance income or cost that the entity does not separately disclose in the same statement or note. [Refer: Finance income (cost)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherFinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherOperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income (expense) that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherOperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2023-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2023-01-01<br> -Paragraph IE33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 126<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SalesAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to the marketing and selling of goods or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SalesAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share of the other comprehensive income of associates and joint ventures accounted for using the equity method that will be reclassified to profit or loss, net of tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82A<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82A&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TransactionsExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transaction expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TransactionsExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539416889040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeStatementAbstract', window );"><strong>Profit or loss [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted loss per share</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (1.50)<span></span>
</td>
<td class="num">$ (0.15)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539422595472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Financial Position - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NonCurrentAssetsAbstract', window );"><strong>Non- current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="nump">$ 8,519,098<span></span>
</td>
<td class="nump">$ 4,598,930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssets', window );">Fixed Assets</a></td>
<td class="nump">1,142,082<span></span>
</td>
<td class="nump">8,918<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">251,440<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use of assets</a></td>
<td class="nump">43,806<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentReceivables', window );">Other Non-Current receivables</a></td>
<td class="nump">8,763,027<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">18,719,453<span></span>
</td>
<td class="nump">4,607,848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">2,527,673<span></span>
</td>
<td class="nump">1,081,808<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShorttermInvestmentsCurrent', window );">Short-term investments</a></td>
<td class="nump">306,034<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Trade receivables</a></td>
<td class="nump">361,097<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherReceivables', window );">Other receivables</a></td>
<td class="nump">1,330,177<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPrepayments', window );">Prepayments</a></td>
<td class="nump">341,107<span></span>
</td>
<td class="nump">2,061<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventories</a></td>
<td class="nump">465,748<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="nump">5,331,836<span></span>
</td>
<td class="nump">1,083,869<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">24,051,289<span></span>
</td>
<td class="nump">5,691,717<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">375,641<span></span>
</td>
<td class="nump">310,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Share premium</a></td>
<td class="nump">66,996,982<span></span>
</td>
<td class="nump">7,290,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareToBeIssuedAmount', window );">Shares to be issued</a></td>
<td class="nump">3,068<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_EquitySettledShareBasedPayments', window );">Equity settled share-based payment</a></td>
<td class="nump">1,335,253<span></span>
</td>
<td class="nump">838,576<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation', window );">Cumulative translation adjustment</a></td>
<td class="nump">18,112<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Accumulated deficit</a></td>
<td class="num">(58,623,123)<span></span>
</td>
<td class="num">(6,834,243)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">10,105,933<span></span>
</td>
<td class="nump">1,604,333<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Accounts payable</a></td>
<td class="nump">7,479,614<span></span>
</td>
<td class="nump">1,226,213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialLiabilities', window );">Financial debts</a></td>
<td class="nump">2,546,243<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="nump">1,685,645<span></span>
</td>
<td class="nump">1,171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WarrantLiability', window );">Warrants liabilities</a></td>
<td class="nump">887,689<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SimplyAgreementForFutureEquitySAFE', window );">Simply Agreement for Future Equity (&#8220;SAFE&#8221;)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,860,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">12,599,191<span></span>
</td>
<td class="nump">4,087,384<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NonCurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialLiabilities', window );">Financial debt</a></td>
<td class="nump">99,046<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentPayables', window );">Other non-current liabilities</a></td>
<td class="nump">175,312<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred Tax Liability</a></td>
<td class="nump">1,071,807<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Total non-current liabilities</a></td>
<td class="nump">1,346,165<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">13,945,356<span></span>
</td>
<td class="nump">4,087,384<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">TOTAL LIABILITIES AND EQUITY</a></td>
<td class="nump">$ 24,051,289<span></span>
</td>
<td class="nump">$ 5,691,717<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current prepayments. [Refer: Prepayments]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2023-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2023-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current trade receivables and non-current other receivables. [Refer: Non-current trade receivables; Other non-current receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities; Current financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph m<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_m&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph m<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_m&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current payables that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount receivable by the entity that it does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2023-01-01<br> -Paragraph 52<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_52_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReserveOfExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity's cumulative undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph IG6<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharePremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount received or receivable from the issuance of the entity's shares in excess of nominal value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharePremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_EquitySettledShareBasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity settled share based payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_EquitySettledShareBasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FixedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed Assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FixedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NonCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NonCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NonCurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NonCurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShareToBeIssuedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of shares to be issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShareToBeIssuedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShorttermInvestmentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShorttermInvestmentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SimplyAgreementForFutureEquitySAFE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Simply Agreement for Future Equity (&#8220;SAFE&#8221;).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SimplyAgreementForFutureEquitySAFE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539416575072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Capital shares issued</div></th>
<th class="th"><div>Capital shares to be issued</div></th>
<th class="th"><div>Share Premium</div></th>
<th class="th"><div>Cumulative translation adjustment</div></th>
<th class="th"><div>Equity settled share based payment</div></th>
<th class="th"><div>Retained (deficit)</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Aug. 20, 2020</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IssueOfShareCapital', window );">Issue of share capital</a></td>
<td class="nump">291,400<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,308,600<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(320,524)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax', window );">Total comprehensive (loss)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(320,524)<span></span>
</td>
<td class="num">(320,524)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">291,400<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,308,600<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(320,524)<span></span>
</td>
<td class="nump">4,279,476<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IssueOfShareCapital', window );">Issue of share capital</a></td>
<td class="nump">18,600<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,981,400<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,986,814)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax', window );">Total comprehensive (loss)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,986,814)<span></span>
</td>
<td class="num">(1,986,814)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Jun. 30, 2021</a></td>
<td class="nump">310,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">7,290,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,307,338)<span></span>
</td>
<td class="nump">5,292,662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_EquitySettledShareBasedPayment', window );">Equity settled share-based payment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">838,576<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">838,576<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss of the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,526,905)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax', window );">Total comprehensive (loss)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,526,905)<span></span>
</td>
<td class="num">(4,526,905)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Jun. 30, 2022</a></td>
<td class="nump">310,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">7,290,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">838,576<span></span>
</td>
<td class="num">(6,834,243)<span></span>
</td>
<td class="nump">1,604,333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IssueOfShareCapital', window );">Issue of share capital</a></td>
<td class="nump">36<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">10,647<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">10,683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_EquitySettledShareBasedPayment', window );">Equity settled share-based payment</a></td>
<td class="nump">2,326<span></span>
</td>
<td class="nump">2,427<span></span>
</td>
<td class="nump">593,684<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">496,677<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,095,114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Issue of share capital (Moolec Science shares)</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,105,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,120,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IssueOfShareCapitalSAFEShares', window );">Issue of share capital (SAFE shares)</a></td>
<td class="nump">2,623<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,170,723<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,173,346<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IssueOfShareCapitalLightJumpShares', window );">Issue of share capital (LightJump shares)</a></td>
<td class="nump">33,639<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">39,610,630<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">39,644,269<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IssueOfShareCapitalBackstopShares', window );">Issue of share capital (Backstop shares)</a></td>
<td class="nump">12,017<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">7,999,023<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,011,040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax', window );">Exchange differences on translation of foreign operations</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">18,112<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">18,112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BusinessCombination', window );">Business combination</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">641<span></span>
</td>
<td class="nump">217,275<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">217,916<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net loss of the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(51,788,880)<span></span>
</td>
<td class="num">(51,788,880)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at Jun. 30, 2023</a></td>
<td class="nump">$ 375,641<span></span>
</td>
<td class="nump">$ 3,068<span></span>
</td>
<td class="nump">$ 66,996,982<span></span>
</td>
<td class="nump">$ 18,112<span></span>
</td>
<td class="nump">$ 1,335,253<span></span>
</td>
<td class="num">$ (58,623,123)<span></span>
</td>
<td class="nump">$ 10,105,933<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of equity instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income that will be reclassified to profit or loss, before tax. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph IG6<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82A<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82A&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2023-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of reclassification adjustments related to exchange differences when the financial statements of foreign operations are translated, net of tax. Reclassification adjustments are amounts reclassified to profit (loss) in the current period that were recognised in other comprehensive income in the current or previous periods. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2023-01-01<br> -Paragraph 48<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_48&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 92<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_92&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_BusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of business combination consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_BusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_EquitySettledShareBasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of equity settled share based payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_EquitySettledShareBasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_IssueOfShareCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of issue of share capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_IssueOfShareCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_IssueOfShareCapitalBackstopShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of issue of share capital (Backstop shares).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_IssueOfShareCapitalBackstopShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_IssueOfShareCapitalLightJumpShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of issue of share capital (LightJump shares).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_IssueOfShareCapitalLightJumpShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_IssueOfShareCapitalSAFEShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of issue of share capital (SAFE shares).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_IssueOfShareCapitalSAFEShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539416566672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the year</a></td>
<td class="num">$ (320,524)<span></span>
</td>
<td class="num">$ (1,986,814)<span></span>
</td>
<td class="num">$ (51,788,880)<span></span>
</td>
<td class="num">$ (4,526,905)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract', window );"><strong>Adjustments to reconcile loss for the year to net cash flows</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncomeTaxExpense', window );">Deferred income tax</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(234,542)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense', window );">Depreciation and amortization</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">122,022<span></span>
</td>
<td class="nump">1,699<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Employee share-based payment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,095,114<span></span>
</td>
<td class="nump">838,576<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of loss from associate</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">390,453<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss', window );">Change in fair value of Simply Agreement for Future Equity (&#8220;SAFE&#8221;)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">313,346<span></span>
</td>
<td class="nump">860,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareBasedPaymentCostOfListingSharesnoncashItem', window );">Share based payment cost of listing shares (non-cash item)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">42,705,061<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncomeCost', window );">Financial income / expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,452,876)<span></span>
</td>
<td class="nump">14,472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ChangesInWorkingCapitalAbstract', window );"><strong>Changes in working capital</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables', window );">Trade receivables</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(44,126)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets', window );">Other receivables</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(276,292)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable', window );">Receivables from related parties</a></td>
<td class="num">(2,299,108)<span></span>
</td>
<td class="nump">2,009,220<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses', window );">Prepayment</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(358)<span></span>
</td>
<td class="num">(339,046)<span></span>
</td>
<td class="num">(1,703)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories', window );">Inventories</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">66,484<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable', window );">Accounts Payable</a></td>
<td class="nump">19,632<span></span>
</td>
<td class="nump">568,026<span></span>
</td>
<td class="nump">1,485,151<span></span>
</td>
<td class="nump">926,711<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OtherLiabilitie', window );">Other liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">837,231<span></span>
</td>
<td class="nump">1,171<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash (used in) / generated by operating activities</a></td>
<td class="num">(2,600,000)<span></span>
</td>
<td class="nump">980,527<span></span>
</td>
<td class="num">(7,511,353)<span></span>
</td>
<td class="num">(1,885,979)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Additions of fixed assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(14,824)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Cash paid for acquisition of ValoraSoy net of the cash acquired</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,930,883)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Additions of Intangible assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(164,362)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments', window );">Short term investment subscriptions</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,572,783)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities', window );">Short-term investments withdrawals</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,346,032<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,336,820)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingOtherEquityInstruments', window );">Proceeds from issuance of share capital to UGVL and Theo (Backstop)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,011,040<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_Proceedsfromissuanceofsharecapital', window );">Proceeds from issuance of share capital to SPAC public holders (Trust)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,988,975<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromCurrentBorrowings', window );">Proceeds from financial debts</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,171,830<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities', window );">Payment of loans</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(876,769)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Payment of loan interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(24,098)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ProceedsFromSAFE', window );">Proceeds from the SAFE</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from of issue of shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">10,683<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ProceedsFromIssueOfShareCapital', window );">Proceeds from issue of share capital</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Proceeds from additional issue of ordinary shares</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Net cash generated from financing activities</a></td>
<td class="nump">2,600,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">11,281,661<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Net increase in cash and cash equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">980,527<span></span>
</td>
<td class="nump">1,433,488<span></span>
</td>
<td class="nump">114,021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition', window );">Cash and cash equivalents at beginning of the year/period</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,081,808<span></span>
</td>
<td class="nump">980,527<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash and equivalents</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">12,377<span></span>
</td>
<td class="num">(12,740)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition', window );">Cash and cash equivalents at end of the year/period</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">980,527<span></span>
</td>
<td class="nump">2,527,673<span></span>
</td>
<td class="nump">1,081,808<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NonCashFinancingActivitiesAbstract', window );"><strong>Non-cash financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei', window );">Issue of Share Capital and Share Premium of New Shareholders through other non current receivables</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,120,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium', window );">Relief of SAFE financial liabilities through the issue of Share Capital and Share Premium</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,173,346<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CapitalizationOfTransactionExpensesThroughAccountsPayable', window );">Capitalization of transaction expenses through Accounts Payable</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,057,833<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NetLiabilitiesAcquiredThroughIssuanceOfShareCapital', window );">Net liabilities acquired through issuance of share capital</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,991,935<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AcquisitionOfBusinessCombinationTroughDeferredPayment', window );">Acquisition of Business Combination trough deferred payment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">488,431<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind', window );">Acquisition of Business Combination trough deferred payment in kind</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">217,916<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares', window );">Acquisition of non-current assets by the issuance of ordinary shares</a></td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in other assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for the decrease (increase) in prepaid expenses to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Current prepaid expenses; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for income tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and cash equivalents in the statement of cash flows when different from the amount of cash and cash equivalents in the statement of financial position. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow (outflow) due to a decrease (increase) in short-term deposits and investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 39<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_39&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income or cost associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) on financial assets at fair value through profit or loss. [Refer: Financial assets at fair value through profit or loss]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_20_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid, classified as financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPaidClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromCurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from current borrowings obtained. [Refer: Current borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromCurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssueOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingOtherEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing equity instruments that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingOtherEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales or maturity of financial instruments, classified as investing activities. [Refer: Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2023-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23_g&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AcquisitionOfBusinessCombinationTroughDeferredPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of acquisition of business combination trough deferred payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AcquisitionOfBusinessCombinationTroughDeferredPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of acquisition of business combination trough deferred payment in kind.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of acquisition of non-current assets by the issuance of ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CapitalizationOfTransactionExpensesThroughAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalization of transaction expenses through accounts payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CapitalizationOfTransactionExpensesThroughAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ChangesInWorkingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ChangesInWorkingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NetLiabilitiesAcquiredThroughIssuanceOfShareCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NetLiabilitiesAcquiredThroughIssuanceOfShareCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NonCashFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NonCashFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_OtherLiabilitie">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_OtherLiabilitie</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ProceedsFromIssueOfShareCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuing of share capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ProceedsFromIssueOfShareCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ProceedsFromSAFE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the SAFE.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ProceedsFromSAFE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_Proceedsfromissuanceofsharecapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of proceeds from issuance of share capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_Proceedsfromissuanceofsharecapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShareBasedPaymentCostOfListingSharesnoncashItem">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShareBasedPaymentCostOfListingSharesnoncashItem</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417449712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>General Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory', window );">General information</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 1. General information</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Moolec Science SA (&#8220;the
Company&#8217;&#8217;, &#8220;the Group&#8221; or &#8220;Moolec Science&#8217;&#8217;) is a public limited liability company (soci&#233;t&#233; anonyme) incorporated
under the laws of the Grand Duchy of Luxembourg on May 23, 2022 (&#8220;date of incorporation&#8221;), created to develop affordable alternative
proteins using molecular farming technology. The Company is registered with the Luxembourg Trade and Companies&#8217; Register (Registre
de Commerce et des Soci&#233;t&#233;s, Luxembourg) under number B268440. Its registered address is 17, Boulevard F.W. Raiffeisen,
L-2411 Luxembourg, Grand Duchy of Luxembourg.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Company Reorganization</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On December 30, 2022
(the &#8220;Closing Date&#8221;), the Company consummated the transactions contemplated by the Business Combination Agreement dated as
of June 14, 2022, by and among LightJump Acquisition Corporation (&#8220;LightJump&#8221; or &#8220;SPAC&#8221;, a Delaware corporation),
Moolec Science Limited (&#8220;Moolec&#8221; or &#8220;Moolec Science Limited&#8221;, a private limited company incorporated under the
laws of England and Wales), the Company, and Moolec Acquisition, Inc. (&#8220;Merger Sub&#8221;, a Delaware corporation) (referred together
with Moolec Science SA as &#8220;the Group&#8221;), as amended by the Business Combination Agreement dated as of November 18, 2022. Pursuant
to the Business Combination Agreement and related agreements:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">all the issued Moolec Ordinary Shares held by Moolec Shareholders were transferred and contributed in
kind to the Company, and were issued, in accordance with the Exchange Ratio (1:0.6370485) (except that the Ordinary Shares to be reduced
by the number of Ordinary Shares already held by Moolec Shareholders immediately prior to the transactions contemplated in the Business
Combination Agreement (&#8220;Exchange&#8221;), being a total of 32,500,000 Ordinary Shares;</td></tr> </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">each Moolec SAFE Holder contributed all of its rights and obligations under each Original SAFE to the
Company in consideration for the issuance by the Company of a simple agreement for future equity on substantially identical terms (mutatis
mutandis) with such adjustments as required under Luxembourg law;</td></tr>
                                                                           </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">each Moolec Shareholder ceased to be the beneficial holder of such Moolec Ordinary Shares and subject
to the submission of all filings required under Law (including any filings required to pay stamp duties), the Company was recorded as
the registered holder of all Ordinary Shares so exchanged and transferred and is the legal and beneficial owner thereof;</td></tr>
                                                                                                                                  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">immediately prior to the Merger but after the Exchange, each Moolec SAFE Holder subscribed for, received
and became holder of Ordinary Shares, in accordance with the respective Moolec SAFE, which included 262,260 Ordinary Shares; and</td></tr> </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">SPAC caused the Certificate of Merger to be executed, acknowledged and filed with the Secretary of State
of the State of Delaware in accordance with the applicable provisions of the DGCL in order to effectuate the Merger. The Merger became
effective on December 30, 2022.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">At the Merger and without
any further action on the part of SPAC, Merger Sub, the Company or Moolec or the holders thereunder:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">each SPAC Common Stock issued and outstanding immediately prior to the Merger, excluding those that had
been redeemed subject to any redemption rights, were exchanged with the Company, against the issue by the Company of new Ordinary Shares,
under the authorized share capital of the Company and subscribed by the contributing holders of SPAC Common Stock for one validly issued
and fully paid Ordinary Share, delivered by the Company;</td></tr></table><p style="margin: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">as a result of the Merger, all SPAC Common Stock ceased to be outstanding, was canceled and ceased to
exist;</td></tr>
                </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">each share of common stock, par value $0.01 of Merger Sub issued and outstanding immediately prior to
the Merger Effective Time was converted and exchanged for one (1) validly issued, fully paid and nonassessable ordinary share, par value
$0.01 per share of the Company; and</td></tr> </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">each SPAC Warrant that was outstanding immediately prior to the Merger, pursuant to the SPAC Warrant Agreement,
ceased to represent a right to acquire one SPAC Common Stock and was converted in accordance with the terms of such SPAC Warrant Agreement,
at the Merger, into a right to acquire one Ordinary Share of the Company on substantially the same terms as were in effect immediately
prior to the Time under the terms of the SPAC Warrant Agreement.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Following the Merger:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td style="text-align: justify">Moolec&#8217;s CFO was freely allotted the shares to satisfy the requirements under the CFO Consulting
Agreement.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Prior to the Closing,
on December 27, 2022, in connection with the vote to approve the adoption of the Business Combination Agreement at LightJump&#8217;s special
meeting of stockholders, certain public holders of SPAC Common Stock exercised their right to redeem 2,572,848 shares of SPAC Common Stock
for cash at a redemption price of approximately $10.23 per share, for an aggregate redemption amount of approximately $ 26.3 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Accordingly, $1,988,975
remained in the Trust Account, for the benefit of the Company, after considering the redemption amount to be paid to the redeeming public
holders of SPAC Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Additionally, pursuant
to the Backstop Agreement, the Sponsor exercised the right to elect to concede Sponsor shares instead of contributing the requisite cash
amount under the Backstop Agreement by conceding a total of 200,276 Sponsor shares of SPAC Common Stock to each of Union Group Ventures
Limited (&#8220;UGVL&#8221;) and THEO I SCSp. (&#8220;Theo&#8221;). UGVL and Theo each contributed $4,005,520 to the Company pursuant
to the terms of the Backstop Agreement and in turn the Company issued 400,552 Ordinary Shares to each of UGVL and Theo.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As a result of the Exchange
and following the consummation of the Transaction, Moolec and SPAC had become direct wholly-owned subsidiaries of the Company and Moolec
shareholders and SPAC shareholders became holders of issued Company Ordinary Shares of Moolec Science S.A.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In accordance with IFRS
2, for the excess of the fair value of shares deemed to have been issued by Moolec over the fair value of LightJump&#8217;s identifiable
net assets at the date of the Company Reorganization, the Company recognized $ 42,705,061 as listing costs included in line item &#8220;Share
based payment cost of listing shares&#8221; as an expense in the Statements of Operations, being a non-cash item.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Negative working capital</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As of June 30, 2023, the
Company has a negative working capital of $7,427,356 increased mainly by reorganization expenses pending to be paid and a temporary mismatch
between account payables together with financial debt and account receivables. However, as part of the continuous efforts of management
to strengthen the financial situation of the Company, as of October 15, 2023, the Company has entered into an agreement to issue a convertible
note due 2026 to Grupo Insud (&#8220;Insud&#8221;). As a consequence of the cash inflow related to the convertible note, the Group concludes
it will, for the foreseeable future, be able to realize its assets and discharge its liabilities in the normal course of operations. See
note 31. Events after the reporting period.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for general information about financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 51<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_51&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417736176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BusinessCombinationAbstract', window );"><strong>Business Combination [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsExplanatory', window );">Business combination</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 2. Business combination</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Summary of ValoraSoy
acquisition</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On April 24, 2023 (the
&#8220;Closing Date&#8221;), the Company completed the acquisition of ValoraSoy S.A. (&#8220;ValoraSoy Food Ingredients&#8221;) from the
sellers in accordance with the share purchase agreement (&#8220;ValoraSoy SPA&#8221;) by and among the Company and the sellers (the &#8220;ValoraSoy
Acquisition&#8221;). As a result of the ValoraSoy Acquisition, the Company acquired all of the issued and outstanding equity securities
of ValoraSoy Food Ingredients from the sellers, and ValoraSoy Food Ingredients became a wholly owned subsidiary of the Company for total
aggregate consideration of $2.6 million, in a combination of cash ($2.4 million of which $1.9 million were an immediate cash payment and
$0.5 million will be paid in 6 months from the Closing Date) and equity (64,093 shares equivalent to $0.2 million which will be transferred
in 12 months from the Closing Date). The acquisition agreement also included a contingent payment in a fixed amount of equity amounting
to 384,558 shares equivalent to $1.7 million, which was determined to be a remuneration agreement for future services (the &#8220;earn-out&#8221;)
and consequently it was excluded from the consideration and will be recognized as an expense over the required service period. The contingent
payment is payable in shares over a three-year period from 2024 to 2026 and subject to the achievement of certain EBITDA targets, as defined
in the ValoraSoy SPA. Such payment is automatically forfeited on termination of employment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">ValoraSoy Food Ingredients
has more than 10 years of experience, specializes in the production of textured soy proteins and has a long history providing high-quality
products and customized solutions to clients in more than 14 countries in 3 different continents. Its products are manufactured using
various extrusion processes obtaining as a result vegetable proteins with texture and fibrousness similar to those of meat with various
applications such as hamburgers, sausages and other meat extenders and plant-based products. This demo center is a state-of-the-art processing
facility located in the Argentine soybean corridor, which helps maximize raw material origination, with an installed crushing capacity
of 10 thousand tons of soybean per year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Details of the purchase
consideration, the net assets acquired and goodwill are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">Purchase consideration:</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: justify; text-indent: 0pt; padding-left: 0.125in">Cash paid</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,931,112</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: 0pt; padding-left: 0.125in">Deferred Payment after 6 months</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">488,431</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: justify; text-indent: 0pt; padding-left: 0.125in">Payment in kind after 12 months</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">217,916</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify; text-indent: 0pt; padding-left: 0.125in">Total purchase consideration</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,637,458</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The assets and liabilities
recognised as a result of the acquisition are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0pt; text-align: justify; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; width: 88%; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Cash and Banks</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">228</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Accounts Receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">316,972</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Other Receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,044,808</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">532,231</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Property, Plant, and Equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,138,026</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Intangible Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,824,054</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Right-of-use of assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43,507</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Accounts Payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,384,980</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Current Financial Debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,176,089</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Current Other Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(356,757</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Non-current Financial Debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(119,464</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Non-current Other Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(177,367</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 1.5pt; text-align: justify; text-indent: 0pt">Deferred Tax Liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,297,436</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 1.5pt; font-weight: bold; text-align: justify; text-indent: 0pt">Net identifiable assets acquired</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,387,733</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 1.5pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif">Goodwill recognized <span style="font-size: 10pt">(i)</span></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">249,725</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; font-weight: bold; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Net assets acquired</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">2,637,458</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(i)</span></td><td style="text-align: justify">The goodwill is attributable to the expected future synergies
from combining operations as well as an assembled workforce, which does not qualify for separate recognition. The Company expects that
the ValoraSoy Acquisition will help to accelerate its growth in the food ingredients industry by expanding its commercial network with
a top-notch sales team and complementing its Molecular Farming Platform with industrial capacity and downstream operations, in addition
to adding a highly experienced team of professionals. It will not be deductible for tax purposes.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The pro-forma revenue
of the combined entity for the year ended June 30, 2023 as though the date for the merger had been as of the beginning of the reporting
period amounts to $5,043,956.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Section Disclosures<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IFRS03_g59-63_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_BusinessCombinationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_BusinessCombinationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539425888064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Standards and Basis of Preparation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract', window );"><strong>Accounting standards and Basis of preparation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory', window );">Accounting standards and Basis of preparation</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 3. Accounting
standards and basis of preparation</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><b>Note 3.1. Compliance
with IFRS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">These Consolidated Financial
Statements of the Group have been prepared in accordance with International Financial Reporting Standards (IFRS) and interpretations issued
by the IFRS Interpretations Committee (IFRS IC) applicable to companies reporting under IFRS. The financial statements comply with IFRS
as issued by the International Accounting Standards Board (IASB).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The consolidated financial
statements of the Group as of June 30, 2023, and June 30, 2022 and for the year ended June 30, 2023 and 2022 were authorized by the Board
of Directors of Moolec Science S.A. on October 30, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 3.2. Basis of
measurement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The consolidated financial
statements have been prepared on the historical cost basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The significant accounting
policies set out in Note 3 have been applied in preparing the consolidated financial statements as of June 30, 2023 and 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Due to the activities
of the Group, costs and expenses presented in the consolidated statements of Comprehensive loss are classified according to their function.
The consolidated statements of Financial Position has been prepared based on the nature of the transactions, distinguishing: (a) current
assets from non-current assets, where current assets are intended as the assets that should be realized, sold or used during the normal
operating cycle, or the assets owned with the aim of being sold in the short-term (within 12 months); (b) current liabilities from non-current
liabilities, where current liabilities are intended as the liabilities that should be paid during the normal operating cycle or over the
12-month period subsequent to the reporting date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 3.3. Functional
and presentation currency</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Items included in the
Consolidated Financial Statements are measured using the currency of the primary economic market in which the Company operates (&#8220;the
functional currency&#8221;). These Consolidated Financial Statements are presented in US Dollars, which is the Company&#8217;s functional
currency.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group has applied
IAS 29 for its newly acquired subsidiary in Argentina. IAS 29 &#8220;Financial reporting in hyperinflationary economies&#8221; requires
that the financial statements of an entity whose functional currency is the currency of a hyperinflationary economy, whether these are
based on the historical cost method or the current cost method, be stated in terms of the measuring unit current at the closing date of
the reporting period. For such purpose, the inflation produced since the acquisition date or the revaluation date, as applicable, must
be computed in non-monetary items. The standard details a series of factors to be considered for concluding whether an economy is hyperinflationary,
including, but not limited to, a cumulative inflation rate over a three-year period that approaches or exceeds 100%. Inflation accumulated
in <span style="-sec-ix-hidden: hidden-fact-231">three</span>&#160;years, as of June&#160;30, 2018, was over 100%. It was for this reason that, in accordance with IAS 29, the Argentine economy
had to be considered as hyperinflationary since July&#160;1, 2018.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In an inflationary period,
any entity that maintains an excess of monetary assets over monetary liabilities, will lose purchasing power, and any entity that maintains
an excess of monetary liabilities over monetary assets, will gain purchasing power, provided that such items are not subject to an adjustment
mechanism.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Briefly, the restatement
mechanism of IAS 29 establishes that monetary assets and liabilities will not be restated because they are already expressed in a current
unit of measurement at the end of the reporting period. Assets and liabilities subject to adjustments based on specific agreements, will
be adjusted according to those agreements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Non-monetary items measured at their current values at the end of the reporting period, such
as the net realizable value or others, do not need to be restated. The remaining non-monetary assets and liabilities will be restated
according to a general price index. The loss or gain for the net monetary position will be included in the net result of the reporting
period, revealing this information in a separate line item.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The inflation adjustment
to the initial balances was calculated by means of a conversion factor derived from the Argentine price indexes published by the National
Institute of Statistics.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The index as of June
30, 2023 and as of April 30, 2023 was&#160;1,709.6115 and&#160;1,497.2147, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group started with
the application of IAS 29, since the ValoraSoy acquisition, as such no comparative figures were presented using IAS 29. However, in the
future the comparative figures in the consolidated financial statements presented in a stable currency will not be adjusted for subsequent
changes in the price levels or exchange rates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 3.4. Use of estimates
and judgements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The preparation of the
Consolidated Financial Statements requires Management to make judgements, estimates and assumptions that affect the application of accounting
policies and the reporting amounts as presented in the Consolidated Financial Statements for all periods presented.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Estimates and underlying
assumptions are reviewed on an ongoing basis. Refer to Note 4 &#8211; Summary of significant accounting policies for further discussion
on accounting treatments applied in preparation of the financial results of the Group as of the reporting period in compliance with IFRS.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 3.5. Going concern</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Management has evaluated
whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Group&#8217;s ability to
continue as a going concern after the accompanying Consolidated Financial Statements are issued. The accompanying Consolidated Financial
Statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities that
might be necessary if the Group is unable to continue as a going concern. The Group concludes it will, for the foreseeable future, be
able to realize its assets and discharge its liabilities in the normal course of operations.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for derivative financial instruments and hedging. [Refer: Financial instruments, class [member]; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417678624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory', window );">Summary of significant accounting policies</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Note 4. Summary
of significant accounting policies</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.1. Basis of
consolidation of subsidiary</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Subsidiaries are entities
controlled by the Company. The financial statements of the Company&#8217;s subsidiaries are included in the Consolidated Financial Statements
from the date that control commences after the acquisition date. The accounting policies of subsidiaries have been changed when necessary
to align them with the policies adopted by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.2. Foreign
currency</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Transactions entered
into by the Group in a currency other than their functional currency are recorded at the relevant exchange rates as of the date upon which
such transactions occur. Foreign currency monetary assets and liabilities are translated at the prevailing exchange rates as of the final
day of each reporting period. Non-monetary assets and liabilities that are measured at fair value in a foreign currency are translated
into the functional currency at the exchange rate when the fair value was determined. Non-monetary items that are measured based on historical
cost in a foreign currency are translated at the exchange rate at the date of the transaction. Exchange differences arising on the retranslation
of unsettled monetary assets and liabilities are recognized immediately through other comprehensive income in the consolidated statements
of operations and are accumulated in equity (attributed to the non-controlling interests when appropriate).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.3. Intangible
assets</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Intangible assets include
projects in-progress (mainly related to internally developing products), software, licenses and other rights, and the purchase value of
customer relationships. The accounting policies regarding the recognition and measurement of such intangible assets are described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration:underline">Internally Generated
Intangible Assets</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Expenditure&#160;on&#160;internally&#160;developed&#160;products&#160;is&#160;capitalized&#160;if&#160;it&#160;can&#160;be&#160;demonstrated&#160;that:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">It&#160;is&#160;technically&#160;feasible&#160;to&#160;develop&#160;the&#160;product&#160;for&#160;it&#160;to&#160;be&#160;sold;</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Adequate&#160;resources&#160;are&#160;available&#160;to&#160;complete&#160;the&#160;development;</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">There&#160;is&#160;an&#160;intention&#160;to&#160;complete&#160;and&#160;sell&#160;the&#160;product;</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The&#160;Group&#160;is&#160;able&#160;to&#160;sell&#160;the&#160;product;</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Sale&#160;of&#160;the&#160;product&#160;will&#160;generate&#160;future&#160;economic&#160;benefits;&#160;and</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Expenditure&#160;on&#160;the&#160;project&#160;can&#160;be&#160;measured&#160;reliably.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Development expenditure
not satisfying the above criteria and expenditure on the research phase of internal projects are recognized in the consolidated statements
of operations as incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Capitalized development
costs are amortized using the straight-line method over the periods the Group expects to benefit from selling the products developed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Useful&#160;lives&#160;and&#160;amortization&#160;methods&#160;are&#160;reviewed&#160;every&#160;year&#160;as&#160;required&#160;by&#160;IAS&#160;38.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The research and development
process can be divided into several discrete steps or phases, which generally begin with discovery, validation and development and end
with regulatory approval and commercial launch. The process for developing seed traits is relatively similar for both GM and non-GM traits.
However, the two differ significantly in later phases of development. For example, obtaining regulatory approval for GM seeds is a far
more comprehensive and lengthy process than for non-GM seeds. Although breeding programs and industrial biotechnology solutions may have
shorter or simpler phases than those described below, the Group has used the industry consensus for seed-trait development phases to characterize
its technology portfolios, which is generally divided into the following six phases:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">i)</td><td style="text-align: justify">Discovery: The first phase in the technology development
process is the discovery or identification of candidate genes or genetic systems, metabolites, or microorganisms potentially capable
of enhancing specified plant characteristics or enabling an agro-industrial biotech solution.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">ii)</td><td style="text-align: justify">Proof of concept: Upon successful validation of the technologies in model systems (in vitro or in vivo),
promising technologies graduate from discovery and are advanced to the proof of concept phase. The goal of this phase is to validate a
technology within the targeted organism before moving forward with technology escalation activities or extensive field validation.</td></tr>
                                                                                                                                            </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">iii)</td><td style="text-align: justify">Early development: In this phase, efficacy field trials are expanded to evaluate the expression level
and phenological characteristics of the traits in multiple geographies and growing cycles, as well as other characteristics in order to
optimize the technology&#8217;s performance in the targeted organisms. The goal of the early development phase is to evaluate the technical
feasibility by identifying the best candidate to scale up the seed stock and to start the regulatory field trials.</td></tr>
                                                                                                                            </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">iv)</td><td style="text-align: justify">Advanced development and deregulation: In this phase, extensive field tests are used to fully demonstrate
the effectiveness of the technology for its intended purpose. In the case of GM traits, the process of obtaining regulatory approvals
from the government agencies is started, and includes field trials for environmental, core and food safety data generation. For solutions
involving microbial fermentation, industrial-scale runs are conducted.</td></tr></table><p style="margin: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">v)</td><td style="text-align: justify">Pre-launch: This phase involves finalizing the regulatory approval process and preparing for the launch
and commercialization of the technology. The range of activities in this phase includes seed increases, pre-commercial production, and
product and solution testing with selected customers. Usually, a more detailed marketing strategy and preparation of marketing materials
occur during this phase.</td></tr>
                                  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">vi)</td><td style="text-align: justify">Product launch: In general, this phase, which is the last milestone of the research and development process,
is carried out by the Group.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We determined that the
Research &amp; Development is more likely than not (&#8220;probable&#8221;) to become a commercialized product and reach compliance with
IAS 38 criteria items at the end of the phase iii &#8220;Early Development&#8221;, when efficacy field trials are performed to determine
the technical feasibility of the project by measuring parameters like expression level and phenological characteristics. The obtention
of desired values for this set of data represents the strongest and clearest indication that the technical feasibility has been proved.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Impairment testing of
intangible assets not yet available for use requires the use of significant assumptions for the estimation of future cash flows and the
determination of discount rates. The significant assumptions and the determination of discount rates for the impairment testing of goodwill
are further explained below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Management&#8217;s estimations
about the demonstrability of the recognition criteria for these assets and the subsequent recoverability represent the best estimate that
can be made based on all the available evidence, existing facts and circumstances and using reasonable and supportable assumptions in
cash flow projections. Therefore, the Consolidated financial statements do not include any adjustments that would result if the Group
were unable to recover the carrying amount of the above-mentioned assets through the generation of enough future economic benefits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Management has made the
estimates considering the cash flow projections projected. The key assumptions utilized are the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="border-bottom: Black 1.5pt solid; width: 30%"><span style="font-family: Times New Roman, Times, Serif"><b>Key assumption</b></span></td> <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 69%"><span style="font-family: Times New Roman, Times, Serif"><b>Management&#8217;s approach</b></span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Discount rate</span></td> <td>&#160;</td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The discount rate used ranges between 10% and 20%</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: middle"><p style="margin-top: 0; margin-bottom: 0"></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Budgeted market share</span></p></td> <td>&#160;</td> <td style="text-align: justify"> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The projected revenue from the products has been estimated by the management based on market penetration data for comparable products and technologies and on future expectations of foreseen economic and market conditions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The value assigned is consistent with external sources of information.</p></td></tr> <tr style="vertical-align: top; background-color: White"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Budgeted product prices</span></td> <td>&#160;</td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The prices estimated in the revenue projections are based on current and projected market prices for the products.</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Budgeted gross margin</span></td> <td>&#160;</td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Based on past performance and management&#8217;s expectations for the future.</span></td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration:underline">Intangible Assets
Acquired in a Business Combination </span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Intangible assets acquired
in a business combination are identified and recognized separately regarding goodwill when they meet the definition of intangible assets
and their fair value can be measured reliably. Such intangible assets are recognized at fair value at acquisition date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">After the initial recognition,
intangible assets acquired in a business combination are valued at cost, net of accumulated amortization, based on the expected attrition
over the respective estimated periods for which the intangible assets will provide economic benefit to the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Intangible assets acquisitions
from ValoraSoy were restated by applying the corresponding adjustment coefficients (as mentioned in Note 3.3) since the date of the business
combination and are translated at the exchange rate at the closing date of the financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration:underline">Software</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Software licenses are
valued at cost, restated as mentioned in Note 3.3, net of the corresponding accumulated amortization and impairment losses. Amortization
is calculated on a straight-line basis over the estimated useful life of the intangible assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.4. Property,
plant and equipment, net </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Property, plant and equipment
assets are measured at historical cost less accumulated depreciation and any impairment loss, except for those acquired in a business
combination, which are then recorded at fair value; assets under construction and land are not depreciated. The cost of the property,
plant and equipment is the fair value of the consideration initially provided to acquire or construct the item and prepare it for use.
Subsequent costs incurred for repair and maintenance, are expensed in the consolidated statements of comprehensive income unless these
costs meet the criteria for capitalization (i.e. extension of the useful life). Depreciation commences when the assets are ready for use.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Property, plant and equipment
is depreciated based on the straight-line method over estimated useful lives.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">An item of property,
plant and equipment will be derecognized upon disposal or when future economic benefits from the continued use of the asset are no longer
expected. The gain or loss arising from the derecognition is measured as the difference between the gain on sale and the carrying amount
of the asset and is recognized through profit or loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The useful lives of property,
plant and equipment are:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Storage</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="white-space: nowrap; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">20 years</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Machinery and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">10 - 20 years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Vehicles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">5 years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Furniture</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">10 years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Computer equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">3 - 5 years</span></td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.5. Goodwill</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Goodwill arising from
the acquisition of a business is recorded at cost at the acquisition date, less accumulated impairment losses, if any.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The acquisitions related
to a foreign operation are considered to be expressed in the functional currency of the foreign operation and are translated at the exchange
rate at the reporting date.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Goodwill acquisition
related to the acquisition of ValoraSoy are recorded at cost, restated by applying the corresponding adjustment coefficients (as mentioned
in Note 3.3) since the date of the business combination and are translated at the exchange rate at the closing date of the financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Note 4.5.1 Goodwill
impairment</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Goodwill is tested for
impairment annually at the cash-generating unit level, which is the level at which the assets generate largely independent cash inflows
and are monitored for internal management purposes. An impairment loss is recognized whenever the carrying amount of an asset or the related
cash-generating unit exceeds its recoverable amount. Impairment losses are recognized in the consolidated statements of profit or loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Impairment losses recognized
for cash-generating units first reduce allocated goodwill and then the carrying amounts of the other assets in the unit on a pro rata
basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.6. Inventories,
net </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Inventories are presented
at the lower of acquisition cost or net realizable value. Cost is determined by the weighted average method. The net realizable value
represents the estimated sale price less all the estimated termination and selling costs. The cost of finished products and products in
progress includes the costs of raw materials, direct labor, other direct costs and the respective direct production expenses (based on
normal operating capacity), excluding borrowing costs. Inventories are presented net of the allowances for obsolescence and, in consolidation,
net of eliminations of unrealized profit on inventories.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.7. Cash and
cash equivalents</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">For the purposes of the
statements of financial position and statements of cash flows, cash and cash equivalents include cash on hand and in banks and short-term
highly liquid investments. Investments can be readily convertible to known amounts of cash and they are subject to insignificant risk
of changes in value in the consolidated statements of financial position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.8. Trade receivables
and other receivables</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Trade receivables represent
amounts owing for goods supplied by the Company prior to the end of the financial period which remain unpaid. They arise from transactions
in the normal operating activities of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Trade receivables are
carried at amortized cost, net of expected credit losses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company derecognizes
a financial asset when the contractual rights to the cash flows from the asset expire, or when it transfers the financial asset and substantially
all the risks and rewards of ownership of the asset to another party. If the Company neither transfers nor retains substantially all the
risks and rewards of ownership and continues to control the transferred asset, the Company recognizes its retained interest in the asset
and an associated liability for amounts it may have to pay. If the Company retains substantially all the risks and rewards of ownership
of a transferred financial asset, the Company continues to recognize the financial asset and also recognizes a collateralized borrowing
for the proceeds received.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.9. Right-of-use
of assets</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Due to the acquisition
of ValoraSoy, the Group acquired rights to use a parcel of land, as part of the acquisition agreement. At the acquisition date, right-of-use
of assets are initially recognized at fair value using a third-party valuation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The ownership of the
parcel of land is held by one of the sellers of ValoraSoy, who has entered into an agreement with the Company whereby he granted the right-of-use
of the property to the Company until the effective fulfillment of his obligation to lift encumbrances, subdivide and assign the property
to the Company within a period of twelve months or longer, if required by the proceedings, from the acquisition date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The right-of-use of land
shall not be depreciated due to the imminent transfer of ownership of the underlying asset to the Group which has an indefinite useful
life.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The right-of-use of assets
are presented in a single line in the consolidated statements of financial position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.10. Share capital
and reserves</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Ordinary shares</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Ordinary shares are classified
as equity. Incremental costs directly attributable to the issue of ordinary shares and share options are recognized as a deduction from
equity, net of any tax effects.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Foreign currency translation
adjustment</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The foreign currency
translation reserve is used to record exchange differences arising from the translation of the financial statements from the functional
currency of Argentine Peso into the presentation currency of US dollar.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.11. Share-based
payment arrangements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Share-based compensation
benefits are provided to certain key employees under the Company Compensation Plan. Under this agreement, some employees and members of
the executive management team as defined by the Board of Directors, were granted share options and restricted stock units (&#8220;RSU&#8221;)
in return for their services to the Group.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group receives services
in exchange for its own equity instruments and does not have any obligation to settle the obligation with cash, so the plan is classified
as equity settled. The only condition to be met is the delivery of service by the employee during a certain period as defined in the Agreements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The fair value of options
granted under the plan is measured at grant date and recognized in accordance with the requirements of IFRS 2, as an employee benefits
expense, with a corresponding increase in equity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The total expense is
recognized over the vesting period, which is the period over which all of the specified vesting conditions are to be satisfied.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">When the options are
exercised, the Company issues the shares to the employee and members to the executive team. The proceeds received, net of any directly
attributable transaction costs, are credited directly to equity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The ValoraSoy acquisition
agreement also included a contingent payment in a fixed amount of equity amounting to 384,558 shares equivalent to $1.7 million, which
was determined to be a remuneration agreement for future services (the &#8220;earn-out&#8221;) and consequently it was excluded from the
consideration and will be recognized as an expense over the required service period. The contingent payment is payable in shares over
a three-year period from 2024 to 2026 and subject to the achievement of certain EBITDA targets, as defined in the ValoraSoy SPA. Such
payment is automatically forfeited on termination of employment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.12. Accounts
payable and other liabilities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Trade and other payables
are recognized when the Group has a legal or a constructive obligation, as a result of a past event, and it is probable that there may
be an outflow of resources embodying economic benefits to settle the obligation and the obligation can be measured reliably. These amounts
represent liabilities for goods and services provided to the Group prior to the end of financial year which are unpaid.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company derecognizes
financial liabilities when, and only when, the Company&#8217;s obligations are discharged, canceled or have expired. The difference between
the carrying amount of the financial liability derecognized and the consideration paid and payable is recognized in profit or loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Other payables correspond
mainly to employment obligations and provisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.13. Taxes</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration:underline">Current income
tax</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Current income tax assets
and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws
used to compute the amount are those that are enacted or substantively enacted at the reporting date in the country where the Group operates
and generates taxable income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Current income tax relating
to items recognized directly in equity is recognized in equity and not in the consolidated statements of operations. Management periodically
evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation
and establishes provisions where appropriate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration:underline">Deferred tax</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Deferred tax is provided
using the liability method on temporary differences between the tax bases of assets and liabilities and their carrying amounts for financial
reporting purposes at the reporting date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Deferred tax liabilities
are recognized for all taxable temporary differences, except:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">When
the deferred tax liability arises from the initial recognition of goodwill or an asset or liability in a transaction that is not a business
combination and, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss, and</span></td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In respect of taxable temporary differences affiliated
with investments in subsidiaries, associates, and interests in joint arrangements, when the timing of the reversal of the temporary differences
can be controlled and it is probable that the temporary differences will not reverse in the foreseeable future.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Deferred tax assets are
recognized for all deductible temporary differences, the carry forward of unused tax credits and any unused tax losses. Deferred tax assets
are recognized to the extent that it is probable that taxable profit will be available against which the deductible temporary differences,
and the carry forward of unused tax credits and unused tax losses can be utilized, except:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">When the deferred tax asset relating to the deductible
temporary difference arises from the initial recognition of an asset or liability in a transaction that is not a business combination
and, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss, and</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In respect of deductible temporary differences
affiliated with investments in subsidiaries, associates and interests in joint arrangements, deferred tax assets are recognized only to
the extent that it is probable that the temporary differences will reverse in the foreseeable future and taxable profit will be available
against which the temporary differences can be utilized.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The carrying amount of
deferred tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable
profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are re-assessed
at each reporting date and are recognized to the extent that it has become probable that future taxable profits will allow the deferred
tax asset to be recovered.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Deferred tax assets and
liabilities are measured at the tax rates that are expected to apply in the year when the asset is realized or the liability is settled,
based on tax rates that have been enacted or substantively enacted at the reporting date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Deferred tax relating
to items recognized outside profit or loss is recognized outside profit or loss. Deferred tax items are recognized in correlation to the
underlying transaction either in OCI or directly in equity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.14. Subsidiaries
and joint arrangements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Where the Company holds
a controlling interest in an entity, such entity is classified as a subsidiary. The Company exercises control over such an entity if all
three of the following elements are present: (i) the Company has the power to direct or cause the direction of the management and policies
of the entity, (ii) the Company is exposed to the variable returns of such entity; and (iii) the Company has power to affect the variability
of such returns. Control is reassessed whenever facts and circumstances indicate that there may be a change in any of these elements of
control.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">De-facto control exists
in situations where the Company has the practical ability to direct the relevant activities of an entity without holding the majority
of the voting rights. In determining whether de facto control exists, the Company considers all relevant facts and circumstances, including:
(i) the relative share of the Company&#8217;s voting rights with respect to both the size and dispersion of other parties who hold voting
rights; (ii) substantive potential voting rights held by the Company and by other parties, (iii) other contractual arrangements; and (iv)
historic patterns in voting attendance. As of the issuance of these Financial Statements, there is no de-facto control over any entity.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company is a party
to a joint arrangement when there is a contractual arrangement that confers joint control over the relevant activities of the arrangement
to the Group and at least one other party. Joint control is assessed under the same principles as control over subsidiaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The subsidiaries and
joint arrangements of the Company, of which their financial results have been included in the Consolidated Financial Statements, and holds
a majority share of the voting rights as of June 30, 2023 are as follows:</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Principal activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Country of incorporation and<br/> principal place of business</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% Equity <br/> interest as of<br/> June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: left">Moolec Science Limited (i)</td><td style="width: 1%">&#160;</td>
    <td style="width: 28%; text-align: center">Investment in subsidiaries</td><td style="width: 1%">&#160;</td>
    <td style="width: 28%; text-align: center">United Kingdom</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">LightJump Acquisition Corporation</td><td>&#160;</td>
    <td style="text-align: center">Investment in subsidiaries</td><td>&#160;</td>
    <td style="text-align: center">USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">ValoraSoy S.A. (ii)</td><td>&#160;</td>
    <td style="text-align: center">Investment in subsidiaries</td><td>&#160;</td>
    <td style="text-align: center">Argentina</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">AG Biomolecules LLC (DE)</td><td>&#160;</td>
    <td style="text-align: center">Investment in subsidiaries</td><td>&#160;</td>
    <td style="text-align: center">USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Microo Foods Ingredients S.L. (iii)</td><td>&#160;</td>
    <td style="text-align: center">Investment in joint arrangements</td><td>&#160;</td>
    <td style="text-align: center">Spain</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50</td><td style="text-align: left">%</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(i)</td><td style="text-align: justify">Moolec Science Limited has a branch office in Argentina,
Moolec Science Limited S.E.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(ii)</td><td style="text-align: justify">Incorporated through the acquisition on April 24, 2023.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(iii)</td><td style="text-align: justify">During December 2022, the Company agreed to participate in
a joint arrangement with the 50% of participation of the newly created company named Microo Food Ingredients Sociedad Limitada.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.15. Financial
instruments </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Financial assets and
liabilities are recognized when an entity of the Group becomes party to the contractual provisions of an instrument.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Financial assets and
liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issue of financial
assets and liabilities (other than those designated at fair value through profit or loss) are added to or deducted from the fair value
of the financial assets or liabilities, when appropriate, at initial recognition. Transaction costs directly attributable to the acquisition
of financial assets or liabilities designated at fair value through profit or loss are recognized immediately through profit or loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company applies a
hierarchy to classify valuation methods used to measure financial instruments carried at fair value. Levels 1 to 3 are defined based on
the degree to which fair value inputs are observable and have a significant effect on the recorded fair value, as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Level 1: Quoted prices (unadjusted) in active markets for
identical assets or liabilities;</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Level 2: Valuation techniques use significant observable
inputs, either directly (i.e., as prices) or indirectly (i.e., derived from prices), or valuations are based on quoted prices for similar
instruments; and</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Level 3: Valuation techniques use significant inputs that
are not based on observable market data (unobservable inputs).</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.15.1. Financial
assets</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Classification of
financial assets </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">If and when applicable
the Company follows the framework and requirements outlined in IFRS 9 to classify financial assets based on whether:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">The financial asset is held within a business model whose
objective is to collect contractual cash flows or whose objective is achieved through the collection of contractual cash flows and the
sale of financial assets; and</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify">The contractual terms give rise to cash flows that are only
payments of principal and interest.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">By default, all other
financial assets are subsequently measured at fair value through profit or loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Trade receivables are
amounts due from customers for goods sold or services performed in the ordinary course of business. They are generally due for settlement
within 30 days and are therefore all classified as current. Trade receivables are recognized initially at the amount of consideration
that is unconditional, unless they contain significant financing components, when they are recognized at fair value. The Group holds the
trade receivables with the objective of collecting the contractual cash flows and therefore measures them subsequently at amortized cost
using the effective interest method.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Gains and losses in
foreign currency</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Trade receivables denominated
in a currency other than the subsidiaries&#8217; functional currency is determined in that foreign currency and converted to the subsidiaries&#8217;
functional currency at the end of each reporting period using the then prevailing spot rate. Exchange differences are recognized through
profit or loss and are classified within financial income / expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Derecognition of financial
assets</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group derecognizes
a financial asset only when the contractual rights to the asset&#8217;s cash flows expire, or when it transfers the financial asset and
substantially all the risks and rewards of ownership of the asset to another party. If the Group does not transfer or retain substantially
all risks and rewards of ownership and continues to control the transferred asset, the Group recognizes its interest retained in the asset
and an associated liability for the amounts to be paid. If the Group retains substantially all the risks and rewards of ownership of a
transferred financial asset, the Group continues to recognize the financial asset and also recognizes a loan secured by the revenue received.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Upon derecognition of
a financial asset measured at amortized cost, the difference between the carrying amount of the asset and the sum of the consideration
received and receivable is recognized through profit or loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group also derecognizes
a financial asset when there is information which indicates that the counterparty is in serious financial difficulty and there is no realistic
prospect of recovery. The derecognized financial assets may still be subject to compliance activities in accordance with the Group&#8217;s
recovery procedures, taking into account legal advice when appropriate. Any recovery is recognized through profit or loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.15.2. Financial
liabilities and equity instruments </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Classification as
debt or equity</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Debt and equity instruments
are classified as financial liabilities or equity in accordance with the substance of the contractual agreement and definitions of financial
liability and equity instrument.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Equity instruments</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">An equity instrument
consists of any contract that evidences a residual interest in the assets of an entity, after deducting all of its liabilities. Equity
instruments issued by a Group entity are recognized for income received, net of direct issue costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The repurchase of equity
instruments of the Group is recognized and deducted directly in equity. No gain or loss is recognized through profit or loss, arising
from the purchase, sale, issue or cancellation of the equity instruments of the Group. During the fiscal year ended June 30, 2023 no repurchase
of equity instruments took place.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Financial liabilities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Financial liabilities
are classified at their inception at fair value through profit or loss or at amortized cost, using the effective interest amortization
method.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Warrant liabilities</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As part of the reorganization,
the Group acquired public warrants (&#8220;Public warrants&#8221;). The warrants are initially recognized at fair value on the date a
derivative contract is entered into, and they are subsequently remeasured to their fair value at the end of each reporting period. Gains
and losses will be recorded in profit or loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">These instruments are
measured at Level 1 fair value based on its quoted price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.16. New standards,
amendments and interpretations of IFRS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="text-decoration:underline">Standards and IFRICs
newly applicable for companies with 30 June 2023 year ends are set out below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">A number of narrow-scope
amendments to IFRS 3, IAS 16, IAS 37 and some annual improvements on IFRS 1, IFRS 9, IAS 41 and IFRS 16</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Amendments to IFRS 3,
&#8216;Business combinations&#8217; update a reference in IFRS 3 to the Conceptual Framework for Financial Reporting without changing
the accounting requirements for business combinations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Amendments to IAS 16,
&#8216;Property, plant and equipment&#8217; prohibit a company from deducting from the cost of property, plant and equipment amounts received
from selling items produced while the company is preparing the asset for its intended use. Instead, a company will recognise such sales
proceeds and related costs in profit or loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Amendments to IAS 37,
&#8216;Provisions, contingent liabilities and contingent assets&#8217; specify which costs a company includes when assessing whether a
contract will be loss-making.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Annual improvements make
minor amendments to IFRS 1, &#8216;First-time Adoption of IFRS&#8217;, IFRS 9, &#8216;Financial instruments&#8217;, IAS 41, &#8216;Agriculture&#8217;
and the Illustrative Examples accompanying IFRS 16, &#8216;Leases&#8217;.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The amendments listed
above did not have any impact on the amounts recognised in the Consolidated Financial Statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><span style="text-decoration:underline">New standards and
interpretations not yet adopted</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Certain new accounting
standards and interpretations have been published that are not mandatory for June 30, 2023 reporting period and have not been early adopted
by the Group. These standards are not expected to have a material impact on the Group in the current or future reporting periods and on
foreseeable future transactions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Amendment to IAS 12-
deferred tax related to assets and liabilities arising from a single transaction</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">These amendments require
companies to recognise deferred tax on transactions that, on initial recognition, give rise to equal amounts of taxable and deductible
temporary differences.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Effective date Annual
periods beginning on or after January 1, 2023<b>. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Narrow scope amendments
to IAS 1, Practice statement 2 and IAS 8</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The amendments aim to
improve accounting policy disclosures and to help users of the financial statements to distinguish between changes in accounting estimates
and changes in accounting policies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Effective date Annual
periods beginning on or after January 1, 2023<b>. </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Amendments to IFRS
16, Lease Liability in a Sale and Leaseback </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The&#160;amendments&#160;include
requirements for sale and leaseback transactions in IFRS 16 to explain how an entity accounts for a sale and leaseback after the date
of the transaction. Sale and leaseback transactions where some or all the lease payments are variable lease payments that do not depend
on an index or rate are most likely to be impacted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Effective date Annual
periods beginning on or after January 1, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">These amendments are
not applicable to the Group.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Amendments to IAS
1, &#8216;Presentation of financial statements&#8217;, on classification of liabilities </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">These narrow-scope amendments
to IAS 1, &#8216;Presentation of financial statements&#8217;, clarify that liabilities are classified as either current or noncurrent,
depending on the rights that exist at the end of the reporting period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Classification is unaffected
by the expectations of the entity or events after the reporting date (for example, the receipt of a waiver or a breach of covenant).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The amendment also clarifies
what IAS 1 means when it refers to the &#8216;settlement&#8217; of a liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Effective date Annual
periods beginning on or after January 1, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Amendments to IAS
7 and IFRS 7, Supplier Finance Arrangements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">These&#160;amendments&#160;require
disclosures to enhance the transparency of supplier finance arrangements and their effects on a company&#8217;s liabilities, cash flows
and exposure to liquidity risk. The disclosure requirements are the IASB&#8217;s response to investors&#8217; concerns that some companies&#8217;
supplier finance arrangements are not sufficiently visible, hindering investors&#8217; analysis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Effective date Annual
periods beginning on or after January 1, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Amendments to IFRS
10 and IAS 28, Sale or Contribution of Assets between an Investor and its Associate or Joint Venture </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The amendments clarify
the accounting treatment for sales or contributions of assets between an investor and its associates or joint ventures. They confirm that
the accounting treatment depends on whether the non-monetary assets sold or contributed to an associate or joint venture constitute a
&#8216;business&#8217; (as defined in IFRS 3 Business Combinations).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Where the non-monetary
assets constitute a business, the investor will recognize the full gain or loss on the sale or contribution of assets. If the assets do
not meet the definition of a business, the gain or loss is recognized by the investor only to the extent of the other investor&#8217;s
interests in the associate or joint venture. The amendments apply prospectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The effective date of
the amendment has not yet been set by the IASB; however, early application of the amendments is permitted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.17. Loss per
share</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group presents basic
and diluted earnings per share (EPS) data for its ordinary shares. Basic EPS is calculated by dividing the profit and loss attributable
to ordinary shareholders of the Group by the weighted average number of ordinary shares outstanding during the period. Diluted EPS is
determined by adjusting the profit or loss attributed to ordinary shareholders and the weighted average number of ordinary shares outstanding
for the effects of all dilutive potential ordinary shares.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As of June 30, 2023 and
2022, Basic EPS and Diluted EPS are the same, employee share based payments are considered dilutive instruments properly included in the
profit and loss account, however they do not impact in EPS diluted calculation because the Group has generated net loss to ordinary shareholders
(See Note 27).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.18. Revenue
</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The group identifies
contracts with customers and evaluates the goods and services committed therein to determine performance obligations and their classification
between performance obligations that are satisfied at a given time or over time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Revenue from satisfaction
of performance obligations at a given time is recognized when the client obtains control of the committed asset or service considering
whether there is a right to collection, if the client has the physical possession, if the client has the legal right and if they have
transferred the risks and benefits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Revenue from sales is
recognized when performance obligations are met, which consists of transforming the significant risks and benefits of ownership of the
goods are transferred to the purchaser, usually when the products are delivered to the purchaser at the determined location, according
to the agreed sales terms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group had no revenues
during 2022 and 2023 until ValoraSoy Acquisition on April 24, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.19. Expenses</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Research and development
costs</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Research costs are expensed
in the period in which these costs are incurred. Development costs are expensed in the period in which these costs are incurred if they
do not meet the criteria for capitalization.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Sales and marketing,
administrative and other operating expenses</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group recognizes
expenses in the period in which these costs are incurred and are presented by function on the consolidated statements of operations. Sales
and marketing expenses primarily relate to marketing materials and research of the Group to increase brand awareness in the marketplace.
Administrative expenses primarily comprise professional fees (mainly related to consultancy, accountancy and legal expenses), payroll
and share based compensation to certain executives. Other operating expenses relate to those that do not depend on general business operations
or relate to the other expense categories.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.20. Segment
reporting</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group operates in
a single operating segment, which is &#8220;science-based food ingredients&#8221;. Operating segments are defined as components of an
enterprise for which separate financial information is regularly evaluated by the chief operating decision maker, who in the Group&#8217;s
case is the Executive Team, in deciding how to allocate resources and assess performance. The Executive Team is composed of the Chief
Executive Officer (&#8220;CEO&#8221;), the Chief Financial Officer (&#8220;CFO&#8221;), the Chief Product Officer (&#8220;CPO&#8221;),
the Chief Technology Officer (&#8220;CTO&#8221;) and the Chief Science Officer (&#8220;CSO&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Executive Team evaluates
the Group&#8217;s financial information and resources and assess the financial performance of these resources on a consolidated basis
on the basis of Net revenue/loss for the period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group&#8217;s revenue,
results and assets for this one reportable segment can be determined by reference to the Consolidated Statement of Comprehensive Income
and Consolidated Statement of Financial Position.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group acquired ValoraSoy
on April 24, 2023. Because of the short-period of time since the acquisition, most of the required disclosures by IFRS 8 Operating Segments,
relating to entity-wide disclosures are not significant to disclose.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As required by IFRS 8
Operating Segments, below are presented applicable entity-wide disclosures related to Moolec Science&#8217;s revenues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration:underline">Revenues breakdown:</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company&#8217;s revenues
arise from operations in Argentina. During the periods covered by these consolidated financial statements the Company had no revenues
from customers attributed to the entity&#8217;s country of domicile.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration:underline">Non-current assets
other than financial instruments</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Non-current assets other
than financial instruments are located in the following countries:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>As of <br/>
June 30,<br/>
 2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>As of <br/>
June 30,<br/>
 2022</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left">Lux</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">251,440</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">United Kingdom</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,774,320</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,607,848</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Argentina</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,930,666</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Total non-current assets other than financial instruments</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">9,956,426</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,607,848</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.21 Business
combinations</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group applies the
acquisition method to account for business combinations. The acquisition cost is measured as the aggregate of the consideration transferred
for the acquisition of a subsidiary, which is measured at fair value at the acquisition date, and the amount of any non-controlling interest
in such subsidiary. The Group recognizes any non-controlling interest in a subsidiary at the non-controlling interest&#8217;s proportionate
share of the recognized amounts of subsidiary&#8217;s identifiable net assets. The acquisition related costs are expensed as incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Any contingent consideration
to be transferred by the Group is recognized at fair value at the acquisition date. The contingent consideration is classified as an asset
or liability that is a financial instrument under IFRS 9 is measured at fair value through profit or loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Goodwill is initially
measured at cost, which is the excess of the aggregate of the consideration transferred and the amount of the non-controlling interest
and any previous interest carried over the net identifiable assets acquired, and liabilities assumed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">After initial recognition,
goodwill is measured at cost less any accumulated impairment losses. For impairment testing, goodwill acquired in a business combination
is, as of the acquisition date, allocated to each of the cash-generating units of the Group that is expected to benefit from the synergies
of the combination, without considering whether other assets or liabilities of the subsidiary are allocated to those units.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Any impairment in the
carrying value is recognized in the consolidated statement of comprehensive income. In the case of acquisitions in stages, prior to the
write-off of the previously held equity interest in the subsidiary, said interest is re-measured at fair value as of the date of acquisition
of control over the subsidiary. The result of the re-measurement at fair value is recognized in profit or loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.22 Critical
accounting judgements and estimates</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group makes certain
estimates and assumptions regarding the future. Estimates and judgments are continually evaluated based on historical experience and other
factors, including expectations of future events that are believed to be reasonable under the circumstances. In the future, actual experience
may differ from these estimates and assumptions. The estimates and assumptions that have a significant risk of causing a material adjustment
to the carrying amounts of assets and liabilities within the next financial year are listed below.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Critical estimates</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Identification and fair value of identifiable intangible
assets arising in acquisitions (Note 4.3).</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Impairment of intangible assets not yet available for use
(Notes 4.3).</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of changes made to accounting policies by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539421993584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comparative Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ComparativeInformationLineItems', window );"><strong>Comparative Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAdditionalInformationExplanatory', window );">Comparative Information</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note
5. Comparative Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The information as of
June 30, 2022 and for the year ended June 30, 2022 and for the periods of January 1, 2021 through June 30, 2021 and from August 21, 2020
through December 31, 2020 disclosed for comparative purposes arises from the consolidated financial statements of Moolec as of those dates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Certain amounts in the
prior year financial statements have been reclassified to conform to the current year presentation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The exchange of shares
related to the Capital Reorganization contemplated by the Business Combination Agreement, explained in Note 2, has been given a retrospective
effect in the share capital of the statement of changes in equity and in Net loss per share purposes in Note 27.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAdditionalInformationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of additional information that is not presented elsewhere in the financial statements, but that is relevant to an understanding of them.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAdditionalInformationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ComparativeInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ComparativeInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539422078256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwillAbstract', window );"><strong>Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory', window );">Intangible Assets</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 6. Intangible
Assets</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; font-weight: bold; text-align: left"></td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Gamma<br/>
 Linolenic<br/>
 Acid (&#8220;GLA&#8217;)<br/>
 assets and<br/>
 licensing<br/>
 rights to<br/>
 Arachidonic <br/>
Acid<br/>
 (&#8220;ARA&#8221;)</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">SPC&#174;<br/>
 technology</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Customer<br/>
 relationship</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Software<br/>
 License</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Total<br/>
 Intangible<br/>
 Assets</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; font-weight: bold; text-align: left">As of December 31, 2020</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-232">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-233">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-234">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-235">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-236">&#160;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated Amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-237">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-238">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-239">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-240">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-241">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net book amount</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-242">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-243">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-244">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-245">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-246">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Year ended June 30, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Opening net book amount</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-247">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-248">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-249">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-250">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-251">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 40%; text-align: left; padding-bottom: 1.5pt">Additions</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">3,000,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">1,598,930</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-252">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-253">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">4,598,930</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Closing net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,000,000</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,598,930</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-254">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-255">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,598,930</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">As of June 30, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,598,930</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-256">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-257">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,598,930</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Accumulated Amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-258">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-259">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-260">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-261">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-262">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Net book amount</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">3,000,000</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,598,930</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-263">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-264">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">4,598,930</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
ended June 30, 2022</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Opening net book amount</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,000,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,598,930</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-265">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-266">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,598,930</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Closing net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,000,000</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,598,930</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-267">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-268">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,598,930</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">As of June 30, 2022</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,598,930</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-269">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-270">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,598,930</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated Amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-271">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-272">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-273">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-274">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-275">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Net book amount</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,000,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,598,930</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-276">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-277">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,598,930</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Year ended June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Opening net book amount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,598,930</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-278">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-279">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,598,930</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101,033</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63,329</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-280">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-281">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">164,362</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Acquisitions through business combinations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-282">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-283">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,819,009</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,045</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,824,054</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Effect of changes in foreign exchange rates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-284">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-285">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,235</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,269</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Amortization (i)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-286">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-287">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(93,247</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,270</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(94,517</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Closing net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,101,033</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,662,259</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,751,997</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,809</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">8,519,098</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">As of June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,101,033</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,662,259</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,845,244</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,079</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,613,615</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated Amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-288">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-289">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(93,247</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,270</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(94,517</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,101,033</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,662,259</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,751,997</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,809</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">8,519,098</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(i)</td><td style="text-align: justify">The charge of the amortization is included in Administrative
expenses and Research and development expenses (see notes 24 and 25).</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS38_g118-128_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsAndGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsAndGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417532080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fixed Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentAbstract', window );"><strong>Fixed Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory', window );">Fixed Assets</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 7. Fixed Assets</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap; text-align: left; font-weight: bold"></td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Chymosin<br/>
 osmosis<br/>
 equipment</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Vehicles</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Furniture</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Storage</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Computer<br/>
 equipment</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Machinery</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Total <br/>
Fixed<br/>
Assets</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap; text-align: left; font-weight: bold">As of December 31, 2020</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Cost</td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b style="-sec-ix-hidden: hidden-fact-290">-</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b style="-sec-ix-hidden: hidden-fact-291">-</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b style="-sec-ix-hidden: hidden-fact-292">-</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b style="-sec-ix-hidden: hidden-fact-293">-</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b style="-sec-ix-hidden: hidden-fact-294">-</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b style="-sec-ix-hidden: hidden-fact-295">-</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b style="-sec-ix-hidden: hidden-fact-296">-</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-style: normal; font-weight: normal">Accumulated
    Depreciation</span></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-297">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-298">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-299">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-300">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-301">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-302">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-303">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Net book amount</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-304">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-305">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-306">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-307">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-308">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-309">-</div></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-310">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">Year ended June 30, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Opening net book amount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-311">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-312">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-313">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-314">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-315">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-316">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-317">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 30%">Additions</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">10,617</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-318">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-319">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-320">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-321">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-322">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">10,617</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Closing net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: right">10,617</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-323">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-324">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-325">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-326">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-327">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">10,617</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">As of June 30, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt">Cost</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,617</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-328">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-329">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-330">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-331">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-332">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,617</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated Depreciation</td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-333">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-334">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-335">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-336">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-337">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-338">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-339">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">10,617</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-340">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-341">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-342">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-343">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-344">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">10,617</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
ended June 30, 2022</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; text-align: left">Opening net book amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right">10,617</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-345">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-346">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-347">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-348">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-349">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right">10,617</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Depreciation (i)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(1,699</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-350">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-351">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-352">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-353">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-354">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(1,699</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Closing net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">8,918</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-355">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-356">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-357">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-358">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-359">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">8,918</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">As of June 30, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; font-size: 10pt; padding-left: 0.125in; text-indent: -0.125in; font-weight: normal; font-style: normal">Cost</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,617</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-360">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-361">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-362">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-363">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-364">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,617</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated Depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,699</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-365">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-366">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-367">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-368">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-369">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,699</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">8,918</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-370">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-371">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-372">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-373">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-374">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">8,918</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">Year ended June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Opening net book amount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,918</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-375">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-376">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-377">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-378">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-379">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,918</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Acquisitions through business combinations, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-380">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,464</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,154</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49,281</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,633</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,055,494</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,138,026</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Effect of changes in foreign exchange rates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-381">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">176</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">340</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,277</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,819</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-382">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-383">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-384">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,143</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,681</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-385">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,824</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Depreciation (i)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,699</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,603</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(106</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,160</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(699</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(22,238</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(27,505</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Closing net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: right">7,219</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">24,037</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">5,083</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">57,604</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">7,606</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,040,533</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,142,082</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">As of June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,617</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,640</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,189</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">58,764</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,305</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,062,771</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,171,286</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated Depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,398</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,603</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(106</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,160</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(699</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(22,238</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(29,204</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: right">7,219</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">24,037</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">5,083</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">57,604</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">7,606</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,040,533</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,142,082</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(i)</td><td style="text-align: justify">The depreciation charge is included in Administrative expenses
and Cost of sales (see notes 24 and 26).</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS16_g73-79_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417445216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInGoodwillAbstract', window );"><strong>Goodwill [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGoodwillExplanatory', window );">Goodwill</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 8. Goodwill</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: center; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt">Goodwill</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">251,440</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-386">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Goodwill</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">251,440</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-387">&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">As of June 30, 2023, no
goodwill impairment losses were recognized.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417549024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right of Use of Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RightofUseOfAssetsAbstract', window );"><strong>Right-of-Use of Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory', window );">Right-of-use of assets</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 9. Right-of-use
of assets</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: center">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Land</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">As of June 30, 2022</td><td>&#160;</td>
    <td style="text-align: left"><b>$</b></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-388">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 88%; text-align: left">Acquisitions through business combinations (i)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">43,507</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Effect of changes in foreign exchange rates</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">299</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">As of June 30, 2023</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">43,806</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.25in">(i)</td><td style="text-align: left">Through the ValoraSoy acquisition, the Group acquired a parcel of land for an original amount of $ 43,507.</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_RightofUseOfAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_RightofUseOfAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417515712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Non-Current Receivables<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentReceivablesAbstract', window );"><strong>Other Non-Current Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory', window );">Other non-current receivables</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 10. Other non-current
receivables</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30, <br/>
2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt">Receivables with shareholders</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">8,763,027</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">-</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Other Non-Current receivables</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">8,763,027</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Moolec Science Limited
issued an aggregate number of Moolec Science Limited ordinary shares equal to 2,354,069 (or 1,500,000 of Moolec Science SA shares after
the transaction) to current individual shareholders of Bioceres S.A., and Bioceres Group PLC, (&#8220;New shareholders&#8221;) Moolec
and the new shareholders entered into a subscription agreement (the &#8220;shareholders&#8217; subscription agreement&#8221;) prior to
the transaction pursuant to which Moolec Science Limited agreed to issue 2,354,069 of Moolec Science Limited ordinary shares. The new
shareholders agreed to pay an aggregate purchase price of $15,000,000 within 5 years from the date of such subscription agreement. Such
shareholders&#8217; subscription agreement accrues an internal rate of return of 13.20%.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other non-current assets. [Refer: Other non-current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417675104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and Cash Equivalents<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory', window );">Cash and cash equivalents</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 11. Cash and cash
equivalents</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">For the purposes of preparing
the Consolidated Statements of Financial Position and Statement of Cash Flows, the item &#8220;Cash and Cash Equivalents&#8221; includes
cash on hand and in banks and short-term highly liquid investments that can be readily convertible to known amounts of cash and they are
subject to insignificant risk of changes in value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Bank overdrafts are classified
as &#8220;Financial Debt&#8221; in the Consolidated Statement of Financial Position.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Cash and cash equivalents
at each year-end, as disclosed in the Consolidated Statement of Cash Flows, may be reconciled against the items related to the Consolidated
Statement of Financial Position as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30, <br/>
2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30, <br/>
2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Cash</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,443</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Bank accounts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,061,636</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,081,808</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Short-term investments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">463,594</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total cash and cash equivalents</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,527,673</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,081,808</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417592480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short Term Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShortTermInvestmentAbstract', window );"><strong>Short-Term Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory', window );">Short term investments</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 12. Short-term
investments</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">As of<br/>
 June 30,<br/>
</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt">Mutual funds</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">306,034</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-389">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Short-term investments</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">306,034</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-390">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of investments accounted for using the equity method. [Refer: Investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShortTermInvestmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShortTermInvestmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539416666528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade Receivable and Other Current Receivables<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract', window );"><strong>Trade Receivable and Other Current Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory', window );">Trade Receivable and Other current receivables</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 13. Trade Receivable
and Other current receivables</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30, <br/>
2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt">Accounts receivable</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">361,097</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-391">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Trade receivable</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">361,097</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-392">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30, <br/>
2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left">Taxes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">952,953</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-393">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">377,224</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-394">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Other current receivables</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,330,177</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-395">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The book value is reasonably
approximate to the fair value given its short-term nature.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other receivables. [Refer: Trade and other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539427227632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfInventoriesAbstract', window );"><strong>Inventories [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInventoriesExplanatory', window );">Inventories</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 14. Inventories</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30, <br/>
2023</td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left">Raw materials</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">179,368</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-396">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Finished goods</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">286,380</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-397">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Inventories</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">465,748</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-398">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInventoriesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS02_g36-39_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInventoriesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417592480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital and Share Premium<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareCapitalAndSharePremiumAbstract', window );"><strong>Share Capital and Share Premium [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory', window );">Share capital and share premium</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 15. Share capital
and share premium</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">As of June 30, 2023, the
share capital stock and share premium amounts to $ 66,996,982.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><i>Reconciliation of share
capital and share premium</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><i>&#160;</i></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Number <br/>
of<br/>
 shares</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Shares<br/>
 issued<br/>
 amount</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Shares<br/>
 to be <br/>
issued<br/>
 amount</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Share <br/>
Premium</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Opening Balance as of August, 2020</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-399">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-400">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-401">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-402">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; width: 52%; text-align: left; padding-bottom: 1.5pt">Issue of share capital</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">29,140,000</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">291,400</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-403">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">4,308,600</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>Balance as of December, 2020</b></span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">29,140,000</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">291,400</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-404">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">4,308,600</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Issue of share capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,860,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,600</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-405">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,981,400</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Balance as of June 30, 2021</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">31,000,000</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">310,000</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-406">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">7,290,000</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Issue of share capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-407">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-408">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-409">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-410">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Balance as of&#160;&#160;June 30, 2022</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">31,000,000</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">310,000</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-411">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">7,290,000</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Issue of share capital (Moolec Science shares)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,500,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-412">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,105,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Issue of share capital (SAFE shares)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-413; font-family: Times New Roman, Times, Serif">&#160;262, 260</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,623</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-414">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,170,723</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Issue of share capital (LightJump shares)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,363,810</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,639</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-415">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39,610,630</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Issue of share capital (Backstop shares)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,201,656</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,017</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-416">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,999,023</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Issue of share capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,519</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-417">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,647</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">From business acquisition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-418">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-419">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">641</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">217,275</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Equity settled share based payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">232,523</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,326</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,427</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">593,684</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Balance as of June 30, 2023</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">37,563,768</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">375,641</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">3,068</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">66,996,982</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="text-decoration:underline">Share Purchase Agreement
</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On April 14, the Company
entered into a Share Purchase Agreement with Nomura Securities International, Inc (&#8220;Nomura&#8221;). The Agreement provides for a
committed equity financing facility under which the Company has the option, but not the obligation, to sell up to the equivalent of $50
million in aggregate gross purchase price of its ordinary shares to Nomura over a 36-month period, subject to the terms of the Agreement.
The Company intends to use the proceeds from any future sales of securities under the financing facility, if it is utilized, for general
corporate purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Sales of ordinary shares
to Nomura, and the timing of any such sales, will be determined by the Company from time to time in its sole discretion and will depend
on a variety of factors, including, among other things, market conditions, the trading price of the ordinary shares and determinations
by the Company regarding the use of proceeds from any sale.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As of June 30, 2023 only
3,600 shares (equivalent to $10,647) were issued under the Share Purchase Agreement.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share capital, reserves and other equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShareCapitalAndSharePremiumAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShareCapitalAndSharePremiumAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417481072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Based Payment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareBasedPaymentAbstract', window );"><strong>Share Based Payment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory', window );">Share Based Payment</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 16. Share based
payment</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Under the share-based
compensation plan, some employees and members of the executive management team as defined by the Board of Directors, were granted share
options or restricted stock units (&#8220;RSU&#8221;) in return for their services to the Group.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">As of June 30, 2023, Moolec
had the following shared-based payment arrangements:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Share option plan for
executives and senior management:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Group 1 granted up to 579,078 underlying ordinary shares.
The options have an exercise price of $1.52 and expire in December 2030 (except one case in June 2031).</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Group 2 granted up to 346,555 underlying ordinary shares.
The options have an exercise price of $8.00 and expire in December 2030.</td>
</tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Group 3 granted up to 700,000 underlying ordinary shares.
The options have an exercise price of $4.25. Five of them expire in January 2033 and the other two in March 2033.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The fair value is defined
as the actuarial expected value of the future benefits under the Plan calculated at the date in which benefits are granted and it is estimated
using the option valuation method known as &#8216;binomial trees&#8217;. The estimate considers the effects of rotation, the vesting schedule
and the possible dilutive effect of the future exercise of options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-indent: 0in; font-weight: bold; text-align: left">Factor</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Group 1</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Group 2</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Group 3</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; width: 64%; text-align: left">Fair value of shares</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2.97</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left">Exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-420">1.52</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-421">8.00</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-422">4.25</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left">Dividend rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-423">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-424">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-425">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left">Reference risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.00</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.00</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.25</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left">Plan duration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10 years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10 years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10 years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left">Fair value of stock options at measurement date</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">9.11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7.25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.04</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">There are no market-related
performance conditions or non-vesting conditions that should be considered for determining the fair value of options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Moolec Science estimates
an expected rotation of 2.00% annually at constant value, taking into account historical patterns of executives maintaining their jobs
and the probability of exercising the options. This estimate is reviewed at the end of each annual or interim period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The following table shows
the amount and exercise price and the movements of the stock options of executives and managers of the Group for the period ended June
30, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; white-space: nowrap; text-indent: 0in; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">June 30, 2023</td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; text-indent: 0in; padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Group 1</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Group 2</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Group 3</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; text-indent: 0in; padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Number<br/>
 of<br/>
 options</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Exercise <br/>
price</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Number <br/>
of<br/>
 options</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Exercise <br/>
price</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Number <br/>
of<br/>
 options</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Exercise <br/>
price</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: 0in">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left">At the beginning</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-426">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-427">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-428">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-429">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-430">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-431">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; width: 28%; text-align: left">Granted during the period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">579,078</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1.52</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">346,555</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">700,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4.25</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left">Forfeited during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-432">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-433">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-434">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-435">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-436">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-437">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left">Exercised during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">253,252</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.52</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">139,957</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">8.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-438">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-439">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left">Expired during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-440">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-441">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-442">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-443">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-444">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-445">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in">At the ending</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">325,826</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.52</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">206,598</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">8.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">700,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4.25</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">The charge of the plans
based on options recognized during the period was $508,149.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 44<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_44&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShareBasedPaymentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShareBasedPaymentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417515712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Other Current and Non-Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesLineItems', window );"><strong>Accounts Payable and Other Current and Non-Current Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory', window );">Accounts Payable and other current and non-current liabilities</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 17. Accounts Payable
and other current and non-current liabilities</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Transaction expenses payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,579,057</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">485,735</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">774,460</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">385,508</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">787,010</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">190,843</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Trade payables</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,339,087</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">164,127</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Accounts payable</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">7,479,614</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,226,213</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30, <br/>
2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left">Related parties</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">677,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-446">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Deferred payment related to Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">492,799</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-447">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Wages</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">221,141</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-448">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,783</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-449">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Pay As You Earn (PAYE)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,551</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,171</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">271,371</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-450">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Other current liabilities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,685,645</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,171</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The book value is reasonably
approximate to the fair value given its short-term nature.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30, <br/>
2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30, <br/>
2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt">Others</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">175,312</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-451">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Other non-current liabilities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">175,312</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-452">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for trade and other payables. [Refer: Trade and other payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417577984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsAbstract', window );"><strong>Financial Debt [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDebtSecuritiesExplanatory', window );">Financial debt</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 18. Financial
debt</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left">Financial Debt denominated in Argentine Pesos</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">517,743</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-453">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Financial Debt denominated in US Dollars</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,028,500</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-454">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Current Financial Debt</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,546,243</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-455">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The book value is reasonably
approximate to the fair value given its short-term nature.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30, <br/>
2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt">Financial Debt denominated in Argentine Pesos</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">99,046</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-456">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Non-current Financial Debt</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">99,046</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-457">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The terms and conditions
of outstanding loans are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Bank entity</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Currency of<br/>
 denomination</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nominal<br/>
 value<br/>
 (equivalent<br/>
 in USD)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nominal<br/>
 interest<br/>
 rate</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Date of<br/>
 maturity</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 28%; text-align: left; padding-bottom: 1.5pt">Banco Macro - pre-financing of exports</td><td style="width: 0.5%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 8%; text-align: center; padding-bottom: 1.5pt">ARS</td><td style="width: 0.5%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 8%; text-align: right">147,874</td><td style="width: 0.5%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 0.5%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">67% - 88 </span></td><td style="white-space: nowrap; width: 0.5%; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="width: 0.5%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 25%; text-align: center; padding-bottom: 1.5pt">07/17/2023-12/27/2023</td><td style="width: 0.5%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 8%; text-align: right">173,236</td><td style="width: 0.5%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 0.5%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 8%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-458">-</div></td><td style="width: 0.5%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Banco Naci&#243;n - pre-financing of exports</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">USD</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,500</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">10/6/2023</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,635</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-459">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Banco C&#243;rdoba - pre-financing of exports</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">ARS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">142,567</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">55% - 88 </span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">01/11/2023 - 06/26/2023</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">156,057</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-460">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Banco Galicia - bank overdrafts</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">ARS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,849</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">144</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">06/30/2023</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,849</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-461">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">HSBC Bank - bank overdrafts</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">ARS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,625</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">108</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">06/30/2023</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,625</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-462">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Banco Santander - bank overdrafts</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">ARS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41,325</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">161</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">06/30/2023</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44,446</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-463">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Banco Galicia - loans</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">ARS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">99,643</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">35%
- 85 </span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">08/21/2023 - 01/25/2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,728</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-464">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">HSBC Bank - loans</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">ARS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,508</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">64</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">07/27/2023</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,940</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-465">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Banco Santander - loans</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">ARS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">119,001</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">50%
- 57 </span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">09/03/2026 - 03/04/2027</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118,185</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-466">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Banco Macro - loans</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">ARS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,705</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">54</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">7/12/2023</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,257</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-467">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Promissory notes</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">USD</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,000,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">05/22/2024 - 06/25/2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,000,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-468">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Asociaci&#243;n mutual AMA &#8211; loans</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">ARS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,316</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">53</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">07/10/2023 - 04/10/2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51,331</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-469">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">Interest rates of our outstanding loans in ARS, correspond
to market rates in the country of incorporation of our newly acquired subsidiary, which deems to be a hyperinflationary economy.</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDebtSecuritiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of debt instruments. [Refer: Debt instruments issued; Debt instruments held]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDebtSecuritiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417597200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_WarrantsLiabilitiesAbstract', window );"><strong>Warrants Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory', window );">Warrants liabilities</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 19. Warrants liabilities</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Each of the Warrants
to purchase an aggregate of 11,110,000 Ordinary Shares are exercisable to purchase one Ordinary Share and only whole warrants are exercisable.
The exercise price of the Warrants is $11.50 per share. A Warrant may be exercised only during the period commencing on the date of the
consummation of the transactions contemplated by the Business Combination Agreement and terminating on the earlier to occur of: the date
that is five (5) years after the date on which the Business Combination is completed or the liquidation of the Company. Redemptions of
warrants for cash once the public warrants become exercisable, may be redeemed (i) in whole and not in part, (ii) at a price of $0.01
per warrant, (iii) upon not less than 30 days&#8217; prior written notice of redemption to each warrant holder, and (iv) if, and only
if, the reported last sale price of the Ordinary Shares equals or exceeds $18.00 per share for any 20 trading days within a 30-trading
day period ending three business days before sending the notice of redemption to each warrant holder. If the public warrants are called
for redemption for cash, management will have the option to require all holders that wish to exercise the public warrants to do so on
a &#8220;cashless basis&#8221;. The private warrants will be treated identical to the public warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Considering that the
fair value as of June 2023 is $0.0799 per Ordinary Share, the valuation of warrants is the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">As of June 30, 2022</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-470">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 88%; text-align: left">Issued by the SPAC</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,666,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Fair value remeasurement (Gain)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(778,811</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">As of June 30, 2023</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">887,689</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">There were no other warrants
outstanding prior to the ones issued by the SPAC.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for warrants. Warrants are financial instruments that give the holder the right to purchase ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_WarrantsLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_WarrantsLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417457312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Simple Agreement for Future Equity (&#8220;SAFE&#8221;)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SimpleAgreementForFutureEquitySafeAbstract', window );"><strong>Simple Agreement for Future Equity Safe [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SimpleAgreementForFutureEquitySAFETextBlock', window );">Simple Agreement for Future Equity (&#8220;SAFE&#8221;)</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 20. Simple Agreement
for Future Equity (&#8220;SAFE&#8221;)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company signed two
simple agreements for future equity (referred to as &#8220;SAFE&#8221; or &#8220;SAFEs&#8221; in plural), in exchange for the payment
by certain investors of the amounts detailed below on or about December 28, 2021. Both SAFEs were signed with two different investors
and for the following amounts:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">One SAFE was signed with
THEO 1 SCSp for the amount of $1,500,000, from which $1,000,000 was received on January 5, 2022 and $500,000 were received on June 30,
2022.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The other SAFE was signed
with SERENITY TRADERS LDT, for the amount of $500,000, fully received on January 6, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Both SAFEs give the investors,
in exchange for the payment of the mentioned amounts, the right to a variable number of shares on the Company&#8217;s Share Capital&#160;subject
to the occurrence of a qualified event or a twelve months maturity, whatever happens before, and in the case of a qualified event, specifically
the shares of the series of equity securities issued to the investors investing new money in the Company in connection with the closing.&#160;These
qualified events are defined as Equity Financing of not less than $20,000,000, Change&#160;of Control, a Direct Listing, an Initial Public
Offering or a De-SPAC Transaction.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The De-SPAC transaction
occurred on December 30, 2022 and defined as a qualified event pursuant the agreement, converted the SAFE in 262,260 shares of the Company
at a purchase price on $ 12.10 for a total of $3,173,346.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The following table presents
the changes in Level 3 financial instruments as of June 30 of each year:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-weight: bold; text-align: left; padding-bottom: 1.5pt">At the beginning</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right">2,860,000</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-471">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-472">&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-473">&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additions</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-474">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-475">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-476">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Results on the change of Fair Value of the SAFE (i)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">313,346</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">860,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-477">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-478">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">SAFE Capitalization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,173,346</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-479">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-480">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-481">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">At the end</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-482">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,860,000</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-483">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-484">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(i)</td><td style="text-align: justify">The result due to the change in the fair value of the SAFE
was included in &#8220;Other financial Results&#8221;.</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SimpleAgreementForFutureEquitySAFETextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SimpleAgreementForFutureEquitySAFETextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SimpleAgreementForFutureEquitySafeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SimpleAgreementForFutureEquitySafeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417597200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Tax and Income Tax<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxandIncomeTaxLineItems', window );"><strong>Deferred Tax and Income Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIncomeTaxExplanatory', window );">Deferred tax and income tax</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 21. Deferred tax
and income tax</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The roll forward of net
deferred tax as of June 30, 2023, 2022, 2021 and 2020 is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2022</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2021</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2020</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Balance at beginning of year</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-485">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-486">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-487">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-488">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: justify">Incorporated through the business combination</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,297,436</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-489">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-490">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-491">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Credited to profit &amp; loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(234,542</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-492">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-493">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-494">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Charged to Other Comprehensive Income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,913</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-495">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-496">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-497">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Balance at year end</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">1,071,807</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-498">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-499">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-500">-</div></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Principal statutory taxes
rates in the countries where the Group operates for all the years presented are:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold"></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Income tax rate</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>Tax Jurisdiction</b></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Argentina</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%-35</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-501">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-502">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-503">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%">Luxembourg</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">15</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-504">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-505">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-506">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">United Kingdom</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">United States of America</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21</td><td style="text-align: left">%</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><i>&#160;</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration:underline">Reconciliation
of effective tax rate</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group&#8217;s reconciliation
of the effective tax rate is based on its domestic tax rate, with a reconciling item in respect of tax rates applied by Group companies
in other jurisdictions.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The tax rate used for
2023 represents the corporate tax rate of 15% from Luxembourg on the taxable income payable by the Group, in accordance with the tax laws
of said jurisdiction. Income tax for other jurisdictions is calculated based on the substantially enacted nominal tax rates prevailing
in the respective jurisdictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December&#160;30, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left; padding-bottom: 1.5pt">Loss before tax</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"><span style="font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"><span style="font-style: normal; font-weight: normal">(52,023,422</span></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-style: normal; font-weight: normal">)</span></td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(4,526,905</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(1,986,814</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(320,524</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Corporate tax rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Income tax (benefit)/expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,803,513</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">860,112</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">377,495</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">60,900</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Effect of difference tax rates subsidiaries operating in other jurisdictions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">428,506</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-507">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-508">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-509">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Tax losses (i)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,631,947</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(860,112</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(377,495</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(60,900</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Non-deductible expenses - listing cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,405,759</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-510">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-511">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-512">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net gain on inflation effect on monetary items</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52,914</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-513">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-514">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-515">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Income tax inflation adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(35,826</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-516">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-517">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-518">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">23,141</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-519">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-520">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-521">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Tax benefit for the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">234,542</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-522">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-523">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-524">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 17.85pt">(i)</td><td style="text-align: justify">Deferred tax assets have not been recognized, because it is not probable that future taxable profit will
be available against which the Group can use the benefits therefrom.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration:underline">Deferred tax</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Deferred tax assets and
liabilities are recognized when the carrying amount of an asset or liability in the Consolidated statement of financial position differs
from its tax base, except for differences arising on the initial recognition of goodwill.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Net deferred tax liabilities
are comprised of the following amounts:</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">Deferred tax asset</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify; padding-bottom: 1.5pt">Tax loss carry-forward</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">292,267</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-525">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total other receivables</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">292,267</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-526">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">Deferred tax liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Customer relationship</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,346,374</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-527">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Other tax liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,700</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total deferred tax liability</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,364,074</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-528">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">&#160;Net deferred tax liability</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,071,807</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-529">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The following table shows
the expiration date of the recognized accumulated tax loss carryforwards pursuant to statutes of limitations:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Fiscal year</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tax-loss<br/>
 carry<br/> forward</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Deferred <br/> tax asset</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Expiration<br/> date</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tax<br/> jurisdiction</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">10,980</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,843</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: center">2027</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center; padding-left: 5.4pt">Argentina</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">2023</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">824,069</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">288,424</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">2028</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt">Argentina</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">835,049</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">292,267</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt; text-align: center">&#160;</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="text-align: right; padding-bottom: 4pt; padding-left: 5.4pt">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>Unrecognized deferred
tax assets </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">As
of June 30, 2023 and 2022 deferred tax assets relating to the operating company in the UK, Luxembourg, Argentina (Moolec Science S.E.)
and United States of America aren&#8217;t recognized because it is not probable that future taxable amounts will be available to utilize those
temporary differences and losses. Therefore, in the present Consolidated Financial Statements, the Company decided not to recognize deferred
income tax assets generated by the tax loss carry forward for the periods ended on June 30, 2023 and 2022 for the amounts of </span>$<span style="font-family: Times New Roman, Times, Serif">1,631,947
and $ 860,112 respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Deferred tax assets have
not been recognized in respect of the following items, because it is not probable that future taxable profit will be available against
which the Group can use the benefits therefrom:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Tax losses per country</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tax effect</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tax effect</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tax effect</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tax effect</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 20%; text-align: justify; padding-bottom: 1.5pt">United Kingdom</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">3,641,516</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">691,888</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">4,526,905</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">860,112</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">1,986,814</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">377,495</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">320,524</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">60,900</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Luxembourg</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,267,560</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">620,837</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Argentina</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,484,790</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">282,110</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">United States of America</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">195,328</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">37,112</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">8,589,194</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,631,947</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">4,526,905</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">860,112</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,986,814</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">377,495</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">320,524</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">60,900</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS12_g79-88_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DeferredTaxandIncomeTaxLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DeferredTaxandIncomeTaxLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539412570784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Income / Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeExpenseGainsOrLossesOfFinancialInstrumentsAbstract', window );"><strong>Financial income / expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory', window );">Financial income / expenses</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify">Note
22. Financial income / expenses</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 December&#160;30,<br/>
 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">Financial Costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Interest expense</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(160,035</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(2,130</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-530">&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-531">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Financial Costs</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right">(160,035</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right">(2,130</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-532">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-533">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Other financial results</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Exchange rate difference</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,386,599</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12,342</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-534">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-535">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of Simply Agreement for Future Equity (&#8220;SAFE&#8221;) - Loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(313,346</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(860,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-536">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-537">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Investment gain related to money market funds</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,009,318</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-538">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-539">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-540">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">778,811</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-541">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-542">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-543">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Interest gain (Shareholders loan)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">693,027</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-544">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-545">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-546">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Inflation adjustment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">245,989</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-547">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-548">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-549">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,325</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-550">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-551">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-552">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Other financial results</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,030,525</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(872,342</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-553">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-554">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total net financial income / expenses</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">870,490</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(874,472</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-555">-</div></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-556">-</div></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of finance income (cost). [Refer: Finance income (cost)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeExpenseGainsOrLossesOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeExpenseGainsOrLossesOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417549024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Operating Expense<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OtherOperatingExpenseLineItems', window );"><strong>Other Operating Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory', window );">Other operating expense</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Note 23. Other operating
expense</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 December&#160;31,<br/>
 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Taxes, duties and penalties</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(62,263</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-557">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-558">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-559">-</div></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Miscellaneous expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(31,944</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(38,985</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(93,252</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(2,639</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total other operating expense</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(94,207</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(38,985</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(93,252</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(2,639</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other operating income or expense. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_OtherOperatingExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_OtherOperatingExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417407136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Administrative Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract', window );"><strong>Administrative Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory', window );">Administrative Expenses</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Note 24. Administrative
expenses</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 December&#160;31,<br/>
 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Audit. legal and accountancy fees</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(2,024,611</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(1,355,046</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(635,173</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(125,867</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Employee Stock Option Plan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,166,755</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(838,576</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-560">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-561">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Payroll Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(880,830</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(254,215</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,544</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-562">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(428,947</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-563">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-564">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-565">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Travel Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(102,305</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(52,532</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(332</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-566">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(92,818</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-567">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-568">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-569">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,107</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-570">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-571">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-572">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other office and admin expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(108,282</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(22,861</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(174,897</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,019</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">Total Administrative expenses</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(4,808,655</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(2,523,230</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(820,946</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(127,886</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of general and administrative expenses. [Refer: Administrative expenses]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417577984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and Development Expense<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ResearchandDevelopmentExpenseLineItems', window );"><strong>Research and Development Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory', window );">Research and development expense</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Note 25. Research
and development expense</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 December&#160;31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Professional fees</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(886,628</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(373,259</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(75,189</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-573">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Laboratories&#8217; related expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(434,551</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(449,442</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(526,753</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-574">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,699</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,699</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-575">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-576">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other research and development expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(28,339</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(160,758</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-577">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(179,061</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">Total Research and development expenses</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(1,351,217</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(985,158</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(601,942</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(179,061</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for research and development expense. [Refer: Research and development expense]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ResearchandDevelopmentExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ResearchandDevelopmentExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417407136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cost of sales<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CostOfSalesAbstract', window );"><strong>Cost of Sales [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCostOfSalesExplanatory', window );">Cost of sales</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 26. Cost of sales</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 December&#160;31,<br/>
 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Inventories at beginning</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-578">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-579">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-580">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-581">&#160;&#160;&#160;&#160;&#160;-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left">Inventories incorporated through the business combination</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(532,231</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-582">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-583">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-584">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Purchases</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(788,751</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-585">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-586">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-587">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Production costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; font-style: italic; text-align: left">Payroll and and professional fees</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">(121,285</td><td style="font-style: italic; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-588">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-589">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-590">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; font-style: italic; text-align: left">Maintenance, energy and fuel related to fixed assets</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">(77,495</td><td style="font-style: italic; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-591">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-592">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-593">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; font-style: italic; text-align: left">Amortization and depreciation</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">(23,398</td><td style="font-style: italic; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-594">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-595">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-596">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; font-style: italic; text-align: left">Other production costs</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">(31,050</td><td style="font-style: italic; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-597">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-598">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-599">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; font-style: italic; text-align: left">Sub-total Production costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(253,228</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-600">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-601">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-602">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency translation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">60,108</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-603">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-604">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-605">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Sub-total</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(1,514,102</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-606">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-607">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-608">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Inventories as of the end</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">465,748</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-609">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-610">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-611">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Cost of sales</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(1,048,354</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-612">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-613">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-614">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCostOfSalesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the cost of sales. [Refer: Cost of sales]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCostOfSalesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CostOfSalesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CostOfSalesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417521888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NetLossperShareLineItems', window );"><strong>Net Loss per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory', window );">Net loss per share</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 27. Net loss per
share</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Basic loss per share
is computed using the weighted-average number of ordinary shares outstanding during the year. Diluted net loss per share is computed using
the weighted-average number of ordinary shares and potentially dilutive, ordinary share equivalents outstanding during the year. The Group&#8217;s
basic and diluted loss per ordinary share are the same because the Group has generated net loss to ordinary shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The following table presents
the calculation of basic and diluted loss per ordinary share for the year ended on June 30, 2023 and June 30, 2022 as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif"><b>Loss attributable to ordinary shareholders (basic and diluted)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Numerator</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31,<br/>
 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left">Loss for the year, attributable to the owners of the Group</td><td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(51,788,880</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left">)</td><td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(4,526,905</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left">)</td><td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(1,986,814</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left">)</td><td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(320,524</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 4pt; padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Loss attributable to the ordinary shareholders</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(51,788,880</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(4,526,905</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(1,986,814</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(320,524</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0"><b>Weighted-average number of ordinary shares (basic and diluted)</b></p>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Denominator</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31,<br/>
 2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Weighted-average number of ordinary shares</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">34,466,258</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">31,000,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">30,239,558</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">29,140,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Net loss attributable to ordinary shareholders per share</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31,<br/>
 2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -0.125in; padding-left: 0.125in"><div style="-sec-ix-hidden: hidden-fact-618; -sec-ix-hidden: hidden-fact-617; -sec-ix-hidden: hidden-fact-616; -sec-ix-hidden: hidden-fact-615">Basic and Diluted</div></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(1.50</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(0.15</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(0.07</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(0.01</td><td style="width: 1%; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS33_g70-73A_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NetLossperShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NetLossperShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417512480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RelatedPartiesLineItems', window );"><strong>Related Parties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRelatedPartyExplanatory', window );">Related parties</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 28. Related parties</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Balances and transactions
between the Group entities, which are related parties, have been eliminated on consolidation and are not disclosed in this note. Transactions
between the Group and its directors and/or executive board members and the Company and the Parent are disclosed below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Transactions with
key management personnel </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Key management personnel
compensation comprised:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Other Related Party
Transactions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-style: italic; text-align: left">In USD ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31,<br/>
 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Short-term employee benefits</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">39,250</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">96,437</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">109,205</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">38,355</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Share based payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">904,861</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">838,576</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-619">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-620">-</div></td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Other Related Party
Transactions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>In USD ($)</i></b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note</b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended<br/>
June 30,<br/>
2023</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended <br/>
June 30,<br/>
2022</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>From the period<br/>
of January 1,<br/>
2021 through<br/>
June 30,<br/>
2021</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>From the period of August 21, 2020 through December&#160;31,<br/>
2020</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share based payment</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 40%; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key management</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">904,861</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">838,576</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-621; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-622; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CFO Shares Alloted</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">364,014</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-623; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-624; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-625; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issue of Additional Shares</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue of share capital</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-626; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-627; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-628; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue of share premium</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,610,630</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-629; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-630; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-631; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent of the Company &#8211; Bioceres Crop Solutions Corp</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-632; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-633; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,000,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-634; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent of the Company &#8211; Union Group Ventures</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-635; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-636; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-637; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent of the Company &#8211; BG Farming Technologies</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-638; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-639; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-640; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Company&#8217;s Cash Balance in Other&#8217;s Accounts</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent of BF Farming Technologies &#8211; Bioceres S.A.</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-641; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-642; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-643; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">300,000</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100% Subsidiary of Bioceres S.A. &#8211; Bioceres LLC</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-644; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-645; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">300,000</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expenses Paid on Behalf of the Company</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent of BG Farming Technologies - Bioceres S.A.</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-646; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">265,810</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">509,628</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">244,029</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100% Subsidiary of Bioceres S.A. - Bioceres LLC</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">238,121</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">156,760</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">453,282</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56,863</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Services Provided by Other Companies</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30% owned by Bioceres S.A. - INMET S.A.- Ingenieria Metabolica S.A</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">286</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">252</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">144,530</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">160,390</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98.6% owned by Bioceres S.A. - INDEAR S.A.- Instituto de Agrobiotecnolog&#237;a Rosario</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">258,279</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,047</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">129,695</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,540</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned by Bioceres S.A. - Agrality Inc.</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85,435</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-647; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-648; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Founded and operated by the Company&#8217;s CPO - Future Foods B.V.</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85,880</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">94,857</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,958</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,801</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moolec Science S.A. Shareholders</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">693,027</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-649; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-650; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-651; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THEO I SCSp</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-652; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,500,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-653; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-654; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.35in">(i)</td><td style="text-align: justify">Expenses paid by Bioceres LLC on behalf of the Company.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.35in">(ii)</td><td style="text-align: justify">The Company entered into an agreement with INMET S.A.- Ingenieria Metabolica S,A through which it would
receive research services in exchange for payment.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.35in">(iii)</td><td style="text-align: justify">The Company entered into an agreement with INDEAR S.A.- Instituto de Agrobiotecnologia Rosario where it
would receive research services in exchange for payment.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.35in">(iv)</td><td style="text-align: justify">The Company entered into an agreement with Agrality Inc, for the provision of services.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.35in">(v)</td><td style="text-align: justify">The Company entered into an agreement with Future Foods B.V. for the provision of services.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.35in">(vi)</td><td style="text-align: justify">Shares issue related to share based payment already vested.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.35in">(vii)</td><td style="text-align: justify">The Company entered into an agreement with shareholders which accrues an internal rate of return.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Other Related Party
Balances</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">In USD ($)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Balance<br/> outstanding<br/> as of<br/> June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Balance<br/> outstanding<br/> as of<br/> June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt">100% Subsidiary of Bioceres S.A. <span style="-sec-ix-hidden: hidden-fact-655">-</span> Bioceres LLC</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(623,629</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(385,508</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Moolec S.A. Shareholders</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,763,027</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-656">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Union Group Ventures Limited</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(677,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-657">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">INDEAR S.A.</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(72,494</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-658">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Future Foods B.V</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(78,337</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-659">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRelatedPartyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Section Disclosures<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS24_g13-24_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRelatedPartyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_RelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_RelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417686640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Risk Management<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract', window );"><strong>Financial Risk Management [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory', window );">Financial risk management</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 29. Financial risk
management</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group&#8217;s activities
are subject to several financial risks: market risk (including the exchange rate risk, the interest rate risk and price risk), credit
risk and liquidity risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The following matters
have been considered by Management in determining the appropriateness of the going concern basis of preparation of the accompanying Consolidated
Financial Statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><b>a)</b></td><td style="text-align: justify"><b>Credit risk</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Credit risk is the risk
of financial loss to the Group if the counterparty to a financial instrument fails to meet its contractual obligations. Financial instruments
held by the Group that are potentially subject to concentration of credit risk are primarily cash and receivables, the latter held as
a result of ValoraSoy Acquisition. Management believes that the credit risk concentrating with respect to cash and amounts receivable
is remote.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The following table sets
forth details of the age of trade and other receivables:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">As at</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">To due become</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt">Up to 3 months</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">450,728</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-660">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><b>b)</b></td><td style="text-align: left"><b>Liquidity risk</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Liquidity risk is the
risk that the Group will encounter difficulty in meeting the obligations affiliated with its financial liabilities that are settled by
delivering cash or another financial asset. The Group&#8217;s approach to managing liquidity is to ensure, as far as possible, that it
will always have sufficient liquidity to meet its liabilities when due, under both normal and stressed conditions, without incurring unacceptable
losses or risking damage to the Group&#8217; s reputation. Given the Group&#8217;s financial position as of June 30, 2023, total current
financial assets $4,524,972 as compared to total financial liabilities of $11,985,860 management expects that the Group will be able to
provide the capital needed to keep the Group liquid and able to fulfill its short-term obligations. Group&#8217;s financial position as
of June 30, 2022, total current financial assets $1,081,808 as compared to total financial liabilities of $1,227,384, which comprised
the SAFE agreement convertible in future Equity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company continuously
monitors and reviews its actual and forecasted cash flows and manages liquidity risk by maintaining adequate cash and cash equivalents,
by utilizing term loans and by monitoring developments in the capital markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The table below analyzes
the Company&#8217;s financial liabilities into relevant maturity groupings based on the remaining period at the balance sheet to the contractual
maturity date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Maturity date</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Within 1<br/>
 year or on<br/>
 demand</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Between 1<br/>
 and 2 years</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Between 2<br/>
 and 5 years</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">More than <br/>
5 years</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Without any<br/>
 established<br/>
 term</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">June 30, 2023</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 28%; text-align: left">Trade Payables</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,479,614</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-661">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-662">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-663">&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-664">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,479,614</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Other liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,776,438</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">180,197</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-665">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-666">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,956,635</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: left">Financial debts</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,578,100</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">72,831</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">108,638</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-667">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-668">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,759,569</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left">Subtotal</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">11,834,152</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">253,028</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">108,638</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-669">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-670">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">12,195,818</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Warrant</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">887,689</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-671">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-672">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-673">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-674">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">887,689</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left">Subtotal</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">887,689</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-675">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-676">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-677">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-678">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">887,689</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">12,721,841</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">253,028</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">108,638</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-679">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-680">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">13,083,507</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">June 30, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Trade Payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,226,213</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-681">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-682">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-683">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-684">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,226,213</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Other liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,171</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-685">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-686">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-687">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-688">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,171</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: left">Simply Agreement for Future Equity (&#8220;SAFE&#8221;)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,860,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-689">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-690">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-691">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-692">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,860,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left">Subtotal</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,087,384</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-693">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-694">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-695">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-696">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,087,384</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,087,384</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-697">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-698">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-699">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,087,384</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><b>c)</b></td><td style="text-align: left"><b>Market risk</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Market risk is the risk
that changes in market prices -e.g. foreign exchange rates, interest rates and equity prices -will affect the Group&#8217;s income or
the value of its holdings of financial instruments including commodity prices and foreign currency exchange rates. The objective of market
risk management is to manage and control market risk exposures within acceptable parameters, while optimizing the return.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><span style="text-decoration:underline">Commodity risk</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In the normal course
of its business, the Company is exposed to risk resulting from fluctuations in the market prices of commodities. The Company does not
engage in transactional hedging of its commodity price risk.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b><i>&#160;</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="text-decoration:underline">Foreign currency exchange
risk</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company is exposed
to foreign exchange risk as a result of transactions being conducted in currencies other than the functional currency of each of the Company
and its subsidiaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company has not entered
into transactions that seek to hedge or mitigate its exposure to exchange rate fluctuations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The carrying amounts
of the Group&#8217;s foreign currency denominated monetary assets and monetary liabilities at the reporting date are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Assets</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Currency</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Argentine pesos</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">765,690</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-700">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">50,073</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-701">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">U.S. Dollar</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">368,186</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-702">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,227,751</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-703">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Pound sterling</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,062</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,025</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-704">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-705">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The following table details
sensitivity to a 10% increase and decrease in the functional currency of each of the companies against the relevant foreign currencies.
The sensitivity analysis includes only the outstanding monetary items denominated in foreign currency and adjusts its conversion at the
end of the period for a 10% change in exchange rates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(+10%) Impact to profit or loss before tax</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(-10%) Impact to profit or loss before tax</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Assets</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Currency</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Argentine pesos</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">76,569</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-706">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(5,007</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-707">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">U.S. Dollar</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36,819</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-708">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(222,775</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-709">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Pound sterling</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,206</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">803</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-710">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-711">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.25in"><b>d)</b></td><td style="text-align: left"><b>Fair value risk</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Fair value and carrying
value of financial instruments:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The following represents
the carrying value and fair value of the Company&#8217;s financial instruments and non-financial derivatives:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Recurring measurements</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Note</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">Financial Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Amortized costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Cash and cash equivalents</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 11%; text-align: center; padding-bottom: 1.5pt">(i)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,064,079</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,081,808</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Trade and other receivables</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">(i)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,454,301</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,061</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Fair value through profit or loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Cash and cash equivalents</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">(ii)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">463,594</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-712">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Short-term investments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">(ii)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">306,034</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-713">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total financial assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">13,288,008</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,083,869</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>

<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><b>Financial Liabilities</b></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Amortized costs</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Trade and other payables</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">(i)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">9,340,571</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">1,227,384</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Financial debt</td>
    <td>&#160;</td>
    <td style="text-align: center">(i)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,645,289</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-714">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Fair value through profit or loss</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Simply Agreement for Future Equity (&#8220;SAFE&#8221;)</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-715">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,860,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Warrant liabilities</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">(ii)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">887,689</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-716">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total financial liabilities</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">12,873,549</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,087,384</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net financial asset /(liability)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">414,459</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(3,003,515</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-size: 10pt">(i)</span></td><td style="text-align: justify">Cash, short-term investments, trade and other receivables, prepayments, trade and other payables, and
loans payable are recorded at carrying value, which approximates fair value due to their short-term nature and generally negligible credit
losses.</td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(ii)</span></td><td style="text-align: justify">Fair value of short-term investment and warrants has been
determined using the quoted market price at the year end (level 1).</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>e) Interest rate risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group&#8217;s financing
costs may be affected by interest rate volatility. Borrowings under the Group&#8217;s interest rate management policy may be fixed or
floating rate. The Group maintains adequate committed borrowing facilities and holds most of its financial assets primarily in cash or
short-term investments that are readily convertible into known amounts of cash.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group&#8217;s interest
rate risk arises from long-term borrowings. Borrowings issued at floating rates expose the Group to cash flow interest rate risk. Borrowings
issued at fixed rates expose the Group to fair value interest rate risk. The Group has not entered into derivative contracts to hedge
this exposure.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Fixed-rate instruments</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Current financial liabilities</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(2,546,243</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-717">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-718">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Non-current financial liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(99,046</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-719">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-720">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Holding all other variables
constant, including levels of our external indebtedness, as of June 30, 2023 a 10% increase/(decrease) in interest rates would increase/(decrease)
interest payable by 11,428/(11,428).</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialRiskManagementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the entity's financial risk management practices and policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialRiskManagementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417647952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Risk Management<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CapitalRiskManagementAbstract', window );"><strong>Capital Risk Management [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfCapitalRiskManagementTextBlock', window );">Capital Risk Management</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 30. Capital risk
management</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company includes
as its capital its share capital and accumulated deficit and has no externally imposed capital requirements. The Company&#8217;s objectives
in managing capital are to safeguard cash as well as maintain financial liquidity and flexibility in order to preserve its ability to
meet financial obligations, deploy capital to develop its mining properties and to maintain investor, creditor and market confidence to
sustain the future development of the business. The Company manages its capital structure and makes adjustments as needed, in order to
have funds available to support its activities. Management reviews its capital management approach on an ongoing basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company&#8217;s financial
strategy is designed to maintain a capital structure consistent with the objective stated above and to respond to business growth opportunities
and changes in economic conditions, In order to maintain or adjust its capital structure, the Company may, from time to time, issue new
shares, acquire or dispose of assets or adjust its capital spending to manage its ability to continue as a going concern. (Note 15).</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CapitalRiskManagementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CapitalRiskManagementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfCapitalRiskManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of capital risk management.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfCapitalRiskManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539426976192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Events after the Reporting Period<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_EventsaftertheReportingPeriodLineItems', window );"><strong>Events after the Reporting Period [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory', window );">Events after the reporting period</a></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">Note 31. Events after
the reporting period</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Management has considered
subsequent events through the date these consolidated financial statements were issued.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As of October 15,
2023, the Company has entered into an agreement to issue a convertible note due 2026 to Grupo Insud (&#8220;Insud&#8221;) in a
principal amount of approximately $21 million (the &#8220;Insud Convertible Note&#8221;) with a strike price of US $6.00 per share.
The Insud Convertible Note will be issued against a cash payment of US $10 million and in-kind contributions to be made by Insud to
Moolec Science. In-kind contributions include credits to access Insud&#8217;s state-of-the-art industrial capabilities, operational
services, and the incorporation of joint agreement participation, started with the Company in the past. At maturity, Moolec Science
will hold the option to deliver ordinary shares, cash, or a combination of cash and ordinary shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The agreement signed
with Insud, follows Moolec Science&#8217;s previous announcement that it entered into a Memorandum of Understanding with Bioceres Crop
Solutions &#8220;BIOX&#8221;) that secures the supply of approximately 15,000 tons of HB4&#174; soybeans (the &#8220;BIOX Supply Agreement&#8221;)
that may be upsized for a similar volume. The BIOX Supply Agreement will be paid through the issuance of a convertible note (the&#160;&#8220;BIOX
Convertible Note&#8217;&#8217;and together with the Insud Convertible Note, the&#160;&#8220;Convertible Notes&#8221;) on arms-length terms to
the Insud Convertible Note.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif">Together,
the Convertible Notes total approximately US $30 million of cash and in-kind contributions that include soybean inventories, operational
services, and the acquisition of joint arrangement participation</span>.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for events after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2023-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IAS10_g17-22_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_EventsaftertheReportingPeriodLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_EventsaftertheReportingPeriodLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539422316032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock', window );">Basis of consolidation of subsidiary</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.1. Basis of
consolidation of subsidiary</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Subsidiaries are entities
controlled by the Company. The financial statements of the Company&#8217;s subsidiaries are included in the Consolidated Financial Statements
from the date that control commences after the acquisition date. The accounting policies of subsidiaries have been changed when necessary
to align them with the policies adopted by the Company.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DescriptionOfAccountingPolicyForForeignCurrencyTextBlock', window );">Foreign currency</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.2. Foreign
currency</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Transactions entered
into by the Group in a currency other than their functional currency are recorded at the relevant exchange rates as of the date upon which
such transactions occur. Foreign currency monetary assets and liabilities are translated at the prevailing exchange rates as of the final
day of each reporting period. Non-monetary assets and liabilities that are measured at fair value in a foreign currency are translated
into the functional currency at the exchange rate when the fair value was determined. Non-monetary items that are measured based on historical
cost in a foreign currency are translated at the exchange rate at the date of the transaction. Exchange differences arising on the retranslation
of unsettled monetary assets and liabilities are recognized immediately through other comprehensive income in the consolidated statements
of operations and are accumulated in equity (attributed to the non-controlling interests when appropriate).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory', window );">Intangible assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.3. Intangible
assets</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Intangible assets include
projects in-progress (mainly related to internally developing products), software, licenses and other rights, and the purchase value of
customer relationships. The accounting policies regarding the recognition and measurement of such intangible assets are described below.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration:underline">Internally Generated
Intangible Assets</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Expenditure&#160;on&#160;internally&#160;developed&#160;products&#160;is&#160;capitalized&#160;if&#160;it&#160;can&#160;be&#160;demonstrated&#160;that:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">It&#160;is&#160;technically&#160;feasible&#160;to&#160;develop&#160;the&#160;product&#160;for&#160;it&#160;to&#160;be&#160;sold;</span></td>
</tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Adequate&#160;resources&#160;are&#160;available&#160;to&#160;complete&#160;the&#160;development;</span></td></tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">There&#160;is&#160;an&#160;intention&#160;to&#160;complete&#160;and&#160;sell&#160;the&#160;product;</span></td></tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The&#160;Group&#160;is&#160;able&#160;to&#160;sell&#160;the&#160;product;</span></td></tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Sale&#160;of&#160;the&#160;product&#160;will&#160;generate&#160;future&#160;economic&#160;benefits;&#160;and</span></td></tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Expenditure&#160;on&#160;the&#160;project&#160;can&#160;be&#160;measured&#160;reliably.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Development expenditure
not satisfying the above criteria and expenditure on the research phase of internal projects are recognized in the consolidated statements
of operations as incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Capitalized development
costs are amortized using the straight-line method over the periods the Group expects to benefit from selling the products developed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Useful&#160;lives&#160;and&#160;amortization&#160;methods&#160;are&#160;reviewed&#160;every&#160;year&#160;as&#160;required&#160;by&#160;IAS&#160;38.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The research and development
process can be divided into several discrete steps or phases, which generally begin with discovery, validation and development and end
with regulatory approval and commercial launch. The process for developing seed traits is relatively similar for both GM and non-GM traits.
However, the two differ significantly in later phases of development. For example, obtaining regulatory approval for GM seeds is a far
more comprehensive and lengthy process than for non-GM seeds. Although breeding programs and industrial biotechnology solutions may have
shorter or simpler phases than those described below, the Group has used the industry consensus for seed-trait development phases to characterize
its technology portfolios, which is generally divided into the following six phases:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">i)</td><td style="text-align: justify">Discovery: The first phase in the technology development
process is the discovery or identification of candidate genes or genetic systems, metabolites, or microorganisms potentially capable
of enhancing specified plant characteristics or enabling an agro-industrial biotech solution.</td>
</tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">ii)</td><td style="text-align: justify">Proof of concept: Upon successful validation of the technologies in model systems (in vitro or in vivo),
promising technologies graduate from discovery and are advanced to the proof of concept phase. The goal of this phase is to validate a
technology within the targeted organism before moving forward with technology escalation activities or extensive field validation.</td></tr>
                                                                                                                                            </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">iii)</td><td style="text-align: justify">Early development: In this phase, efficacy field trials are expanded to evaluate the expression level
and phenological characteristics of the traits in multiple geographies and growing cycles, as well as other characteristics in order to
optimize the technology&#8217;s performance in the targeted organisms. The goal of the early development phase is to evaluate the technical
feasibility by identifying the best candidate to scale up the seed stock and to start the regulatory field trials.</td></tr>
                                                                                                                            </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">iv)</td><td style="text-align: justify">Advanced development and deregulation: In this phase, extensive field tests are used to fully demonstrate
the effectiveness of the technology for its intended purpose. In the case of GM traits, the process of obtaining regulatory approvals
from the government agencies is started, and includes field trials for environmental, core and food safety data generation. For solutions
involving microbial fermentation, industrial-scale runs are conducted.</td></tr></table><p style="margin: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">v)</td><td style="text-align: justify">Pre-launch: This phase involves finalizing the regulatory approval process and preparing for the launch
and commercialization of the technology. The range of activities in this phase includes seed increases, pre-commercial production, and
product and solution testing with selected customers. Usually, a more detailed marketing strategy and preparation of marketing materials
occur during this phase.</td></tr>
                                  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">vi)</td><td style="text-align: justify">Product launch: In general, this phase, which is the last milestone of the research and development process,
is carried out by the Group.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We determined that the
Research &amp; Development is more likely than not (&#8220;probable&#8221;) to become a commercialized product and reach compliance with
IAS 38 criteria items at the end of the phase iii &#8220;Early Development&#8221;, when efficacy field trials are performed to determine
the technical feasibility of the project by measuring parameters like expression level and phenological characteristics. The obtention
of desired values for this set of data represents the strongest and clearest indication that the technical feasibility has been proved.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Impairment testing of
intangible assets not yet available for use requires the use of significant assumptions for the estimation of future cash flows and the
determination of discount rates. The significant assumptions and the determination of discount rates for the impairment testing of goodwill
are further explained below.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Management&#8217;s estimations
about the demonstrability of the recognition criteria for these assets and the subsequent recoverability represent the best estimate that
can be made based on all the available evidence, existing facts and circumstances and using reasonable and supportable assumptions in
cash flow projections. Therefore, the Consolidated financial statements do not include any adjustments that would result if the Group
were unable to recover the carrying amount of the above-mentioned assets through the generation of enough future economic benefits.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Management has made the
estimates considering the cash flow projections projected. The key assumptions utilized are the following:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="border-bottom: Black 1.5pt solid; width: 30%"><span style="font-family: Times New Roman, Times, Serif"><b>Key assumption</b></span></td> <td style="padding-bottom: 1.5pt; width: 1%">&#160;</td> <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 69%"><span style="font-family: Times New Roman, Times, Serif"><b>Management&#8217;s approach</b></span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Discount rate</span></td> <td>&#160;</td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The discount rate used ranges between 10% and 20%</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: middle"><p style="margin-top: 0; margin-bottom: 0"></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Budgeted market share</span></p></td> <td>&#160;</td> <td style="text-align: justify"> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The projected revenue from the products has been estimated by the management based on market penetration data for comparable products and technologies and on future expectations of foreseen economic and market conditions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The value assigned is consistent with external sources of information.</p></td></tr> <tr style="vertical-align: top; background-color: White"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Budgeted product prices</span></td> <td>&#160;</td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The prices estimated in the revenue projections are based on current and projected market prices for the products.</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td>&#160;</td> <td>&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Budgeted gross margin</span></td> <td>&#160;</td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Based on past performance and management&#8217;s expectations for the future.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration:underline">Intangible Assets
Acquired in a Business Combination </span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Intangible assets acquired
in a business combination are identified and recognized separately regarding goodwill when they meet the definition of intangible assets
and their fair value can be measured reliably. Such intangible assets are recognized at fair value at acquisition date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">After the initial recognition,
intangible assets acquired in a business combination are valued at cost, net of accumulated amortization, based on the expected attrition
over the respective estimated periods for which the intangible assets will provide economic benefit to the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Intangible assets acquisitions
from ValoraSoy were restated by applying the corresponding adjustment coefficients (as mentioned in Note 3.3) since the date of the business
combination and are translated at the exchange rate at the closing date of the financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration:underline">Software</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Software licenses are
valued at cost, restated as mentioned in Note 3.3, net of the corresponding accumulated amortization and impairment losses. Amortization
is calculated on a straight-line basis over the estimated useful life of the intangible assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory', window );">Property, plant and equipment, net</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.4. Property,
plant and equipment, net </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Property, plant and equipment
assets are measured at historical cost less accumulated depreciation and any impairment loss, except for those acquired in a business
combination, which are then recorded at fair value; assets under construction and land are not depreciated. The cost of the property,
plant and equipment is the fair value of the consideration initially provided to acquire or construct the item and prepare it for use.
Subsequent costs incurred for repair and maintenance, are expensed in the consolidated statements of comprehensive income unless these
costs meet the criteria for capitalization (i.e. extension of the useful life). Depreciation commences when the assets are ready for use.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Property, plant and equipment
is depreciated based on the straight-line method over estimated useful lives.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">An item of property,
plant and equipment will be derecognized upon disposal or when future economic benefits from the continued use of the asset are no longer
expected. The gain or loss arising from the derecognition is measured as the difference between the gain on sale and the carrying amount
of the asset and is recognized through profit or loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The useful lives of property,
plant and equipment are:</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Storage</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="white-space: nowrap; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">20 years</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Machinery and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">10 - 20 years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Vehicles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">5 years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Furniture</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">10 years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Computer equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">3 - 5 years</span></td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory', window );">Goodwill</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.5. Goodwill</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Goodwill arising from
the acquisition of a business is recorded at cost at the acquisition date, less accumulated impairment losses, if any.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The acquisitions related
to a foreign operation are considered to be expressed in the functional currency of the foreign operation and are translated at the exchange
rate at the reporting date.&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Goodwill acquisition
related to the acquisition of ValoraSoy are recorded at cost, restated by applying the corresponding adjustment coefficients (as mentioned
in Note 3.3) since the date of the business combination and are translated at the exchange rate at the closing date of the financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Note 4.5.1 Goodwill
impairment</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Goodwill is tested for
impairment annually at the cash-generating unit level, which is the level at which the assets generate largely independent cash inflows
and are monitored for internal management purposes. An impairment loss is recognized whenever the carrying amount of an asset or the related
cash-generating unit exceeds its recoverable amount. Impairment losses are recognized in the consolidated statements of profit or loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Impairment losses recognized
for cash-generating units first reduce allocated goodwill and then the carrying amounts of the other assets in the unit on a pro rata
basis.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories', window );">Inventories, net</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.6. Inventories,
net </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Inventories are presented
at the lower of acquisition cost or net realizable value. Cost is determined by the weighted average method. The net realizable value
represents the estimated sale price less all the estimated termination and selling costs. The cost of finished products and products in
progress includes the costs of raw materials, direct labor, other direct costs and the respective direct production expenses (based on
normal operating capacity), excluding borrowing costs. Inventories are presented net of the allowances for obsolescence and, in consolidation,
net of eliminations of unrealized profit on inventories.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.7. Cash and
cash equivalents</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">For the purposes of the
statements of financial position and statements of cash flows, cash and cash equivalents include cash on hand and in banks and short-term
highly liquid investments. Investments can be readily convertible to known amounts of cash and they are subject to insignificant risk
of changes in value in the consolidated statements of financial position.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory', window );">Trade receivables and other receivables</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.8. Trade receivables
and other receivables</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Trade receivables represent
amounts owing for goods supplied by the Company prior to the end of the financial period which remain unpaid. They arise from transactions
in the normal operating activities of the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Trade receivables are
carried at amortized cost, net of expected credit losses.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company derecognizes
a financial asset when the contractual rights to the cash flows from the asset expire, or when it transfers the financial asset and substantially
all the risks and rewards of ownership of the asset to another party. If the Company neither transfers nor retains substantially all the
risks and rewards of ownership and continues to control the transferred asset, the Company recognizes its retained interest in the asset
and an associated liability for amounts it may have to pay. If the Company retains substantially all the risks and rewards of ownership
of a transferred financial asset, the Company continues to recognize the financial asset and also recognizes a collateralized borrowing
for the proceeds received.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock', window );">Right-of-use of assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.9. Right-of-use
of assets</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Due to the acquisition
of ValoraSoy, the Group acquired rights to use a parcel of land, as part of the acquisition agreement. At the acquisition date, right-of-use
of assets are initially recognized at fair value using a third-party valuation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The ownership of the
parcel of land is held by one of the sellers of ValoraSoy, who has entered into an agreement with the Company whereby he granted the right-of-use
of the property to the Company until the effective fulfillment of his obligation to lift encumbrances, subdivide and assign the property
to the Company within a period of twelve months or longer, if required by the proceedings, from the acquisition date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The right-of-use of land
shall not be depreciated due to the imminent transfer of ownership of the underlying asset to the Group which has an indefinite useful
life.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The right-of-use of assets
are presented in a single line in the consolidated statements of financial position.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock', window );">Share capital and reserves</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.10. Share capital
and reserves</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Ordinary shares</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Ordinary shares are classified
as equity. Incremental costs directly attributable to the issue of ordinary shares and share options are recognized as a deduction from
equity, net of any tax effects.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Foreign currency translation
adjustment</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The foreign currency
translation reserve is used to record exchange differences arising from the translation of the financial statements from the functional
currency of Argentine Peso into the presentation currency of US dollar.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory', window );">Share-based payment arrangements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.11. Share-based
payment arrangements</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Share-based compensation
benefits are provided to certain key employees under the Company Compensation Plan. Under this agreement, some employees and members of
the executive management team as defined by the Board of Directors, were granted share options and restricted stock units (&#8220;RSU&#8221;)
in return for their services to the Group.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group receives services
in exchange for its own equity instruments and does not have any obligation to settle the obligation with cash, so the plan is classified
as equity settled. The only condition to be met is the delivery of service by the employee during a certain period as defined in the Agreements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The fair value of options
granted under the plan is measured at grant date and recognized in accordance with the requirements of IFRS 2, as an employee benefits
expense, with a corresponding increase in equity.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The total expense is
recognized over the vesting period, which is the period over which all of the specified vesting conditions are to be satisfied.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">When the options are
exercised, the Company issues the shares to the employee and members to the executive team. The proceeds received, net of any directly
attributable transaction costs, are credited directly to equity.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The ValoraSoy acquisition
agreement also included a contingent payment in a fixed amount of equity amounting to 384,558 shares equivalent to $1.7 million, which
was determined to be a remuneration agreement for future services (the &#8220;earn-out&#8221;) and consequently it was excluded from the
consideration and will be recognized as an expense over the required service period. The contingent payment is payable in shares over
a three-year period from 2024 to 2026 and subject to the achievement of certain EBITDA targets, as defined in the ValoraSoy SPA. Such
payment is automatically forfeited on termination of employment.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock', window );">Accounts payable and other liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.12. Accounts
payable and other liabilities</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Trade and other payables
are recognized when the Group has a legal or a constructive obligation, as a result of a past event, and it is probable that there may
be an outflow of resources embodying economic benefits to settle the obligation and the obligation can be measured reliably. These amounts
represent liabilities for goods and services provided to the Group prior to the end of financial year which are unpaid.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company derecognizes
financial liabilities when, and only when, the Company&#8217;s obligations are discharged, canceled or have expired. The difference between
the carrying amount of the financial liability derecognized and the consideration paid and payable is recognized in profit or loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Other payables correspond
mainly to employment obligations and provisions.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory', window );">Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.13. Taxes</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration:underline">Current income
tax</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Current income tax assets
and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws
used to compute the amount are those that are enacted or substantively enacted at the reporting date in the country where the Group operates
and generates taxable income.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Current income tax relating
to items recognized directly in equity is recognized in equity and not in the consolidated statements of operations. Management periodically
evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation
and establishes provisions where appropriate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration:underline">Deferred tax</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Deferred tax is provided
using the liability method on temporary differences between the tax bases of assets and liabilities and their carrying amounts for financial
reporting purposes at the reporting date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Deferred tax liabilities
are recognized for all taxable temporary differences, except:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">When
the deferred tax liability arises from the initial recognition of goodwill or an asset or liability in a transaction that is not a business
combination and, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss, and</span></td>
</tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in">-</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In respect of taxable temporary differences affiliated
with investments in subsidiaries, associates, and interests in joint arrangements, when the timing of the reversal of the temporary differences
can be controlled and it is probable that the temporary differences will not reverse in the foreseeable future.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Deferred tax assets are
recognized for all deductible temporary differences, the carry forward of unused tax credits and any unused tax losses. Deferred tax assets
are recognized to the extent that it is probable that taxable profit will be available against which the deductible temporary differences,
and the carry forward of unused tax credits and unused tax losses can be utilized, except:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">When the deferred tax asset relating to the deductible
temporary difference arises from the initial recognition of an asset or liability in a transaction that is not a business combination
and, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss, and</span></td></tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-size: 10pt">-</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In respect of deductible temporary differences
affiliated with investments in subsidiaries, associates and interests in joint arrangements, deferred tax assets are recognized only to
the extent that it is probable that the temporary differences will reverse in the foreseeable future and taxable profit will be available
against which the temporary differences can be utilized.</span></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The carrying amount of
deferred tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable
profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are re-assessed
at each reporting date and are recognized to the extent that it has become probable that future taxable profits will allow the deferred
tax asset to be recovered.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Deferred tax assets and
liabilities are measured at the tax rates that are expected to apply in the year when the asset is realized or the liability is settled,
based on tax rates that have been enacted or substantively enacted at the reporting date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Deferred tax relating
to items recognized outside profit or loss is recognized outside profit or loss. Deferred tax items are recognized in correlation to the
underlying transaction either in OCI or directly in equity.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock', window );">Subsidiaries and joint arrangements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.14. Subsidiaries
and joint arrangements</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Where the Company holds
a controlling interest in an entity, such entity is classified as a subsidiary. The Company exercises control over such an entity if all
three of the following elements are present: (i) the Company has the power to direct or cause the direction of the management and policies
of the entity, (ii) the Company is exposed to the variable returns of such entity; and (iii) the Company has power to affect the variability
of such returns. Control is reassessed whenever facts and circumstances indicate that there may be a change in any of these elements of
control.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">De-facto control exists
in situations where the Company has the practical ability to direct the relevant activities of an entity without holding the majority
of the voting rights. In determining whether de facto control exists, the Company considers all relevant facts and circumstances, including:
(i) the relative share of the Company&#8217;s voting rights with respect to both the size and dispersion of other parties who hold voting
rights; (ii) substantive potential voting rights held by the Company and by other parties, (iii) other contractual arrangements; and (iv)
historic patterns in voting attendance. As of the issuance of these Financial Statements, there is no de-facto control over any entity.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company is a party
to a joint arrangement when there is a contractual arrangement that confers joint control over the relevant activities of the arrangement
to the Group and at least one other party. Joint control is assessed under the same principles as control over subsidiaries.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The subsidiaries and
joint arrangements of the Company, of which their financial results have been included in the Consolidated Financial Statements, and holds
a majority share of the voting rights as of June 30, 2023 are as follows:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Principal activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Country of incorporation and<br/> principal place of business</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% Equity <br/> interest as of<br/> June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: left">Moolec Science Limited (i)</td><td style="width: 1%">&#160;</td>
    <td style="width: 28%; text-align: center">Investment in subsidiaries</td><td style="width: 1%">&#160;</td>
    <td style="width: 28%; text-align: center">United Kingdom</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">LightJump Acquisition Corporation</td><td>&#160;</td>
    <td style="text-align: center">Investment in subsidiaries</td><td>&#160;</td>
    <td style="text-align: center">USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">ValoraSoy S.A. (ii)</td><td>&#160;</td>
    <td style="text-align: center">Investment in subsidiaries</td><td>&#160;</td>
    <td style="text-align: center">Argentina</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">AG Biomolecules LLC (DE)</td><td>&#160;</td>
    <td style="text-align: center">Investment in subsidiaries</td><td>&#160;</td>
    <td style="text-align: center">USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Microo Foods Ingredients S.L. (iii)</td><td>&#160;</td>
    <td style="text-align: center">Investment in joint arrangements</td><td>&#160;</td>
    <td style="text-align: center">Spain</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50</td><td style="text-align: left">%</td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(i)</td><td style="text-align: justify">Moolec Science Limited has a branch office in Argentina,
Moolec Science Limited S.E.</td>
</tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(ii)</td><td style="text-align: justify">Incorporated through the acquisition on April 24, 2023.</td>
</tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(iii)</td><td style="text-align: justify">During December 2022, the Company agreed to participate in
a joint arrangement with the 50% of participation of the newly created company named Microo Food Ingredients Sociedad Limitada.</td>
</tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory', window );">Financial instruments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.15. Financial
instruments </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Financial assets and
liabilities are recognized when an entity of the Group becomes party to the contractual provisions of an instrument.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Financial assets and
liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issue of financial
assets and liabilities (other than those designated at fair value through profit or loss) are added to or deducted from the fair value
of the financial assets or liabilities, when appropriate, at initial recognition. Transaction costs directly attributable to the acquisition
of financial assets or liabilities designated at fair value through profit or loss are recognized immediately through profit or loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company applies a
hierarchy to classify valuation methods used to measure financial instruments carried at fair value. Levels 1 to 3 are defined based on
the degree to which fair value inputs are observable and have a significant effect on the recorded fair value, as follows:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Level 1: Quoted prices (unadjusted) in active markets for
identical assets or liabilities;</td>
</tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Level 2: Valuation techniques use significant observable
inputs, either directly (i.e., as prices) or indirectly (i.e., derived from prices), or valuations are based on quoted prices for similar
instruments; and</td>
</tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Level 3: Valuation techniques use significant inputs that
are not based on observable market data (unobservable inputs).</td>
</tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory', window );">Financial assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.15.1. Financial
assets</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Classification of
financial assets </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">If and when applicable
the Company follows the framework and requirements outlined in IFRS 9 to classify financial assets based on whether:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">The financial asset is held within a business model whose
objective is to collect contractual cash flows or whose objective is achieved through the collection of contractual cash flows and the
sale of financial assets; and</td>
</tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: justify">The contractual terms give rise to cash flows that are only
payments of principal and interest.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">By default, all other
financial assets are subsequently measured at fair value through profit or loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Trade receivables are
amounts due from customers for goods sold or services performed in the ordinary course of business. They are generally due for settlement
within 30 days and are therefore all classified as current. Trade receivables are recognized initially at the amount of consideration
that is unconditional, unless they contain significant financing components, when they are recognized at fair value. The Group holds the
trade receivables with the objective of collecting the contractual cash flows and therefore measures them subsequently at amortized cost
using the effective interest method.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Gains and losses in
foreign currency</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Trade receivables denominated
in a currency other than the subsidiaries&#8217; functional currency is determined in that foreign currency and converted to the subsidiaries&#8217;
functional currency at the end of each reporting period using the then prevailing spot rate. Exchange differences are recognized through
profit or loss and are classified within financial income / expenses.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Derecognition of financial
assets</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group derecognizes
a financial asset only when the contractual rights to the asset&#8217;s cash flows expire, or when it transfers the financial asset and
substantially all the risks and rewards of ownership of the asset to another party. If the Group does not transfer or retain substantially
all risks and rewards of ownership and continues to control the transferred asset, the Group recognizes its interest retained in the asset
and an associated liability for the amounts to be paid. If the Group retains substantially all the risks and rewards of ownership of a
transferred financial asset, the Group continues to recognize the financial asset and also recognizes a loan secured by the revenue received.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Upon derecognition of
a financial asset measured at amortized cost, the difference between the carrying amount of the asset and the sum of the consideration
received and receivable is recognized through profit or loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group also derecognizes
a financial asset when there is information which indicates that the counterparty is in serious financial difficulty and there is no realistic
prospect of recovery. The derecognized financial assets may still be subject to compliance activities in accordance with the Group&#8217;s
recovery procedures, taking into account legal advice when appropriate. Any recovery is recognized through profit or loss.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory', window );">Financial liabilities and equity instruments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.15.2. Financial
liabilities and equity instruments </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Classification as
debt or equity</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Debt and equity instruments
are classified as financial liabilities or equity in accordance with the substance of the contractual agreement and definitions of financial
liability and equity instrument.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Equity instruments</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">An equity instrument
consists of any contract that evidences a residual interest in the assets of an entity, after deducting all of its liabilities. Equity
instruments issued by a Group entity are recognized for income received, net of direct issue costs.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The repurchase of equity
instruments of the Group is recognized and deducted directly in equity. No gain or loss is recognized through profit or loss, arising
from the purchase, sale, issue or cancellation of the equity instruments of the Group. During the fiscal year ended June 30, 2023 no repurchase
of equity instruments took place.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Financial liabilities</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Financial liabilities
are classified at their inception at fair value through profit or loss or at amortized cost, using the effective interest amortization
method.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Warrant liabilities</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As part of the reorganization,
the Group acquired public warrants (&#8220;Public warrants&#8221;). The warrants are initially recognized at fair value on the date a
derivative contract is entered into, and they are subsequently remeasured to their fair value at the end of each reporting period. Gains
and losses will be recorded in profit or loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">These instruments are
measured at Level 1 fair value based on its quoted price.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock', window );">New standards, amendments and interpretations of IFRS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.16. New standards,
amendments and interpretations of IFRS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="text-decoration:underline">Standards and IFRICs
newly applicable for companies with 30 June 2023 year ends are set out below.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">A number of narrow-scope
amendments to IFRS 3, IAS 16, IAS 37 and some annual improvements on IFRS 1, IFRS 9, IAS 41 and IFRS 16</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Amendments to IFRS 3,
&#8216;Business combinations&#8217; update a reference in IFRS 3 to the Conceptual Framework for Financial Reporting without changing
the accounting requirements for business combinations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Amendments to IAS 16,
&#8216;Property, plant and equipment&#8217; prohibit a company from deducting from the cost of property, plant and equipment amounts received
from selling items produced while the company is preparing the asset for its intended use. Instead, a company will recognise such sales
proceeds and related costs in profit or loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Amendments to IAS 37,
&#8216;Provisions, contingent liabilities and contingent assets&#8217; specify which costs a company includes when assessing whether a
contract will be loss-making.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Annual improvements make
minor amendments to IFRS 1, &#8216;First-time Adoption of IFRS&#8217;, IFRS 9, &#8216;Financial instruments&#8217;, IAS 41, &#8216;Agriculture&#8217;
and the Illustrative Examples accompanying IFRS 16, &#8216;Leases&#8217;.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The amendments listed
above did not have any impact on the amounts recognised in the Consolidated Financial Statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><span style="text-decoration:underline">New standards and
interpretations not yet adopted</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Certain new accounting
standards and interpretations have been published that are not mandatory for June 30, 2023 reporting period and have not been early adopted
by the Group. These standards are not expected to have a material impact on the Group in the current or future reporting periods and on
foreseeable future transactions:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Amendment to IAS 12-
deferred tax related to assets and liabilities arising from a single transaction</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">These amendments require
companies to recognise deferred tax on transactions that, on initial recognition, give rise to equal amounts of taxable and deductible
temporary differences.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Effective date Annual
periods beginning on or after January 1, 2023<b>. </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Narrow scope amendments
to IAS 1, Practice statement 2 and IAS 8</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The amendments aim to
improve accounting policy disclosures and to help users of the financial statements to distinguish between changes in accounting estimates
and changes in accounting policies.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Effective date Annual
periods beginning on or after January 1, 2023<b>. </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Amendments to IFRS
16, Lease Liability in a Sale and Leaseback </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The&#160;amendments&#160;include
requirements for sale and leaseback transactions in IFRS 16 to explain how an entity accounts for a sale and leaseback after the date
of the transaction. Sale and leaseback transactions where some or all the lease payments are variable lease payments that do not depend
on an index or rate are most likely to be impacted.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Effective date Annual
periods beginning on or after January 1, 2024.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">These amendments are
not applicable to the Group.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Amendments to IAS
1, &#8216;Presentation of financial statements&#8217;, on classification of liabilities </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">These narrow-scope amendments
to IAS 1, &#8216;Presentation of financial statements&#8217;, clarify that liabilities are classified as either current or noncurrent,
depending on the rights that exist at the end of the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Classification is unaffected
by the expectations of the entity or events after the reporting date (for example, the receipt of a waiver or a breach of covenant).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The amendment also clarifies
what IAS 1 means when it refers to the &#8216;settlement&#8217; of a liability.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Effective date Annual
periods beginning on or after January 1, 2024.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Amendments to IAS
7 and IFRS 7, Supplier Finance Arrangements</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">These&#160;amendments&#160;require
disclosures to enhance the transparency of supplier finance arrangements and their effects on a company&#8217;s liabilities, cash flows
and exposure to liquidity risk. The disclosure requirements are the IASB&#8217;s response to investors&#8217; concerns that some companies&#8217;
supplier finance arrangements are not sufficiently visible, hindering investors&#8217; analysis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Effective date Annual
periods beginning on or after January 1, 2024.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Amendments to IFRS
10 and IAS 28, Sale or Contribution of Assets between an Investor and its Associate or Joint Venture </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The amendments clarify
the accounting treatment for sales or contributions of assets between an investor and its associates or joint ventures. They confirm that
the accounting treatment depends on whether the non-monetary assets sold or contributed to an associate or joint venture constitute a
&#8216;business&#8217; (as defined in IFRS 3 Business Combinations).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Where the non-monetary
assets constitute a business, the investor will recognize the full gain or loss on the sale or contribution of assets. If the assets do
not meet the definition of a business, the gain or loss is recognized by the investor only to the extent of the other investor&#8217;s
interests in the associate or joint venture. The amendments apply prospectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The effective date of
the amendment has not yet been set by the IASB; however, early application of the amendments is permitted.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DescriptionOfAccountingPolicyForLossPerShareTextBlock', window );">Loss per share</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.17. Loss per
share</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group presents basic
and diluted earnings per share (EPS) data for its ordinary shares. Basic EPS is calculated by dividing the profit and loss attributable
to ordinary shareholders of the Group by the weighted average number of ordinary shares outstanding during the period. Diluted EPS is
determined by adjusting the profit or loss attributed to ordinary shareholders and the weighted average number of ordinary shares outstanding
for the effects of all dilutive potential ordinary shares.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As of June 30, 2023 and
2022, Basic EPS and Diluted EPS are the same, employee share based payments are considered dilutive instruments properly included in the
profit and loss account, however they do not impact in EPS diluted calculation because the Group has generated net loss to ordinary shareholders
(See Note 27).</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue', window );">Revenue</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.18. Revenue
</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The group identifies
contracts with customers and evaluates the goods and services committed therein to determine performance obligations and their classification
between performance obligations that are satisfied at a given time or over time.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Revenue from satisfaction
of performance obligations at a given time is recognized when the client obtains control of the committed asset or service considering
whether there is a right to collection, if the client has the physical possession, if the client has the legal right and if they have
transferred the risks and benefits.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Revenue from sales is
recognized when performance obligations are met, which consists of transforming the significant risks and benefits of ownership of the
goods are transferred to the purchaser, usually when the products are delivered to the purchaser at the determined location, according
to the agreed sales terms.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group had no revenues
during 2022 and 2023 until ValoraSoy Acquisition on April 24, 2023.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory', window );">Expenses</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.19. Expenses</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Research and development
costs</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Research costs are expensed
in the period in which these costs are incurred. Development costs are expensed in the period in which these costs are incurred if they
do not meet the criteria for capitalization.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Sales and marketing,
administrative and other operating expenses</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group recognizes
expenses in the period in which these costs are incurred and are presented by function on the consolidated statements of operations. Sales
and marketing expenses primarily relate to marketing materials and research of the Group to increase brand awareness in the marketplace.
Administrative expenses primarily comprise professional fees (mainly related to consultancy, accountancy and legal expenses), payroll
and share based compensation to certain executives. Other operating expenses relate to those that do not depend on general business operations
or relate to the other expense categories.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory', window );">Segment reporting</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.20. Segment
reporting</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group operates in
a single operating segment, which is &#8220;science-based food ingredients&#8221;. Operating segments are defined as components of an
enterprise for which separate financial information is regularly evaluated by the chief operating decision maker, who in the Group&#8217;s
case is the Executive Team, in deciding how to allocate resources and assess performance. The Executive Team is composed of the Chief
Executive Officer (&#8220;CEO&#8221;), the Chief Financial Officer (&#8220;CFO&#8221;), the Chief Product Officer (&#8220;CPO&#8221;),
the Chief Technology Officer (&#8220;CTO&#8221;) and the Chief Science Officer (&#8220;CSO&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Executive Team evaluates
the Group&#8217;s financial information and resources and assess the financial performance of these resources on a consolidated basis
on the basis of Net revenue/loss for the period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group&#8217;s revenue,
results and assets for this one reportable segment can be determined by reference to the Consolidated Statement of Comprehensive Income
and Consolidated Statement of Financial Position.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group acquired ValoraSoy
on April 24, 2023. Because of the short-period of time since the acquisition, most of the required disclosures by IFRS 8 Operating Segments,
relating to entity-wide disclosures are not significant to disclose.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As required by IFRS 8
Operating Segments, below are presented applicable entity-wide disclosures related to Moolec Science&#8217;s revenues.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration:underline">Revenues breakdown:</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company&#8217;s revenues
arise from operations in Argentina. During the periods covered by these consolidated financial statements the Company had no revenues
from customers attributed to the entity&#8217;s country of domicile.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i><span style="text-decoration:underline">Non-current assets
other than financial instruments</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Non-current assets other
than financial instruments are located in the following countries:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>As of <br/>
June 30,<br/>
 2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>As of <br/>
June 30,<br/>
 2022</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left">Lux</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">251,440</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">United Kingdom</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,774,320</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,607,848</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Argentina</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,930,666</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Total non-current assets other than financial instruments</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">9,956,426</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,607,848</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory', window );">Business combinations</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.21 Business
combinations</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group applies the
acquisition method to account for business combinations. The acquisition cost is measured as the aggregate of the consideration transferred
for the acquisition of a subsidiary, which is measured at fair value at the acquisition date, and the amount of any non-controlling interest
in such subsidiary. The Group recognizes any non-controlling interest in a subsidiary at the non-controlling interest&#8217;s proportionate
share of the recognized amounts of subsidiary&#8217;s identifiable net assets. The acquisition related costs are expensed as incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Any contingent consideration
to be transferred by the Group is recognized at fair value at the acquisition date. The contingent consideration is classified as an asset
or liability that is a financial instrument under IFRS 9 is measured at fair value through profit or loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Goodwill is initially
measured at cost, which is the excess of the aggregate of the consideration transferred and the amount of the non-controlling interest
and any previous interest carried over the net identifiable assets acquired, and liabilities assumed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">After initial recognition,
goodwill is measured at cost less any accumulated impairment losses. For impairment testing, goodwill acquired in a business combination
is, as of the acquisition date, allocated to each of the cash-generating units of the Group that is expected to benefit from the synergies
of the combination, without considering whether other assets or liabilities of the subsidiary are allocated to those units.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Any impairment in the
carrying value is recognized in the consolidated statement of comprehensive income. In the case of acquisitions in stages, prior to the
write-off of the previously held equity interest in the subsidiary, said interest is re-measured at fair value as of the date of acquisition
of control over the subsidiary. The result of the re-measurement at fair value is recognized in profit or loss.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory', window );">Critical accounting judgements and estimates</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Note 4.22 Critical
accounting judgements and estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Group makes certain
estimates and assumptions regarding the future. Estimates and judgments are continually evaluated based on historical experience and other
factors, including expectations of future events that are believed to be reasonable under the circumstances. In the future, actual experience
may differ from these estimates and assumptions. The estimates and assumptions that have a significant risk of causing a material adjustment
to the carrying amounts of assets and liabilities within the next financial year are listed below.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Critical estimates</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Identification and fair value of identifiable intangible
assets arising in acquisitions (Note 4.3).</td>
</tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">-</td><td style="text-align: justify">Impairment of intangible assets not yet available for use
(Notes 4.3).</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for business combinations. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for financial instruments. [Refer: Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for intangible assets and goodwill. [Refer: Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 36<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_36_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for recognising revenue. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for trade and other receivables. [Refer: Trade and other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 46<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_46&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of accounting policy for accounts payable and other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of accounting policy for basis of consolidation of subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DescriptionOfAccountingPolicyForForeignCurrencyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of accounting policy for foreign currency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DescriptionOfAccountingPolicyForForeignCurrencyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DescriptionOfAccountingPolicyForLossPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of accounting policy for loss per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DescriptionOfAccountingPolicyForLossPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of accounting policy for new standards, amendments and interpretations of IFRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of accounting policy for right-of-use of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of accounting policy for share capital and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of accounting policy for subsidiaries and joint arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417748592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BusinessCombinationAbstract', window );"><strong>Business Combination [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfNetAssetsAcquiredAndGoodwill', window );">Schedule of Net Assets Acquired and Goodwill</a></td>
<td class="text">Details of the purchase
consideration, the net assets acquired and goodwill are as follows:<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">Purchase consideration:</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: justify; text-indent: 0pt; padding-left: 0.125in">Cash paid</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,931,112</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; text-indent: 0pt; padding-left: 0.125in">Deferred Payment after 6 months</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">488,431</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: justify; text-indent: 0pt; padding-left: 0.125in">Payment in kind after 12 months</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">217,916</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify; text-indent: 0pt; padding-left: 0.125in">Total purchase consideration</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,637,458</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock', window );">Schedule of Assets and Liabilities Recognised</a></td>
<td class="text">The assets and liabilities
recognised as a result of the acquisition are as follows:<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0pt; text-align: justify; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; width: 88%; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Cash and Banks</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">228</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Accounts Receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">316,972</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Other Receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,044,808</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">532,231</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Property, Plant, and Equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,138,026</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Intangible Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,824,054</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Right-of-use of assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43,507</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Accounts Payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,384,980</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Current Financial Debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,176,089</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Current Other Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(356,757</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Non-current Financial Debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(119,464</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Non-current Other Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(177,367</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 1.5pt; text-align: justify; text-indent: 0pt">Deferred Tax Liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,297,436</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 1.5pt; font-weight: bold; text-align: justify; text-indent: 0pt">Net identifiable assets acquired</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,387,733</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 1.5pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif">Goodwill recognized <span style="font-size: 10pt">(i)</span></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">249,725</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-top: 0pt; font-weight: bold; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt">Net assets acquired</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">2,637,458</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_BusinessCombinationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_BusinessCombinationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfNetAssetsAcquiredAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfNetAssetsAcquiredAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph (a)<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417468976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory', window );">Schedule of Useful Lives of Property, Plant and Equipment</a></td>
<td class="text">The useful lives of property,
plant and equipment are:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">Storage</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="white-space: nowrap; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">20 years</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Machinery and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">10 - 20 years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Vehicles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">5 years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Furniture</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">10 years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Computer equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">3 - 5 years</span></td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory', window );">Schedule of Consolidated Financial Statements</a></td>
<td class="text">The subsidiaries and
joint arrangements of the Company, of which their financial results have been included in the Consolidated Financial Statements, and holds
a majority share of the voting rights as of June 30, 2023 are as follows:<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Principal activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Country of incorporation and<br/> principal place of business</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">% Equity <br/> interest as of<br/> June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: left">Moolec Science Limited (i)</td><td style="width: 1%">&#160;</td>
    <td style="width: 28%; text-align: center">Investment in subsidiaries</td><td style="width: 1%">&#160;</td>
    <td style="width: 28%; text-align: center">United Kingdom</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">LightJump Acquisition Corporation</td><td>&#160;</td>
    <td style="text-align: center">Investment in subsidiaries</td><td>&#160;</td>
    <td style="text-align: center">USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">ValoraSoy S.A. (ii)</td><td>&#160;</td>
    <td style="text-align: center">Investment in subsidiaries</td><td>&#160;</td>
    <td style="text-align: center">Argentina</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">AG Biomolecules LLC (DE)</td><td>&#160;</td>
    <td style="text-align: center">Investment in subsidiaries</td><td>&#160;</td>
    <td style="text-align: center">USA</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Microo Foods Ingredients S.L. (iii)</td><td>&#160;</td>
    <td style="text-align: center">Investment in joint arrangements</td><td>&#160;</td>
    <td style="text-align: center">Spain</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50</td><td style="text-align: left">%</td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(i)</td><td style="text-align: justify">Moolec Science Limited has a branch office in Argentina,
Moolec Science Limited S.E.</td>
</tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(ii)</td><td style="text-align: justify">Incorporated through the acquisition on April 24, 2023.</td>
</tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(iii)</td><td style="text-align: justify">During December 2022, the Company agreed to participate in
a joint arrangement with the 50% of participation of the newly created company named Microo Food Ingredients Sociedad Limitada.</td>
</tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock', window );">Schedule of Non-Current Assets Other than Financial Instruments</a></td>
<td class="text">Non-current assets other
than financial instruments are located in the following countries:<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>As of <br/>
June 30,<br/>
 2023</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>As of <br/>
June 30,<br/>
 2022</b></td><td style="text-align: center; padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left">Lux</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">251,440</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">United Kingdom</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,774,320</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,607,848</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Argentina</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,930,666</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Total non-current assets other than financial instruments</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">9,956,426</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,607,848</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of subsidiaries. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2023-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B4<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B4_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417655120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwillAbstract', window );"><strong>Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfIntangibleAssetsExplanatoryTableTextBlock', window );">Schedule of Intangible Assets</a></td>
<td class="text">Intangible
Assets<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; font-weight: bold; text-align: left"></td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Gamma<br/>
 Linolenic<br/>
 Acid (&#8220;GLA&#8217;)<br/>
 assets and<br/>
 licensing<br/>
 rights to<br/>
 Arachidonic <br/>
Acid<br/>
 (&#8220;ARA&#8221;)</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">SPC&#174;<br/>
 technology</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Customer<br/>
 relationship</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Software<br/>
 License</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Total<br/>
 Intangible<br/>
 Assets</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; font-weight: bold; text-align: left">As of December 31, 2020</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-232">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-233">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-234">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-235">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-236">&#160;</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated Amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-237">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-238">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-239">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-240">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-241">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net book amount</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-242">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-243">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-244">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-245">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-246">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Year ended June 30, 2021</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Opening net book amount</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-247">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-248">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-249">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-250">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-251">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 40%; text-align: left; padding-bottom: 1.5pt">Additions</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">3,000,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">1,598,930</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-252">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-253">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">4,598,930</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Closing net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,000,000</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,598,930</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-254">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-255">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,598,930</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">As of June 30, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,598,930</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-256">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-257">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,598,930</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Accumulated Amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-258">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-259">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-260">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-261">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-262">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Net book amount</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">3,000,000</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">1,598,930</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-263">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-264">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">4,598,930</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
ended June 30, 2022</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Opening net book amount</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,000,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,598,930</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-265">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-266">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,598,930</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Closing net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,000,000</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,598,930</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-267">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-268">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,598,930</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">As of June 30, 2022</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,598,930</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-269">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-270">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,598,930</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated Amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-271">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-272">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-273">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-274">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-275">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Net book amount</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,000,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,598,930</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-276">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-277">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,598,930</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Year ended June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Opening net book amount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,598,930</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-278">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-279">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,598,930</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">101,033</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63,329</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-280">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-281">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">164,362</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Acquisitions through business combinations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-282">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-283">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,819,009</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,045</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,824,054</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Effect of changes in foreign exchange rates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-284">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-285">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,235</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">26,269</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Amortization (i)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-286">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-287">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(93,247</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,270</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(94,517</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Closing net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,101,033</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,662,259</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,751,997</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,809</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">8,519,098</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">As of June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,101,033</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,662,259</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,845,244</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,079</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,613,615</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated Amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-288">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-289">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(93,247</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,270</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(94,517</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,101,033</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,662,259</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,751,997</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,809</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">8,519,098</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(i)</td><td style="text-align: justify">The charge of the amortization is included in Administrative
expenses and Research and development expenses (see notes 24 and 25).</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsAndGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsAndGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfIntangibleAssetsExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfIntangibleAssetsExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417754960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fixed Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentAbstract', window );"><strong>Fixed Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfFixedAssetstextBlock', window );">Schedule of Fixed Assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap; text-align: left; font-weight: bold"></td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Chymosin<br/>
 osmosis<br/>
 equipment</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Vehicles</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Furniture</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Storage</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Computer<br/>
 equipment</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Machinery</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Total <br/>
Fixed<br/>
Assets</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap; text-align: left; font-weight: bold">As of December 31, 2020</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Cost</td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b style="-sec-ix-hidden: hidden-fact-290">-</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b style="-sec-ix-hidden: hidden-fact-291">-</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b style="-sec-ix-hidden: hidden-fact-292">-</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b style="-sec-ix-hidden: hidden-fact-293">-</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b style="-sec-ix-hidden: hidden-fact-294">-</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b style="-sec-ix-hidden: hidden-fact-295">-</b></td><td style="text-align: left"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td style="text-align: left"><b>&#160;</b></td><td style="text-align: right"><b style="-sec-ix-hidden: hidden-fact-296">-</b></td><td style="text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-style: normal; font-weight: normal">Accumulated
    Depreciation</span></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-297">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-298">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-299">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-300">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-301">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-302">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-303">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Net book amount</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-304">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-305">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-306">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-307">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-308">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-309">-</div></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-310">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">Year ended June 30, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Opening net book amount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-311">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-312">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-313">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-314">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-315">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-316">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-317">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 30%">Additions</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">10,617</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-318">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-319">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-320">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-321">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-322">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">10,617</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Closing net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: right">10,617</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-323">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-324">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-325">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-326">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-327">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">10,617</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">As of June 30, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt">Cost</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,617</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-328">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-329">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-330">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-331">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-332">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,617</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated Depreciation</td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-333">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-334">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-335">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-336">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-337">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-338">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><b style="-sec-ix-hidden: hidden-fact-339">-</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">10,617</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-340">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-341">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-342">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-343">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-344">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">10,617</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year
ended June 30, 2022</b></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; text-align: left">Opening net book amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right">10,617</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-345">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-346">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-347">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-348">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-349">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right">10,617</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Depreciation (i)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(1,699</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-350">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-351">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-352">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-353">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-354">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(1,699</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Closing net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">8,918</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-355">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-356">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-357">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-358">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-359">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">8,918</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">As of June 30, 2022</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; font-size: 10pt; padding-left: 0.125in; text-indent: -0.125in; font-weight: normal; font-style: normal">Cost</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,617</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-360">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-361">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-362">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-363">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-364">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">10,617</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated Depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,699</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-365">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-366">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-367">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-368">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-369">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,699</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">8,918</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-370">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-371">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-372">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-373">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-374">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">8,918</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">Year ended June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Opening net book amount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,918</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-375">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-376">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-377">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-378">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-379">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,918</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Acquisitions through business combinations, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-380">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,464</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,154</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49,281</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,633</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,055,494</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,138,026</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Effect of changes in foreign exchange rates</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-381">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">176</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">340</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(9</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,277</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,819</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Additions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-382">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-383">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-384">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,143</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,681</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-385">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,824</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Depreciation (i)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,699</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,603</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(106</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,160</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(699</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(22,238</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(27,505</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Closing net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: right">7,219</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">24,037</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">5,083</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">57,604</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">7,606</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,040,533</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,142,082</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">As of June 30, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in">Cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,617</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,640</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,189</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">58,764</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,305</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,062,771</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,171,286</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated Depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,398</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,603</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(106</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,160</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(699</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(22,238</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(29,204</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net book amount</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: right">7,219</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">24,037</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">5,083</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">57,604</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">7,606</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,040,533</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,142,082</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(i)</td><td style="text-align: justify">The depreciation charge is included in Administrative expenses
and Cost of sales (see notes 24 and 26).</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfFixedAssetstextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfFixedAssetstextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417634656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInGoodwillAbstract', window );"><strong>Goodwill [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory', window );">Schedule of Goodwill</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt">Goodwill</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">251,440</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-386">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Goodwill</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">251,440</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-387">&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 118<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_118&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417704944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right of Use of Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RightofUseOfAssetsAbstract', window );"><strong>Right-of-Use of Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfRightofuseOfAssetsTableTextBlock', window );">Schedule of Right of Use of Assets</a></td>
<td class="text">Right-of-use
of assets<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: center">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Land</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">As of June 30, 2022</td><td>&#160;</td>
    <td style="text-align: left"><b>$</b></td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-388">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 88%; text-align: left">Acquisitions through business combinations (i)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">43,507</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Effect of changes in foreign exchange rates</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">299</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">As of June 30, 2023</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">43,806</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.25in">(i)</td><td style="text-align: left">Through the ValoraSoy acquisition, the Group acquired a parcel of land for an original amount of $ 43,507.</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_RightofUseOfAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_RightofUseOfAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfRightofuseOfAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of Schedule of Right-of-use of Assets Table Text Block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfRightofuseOfAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417792000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Non-Current Receivables (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentReceivablesAbstract', window );"><strong>Other Non-Current Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfOtherNoncurrentReceivableTableTextBlock', window );">Schedule of Other Non-Current Receivables</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30, <br/>
2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt">Receivables with shareholders</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">8,763,027</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">-</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Other Non-Current receivables</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">8,763,027</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfOtherNoncurrentReceivableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of schedule of other non-current receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfOtherNoncurrentReceivableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417696512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and Cash Equivalents (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CashandCashEquivalentsTablesLineItems', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRestrictedCashAndCashEquivalentsExplanatory', window );">Schedule of Cash and Cash Equivalents</a></td>
<td class="text">Cash and cash equivalents
at each year-end, as disclosed in the Consolidated Statement of Cash Flows, may be reconciled against the items related to the Consolidated
Statement of Financial Position as follows:<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30, <br/>
2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30, <br/>
2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Cash</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,443</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Bank accounts</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,061,636</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,081,808</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Short-term investments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">463,594</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total cash and cash equivalents</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,527,673</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,081,808</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRestrictedCashAndCashEquivalentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRestrictedCashAndCashEquivalentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CashandCashEquivalentsTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CashandCashEquivalentsTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417727456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short Term Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShortTermInvestmentAbstract', window );"><strong>Short-Term Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfShortTermInvestmentsTableTextBlock', window );">Schedule of Short Term Investments</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">As of<br/>
 June 30,<br/>
</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt">Mutual funds</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">306,034</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-389">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Short-term investments</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">306,034</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-390">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of Short-Term Investments Table Text Block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShortTermInvestmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShortTermInvestmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539426936208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade Receivable and Other Current Receivables (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract', window );"><strong>Trade Receivable and Other Current Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfTradeReceivableTextBlock', window );">Schedule of Trade Receivable</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30, <br/>
2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt">Accounts receivable</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">361,097</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-391">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Trade receivable</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">361,097</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-392">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfOtherCurrentReceivablesTextBlock', window );">Schedule of Other Current Receivables</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30, <br/>
2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left">Taxes</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">952,953</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-393">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">377,224</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-394">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Other current receivables</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,330,177</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-395">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfOtherCurrentReceivablesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Other Current Receivables Text Block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfOtherCurrentReceivablesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfTradeReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Trade Receivable Text Block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfTradeReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417669312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfInventoriesAbstract', window );"><strong>Inventories [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfInventoriesTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30, <br/>
2023</td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left">Raw materials</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">179,368</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-396">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Finished goods</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">286,380</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-397">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Inventories</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">465,748</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-398">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfInventoriesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The table disclosue of inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfInventoriesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417793024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital and Share Premium (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareCapitalAndSharePremiumAbstract', window );"><strong>Share Capital and Share Premium [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock', window );">Schedule of Reconciliation of Share Capital and Share Premium</a></td>
<td class="text"><i>Reconciliation of share
capital and share premium</i><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Number <br/>
of<br/>
 shares</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Shares<br/>
 issued<br/>
 amount</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Shares<br/>
 to be <br/>
issued<br/>
 amount</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Share <br/>
Premium</td><td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Opening Balance as of August, 2020</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-399">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-400">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-401">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-402">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; width: 52%; text-align: left; padding-bottom: 1.5pt">Issue of share capital</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">29,140,000</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">291,400</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-403">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right">4,308,600</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"><b>Balance as of December, 2020</b></span></td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">29,140,000</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">291,400</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-404">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">4,308,600</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Issue of share capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,860,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,600</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-405">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,981,400</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Balance as of June 30, 2021</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">31,000,000</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">310,000</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-406">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">7,290,000</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Issue of share capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-407">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-408">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-409">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-410">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Balance as of&#160;&#160;June 30, 2022</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">31,000,000</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">310,000</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-411">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">7,290,000</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Issue of share capital (Moolec Science shares)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,500,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-412">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,105,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Issue of share capital (SAFE shares)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-413; font-family: Times New Roman, Times, Serif">&#160;262, 260</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,623</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-414">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,170,723</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Issue of share capital (LightJump shares)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,363,810</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,639</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-415">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39,610,630</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Issue of share capital (Backstop shares)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,201,656</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,017</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-416">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,999,023</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Issue of share capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,519</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-417">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,647</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">From business acquisition</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-418">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-419">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">641</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">217,275</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt">Equity settled share based payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">232,523</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,326</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,427</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">593,684</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Balance as of June 30, 2023</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">37,563,768</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">375,641</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">3,068</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">66,996,982</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of Reconciliation of Share Capital and Share Premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShareCapitalAndSharePremiumAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShareCapitalAndSharePremiumAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539426949536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Based Payment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareBasedPaymentAbstract', window );"><strong>Share Based Payment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory', window );">Schedule and the Possible Dilutive Effect of the Future Exercise of Options</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-indent: 0in; font-weight: bold; text-align: left">Factor</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Group 1</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Group 2</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Group 3</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; width: 64%; text-align: left">Fair value of shares</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2.97</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left">Exercise price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-420">1.52</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-421">8.00</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-422">4.25</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">70</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left">Dividend rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-423">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-424">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-425">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left">Reference risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.00</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.00</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.25</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left">Plan duration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10 years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10 years</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">10 years</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left">Fair value of stock options at measurement date</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">9.11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7.25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2.04</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory', window );">Schedule of Amount and Exercise Price and the Movements of the Stock Options of Executives and Managers</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; white-space: nowrap; text-indent: 0in; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="22" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">June 30, 2023</td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; text-indent: 0in; padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Group 1</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Group 2</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Group 3</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; text-indent: 0in; padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Number<br/>
 of<br/>
 options</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Exercise <br/>
price</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Number <br/>
of<br/>
 options</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Exercise <br/>
price</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Number <br/>
of<br/>
 options</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold">Exercise <br/>
price</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-indent: 0in">&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left">At the beginning</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-426">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-427">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-428">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-429">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-430">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-431">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; width: 28%; text-align: left">Granted during the period</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">579,078</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1.52</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">346,555</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8.00</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">700,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4.25</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left">Forfeited during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-432">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-433">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-434">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-435">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-436">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-437">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in; text-align: left">Exercised during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">253,252</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.52</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">139,957</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">8.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-438">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-439">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: 0in; text-align: left">Expired during the period</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-440">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-441">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-442">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-443">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-444">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-445">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 0in">At the ending</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">325,826</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1.52</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">206,598</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">8.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">700,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4.25</td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShareBasedPaymentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShareBasedPaymentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417649696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Other Current and Non-Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesLineItems', window );"><strong>Accounts Payable and Other Current and Non-Current Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfAccountsPayable', window );">Schedule of Accounts Payable</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Transaction expenses payable</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,579,057</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">485,735</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">774,460</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">385,508</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">787,010</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">190,843</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Trade payables</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,339,087</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">164,127</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Accounts payable</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">7,479,614</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,226,213</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30, <br/>
2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left">Related parties</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">677,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-446">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Deferred payment related to Business Combination</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">492,799</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-447">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Wages</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">221,141</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-448">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21,783</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-449">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Pay As You Earn (PAYE)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,551</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,171</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">271,371</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-450">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Other current liabilities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,685,645</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,171</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30, <br/>
2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30, <br/>
2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt">Others</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">175,312</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-451">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Other non-current liabilities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">175,312</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>$</b></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-452">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539413348672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsAbstract', window );"><strong>Financial Debt [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsExplanatory', window );">Schedule of Financial Debt</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left">Financial Debt denominated in Argentine Pesos</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">517,743</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-453">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Financial Debt denominated in US Dollars</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,028,500</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-454">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Current Financial Debt</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,546,243</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-455">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfAgeOfFinancialAssetsThatArePastDueButNotImpaired', window );">Schedule of Book Value is Reasonably Approximate to the Fair Value given its Short-Term Nature</a></td>
<td class="text">The book value is reasonably
approximate to the fair value given its short-term nature.<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">As of <br/>
June 30, <br/>
2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt">Financial Debt denominated in Argentine Pesos</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">99,046</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-456">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Non-current Financial Debt</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">99,046</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-457">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory', window );">Schedule of Terms and Conditions of Outstanding Loans</a></td>
<td class="text">The terms and conditions
of outstanding loans are as follows:<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Bank entity</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Currency of<br/>
 denomination</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nominal<br/>
 value<br/>
 (equivalent<br/>
 in USD)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nominal<br/>
 interest<br/>
 rate</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Date of<br/>
 maturity</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 28%; text-align: left; padding-bottom: 1.5pt">Banco Macro - pre-financing of exports</td><td style="width: 0.5%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 8%; text-align: center; padding-bottom: 1.5pt">ARS</td><td style="width: 0.5%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 8%; text-align: right">147,874</td><td style="width: 0.5%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 0.5%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">67% - 88 </span></td><td style="white-space: nowrap; width: 0.5%; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="width: 0.5%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 25%; text-align: center; padding-bottom: 1.5pt">07/17/2023-12/27/2023</td><td style="width: 0.5%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 8%; text-align: right">173,236</td><td style="width: 0.5%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 0.5%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 0.5%; text-align: left">&#160;</td><td style="width: 8%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-458">-</div></td><td style="width: 0.5%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Banco Naci&#243;n - pre-financing of exports</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">USD</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,500</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">10/6/2023</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,635</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-459">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Banco C&#243;rdoba - pre-financing of exports</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">ARS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">142,567</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">55% - 88 </span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">01/11/2023 - 06/26/2023</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">156,057</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-460">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Banco Galicia - bank overdrafts</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">ARS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,849</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">144</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">06/30/2023</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18,849</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-461">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">HSBC Bank - bank overdrafts</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">ARS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,625</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">108</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">06/30/2023</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,625</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-462">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Banco Santander - bank overdrafts</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">ARS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">41,325</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">161</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">06/30/2023</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">44,446</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-463">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Banco Galicia - loans</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">ARS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">99,643</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">35%
- 85 </span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">08/21/2023 - 01/25/2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,728</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-464">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">HSBC Bank - loans</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">ARS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19,508</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">64</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">07/27/2023</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,940</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-465">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Banco Santander - loans</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">ARS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">119,001</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">50%
- 57 </span></td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">09/03/2026 - 03/04/2027</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">118,185</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-466">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Banco Macro - loans</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">ARS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11,705</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">54</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">7/12/2023</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,257</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-467">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Promissory notes</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">USD</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,000,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">05/22/2024 - 06/25/2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,000,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-468">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Asociaci&#243;n mutual AMA &#8211; loans</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">ARS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,316</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">53</td><td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">%(*)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">07/10/2023 - 04/10/2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">51,331</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-469">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">Interest rates of our outstanding loans in ARS, correspond
to market rates in the country of incorporation of our newly acquired subsidiary, which deems to be a hyperinflationary economy.</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfAgeOfFinancialAssetsThatArePastDueButNotImpaired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Analysis of the age of financial assets that are past due but not impaired. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expired 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 37<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_37_a&amp;doctype=Standard&amp;book=b<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfAgeOfFinancialAssetsThatArePastDueButNotImpaired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417709344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_WarrantsLiabilitiesAbstract', window );"><strong>Warrants Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory', window );">Schedule of Fair Value Ordinary Share of Warrants</a></td>
<td class="text">Considering that the
fair value as of June 2023 is $0.0799 per Ordinary Share, the valuation of warrants is the following:<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">As of June 30, 2022</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-470">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 88%; text-align: left">Issued by the SPAC</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,666,500</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Fair value remeasurement (Gain)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(778,811</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">As of June 30, 2023</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">887,689</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the fair value measurement of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_WarrantsLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_WarrantsLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417756704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Simple Agreement for Future Equity (&#8220;SAFE&#8221;) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SimpleAgreementForFutureEquitySafeAbstract', window );"><strong>Simple Agreement for Future Equity Safe [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory', window );">Schedule of Financial Instruments</a></td>
<td class="text">The following table presents
the changes in Level 3 financial instruments as of June 30 of each year:<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-weight: bold; text-align: left; padding-bottom: 1.5pt">At the beginning</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right">2,860,000</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-471">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-472">&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-473">&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Additions</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-474">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-475">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-476">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Results on the change of Fair Value of the SAFE (i)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">313,346</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">860,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-477">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-478">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">SAFE Capitalization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,173,346</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-479">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-480">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-481">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">At the end</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-482">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,860,000</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-483">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-484">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(i)</td><td style="text-align: justify">The result due to the change in the fair value of the SAFE
was included in &#8220;Other financial Results&#8221;.</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Section Scope<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;doctype=Standard&amp;dita_xref=IFRS07_g3-5A_TI<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SimpleAgreementForFutureEquitySafeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SimpleAgreementForFutureEquitySafeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539413282352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Tax and Income Tax (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract', window );"><strong>General Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDeferredTaxesExplanatory', window );">Schedule of Net Deferred Tax Liabilities</a></td>
<td class="text">The roll forward of net
deferred tax as of June 30, 2023, 2022, 2021 and 2020 is as follows:<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2023</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2022</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2021</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><b>2020</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Balance at beginning of year</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-485">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-486">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-487">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-488">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: justify">Incorporated through the business combination</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,297,436</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-489">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-490">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-491">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Credited to profit &amp; loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(234,542</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-492">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-493">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-494">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Charged to Other Comprehensive Income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,913</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-495">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-496">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-497">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Balance at year end</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">1,071,807</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-498">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-499">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-500">-</div></td><td style="text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfStatutoryTaxesInCountriesTableTextBlock', window );">Schedule of Principal Statutory Taxes Rates in the Countries</a></td>
<td class="text">Principal statutory taxes
rates in the countries where the Group operates for all the years presented are:<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold"></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Income tax rate</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b>Tax Jurisdiction</b></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Argentina</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%-35</span></td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-501">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-502">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-503">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%">Luxembourg</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">15</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-504">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-505">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-506">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">United Kingdom</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">United States of America</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">21</td><td style="text-align: left">%</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><i>&#160;</i></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock', window );">Schedule of Income Tax for Other Jurisdictions</a></td>
<td class="text">Income tax for other jurisdictions is calculated based on the substantially enacted nominal tax rates prevailing
in the respective jurisdictions.<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of December&#160;30, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left; padding-bottom: 1.5pt">Loss before tax</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"><span style="font-style: normal; font-weight: normal">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"><span style="font-style: normal; font-weight: normal">(52,023,422</span></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-style: normal; font-weight: normal">)</span></td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(4,526,905</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(1,986,814</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(320,524</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Corporate tax rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Income tax (benefit)/expense</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,803,513</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">860,112</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">377,495</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">60,900</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Effect of difference tax rates subsidiaries operating in other jurisdictions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">428,506</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-507">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-508">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-509">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Tax losses (i)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,631,947</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(860,112</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(377,495</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(60,900</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Non-deductible expenses - listing cost</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,405,759</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-510">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-511">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-512">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Net gain on inflation effect on monetary items</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52,914</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-513">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-514">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-515">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Income tax inflation adjustment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(35,826</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-516">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-517">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-518">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">23,141</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-519">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-520">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-521">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Tax benefit for the year</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">234,542</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-522">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-523">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-524">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 17.85pt">(i)</td><td style="text-align: justify">Deferred tax assets have not been recognized, because it is not probable that future taxable profit will
be available against which the Group can use the benefits therefrom.</td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock', window );">Schedule of Net Deferred Tax Liabilities</a></td>
<td class="text">Net deferred tax liabilities
are comprised of the following amounts:<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">Deferred tax asset</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: justify; padding-bottom: 1.5pt">Tax loss carry-forward</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">292,267</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-525">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total other receivables</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">292,267</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-526">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify">Deferred tax liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Customer relationship</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,346,374</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-527">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Other tax liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,700</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Total deferred tax liability</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,364,074</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-528">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">&#160;Net deferred tax liability</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,071,807</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-529">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock', window );">Schedule of Accumulated Tax Loss Carryforwards</a></td>
<td class="text">The following table shows
the expiration date of the recognized accumulated tax loss carryforwards pursuant to statutes of limitations:<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Fiscal year</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tax-loss<br/>
 carry<br/> forward</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Deferred <br/> tax asset</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Expiration<br/> date</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tax<br/> jurisdiction</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">2022</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">10,980</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,843</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: center">2027</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center; padding-left: 5.4pt">Argentina</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">2023</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">824,069</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">288,424</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">2028</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt">Argentina</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">835,049</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">292,267</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt; text-align: center">&#160;</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="text-align: right; padding-bottom: 4pt; padding-left: 5.4pt">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfEstimatedFutureTaxableProfitTableTextBlock', window );">Schedule of Estimated Future Taxable Profit.</a></td>
<td class="text">Deferred tax assets have
not been recognized in respect of the following items, because it is not probable that future taxable profit will be available against
which the Group can use the benefits therefrom:<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Tax losses per country</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tax effect</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tax effect</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tax effect</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Tax effect</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 20%; text-align: justify; padding-bottom: 1.5pt">United Kingdom</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">3,641,516</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">691,888</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">4,526,905</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">860,112</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">1,986,814</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">377,495</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">320,524</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right">60,900</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Luxembourg</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,267,560</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">620,837</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 1.5pt">Argentina</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,484,790</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">282,110</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">United States of America</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">195,328</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">37,112</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">8,589,194</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,631,947</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">4,526,905</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">860,112</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,986,814</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">377,495</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">320,524</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">60,900</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDeferredTaxesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDeferredTaxesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndOtherExplanatoryInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndOtherExplanatoryInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfStatutoryTaxesInCountriesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of statutory taxes in countries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfStatutoryTaxesInCountriesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of accumulated tax loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfEstimatedFutureTaxableProfitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of estimated future taxable profit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfEstimatedFutureTaxableProfitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of income tax for other jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417691056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Income / Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeExpenseGainsOrLossesOfFinancialInstrumentsAbstract', window );"><strong>Financial income / expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinanceIncomeExplanatory', window );">Schedule of Financial Income Expenses</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 December&#160;30,<br/>
 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">Financial Costs</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; padding-bottom: 1.5pt">Interest expense</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(160,035</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(2,130</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-530">&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-531">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Financial Costs</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right">(160,035</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right">(2,130</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-532">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left"><b>$</b></td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-533">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Other financial results</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Exchange rate difference</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,386,599</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(12,342</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-534">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-535">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value of Simply Agreement for Future Equity (&#8220;SAFE&#8221;) - Loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(313,346</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(860,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-536">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-537">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Investment gain related to money market funds</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,009,318</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-538">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-539">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-540">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in warrants</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">778,811</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-541">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-542">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-543">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Interest gain (Shareholders loan)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">693,027</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-544">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-545">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-546">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Inflation adjustment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">245,989</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-547">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-548">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-549">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,325</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-550">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-551">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-552">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Other financial results</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,030,525</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(872,342</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-553">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-554">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total net financial income / expenses</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">870,490</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(874,472</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-555">-</div></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-556">-</div></td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinanceIncomeExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of finance income. [Refer: Finance income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinanceIncomeExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeExpenseGainsOrLossesOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeExpenseGainsOrLossesOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539413274384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Operating Expense (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OtherOperatingExpenseTablesLineItems', window );"><strong>Other Operating Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfOtherOperatingExpensesTableTextBlock', window );">Schedule of Other Operating Expense</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 December&#160;31,<br/>
 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Taxes, duties and penalties</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(62,263</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-557">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-558">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-559">-</div></td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Miscellaneous expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(31,944</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(38,985</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(93,252</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(2,639</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total other operating expense</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(94,207</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(38,985</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(93,252</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(2,639</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_OtherOperatingExpenseTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_OtherOperatingExpenseTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfOtherOperatingExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfOtherOperatingExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417743104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Administrative Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract', window );"><strong>Administrative Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock', window );">Schedule of Administrative Expenses</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 December&#160;31,<br/>
 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Audit. legal and accountancy fees</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(2,024,611</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(1,355,046</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(635,173</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(125,867</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Employee Stock Option Plan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,166,755</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(838,576</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-560">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-561">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Payroll Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(880,830</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(254,215</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(10,544</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-562">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Insurance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(428,947</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-563">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-564">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-565">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Travel Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(102,305</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(52,532</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(332</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-566">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(92,818</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-567">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-568">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-569">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(4,107</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-570">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-571">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-572">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other office and admin expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(108,282</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(22,861</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(174,897</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,019</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">Total Administrative expenses</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(4,808,655</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(2,523,230</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(820,946</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(127,886</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of general and administrative expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417721728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and Development Expense (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ResearchandDevelopmentExpenseTablesLineItems', window );"><strong>Research and Development Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory', window );">Schedule of Research and Development Expense</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 December&#160;31, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Professional fees</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(886,628</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(373,259</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(75,189</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-573">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Laboratories&#8217; related expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(434,551</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(449,442</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(526,753</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-574">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,699</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,699</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-575">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-576">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Other research and development expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(28,339</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(160,758</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-577">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(179,061</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">Total Research and development expenses</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(1,351,217</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(985,158</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(601,942</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="padding-bottom: 4pt; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(179,061</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of research and development expense. [Refer: Research and development expense]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ResearchandDevelopmentExpenseTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ResearchandDevelopmentExpenseTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417727456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cost of sales (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CostOfSalesAbstract', window );"><strong>Cost of Sales [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfCostOfSalesTableTextBlock', window );">Schedule of Cost of Sales</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 December&#160;31,<br/>
 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Inventories at beginning</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-578">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-579">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-580">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-581">&#160;&#160;&#160;&#160;&#160;-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left">Inventories incorporated through the business combination</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(532,231</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-582">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-583">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-584">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Purchases</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(788,751</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-585">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-586">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-587">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Production costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; font-style: italic; text-align: left">Payroll and and professional fees</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">(121,285</td><td style="font-style: italic; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-588">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-589">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-590">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; font-style: italic; text-align: left">Maintenance, energy and fuel related to fixed assets</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">(77,495</td><td style="font-style: italic; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-591">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-592">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-593">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; font-style: italic; text-align: left">Amortization and depreciation</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">(23,398</td><td style="font-style: italic; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-594">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-595">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-596">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; font-style: italic; text-align: left">Other production costs</td><td style="font-style: italic">&#160;</td>
    <td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">(31,050</td><td style="font-style: italic; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-597">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-598">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-599">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; font-style: italic; text-align: left">Sub-total Production costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(253,228</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-600">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-601">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-602">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Foreign currency translation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">60,108</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-603">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-604">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-605">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Sub-total</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(1,514,102</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-606">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-607">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-608">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Inventories as of the end</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">465,748</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-609">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-610">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-611">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Cost of sales</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(1,048,354</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-612">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-613">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-614">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CostOfSalesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CostOfSalesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfCostOfSalesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfCostOfSalesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417763344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NetLossperShareTablesLineItems', window );"><strong>Net Loss per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareExplanatory', window );">Schedule of Net Loss Per Share</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Numerator</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31,<br/>
 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left">Loss for the year, attributable to the owners of the Group</td><td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(51,788,880</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left">)</td><td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(4,526,905</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left">)</td><td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(1,986,814</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left">)</td><td style="padding-bottom: 1.5pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">(320,524</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 4pt; padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Loss attributable to the ordinary shareholders</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(51,788,880</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(4,526,905</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(1,986,814</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(320,524</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td></tr>
</table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Denominator</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31,<br/>
 2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Weighted-average number of ordinary shares</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">34,466,258</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">31,000,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">30,239,558</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">29,140,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
</table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Net loss attributable to ordinary shareholders per share</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31,<br/>
 2020</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -0.125in; padding-left: 0.125in"><div style="-sec-ix-hidden: hidden-fact-618; -sec-ix-hidden: hidden-fact-617; -sec-ix-hidden: hidden-fact-616; -sec-ix-hidden: hidden-fact-615">Basic and Diluted</div></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(1.50</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(0.15</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(0.07</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(0.01</td><td style="width: 1%; text-align: left">)</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NetLossperShareTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NetLossperShareTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539422529568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RelatedPartiesTablesLineItems', window );"><strong>Related Parties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfOtherRelatedPartyTransactions', window );">Schedule of Other Related Party Transactions</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-style: italic; text-align: left">In USD ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31,<br/>
 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left">Short-term employee benefits</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">39,250</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">96,437</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">109,205</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">38,355</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Share based payment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">904,861</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">838,576</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-619">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-620">-</div></td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfShareBasedPayment', window );">Schedule of Share Based Payment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>In USD ($)</i></b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note</b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended<br/>
June 30,<br/>
2023</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended <br/>
June 30,<br/>
2022</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>From the period<br/>
of January 1,<br/>
2021 through<br/>
June 30,<br/>
2021</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>From the period of August 21, 2020 through December&#160;31,<br/>
2020</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share based payment</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 40%; padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key management</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">904,861</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">838,576</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-621; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-622; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CFO Shares Alloted</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">364,014</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-623; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-624; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-625; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issue of Additional Shares</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue of share capital</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-626; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-627; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-628; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue of share premium</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,610,630</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-629; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-630; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-631; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent of the Company &#8211; Bioceres Crop Solutions Corp</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-632; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-633; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,000,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-634; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent of the Company &#8211; Union Group Ventures</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-635; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-636; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-637; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent of the Company &#8211; BG Farming Technologies</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-638; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-639; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-640; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Company&#8217;s Cash Balance in Other&#8217;s Accounts</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent of BF Farming Technologies &#8211; Bioceres S.A.</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-641; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-642; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-643; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">300,000</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100% Subsidiary of Bioceres S.A. &#8211; Bioceres LLC</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-644; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-645; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">300,000</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expenses Paid on Behalf of the Company</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parent of BG Farming Technologies - Bioceres S.A.</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-646; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">265,810</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">509,628</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">244,029</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100% Subsidiary of Bioceres S.A. - Bioceres LLC</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">238,121</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">156,760</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">453,282</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56,863</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Services Provided by Other Companies</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30% owned by Bioceres S.A. - INMET S.A.- Ingenieria Metabolica S.A</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">286</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">252</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">144,530</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">160,390</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98.6% owned by Bioceres S.A. - INDEAR S.A.- Instituto de Agrobiotecnolog&#237;a Rosario</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">258,279</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,047</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">129,695</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,540</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned by Bioceres S.A. - Agrality Inc.</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85,435</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-647; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-648; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Founded and operated by the Company&#8217;s CPO - Future Foods B.V.</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85,880</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">94,857</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,958</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,801</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moolec Science S.A. Shareholders</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">693,027</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-649; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-650; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-651; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THEO I SCSp</span></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-652; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,500,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-653; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-654; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.35in">(i)</td><td style="text-align: justify">Expenses paid by Bioceres LLC on behalf of the Company.</td></tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.35in">(ii)</td><td style="text-align: justify">The Company entered into an agreement with INMET S.A.- Ingenieria Metabolica S,A through which it would
receive research services in exchange for payment.</td></tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.35in">(iii)</td><td style="text-align: justify">The Company entered into an agreement with INDEAR S.A.- Instituto de Agrobiotecnologia Rosario where it
would receive research services in exchange for payment.</td></tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.35in">(iv)</td><td style="text-align: justify">The Company entered into an agreement with Agrality Inc, for the provision of services.</td></tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.35in">(v)</td><td style="text-align: justify">The Company entered into an agreement with Future Foods B.V. for the provision of services.</td></tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.35in">(vi)</td><td style="text-align: justify">Shares issue related to share based payment already vested.</td></tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0%"></td><td style="width: 0.35in">(vii)</td><td style="text-align: justify">The Company entered into an agreement with shareholders which accrues an internal rate of return.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfOtherRelatedPartyBalances', window );">Schedule of other related party balances</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left">In USD ($)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Balance<br/> outstanding<br/> as of<br/> June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Balance<br/> outstanding<br/> as of<br/> June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt">100% Subsidiary of Bioceres S.A. <span style="-sec-ix-hidden: hidden-fact-655">-</span> Bioceres LLC</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(623,629</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(385,508</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Moolec S.A. Shareholders</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,763,027</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-656">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Union Group Ventures Limited</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(677,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-657">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">INDEAR S.A.</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(72,494</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-658">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Future Foods B.V</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(78,337</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-659">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_RelatedPartiesTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_RelatedPartiesTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfOtherRelatedPartyBalances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfOtherRelatedPartyBalances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfOtherRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfOtherRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfShareBasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfShareBasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539427264096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Risk Management (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract', window );"><strong>Financial Risk Management [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTradingIncomeExpenseExplanatory', window );">Schedule of Trade and Other Receivables</a></td>
<td class="text">The following table sets
forth details of the age of trade and other receivables:<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">As at</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">To due become</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt">Up to 3 months</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">450,728</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-660">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities', window );">Schedule of Contractual Maturity Date</a></td>
<td class="text">The table below analyzes
the Company&#8217;s financial liabilities into relevant maturity groupings based on the remaining period at the balance sheet to the contractual
maturity date.<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Maturity date</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Within 1<br/>
 year or on<br/>
 demand</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Between 1<br/>
 and 2 years</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Between 2<br/>
 and 5 years</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">More than <br/>
5 years</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Without any<br/>
 established<br/>
 term</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">June 30, 2023</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: left">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 28%; text-align: left">Trade Payables</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,479,614</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-661">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-662">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-663">&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-664">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">7,479,614</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Other liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,776,438</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">180,197</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-665">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-666">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,956,635</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: left">Financial debts</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,578,100</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">72,831</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">108,638</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-667">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-668">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,759,569</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left">Subtotal</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">11,834,152</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">253,028</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">108,638</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-669">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-670">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">12,195,818</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Warrant</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">887,689</td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-671">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-672">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-673">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-674">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">887,689</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left">Subtotal</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">887,689</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-675">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-676">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-677">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-678">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">887,689</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">12,721,841</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">253,028</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">108,638</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-679">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-680">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">13,083,507</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">June 30, 2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Trade Payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,226,213</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-681">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-682">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-683">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-684">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,226,213</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Other liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,171</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-685">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-686">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-687">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-688">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,171</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: left">Simply Agreement for Future Equity (&#8220;SAFE&#8221;)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,860,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-689">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-690">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-691">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-692">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,860,000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left">Subtotal</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,087,384</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-693">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-694">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-695">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-696">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,087,384</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,087,384</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-697">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-698">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-699">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,087,384</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory', window );">Schedule of Foreign Currency Exchange Risk</a></td>
<td class="text">The carrying amounts
of the Group&#8217;s foreign currency denominated monetary assets and monetary liabilities at the reporting date are as follows:<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Assets</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Currency</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Argentine pesos</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">765,690</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-700">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">50,073</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-701">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">U.S. Dollar</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">368,186</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-702">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,227,751</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-703">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Pound sterling</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,062</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,025</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-704">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-705">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(+10%) Impact to profit or loss before tax</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(-10%) Impact to profit or loss before tax</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Assets</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Currency</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Argentine pesos</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">76,569</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-706">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(5,007</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">&#160;</td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-707">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">U.S. Dollar</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36,819</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-708">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(222,775</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-709">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Pound sterling</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,206</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">803</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-710">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-711">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory', window );">Schedule of Fair Value and Carrying Value of Financial Instruments</a></td>
<td class="text"><b>Fair value and carrying
value of financial instruments:</b><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Recurring measurements</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Note</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">Financial Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">Amortized costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Cash and cash equivalents</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 11%; text-align: center; padding-bottom: 1.5pt">(i)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2,064,079</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">1,081,808</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Trade and other receivables</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">(i)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10,454,301</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,061</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Fair value through profit or loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Cash and cash equivalents</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">(ii)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">463,594</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-712">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Short-term investments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">(ii)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">306,034</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-713">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total financial assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left; padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">13,288,008</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,083,869</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>

<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><b>Financial Liabilities</b></td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Amortized costs</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Trade and other payables</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: center">(i)</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">9,340,571</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td>
    <td style="width: 9%; text-align: right">1,227,384</td>
    <td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Financial debt</td>
    <td>&#160;</td>
    <td style="text-align: center">(i)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,645,289</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-714">-</div></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Fair value through profit or loss</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Simply Agreement for Future Equity (&#8220;SAFE&#8221;)</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-715">-</div></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="text-align: right">2,860,000</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Warrant liabilities</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">(ii)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right">887,689</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-716">-</div></td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total financial liabilities</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">12,873,549</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,087,384</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net financial asset /(liability)</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">414,459</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td>
    <td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(3,003,515</td>
    <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr>
  </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0.25in"><span style="font-size: 10pt">(i)</span></td><td style="text-align: justify">Cash, short-term investments, trade and other receivables, prepayments, trade and other payables, and
loans payable are recorded at carrying value, which approximates fair value due to their short-term nature and generally negligible credit
losses.</td></tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(ii)</span></td><td style="text-align: justify">Fair value of short-term investment and warrants has been
determined using the quoted market price at the year end (level 1).</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DisclosureOfFixedRateInstruments', window );">Schedule of Fixed-Rate Instruments</a></td>
<td class="text">The Group has not entered into derivative contracts to hedge
this exposure.<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Fixed-rate instruments</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/>
 June 30,<br/>
 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/>
June 30,<br/>
 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Current financial liabilities</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(2,546,243</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-717">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-718">-</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Non-current financial liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(99,046</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-719">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-720">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for the currency of the primary economic environment in which the entity operates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the fair value of financial instruments. [Refer: Financial instruments, class [member]; At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTradingIncomeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trading income (expense). [Refer: Trading income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTradingIncomeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a maturity analysis for derivative financial liabilities, including the remaining contractual maturities for those derivative financial liabilities for which contractual maturities are essential for an understanding of the timing of the cash flows. [Refer: Derivative financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 39<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_39_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DisclosureOfFixedRateInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of fixed rate instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DisclosureOfFixedRateInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539422569136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 27, 2022</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_GeneralInformationDetailsLineItems', window );"><strong>General Information (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CommonStockExercised', window );">Common stock exercised</a></td>
<td class="nump">2,572,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RedemptionPrice', window );">Redemption price</a></td>
<td class="nump">$ 10.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AggregateRedemption', window );">Aggregate redemption</a></td>
<td class="nump">$ 26,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TrustAccount', window );">Trust account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,988,975<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SponsorShares', window );">Sponsor shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets', window );">Contributed amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,005,520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareBasedPaymentCost', window );">Share based payment cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,705,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NegativeWorkingCapital', window );">Negative Working Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,427,356<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_MoolecSAFEMember', window );">Moolec SAFE [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_GeneralInformationDetailsLineItems', window );"><strong>General Information (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">262,260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_UGVLAndTheoMember', window );">UGVL and Theo [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_GeneralInformationDetailsLineItems', window );"><strong>General Information (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,552<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the number of ordinary shares issued. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount real estate contributes to the fair value of defined benefit plan assets. [Refer: Plan assets, at fair value; Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2023-01-01<br> -Paragraph 142<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_142_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AggregateRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AggregateRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CommonStockExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CommonStockExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_GeneralInformationDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_GeneralInformationDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NegativeWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Negative working capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NegativeWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_RedemptionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_RedemptionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShareBasedPaymentCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShareBasedPaymentCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SponsorShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SponsorShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_MoolecSAFEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_MoolecSAFEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_UGVLAndTheoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_UGVLAndTheoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539422341520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 24, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BusinessCombinationAbstract', window );"><strong>Business Combination [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Total aggregate amount</a></td>
<td class="nump">$ 2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Combination of cash</a></td>
<td class="nump">2,400,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueCostsNotRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Cash payments</a></td>
<td class="nump">1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CashPayment', window );">Cash payment</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares', window );">Equity (in Shares)</a></td>
<td class="nump">64,093<span></span>
</td>
<td class="nump">384,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareEquivalent', window );">Shares equivalent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExperienceDate', window );">Experience years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Pro-forma revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,043,956<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_f_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueCostsNotRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of issue costs not recognised as an expense for transactions recognised separately from the acquisition of assets and assumption of liabilities in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph m<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_m&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueCostsNotRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issue under options and contracts for the sale of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_79_a_vii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_BusinessCombinationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_BusinessCombinationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CashPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CashPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ExperienceDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Experience date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ExperienceDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShareEquivalent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share equivalent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShareEquivalent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539413511968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination (Details) - Schedule of Net Assets Acquired and Goodwill<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PurchaseConsiderationAbstract', window );"><strong>Purchase consideration:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CashPaid', window );">Cash paid</a></td>
<td class="nump">$ 1,931,112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredPaymentAfter6Months', window );">Deferred Payment after 6 months</a></td>
<td class="nump">488,431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherPayables', window );">Payment in kind after 12 months</a></td>
<td class="nump">217,916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ConsiderationPaid', window );">Total purchase consideration</a></td>
<td class="nump">$ 2,637,458<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts payable that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ConsiderationPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of consideration paid in respect of both obtaining and losing control of subsidiaries or other businesses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ConsiderationPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DeferredPaymentAfter6Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred payment after 6 months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DeferredPaymentAfter6Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PurchaseConsiderationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PurchaseConsiderationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539412484640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination (Details) - Schedule of Assets and Liabilities Recognised - Fair Value [Member]<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedBalanceSheetStatementsCaptionsLineItems', window );"><strong>Condensed Balance Sheet Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BalancesWithBanks', window );">Cash and Banks</a></td>
<td class="nump">$ 228<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivables', window );">Accounts Receivable</a></td>
<td class="nump">316,972<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentReceivables', window );">Other Receivable</a></td>
<td class="nump">1,044,808<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherInventories', window );">Inventory</a></td>
<td class="nump">532,231<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, Plant, and Equipment</a></td>
<td class="nump">1,138,026<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Intangible Assets</a></td>
<td class="nump">3,824,054<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Right-of-use of assets</a></td>
<td class="nump">43,507<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPayables', window );">Accounts Payable</a></td>
<td class="num">(1,384,980)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilities', window );">Current Financial Debt</a></td>
<td class="num">(1,176,089)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherLiabilities', window );">Current Other Liabilities</a></td>
<td class="num">(356,757)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilities', window );">Non-current Financial Debt</a></td>
<td class="num">(119,464)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentLiabilities', window );">Non-current Other Liabilities</a></td>
<td class="num">(177,367)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxLiabilities', window );">Deferred Tax Liability</a></td>
<td class="num">(1,297,436)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed', window );">Net identifiable assets acquired</a></td>
<td class="nump">2,387,733<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill recognized (i)</a></td>
<td class="nump">249,725<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetAssetsLiabilities', window );">Net assets acquired</a></td>
<td class="nump">$ 2,637,458<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The goodwill is attributable to the expected future synergies from combining operations as well as an assembled workforce, which does not qualify for separate recognition. The Company expects that the ValoraSoy Acquisition will help to accelerate its growth in the food ingredients industry by expanding its commercial network with a top-notch sales team and complementing its Molecular Farming Platform with industrial capacity and downstream operations, in addition to adding a highly experienced team of professionals. It will not be deductible for tax purposes.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsToRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_h&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsToRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BalancesWithBanks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash balances held at banks.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BalancesWithBanks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GoodwillRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetAssetsLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets less the amount of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph IG63<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_IG63&amp;doctype=Implementation%20Guidance<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetAssetsLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax liabilities net of deferred tax assets, when the absolute amount of deferred tax liabilities is greater than the absolute amount of deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current trade payables and non-current other payables. [Refer: Other non-current payables; Non-current trade payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current other receivables. [Refer: Other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 119<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_119&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory that the entity does not separately disclose in the same statement or note. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of trade receivables and other receivables. [Refer: Trade receivables; Other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedBalanceSheetStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedBalanceSheetStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539412189120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Standards and Basis of Preparation (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Apr. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract', window );"><strong>Accounting standards and Basis of preparation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CumulativeInflationRate', window );">Cumulative inflation rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_Accumulated', window );">Accumulated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InflationAccumulated', window );">Inflation accumulated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ArgentinePriceIndexes', window );">Argentine price indexes</a></td>
<td class="nump">$ 1,709.6115<span></span>
</td>
<td class="nump">$ 1,497.2147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_Accumulated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_Accumulated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ArgentinePriceIndexes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Argentine price indexes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ArgentinePriceIndexes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CumulativeInflationRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cumulative inflation rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CumulativeInflationRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InflationAccumulated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inflation accumulated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InflationAccumulated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539413099520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfSharesToBeIssuedOfContingentPayment', window );">Number of shares to be issued of contingent payment (in Shares)</a></td>
<td class="nump">384,558<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Shares equivalent amount (in Dollars)</a></td>
<td class="nump">$ 1.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_JointArrangementParticipationPercentage', window );">Participation percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Discount rate</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SummaryofSignificantAccountingPoliciesDetailsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets', window );">Discount rate</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of a reasonably possible increase in an unobservable input used in fair value measurement of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_JointArrangementParticipationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Joint arrangement participation percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_JointArrangementParticipationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NumberOfSharesToBeIssuedOfContingentPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares to be issued of contingent payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NumberOfSharesToBeIssuedOfContingentPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SummaryofSignificantAccountingPoliciesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SummaryofSignificantAccountingPoliciesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539424470096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details) - Schedule of Useful Lives of Property, Plant and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mlec_StorageMember', window );">Storage [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) - Schedule of Useful Lives of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">20 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember', window );">Machinery and equipment [Member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) - Schedule of Useful Lives of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember', window );">Machinery and equipment [Member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) - Schedule of Useful Lives of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">20 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) - Schedule of Useful Lives of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mlec_FurnitureMember', window );">Furniture [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) - Schedule of Useful Lives of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Computer equipment [Member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) - Schedule of Useful Lives of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Computer equipment [Member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) - Schedule of Useful Lives of Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mlec_StorageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mlec_StorageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mlec_FurnitureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mlec_FurnitureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539412155760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details) - Schedule of Consolidated Financial Statements<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2"><div>Jun. 30, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_MoolecScienceLimitedMember', window );">Moolec Science Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) - Schedule of Consolidated Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Principal activities</a></td>
<td class="text">Investment in subsidiaries<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporation', window );">Country of incorporation and principal place of business</a></td>
<td class="text">United Kingdom<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">% Equity interest as of June 30, 2023</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_LightJumpAcquisitionCorporationMember', window );">LightJump Acquisition Corporation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) - Schedule of Consolidated Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Principal activities</a></td>
<td class="text">Investment in subsidiaries<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporation', window );">Country of incorporation and principal place of business</a></td>
<td class="text">USA<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">% Equity interest as of June 30, 2023</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_ValoraSoySAMember', window );">ValoraSoy S.A. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) - Schedule of Consolidated Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Principal activities</a></td>
<td class="text">Investment in subsidiaries<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporation', window );">Country of incorporation and principal place of business</a></td>
<td class="text">Argentina<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">% Equity interest as of June 30, 2023</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_AGBiomoleculesLLCDEMember', window );">AG Biomolecules LLC (DE) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) - Schedule of Consolidated Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Principal activities</a></td>
<td class="text">Investment in subsidiaries<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporation', window );">Country of incorporation and principal place of business</a></td>
<td class="text">USA<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">% Equity interest as of June 30, 2023</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_MicrooFoodsIngredientsSLMember', window );">Microo Foods Ingredients S.L. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) - Schedule of Consolidated Financial Statements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary', window );">Principal activities</a></td>
<td class="text">Investment in joint arrangements<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CountryOfIncorporation', window );">Country of incorporation and principal place of business</a></td>
<td class="text">Spain<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary', window );">% Equity interest as of June 30, 2023</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Moolec Science Limited has a branch office in Argentina,
Moolec Science Limited S.E.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Incorporated through the acquisition on April 24, 2023.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">During December 2022, the Company agreed to participate in
a joint arrangement with the 50% of participation of the newly created company named Microo Food Ingredients Sociedad Limitada.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CountryOfIncorporation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The country in which the entity is incorporated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 138<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_138_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CountryOfIncorporation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The country in which a subsidiary of the entity is incorporated. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2023-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_16_b_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17_b_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 12<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_12_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 19B<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_19B_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfVotingPowerHeldInSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of the voting rights in a subsidiary held by the entity. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2023-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 19B<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_19B_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfVotingPowerHeldInSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_MoolecScienceLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_MoolecScienceLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_LightJumpAcquisitionCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_LightJumpAcquisitionCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_ValoraSoySAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_ValoraSoySAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_AGBiomoleculesLLCDEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_AGBiomoleculesLLCDEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_MicrooFoodsIngredientsSLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_MicrooFoodsIngredientsSLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539424320400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details) - Schedule of Non-Current Assets Other than Financial Instruments - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) - Schedule of Non-Current Assets Other than Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OtherNonCurrentAssetsOtherThanFinancialAssets', window );">Total non-current assets other than financial instruments</a></td>
<td class="nump">$ 9,956,426<span></span>
</td>
<td class="nump">$ 4,607,848<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_LuxMember', window );">Lux [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) - Schedule of Non-Current Assets Other than Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OtherNonCurrentAssetsOtherThanFinancialAssets', window );">Total non-current assets other than financial instruments</a></td>
<td class="nump">251,440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=country_GB', window );">United Kingdom [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) - Schedule of Non-Current Assets Other than Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OtherNonCurrentAssetsOtherThanFinancialAssets', window );">Total non-current assets other than financial instruments</a></td>
<td class="nump">4,774,320<span></span>
</td>
<td class="nump">$ 4,607,848<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=country_AR', window );">Argentina [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsLineItems', window );"><strong>Summary of Significant Accounting Policies (Details) - Schedule of Non-Current Assets Other than Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OtherNonCurrentAssetsOtherThanFinancialAssets', window );">Total non-current assets other than financial instruments</a></td>
<td class="nump">$ 4,930,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_OtherNonCurrentAssetsOtherThanFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other non current assets other than financial assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_OtherNonCurrentAssetsOtherThanFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=mlec_LuxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=mlec_LuxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=country_AR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=country_AR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539411575472">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Details) - Schedule of Intangible Assets - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems', window );"><strong>Intangible Assets (Details) - Schedule of Intangible Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_Cost', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 8,613,615<span></span>
</td>
<td class="nump">$ 4,598,930<span></span>
</td>
<td class="nump">$ 4,598,930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Accumulated Amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="num">(94,517)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NetBookAmount', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">8,519,098<span></span>
</td>
<td class="nump">4,598,930<span></span>
</td>
<td class="nump">4,598,930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,598,930<span></span>
</td>
<td class="nump">4,598,930<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,598,930<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Acquisitions through business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,824,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Effect of changes in foreign exchange rates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_Amortization', window );">Amortization (i)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(94,517)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,519,098<span></span>
</td>
<td class="nump">4,598,930<span></span>
</td>
<td class="nump">4,598,930<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=mlec_GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember', window );">Gamma Linolenic Acid (&#8220;GLA&#8217;) assets and licensing rights to Arachidonic Acid (&#8220;ARA&#8221;) [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems', window );"><strong>Intangible Assets (Details) - Schedule of Intangible Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_Cost', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,101,033<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Accumulated Amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NetBookAmount', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,101,033<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Acquisitions through business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Effect of changes in foreign exchange rates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_Amortization', window );">Amortization (i)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,101,033<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=mlec_SPCTechnologyMember', window );">SPC&#174; technology [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems', window );"><strong>Intangible Assets (Details) - Schedule of Intangible Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_Cost', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,662,259<span></span>
</td>
<td class="nump">1,598,930<span></span>
</td>
<td class="nump">1,598,930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Accumulated Amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NetBookAmount', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,662,259<span></span>
</td>
<td class="nump">1,598,930<span></span>
</td>
<td class="nump">1,598,930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,598,930<span></span>
</td>
<td class="nump">1,598,930<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,598,930<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Acquisitions through business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Effect of changes in foreign exchange rates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_Amortization', window );">Amortization (i)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,662,259<span></span>
</td>
<td class="nump">1,598,930<span></span>
</td>
<td class="nump">1,598,930<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=mlec_CustomerRelationshipMember', window );">Customer relationship [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems', window );"><strong>Intangible Assets (Details) - Schedule of Intangible Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_Cost', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,845,244<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Accumulated Amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="num">(93,247)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NetBookAmount', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,751,997<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Acquisitions through business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,819,009<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Effect of changes in foreign exchange rates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_Amortization', window );">Amortization (i)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(93,247)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,751,997<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=mlec_SoftwareLicenseMember', window );">Software License [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems', window );"><strong>Intangible Assets (Details) - Schedule of Intangible Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_Cost', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">5,079<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Accumulated Amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,270)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NetBookAmount', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,809<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Acquisitions through business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Effect of changes in foreign exchange rates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_Amortization', window );">Amortization (i)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,270)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,809<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The charge of the amortization is included in Administrative
expenses and Research and development expenses (see notes 24 and 25).</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in intangible assets and goodwill resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_118_e_vi&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_118_e_vii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_Amortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_Amortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_Cost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_Cost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NetBookAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net book amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NetBookAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_YearEndedJune302021Abstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_YearEndedJune302021Abstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=mlec_GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=mlec_GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=mlec_SPCTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=mlec_SPCTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=mlec_CustomerRelationshipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=mlec_CustomerRelationshipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=mlec_SoftwareLicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=mlec_SoftwareLicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539405696480">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Fixed Assets (Details) - Schedule of Fixed Assets - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,142,082<span></span>
</td>
<td class="nump">$ 8,918<span></span>
</td>
<td class="nump">$ 10,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,142,082<span></span>
</td>
<td class="nump">8,918<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,142,082<span></span>
</td>
<td class="nump">8,918<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,918<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Acquisitions through business combinations, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,138,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Effect of changes in foreign exchange rates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(27,505)<span></span>
</td>
<td class="num">(1,699)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,824<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,142,082<span></span>
</td>
<td class="nump">8,918<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mlec_ChymosinOsmosisEquipmentMember', window );">Chymosin osmosis equipment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,219<span></span>
</td>
<td class="nump">8,918<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,219<span></span>
</td>
<td class="nump">8,918<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,219<span></span>
</td>
<td class="nump">8,918<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,918<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Acquisitions through business combinations, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Effect of changes in foreign exchange rates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(1,699)<span></span>
</td>
<td class="num">(1,699)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,219<span></span>
</td>
<td class="nump">8,918<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember', window );">Vehicles [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">24,037<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">24,037<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">24,037<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Acquisitions through business combinations, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Effect of changes in foreign exchange rates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(1,603)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">24,037<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mlec_FurnitureMember', window );">Furniture [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,083<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,083<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,083<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Acquisitions through business combinations, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Effect of changes in foreign exchange rates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(106)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,083<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mlec_StorageMember', window );">Storage [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">57,604<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">57,604<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">57,604<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Acquisitions through business combinations, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">49,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Effect of changes in foreign exchange rates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(1,160)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">57,604<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Computer equipment [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,606<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,606<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,606<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Acquisitions through business combinations, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Effect of changes in foreign exchange rates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(699)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,606<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember', window );">Machinery [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,040,533<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,040,533<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,040,533<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Acquisitions through business combinations, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,055,494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Effect of changes in foreign exchange rates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(22,238)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,040,533<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,171,286<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,171,286<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,171,286<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,617<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,171,286<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member] | Chymosin osmosis equipment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,617<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,617<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,617<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,617<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,617<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member] | Vehicles [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25,640<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25,640<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25,640<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25,640<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member] | Furniture [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,189<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,189<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,189<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,189<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member] | Storage [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">58,764<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">58,764<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">58,764<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">58,764<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member] | Computer equipment [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,305<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,305<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,305<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,305<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Cost [Member] | Machinery [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,062,771<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,062,771<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,062,771<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,062,771<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated Depreciation [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(29,204)<span></span>
</td>
<td class="num">(1,699)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(29,204)<span></span>
</td>
<td class="num">(1,699)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(29,204)<span></span>
</td>
<td class="num">(1,699)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,699)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(29,204)<span></span>
</td>
<td class="num">(1,699)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated Depreciation [Member] | Chymosin osmosis equipment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,398)<span></span>
</td>
<td class="num">(1,699)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,398)<span></span>
</td>
<td class="num">(1,699)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,398)<span></span>
</td>
<td class="num">(1,699)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,699)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,398)<span></span>
</td>
<td class="num">(1,699)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated Depreciation [Member] | Vehicles [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,603)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,603)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,603)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,603)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated Depreciation [Member] | Furniture [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(106)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(106)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(106)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(106)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated Depreciation [Member] | Storage [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,160)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,160)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,160)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,160)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated Depreciation [Member] | Computer equipment [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(699)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(699)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(699)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(699)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated Depreciation [Member] | Machinery [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(22,238)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(22,238)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(22,238)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(22,238)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=mlec_NetBookAmountMember', window );">Net book amount [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,142,082<span></span>
</td>
<td class="nump">8,918<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,142,082<span></span>
</td>
<td class="nump">8,918<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,142,082<span></span>
</td>
<td class="nump">8,918<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,918<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,142,082<span></span>
</td>
<td class="nump">8,918<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=mlec_NetBookAmountMember', window );">Net book amount [Member] | Chymosin osmosis equipment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,219<span></span>
</td>
<td class="nump">8,918<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,219<span></span>
</td>
<td class="nump">8,918<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,219<span></span>
</td>
<td class="nump">8,918<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,918<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,219<span></span>
</td>
<td class="nump">8,918<span></span>
</td>
<td class="nump">10,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=mlec_NetBookAmountMember', window );">Net book amount [Member] | Vehicles [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">24,037<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">24,037<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">24,037<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">24,037<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=mlec_NetBookAmountMember', window );">Net book amount [Member] | Furniture [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,083<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,083<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,083<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,083<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=mlec_NetBookAmountMember', window );">Net book amount [Member] | Storage [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">57,604<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">57,604<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">57,604<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">57,604<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=mlec_NetBookAmountMember', window );">Net book amount [Member] | Computer equipment [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,606<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,606<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,606<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,606<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=mlec_NetBookAmountMember', window );">Net book amount [Member] | Machinery [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems', window );"><strong>Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,040,533<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Accumulated Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,040,533<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,040,533<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_YearEndedJune302021Abstract0', window );"><strong>Year ended June 30, 2021</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Opening net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Closing net book amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,040,533<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The depreciation charge is included in Administrative expenses
and Cost of sales (see notes 24 and 26).</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in property, plant and equipment resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73_e_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73_e_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73_e_vii&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 75<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_75_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73_e_viii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_YearEndedJune302021Abstract0">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_YearEndedJune302021Abstract0</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mlec_ChymosinOsmosisEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mlec_ChymosinOsmosisEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mlec_FurnitureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mlec_FurnitureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mlec_StorageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=mlec_StorageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=mlec_NetBookAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=mlec_NetBookAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417710656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill (Details) - Schedule of Goodwill - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfGoodwillAbstract', window );"><strong>Schedule of Goodwill [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 251,440<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TotalGoodwill', window );">Total Goodwill</a></td>
<td class="nump">$ 251,440<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2023-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2023-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2023-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TotalGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TotalGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417731504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right of Use of Assets (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RightofUseOfAssetsAbstract', window );"><strong>Right-of-Use of Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OriginalAmount', window );">Original amount</a></td>
<td class="nump">$ 43,507<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_OriginalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Original amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_OriginalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_RightofUseOfAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_RightofUseOfAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539412527504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right of Use of Assets (Details) - Schedule of Right of Use of Assets<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfRightOfUseOfAssetsAbstract', window );"><strong>Schedule of Right-of-Use of Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">As of June 30, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AcquisitionsThroughBusinessCombinationsi', window );">Acquisitions through business combinations (i)</a></td>
<td class="nump">43,507<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_EffectOfChangesInForeignExchangeRates', window );">Effect of changes in foreign exchange rates</a></td>
<td class="nump">299<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">As of June 30, 2023</a></td>
<td class="nump">$ 43,806<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Through the ValoraSoy acquisition, the Group acquired a parcel of land for an original amount of $ 43,507.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AcquisitionsThroughBusinessCombinationsi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisitions through business combinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AcquisitionsThroughBusinessCombinationsi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_EffectOfChangesInForeignExchangeRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effect of changes in foreign exchange rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_EffectOfChangesInForeignExchangeRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfRightOfUseOfAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfRightOfUseOfAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539412155584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Non-Current Receivables (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OtherNonCurrentReceivablesDetailsLineItems', window );"><strong>Other Non-Current Receivables (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Ordinary shares issued</a></td>
<td class="nump">32,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AggregatePurchasePrice', window );">Aggregate purchase price (in Dollars) | $</a></td>
<td class="nump">$ 15,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PurchasePaymentTerms', window );">Purchase payment term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Internal rate percentage</a></td>
<td class="nump">13.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OtherNonCurrentReceivablesDetailsLineItems', window );"><strong>Other Non-Current Receivables (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Ordinary shares issued</a></td>
<td class="nump">2,354,069<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OtherNonCurrentReceivablesDetailsLineItems', window );"><strong>Other Non-Current Receivables (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Ordinary shares issued</a></td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_MoolecScienceLimitedMember', window );">Moolec Science Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OtherNonCurrentReceivablesDetailsLineItems', window );"><strong>Other Non-Current Receivables (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued', window );">Ordinary shares issued</a></td>
<td class="nump">2,354,069<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the number of ordinary shares issued. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AggregatePurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate purchase price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AggregatePurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_OtherNonCurrentReceivablesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_OtherNonCurrentReceivablesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PurchasePaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of purchase payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PurchasePaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_MoolecScienceLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_MoolecScienceLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539421771008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Non-Current Receivables (Details) - Schedule of Other Non-Current Receivables - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfOtherNonCurrentReceivablesAbstract', window );"><strong>Schedule Of Other Non Current Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentReceivables', window );">Receivables with shareholders</a></td>
<td class="nump">$ 8,763,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentReceivables', window );">Total Other Non-Current receivables</a></td>
<td class="nump">$ 8,763,027<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current trade receivables and non-current other receivables. [Refer: Non-current trade receivables; Other non-current receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current other receivables. [Refer: Other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfOtherNonCurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfOtherNonCurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539405684512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash and Cash Equivalents (Details) - Schedule of Cash and Cash Equivalents - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems', window );"><strong>Schedule of cash and cash equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Cash', window );">Cash</a></td>
<td class="nump">$ 2,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepositsFromBanks', window );">Bank accounts</a></td>
<td class="nump">2,061,636<span></span>
</td>
<td class="nump">$ 1,081,808<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents', window );">Short-term investments</a></td>
<td class="nump">463,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCashAndCashEquivalents', window );">Total cash and cash equivalents</a></td>
<td class="nump">$ 2,527,673<span></span>
</td>
<td class="nump">$ 1,081,808<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits. [Refer: Cash on hand]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepositsFromBanks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deposit liabilities from banks held by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepositsFromBanks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and cash equivalents that the entity does not separately disclose in the same statement or note. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A classification of cash equivalents representing short-term deposits. [Refer: Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539416473312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short Term Investments (Details) - Schedule of Short Term Investments - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfShortTermInvestmentsAbstract', window );"><strong>Schedule of Short Term Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_MutualFunds', window );">Mutual funds</a></td>
<td class="nump">$ 306,034<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TotalMutualFunds', window );">Total Short-term investments</a></td>
<td class="nump">$ 306,034<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_MutualFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of short term mutual funds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_MutualFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfShortTermInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfShortTermInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TotalMutualFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of total short-term investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TotalMutualFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539413534816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Trade Receivable and Other Current Receivables (Details) - Schedule of Trade Receivable - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfTradeReceivableAbstract', window );"><strong>Schedule Of Trade Receivable Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Accounts receivable</a></td>
<td class="nump">$ 361,097<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivables', window );">Total Trade receivable</a></td>
<td class="nump">$ 361,097<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of trade receivables and other receivables. [Refer: Trade receivables; Other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount due from customers for goods and services sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfTradeReceivableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfTradeReceivableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539412251440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Trade Receivable and Other Current Receivables (Details) - Schedule of Other Current Receivables - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfOtherCurrentReceivablesAbstract', window );"><strong>Schedule of Other Current Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentValueAddedTaxReceivables', window );">Taxes</a></td>
<td class="nump">$ 952,953<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentReceivables', window );">Others</a></td>
<td class="nump">377,224<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivables', window );">Total Other current receivables</a></td>
<td class="nump">$ 1,330,177<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentValueAddedTaxReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current value added tax receivables. [Refer: Value added tax receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentValueAddedTaxReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current other receivables. [Refer: Other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfOtherCurrentReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfOtherCurrentReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417470416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - Schedule of Inventories - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfInventoriesAbstract', window );"><strong>Schedule of Inventories [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 179,368<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinishedGoods', window );">Finished goods</a></td>
<td class="nump">286,380<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InventoriesTotal', window );">Total Inventories</a></td>
<td class="nump">$ 465,748<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InventoriesTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets: (a) held for sale in the ordinary course of business; (b) in the process of production for such sale; or (c) in the form of materials or supplies to be consumed in the production process or in the rendering of services. Inventories encompass goods purchased and held for resale including, for example, merchandise purchased by a retailer and held for resale, or land and other property held for resale. Inventories also encompass finished goods produced, or work in progress being produced, by the entity and include materials and supplies awaiting use in the production process. [Refer: Current finished goods; Current merchandise; Current work in progress; Land]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InventoriesTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A classification of current inventory representing the amount of assets to be consumed in the production process or in the rendering of services. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539422424656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share Capital and Share Premium (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Apr. 14, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareCapitalAndSharePremiumAbstract', window );"><strong>Share Capital and Share Premium [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareCapitalStockAndSharePremiumAmounts', window );">Share capital stock and share premium amounts</a></td>
<td class="nump">$ 66,996,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_Equivalent', window );">Equivalent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SharePurchaseAgreementOverPeriod', window );">Share purchase Agreement over period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_UnderIssuedSharePurchaseAgreement', window );">Shares issued (in Shares)</a></td>
<td class="nump">3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SharePurchaseAgreement', window );">Share Purchase Agreement</a></td>
<td class="nump">$ 10,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_Equivalent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Amount Equivalent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_Equivalent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShareCapitalAndSharePremiumAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShareCapitalAndSharePremiumAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShareCapitalStockAndSharePremiumAmounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShareCapitalStockAndSharePremiumAmounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SharePurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Purchase Agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SharePurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SharePurchaseAgreementOverPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share purchase Agreement over period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SharePurchaseAgreementOverPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_UnderIssuedSharePurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of under share issued agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_UnderIssuedSharePurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539412933824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital and Share Premium (Details) - Schedule of Reconciliation of Share Capital and Share Premium - USD ($)<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems', window );"><strong>Share Capital and Share Premium (Details) - Schedule of Reconciliation of Share Capital and Share Premium [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares,Opening balance (in Shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">29,140,000<span></span>
</td>
<td class="nump">31,000,000<span></span>
</td>
<td class="nump">31,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SharesIssuedAmount', window );">Shares issued amount,Opening balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 291,400<span></span>
</td>
<td class="nump">$ 310,000<span></span>
</td>
<td class="nump">$ 310,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareToBeIssuedAmount', window );">Shares to be issued amount,Opening balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Share Premium,Opening balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 4,308,600<span></span>
</td>
<td class="nump">$ 7,290,000<span></span>
</td>
<td class="nump">$ 7,290,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfSharesIssueOfShareCapitalinShares', window );">Number of shares, Issue of share capital (in Shares)</a></td>
<td class="nump">29,140,000<span></span>
</td>
<td class="nump">1,860,000<span></span>
</td>
<td class="nump">3,519<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsForShareIssueCosts', window );">Shares issued amount, Issue of share capital</a></td>
<td class="nump">$ 291,400<span></span>
</td>
<td class="nump">$ 18,600<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SharesToBeIssuedAmountIssueOfShareCapital', window );">Shares to be issued amount, Issue of share capital</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SharePremiumIssueOfShareCapital', window );">Share Premium, Issue of share capital</a></td>
<td class="nump">$ 4,308,600<span></span>
</td>
<td class="nump">$ 2,981,400<span></span>
</td>
<td class="nump">$ 10,647<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfSharesFromBusinessAcquisition', window );">Number of shares, From business acquisition (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SharesIssuedAmountFromBusinessAcquisition', window );">Shares issued amount, From business acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SharesToBeIssuedAmountFromBusinessAcquisition', window );">Shares to be issued amount, From business acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SharePremiumFromBusinessAcquisition', window );">Share Premium, From business acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 217,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfShareEquitySettledShareBasedPayment', window );">Number of shares, Equity settled share based payment (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SharesIssuedAmountEquitySettledShareBasedPayment', window );">Shares issued amount, Equity settled share based payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SharesToBeIssuedAmountEquitySettledShareBasedPayment', window );">Shares to be issued amount, Equity settled share based payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SharePremiumEquitySettledShareBasedPayment', window );">Share Premium, Equity settled share based payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 593,684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares, Ending balance (in Shares)</a></td>
<td class="nump">29,140,000<span></span>
</td>
<td class="nump">31,000,000<span></span>
</td>
<td class="nump">37,563,768<span></span>
</td>
<td class="nump">31,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SharesIssuedAmount', window );">Shares issued amount, Ending balance</a></td>
<td class="nump">$ 291,400<span></span>
</td>
<td class="nump">$ 310,000<span></span>
</td>
<td class="nump">$ 375,641<span></span>
</td>
<td class="nump">$ 310,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareToBeIssuedAmount', window );">Shares to be issued amount, Ending balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,068<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Share Premium, Ending balance</a></td>
<td class="nump">$ 4,308,600<span></span>
</td>
<td class="nump">$ 7,290,000<span></span>
</td>
<td class="nump">$ 66,996,982<span></span>
</td>
<td class="nump">$ 7,290,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=mlec_MoolecScienceSharesMember', window );">Issue of share capital (Moolec Science shares) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems', window );"><strong>Share Capital and Share Premium (Details) - Schedule of Reconciliation of Share Capital and Share Premium [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfSharesIssueOfShareCapitalinShares', window );">Number of shares, Issue of share capital (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsForShareIssueCosts', window );">Shares issued amount, Issue of share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SharesToBeIssuedAmountIssueOfShareCapital', window );">Shares to be issued amount, Issue of share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SharePremiumIssueOfShareCapital', window );">Share Premium, Issue of share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,105,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=mlec_SAFESharesMember', window );">Issue of share capital (SAFE shares) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems', window );"><strong>Share Capital and Share Premium (Details) - Schedule of Reconciliation of Share Capital and Share Premium [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfSharesIssueOfShareCapitalinShares', window );">Number of shares, Issue of share capital (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">262,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsForShareIssueCosts', window );">Shares issued amount, Issue of share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SharesToBeIssuedAmountIssueOfShareCapital', window );">Shares to be issued amount, Issue of share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SharePremiumIssueOfShareCapital', window );">Share Premium, Issue of share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,170,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=mlec_LightJumpSharesMember', window );">Issue of share capital (LightJump shares) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems', window );"><strong>Share Capital and Share Premium (Details) - Schedule of Reconciliation of Share Capital and Share Premium [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfSharesIssueOfShareCapitalinShares', window );">Number of shares, Issue of share capital (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,363,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsForShareIssueCosts', window );">Shares issued amount, Issue of share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SharesToBeIssuedAmountIssueOfShareCapital', window );">Shares to be issued amount, Issue of share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SharePremiumIssueOfShareCapital', window );">Share Premium, Issue of share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,610,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=mlec_BackstopSharesMember', window );">Issue of share capital (Backstop shares) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems', window );"><strong>Share Capital and Share Premium (Details) - Schedule of Reconciliation of Share Capital and Share Premium [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfSharesIssueOfShareCapitalinShares', window );">Number of shares, Issue of share capital (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,201,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsForShareIssueCosts', window );">Shares issued amount, Issue of share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SharesToBeIssuedAmountIssueOfShareCapital', window );">Shares to be issued amount, Issue of share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SharePremiumIssueOfShareCapital', window );">Share Premium, Issue of share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,999,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsForShareIssueCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for share issue costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsForShareIssueCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharePremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount received or receivable from the issuance of the entity's shares in excess of nominal value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharePremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NumberOfShareEquitySettledShareBasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A share-based payment is a transaction in which the entity receives goods or services either as consideration for its equity instruments or by incurring liabilities for amounts based on the price of the entity's shares or other equity instruments of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NumberOfShareEquitySettledShareBasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NumberOfSharesFromBusinessAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisition occurs when one company buys the shares of another company in an effort to gain control over that company. In simple terms you can say that acquisition is an act of one company taking over or acquiring another company's controlling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NumberOfSharesFromBusinessAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NumberOfSharesIssueOfShareCapitalinShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issue of share capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NumberOfSharesIssueOfShareCapitalinShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SharePremiumEquitySettledShareBasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of share premium equity settled share based payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SharePremiumEquitySettledShareBasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SharePremiumFromBusinessAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of share premium from business acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SharePremiumFromBusinessAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SharePremiumIssueOfShareCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of share premium issue of share capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SharePremiumIssueOfShareCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShareToBeIssuedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of shares to be issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShareToBeIssuedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SharesIssuedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of shares issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SharesIssuedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SharesIssuedAmountEquitySettledShareBasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of shares issued amount equity settled share based payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SharesIssuedAmountEquitySettledShareBasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SharesIssuedAmountFromBusinessAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of shares issued amount from business acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SharesIssuedAmountFromBusinessAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SharesToBeIssuedAmountEquitySettledShareBasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of shares to be issued equity settled share based payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SharesToBeIssuedAmountEquitySettledShareBasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SharesToBeIssuedAmountFromBusinessAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of shares to be issued from business acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SharesToBeIssuedAmountFromBusinessAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SharesToBeIssuedAmountIssueOfShareCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of shares to be issued amount issue of share capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SharesToBeIssuedAmountIssueOfShareCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=mlec_MoolecScienceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=mlec_MoolecScienceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=mlec_SAFESharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=mlec_SAFESharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=mlec_LightJumpSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=mlec_LightJumpSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=mlec_BackstopSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=mlec_BackstopSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539424310592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Based Payment (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareBasedPaymentDetailsLineItems', window );"><strong>Share Based Payment (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ConstantValuePercentage', window );">Constant value percentage</a></td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OptionsRecognizedAmount', window );">Options recognized amount | $</a></td>
<td class="nump">$ 508,149<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_Group1GrantedMember', window );">Group 1 Granted [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareBasedPaymentDetailsLineItems', window );"><strong>Share Based Payment (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OrdinaryShares', window );">Ordinary shares | shares</a></td>
<td class="nump">579,078<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019', window );">Exercise price | $ / shares</a></td>
<td class="nump">$ 1.52<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_Group2GrantedMember', window );">Group 2 Granted [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareBasedPaymentDetailsLineItems', window );"><strong>Share Based Payment (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OrdinaryShares', window );">Ordinary shares | shares</a></td>
<td class="nump">346,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019', window );">Exercise price | $ / shares</a></td>
<td class="nump">$ 8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_Group3GrantedMember', window );">Group 3 Granted [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareBasedPaymentDetailsLineItems', window );"><strong>Share Based Payment (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OrdinaryShares', window );">Ordinary shares | shares</a></td>
<td class="nump">700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019', window );">Exercise price | $ / shares</a></td>
<td class="nump">$ 4.25<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45_b_v&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ConstantValuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of constant value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ConstantValuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_OptionsRecognizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of options recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_OptionsRecognizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_OrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_OrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShareBasedPaymentDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShareBasedPaymentDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_Group1GrantedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_Group1GrantedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_Group2GrantedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_Group2GrantedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_Group3GrantedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=mlec_Group3GrantedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539411467568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Based Payment (Details) - Schedule and the Possible Dilutive Effect of the Future Exercise of Options<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>$ / shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CreationDateAxis=mlec_Group1Member', window );">Group 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems', window );"><strong>Share Based Payment (Details) - Schedule and the Possible Dilutive Effect of the Future Exercise of Options [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FairValueOfSharesinShares', window );">Fair value of shares (in Dollars per share)</a></td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExercisePrice', window );">Exercise price</a></td>
<td class="text">$1.52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">70.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Dividend rate</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Reference risk-free interest rate</a></td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PlanDuration', window );">Plan duration</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FairValueOfStockOptionsAtMeasurementDate', window );">Fair value of stock options at measurement date</a></td>
<td class="text">9 years 1 month 9 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CreationDateAxis=mlec_Group2Member', window );">Group 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems', window );"><strong>Share Based Payment (Details) - Schedule and the Possible Dilutive Effect of the Future Exercise of Options [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FairValueOfSharesinShares', window );">Fair value of shares (in Dollars per share)</a></td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExercisePrice', window );">Exercise price</a></td>
<td class="text">$8.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">70.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Dividend rate</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Reference risk-free interest rate</a></td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PlanDuration', window );">Plan duration</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FairValueOfStockOptionsAtMeasurementDate', window );">Fair value of stock options at measurement date</a></td>
<td class="text">7 years 3 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CreationDateAxis=mlec_Group3Member', window );">Group 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems', window );"><strong>Share Based Payment (Details) - Schedule and the Possible Dilutive Effect of the Future Exercise of Options [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FairValueOfSharesinShares', window );">Fair value of shares (in Dollars per share)</a></td>
<td class="nump">$ 2.97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExercisePrice', window );">Exercise price</a></td>
<td class="text">$4.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility</a></td>
<td class="nump">70.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Dividend rate</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Reference risk-free interest rate</a></td>
<td class="nump">4.25%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PlanDuration', window );">Plan duration</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FairValueOfStockOptionsAtMeasurementDate', window );">Fair value of stock options at measurement date</a></td>
<td class="text">2 years 14 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of an expected dividend used to calculate the fair value of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FairValueOfSharesinShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of shares price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FairValueOfSharesinShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FairValueOfStockOptionsAtMeasurementDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of stock options at measurement date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FairValueOfStockOptionsAtMeasurementDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PlanDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The duration of plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PlanDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CreationDateAxis=mlec_Group1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CreationDateAxis=mlec_Group1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CreationDateAxis=mlec_Group2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CreationDateAxis=mlec_Group2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CreationDateAxis=mlec_Group3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CreationDateAxis=mlec_Group3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539411524912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Based Payment (Details) - Schedule of Amount and Exercise Price and the Movements of the Stock Options of Executives and Managers<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CreationDateAxis=mlec_Group1Member', window );">Group 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems', window );"><strong>Share Based Payment (Details) - Schedule of Amount and Exercise Price and the Movements of the Stock Options of Executives and Managers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfOptionsAtTheBeginning', window );">Number of options, At the beginning | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExercisePriceAtTheBeginning', window );">Exercise price, At the beginning | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfOptionsGrantedDuringThePeriod', window );">Number of options, Granted during the period | shares</a></td>
<td class="nump">579,078<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExercisePriceGrantedDuringThePeriod', window );">Exercise price, Granted during the period | $ / shares</a></td>
<td class="nump">$ 1.52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfOptionsForfeitedDuringThePeriod', window );">Number of options, Forfeited during the period | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExercisePriceForfeitedDuringThePeriod', window );">Exercise price, Forfeited during the period | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfOptionsExercisedDuringThePeriod', window );">Number of options, Exercised during the period | shares</a></td>
<td class="nump">253,252<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExercisePriceExercisedDuringThePeriod', window );">Exercise price, Exercised during the period | $ / shares</a></td>
<td class="nump">$ 1.52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfOptionsExpiredDuringThePeriod', window );">Number of options, Expired during the period | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExercisePriceExpiredDuringThePeriod', window );">Exercise price, Expired during the period | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfOptionsAtTheEnding', window );">Number of options,At the ending | shares</a></td>
<td class="nump">325,826<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExercisePriceAtTheEnding', window );">Exercise price, At the ending | $ / shares</a></td>
<td class="nump">$ 1.52<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CreationDateAxis=mlec_Group2Member', window );">Group 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems', window );"><strong>Share Based Payment (Details) - Schedule of Amount and Exercise Price and the Movements of the Stock Options of Executives and Managers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfOptionsAtTheBeginning', window );">Number of options, At the beginning | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExercisePriceAtTheBeginning', window );">Exercise price, At the beginning | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfOptionsGrantedDuringThePeriod', window );">Number of options, Granted during the period | shares</a></td>
<td class="nump">346,555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExercisePriceGrantedDuringThePeriod', window );">Exercise price, Granted during the period | $ / shares</a></td>
<td class="nump">$ 8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfOptionsForfeitedDuringThePeriod', window );">Number of options, Forfeited during the period | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExercisePriceForfeitedDuringThePeriod', window );">Exercise price, Forfeited during the period | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfOptionsExercisedDuringThePeriod', window );">Number of options, Exercised during the period | shares</a></td>
<td class="nump">139,957<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExercisePriceExercisedDuringThePeriod', window );">Exercise price, Exercised during the period | $ / shares</a></td>
<td class="nump">$ 8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfOptionsExpiredDuringThePeriod', window );">Number of options, Expired during the period | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExercisePriceExpiredDuringThePeriod', window );">Exercise price, Expired during the period | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfOptionsAtTheEnding', window );">Number of options,At the ending | shares</a></td>
<td class="nump">206,598<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExercisePriceAtTheEnding', window );">Exercise price, At the ending | $ / shares</a></td>
<td class="nump">$ 8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CreationDateAxis=mlec_Group3Member', window );">Group 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems', window );"><strong>Share Based Payment (Details) - Schedule of Amount and Exercise Price and the Movements of the Stock Options of Executives and Managers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfOptionsAtTheBeginning', window );">Number of options, At the beginning | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExercisePriceAtTheBeginning', window );">Exercise price, At the beginning | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfOptionsGrantedDuringThePeriod', window );">Number of options, Granted during the period | shares</a></td>
<td class="nump">700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExercisePriceGrantedDuringThePeriod', window );">Exercise price, Granted during the period | $ / shares</a></td>
<td class="nump">$ 4.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfOptionsForfeitedDuringThePeriod', window );">Number of options, Forfeited during the period | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExercisePriceForfeitedDuringThePeriod', window );">Exercise price, Forfeited during the period | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfOptionsExercisedDuringThePeriod', window );">Number of options, Exercised during the period | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExercisePriceExercisedDuringThePeriod', window );">Exercise price, Exercised during the period | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfOptionsExpiredDuringThePeriod', window );">Number of options, Expired during the period | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExercisePriceExpiredDuringThePeriod', window );">Exercise price, Expired during the period | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfOptionsAtTheEnding', window );">Number of options,At the ending | shares</a></td>
<td class="nump">700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExercisePriceAtTheEnding', window );">Exercise price, At the ending | $ / shares</a></td>
<td class="nump">$ 4.25<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ExercisePriceAtTheBeginning">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share balance at beginning.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ExercisePriceAtTheBeginning</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ExercisePriceAtTheEnding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share balance at the ending.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ExercisePriceAtTheEnding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ExercisePriceExercisedDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price, exercised during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ExercisePriceExercisedDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ExercisePriceExpiredDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price, expired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ExercisePriceExpiredDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ExercisePriceForfeitedDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price, forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ExercisePriceForfeitedDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ExercisePriceGrantedDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price, granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ExercisePriceGrantedDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NumberOfOptionsAtTheBeginning">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NumberOfOptionsAtTheBeginning</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NumberOfOptionsAtTheEnding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options, at the ending.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NumberOfOptionsAtTheEnding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NumberOfOptionsExercisedDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options shares exercised during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NumberOfOptionsExercisedDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NumberOfOptionsExpiredDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options shares expired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NumberOfOptionsExpiredDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NumberOfOptionsForfeitedDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options shares forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NumberOfOptionsForfeitedDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NumberOfOptionsGrantedDuringThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of option granted shares during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NumberOfOptionsGrantedDuringThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CreationDateAxis=mlec_Group1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CreationDateAxis=mlec_Group1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CreationDateAxis=mlec_Group2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CreationDateAxis=mlec_Group2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CreationDateAxis=mlec_Group3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CreationDateAxis=mlec_Group3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539412448032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts Payable and Other Current and Non-Current Liabilities (Details) - Schedule of Accounts Payable - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfAccountsPayableAbstract', window );"><strong>Schedule of Accounts Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities', window );">Transaction expenses payable</a></td>
<td class="nump">$ 3,579,057<span></span>
</td>
<td class="nump">$ 485,735<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties', window );">Related parties</a></td>
<td class="nump">774,460<span></span>
</td>
<td class="nump">385,508<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AccrualsClassifiedAsNoncurrent', window );">Accruals</a></td>
<td class="nump">787,010<span></span>
</td>
<td class="nump">190,843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="nump">2,339,087<span></span>
</td>
<td class="nump">164,127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Total Accounts payable</a></td>
<td class="nump">7,479,614<span></span>
</td>
<td class="nump">1,226,213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPayablesToRelatedParties', window );">Related parties</a></td>
<td class="nump">677,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredPaymentRelatedToBusinessCombination', window );">Deferred payment related to Business Combination</a></td>
<td class="nump">492,799<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_Wages', window );">Wages</a></td>
<td class="nump">221,141<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_Taxes', window );">Taxes</a></td>
<td class="nump">21,783<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PayAsYouEarnPAYE', window );">Pay As You Earn (PAYE)</a></td>
<td class="nump">1,551<span></span>
</td>
<td class="nump">1,171<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentNonfinancialLiabilities', window );">Others</a></td>
<td class="nump">271,371<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentLiabilities', window );">Total Other current liabilities</a></td>
<td class="nump">1,685,645<span></span>
</td>
<td class="nump">1,171<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentNonfinancialLiabilities', window );">Others</a></td>
<td class="nump">175,312<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentLiabilities', window );">Other non-current liabilities</a></td>
<td class="nump">$ 175,312<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AccrualsClassifiedAsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of accruals classified as non-current. [Refer: Accruals]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AccrualsClassifiedAsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current accrued expenses and other current liabilities. [Refer: Accruals; Other current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentNonfinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current non-financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentNonfinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentNonfinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current non-financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentNonfinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of trade payables and other payables. [Refer: Trade payables; Other payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of payment due to suppliers for goods and services used in the entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DeferredPaymentRelatedToBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DeferredPaymentRelatedToBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PayAsYouEarnPAYE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pay as you earn.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PayAsYouEarnPAYE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfAccountsPayableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfAccountsPayableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_Taxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_Taxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_Wages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of wages.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_Wages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539413401168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Debt (Details) - Schedule of Financial Debt - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofFinancialDebtLineItems', window );"><strong>Financial Debt (Details) - Schedule of Financial Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialAssetsAtAmortisedCost', window );">Total Current Financial Debt</a></td>
<td class="nump">$ 2,546,243<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=currency_ARS', window );">Financial Debt denominated in Argentine Pesos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofFinancialDebtLineItems', window );"><strong>Financial Debt (Details) - Schedule of Financial Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialAssetsAtAmortisedCost', window );">Total Current Financial Debt</a></td>
<td class="nump">517,743<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=country_US', window );">Financial Debt denominated in US Dollars [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofFinancialDebtLineItems', window );"><strong>Financial Debt (Details) - Schedule of Financial Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialAssetsAtAmortisedCost', window );">Total Current Financial Debt</a></td>
<td class="nump">$ 2,028,500<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentFinancialAssetsAtAmortisedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial assets measured at amortised cost. [Refer: Financial assets at amortised cost]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 8<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_8_f&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentFinancialAssetsAtAmortisedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FinancialDebtDetailsScheduleofFinancialDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FinancialDebtDetailsScheduleofFinancialDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=currency_ARS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=currency_ARS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539424444224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Debt (Details) - Schedule of Book Value is Reasonably Approximate to the Fair Value given its Short-Term Nature - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureLineItems', window );"><strong>Financial Debt (Details) - Schedule of Book Value is Reasonably Approximate to the Fair Value given its Short-Term Nature [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssets', window );">Total Non-current Financial Debt</a></td>
<td class="nump">$ 99,046<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CounterpartiesAxis=currency_ARS', window );">Financial Debt denominated in Argentine Pesos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureLineItems', window );"><strong>Financial Debt (Details) - Schedule of Book Value is Reasonably Approximate to the Fair Value given its Short-Term Nature [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssets', window );">Total Non-current Financial Debt</a></td>
<td class="nump">$ 99,046<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=currency_ARS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=currency_ARS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539404360064">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoMacroPreFinancingOfExportsMember', window );">Banco Macro - Pre-Financing of Exports [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingOriginalCurrency', window );">Currency of denomination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">ARS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk', window );">Nominal value (equivalent in USD)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 147,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Outstanding loans balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 173,236<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoMacroPreFinancingOfExportsMember', window );">Banco Macro - Pre-Financing of Exports [Member] | Bottom of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NominalInterestRate', window );">Nominal interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingMaturity', window );">Date of maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">07/17/2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoMacroPreFinancingOfExportsMember', window );">Banco Macro - Pre-Financing of Exports [Member] | Top of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NominalInterestRate', window );">Nominal interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">88.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingMaturity', window );">Date of maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">12/27/2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoNacinPreFinancingOfExportsMember', window );">Banco Naci&#243;n - Pre-Financing of Exports [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingOriginalCurrency', window );">Currency of denomination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">USD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk', window );">Nominal value (equivalent in USD)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 28,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingMaturity', window );">Date of maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">10/6/2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Outstanding loans balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 28,635<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoNacinPreFinancingOfExportsMember', window );">Banco Naci&#243;n - Pre-Financing of Exports [Member] | Bottom of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NominalInterestRate', window );">Nominal interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoNacinPreFinancingOfExportsMember', window );">Banco Naci&#243;n - Pre-Financing of Exports [Member] | Top of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NominalInterestRate', window );">Nominal interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoCrdobaPreFinancingOfExportsMember', window );">Banco C&#243;rdoba - Pre-Financing of Exports [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingOriginalCurrency', window );">Currency of denomination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">ARS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk', window );">Nominal value (equivalent in USD)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 142,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Outstanding loans balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 156,057<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoCrdobaPreFinancingOfExportsMember', window );">Banco C&#243;rdoba - Pre-Financing of Exports [Member] | Bottom of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NominalInterestRate', window );">Nominal interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">55.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingMaturity', window );">Date of maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">01/11/2023 <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoCrdobaPreFinancingOfExportsMember', window );">Banco C&#243;rdoba - Pre-Financing of Exports [Member] | Top of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NominalInterestRate', window );">Nominal interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">88.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingMaturity', window );">Date of maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> 06/26/2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoGaliciaBankOverdraftsMember', window );">Banco Galicia - Bank Overdrafts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingOriginalCurrency', window );">Currency of denomination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">ARS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk', window );">Nominal value (equivalent in USD)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 18,849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingMaturity', window );">Date of maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">06/30/2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Outstanding loans balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 18,849<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoGaliciaBankOverdraftsMember', window );">Banco Galicia - Bank Overdrafts [Member] | Bottom of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NominalInterestRate', window );">Nominal interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">144.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoGaliciaBankOverdraftsMember', window );">Banco Galicia - Bank Overdrafts [Member] | Top of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NominalInterestRate', window );">Nominal interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">144.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_HSBCBankBankOverdraftsMember', window );">HSBC Bank - Bank Overdrafts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingOriginalCurrency', window );">Currency of denomination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">ARS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk', window );">Nominal value (equivalent in USD)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingMaturity', window );">Date of maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">06/30/2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Outstanding loans balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4,625<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_HSBCBankBankOverdraftsMember', window );">HSBC Bank - Bank Overdrafts [Member] | Bottom of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NominalInterestRate', window );">Nominal interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">108.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_HSBCBankBankOverdraftsMember', window );">HSBC Bank - Bank Overdrafts [Member] | Top of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NominalInterestRate', window );">Nominal interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">108.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoSantanderBankOverdraftsMember', window );">Banco Santander - Bank Overdrafts [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingOriginalCurrency', window );">Currency of denomination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">ARS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk', window );">Nominal value (equivalent in USD)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 41,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingMaturity', window );">Date of maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">06/30/2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Outstanding loans balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 44,446<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoSantanderBankOverdraftsMember', window );">Banco Santander - Bank Overdrafts [Member] | Bottom of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NominalInterestRate', window );">Nominal interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">161.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoSantanderBankOverdraftsMember', window );">Banco Santander - Bank Overdrafts [Member] | Top of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NominalInterestRate', window );">Nominal interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">161.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoGaliciaLoansMember', window );">Banco Galicia - Loans [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingOriginalCurrency', window );">Currency of denomination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">ARS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk', window );">Nominal value (equivalent in USD)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 99,643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Outstanding loans balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 33,728<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoGaliciaLoansMember', window );">Banco Galicia - Loans [Member] | Bottom of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NominalInterestRate', window );">Nominal interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingMaturity', window );">Date of maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">08/21/2023 <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoGaliciaLoansMember', window );">Banco Galicia - Loans [Member] | Top of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NominalInterestRate', window );">Nominal interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingMaturity', window );">Date of maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> 01/25/2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_HSBCBankLoansMember', window );">HSBC Bank - Loans [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingOriginalCurrency', window );">Currency of denomination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">ARS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk', window );">Nominal value (equivalent in USD)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 19,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingMaturity', window );">Date of maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">07/27/2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Outstanding loans balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 14,940<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_HSBCBankLoansMember', window );">HSBC Bank - Loans [Member] | Bottom of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NominalInterestRate', window );">Nominal interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">64.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_HSBCBankLoansMember', window );">HSBC Bank - Loans [Member] | Top of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NominalInterestRate', window );">Nominal interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">64.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoSantanderLoansMember', window );">Banco Santander - Loans [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingOriginalCurrency', window );">Currency of denomination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">ARS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk', window );">Nominal value (equivalent in USD)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 119,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Outstanding loans balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 118,185<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoSantanderLoansMember', window );">Banco Santander - Loans [Member] | Bottom of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NominalInterestRate', window );">Nominal interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingMaturity', window );">Date of maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">09/03/2026 <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoSantanderLoansMember', window );">Banco Santander - Loans [Member] | Top of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NominalInterestRate', window );">Nominal interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">57.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingMaturity', window );">Date of maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> 03/04/2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoMacroLoansMember', window );">Banco Macro - Loans [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingOriginalCurrency', window );">Currency of denomination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">ARS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk', window );">Nominal value (equivalent in USD)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 11,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingMaturity', window );">Date of maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">7/12/2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Outstanding loans balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,257<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoMacroLoansMember', window );">Banco Macro - Loans [Member] | Bottom of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NominalInterestRate', window );">Nominal interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">54.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoMacroLoansMember', window );">Banco Macro - Loans [Member] | Top of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NominalInterestRate', window );">Nominal interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">54.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_PromissoryNotesMember', window );">Promissory Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingOriginalCurrency', window );">Currency of denomination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">USD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk', window );">Nominal value (equivalent in USD)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Outstanding loans balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_PromissoryNotesMember', window );">Promissory Notes [Member] | Bottom of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NominalInterestRate', window );">Nominal interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingMaturity', window );">Date of maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">05/22/2024 <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_PromissoryNotesMember', window );">Promissory Notes [Member] | Top of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NominalInterestRate', window );">Nominal interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingMaturity', window );">Date of maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> 06/25/2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_AsociacinMutualAMALoansMember', window );">Asociaci&#243;n Mutual AMA &#8211; Loans [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingOriginalCurrency', window );">Currency of denomination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">ARS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk', window );">Nominal value (equivalent in USD)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 42,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Outstanding loans balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 51,331<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_AsociacinMutualAMALoansMember', window );">Asociaci&#243;n Mutual AMA &#8211; Loans [Member] | Bottom of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NominalInterestRate', window );">Nominal interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">53.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingMaturity', window );">Date of maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">07/10/2023 <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=mlec_AsociacinMutualAMALoansMember', window );">Asociaci&#243;n Mutual AMA &#8211; Loans [Member] | Top of Range [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems', window );"><strong>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NominalInterestRate', window );">Nominal interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">53.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_BorrowingMaturity', window );">Date of maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> 04/10/2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Interest rates of our outstanding loans in ARS, correspond
to market rates in the country of incorporation of our newly acquired subsidiary, which deems to be a hyperinflationary economy.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal or principal amount of a financial instrument on discontinuation of its measurement at fair value through profit or loss, because a credit derivative is used to manage the credit risk of that financial instrument. [Refer: Credit risk [member]; Derivatives [member]; Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 24G<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24G_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_BorrowingMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_BorrowingMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_BorrowingOriginalCurrency">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Currency of denomination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_BorrowingOriginalCurrency</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NominalInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NominalInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoMacroPreFinancingOfExportsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_BancoMacroPreFinancingOfExportsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoNacinPreFinancingOfExportsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_BancoNacinPreFinancingOfExportsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoCrdobaPreFinancingOfExportsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_BancoCrdobaPreFinancingOfExportsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoGaliciaBankOverdraftsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_BancoGaliciaBankOverdraftsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_HSBCBankBankOverdraftsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_HSBCBankBankOverdraftsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoSantanderBankOverdraftsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_BancoSantanderBankOverdraftsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoGaliciaLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_BancoGaliciaLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_HSBCBankLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_HSBCBankLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoSantanderLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_BancoSantanderLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_BancoMacroLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_BancoMacroLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_PromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_PromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=mlec_AsociacinMutualAMALoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=mlec_AsociacinMutualAMALoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539427370240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants Liabilities (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_WarrantsLiabilitiesAbstract', window );"><strong>Warrants Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AggregateShares', window );">Aggregate shares (in Shares) | shares</a></td>
<td class="nump">11,110,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceShareOptionsGranted2019', window );">Exercise price</a></td>
<td class="nump">$ 11.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PricePerWarrant', window );">Price per warrant</a></td>
<td class="nump">0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExercisePricePerShare', window );">Exercise price per share</a></td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaidOrdinarySharesPerShare', window );">Ordinary shares per share</a></td>
<td class="nump">$ 0.0799<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPaidOrdinarySharesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends paid per ordinary share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 34<br> -IssueDate 2023-01-01<br> -Paragraph 16A<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=34&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_16A_f&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPaidOrdinarySharesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exercise price of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AggregateShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AggregateShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ExercisePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ExercisePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PricePerWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price per warrant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PricePerWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_WarrantsLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_WarrantsLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539417515040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants Liabilities (Details) - Schedule of Fair Value Ordinary Share of Warrants - Warrants [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsLineItems', window );"><strong>Warrants Liabilities (Details) - Schedule of Fair Value Ordinary Share of Warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_WarrantAndRightsOutstanding', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementEntitysOwnEquityInstruments', window );">Issued by the SPAC</a></td>
<td class="nump">1,666,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FairValueAdjustmentOfWarrant', window );">Fair value remeasurement (Gain)</a></td>
<td class="num">(778,811)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_WarrantAndRightsOutstanding', window );">Balance</a></td>
<td class="nump">$ 887,689<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementEntitysOwnEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) excluding exchange differences, recognised in profit or loss, on the fair value measurement of the entity's own equity instruments. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_e_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementEntitysOwnEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FairValueAdjustmentOfWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FairValueAdjustmentOfWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_WarrantAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_WarrantAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_WarrantReserveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_WarrantReserveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539411457024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Simple Agreement for Future Equity (&#8220;SAFE&#8221;) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jan. 06, 2022</div></th>
<th class="th"><div>Jan. 05, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SimpleAgreementForFutureEquitySafeAbstract', window );"><strong>Simple Agreement for Future Equity Safe [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Signed amount</a></td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentReceivablesFromSaleOfProperties', window );">Amount received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities', window );">Equity financing</a></td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ConvertedShares', window );">Converted shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">262,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PurchasePricePerShare', window );">Purchase price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PurchasePrice', window );">Total purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,173,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentReceivablesFromSaleOfProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current receivables from sale of properties. [Refer: Receivables from sale of properties]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentReceivablesFromSaleOfProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for dividends paid to equity holders of the parent, classified as financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ConvertedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of converted shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ConvertedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PurchasePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PurchasePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PurchasePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PurchasePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SimpleAgreementForFutureEquitySafeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SimpleAgreementForFutureEquitySafeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539422372160">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Simple Agreement for Future Equity (&#8220;SAFE&#8221;) (Details) - Schedule of Financial Instruments - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfFinancialInstrumentsAbstract', window );"><strong>Schedule of Financial Instruments [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue', window );">At the beginning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 2,860,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_Additions', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Results on the change of Fair Value of the SAFE</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">313,346<span></span>
</td>
<td class="nump">860,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SAFECapitalization', window );">SAFE Capitalization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,173,346)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue', window );">At the end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,860,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The result due to the change in the fair value of the SAFE
was included in &#8220;Other financial Results&#8221;.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_Additions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_Additions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SAFECapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Safe capitalization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SAFECapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539422269664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Tax and Income Tax (Details) - LUXEMBOURG - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxandIncomeTaxDetailsLineItems', window );"><strong>Deferred Tax and Income Tax (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IncomeTaxRate', window );">Income tax rate</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncome', window );">Deferred income tax assets</a></td>
<td class="nump">$ 1,631,947<span></span>
</td>
<td class="nump">$ 860,112<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DeferredTaxandIncomeTaxDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DeferredTaxandIncomeTaxDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_IncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_IncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_LU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_LU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539424475856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Tax and Income Tax (Details) - Schedule of Roll Forward of Net Deferred Tax - USD ($)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfRollForwardOfNetDeferredTaxAbstract', window );"><strong>Schedule of Roll Forward of Net Deferred Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Balance at beginning of year</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IncorporatedThroughTheBusinessCombination', window );">Incorporated through the business combination</a></td>
<td class="nump">1,297,436<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss', window );">Credited to profit &amp; loss</a></td>
<td class="num">(234,542)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ChargedToOtherComprehensiveIncome', window );">Charged to Other Comprehensive Income</a></td>
<td class="nump">8,913<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Balance at year end</a></td>
<td class="nump">$ 1,071,807<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ChargedToOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Charged to Other Comprehensive Income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ChargedToOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax expense income recognized in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_IncorporatedThroughTheBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>IncorporatedThroughTheBusinessCombination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_IncorporatedThroughTheBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfRollForwardOfNetDeferredTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfRollForwardOfNetDeferredTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539424291792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Deferred Tax and Income Tax (Details) - Schedule of Principal Statutory Taxes Rates in the Countries<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_AR', window );">Argentina [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesLineItems', window );"><strong>Deferred Tax and Income Tax (Details) - Schedule of Principal Statutory Taxes Rates in the Countries [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TaxJurisdiction', window );">Income tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_AR', window );">Argentina [Member] | Bottom of Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesLineItems', window );"><strong>Deferred Tax and Income Tax (Details) - Schedule of Principal Statutory Taxes Rates in the Countries [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TaxJurisdiction', window );">Income tax rate</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_AR', window );">Argentina [Member] | Top of Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesLineItems', window );"><strong>Deferred Tax and Income Tax (Details) - Schedule of Principal Statutory Taxes Rates in the Countries [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TaxJurisdiction', window );">Income tax rate</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_LU', window );">Luxembourg [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesLineItems', window );"><strong>Deferred Tax and Income Tax (Details) - Schedule of Principal Statutory Taxes Rates in the Countries [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TaxJurisdiction', window );">Income tax rate</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_GB', window );">United Kingdom [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesLineItems', window );"><strong>Deferred Tax and Income Tax (Details) - Schedule of Principal Statutory Taxes Rates in the Countries [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TaxJurisdiction', window );">Income tax rate</a></td>
<td class="nump">19.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=currency_USD', window );">United States of America [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesLineItems', window );"><strong>Deferred Tax and Income Tax (Details) - Schedule of Principal Statutory Taxes Rates in the Countries [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TaxJurisdiction', window );">Income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TaxJurisdiction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TaxJurisdiction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_AR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_AR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_LU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_LU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539424358336">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Deferred Tax and Income Tax (Details) - Schedule of Income Tax for Other Jurisdictions - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfIncomeTaxForOtherJurisdictionsAbstract', window );"><strong>Schedule of Income Tax For Other Jurisdictions [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_LossBeforeTax', window );">Loss before tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (52,023,422)<span></span>
</td>
<td class="num">$ (4,526,905)<span></span>
</td>
<td class="num">$ (1,986,814)<span></span>
</td>
<td class="num">$ (320,524)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CorporateTaxRate', window );">Corporate tax rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AccruedIncomeOtherThanContractAssets', window );">Income tax (benefit)/expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 7,803,513<span></span>
</td>
<td class="nump">$ 860,112<span></span>
</td>
<td class="nump">$ 377,495<span></span>
</td>
<td class="nump">$ 60,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions', window );">Effect of difference tax rates subsidiaries operating in other jurisdictions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">428,506<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TaxLosses', window );">Tax losses</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(1,631,947)<span></span>
</td>
<td class="num">(860,112)<span></span>
</td>
<td class="num">(377,495)<span></span>
</td>
<td class="num">(60,900)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NondeductibleExpensesListingCost', window );">Non-deductible expenses - listing cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(6,405,759)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NetGainOnInflationEffectOnMonetaryItems', window );">Net gain on inflation effect on monetary items</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">52,914<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IncomeTaxInflationAdjustment', window );">Income tax inflation adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(35,826)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_Others', window );">Others</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23,141<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TaxBenefitForTheYear', window );">Tax benefit for the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 234,542<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Deferred tax assets have not been recognized, because it is not probable that future taxable profit will
be available against which the Group can use the benefits therefrom.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AccruedIncomeOtherThanContractAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing income that has been earned but is not yet a receivable, other than contract assets. [Refer: Contract assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AccruedIncomeOtherThanContractAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CorporateTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CorporateTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_IncomeTaxInflationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_IncomeTaxInflationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_LossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_LossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NetGainOnInflationEffectOnMonetaryItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net gain on inflation effect on monetary items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NetGainOnInflationEffectOnMonetaryItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NondeductibleExpensesListingCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NondeductibleExpensesListingCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_Others">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_Others</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfIncomeTaxForOtherJurisdictionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfIncomeTaxForOtherJurisdictionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TaxBenefitForTheYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TaxBenefitForTheYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TaxLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TaxLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539424457616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Deferred Tax and Income Tax (Details) - Schedule of Net Deferred Tax Liabilities - Net deferred tax liabilities [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetAbstract', window );"><strong>Deferred tax asset</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised', window );">Tax loss carry-forward</a></td>
<td class="nump">$ 292,267<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivables', window );">Total other receivables</a></td>
<td class="nump">292,267<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxLiabilityAbstract', window );"><strong>Deferred tax liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CustomerRelationship', window );">Customer relationship</a></td>
<td class="nump">1,346,374<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherLiabilities', window );">Other tax liabilities</a></td>
<td class="nump">17,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Total deferred tax liability</a></td>
<td class="nump">1,364,074<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxLiabilities', window );">Net deferred tax liability</a></td>
<td class="nump">$ 1,071,807<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax liabilities net of deferred tax assets, when the absolute amount of deferred tax liabilities is greater than the absolute amount of deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of unused tax losses for which no deferred tax asset is recognised in the statement of financial position. [Refer: Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CustomerRelationship">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Customer relationship.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CustomerRelationship</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DeferredTaxAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DeferredTaxAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DeferredTaxLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DeferredTaxLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_NetDeferredTaxLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_NetDeferredTaxLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539424311424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Tax and Income Tax (Details) - Schedule of Accumulated Tax Loss Carryforwards<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems', window );"><strong>Deferred Tax and Income Tax (Details) - Schedule of Accumulated Tax Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TaxlossCarryForward', window );">Tax-loss carry forward</a></td>
<td class="nump">$ 835,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax asset</a></td>
<td class="nump">292,267<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CreationDateAxis=mlec_TwoThousandTwentyTwoMember', window );">2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems', window );"><strong>Deferred Tax and Income Tax (Details) - Schedule of Accumulated Tax Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TaxlossCarryForward', window );">Tax-loss carry forward</a></td>
<td class="nump">10,980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax asset</a></td>
<td class="nump">$ 3,843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits', window );">Expiration date</a></td>
<td class="text">2027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory', window );">Tax jurisdiction</a></td>
<td class="text">Argentina<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CreationDateAxis=mlec_TwoThousandTwentyThreeMember', window );">2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems', window );"><strong>Deferred Tax and Income Tax (Details) - Schedule of Accumulated Tax Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TaxlossCarryForward', window );">Tax-loss carry forward</a></td>
<td class="nump">$ 824,069<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax asset</a></td>
<td class="nump">$ 288,424<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits', window );">Expiration date</a></td>
<td class="text">2028<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory', window );">Tax jurisdiction</a></td>
<td class="text">Argentina<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the expiry date (if any) of deductible temporary differences, unused tax losses and unused tax credits for which no deferred tax asset is recognised in the statement of financial position. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the nature of the evidence supporting the recognition of a deferred tax asset when: (a) the utilisation of the deferred tax asset is dependent on future taxable profits in excess of the profits arising from the reversal of existing taxable temporary differences; and (b) the entity has suffered a loss in either the current or preceding period in the tax jurisdiction to which the deferred tax asset relates. [Refer: Temporary differences [member]; Deferred tax asset when utilisation is dependent on future taxable profits in excess of profits from reversal of taxable temporary differences and entity has suffered loss in jurisdiction to which deferred tax asset relates]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 82<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_82&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TaxlossCarryForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tax-loss carry forward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TaxlossCarryForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CreationDateAxis=mlec_TwoThousandTwentyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CreationDateAxis=mlec_TwoThousandTwentyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CreationDateAxis=mlec_TwoThousandTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CreationDateAxis=mlec_TwoThousandTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539411558960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Deferred Tax and Income Tax (Details) - Schedule of Estimated Future Taxable Profit. - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems', window );"><strong>Deferred Tax and Income Tax (Details) - Schedule of Estimated Future Taxable Profit. [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetsGrossAmount', window );">Deferred tax assets, Gross amount</a></td>
<td class="nump">$ 8,589,194<span></span>
</td>
<td class="nump">$ 4,526,905<span></span>
</td>
<td class="nump">$ 1,986,814<span></span>
</td>
<td class="nump">$ 320,524<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetsTaxEffect', window );">Deferred tax assets, Tax effect</a></td>
<td class="nump">1,631,947<span></span>
</td>
<td class="nump">860,112<span></span>
</td>
<td class="nump">377,495<span></span>
</td>
<td class="nump">60,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_GB', window );">United Kingdom [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems', window );"><strong>Deferred Tax and Income Tax (Details) - Schedule of Estimated Future Taxable Profit. [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetsGrossAmount', window );">Deferred tax assets, Gross amount</a></td>
<td class="nump">3,641,516<span></span>
</td>
<td class="nump">4,526,905<span></span>
</td>
<td class="nump">1,986,814<span></span>
</td>
<td class="nump">320,524<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetsTaxEffect', window );">Deferred tax assets, Tax effect</a></td>
<td class="nump">691,888<span></span>
</td>
<td class="nump">$ 860,112<span></span>
</td>
<td class="nump">$ 377,495<span></span>
</td>
<td class="nump">$ 60,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_LU', window );">Luxembourg [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems', window );"><strong>Deferred Tax and Income Tax (Details) - Schedule of Estimated Future Taxable Profit. [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetsGrossAmount', window );">Deferred tax assets, Gross amount</a></td>
<td class="nump">3,267,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetsTaxEffect', window );">Deferred tax assets, Tax effect</a></td>
<td class="nump">620,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_AR', window );">Argentina [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems', window );"><strong>Deferred Tax and Income Tax (Details) - Schedule of Estimated Future Taxable Profit. [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetsGrossAmount', window );">Deferred tax assets, Gross amount</a></td>
<td class="nump">1,484,790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetsTaxEffect', window );">Deferred tax assets, Tax effect</a></td>
<td class="nump">282,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=currency_USD', window );">United States of America [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems', window );"><strong>Deferred Tax and Income Tax (Details) - Schedule of Estimated Future Taxable Profit. [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetsGrossAmount', window );">Deferred tax assets, Gross amount</a></td>
<td class="nump">195,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_DeferredTaxAssetsTaxEffect', window );">Deferred tax assets, Tax effect</a></td>
<td class="nump">$ 37,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DeferredTaxAssetsGrossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets, gross amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DeferredTaxAssetsGrossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DeferredTaxAssetsTaxEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DeferredTaxAssetsTaxEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_LU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_LU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_AR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_AR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539411506336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Income / Expenses (Details) - Schedule of Financial Income Expenses - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialCostsAbstract', window );"><strong>Financial Costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InterestExpenses', window );">Interest expense</a></td>
<td class="num">$ (160,035)<span></span>
</td>
<td class="num">$ (2,130)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TotalFinancialCosts', window );">Total Financial Costs</a></td>
<td class="num">(160,035)<span></span>
</td>
<td class="num">(2,130)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OtherFinancialResultsAbstract', window );"><strong>Other financial results</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExchangeRateDifference', window );">Exchange rate difference</a></td>
<td class="num">(1,386,599)<span></span>
</td>
<td class="num">(12,342)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss', window );">Change in fair value of Simply Agreement for Future Equity (&#8220;SAFE&#8221;) - Loss</a></td>
<td class="num">(313,346)<span></span>
</td>
<td class="num">(860,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InvestmentGainRelatedToMoneyMarketFunds', window );">Investment gain related to money market funds</a></td>
<td class="nump">1,009,318<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ChangeInWarrants', window );">Change in warrants</a></td>
<td class="nump">778,811<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LoansAndReceivables', window );">Interest gain (Shareholders loan)</a></td>
<td class="nump">693,027<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InflationAdjustment', window );">Inflation adjustment</a></td>
<td class="nump">245,989<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OtherFinancialResults', window );">Other</a></td>
<td class="nump">3,325<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TotalOtherFinancialResults', window );">Total Other financial results</a></td>
<td class="nump">1,030,525<span></span>
</td>
<td class="num">(872,342)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NetFinancialIncomeExpenses', window );">Total net financial income / expenses</a></td>
<td class="nump">$ 870,490<span></span>
</td>
<td class="num">$ (874,472)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LoansAndReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-derivative financial assets with fixed or determinable payments that are not quoted in an active market, other than: (a) those that the entity intends to sell immediately or in the near term, which shall be classified as held for trading, and those that the entity, upon initial recognition, designates as at fair value through profit or loss; (b) those that the entity, upon initial recognition, designates as available for sale; or (c) those for which the holder may not recover substantially all of its initial investment, other than because of credit deterioration, which shall be classified as available for sale. An interest acquired in a pool of assets that are not loans or receivables (for example, an interest in a mutual fund or a similar fund) is not a loan or receivable. [Refer: Derivative financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expired 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 8<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_8_c&amp;doctype=Standard&amp;book=b<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LoansAndReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ChangeInWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of change in warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ChangeInWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ExchangeRateDifference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of exchange rate difference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ExchangeRateDifference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FinancialCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FinancialCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InflationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of inflation adjustment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InflationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InterestExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InterestExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InvestmentGainRelatedToMoneyMarketFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InvestmentGainRelatedToMoneyMarketFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NetFinancialIncomeExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total net financial income / expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NetFinancialIncomeExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_OtherFinancialResults">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_OtherFinancialResults</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_OtherFinancialResultsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_OtherFinancialResultsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TotalFinancialCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TotalFinancialCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TotalOtherFinancialResults">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of total other financial results.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TotalOtherFinancialResults</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539413526848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Operating Expense (Details) - Schedule of Other Operating Expense - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfOtherOperatingExpenseAbstract', window );"><strong>Schedule of Other Operating Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TaxesDutiesAndPenalties', window );">Taxes, duties and penalties</a></td>
<td class="num">$ (62,263)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Miscellaneous expenses</a></td>
<td class="num">(31,944)<span></span>
</td>
<td class="num">(38,985)<span></span>
</td>
<td class="num">(93,252)<span></span>
</td>
<td class="num">(2,639)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OtherOperatingExpense', window );">Total other operating expense</a></td>
<td class="num">$ (94,207)<span></span>
</td>
<td class="num">$ (38,985)<span></span>
</td>
<td class="num">$ (93,252)<span></span>
</td>
<td class="num">$ (2,639)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousOtherOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of miscellaneous other operating expenses. [Refer: Other operating income (expense)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousOtherOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_OtherOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of total other operating expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_OtherOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfOtherOperatingExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfOtherOperatingExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TaxesDutiesAndPenalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of taxes, duties and penalties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TaxesDutiesAndPenalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539404135568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Administrative Expenses (Details) - Schedule of Administrative Expenses - USD ($)<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfAdministrativeExpensesAbstract', window );"><strong>Schedule of Administrative Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AuditLegalAndAccountancyFee', window );">Audit. legal and accountancy fees</a></td>
<td class="num">$ (125,867)<span></span>
</td>
<td class="num">$ (635,173)<span></span>
</td>
<td class="num">$ (2,024,611)<span></span>
</td>
<td class="num">$ (1,355,046)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EmployeeBenefitsExpense', window );">Employee Stock Option Plan</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,166,755)<span></span>
</td>
<td class="num">(838,576)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PayrollExpenses', window );">Payroll Expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(10,544)<span></span>
</td>
<td class="num">(880,830)<span></span>
</td>
<td class="num">(254,215)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InsuranceExpense', window );">Insurance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(428,947)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TravelExpense', window );">Travel Expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(332)<span></span>
</td>
<td class="num">(102,305)<span></span>
</td>
<td class="num">(52,532)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AmortizationExpense', window );">Amortization</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(92,818)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,107)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Other office and admin expenses</a></td>
<td class="num">(2,019)<span></span>
</td>
<td class="num">(174,897)<span></span>
</td>
<td class="num">(108,282)<span></span>
</td>
<td class="num">(22,861)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdministrativeExpense', window );">Total Administrative expenses</a></td>
<td class="num">$ (127,886)<span></span>
</td>
<td class="num">$ (820,946)<span></span>
</td>
<td class="num">$ (4,808,655)<span></span>
</td>
<td class="num">$ (2,523,230)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses that the entity classifies as being administrative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2023-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_35_b_vi&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EmployeeBenefitsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 104<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EmployeeBenefitsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InsuranceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from purchased insurance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InsuranceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to selling, general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TravelExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from travel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TravelExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AuditLegalAndAccountancyFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AuditLegalAndAccountancyFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PayrollExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PayrollExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfAdministrativeExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfAdministrativeExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539412278032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and Development Expense (Details) - Schedule of Research and Development Expense - USD ($)<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems', window );"><strong>Schedule of Research and Development Expense [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Professional fees</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (75,189)<span></span>
</td>
<td class="num">$ (886,628)<span></span>
</td>
<td class="num">$ (373,259)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_LaboratoriesRelatedExpenses', window );">Laboratories&#8217; related expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(526,753)<span></span>
</td>
<td class="num">(434,551)<span></span>
</td>
<td class="num">(449,442)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationExpense', window );">Amortization</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,699)<span></span>
</td>
<td class="num">(1,699)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OtherResearchAndDevelopmentExpenses', window );">Other research and development expenses</a></td>
<td class="num">(179,061)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(28,339)<span></span>
</td>
<td class="num">(160,758)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Total Research and development expenses</a></td>
<td class="num">$ (179,061)<span></span>
</td>
<td class="num">$ (601,942)<span></span>
</td>
<td class="num">$ (1,351,217)<span></span>
</td>
<td class="num">$ (985,158)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of amortisation expense. Amortisation is the systematic allocation of depreciable amounts of intangible assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfessionalFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable for professional services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfessionalFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure directly attributable to research or development activities, recognised in profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2023-01-01<br> -Paragraph 126<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_LaboratoriesRelatedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of labor-related expenses classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_LaboratoriesRelatedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_OtherResearchAndDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other research and development expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_OtherResearchAndDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539404073232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cost of sales (Details) - Schedule of Cost of sales - USD ($)<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CostofsalesDetailsScheduleofCostofsalesLineItems', window );"><strong>Schedule of Cost Sales [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventories at beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_InventoriesIncorporatedThroughTheBusinessCombination', window );">Inventories incorporated through the business combination</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(532,231)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchasesFairValueMeasurementAssets', window );">Purchases</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(788,751)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ProductionCostsAbstract', window );"><strong>Production costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PayrollAndAndProfessionalFees', window );">Payroll and and professional fees</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(121,285)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepairsAndMaintenanceExpense', window );">Maintenance, energy and fuel related to fixed assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(77,495)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationAndAmortisationExpense', window );">Amortization and depreciation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(23,398)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OtherProductionCosts', window );">Other production costs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(31,050)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RawMaterialsAndConsumablesUsed', window );">Sub-total Production costs</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(253,228)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations', window );">Foreign currency translation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">60,108<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TotalOtherProductionCost', window );">Sub-total</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,514,102)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventories as of the end</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">465,748<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (1,048,354)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2023-01-01<br> -Paragraph 23<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_23_e&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 104<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_104&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2023-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, after reclassification adjustments, related to hedges of net investments in foreign operations. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 39<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=39&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 9<br> -IssueDate 2023-01-01<br> -Paragraph 6.5.13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=9&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_6.5.13_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchasesFairValueMeasurementAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in the fair value measurement of assets resulting from purchases of those assets. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2023-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_93_e_iii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchasesFairValueMeasurementAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RawMaterialsAndConsumablesUsed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of raw materials and consumables used in the production process or in the rendering of services. [Refer: Current raw materials]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RawMaterialsAndConsumablesUsed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepairsAndMaintenanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses incurred for the day-to-day servicing of assets, which may include the cost of labour, consumables or small parts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepairsAndMaintenanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CostofsalesDetailsScheduleofCostofsalesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CostofsalesDetailsScheduleofCostofsalesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_InventoriesIncorporatedThroughTheBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventories incorporated through the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_InventoriesIncorporatedThroughTheBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_OtherProductionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other production costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_OtherProductionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PayrollAndAndProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid payroll and and professional fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PayrollAndAndProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ProductionCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ProductionCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TotalOtherProductionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other cost of sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TotalOtherProductionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539426897888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share (Details) - Schedule of Net Loss Per Share - USD ($)<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NetLossperShareDetailsScheduleofNetLossPerShareLineItems', window );"><strong>Schedule of net loss per share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects', window );">Loss for the year, attributable to the owners of the Group</a></td>
<td class="num">$ (320,524)<span></span>
</td>
<td class="num">$ (1,986,814)<span></span>
</td>
<td class="num">$ (51,788,880)<span></span>
</td>
<td class="num">$ (4,526,905)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects', window );">Loss attributable to the ordinary shareholders</a></td>
<td class="num">$ (320,524)<span></span>
</td>
<td class="num">$ (1,986,814)<span></span>
</td>
<td class="num">$ (51,788,880)<span></span>
</td>
<td class="num">$ (4,526,905)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Weighted-average number of ordinary shares (in Shares)</a></td>
<td class="nump">29,140,000<span></span>
</td>
<td class="nump">30,239,558<span></span>
</td>
<td class="nump">34,466,258<span></span>
</td>
<td class="nump">31,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations', window );">Basic (in Dollars per share)</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (1.5)<span></span>
</td>
<td class="num">$ (0.15)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Basic earnings (loss) per share from discontinued operations. [Refer: Basic earnings (loss) per share; Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) attributable to ordinary equity holders of the parent entity, adjusted for the effects of all dilutive potential ordinary shares. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 70<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_70_a&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NetLossperShareDetailsScheduleofNetLossPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NetLossperShareDetailsScheduleofNetLossPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539426875072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss per Share (Details) - Schedule of Net Loss Per Share (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsLineItems', window );"><strong>Schedule of net loss per share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations', window );">Diluted</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (1.50)<span></span>
</td>
<td class="num">$ (0.15)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Diluted earnings (loss) per share from discontinued operations. [Refer: Diluted earnings (loss) per share; Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2023-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539416676688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties (Details) - Schedule of Other Related Party Transactions - USD ($)<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsLineItems', window );"><strong>Schedule of other related party transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermEmployeeBenefitsExpense', window );">Short-term employee benefits</a></td>
<td class="nump">$ 38,355<span></span>
</td>
<td class="nump">$ 109,205<span></span>
</td>
<td class="nump">$ 39,250<span></span>
</td>
<td class="nump">$ 96,437<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermEmployeeBenefitsAccruals', window );">Share based payment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 904,861<span></span>
</td>
<td class="nump">$ 838,576<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermEmployeeBenefitsAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of accruals for employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services. [Refer: Accruals classified as current]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermEmployeeBenefitsAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermEmployeeBenefitsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermEmployeeBenefitsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539412638992">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Related Parties (Details) - Schedule of Share Based Payment - USD ($)<br></strong></div></th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShareBasedPaymentAbstract', window );"><strong>Share based payment</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Key management</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 904,861<span></span>
</td>
<td class="nump">$ 838,576<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CFOSharesAlloted', window );">CFO Shares Alloted</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">364,014<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IssueOfAdditionalSharesAbstract', window );"><strong>Issue of Additional Shares</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IssueOfSharesCapital', window );">Issue of share capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IssueOfSharePremium', window );">Issue of share premium</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">39,610,630<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresCropSolutionsCorpMember', window );">Bioceres Crop Solutions Corp [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IssueOfAdditionalSharesAbstract', window );"><strong>Issue of Additional Shares</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Parent of the Company</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_UnionGroupVenturesMember', window );">Union Group Ventures [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IssueOfAdditionalSharesAbstract', window );"><strong>Issue of Additional Shares</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Parent of the Company</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BGFarmingTechnologiesMember', window );">BG Farming Technologies [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IssueOfAdditionalSharesAbstract', window );"><strong>Issue of Additional Shares</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Parent of the Company</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSAMember', window );">Bioceres S.A. [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CompanySCashBalanceInOtherSAccountsAbstract', window );"><strong>Company&#8217;s Cash Balance in Other&#8217;s Accounts</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashEquivalents', window );">Company&#8217;s Cash Balance in Other&#8217;s Accounts</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">300,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExpensesPaidOnBehalfOfTheCompanyAbstract', window );"><strong>Expenses Paid on Behalf of the Company</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExpensesPaid', window );">Expenses Paid on Behalf of the Company</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">244,029<span></span>
</td>
<td class="nump">509,628<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">265,810<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresLLCMember', window );">Bioceres LLC [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CompanySCashBalanceInOtherSAccountsAbstract', window );"><strong>Company&#8217;s Cash Balance in Other&#8217;s Accounts</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashEquivalents', window );">Company&#8217;s Cash Balance in Other&#8217;s Accounts</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExpensesPaidOnBehalfOfTheCompanyAbstract', window );"><strong>Expenses Paid on Behalf of the Company</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ExpensesPaid', window );">Expenses Paid on Behalf of the Company</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">56,863<span></span>
</td>
<td class="nump">453,282<span></span>
</td>
<td class="nump">238,121<span></span>
</td>
<td class="nump">156,760<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSAINMETSAIngenieriaMetabolicaSAMember', window );">30% owned by Bioceres S.A. - INMET S.A.- Ingenieria Metabolica S.A [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ServicesProvidedByOtherCompaniesAbstract', window );"><strong>Services Provided by Other Companies</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ServicesProvidedByOtherCompanies', window );">Services Provided by Other Companies</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">160,390<span></span>
</td>
<td class="nump">144,530<span></span>
</td>
<td class="nump">286<span></span>
</td>
<td class="nump">252<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember', window );">98.6% owned by Bioceres S.A. - INDEAR S.A.- Instituto de Agrobiotecnolog&#237;a Rosario [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ServicesProvidedByOtherCompaniesAbstract', window );"><strong>Services Provided by Other Companies</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ServicesProvidedByOtherCompanies', window );">Services Provided by Other Companies</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">2,540<span></span>
</td>
<td class="nump">129,695<span></span>
</td>
<td class="nump">258,279<span></span>
</td>
<td class="nump">57,047<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSAAgralityIncMember', window );">Bioceres S.A. - Agrality Inc.[Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ServicesProvidedByOtherCompaniesAbstract', window );"><strong>Services Provided by Other Companies</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ServicesProvidedByOtherCompanies', window );">Services Provided by Other Companies</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">85,435<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_FutureFoodsBVMember', window );">Future Foods B.V. Member</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ServicesProvidedByOtherCompaniesAbstract', window );"><strong>Services Provided by Other Companies</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ServicesProvidedByOtherCompanies', window );">Services Provided by Other Companies</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="nump">17,801<span></span>
</td>
<td class="nump">35,958<span></span>
</td>
<td class="nump">85,880<span></span>
</td>
<td class="nump">94,857<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_MoolecScienceSAMember', window );">Moolec Science S.A. [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ServicesProvidedByOtherCompaniesAbstract', window );"><strong>Services Provided by Other Companies</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ServicesProvidedByOtherCompanies', window );">Services Provided by Other Companies</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">693,027<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_THEOISCSpMember', window );">THEO I SCSp [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ServicesProvidedByOtherCompaniesAbstract', window );"><strong>Services Provided by Other Companies</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ServicesProvidedByOtherCompanies', window );">Services Provided by Other Companies</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Shares issue related to share based payment already vested.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Expenses paid by Bioceres LLC on behalf of the Company.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The Company entered into an agreement with INMET S.A.- Ingenieria Metabolica S,A through which it would
receive research services in exchange for payment.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">The Company entered into an agreement with INDEAR S.A.- Instituto de Agrobiotecnologia Rosario where it
would receive research services in exchange for payment.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">The Company entered into an agreement with Agrality Inc, for the provision of services.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">The Company entered into an agreement with Future Foods B.V. for the provision of services.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">The Company entered into an agreement with shareholders which accrues an internal rate of return.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81B_a_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CFOSharesAlloted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>CFO Shares Alloted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CFOSharesAlloted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CompanySCashBalanceInOtherSAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CompanySCashBalanceInOtherSAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ExpensesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ExpensesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ExpensesPaidOnBehalfOfTheCompanyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ExpensesPaidOnBehalfOfTheCompanyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_IssueOfAdditionalSharesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_IssueOfAdditionalSharesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_IssueOfSharePremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issue of share premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_IssueOfSharePremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_IssueOfSharesCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital arising from issuing ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_IssueOfSharesCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ServicesProvidedByOtherCompanies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Services provided by other companies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ServicesProvidedByOtherCompanies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ServicesProvidedByOtherCompaniesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ServicesProvidedByOtherCompaniesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShareBasedPaymentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShareBasedPaymentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresCropSolutionsCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresCropSolutionsCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_UnionGroupVenturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_UnionGroupVenturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BGFarmingTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BGFarmingTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSAINMETSAIngenieriaMetabolicaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSAINMETSAIngenieriaMetabolicaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSAAgralityIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSAAgralityIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_FutureFoodsBVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_FutureFoodsBVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_MoolecScienceSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_MoolecScienceSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_THEOISCSpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_THEOISCSpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539424512080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties (Details) - Schedule of Share Based Payment (Parentheticals)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2"><div>Jun. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsLineItems', window );"><strong>Related Parties (Details) - Schedule of Share Based Payment (Parentheticals) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SubsidiaryPercentage', window );">Subsidiary percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresLLCMember', window );">Bioceres LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsLineItems', window );"><strong>Related Parties (Details) - Schedule of Share Based Payment (Parentheticals) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SubsidiaryPercentage', window );">Subsidiary percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSAINMETSAIngenieriaMetabolicaSAMember', window );">30% owned by Bioceres S.A. - INMET S.A.- Ingenieria Metabolica S.A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsLineItems', window );"><strong>Related Parties (Details) - Schedule of Share Based Payment (Parentheticals) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OwnedPercentage', window );">Owned percentage</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember', window );">98.6% owned by Bioceres S.A. - INDEAR S.A.- Instituto de Agrobiotecnolog&#237;a Rosario [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsLineItems', window );"><strong>Related Parties (Details) - Schedule of Share Based Payment (Parentheticals) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OwnedPercentage', window );">Owned percentage</a></td>
<td class="nump">98.60%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Expenses paid by Bioceres LLC on behalf of the Company.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The Company entered into an agreement with INMET S.A.- Ingenieria Metabolica S,A through which it would
receive research services in exchange for payment.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The Company entered into an agreement with INDEAR S.A.- Instituto de Agrobiotecnologia Rosario where it
would receive research services in exchange for payment.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_OwnedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Owned percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_OwnedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SubsidiaryPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subsidiary percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SubsidiaryPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSAINMETSAIngenieriaMetabolicaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSAINMETSAIngenieriaMetabolicaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539416731296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Related Parties (Details) - Schedule of other related party balances - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSABioceresLLCMember', window );">100% Subsidiary of Bioceres S.A. - Bioceres LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesLineItems', window );"><strong>Related Parties (Details) - Schedule of other related party balances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OtherRelatedPartyBalances', window );">Other related party balances</a></td>
<td class="num">$ (623,629)<span></span>
</td>
<td class="num">$ (385,508)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_MoolecSAShareholdersMember', window );">Moolec S.A. Shareholders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesLineItems', window );"><strong>Related Parties (Details) - Schedule of other related party balances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OtherRelatedPartyBalances', window );">Other related party balances</a></td>
<td class="nump">8,763,027<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_UnionGroupVenturesLimitedMember', window );">Union Group Ventures Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesLineItems', window );"><strong>Related Parties (Details) - Schedule of other related party balances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OtherRelatedPartyBalances', window );">Other related party balances</a></td>
<td class="num">(677,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_INDEARSAMember', window );">INDEAR S.A. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesLineItems', window );"><strong>Related Parties (Details) - Schedule of other related party balances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OtherRelatedPartyBalances', window );">Other related party balances</a></td>
<td class="num">(72,494)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_FutureFoodsBVMember', window );">Future Foods B.V [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesLineItems', window );"><strong>Related Parties (Details) - Schedule of other related party balances [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_OtherRelatedPartyBalances', window );">Other related party balances</a></td>
<td class="num">$ (78,337)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_OtherRelatedPartyBalances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_OtherRelatedPartyBalances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSABioceresLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSABioceresLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_MoolecSAShareholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_MoolecSAShareholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_UnionGroupVenturesLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_UnionGroupVenturesLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_INDEARSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_INDEARSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_FutureFoodsBVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_FutureFoodsBVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539426930640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties (Details) - Schedule of other related party balances (Parentheticals)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSABioceresLLCMember', window );">100% Subsidiary of Bioceres S.A. - Bioceres LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsLineItems', window );"><strong>Related Parties (Details) - Schedule of other related party balances (Parentheticals) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SubsidiaryPercentage', window );">Subsidiary percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SubsidiaryPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subsidiary percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SubsidiaryPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSABioceresLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_BioceresSABioceresLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539424325632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Risk Management (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialRiskManagementDetailsLineItems', window );"><strong>Financial Risk Management (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities</a></td>
<td class="nump">$ 2,759,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageOfFunctionalCurrency', window );">Percentage of functional currency</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxRateEffectOfForeignTaxRates', window );">Percentage of exchange rate</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_PercentageOfInterestRates', window );">Percentage of interest rates</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IncreasedecreaseInterestPayable', window );">Interest payable</a></td>
<td class="num">$ (11,428)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember', window );">Liquidity Risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialRiskManagementDetailsLineItems', window );"><strong>Financial Risk Management (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentFinancialAssets', window );">Total current financial assets</a></td>
<td class="nump">4,524,972<span></span>
</td>
<td class="nump">$ 1,081,808<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities</a></td>
<td class="nump">11,985,860<span></span>
</td>
<td class="nump">$ 1,227,384<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest Rate Risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialRiskManagementDetailsLineItems', window );"><strong>Financial Risk Management (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_IncreasedecreaseInterestPayable', window );">Interest payable</a></td>
<td class="nump">$ 11,428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxRateEffectOfForeignTaxRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from the application of foreign tax rates. [Refer: Average effective tax rate; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxRateEffectOfForeignTaxRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FinancialRiskManagementDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FinancialRiskManagementDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_IncreasedecreaseInterestPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase/(decrease) interest payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_IncreasedecreaseInterestPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PercentageOfFunctionalCurrency">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of functional currency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PercentageOfFunctionalCurrency</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_PercentageOfInterestRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_PercentageOfInterestRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539413508816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Risk Management (Details) - Schedule of Trade and Other Receivables - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=mlec_UpToThreeMonthsMember', window );">Up to 3 months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ToDueBecomeAbstract', window );"><strong>To due become</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivables', window );">Up to 3 months</a></td>
<td class="nump">$ 450,728<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of trade receivables and other receivables. [Refer: Trade receivables; Other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ToDueBecomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ToDueBecomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=mlec_UpToThreeMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=mlec_UpToThreeMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R120.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539412976544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Risk Management (Details) - Schedule of Contractual Maturity Date - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems', window );"><strong>Financial Risk Management (Details) - Schedule of Contractual Maturity Date [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade Payables</a></td>
<td class="nump">$ 7,479,614<span></span>
</td>
<td class="nump">$ 1,226,213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">1,956,635<span></span>
</td>
<td class="nump">1,171<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SimplyAgreementForFutureEquitySAFE', window );">Simply Agreement for Future Equity (&#8220;SAFE&#8221;)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,860,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial debts</a></td>
<td class="nump">2,759,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SubtotalNonDerivatesLiabilities', window );">Subtotal</a></td>
<td class="nump">12,195,818<span></span>
</td>
<td class="nump">4,087,384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WarrantLiability', window );">Warrant</a></td>
<td class="nump">887,689<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SubtotalDerivatesLiabilities', window );">Subtotal</a></td>
<td class="nump">887,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TotalLiabilities', window );">Total</a></td>
<td class="nump">13,083,507<span></span>
</td>
<td class="nump">4,087,384<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=mlec_WithinOneYearOrOnDemandMember', window );">Within 1 year or on demand [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems', window );"><strong>Financial Risk Management (Details) - Schedule of Contractual Maturity Date [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayables', window );">Trade Payables</a></td>
<td class="nump">7,479,614<span></span>
</td>
<td class="nump">1,226,213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">1,776,438<span></span>
</td>
<td class="nump">1,171<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SimplyAgreementForFutureEquitySAFE', window );">Simply Agreement for Future Equity (&#8220;SAFE&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,860,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial debts</a></td>
<td class="nump">2,578,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SubtotalNonDerivatesLiabilities', window );">Subtotal</a></td>
<td class="nump">11,834,152<span></span>
</td>
<td class="nump">4,087,384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WarrantLiability', window );">Warrant</a></td>
<td class="nump">887,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SubtotalDerivatesLiabilities', window );">Subtotal</a></td>
<td class="nump">887,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TotalLiabilities', window );">Total</a></td>
<td class="nump">12,721,841<span></span>
</td>
<td class="nump">4,087,384<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=mlec_BetweenOneAndTwoYearsMember', window );">Between 1 and 2 years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems', window );"><strong>Financial Risk Management (Details) - Schedule of Contractual Maturity Date [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPayables', window );">Trade Payables</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">180,197<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SimplyAgreementForFutureEquitySAFE', window );">Simply Agreement for Future Equity (&#8220;SAFE&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial debts</a></td>
<td class="nump">72,831<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SubtotalNonDerivatesLiabilities', window );">Subtotal</a></td>
<td class="nump">253,028<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WarrantLiability', window );">Warrant</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SubtotalDerivatesLiabilities', window );">Subtotal</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TotalLiabilities', window );">Total</a></td>
<td class="nump">253,028<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=mlec_BetweenTwoAndFiveYearsMember', window );">Between 2 and 5 years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems', window );"><strong>Financial Risk Management (Details) - Schedule of Contractual Maturity Date [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPayables', window );">Trade Payables</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherLiabilities', window );">Other liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SimplyAgreementForFutureEquitySAFE', window );">Simply Agreement for Future Equity (&#8220;SAFE&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial debts</a></td>
<td class="nump">108,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SubtotalNonDerivatesLiabilities', window );">Subtotal</a></td>
<td class="nump">108,638<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WarrantLiability', window );">Warrant</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SubtotalDerivatesLiabilities', window );">Subtotal</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TotalLiabilities', window );">Total</a></td>
<td class="nump">108,638<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=mlec_MoreThanFiveYearsMember', window );">More than 5 years [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems', window );"><strong>Financial Risk Management (Details) - Schedule of Contractual Maturity Date [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPayables', window );">Trade Payables</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherLiabilities', window );">Other liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SimplyAgreementForFutureEquitySAFE', window );">Simply Agreement for Future Equity (&#8220;SAFE&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial debts</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SubtotalNonDerivatesLiabilities', window );">Subtotal</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WarrantLiability', window );">Warrant</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SubtotalDerivatesLiabilities', window );">Subtotal</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TotalLiabilities', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=mlec_WithoutAnyEstablishedTermMember', window );">Without any established term [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems', window );"><strong>Financial Risk Management (Details) - Schedule of Contractual Maturity Date [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentPayables', window );">Trade Payables</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherLiabilities', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SimplyAgreementForFutureEquitySAFE', window );">Simply Agreement for Future Equity (&#8220;SAFE&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial debts</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SubtotalNonDerivatesLiabilities', window );">Subtotal</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WarrantLiability', window );">Warrant</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SubtotalDerivatesLiabilities', window );">Subtotal</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_TotalLiabilities', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current trade payables and non-current other payables. [Refer: Other non-current payables; Non-current trade payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of trade payables and other payables. [Refer: Trade payables; Other payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SimplyAgreementForFutureEquitySAFE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Simply Agreement for Future Equity (&#8220;SAFE&#8221;).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SimplyAgreementForFutureEquitySAFE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SubtotalDerivatesLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subtotal of derivates liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SubtotalDerivatesLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SubtotalNonDerivatesLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subtotal of non-derivates liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SubtotalNonDerivatesLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_TotalLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_TotalLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=mlec_WithinOneYearOrOnDemandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=mlec_WithinOneYearOrOnDemandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=mlec_BetweenOneAndTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=mlec_BetweenOneAndTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=mlec_BetweenTwoAndFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=mlec_BetweenTwoAndFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=mlec_MoreThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=mlec_MoreThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=mlec_WithoutAnyEstablishedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=mlec_WithoutAnyEstablishedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R121.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539412899184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Risk Management (Details) - Schedule of Foreign Currency Exchange Risk - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=mlec_ArgentinePesosMember', window );">Argentine pesos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems', window );"><strong>Financial Risk Management (Details) - Schedule of Foreign Currency Exchange Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ForeignCurrencyExchangeRiskAssets', window );">Foreign currency exchange risk assets</a></td>
<td class="nump">$ 765,690<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ForeignCurrencyExchangeRiskLiabilities', window );">Foreign currency exchange risk liabilities</a></td>
<td class="nump">50,073<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=mlec_ArgentinePesosMember', window );">Argentine pesos [Member] | (+10%) Impact to profit or loss before tax assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems', window );"><strong>Financial Risk Management (Details) - Schedule of Foreign Currency Exchange Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ForeignCurrencyExchangeRiskAssets', window );">Foreign currency exchange risk assets</a></td>
<td class="nump">76,569<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=mlec_ArgentinePesosMember', window );">Argentine pesos [Member] | (-10%) Impact to profit or loss before tax liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems', window );"><strong>Financial Risk Management (Details) - Schedule of Foreign Currency Exchange Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ForeignCurrencyExchangeRiskLiabilities', window );">Foreign currency exchange risk liabilities</a></td>
<td class="num">(5,007)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=mlec_USDollarMember', window );">U.S. Dollar [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems', window );"><strong>Financial Risk Management (Details) - Schedule of Foreign Currency Exchange Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ForeignCurrencyExchangeRiskAssets', window );">Foreign currency exchange risk assets</a></td>
<td class="nump">368,186<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ForeignCurrencyExchangeRiskLiabilities', window );">Foreign currency exchange risk liabilities</a></td>
<td class="nump">2,227,751<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=mlec_USDollarMember', window );">U.S. Dollar [Member] | (+10%) Impact to profit or loss before tax assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems', window );"><strong>Financial Risk Management (Details) - Schedule of Foreign Currency Exchange Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ForeignCurrencyExchangeRiskAssets', window );">Foreign currency exchange risk assets</a></td>
<td class="nump">36,819<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=mlec_USDollarMember', window );">U.S. Dollar [Member] | (-10%) Impact to profit or loss before tax liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems', window );"><strong>Financial Risk Management (Details) - Schedule of Foreign Currency Exchange Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ForeignCurrencyExchangeRiskLiabilities', window );">Foreign currency exchange risk liabilities</a></td>
<td class="num">(222,775)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=mlec_PoundSterlingMember', window );">Pound sterling [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems', window );"><strong>Financial Risk Management (Details) - Schedule of Foreign Currency Exchange Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ForeignCurrencyExchangeRiskAssets', window );">Foreign currency exchange risk assets</a></td>
<td class="nump">22,062<span></span>
</td>
<td class="nump">8,025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ForeignCurrencyExchangeRiskLiabilities', window );">Foreign currency exchange risk liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=mlec_PoundSterlingMember', window );">Pound sterling [Member] | (+10%) Impact to profit or loss before tax assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems', window );"><strong>Financial Risk Management (Details) - Schedule of Foreign Currency Exchange Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ForeignCurrencyExchangeRiskAssets', window );">Foreign currency exchange risk assets</a></td>
<td class="nump">2,206<span></span>
</td>
<td class="nump">803<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=mlec_PoundSterlingMember', window );">Pound sterling [Member] | (-10%) Impact to profit or loss before tax liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems', window );"><strong>Financial Risk Management (Details) - Schedule of Foreign Currency Exchange Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ForeignCurrencyExchangeRiskLiabilities', window );">Foreign currency exchange risk liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ForeignCurrencyExchangeRiskAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign currency exchange risk assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ForeignCurrencyExchangeRiskAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ForeignCurrencyExchangeRiskLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign currency exchange risk liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ForeignCurrencyExchangeRiskLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=mlec_ArgentinePesosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=mlec_ArgentinePesosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_ImpactToProfitOrLossBeforeTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_ImpactToProfitOrLossBeforeTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_ImpactToProfitOrLossBeforeTaxLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=mlec_ImpactToProfitOrLossBeforeTaxLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=mlec_USDollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=mlec_USDollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=mlec_PoundSterlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=mlec_PoundSterlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R122.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539411504800">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Financial Risk Management (Details) - Schedule of Fair Value and Carrying Value of Financial Instruments - Financial instruments, class [member] - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_AmortizedCostsAbstract', window );"><strong>Amortized costs</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 2,064,079<span></span>
</td>
<td class="nump">$ 1,081,808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivables', window );">Trade and other receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">10,454,301<span></span>
</td>
<td class="nump">2,061<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FairValueThroughProfitOrLossAbstract', window );"><strong>Fair value through profit or loss</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">463,594<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ShorttermInvestmentsCurrent', window );">Short-term investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">306,034<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total financial assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">13,288,008<span></span>
</td>
<td class="nump">1,083,869<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialLiabilitiesAbstract', window );"><strong>Financial Liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Trade and other payables</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">9,340,571<span></span>
</td>
<td class="nump">1,227,384<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FinancialDebts', window );">Financial debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,645,289<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_FairValueThroughProfitOrLossAbstract0', window );"><strong>Fair value through profit or loss</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_SimplyAgreementForFutureEquitySAFE', window );">Simply Agreement for Future Equity (&#8220;SAFE&#8221;)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,860,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WarrantLiability', window );">Warrant liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">887,689<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,873,549<span></span>
</td>
<td class="nump">4,087,384<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssetsLiabilities', window );">Net financial asset /(liability)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 414,459<span></span>
</td>
<td class="num">$ (3,003,515)<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Cash, short-term investments, trade and other receivables, prepayments, trade and other payables, and
loans payable are recorded at carrying value, which approximates fair value due to their short-term nature and generally negligible credit
losses.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Fair value of short-term investment and warrants has been
determined using the quoted market price at the year end (level 1).</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current assets less the amount of current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A classification of cash equivalents representing short-term investments. [Refer: Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of warrant liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_AmortizedCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_AmortizedCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FairValueThroughProfitOrLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FairValueThroughProfitOrLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FairValueThroughProfitOrLossAbstract0">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FairValueThroughProfitOrLossAbstract0</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FinancialDebts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of financial debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FinancialDebts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_FinancialLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_FinancialLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ShorttermInvestmentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ShorttermInvestmentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_SimplyAgreementForFutureEquitySAFE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Simply Agreement for Future Equity (&#8220;SAFE&#8221;).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_SimplyAgreementForFutureEquitySAFE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_ClassesOfFinancialInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_ClassesOfFinancialInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R123.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539426700352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Risk Management (Details) - Schedule of Fixed-Rate Instruments - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_ScheduleOfFixedRateInstrumentsAbstract', window );"><strong>Schedule of Fixed Rate Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentFinancialLiabilities', window );">Current financial liabilities</a></td>
<td class="num">$ (2,546,243)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentFinancialLiabilities', window );">Non-current financial liabilities</a></td>
<td class="num">$ (99,046)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities; Current financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph m<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_m&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2023-01-01<br> -Paragraph B13<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_B13_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2023-03-23<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2023-01-01<br> -Paragraph 54<br> -Subparagraph m<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_54_m&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_ScheduleOfFixedRateInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_ScheduleOfFixedRateInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R124.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140539416614960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Events after the Reporting Period (Details) - Forecast [Member]<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th">
<div>Oct. 15, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_EventsaftertheReportingPeriodDetailsLineItems', window );"><strong>Events after the Reporting Period (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk', window );">Principal amount</a></td>
<td class="nump">$ 21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_StrikePricePerShare', window );">Strike price per share (in Dollars per share) | $ / shares</a></td>
<td class="nump">$ 6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties', window );">Cash payment</a></td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_NumberOfStockInventories', window );">Secures the supply of tons</a></td>
<td class="nump">15,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mlec_CashPaidInKindInterest', window );">Cash and in kind</a></td>
<td class="nump">$ 30<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for repayments of advances and loans from related parties. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal or principal amount of a financial instrument on discontinuation of its measurement at fair value through profit or loss, because a credit derivative is used to manage the credit risk of that financial instrument. [Refer: Credit risk [member]; Derivatives [member]; Financial instruments, class [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2023-01-01<br> -Paragraph 24G<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2023-en-r&amp;anchor=para_24G_c&amp;doctype=Standard<br> -URIDate 2023-03-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_CashPaidInKindInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of cash paid in kind interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_CashPaidInKindInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_EventsaftertheReportingPeriodDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_EventsaftertheReportingPeriodDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_NumberOfStockInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of soybean inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_NumberOfStockInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mlec_StrikePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Strike price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mlec_StrikePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mlec_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>f20f2023_moolecsci_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2023"
  xmlns:currency="http://xbrl.sec.gov/currency/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mlec="http://www.moolecscience.com/20230630"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mlec-20230630.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-20</instant>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-20</instant>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-20</instant>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:CumulativeTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-20</instant>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:EquitySettledShareBasedPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-20</instant>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-20</instant>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2020-08-20</instant>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:CumulativeTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:EquitySettledShareBasedPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:CumulativeTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:EquitySettledShareBasedPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:CumulativeTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:EquitySettledShareBasedPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:CumulativeTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:EquitySettledShareBasedPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:CumulativeTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:EquitySettledShareBasedPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:CumulativeTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:EquitySettledShareBasedPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:CumulativeTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:EquitySettledShareBasedPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ClassesOfShareCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:CumulativeTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">mlec:EquitySettledShareBasedPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:MoolecSAFEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:MoolecSAFEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2022-12-27</startDate>
            <endDate>2022-12-27</endDate>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2022-12-27</instant>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:UGVLAndTheoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2023-04-24</instant>
        </period>
    </context>
    <context id="c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2023-04-24</startDate>
            <endDate>2023-04-24</endDate>
        </period>
    </context>
    <context id="c71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2018-06-30</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="c74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2023-06-30</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2023-04-30</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <context id="c76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:MoolecScienceLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:LightJumpAcquisitionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ValoraSoySAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:AGBiomoleculesLLCDEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:MicrooFoodsIngredientsSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">mlec:LuxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">country:AR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-31</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SPCTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-31</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:CustomerRelationshipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-31</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SoftwareLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-31</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2020-12-31</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SPCTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:CustomerRelationshipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SoftwareLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="c105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SPCTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="c106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:CustomerRelationshipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="c107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SoftwareLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="c108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="c109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SPCTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:CustomerRelationshipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SoftwareLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SPCTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:CustomerRelationshipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SoftwareLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SPCTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:CustomerRelationshipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SoftwareLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SPCTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:CustomerRelationshipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SoftwareLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SPCTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:CustomerRelationshipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SoftwareLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SPCTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:CustomerRelationshipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">mlec:SoftwareLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="c156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="c157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="c158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="c159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="c160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="c161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:ChymosinOsmosisEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:FurnitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">mlec:StorageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">mlec:NetBookAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2023-04-14</startDate>
            <endDate>2023-04-14</endDate>
        </period>
    </context>
    <context id="c260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:MoolecScienceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:MoolecScienceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:SAFESharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:SAFESharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:LightJumpSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:LightJumpSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:BackstopSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">mlec:BackstopSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:Group1GrantedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:Group2GrantedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">mlec:Group3GrantedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">mlec:Group1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">mlec:Group2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">mlec:Group3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">currency:ARS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">currency:ARS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoMacroPreFinancingOfExportsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoMacroPreFinancingOfExportsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoMacroPreFinancingOfExportsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoMacroPreFinancingOfExportsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoNacinPreFinancingOfExportsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoNacinPreFinancingOfExportsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoNacinPreFinancingOfExportsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoNacinPreFinancingOfExportsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoCrdobaPreFinancingOfExportsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoCrdobaPreFinancingOfExportsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoCrdobaPreFinancingOfExportsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoCrdobaPreFinancingOfExportsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoGaliciaBankOverdraftsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoGaliciaBankOverdraftsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoGaliciaBankOverdraftsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoGaliciaBankOverdraftsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:HSBCBankBankOverdraftsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:HSBCBankBankOverdraftsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:HSBCBankBankOverdraftsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:HSBCBankBankOverdraftsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoSantanderBankOverdraftsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoSantanderBankOverdraftsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoSantanderBankOverdraftsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoSantanderBankOverdraftsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoGaliciaLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoGaliciaLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoGaliciaLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoGaliciaLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:HSBCBankLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:HSBCBankLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:HSBCBankLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:HSBCBankLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoSantanderLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoSantanderLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoSantanderLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoSantanderLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoMacroLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoMacroLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoMacroLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:BancoMacroLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:PromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:PromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:PromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:AsociacinMutualAMALoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:AsociacinMutualAMALoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:AsociacinMutualAMALoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">mlec:AsociacinMutualAMALoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2022-01-05</instant>
        </period>
    </context>
    <context id="c330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2022-01-06</instant>
        </period>
    </context>
    <context id="c331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="c332">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:LU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c333">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:LU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:LU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="c336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="c337">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c338">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="c342">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:LU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:LU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c344">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:LU</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="c345">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="c349">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">currency:USD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c350">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">currency:USD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c351">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">currency:USD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c352">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">currency:USD</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="c353">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <instant>2020-12-30</instant>
        </period>
    </context>
    <context id="c354">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2022-06-30</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c355">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2021-06-30</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c356">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
        </entity>
        <period>
            <startDate>2020-12-30</startDate>
            <endDate>2020-12-30</endDate>
        </period>
    </context>
    <context id="c357">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:NetDeferredTaxLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c358">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:NetDeferredTaxLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">mlec:TwoThousandTwentyTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c360">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">mlec:TwoThousandTwentyTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c361">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">mlec:TwoThousandTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c362">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CreationDateAxis">mlec:TwoThousandTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c363">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c364">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c365">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c366">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c367">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresCropSolutionsCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c368">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:UnionGroupVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c369">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:UnionGroupVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c370">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:UnionGroupVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c371">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:UnionGroupVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c372">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BGFarmingTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c373">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BGFarmingTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c374">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BGFarmingTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c375">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BGFarmingTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c376">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c377">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c378">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c379">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c380">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c381">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c382">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c383">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c384">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c385">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c386">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c387">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c388">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c389">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c391">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c392">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAINMETSAIngenieriaMetabolicaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c393">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAINMETSAIngenieriaMetabolicaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c394">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAINMETSAIngenieriaMetabolicaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c395">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAINMETSAIngenieriaMetabolicaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c396">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c397">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c398">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c399">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c400">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAAgralityIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAAgralityIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAAgralityIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSAAgralityIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:FutureFoodsBVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:FutureFoodsBVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:FutureFoodsBVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:FutureFoodsBVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c408">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:MoolecScienceSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c409">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:MoolecScienceSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c410">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:MoolecScienceSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c411">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:MoolecScienceSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:THEOISCSpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:THEOISCSpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:THEOISCSpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:THEOISCSpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSABioceresLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSABioceresLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSABioceresLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c419">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:BioceresSABioceresLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:MoolecSAShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:MoolecSAShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:UnionGroupVenturesLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:UnionGroupVenturesLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:INDEARSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c425">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:INDEARSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:FutureFoodsBVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:FutureFoodsBVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c431">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:UpToThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c432">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:UpToThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c433">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:WithinOneYearOrOnDemandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c434">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:BetweenOneAndTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c435">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:BetweenTwoAndFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c436">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:MoreThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c437">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:WithoutAnyEstablishedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c438">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:WithinOneYearOrOnDemandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c439">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:BetweenOneAndTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c440">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:BetweenTwoAndFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c441">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:MoreThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c442">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">mlec:WithoutAnyEstablishedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c443">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:ArgentinePesosMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c444">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:ArgentinePesosMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c445">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:USDollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c446">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:USDollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c447">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:PoundSterlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c448">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:PoundSterlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c449">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ImpactToProfitOrLossBeforeTaxAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:ArgentinePesosMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c450">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ImpactToProfitOrLossBeforeTaxAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:ArgentinePesosMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c451">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ImpactToProfitOrLossBeforeTaxLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:ArgentinePesosMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c452">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ImpactToProfitOrLossBeforeTaxLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:ArgentinePesosMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c453">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ImpactToProfitOrLossBeforeTaxAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:USDollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c454">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ImpactToProfitOrLossBeforeTaxAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:USDollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c455">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ImpactToProfitOrLossBeforeTaxLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:USDollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c456">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ImpactToProfitOrLossBeforeTaxLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:USDollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c457">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ImpactToProfitOrLossBeforeTaxAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:PoundSterlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c458">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ImpactToProfitOrLossBeforeTaxAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:PoundSterlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c459">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ImpactToProfitOrLossBeforeTaxLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:PoundSterlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c460">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">mlec:ImpactToProfitOrLossBeforeTaxLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">mlec:PoundSterlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c461">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:ClassesOfFinancialInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c462">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:ClassesOfFinancialInstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c463">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-15</instant>
        </period>
    </context>
    <context id="c464">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001937737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-15</startDate>
            <endDate>2023-10-15</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <dei:DocumentType contextRef="c0">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="c0">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport contextRef="c0">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c0">2023-06-30</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c0">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c0">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="c0">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport contextRef="c0">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber contextRef="c0">001-41586</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0">Moolec Science SA</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0">N4</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="c0">17, Boulevard F. W.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c0">RaiffeisenL-2411 Luxembourg</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c0">Grand Duchy of Luxembourg</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="c0">LU</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="c1">B268440</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressPostalZipCode contextRef="c0">B268440</dei:EntityAddressPostalZipCode>
    <dei:ContactPersonnelName contextRef="c1">Florencia Bottero</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1 contextRef="c1">17, Boulevard F. W.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c1">RaiffeisenL-2411 Luxembourg</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c1">Grand Duchy of Luxembourg</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="c1">LU</dei:EntityAddressCountry>
    <dei:ContactPersonnelEmailAddress contextRef="c1">legal@moolecscience.com</dei:ContactPersonnelEmailAddress>
    <dei:CityAreaCode contextRef="c1">+54</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c1">341 486 1100</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c0">Ordinary Shares, with nominal value of US$0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c0">MLEC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c0">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding contextRef="c2" decimals="INF" unitRef="shares">37563768</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c0">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c0">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c0">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c0">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="c0">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c0">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="c0">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c0">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="c0">false</dei:EntityShellCompany>
    <dei:AuditorFirmId contextRef="c0">1349</dei:AuditorFirmId>
    <dei:AuditorName contextRef="c0">Sebastian Azagra</dei:AuditorName>
    <dei:AuditorLocation contextRef="c0">Rosario, Argentina</dei:AuditorLocation>
    <ifrs-full:Revenue contextRef="c0" decimals="0" unitRef="usd">905049</ifrs-full:Revenue>
    <ifrs-full:CostOfSales contextRef="c0" decimals="0" unitRef="usd">1048354</ifrs-full:CostOfSales>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c0" decimals="0" unitRef="usd">1351217</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c3" decimals="0" unitRef="usd">985158</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c4" decimals="0" unitRef="usd">601942</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c5" decimals="0" unitRef="usd">179061</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:SalesAndMarketingExpense contextRef="c0" decimals="0" unitRef="usd">256421</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense contextRef="c3" decimals="0" unitRef="usd">105060</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense contextRef="c4" decimals="0" unitRef="usd">80221</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense contextRef="c5" decimals="0" unitRef="usd">10938</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:AdministrativeExpense contextRef="c0" decimals="0" unitRef="usd">4808655</ifrs-full:AdministrativeExpense>
    <ifrs-full:AdministrativeExpense contextRef="c3" decimals="0" unitRef="usd">2523230</ifrs-full:AdministrativeExpense>
    <ifrs-full:AdministrativeExpense contextRef="c4" decimals="0" unitRef="usd">820946</ifrs-full:AdministrativeExpense>
    <ifrs-full:AdministrativeExpense contextRef="c5" decimals="0" unitRef="usd">127886</ifrs-full:AdministrativeExpense>
    <ifrs-full:OtherOperatingIncomeExpense contextRef="c0" decimals="0" unitRef="usd">-94207</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense contextRef="c3" decimals="0" unitRef="usd">-38985</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense contextRef="c4" decimals="0" unitRef="usd">-93252</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense contextRef="c5" decimals="0" unitRef="usd">-2639</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:ProfitLossFromOperatingActivities contextRef="c0" decimals="0" unitRef="usd">-6653805</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities contextRef="c3" decimals="0" unitRef="usd">-3652433</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities contextRef="c4" decimals="0" unitRef="usd">-1596361</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities contextRef="c5" decimals="0" unitRef="usd">-320524</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax contextRef="c4" decimals="0" unitRef="usd">-390453</ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:FinanceCosts contextRef="c0" decimals="0" unitRef="usd">160035</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts contextRef="c3" decimals="0" unitRef="usd">2130</ifrs-full:FinanceCosts>
    <ifrs-full:OtherFinanceIncomeCost contextRef="c0" decimals="0" unitRef="usd">1030525</ifrs-full:OtherFinanceIncomeCost>
    <ifrs-full:OtherFinanceIncomeCost contextRef="c3" decimals="0" unitRef="usd">-872342</ifrs-full:OtherFinanceIncomeCost>
    <mlec:TransactionsExpenses contextRef="c0" decimals="0" unitRef="usd">3535046</mlec:TransactionsExpenses>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c0" decimals="0" unitRef="usd">42705061</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ProfitLossBeforeTax contextRef="c0" decimals="0" unitRef="usd">-52023422</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="c3" decimals="0" unitRef="usd">-4526905</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="c4" decimals="0" unitRef="usd">-1986814</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="c5" decimals="0" unitRef="usd">-320524</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c0" decimals="0" unitRef="usd">-234542</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss contextRef="c0" decimals="0" unitRef="usd">-51788880</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c3" decimals="0" unitRef="usd">-4526905</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c4" decimals="0" unitRef="usd">-1986814</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c5" decimals="0" unitRef="usd">-320524</ifrs-full:ProfitLoss>
    <ifrs-full:BasicEarningsLossPerShare contextRef="c0" decimals="2" unitRef="usdPershares">-1.5</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare contextRef="c3" decimals="2" unitRef="usdPershares">-0.15</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare contextRef="c4" decimals="2" unitRef="usdPershares">-0.07</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare contextRef="c5" decimals="2" unitRef="usdPershares">-0.01</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:ProfitLoss contextRef="c0" decimals="0" unitRef="usd">-51788880</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c3" decimals="0" unitRef="usd">-4526905</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c4" decimals="0" unitRef="usd">-1986814</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c5" decimals="0" unitRef="usd">-320524</ifrs-full:ProfitLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax contextRef="c0" decimals="0" unitRef="usd">18112</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax>
    <ifrs-full:OtherComprehensiveIncome contextRef="c0" decimals="0" unitRef="usd">18112</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c0" decimals="0" unitRef="usd">-51770768</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c3" decimals="0" unitRef="usd">-4526905</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c4" decimals="0" unitRef="usd">-1986814</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c5" decimals="0" unitRef="usd">-320524</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c2" decimals="0" unitRef="usd">8519098</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c6" decimals="0" unitRef="usd">4598930</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <mlec:FixedAssets contextRef="c2" decimals="0" unitRef="usd">1142082</mlec:FixedAssets>
    <mlec:FixedAssets contextRef="c6" decimals="0" unitRef="usd">8918</mlec:FixedAssets>
    <ifrs-full:Goodwill contextRef="c2" decimals="0" unitRef="usd">251440</ifrs-full:Goodwill>
    <ifrs-full:RightofuseAssets contextRef="c2" decimals="0" unitRef="usd">43806</ifrs-full:RightofuseAssets>
    <ifrs-full:NoncurrentReceivables contextRef="c2" decimals="0" unitRef="usd">8763027</ifrs-full:NoncurrentReceivables>
    <ifrs-full:NoncurrentAssets contextRef="c2" decimals="0" unitRef="usd">18719453</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c6" decimals="0" unitRef="usd">4607848</ifrs-full:NoncurrentAssets>
    <ifrs-full:CashAndCashEquivalents contextRef="c2" decimals="0" unitRef="usd">2527673</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c6" decimals="0" unitRef="usd">1081808</ifrs-full:CashAndCashEquivalents>
    <mlec:ShorttermInvestmentsCurrent contextRef="c2" decimals="0" unitRef="usd">306034</mlec:ShorttermInvestmentsCurrent>
    <ifrs-full:CurrentTradeReceivables contextRef="c2" decimals="0" unitRef="usd">361097</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:OtherReceivables contextRef="c2" decimals="0" unitRef="usd">1330177</ifrs-full:OtherReceivables>
    <ifrs-full:CurrentPrepayments contextRef="c2" decimals="0" unitRef="usd">341107</ifrs-full:CurrentPrepayments>
    <ifrs-full:CurrentPrepayments contextRef="c6" decimals="0" unitRef="usd">2061</ifrs-full:CurrentPrepayments>
    <ifrs-full:Inventories contextRef="c2" decimals="0" unitRef="usd">465748</ifrs-full:Inventories>
    <ifrs-full:CurrentAssets contextRef="c2" decimals="0" unitRef="usd">5331836</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets contextRef="c6" decimals="0" unitRef="usd">1083869</ifrs-full:CurrentAssets>
    <ifrs-full:Assets contextRef="c2" decimals="0" unitRef="usd">24051289</ifrs-full:Assets>
    <ifrs-full:Assets contextRef="c6" decimals="0" unitRef="usd">5691717</ifrs-full:Assets>
    <ifrs-full:IssuedCapital contextRef="c2" decimals="0" unitRef="usd">375641</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital contextRef="c6" decimals="0" unitRef="usd">310000</ifrs-full:IssuedCapital>
    <ifrs-full:SharePremium contextRef="c2" decimals="0" unitRef="usd">66996982</ifrs-full:SharePremium>
    <ifrs-full:SharePremium contextRef="c6" decimals="0" unitRef="usd">7290000</ifrs-full:SharePremium>
    <mlec:ShareToBeIssuedAmount contextRef="c2" decimals="0" unitRef="usd">3068</mlec:ShareToBeIssuedAmount>
    <mlec:EquitySettledShareBasedPayments contextRef="c2" decimals="0" unitRef="usd">1335253</mlec:EquitySettledShareBasedPayments>
    <mlec:EquitySettledShareBasedPayments contextRef="c6" decimals="0" unitRef="usd">838576</mlec:EquitySettledShareBasedPayments>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation contextRef="c2" decimals="0" unitRef="usd">18112</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:RetainedEarnings contextRef="c2" decimals="0" unitRef="usd">-58623123</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings contextRef="c6" decimals="0" unitRef="usd">-6834243</ifrs-full:RetainedEarnings>
    <ifrs-full:Equity contextRef="c2" decimals="0" unitRef="usd">10105933</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c6" decimals="0" unitRef="usd">1604333</ifrs-full:Equity>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="c2" decimals="0" unitRef="usd">7479614</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="c6" decimals="0" unitRef="usd">1226213</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:OtherCurrentFinancialLiabilities contextRef="c2" decimals="0" unitRef="usd">2546243</ifrs-full:OtherCurrentFinancialLiabilities>
    <ifrs-full:OtherCurrentLiabilities contextRef="c2" decimals="0" unitRef="usd">1685645</ifrs-full:OtherCurrentLiabilities>
    <ifrs-full:OtherCurrentLiabilities contextRef="c6" decimals="0" unitRef="usd">1171</ifrs-full:OtherCurrentLiabilities>
    <ifrs-full:WarrantLiability contextRef="c2" decimals="0" unitRef="usd">887689</ifrs-full:WarrantLiability>
    <mlec:SimplyAgreementForFutureEquitySAFE contextRef="c6" decimals="0" unitRef="usd">2860000</mlec:SimplyAgreementForFutureEquitySAFE>
    <ifrs-full:CurrentLiabilities contextRef="c2" decimals="0" unitRef="usd">12599191</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities contextRef="c6" decimals="0" unitRef="usd">4087384</ifrs-full:CurrentLiabilities>
    <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="c2" decimals="0" unitRef="usd">99046</ifrs-full:OtherNoncurrentFinancialLiabilities>
    <ifrs-full:OtherNoncurrentPayables contextRef="c2" decimals="0" unitRef="usd">175312</ifrs-full:OtherNoncurrentPayables>
    <ifrs-full:DeferredTaxLiabilities contextRef="c2" decimals="0" unitRef="usd">1071807</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c2" decimals="0" unitRef="usd">1346165</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Liabilities contextRef="c2" decimals="0" unitRef="usd">13945356</ifrs-full:Liabilities>
    <ifrs-full:Liabilities contextRef="c6" decimals="0" unitRef="usd">4087384</ifrs-full:Liabilities>
    <ifrs-full:EquityAndLiabilities contextRef="c2" decimals="0" unitRef="usd">24051289</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities contextRef="c6" decimals="0" unitRef="usd">5691717</ifrs-full:EquityAndLiabilities>
    <mlec:IssueOfShareCapital contextRef="c14" decimals="0" unitRef="usd">291400</mlec:IssueOfShareCapital>
    <mlec:IssueOfShareCapital contextRef="c16" decimals="0" unitRef="usd">4308600</mlec:IssueOfShareCapital>
    <mlec:IssueOfShareCapital contextRef="c5" decimals="0" unitRef="usd">4600000</mlec:IssueOfShareCapital>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax contextRef="c19" decimals="0" unitRef="usd">-320524</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax contextRef="c5" decimals="0" unitRef="usd">-320524</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax>
    <ifrs-full:Equity contextRef="c20" decimals="0" unitRef="usd">291400</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c22" decimals="0" unitRef="usd">4308600</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c25" decimals="0" unitRef="usd">-320524</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c26" decimals="0" unitRef="usd">4279476</ifrs-full:Equity>
    <mlec:IssueOfShareCapital contextRef="c27" decimals="0" unitRef="usd">18600</mlec:IssueOfShareCapital>
    <mlec:IssueOfShareCapital contextRef="c29" decimals="0" unitRef="usd">2981400</mlec:IssueOfShareCapital>
    <mlec:IssueOfShareCapital contextRef="c4" decimals="0" unitRef="usd">3000000</mlec:IssueOfShareCapital>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax contextRef="c32" decimals="0" unitRef="usd">-1986814</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax contextRef="c4" decimals="0" unitRef="usd">-1986814</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax>
    <ifrs-full:Equity contextRef="c33" decimals="0" unitRef="usd">310000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c35" decimals="0" unitRef="usd">7290000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c38" decimals="0" unitRef="usd">-2307338</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c39" decimals="0" unitRef="usd">5292662</ifrs-full:Equity>
    <mlec:EquitySettledShareBasedPayment contextRef="c44" decimals="0" unitRef="usd">838576</mlec:EquitySettledShareBasedPayment>
    <mlec:EquitySettledShareBasedPayment contextRef="c3" decimals="0" unitRef="usd">838576</mlec:EquitySettledShareBasedPayment>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax contextRef="c45" decimals="0" unitRef="usd">-4526905</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax contextRef="c3" decimals="0" unitRef="usd">-4526905</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax>
    <ifrs-full:Equity contextRef="c46" decimals="0" unitRef="usd">310000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c48" decimals="0" unitRef="usd">7290000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c50" decimals="0" unitRef="usd">838576</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c51" decimals="0" unitRef="usd">-6834243</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c6" decimals="0" unitRef="usd">1604333</ifrs-full:Equity>
    <ifrs-full:IssueOfEquity contextRef="c52" decimals="0" unitRef="usd">15000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity contextRef="c54" decimals="0" unitRef="usd">8105000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity contextRef="c0" decimals="0" unitRef="usd">8120000</ifrs-full:IssueOfEquity>
    <mlec:IssueOfShareCapitalSAFEShares contextRef="c52" decimals="0" unitRef="usd">2623</mlec:IssueOfShareCapitalSAFEShares>
    <mlec:IssueOfShareCapitalSAFEShares contextRef="c54" decimals="0" unitRef="usd">3170723</mlec:IssueOfShareCapitalSAFEShares>
    <mlec:IssueOfShareCapitalSAFEShares contextRef="c0" decimals="0" unitRef="usd">3173346</mlec:IssueOfShareCapitalSAFEShares>
    <mlec:IssueOfShareCapitalLightJumpShares contextRef="c52" decimals="0" unitRef="usd">33639</mlec:IssueOfShareCapitalLightJumpShares>
    <mlec:IssueOfShareCapitalLightJumpShares contextRef="c54" decimals="0" unitRef="usd">39610630</mlec:IssueOfShareCapitalLightJumpShares>
    <mlec:IssueOfShareCapitalLightJumpShares contextRef="c0" decimals="0" unitRef="usd">39644269</mlec:IssueOfShareCapitalLightJumpShares>
    <mlec:IssueOfShareCapitalBackstopShares contextRef="c52" decimals="0" unitRef="usd">12017</mlec:IssueOfShareCapitalBackstopShares>
    <mlec:IssueOfShareCapitalBackstopShares contextRef="c54" decimals="0" unitRef="usd">7999023</mlec:IssueOfShareCapitalBackstopShares>
    <mlec:IssueOfShareCapitalBackstopShares contextRef="c0" decimals="0" unitRef="usd">8011040</mlec:IssueOfShareCapitalBackstopShares>
    <mlec:IssueOfShareCapital contextRef="c52" decimals="0" unitRef="usd">36</mlec:IssueOfShareCapital>
    <mlec:IssueOfShareCapital contextRef="c54" decimals="0" unitRef="usd">10647</mlec:IssueOfShareCapital>
    <mlec:IssueOfShareCapital contextRef="c0" decimals="0" unitRef="usd">10683</mlec:IssueOfShareCapital>
    <mlec:EquitySettledShareBasedPayment contextRef="c52" decimals="0" unitRef="usd">2326</mlec:EquitySettledShareBasedPayment>
    <mlec:EquitySettledShareBasedPayment contextRef="c53" decimals="0" unitRef="usd">2427</mlec:EquitySettledShareBasedPayment>
    <mlec:EquitySettledShareBasedPayment contextRef="c54" decimals="0" unitRef="usd">593684</mlec:EquitySettledShareBasedPayment>
    <mlec:EquitySettledShareBasedPayment contextRef="c56" decimals="0" unitRef="usd">496677</mlec:EquitySettledShareBasedPayment>
    <mlec:EquitySettledShareBasedPayment contextRef="c0" decimals="0" unitRef="usd">1095114</mlec:EquitySettledShareBasedPayment>
    <ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax contextRef="c55" decimals="0" unitRef="usd">18112</ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax>
    <ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax contextRef="c0" decimals="0" unitRef="usd">18112</ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax>
    <mlec:BusinessCombination contextRef="c53" decimals="0" unitRef="usd">641</mlec:BusinessCombination>
    <mlec:BusinessCombination contextRef="c54" decimals="0" unitRef="usd">217275</mlec:BusinessCombination>
    <mlec:BusinessCombination contextRef="c0" decimals="0" unitRef="usd">217916</mlec:BusinessCombination>
    <ifrs-full:ProfitLoss contextRef="c57" decimals="0" unitRef="usd">-51788880</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c0" decimals="0" unitRef="usd">-51788880</ifrs-full:ProfitLoss>
    <ifrs-full:Equity contextRef="c58" decimals="0" unitRef="usd">375641</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c59" decimals="0" unitRef="usd">3068</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c60" decimals="0" unitRef="usd">66996982</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c61" decimals="0" unitRef="usd">18112</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c62" decimals="0" unitRef="usd">1335253</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c63" decimals="0" unitRef="usd">-58623123</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c2" decimals="0" unitRef="usd">10105933</ifrs-full:Equity>
    <ifrs-full:ProfitLoss contextRef="c0" decimals="0" unitRef="usd">-51788880</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c3" decimals="0" unitRef="usd">-4526905</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c4" decimals="0" unitRef="usd">-1986814</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c5" decimals="0" unitRef="usd">-320524</ifrs-full:ProfitLoss>
    <ifrs-full:AdjustmentsForIncomeTaxExpense contextRef="c0" decimals="0" unitRef="usd">-234542</ifrs-full:AdjustmentsForIncomeTaxExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense contextRef="c0" decimals="0" unitRef="usd">122022</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense contextRef="c3" decimals="0" unitRef="usd">1699</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForSharebasedPayments contextRef="c0" decimals="0" unitRef="usd">1095114</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments contextRef="c3" decimals="0" unitRef="usd">838576</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="c4" decimals="0" unitRef="usd">-390453</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss contextRef="c0" decimals="0" unitRef="usd">-313346</ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss contextRef="c3" decimals="0" unitRef="usd">-860000</ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss>
    <mlec:ShareBasedPaymentCostOfListingSharesnoncashItem contextRef="c0" decimals="0" unitRef="usd">42705061</mlec:ShareBasedPaymentCostOfListingSharesnoncashItem>
    <ifrs-full:FinanceIncomeCost contextRef="c0" decimals="0" unitRef="usd">1452876</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost contextRef="c3" decimals="0" unitRef="usd">-14472</ifrs-full:FinanceIncomeCost>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables contextRef="c0" decimals="0" unitRef="usd">-44126</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets contextRef="c0" decimals="0" unitRef="usd">-276292</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable contextRef="c4" decimals="0" unitRef="usd">2009220</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable contextRef="c5" decimals="0" unitRef="usd">-2299108</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses contextRef="c0" decimals="0" unitRef="usd">-339046</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses contextRef="c3" decimals="0" unitRef="usd">-1703</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses contextRef="c4" decimals="0" unitRef="usd">-358</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories contextRef="c0" decimals="0" unitRef="usd">66484</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable contextRef="c0" decimals="0" unitRef="usd">1485151</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable contextRef="c3" decimals="0" unitRef="usd">926711</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable contextRef="c4" decimals="0" unitRef="usd">568026</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable contextRef="c5" decimals="0" unitRef="usd">19632</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <mlec:OtherLiabilitie contextRef="c0" decimals="0" unitRef="usd">-837231</mlec:OtherLiabilitie>
    <mlec:OtherLiabilitie contextRef="c3" decimals="0" unitRef="usd">-1171</mlec:OtherLiabilitie>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="c0" decimals="0" unitRef="usd">-7511353</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="c3" decimals="0" unitRef="usd">-1885979</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="c4" decimals="0" unitRef="usd">980527</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="c5" decimals="0" unitRef="usd">-2600000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c0" decimals="0" unitRef="usd">14824</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities contextRef="c0" decimals="0" unitRef="usd">1930883</ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="c0" decimals="0" unitRef="usd">164362</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments contextRef="c0" decimals="0" unitRef="usd">-2572783</ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments>
    <ifrs-full:ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities contextRef="c0" decimals="0" unitRef="usd">2346032</ifrs-full:ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="c0" decimals="0" unitRef="usd">-2336820</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:ProceedsFromIssuingOtherEquityInstruments contextRef="c0" decimals="0" unitRef="usd">8011040</ifrs-full:ProceedsFromIssuingOtherEquityInstruments>
    <mlec:Proceedsfromissuanceofsharecapital contextRef="c0" decimals="0" unitRef="usd">1988975</mlec:Proceedsfromissuanceofsharecapital>
    <ifrs-full:ProceedsFromCurrentBorrowings contextRef="c0" decimals="0" unitRef="usd">2171830</ifrs-full:ProceedsFromCurrentBorrowings>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities contextRef="c0" decimals="0" unitRef="usd">876769</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities contextRef="c0" decimals="0" unitRef="usd">24098</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <mlec:ProceedsFromSAFE contextRef="c3" decimals="0" unitRef="usd">2000000</mlec:ProceedsFromSAFE>
    <ifrs-full:ProceedsFromIssuingShares contextRef="c0" decimals="0" unitRef="usd">10683</ifrs-full:ProceedsFromIssuingShares>
    <mlec:ProceedsFromIssueOfShareCapital contextRef="c5" decimals="0" unitRef="usd">600000</mlec:ProceedsFromIssueOfShareCapital>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares contextRef="c5" decimals="0" unitRef="usd">2000000</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="c0" decimals="0" unitRef="usd">11281661</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="c3" decimals="0" unitRef="usd">2000000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="c5" decimals="0" unitRef="usd">2600000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="c0" decimals="0" unitRef="usd">1433488</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="c3" decimals="0" unitRef="usd">114021</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="c4" decimals="0" unitRef="usd">980527</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition contextRef="c6" decimals="0" unitRef="usd">1081808</ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition>
    <ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition contextRef="c39" decimals="0" unitRef="usd">980527</ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="c0" decimals="0" unitRef="usd">12377</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="c3" decimals="0" unitRef="usd">-12740</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition contextRef="c2" decimals="0" unitRef="usd">2527673</ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition>
    <ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition contextRef="c6" decimals="0" unitRef="usd">1081808</ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition>
    <ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition contextRef="c39" decimals="0" unitRef="usd">980527</ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition>
    <mlec:IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei contextRef="c0" decimals="0" unitRef="usd">8120000</mlec:IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei>
    <mlec:ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium contextRef="c0" decimals="0" unitRef="usd">3173346</mlec:ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium>
    <mlec:CapitalizationOfTransactionExpensesThroughAccountsPayable contextRef="c0" decimals="0" unitRef="usd">1057833</mlec:CapitalizationOfTransactionExpensesThroughAccountsPayable>
    <mlec:NetLiabilitiesAcquiredThroughIssuanceOfShareCapital contextRef="c0" decimals="0" unitRef="usd">3991935</mlec:NetLiabilitiesAcquiredThroughIssuanceOfShareCapital>
    <mlec:AcquisitionOfBusinessCombinationTroughDeferredPayment contextRef="c0" decimals="0" unitRef="usd">488431</mlec:AcquisitionOfBusinessCombinationTroughDeferredPayment>
    <mlec:AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind contextRef="c0" decimals="0" unitRef="usd">217916</mlec:AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind>
    <mlec:AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares contextRef="c4" decimals="0" unitRef="usd">3000000</mlec:AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares>
    <mlec:AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares contextRef="c5" decimals="0" unitRef="usd">2000000</mlec:AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares>
    <ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Note 1. General information&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Moolec Science SA (&#x201c;the
Company&#x2019;&#x2019;, &#x201c;the Group&#x201d; or &#x201c;Moolec Science&#x2019;&#x2019;) is a public limited liability company (soci&#xe9;t&#xe9; anonyme) incorporated
under the laws of the Grand Duchy of Luxembourg on May 23, 2022 (&#x201c;date of incorporation&#x201d;), created to develop affordable alternative
proteins using molecular farming technology. The Company is registered with the Luxembourg Trade and Companies&#x2019; Register (Registre
de Commerce et des Soci&#xe9;t&#xe9;s, Luxembourg) under number B268440. Its registered address is 17, Boulevard F.W. Raiffeisen,
L-2411 Luxembourg, Grand Duchy of Luxembourg.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Company Reorganization&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;On December 30, 2022
(the &#x201c;Closing Date&#x201d;), the Company consummated the transactions contemplated by the Business Combination Agreement dated as
of June 14, 2022, by and among LightJump Acquisition Corporation (&#x201c;LightJump&#x201d; or &#x201c;SPAC&#x201d;, a Delaware corporation),
Moolec Science Limited (&#x201c;Moolec&#x201d; or &#x201c;Moolec Science Limited&#x201d;, a private limited company incorporated under the
laws of England and Wales), the Company, and Moolec Acquisition, Inc. (&#x201c;Merger Sub&#x201d;, a Delaware corporation) (referred together
with Moolec Science SA as &#x201c;the Group&#x201d;), as amended by the Business Combination Agreement dated as of November 18, 2022. Pursuant
to the Business Combination Agreement and related agreements:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;all the issued Moolec Ordinary Shares held by Moolec Shareholders were transferred and contributed in
kind to the Company, and were issued, in accordance with the Exchange Ratio (1:0.6370485) (except that the Ordinary Shares to be reduced
by the number of Ordinary Shares already held by Moolec Shareholders immediately prior to the transactions contemplated in the Business
Combination Agreement (&#x201c;Exchange&#x201d;), being a total of 32,500,000 Ordinary Shares;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;each Moolec SAFE Holder contributed all of its rights and obligations under each Original SAFE to the
Company in consideration for the issuance by the Company of a simple agreement for future equity on substantially identical terms (mutatis
mutandis) with such adjustments as required under Luxembourg law;&lt;/td&gt;&lt;/tr&gt;
                                                                           &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;each Moolec Shareholder ceased to be the beneficial holder of such Moolec Ordinary Shares and subject
to the submission of all filings required under Law (including any filings required to pay stamp duties), the Company was recorded as
the registered holder of all Ordinary Shares so exchanged and transferred and is the legal and beneficial owner thereof;&lt;/td&gt;&lt;/tr&gt;
                                                                                                                                  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;immediately prior to the Merger but after the Exchange, each Moolec SAFE Holder subscribed for, received
and became holder of Ordinary Shares, in accordance with the respective Moolec SAFE, which included 262,260 Ordinary Shares; and&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;SPAC caused the Certificate of Merger to be executed, acknowledged and filed with the Secretary of State
of the State of Delaware in accordance with the applicable provisions of the DGCL in order to effectuate the Merger. The Merger became
effective on December 30, 2022.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;At the Merger and without
any further action on the part of SPAC, Merger Sub, the Company or Moolec or the holders thereunder:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;each SPAC Common Stock issued and outstanding immediately prior to the Merger, excluding those that had
been redeemed subject to any redemption rights, were exchanged with the Company, against the issue by the Company of new Ordinary Shares,
under the authorized share capital of the Company and subscribed by the contributing holders of SPAC Common Stock for one validly issued
and fully paid Ordinary Share, delivered by the Company;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;as a result of the Merger, all SPAC Common Stock ceased to be outstanding, was canceled and ceased to
exist;&lt;/td&gt;&lt;/tr&gt;
                &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;each share of common stock, par value $0.01 of Merger Sub issued and outstanding immediately prior to
the Merger Effective Time was converted and exchanged for one (1) validly issued, fully paid and nonassessable ordinary share, par value
$0.01 per share of the Company; and&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;each SPAC Warrant that was outstanding immediately prior to the Merger, pursuant to the SPAC Warrant Agreement,
ceased to represent a right to acquire one SPAC Common Stock and was converted in accordance with the terms of such SPAC Warrant Agreement,
at the Merger, into a right to acquire one Ordinary Share of the Company on substantially the same terms as were in effect immediately
prior to the Time under the terms of the SPAC Warrant Agreement.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Following the Merger:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Moolec&#x2019;s CFO was freely allotted the shares to satisfy the requirements under the CFO Consulting
Agreement.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Prior to the Closing,
on December 27, 2022, in connection with the vote to approve the adoption of the Business Combination Agreement at LightJump&#x2019;s special
meeting of stockholders, certain public holders of SPAC Common Stock exercised their right to redeem 2,572,848 shares of SPAC Common Stock
for cash at a redemption price of approximately $10.23 per share, for an aggregate redemption amount of approximately $ 26.3 million.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Accordingly, $1,988,975
remained in the Trust Account, for the benefit of the Company, after considering the redemption amount to be paid to the redeeming public
holders of SPAC Common Stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Additionally, pursuant
to the Backstop Agreement, the Sponsor exercised the right to elect to concede Sponsor shares instead of contributing the requisite cash
amount under the Backstop Agreement by conceding a total of 200,276 Sponsor shares of SPAC Common Stock to each of Union Group Ventures
Limited (&#x201c;UGVL&#x201d;) and THEO I SCSp. (&#x201c;Theo&#x201d;). UGVL and Theo each contributed $4,005,520 to the Company pursuant
to the terms of the Backstop Agreement and in turn the Company issued 400,552 Ordinary Shares to each of UGVL and Theo.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;As a result of the Exchange
and following the consummation of the Transaction, Moolec and SPAC had become direct wholly-owned subsidiaries of the Company and Moolec
shareholders and SPAC shareholders became holders of issued Company Ordinary Shares of Moolec Science S.A.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;In accordance with IFRS
2, for the excess of the fair value of shares deemed to have been issued by Moolec over the fair value of LightJump&#x2019;s identifiable
net assets at the date of the Company Reorganization, the Company recognized $ 42,705,061 as listing costs included in line item &#x201c;Share
based payment cost of listing shares&#x201d; as an expense in the Statements of Operations, being a non-cash item.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Negative working capital&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;As of June 30, 2023, the
Company has a negative working capital of $7,427,356 increased mainly by reorganization expenses pending to be paid and a temporary mismatch
between account payables together with financial debt and account receivables. However, as part of the continuous efforts of management
to strengthen the financial situation of the Company, as of October 15, 2023, the Company has entered into an agreement to issue a convertible
note due 2026 to Grupo Insud (&#x201c;Insud&#x201d;). As a consequence of the cash inflow related to the convertible note, the Group concludes
it will, for the foreseeable future, be able to realize its assets and discharge its liabilities in the normal course of operations. See
note 31. Events after the reporting period.&lt;/p&gt;</ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued contextRef="c0" decimals="0" unitRef="shares">32500000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued contextRef="c64" decimals="0" unitRef="shares">262260</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:ParValuePerShare contextRef="c65" decimals="2" unitRef="usdPershares">0.01</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare contextRef="c2" decimals="2" unitRef="usdPershares">0.01</ifrs-full:ParValuePerShare>
    <mlec:CommonStockExercised contextRef="c66" decimals="0" unitRef="shares">2572848</mlec:CommonStockExercised>
    <mlec:RedemptionPrice contextRef="c67" decimals="2" unitRef="usdPershares">10.23</mlec:RedemptionPrice>
    <mlec:AggregateRedemption contextRef="c66" decimals="-5" unitRef="usd">26300000</mlec:AggregateRedemption>
    <mlec:TrustAccount contextRef="c0" decimals="0" unitRef="usd">1988975</mlec:TrustAccount>
    <mlec:SponsorShares contextRef="c0" decimals="0" unitRef="shares">200276</mlec:SponsorShares>
    <ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets contextRef="c2" decimals="0" unitRef="usd">4005520</ifrs-full:PropertyAmountContributedToFairValueOfPlanAssets>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued contextRef="c68" decimals="0" unitRef="shares">400552</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <mlec:ShareBasedPaymentCost contextRef="c0" decimals="0" unitRef="usd">42705061</mlec:ShareBasedPaymentCost>
    <mlec:NegativeWorkingCapital contextRef="c2" decimals="0" unitRef="usd">7427356</mlec:NegativeWorkingCapital>
    <ifrs-full:DisclosureOfBusinessCombinationsExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Note 2. Business combination&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Summary of ValoraSoy
acquisition&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;On April 24, 2023 (the
&#x201c;Closing Date&#x201d;), the Company completed the acquisition of ValoraSoy S.A. (&#x201c;ValoraSoy Food Ingredients&#x201d;) from the
sellers in accordance with the share purchase agreement (&#x201c;ValoraSoy SPA&#x201d;) by and among the Company and the sellers (the &#x201c;ValoraSoy
Acquisition&#x201d;). As a result of the ValoraSoy Acquisition, the Company acquired all of the issued and outstanding equity securities
of ValoraSoy Food Ingredients from the sellers, and ValoraSoy Food Ingredients became a wholly owned subsidiary of the Company for total
aggregate consideration of $2.6 million, in a combination of cash ($2.4 million of which $1.9 million were an immediate cash payment and
$0.5 million will be paid in 6 months from the Closing Date) and equity (64,093 shares equivalent to $0.2 million which will be transferred
in 12 months from the Closing Date). The acquisition agreement also included a contingent payment in a fixed amount of equity amounting
to 384,558 shares equivalent to $1.7 million, which was determined to be a remuneration agreement for future services (the &#x201c;earn-out&#x201d;)
and consequently it was excluded from the consideration and will be recognized as an expense over the required service period. The contingent
payment is payable in shares over a three-year period from 2024 to 2026 and subject to the achievement of certain EBITDA targets, as defined
in the ValoraSoy SPA. Such payment is automatically forfeited on termination of employment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;ValoraSoy Food Ingredients
has more than 10 years of experience, specializes in the production of textured soy proteins and has a long history providing high-quality
products and customized solutions to clients in more than 14 countries in 3 different continents. Its products are manufactured using
various extrusion processes obtaining as a result vegetable proteins with texture and fibrousness similar to those of meat with various
applications such as hamburgers, sausages and other meat extenders and plant-based products. This demo center is a state-of-the-art processing
facility located in the Argentine soybean corridor, which helps maximize raw material origination, with an installed crushing capacity
of 10 thousand tons of soybean per year.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Details of the purchase
consideration, the net assets acquired and goodwill are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;Purchase consideration:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: justify; text-indent: 0pt; padding-left: 0.125in"&gt;Cash paid&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,931,112&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; text-indent: 0pt; padding-left: 0.125in"&gt;Deferred Payment after 6 months&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;488,431&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: justify; text-indent: 0pt; padding-left: 0.125in"&gt;Payment in kind after 12 months&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;217,916&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify; text-indent: 0pt; padding-left: 0.125in"&gt;Total purchase consideration&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;2,637,458&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The assets and liabilities
recognised as a result of the acquisition are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-top: 0pt; text-align: justify; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0pt; width: 88%; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Cash and Banks&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;228&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Accounts Receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;316,972&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Other Receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,044,808&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Inventory&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;532,231&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Property, Plant, and Equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,138,026&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Intangible Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,824,054&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Right-of-use of assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;43,507&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Accounts Payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,384,980&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Current Financial Debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,176,089&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Current Other Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(356,757&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Non-current Financial Debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(119,464&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Non-current Other Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(177,367&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 1.5pt; text-align: justify; text-indent: 0pt"&gt;Deferred Tax Liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,297,436&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 1.5pt; font-weight: bold; text-align: justify; text-indent: 0pt"&gt;Net identifiable assets acquired&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;2,387,733&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 1.5pt; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Goodwill recognized &lt;span style="font-size: 10pt"&gt;(i)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;249,725&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0pt; font-weight: bold; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Net assets acquired&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;2,637,458&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The goodwill is attributable to the expected future synergies
from combining operations as well as an assembled workforce, which does not qualify for separate recognition. The Company expects that
the ValoraSoy Acquisition will help to accelerate its growth in the food ingredients industry by expanding its commercial network with
a top-notch sales team and complementing its Molecular Farming Platform with industrial capacity and downstream operations, in addition
to adding a highly experienced team of professionals. It will not be deductible for tax purposes.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The pro-forma revenue
of the combined entity for the year ended June 30, 2023 as though the date for the merger had been as of the beginning of the reporting
period amounts to $5,043,956.&lt;/p&gt;</ifrs-full:DisclosureOfBusinessCombinationsExplanatory>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred contextRef="c69" decimals="-5" unitRef="usd">2600000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:CashTransferred contextRef="c69" decimals="-5" unitRef="usd">2400000</ifrs-full:CashTransferred>
    <ifrs-full:IssueCostsNotRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination contextRef="c70" decimals="-5" unitRef="usd">1900000</ifrs-full:IssueCostsNotRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <mlec:CashPayment contextRef="c69" decimals="-5" unitRef="usd">500000</mlec:CashPayment>
    <ifrs-full:SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares contextRef="c69" decimals="0" unitRef="shares">64093</ifrs-full:SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares>
    <ifrs-full:CashTransferred contextRef="c2" decimals="-5" unitRef="usd">200000</ifrs-full:CashTransferred>
    <ifrs-full:SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares contextRef="c2" decimals="0" unitRef="shares">384558</ifrs-full:SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares>
    <mlec:ShareEquivalent contextRef="c0" decimals="-5" unitRef="usd">1700000</mlec:ShareEquivalent>
    <mlec:ExperienceDate contextRef="c2">P10Y</mlec:ExperienceDate>
    <mlec:ScheduleOfNetAssetsAcquiredAndGoodwill contextRef="c0">Details of the purchase
consideration, the net assets acquired and goodwill are as follows:&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;Purchase consideration:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: justify; text-indent: 0pt; padding-left: 0.125in"&gt;Cash paid&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,931,112&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; text-indent: 0pt; padding-left: 0.125in"&gt;Deferred Payment after 6 months&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;488,431&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: justify; text-indent: 0pt; padding-left: 0.125in"&gt;Payment in kind after 12 months&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;217,916&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: justify; text-indent: 0pt; padding-left: 0.125in"&gt;Total purchase consideration&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;2,637,458&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:ScheduleOfNetAssetsAcquiredAndGoodwill>
    <mlec:CashPaid contextRef="c2" decimals="0" unitRef="usd">1931112</mlec:CashPaid>
    <mlec:DeferredPaymentAfter6Months contextRef="c0" decimals="0" unitRef="usd">488431</mlec:DeferredPaymentAfter6Months>
    <ifrs-full:OtherPayables contextRef="c2" decimals="0" unitRef="usd">217916</ifrs-full:OtherPayables>
    <mlec:ConsiderationPaid contextRef="c2" decimals="0" unitRef="usd">2637458</mlec:ConsiderationPaid>
    <srt:ScheduleOfCondensedBalanceSheetTableTextBlock contextRef="c0">The assets and liabilities
recognised as a result of the acquisition are as follows:&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-top: 0pt; text-align: justify; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0pt; width: 88%; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Cash and Banks&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;228&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Accounts Receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;316,972&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Other Receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,044,808&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Inventory&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;532,231&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Property, Plant, and Equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,138,026&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Intangible Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,824,054&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Right-of-use of assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;43,507&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Accounts Payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,384,980&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Current Financial Debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,176,089&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Current Other Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(356,757&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Non-current Financial Debt&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(119,464&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0pt; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Non-current Other Liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(177,367&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 1.5pt; text-align: justify; text-indent: 0pt"&gt;Deferred Tax Liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,297,436&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding: 0pt 0pt 1.5pt; font-weight: bold; text-align: justify; text-indent: 0pt"&gt;Net identifiable assets acquired&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;2,387,733&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding: 0pt 0pt 1.5pt; text-align: justify; text-indent: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Goodwill recognized &lt;span style="font-size: 10pt"&gt;(i)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;249,725&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-top: 0pt; font-weight: bold; text-align: justify; padding-left: 0pt; padding-right: 0pt; text-indent: 0pt"&gt;Net assets acquired&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;2,637,458&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</srt:ScheduleOfCondensedBalanceSheetTableTextBlock>
    <ifrs-full:BalancesWithBanks contextRef="c71" decimals="0" unitRef="usd">228</ifrs-full:BalancesWithBanks>
    <ifrs-full:TradeAndOtherReceivables contextRef="c71" decimals="0" unitRef="usd">316972</ifrs-full:TradeAndOtherReceivables>
    <ifrs-full:OtherCurrentReceivables contextRef="c71" decimals="0" unitRef="usd">1044808</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:OtherInventories contextRef="c71" decimals="0" unitRef="usd">532231</ifrs-full:OtherInventories>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate contextRef="c71" decimals="0" unitRef="usd">1138026</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:OtherIntangibleAssets contextRef="c71" decimals="0" unitRef="usd">3824054</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:AdditionsToRightofuseAssets contextRef="c72" decimals="0" unitRef="usd">43507</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:NoncurrentPayables contextRef="c71" decimals="0" unitRef="usd">1384980</ifrs-full:NoncurrentPayables>
    <ifrs-full:CurrentFinancialLiabilities contextRef="c71" decimals="0" unitRef="usd">1176089</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:OtherLiabilities contextRef="c71" decimals="0" unitRef="usd">356757</ifrs-full:OtherLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities contextRef="c71" decimals="0" unitRef="usd">119464</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities contextRef="c71" decimals="0" unitRef="usd">177367</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:NetDeferredTaxLiabilities contextRef="c71" decimals="0" unitRef="usd">-1297436</ifrs-full:NetDeferredTaxLiabilities>
    <ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed contextRef="c71" decimals="0" unitRef="usd">2387733</ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate contextRef="c71" decimals="0" id="ix_0_fact" unitRef="usd">249725</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:NetAssetsLiabilities contextRef="c71" decimals="0" unitRef="usd">2637458</ifrs-full:NetAssetsLiabilities>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="c0" decimals="0" unitRef="usd">5043956</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Note 3. Accounting
standards and basis of preparation&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;&lt;b&gt;Note 3.1. Compliance
with IFRS&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;These Consolidated Financial
Statements of the Group have been prepared in accordance with International Financial Reporting Standards (IFRS) and interpretations issued
by the IFRS Interpretations Committee (IFRS IC) applicable to companies reporting under IFRS. The financial statements comply with IFRS
as issued by the International Accounting Standards Board (IASB).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The consolidated financial
statements of the Group as of June 30, 2023, and June 30, 2022 and for the year ended June 30, 2023 and 2022 were authorized by the Board
of Directors of Moolec Science S.A. on October 30, 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 3.2. Basis of
measurement&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The consolidated financial
statements have been prepared on the historical cost basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The significant accounting
policies set out in Note 3 have been applied in preparing the consolidated financial statements as of June 30, 2023 and 2022.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Due to the activities
of the Group, costs and expenses presented in the consolidated statements of Comprehensive loss are classified according to their function.
The consolidated statements of Financial Position has been prepared based on the nature of the transactions, distinguishing: (a) current
assets from non-current assets, where current assets are intended as the assets that should be realized, sold or used during the normal
operating cycle, or the assets owned with the aim of being sold in the short-term (within 12 months); (b) current liabilities from non-current
liabilities, where current liabilities are intended as the liabilities that should be paid during the normal operating cycle or over the
12-month period subsequent to the reporting date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 3.3. Functional
and presentation currency&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Items included in the
Consolidated Financial Statements are measured using the currency of the primary economic market in which the Company operates (&#x201c;the
functional currency&#x201d;). These Consolidated Financial Statements are presented in US Dollars, which is the Company&#x2019;s functional
currency.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group has applied
IAS 29 for its newly acquired subsidiary in Argentina. IAS 29 &#x201c;Financial reporting in hyperinflationary economies&#x201d; requires
that the financial statements of an entity whose functional currency is the currency of a hyperinflationary economy, whether these are
based on the historical cost method or the current cost method, be stated in terms of the measuring unit current at the closing date of
the reporting period. For such purpose, the inflation produced since the acquisition date or the revaluation date, as applicable, must
be computed in non-monetary items. The standard details a series of factors to be considered for concluding whether an economy is hyperinflationary,
including, but not limited to, a cumulative inflation rate over a three-year period that approaches or exceeds 100%. Inflation accumulated
in &lt;span style="-sec-ix-hidden: hidden-fact-231"&gt;three&lt;/span&gt;&#160;years, as of June&#160;30, 2018, was over 100%. It was for this reason that, in accordance with IAS 29, the Argentine economy
had to be considered as hyperinflationary since July&#160;1, 2018.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;In an inflationary period,
any entity that maintains an excess of monetary assets over monetary liabilities, will lose purchasing power, and any entity that maintains
an excess of monetary liabilities over monetary assets, will gain purchasing power, provided that such items are not subject to an adjustment
mechanism.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Briefly, the restatement
mechanism of IAS 29 establishes that monetary assets and liabilities will not be restated because they are already expressed in a current
unit of measurement at the end of the reporting period. Assets and liabilities subject to adjustments based on specific agreements, will
be adjusted according to those agreements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Non-monetary items measured at their current values at the end of the reporting period, such
as the net realizable value or others, do not need to be restated. The remaining non-monetary assets and liabilities will be restated
according to a general price index. The loss or gain for the net monetary position will be included in the net result of the reporting
period, revealing this information in a separate line item.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The inflation adjustment
to the initial balances was calculated by means of a conversion factor derived from the Argentine price indexes published by the National
Institute of Statistics.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The index as of June
30, 2023 and as of April 30, 2023 was&#160;1,709.6115 and&#160;1,497.2147, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group started with
the application of IAS 29, since the ValoraSoy acquisition, as such no comparative figures were presented using IAS 29. However, in the
future the comparative figures in the consolidated financial statements presented in a stable currency will not be adjusted for subsequent
changes in the price levels or exchange rates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 3.4. Use of estimates
and judgements&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The preparation of the
Consolidated Financial Statements requires Management to make judgements, estimates and assumptions that affect the application of accounting
policies and the reporting amounts as presented in the Consolidated Financial Statements for all periods presented.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Estimates and underlying
assumptions are reviewed on an ongoing basis. Refer to Note 4 &#x2013; Summary of significant accounting policies for further discussion
on accounting treatments applied in preparation of the financial results of the Group as of the reporting period in compliance with IFRS.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 3.5. Going concern&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Management has evaluated
whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Group&#x2019;s ability to
continue as a going concern after the accompanying Consolidated Financial Statements are issued. The accompanying Consolidated Financial
Statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities that
might be necessary if the Group is unable to continue as a going concern. The Group concludes it will, for the foreseeable future, be
able to realize its assets and discharge its liabilities in the normal course of operations.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory>
    <mlec:CumulativeInflationRate contextRef="c0" decimals="2" unitRef="pure">1</mlec:CumulativeInflationRate>
    <mlec:InflationAccumulated contextRef="c73" decimals="2" unitRef="pure">1</mlec:InflationAccumulated>
    <mlec:ArgentinePriceIndexes contextRef="c74" decimals="4" unitRef="usd">1709.6115</mlec:ArgentinePriceIndexes>
    <mlec:ArgentinePriceIndexes contextRef="c75" decimals="4" unitRef="usd">1497.2147</mlec:ArgentinePriceIndexes>
    <ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Note 4. Summary
of significant accounting policies&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.1. Basis of
consolidation of subsidiary&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Subsidiaries are entities
controlled by the Company. The financial statements of the Company&#x2019;s subsidiaries are included in the Consolidated Financial Statements
from the date that control commences after the acquisition date. The accounting policies of subsidiaries have been changed when necessary
to align them with the policies adopted by the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.2. Foreign
currency&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Transactions entered
into by the Group in a currency other than their functional currency are recorded at the relevant exchange rates as of the date upon which
such transactions occur. Foreign currency monetary assets and liabilities are translated at the prevailing exchange rates as of the final
day of each reporting period. Non-monetary assets and liabilities that are measured at fair value in a foreign currency are translated
into the functional currency at the exchange rate when the fair value was determined. Non-monetary items that are measured based on historical
cost in a foreign currency are translated at the exchange rate at the date of the transaction. Exchange differences arising on the retranslation
of unsettled monetary assets and liabilities are recognized immediately through other comprehensive income in the consolidated statements
of operations and are accumulated in equity (attributed to the non-controlling interests when appropriate).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.3. Intangible
assets&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Intangible assets include
projects in-progress (mainly related to internally developing products), software, licenses and other rights, and the purchase value of
customer relationships. The accounting policies regarding the recognition and measurement of such intangible assets are described below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Internally Generated
Intangible Assets&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Expenditure&#160;on&#160;internally&#160;developed&#160;products&#160;is&#160;capitalized&#160;if&#160;it&#160;can&#160;be&#160;demonstrated&#160;that:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;It&#160;is&#160;technically&#160;feasible&#160;to&#160;develop&#160;the&#160;product&#160;for&#160;it&#160;to&#160;be&#160;sold;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Adequate&#160;resources&#160;are&#160;available&#160;to&#160;complete&#160;the&#160;development;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;There&#160;is&#160;an&#160;intention&#160;to&#160;complete&#160;and&#160;sell&#160;the&#160;product;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The&#160;Group&#160;is&#160;able&#160;to&#160;sell&#160;the&#160;product;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Sale&#160;of&#160;the&#160;product&#160;will&#160;generate&#160;future&#160;economic&#160;benefits;&#160;and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expenditure&#160;on&#160;the&#160;project&#160;can&#160;be&#160;measured&#160;reliably.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Development expenditure
not satisfying the above criteria and expenditure on the research phase of internal projects are recognized in the consolidated statements
of operations as incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Capitalized development
costs are amortized using the straight-line method over the periods the Group expects to benefit from selling the products developed.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Useful&#160;lives&#160;and&#160;amortization&#160;methods&#160;are&#160;reviewed&#160;every&#160;year&#160;as&#160;required&#160;by&#160;IAS&#160;38.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The research and development
process can be divided into several discrete steps or phases, which generally begin with discovery, validation and development and end
with regulatory approval and commercial launch. The process for developing seed traits is relatively similar for both GM and non-GM traits.
However, the two differ significantly in later phases of development. For example, obtaining regulatory approval for GM seeds is a far
more comprehensive and lengthy process than for non-GM seeds. Although breeding programs and industrial biotechnology solutions may have
shorter or simpler phases than those described below, the Group has used the industry consensus for seed-trait development phases to characterize
its technology portfolios, which is generally divided into the following six phases:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;i)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Discovery: The first phase in the technology development
process is the discovery or identification of candidate genes or genetic systems, metabolites, or microorganisms potentially capable
of enhancing specified plant characteristics or enabling an agro-industrial biotech solution.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;ii)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Proof of concept: Upon successful validation of the technologies in model systems (in vitro or in vivo),
promising technologies graduate from discovery and are advanced to the proof of concept phase. The goal of this phase is to validate a
technology within the targeted organism before moving forward with technology escalation activities or extensive field validation.&lt;/td&gt;&lt;/tr&gt;
                                                                                                                                            &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;iii)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Early development: In this phase, efficacy field trials are expanded to evaluate the expression level
and phenological characteristics of the traits in multiple geographies and growing cycles, as well as other characteristics in order to
optimize the technology&#x2019;s performance in the targeted organisms. The goal of the early development phase is to evaluate the technical
feasibility by identifying the best candidate to scale up the seed stock and to start the regulatory field trials.&lt;/td&gt;&lt;/tr&gt;
                                                                                                                            &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;iv)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Advanced development and deregulation: In this phase, extensive field tests are used to fully demonstrate
the effectiveness of the technology for its intended purpose. In the case of GM traits, the process of obtaining regulatory approvals
from the government agencies is started, and includes field trials for environmental, core and food safety data generation. For solutions
involving microbial fermentation, industrial-scale runs are conducted.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;v)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Pre-launch: This phase involves finalizing the regulatory approval process and preparing for the launch
and commercialization of the technology. The range of activities in this phase includes seed increases, pre-commercial production, and
product and solution testing with selected customers. Usually, a more detailed marketing strategy and preparation of marketing materials
occur during this phase.&lt;/td&gt;&lt;/tr&gt;
                                  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;vi)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Product launch: In general, this phase, which is the last milestone of the research and development process,
is carried out by the Group.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;We determined that the
Research &amp;amp; Development is more likely than not (&#x201c;probable&#x201d;) to become a commercialized product and reach compliance with
IAS 38 criteria items at the end of the phase iii &#x201c;Early Development&#x201d;, when efficacy field trials are performed to determine
the technical feasibility of the project by measuring parameters like expression level and phenological characteristics. The obtention
of desired values for this set of data represents the strongest and clearest indication that the technical feasibility has been proved.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Impairment testing of
intangible assets not yet available for use requires the use of significant assumptions for the estimation of future cash flows and the
determination of discount rates. The significant assumptions and the determination of discount rates for the impairment testing of goodwill
are further explained below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Management&#x2019;s estimations
about the demonstrability of the recognition criteria for these assets and the subsequent recoverability represent the best estimate that
can be made based on all the available evidence, existing facts and circumstances and using reasonable and supportable assumptions in
cash flow projections. Therefore, the Consolidated financial statements do not include any adjustments that would result if the Group
were unable to recover the carrying amount of the above-mentioned assets through the generation of enough future economic benefits.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Management has made the
estimates considering the cash flow projections projected. The key assumptions utilized are the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 30%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Key assumption&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; width: 69%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Management&#x2019;s approach&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Discount rate&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The discount rate used ranges between 10% and 20%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top; background-color: White"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; vertical-align: middle"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt; &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Budgeted market share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: justify"&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"&gt;The projected revenue from the products has been estimated by the management based on market penetration data for comparable products and technologies and on future expectations of foreseen economic and market conditions.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"&gt;The value assigned is consistent with external sources of information.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top; background-color: White"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Budgeted product prices&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The prices estimated in the revenue projections are based on current and projected market prices for the products.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top; background-color: White"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Budgeted gross margin&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Based on past performance and management&#x2019;s expectations for the future.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Intangible Assets
Acquired in a Business Combination &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Intangible assets acquired
in a business combination are identified and recognized separately regarding goodwill when they meet the definition of intangible assets
and their fair value can be measured reliably. Such intangible assets are recognized at fair value at acquisition date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;After the initial recognition,
intangible assets acquired in a business combination are valued at cost, net of accumulated amortization, based on the expected attrition
over the respective estimated periods for which the intangible assets will provide economic benefit to the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Intangible assets acquisitions
from ValoraSoy were restated by applying the corresponding adjustment coefficients (as mentioned in Note 3.3) since the date of the business
combination and are translated at the exchange rate at the closing date of the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Software&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Software licenses are
valued at cost, restated as mentioned in Note 3.3, net of the corresponding accumulated amortization and impairment losses. Amortization
is calculated on a straight-line basis over the estimated useful life of the intangible assets.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.4. Property,
plant and equipment, net &lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Property, plant and equipment
assets are measured at historical cost less accumulated depreciation and any impairment loss, except for those acquired in a business
combination, which are then recorded at fair value; assets under construction and land are not depreciated. The cost of the property,
plant and equipment is the fair value of the consideration initially provided to acquire or construct the item and prepare it for use.
Subsequent costs incurred for repair and maintenance, are expensed in the consolidated statements of comprehensive income unless these
costs meet the criteria for capitalization (i.e. extension of the useful life). Depreciation commences when the assets are ready for use.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Property, plant and equipment
is depreciated based on the straight-line method over estimated useful lives.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;An item of property,
plant and equipment will be derecognized upon disposal or when future economic benefits from the continued use of the asset are no longer
expected. The gain or loss arising from the derecognition is measured as the difference between the gain on sale and the carrying amount
of the asset and is recognized through profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The useful lives of property,
plant and equipment are:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Storage&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 9%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20 years&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Machinery and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10 - 20 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Vehicles&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Furniture&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Computer equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3 - 5 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.5. Goodwill&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Goodwill arising from
the acquisition of a business is recorded at cost at the acquisition date, less accumulated impairment losses, if any.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The acquisitions related
to a foreign operation are considered to be expressed in the functional currency of the foreign operation and are translated at the exchange
rate at the reporting date.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Goodwill acquisition
related to the acquisition of ValoraSoy are recorded at cost, restated by applying the corresponding adjustment coefficients (as mentioned
in Note 3.3) since the date of the business combination and are translated at the exchange rate at the closing date of the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Note 4.5.1 Goodwill
impairment&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Goodwill is tested for
impairment annually at the cash-generating unit level, which is the level at which the assets generate largely independent cash inflows
and are monitored for internal management purposes. An impairment loss is recognized whenever the carrying amount of an asset or the related
cash-generating unit exceeds its recoverable amount. Impairment losses are recognized in the consolidated statements of profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Impairment losses recognized
for cash-generating units first reduce allocated goodwill and then the carrying amounts of the other assets in the unit on a pro rata
basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.6. Inventories,
net &lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Inventories are presented
at the lower of acquisition cost or net realizable value. Cost is determined by the weighted average method. The net realizable value
represents the estimated sale price less all the estimated termination and selling costs. The cost of finished products and products in
progress includes the costs of raw materials, direct labor, other direct costs and the respective direct production expenses (based on
normal operating capacity), excluding borrowing costs. Inventories are presented net of the allowances for obsolescence and, in consolidation,
net of eliminations of unrealized profit on inventories.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.7. Cash and
cash equivalents&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;For the purposes of the
statements of financial position and statements of cash flows, cash and cash equivalents include cash on hand and in banks and short-term
highly liquid investments. Investments can be readily convertible to known amounts of cash and they are subject to insignificant risk
of changes in value in the consolidated statements of financial position.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.8. Trade receivables
and other receivables&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Trade receivables represent
amounts owing for goods supplied by the Company prior to the end of the financial period which remain unpaid. They arise from transactions
in the normal operating activities of the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Trade receivables are
carried at amortized cost, net of expected credit losses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Company derecognizes
a financial asset when the contractual rights to the cash flows from the asset expire, or when it transfers the financial asset and substantially
all the risks and rewards of ownership of the asset to another party. If the Company neither transfers nor retains substantially all the
risks and rewards of ownership and continues to control the transferred asset, the Company recognizes its retained interest in the asset
and an associated liability for amounts it may have to pay. If the Company retains substantially all the risks and rewards of ownership
of a transferred financial asset, the Company continues to recognize the financial asset and also recognizes a collateralized borrowing
for the proceeds received.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.9. Right-of-use
of assets&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Due to the acquisition
of ValoraSoy, the Group acquired rights to use a parcel of land, as part of the acquisition agreement. At the acquisition date, right-of-use
of assets are initially recognized at fair value using a third-party valuation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The ownership of the
parcel of land is held by one of the sellers of ValoraSoy, who has entered into an agreement with the Company whereby he granted the right-of-use
of the property to the Company until the effective fulfillment of his obligation to lift encumbrances, subdivide and assign the property
to the Company within a period of twelve months or longer, if required by the proceedings, from the acquisition date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The right-of-use of land
shall not be depreciated due to the imminent transfer of ownership of the underlying asset to the Group which has an indefinite useful
life.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The right-of-use of assets
are presented in a single line in the consolidated statements of financial position.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.10. Share capital
and reserves&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Ordinary shares&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Ordinary shares are classified
as equity. Incremental costs directly attributable to the issue of ordinary shares and share options are recognized as a deduction from
equity, net of any tax effects.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Foreign currency translation
adjustment&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The foreign currency
translation reserve is used to record exchange differences arising from the translation of the financial statements from the functional
currency of Argentine Peso into the presentation currency of US dollar.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.11. Share-based
payment arrangements&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Share-based compensation
benefits are provided to certain key employees under the Company Compensation Plan. Under this agreement, some employees and members of
the executive management team as defined by the Board of Directors, were granted share options and restricted stock units (&#x201c;RSU&#x201d;)
in return for their services to the Group.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group receives services
in exchange for its own equity instruments and does not have any obligation to settle the obligation with cash, so the plan is classified
as equity settled. The only condition to be met is the delivery of service by the employee during a certain period as defined in the Agreements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The fair value of options
granted under the plan is measured at grant date and recognized in accordance with the requirements of IFRS 2, as an employee benefits
expense, with a corresponding increase in equity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The total expense is
recognized over the vesting period, which is the period over which all of the specified vesting conditions are to be satisfied.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;When the options are
exercised, the Company issues the shares to the employee and members to the executive team. The proceeds received, net of any directly
attributable transaction costs, are credited directly to equity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The ValoraSoy acquisition
agreement also included a contingent payment in a fixed amount of equity amounting to 384,558 shares equivalent to $1.7 million, which
was determined to be a remuneration agreement for future services (the &#x201c;earn-out&#x201d;) and consequently it was excluded from the
consideration and will be recognized as an expense over the required service period. The contingent payment is payable in shares over
a three-year period from 2024 to 2026 and subject to the achievement of certain EBITDA targets, as defined in the ValoraSoy SPA. Such
payment is automatically forfeited on termination of employment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.12. Accounts
payable and other liabilities&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Trade and other payables
are recognized when the Group has a legal or a constructive obligation, as a result of a past event, and it is probable that there may
be an outflow of resources embodying economic benefits to settle the obligation and the obligation can be measured reliably. These amounts
represent liabilities for goods and services provided to the Group prior to the end of financial year which are unpaid.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Company derecognizes
financial liabilities when, and only when, the Company&#x2019;s obligations are discharged, canceled or have expired. The difference between
the carrying amount of the financial liability derecognized and the consideration paid and payable is recognized in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Other payables correspond
mainly to employment obligations and provisions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.13. Taxes&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Current income
tax&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Current income tax assets
and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws
used to compute the amount are those that are enacted or substantively enacted at the reporting date in the country where the Group operates
and generates taxable income.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Current income tax relating
to items recognized directly in equity is recognized in equity and not in the consolidated statements of operations. Management periodically
evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation
and establishes provisions where appropriate.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Deferred tax&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Deferred tax is provided
using the liability method on temporary differences between the tax bases of assets and liabilities and their carrying amounts for financial
reporting purposes at the reporting date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Deferred tax liabilities
are recognized for all taxable temporary differences, except:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;When
the deferred tax liability arises from the initial recognition of goodwill or an asset or liability in a transaction that is not a business
combination and, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss, and&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In respect of taxable temporary differences affiliated
with investments in subsidiaries, associates, and interests in joint arrangements, when the timing of the reversal of the temporary differences
can be controlled and it is probable that the temporary differences will not reverse in the foreseeable future.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Deferred tax assets are
recognized for all deductible temporary differences, the carry forward of unused tax credits and any unused tax losses. Deferred tax assets
are recognized to the extent that it is probable that taxable profit will be available against which the deductible temporary differences,
and the carry forward of unused tax credits and unused tax losses can be utilized, except:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;When the deferred tax asset relating to the deductible
temporary difference arises from the initial recognition of an asset or liability in a transaction that is not a business combination
and, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss, and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In respect of deductible temporary differences
affiliated with investments in subsidiaries, associates and interests in joint arrangements, deferred tax assets are recognized only to
the extent that it is probable that the temporary differences will reverse in the foreseeable future and taxable profit will be available
against which the temporary differences can be utilized.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The carrying amount of
deferred tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable
profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are re-assessed
at each reporting date and are recognized to the extent that it has become probable that future taxable profits will allow the deferred
tax asset to be recovered.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Deferred tax assets and
liabilities are measured at the tax rates that are expected to apply in the year when the asset is realized or the liability is settled,
based on tax rates that have been enacted or substantively enacted at the reporting date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Deferred tax relating
to items recognized outside profit or loss is recognized outside profit or loss. Deferred tax items are recognized in correlation to the
underlying transaction either in OCI or directly in equity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.14. Subsidiaries
and joint arrangements&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Where the Company holds
a controlling interest in an entity, such entity is classified as a subsidiary. The Company exercises control over such an entity if all
three of the following elements are present: (i) the Company has the power to direct or cause the direction of the management and policies
of the entity, (ii) the Company is exposed to the variable returns of such entity; and (iii) the Company has power to affect the variability
of such returns. Control is reassessed whenever facts and circumstances indicate that there may be a change in any of these elements of
control.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;De-facto control exists
in situations where the Company has the practical ability to direct the relevant activities of an entity without holding the majority
of the voting rights. In determining whether de facto control exists, the Company considers all relevant facts and circumstances, including:
(i) the relative share of the Company&#x2019;s voting rights with respect to both the size and dispersion of other parties who hold voting
rights; (ii) substantive potential voting rights held by the Company and by other parties, (iii) other contractual arrangements; and (iv)
historic patterns in voting attendance. As of the issuance of these Financial Statements, there is no de-facto control over any entity.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Company is a party
to a joint arrangement when there is a contractual arrangement that confers joint control over the relevant activities of the arrangement
to the Group and at least one other party. Joint control is assessed under the same principles as control over subsidiaries.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The subsidiaries and
joint arrangements of the Company, of which their financial results have been included in the Consolidated Financial Statements, and holds
a majority share of the voting rights as of June 30, 2023 are as follows:&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Name&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Principal activities&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Country of incorporation and&lt;br/&gt; principal place of business&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;% Equity &lt;br/&gt; interest as of&lt;br/&gt; June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 30%; text-align: left"&gt;Moolec Science Limited (i)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 28%; text-align: center"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 28%; text-align: center"&gt;United Kingdom&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;LightJump Acquisition Corporation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;ValoraSoy S.A. (ii)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Argentina&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;AG Biomolecules LLC (DE)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Microo Foods Ingredients S.L. (iii)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Investment in joint arrangements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Spain&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;50&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(i)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Moolec Science Limited has a branch office in Argentina,
Moolec Science Limited S.E.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(ii)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Incorporated through the acquisition on April 24, 2023.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(iii)&lt;/td&gt;&lt;td style="text-align: justify"&gt;During December 2022, the Company agreed to participate in
a joint arrangement with the 50% of participation of the newly created company named Microo Food Ingredients Sociedad Limitada.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.15. Financial
instruments &lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Financial assets and
liabilities are recognized when an entity of the Group becomes party to the contractual provisions of an instrument.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Financial assets and
liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issue of financial
assets and liabilities (other than those designated at fair value through profit or loss) are added to or deducted from the fair value
of the financial assets or liabilities, when appropriate, at initial recognition. Transaction costs directly attributable to the acquisition
of financial assets or liabilities designated at fair value through profit or loss are recognized immediately through profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Company applies a
hierarchy to classify valuation methods used to measure financial instruments carried at fair value. Levels 1 to 3 are defined based on
the degree to which fair value inputs are observable and have a significant effect on the recorded fair value, as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Level 1: Quoted prices (unadjusted) in active markets for
identical assets or liabilities;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Level 2: Valuation techniques use significant observable
inputs, either directly (i.e., as prices) or indirectly (i.e., derived from prices), or valuations are based on quoted prices for similar
instruments; and&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Level 3: Valuation techniques use significant inputs that
are not based on observable market data (unobservable inputs).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.15.1. Financial
assets&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Classification of
financial assets &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;If and when applicable
the Company follows the framework and requirements outlined in IFRS 9 to classify financial assets based on whether:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The financial asset is held within a business model whose
objective is to collect contractual cash flows or whose objective is achieved through the collection of contractual cash flows and the
sale of financial assets; and&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The contractual terms give rise to cash flows that are only
payments of principal and interest.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;By default, all other
financial assets are subsequently measured at fair value through profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Trade receivables are
amounts due from customers for goods sold or services performed in the ordinary course of business. They are generally due for settlement
within 30 days and are therefore all classified as current. Trade receivables are recognized initially at the amount of consideration
that is unconditional, unless they contain significant financing components, when they are recognized at fair value. The Group holds the
trade receivables with the objective of collecting the contractual cash flows and therefore measures them subsequently at amortized cost
using the effective interest method.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Gains and losses in
foreign currency&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Trade receivables denominated
in a currency other than the subsidiaries&#x2019; functional currency is determined in that foreign currency and converted to the subsidiaries&#x2019;
functional currency at the end of each reporting period using the then prevailing spot rate. Exchange differences are recognized through
profit or loss and are classified within financial income / expenses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Derecognition of financial
assets&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group derecognizes
a financial asset only when the contractual rights to the asset&#x2019;s cash flows expire, or when it transfers the financial asset and
substantially all the risks and rewards of ownership of the asset to another party. If the Group does not transfer or retain substantially
all risks and rewards of ownership and continues to control the transferred asset, the Group recognizes its interest retained in the asset
and an associated liability for the amounts to be paid. If the Group retains substantially all the risks and rewards of ownership of a
transferred financial asset, the Group continues to recognize the financial asset and also recognizes a loan secured by the revenue received.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Upon derecognition of
a financial asset measured at amortized cost, the difference between the carrying amount of the asset and the sum of the consideration
received and receivable is recognized through profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group also derecognizes
a financial asset when there is information which indicates that the counterparty is in serious financial difficulty and there is no realistic
prospect of recovery. The derecognized financial assets may still be subject to compliance activities in accordance with the Group&#x2019;s
recovery procedures, taking into account legal advice when appropriate. Any recovery is recognized through profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.15.2. Financial
liabilities and equity instruments &lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Classification as
debt or equity&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Debt and equity instruments
are classified as financial liabilities or equity in accordance with the substance of the contractual agreement and definitions of financial
liability and equity instrument.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Equity instruments&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;An equity instrument
consists of any contract that evidences a residual interest in the assets of an entity, after deducting all of its liabilities. Equity
instruments issued by a Group entity are recognized for income received, net of direct issue costs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The repurchase of equity
instruments of the Group is recognized and deducted directly in equity. No gain or loss is recognized through profit or loss, arising
from the purchase, sale, issue or cancellation of the equity instruments of the Group. During the fiscal year ended June 30, 2023 no repurchase
of equity instruments took place.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Financial liabilities&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Financial liabilities
are classified at their inception at fair value through profit or loss or at amortized cost, using the effective interest amortization
method.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Warrant liabilities&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;As part of the reorganization,
the Group acquired public warrants (&#x201c;Public warrants&#x201d;). The warrants are initially recognized at fair value on the date a
derivative contract is entered into, and they are subsequently remeasured to their fair value at the end of each reporting period. Gains
and losses will be recorded in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;These instruments are
measured at Level 1 fair value based on its quoted price.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.16. New standards,
amendments and interpretations of IFRS&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="text-decoration:underline"&gt;Standards and IFRICs
newly applicable for companies with 30 June 2023 year ends are set out below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;A number of narrow-scope
amendments to IFRS 3, IAS 16, IAS 37 and some annual improvements on IFRS 1, IFRS 9, IAS 41 and IFRS 16&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Amendments to IFRS 3,
&#x2018;Business combinations&#x2019; update a reference in IFRS 3 to the Conceptual Framework for Financial Reporting without changing
the accounting requirements for business combinations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Amendments to IAS 16,
&#x2018;Property, plant and equipment&#x2019; prohibit a company from deducting from the cost of property, plant and equipment amounts received
from selling items produced while the company is preparing the asset for its intended use. Instead, a company will recognise such sales
proceeds and related costs in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Amendments to IAS 37,
&#x2018;Provisions, contingent liabilities and contingent assets&#x2019; specify which costs a company includes when assessing whether a
contract will be loss-making.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Annual improvements make
minor amendments to IFRS 1, &#x2018;First-time Adoption of IFRS&#x2019;, IFRS 9, &#x2018;Financial instruments&#x2019;, IAS 41, &#x2018;Agriculture&#x2019;
and the Illustrative Examples accompanying IFRS 16, &#x2018;Leases&#x2019;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The amendments listed
above did not have any impact on the amounts recognised in the Consolidated Financial Statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;New standards and
interpretations not yet adopted&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Certain new accounting
standards and interpretations have been published that are not mandatory for June 30, 2023 reporting period and have not been early adopted
by the Group. These standards are not expected to have a material impact on the Group in the current or future reporting periods and on
foreseeable future transactions:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Amendment to IAS 12-
deferred tax related to assets and liabilities arising from a single transaction&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;These amendments require
companies to recognise deferred tax on transactions that, on initial recognition, give rise to equal amounts of taxable and deductible
temporary differences.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Effective date Annual
periods beginning on or after January 1, 2023&lt;b&gt;. &lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Narrow scope amendments
to IAS 1, Practice statement 2 and IAS 8&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The amendments aim to
improve accounting policy disclosures and to help users of the financial statements to distinguish between changes in accounting estimates
and changes in accounting policies.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Effective date Annual
periods beginning on or after January 1, 2023&lt;b&gt;. &lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Amendments to IFRS
16, Lease Liability in a Sale and Leaseback &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The&#160;amendments&#160;include
requirements for sale and leaseback transactions in IFRS 16 to explain how an entity accounts for a sale and leaseback after the date
of the transaction. Sale and leaseback transactions where some or all the lease payments are variable lease payments that do not depend
on an index or rate are most likely to be impacted.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Effective date Annual
periods beginning on or after January 1, 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;These amendments are
not applicable to the Group.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Amendments to IAS
1, &#x2018;Presentation of financial statements&#x2019;, on classification of liabilities &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;These narrow-scope amendments
to IAS 1, &#x2018;Presentation of financial statements&#x2019;, clarify that liabilities are classified as either current or noncurrent,
depending on the rights that exist at the end of the reporting period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Classification is unaffected
by the expectations of the entity or events after the reporting date (for example, the receipt of a waiver or a breach of covenant).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The amendment also clarifies
what IAS 1 means when it refers to the &#x2018;settlement&#x2019; of a liability.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Effective date Annual
periods beginning on or after January 1, 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Amendments to IAS
7 and IFRS 7, Supplier Finance Arrangements&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;These&#160;amendments&#160;require
disclosures to enhance the transparency of supplier finance arrangements and their effects on a company&#x2019;s liabilities, cash flows
and exposure to liquidity risk. The disclosure requirements are the IASB&#x2019;s response to investors&#x2019; concerns that some companies&#x2019;
supplier finance arrangements are not sufficiently visible, hindering investors&#x2019; analysis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Effective date Annual
periods beginning on or after January 1, 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Amendments to IFRS
10 and IAS 28, Sale or Contribution of Assets between an Investor and its Associate or Joint Venture &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The amendments clarify
the accounting treatment for sales or contributions of assets between an investor and its associates or joint ventures. They confirm that
the accounting treatment depends on whether the non-monetary assets sold or contributed to an associate or joint venture constitute a
&#x2018;business&#x2019; (as defined in IFRS 3 Business Combinations).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Where the non-monetary
assets constitute a business, the investor will recognize the full gain or loss on the sale or contribution of assets. If the assets do
not meet the definition of a business, the gain or loss is recognized by the investor only to the extent of the other investor&#x2019;s
interests in the associate or joint venture. The amendments apply prospectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The effective date of
the amendment has not yet been set by the IASB; however, early application of the amendments is permitted.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.17. Loss per
share&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group presents basic
and diluted earnings per share (EPS) data for its ordinary shares. Basic EPS is calculated by dividing the profit and loss attributable
to ordinary shareholders of the Group by the weighted average number of ordinary shares outstanding during the period. Diluted EPS is
determined by adjusting the profit or loss attributed to ordinary shareholders and the weighted average number of ordinary shares outstanding
for the effects of all dilutive potential ordinary shares.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;As of June 30, 2023 and
2022, Basic EPS and Diluted EPS are the same, employee share based payments are considered dilutive instruments properly included in the
profit and loss account, however they do not impact in EPS diluted calculation because the Group has generated net loss to ordinary shareholders
(See Note 27).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.18. Revenue
&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The group identifies
contracts with customers and evaluates the goods and services committed therein to determine performance obligations and their classification
between performance obligations that are satisfied at a given time or over time.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Revenue from satisfaction
of performance obligations at a given time is recognized when the client obtains control of the committed asset or service considering
whether there is a right to collection, if the client has the physical possession, if the client has the legal right and if they have
transferred the risks and benefits.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Revenue from sales is
recognized when performance obligations are met, which consists of transforming the significant risks and benefits of ownership of the
goods are transferred to the purchaser, usually when the products are delivered to the purchaser at the determined location, according
to the agreed sales terms.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group had no revenues
during 2022 and 2023 until ValoraSoy Acquisition on April 24, 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.19. Expenses&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Research and development
costs&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Research costs are expensed
in the period in which these costs are incurred. Development costs are expensed in the period in which these costs are incurred if they
do not meet the criteria for capitalization.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Sales and marketing,
administrative and other operating expenses&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group recognizes
expenses in the period in which these costs are incurred and are presented by function on the consolidated statements of operations. Sales
and marketing expenses primarily relate to marketing materials and research of the Group to increase brand awareness in the marketplace.
Administrative expenses primarily comprise professional fees (mainly related to consultancy, accountancy and legal expenses), payroll
and share based compensation to certain executives. Other operating expenses relate to those that do not depend on general business operations
or relate to the other expense categories.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.20. Segment
reporting&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group operates in
a single operating segment, which is &#x201c;science-based food ingredients&#x201d;. Operating segments are defined as components of an
enterprise for which separate financial information is regularly evaluated by the chief operating decision maker, who in the Group&#x2019;s
case is the Executive Team, in deciding how to allocate resources and assess performance. The Executive Team is composed of the Chief
Executive Officer (&#x201c;CEO&#x201d;), the Chief Financial Officer (&#x201c;CFO&#x201d;), the Chief Product Officer (&#x201c;CPO&#x201d;),
the Chief Technology Officer (&#x201c;CTO&#x201d;) and the Chief Science Officer (&#x201c;CSO&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Executive Team evaluates
the Group&#x2019;s financial information and resources and assess the financial performance of these resources on a consolidated basis
on the basis of Net revenue/loss for the period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group&#x2019;s revenue,
results and assets for this one reportable segment can be determined by reference to the Consolidated Statement of Comprehensive Income
and Consolidated Statement of Financial Position.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group acquired ValoraSoy
on April 24, 2023. Because of the short-period of time since the acquisition, most of the required disclosures by IFRS 8 Operating Segments,
relating to entity-wide disclosures are not significant to disclose.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;As required by IFRS 8
Operating Segments, below are presented applicable entity-wide disclosures related to Moolec Science&#x2019;s revenues.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Revenues breakdown:&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Company&#x2019;s revenues
arise from operations in Argentina. During the periods covered by these consolidated financial statements the Company had no revenues
from customers attributed to the entity&#x2019;s country of domicile.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Non-current assets
other than financial instruments&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Non-current assets other
than financial instruments are located in the following countries:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2023&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2022&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left"&gt;Lux&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;251,440&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;United Kingdom&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,774,320&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,607,848&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Argentina&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,930,666&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Total non-current assets other than financial instruments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;9,956,426&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4,607,848&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.21 Business
combinations&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group applies the
acquisition method to account for business combinations. The acquisition cost is measured as the aggregate of the consideration transferred
for the acquisition of a subsidiary, which is measured at fair value at the acquisition date, and the amount of any non-controlling interest
in such subsidiary. The Group recognizes any non-controlling interest in a subsidiary at the non-controlling interest&#x2019;s proportionate
share of the recognized amounts of subsidiary&#x2019;s identifiable net assets. The acquisition related costs are expensed as incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Any contingent consideration
to be transferred by the Group is recognized at fair value at the acquisition date. The contingent consideration is classified as an asset
or liability that is a financial instrument under IFRS 9 is measured at fair value through profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Goodwill is initially
measured at cost, which is the excess of the aggregate of the consideration transferred and the amount of the non-controlling interest
and any previous interest carried over the net identifiable assets acquired, and liabilities assumed.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;After initial recognition,
goodwill is measured at cost less any accumulated impairment losses. For impairment testing, goodwill acquired in a business combination
is, as of the acquisition date, allocated to each of the cash-generating units of the Group that is expected to benefit from the synergies
of the combination, without considering whether other assets or liabilities of the subsidiary are allocated to those units.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Any impairment in the
carrying value is recognized in the consolidated statement of comprehensive income. In the case of acquisitions in stages, prior to the
write-off of the previously held equity interest in the subsidiary, said interest is re-measured at fair value as of the date of acquisition
of control over the subsidiary. The result of the re-measurement at fair value is recognized in profit or loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.22 Critical
accounting judgements and estimates&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group makes certain
estimates and assumptions regarding the future. Estimates and judgments are continually evaluated based on historical experience and other
factors, including expectations of future events that are believed to be reasonable under the circumstances. In the future, actual experience
may differ from these estimates and assumptions. The estimates and assumptions that have a significant risk of causing a material adjustment
to the carrying amounts of assets and liabilities within the next financial year are listed below.&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Critical estimates&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Identification and fair value of identifiable intangible
assets arising in acquisitions (Note 4.3).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Impairment of intangible assets not yet available for use
(Notes 4.3).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory>
    <mlec:DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.1. Basis of
consolidation of subsidiary&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Subsidiaries are entities
controlled by the Company. The financial statements of the Company&#x2019;s subsidiaries are included in the Consolidated Financial Statements
from the date that control commences after the acquisition date. The accounting policies of subsidiaries have been changed when necessary
to align them with the policies adopted by the Company.&lt;/p&gt;</mlec:DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock>
    <mlec:DescriptionOfAccountingPolicyForForeignCurrencyTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.2. Foreign
currency&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Transactions entered
into by the Group in a currency other than their functional currency are recorded at the relevant exchange rates as of the date upon which
such transactions occur. Foreign currency monetary assets and liabilities are translated at the prevailing exchange rates as of the final
day of each reporting period. Non-monetary assets and liabilities that are measured at fair value in a foreign currency are translated
into the functional currency at the exchange rate when the fair value was determined. Non-monetary items that are measured based on historical
cost in a foreign currency are translated at the exchange rate at the date of the transaction. Exchange differences arising on the retranslation
of unsettled monetary assets and liabilities are recognized immediately through other comprehensive income in the consolidated statements
of operations and are accumulated in equity (attributed to the non-controlling interests when appropriate).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;</mlec:DescriptionOfAccountingPolicyForForeignCurrencyTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.3. Intangible
assets&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Intangible assets include
projects in-progress (mainly related to internally developing products), software, licenses and other rights, and the purchase value of
customer relationships. The accounting policies regarding the recognition and measurement of such intangible assets are described below.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Internally Generated
Intangible Assets&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Expenditure&#160;on&#160;internally&#160;developed&#160;products&#160;is&#160;capitalized&#160;if&#160;it&#160;can&#160;be&#160;demonstrated&#160;that:&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;It&#160;is&#160;technically&#160;feasible&#160;to&#160;develop&#160;the&#160;product&#160;for&#160;it&#160;to&#160;be&#160;sold;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Adequate&#160;resources&#160;are&#160;available&#160;to&#160;complete&#160;the&#160;development;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;There&#160;is&#160;an&#160;intention&#160;to&#160;complete&#160;and&#160;sell&#160;the&#160;product;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The&#160;Group&#160;is&#160;able&#160;to&#160;sell&#160;the&#160;product;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Sale&#160;of&#160;the&#160;product&#160;will&#160;generate&#160;future&#160;economic&#160;benefits;&#160;and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expenditure&#160;on&#160;the&#160;project&#160;can&#160;be&#160;measured&#160;reliably.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Development expenditure
not satisfying the above criteria and expenditure on the research phase of internal projects are recognized in the consolidated statements
of operations as incurred.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Capitalized development
costs are amortized using the straight-line method over the periods the Group expects to benefit from selling the products developed.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Useful&#160;lives&#160;and&#160;amortization&#160;methods&#160;are&#160;reviewed&#160;every&#160;year&#160;as&#160;required&#160;by&#160;IAS&#160;38.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The research and development
process can be divided into several discrete steps or phases, which generally begin with discovery, validation and development and end
with regulatory approval and commercial launch. The process for developing seed traits is relatively similar for both GM and non-GM traits.
However, the two differ significantly in later phases of development. For example, obtaining regulatory approval for GM seeds is a far
more comprehensive and lengthy process than for non-GM seeds. Although breeding programs and industrial biotechnology solutions may have
shorter or simpler phases than those described below, the Group has used the industry consensus for seed-trait development phases to characterize
its technology portfolios, which is generally divided into the following six phases:&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;i)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Discovery: The first phase in the technology development
process is the discovery or identification of candidate genes or genetic systems, metabolites, or microorganisms potentially capable
of enhancing specified plant characteristics or enabling an agro-industrial biotech solution.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;ii)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Proof of concept: Upon successful validation of the technologies in model systems (in vitro or in vivo),
promising technologies graduate from discovery and are advanced to the proof of concept phase. The goal of this phase is to validate a
technology within the targeted organism before moving forward with technology escalation activities or extensive field validation.&lt;/td&gt;&lt;/tr&gt;
                                                                                                                                            &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;iii)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Early development: In this phase, efficacy field trials are expanded to evaluate the expression level
and phenological characteristics of the traits in multiple geographies and growing cycles, as well as other characteristics in order to
optimize the technology&#x2019;s performance in the targeted organisms. The goal of the early development phase is to evaluate the technical
feasibility by identifying the best candidate to scale up the seed stock and to start the regulatory field trials.&lt;/td&gt;&lt;/tr&gt;
                                                                                                                            &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;iv)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Advanced development and deregulation: In this phase, extensive field tests are used to fully demonstrate
the effectiveness of the technology for its intended purpose. In the case of GM traits, the process of obtaining regulatory approvals
from the government agencies is started, and includes field trials for environmental, core and food safety data generation. For solutions
involving microbial fermentation, industrial-scale runs are conducted.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;v)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Pre-launch: This phase involves finalizing the regulatory approval process and preparing for the launch
and commercialization of the technology. The range of activities in this phase includes seed increases, pre-commercial production, and
product and solution testing with selected customers. Usually, a more detailed marketing strategy and preparation of marketing materials
occur during this phase.&lt;/td&gt;&lt;/tr&gt;
                                  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;vi)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Product launch: In general, this phase, which is the last milestone of the research and development process,
is carried out by the Group.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;We determined that the
Research &amp;amp; Development is more likely than not (&#x201c;probable&#x201d;) to become a commercialized product and reach compliance with
IAS 38 criteria items at the end of the phase iii &#x201c;Early Development&#x201d;, when efficacy field trials are performed to determine
the technical feasibility of the project by measuring parameters like expression level and phenological characteristics. The obtention
of desired values for this set of data represents the strongest and clearest indication that the technical feasibility has been proved.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Impairment testing of
intangible assets not yet available for use requires the use of significant assumptions for the estimation of future cash flows and the
determination of discount rates. The significant assumptions and the determination of discount rates for the impairment testing of goodwill
are further explained below.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Management&#x2019;s estimations
about the demonstrability of the recognition criteria for these assets and the subsequent recoverability represent the best estimate that
can be made based on all the available evidence, existing facts and circumstances and using reasonable and supportable assumptions in
cash flow projections. Therefore, the Consolidated financial statements do not include any adjustments that would result if the Group
were unable to recover the carrying amount of the above-mentioned assets through the generation of enough future economic benefits.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Management has made the
estimates considering the cash flow projections projected. The key assumptions utilized are the following:&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 30%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Key assumption&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: center; width: 69%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Management&#x2019;s approach&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Discount rate&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The discount rate used ranges between 10% and 20%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top; background-color: White"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; vertical-align: middle"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt; &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Budgeted market share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: justify"&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"&gt;The projected revenue from the products has been estimated by the management based on market penetration data for comparable products and technologies and on future expectations of foreseen economic and market conditions.&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"&gt;The value assigned is consistent with external sources of information.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top; background-color: White"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Budgeted product prices&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The prices estimated in the revenue projections are based on current and projected market prices for the products.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top; background-color: White"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt; &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Budgeted gross margin&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Based on past performance and management&#x2019;s expectations for the future.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Intangible Assets
Acquired in a Business Combination &lt;/span&gt;&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Intangible assets acquired
in a business combination are identified and recognized separately regarding goodwill when they meet the definition of intangible assets
and their fair value can be measured reliably. Such intangible assets are recognized at fair value at acquisition date.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;After the initial recognition,
intangible assets acquired in a business combination are valued at cost, net of accumulated amortization, based on the expected attrition
over the respective estimated periods for which the intangible assets will provide economic benefit to the Company.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Intangible assets acquisitions
from ValoraSoy were restated by applying the corresponding adjustment coefficients (as mentioned in Note 3.3) since the date of the business
combination and are translated at the exchange rate at the closing date of the financial statements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Software&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Software licenses are
valued at cost, restated as mentioned in Note 3.3, net of the corresponding accumulated amortization and impairment losses. Amortization
is calculated on a straight-line basis over the estimated useful life of the intangible assets.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c76" decimals="2" unitRef="pure">0.10</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets contextRef="c77" decimals="2" unitRef="pure">0.20</ifrs-full:PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets>
    <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.4. Property,
plant and equipment, net &lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Property, plant and equipment
assets are measured at historical cost less accumulated depreciation and any impairment loss, except for those acquired in a business
combination, which are then recorded at fair value; assets under construction and land are not depreciated. The cost of the property,
plant and equipment is the fair value of the consideration initially provided to acquire or construct the item and prepare it for use.
Subsequent costs incurred for repair and maintenance, are expensed in the consolidated statements of comprehensive income unless these
costs meet the criteria for capitalization (i.e. extension of the useful life). Depreciation commences when the assets are ready for use.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Property, plant and equipment
is depreciated based on the straight-line method over estimated useful lives.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;An item of property,
plant and equipment will be derecognized upon disposal or when future economic benefits from the continued use of the asset are no longer
expected. The gain or loss arising from the derecognition is measured as the difference between the gain on sale and the carrying amount
of the asset and is recognized through profit or loss.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The useful lives of property,
plant and equipment are:&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Storage&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 9%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20 years&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Machinery and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10 - 20 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Vehicles&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Furniture&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Computer equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3 - 5 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory contextRef="c0">The useful lives of property,
plant and equipment are:&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Storage&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 9%; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;20 years&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Machinery and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10 - 20 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Vehicles&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Furniture&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Computer equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3 - 5 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c79">P20Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c80">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c81">P20Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c82">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c83">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c84">P3Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c85">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:DescriptionOfAccountingPolicyForGoodwillExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.5. Goodwill&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Goodwill arising from
the acquisition of a business is recorded at cost at the acquisition date, less accumulated impairment losses, if any.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The acquisitions related
to a foreign operation are considered to be expressed in the functional currency of the foreign operation and are translated at the exchange
rate at the reporting date.&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Goodwill acquisition
related to the acquisition of ValoraSoy are recorded at cost, restated by applying the corresponding adjustment coefficients (as mentioned
in Note 3.3) since the date of the business combination and are translated at the exchange rate at the closing date of the financial statements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Note 4.5.1 Goodwill
impairment&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Goodwill is tested for
impairment annually at the cash-generating unit level, which is the level at which the assets generate largely independent cash inflows
and are monitored for internal management purposes. An impairment loss is recognized whenever the carrying amount of an asset or the related
cash-generating unit exceeds its recoverable amount. Impairment losses are recognized in the consolidated statements of profit or loss.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Impairment losses recognized
for cash-generating units first reduce allocated goodwill and then the carrying amounts of the other assets in the unit on a pro rata
basis.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForGoodwillExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.6. Inventories,
net &lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Inventories are presented
at the lower of acquisition cost or net realizable value. Cost is determined by the weighted average method. The net realizable value
represents the estimated sale price less all the estimated termination and selling costs. The cost of finished products and products in
progress includes the costs of raw materials, direct labor, other direct costs and the respective direct production expenses (based on
normal operating capacity), excluding borrowing costs. Inventories are presented net of the allowances for obsolescence and, in consolidation,
net of eliminations of unrealized profit on inventories.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories>
    <ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.7. Cash and
cash equivalents&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;For the purposes of the
statements of financial position and statements of cash flows, cash and cash equivalents include cash on hand and in banks and short-term
highly liquid investments. Investments can be readily convertible to known amounts of cash and they are subject to insignificant risk
of changes in value in the consolidated statements of financial position.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents>
    <ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.8. Trade receivables
and other receivables&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Trade receivables represent
amounts owing for goods supplied by the Company prior to the end of the financial period which remain unpaid. They arise from transactions
in the normal operating activities of the Company.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Trade receivables are
carried at amortized cost, net of expected credit losses.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Company derecognizes
a financial asset when the contractual rights to the cash flows from the asset expire, or when it transfers the financial asset and substantially
all the risks and rewards of ownership of the asset to another party. If the Company neither transfers nor retains substantially all the
risks and rewards of ownership and continues to control the transferred asset, the Company recognizes its retained interest in the asset
and an associated liability for amounts it may have to pay. If the Company retains substantially all the risks and rewards of ownership
of a transferred financial asset, the Company continues to recognize the financial asset and also recognizes a collateralized borrowing
for the proceeds received.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory>
    <mlec:DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.9. Right-of-use
of assets&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Due to the acquisition
of ValoraSoy, the Group acquired rights to use a parcel of land, as part of the acquisition agreement. At the acquisition date, right-of-use
of assets are initially recognized at fair value using a third-party valuation.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The ownership of the
parcel of land is held by one of the sellers of ValoraSoy, who has entered into an agreement with the Company whereby he granted the right-of-use
of the property to the Company until the effective fulfillment of his obligation to lift encumbrances, subdivide and assign the property
to the Company within a period of twelve months or longer, if required by the proceedings, from the acquisition date.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The right-of-use of land
shall not be depreciated due to the imminent transfer of ownership of the underlying asset to the Group which has an indefinite useful
life.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The right-of-use of assets
are presented in a single line in the consolidated statements of financial position.&lt;/p&gt;</mlec:DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock>
    <mlec:DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.10. Share capital
and reserves&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Ordinary shares&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Ordinary shares are classified
as equity. Incremental costs directly attributable to the issue of ordinary shares and share options are recognized as a deduction from
equity, net of any tax effects.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Foreign currency translation
adjustment&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The foreign currency
translation reserve is used to record exchange differences arising from the translation of the financial statements from the functional
currency of Argentine Peso into the presentation currency of US dollar.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</mlec:DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.11. Share-based
payment arrangements&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Share-based compensation
benefits are provided to certain key employees under the Company Compensation Plan. Under this agreement, some employees and members of
the executive management team as defined by the Board of Directors, were granted share options and restricted stock units (&#x201c;RSU&#x201d;)
in return for their services to the Group.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group receives services
in exchange for its own equity instruments and does not have any obligation to settle the obligation with cash, so the plan is classified
as equity settled. The only condition to be met is the delivery of service by the employee during a certain period as defined in the Agreements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The fair value of options
granted under the plan is measured at grant date and recognized in accordance with the requirements of IFRS 2, as an employee benefits
expense, with a corresponding increase in equity.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The total expense is
recognized over the vesting period, which is the period over which all of the specified vesting conditions are to be satisfied.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;When the options are
exercised, the Company issues the shares to the employee and members to the executive team. The proceeds received, net of any directly
attributable transaction costs, are credited directly to equity.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The ValoraSoy acquisition
agreement also included a contingent payment in a fixed amount of equity amounting to 384,558 shares equivalent to $1.7 million, which
was determined to be a remuneration agreement for future services (the &#x201c;earn-out&#x201d;) and consequently it was excluded from the
consideration and will be recognized as an expense over the required service period. The contingent payment is payable in shares over
a three-year period from 2024 to 2026 and subject to the achievement of certain EBITDA targets, as defined in the ValoraSoy SPA. Such
payment is automatically forfeited on termination of employment.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory>
    <mlec:NumberOfSharesToBeIssuedOfContingentPayment contextRef="c0" decimals="0" unitRef="shares">384558</mlec:NumberOfSharesToBeIssuedOfContingentPayment>
    <ifrs-full:ShareIssueRelatedCost contextRef="c0" decimals="-5" unitRef="usd">1700000</ifrs-full:ShareIssueRelatedCost>
    <mlec:DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.12. Accounts
payable and other liabilities&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Trade and other payables
are recognized when the Group has a legal or a constructive obligation, as a result of a past event, and it is probable that there may
be an outflow of resources embodying economic benefits to settle the obligation and the obligation can be measured reliably. These amounts
represent liabilities for goods and services provided to the Group prior to the end of financial year which are unpaid.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Company derecognizes
financial liabilities when, and only when, the Company&#x2019;s obligations are discharged, canceled or have expired. The difference between
the carrying amount of the financial liability derecognized and the consideration paid and payable is recognized in profit or loss.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Other payables correspond
mainly to employment obligations and provisions.&lt;/p&gt;</mlec:DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.13. Taxes&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Current income
tax&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Current income tax assets
and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates and tax laws
used to compute the amount are those that are enacted or substantively enacted at the reporting date in the country where the Group operates
and generates taxable income.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Current income tax relating
to items recognized directly in equity is recognized in equity and not in the consolidated statements of operations. Management periodically
evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation
and establishes provisions where appropriate.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Deferred tax&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Deferred tax is provided
using the liability method on temporary differences between the tax bases of assets and liabilities and their carrying amounts for financial
reporting purposes at the reporting date.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Deferred tax liabilities
are recognized for all taxable temporary differences, except:&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;When
the deferred tax liability arises from the initial recognition of goodwill or an asset or liability in a transaction that is not a business
combination and, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss, and&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In respect of taxable temporary differences affiliated
with investments in subsidiaries, associates, and interests in joint arrangements, when the timing of the reversal of the temporary differences
can be controlled and it is probable that the temporary differences will not reverse in the foreseeable future.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Deferred tax assets are
recognized for all deductible temporary differences, the carry forward of unused tax credits and any unused tax losses. Deferred tax assets
are recognized to the extent that it is probable that taxable profit will be available against which the deductible temporary differences,
and the carry forward of unused tax credits and unused tax losses can be utilized, except:&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;When the deferred tax asset relating to the deductible
temporary difference arises from the initial recognition of an asset or liability in a transaction that is not a business combination
and, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss, and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;In respect of deductible temporary differences
affiliated with investments in subsidiaries, associates and interests in joint arrangements, deferred tax assets are recognized only to
the extent that it is probable that the temporary differences will reverse in the foreseeable future and taxable profit will be available
against which the temporary differences can be utilized.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The carrying amount of
deferred tax assets is reviewed at each reporting date and reduced to the extent that it is no longer probable that sufficient taxable
profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are re-assessed
at each reporting date and are recognized to the extent that it has become probable that future taxable profits will allow the deferred
tax asset to be recovered.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Deferred tax assets and
liabilities are measured at the tax rates that are expected to apply in the year when the asset is realized or the liability is settled,
based on tax rates that have been enacted or substantively enacted at the reporting date.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Deferred tax relating
to items recognized outside profit or loss is recognized outside profit or loss. Deferred tax items are recognized in correlation to the
underlying transaction either in OCI or directly in equity.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory>
    <mlec:DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.14. Subsidiaries
and joint arrangements&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Where the Company holds
a controlling interest in an entity, such entity is classified as a subsidiary. The Company exercises control over such an entity if all
three of the following elements are present: (i) the Company has the power to direct or cause the direction of the management and policies
of the entity, (ii) the Company is exposed to the variable returns of such entity; and (iii) the Company has power to affect the variability
of such returns. Control is reassessed whenever facts and circumstances indicate that there may be a change in any of these elements of
control.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;De-facto control exists
in situations where the Company has the practical ability to direct the relevant activities of an entity without holding the majority
of the voting rights. In determining whether de facto control exists, the Company considers all relevant facts and circumstances, including:
(i) the relative share of the Company&#x2019;s voting rights with respect to both the size and dispersion of other parties who hold voting
rights; (ii) substantive potential voting rights held by the Company and by other parties, (iii) other contractual arrangements; and (iv)
historic patterns in voting attendance. As of the issuance of these Financial Statements, there is no de-facto control over any entity.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Company is a party
to a joint arrangement when there is a contractual arrangement that confers joint control over the relevant activities of the arrangement
to the Group and at least one other party. Joint control is assessed under the same principles as control over subsidiaries.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The subsidiaries and
joint arrangements of the Company, of which their financial results have been included in the Consolidated Financial Statements, and holds
a majority share of the voting rights as of June 30, 2023 are as follows:&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Name&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Principal activities&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Country of incorporation and&lt;br/&gt; principal place of business&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;% Equity &lt;br/&gt; interest as of&lt;br/&gt; June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 30%; text-align: left"&gt;Moolec Science Limited (i)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 28%; text-align: center"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 28%; text-align: center"&gt;United Kingdom&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;LightJump Acquisition Corporation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;ValoraSoy S.A. (ii)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Argentina&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;AG Biomolecules LLC (DE)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Microo Foods Ingredients S.L. (iii)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Investment in joint arrangements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Spain&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;50&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(i)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Moolec Science Limited has a branch office in Argentina,
Moolec Science Limited S.E.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(ii)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Incorporated through the acquisition on April 24, 2023.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(iii)&lt;/td&gt;&lt;td style="text-align: justify"&gt;During December 2022, the Company agreed to participate in
a joint arrangement with the 50% of participation of the newly created company named Microo Food Ingredients Sociedad Limitada.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</mlec:DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock>
    <ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory contextRef="c0">The subsidiaries and
joint arrangements of the Company, of which their financial results have been included in the Consolidated Financial Statements, and holds
a majority share of the voting rights as of June 30, 2023 are as follows:&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Name&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Principal activities&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Country of incorporation and&lt;br/&gt; principal place of business&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;% Equity &lt;br/&gt; interest as of&lt;br/&gt; June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 30%; text-align: left"&gt;Moolec Science Limited (i)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 28%; text-align: center"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 28%; text-align: center"&gt;United Kingdom&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;LightJump Acquisition Corporation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;ValoraSoy S.A. (ii)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Argentina&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;AG Biomolecules LLC (DE)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Investment in subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;USA&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;100&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Microo Foods Ingredients S.L. (iii)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Investment in joint arrangements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Spain&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;50&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(i)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Moolec Science Limited has a branch office in Argentina,
Moolec Science Limited S.E.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(ii)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Incorporated through the acquisition on April 24, 2023.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(iii)&lt;/td&gt;&lt;td style="text-align: justify"&gt;During December 2022, the Company agreed to participate in
a joint arrangement with the 50% of participation of the newly created company named Microo Food Ingredients Sociedad Limitada.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="c86" id="ix_1_fact">Investment in subsidiaries</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:CountryOfIncorporation contextRef="c86" id="ix_2_fact">United Kingdom</ifrs-full:CountryOfIncorporation>
    <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="c86" decimals="2" id="ix_3_fact" unitRef="pure">1</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="c87">Investment in subsidiaries</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:CountryOfIncorporation contextRef="c87">USA</ifrs-full:CountryOfIncorporation>
    <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="c87" decimals="2" unitRef="pure">1</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="c88" id="ix_4_fact">Investment in subsidiaries</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:CountryOfIncorporation contextRef="c88" id="ix_5_fact">Argentina</ifrs-full:CountryOfIncorporation>
    <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="c88" decimals="2" id="ix_6_fact" unitRef="pure">1</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="c89">Investment in subsidiaries</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:CountryOfIncorporation contextRef="c89">USA</ifrs-full:CountryOfIncorporation>
    <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="c89" decimals="2" unitRef="pure">1</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
    <ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary contextRef="c90" id="ix_7_fact">Investment in joint arrangements</ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary>
    <ifrs-full:CountryOfIncorporation contextRef="c90" id="ix_8_fact">Spain</ifrs-full:CountryOfIncorporation>
    <ifrs-full:ProportionOfVotingPowerHeldInSubsidiary contextRef="c90" decimals="2" id="ix_9_fact" unitRef="pure">0.50</ifrs-full:ProportionOfVotingPowerHeldInSubsidiary>
    <mlec:JointArrangementParticipationPercentage contextRef="c78" decimals="2" unitRef="pure">0.50</mlec:JointArrangementParticipationPercentage>
    <ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.15. Financial
instruments &lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Financial assets and
liabilities are recognized when an entity of the Group becomes party to the contractual provisions of an instrument.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Financial assets and
liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issue of financial
assets and liabilities (other than those designated at fair value through profit or loss) are added to or deducted from the fair value
of the financial assets or liabilities, when appropriate, at initial recognition. Transaction costs directly attributable to the acquisition
of financial assets or liabilities designated at fair value through profit or loss are recognized immediately through profit or loss.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Company applies a
hierarchy to classify valuation methods used to measure financial instruments carried at fair value. Levels 1 to 3 are defined based on
the degree to which fair value inputs are observable and have a significant effect on the recorded fair value, as follows:&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Level 1: Quoted prices (unadjusted) in active markets for
identical assets or liabilities;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Level 2: Valuation techniques use significant observable
inputs, either directly (i.e., as prices) or indirectly (i.e., derived from prices), or valuations are based on quoted prices for similar
instruments; and&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Level 3: Valuation techniques use significant inputs that
are not based on observable market data (unobservable inputs).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.15.1. Financial
assets&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Classification of
financial assets &lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;If and when applicable
the Company follows the framework and requirements outlined in IFRS 9 to classify financial assets based on whether:&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The financial asset is held within a business model whose
objective is to collect contractual cash flows or whose objective is achieved through the collection of contractual cash flows and the
sale of financial assets; and&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The contractual terms give rise to cash flows that are only
payments of principal and interest.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;By default, all other
financial assets are subsequently measured at fair value through profit or loss.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Trade receivables are
amounts due from customers for goods sold or services performed in the ordinary course of business. They are generally due for settlement
within 30 days and are therefore all classified as current. Trade receivables are recognized initially at the amount of consideration
that is unconditional, unless they contain significant financing components, when they are recognized at fair value. The Group holds the
trade receivables with the objective of collecting the contractual cash flows and therefore measures them subsequently at amortized cost
using the effective interest method.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Gains and losses in
foreign currency&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Trade receivables denominated
in a currency other than the subsidiaries&#x2019; functional currency is determined in that foreign currency and converted to the subsidiaries&#x2019;
functional currency at the end of each reporting period using the then prevailing spot rate. Exchange differences are recognized through
profit or loss and are classified within financial income / expenses.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Derecognition of financial
assets&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group derecognizes
a financial asset only when the contractual rights to the asset&#x2019;s cash flows expire, or when it transfers the financial asset and
substantially all the risks and rewards of ownership of the asset to another party. If the Group does not transfer or retain substantially
all risks and rewards of ownership and continues to control the transferred asset, the Group recognizes its interest retained in the asset
and an associated liability for the amounts to be paid. If the Group retains substantially all the risks and rewards of ownership of a
transferred financial asset, the Group continues to recognize the financial asset and also recognizes a loan secured by the revenue received.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Upon derecognition of
a financial asset measured at amortized cost, the difference between the carrying amount of the asset and the sum of the consideration
received and receivable is recognized through profit or loss.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group also derecognizes
a financial asset when there is information which indicates that the counterparty is in serious financial difficulty and there is no realistic
prospect of recovery. The derecognized financial assets may still be subject to compliance activities in accordance with the Group&#x2019;s
recovery procedures, taking into account legal advice when appropriate. Any recovery is recognized through profit or loss.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.15.2. Financial
liabilities and equity instruments &lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Classification as
debt or equity&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Debt and equity instruments
are classified as financial liabilities or equity in accordance with the substance of the contractual agreement and definitions of financial
liability and equity instrument.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Equity instruments&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;An equity instrument
consists of any contract that evidences a residual interest in the assets of an entity, after deducting all of its liabilities. Equity
instruments issued by a Group entity are recognized for income received, net of direct issue costs.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The repurchase of equity
instruments of the Group is recognized and deducted directly in equity. No gain or loss is recognized through profit or loss, arising
from the purchase, sale, issue or cancellation of the equity instruments of the Group. During the fiscal year ended June 30, 2023 no repurchase
of equity instruments took place.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Financial liabilities&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Financial liabilities
are classified at their inception at fair value through profit or loss or at amortized cost, using the effective interest amortization
method.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Warrant liabilities&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;As part of the reorganization,
the Group acquired public warrants (&#x201c;Public warrants&#x201d;). The warrants are initially recognized at fair value on the date a
derivative contract is entered into, and they are subsequently remeasured to their fair value at the end of each reporting period. Gains
and losses will be recorded in profit or loss.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;These instruments are
measured at Level 1 fair value based on its quoted price.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory>
    <mlec:DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.16. New standards,
amendments and interpretations of IFRS&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="text-decoration:underline"&gt;Standards and IFRICs
newly applicable for companies with 30 June 2023 year ends are set out below.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;A number of narrow-scope
amendments to IFRS 3, IAS 16, IAS 37 and some annual improvements on IFRS 1, IFRS 9, IAS 41 and IFRS 16&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Amendments to IFRS 3,
&#x2018;Business combinations&#x2019; update a reference in IFRS 3 to the Conceptual Framework for Financial Reporting without changing
the accounting requirements for business combinations.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Amendments to IAS 16,
&#x2018;Property, plant and equipment&#x2019; prohibit a company from deducting from the cost of property, plant and equipment amounts received
from selling items produced while the company is preparing the asset for its intended use. Instead, a company will recognise such sales
proceeds and related costs in profit or loss.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Amendments to IAS 37,
&#x2018;Provisions, contingent liabilities and contingent assets&#x2019; specify which costs a company includes when assessing whether a
contract will be loss-making.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Annual improvements make
minor amendments to IFRS 1, &#x2018;First-time Adoption of IFRS&#x2019;, IFRS 9, &#x2018;Financial instruments&#x2019;, IAS 41, &#x2018;Agriculture&#x2019;
and the Illustrative Examples accompanying IFRS 16, &#x2018;Leases&#x2019;.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The amendments listed
above did not have any impact on the amounts recognised in the Consolidated Financial Statements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&lt;span style="text-decoration:underline"&gt;New standards and
interpretations not yet adopted&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Certain new accounting
standards and interpretations have been published that are not mandatory for June 30, 2023 reporting period and have not been early adopted
by the Group. These standards are not expected to have a material impact on the Group in the current or future reporting periods and on
foreseeable future transactions:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Amendment to IAS 12-
deferred tax related to assets and liabilities arising from a single transaction&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;These amendments require
companies to recognise deferred tax on transactions that, on initial recognition, give rise to equal amounts of taxable and deductible
temporary differences.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Effective date Annual
periods beginning on or after January 1, 2023&lt;b&gt;. &lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Narrow scope amendments
to IAS 1, Practice statement 2 and IAS 8&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The amendments aim to
improve accounting policy disclosures and to help users of the financial statements to distinguish between changes in accounting estimates
and changes in accounting policies.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Effective date Annual
periods beginning on or after January 1, 2023&lt;b&gt;. &lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Amendments to IFRS
16, Lease Liability in a Sale and Leaseback &lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The&#160;amendments&#160;include
requirements for sale and leaseback transactions in IFRS 16 to explain how an entity accounts for a sale and leaseback after the date
of the transaction. Sale and leaseback transactions where some or all the lease payments are variable lease payments that do not depend
on an index or rate are most likely to be impacted.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Effective date Annual
periods beginning on or after January 1, 2024.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;These amendments are
not applicable to the Group.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Amendments to IAS
1, &#x2018;Presentation of financial statements&#x2019;, on classification of liabilities &lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;These narrow-scope amendments
to IAS 1, &#x2018;Presentation of financial statements&#x2019;, clarify that liabilities are classified as either current or noncurrent,
depending on the rights that exist at the end of the reporting period.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Classification is unaffected
by the expectations of the entity or events after the reporting date (for example, the receipt of a waiver or a breach of covenant).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The amendment also clarifies
what IAS 1 means when it refers to the &#x2018;settlement&#x2019; of a liability.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Effective date Annual
periods beginning on or after January 1, 2024.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Amendments to IAS
7 and IFRS 7, Supplier Finance Arrangements&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;These&#160;amendments&#160;require
disclosures to enhance the transparency of supplier finance arrangements and their effects on a company&#x2019;s liabilities, cash flows
and exposure to liquidity risk. The disclosure requirements are the IASB&#x2019;s response to investors&#x2019; concerns that some companies&#x2019;
supplier finance arrangements are not sufficiently visible, hindering investors&#x2019; analysis.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Effective date Annual
periods beginning on or after January 1, 2024.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Amendments to IFRS
10 and IAS 28, Sale or Contribution of Assets between an Investor and its Associate or Joint Venture &lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The amendments clarify
the accounting treatment for sales or contributions of assets between an investor and its associates or joint ventures. They confirm that
the accounting treatment depends on whether the non-monetary assets sold or contributed to an associate or joint venture constitute a
&#x2018;business&#x2019; (as defined in IFRS 3 Business Combinations).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Where the non-monetary
assets constitute a business, the investor will recognize the full gain or loss on the sale or contribution of assets. If the assets do
not meet the definition of a business, the gain or loss is recognized by the investor only to the extent of the other investor&#x2019;s
interests in the associate or joint venture. The amendments apply prospectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The effective date of
the amendment has not yet been set by the IASB; however, early application of the amendments is permitted.&lt;/p&gt;</mlec:DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock>
    <mlec:DescriptionOfAccountingPolicyForLossPerShareTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.17. Loss per
share&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group presents basic
and diluted earnings per share (EPS) data for its ordinary shares. Basic EPS is calculated by dividing the profit and loss attributable
to ordinary shareholders of the Group by the weighted average number of ordinary shares outstanding during the period. Diluted EPS is
determined by adjusting the profit or loss attributed to ordinary shareholders and the weighted average number of ordinary shares outstanding
for the effects of all dilutive potential ordinary shares.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;As of June 30, 2023 and
2022, Basic EPS and Diluted EPS are the same, employee share based payments are considered dilutive instruments properly included in the
profit and loss account, however they do not impact in EPS diluted calculation because the Group has generated net loss to ordinary shareholders
(See Note 27).&lt;/p&gt;</mlec:DescriptionOfAccountingPolicyForLossPerShareTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.18. Revenue
&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The group identifies
contracts with customers and evaluates the goods and services committed therein to determine performance obligations and their classification
between performance obligations that are satisfied at a given time or over time.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Revenue from satisfaction
of performance obligations at a given time is recognized when the client obtains control of the committed asset or service considering
whether there is a right to collection, if the client has the physical possession, if the client has the legal right and if they have
transferred the risks and benefits.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Revenue from sales is
recognized when performance obligations are met, which consists of transforming the significant risks and benefits of ownership of the
goods are transferred to the purchaser, usually when the products are delivered to the purchaser at the determined location, according
to the agreed sales terms.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group had no revenues
during 2022 and 2023 until ValoraSoy Acquisition on April 24, 2023.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue>
    <ifrs-full:DescriptionOfAccountingPolicyForExpensesExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.19. Expenses&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Research and development
costs&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Research costs are expensed
in the period in which these costs are incurred. Development costs are expensed in the period in which these costs are incurred if they
do not meet the criteria for capitalization.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;Sales and marketing,
administrative and other operating expenses&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group recognizes
expenses in the period in which these costs are incurred and are presented by function on the consolidated statements of operations. Sales
and marketing expenses primarily relate to marketing materials and research of the Group to increase brand awareness in the marketplace.
Administrative expenses primarily comprise professional fees (mainly related to consultancy, accountancy and legal expenses), payroll
and share based compensation to certain executives. Other operating expenses relate to those that do not depend on general business operations
or relate to the other expense categories.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForExpensesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.20. Segment
reporting&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group operates in
a single operating segment, which is &#x201c;science-based food ingredients&#x201d;. Operating segments are defined as components of an
enterprise for which separate financial information is regularly evaluated by the chief operating decision maker, who in the Group&#x2019;s
case is the Executive Team, in deciding how to allocate resources and assess performance. The Executive Team is composed of the Chief
Executive Officer (&#x201c;CEO&#x201d;), the Chief Financial Officer (&#x201c;CFO&#x201d;), the Chief Product Officer (&#x201c;CPO&#x201d;),
the Chief Technology Officer (&#x201c;CTO&#x201d;) and the Chief Science Officer (&#x201c;CSO&#x201d;).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Executive Team evaluates
the Group&#x2019;s financial information and resources and assess the financial performance of these resources on a consolidated basis
on the basis of Net revenue/loss for the period.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group&#x2019;s revenue,
results and assets for this one reportable segment can be determined by reference to the Consolidated Statement of Comprehensive Income
and Consolidated Statement of Financial Position.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group acquired ValoraSoy
on April 24, 2023. Because of the short-period of time since the acquisition, most of the required disclosures by IFRS 8 Operating Segments,
relating to entity-wide disclosures are not significant to disclose.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;As required by IFRS 8
Operating Segments, below are presented applicable entity-wide disclosures related to Moolec Science&#x2019;s revenues.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Revenues breakdown:&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Company&#x2019;s revenues
arise from operations in Argentina. During the periods covered by these consolidated financial statements the Company had no revenues
from customers attributed to the entity&#x2019;s country of domicile.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Non-current assets
other than financial instruments&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Non-current assets other
than financial instruments are located in the following countries:&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2023&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2022&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left"&gt;Lux&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;251,440&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;United Kingdom&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,774,320&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,607,848&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Argentina&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,930,666&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Total non-current assets other than financial instruments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;9,956,426&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4,607,848&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory>
    <mlec:ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock contextRef="c0">Non-current assets other
than financial instruments are located in the following countries:&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2023&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2022&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left"&gt;Lux&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;251,440&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;United Kingdom&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,774,320&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,607,848&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Argentina&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,930,666&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Total non-current assets other than financial instruments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;9,956,426&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4,607,848&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock>
    <mlec:OtherNonCurrentAssetsOtherThanFinancialAssets contextRef="c91" decimals="0" unitRef="usd">251440</mlec:OtherNonCurrentAssetsOtherThanFinancialAssets>
    <mlec:OtherNonCurrentAssetsOtherThanFinancialAssets contextRef="c92" decimals="0" unitRef="usd">4774320</mlec:OtherNonCurrentAssetsOtherThanFinancialAssets>
    <mlec:OtherNonCurrentAssetsOtherThanFinancialAssets contextRef="c93" decimals="0" unitRef="usd">4607848</mlec:OtherNonCurrentAssetsOtherThanFinancialAssets>
    <mlec:OtherNonCurrentAssetsOtherThanFinancialAssets contextRef="c94" decimals="0" unitRef="usd">4930666</mlec:OtherNonCurrentAssetsOtherThanFinancialAssets>
    <mlec:OtherNonCurrentAssetsOtherThanFinancialAssets contextRef="c2" decimals="0" unitRef="usd">9956426</mlec:OtherNonCurrentAssetsOtherThanFinancialAssets>
    <mlec:OtherNonCurrentAssetsOtherThanFinancialAssets contextRef="c6" decimals="0" unitRef="usd">4607848</mlec:OtherNonCurrentAssetsOtherThanFinancialAssets>
    <ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.21 Business
combinations&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group applies the
acquisition method to account for business combinations. The acquisition cost is measured as the aggregate of the consideration transferred
for the acquisition of a subsidiary, which is measured at fair value at the acquisition date, and the amount of any non-controlling interest
in such subsidiary. The Group recognizes any non-controlling interest in a subsidiary at the non-controlling interest&#x2019;s proportionate
share of the recognized amounts of subsidiary&#x2019;s identifiable net assets. The acquisition related costs are expensed as incurred.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Any contingent consideration
to be transferred by the Group is recognized at fair value at the acquisition date. The contingent consideration is classified as an asset
or liability that is a financial instrument under IFRS 9 is measured at fair value through profit or loss.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Goodwill is initially
measured at cost, which is the excess of the aggregate of the consideration transferred and the amount of the non-controlling interest
and any previous interest carried over the net identifiable assets acquired, and liabilities assumed.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;After initial recognition,
goodwill is measured at cost less any accumulated impairment losses. For impairment testing, goodwill acquired in a business combination
is, as of the acquisition date, allocated to each of the cash-generating units of the Group that is expected to benefit from the synergies
of the combination, without considering whether other assets or liabilities of the subsidiary are allocated to those units.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Any impairment in the
carrying value is recognized in the consolidated statement of comprehensive income. In the case of acquisitions in stages, prior to the
write-off of the previously held equity interest in the subsidiary, said interest is re-measured at fair value as of the date of acquisition
of control over the subsidiary. The result of the re-measurement at fair value is recognized in profit or loss.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory>
    <ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note 4.22 Critical
accounting judgements and estimates&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group makes certain
estimates and assumptions regarding the future. Estimates and judgments are continually evaluated based on historical experience and other
factors, including expectations of future events that are believed to be reasonable under the circumstances. In the future, actual experience
may differ from these estimates and assumptions. The estimates and assumptions that have a significant risk of causing a material adjustment
to the carrying amounts of assets and liabilities within the next financial year are listed below.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Critical estimates&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Identification and fair value of identifiable intangible
assets arising in acquisitions (Note 4.3).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;-&lt;/td&gt;&lt;td style="text-align: justify"&gt;Impairment of intangible assets not yet available for use
(Notes 4.3).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory>
    <ifrs-full:DisclosureOfAdditionalInformationExplanatory contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Note
5. Comparative Information&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The information as of
June 30, 2022 and for the year ended June 30, 2022 and for the periods of January 1, 2021 through June 30, 2021 and from August 21, 2020
through December 31, 2020 disclosed for comparative purposes arises from the consolidated financial statements of Moolec as of those dates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Certain amounts in the
prior year financial statements have been reclassified to conform to the current year presentation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The exchange of shares
related to the Capital Reorganization contemplated by the Business Combination Agreement, explained in Note 2, has been given a retrospective
effect in the share capital of the statement of changes in equity and in Net loss per share purposes in Note 27.&lt;/p&gt;</ifrs-full:DisclosureOfAdditionalInformationExplanatory>
    <ifrs-full:DisclosureOfIntangibleAssetsExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Note 6. Intangible
Assets&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; font-weight: bold; text-align: left"&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Gamma&lt;br/&gt;
 Linolenic&lt;br/&gt;
 Acid (&#x201c;GLA&#x2019;)&lt;br/&gt;
 assets and&lt;br/&gt;
 licensing&lt;br/&gt;
 rights to&lt;br/&gt;
 Arachidonic &lt;br/&gt;
Acid&lt;br/&gt;
 (&#x201c;ARA&#x201d;)&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;SPC&#xae;&lt;br/&gt;
 technology&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Customer&lt;br/&gt;
 relationship&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Software&lt;br/&gt;
 License&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Total&lt;br/&gt;
 Intangible&lt;br/&gt;
 Assets&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; font-weight: bold; text-align: left"&gt;As of December 31, 2020&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-232"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-233"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-234"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-235"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-236"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Accumulated Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-237"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-238"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-239"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-240"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-241"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Net book amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-242"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-243"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-244"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-245"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-246"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Year ended June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Opening net book amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-247"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-248"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-249"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-250"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-251"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 40%; text-align: left; padding-bottom: 1.5pt"&gt;Additions&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;3,000,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;1,598,930&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-252"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-253"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;4,598,930&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Closing net book amount&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;3,000,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,598,930&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-254"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-255"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;4,598,930&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;As of June 30, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,598,930&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-256"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-257"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,598,930&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Accumulated Amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-258"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-259"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-260"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-261"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-262"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;Net book amount&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;3,000,000&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,598,930&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-263"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-264"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;4,598,930&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
ended June 30, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Opening net book amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,000,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,598,930&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-265"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-266"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,598,930&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Closing net book amount&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;3,000,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,598,930&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-267"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-268"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;4,598,930&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;As of June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,598,930&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-269"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-270"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,598,930&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Accumulated Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-271"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-272"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-273"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-274"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-275"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Net book amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,000,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,598,930&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-276"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-277"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,598,930&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;Year ended June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Opening net book amount&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,598,930&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-278"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-279"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,598,930&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;101,033&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;63,329&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-280"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-281"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;164,362&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Acquisitions through business combinations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-282"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-283"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,819,009&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,045&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,824,054&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Effect of changes in foreign exchange rates&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-284"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-285"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,235&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,269&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Amortization (i)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-286"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-287"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(93,247&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,270&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(94,517&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Closing net book amount&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;3,101,033&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,662,259&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;3,751,997&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;3,809&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;8,519,098&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;As of June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,101,033&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,662,259&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,845,244&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,079&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,613,615&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Accumulated Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-288"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-289"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(93,247&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,270&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(94,517&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Net book amount&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;3,101,033&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,662,259&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;3,751,997&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;3,809&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;8,519,098&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(i)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The charge of the amortization is included in Administrative
expenses and Research and development expenses (see notes 24 and 25).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfIntangibleAssetsExplanatory>
    <mlec:DisclosureOfIntangibleAssetsExplanatoryTableTextBlock contextRef="c0">Intangible
Assets&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; font-weight: bold; text-align: left"&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Gamma&lt;br/&gt;
 Linolenic&lt;br/&gt;
 Acid (&#x201c;GLA&#x2019;)&lt;br/&gt;
 assets and&lt;br/&gt;
 licensing&lt;br/&gt;
 rights to&lt;br/&gt;
 Arachidonic &lt;br/&gt;
Acid&lt;br/&gt;
 (&#x201c;ARA&#x201d;)&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;SPC&#xae;&lt;br/&gt;
 technology&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Customer&lt;br/&gt;
 relationship&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Software&lt;br/&gt;
 License&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Total&lt;br/&gt;
 Intangible&lt;br/&gt;
 Assets&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; font-weight: bold; text-align: left"&gt;As of December 31, 2020&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-232"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-233"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-234"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-235"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-236"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Accumulated Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-237"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-238"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-239"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-240"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-241"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Net book amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-242"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-243"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-244"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-245"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-246"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Year ended June 30, 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Opening net book amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-247"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-248"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-249"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-250"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-251"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 40%; text-align: left; padding-bottom: 1.5pt"&gt;Additions&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;3,000,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;1,598,930&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-252"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-253"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;4,598,930&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Closing net book amount&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;3,000,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,598,930&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-254"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-255"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;4,598,930&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;As of June 30, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,598,930&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-256"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-257"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,598,930&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Accumulated Amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-258"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-259"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-260"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-261"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-262"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;Net book amount&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;3,000,000&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,598,930&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-263"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-264"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;4,598,930&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
ended June 30, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Opening net book amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,000,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,598,930&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-265"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-266"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,598,930&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Closing net book amount&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;3,000,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,598,930&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-267"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-268"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;4,598,930&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;As of June 30, 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,598,930&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-269"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-270"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,598,930&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Accumulated Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-271"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-272"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-273"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-274"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-275"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Net book amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,000,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,598,930&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-276"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-277"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,598,930&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;Year ended June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Opening net book amount&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,598,930&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-278"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-279"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,598,930&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;101,033&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;63,329&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-280"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-281"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;164,362&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Acquisitions through business combinations&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-282"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-283"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,819,009&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,045&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,824,054&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Effect of changes in foreign exchange rates&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-284"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-285"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,235&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;26,269&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Amortization (i)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-286"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-287"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(93,247&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,270&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(94,517&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Closing net book amount&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;3,101,033&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,662,259&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;3,751,997&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;3,809&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;8,519,098&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;As of June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,101,033&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,662,259&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,845,244&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,079&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,613,615&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Accumulated Amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-288"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-289"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(93,247&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,270&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(94,517&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Net book amount&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;3,101,033&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,662,259&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;3,751,997&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;3,809&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;8,519,098&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(i)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The charge of the amortization is included in Administrative
expenses and Research and development expenses (see notes 24 and 25).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</mlec:DisclosureOfIntangibleAssetsExplanatoryTableTextBlock>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c109" decimals="0" unitRef="usd">3000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c110" decimals="0" unitRef="usd">1598930</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c113" decimals="0" unitRef="usd">4598930</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c114" decimals="0" unitRef="usd">3000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c115" decimals="0" unitRef="usd">1598930</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c39" decimals="0" unitRef="usd">4598930</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <mlec:Cost contextRef="c109" decimals="0" unitRef="usd">3000000</mlec:Cost>
    <mlec:Cost contextRef="c110" decimals="0" unitRef="usd">1598930</mlec:Cost>
    <mlec:Cost contextRef="c113" decimals="0" unitRef="usd">4598930</mlec:Cost>
    <mlec:NetBookAmount contextRef="c114" decimals="0" unitRef="usd">3000000</mlec:NetBookAmount>
    <mlec:NetBookAmount contextRef="c115" decimals="0" unitRef="usd">1598930</mlec:NetBookAmount>
    <mlec:NetBookAmount contextRef="c39" decimals="0" unitRef="usd">4598930</mlec:NetBookAmount>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c114" decimals="0" unitRef="usd">3000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c115" decimals="0" unitRef="usd">1598930</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c39" decimals="0" unitRef="usd">4598930</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c118" decimals="0" unitRef="usd">3000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c119" decimals="0" unitRef="usd">1598930</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c6" decimals="0" unitRef="usd">4598930</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <mlec:Cost contextRef="c122" decimals="0" unitRef="usd">3000000</mlec:Cost>
    <mlec:Cost contextRef="c123" decimals="0" unitRef="usd">1598930</mlec:Cost>
    <mlec:Cost contextRef="c3" decimals="0" unitRef="usd">4598930</mlec:Cost>
    <mlec:NetBookAmount contextRef="c118" decimals="0" unitRef="usd">3000000</mlec:NetBookAmount>
    <mlec:NetBookAmount contextRef="c119" decimals="0" unitRef="usd">1598930</mlec:NetBookAmount>
    <mlec:NetBookAmount contextRef="c6" decimals="0" unitRef="usd">4598930</mlec:NetBookAmount>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c118" decimals="0" unitRef="usd">3000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c119" decimals="0" unitRef="usd">1598930</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c6" decimals="0" unitRef="usd">4598930</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c126" decimals="0" unitRef="usd">101033</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c127" decimals="0" unitRef="usd">63329</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill contextRef="c0" decimals="0" unitRef="usd">164362</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="c128" decimals="0" unitRef="usd">3819009</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="c129" decimals="0" unitRef="usd">5045</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="c0" decimals="0" unitRef="usd">3824054</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill contextRef="c128" decimals="0" unitRef="usd">26235</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill contextRef="c129" decimals="0" unitRef="usd">34</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill contextRef="c0" decimals="0" unitRef="usd">26269</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <mlec:Amortization
      contextRef="c128"
      decimals="0"
      id="ix_10_fact"
      unitRef="usd">93247</mlec:Amortization>
    <mlec:Amortization
      contextRef="c129"
      decimals="0"
      id="ix_11_fact"
      unitRef="usd">1270</mlec:Amortization>
    <mlec:Amortization contextRef="c0" decimals="0" id="ix_12_fact" unitRef="usd">94517</mlec:Amortization>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c130" decimals="0" unitRef="usd">3101033</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c131" decimals="0" unitRef="usd">1662259</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c132" decimals="0" unitRef="usd">3751997</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c133" decimals="0" unitRef="usd">3809</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c2" decimals="0" unitRef="usd">8519098</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <mlec:Cost contextRef="c126" decimals="0" unitRef="usd">3101033</mlec:Cost>
    <mlec:Cost contextRef="c127" decimals="0" unitRef="usd">1662259</mlec:Cost>
    <mlec:Cost contextRef="c128" decimals="0" unitRef="usd">3845244</mlec:Cost>
    <mlec:Cost contextRef="c129" decimals="0" unitRef="usd">5079</mlec:Cost>
    <mlec:Cost contextRef="c0" decimals="0" unitRef="usd">8613615</mlec:Cost>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="c128" decimals="0" unitRef="usd">93247</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="c129" decimals="0" unitRef="usd">1270</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill contextRef="c0" decimals="0" unitRef="usd">94517</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <mlec:NetBookAmount contextRef="c130" decimals="0" unitRef="usd">3101033</mlec:NetBookAmount>
    <mlec:NetBookAmount contextRef="c131" decimals="0" unitRef="usd">1662259</mlec:NetBookAmount>
    <mlec:NetBookAmount contextRef="c132" decimals="0" unitRef="usd">3751997</mlec:NetBookAmount>
    <mlec:NetBookAmount contextRef="c133" decimals="0" unitRef="usd">3809</mlec:NetBookAmount>
    <mlec:NetBookAmount contextRef="c2" decimals="0" unitRef="usd">8519098</mlec:NetBookAmount>
    <ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Note 7. Fixed Assets&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap; text-align: left; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Chymosin&lt;br/&gt;
 osmosis&lt;br/&gt;
 equipment&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Vehicles&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Furniture&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Storage&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Computer&lt;br/&gt;
 equipment&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Machinery&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Total &lt;br/&gt;
Fixed&lt;br/&gt;
Assets&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap; text-align: left; font-weight: bold"&gt;As of December 31, 2020&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Cost&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-290"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-291"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-292"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-293"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-294"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-295"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-296"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-style: normal; font-weight: normal"&gt;Accumulated
    Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-297"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-298"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-299"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-300"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-301"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-302"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-303"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;Net book amount&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-304"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-305"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-306"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-307"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-308"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-309"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-310"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;Year ended June 30, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Opening net book amount&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-311"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-312"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-313"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-314"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-315"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-316"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-317"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 30%"&gt;Additions&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-318"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-319"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-320"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-321"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-322"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Closing net book amount&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-323"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-324"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-325"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-326"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-327"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;As of June 30, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"&gt;Cost&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-328"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-329"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-330"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-331"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-332"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Accumulated Depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-333"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-334"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-335"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-336"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-337"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-338"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-339"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Net book amount&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-340"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-341"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-342"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-343"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-344"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
ended June 30, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Opening net book amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-345"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-346"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-347"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-348"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-349"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Depreciation (i)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(1,699&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-350"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-351"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-352"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-353"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-354"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(1,699&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Closing net book amount&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;8,918&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-355"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-356"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-357"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-358"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-359"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;8,918&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;As of June 30, 2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-size: 10pt; padding-left: 0.125in; text-indent: -0.125in; font-weight: normal; font-style: normal"&gt;Cost&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-360"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-361"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-362"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-363"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-364"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Accumulated Depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,699&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-365"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-366"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-367"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-368"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-369"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,699&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Net book amount&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;8,918&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-370"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-371"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-372"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-373"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-374"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;8,918&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;Year ended June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Opening net book amount&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,918&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-375"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-376"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-377"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-378"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-379"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,918&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Acquisitions through business combinations, net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-380"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,464&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,154&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;49,281&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,633&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,055,494&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,138,026&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Effect of changes in foreign exchange rates&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-381"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;176&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;340&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,277&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,819&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-382"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-383"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-384"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,143&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,681&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-385"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,824&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Depreciation (i)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,699&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,603&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(106&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,160&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(699&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(22,238&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(27,505&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Closing net book amount&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: right"&gt;7,219&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;24,037&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;5,083&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;57,604&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;7,606&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,040,533&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,142,082&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;As of June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,640&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,189&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;58,764&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,305&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,062,771&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,171,286&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Accumulated Depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,398&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,603&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(106&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,160&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(699&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(22,238&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(29,204&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Net book amount&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: right"&gt;7,219&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;24,037&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;5,083&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;57,604&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;7,606&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,040,533&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,142,082&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(i)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The depreciation charge is included in Administrative expenses
and Cost of sales (see notes 24 and 26).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory>
    <mlec:ScheduleOfFixedAssetstextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap; text-align: left; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Chymosin&lt;br/&gt;
 osmosis&lt;br/&gt;
 equipment&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Vehicles&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Furniture&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Storage&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Computer&lt;br/&gt;
 equipment&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Machinery&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Total &lt;br/&gt;
Fixed&lt;br/&gt;
Assets&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap; text-align: left; font-weight: bold"&gt;As of December 31, 2020&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Cost&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-290"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-291"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-292"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-293"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-294"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-295"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-296"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-style: normal; font-weight: normal"&gt;Accumulated
    Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-297"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-298"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-299"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-300"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-301"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-302"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-303"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;Net book amount&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-304"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-305"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-306"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-307"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-308"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-309"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-310"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;Year ended June 30, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Opening net book amount&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-311"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-312"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-313"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-314"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-315"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-316"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-317"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 30%"&gt;Additions&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-318"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-319"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-320"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-321"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-322"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Closing net book amount&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-323"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-324"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-325"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-326"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-327"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;As of June 30, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"&gt;Cost&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-328"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-329"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-330"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-331"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-332"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Accumulated Depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-333"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-334"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-335"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-336"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-337"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-338"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;b style="-sec-ix-hidden: hidden-fact-339"&gt;-&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Net book amount&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-340"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-341"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-342"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-343"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-344"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
ended June 30, 2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Opening net book amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-345"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-346"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-347"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-348"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-349"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Depreciation (i)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(1,699&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-350"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-351"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-352"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-353"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-354"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(1,699&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Closing net book amount&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;8,918&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-355"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-356"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-357"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-358"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-359"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;8,918&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;As of June 30, 2022&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-size: 10pt; padding-left: 0.125in; text-indent: -0.125in; font-weight: normal; font-style: normal"&gt;Cost&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-360"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-361"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-362"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-363"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-364"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Accumulated Depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,699&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-365"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-366"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-367"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-368"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-369"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,699&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Net book amount&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;8,918&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-370"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-371"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-372"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-373"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-374"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;8,918&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;Year ended June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Opening net book amount&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,918&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-375"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-376"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-377"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-378"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-379"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,918&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Acquisitions through business combinations, net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-380"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,464&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,154&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;49,281&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,633&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,055,494&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,138,026&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Effect of changes in foreign exchange rates&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-381"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;176&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;340&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,277&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,819&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Additions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-382"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-383"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-384"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9,143&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,681&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-385"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,824&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Depreciation (i)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,699&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,603&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(106&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,160&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(699&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(22,238&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(27,505&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Closing net book amount&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: right"&gt;7,219&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;24,037&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;5,083&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;57,604&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;7,606&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,040,533&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,142,082&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold"&gt;As of June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in"&gt;Cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,617&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;25,640&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,189&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;58,764&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,305&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,062,771&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,171,286&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Accumulated Depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,398&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,603&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(106&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,160&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(699&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(22,238&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(29,204&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Net book amount&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; font-weight: bold; text-align: right"&gt;7,219&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;24,037&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;5,083&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;57,604&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;7,606&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,040,533&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,142,082&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(i)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The depreciation charge is included in Administrative expenses
and Cost of sales (see notes 24 and 26).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</mlec:ScheduleOfFixedAssetstextBlock>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c161" decimals="0" unitRef="usd">10617</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c113" decimals="0" unitRef="usd">10617</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c167" decimals="0" unitRef="usd">10617</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c39" decimals="0" unitRef="usd">10617</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c173" decimals="0" unitRef="usd">10617</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c179" decimals="0" unitRef="usd">10617</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c187" decimals="0" unitRef="usd">10617</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c193" decimals="0" unitRef="usd">10617</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c167" decimals="0" unitRef="usd">10617</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c39" decimals="0" unitRef="usd">10617</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="c194"
      decimals="0"
      id="ix_13_fact"
      unitRef="usd">1699</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c3" decimals="0" id="ix_14_fact" unitRef="usd">1699</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c200" decimals="0" unitRef="usd">8918</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c6" decimals="0" unitRef="usd">8918</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c206" decimals="0" unitRef="usd">10617</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c212" decimals="0" unitRef="usd">10617</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c213" decimals="0" unitRef="usd">-1699</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c219" decimals="0" unitRef="usd">-1699</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c220" decimals="0" unitRef="usd">8918</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c226" decimals="0" unitRef="usd">8918</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c200" decimals="0" unitRef="usd">8918</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c6" decimals="0" unitRef="usd">8918</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c82" decimals="0" unitRef="usd">25464</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c83" decimals="0" unitRef="usd">5154</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c79" decimals="0" unitRef="usd">49281</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c228" decimals="0" unitRef="usd">2633</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c229" decimals="0" unitRef="usd">1055494</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c0" decimals="0" unitRef="usd">1138026</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c82" decimals="0" unitRef="usd">176</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c83" decimals="0" unitRef="usd">35</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c79" decimals="0" unitRef="usd">340</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c228" decimals="0" unitRef="usd">-9</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c229" decimals="0" unitRef="usd">7277</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c0" decimals="0" unitRef="usd">7819</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c79" decimals="0" unitRef="usd">9143</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c228" decimals="0" unitRef="usd">5681</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c0" decimals="0" unitRef="usd">14824</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="c227"
      decimals="0"
      id="ix_15_fact"
      unitRef="usd">1699</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c82" decimals="0" id="ix_16_fact" unitRef="usd">1603</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c83" decimals="0" id="ix_17_fact" unitRef="usd">106</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c79" decimals="0" id="ix_18_fact" unitRef="usd">1160</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="c228"
      decimals="0"
      id="ix_19_fact"
      unitRef="usd">699</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="c229"
      decimals="0"
      id="ix_20_fact"
      unitRef="usd">22238</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="c0" decimals="0" id="ix_21_fact" unitRef="usd">27505</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c230" decimals="0" unitRef="usd">7219</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c231" decimals="0" unitRef="usd">24037</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c232" decimals="0" unitRef="usd">5083</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c233" decimals="0" unitRef="usd">57604</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c234" decimals="0" unitRef="usd">7606</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c235" decimals="0" unitRef="usd">1040533</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c2" decimals="0" unitRef="usd">1142082</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c236" decimals="0" unitRef="usd">10617</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c237" decimals="0" unitRef="usd">25640</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c238" decimals="0" unitRef="usd">5189</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c239" decimals="0" unitRef="usd">58764</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c240" decimals="0" unitRef="usd">8305</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c241" decimals="0" unitRef="usd">1062771</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c242" decimals="0" unitRef="usd">1171286</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c243" decimals="0" unitRef="usd">-3398</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c244" decimals="0" unitRef="usd">-1603</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c245" decimals="0" unitRef="usd">-106</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c246" decimals="0" unitRef="usd">-1160</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c247" decimals="0" unitRef="usd">-699</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c248" decimals="0" unitRef="usd">-22238</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c249" decimals="0" unitRef="usd">-29204</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c250" decimals="0" unitRef="usd">7219</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c251" decimals="0" unitRef="usd">24037</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c252" decimals="0" unitRef="usd">5083</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c253" decimals="0" unitRef="usd">57604</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c254" decimals="0" unitRef="usd">7606</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c255" decimals="0" unitRef="usd">1040533</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c256" decimals="0" unitRef="usd">1142082</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DisclosureOfGoodwillExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Note 8. Goodwill&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt"&gt;Goodwill&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;251,440&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-386"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Goodwill&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;251,440&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-387"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;As of June 30, 2023, no
goodwill impairment losses were recognized.&lt;/p&gt;</ifrs-full:DisclosureOfGoodwillExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt"&gt;Goodwill&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;251,440&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-386"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Goodwill&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;251,440&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-387"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory>
    <ifrs-full:Goodwill contextRef="c2" decimals="0" unitRef="usd">251440</ifrs-full:Goodwill>
    <mlec:TotalGoodwill contextRef="c2" decimals="0" unitRef="usd">251440</mlec:TotalGoodwill>
    <ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Note 9. Right-of-use
of assets&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Land&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;As of June 30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-388"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 88%; text-align: left"&gt;Acquisitions through business combinations (i)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;43,507&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Effect of changes in foreign exchange rates&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;299&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;As of June 30, 2023&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;43,806&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;(i)&lt;/td&gt;&lt;td style="text-align: left"&gt;Through the ValoraSoy acquisition, the Group acquired a parcel of land for an original amount of $ 43,507.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory>
    <mlec:ScheduleOfRightofuseOfAssetsTableTextBlock contextRef="c0">Right-of-use
of assets&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Land&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;As of June 30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-388"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 88%; text-align: left"&gt;Acquisitions through business combinations (i)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;43,507&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Effect of changes in foreign exchange rates&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;299&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;As of June 30, 2023&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;43,806&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;(i)&lt;/td&gt;&lt;td style="text-align: left"&gt;Through the ValoraSoy acquisition, the Group acquired a parcel of land for an original amount of $ 43,507.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</mlec:ScheduleOfRightofuseOfAssetsTableTextBlock>
    <mlec:AcquisitionsThroughBusinessCombinationsi contextRef="c0" decimals="0" id="ix_22_fact" unitRef="usd">43507</mlec:AcquisitionsThroughBusinessCombinationsi>
    <mlec:EffectOfChangesInForeignExchangeRates contextRef="c0" decimals="0" unitRef="usd">299</mlec:EffectOfChangesInForeignExchangeRates>
    <ifrs-full:RightofuseAssets contextRef="c2" decimals="0" unitRef="usd">43806</ifrs-full:RightofuseAssets>
    <mlec:OriginalAmount contextRef="c0" decimals="0" unitRef="usd">43507</mlec:OriginalAmount>
    <ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Note 10. Other non-current
receivables&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt"&gt;Receivables with shareholders&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;8,763,027&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Other Non-Current receivables&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;8,763,027&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Moolec Science Limited
issued an aggregate number of Moolec Science Limited ordinary shares equal to 2,354,069 (or 1,500,000 of Moolec Science SA shares after
the transaction) to current individual shareholders of Bioceres S.A., and Bioceres Group PLC, (&#x201c;New shareholders&#x201d;) Moolec
and the new shareholders entered into a subscription agreement (the &#x201c;shareholders&#x2019; subscription agreement&#x201d;) prior to
the transaction pursuant to which Moolec Science Limited agreed to issue 2,354,069 of Moolec Science Limited ordinary shares. The new
shareholders agreed to pay an aggregate purchase price of $15,000,000 within 5 years from the date of such subscription agreement. Such
shareholders&#x2019; subscription agreement accrues an internal rate of return of 13.20%.&lt;/p&gt;</ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory>
    <mlec:ScheduleOfOtherNoncurrentReceivableTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt"&gt;Receivables with shareholders&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;8,763,027&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Other Non-Current receivables&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;8,763,027&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:ScheduleOfOtherNoncurrentReceivableTableTextBlock>
    <ifrs-full:OtherNoncurrentReceivables contextRef="c2" decimals="0" unitRef="usd">8763027</ifrs-full:OtherNoncurrentReceivables>
    <ifrs-full:NoncurrentReceivables contextRef="c2" decimals="0" unitRef="usd">8763027</ifrs-full:NoncurrentReceivables>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued contextRef="c257" decimals="0" unitRef="shares">2354069</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued contextRef="c258" decimals="0" unitRef="shares">1500000</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued contextRef="c86" decimals="0" unitRef="shares">2354069</ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued>
    <mlec:AggregatePurchasePrice contextRef="c0" decimals="0" unitRef="usd">15000000</mlec:AggregatePurchasePrice>
    <mlec:PurchasePaymentTerms contextRef="c0">P5Y</mlec:PurchasePaymentTerms>
    <ifrs-full:BorrowingsInterestRate contextRef="c2" decimals="4" unitRef="pure">0.132</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Note 11. Cash and cash
equivalents&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;For the purposes of preparing
the Consolidated Statements of Financial Position and Statement of Cash Flows, the item &#x201c;Cash and Cash Equivalents&#x201d; includes
cash on hand and in banks and short-term highly liquid investments that can be readily convertible to known amounts of cash and they are
subject to insignificant risk of changes in value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Bank overdrafts are classified
as &#x201c;Financial Debt&#x201d; in the Consolidated Statement of Financial Position.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Cash and cash equivalents
at each year-end, as disclosed in the Consolidated Statement of Cash Flows, may be reconciled against the items related to the Consolidated
Statement of Financial Position as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30, &lt;br/&gt;
2022&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Cash&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,443&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Bank accounts&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,061,636&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,081,808&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Short-term investments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;463,594&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total cash and cash equivalents&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;2,527,673&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,081,808&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory>
    <ifrs-full:DisclosureOfRestrictedCashAndCashEquivalentsExplanatory contextRef="c0">Cash and cash equivalents
at each year-end, as disclosed in the Consolidated Statement of Cash Flows, may be reconciled against the items related to the Consolidated
Statement of Financial Position as follows:&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30, &lt;br/&gt;
2022&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Cash&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,443&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Bank accounts&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,061,636&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,081,808&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Short-term investments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;463,594&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total cash and cash equivalents&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;2,527,673&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,081,808&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfRestrictedCashAndCashEquivalentsExplanatory>
    <ifrs-full:Cash contextRef="c2" decimals="0" unitRef="usd">2443</ifrs-full:Cash>
    <ifrs-full:DepositsFromBanks contextRef="c2" decimals="0" unitRef="usd">2061636</ifrs-full:DepositsFromBanks>
    <ifrs-full:DepositsFromBanks contextRef="c6" decimals="0" unitRef="usd">1081808</ifrs-full:DepositsFromBanks>
    <ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents contextRef="c2" decimals="0" unitRef="usd">463594</ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents>
    <ifrs-full:OtherCashAndCashEquivalents contextRef="c2" decimals="0" unitRef="usd">2527673</ifrs-full:OtherCashAndCashEquivalents>
    <ifrs-full:OtherCashAndCashEquivalents contextRef="c6" decimals="0" unitRef="usd">1081808</ifrs-full:OtherCashAndCashEquivalents>
    <ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Note 12. Short-term
investments&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt"&gt;Mutual funds&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;306,034&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-389"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Short-term investments&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;306,034&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-390"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory>
    <mlec:DisclosureOfShortTermInvestmentsTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2022&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt"&gt;Mutual funds&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;306,034&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-389"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Short-term investments&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;306,034&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-390"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:DisclosureOfShortTermInvestmentsTableTextBlock>
    <mlec:MutualFunds contextRef="c2" decimals="0" unitRef="usd">306034</mlec:MutualFunds>
    <mlec:TotalMutualFunds contextRef="c0" decimals="0" unitRef="usd">306034</mlec:TotalMutualFunds>
    <ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Note 13. Trade Receivable
and Other current receivables&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt"&gt;Accounts receivable&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;361,097&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-391"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Trade receivable&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;361,097&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-392"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left"&gt;Taxes&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;952,953&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-393"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;377,224&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-394"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Other current receivables&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,330,177&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-395"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The book value is reasonably
approximate to the fair value given its short-term nature.&lt;/p&gt;</ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory>
    <mlec:ScheduleOfTradeReceivableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt"&gt;Accounts receivable&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;361,097&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-391"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Trade receivable&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;361,097&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-392"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:ScheduleOfTradeReceivableTextBlock>
    <ifrs-full:TradeReceivables contextRef="c2" decimals="0" unitRef="usd">361097</ifrs-full:TradeReceivables>
    <ifrs-full:TradeAndOtherReceivables contextRef="c2" decimals="0" unitRef="usd">361097</ifrs-full:TradeAndOtherReceivables>
    <mlec:ScheduleOfOtherCurrentReceivablesTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left"&gt;Taxes&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;952,953&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-393"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;377,224&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-394"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Other current receivables&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,330,177&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-395"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:ScheduleOfOtherCurrentReceivablesTextBlock>
    <ifrs-full:CurrentValueAddedTaxReceivables contextRef="c2" decimals="0" unitRef="usd">952953</ifrs-full:CurrentValueAddedTaxReceivables>
    <ifrs-full:OtherCurrentReceivables contextRef="c2" decimals="0" unitRef="usd">377224</ifrs-full:OtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables contextRef="c2" decimals="0" unitRef="usd">1330177</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:DisclosureOfInventoriesExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Note 14. Inventories&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left"&gt;Raw materials&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;179,368&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-396"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Finished goods&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;286,380&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-397"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Inventories&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;465,748&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-398"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfInventoriesExplanatory>
    <mlec:DisclosureOfInventoriesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left"&gt;Raw materials&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;179,368&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-396"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Finished goods&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;286,380&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-397"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Inventories&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;465,748&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-398"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:DisclosureOfInventoriesTableTextBlock>
    <ifrs-full:RawMaterials contextRef="c2" decimals="0" unitRef="usd">179368</ifrs-full:RawMaterials>
    <ifrs-full:FinishedGoods contextRef="c2" decimals="0" unitRef="usd">286380</ifrs-full:FinishedGoods>
    <ifrs-full:InventoriesTotal contextRef="c2" decimals="0" unitRef="usd">465748</ifrs-full:InventoriesTotal>
    <ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Note 15. Share capital
and share premium&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;As of June 30, 2023, the
share capital stock and share premium amounts to $ 66,996,982.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;&lt;i&gt;Reconciliation of share
capital and share premium&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Number &lt;br/&gt;
of&lt;br/&gt;
 shares&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Shares&lt;br/&gt;
 issued&lt;br/&gt;
 amount&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Shares&lt;br/&gt;
 to be &lt;br/&gt;
issued&lt;br/&gt;
 amount&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Share &lt;br/&gt;
Premium&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt"&gt;Opening Balance as of August, 2020&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-399"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-400"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-401"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-402"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in; width: 52%; text-align: left; padding-bottom: 1.5pt"&gt;Issue of share capital&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;29,140,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;291,400&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-403"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;4,308,600&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance as of December, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;29,140,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;291,400&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-404"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;4,308,600&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt"&gt;Issue of share capital&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,860,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,600&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-405"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,981,400&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Balance as of June 30, 2021&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;31,000,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;310,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-406"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;7,290,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt"&gt;Issue of share capital&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-407"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-408"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-409"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-410"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Balance as of&#160;&#160;June 30, 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;31,000,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;310,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-411"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;7,290,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt"&gt;Issue of share capital (Moolec Science shares)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,500,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-412"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,105,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt"&gt;Issue of share capital (SAFE shares)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-413; font-family: Times New Roman, Times, Serif"&gt;&#160;262, 260&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,623&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-414"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,170,723&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt"&gt;Issue of share capital (LightJump shares)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,363,810&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,639&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-415"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;39,610,630&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt"&gt;Issue of share capital (Backstop shares)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,201,656&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,017&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-416"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,999,023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt"&gt;Issue of share capital&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,519&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-417"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,647&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt"&gt;From business acquisition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-418"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-419"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;641&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;217,275&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt"&gt;Equity settled share based payment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;232,523&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,326&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,427&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;593,684&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Balance as of June 30, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;37,563,768&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;375,641&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;3,068&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;66,996,982&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="text-decoration:underline"&gt;Share Purchase Agreement
&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;On April 14, the Company
entered into a Share Purchase Agreement with Nomura Securities International, Inc (&#x201c;Nomura&#x201d;). The Agreement provides for a
committed equity financing facility under which the Company has the option, but not the obligation, to sell up to the equivalent of $50
million in aggregate gross purchase price of its ordinary shares to Nomura over a 36-month period, subject to the terms of the Agreement.
The Company intends to use the proceeds from any future sales of securities under the financing facility, if it is utilized, for general
corporate purposes.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Sales of ordinary shares
to Nomura, and the timing of any such sales, will be determined by the Company from time to time in its sole discretion and will depend
on a variety of factors, including, among other things, market conditions, the trading price of the ordinary shares and determinations
by the Company regarding the use of proceeds from any sale.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;As of June 30, 2023 only
3,600 shares (equivalent to $10,647) were issued under the Share Purchase Agreement.&lt;/p&gt;</ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory>
    <mlec:ShareCapitalStockAndSharePremiumAmounts contextRef="c2" decimals="0" unitRef="usd">66996982</mlec:ShareCapitalStockAndSharePremiumAmounts>
    <mlec:ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock contextRef="c0">&lt;i&gt;Reconciliation of share
capital and share premium&lt;/i&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Number &lt;br/&gt;
of&lt;br/&gt;
 shares&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Shares&lt;br/&gt;
 issued&lt;br/&gt;
 amount&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Shares&lt;br/&gt;
 to be &lt;br/&gt;
issued&lt;br/&gt;
 amount&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;Share &lt;br/&gt;
Premium&lt;/td&gt;&lt;td style="white-space: nowrap; text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt"&gt;Opening Balance as of August, 2020&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-399"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-400"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-401"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-402"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in; width: 52%; text-align: left; padding-bottom: 1.5pt"&gt;Issue of share capital&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;29,140,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;291,400&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-403"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;4,308,600&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance as of December, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;29,140,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;291,400&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-404"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;4,308,600&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt"&gt;Issue of share capital&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,860,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,600&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-405"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,981,400&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Balance as of June 30, 2021&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;31,000,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;310,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-406"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;7,290,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt"&gt;Issue of share capital&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-407"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-408"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-409"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-410"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Balance as of&#160;&#160;June 30, 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;31,000,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;310,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-411"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;7,290,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt"&gt;Issue of share capital (Moolec Science shares)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,500,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-412"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,105,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt"&gt;Issue of share capital (SAFE shares)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-413; font-family: Times New Roman, Times, Serif"&gt;&#160;262, 260&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,623&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-414"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,170,723&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt"&gt;Issue of share capital (LightJump shares)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,363,810&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,639&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-415"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;39,610,630&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt"&gt;Issue of share capital (Backstop shares)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,201,656&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,017&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-416"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,999,023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt"&gt;Issue of share capital&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,519&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-417"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,647&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt"&gt;From business acquisition&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-418"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-419"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;641&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;217,275&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in; text-align: left; padding-bottom: 1.5pt"&gt;Equity settled share based payment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;232,523&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,326&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,427&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;593,684&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Balance as of June 30, 2023&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;37,563,768&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;375,641&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;3,068&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;66,996,982&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock>
    <mlec:NumberOfSharesIssueOfShareCapitalinShares contextRef="c5" decimals="INF" unitRef="shares">29140000</mlec:NumberOfSharesIssueOfShareCapitalinShares>
    <ifrs-full:PaymentsForShareIssueCosts contextRef="c5" decimals="0" unitRef="usd">291400</ifrs-full:PaymentsForShareIssueCosts>
    <mlec:SharePremiumIssueOfShareCapital contextRef="c5" decimals="0" unitRef="usd">4308600</mlec:SharePremiumIssueOfShareCapital>
    <ifrs-full:NumberOfSharesIssued contextRef="c26" decimals="INF" unitRef="shares">29140000</ifrs-full:NumberOfSharesIssued>
    <mlec:SharesIssuedAmount contextRef="c26" decimals="0" unitRef="usd">291400</mlec:SharesIssuedAmount>
    <ifrs-full:SharePremium contextRef="c26" decimals="0" unitRef="usd">4308600</ifrs-full:SharePremium>
    <mlec:NumberOfSharesIssueOfShareCapitalinShares contextRef="c4" decimals="INF" unitRef="shares">1860000</mlec:NumberOfSharesIssueOfShareCapitalinShares>
    <ifrs-full:PaymentsForShareIssueCosts contextRef="c4" decimals="0" unitRef="usd">18600</ifrs-full:PaymentsForShareIssueCosts>
    <mlec:SharePremiumIssueOfShareCapital contextRef="c4" decimals="0" unitRef="usd">2981400</mlec:SharePremiumIssueOfShareCapital>
    <ifrs-full:NumberOfSharesIssued contextRef="c39" decimals="INF" unitRef="shares">31000000</ifrs-full:NumberOfSharesIssued>
    <mlec:SharesIssuedAmount contextRef="c39" decimals="0" unitRef="usd">310000</mlec:SharesIssuedAmount>
    <ifrs-full:SharePremium contextRef="c39" decimals="0" unitRef="usd">7290000</ifrs-full:SharePremium>
    <ifrs-full:NumberOfSharesIssued contextRef="c6" decimals="INF" unitRef="shares">31000000</ifrs-full:NumberOfSharesIssued>
    <mlec:SharesIssuedAmount contextRef="c6" decimals="0" unitRef="usd">310000</mlec:SharesIssuedAmount>
    <ifrs-full:SharePremium contextRef="c6" decimals="0" unitRef="usd">7290000</ifrs-full:SharePremium>
    <mlec:NumberOfSharesIssueOfShareCapitalinShares contextRef="c260" decimals="INF" unitRef="shares">1500000</mlec:NumberOfSharesIssueOfShareCapitalinShares>
    <ifrs-full:PaymentsForShareIssueCosts contextRef="c260" decimals="0" unitRef="usd">15000</ifrs-full:PaymentsForShareIssueCosts>
    <mlec:SharePremiumIssueOfShareCapital contextRef="c260" decimals="0" unitRef="usd">8105000</mlec:SharePremiumIssueOfShareCapital>
    <ifrs-full:PaymentsForShareIssueCosts contextRef="c262" decimals="0" unitRef="usd">2623</ifrs-full:PaymentsForShareIssueCosts>
    <mlec:SharePremiumIssueOfShareCapital contextRef="c262" decimals="0" unitRef="usd">3170723</mlec:SharePremiumIssueOfShareCapital>
    <mlec:NumberOfSharesIssueOfShareCapitalinShares contextRef="c264" decimals="INF" unitRef="shares">3363810</mlec:NumberOfSharesIssueOfShareCapitalinShares>
    <ifrs-full:PaymentsForShareIssueCosts contextRef="c264" decimals="0" unitRef="usd">33639</ifrs-full:PaymentsForShareIssueCosts>
    <mlec:SharePremiumIssueOfShareCapital contextRef="c264" decimals="0" unitRef="usd">39610630</mlec:SharePremiumIssueOfShareCapital>
    <mlec:NumberOfSharesIssueOfShareCapitalinShares contextRef="c266" decimals="INF" unitRef="shares">1201656</mlec:NumberOfSharesIssueOfShareCapitalinShares>
    <ifrs-full:PaymentsForShareIssueCosts contextRef="c266" decimals="0" unitRef="usd">12017</ifrs-full:PaymentsForShareIssueCosts>
    <mlec:SharePremiumIssueOfShareCapital contextRef="c266" decimals="0" unitRef="usd">7999023</mlec:SharePremiumIssueOfShareCapital>
    <mlec:NumberOfSharesIssueOfShareCapitalinShares contextRef="c0" decimals="INF" unitRef="shares">3519</mlec:NumberOfSharesIssueOfShareCapitalinShares>
    <ifrs-full:PaymentsForShareIssueCosts contextRef="c0" decimals="0" unitRef="usd">36</ifrs-full:PaymentsForShareIssueCosts>
    <mlec:SharePremiumIssueOfShareCapital contextRef="c0" decimals="0" unitRef="usd">10647</mlec:SharePremiumIssueOfShareCapital>
    <mlec:SharesToBeIssuedAmountFromBusinessAcquisition contextRef="c0" decimals="0" unitRef="usd">641</mlec:SharesToBeIssuedAmountFromBusinessAcquisition>
    <mlec:SharePremiumFromBusinessAcquisition contextRef="c0" decimals="0" unitRef="usd">217275</mlec:SharePremiumFromBusinessAcquisition>
    <mlec:NumberOfShareEquitySettledShareBasedPayment contextRef="c0" decimals="INF" unitRef="shares">232523</mlec:NumberOfShareEquitySettledShareBasedPayment>
    <mlec:SharesIssuedAmountEquitySettledShareBasedPayment contextRef="c0" decimals="0" unitRef="usd">2326</mlec:SharesIssuedAmountEquitySettledShareBasedPayment>
    <mlec:SharesToBeIssuedAmountEquitySettledShareBasedPayment contextRef="c0" decimals="0" unitRef="usd">2427</mlec:SharesToBeIssuedAmountEquitySettledShareBasedPayment>
    <mlec:SharePremiumEquitySettledShareBasedPayment contextRef="c0" decimals="0" unitRef="usd">593684</mlec:SharePremiumEquitySettledShareBasedPayment>
    <ifrs-full:NumberOfSharesIssued contextRef="c2" decimals="INF" unitRef="shares">37563768</ifrs-full:NumberOfSharesIssued>
    <mlec:SharesIssuedAmount contextRef="c2" decimals="0" unitRef="usd">375641</mlec:SharesIssuedAmount>
    <mlec:ShareToBeIssuedAmount contextRef="c2" decimals="0" unitRef="usd">3068</mlec:ShareToBeIssuedAmount>
    <ifrs-full:SharePremium contextRef="c2" decimals="0" unitRef="usd">66996982</ifrs-full:SharePremium>
    <mlec:Equivalent contextRef="c259" decimals="-6" unitRef="usd">50000000</mlec:Equivalent>
    <mlec:SharePurchaseAgreementOverPeriod contextRef="c259">P36M</mlec:SharePurchaseAgreementOverPeriod>
    <mlec:UnderIssuedSharePurchaseAgreement contextRef="c2" decimals="0" unitRef="shares">3600</mlec:UnderIssuedSharePurchaseAgreement>
    <mlec:SharePurchaseAgreement contextRef="c74" decimals="0" unitRef="usd">10647</mlec:SharePurchaseAgreement>
    <ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Note 16. Share based
payment&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Under the share-based
compensation plan, some employees and members of the executive management team as defined by the Board of Directors, were granted share
options or restricted stock units (&#x201c;RSU&#x201d;) in return for their services to the Group.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;As of June 30, 2023, Moolec
had the following shared-based payment arrangements:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Share option plan for
executives and senior management:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Group 1 granted up to 579,078 underlying ordinary shares.
The options have an exercise price of $1.52 and expire in December 2030 (except one case in June 2031).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Group 2 granted up to 346,555 underlying ordinary shares.
The options have an exercise price of $8.00 and expire in December 2030.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&#x25cf;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Group 3 granted up to 700,000 underlying ordinary shares.
The options have an exercise price of $4.25. Five of them expire in January 2033 and the other two in March 2033.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The fair value is defined
as the actuarial expected value of the future benefits under the Plan calculated at the date in which benefits are granted and it is estimated
using the option valuation method known as &#x2018;binomial trees&#x2019;. The estimate considers the effects of rotation, the vesting schedule
and the possible dilutive effect of the future exercise of options.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-indent: 0in; font-weight: bold; text-align: left"&gt;Factor&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Group 1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Group 2&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Group 3&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; width: 64%; text-align: left"&gt;Fair value of shares&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2.97&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in; text-align: left"&gt;Exercise price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-420"&gt;1.52&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-421"&gt;8.00&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-422"&gt;4.25&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;70&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;70&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;70&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in; text-align: left"&gt;Dividend rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-423"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-424"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-425"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; text-align: left"&gt;Reference risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.00&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.00&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.25&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in; text-align: left"&gt;Plan duration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; text-align: left"&gt;Fair value of stock options at measurement date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;9.11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;7.25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2.04&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;There are no market-related
performance conditions or non-vesting conditions that should be considered for determining the fair value of options.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Moolec Science estimates
an expected rotation of 2.00% annually at constant value, taking into account historical patterns of executives maintaining their jobs
and the probability of exercising the options. This estimate is reviewed at the end of each annual or interim period.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The following table shows
the amount and exercise price and the movements of the stock options of executives and managers of the Group for the period ended June
30, 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; white-space: nowrap; text-indent: 0in; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="22" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; text-indent: 0in; padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Group 1&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Group 2&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Group 3&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; text-indent: 0in; padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Number&lt;br/&gt;
 of&lt;br/&gt;
 options&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Exercise &lt;br/&gt;
price&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Number &lt;br/&gt;
of&lt;br/&gt;
 options&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Exercise &lt;br/&gt;
price&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Number &lt;br/&gt;
of&lt;br/&gt;
 options&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Exercise &lt;br/&gt;
price&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: 0in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; text-align: left"&gt;At the beginning&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-426"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-427"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-428"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-429"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-430"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-431"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in; width: 28%; text-align: left"&gt;Granted during the period&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;579,078&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1.52&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;346,555&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;700,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4.25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; text-align: left"&gt;Forfeited during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-432"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-433"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-434"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-435"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-436"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-437"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in; text-align: left"&gt;Exercised during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;253,252&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1.52&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;139,957&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;8.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-438"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-439"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; text-align: left"&gt;Expired during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-440"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-441"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-442"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-443"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-444"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-445"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in"&gt;At the ending&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;325,826&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1.52&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;206,598&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;8.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;700,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4.25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;The charge of the plans
based on options recognized during the period was $508,149.&lt;/p&gt;</ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory>
    <mlec:OrdinaryShares contextRef="c268" decimals="0" unitRef="shares">579078</mlec:OrdinaryShares>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019 contextRef="c268" decimals="2" unitRef="usdPershares">1.52</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019>
    <mlec:OrdinaryShares contextRef="c269" decimals="0" unitRef="shares">346555</mlec:OrdinaryShares>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019 contextRef="c269" decimals="2" unitRef="usdPershares">8</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019>
    <mlec:OrdinaryShares contextRef="c270" decimals="0" unitRef="shares">700000</mlec:OrdinaryShares>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019 contextRef="c270" decimals="2" unitRef="usdPershares">4.25</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019>
    <ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-indent: 0in; font-weight: bold; text-align: left"&gt;Factor&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Group 1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Group 2&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Group 3&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; width: 64%; text-align: left"&gt;Fair value of shares&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2.97&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in; text-align: left"&gt;Exercise price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-420"&gt;1.52&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-421"&gt;8.00&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-422"&gt;4.25&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;70&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;70&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;70&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in; text-align: left"&gt;Dividend rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-423"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-424"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-425"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; text-align: left"&gt;Reference risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.00&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.00&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.25&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in; text-align: left"&gt;Plan duration&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;10 years&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; text-align: left"&gt;Fair value of stock options at measurement date&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;9.11&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;7.25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2.04&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory>
    <mlec:FairValueOfSharesinShares contextRef="c271" decimals="2" unitRef="usdPershares">1</mlec:FairValueOfSharesinShares>
    <mlec:FairValueOfSharesinShares contextRef="c272" decimals="2" unitRef="usdPershares">1</mlec:FairValueOfSharesinShares>
    <mlec:FairValueOfSharesinShares contextRef="c273" decimals="2" unitRef="usdPershares">2.97</mlec:FairValueOfSharesinShares>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="c271" decimals="2" unitRef="pure">0.70</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="c272" decimals="2" unitRef="pure">0.70</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="c273" decimals="2" unitRef="pure">0.70</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="c271" decimals="4" unitRef="pure">0.03</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="c272" decimals="4" unitRef="pure">0.03</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="c273" decimals="4" unitRef="pure">0.0425</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <mlec:PlanDuration contextRef="c271">P10Y</mlec:PlanDuration>
    <mlec:PlanDuration contextRef="c272">P10Y</mlec:PlanDuration>
    <mlec:PlanDuration contextRef="c273">P10Y</mlec:PlanDuration>
    <mlec:FairValueOfStockOptionsAtMeasurementDate contextRef="c271">P9Y1M9D</mlec:FairValueOfStockOptionsAtMeasurementDate>
    <mlec:FairValueOfStockOptionsAtMeasurementDate contextRef="c272">P7Y3M</mlec:FairValueOfStockOptionsAtMeasurementDate>
    <mlec:FairValueOfStockOptionsAtMeasurementDate contextRef="c273">P2Y14D</mlec:FairValueOfStockOptionsAtMeasurementDate>
    <mlec:ConstantValuePercentage contextRef="c0" decimals="4" unitRef="pure">0.02</mlec:ConstantValuePercentage>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; white-space: nowrap; text-indent: 0in; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="22" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;June 30, 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; text-indent: 0in; padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Group 1&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Group 2&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Group 3&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; text-indent: 0in; padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Number&lt;br/&gt;
 of&lt;br/&gt;
 options&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Exercise &lt;br/&gt;
price&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Number &lt;br/&gt;
of&lt;br/&gt;
 options&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Exercise &lt;br/&gt;
price&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Number &lt;br/&gt;
of&lt;br/&gt;
 options&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"&gt;Exercise &lt;br/&gt;
price&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-indent: 0in"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; text-align: left"&gt;At the beginning&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-426"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-427"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-428"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-429"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-430"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-431"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in; width: 28%; text-align: left"&gt;Granted during the period&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;579,078&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1.52&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;346,555&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8.00&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;700,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4.25&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; text-align: left"&gt;Forfeited during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-432"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-433"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-434"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-435"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-436"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-437"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in; text-align: left"&gt;Exercised during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;253,252&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1.52&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;139,957&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;8.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-438"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-439"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: 0in; text-align: left"&gt;Expired during the period&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-440"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-441"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-442"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-443"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-444"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-445"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-indent: 0in"&gt;At the ending&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;325,826&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1.52&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;206,598&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;8.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;700,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;4.25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory>
    <mlec:NumberOfOptionsGrantedDuringThePeriod contextRef="c271" decimals="INF" unitRef="shares">579078</mlec:NumberOfOptionsGrantedDuringThePeriod>
    <mlec:ExercisePriceGrantedDuringThePeriod contextRef="c271" decimals="2" unitRef="usdPershares">1.52</mlec:ExercisePriceGrantedDuringThePeriod>
    <mlec:NumberOfOptionsGrantedDuringThePeriod contextRef="c272" decimals="INF" unitRef="shares">346555</mlec:NumberOfOptionsGrantedDuringThePeriod>
    <mlec:ExercisePriceGrantedDuringThePeriod contextRef="c272" decimals="2" unitRef="usdPershares">8</mlec:ExercisePriceGrantedDuringThePeriod>
    <mlec:NumberOfOptionsGrantedDuringThePeriod contextRef="c273" decimals="INF" unitRef="shares">700000</mlec:NumberOfOptionsGrantedDuringThePeriod>
    <mlec:ExercisePriceGrantedDuringThePeriod contextRef="c273" decimals="2" unitRef="usdPershares">4.25</mlec:ExercisePriceGrantedDuringThePeriod>
    <mlec:NumberOfOptionsExercisedDuringThePeriod contextRef="c271" decimals="INF" unitRef="shares">253252</mlec:NumberOfOptionsExercisedDuringThePeriod>
    <mlec:ExercisePriceExercisedDuringThePeriod contextRef="c271" decimals="2" unitRef="usdPershares">1.52</mlec:ExercisePriceExercisedDuringThePeriod>
    <mlec:NumberOfOptionsExercisedDuringThePeriod contextRef="c272" decimals="INF" unitRef="shares">139957</mlec:NumberOfOptionsExercisedDuringThePeriod>
    <mlec:ExercisePriceExercisedDuringThePeriod contextRef="c272" decimals="2" unitRef="usdPershares">8</mlec:ExercisePriceExercisedDuringThePeriod>
    <mlec:NumberOfOptionsAtTheEnding contextRef="c271" decimals="INF" unitRef="shares">325826</mlec:NumberOfOptionsAtTheEnding>
    <mlec:ExercisePriceAtTheEnding contextRef="c271" decimals="2" unitRef="usdPershares">1.52</mlec:ExercisePriceAtTheEnding>
    <mlec:NumberOfOptionsAtTheEnding contextRef="c272" decimals="INF" unitRef="shares">206598</mlec:NumberOfOptionsAtTheEnding>
    <mlec:ExercisePriceAtTheEnding contextRef="c272" decimals="2" unitRef="usdPershares">8</mlec:ExercisePriceAtTheEnding>
    <mlec:NumberOfOptionsAtTheEnding contextRef="c273" decimals="INF" unitRef="shares">700000</mlec:NumberOfOptionsAtTheEnding>
    <mlec:ExercisePriceAtTheEnding contextRef="c273" decimals="2" unitRef="usdPershares">4.25</mlec:ExercisePriceAtTheEnding>
    <mlec:OptionsRecognizedAmount contextRef="c0" decimals="0" unitRef="usd">508149</mlec:OptionsRecognizedAmount>
    <ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Note 17. Accounts Payable
and other current and non-current liabilities&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Transaction expenses payable&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,579,057&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;485,735&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;774,460&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;385,508&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;787,010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;190,843&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Trade payables&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,339,087&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;164,127&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Accounts payable&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;7,479,614&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,226,213&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left"&gt;Related parties&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;677,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-446"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Deferred payment related to Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;492,799&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-447"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Wages&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;221,141&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-448"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21,783&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-449"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Pay As You Earn (PAYE)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,551&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,171&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;271,371&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-450"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Other current liabilities&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,685,645&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,171&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The book value is reasonably
approximate to the fair value given its short-term nature.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30, &lt;br/&gt;
2022&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt"&gt;Others&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;175,312&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-451"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Other non-current liabilities&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;175,312&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-452"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory>
    <mlec:ScheduleOfAccountsPayable contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Transaction expenses payable&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,579,057&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;485,735&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;774,460&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;385,508&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;787,010&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;190,843&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Trade payables&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,339,087&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;164,127&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Accounts payable&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;7,479,614&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,226,213&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left"&gt;Related parties&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;677,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-446"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Deferred payment related to Business Combination&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;492,799&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-447"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Wages&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;221,141&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-448"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Taxes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21,783&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-449"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Pay As You Earn (PAYE)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,551&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,171&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;271,371&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-450"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Other current liabilities&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,685,645&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,171&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30, &lt;br/&gt;
2023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30, &lt;br/&gt;
2022&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt"&gt;Others&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;175,312&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-451"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Other non-current liabilities&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;175,312&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-452"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:ScheduleOfAccountsPayable>
    <ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities contextRef="c2" decimals="0" unitRef="usd">3579057</ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities>
    <ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities contextRef="c6" decimals="0" unitRef="usd">485735</ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities>
    <ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties contextRef="c2" decimals="0" unitRef="usd">774460</ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties contextRef="c6" decimals="0" unitRef="usd">385508</ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties>
    <ifrs-full:AccrualsClassifiedAsNoncurrent contextRef="c2" decimals="0" unitRef="usd">787010</ifrs-full:AccrualsClassifiedAsNoncurrent>
    <ifrs-full:AccrualsClassifiedAsNoncurrent contextRef="c6" decimals="0" unitRef="usd">190843</ifrs-full:AccrualsClassifiedAsNoncurrent>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers contextRef="c2" decimals="0" unitRef="usd">2339087</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers contextRef="c6" decimals="0" unitRef="usd">164127</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherPayables contextRef="c2" decimals="0" unitRef="usd">7479614</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables contextRef="c6" decimals="0" unitRef="usd">1226213</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:NoncurrentPayablesToRelatedParties contextRef="c2" decimals="0" unitRef="usd">677000</ifrs-full:NoncurrentPayablesToRelatedParties>
    <mlec:DeferredPaymentRelatedToBusinessCombination contextRef="c2" decimals="0" unitRef="usd">492799</mlec:DeferredPaymentRelatedToBusinessCombination>
    <mlec:Wages contextRef="c2" decimals="0" unitRef="usd">221141</mlec:Wages>
    <mlec:Taxes contextRef="c2" decimals="0" unitRef="usd">21783</mlec:Taxes>
    <mlec:PayAsYouEarnPAYE contextRef="c2" decimals="0" unitRef="usd">1551</mlec:PayAsYouEarnPAYE>
    <mlec:PayAsYouEarnPAYE contextRef="c6" decimals="0" unitRef="usd">1171</mlec:PayAsYouEarnPAYE>
    <ifrs-full:OtherCurrentNonfinancialLiabilities contextRef="c2" decimals="0" unitRef="usd">271371</ifrs-full:OtherCurrentNonfinancialLiabilities>
    <ifrs-full:OtherCurrentLiabilities contextRef="c2" decimals="0" unitRef="usd">1685645</ifrs-full:OtherCurrentLiabilities>
    <ifrs-full:OtherCurrentLiabilities contextRef="c6" decimals="0" unitRef="usd">1171</ifrs-full:OtherCurrentLiabilities>
    <ifrs-full:OtherNoncurrentNonfinancialLiabilities contextRef="c2" decimals="0" unitRef="usd">175312</ifrs-full:OtherNoncurrentNonfinancialLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities contextRef="c2" decimals="0" unitRef="usd">175312</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:DisclosureOfDebtSecuritiesExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Note 18. Financial
debt&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left"&gt;Financial Debt denominated in Argentine Pesos&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;517,743&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-453"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Financial Debt denominated in US Dollars&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,028,500&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-454"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Current Financial Debt&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;2,546,243&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-455"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The book value is reasonably
approximate to the fair value given its short-term nature.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30, &lt;br/&gt;
2022&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt"&gt;Financial Debt denominated in Argentine Pesos&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;99,046&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-456"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Non-current Financial Debt&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;99,046&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-457"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The terms and conditions
of outstanding loans are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Bank entity&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Currency of&lt;br/&gt;
 denomination&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Nominal&lt;br/&gt;
 value&lt;br/&gt;
 (equivalent&lt;br/&gt;
 in USD)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Nominal&lt;br/&gt;
 interest&lt;br/&gt;
 rate&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Date of&lt;br/&gt;
 maturity&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 28%; text-align: left; padding-bottom: 1.5pt"&gt;Banco Macro - pre-financing of exports&lt;/td&gt;&lt;td style="width: 0.5%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 8%; text-align: center; padding-bottom: 1.5pt"&gt;ARS&lt;/td&gt;&lt;td style="width: 0.5%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;147,874&lt;/td&gt;&lt;td style="width: 0.5%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 0.5%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;67% - 88 &lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 0.5%; padding-bottom: 1.5pt; text-align: left"&gt;%(*)&lt;/td&gt;
    &lt;td style="width: 0.5%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 25%; text-align: center; padding-bottom: 1.5pt"&gt;07/17/2023-12/27/2023&lt;/td&gt;&lt;td style="width: 0.5%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;173,236&lt;/td&gt;&lt;td style="width: 0.5%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 0.5%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-458"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 0.5%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Banco Naci&#xf3;n - pre-financing of exports&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;USD&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,500&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;10/6/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,635&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-459"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Banco C&#xf3;rdoba - pre-financing of exports&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;ARS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;142,567&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;55% - 88 &lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;%(*)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;01/11/2023 - 06/26/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;156,057&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-460"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Banco Galicia - bank overdrafts&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;ARS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,849&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;144&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;%(*)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,849&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-461"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;HSBC Bank - bank overdrafts&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;ARS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,625&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;108&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;%(*)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,625&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-462"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Banco Santander - bank overdrafts&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;ARS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;41,325&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;161&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;%(*)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;44,446&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-463"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Banco Galicia - loans&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;ARS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;99,643&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;35%
- 85 &lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;%(*)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;08/21/2023 - 01/25/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,728&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-464"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;HSBC Bank - loans&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;ARS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19,508&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;64&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;%(*)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;07/27/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,940&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-465"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Banco Santander - loans&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;ARS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;119,001&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50%
- 57 &lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;%(*)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;09/03/2026 - 03/04/2027&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;118,185&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-466"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Banco Macro - loans&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;ARS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,705&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;54&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;%(*)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;7/12/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,257&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-467"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Promissory notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;USD&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,000,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;05/22/2024 - 06/25/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,000,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-468"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Asociaci&#xf3;n mutual AMA &#x2013; loans&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;ARS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;42,316&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;53&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;%(*)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;07/10/2023 - 04/10/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51,331&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-469"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Interest rates of our outstanding loans in ARS, correspond
to market rates in the country of incorporation of our newly acquired subsidiary, which deems to be a hyperinflationary economy.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfDebtSecuritiesExplanatory>
    <ifrs-full:DisclosureOfFinancialAssetsExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left"&gt;Financial Debt denominated in Argentine Pesos&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;517,743&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-453"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Financial Debt denominated in US Dollars&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,028,500&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-454"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Current Financial Debt&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;2,546,243&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-455"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfFinancialAssetsExplanatory>
    <ifrs-full:CurrentFinancialAssetsAtAmortisedCost contextRef="c274" decimals="0" unitRef="usd">517743</ifrs-full:CurrentFinancialAssetsAtAmortisedCost>
    <ifrs-full:CurrentFinancialAssetsAtAmortisedCost contextRef="c276" decimals="0" unitRef="usd">2028500</ifrs-full:CurrentFinancialAssetsAtAmortisedCost>
    <ifrs-full:CurrentFinancialAssetsAtAmortisedCost contextRef="c2" decimals="0" unitRef="usd">2546243</ifrs-full:CurrentFinancialAssetsAtAmortisedCost>
    <ifrs-full:AnalysisOfAgeOfFinancialAssetsThatArePastDueButNotImpaired contextRef="c0">The book value is reasonably
approximate to the fair value given its short-term nature.&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30, &lt;br/&gt;
2022&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt"&gt;Financial Debt denominated in Argentine Pesos&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;99,046&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-456"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Non-current Financial Debt&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;99,046&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-457"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:AnalysisOfAgeOfFinancialAssetsThatArePastDueButNotImpaired>
    <ifrs-full:NoncurrentFinancialAssets contextRef="c274" decimals="0" unitRef="usd">99046</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets contextRef="c2" decimals="0" unitRef="usd">99046</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory contextRef="c0">The terms and conditions
of outstanding loans are as follows:&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Bank entity&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Currency of&lt;br/&gt;
 denomination&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Nominal&lt;br/&gt;
 value&lt;br/&gt;
 (equivalent&lt;br/&gt;
 in USD)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Nominal&lt;br/&gt;
 interest&lt;br/&gt;
 rate&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Date of&lt;br/&gt;
 maturity&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 28%; text-align: left; padding-bottom: 1.5pt"&gt;Banco Macro - pre-financing of exports&lt;/td&gt;&lt;td style="width: 0.5%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 8%; text-align: center; padding-bottom: 1.5pt"&gt;ARS&lt;/td&gt;&lt;td style="width: 0.5%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;147,874&lt;/td&gt;&lt;td style="width: 0.5%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 0.5%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;67% - 88 &lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 0.5%; padding-bottom: 1.5pt; text-align: left"&gt;%(*)&lt;/td&gt;
    &lt;td style="width: 0.5%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 25%; text-align: center; padding-bottom: 1.5pt"&gt;07/17/2023-12/27/2023&lt;/td&gt;&lt;td style="width: 0.5%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;173,236&lt;/td&gt;&lt;td style="width: 0.5%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 0.5%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 0.5%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-458"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 0.5%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Banco Naci&#xf3;n - pre-financing of exports&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;USD&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,500&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;10/6/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,635&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-459"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Banco C&#xf3;rdoba - pre-financing of exports&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;ARS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;142,567&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;55% - 88 &lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;%(*)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;01/11/2023 - 06/26/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;156,057&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-460"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Banco Galicia - bank overdrafts&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;ARS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,849&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;144&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;%(*)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;18,849&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-461"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;HSBC Bank - bank overdrafts&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;ARS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,625&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;108&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;%(*)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,625&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-462"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Banco Santander - bank overdrafts&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;ARS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;41,325&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;161&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;%(*)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;06/30/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;44,446&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-463"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Banco Galicia - loans&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;ARS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;99,643&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;35%
- 85 &lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;%(*)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;08/21/2023 - 01/25/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,728&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-464"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;HSBC Bank - loans&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;ARS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19,508&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;64&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;%(*)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;07/27/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;14,940&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-465"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Banco Santander - loans&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;ARS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;119,001&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;50%
- 57 &lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;%(*)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;09/03/2026 - 03/04/2027&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;118,185&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-466"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Banco Macro - loans&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;ARS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;11,705&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;54&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;%(*)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;7/12/2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,257&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-467"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Promissory notes&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;USD&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,000,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;05/22/2024 - 06/25/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,000,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-468"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Asociaci&#xf3;n mutual AMA &#x2013; loans&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;ARS&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;42,316&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;53&lt;/td&gt;&lt;td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"&gt;%(*)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;07/10/2023 - 04/10/2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;51,331&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-469"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Interest rates of our outstanding loans in ARS, correspond
to market rates in the country of incorporation of our newly acquired subsidiary, which deems to be a hyperinflationary economy.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory>
    <mlec:BorrowingOriginalCurrency contextRef="c278">ARS</mlec:BorrowingOriginalCurrency>
    <ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk contextRef="c278" decimals="0" unitRef="usd">147874</ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk>
    <mlec:NominalInterestRate
      contextRef="c279"
      decimals="2"
      id="ix_23_fact"
      unitRef="pure">0.67</mlec:NominalInterestRate>
    <mlec:NominalInterestRate
      contextRef="c280"
      decimals="2"
      id="ix_24_fact"
      unitRef="pure">0.88</mlec:NominalInterestRate>
    <mlec:BorrowingMaturity contextRef="c279">07/17/2023</mlec:BorrowingMaturity>
    <mlec:BorrowingMaturity contextRef="c280">12/27/2023</mlec:BorrowingMaturity>
    <ifrs-full:Borrowings contextRef="c278" decimals="0" unitRef="usd">173236</ifrs-full:Borrowings>
    <mlec:BorrowingOriginalCurrency contextRef="c282">USD</mlec:BorrowingOriginalCurrency>
    <ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk contextRef="c282" decimals="0" unitRef="usd">28500</ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk>
    <mlec:NominalInterestRate contextRef="c283" decimals="2" unitRef="pure">0.02</mlec:NominalInterestRate>
    <mlec:NominalInterestRate contextRef="c284" decimals="2" unitRef="pure">0.02</mlec:NominalInterestRate>
    <mlec:BorrowingMaturity contextRef="c282">10/6/2023</mlec:BorrowingMaturity>
    <ifrs-full:Borrowings contextRef="c282" decimals="0" unitRef="usd">28635</ifrs-full:Borrowings>
    <mlec:BorrowingOriginalCurrency contextRef="c286">ARS</mlec:BorrowingOriginalCurrency>
    <ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk contextRef="c286" decimals="0" unitRef="usd">142567</ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk>
    <mlec:NominalInterestRate
      contextRef="c287"
      decimals="2"
      id="ix_25_fact"
      unitRef="pure">0.55</mlec:NominalInterestRate>
    <mlec:NominalInterestRate
      contextRef="c288"
      decimals="2"
      id="ix_26_fact"
      unitRef="pure">0.88</mlec:NominalInterestRate>
    <mlec:BorrowingMaturity contextRef="c287">01/11/2023 </mlec:BorrowingMaturity>
    <mlec:BorrowingMaturity contextRef="c288"> 06/26/2023</mlec:BorrowingMaturity>
    <ifrs-full:Borrowings contextRef="c286" decimals="0" unitRef="usd">156057</ifrs-full:Borrowings>
    <mlec:BorrowingOriginalCurrency contextRef="c290">ARS</mlec:BorrowingOriginalCurrency>
    <ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk contextRef="c290" decimals="0" unitRef="usd">18849</ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk>
    <mlec:NominalInterestRate
      contextRef="c291"
      decimals="2"
      id="ix_27_fact"
      unitRef="pure">1.44</mlec:NominalInterestRate>
    <mlec:NominalInterestRate
      contextRef="c292"
      decimals="2"
      id="ix_28_fact"
      unitRef="pure">1.44</mlec:NominalInterestRate>
    <mlec:BorrowingMaturity contextRef="c290">06/30/2023</mlec:BorrowingMaturity>
    <ifrs-full:Borrowings contextRef="c290" decimals="0" unitRef="usd">18849</ifrs-full:Borrowings>
    <mlec:BorrowingOriginalCurrency contextRef="c294">ARS</mlec:BorrowingOriginalCurrency>
    <ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk contextRef="c294" decimals="0" unitRef="usd">4625</ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk>
    <mlec:NominalInterestRate
      contextRef="c295"
      decimals="2"
      id="ix_29_fact"
      unitRef="pure">1.08</mlec:NominalInterestRate>
    <mlec:NominalInterestRate
      contextRef="c296"
      decimals="2"
      id="ix_30_fact"
      unitRef="pure">1.08</mlec:NominalInterestRate>
    <mlec:BorrowingMaturity contextRef="c294">06/30/2023</mlec:BorrowingMaturity>
    <ifrs-full:Borrowings contextRef="c294" decimals="0" unitRef="usd">4625</ifrs-full:Borrowings>
    <mlec:BorrowingOriginalCurrency contextRef="c298">ARS</mlec:BorrowingOriginalCurrency>
    <ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk contextRef="c298" decimals="0" unitRef="usd">41325</ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk>
    <mlec:NominalInterestRate
      contextRef="c299"
      decimals="2"
      id="ix_31_fact"
      unitRef="pure">1.61</mlec:NominalInterestRate>
    <mlec:NominalInterestRate
      contextRef="c300"
      decimals="2"
      id="ix_32_fact"
      unitRef="pure">1.61</mlec:NominalInterestRate>
    <mlec:BorrowingMaturity contextRef="c298">06/30/2023</mlec:BorrowingMaturity>
    <ifrs-full:Borrowings contextRef="c298" decimals="0" unitRef="usd">44446</ifrs-full:Borrowings>
    <mlec:BorrowingOriginalCurrency contextRef="c302">ARS</mlec:BorrowingOriginalCurrency>
    <ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk contextRef="c302" decimals="0" unitRef="usd">99643</ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk>
    <mlec:NominalInterestRate
      contextRef="c303"
      decimals="2"
      id="ix_33_fact"
      unitRef="pure">0.35</mlec:NominalInterestRate>
    <mlec:NominalInterestRate
      contextRef="c304"
      decimals="2"
      id="ix_34_fact"
      unitRef="pure">0.85</mlec:NominalInterestRate>
    <mlec:BorrowingMaturity contextRef="c303">08/21/2023 </mlec:BorrowingMaturity>
    <mlec:BorrowingMaturity contextRef="c304"> 01/25/2024</mlec:BorrowingMaturity>
    <ifrs-full:Borrowings contextRef="c302" decimals="0" unitRef="usd">33728</ifrs-full:Borrowings>
    <mlec:BorrowingOriginalCurrency contextRef="c306">ARS</mlec:BorrowingOriginalCurrency>
    <ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk contextRef="c306" decimals="0" unitRef="usd">19508</ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk>
    <mlec:NominalInterestRate
      contextRef="c307"
      decimals="2"
      id="ix_35_fact"
      unitRef="pure">0.64</mlec:NominalInterestRate>
    <mlec:NominalInterestRate
      contextRef="c308"
      decimals="2"
      id="ix_36_fact"
      unitRef="pure">0.64</mlec:NominalInterestRate>
    <mlec:BorrowingMaturity contextRef="c306">07/27/2023</mlec:BorrowingMaturity>
    <ifrs-full:Borrowings contextRef="c306" decimals="0" unitRef="usd">14940</ifrs-full:Borrowings>
    <mlec:BorrowingOriginalCurrency contextRef="c310">ARS</mlec:BorrowingOriginalCurrency>
    <ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk contextRef="c310" decimals="0" unitRef="usd">119001</ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk>
    <mlec:NominalInterestRate
      contextRef="c311"
      decimals="2"
      id="ix_37_fact"
      unitRef="pure">0.50</mlec:NominalInterestRate>
    <mlec:NominalInterestRate
      contextRef="c312"
      decimals="2"
      id="ix_38_fact"
      unitRef="pure">0.57</mlec:NominalInterestRate>
    <mlec:BorrowingMaturity contextRef="c311">09/03/2026 </mlec:BorrowingMaturity>
    <mlec:BorrowingMaturity contextRef="c312"> 03/04/2027</mlec:BorrowingMaturity>
    <ifrs-full:Borrowings contextRef="c310" decimals="0" unitRef="usd">118185</ifrs-full:Borrowings>
    <mlec:BorrowingOriginalCurrency contextRef="c314">ARS</mlec:BorrowingOriginalCurrency>
    <ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk contextRef="c314" decimals="0" unitRef="usd">11705</ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk>
    <mlec:NominalInterestRate
      contextRef="c315"
      decimals="2"
      id="ix_39_fact"
      unitRef="pure">0.54</mlec:NominalInterestRate>
    <mlec:NominalInterestRate
      contextRef="c316"
      decimals="2"
      id="ix_40_fact"
      unitRef="pure">0.54</mlec:NominalInterestRate>
    <mlec:BorrowingMaturity contextRef="c314">7/12/2023</mlec:BorrowingMaturity>
    <ifrs-full:Borrowings contextRef="c314" decimals="0" unitRef="usd">1257</ifrs-full:Borrowings>
    <mlec:BorrowingOriginalCurrency contextRef="c318">USD</mlec:BorrowingOriginalCurrency>
    <ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk contextRef="c318" decimals="0" unitRef="usd">2000000</ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk>
    <mlec:NominalInterestRate contextRef="c319" decimals="2" unitRef="pure">0</mlec:NominalInterestRate>
    <mlec:NominalInterestRate contextRef="c320" decimals="2" unitRef="pure">0</mlec:NominalInterestRate>
    <mlec:BorrowingMaturity contextRef="c319">05/22/2024 </mlec:BorrowingMaturity>
    <mlec:BorrowingMaturity contextRef="c320"> 06/25/2024</mlec:BorrowingMaturity>
    <ifrs-full:Borrowings contextRef="c318" decimals="0" unitRef="usd">2000000</ifrs-full:Borrowings>
    <mlec:BorrowingOriginalCurrency contextRef="c322">ARS</mlec:BorrowingOriginalCurrency>
    <ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk contextRef="c322" decimals="0" unitRef="usd">42316</ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk>
    <mlec:NominalInterestRate
      contextRef="c323"
      decimals="2"
      id="ix_41_fact"
      unitRef="pure">0.53</mlec:NominalInterestRate>
    <mlec:NominalInterestRate
      contextRef="c324"
      decimals="2"
      id="ix_42_fact"
      unitRef="pure">0.53</mlec:NominalInterestRate>
    <mlec:BorrowingMaturity contextRef="c323">07/10/2023 </mlec:BorrowingMaturity>
    <mlec:BorrowingMaturity contextRef="c324"> 04/10/2024</mlec:BorrowingMaturity>
    <ifrs-full:Borrowings contextRef="c322" decimals="0" unitRef="usd">51331</ifrs-full:Borrowings>
    <ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Note 19. Warrants liabilities&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Each of the Warrants
to purchase an aggregate of 11,110,000 Ordinary Shares are exercisable to purchase one Ordinary Share and only whole warrants are exercisable.
The exercise price of the Warrants is $11.50 per share. A Warrant may be exercised only during the period commencing on the date of the
consummation of the transactions contemplated by the Business Combination Agreement and terminating on the earlier to occur of: the date
that is five (5) years after the date on which the Business Combination is completed or the liquidation of the Company. Redemptions of
warrants for cash once the public warrants become exercisable, may be redeemed (i) in whole and not in part, (ii) at a price of $0.01
per warrant, (iii) upon not less than 30 days&#x2019; prior written notice of redemption to each warrant holder, and (iv) if, and only
if, the reported last sale price of the Ordinary Shares equals or exceeds $18.00 per share for any 20 trading days within a 30-trading
day period ending three business days before sending the notice of redemption to each warrant holder. If the public warrants are called
for redemption for cash, management will have the option to require all holders that wish to exercise the public warrants to do so on
a &#x201c;cashless basis&#x201d;. The private warrants will be treated identical to the public warrants.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Considering that the
fair value as of June 2023 is $0.0799 per Ordinary Share, the valuation of warrants is the following:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;As of June 30, 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-470"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Issued by the SPAC&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,666,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Fair value remeasurement (Gain)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(778,811&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;As of June 30, 2023&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;887,689&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;There were no other warrants
outstanding prior to the ones issued by the SPAC.&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory>
    <mlec:AggregateShares contextRef="c0" decimals="0" unitRef="shares">11110000</mlec:AggregateShares>
    <ifrs-full:ExercisePriceShareOptionsGranted2019 contextRef="c0" decimals="2" unitRef="usdPershares">11.5</ifrs-full:ExercisePriceShareOptionsGranted2019>
    <mlec:PricePerWarrant contextRef="c0" decimals="2" unitRef="usdPershares">0.01</mlec:PricePerWarrant>
    <mlec:ExercisePricePerShare contextRef="c0" decimals="2" unitRef="usdPershares">18</mlec:ExercisePricePerShare>
    <ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory contextRef="c0">Considering that the
fair value as of June 2023 is $0.0799 per Ordinary Share, the valuation of warrants is the following:&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;As of June 30, 2022&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-470"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;Issued by the SPAC&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,666,500&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Fair value remeasurement (Gain)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(778,811&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;As of June 30, 2023&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;887,689&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory>
    <ifrs-full:DividendsPaidOrdinarySharesPerShare contextRef="c0" decimals="4" unitRef="usdPershares">0.0799</ifrs-full:DividendsPaidOrdinarySharesPerShare>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementEntitysOwnEquityInstruments contextRef="c327" decimals="0" unitRef="usd">1666500</ifrs-full:GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementEntitysOwnEquityInstruments>
    <mlec:FairValueAdjustmentOfWarrant contextRef="c327" decimals="0" unitRef="usd">-778811</mlec:FairValueAdjustmentOfWarrant>
    <mlec:WarrantAndRightsOutstanding contextRef="c328" decimals="0" unitRef="usd">887689</mlec:WarrantAndRightsOutstanding>
    <mlec:SimpleAgreementForFutureEquitySAFETextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Note 20. Simple Agreement
for Future Equity (&#x201c;SAFE&#x201d;)&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Company signed two
simple agreements for future equity (referred to as &#x201c;SAFE&#x201d; or &#x201c;SAFEs&#x201d; in plural), in exchange for the payment
by certain investors of the amounts detailed below on or about December 28, 2021. Both SAFEs were signed with two different investors
and for the following amounts:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;One SAFE was signed with
THEO 1 SCSp for the amount of $1,500,000, from which $1,000,000 was received on January 5, 2022 and $500,000 were received on June 30,
2022.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The other SAFE was signed
with SERENITY TRADERS LDT, for the amount of $500,000, fully received on January 6, 2022.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Both SAFEs give the investors,
in exchange for the payment of the mentioned amounts, the right to a variable number of shares on the Company&#x2019;s Share Capital&#160;subject
to the occurrence of a qualified event or a twelve months maturity, whatever happens before, and in the case of a qualified event, specifically
the shares of the series of equity securities issued to the investors investing new money in the Company in connection with the closing.&#160;These
qualified events are defined as Equity Financing of not less than $20,000,000, Change&#160;of Control, a Direct Listing, an Initial Public
Offering or a De-SPAC Transaction.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The De-SPAC transaction
occurred on December 30, 2022 and defined as a qualified event pursuant the agreement, converted the SAFE in 262,260 shares of the Company
at a purchase price on $ 12.10 for a total of $3,173,346.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The following table presents
the changes in Level 3 financial instruments as of June 30 of each year:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;At the beginning&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"&gt;2,860,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-471"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-472"&gt;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-473"&gt;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Additions&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-474"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-475"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-476"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Results on the change of Fair Value of the SAFE (i)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;313,346&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;860,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-477"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-478"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;SAFE Capitalization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,173,346&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-479"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-480"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-481"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;At the end&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-482"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;2,860,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-483"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-484"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(i)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The result due to the change in the fair value of the SAFE
was included in &#x201c;Other financial Results&#x201d;.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</mlec:SimpleAgreementForFutureEquitySAFETextBlock>
    <ifrs-full:NotionalAmount contextRef="c2" decimals="0" unitRef="usd">1500000</ifrs-full:NotionalAmount>
    <ifrs-full:CurrentReceivablesFromSaleOfProperties contextRef="c329" decimals="0" unitRef="usd">1000000</ifrs-full:CurrentReceivablesFromSaleOfProperties>
    <ifrs-full:CurrentReceivablesFromSaleOfProperties contextRef="c6" decimals="0" unitRef="usd">500000</ifrs-full:CurrentReceivablesFromSaleOfProperties>
    <ifrs-full:CurrentReceivablesFromSaleOfProperties contextRef="c330" decimals="0" unitRef="usd">500000</ifrs-full:CurrentReceivablesFromSaleOfProperties>
    <ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities contextRef="c0" decimals="0" unitRef="usd">20000000</ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities>
    <mlec:ConvertedShares contextRef="c331" decimals="0" unitRef="shares">262260</mlec:ConvertedShares>
    <mlec:PurchasePricePerShare contextRef="c331" decimals="2" unitRef="usdPershares">12.1</mlec:PurchasePricePerShare>
    <mlec:PurchasePrice contextRef="c331" decimals="0" unitRef="usd">3173346</mlec:PurchasePrice>
    <ifrs-full:DisclosureOfFinancialInstrumentsExplanatory contextRef="c0">The following table presents
the changes in Level 3 financial instruments as of June 30 of each year:&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;At the beginning&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"&gt;2,860,000&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-471"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-472"&gt;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-473"&gt;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Additions&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-474"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,000,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-475"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-476"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Results on the change of Fair Value of the SAFE (i)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;313,346&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;860,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-477"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-478"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;SAFE Capitalization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,173,346&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-479"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-480"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-481"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;At the end&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-482"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;2,860,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-483"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-484"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;(i)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The result due to the change in the fair value of the SAFE
was included in &#x201c;Other financial Results&#x201d;.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfFinancialInstrumentsExplanatory>
    <mlec:FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue contextRef="c2" decimals="0" unitRef="usd">2860000</mlec:FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue>
    <mlec:Additions contextRef="c6" decimals="0" unitRef="usd">2000000</mlec:Additions>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c2" decimals="0" id="ix_43_fact" unitRef="usd">313346</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c6" decimals="0" id="ix_44_fact" unitRef="usd">860000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <mlec:SAFECapitalization contextRef="c2" decimals="0" unitRef="usd">-3173346</mlec:SAFECapitalization>
    <mlec:ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue contextRef="c6" decimals="0" unitRef="usd">2860000</mlec:ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue>
    <ifrs-full:DisclosureOfIncomeTaxExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Note 21. Deferred tax
and income tax&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The roll forward of net
deferred tax as of June 30, 2023, 2022, 2021 and 2020 is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;Balance at beginning of year&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-485"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-486"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-487"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-488"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%; text-align: justify"&gt;Incorporated through the business combination&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,297,436&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-489"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-490"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-491"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Credited to profit &amp;amp; loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(234,542&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-492"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-493"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-494"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Charged to Other Comprehensive Income&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,913&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-495"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-496"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-497"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;Balance at year end&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,071,807&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-498"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-499"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-500"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Principal statutory taxes
rates in the countries where the Group operates for all the years presented are:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Income tax rate&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;Tax Jurisdiction&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Argentina&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25%-35&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-501"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-502"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-503"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%"&gt;Luxembourg&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;15&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-504"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-505"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-506"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;United Kingdom&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;United States of America&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Reconciliation
of effective tax rate&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group&#x2019;s reconciliation
of the effective tax rate is based on its domestic tax rate, with a reconciling item in respect of tax rates applied by Group companies
in other jurisdictions.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The tax rate used for
2023 represents the corporate tax rate of 15% from Luxembourg on the taxable income payable by the Group, in accordance with the tax laws
of said jurisdiction. Income tax for other jurisdictions is calculated based on the substantially enacted nominal tax rates prevailing
in the respective jurisdictions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December&#160;30, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left; padding-bottom: 1.5pt"&gt;Loss before tax&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&lt;span style="font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"&gt;&lt;span style="font-style: normal; font-weight: normal"&gt;(52,023,422&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-style: normal; font-weight: normal"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(4,526,905&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(1,986,814&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(320,524&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;Corporate tax rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Income tax (benefit)/expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,803,513&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;860,112&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;377,495&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;60,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Effect of difference tax rates subsidiaries operating in other jurisdictions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;428,506&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-507"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-508"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-509"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Tax losses (i)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,631,947&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(860,112&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(377,495&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(60,900&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Non-deductible expenses - listing cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6,405,759&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-510"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-511"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-512"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Net gain on inflation effect on monetary items&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;52,914&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-513"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-514"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-515"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Income tax inflation adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(35,826&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-516"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-517"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-518"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;23,141&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-519"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-520"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-521"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Tax benefit for the year&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;234,542&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-522"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-523"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-524"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;(i)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Deferred tax assets have not been recognized, because it is not probable that future taxable profit will
be available against which the Group can use the benefits therefrom.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;i&gt;&lt;span style="text-decoration:underline"&gt;Deferred tax&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Deferred tax assets and
liabilities are recognized when the carrying amount of an asset or liability in the Consolidated statement of financial position differs
from its tax base, except for differences arising on the initial recognition of goodwill.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Net deferred tax liabilities
are comprised of the following amounts:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;Deferred tax asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: justify; padding-bottom: 1.5pt"&gt;Tax loss carry-forward&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;292,267&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-525"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt"&gt;Total other receivables&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;292,267&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-526"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;Deferred tax liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Customer relationship&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,346,374&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-527"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Other tax liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,700&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt"&gt;Total deferred tax liability&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,364,074&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-528"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt"&gt;&#160;Net deferred tax liability&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,071,807&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-529"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The following table shows
the expiration date of the recognized accumulated tax loss carryforwards pursuant to statutes of limitations:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Fiscal year&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tax-loss&lt;br/&gt;
 carry&lt;br/&gt; forward&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Deferred &lt;br/&gt; tax asset&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Expiration&lt;br/&gt; date&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tax&lt;br/&gt; jurisdiction&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10,980&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,843&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: center"&gt;2027&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: center; padding-left: 5.4pt"&gt;Argentina&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;824,069&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;288,424&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;2028&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt"&gt;Argentina&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;835,049&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;292,267&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&lt;i&gt;Unrecognized deferred
tax assets &lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
of June 30, 2023 and 2022 deferred tax assets relating to the operating company in the UK, Luxembourg, Argentina (Moolec Science S.E.)
and United States of America aren&#x2019;t recognized because it is not probable that future taxable amounts will be available to utilize those
temporary differences and losses. Therefore, in the present Consolidated Financial Statements, the Company decided not to recognize deferred
income tax assets generated by the tax loss carry forward for the periods ended on June 30, 2023 and 2022 for the amounts of &lt;/span&gt;$&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,631,947
and $ 860,112 respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Deferred tax assets have
not been recognized in respect of the following items, because it is not probable that future taxable profit will be available against
which the Group can use the benefits therefrom:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Tax losses per country&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Gross amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tax effect&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Gross amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tax effect&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Gross amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tax effect&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Gross amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tax effect&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 20%; text-align: justify; padding-bottom: 1.5pt"&gt;United Kingdom&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;3,641,516&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;691,888&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;4,526,905&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;860,112&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;1,986,814&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;377,495&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;320,524&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;60,900&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Luxembourg&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,267,560&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;620,837&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Argentina&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,484,790&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;282,110&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;United States of America&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;195,328&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;37,112&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 4pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;8,589,194&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;1,631,947&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;4,526,905&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;860,112&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;1,986,814&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;377,495&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;320,524&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;60,900&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfIncomeTaxExplanatory>
    <ifrs-full:DisclosureOfDeferredTaxesExplanatory contextRef="c0">The roll forward of net
deferred tax as of June 30, 2023, 2022, 2021 and 2020 is as follows:&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;Balance at beginning of year&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-485"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-486"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-487"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-488"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%; text-align: justify"&gt;Incorporated through the business combination&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,297,436&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-489"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-490"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-491"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Credited to profit &amp;amp; loss&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(234,542&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-492"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-493"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-494"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Charged to Other Comprehensive Income&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8,913&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-495"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-496"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-497"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;Balance at year end&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,071,807&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-498"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-499"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-500"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfDeferredTaxesExplanatory>
    <mlec:IncorporatedThroughTheBusinessCombination contextRef="c0" decimals="0" unitRef="usd">1297436</mlec:IncorporatedThroughTheBusinessCombination>
    <mlec:DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss contextRef="c0" decimals="0" unitRef="usd">234542</mlec:DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss>
    <mlec:ChargedToOtherComprehensiveIncome contextRef="c0" decimals="0" unitRef="usd">8913</mlec:ChargedToOtherComprehensiveIncome>
    <ifrs-full:DeferredTaxLiabilities contextRef="c2" decimals="0" unitRef="usd">1071807</ifrs-full:DeferredTaxLiabilities>
    <mlec:DisclosureOfStatutoryTaxesInCountriesTableTextBlock contextRef="c0">Principal statutory taxes
rates in the countries where the Group operates for all the years presented are:&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Income tax rate&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;b&gt;Tax Jurisdiction&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Argentina&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25%-35&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-501"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-502"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-503"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%"&gt;Luxembourg&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;15&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-504"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-505"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-506"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;United Kingdom&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;United States of America&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;21&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;</mlec:DisclosureOfStatutoryTaxesInCountriesTableTextBlock>
    <mlec:TaxJurisdiction contextRef="c337" decimals="2" unitRef="pure">0.25</mlec:TaxJurisdiction>
    <mlec:TaxJurisdiction contextRef="c338" decimals="2" unitRef="pure">0.35</mlec:TaxJurisdiction>
    <mlec:TaxJurisdiction contextRef="c332" decimals="2" unitRef="pure">0.15</mlec:TaxJurisdiction>
    <mlec:TaxJurisdiction contextRef="c345" decimals="2" unitRef="pure">0.19</mlec:TaxJurisdiction>
    <mlec:TaxJurisdiction contextRef="c346" decimals="2" unitRef="pure">0.19</mlec:TaxJurisdiction>
    <mlec:TaxJurisdiction contextRef="c347" decimals="2" unitRef="pure">0.19</mlec:TaxJurisdiction>
    <mlec:TaxJurisdiction contextRef="c348" decimals="2" unitRef="pure">0.19</mlec:TaxJurisdiction>
    <mlec:TaxJurisdiction contextRef="c349" decimals="2" unitRef="pure">0.21</mlec:TaxJurisdiction>
    <mlec:TaxJurisdiction contextRef="c350" decimals="2" unitRef="pure">0.21</mlec:TaxJurisdiction>
    <mlec:TaxJurisdiction contextRef="c351" decimals="2" unitRef="pure">0.21</mlec:TaxJurisdiction>
    <mlec:TaxJurisdiction contextRef="c352" decimals="2" unitRef="pure">0.21</mlec:TaxJurisdiction>
    <mlec:IncomeTaxRate contextRef="c332" decimals="2" unitRef="pure">0.15</mlec:IncomeTaxRate>
    <mlec:ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock contextRef="c0">Income tax for other jurisdictions is calculated based on the substantially enacted nominal tax rates prevailing
in the respective jurisdictions.&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of December&#160;30, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left; padding-bottom: 1.5pt"&gt;Loss before tax&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&lt;span style="font-style: normal; font-weight: normal"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right"&gt;&lt;span style="font-style: normal; font-weight: normal"&gt;(52,023,422&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;span style="font-style: normal; font-weight: normal"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(4,526,905&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(1,986,814&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(320,524&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;Corporate tax rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;15&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;19&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Income tax (benefit)/expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,803,513&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;860,112&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;377,495&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;60,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Effect of difference tax rates subsidiaries operating in other jurisdictions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;428,506&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-507"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-508"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-509"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Tax losses (i)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,631,947&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(860,112&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(377,495&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(60,900&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Non-deductible expenses - listing cost&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6,405,759&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-510"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-511"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-512"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Net gain on inflation effect on monetary items&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;52,914&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-513"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-514"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-515"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Income tax inflation adjustment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(35,826&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-516"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-517"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-518"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"&gt;Others&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;23,141&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-519"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-520"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-521"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Tax benefit for the year&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;234,542&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-522"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-523"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-524"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 17.85pt"&gt;(i)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Deferred tax assets have not been recognized, because it is not probable that future taxable profit will
be available against which the Group can use the benefits therefrom.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</mlec:ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock>
    <mlec:LossBeforeTax contextRef="c2" decimals="0" unitRef="usd">52023422</mlec:LossBeforeTax>
    <mlec:LossBeforeTax contextRef="c6" decimals="0" unitRef="usd">4526905</mlec:LossBeforeTax>
    <mlec:LossBeforeTax contextRef="c39" decimals="0" unitRef="usd">1986814</mlec:LossBeforeTax>
    <mlec:LossBeforeTax contextRef="c353" decimals="0" unitRef="usd">320524</mlec:LossBeforeTax>
    <mlec:CorporateTaxRate contextRef="c2" decimals="2" unitRef="pure">0.15</mlec:CorporateTaxRate>
    <mlec:CorporateTaxRate contextRef="c6" decimals="2" unitRef="pure">0.19</mlec:CorporateTaxRate>
    <mlec:CorporateTaxRate contextRef="c39" decimals="2" unitRef="pure">0.19</mlec:CorporateTaxRate>
    <mlec:CorporateTaxRate contextRef="c353" decimals="2" unitRef="pure">0.19</mlec:CorporateTaxRate>
    <ifrs-full:AccruedIncomeOtherThanContractAssets contextRef="c2" decimals="0" unitRef="usd">7803513</ifrs-full:AccruedIncomeOtherThanContractAssets>
    <ifrs-full:AccruedIncomeOtherThanContractAssets contextRef="c6" decimals="0" unitRef="usd">860112</ifrs-full:AccruedIncomeOtherThanContractAssets>
    <ifrs-full:AccruedIncomeOtherThanContractAssets contextRef="c39" decimals="0" unitRef="usd">377495</ifrs-full:AccruedIncomeOtherThanContractAssets>
    <ifrs-full:AccruedIncomeOtherThanContractAssets contextRef="c353" decimals="0" unitRef="usd">60900</ifrs-full:AccruedIncomeOtherThanContractAssets>
    <mlec:EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions contextRef="c2" decimals="0" unitRef="usd">428506</mlec:EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions>
    <mlec:TaxLosses contextRef="c2" decimals="0" id="ix_45_fact" unitRef="usd">1631947</mlec:TaxLosses>
    <mlec:TaxLosses contextRef="c6" decimals="0" id="ix_46_fact" unitRef="usd">860112</mlec:TaxLosses>
    <mlec:TaxLosses contextRef="c39" decimals="0" id="ix_47_fact" unitRef="usd">377495</mlec:TaxLosses>
    <mlec:TaxLosses
      contextRef="c353"
      decimals="0"
      id="ix_48_fact"
      unitRef="usd">60900</mlec:TaxLosses>
    <mlec:NondeductibleExpensesListingCost contextRef="c2" decimals="0" unitRef="usd">6405759</mlec:NondeductibleExpensesListingCost>
    <mlec:NetGainOnInflationEffectOnMonetaryItems contextRef="c2" decimals="0" unitRef="usd">52914</mlec:NetGainOnInflationEffectOnMonetaryItems>
    <mlec:IncomeTaxInflationAdjustment contextRef="c2" decimals="0" unitRef="usd">35826</mlec:IncomeTaxInflationAdjustment>
    <mlec:Others contextRef="c74" decimals="0" unitRef="usd">23141</mlec:Others>
    <mlec:TaxBenefitForTheYear contextRef="c2" decimals="0" unitRef="usd">-234542</mlec:TaxBenefitForTheYear>
    <mlec:ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock contextRef="c0">Net deferred tax liabilities
are comprised of the following amounts:&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;Deferred tax asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: justify; padding-bottom: 1.5pt"&gt;Tax loss carry-forward&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;292,267&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-525"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt"&gt;Total other receivables&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;292,267&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-526"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;Deferred tax liability&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Customer relationship&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,346,374&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-527"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Other tax liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;17,700&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt"&gt;Total deferred tax liability&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,364,074&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-528"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt"&gt;&#160;Net deferred tax liability&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,071,807&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-529"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised contextRef="c357" decimals="0" unitRef="usd">292267</ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised>
    <ifrs-full:TradeAndOtherCurrentReceivables contextRef="c357" decimals="0" unitRef="usd">292267</ifrs-full:TradeAndOtherCurrentReceivables>
    <mlec:CustomerRelationship contextRef="c357" decimals="0" unitRef="usd">1346374</mlec:CustomerRelationship>
    <ifrs-full:OtherLiabilities contextRef="c357" decimals="0" unitRef="usd">17700</ifrs-full:OtherLiabilities>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c357" decimals="0" unitRef="usd">1364074</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:NetDeferredTaxLiabilities contextRef="c357" decimals="0" unitRef="usd">1071807</ifrs-full:NetDeferredTaxLiabilities>
    <mlec:ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock contextRef="c0">The following table shows
the expiration date of the recognized accumulated tax loss carryforwards pursuant to statutes of limitations:&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Fiscal year&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tax-loss&lt;br/&gt;
 carry&lt;br/&gt; forward&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Deferred &lt;br/&gt; tax asset&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Expiration&lt;br/&gt; date&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tax&lt;br/&gt; jurisdiction&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;2022&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;10,980&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;3,843&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: center"&gt;2027&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: center; padding-left: 5.4pt"&gt;Argentina&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;824,069&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;288,424&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;2028&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt; padding-left: 5.4pt"&gt;Argentina&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;835,049&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;292,267&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right; padding-bottom: 4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;</mlec:ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock>
    <mlec:TaxlossCarryForward contextRef="c359" decimals="0" unitRef="usd">10980</mlec:TaxlossCarryForward>
    <ifrs-full:DeferredTaxAssets contextRef="c359" decimals="0" unitRef="usd">3843</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits contextRef="c360">2027</ifrs-full:DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits>
    <ifrs-full:DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory contextRef="c360">Argentina</ifrs-full:DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory>
    <mlec:TaxlossCarryForward contextRef="c361" decimals="0" unitRef="usd">824069</mlec:TaxlossCarryForward>
    <ifrs-full:DeferredTaxAssets contextRef="c361" decimals="0" unitRef="usd">288424</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits contextRef="c362">2028</ifrs-full:DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits>
    <ifrs-full:DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory contextRef="c362">Argentina</ifrs-full:DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory>
    <mlec:TaxlossCarryForward contextRef="c2" decimals="0" unitRef="usd">835049</mlec:TaxlossCarryForward>
    <ifrs-full:DeferredTaxAssets contextRef="c2" decimals="0" unitRef="usd">292267</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxExpenseIncome contextRef="c333" decimals="0" unitRef="usd">1631947</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome contextRef="c334" decimals="0" unitRef="usd">860112</ifrs-full:DeferredTaxExpenseIncome>
    <mlec:ScheduleOfEstimatedFutureTaxableProfitTableTextBlock contextRef="c0">Deferred tax assets have
not been recognized in respect of the following items, because it is not probable that future taxable profit will be available against
which the Group can use the benefits therefrom:&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Tax losses per country&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Gross amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tax effect&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Gross amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tax effect&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Gross amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tax effect&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Gross amount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Tax effect&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 20%; text-align: justify; padding-bottom: 1.5pt"&gt;United Kingdom&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;3,641,516&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;691,888&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;4,526,905&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;860,112&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;1,986,814&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;377,495&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;320,524&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 7%; text-align: right"&gt;60,900&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Luxembourg&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,267,560&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;620,837&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Argentina&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,484,790&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;282,110&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;United States of America&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;195,328&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;37,112&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: justify; padding-bottom: 4pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;8,589,194&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;1,631,947&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;4,526,905&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;860,112&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;1,986,814&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;377,495&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;320,524&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;60,900&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:ScheduleOfEstimatedFutureTaxableProfitTableTextBlock>
    <mlec:DeferredTaxAssetsGrossAmount contextRef="c345" decimals="0" unitRef="usd">3641516</mlec:DeferredTaxAssetsGrossAmount>
    <mlec:DeferredTaxAssetsTaxEffect contextRef="c345" decimals="0" unitRef="usd">691888</mlec:DeferredTaxAssetsTaxEffect>
    <mlec:DeferredTaxAssetsGrossAmount contextRef="c346" decimals="0" unitRef="usd">4526905</mlec:DeferredTaxAssetsGrossAmount>
    <mlec:DeferredTaxAssetsTaxEffect contextRef="c346" decimals="0" unitRef="usd">860112</mlec:DeferredTaxAssetsTaxEffect>
    <mlec:DeferredTaxAssetsGrossAmount contextRef="c347" decimals="0" unitRef="usd">1986814</mlec:DeferredTaxAssetsGrossAmount>
    <mlec:DeferredTaxAssetsTaxEffect contextRef="c347" decimals="0" unitRef="usd">377495</mlec:DeferredTaxAssetsTaxEffect>
    <mlec:DeferredTaxAssetsGrossAmount contextRef="c348" decimals="0" unitRef="usd">320524</mlec:DeferredTaxAssetsGrossAmount>
    <mlec:DeferredTaxAssetsTaxEffect contextRef="c348" decimals="0" unitRef="usd">60900</mlec:DeferredTaxAssetsTaxEffect>
    <mlec:DeferredTaxAssetsGrossAmount contextRef="c332" decimals="0" unitRef="usd">3267560</mlec:DeferredTaxAssetsGrossAmount>
    <mlec:DeferredTaxAssetsTaxEffect contextRef="c332" decimals="0" unitRef="usd">620837</mlec:DeferredTaxAssetsTaxEffect>
    <mlec:DeferredTaxAssetsGrossAmount contextRef="c363" decimals="0" unitRef="usd">1484790</mlec:DeferredTaxAssetsGrossAmount>
    <mlec:DeferredTaxAssetsTaxEffect contextRef="c363" decimals="0" unitRef="usd">282110</mlec:DeferredTaxAssetsTaxEffect>
    <mlec:DeferredTaxAssetsGrossAmount contextRef="c349" decimals="0" unitRef="usd">195328</mlec:DeferredTaxAssetsGrossAmount>
    <mlec:DeferredTaxAssetsTaxEffect contextRef="c349" decimals="0" unitRef="usd">37112</mlec:DeferredTaxAssetsTaxEffect>
    <mlec:DeferredTaxAssetsGrossAmount contextRef="c2" decimals="0" unitRef="usd">8589194</mlec:DeferredTaxAssetsGrossAmount>
    <mlec:DeferredTaxAssetsTaxEffect contextRef="c2" decimals="0" unitRef="usd">1631947</mlec:DeferredTaxAssetsTaxEffect>
    <mlec:DeferredTaxAssetsGrossAmount contextRef="c6" decimals="0" unitRef="usd">4526905</mlec:DeferredTaxAssetsGrossAmount>
    <mlec:DeferredTaxAssetsTaxEffect contextRef="c6" decimals="0" unitRef="usd">860112</mlec:DeferredTaxAssetsTaxEffect>
    <mlec:DeferredTaxAssetsGrossAmount contextRef="c39" decimals="0" unitRef="usd">1986814</mlec:DeferredTaxAssetsGrossAmount>
    <mlec:DeferredTaxAssetsTaxEffect contextRef="c39" decimals="0" unitRef="usd">377495</mlec:DeferredTaxAssetsTaxEffect>
    <mlec:DeferredTaxAssetsGrossAmount contextRef="c108" decimals="0" unitRef="usd">320524</mlec:DeferredTaxAssetsGrossAmount>
    <mlec:DeferredTaxAssetsTaxEffect contextRef="c108" decimals="0" unitRef="usd">60900</mlec:DeferredTaxAssetsTaxEffect>
    <ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"&gt;Note
22. Financial income / expenses&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 December&#160;30,&lt;br/&gt;
 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;Financial Costs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 1.5pt"&gt;Interest expense&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(160,035&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(2,130&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-530"&gt;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-531"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Financial Costs&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(160,035&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(2,130&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-532"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-533"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Other financial results&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Exchange rate difference&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,386,599&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12,342&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-534"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-535"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of Simply Agreement for Future Equity (&#x201c;SAFE&#x201d;) - Loss&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(313,346&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(860,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-536"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-537"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Investment gain related to money market funds&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,009,318&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-538"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-539"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-540"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;778,811&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-541"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-542"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-543"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Interest gain (Shareholders loan)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;693,027&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-544"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-545"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-546"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Inflation adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;245,989&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-547"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-548"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-549"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,325&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-550"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-551"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-552"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Other financial results&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,030,525&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(872,342&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-553"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-554"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Total net financial income / expenses&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;870,490&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(874,472&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-555"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-556"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory>
    <ifrs-full:DisclosureOfFinanceIncomeExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 December&#160;30,&lt;br/&gt;
 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;Financial Costs&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; padding-bottom: 1.5pt"&gt;Interest expense&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(160,035&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(2,130&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-530"&gt;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-531"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Financial Costs&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(160,035&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(2,130&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-532"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-533"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Other financial results&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Exchange rate difference&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,386,599&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(12,342&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-534"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-535"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in fair value of Simply Agreement for Future Equity (&#x201c;SAFE&#x201d;) - Loss&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(313,346&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(860,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-536"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-537"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Investment gain related to money market funds&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,009,318&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-538"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-539"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-540"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in warrants&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;778,811&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-541"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-542"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-543"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Interest gain (Shareholders loan)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;693,027&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-544"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-545"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-546"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Inflation adjustment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;245,989&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-547"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-548"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-549"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,325&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-550"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-551"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-552"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total Other financial results&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,030,525&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(872,342&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-553"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-554"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Total net financial income / expenses&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;870,490&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(874,472&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-555"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-556"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfFinanceIncomeExplanatory>
    <mlec:InterestExpenses contextRef="c2" decimals="0" unitRef="usd">160035</mlec:InterestExpenses>
    <mlec:InterestExpenses contextRef="c6" decimals="0" unitRef="usd">2130</mlec:InterestExpenses>
    <mlec:TotalFinancialCosts contextRef="c2" decimals="0" unitRef="usd">160035</mlec:TotalFinancialCosts>
    <mlec:TotalFinancialCosts contextRef="c6" decimals="0" unitRef="usd">2130</mlec:TotalFinancialCosts>
    <mlec:ExchangeRateDifference contextRef="c2" decimals="0" unitRef="usd">1386599</mlec:ExchangeRateDifference>
    <mlec:ExchangeRateDifference contextRef="c6" decimals="0" unitRef="usd">12342</mlec:ExchangeRateDifference>
    <mlec:ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss contextRef="c2" decimals="0" unitRef="usd">313346</mlec:ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss>
    <mlec:ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss contextRef="c6" decimals="0" unitRef="usd">860000</mlec:ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss>
    <mlec:InvestmentGainRelatedToMoneyMarketFunds contextRef="c2" decimals="0" unitRef="usd">1009318</mlec:InvestmentGainRelatedToMoneyMarketFunds>
    <mlec:ChangeInWarrants contextRef="c2" decimals="0" unitRef="usd">778811</mlec:ChangeInWarrants>
    <ifrs-full:LoansAndReceivables contextRef="c2" decimals="0" unitRef="usd">693027</ifrs-full:LoansAndReceivables>
    <mlec:InflationAdjustment contextRef="c2" decimals="0" unitRef="usd">245989</mlec:InflationAdjustment>
    <mlec:OtherFinancialResults contextRef="c2" decimals="0" unitRef="usd">-3325</mlec:OtherFinancialResults>
    <mlec:TotalOtherFinancialResults contextRef="c2" decimals="0" unitRef="usd">-1030525</mlec:TotalOtherFinancialResults>
    <mlec:TotalOtherFinancialResults contextRef="c6" decimals="0" unitRef="usd">872342</mlec:TotalOtherFinancialResults>
    <mlec:NetFinancialIncomeExpenses contextRef="c2" decimals="0" unitRef="usd">870490</mlec:NetFinancialIncomeExpenses>
    <mlec:NetFinancialIncomeExpenses contextRef="c6" decimals="0" unitRef="usd">-874472</mlec:NetFinancialIncomeExpenses>
    <ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Note 23. Other operating
expense&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 December&#160;31,&lt;br/&gt;
 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Taxes, duties and penalties&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(62,263&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-557"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-558"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-559"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Miscellaneous expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(31,944&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(38,985&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(93,252&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(2,639&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Total other operating expense&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(94,207&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(38,985&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(93,252&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(2,639&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory>
    <mlec:ScheduleOfOtherOperatingExpensesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 December&#160;31,&lt;br/&gt;
 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Taxes, duties and penalties&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(62,263&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-557"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-558"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-559"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Miscellaneous expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(31,944&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(38,985&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(93,252&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(2,639&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 4pt"&gt;Total other operating expense&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(94,207&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(38,985&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(93,252&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(2,639&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:ScheduleOfOtherOperatingExpensesTableTextBlock>
    <mlec:TaxesDutiesAndPenalties contextRef="c2" decimals="0" unitRef="usd">-62263</mlec:TaxesDutiesAndPenalties>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c74" decimals="0" unitRef="usd">31944</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c354" decimals="0" unitRef="usd">38985</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c355" decimals="0" unitRef="usd">93252</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense contextRef="c99" decimals="0" unitRef="usd">2639</ifrs-full:MiscellaneousOtherOperatingExpense>
    <mlec:OtherOperatingExpense contextRef="c2" decimals="0" unitRef="usd">94207</mlec:OtherOperatingExpense>
    <mlec:OtherOperatingExpense contextRef="c6" decimals="0" unitRef="usd">38985</mlec:OtherOperatingExpense>
    <mlec:OtherOperatingExpense contextRef="c39" decimals="0" unitRef="usd">93252</mlec:OtherOperatingExpense>
    <mlec:OtherOperatingExpense contextRef="c26" decimals="0" unitRef="usd">2639</mlec:OtherOperatingExpense>
    <ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Note 24. Administrative
expenses&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 December&#160;31,&lt;br/&gt;
 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Audit. legal and accountancy fees&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(2,024,611&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(1,355,046&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(635,173&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(125,867&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Employee Stock Option Plan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,166,755&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(838,576&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-560"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-561"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Payroll Expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(880,830&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(254,215&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,544&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-562"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Insurance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(428,947&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-563"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-564"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-565"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Travel Expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(102,305&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(52,532&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(332&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-566"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(92,818&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-567"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-568"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-569"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,107&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-570"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-571"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-572"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other office and admin expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(108,282&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(22,861&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(174,897&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;Total Administrative expenses&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(4,808,655&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(2,523,230&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(820,946&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(127,886&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory>
    <mlec:DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 December&#160;31,&lt;br/&gt;
 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Audit. legal and accountancy fees&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(2,024,611&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(1,355,046&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(635,173&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(125,867&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Employee Stock Option Plan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,166,755&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(838,576&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-560"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-561"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Payroll Expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(880,830&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(254,215&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,544&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-562"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Insurance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(428,947&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-563"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-564"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-565"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Travel Expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(102,305&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(52,532&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(332&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-566"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(92,818&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-567"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-568"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-569"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(4,107&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-570"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-571"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-572"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other office and admin expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(108,282&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(22,861&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(174,897&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;Total Administrative expenses&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(4,808,655&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(2,523,230&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(820,946&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(127,886&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock>
    <mlec:AuditLegalAndAccountancyFee contextRef="c0" decimals="0" unitRef="usd">2024611</mlec:AuditLegalAndAccountancyFee>
    <mlec:AuditLegalAndAccountancyFee contextRef="c3" decimals="0" unitRef="usd">1355046</mlec:AuditLegalAndAccountancyFee>
    <mlec:AuditLegalAndAccountancyFee contextRef="c4" decimals="0" unitRef="usd">635173</mlec:AuditLegalAndAccountancyFee>
    <mlec:AuditLegalAndAccountancyFee contextRef="c5" decimals="0" unitRef="usd">125867</mlec:AuditLegalAndAccountancyFee>
    <ifrs-full:EmployeeBenefitsExpense contextRef="c0" decimals="0" unitRef="usd">1166755</ifrs-full:EmployeeBenefitsExpense>
    <ifrs-full:EmployeeBenefitsExpense contextRef="c3" decimals="0" unitRef="usd">838576</ifrs-full:EmployeeBenefitsExpense>
    <mlec:PayrollExpenses contextRef="c0" decimals="0" unitRef="usd">880830</mlec:PayrollExpenses>
    <mlec:PayrollExpenses contextRef="c3" decimals="0" unitRef="usd">254215</mlec:PayrollExpenses>
    <mlec:PayrollExpenses contextRef="c4" decimals="0" unitRef="usd">10544</mlec:PayrollExpenses>
    <ifrs-full:InsuranceExpense contextRef="c0" decimals="0" unitRef="usd">428947</ifrs-full:InsuranceExpense>
    <ifrs-full:TravelExpense contextRef="c0" decimals="0" unitRef="usd">102305</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense contextRef="c3" decimals="0" unitRef="usd">52532</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense contextRef="c4" decimals="0" unitRef="usd">332</ifrs-full:TravelExpense>
    <mlec:AmortizationExpense contextRef="c0" decimals="0" unitRef="usd">92818</mlec:AmortizationExpense>
    <ifrs-full:DepreciationExpense contextRef="c0" decimals="0" unitRef="usd">4107</ifrs-full:DepreciationExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="c0" decimals="0" unitRef="usd">108282</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="c3" decimals="0" unitRef="usd">22861</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="c4" decimals="0" unitRef="usd">174897</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="c5" decimals="0" unitRef="usd">2019</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:AdministrativeExpense contextRef="c0" decimals="0" unitRef="usd">4808655</ifrs-full:AdministrativeExpense>
    <ifrs-full:AdministrativeExpense contextRef="c3" decimals="0" unitRef="usd">2523230</ifrs-full:AdministrativeExpense>
    <ifrs-full:AdministrativeExpense contextRef="c4" decimals="0" unitRef="usd">820946</ifrs-full:AdministrativeExpense>
    <ifrs-full:AdministrativeExpense contextRef="c5" decimals="0" unitRef="usd">127886</ifrs-full:AdministrativeExpense>
    <ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Note 25. Research
and development expense&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 December&#160;31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Professional fees&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(886,628&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(373,259&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(75,189&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-573"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Laboratories&#x2019; related expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(434,551&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(449,442&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(526,753&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-574"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,699&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,699&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-575"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-576"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other research and development expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(28,339&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(160,758&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-577"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(179,061&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;Total Research and development expenses&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(1,351,217&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(985,158&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(601,942&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(179,061&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory>
    <ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 December&#160;31, 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Professional fees&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(886,628&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(373,259&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(75,189&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-573"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Laboratories&#x2019; related expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(434,551&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(449,442&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(526,753&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-574"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Amortization&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,699&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,699&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-575"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-576"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other research and development expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(28,339&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(160,758&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-577"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(179,061&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;Total Research and development expenses&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(1,351,217&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(985,158&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(601,942&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(179,061&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory>
    <ifrs-full:ProfessionalFeesExpense contextRef="c0" decimals="0" unitRef="usd">886628</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c3" decimals="0" unitRef="usd">373259</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense contextRef="c4" decimals="0" unitRef="usd">75189</ifrs-full:ProfessionalFeesExpense>
    <mlec:LaboratoriesRelatedExpenses contextRef="c0" decimals="0" unitRef="usd">434551</mlec:LaboratoriesRelatedExpenses>
    <mlec:LaboratoriesRelatedExpenses contextRef="c3" decimals="0" unitRef="usd">449442</mlec:LaboratoriesRelatedExpenses>
    <mlec:LaboratoriesRelatedExpenses contextRef="c4" decimals="0" unitRef="usd">526753</mlec:LaboratoriesRelatedExpenses>
    <ifrs-full:AmortisationExpense contextRef="c0" decimals="0" unitRef="usd">1699</ifrs-full:AmortisationExpense>
    <ifrs-full:AmortisationExpense contextRef="c3" decimals="0" unitRef="usd">1699</ifrs-full:AmortisationExpense>
    <mlec:OtherResearchAndDevelopmentExpenses contextRef="c0" decimals="0" unitRef="usd">28339</mlec:OtherResearchAndDevelopmentExpenses>
    <mlec:OtherResearchAndDevelopmentExpenses contextRef="c3" decimals="0" unitRef="usd">160758</mlec:OtherResearchAndDevelopmentExpenses>
    <mlec:OtherResearchAndDevelopmentExpenses contextRef="c5" decimals="0" unitRef="usd">179061</mlec:OtherResearchAndDevelopmentExpenses>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c0" decimals="0" unitRef="usd">1351217</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c3" decimals="0" unitRef="usd">985158</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c4" decimals="0" unitRef="usd">601942</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c5" decimals="0" unitRef="usd">179061</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:DisclosureOfCostOfSalesExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Note 26. Cost of sales&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 December&#160;31,&lt;br/&gt;
 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Inventories at beginning&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-578"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-579"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-580"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-581"&gt;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Inventories incorporated through the business combination&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(532,231&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-582"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-583"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-584"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Purchases&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(788,751&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-585"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-586"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-587"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Production costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; font-style: italic; text-align: left"&gt;Payroll and and professional fees&lt;/td&gt;&lt;td style="font-style: italic"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-style: italic; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; text-align: right"&gt;(121,285&lt;/td&gt;&lt;td style="font-style: italic; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-588"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-589"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-590"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; font-style: italic; text-align: left"&gt;Maintenance, energy and fuel related to fixed assets&lt;/td&gt;&lt;td style="font-style: italic"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-style: italic; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; text-align: right"&gt;(77,495&lt;/td&gt;&lt;td style="font-style: italic; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-591"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-592"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-593"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; font-style: italic; text-align: left"&gt;Amortization and depreciation&lt;/td&gt;&lt;td style="font-style: italic"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-style: italic; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; text-align: right"&gt;(23,398&lt;/td&gt;&lt;td style="font-style: italic; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-594"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-595"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-596"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; font-style: italic; text-align: left"&gt;Other production costs&lt;/td&gt;&lt;td style="font-style: italic"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-style: italic; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; text-align: right"&gt;(31,050&lt;/td&gt;&lt;td style="font-style: italic; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-597"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-598"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-599"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; font-style: italic; text-align: left"&gt;Sub-total Production costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(253,228&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-600"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-601"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-602"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Foreign currency translation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;60,108&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-603"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-604"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-605"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Sub-total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(1,514,102&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-606"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-607"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-608"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Inventories as of the end&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;465,748&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-609"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-610"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-611"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Cost of sales&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(1,048,354&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-612"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-613"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-614"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfCostOfSalesExplanatory>
    <mlec:ScheduleOfCostOfSalesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 December&#160;31,&lt;br/&gt;
 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Inventories at beginning&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-578"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-579"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-580"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-581"&gt;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Inventories incorporated through the business combination&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(532,231&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-582"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-583"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-584"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Purchases&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(788,751&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-585"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-586"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-587"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Production costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; font-style: italic; text-align: left"&gt;Payroll and and professional fees&lt;/td&gt;&lt;td style="font-style: italic"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-style: italic; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; text-align: right"&gt;(121,285&lt;/td&gt;&lt;td style="font-style: italic; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-588"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-589"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-590"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; font-style: italic; text-align: left"&gt;Maintenance, energy and fuel related to fixed assets&lt;/td&gt;&lt;td style="font-style: italic"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-style: italic; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; text-align: right"&gt;(77,495&lt;/td&gt;&lt;td style="font-style: italic; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-591"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-592"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-593"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; font-style: italic; text-align: left"&gt;Amortization and depreciation&lt;/td&gt;&lt;td style="font-style: italic"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-style: italic; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; text-align: right"&gt;(23,398&lt;/td&gt;&lt;td style="font-style: italic; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-594"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-595"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-596"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; font-style: italic; text-align: left"&gt;Other production costs&lt;/td&gt;&lt;td style="font-style: italic"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-style: italic; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-style: italic; text-align: right"&gt;(31,050&lt;/td&gt;&lt;td style="font-style: italic; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-597"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-598"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-599"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; font-style: italic; text-align: left"&gt;Sub-total Production costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(253,228&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-600"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-601"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-602"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Foreign currency translation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;60,108&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-603"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-604"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-605"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Sub-total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(1,514,102&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-606"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-607"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-608"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Inventories as of the end&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;465,748&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-609"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-610"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-611"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Cost of sales&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(1,048,354&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-612"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-613"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-614"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:ScheduleOfCostOfSalesTableTextBlock>
    <mlec:InventoriesIncorporatedThroughTheBusinessCombination contextRef="c0" decimals="0" unitRef="usd">532231</mlec:InventoriesIncorporatedThroughTheBusinessCombination>
    <ifrs-full:PurchasesFairValueMeasurementAssets contextRef="c0" decimals="0" unitRef="usd">788751</ifrs-full:PurchasesFairValueMeasurementAssets>
    <mlec:PayrollAndAndProfessionalFees contextRef="c0" decimals="0" unitRef="usd">121285</mlec:PayrollAndAndProfessionalFees>
    <ifrs-full:RepairsAndMaintenanceExpense contextRef="c0" decimals="0" unitRef="usd">77495</ifrs-full:RepairsAndMaintenanceExpense>
    <ifrs-full:DepreciationAndAmortisationExpense contextRef="c0" decimals="0" unitRef="usd">23398</ifrs-full:DepreciationAndAmortisationExpense>
    <mlec:OtherProductionCosts contextRef="c0" decimals="0" unitRef="usd">-31050</mlec:OtherProductionCosts>
    <ifrs-full:RawMaterialsAndConsumablesUsed contextRef="c0" decimals="0" unitRef="usd">253228</ifrs-full:RawMaterialsAndConsumablesUsed>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations contextRef="c0" decimals="0" unitRef="usd">60108</ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations>
    <mlec:TotalOtherProductionCost contextRef="c0" decimals="0" unitRef="usd">-1514102</mlec:TotalOtherProductionCost>
    <ifrs-full:Inventories contextRef="c2" decimals="0" unitRef="usd">465748</ifrs-full:Inventories>
    <ifrs-full:CostOfSales contextRef="c0" decimals="0" unitRef="usd">1048354</ifrs-full:CostOfSales>
    <ifrs-full:DisclosureOfEarningsPerShareExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Note 27. Net loss per
share&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Basic loss per share
is computed using the weighted-average number of ordinary shares outstanding during the year. Diluted net loss per share is computed using
the weighted-average number of ordinary shares and potentially dilutive, ordinary share equivalents outstanding during the year. The Group&#x2019;s
basic and diluted loss per ordinary share are the same because the Group has generated net loss to ordinary shareholders.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The following table presents
the calculation of basic and diluted loss per ordinary share for the year ended on June 30, 2023 and June 30, 2022 as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Loss attributable to ordinary shareholders (basic and diluted)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;Numerator&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;br/&gt;
 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left"&gt;Loss for the year, attributable to the owners of the Group&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(51,788,880&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(4,526,905&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(1,986,814&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(320,524&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 4pt; padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;Loss attributable to the ordinary shareholders&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(51,788,880&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(4,526,905&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(1,986,814&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(320,524&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;b&gt;Weighted-average number of ordinary shares (basic and diluted)&lt;/b&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Denominator&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;br/&gt;
 2020&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Weighted-average number of ordinary shares&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;34,466,258&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;31,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;30,239,558&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;29,140,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Net loss attributable to ordinary shareholders per share&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;br/&gt;
 2020&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-618; -sec-ix-hidden: hidden-fact-617; -sec-ix-hidden: hidden-fact-616; -sec-ix-hidden: hidden-fact-615"&gt;Basic and Diluted&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(1.50&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(0.15&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(0.07&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(0.01&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfEarningsPerShareExplanatory>
    <ifrs-full:EarningsPerShareExplanatory contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;Numerator&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;br/&gt;
 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; width: 52%; text-align: left"&gt;Loss for the year, attributable to the owners of the Group&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(51,788,880&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(4,526,905&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(1,986,814&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;(320,524&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 4pt; padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;Loss attributable to the ordinary shareholders&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(51,788,880&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(4,526,905&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(1,986,814&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"&gt;(320,524&lt;/td&gt;&lt;td style="padding-bottom: 4pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Denominator&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;br/&gt;
 2020&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;Weighted-average number of ordinary shares&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;34,466,258&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;31,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;30,239,558&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;29,140,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Net loss attributable to ordinary shareholders per share&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2021&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;br/&gt;
 2020&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left; text-indent: -0.125in; padding-left: 0.125in"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-618; -sec-ix-hidden: hidden-fact-617; -sec-ix-hidden: hidden-fact-616; -sec-ix-hidden: hidden-fact-615"&gt;Basic and Diluted&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(1.50&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(0.15&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(0.07&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(0.01&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:EarningsPerShareExplanatory>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects contextRef="c0" decimals="0" unitRef="usd">-51788880</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects contextRef="c3" decimals="0" unitRef="usd">-4526905</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects contextRef="c4" decimals="0" unitRef="usd">-1986814</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects contextRef="c5" decimals="0" unitRef="usd">-320524</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects contextRef="c0" decimals="0" unitRef="usd">-51788880</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects contextRef="c3" decimals="0" unitRef="usd">-4526905</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects contextRef="c4" decimals="0" unitRef="usd">-1986814</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects contextRef="c5" decimals="0" unitRef="usd">-320524</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects>
    <ifrs-full:AdjustedWeightedAverageShares contextRef="c0" decimals="INF" unitRef="shares">34466258</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares contextRef="c3" decimals="INF" unitRef="shares">31000000</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares contextRef="c4" decimals="INF" unitRef="shares">30239558</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares contextRef="c5" decimals="INF" unitRef="shares">29140000</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations contextRef="c0" decimals="2" unitRef="usdPershares">-1.5</ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations>
    <ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations contextRef="c3" decimals="2" unitRef="usdPershares">-0.15</ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations>
    <ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations contextRef="c4" decimals="2" unitRef="usdPershares">-0.07</ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations>
    <ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations contextRef="c5" decimals="2" unitRef="usdPershares">-0.01</ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Note 28. Related parties&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Balances and transactions
between the Group entities, which are related parties, have been eliminated on consolidation and are not disclosed in this note. Transactions
between the Group and its directors and/or executive board members and the Company and the Parent are disclosed below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Transactions with
key management personnel &lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Key management personnel
compensation comprised:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Other Related Party
Transactions&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-style: italic; text-align: left"&gt;In USD ($)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;br/&gt;
 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Short-term employee benefits&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;39,250&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;96,437&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;109,205&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;38,355&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Share based payment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;904,861&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;838,576&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-619"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-620"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Other Related Party
Transactions&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: black 1.5pt solid; padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;In USD ($)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For the year ended&lt;br/&gt;
June 30,&lt;br/&gt;
2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For the year ended &lt;br/&gt;
June 30,&lt;br/&gt;
2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;From the period&lt;br/&gt;
of January 1,&lt;br/&gt;
2021 through&lt;br/&gt;
June 30,&lt;br/&gt;
2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;From the period of August 21, 2020 through December&#160;31,&lt;br/&gt;
2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Share based payment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 40%; padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Key management&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;904,861&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;838,576&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-621; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-622; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;CFO Shares Alloted&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(vi)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;364,014&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-623; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-624; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-625; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Issue of Additional Shares&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue of share capital&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-626; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-627; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-628; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue of share premium&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;39,610,630&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-629; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-630; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-631; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Parent of the Company &#x2013; Bioceres Crop Solutions Corp&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-632; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-633; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-634; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Parent of the Company &#x2013; Union Group Ventures&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-635; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-636; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-637; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Parent of the Company &#x2013; BG Farming Technologies&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-638; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-639; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-640; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Company&#x2019;s Cash Balance in Other&#x2019;s Accounts&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Parent of BF Farming Technologies &#x2013; Bioceres S.A.&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-641; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-642; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-643; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;300,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100% Subsidiary of Bioceres S.A. &#x2013; Bioceres LLC&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-644; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-645; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;300,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Expenses Paid on Behalf of the Company&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Parent of BG Farming Technologies - Bioceres S.A.&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-646; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;265,810&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;509,628&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;244,029&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100% Subsidiary of Bioceres S.A. - Bioceres LLC&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;238,121&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;156,760&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;453,282&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;56,863&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Services Provided by Other Companies&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30% owned by Bioceres S.A. - INMET S.A.- Ingenieria Metabolica S.A&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;286&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;252&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;144,530&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;160,390&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;98.6% owned by Bioceres S.A. - INDEAR S.A.- Instituto de Agrobiotecnolog&#xed;a Rosario&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(iii)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;258,279&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;57,047&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;129,695&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,540&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Owned by Bioceres S.A. - Agrality Inc.&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(iv)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;85,435&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-647; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-648; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Founded and operated by the Company&#x2019;s CPO - Future Foods B.V.&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(v)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;85,880&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;94,857&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35,958&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,801&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Moolec Science S.A. Shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(vii)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;693,027&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-649; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-650; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-651; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;THEO I SCSp&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-652; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-653; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-654; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 0.35in"&gt;(i)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Expenses paid by Bioceres LLC on behalf of the Company.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 0.35in"&gt;(ii)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Company entered into an agreement with INMET S.A.- Ingenieria Metabolica S,A through which it would
receive research services in exchange for payment.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 0.35in"&gt;(iii)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Company entered into an agreement with INDEAR S.A.- Instituto de Agrobiotecnologia Rosario where it
would receive research services in exchange for payment.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 0.35in"&gt;(iv)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Company entered into an agreement with Agrality Inc, for the provision of services.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 0.35in"&gt;(v)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Company entered into an agreement with Future Foods B.V. for the provision of services.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 0.35in"&gt;(vi)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Shares issue related to share based payment already vested.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 0.35in"&gt;(vii)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Company entered into an agreement with shareholders which accrues an internal rate of return.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Other Related Party
Balances&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left"&gt;In USD ($)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Balance&lt;br/&gt; outstanding&lt;br/&gt; as of&lt;br/&gt; June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Balance&lt;br/&gt; outstanding&lt;br/&gt; as of&lt;br/&gt; June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-bottom: 1.5pt"&gt;100% Subsidiary of Bioceres S.A. &lt;span style="-sec-ix-hidden: hidden-fact-655"&gt;-&lt;/span&gt; Bioceres LLC&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(623,629&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(385,508&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Moolec S.A. Shareholders&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,763,027&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-656"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Union Group Ventures Limited&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(677,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-657"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;INDEAR S.A.&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(72,494&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-658"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Future Foods B.V&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(78,337&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-659"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <mlec:ScheduleOfOtherRelatedPartyTransactions contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-style: italic; text-align: left"&gt;In USD ($)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;br/&gt;
 2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Short-term employee benefits&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;39,250&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;96,437&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;109,205&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;38,355&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Share based payment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;904,861&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;838,576&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-619"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-620"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</mlec:ScheduleOfOtherRelatedPartyTransactions>
    <ifrs-full:ShorttermEmployeeBenefitsExpense contextRef="c0" decimals="0" unitRef="usd">39250</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <ifrs-full:ShorttermEmployeeBenefitsExpense contextRef="c3" decimals="0" unitRef="usd">96437</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <ifrs-full:ShorttermEmployeeBenefitsExpense contextRef="c4" decimals="0" unitRef="usd">109205</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <ifrs-full:ShorttermEmployeeBenefitsExpense contextRef="c5" decimals="0" unitRef="usd">38355</ifrs-full:ShorttermEmployeeBenefitsExpense>
    <ifrs-full:ShorttermEmployeeBenefitsAccruals contextRef="c2" decimals="0" unitRef="usd">904861</ifrs-full:ShorttermEmployeeBenefitsAccruals>
    <ifrs-full:ShorttermEmployeeBenefitsAccruals contextRef="c6" decimals="0" unitRef="usd">838576</ifrs-full:ShorttermEmployeeBenefitsAccruals>
    <mlec:ScheduleOfShareBasedPayment contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: black 1.5pt solid; padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;In USD ($)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For the year ended&lt;br/&gt;
June 30,&lt;br/&gt;
2023&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For the year ended &lt;br/&gt;
June 30,&lt;br/&gt;
2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;From the period&lt;br/&gt;
of January 1,&lt;br/&gt;
2021 through&lt;br/&gt;
June 30,&lt;br/&gt;
2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;From the period of August 21, 2020 through December&#160;31,&lt;br/&gt;
2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Share based payment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="width: 40%; padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Key management&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;904,861&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;838,576&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-621; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-622; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;CFO Shares Alloted&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(vi)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;364,014&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-623; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-624; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-625; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Issue of Additional Shares&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue of share capital&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-626; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-627; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-628; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Issue of share premium&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;39,610,630&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-629; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-630; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-631; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Parent of the Company &#x2013; Bioceres Crop Solutions Corp&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-632; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-633; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-634; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Parent of the Company &#x2013; Union Group Ventures&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-635; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-636; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-637; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Parent of the Company &#x2013; BG Farming Technologies&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-638; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-639; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-640; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Company&#x2019;s Cash Balance in Other&#x2019;s Accounts&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Parent of BF Farming Technologies &#x2013; Bioceres S.A.&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-641; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-642; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-643; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;300,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100% Subsidiary of Bioceres S.A. &#x2013; Bioceres LLC&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-644; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-645; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;300,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Expenses Paid on Behalf of the Company&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Parent of BG Farming Technologies - Bioceres S.A.&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-646; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;265,810&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;509,628&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;244,029&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;100% Subsidiary of Bioceres S.A. - Bioceres LLC&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(i)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;238,121&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;156,760&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;453,282&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;56,863&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Services Provided by Other Companies&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;30% owned by Bioceres S.A. - INMET S.A.- Ingenieria Metabolica S.A&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(ii)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;286&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;252&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;144,530&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;160,390&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;98.6% owned by Bioceres S.A. - INDEAR S.A.- Instituto de Agrobiotecnolog&#xed;a Rosario&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(iii)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;258,279&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;57,047&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;129,695&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,540&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Owned by Bioceres S.A. - Agrality Inc.&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(iv)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;85,435&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-647; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-648; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Founded and operated by the Company&#x2019;s CPO - Future Foods B.V.&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(v)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;85,880&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;94,857&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35,958&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,801&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Moolec Science S.A. Shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(vii)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;693,027&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-649; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-650; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-651; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;THEO I SCSp&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-652; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,500,000&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-653; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-654; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 0.35in"&gt;(i)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Expenses paid by Bioceres LLC on behalf of the Company.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 0.35in"&gt;(ii)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Company entered into an agreement with INMET S.A.- Ingenieria Metabolica S,A through which it would
receive research services in exchange for payment.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 0.35in"&gt;(iii)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Company entered into an agreement with INDEAR S.A.- Instituto de Agrobiotecnologia Rosario where it
would receive research services in exchange for payment.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 0.35in"&gt;(iv)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Company entered into an agreement with Agrality Inc, for the provision of services.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 0.35in"&gt;(v)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Company entered into an agreement with Future Foods B.V. for the provision of services.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 0.35in"&gt;(vi)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Shares issue related to share based payment already vested.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0%"&gt;&lt;/td&gt;&lt;td style="width: 0.35in"&gt;(vii)&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Company entered into an agreement with shareholders which accrues an internal rate of return.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</mlec:ScheduleOfShareBasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="c0" decimals="0" unitRef="usd">904861</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="c3" decimals="0" unitRef="usd">838576</ifrs-full:KeyManagementPersonnelCompensation>
    <mlec:CFOSharesAlloted contextRef="c0" decimals="0" id="ix_73_fact" unitRef="usd">364014</mlec:CFOSharesAlloted>
    <mlec:IssueOfSharesCapital contextRef="c2" decimals="0" unitRef="usd">15000</mlec:IssueOfSharesCapital>
    <mlec:IssueOfSharePremium contextRef="c2" decimals="0" unitRef="usd">39610630</mlec:IssueOfSharePremium>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="c366" decimals="0" unitRef="usd">3000000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="c371" decimals="0" unitRef="usd">2000000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="c375" decimals="0" unitRef="usd">2000000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:CashEquivalents contextRef="c379" decimals="0" unitRef="usd">300000</ifrs-full:CashEquivalents>
    <mlec:SubsidiaryPercentage contextRef="c0" decimals="2" unitRef="pure">1</mlec:SubsidiaryPercentage>
    <ifrs-full:CashEquivalents contextRef="c382" decimals="0" unitRef="usd">500000</ifrs-full:CashEquivalents>
    <ifrs-full:CashEquivalents contextRef="c383" decimals="0" unitRef="usd">300000</ifrs-full:CashEquivalents>
    <mlec:ExpensesPaid
      contextRef="c385"
      decimals="0"
      id="ix_49_fact"
      unitRef="usd">265810</mlec:ExpensesPaid>
    <mlec:ExpensesPaid
      contextRef="c386"
      decimals="0"
      id="ix_50_fact"
      unitRef="usd">509628</mlec:ExpensesPaid>
    <mlec:ExpensesPaid
      contextRef="c387"
      decimals="0"
      id="ix_51_fact"
      unitRef="usd">244029</mlec:ExpensesPaid>
    <mlec:SubsidiaryPercentage
      contextRef="c388"
      decimals="2"
      id="ix_56_fact"
      unitRef="pure">1</mlec:SubsidiaryPercentage>
    <mlec:ExpensesPaid
      contextRef="c388"
      decimals="0"
      id="ix_52_fact"
      unitRef="usd">238121</mlec:ExpensesPaid>
    <mlec:ExpensesPaid
      contextRef="c389"
      decimals="0"
      id="ix_53_fact"
      unitRef="usd">156760</mlec:ExpensesPaid>
    <mlec:ExpensesPaid
      contextRef="c390"
      decimals="0"
      id="ix_54_fact"
      unitRef="usd">453282</mlec:ExpensesPaid>
    <mlec:ExpensesPaid
      contextRef="c391"
      decimals="0"
      id="ix_55_fact"
      unitRef="usd">56863</mlec:ExpensesPaid>
    <mlec:OwnedPercentage
      contextRef="c392"
      decimals="2"
      id="ix_61_fact"
      unitRef="pure">0.30</mlec:OwnedPercentage>
    <mlec:ServicesProvidedByOtherCompanies
      contextRef="c392"
      decimals="0"
      id="ix_57_fact"
      unitRef="usd">286</mlec:ServicesProvidedByOtherCompanies>
    <mlec:ServicesProvidedByOtherCompanies
      contextRef="c393"
      decimals="0"
      id="ix_58_fact"
      unitRef="usd">252</mlec:ServicesProvidedByOtherCompanies>
    <mlec:ServicesProvidedByOtherCompanies
      contextRef="c394"
      decimals="0"
      id="ix_59_fact"
      unitRef="usd">144530</mlec:ServicesProvidedByOtherCompanies>
    <mlec:ServicesProvidedByOtherCompanies
      contextRef="c395"
      decimals="0"
      id="ix_60_fact"
      unitRef="usd">160390</mlec:ServicesProvidedByOtherCompanies>
    <mlec:OwnedPercentage
      contextRef="c396"
      decimals="3"
      id="ix_66_fact"
      unitRef="pure">0.986</mlec:OwnedPercentage>
    <mlec:ServicesProvidedByOtherCompanies
      contextRef="c396"
      decimals="0"
      id="ix_62_fact"
      unitRef="usd">258279</mlec:ServicesProvidedByOtherCompanies>
    <mlec:ServicesProvidedByOtherCompanies
      contextRef="c397"
      decimals="0"
      id="ix_63_fact"
      unitRef="usd">57047</mlec:ServicesProvidedByOtherCompanies>
    <mlec:ServicesProvidedByOtherCompanies
      contextRef="c398"
      decimals="0"
      id="ix_64_fact"
      unitRef="usd">129695</mlec:ServicesProvidedByOtherCompanies>
    <mlec:ServicesProvidedByOtherCompanies
      contextRef="c399"
      decimals="0"
      id="ix_65_fact"
      unitRef="usd">2540</mlec:ServicesProvidedByOtherCompanies>
    <mlec:ServicesProvidedByOtherCompanies
      contextRef="c400"
      decimals="0"
      id="ix_67_fact"
      unitRef="usd">5000</mlec:ServicesProvidedByOtherCompanies>
    <mlec:ServicesProvidedByOtherCompanies
      contextRef="c401"
      decimals="0"
      id="ix_68_fact"
      unitRef="usd">85435</mlec:ServicesProvidedByOtherCompanies>
    <mlec:ServicesProvidedByOtherCompanies
      contextRef="c404"
      decimals="0"
      id="ix_69_fact"
      unitRef="usd">85880</mlec:ServicesProvidedByOtherCompanies>
    <mlec:ServicesProvidedByOtherCompanies
      contextRef="c405"
      decimals="0"
      id="ix_70_fact"
      unitRef="usd">94857</mlec:ServicesProvidedByOtherCompanies>
    <mlec:ServicesProvidedByOtherCompanies
      contextRef="c406"
      decimals="0"
      id="ix_71_fact"
      unitRef="usd">35958</mlec:ServicesProvidedByOtherCompanies>
    <mlec:ServicesProvidedByOtherCompanies
      contextRef="c407"
      decimals="0"
      id="ix_72_fact"
      unitRef="usd">17801</mlec:ServicesProvidedByOtherCompanies>
    <mlec:ServicesProvidedByOtherCompanies
      contextRef="c408"
      decimals="0"
      id="ix_74_fact"
      unitRef="usd">693027</mlec:ServicesProvidedByOtherCompanies>
    <mlec:ServicesProvidedByOtherCompanies contextRef="c413" decimals="0" unitRef="usd">1500000</mlec:ServicesProvidedByOtherCompanies>
    <mlec:ScheduleOfOtherRelatedPartyBalances contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic; text-align: left"&gt;In USD ($)&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Balance&lt;br/&gt; outstanding&lt;br/&gt; as of&lt;br/&gt; June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Balance&lt;br/&gt; outstanding&lt;br/&gt; as of&lt;br/&gt; June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-bottom: 1.5pt"&gt;100% Subsidiary of Bioceres S.A. &lt;span style="-sec-ix-hidden: hidden-fact-655"&gt;-&lt;/span&gt; Bioceres LLC&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(623,629&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(385,508&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Moolec S.A. Shareholders&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,763,027&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-656"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Union Group Ventures Limited&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(677,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-657"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;INDEAR S.A.&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(72,494&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-658"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Future Foods B.V&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(78,337&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-659"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:ScheduleOfOtherRelatedPartyBalances>
    <mlec:SubsidiaryPercentage contextRef="c418" decimals="2" unitRef="pure">1</mlec:SubsidiaryPercentage>
    <mlec:OtherRelatedPartyBalances contextRef="c416" decimals="0" unitRef="usd">-623629</mlec:OtherRelatedPartyBalances>
    <mlec:OtherRelatedPartyBalances contextRef="c417" decimals="0" unitRef="usd">-385508</mlec:OtherRelatedPartyBalances>
    <mlec:OtherRelatedPartyBalances contextRef="c420" decimals="0" unitRef="usd">8763027</mlec:OtherRelatedPartyBalances>
    <mlec:OtherRelatedPartyBalances contextRef="c422" decimals="0" unitRef="usd">-677000</mlec:OtherRelatedPartyBalances>
    <mlec:OtherRelatedPartyBalances contextRef="c424" decimals="0" unitRef="usd">-72494</mlec:OtherRelatedPartyBalances>
    <mlec:OtherRelatedPartyBalances contextRef="c426" decimals="0" unitRef="usd">-78337</mlec:OtherRelatedPartyBalances>
    <ifrs-full:DisclosureOfFinancialRiskManagementExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Note 29. Financial risk
management&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group&#x2019;s activities
are subject to several financial risks: market risk (including the exchange rate risk, the interest rate risk and price risk), credit
risk and liquidity risk.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The following matters
have been considered by Management in determining the appropriateness of the going concern basis of preparation of the accompanying Consolidated
Financial Statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;b&gt;a)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Credit risk&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Credit risk is the risk
of financial loss to the Group if the counterparty to a financial instrument fails to meet its contractual obligations. Financial instruments
held by the Group that are potentially subject to concentration of credit risk are primarily cash and receivables, the latter held as
a result of ValoraSoy Acquisition. Management believes that the credit risk concentrating with respect to cash and amounts receivable
is remote.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The following table sets
forth details of the age of trade and other receivables:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"&gt;As at&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;To due become&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-bottom: 1.5pt"&gt;Up to 3 months&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;450,728&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-660"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;b&gt;b)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Liquidity risk&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Liquidity risk is the
risk that the Group will encounter difficulty in meeting the obligations affiliated with its financial liabilities that are settled by
delivering cash or another financial asset. The Group&#x2019;s approach to managing liquidity is to ensure, as far as possible, that it
will always have sufficient liquidity to meet its liabilities when due, under both normal and stressed conditions, without incurring unacceptable
losses or risking damage to the Group&#x2019; s reputation. Given the Group&#x2019;s financial position as of June 30, 2023, total current
financial assets $4,524,972 as compared to total financial liabilities of $11,985,860 management expects that the Group will be able to
provide the capital needed to keep the Group liquid and able to fulfill its short-term obligations. Group&#x2019;s financial position as
of June 30, 2022, total current financial assets $1,081,808 as compared to total financial liabilities of $1,227,384, which comprised
the SAFE agreement convertible in future Equity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Company continuously
monitors and reviews its actual and forecasted cash flows and manages liquidity risk by maintaining adequate cash and cash equivalents,
by utilizing term loans and by monitoring developments in the capital markets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The table below analyzes
the Company&#x2019;s financial liabilities into relevant maturity groupings based on the remaining period at the balance sheet to the contractual
maturity date.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Maturity date&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Within 1&lt;br/&gt;
 year or on&lt;br/&gt;
 demand&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Between 1&lt;br/&gt;
 and 2 years&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Between 2&lt;br/&gt;
 and 5 years&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;More than &lt;br/&gt;
5 years&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Without any&lt;br/&gt;
 established&lt;br/&gt;
 term&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 28%; text-align: left"&gt;Trade Payables&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,479,614&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-661"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-662"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-663"&gt;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-664"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,479,614&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Other liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,776,438&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;180,197&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-665"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-666"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,956,635&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: left"&gt;Financial debts&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,578,100&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;72,831&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;108,638&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-667"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-668"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,759,569&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;11,834,152&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;253,028&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;108,638&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-669"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-670"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;12,195,818&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Warrant&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;887,689&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-671"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-672"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-673"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-674"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;887,689&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;887,689&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-675"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-676"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-677"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-678"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;887,689&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;12,721,841&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;253,028&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;108,638&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-679"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-680"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;13,083,507&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;June 30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Trade Payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,226,213&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-681"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-682"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-683"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-684"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,226,213&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Other liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,171&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-685"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-686"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-687"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-688"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,171&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: left"&gt;Simply Agreement for Future Equity (&#x201c;SAFE&#x201d;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,860,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-689"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-690"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-691"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-692"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,860,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;4,087,384&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-693"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-694"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-695"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-696"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;4,087,384&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;4,087,384&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-697"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-698"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-699"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;4,087,384&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;b&gt;c)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Market risk&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Market risk is the risk
that changes in market prices -e.g. foreign exchange rates, interest rates and equity prices -will affect the Group&#x2019;s income or
the value of its holdings of financial instruments including commodity prices and foreign currency exchange rates. The objective of market
risk management is to manage and control market risk exposures within acceptable parameters, while optimizing the return.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;&lt;span style="text-decoration:underline"&gt;Commodity risk&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;In the normal course
of its business, the Company is exposed to risk resulting from fluctuations in the market prices of commodities. The Company does not
engage in transactional hedging of its commodity price risk.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="text-decoration:underline"&gt;Foreign currency exchange
risk&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Company is exposed
to foreign exchange risk as a result of transactions being conducted in currencies other than the functional currency of each of the Company
and its subsidiaries.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Company has not entered
into transactions that seek to hedge or mitigate its exposure to exchange rate fluctuations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The carrying amounts
of the Group&#x2019;s foreign currency denominated monetary assets and monetary liabilities at the reporting date are as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Currency&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Argentine pesos&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;765,690&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-700"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;50,073&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-701"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;U.S. Dollar&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;368,186&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-702"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,227,751&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-703"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Pound sterling&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,062&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-704"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-705"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The following table details
sensitivity to a 10% increase and decrease in the functional currency of each of the companies against the relevant foreign currencies.
The sensitivity analysis includes only the outstanding monetary items denominated in foreign currency and adjusts its conversion at the
end of the period for a 10% change in exchange rates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(+10%) Impact to profit or loss before tax&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(-10%) Impact to profit or loss before tax&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Currency&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Argentine pesos&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;76,569&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-706"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(5,007&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-707"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;U.S. Dollar&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36,819&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-708"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(222,775&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-709"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Pound sterling&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,206&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;803&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-710"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-711"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;b&gt;d)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;b&gt;Fair value risk&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;Fair value and carrying
value of financial instruments:&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The following represents
the carrying value and fair value of the Company&#x2019;s financial instruments and non-financial derivatives:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Recurring measurements&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Note&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Financial Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;Amortized costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1.5pt"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: center; padding-bottom: 1.5pt"&gt;(i)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,064,079&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,081,808&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Trade and other receivables&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;(i)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,454,301&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,061&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Fair value through profit or loss&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;(ii)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;463,594&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-712"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Short-term investments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;(ii)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;306,034&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-713"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total financial assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;13,288,008&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,083,869&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;Financial Liabilities&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Amortized costs&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Trade and other payables&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: center"&gt;(i)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;9,340,571&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,227,384&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Financial debt&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;(i)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,645,289&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-714"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Fair value through profit or loss&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Simply Agreement for Future Equity (&#x201c;SAFE&#x201d;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-715"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,860,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Warrant liabilities&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;(ii)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;887,689&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-716"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total financial liabilities&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;12,873,549&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;4,087,384&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Net financial asset /(liability)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;414,459&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(3,003,515&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Cash, short-term investments, trade and other receivables, prepayments, trade and other payables, and
loans payable are recorded at carrying value, which approximates fair value due to their short-term nature and generally negligible credit
losses.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;(ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Fair value of short-term investment and warrants has been
determined using the quoted market price at the year end (level 1).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;e) Interest rate risk&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group&#x2019;s financing
costs may be affected by interest rate volatility. Borrowings under the Group&#x2019;s interest rate management policy may be fixed or
floating rate. The Group maintains adequate committed borrowing facilities and holds most of its financial assets primarily in cash or
short-term investments that are readily convertible into known amounts of cash.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Group&#x2019;s interest
rate risk arises from long-term borrowings. Borrowings issued at floating rates expose the Group to cash flow interest rate risk. Borrowings
issued at fixed rates expose the Group to fair value interest rate risk. The Group has not entered into derivative contracts to hedge
this exposure.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Fixed-rate instruments&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Current financial liabilities&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(2,546,243&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-717"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-718"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Non-current financial liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(99,046&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-719"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-720"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Holding all other variables
constant, including levels of our external indebtedness, as of June 30, 2023 a 10% increase/(decrease) in interest rates would increase/(decrease)
interest payable by 11,428/(11,428).&lt;/p&gt;</ifrs-full:DisclosureOfFinancialRiskManagementExplanatory>
    <ifrs-full:DisclosureOfTradingIncomeExpenseExplanatory contextRef="c0">The following table sets
forth details of the age of trade and other receivables:&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify"&gt;As at&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;To due become&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-bottom: 1.5pt"&gt;Up to 3 months&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;450,728&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-660"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:DisclosureOfTradingIncomeExpenseExplanatory>
    <ifrs-full:TradeAndOtherReceivables contextRef="c431" decimals="0" unitRef="usd">450728</ifrs-full:TradeAndOtherReceivables>
    <ifrs-full:CurrentFinancialAssets contextRef="c428" decimals="0" unitRef="usd">4524972</ifrs-full:CurrentFinancialAssets>
    <ifrs-full:FinancialLiabilities contextRef="c428" decimals="0" unitRef="usd">11985860</ifrs-full:FinancialLiabilities>
    <ifrs-full:CurrentFinancialAssets contextRef="c429" decimals="0" unitRef="usd">1081808</ifrs-full:CurrentFinancialAssets>
    <ifrs-full:FinancialLiabilities contextRef="c429" decimals="0" unitRef="usd">1227384</ifrs-full:FinancialLiabilities>
    <ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities contextRef="c0">The table below analyzes
the Company&#x2019;s financial liabilities into relevant maturity groupings based on the remaining period at the balance sheet to the contractual
maturity date.&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Maturity date&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Within 1&lt;br/&gt;
 year or on&lt;br/&gt;
 demand&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Between 1&lt;br/&gt;
 and 2 years&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Between 2&lt;br/&gt;
 and 5 years&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;More than &lt;br/&gt;
5 years&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Without any&lt;br/&gt;
 established&lt;br/&gt;
 term&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;June 30, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; width: 28%; text-align: left"&gt;Trade Payables&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,479,614&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-661"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-662"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-663"&gt;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-664"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;7,479,614&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Other liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,776,438&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;180,197&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-665"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-666"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,956,635&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: left"&gt;Financial debts&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,578,100&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;72,831&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;108,638&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-667"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-668"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,759,569&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;11,834,152&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;253,028&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;108,638&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-669"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-670"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;12,195,818&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Warrant&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;887,689&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-671"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-672"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-673"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-674"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;887,689&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;887,689&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-675"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-676"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-677"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-678"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;887,689&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;12,721,841&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;253,028&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;108,638&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-679"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-680"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;13,083,507&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left"&gt;June 30, 2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Trade Payables&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,226,213&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-681"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-682"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-683"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-684"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,226,213&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left"&gt;Other liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,171&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-685"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-686"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-687"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-688"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,171&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; text-align: left"&gt;Simply Agreement for Future Equity (&#x201c;SAFE&#x201d;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,860,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-689"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-690"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-691"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-692"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,860,000&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;Subtotal&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;4,087,384&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-693"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-694"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-695"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-696"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;4,087,384&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;4,087,384&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-697"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-698"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-699"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;4,087,384&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities>
    <ifrs-full:TradeAndOtherPayables contextRef="c433" decimals="0" unitRef="usd">7479614</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables contextRef="c2" decimals="0" unitRef="usd">7479614</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:OtherLiabilities contextRef="c433" decimals="0" unitRef="usd">1776438</ifrs-full:OtherLiabilities>
    <ifrs-full:OtherLiabilities contextRef="c434" decimals="0" unitRef="usd">180197</ifrs-full:OtherLiabilities>
    <ifrs-full:OtherLiabilities contextRef="c2" decimals="0" unitRef="usd">1956635</ifrs-full:OtherLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c433" decimals="0" unitRef="usd">2578100</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c434" decimals="0" unitRef="usd">72831</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c435" decimals="0" unitRef="usd">108638</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c2" decimals="0" unitRef="usd">2759569</ifrs-full:FinancialLiabilities>
    <mlec:SubtotalNonDerivatesLiabilities contextRef="c433" decimals="0" unitRef="usd">11834152</mlec:SubtotalNonDerivatesLiabilities>
    <mlec:SubtotalNonDerivatesLiabilities contextRef="c434" decimals="0" unitRef="usd">253028</mlec:SubtotalNonDerivatesLiabilities>
    <mlec:SubtotalNonDerivatesLiabilities contextRef="c435" decimals="0" unitRef="usd">108638</mlec:SubtotalNonDerivatesLiabilities>
    <mlec:SubtotalNonDerivatesLiabilities contextRef="c2" decimals="0" unitRef="usd">12195818</mlec:SubtotalNonDerivatesLiabilities>
    <ifrs-full:WarrantLiability contextRef="c433" decimals="0" unitRef="usd">887689</ifrs-full:WarrantLiability>
    <ifrs-full:WarrantLiability contextRef="c2" decimals="0" unitRef="usd">887689</ifrs-full:WarrantLiability>
    <mlec:SubtotalDerivatesLiabilities contextRef="c433" decimals="0" unitRef="usd">887689</mlec:SubtotalDerivatesLiabilities>
    <mlec:SubtotalDerivatesLiabilities contextRef="c2" decimals="0" unitRef="usd">887689</mlec:SubtotalDerivatesLiabilities>
    <mlec:TotalLiabilities contextRef="c433" decimals="0" unitRef="usd">12721841</mlec:TotalLiabilities>
    <mlec:TotalLiabilities contextRef="c434" decimals="0" unitRef="usd">253028</mlec:TotalLiabilities>
    <mlec:TotalLiabilities contextRef="c435" decimals="0" unitRef="usd">108638</mlec:TotalLiabilities>
    <mlec:TotalLiabilities contextRef="c2" decimals="0" unitRef="usd">13083507</mlec:TotalLiabilities>
    <ifrs-full:TradeAndOtherPayables contextRef="c438" decimals="0" unitRef="usd">1226213</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:TradeAndOtherPayables contextRef="c6" decimals="0" unitRef="usd">1226213</ifrs-full:TradeAndOtherPayables>
    <ifrs-full:OtherLiabilities contextRef="c438" decimals="0" unitRef="usd">1171</ifrs-full:OtherLiabilities>
    <ifrs-full:OtherLiabilities contextRef="c6" decimals="0" unitRef="usd">1171</ifrs-full:OtherLiabilities>
    <mlec:SimplyAgreementForFutureEquitySAFE contextRef="c438" decimals="0" unitRef="usd">2860000</mlec:SimplyAgreementForFutureEquitySAFE>
    <mlec:SimplyAgreementForFutureEquitySAFE contextRef="c6" decimals="0" unitRef="usd">2860000</mlec:SimplyAgreementForFutureEquitySAFE>
    <mlec:SubtotalNonDerivatesLiabilities contextRef="c438" decimals="0" unitRef="usd">4087384</mlec:SubtotalNonDerivatesLiabilities>
    <mlec:SubtotalNonDerivatesLiabilities contextRef="c6" decimals="0" unitRef="usd">4087384</mlec:SubtotalNonDerivatesLiabilities>
    <mlec:TotalLiabilities contextRef="c438" decimals="0" unitRef="usd">4087384</mlec:TotalLiabilities>
    <mlec:TotalLiabilities contextRef="c6" decimals="0" unitRef="usd">4087384</mlec:TotalLiabilities>
    <ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory contextRef="c0">The carrying amounts
of the Group&#x2019;s foreign currency denominated monetary assets and monetary liabilities at the reporting date are as follows:&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Currency&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Argentine pesos&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;765,690&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-700"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;50,073&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-701"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;U.S. Dollar&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;368,186&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-702"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,227,751&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-703"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Pound sterling&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;22,062&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-704"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-705"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(+10%) Impact to profit or loss before tax&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;(-10%) Impact to profit or loss before tax&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Currency&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Argentine pesos&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;76,569&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-706"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(5,007&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-707"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;U.S. Dollar&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36,819&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-708"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(222,775&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-709"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Pound sterling&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,206&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;803&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-710"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-711"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;</ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory>
    <mlec:ForeignCurrencyExchangeRiskAssets contextRef="c443" decimals="0" unitRef="usd">765690</mlec:ForeignCurrencyExchangeRiskAssets>
    <mlec:ForeignCurrencyExchangeRiskLiabilities contextRef="c443" decimals="0" unitRef="usd">50073</mlec:ForeignCurrencyExchangeRiskLiabilities>
    <mlec:ForeignCurrencyExchangeRiskAssets contextRef="c445" decimals="0" unitRef="usd">368186</mlec:ForeignCurrencyExchangeRiskAssets>
    <mlec:ForeignCurrencyExchangeRiskLiabilities contextRef="c445" decimals="0" unitRef="usd">2227751</mlec:ForeignCurrencyExchangeRiskLiabilities>
    <mlec:ForeignCurrencyExchangeRiskAssets contextRef="c447" decimals="0" unitRef="usd">22062</mlec:ForeignCurrencyExchangeRiskAssets>
    <mlec:ForeignCurrencyExchangeRiskAssets contextRef="c448" decimals="0" unitRef="usd">8025</mlec:ForeignCurrencyExchangeRiskAssets>
    <mlec:PercentageOfFunctionalCurrency contextRef="c0" decimals="2" unitRef="pure">0.10</mlec:PercentageOfFunctionalCurrency>
    <ifrs-full:TaxRateEffectOfForeignTaxRates contextRef="c0" decimals="2" unitRef="pure">0.10</ifrs-full:TaxRateEffectOfForeignTaxRates>
    <mlec:ForeignCurrencyExchangeRiskAssets contextRef="c449" decimals="0" unitRef="usd">76569</mlec:ForeignCurrencyExchangeRiskAssets>
    <mlec:ForeignCurrencyExchangeRiskLiabilities contextRef="c451" decimals="0" unitRef="usd">-5007</mlec:ForeignCurrencyExchangeRiskLiabilities>
    <mlec:ForeignCurrencyExchangeRiskAssets contextRef="c453" decimals="0" unitRef="usd">36819</mlec:ForeignCurrencyExchangeRiskAssets>
    <mlec:ForeignCurrencyExchangeRiskLiabilities contextRef="c455" decimals="0" unitRef="usd">-222775</mlec:ForeignCurrencyExchangeRiskLiabilities>
    <mlec:ForeignCurrencyExchangeRiskAssets contextRef="c457" decimals="0" unitRef="usd">2206</mlec:ForeignCurrencyExchangeRiskAssets>
    <mlec:ForeignCurrencyExchangeRiskAssets contextRef="c458" decimals="0" unitRef="usd">803</mlec:ForeignCurrencyExchangeRiskAssets>
    <ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory contextRef="c0">&lt;b&gt;Fair value and carrying
value of financial instruments:&lt;/b&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Recurring measurements&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Note&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Financial Assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;Amortized costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1.5pt"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: center; padding-bottom: 1.5pt"&gt;(i)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,064,079&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,081,808&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Trade and other receivables&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;(i)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,454,301&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,061&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Fair value through profit or loss&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;(ii)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;463,594&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-712"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Short-term investments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;(ii)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;306,034&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-713"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total financial assets&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;13,288,008&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;1,083,869&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;b&gt;Financial Liabilities&lt;/b&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Amortized costs&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Trade and other payables&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: center"&gt;(i)&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;9,340,571&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; text-align: right"&gt;1,227,384&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Financial debt&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;(i)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,645,289&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-714"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Fair value through profit or loss&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Simply Agreement for Future Equity (&#x201c;SAFE&#x201d;)&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-715"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;2,860,000&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Warrant liabilities&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;(ii)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;887,689&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-716"&gt;-&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total financial liabilities&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;12,873,549&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;4,087,384&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Net financial asset /(liability)&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;414,459&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"&gt;(3,003,515&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;span style="font-size: 10pt"&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Cash, short-term investments, trade and other receivables, prepayments, trade and other payables, and
loans payable are recorded at carrying value, which approximates fair value due to their short-term nature and generally negligible credit
losses.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;(ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Fair value of short-term investment and warrants has been
determined using the quoted market price at the year end (level 1).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;</ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory>
    <ifrs-full:CashAndCashEquivalents
      contextRef="c461"
      decimals="0"
      id="ix_75_fact"
      unitRef="usd">2064079</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="c462"
      decimals="0"
      id="ix_76_fact"
      unitRef="usd">1081808</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="c461"
      decimals="0"
      id="ix_77_fact"
      unitRef="usd">10454301</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="c462"
      decimals="0"
      id="ix_78_fact"
      unitRef="usd">2061</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents
      contextRef="c461"
      decimals="0"
      id="ix_82_fact"
      unitRef="usd">463594</ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents>
    <mlec:ShorttermInvestmentsCurrent
      contextRef="c461"
      decimals="0"
      id="ix_83_fact"
      unitRef="usd">306034</mlec:ShorttermInvestmentsCurrent>
    <ifrs-full:CurrentAssets contextRef="c461" decimals="0" unitRef="usd">13288008</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets contextRef="c462" decimals="0" unitRef="usd">1083869</ifrs-full:CurrentAssets>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="c461"
      decimals="0"
      id="ix_79_fact"
      unitRef="usd">9340571</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="c462"
      decimals="0"
      id="ix_80_fact"
      unitRef="usd">1227384</ifrs-full:TradeAndOtherCurrentPayables>
    <mlec:FinancialDebts
      contextRef="c461"
      decimals="0"
      id="ix_81_fact"
      unitRef="usd">2645289</mlec:FinancialDebts>
    <mlec:SimplyAgreementForFutureEquitySAFE contextRef="c462" decimals="0" unitRef="usd">2860000</mlec:SimplyAgreementForFutureEquitySAFE>
    <ifrs-full:WarrantLiability
      contextRef="c461"
      decimals="0"
      id="ix_84_fact"
      unitRef="usd">887689</ifrs-full:WarrantLiability>
    <ifrs-full:FinancialLiabilities contextRef="c461" decimals="0" unitRef="usd">12873549</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c462" decimals="0" unitRef="usd">4087384</ifrs-full:FinancialLiabilities>
    <ifrs-full:CurrentAssetsLiabilities contextRef="c461" decimals="0" unitRef="usd">414459</ifrs-full:CurrentAssetsLiabilities>
    <ifrs-full:CurrentAssetsLiabilities contextRef="c462" decimals="0" unitRef="usd">-3003515</ifrs-full:CurrentAssetsLiabilities>
    <mlec:DisclosureOfFixedRateInstruments contextRef="c0">The Group has not entered into derivative contracts to hedge
this exposure.&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"&gt;Fixed-rate instruments&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of&lt;br/&gt;
 June 30,&lt;br/&gt;
 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;As of &lt;br/&gt;
June 30,&lt;br/&gt;
 2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Current financial liabilities&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(2,546,243&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-717"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-718"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Non-current financial liabilities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(99,046&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-719"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-720"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</mlec:DisclosureOfFixedRateInstruments>
    <ifrs-full:OtherCurrentFinancialLiabilities contextRef="c2" decimals="0" unitRef="usd">2546243</ifrs-full:OtherCurrentFinancialLiabilities>
    <ifrs-full:OtherNoncurrentFinancialLiabilities contextRef="c2" decimals="0" unitRef="usd">99046</ifrs-full:OtherNoncurrentFinancialLiabilities>
    <mlec:PercentageOfInterestRates contextRef="c0" decimals="2" unitRef="pure">0.10</mlec:PercentageOfInterestRates>
    <mlec:IncreasedecreaseInterestPayable contextRef="c430" decimals="0" unitRef="usd">11428</mlec:IncreasedecreaseInterestPayable>
    <mlec:IncreasedecreaseInterestPayable contextRef="c0" decimals="0" unitRef="usd">-11428</mlec:IncreasedecreaseInterestPayable>
    <mlec:DisclosureOfCapitalRiskManagementTextBlock contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Note 30. Capital risk
management&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Company includes
as its capital its share capital and accumulated deficit and has no externally imposed capital requirements. The Company&#x2019;s objectives
in managing capital are to safeguard cash as well as maintain financial liquidity and flexibility in order to preserve its ability to
meet financial obligations, deploy capital to develop its mining properties and to maintain investor, creditor and market confidence to
sustain the future development of the business. The Company manages its capital structure and makes adjustments as needed, in order to
have funds available to support its activities. Management reviews its capital management approach on an ongoing basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The Company&#x2019;s financial
strategy is designed to maintain a capital structure consistent with the objective stated above and to respond to business growth opportunities
and changes in economic conditions, In order to maintain or adjust its capital structure, the Company may, from time to time, issue new
shares, acquire or dispose of assets or adjust its capital spending to manage its ability to continue as a going concern. (Note 15).&lt;/p&gt;</mlec:DisclosureOfCapitalRiskManagementTextBlock>
    <ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory contextRef="c0">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"&gt;Note 31. Events after
the reporting period&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;Management has considered
subsequent events through the date these consolidated financial statements were issued.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;As of October 15,
2023, the Company has entered into an agreement to issue a convertible note due 2026 to Grupo Insud (&#x201c;Insud&#x201d;) in a
principal amount of approximately $21 million (the &#x201c;Insud Convertible Note&#x201d;) with a strike price of US $6.00 per share.
The Insud Convertible Note will be issued against a cash payment of US $10 million and in-kind contributions to be made by Insud to
Moolec Science. In-kind contributions include credits to access Insud&#x2019;s state-of-the-art industrial capabilities, operational
services, and the incorporation of joint agreement participation, started with the Company in the past. At maturity, Moolec Science
will hold the option to deliver ordinary shares, cash, or a combination of cash and ordinary shares.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;The agreement signed
with Insud, follows Moolec Science&#x2019;s previous announcement that it entered into a Memorandum of Understanding with Bioceres Crop
Solutions &#x201c;BIOX&#x201d;) that secures the supply of approximately 15,000 tons of HB4&#xae; soybeans (the &#x201c;BIOX Supply Agreement&#x201d;)
that may be upsized for a similar volume. The BIOX Supply Agreement will be paid through the issuance of a convertible note (the&#160;&#x201c;BIOX
Convertible Note&#x2019;&#x2019;and together with the Insud Convertible Note, the&#160;&#x201c;Convertible Notes&#x201d;) on arms-length terms to
the Insud Convertible Note.&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Together,
the Convertible Notes total approximately US $30 million of cash and in-kind contributions that include soybean inventories, operational
services, and the acquisition of joint arrangement participation&lt;/span&gt;.&lt;/p&gt;</ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory>
    <ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk contextRef="c463" decimals="-6" unitRef="usd">21000000</ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk>
    <mlec:StrikePricePerShare contextRef="c464" decimals="2" unitRef="usdPershares">6</mlec:StrikePricePerShare>
    <ifrs-full:CashRepaymentsOfAdvancesAndLoansFromRelatedParties contextRef="c464" decimals="-6" unitRef="usd">10000000</ifrs-full:CashRepaymentsOfAdvancesAndLoansFromRelatedParties>
    <mlec:NumberOfStockInventories contextRef="c464" decimals="0" unitRef="pure">15000</mlec:NumberOfStockInventories>
    <mlec:CashPaidInKindInterest contextRef="c464" decimals="-6" unitRef="usd">30000000</mlec:CashPaidInKindInterest>
    <dei:DocumentAccountingStandard contextRef="c0" id="hidden-fact-0">International Financial Reporting Standards</dei:DocumentAccountingStandard>
    <ifrs-full:Revenue
      contextRef="c3"
      id="hidden-fact-1"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="c4"
      id="hidden-fact-2"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Revenue
      contextRef="c5"
      id="hidden-fact-3"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CostOfSales
      contextRef="c3"
      id="hidden-fact-4"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CostOfSales
      contextRef="c4"
      id="hidden-fact-5"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CostOfSales
      contextRef="c5"
      id="hidden-fact-6"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="c0"
      id="hidden-fact-7"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="c3"
      id="hidden-fact-8"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="c5"
      id="hidden-fact-9"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinanceCosts
      contextRef="c4"
      id="hidden-fact-10"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinanceCosts
      contextRef="c5"
      id="hidden-fact-11"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherFinanceIncomeCost
      contextRef="c4"
      id="hidden-fact-12"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherFinanceIncomeCost
      contextRef="c5"
      id="hidden-fact-13"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:TransactionsExpenses
      contextRef="c3"
      id="hidden-fact-14"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:TransactionsExpenses
      contextRef="c4"
      id="hidden-fact-15"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:TransactionsExpenses
      contextRef="c5"
      id="hidden-fact-16"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="c3"
      id="hidden-fact-17"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="c4"
      id="hidden-fact-18"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="c5"
      id="hidden-fact-19"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="c3"
      id="hidden-fact-20"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="c4"
      id="hidden-fact-21"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="c5"
      id="hidden-fact-22"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c5"
      decimals="2"
      id="hidden-fact-23"
      unitRef="usdPershares">-0.01</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c4"
      decimals="2"
      id="hidden-fact-24"
      unitRef="usdPershares">-0.07</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c3"
      decimals="2"
      id="hidden-fact-25"
      unitRef="usdPershares">-0.15</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c0"
      decimals="2"
      id="hidden-fact-26"
      unitRef="usdPershares">-1.50</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax
      contextRef="c3"
      id="hidden-fact-27"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax
      contextRef="c4"
      id="hidden-fact-28"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax
      contextRef="c5"
      id="hidden-fact-29"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="c3"
      id="hidden-fact-30"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="c4"
      id="hidden-fact-31"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="c5"
      id="hidden-fact-32"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Goodwill
      contextRef="c6"
      id="hidden-fact-33"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RightofuseAssets
      contextRef="c6"
      id="hidden-fact-34"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentReceivables
      contextRef="c6"
      id="hidden-fact-35"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ShorttermInvestmentsCurrent
      contextRef="c6"
      id="hidden-fact-36"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentTradeReceivables
      contextRef="c6"
      id="hidden-fact-37"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherReceivables
      contextRef="c6"
      id="hidden-fact-38"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Inventories
      contextRef="c6"
      id="hidden-fact-39"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ShareToBeIssuedAmount
      contextRef="c6"
      id="hidden-fact-40"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation
      contextRef="c6"
      id="hidden-fact-41"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherCurrentFinancialLiabilities
      contextRef="c6"
      id="hidden-fact-42"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:WarrantLiability
      contextRef="c6"
      id="hidden-fact-43"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SimplyAgreementForFutureEquitySAFE
      contextRef="c2"
      id="hidden-fact-44"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentFinancialLiabilities
      contextRef="c6"
      id="hidden-fact-45"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentPayables
      contextRef="c6"
      id="hidden-fact-46"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="c6"
      id="hidden-fact-47"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentLiabilities
      contextRef="c6"
      id="hidden-fact-48"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="c7"
      id="hidden-fact-49"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="c8"
      id="hidden-fact-50"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="c9"
      id="hidden-fact-51"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="c10"
      id="hidden-fact-52"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="c11"
      id="hidden-fact-53"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="c12"
      id="hidden-fact-54"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="c13"
      id="hidden-fact-55"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapital
      contextRef="c15"
      id="hidden-fact-56"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapital
      contextRef="c17"
      id="hidden-fact-57"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapital
      contextRef="c18"
      id="hidden-fact-58"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapital
      contextRef="c19"
      id="hidden-fact-59"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax
      contextRef="c14"
      id="hidden-fact-60"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax
      contextRef="c15"
      id="hidden-fact-61"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax
      contextRef="c16"
      id="hidden-fact-62"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax
      contextRef="c17"
      id="hidden-fact-63"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax
      contextRef="c18"
      id="hidden-fact-64"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="c21"
      id="hidden-fact-65"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="c23"
      id="hidden-fact-66"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="c24"
      id="hidden-fact-67"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapital
      contextRef="c28"
      id="hidden-fact-68"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapital
      contextRef="c30"
      id="hidden-fact-69"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapital
      contextRef="c31"
      id="hidden-fact-70"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapital
      contextRef="c32"
      id="hidden-fact-71"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax
      contextRef="c27"
      id="hidden-fact-72"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax
      contextRef="c28"
      id="hidden-fact-73"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax
      contextRef="c29"
      id="hidden-fact-74"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax
      contextRef="c30"
      id="hidden-fact-75"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax
      contextRef="c31"
      id="hidden-fact-76"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="c34"
      id="hidden-fact-77"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="c36"
      id="hidden-fact-78"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="c37"
      id="hidden-fact-79"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:EquitySettledShareBasedPayment
      contextRef="c40"
      id="hidden-fact-80"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:EquitySettledShareBasedPayment
      contextRef="c41"
      id="hidden-fact-81"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:EquitySettledShareBasedPayment
      contextRef="c42"
      id="hidden-fact-82"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:EquitySettledShareBasedPayment
      contextRef="c43"
      id="hidden-fact-83"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:EquitySettledShareBasedPayment
      contextRef="c45"
      id="hidden-fact-84"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax
      contextRef="c40"
      id="hidden-fact-85"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax
      contextRef="c41"
      id="hidden-fact-86"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax
      contextRef="c42"
      id="hidden-fact-87"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax
      contextRef="c43"
      id="hidden-fact-88"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax
      contextRef="c44"
      id="hidden-fact-89"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="c47"
      id="hidden-fact-90"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="c49"
      id="hidden-fact-91"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="c53"
      id="hidden-fact-92"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="c55"
      id="hidden-fact-93"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="c56"
      id="hidden-fact-94"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="c57"
      id="hidden-fact-95"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapitalSAFEShares
      contextRef="c53"
      id="hidden-fact-96"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapitalSAFEShares
      contextRef="c55"
      id="hidden-fact-97"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapitalSAFEShares
      contextRef="c56"
      id="hidden-fact-98"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapitalSAFEShares
      contextRef="c57"
      id="hidden-fact-99"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapitalLightJumpShares
      contextRef="c53"
      id="hidden-fact-100"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapitalLightJumpShares
      contextRef="c55"
      id="hidden-fact-101"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapitalLightJumpShares
      contextRef="c56"
      id="hidden-fact-102"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapitalLightJumpShares
      contextRef="c57"
      id="hidden-fact-103"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapitalBackstopShares
      contextRef="c53"
      id="hidden-fact-104"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapitalBackstopShares
      contextRef="c55"
      id="hidden-fact-105"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapitalBackstopShares
      contextRef="c56"
      id="hidden-fact-106"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapitalBackstopShares
      contextRef="c57"
      id="hidden-fact-107"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapital
      contextRef="c53"
      id="hidden-fact-108"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapital
      contextRef="c55"
      id="hidden-fact-109"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapital
      contextRef="c56"
      id="hidden-fact-110"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapital
      contextRef="c57"
      id="hidden-fact-111"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:EquitySettledShareBasedPayment
      contextRef="c55"
      id="hidden-fact-112"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:EquitySettledShareBasedPayment
      contextRef="c57"
      id="hidden-fact-113"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax
      contextRef="c52"
      id="hidden-fact-114"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax
      contextRef="c53"
      id="hidden-fact-115"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax
      contextRef="c54"
      id="hidden-fact-116"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax
      contextRef="c56"
      id="hidden-fact-117"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax
      contextRef="c57"
      id="hidden-fact-118"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:BusinessCombination
      contextRef="c52"
      id="hidden-fact-119"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:BusinessCombination
      contextRef="c55"
      id="hidden-fact-120"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:BusinessCombination
      contextRef="c56"
      id="hidden-fact-121"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:BusinessCombination
      contextRef="c57"
      id="hidden-fact-122"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c52"
      id="hidden-fact-123"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c53"
      id="hidden-fact-124"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c54"
      id="hidden-fact-125"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c55"
      id="hidden-fact-126"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="c56"
      id="hidden-fact-127"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForIncomeTaxExpense
      contextRef="c3"
      id="hidden-fact-128"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForIncomeTaxExpense
      contextRef="c4"
      id="hidden-fact-129"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForIncomeTaxExpense
      contextRef="c5"
      id="hidden-fact-130"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="c4"
      id="hidden-fact-131"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="c5"
      id="hidden-fact-132"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="c4"
      id="hidden-fact-133"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="c5"
      id="hidden-fact-134"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="c0"
      id="hidden-fact-135"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="c3"
      id="hidden-fact-136"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="c5"
      id="hidden-fact-137"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c4"
      id="hidden-fact-138"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="c5"
      id="hidden-fact-139"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ShareBasedPaymentCostOfListingSharesnoncashItem
      contextRef="c3"
      id="hidden-fact-140"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ShareBasedPaymentCostOfListingSharesnoncashItem
      contextRef="c4"
      id="hidden-fact-141"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ShareBasedPaymentCostOfListingSharesnoncashItem
      contextRef="c5"
      id="hidden-fact-142"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinanceIncomeCost
      contextRef="c4"
      id="hidden-fact-143"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinanceIncomeCost
      contextRef="c5"
      id="hidden-fact-144"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables
      contextRef="c3"
      id="hidden-fact-145"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables
      contextRef="c4"
      id="hidden-fact-146"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables
      contextRef="c5"
      id="hidden-fact-147"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets
      contextRef="c3"
      id="hidden-fact-148"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets
      contextRef="c4"
      id="hidden-fact-149"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets
      contextRef="c5"
      id="hidden-fact-150"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="c0"
      id="hidden-fact-151"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="c3"
      id="hidden-fact-152"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses
      contextRef="c5"
      id="hidden-fact-153"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="c3"
      id="hidden-fact-154"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="c4"
      id="hidden-fact-155"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="c5"
      id="hidden-fact-156"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:OtherLiabilitie
      contextRef="c4"
      id="hidden-fact-157"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:OtherLiabilitie
      contextRef="c5"
      id="hidden-fact-158"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="c3"
      id="hidden-fact-159"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="c4"
      id="hidden-fact-160"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="c5"
      id="hidden-fact-161"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="c3"
      id="hidden-fact-162"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="c4"
      id="hidden-fact-163"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="c5"
      id="hidden-fact-164"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="c3"
      id="hidden-fact-165"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="c4"
      id="hidden-fact-166"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="c5"
      id="hidden-fact-167"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments
      contextRef="c3"
      id="hidden-fact-168"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments
      contextRef="c4"
      id="hidden-fact-169"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments
      contextRef="c5"
      id="hidden-fact-170"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities
      contextRef="c3"
      id="hidden-fact-171"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities
      contextRef="c4"
      id="hidden-fact-172"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities
      contextRef="c5"
      id="hidden-fact-173"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="c3"
      id="hidden-fact-174"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="c4"
      id="hidden-fact-175"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="c5"
      id="hidden-fact-176"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromIssuingOtherEquityInstruments
      contextRef="c3"
      id="hidden-fact-177"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromIssuingOtherEquityInstruments
      contextRef="c4"
      id="hidden-fact-178"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromIssuingOtherEquityInstruments
      contextRef="c5"
      id="hidden-fact-179"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:Proceedsfromissuanceofsharecapital
      contextRef="c3"
      id="hidden-fact-180"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:Proceedsfromissuanceofsharecapital
      contextRef="c4"
      id="hidden-fact-181"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:Proceedsfromissuanceofsharecapital
      contextRef="c5"
      id="hidden-fact-182"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromCurrentBorrowings
      contextRef="c3"
      id="hidden-fact-183"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromCurrentBorrowings
      contextRef="c4"
      id="hidden-fact-184"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromCurrentBorrowings
      contextRef="c5"
      id="hidden-fact-185"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="c3"
      id="hidden-fact-186"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="c4"
      id="hidden-fact-187"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="c5"
      id="hidden-fact-188"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="c3"
      id="hidden-fact-189"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="c4"
      id="hidden-fact-190"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities
      contextRef="c5"
      id="hidden-fact-191"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ProceedsFromSAFE
      contextRef="c0"
      id="hidden-fact-192"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ProceedsFromSAFE
      contextRef="c4"
      id="hidden-fact-193"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ProceedsFromSAFE
      contextRef="c5"
      id="hidden-fact-194"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="c3"
      id="hidden-fact-195"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="c4"
      id="hidden-fact-196"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="c5"
      id="hidden-fact-197"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ProceedsFromIssueOfShareCapital
      contextRef="c0"
      id="hidden-fact-198"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ProceedsFromIssueOfShareCapital
      contextRef="c3"
      id="hidden-fact-199"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ProceedsFromIssueOfShareCapital
      contextRef="c4"
      id="hidden-fact-200"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="c0"
      id="hidden-fact-201"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="c3"
      id="hidden-fact-202"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="c4"
      id="hidden-fact-203"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="c4"
      id="hidden-fact-204"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="c5"
      id="hidden-fact-205"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition
      contextRef="c26"
      id="hidden-fact-206"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition
      contextRef="c13"
      id="hidden-fact-207"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="c4"
      id="hidden-fact-208"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="c5"
      id="hidden-fact-209"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition
      contextRef="c26"
      id="hidden-fact-210"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei
      contextRef="c3"
      id="hidden-fact-211"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei
      contextRef="c4"
      id="hidden-fact-212"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei
      contextRef="c5"
      id="hidden-fact-213"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium
      contextRef="c3"
      id="hidden-fact-214"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium
      contextRef="c4"
      id="hidden-fact-215"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium
      contextRef="c5"
      id="hidden-fact-216"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:CapitalizationOfTransactionExpensesThroughAccountsPayable
      contextRef="c3"
      id="hidden-fact-217"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:CapitalizationOfTransactionExpensesThroughAccountsPayable
      contextRef="c4"
      id="hidden-fact-218"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:CapitalizationOfTransactionExpensesThroughAccountsPayable
      contextRef="c5"
      id="hidden-fact-219"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NetLiabilitiesAcquiredThroughIssuanceOfShareCapital
      contextRef="c3"
      id="hidden-fact-220"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NetLiabilitiesAcquiredThroughIssuanceOfShareCapital
      contextRef="c4"
      id="hidden-fact-221"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NetLiabilitiesAcquiredThroughIssuanceOfShareCapital
      contextRef="c5"
      id="hidden-fact-222"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AcquisitionOfBusinessCombinationTroughDeferredPayment
      contextRef="c3"
      id="hidden-fact-223"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AcquisitionOfBusinessCombinationTroughDeferredPayment
      contextRef="c4"
      id="hidden-fact-224"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AcquisitionOfBusinessCombinationTroughDeferredPayment
      contextRef="c5"
      id="hidden-fact-225"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind
      contextRef="c3"
      id="hidden-fact-226"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind
      contextRef="c4"
      id="hidden-fact-227"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind
      contextRef="c5"
      id="hidden-fact-228"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares
      contextRef="c0"
      id="hidden-fact-229"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares
      contextRef="c3"
      id="hidden-fact-230"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:Accumulated contextRef="c73" id="hidden-fact-231">P3Y</mlec:Accumulated>
    <mlec:Cost
      contextRef="c95"
      id="hidden-fact-232"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:Cost
      contextRef="c96"
      id="hidden-fact-233"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:Cost
      contextRef="c97"
      id="hidden-fact-234"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:Cost
      contextRef="c98"
      id="hidden-fact-235"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:Cost
      contextRef="c99"
      id="hidden-fact-236"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="c95"
      id="hidden-fact-237"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="c96"
      id="hidden-fact-238"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="c97"
      id="hidden-fact-239"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="c98"
      id="hidden-fact-240"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="c99"
      id="hidden-fact-241"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NetBookAmount
      contextRef="c100"
      id="hidden-fact-242"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NetBookAmount
      contextRef="c101"
      id="hidden-fact-243"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NetBookAmount
      contextRef="c102"
      id="hidden-fact-244"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NetBookAmount
      contextRef="c103"
      id="hidden-fact-245"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NetBookAmount
      contextRef="c26"
      id="hidden-fact-246"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c104"
      id="hidden-fact-247"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c105"
      id="hidden-fact-248"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c106"
      id="hidden-fact-249"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c107"
      id="hidden-fact-250"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c108"
      id="hidden-fact-251"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="c111"
      id="hidden-fact-252"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="c112"
      id="hidden-fact-253"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c116"
      id="hidden-fact-254"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c117"
      id="hidden-fact-255"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:Cost
      contextRef="c111"
      id="hidden-fact-256"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:Cost
      contextRef="c112"
      id="hidden-fact-257"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="c109"
      id="hidden-fact-258"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="c110"
      id="hidden-fact-259"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="c111"
      id="hidden-fact-260"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="c112"
      id="hidden-fact-261"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="c113"
      id="hidden-fact-262"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NetBookAmount
      contextRef="c116"
      id="hidden-fact-263"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NetBookAmount
      contextRef="c117"
      id="hidden-fact-264"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c116"
      id="hidden-fact-265"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c117"
      id="hidden-fact-266"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c120"
      id="hidden-fact-267"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c121"
      id="hidden-fact-268"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:Cost
      contextRef="c124"
      id="hidden-fact-269"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:Cost
      contextRef="c125"
      id="hidden-fact-270"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="c122"
      id="hidden-fact-271"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="c123"
      id="hidden-fact-272"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="c124"
      id="hidden-fact-273"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="c125"
      id="hidden-fact-274"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="c3"
      id="hidden-fact-275"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NetBookAmount
      contextRef="c120"
      id="hidden-fact-276"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NetBookAmount
      contextRef="c121"
      id="hidden-fact-277"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c120"
      id="hidden-fact-278"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="c121"
      id="hidden-fact-279"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="c128"
      id="hidden-fact-280"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="c129"
      id="hidden-fact-281"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="c126"
      id="hidden-fact-282"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="c127"
      id="hidden-fact-283"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="c126"
      id="hidden-fact-284"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="c127"
      id="hidden-fact-285"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:Amortization
      contextRef="c126"
      id="hidden-fact-286"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:Amortization
      contextRef="c127"
      id="hidden-fact-287"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="c126"
      id="hidden-fact-288"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="c127"
      id="hidden-fact-289"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c134"
      id="hidden-fact-290"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c135"
      id="hidden-fact-291"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c136"
      id="hidden-fact-292"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c137"
      id="hidden-fact-293"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c138"
      id="hidden-fact-294"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c139"
      id="hidden-fact-295"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c140"
      id="hidden-fact-296"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c141"
      id="hidden-fact-297"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c142"
      id="hidden-fact-298"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c143"
      id="hidden-fact-299"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c144"
      id="hidden-fact-300"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c145"
      id="hidden-fact-301"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c146"
      id="hidden-fact-302"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c147"
      id="hidden-fact-303"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c148"
      id="hidden-fact-304"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c149"
      id="hidden-fact-305"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c150"
      id="hidden-fact-306"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c151"
      id="hidden-fact-307"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c152"
      id="hidden-fact-308"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c153"
      id="hidden-fact-309"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c154"
      id="hidden-fact-310"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c155"
      id="hidden-fact-311"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c156"
      id="hidden-fact-312"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c157"
      id="hidden-fact-313"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c158"
      id="hidden-fact-314"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c159"
      id="hidden-fact-315"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c160"
      id="hidden-fact-316"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c108"
      id="hidden-fact-317"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c162"
      id="hidden-fact-318"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c163"
      id="hidden-fact-319"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c164"
      id="hidden-fact-320"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c165"
      id="hidden-fact-321"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c166"
      id="hidden-fact-322"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c168"
      id="hidden-fact-323"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c169"
      id="hidden-fact-324"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c170"
      id="hidden-fact-325"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c171"
      id="hidden-fact-326"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c172"
      id="hidden-fact-327"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c174"
      id="hidden-fact-328"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c175"
      id="hidden-fact-329"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c176"
      id="hidden-fact-330"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c177"
      id="hidden-fact-331"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c178"
      id="hidden-fact-332"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c180"
      id="hidden-fact-333"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c181"
      id="hidden-fact-334"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c182"
      id="hidden-fact-335"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c183"
      id="hidden-fact-336"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c184"
      id="hidden-fact-337"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c185"
      id="hidden-fact-338"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c186"
      id="hidden-fact-339"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c188"
      id="hidden-fact-340"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c189"
      id="hidden-fact-341"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c190"
      id="hidden-fact-342"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c191"
      id="hidden-fact-343"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c192"
      id="hidden-fact-344"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c168"
      id="hidden-fact-345"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c169"
      id="hidden-fact-346"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c170"
      id="hidden-fact-347"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c171"
      id="hidden-fact-348"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c172"
      id="hidden-fact-349"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="c195"
      id="hidden-fact-350"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="c196"
      id="hidden-fact-351"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="c197"
      id="hidden-fact-352"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="c198"
      id="hidden-fact-353"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="c199"
      id="hidden-fact-354"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c201"
      id="hidden-fact-355"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c202"
      id="hidden-fact-356"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c203"
      id="hidden-fact-357"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c204"
      id="hidden-fact-358"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c205"
      id="hidden-fact-359"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c207"
      id="hidden-fact-360"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c208"
      id="hidden-fact-361"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c209"
      id="hidden-fact-362"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c210"
      id="hidden-fact-363"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c211"
      id="hidden-fact-364"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c214"
      id="hidden-fact-365"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c215"
      id="hidden-fact-366"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c216"
      id="hidden-fact-367"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c217"
      id="hidden-fact-368"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c218"
      id="hidden-fact-369"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c221"
      id="hidden-fact-370"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c222"
      id="hidden-fact-371"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c223"
      id="hidden-fact-372"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c224"
      id="hidden-fact-373"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c225"
      id="hidden-fact-374"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c201"
      id="hidden-fact-375"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c202"
      id="hidden-fact-376"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c203"
      id="hidden-fact-377"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c204"
      id="hidden-fact-378"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="c205"
      id="hidden-fact-379"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c227"
      id="hidden-fact-380"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment
      contextRef="c227"
      id="hidden-fact-381"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c227"
      id="hidden-fact-382"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c82"
      id="hidden-fact-383"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c83"
      id="hidden-fact-384"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="c229"
      id="hidden-fact-385"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Goodwill
      contextRef="c6"
      id="hidden-fact-386"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:TotalGoodwill
      contextRef="c6"
      id="hidden-fact-387"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RightofuseAssets
      contextRef="c6"
      id="hidden-fact-388"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:MutualFunds
      contextRef="c6"
      id="hidden-fact-389"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:TotalMutualFunds
      contextRef="c3"
      id="hidden-fact-390"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:TradeReceivables
      contextRef="c6"
      id="hidden-fact-391"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherReceivables
      contextRef="c6"
      id="hidden-fact-392"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentValueAddedTaxReceivables
      contextRef="c6"
      id="hidden-fact-393"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherCurrentReceivables
      contextRef="c6"
      id="hidden-fact-394"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="c6"
      id="hidden-fact-395"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RawMaterials
      contextRef="c6"
      id="hidden-fact-396"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinishedGoods
      contextRef="c6"
      id="hidden-fact-397"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:InventoriesTotal
      contextRef="c6"
      id="hidden-fact-398"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c13"
      id="hidden-fact-399"
      unitRef="shares"
      xsi:nil="true"/>
    <mlec:SharesIssuedAmount
      contextRef="c13"
      id="hidden-fact-400"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ShareToBeIssuedAmount
      contextRef="c13"
      id="hidden-fact-401"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:SharePremium
      contextRef="c13"
      id="hidden-fact-402"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SharesToBeIssuedAmountIssueOfShareCapital
      contextRef="c26"
      id="hidden-fact-403"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ShareToBeIssuedAmount
      contextRef="c26"
      id="hidden-fact-404"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SharesToBeIssuedAmountIssueOfShareCapital
      contextRef="c39"
      id="hidden-fact-405"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ShareToBeIssuedAmount
      contextRef="c39"
      id="hidden-fact-406"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NumberOfSharesIssueOfShareCapitalinShares
      contextRef="c3"
      id="hidden-fact-407"
      unitRef="shares"
      xsi:nil="true"/>
    <ifrs-full:PaymentsForShareIssueCosts
      contextRef="c3"
      id="hidden-fact-408"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SharesToBeIssuedAmountIssueOfShareCapital
      contextRef="c6"
      id="hidden-fact-409"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SharePremiumIssueOfShareCapital
      contextRef="c3"
      id="hidden-fact-410"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ShareToBeIssuedAmount
      contextRef="c6"
      id="hidden-fact-411"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SharesToBeIssuedAmountIssueOfShareCapital
      contextRef="c261"
      id="hidden-fact-412"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NumberOfSharesIssueOfShareCapitalinShares
      contextRef="c262"
      decimals="INF"
      id="hidden-fact-413"
      unitRef="shares">262260</mlec:NumberOfSharesIssueOfShareCapitalinShares>
    <mlec:SharesToBeIssuedAmountIssueOfShareCapital
      contextRef="c263"
      id="hidden-fact-414"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SharesToBeIssuedAmountIssueOfShareCapital
      contextRef="c265"
      id="hidden-fact-415"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SharesToBeIssuedAmountIssueOfShareCapital
      contextRef="c267"
      id="hidden-fact-416"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SharesToBeIssuedAmountIssueOfShareCapital
      contextRef="c2"
      id="hidden-fact-417"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NumberOfSharesFromBusinessAcquisition
      contextRef="c0"
      id="hidden-fact-418"
      unitRef="shares"
      xsi:nil="true"/>
    <mlec:SharesIssuedAmountFromBusinessAcquisition
      contextRef="c0"
      id="hidden-fact-419"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ExercisePrice contextRef="c271" id="hidden-fact-420">$1.52</mlec:ExercisePrice>
    <mlec:ExercisePrice contextRef="c272" id="hidden-fact-421">$8.00</mlec:ExercisePrice>
    <mlec:ExercisePrice contextRef="c273" id="hidden-fact-422">$4.25</mlec:ExercisePrice>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="c271"
      id="hidden-fact-423"
      unitRef="pure"
      xsi:nil="true"/>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="c272"
      id="hidden-fact-424"
      unitRef="pure"
      xsi:nil="true"/>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="c273"
      id="hidden-fact-425"
      unitRef="pure"
      xsi:nil="true"/>
    <mlec:NumberOfOptionsAtTheBeginning
      contextRef="c271"
      id="hidden-fact-426"
      unitRef="shares"
      xsi:nil="true"/>
    <mlec:ExercisePriceAtTheBeginning
      contextRef="c271"
      id="hidden-fact-427"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <mlec:NumberOfOptionsAtTheBeginning
      contextRef="c272"
      id="hidden-fact-428"
      unitRef="shares"
      xsi:nil="true"/>
    <mlec:ExercisePriceAtTheBeginning
      contextRef="c272"
      id="hidden-fact-429"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <mlec:NumberOfOptionsAtTheBeginning
      contextRef="c273"
      id="hidden-fact-430"
      unitRef="shares"
      xsi:nil="true"/>
    <mlec:ExercisePriceAtTheBeginning
      contextRef="c273"
      id="hidden-fact-431"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <mlec:NumberOfOptionsForfeitedDuringThePeriod
      contextRef="c271"
      id="hidden-fact-432"
      unitRef="shares"
      xsi:nil="true"/>
    <mlec:ExercisePriceForfeitedDuringThePeriod
      contextRef="c271"
      id="hidden-fact-433"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <mlec:NumberOfOptionsForfeitedDuringThePeriod
      contextRef="c272"
      id="hidden-fact-434"
      unitRef="shares"
      xsi:nil="true"/>
    <mlec:ExercisePriceForfeitedDuringThePeriod
      contextRef="c272"
      id="hidden-fact-435"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <mlec:NumberOfOptionsForfeitedDuringThePeriod
      contextRef="c273"
      id="hidden-fact-436"
      unitRef="shares"
      xsi:nil="true"/>
    <mlec:ExercisePriceForfeitedDuringThePeriod
      contextRef="c273"
      id="hidden-fact-437"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <mlec:NumberOfOptionsExercisedDuringThePeriod
      contextRef="c273"
      id="hidden-fact-438"
      unitRef="shares"
      xsi:nil="true"/>
    <mlec:ExercisePriceExercisedDuringThePeriod
      contextRef="c273"
      id="hidden-fact-439"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <mlec:NumberOfOptionsExpiredDuringThePeriod
      contextRef="c271"
      id="hidden-fact-440"
      unitRef="shares"
      xsi:nil="true"/>
    <mlec:ExercisePriceExpiredDuringThePeriod
      contextRef="c271"
      id="hidden-fact-441"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <mlec:NumberOfOptionsExpiredDuringThePeriod
      contextRef="c272"
      id="hidden-fact-442"
      unitRef="shares"
      xsi:nil="true"/>
    <mlec:ExercisePriceExpiredDuringThePeriod
      contextRef="c272"
      id="hidden-fact-443"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <mlec:NumberOfOptionsExpiredDuringThePeriod
      contextRef="c273"
      id="hidden-fact-444"
      unitRef="shares"
      xsi:nil="true"/>
    <mlec:ExercisePriceExpiredDuringThePeriod
      contextRef="c273"
      id="hidden-fact-445"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentPayablesToRelatedParties
      contextRef="c6"
      id="hidden-fact-446"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:DeferredPaymentRelatedToBusinessCombination
      contextRef="c6"
      id="hidden-fact-447"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:Wages
      contextRef="c6"
      id="hidden-fact-448"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:Taxes
      contextRef="c6"
      id="hidden-fact-449"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherCurrentNonfinancialLiabilities
      contextRef="c6"
      id="hidden-fact-450"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentNonfinancialLiabilities
      contextRef="c6"
      id="hidden-fact-451"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="c6"
      id="hidden-fact-452"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentFinancialAssetsAtAmortisedCost
      contextRef="c275"
      id="hidden-fact-453"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentFinancialAssetsAtAmortisedCost
      contextRef="c277"
      id="hidden-fact-454"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CurrentFinancialAssetsAtAmortisedCost
      contextRef="c6"
      id="hidden-fact-455"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="c275"
      id="hidden-fact-456"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="c6"
      id="hidden-fact-457"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Borrowings
      contextRef="c281"
      id="hidden-fact-458"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Borrowings
      contextRef="c285"
      id="hidden-fact-459"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Borrowings
      contextRef="c289"
      id="hidden-fact-460"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Borrowings
      contextRef="c293"
      id="hidden-fact-461"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Borrowings
      contextRef="c297"
      id="hidden-fact-462"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Borrowings
      contextRef="c301"
      id="hidden-fact-463"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Borrowings
      contextRef="c305"
      id="hidden-fact-464"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Borrowings
      contextRef="c309"
      id="hidden-fact-465"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Borrowings
      contextRef="c313"
      id="hidden-fact-466"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Borrowings
      contextRef="c317"
      id="hidden-fact-467"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Borrowings
      contextRef="c321"
      id="hidden-fact-468"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Borrowings
      contextRef="c325"
      id="hidden-fact-469"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:WarrantAndRightsOutstanding
      contextRef="c326"
      id="hidden-fact-470"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue
      contextRef="c6"
      id="hidden-fact-471"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue
      contextRef="c39"
      id="hidden-fact-472"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue
      contextRef="c108"
      id="hidden-fact-473"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:Additions
      contextRef="c2"
      id="hidden-fact-474"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:Additions
      contextRef="c39"
      id="hidden-fact-475"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:Additions
      contextRef="c108"
      id="hidden-fact-476"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="c39"
      id="hidden-fact-477"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="c108"
      id="hidden-fact-478"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SAFECapitalization
      contextRef="c6"
      id="hidden-fact-479"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SAFECapitalization
      contextRef="c39"
      id="hidden-fact-480"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SAFECapitalization
      contextRef="c108"
      id="hidden-fact-481"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue
      contextRef="c2"
      id="hidden-fact-482"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue
      contextRef="c39"
      id="hidden-fact-483"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue
      contextRef="c108"
      id="hidden-fact-484"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="c6"
      id="hidden-fact-485"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="c39"
      id="hidden-fact-486"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="c108"
      id="hidden-fact-487"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="c335"
      id="hidden-fact-488"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncorporatedThroughTheBusinessCombination
      contextRef="c3"
      id="hidden-fact-489"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncorporatedThroughTheBusinessCombination
      contextRef="c113"
      id="hidden-fact-490"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncorporatedThroughTheBusinessCombination
      contextRef="c336"
      id="hidden-fact-491"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss
      contextRef="c3"
      id="hidden-fact-492"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss
      contextRef="c113"
      id="hidden-fact-493"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss
      contextRef="c336"
      id="hidden-fact-494"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ChargedToOtherComprehensiveIncome
      contextRef="c3"
      id="hidden-fact-495"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ChargedToOtherComprehensiveIncome
      contextRef="c113"
      id="hidden-fact-496"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ChargedToOtherComprehensiveIncome
      contextRef="c336"
      id="hidden-fact-497"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="c6"
      id="hidden-fact-498"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="c39"
      id="hidden-fact-499"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="c108"
      id="hidden-fact-500"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:TaxJurisdiction
      contextRef="c339"
      id="hidden-fact-501"
      unitRef="pure"
      xsi:nil="true"/>
    <mlec:TaxJurisdiction
      contextRef="c340"
      id="hidden-fact-502"
      unitRef="pure"
      xsi:nil="true"/>
    <mlec:TaxJurisdiction
      contextRef="c341"
      id="hidden-fact-503"
      unitRef="pure"
      xsi:nil="true"/>
    <mlec:TaxJurisdiction
      contextRef="c342"
      id="hidden-fact-504"
      unitRef="pure"
      xsi:nil="true"/>
    <mlec:TaxJurisdiction
      contextRef="c343"
      id="hidden-fact-505"
      unitRef="pure"
      xsi:nil="true"/>
    <mlec:TaxJurisdiction
      contextRef="c344"
      id="hidden-fact-506"
      unitRef="pure"
      xsi:nil="true"/>
    <mlec:EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions
      contextRef="c6"
      id="hidden-fact-507"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions
      contextRef="c39"
      id="hidden-fact-508"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions
      contextRef="c353"
      id="hidden-fact-509"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NondeductibleExpensesListingCost
      contextRef="c6"
      id="hidden-fact-510"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NondeductibleExpensesListingCost
      contextRef="c39"
      id="hidden-fact-511"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NondeductibleExpensesListingCost
      contextRef="c353"
      id="hidden-fact-512"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NetGainOnInflationEffectOnMonetaryItems
      contextRef="c6"
      id="hidden-fact-513"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NetGainOnInflationEffectOnMonetaryItems
      contextRef="c39"
      id="hidden-fact-514"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NetGainOnInflationEffectOnMonetaryItems
      contextRef="c353"
      id="hidden-fact-515"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncomeTaxInflationAdjustment
      contextRef="c6"
      id="hidden-fact-516"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncomeTaxInflationAdjustment
      contextRef="c39"
      id="hidden-fact-517"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IncomeTaxInflationAdjustment
      contextRef="c353"
      id="hidden-fact-518"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:Others
      contextRef="c354"
      id="hidden-fact-519"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:Others
      contextRef="c355"
      id="hidden-fact-520"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:Others
      contextRef="c356"
      id="hidden-fact-521"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:TaxBenefitForTheYear
      contextRef="c6"
      id="hidden-fact-522"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:TaxBenefitForTheYear
      contextRef="c39"
      id="hidden-fact-523"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:TaxBenefitForTheYear
      contextRef="c353"
      id="hidden-fact-524"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised
      contextRef="c358"
      id="hidden-fact-525"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherCurrentReceivables
      contextRef="c358"
      id="hidden-fact-526"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:CustomerRelationship
      contextRef="c358"
      id="hidden-fact-527"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DeferredTaxLiabilityAsset
      contextRef="c358"
      id="hidden-fact-528"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NetDeferredTaxLiabilities
      contextRef="c358"
      id="hidden-fact-529"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:InterestExpenses
      contextRef="c39"
      id="hidden-fact-530"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:InterestExpenses
      contextRef="c26"
      id="hidden-fact-531"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:TotalFinancialCosts
      contextRef="c39"
      id="hidden-fact-532"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:TotalFinancialCosts
      contextRef="c26"
      id="hidden-fact-533"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ExchangeRateDifference
      contextRef="c39"
      id="hidden-fact-534"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ExchangeRateDifference
      contextRef="c26"
      id="hidden-fact-535"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss
      contextRef="c39"
      id="hidden-fact-536"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss
      contextRef="c26"
      id="hidden-fact-537"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:InvestmentGainRelatedToMoneyMarketFunds
      contextRef="c6"
      id="hidden-fact-538"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:InvestmentGainRelatedToMoneyMarketFunds
      contextRef="c39"
      id="hidden-fact-539"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:InvestmentGainRelatedToMoneyMarketFunds
      contextRef="c26"
      id="hidden-fact-540"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ChangeInWarrants
      contextRef="c6"
      id="hidden-fact-541"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ChangeInWarrants
      contextRef="c39"
      id="hidden-fact-542"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ChangeInWarrants
      contextRef="c26"
      id="hidden-fact-543"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:LoansAndReceivables
      contextRef="c6"
      id="hidden-fact-544"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:LoansAndReceivables
      contextRef="c39"
      id="hidden-fact-545"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:LoansAndReceivables
      contextRef="c26"
      id="hidden-fact-546"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:InflationAdjustment
      contextRef="c6"
      id="hidden-fact-547"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:InflationAdjustment
      contextRef="c39"
      id="hidden-fact-548"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:InflationAdjustment
      contextRef="c26"
      id="hidden-fact-549"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:OtherFinancialResults
      contextRef="c6"
      id="hidden-fact-550"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:OtherFinancialResults
      contextRef="c39"
      id="hidden-fact-551"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:OtherFinancialResults
      contextRef="c26"
      id="hidden-fact-552"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:TotalOtherFinancialResults
      contextRef="c39"
      id="hidden-fact-553"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:TotalOtherFinancialResults
      contextRef="c26"
      id="hidden-fact-554"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NetFinancialIncomeExpenses
      contextRef="c39"
      id="hidden-fact-555"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:NetFinancialIncomeExpenses
      contextRef="c26"
      id="hidden-fact-556"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:TaxesDutiesAndPenalties
      contextRef="c6"
      id="hidden-fact-557"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:TaxesDutiesAndPenalties
      contextRef="c39"
      id="hidden-fact-558"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:TaxesDutiesAndPenalties
      contextRef="c26"
      id="hidden-fact-559"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="c4"
      id="hidden-fact-560"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:EmployeeBenefitsExpense
      contextRef="c5"
      id="hidden-fact-561"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:PayrollExpenses
      contextRef="c5"
      id="hidden-fact-562"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:InsuranceExpense
      contextRef="c3"
      id="hidden-fact-563"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:InsuranceExpense
      contextRef="c4"
      id="hidden-fact-564"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:InsuranceExpense
      contextRef="c5"
      id="hidden-fact-565"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:TravelExpense
      contextRef="c5"
      id="hidden-fact-566"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AmortizationExpense
      contextRef="c3"
      id="hidden-fact-567"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AmortizationExpense
      contextRef="c4"
      id="hidden-fact-568"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:AmortizationExpense
      contextRef="c5"
      id="hidden-fact-569"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DepreciationExpense
      contextRef="c3"
      id="hidden-fact-570"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DepreciationExpense
      contextRef="c4"
      id="hidden-fact-571"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DepreciationExpense
      contextRef="c5"
      id="hidden-fact-572"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="c5"
      id="hidden-fact-573"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:LaboratoriesRelatedExpenses
      contextRef="c5"
      id="hidden-fact-574"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AmortisationExpense
      contextRef="c4"
      id="hidden-fact-575"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:AmortisationExpense
      contextRef="c5"
      id="hidden-fact-576"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:OtherResearchAndDevelopmentExpenses
      contextRef="c4"
      id="hidden-fact-577"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Inventories
      contextRef="c6"
      id="hidden-fact-578"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Inventories
      contextRef="c39"
      id="hidden-fact-579"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Inventories
      contextRef="c26"
      id="hidden-fact-580"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Inventories
      contextRef="c13"
      id="hidden-fact-581"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:InventoriesIncorporatedThroughTheBusinessCombination
      contextRef="c3"
      id="hidden-fact-582"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:InventoriesIncorporatedThroughTheBusinessCombination
      contextRef="c4"
      id="hidden-fact-583"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:InventoriesIncorporatedThroughTheBusinessCombination
      contextRef="c5"
      id="hidden-fact-584"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PurchasesFairValueMeasurementAssets
      contextRef="c3"
      id="hidden-fact-585"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PurchasesFairValueMeasurementAssets
      contextRef="c4"
      id="hidden-fact-586"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:PurchasesFairValueMeasurementAssets
      contextRef="c5"
      id="hidden-fact-587"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:PayrollAndAndProfessionalFees
      contextRef="c3"
      id="hidden-fact-588"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:PayrollAndAndProfessionalFees
      contextRef="c4"
      id="hidden-fact-589"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:PayrollAndAndProfessionalFees
      contextRef="c5"
      id="hidden-fact-590"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RepairsAndMaintenanceExpense
      contextRef="c3"
      id="hidden-fact-591"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RepairsAndMaintenanceExpense
      contextRef="c4"
      id="hidden-fact-592"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RepairsAndMaintenanceExpense
      contextRef="c5"
      id="hidden-fact-593"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="c3"
      id="hidden-fact-594"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="c4"
      id="hidden-fact-595"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DepreciationAndAmortisationExpense
      contextRef="c5"
      id="hidden-fact-596"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:OtherProductionCosts
      contextRef="c3"
      id="hidden-fact-597"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:OtherProductionCosts
      contextRef="c4"
      id="hidden-fact-598"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:OtherProductionCosts
      contextRef="c5"
      id="hidden-fact-599"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RawMaterialsAndConsumablesUsed
      contextRef="c3"
      id="hidden-fact-600"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RawMaterialsAndConsumablesUsed
      contextRef="c4"
      id="hidden-fact-601"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:RawMaterialsAndConsumablesUsed
      contextRef="c5"
      id="hidden-fact-602"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations
      contextRef="c3"
      id="hidden-fact-603"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations
      contextRef="c4"
      id="hidden-fact-604"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations
      contextRef="c5"
      id="hidden-fact-605"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:TotalOtherProductionCost
      contextRef="c3"
      id="hidden-fact-606"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:TotalOtherProductionCost
      contextRef="c4"
      id="hidden-fact-607"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:TotalOtherProductionCost
      contextRef="c5"
      id="hidden-fact-608"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Inventories
      contextRef="c6"
      id="hidden-fact-609"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Inventories
      contextRef="c39"
      id="hidden-fact-610"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:Inventories
      contextRef="c26"
      id="hidden-fact-611"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CostOfSales
      contextRef="c3"
      id="hidden-fact-612"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CostOfSales
      contextRef="c4"
      id="hidden-fact-613"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CostOfSales
      contextRef="c5"
      id="hidden-fact-614"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations
      contextRef="c5"
      decimals="2"
      id="hidden-fact-615"
      unitRef="usdPershares">-0.01</ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations>
    <ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations
      contextRef="c4"
      decimals="2"
      id="hidden-fact-616"
      unitRef="usdPershares">-0.07</ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations>
    <ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations
      contextRef="c3"
      decimals="2"
      id="hidden-fact-617"
      unitRef="usdPershares">-0.15</ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations>
    <ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations
      contextRef="c0"
      decimals="2"
      id="hidden-fact-618"
      unitRef="usdPershares">-1.50</ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations>
    <ifrs-full:ShorttermEmployeeBenefitsAccruals
      contextRef="c39"
      id="hidden-fact-619"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ShorttermEmployeeBenefitsAccruals
      contextRef="c26"
      id="hidden-fact-620"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="c4"
      id="hidden-fact-621"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="c5"
      id="hidden-fact-622"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:CFOSharesAlloted
      contextRef="c3"
      id="hidden-fact-623"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:CFOSharesAlloted
      contextRef="c4"
      id="hidden-fact-624"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:CFOSharesAlloted
      contextRef="c5"
      id="hidden-fact-625"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfSharesCapital
      contextRef="c6"
      id="hidden-fact-626"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfSharesCapital
      contextRef="c39"
      id="hidden-fact-627"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfSharesCapital
      contextRef="c26"
      id="hidden-fact-628"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfSharePremium
      contextRef="c6"
      id="hidden-fact-629"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfSharePremium
      contextRef="c39"
      id="hidden-fact-630"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:IssueOfSharePremium
      contextRef="c26"
      id="hidden-fact-631"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="c364"
      id="hidden-fact-632"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="c365"
      id="hidden-fact-633"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="c367"
      id="hidden-fact-634"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="c368"
      id="hidden-fact-635"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="c369"
      id="hidden-fact-636"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="c370"
      id="hidden-fact-637"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="c372"
      id="hidden-fact-638"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="c373"
      id="hidden-fact-639"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="c374"
      id="hidden-fact-640"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CashEquivalents
      contextRef="c376"
      id="hidden-fact-641"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CashEquivalents
      contextRef="c377"
      id="hidden-fact-642"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CashEquivalents
      contextRef="c378"
      id="hidden-fact-643"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CashEquivalents
      contextRef="c380"
      id="hidden-fact-644"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:CashEquivalents
      contextRef="c381"
      id="hidden-fact-645"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ExpensesPaid
      contextRef="c384"
      id="hidden-fact-646"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ServicesProvidedByOtherCompanies
      contextRef="c402"
      id="hidden-fact-647"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ServicesProvidedByOtherCompanies
      contextRef="c403"
      id="hidden-fact-648"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ServicesProvidedByOtherCompanies
      contextRef="c409"
      id="hidden-fact-649"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ServicesProvidedByOtherCompanies
      contextRef="c410"
      id="hidden-fact-650"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ServicesProvidedByOtherCompanies
      contextRef="c411"
      id="hidden-fact-651"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ServicesProvidedByOtherCompanies
      contextRef="c412"
      id="hidden-fact-652"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ServicesProvidedByOtherCompanies
      contextRef="c414"
      id="hidden-fact-653"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ServicesProvidedByOtherCompanies
      contextRef="c415"
      id="hidden-fact-654"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SubsidiaryPercentage
      contextRef="c419"
      id="hidden-fact-655"
      unitRef="pure"
      xsi:nil="true"/>
    <mlec:OtherRelatedPartyBalances
      contextRef="c421"
      id="hidden-fact-656"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:OtherRelatedPartyBalances
      contextRef="c423"
      id="hidden-fact-657"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:OtherRelatedPartyBalances
      contextRef="c425"
      id="hidden-fact-658"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:OtherRelatedPartyBalances
      contextRef="c427"
      id="hidden-fact-659"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherReceivables
      contextRef="c432"
      id="hidden-fact-660"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentPayables
      contextRef="c434"
      id="hidden-fact-661"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentPayables
      contextRef="c435"
      id="hidden-fact-662"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentPayables
      contextRef="c436"
      id="hidden-fact-663"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentPayables
      contextRef="c437"
      id="hidden-fact-664"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherLiabilities
      contextRef="c435"
      id="hidden-fact-665"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherLiabilities
      contextRef="c436"
      id="hidden-fact-666"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="c436"
      id="hidden-fact-667"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilities
      contextRef="c437"
      id="hidden-fact-668"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SubtotalNonDerivatesLiabilities
      contextRef="c436"
      id="hidden-fact-669"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SubtotalNonDerivatesLiabilities
      contextRef="c437"
      id="hidden-fact-670"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:WarrantLiability
      contextRef="c434"
      id="hidden-fact-671"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:WarrantLiability
      contextRef="c435"
      id="hidden-fact-672"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:WarrantLiability
      contextRef="c436"
      id="hidden-fact-673"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:WarrantLiability
      contextRef="c437"
      id="hidden-fact-674"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SubtotalDerivatesLiabilities
      contextRef="c434"
      id="hidden-fact-675"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SubtotalDerivatesLiabilities
      contextRef="c435"
      id="hidden-fact-676"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SubtotalDerivatesLiabilities
      contextRef="c436"
      id="hidden-fact-677"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SubtotalDerivatesLiabilities
      contextRef="c437"
      id="hidden-fact-678"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:TotalLiabilities
      contextRef="c436"
      id="hidden-fact-679"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:TotalLiabilities
      contextRef="c437"
      id="hidden-fact-680"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentPayables
      contextRef="c439"
      id="hidden-fact-681"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentPayables
      contextRef="c440"
      id="hidden-fact-682"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentPayables
      contextRef="c441"
      id="hidden-fact-683"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentPayables
      contextRef="c442"
      id="hidden-fact-684"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherLiabilities
      contextRef="c439"
      id="hidden-fact-685"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherLiabilities
      contextRef="c440"
      id="hidden-fact-686"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherLiabilities
      contextRef="c441"
      id="hidden-fact-687"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherLiabilities
      contextRef="c442"
      id="hidden-fact-688"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SimplyAgreementForFutureEquitySAFE
      contextRef="c439"
      id="hidden-fact-689"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SimplyAgreementForFutureEquitySAFE
      contextRef="c440"
      id="hidden-fact-690"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SimplyAgreementForFutureEquitySAFE
      contextRef="c441"
      id="hidden-fact-691"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SimplyAgreementForFutureEquitySAFE
      contextRef="c442"
      id="hidden-fact-692"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SubtotalNonDerivatesLiabilities
      contextRef="c439"
      id="hidden-fact-693"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SubtotalNonDerivatesLiabilities
      contextRef="c440"
      id="hidden-fact-694"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SubtotalNonDerivatesLiabilities
      contextRef="c441"
      id="hidden-fact-695"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SubtotalNonDerivatesLiabilities
      contextRef="c442"
      id="hidden-fact-696"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:TotalLiabilities
      contextRef="c439"
      id="hidden-fact-697"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:TotalLiabilities
      contextRef="c440"
      id="hidden-fact-698"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:TotalLiabilities
      contextRef="c441"
      id="hidden-fact-699"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ForeignCurrencyExchangeRiskAssets
      contextRef="c444"
      id="hidden-fact-700"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ForeignCurrencyExchangeRiskLiabilities
      contextRef="c444"
      id="hidden-fact-701"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ForeignCurrencyExchangeRiskAssets
      contextRef="c446"
      id="hidden-fact-702"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ForeignCurrencyExchangeRiskLiabilities
      contextRef="c446"
      id="hidden-fact-703"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ForeignCurrencyExchangeRiskLiabilities
      contextRef="c447"
      id="hidden-fact-704"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ForeignCurrencyExchangeRiskLiabilities
      contextRef="c448"
      id="hidden-fact-705"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ForeignCurrencyExchangeRiskAssets
      contextRef="c450"
      id="hidden-fact-706"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ForeignCurrencyExchangeRiskLiabilities
      contextRef="c452"
      id="hidden-fact-707"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ForeignCurrencyExchangeRiskAssets
      contextRef="c454"
      id="hidden-fact-708"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ForeignCurrencyExchangeRiskLiabilities
      contextRef="c456"
      id="hidden-fact-709"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ForeignCurrencyExchangeRiskLiabilities
      contextRef="c459"
      id="hidden-fact-710"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ForeignCurrencyExchangeRiskLiabilities
      contextRef="c460"
      id="hidden-fact-711"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents
      contextRef="c462"
      id="hidden-fact-712"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:ShorttermInvestmentsCurrent
      contextRef="c462"
      id="hidden-fact-713"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:FinancialDebts
      contextRef="c462"
      id="hidden-fact-714"
      unitRef="usd"
      xsi:nil="true"/>
    <mlec:SimplyAgreementForFutureEquitySAFE
      contextRef="c461"
      id="hidden-fact-715"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:WarrantLiability
      contextRef="c462"
      id="hidden-fact-716"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherCurrentFinancialLiabilities
      contextRef="c6"
      id="hidden-fact-717"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherCurrentFinancialLiabilities
      contextRef="c39"
      id="hidden-fact-718"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentFinancialLiabilities
      contextRef="c6"
      id="hidden-fact-719"
      unitRef="usd"
      xsi:nil="true"/>
    <ifrs-full:OtherNoncurrentFinancialLiabilities
      contextRef="c39"
      id="hidden-fact-720"
      unitRef="usd"
      xsi:nil="true"/>
    <dei:AmendmentFlag contextRef="c0">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c0">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c0">0001937737</dei:EntityCentralIndexKey>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#ix_0_fact"
          xlink:label="ix_0_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_0_footnote" xlink:label="ix_0_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The goodwill is attributable to the expected future synergies from combining operations as well as an assembled workforce, which does not qualify for separate recognition. The Company expects that the ValoraSoy Acquisition will help to accelerate its growth in the food ingredients industry by expanding its commercial network with a top-notch sales team and complementing its Molecular Farming Platform with industrial capacity and downstream operations, in addition to adding a highly experienced team of professionals. It will not be deductible for tax purposes.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_2_fact"
          xlink:label="ix_2_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_3_fact"
          xlink:label="ix_3_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_1_fact"
          xlink:label="ix_1_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_1_footnote" xlink:label="ix_1_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Moolec Science Limited has a branch office in Argentina,
Moolec Science Limited S.E.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_2_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_3_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_4_fact"
          xlink:label="ix_4_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_6_fact"
          xlink:label="ix_6_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_5_fact"
          xlink:label="ix_5_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_2_footnote" xlink:label="ix_2_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Incorporated through the acquisition on April 24, 2023.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_4_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_6_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_5_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_9_fact"
          xlink:label="ix_9_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_7_fact"
          xlink:label="ix_7_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_8_fact"
          xlink:label="ix_8_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_3_footnote" xlink:label="ix_3_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">During December 2022, the Company agreed to participate in
a joint arrangement with the 50% of participation of the newly created company named Microo Food Ingredients Sociedad Limitada.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_9_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_7_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_8_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-286"
          xlink:label="hidden-fact-286"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_12_fact"
          xlink:label="ix_12_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_10_fact"
          xlink:label="ix_10_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-287"
          xlink:label="hidden-fact-287"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_11_fact"
          xlink:label="ix_11_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_4_footnote" xlink:label="ix_4_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The charge of the amortization is included in Administrative
expenses and Research and development expenses (see notes 24 and 25).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-286"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_12_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_10_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-287"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_11_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-351"
          xlink:label="hidden-fact-351"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-353"
          xlink:label="hidden-fact-353"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-354"
          xlink:label="hidden-fact-354"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_14_fact"
          xlink:label="ix_14_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_15_fact"
          xlink:label="ix_15_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_19_fact"
          xlink:label="ix_19_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_18_fact"
          xlink:label="ix_18_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_20_fact"
          xlink:label="ix_20_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_21_fact"
          xlink:label="ix_21_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_16_fact"
          xlink:label="ix_16_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_13_fact"
          xlink:label="ix_13_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-352"
          xlink:label="hidden-fact-352"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_17_fact"
          xlink:label="ix_17_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-350"
          xlink:label="hidden-fact-350"
          xlink:type="locator"/>
        <link:footnote id="ix_5_footnote" xlink:label="ix_5_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The depreciation charge is included in Administrative expenses
and Cost of sales (see notes 24 and 26).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-351"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-353"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-354"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_14_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_15_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_19_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_18_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_20_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_21_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_16_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_13_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-352"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_17_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-350"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_22_fact"
          xlink:label="ix_22_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_6_footnote" xlink:label="ix_6_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Through the ValoraSoy acquisition, the Group acquired a parcel of land for an original amount of $ 43,507.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_22_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_35_fact"
          xlink:label="ix_35_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_33_fact"
          xlink:label="ix_33_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_25_fact"
          xlink:label="ix_25_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_26_fact"
          xlink:label="ix_26_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_40_fact"
          xlink:label="ix_40_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_27_fact"
          xlink:label="ix_27_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_34_fact"
          xlink:label="ix_34_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_39_fact"
          xlink:label="ix_39_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_24_fact"
          xlink:label="ix_24_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_23_fact"
          xlink:label="ix_23_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_31_fact"
          xlink:label="ix_31_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_28_fact"
          xlink:label="ix_28_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_41_fact"
          xlink:label="ix_41_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_32_fact"
          xlink:label="ix_32_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_37_fact"
          xlink:label="ix_37_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_42_fact"
          xlink:label="ix_42_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_38_fact"
          xlink:label="ix_38_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_36_fact"
          xlink:label="ix_36_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_30_fact"
          xlink:label="ix_30_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_29_fact"
          xlink:label="ix_29_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_7_footnote" xlink:label="ix_7_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Interest rates of our outstanding loans in ARS, correspond
to market rates in the country of incorporation of our newly acquired subsidiary, which deems to be a hyperinflationary economy.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_35_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_33_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_25_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_26_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_40_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_27_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_34_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_39_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_24_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_23_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_31_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_28_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_41_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_32_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_37_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_42_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_38_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_36_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_30_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_29_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_44_fact"
          xlink:label="ix_44_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-477"
          xlink:label="hidden-fact-477"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_43_fact"
          xlink:label="ix_43_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-478"
          xlink:label="hidden-fact-478"
          xlink:type="locator"/>
        <link:footnote id="ix_8_footnote" xlink:label="ix_8_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The result due to the change in the fair value of the SAFE
was included in &#x201c;Other financial Results&#x201d;.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_44_fact"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-477"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_43_fact"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-478"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_47_fact"
          xlink:label="ix_47_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_48_fact"
          xlink:label="ix_48_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_46_fact"
          xlink:label="ix_46_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_45_fact"
          xlink:label="ix_45_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_9_footnote" xlink:label="ix_9_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Deferred tax assets have not been recognized, because it is not probable that future taxable profit will
be available against which the Group can use the benefits therefrom.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_47_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_48_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_46_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_45_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_53_fact"
          xlink:label="ix_53_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-646"
          xlink:label="hidden-fact-646"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_56_fact"
          xlink:label="ix_56_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_54_fact"
          xlink:label="ix_54_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_52_fact"
          xlink:label="ix_52_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_55_fact"
          xlink:label="ix_55_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_49_fact"
          xlink:label="ix_49_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_51_fact"
          xlink:label="ix_51_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_50_fact"
          xlink:label="ix_50_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_10_footnote" xlink:label="ix_10_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Expenses paid by Bioceres LLC on behalf of the Company.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_53_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-646"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_56_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_54_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_52_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_55_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_49_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_51_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_50_fact"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_58_fact"
          xlink:label="ix_58_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_57_fact"
          xlink:label="ix_57_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_61_fact"
          xlink:label="ix_61_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_59_fact"
          xlink:label="ix_59_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_60_fact"
          xlink:label="ix_60_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_11_footnote" xlink:label="ix_11_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company entered into an agreement with INMET S.A.- Ingenieria Metabolica S,A through which it would
receive research services in exchange for payment.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_58_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_57_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_61_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_59_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_60_fact"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_65_fact"
          xlink:label="ix_65_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_62_fact"
          xlink:label="ix_62_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_63_fact"
          xlink:label="ix_63_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_64_fact"
          xlink:label="ix_64_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_66_fact"
          xlink:label="ix_66_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_12_footnote" xlink:label="ix_12_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company entered into an agreement with INDEAR S.A.- Instituto de Agrobiotecnologia Rosario where it
would receive research services in exchange for payment.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_65_fact"
          xlink:to="ix_12_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_62_fact"
          xlink:to="ix_12_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_63_fact"
          xlink:to="ix_12_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_64_fact"
          xlink:to="ix_12_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_66_fact"
          xlink:to="ix_12_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_67_fact"
          xlink:label="ix_67_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_68_fact"
          xlink:label="ix_68_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-647"
          xlink:label="hidden-fact-647"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-648"
          xlink:label="hidden-fact-648"
          xlink:type="locator"/>
        <link:footnote id="ix_13_footnote" xlink:label="ix_13_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company entered into an agreement with Agrality Inc, for the provision of services.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_67_fact"
          xlink:to="ix_13_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_68_fact"
          xlink:to="ix_13_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-647"
          xlink:to="ix_13_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-648"
          xlink:to="ix_13_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_69_fact"
          xlink:label="ix_69_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_70_fact"
          xlink:label="ix_70_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_72_fact"
          xlink:label="ix_72_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_71_fact"
          xlink:label="ix_71_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_14_footnote" xlink:label="ix_14_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company entered into an agreement with Future Foods B.V. for the provision of services.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_69_fact"
          xlink:to="ix_14_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_70_fact"
          xlink:to="ix_14_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_72_fact"
          xlink:to="ix_14_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_71_fact"
          xlink:to="ix_14_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-624"
          xlink:label="hidden-fact-624"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-625"
          xlink:label="hidden-fact-625"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_73_fact"
          xlink:label="ix_73_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-623"
          xlink:label="hidden-fact-623"
          xlink:type="locator"/>
        <link:footnote id="ix_15_footnote" xlink:label="ix_15_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Shares issue related to share based payment already vested.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-624"
          xlink:to="ix_15_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-625"
          xlink:to="ix_15_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_73_fact"
          xlink:to="ix_15_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-623"
          xlink:to="ix_15_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_74_fact"
          xlink:label="ix_74_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-649"
          xlink:label="hidden-fact-649"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-650"
          xlink:label="hidden-fact-650"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-651"
          xlink:label="hidden-fact-651"
          xlink:type="locator"/>
        <link:footnote id="ix_16_footnote" xlink:label="ix_16_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company entered into an agreement with shareholders which accrues an internal rate of return.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_74_fact"
          xlink:to="ix_16_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-649"
          xlink:to="ix_16_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-650"
          xlink:to="ix_16_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-651"
          xlink:to="ix_16_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_79_fact"
          xlink:label="ix_79_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_78_fact"
          xlink:label="ix_78_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_80_fact"
          xlink:label="ix_80_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_76_fact"
          xlink:label="ix_76_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_81_fact"
          xlink:label="ix_81_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-714"
          xlink:label="hidden-fact-714"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_77_fact"
          xlink:label="ix_77_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_75_fact"
          xlink:label="ix_75_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_17_footnote" xlink:label="ix_17_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Cash, short-term investments, trade and other receivables, prepayments, trade and other payables, and
loans payable are recorded at carrying value, which approximates fair value due to their short-term nature and generally negligible credit
losses.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_79_fact"
          xlink:to="ix_17_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_78_fact"
          xlink:to="ix_17_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_80_fact"
          xlink:to="ix_17_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_76_fact"
          xlink:to="ix_17_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_81_fact"
          xlink:to="ix_17_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-714"
          xlink:to="ix_17_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_77_fact"
          xlink:to="ix_17_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_75_fact"
          xlink:to="ix_17_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_84_fact"
          xlink:label="ix_84_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-713"
          xlink:label="hidden-fact-713"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_82_fact"
          xlink:label="ix_82_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-712"
          xlink:label="hidden-fact-712"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-716"
          xlink:label="hidden-fact-716"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_83_fact"
          xlink:label="ix_83_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_18_footnote" xlink:label="ix_18_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Fair value of short-term investment and warrants has been
determined using the quoted market price at the year end (level 1).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_84_fact"
          xlink:to="ix_18_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-713"
          xlink:to="ix_18_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_82_fact"
          xlink:to="ix_18_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-712"
          xlink:to="ix_18_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-716"
          xlink:to="ix_18_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_83_fact"
          xlink:to="ix_18_footnote"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>138
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( )F*7E<'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " "9BEY7*!!E(NT    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)O)TW10^CFLN))07!!\1:2V=U@TX9DI-VW-XV[740?P&-F_GSS
M#4QG@C1CQ.<X!HSD,-W,OA^2-&'#CD1! B1S1*]3G1-#;N['Z#7E9SQ T.9#
M'Q $YW?@D;35I&$!5F$E,M59(TU$36,\XZU9\>$S]@5F#6"/'@=*T-0-,+5,
M#*>Y[^ *6&"$T:?O MJ56*I_8DL'V#DY)[>FIFFJI[;D\@X-O#T]OI1U*S<D
MTH/!_"LY2:> &W:9_-IN[W</3 DNVJKA5<MWHI&"2W'[OKC^\+L*^]&ZO?O'
MQA=!U<&ONU!?4$L#!!0    ( )F*7E>97)PC$ 8  )PG   3    >&PO=&AE
M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?
MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@
MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?<D3$L/<@HL(2W@4R]9<
MX%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A T%116F]?(+3E'S/X%<M4C66C 1-7
M02:YB+3R^6S%_-K>/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1
MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP
M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?=
MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP
M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%,
M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I
MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88<G;CL3<CH<9T)\S_;VD:4E
M,L_O^0KK3CQG'U:6L%W/S^2>C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ
MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A
M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;S<HY=8%0&7&-\TJC4LQ=9XE<#QK9P\
M'1,2S90+!D&&ER0F$JDY?DU($_XKI=K^G-- \)0O)/I*D8]ILR.G=";-Z#,:
MP4:O&W6':-(\>OX%^9PU"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:
M<K46@;9QJ81@6A+&T7A.TK01_%FL-9,^8,CLS9%USM:1#A&27C="/F+.BY 1
MOQZ&.$J:[:)Q6 3]GE[#2<'H@LMF_;A^AM4S;"R.]T?4%TKD#R:G/^DR- >C
MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_
M+GW/I>^Y]#VATK<W(WUGP=.+6]Y&;EO$^ZXQVM<T+BAC5W+-R,=4KY,IV#F?
MP.S]:#Z>\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE"<M4TV4WBA*>
M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT
ML<QP3A[+##MG/)(=MG>@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3
M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'
M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\
M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^
M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON<K2<15.+]%,[82EQB\X^;'
M<4Y3N!)VM@\",KF[.:EZ93%GIO+?+0P)+%N(61+B35WMU>>;G*YZ(G;ZEW?!
M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4<!A87,N10[I*0
M!A,!S93)1/ "@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E$A2*L P%(1=R
MX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TS<D/85"7SKMHF"X7;XE3-NQJ^)F!+
MPWING2TG_]M>U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83
M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'
M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
MF8I>5Y+6+@\<!P  CR$  !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6RM
M6EUSVS86?<^OP*@[.^W4MO@ER4EM3679:MUU'-=RFLGN[ -,0A(G)* "H&7W
MU^\%*!%*"UTRV;[8(D4<'GR=<^^%SC9"?E(KQC1Y+@NNSGLKK==O^GV5KEA)
MU8E8,P[?+(0LJ89+N>RKM60TLXW*HA\%P;!?TISWQF?VWIT<GXE*%SEG=Y*H
MJBRI?+E@A=B<]\+>[L9]OEQI<Z,_/EO3)9LS_7Y])^&JWZ!D><FXR@4GDBW.
M>Y/PS<7 -K!/_):SC=K[3$Q7'H7X9"ZNL_->8!BQ@J7:0%#X]\2FK"@,$O#X
M?0O::]YI&NY_WJ'/;.>A,X]4L:DH/N297IWW3GLD8PM:%?I>;'YFVPX-#%XJ
M"F7_DDW]["#ND;126I3;QL"@S'G]GSYO!V*_P>A @VC;(+*\ZQ=9EI=4T_&9
M%!LBS=. 9C[8KMK60"[G9E;F6L*W.;33XTN15C#(FDQX1JZXSO4+N>;U;,.H
MG?4UO,0\VD^W@!<U8'0 ,(S(6\'U2@%:QK+/ ?K KJ$8[2A>1"CB+Q4_(7%P
M1*(@BHE:4<D4 ALW/8\M;-S6\[WNDAMXB%QK5BI?SVO Q ]H]L\;M:8I.^_!
M!E%,/K'>^)_?A,/@!X1NTM!-,/3Q=F[NV3)76E+@?4M+YF.)X[P5 G;$JWF:
M,YXR,I\@W 8-MP&*^2!IEO,EF;^4CZ+P<<+;O[VYFB(TA@V-(0K3S.C#R]H[
M,GCS*#B>(2Q&#8L1"C.MI#0D9KE*:4$^,BK-5B"P/;VD<+3CXV!X' <(K].&
MUVF7!30590D+?:Y%^NF(S.UN(N\JK33E9A)]%&O@@04V,O\TCD>#83P:GI[U
MGSR47C>47J.4)C!;F9VQ64&];\;;+VBA&#(T8>!4,.@T.,!%PJ1=@W0]DW^Q
M%Z_^X5!!$(2OX]$H'F',]O0Y[,1LNZKNV5I(;3>;IKKRRE0+XD=4/L/(,8NZ
M,/M-%!77X.BPX@LF_8QPI%N!$7*"'J("O"-D:9 I;+>ED/X9Q'%N!3^F:0J1
M@P20K ;$&#H-#SN)^ <(0HX_<;&!?<BH$AQ><JU4]>>W;-GBF/C@.0D/<0UN
MQ/..R5QDJ&2U0#6&;1T;8^>4/>PH[?NJ.H.;_N76)O0X*Z?T(2[.?V:U';K#
MO'"XV4>,E=/YL)/07Y5,+HU0_ 0(>F6$?TVY?S_@@%I6J,HZN0]QO=XRFZ]@
M_:-\_C_9CYSL1YUD_^J90 @#F8:- >M9]/%J06OEY40_PB7Z>CJ[)Y,JR[60
M9*(U W>VW [Y9 M>*S,G^A$NU<V2WP6BEI;Q(F9N>[GAB*W<G/Y'N&[OY3*\
M@NU8>Z67$@[4LN CI_<1KLTN(G7+"V&%@[4.E-/ZJ*/6?[83,68X7BLSI_,1
M+LU[%DYNJ_+1[X@M(!" '2?AX'2(47(B'^&JW"3%J9 P/G;!']4KGL#NG J(
M?J2)JS.O5[:@WR882:?Y42?-GV09A//J:/>ASF??<3\S'#(<';VZ$%7!GJ@$
M3SLA'TXPJLX$HDXFX*?ZL!%>JCCD/<T7"Y8KQF^.HR0,7]U4SPQ2T4HN$<JQ
MLXFXDTTTE*?F"N;^ 2(X;YT A_L)Q"![=5FE*T!9D&YDG7?$G1(&1[9>H%Z>
M.-+->XR0LXRX4Y[0$+H3X&8%^7>^/KAI6A!! $Z3!$N*X[TJ$*[U#[D&K8%I
M"*-O'[^#>#RM)-#ULL*1WDG(GTT>5"?51V230]C%10EW"_)$B\J^Y_W\'\%)
M$)(U)"FVF(5UPSE-C)O#CC?$,NF*\B4[6!YJ ;J=S"\GOV*<G,W$N"TTRJDA
MD;+55Y-1T%TNZR6'(^*I:^QL)NZ<3G#*TQSFIPEAR)645M>!9%TY_H^)NO[K
MI8N_ILT78V="<<=,8Y*F9C]O"P \ VWV$L/A[)1P:V70=3<(GU47+#@ZWLZ>
M8MQ+=J'L+)<EN;[T,FYQHSAYC5%Q]A.WU)RV5 YN#[SYG#U2I7/*R>0/NI04
MJ^PZ?TEP0]AQNA'IP:I["\2]4!32%K!3N61F?:#,G)DDN 5<5 KN@#M/!=>P
MA[W,4(BO+8L[>TFBO[N.GZ#V\K6,G>4DG>I47Q2LM4!^6;"6[!TZ="I8?5&P
MU@+Y=<%:XEPGZ>0ZG8.U%KBO"=829T1)IWRG2[#6@H0&:XDSFJ13MO,EP5H+
M8GNPEC@?27 7V*J0*=$HP3DK#A^"X4"S0D ( IX'NT:#%V(UU,1Y2X*;PU_I
M794T+W:CZ>6)(Q9L28L?2WMFI^HCNY-4E-B9G7.= 6X9=F-,)*,'9[8%X/L!
MEKP.G,D,6O(,88NG*\&QI+\%)$Y"DIP.21@&WK76WSLC-Y51^TL 16PT51^7
M-W>;7QM,ZC-V]WC]4X6WU!16%2G8 IH&)R-0$%F?_M<76JSMB?LCK"U1VH\K
M1C,FS0/P_4((O;LP+VA^@S'^'U!+ P04    " "9BEY7R;A7#4P&  !0(
M&    'AL+W=O<FMS:&5E=',O<VAE970R+GAM;*U:;6_;-A#^*X0W#!VPQB3U
M8BES##26BW58MZ)IM\^,3-M")=$3:2?Y]R,E1;+D$Q.OZH?8DN\>\AX=C\]1
MG3^(XIO<<:[08Y;F\F:R4VI_/9W*>,<S)J_$GN?ZEXTH,J;T9;&=RGW!V;IT
MRM(IQ=B?9BS))XMY>>]3L9B+@TJ3G'\JD#QD&2N>;GDJ'FXF9/)\XW.RW2ES
M8[J8[]F6WW'U=?^IT%?3!F6=9#R7B<A1P3<WDW?D>D5=XU!:_)WP!WGR'9E0
M[H7X9BX^K&\FV,R(ISQ6!H+ICR-?\C0U2'H>_]:@DV9,XWCZ_1G]?1F\#N:>
M2;X4Z3_)6NUN)L$$K?F&'5+U63S\QNN /(,7BU26?]%#9>O[$Q0?I!)9[:QG
MD"5Y]<D>:R).'#0.[$!K!_I:!Z=V</H.0U-R:P>W[^ ..'BU0QGZM(J])"YB
MBBWFA7A A;'6:.9+R7[IK?E*<I,H=ZK0OR;:3RV6(I<B3=9,\36Z4_I#9X&2
M2&S04F0Z]W8F*8X<_2&D1&_1U[L(O?GQY_E4Z<$-Q#2N![JM!J(# [GHH\C5
M3J)5ON9KP']I]_=?\H_L_H1: *::M88Z^DS=+;4B1CR^0@[Y!5%,,120W?WW
M0Z[=<>E.H'A>[^X [JO7NU,+&4Z31TZ)YPSGD4KR0Y)OD2YB!3-50$)94L&X
M,(PIB]=RSV)^,]&Y)WEQY)/%3S\0'_\*,3PF6#0FV&HDL,ZS<)MGX=K0%Y_Y
MD><'#K%O=82GA2#B1\*)*AR_Q#%[VG$18@^[X7QZ/&7S^X?K$.DU1'I6(I="
M*E,))4LYF,Q6]POH' DGJG"\$SK?$NP&CN?V"/W^ 3N$^@VA_@N9*3DKXAUB
M^5IOYT>M4_9FOT'\42L?"::L#\0T"[%/NB$M 3L?D]"E7;L(PG,\0LFLQQ%@
M& 8>\8+&KL/!K.%@9N7@(RN^<64*I27H&?0@0R?HQ0R8!;J>]ZB) #/J^6[?
M;@6.ZF$?PQ$'3<2!->)W:RU<$JG,KJ"5A"7L )@ G06!WXL;L LH#MV>7038
MN0$.?,_K10X84H\ZU!D(/6Q"#ZVA_Z5VO'C>$>V// 2FX#N]2K@$K$)'3[47
M.&3F4MQ/<<#,"722PT$3W(I*; V[%(N;0F0OB($:ICL!BCW:JU=+R)!XH>_T
MRT $6?J^YP2X_\S!P7T]MN,,Q'\BJHDU_KL=*[C9.=*&"":EB!.MKT$>K' 7
M;"0U4#>F$+N>TZ=II!%7(P!U2:8MR=1*\OLD9[FF-$5FGP9IM0)<0NM(0%$-
MU,UC'V/G+#D!0TJ&RA%I93JQ*L^Z(&T:ZO1T=4L-+\[_H6%A]D8"BFJ@4U((
M=G2Y.&/OW/!M,*/.B1CH\M=*:V+7UE\*EDM6'7+4Q1PF;RRE/1905 -U2X/G
M:+7M]]D;66Z35F\3N^"NZJ8Y^%FC/7LJI6%<B_!4*PBSA4IC W,^EAP?"R@B
M@"!WZ<QHJK[V&F',+NFM)B=V4?XG5]4^=<\W0M/_(8]%QI%BCR#)@"R&MVQ(
M:(>!'Q"WOQ<!EIXYUG I[;,$F+H>]4,\I%E:64[LNKP-6Q.1\TT";RE6D$MR
M;"2@B)RK=LV<U^][5B,,V&6VE?_$KO^;!-.K6&\_Z$GW@""WP=EIP$!J 88#
MJ058>D1W%$& ^_P IO;4:IL 8N\";IE,XJKG3=*#.6DMZ=#2N*IFZ$V2HTBD
M*2M.[L*'K-5(L]-9XBO<;X8'S&:X\^],.U=>08?7J[/-%<0F RS1MFF@V'J$
M6$F3N'/JG)2+<FKH@MB@UC;DTM/$4=&B4=%68Z%UGTW;T%![0_/:)5S#O+R$
M(4-X"4.6 TL8,K4N8=HV&_2%9D/OC,G6:+YXQ_(MURMYL^$%SV.N2<F1,KHP
M+3M=P]&F-K>WO_8Q+]A,Q@**Z'G;00)"^GO)".-UGT/;OU![__)%*-VUB.%2
M\<:D*5@Z[<B7L#U6/T.!?@9B^_O'Z[+==COTA6ZG9+O+<W6D(0I['3@_V!^H
M X#A0!T +'4=F.&9'_0) TSA.C ]>7.:\6);OK*6.N)#KJHW@<W=YK7XN_)E
M<.]^1*Y7U<OM%J9ZU_Z1%=LDERCE&PV)KV;Z<1?5Z^OJ0HE]^7[V7B@ELO+K
MCK,U+XR!_GTCA'J^, ,T_XE@\1]02P,$%     @ F8I>5T<&3P:I @  # @
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M]I5-[6DZ6E3V<ET+C5>U;>98KD$: YS/A-#[CEF@^P"(_@%02P,$%     @
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M.Z]_>Z[?*+FN?KZ]D4K)M'I<"1Z)O#30WR^E5$]ORE^$=_\#8/0_4$L#!!0
M   ( )F*7E<,W JF%P<  &DT   8    >&PO=V]R:W-H965T<R]S:&5E=#4N
M>&ULK9MK;]LV%(;_"N$-0P8LL4CJVB4&FEB7%NL0-.OV6;'I6*LNKD0GS;\?
M*:N^B!1M9Z= :MGF>8ZD\Y(Z?B%=OU3UUV;)&$??B[QL;D9+SE?OQN-FMF1%
MVEQ5*U:*;Q957:1<O*V?QLVJ9NF\#2KR,;$L=URD63F:7+>?W=>3ZVK-\ZQD
M]S5JUD61UJ^W+*]>;D9X]..#S]G3DLL/QI/K5?K$'AC_LKJOQ;OQEC+/"E8V
M656BFBUN1N_QNX38,J =\7?&7IJ];20/Y;&JOLHW'^8W(TON$<O9C$M$*EZ>
MV1W+<TD2^_&M@XZV.67@_O8/>M0>O#B8Q[1A=U7^3S;GRYN1/T)SMDC7.?]<
MO22L.R!'\F95WK3_HY?-6$<,GJT;7A5=L-B#(BLWK^GW[D3L!1 R$$"Z -(/
M&,I NP#:"\#V0(#=!=B] #H4X'0!3C_ &0APNP"WOTO!0(#7!7C] #H0X'<!
M?EO=33G:6DY3GDZNZ^H%U7*TH,F-5A!MM"AA5DKM/O!:?)N).#ZYJ\JFRK-Y
MRMD</7#Q(H3)&U0MT-TR+9]8@[(2A=_6&7]%E^C+PQ1=_/SK]9B+W)(PGG5Y
M;C=YR%">=)7Q-$?-,JTELVG6;*[!W)V%X15Z9,.PJ1GV("'HOF9%MBXTX>&1
M?5D7ZSR54P_Q.BT;N2UGX_Q?439Y%C7(R(SLSG/#.,]%/=JC;*?F'*W2UP%F
M;&9^9EPL88)P(:9T-LNXKGJ)F?%7)4[Z8=A8"&VK-K)5&VDY]@#G-LW3<L90
MRM'[]=,5(M9OXH]8.CT927))?]>LTAF[&8DUNV'U,QM-D$Y00)PI$"<$XD1
MG!B(D_Q_SH&DZ%92U"BI#W+RR^5J,UEFFP5")Z@-QVDY\I+^/"$!MBTAON=]
MO1C3G:$7-9U-+=_MYPN!\D5 G!B(DVB.7QR\M7?\!_6VM_6VC?7^4_1S>=6T
M5RB^9.B5I;6NVD:*_C!^^0F[UN^Z-002-H6$A9"P"!(60\(26Q'3)2660VR]
MF)RMF!RCF-KK&II5A=B'I6S(Q;7\0JI+V^$866=<D8 X4R!.",2)@#BQ<[38
M&U$<'W<@"G<K"O?4)F7*9E>(XN$FQ3WMFF),>$;%U73Z:PI0O@B($ZO[K:^H
MYOB(%]B>JZ^HMZVH!]0C>,H.8/7TWAFSG5%.-1L)?%4^(5"^"(@3 W$2]?BI
M96@1_&VY?9 6P4@YMT6 A$TA82$D+(*$Q9"PQ%?7&!SXKIA/>C4%6S4%@#V"
MD75&CP#$F0)Q0B!.!,2)@^/5WLCBA($'LL#6SCFS3NT3/JY+T2=LS RL-<<L
M=:G#!RM=YWX94YY1=TU"CP1JQA J8P0%BC6[?DFHY5'J]VJK&>F0@+@N&:CM
MGBN*C;75&7&7QXRX6S/TC-D/!9I"@4(H4-2!]FOF4]_9:_$Z%0 E3(XG/-3(
MSLO$9C/SU#;#C#FWSP"E34%I(2@M J7%H+2DHQVL4;9#W,!R!F2U\S.QV= \
MK]\PP\Y9<J!\3RA0" 6*H$ Q5CU-I>J=/DX8>:B/G?^)S0;H0-M!M.I0?3-]
MV_$&LTY??#7A0-L!E#'29-1?3S06HNM3F]BT7SMUI%@&;$KI0.EV;B,VVXVG
M^Q!8];:HVR\:E(^H288MU_;Z)8/R":% ,10HT9\!?ZC@.R<1FZW$-[:1&E>1
M$J7\FE$VZ15MJAGE!-3U[7YQH2Q#34([<%W/Z\]'H(2))B&V @</_L#;N8;X
M+;8ANOA453F;H8=9QN1"O+D707]UUOB)CF;YA3(4-?E\;*D90ZB,$10HA@(E
MVG- AEU%O+,5L=E7'-+#P_LH-*I M::(2VA?!&]PP_0B4--1[%E>/V,(E3&"
M L50H$1_#BBUAW[U[=Q ;+8#AT3PA[Q)[N.Z6!F5H+I1E+HTZ$L!ROW3Y0M<
M<6FCRH( 9?!!@6(H4*(_";8MNG&]&,C. B1F"W!(#+?I[&O#*Z,6B&I>B64*
M]ZZ3=^8]..?^)8TC& 2!I2P+4!DC*% ,!4HTY\"W,+;L@6L#V1F&Y(AA^'W6
MWBZ)YMEBP6K9&#2H*@_N#!0Z650URY[$YHK5[8>-5AI0/B(4: H%"HGJQF$?
M8W*HP0@J7PP%2H[N^*%P]NZ(/')+Y+H1GS2-='P>L[(5A5838/=#JM:5:^/>
MSP;-(((]XCG]M0+L;D:PVQG![F?4GH( #W009&?P$;/!=ZIO;,:<4W$H:P\*
M%$*!(BA03#2&G8,]7_SKM4K)24,/M;$S]\B;S#VJU<<&Y>[W-9ZCS.4[W3C+
M]?LS7AWEND'@!C[ISWEUI'8)UPRCU"%.K]^(-0,O'5_\0,+]UB31,2WQ S=0
MO+GQWB,1\B&<3VG]E)4-RME"A%I7GBA?O7FN9?-&=&OM4Q*/%>=5T6XN63IG
MM1P@OE]4%?_Q1CYXL7VZ:/(?4$L#!!0    ( )F*7E?K]$_63 L  .!)   8
M    >&PO=V]R:W-H965T<R]S:&5E=#8N>&ULK5QM<YLZ%OXK&M^=.[DSFQJ]
M\-8FF4D"W>W.O=U,TW8_*UB.V6)P)9R7_?4K"6P,R$IHU ^-C8^> \\Y2.>1
M!&>/%?\A5HS5X&E=E.)\MJKKS?OY7&0KMJ;B7;5AI?QE6?$UK>57?C\7&\[H
M0C=:%W/D><%\3?-R=G&FC]WPB[-J6Q=YR6XX$-OUFO+G*U94C^<S.-L=^)+?
MKVIU8'YQMJ'W[);5WS8W7'Z;[U$6^9J5(J]*P-GR?'8)WZ>^;J MON?L41Q\
M!NI2[JKJA_KR:7$^\]09L8)EM8*@\L\#NV9%H9#D>?QL06=[GZKAX><=^D=]
M\?)B[JA@UU7QGWQ1K\YGT0PLV))NB_I+]?A/UEZ0K_"RJA#Z?_#8VGHSD&U%
M7:W;QO(,UGG9_*5/+1$'#22.N0%J&Z#7-L!M SQL$!QI0-H&9-B '&G@MPWT
MI<^;:]?$);2F%V>\>@1<64LT]4&SKUM+OO)2)<IMS>6ON6Q77UQ7I:B*?$%K
MM@"WM?PCLZ 6H%J":RI6X*/,) %.P;?;!)S\[8^S>2V=JJ;SK'5PU3A 1QP0
M\%=5UBL!TG+!%H;VU_;VP4OM$WM[B"P <\G6GC*TH^P*61$3EKT#&/X=( ]Y
MI@NR-__7MI3-/=T<FJ[G]<VQH7GZ^N;(0@;>YP_6>/A8_J@D6>HD6?)J#60/
MQFF=E_=-%Y#7.1.FI&E0B1E5]8[OQ89F['PFNS_!^ .;7?S^&PR\#R;"78(E
M+L%21V"]T)!]:(@-_>+/2LB@5!S4*P:>&>6F.#00@890@\K#Q2E&GH_(V?SA
MD&*#'8RC(((#P\1@Z,,PDO^\OF5JL"0^"F+/WQOVKMO?7[=O3<G+Q7]EO]ET
M8W4E1[.L*K.\8* 8$J)^+N5@G.V3V$21[S)578(E+L%21V"]D 7[D 765$W8
MDG$N1Z"\S*HU S5],D7""F(^16 *@B.<I,'Q#S,88>(3-,CTM_OKL1KN60U?
M8%7B93EM*K)R >BZXG7^/WW Q*\5;@*_CG"2<,0O1,VXU:/78!;$L;D3B?;<
M15;NTO6FJ)X9 V)%.3M5M>@";.BSZE9,U%G1)E#G"">)QIQXL0^'W74ZMHMP
MY(>!F;UXSUYL9>]6D:9JR*;+584!%:)2N<A,[%G1)K 7CZX&QQ[Q\6",<N0N
M?3M.CUWH=46[9^7W>D7+>R9[2["D.0</M-AJNF]SF;;/X/*>,UW'Z]'NX[;>
MRFBD/[=Y_0Q.?O\MDC?1A]O+CZG^"#^8JWKK&4R(B2N@I 7J11=B3()!2AOL
MHL"3_\PY#0^D$GQ%5O>Z I!5HM:)G@M=]>KN0H"3LBI/=5F12T5E)MCJ; K!
MCH"2%NB0.()"S_<".*3X[2[[,4!=#) U!A_SDLIJCA:[4F$.V-.&E<(L,^QH
M4TAV!)2T0+VB <JZ-PI'>3RVA(2$Z$@:=XH-OB#9=.<A5.^A)G%4UF9TD]>T
M,#+H5*DY14N<HJ6NT/IAZ=0:M,NUKYPNF%(K+'^@=\61?+9B3,EG1T!)"]3+
M9T(@&F7SVQWVB>WD(+1*EXM_2[G'7R3V%^2/F5A'0$D+U%<788#B8?GKP&.?
MV4ZU0;ML^])QVA1YG!5Z(G%#^;&)'V@232B.H1<-IAP,ELCS8H0&$PF)_2PG
MU',.@/I,=DH-VJ7:#6<6<6%O/"4YQU+I%/O1D$^3E2JD1_>TP1"&'CXR0G7:
M"]K%UZ?R03)1\6,IY$ILN0)*X%A&!0&)AF++@;\^HYT>@W9!=IEEU59-B-W0
M9W6_&FD=JR<8!Q@-;\NQF1]$WK##3TQP)/*A/RHFQX8Q"D((S6F$.I6$["JI
MZ?B+G-[EQ=&):#O&A&1R!90@@W[!(<)#W@QV$(;'6.M4#K*KG,^["=&3K= S
M<G_(&ON>E6I>7WZ_>W[U'#\:ZXE3I)78H >_-EC&D>>C<)!3)L30AQ /)7YJ
MLH11Y,?AD8DAU$D0A"8M>>2RMQ*OH>,7),3Q2MHI6N(4+76%U@]0)W"0M5*_
MN%PL<C7%J5<QE_F3S%HJ!*O-4?F%JM]\_SL"2EJ@@4*,ADLRJ0.'?8([J8+L
M4D7? 1N:+_3\$LU^;G.A&5>$?Z=%Q>EM]:R75N0!M=JB.Q1MR(V+N%=VCU/"
MX$K8((.P@3'VHFC4USB6-JB3-L@N;7J9_JFLI;#/Y>AN2W=7.L<54((,.@<&
M! =#G>/ 8Y_F3N<@N\ZY756\!C7CN\Y>3_V)[9W(>+[1 3!R[6J]RA50@DSB
MRP]1.,YIQU((=5((V:60)OMT0+8 CWF]6G#Z2 LSUZXDDBN@!(W%$<(D\(8%
M=>K 8Y_J3F<AN\[:EWIMI??Z4L:5 G,%E*"Q CM%& ?1<+8@=>"R3W<GPE \
MJ7!<-G/9+[/]"^M,EL+1)5KB%"UUA=;?RM0)1FP7C#>\RAA;[.IZ(;8R/GIA
M32_K[*;)U;:1;__X_J=>4_^Z8A4XN:+9#U%7&^-*C]WKA+O%%5""#1+3@] C
MPYO%@<=^+#H9BNTR=$(L;F\NK\%F>U?D&5A5Q8)Q 4Z^\JVHS>%PM?#F"BC!
M8[$*XRB*0W\8#L?K;K@3O=B^[M8/QW*_"K=@=^9"TXXWA657*V]XO)Z&8 @C
M/$KZMWOLLWRPF=*N7&_:566]<X*:JTH[Q!1B70E6;!"L41B$03PDUK%BQ9UB
MQ7;%.B!6%CJRP)2ECIEA5UK4%5""#5H4$2^.A@0[5J*X4Z+8KD3[_8.2_&J#
MB9%=5PK4%5#B"BC%8RF+/._XUA/<*5!L5Z!]>F46JP&Q&PW-:>Q*?KH"2O!8
M?D(O&&E/!_[Z-'?:$[^T##<L.L85AY'JL=8SSG/;W4]ATA%0Z@"HSW4G/K%=
M?/:YINU,EMK8LZ.]X@M99_!G6XZ/9=_PCFN9=R4T70&E#H#ZS'<Z%-L7 _>R
MOUO5F:1'\7C!SKRL8S^/*:0;UA(ABF PVIEF.C=;%TPZ<4CLXE"QEI<99U3H
MG9?-E+94@/H#^[G-'VBAIJI,E-FQ)_3%9*S<C"ME!CM(,";1L&0P&4*B'TTR
M\M4).&(7<-?'^ &T!G?L/B]+E6KM H%Z'&.^83ROC,L#=E]3^'.EV8A!LWD1
MC(;;6%*#X2!B?8([24;LDBQ=+EFF2UKVE#4;@M7-#+)V?U]UD*,OI:<KL>8*
M*"&&S8\(A^&07--N2A228W=[I\2(78E9LY?)XZ_,6U=BC8PUEOF^']LA:16$
MPR++8#C,WSYU!X^=$>LTY^?=UN?7CB?D%U3+\?E-IVB)4[34%5H_,IU((W:1
M]FE7634[V:_;*325YLV1&\[6^58+C,_LL3FXFU&K5[S:WJ] I7?5E*IWV7*N
M1/4+6ROM)S7E'G E^,A8IT40C0N8U(''?J@ZP4=>VEI9Y&RI8R5U],&$V\%V
MIGU(5$>4OS*VQ@BY4HJN@!(R5HH8AH:'/1QX[$>HTXK$KA5;AMO'Z?1XP&DI
M:/,"A-U#"?L8O68'GMWCE#BXTIG$\&R=YX<1'@TGCG4DZ70D>7D1\_"FV.TR
MV3-_=.W & )7*YNN@!(REK@XCF&,AXL##CSV0] )2O+2[M+>#J"KK9 &0H#K
M:GTG.RY]O&Z"L=@]Z6O9[FSW-B4&KO0G&:M*J:3(:$NF X?]1]X[=>K;U>D;
M0J#$[(^\--:O=J\30N$**/''>A7!,(;#@<&!PWXH.N'KVX7O(!3Z2<"V4FKV
M9:D]M+LA>]<QO6*NJW5[^,($\UR7P1";#!/[A4R8RW( U) ]/WB3S9KQ>_T*
M(0'TT-F\H65_=/^:HDO]<I[!\02^3YN7#74PS;N/_J+\/B\%*-A20GKO0IE*
MO'F=4/.EKC;Z?3EW55U7:_UQQ:BL@96!_'U95?7NBW*P?ZG3Q?\!4$L#!!0
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MB=XO]_\4X3?802_R<K7 UO'HXNS(DX+V"]H4OU*?@SN;@O]<@0@H2POP^\+
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M4SG[BY=*\P=U"'CZHY5&N@M_UFS3:%FR>.;+P"YL(8)??UG%\?3]7:F@=,>
M.N&.HO=O0X8+E.&&UP<RUI3"BLR=GFH^-<D>QILQN^BT'H\_*96QS_5.BTR*
MVIK>!LNUJDAC@-8NA39,4F^G2F>\3@7:QQ;.H"FX%JQI=5J@:QF')@$VL2_8
M>KC?#.JW!\;KC/%*(;C3<.C4Z>W,4C+8<U7!YAAFKW+,-H9Q,)@!4U#L)'@T
M?B)QGC^7,83/>%GV8M*8ED[@"QC66'R@(@C<M >XEK8:FH0)SE+\/)=##OM@
M0J?Q%8&M2'F%)+)]H<H2H-G7<,.T6R,SV:'HU'=,"V:5Y67 =]"R TB !U!Y
M)C3O,? F'B_ :67I0J<RG@$4-U)N"G:!>[/^'IWN"YD6[$TT7@^G>X%:\YK)
MJH++SAJ)-OS@2H[H@C?3\?QX'_\1%"[(C"S##\]?0V9.\?W6I:=+\L5B%D[7
MB<>7<:>/O"0K5C$8B8]&G)^]*1!-;7*AD=, %D&9KYH<LV_/NN:(8%X:!:_3
MLLT(#)19"T'ZJ8_893.73\)!N:T=\+H(_ $$ GB<K&;A?+[Z23C1>'FL4!</
M-QA[5FA,(^IM1<$1O*NV[HM[=)6 D+>VU80U_2A3<=XY@NOZ$E#NFR6@3!-2
MX CD 35IG4GQU(4[I.L<3R37IUJ+5.UJ^5\*WA LQ!.6&)" >A3:R6K1]5;G
M%&N$EBKS23^F,QC2:2BS?%L*RFR7*Z>-0Q^"O3P@DDZ+=Q&,.:/LX/_">8=N
M^0]V$3KSA%A(\>BS1% 7VF*'8A]O/W_[L&&6ZYVPU)B4[9Q23:@YIP[PUA@\
MGAZ!#C]YBYT!.4DY-2KRGPM))(P<^:(-W27 S\K)C5_I_0#T":BB@+9 *J,I
MHU"-4_!$ 0O0;LA,(U+)2R3=,3(YVFB5M6EOS8HG@@'R "/XR0I9&Y<8,L!9
M281;2&P\VOW^*!VU%5BK+G^TT&P/0:?1B_GMR%79J+(E.X:2FY:>L^#%B=LS
ME!6HA[ONEX1E,D<W4M)\O4EFS#Y#\&@%TA6OVQPK@G.=YN@N>.2H<DN0M+IU
MVRDD &Q#F-A2%<EQ?D+ZCP+%=.@9 O=SRN?$A9/+K896-Z>-1--Q[:&B"+@Y
MJP2W7JJS'_"F*5%F'[@A&,!FP:MM"^P0J1O>&FS6/ET*)=%>"ZP*[&G:_]"4
MO+:7M-IF0^C4")*05R&?R PD"5H,$\>*2Y5?0MDEU[:/G-*"+$FJ$BH)IT36
MPV"CJ9608*K\5J 8&-9:9DKWE%*(LC&TU4HJ)]-\CR^P"3PQI>6NPVSHPR>:
MK^$()A= @ H4E.Z48QDCC"!5P"C2AMAI9%-R<-;;!F(=@,?L THB2]./KGY3
M",YXQ8_D&D]''/4E3 Q3&<IWZ!5'.H04)#_'<%1[\RZX[]>.,V7O@CL_E3!T
MHG"=1&$4Q<$'X:<"N^^G54[Y'D;2;+4*9TD4W!^I_;ND%<5=.\Z1.%J&ZV@1
M?*.Y>UQ\SFGR#8O#1;(,9Z!\-V"ZJ*"OE'Q+!:3UH6-0TS'HL^7E;"H]B_P3
MEYK8I!4^6-)\R^OO\"]>83UR76C85Y$*#!IJB21:A.ME'/SI 'KR0Q1.9[-P
M-5T%G^M'1$[$,$_B,*9D:#R7:GL(V3W!UR\P'^%6XW*$S":K$,P+42Q).TGZ
M-C[6)%QAHYW.9X%[!"4TM[[%NF3,DG ^71Y]O>^8_R(*:5JN5U/V-KAKM2./
M3P!G3<P'/&TMW8F6BW"Z6I_<\9']_9A?=I',%^%ROL2E/U1]F?Y,6;0.9XO9
MLULOJ(N6RS!9D+H!3=_XTW#G0'[%:Y0]69 RP!F00%/FTD7V'-N$DF2U#)=)
M$OS68_QDJE[(MW@J6(?+>.Z4O23?H2R@NX2TH5>(2"R(>-MZ2NSF(0V3E&BC
M7Q<.6"=V!$8W3OUF2)U.A>](#\#;"VH_-^7)BVI+K$!O C#Y:"YYALD4LE0K
MR]PDR?V":D3#->V*762DTV\ _1KK?3(T0FSPT[7=[QU$8A0+GD5$*9Q>"=$=
MGOQ 6AT7YC1<Y<EBC4;&& .PM\Y:M\^3( *NA'9@ /U01([^ BP<JKE$+ C+
M8%.#=X)7?B*Z)Z[*L:U7\D65>":@4?*)T^S?4;M8>I?CN;0S3T9Z G6:,BSX
M."?%QW3['3W+7-"T.])GFG1N2)>'DWT@\TZAIS @<AH0JL;62O/59XMJ@4T-
M"QUM" 0#]\@ S(*X&HP\XRL!\4OWZ@E% @> 53H.\GB (8K6=D\<.'=[&$VW
MC/V.A71XAT 8H:&P\T^'&=6GET&>,3 Q.C/X) A(/=-M!8:/1UW>+8Z-TFYW
M[G8]OTR[Q>/-'(25A.OY8OS2*X#)R5L:9Y'>11F_EO@7-L/I\+IKX]_R'*_[
M=V5?L!W2$E&*'*+3\7(^8MJ_?_)? !'WSF>K+'8D][$0'%. +N!WX-#V7\C
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MY\R#6$D:/%U8*G!0M1/N^?!UOI(.M!ATXJYC^V$VQQN]19JVU?A!0O,21-7
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M^%"4>:@2/A2-,C6*+M<HWI\1MB&6D>!&]=JS\WOD5JV,_A%+RFY82Q^A^\<
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MD"C- II?"6+<=\P&^Z)T]@]02P,$%     @ F8I>5R;5DGPZ @   @4  !D
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M#5<2-!;38#8ZFX^=OW>XX[@R&WMPE2R4NG>'[_DTB)P@%)A91V"T/.(Y"N%
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M--QPUT &;*E5LRQAT1A*80QDJEIPR=K;#_PCC)/]P^AX<%$4U'2.F)5,+M$
MET #A%I$ CZU1M#,TDU\>KHE>T+9"782'0T<]W>7V98(=TPHS6[4,W5T+V[?
M7WTEK[HU:\R!0<UTAL+!!57I) "3H#1?DFP!K%*-]#KW.NG#;>\6;K17A7KI
MAXBKGH+;3NNM_9R:M>WYXMX.N4NF*;4!@06%1L/CPP!T.SC:@U6U;]:%LM3Z
M?EO2K$7M'.B^4/2:W<$EZ*=W^A]02P,$%     @ F8I>5U;_9R^% P  5 @
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M.J2MYF^C;F)5XV^ I;)TG_AA1;L;M0/0>JFH">PFSD'_EV#^/U!+ P04
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MO0M_P]E.]_=$[*HHJV&%6&%I%,ZF S1-=_?R+U;5[KZS5!:W)_>8X[HJ-$W
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M;@7/14T">+Y6RG07M$'_7?/Z/U!+ P04    " "9BEY7RL[8#E8#  !I!P
M&0   'AL+W=O<FMS:&5E=',O<VAE970R."YX;6R%5=MRVS80?==7[#">C#+#
MF"2H"V5+FI%=>>).DGJB7AXZ?8#)I8B:!!0 M.R_[X*D:*6UU0>1 +CG[#F
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MSI9-[S>.%I7KMZ70IGN=F9MQB=(&F/V5,+?1.O: ;@ GOP!02P,$%     @
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M+-9%WZSQ0P3:)6"\4GC@AXZ;8/RT+?\'4$L#!!0    ( )F*7E=18H.ZE@,
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M"!TB=\K(54*<!? 3$0/C$&(X5D!Q#4,:A&&*_C'D(:H/ZLF?V",JSQ0(0):
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MZDBWGTI"_\;SXF_N202]A7U6-=6;G%#()T>85,B?HWT9)G"H?ILO.%C!7EL
MK1  (";FR&PB/L,*:DT*/&A#J&DA%I &.@=KMB'-U,2!Q#UV1^5 2.V(.%O5
M>9A5CPWF>G&'H!>1^"?/D,@$<1V')ZRS79,2*7B/FF.L:*.GI-G9_$QQ1$FR
M9NE\(JR/([;R/B%+G=Z%4-T,5)<ZHVC<LJIG@D7RG23DB=YB7 OR>X@_JKX,
M3%>U1E>B*ZM0 8.;2>&P\_9X1M8,K R_A%DU48'W>O*4K36,1'+'KG0DJVH)
M%)HUJTP\9Q@ACJMI&(/0N5SD"FF"1E?R.3) -TPO>5C#I#E[>1&*M"XFJ>4=
M\DZ* ^ ?J" !SB"JC%9E38\E)/(",REY5-<?E2+J9)()\Q7 N9A_!<$$#X7\
MXYY]XT-,,_Y[;!L^G$ _8/(_6[+$19=I^87QB/+8SA';W0[("P1,D<,@:X*X
M1" 8!30<(5X^M&/R@E+6@!Q;S27^4E9WI>6$?H'D8$3\:;HEA28I"]R&O4#K
M^X+*-PMQXIF^P.(>OC^$VQ1'O32E?)>3)_NYQE &T%8&<%T6<1)Z^'849Z9'
M%IS!5-3^'&YTCN%S(4[F/,#O-!D"955#T:LB']0\(>]#?*SZ@6L#1W)1BD)2
M9VB/ VF"-&6&>R0E7>,;IL['R6$-F(U-[XJ*T48@0.XY31- 1[!//X[<L][O
MN@)1G0?GVF>S4V/# F#-!EEO\28ZE6S &COT*5-Y@8+'1'2]_<DOP_PYAOG4
M&$:?+()B@Q'V&)S!F,2P9YM*GJ)3R8.XWXC;'A/E.$'H#O02+%R(S6:T0$K&
MCT,*QB709P10 $].OX;%E.1=P72C)EZ BCYWSP(XH88M><X]E1H_G%?GJ368
M.(N6$PY 5+^6H\Y:&:/T3:^R'DMJ925N#ZW\8;>)HCH 6[-Q<3V'= B'R1W?
M W)'=J;=6>\PXSU&L/$;/HD$(.@K"Q?,12DH=5I$GY?"SD2N6'UF.LG6DQQN
M$3C<8I(/4='X>;4Y%^_,Z1JB>P82AO;-/+%#.C]D\K[+1LQ.9\U.FR'MW:F!
M&G&)*>+\*J,,QH(T"S JD0P\C1A5,P6U*^/4\^M33H%Z?+5<#*N>SY-1*LX9
M2#'GI5Z?$SDFG#5)\4[D1'TJ=O$&4-G=8=8/L&B3284*)U)N#)Z[744!9*GX
MY/3MU&PTE+TJ9MYA.@*,C=XOP.96<L[[V[;NXEYD*<%B*5&0-2L2LR8W8 II
M212F_%3+(M^F6M-3Y!O@D.6JVR]K4@QG2(><=\XT0('D:&+7FU@2C%.51KC.
MNZRX)2L7R^#)T$/O(3EN;*&'(1DX(9@\\.[1"N2Z1P=X-*[9(;- -SMY0X,G
M=AUP.=^CE5(&UC_*N<F5S_X2S\0#KK.4Q8.ERBB)OJH[T:&7>7R5&HZ-U'*"
M&.)E@0&O\C^@/X5N )>3=?IO;B@U0ESJPFO)KASG,+^AZ%^KZB_F2329LY,E
M?\&0-Q:44J[&\#.]6"!&8OC<(851@2>JOBLN_)-P42.V%GEYN/934V\(&YJ&
MXRA5?P92MG&>2C.[>M%OE +K3.TW\GWR(D(X&DBB3;\*%38CQ=2VHM9XX3X;
M_Z(^Z\RS"BCD19H6S=Z_X%,;J^3U-&7'FO"QA1>"(]191^AUO47_(.#LIZRI
M0G6*(+<$6,P+O]PD:Y2<];19&#H_7$XW:2 <.F>3&50*<=-3,M#^I'7XL+X/
MEX*A/+H;&]T^0&$L,.'Y,'U<A4D]Q.%6P#=1-\=<J6Q_**ICEFGDT++2=V:T
MY!-PMWGRBSR$U54J/[#P=I^9D;C\=;]D6<2I\5^S54="P#@5VRS=)U2=OK%.
MF[<55GW 0;TGJJEJ+$?"S .513V:8*(%NEJUODR ?7*:T?OSS2^:S(NV!NAX
M75UJYDV.55/U+:7\6 X[-Q6DHC\U_DD<QJ.YYO6C&2M%WCF%-_F **^YRCB5
ME'1/!&XL^;B*G7V X0<2S&A+((@9J8N48E=CC$<&$>]65;*ES>E8$ES89SZ$
MN\XPXL1M5V17>@!ZDIK\G7J,$9EJSDSDQ+4B@YA2<8!8CLKI 094T_W88#L]
MQ;[W7DX22JD5LAB?7BU.+9+A7C)]_/[GFV1!6AZ,[G>C].#$SS7C$=)>)$)3
M]4/)/F^IK9"?R[NP9F<6YM,L;B5_E@'5<]FK1H(/2U2_\&4UH=!,QPBY=!R[
MX+IJJ@S.\93_IG:HD0ZP-\Q.;[#&PY(RR1A)I6;AHH:\0L<2K?[FB18IU12+
M6I,BDC0JYUPLYX*MS_*0P_-L@:-FI-(1ZX<,Q$UHR2C_06\EB\AWGTG%H-I2
MO$(X);>KR+]RBHU$((1<^ L*1U7)U<NGLV?/7BIT@E<,?_S]Y?P%%BX4(2'#
MQ6TUY'0P;WW?^3S8L%1D$1+W]LSF,<)8.%26UN5YU;6^YD",9\E\P"!.2YT\
MV.F*IJ6(11=G7N![&HOO:0K>P9N83#/1?I4#:(^3SSX*'X,3[:8C'2I 5F"%
MHSDT9V"SYU1 +8A.2UQ<+)XB=.#_Y^K,4%\>J]:[/+OU?1*4TWQX^_'S^VLI
M2./*MQ[+"=AQ\^F:\P6=66?:M16FD$KO@JK>9+FD2O6RXID$R.2;T@="8Y_+
MZ<X^TK@J@"KXYDQ#DE&M8'I@U0H6<VV.U;C).<1+%GZ3IUG[[\7LC&U!5D52
M9%O.VDA-/M&M%5#,8C7%G+P?E .+V;>M%)DQTDA)3:)5&AAT3(\.2:;$HAY*
MZ\:XAN\2 :RH6I/Q,TP4.2DP-<QAOCJ=8?J9*PS8-Q0"/Q$ @UN4(SI"NE:;
M"F ;\Y &E98H(R1S&<?HN.,QO&D7A"<UDPSMXB@?#:?W2<8!!-)E)&^P,F>+
M''N%\A.KPV"YI)"P5U)6,\R#<2="N;'.'GQN41*03YF)^!1NGH->RD^:GJ3O
MQV7_$F&P$=I.6L6@]/"D'.^?@VNW>4.9Z5-4'EKH7$[WT/F<?CU!Q-/O*1%?
M ;!QB.2=I*)STIE#8RW^BNPWDT3=[VID=2?BJ'P^WM/-HDFBYRHYL/D$'H%@
M*TPA%-2UNZJFP47M@<FE2Q8>)'PJTKO&J<FWXGPA.S&G*F)ZH^\KE97IBLN*
M@V.56DGH#Z/Y*,$) </6XI8R],:! @E^:-9#0WMA"870FX]!DYM9E%MT'G%!
MGL$]KXZ$GDT#Y%05@KI>M _PEH0^*E'I"TM*%E).:Z<;[U'!S7S!*(&69W\5
MXZ5)I-,'A7.)(>9MEVJ=D?(9C.2LF/'2JUKRW RC:B 4#^C\9AT+L\@:U-XP
M3-T8XI%#,"VI,)51W-TX2?0A#ZS2A2XP@5%H"B+*Y#T</3H_K-/ YN'A>$MM
M$7*JR9>O,1AD6) &IKS*F:YN&EP]D1(5[<?,U1>A%&? ,(%@W^B&- 48&RRA
M^N[8$AN908)EQOTQ4KU@R_1(4)O4FC 0Z<!6!R>RS-D>'<\ZYOB[%E3F^[&.
M;? [^Y1"[&@7-\IB!HYQ) 5*S--GTC[I8^D1&:>9 B#.";NBA"&B !-S)I74
M='^<A8!0HQ7OVE<-'OU[E?=<*;.@!V'G!"Z#9)P SMF$%@BC2],*0]-J<T(!
M.K$].DD\%Y[2LT INN+Z4ZD4BC SA"#<"%**CW "+[V$]VTW**^"V3R,S\9:
MXW/;S4\:0AU93Y](O&'9<J4FXN$8?&)T47LF5&FFF)3;V-RW>W?HO![RP%T.
M=JBJI)84]HDY&1 S$Z,*&]U]6*H;6^I#"?]?(G:;'>G^/Q+[?<?F KTGOX;>
M'T;NP\,:N-@KUBS=@]!VFJSO)6G5L"9QWPUQ?WS.'K:*33]0XMT8$$C?D<9H
ML+%>(U3CFL-LQPFR]IGZ/4@UG6;XZG[=25JG%KUH'J8LY&S@=H3:6-L-N_ZE
MM*K=R0,_QT^8=NTF]OL@;L;%NJ1JQIN60XX/6'"#=VBWY/I;\@K\"<X/U'6?
M91!T^:"9&RN!TK,5/<5<M=4HC!:2;:#-4P+G:=0!/7.AZB2>,?1C_FT606_K
MDVI\U;5H;_;84$^5'W^H-XVT[!@D%I,)6G@?/CKC3,S6,F'AF?#.7]Y]Q%F&
M-L:D51I*[BZG:^[B#N" LD.V-VJS3H^J-NO3>=1BW(U/@,)0[#1U;.RJ8HVI
M5&--;DEDE=RJ_#CC1JG\(0YTL*\I=#N/72?J]VY\EA$Y.6DT/SI5:A2%(U=E
M**+0+G99(1LPL?%7R>/\+-Z+E L=*%$96ZQP(BUEAG>-5"30=R:T:<)>Y(V0
M)K*:1J&[?YSW9LNI7+QJ KNY!=@3 U%+L-I8H%%/4AQG9-E^R2S,S7!$PDY'
MDI$QLYIAR80O'#)D^)_JC"%M6?KN/O:02]",3ETK60!J'OC<XQZG13(\QSE"
MZA@UY:#HF[%W[X;XIF>$Z7E4MJE<*IP7<Q=I4AYG&@:$09T#.Y@@ JOYND__
MCAZ2HY[=;47\B7..J)>7Q@6H9=,N(]I?9\G85@8I8>0CX_1RO[H3<)Y)\ .;
M63A%4^W3J5'2\2;^T9H'O@1JZDFQ(DQ(H_AE#C_66LT8$@G9)5D1?&10QX.^
M9EPVS#TT6^Q-KZE,%A(XZ?(8SS03M-8^W2'[TK(?)8#;,Z=ENS! BS4MG!_,
M<^,W)042Y\FUSR_%.!D%%SU>CEU@,!.<9@UGW4=2XCS$E B)8D9%?4DIZ8O+
MP@;\TPM=Z7M\:J.)WIM V9H\3+2""00GD1Z&<I$;FS0=+#I"5SZEE[4F;_1/
MT42X0&4+(:K;I*3\ '9B5T/J'-SCRD&(2"NCGMQR(V(E1N49?O8Z<&Z<.Q*/
ML+<__.HK*MA?H&)+*3ZFJ1B)^0Z!/W4 +[T;A7MI-B)AFE?NSPB73PP7/,QP
M)N_$Q4F=,T"O0'W>1S3^D'P@%<']5%5%MDIN4',&'/TQWU-("TD_I-OWS2+0
M@.FI_X;%KL&DO+RX2/[@?L15_ZG;'Y)KD]OVSLP\->+-M0QC@G#SZSF3_,2+
MFJN3RNO7/R1O\VJ/N^H047[\\5WR^/V'Z>WXR7^B7J[)]Q2?^5ANT7CGE)CY
MCW/A%?% (UAU<\!PXS,<#^%X L0<$:.LQ!T<TB;GGIE^/[-39W,S_S!W A8]
M5U,0S%:T*:B$,8%PBF3QE'&(7L:6NIR*\3Y;48P>?UO$LH."S6O.:P9VB2A&
M+G0WRF,T=^+9Q1^H",Z_8G26,KO#'!*0_*WD%E&F>(JMY0SL8]"# 9ZMTS4#
M(%VGDWIMJ!F^G"[]#31J,FM&-=D'E1!?/IL'LG<V6>?[./-ZW*[J1TZ#OE"9
M-EMB!7*JL4^0M=S<N-59ZP@KF3]L)2'=>/RBD;F]]462$;WM-YF5&&%E'9(4
M@P_]A _^<71EC/2TSK>E5MV:U*#QLO@SZ4$L\57J2L[]0$TNH!]$M;!-'UQ5
M% J?#:[2()?7B&]M#&0/A92+(KZC"_FUT'C(Q25C;04\6Z!J'A@&M*&LQI:8
MA(IB5YG,<]\67T-[@E%F0Y903*F-1;<?L2RY22XIIT:NMY#L/JTI9"\'<BM\
MB$5X=#7.H1,;K%IBQ-WG-W#N7-3VD--:PPT(4GT>AIM% OB<UY=<ODK^IZNX
MJ1CGXG0EY[YFZS-.,Y-D16P(UG#1-K7*6ITZU]=^\,4KS$T1H'(WRG]@\A7:
MAG;M87>.]SQ3/X%'-^HDPN4*M,XS;N_=_QV;Y-TJ><B35&+D#[?7_NP?T>8W
MW)$>>_I;7JBW6_"NKAZX*SD^ZKFH#6?\O.9 I=<:=:8#Z)M?>(2S2<$1"IPO
MIRN<^UQT5&9,#Q%DQJ65&H(%[\1!X=O2NP$#^+CAM"QA0!*2=59X"X8R)\..
MJWB+HOA8;7(C7^A(>BQE.7X3T?)@9@]XL4)?N3_^[IOG+[YYW;OUS;OWR!3S
M)10^6L#-YN^0F[N*@L;YK7;\QBHD+C0.@LW4OU&A&TJ!Z#W)^HH5(1E)-) 3
MXVF'U$9N;>GOF;'6;M,.A'9YDVQQ%52+B.L/8WO)B%Y_32:3)@%>:3>!A7GR
M]JB73\[8/XU0'F* 1-M#-M^):\%.,O31:D<-;:^U::1O"&W+.=$RKTR.<V@/
M+,:0+SM855W--2)Z\+YN,[/W0'29W#6!WEZR'P5CKBZ GH_A JQ6VYH2;&)7
MGG1@/+&WV-.J.DZ<X,(X$G**G(:ZNM*GSF(_ZM#&B6ON4O(>!8XEIT49M_M#
M5<:AX&-_.7W]*F3-H;5(N-D.MN3U[4 %M'Q&>-\190KC!9*".331/D:J0=6K
MR;D(55C>[ZJ]$'Z@@D=2XSC."3;#X(:WX2F!.*PHC5*;3)ZX,S"RWL0!-=K4
M)N[@D$OH<GC7'&?&8@5Y<(J.S.&F;LWCY+S1"_[,=47MCAI&^VL#FT/%_5Y/
MWE87QX>8FEU?H1/J,/0@]&,U+0H@/?$]&= 7V@L #S3Q@(KW5##[U,$!VL5E
MS/2T]QD:E/PM5<SNMY34/K"*67:M11:AK$Y+F$=*J/\#U<N^6,36+GMZ,T7,
M84_WUBX'AB?78"6<-QKM_%^I6B;3T]U;M<P3_<LURT4%FVVR56=J+K5;KZ]2
MYNMPUCV$'T%D*T;[!?_M:"IK2 $9:7+MU\TL93_:W-#I,K4Z13CBKVCY)GY6
M!,X#>PVP+]CT1=;*$HFT-"$#@5(RLIJ=#CEG22!CZQHS.@(F7X':<@SB1=S9
M%.'%UOW(MWRBAD2?Q9D=)?@.M!T,]<  ',@W28;F:H3XVHRQHAZ"D?(>I]-S
M_<D:!> ,<R,ED%AI*HHDK:=KJF;HF_S8O>KHM_*P YNZ,#MTCEE,=WL)5D@_
M6W%8+S9FH=PS?+!0%M9"N7^NOO62-FZ=+6GS\O![_#C^LNL)L;0920;7JYGT
M[=&S%K;EPRYQR"/4^Y1KTV4Z+D)V)G%R;+5S\:%'N[\>J==STJ"\T9HF70M3
MF-X/('4/^;HC:3W2E2*.),[D/FM)>$+>P[5?*"(,L'2=D5.2G&_<04\O1F1W
MXT@.JF@.@_(LB7JR'\^TI +U1V]"]:51T>212S,F&3X0\<V-I#0D?Z[BIIP/
MH;B9E@J'VXQTA3/JPC539V0MA0QQ$?$(EMLMS-65SC(+KQ[B7!>^DBD.X! [
MU-E=*!VS@[=5]07K&#&0.$[GH]\.J*>5.%9.5ZP1-3[$/8@9GD/A-ZGXVV;3
M3JV OU%X(*Y^N8[;9-097PLF#<V="1EJXXU#MRSR57+'@X4*W$_Q]UKFQBCH
MGWY@ PWQ]LGE<N3\XI"W)]4\;G?A;_T]#BUQ=*V($L%:;]R@_@$&@UA0SEA0
MM@*O7H_7LWRF\')4* PVO=5HQ%=IE^,=.L@VK!=O4DZ%WE6+>SI,97=8MU"N
M44L$J,&ZUJ&(.2X2\*6VHP+K09VL+I\#BXBF= ^;$B.U_ 8]!5]]?-<XCE>9
MH@=_XT69JPU^=<$D3N2M="\.&F24>+\4WVQSG90=A=I@SC+%UCKGS:HZ9':)
M@#&TG*L9W1)[^9S_OWK!Y6)T910U^,2>F7CQD/ C\=Y=SL2+QZ\]O=3=X%#)
M]=@\CE2BYZ_?CB3R>NNZ.S!M /ZI^JL.PZO0J(7X#*[M>^]P1( %;O6S1W1-
M@R&;EQ+NXNS?R$E)U\*.+6_>WQ*#3+<TV==:MP90W.7+O.6KN-AW2I=8>KEJ
MNDASL\7#U+C>ME*!Z:(+ACGUCWLD4K0OEZ+#54CG"#?*!2-B<-5?Q]?\-6V6
M8K*U?U\R@XG3H2<=TZ]0R#7.5UJSF5%($%;2F?O<9 C9JQ<6LA)GG-FJWKY^
M:'YB#4:!SK7I1[$YI*-D (%VJ&1UF])!;.93ZCQ?5KZ(:S[?D_J..OF00N W
MX(5Y2<V[!F0 =",[^QZ[KIY3TOKUFNO@E4?(X@.)^5=&PEGA8:)#__#UMB8S
M"5BRNI74/OQ8%!W=J8>2YP/?4$RMHADL" &A9#_:CW0%H PD_:+#[M#JPOQC
MNNQ[G:_C?A'8=#=$N@S6,N8\/+6EQW+)-=-GL_[2,X0IC/-.JK*!PQJR=]$@
M UX=TF](*Z!^I][#CC/L\6V^N1/..=:\!EXY'P#DUDJ80DP7Y,D277PK( M7
MLSZ9TJ8[2SA1VZCV("SZKC@,I(0P5/'WUZ>W)KF1M'[;Z_!5H%3/ A?G<1*^
M:;A]JL[--M/QC9MLQO%G*6[VV"4LV@5Y&#PX32^3'D%@UDRG-DO"O0XV7#Z+
MHRDP"]ILIJVQI+L'6^%DY0L:/UY;)0G&K,$IB.E:=,JJY*0$-JG^E,)#,-"E
MH X@.(GKA,2U@8%3@,^23YP8FH4JS63!PA=^?]FGS#3?8PV(<*BH[ 7S>(]4
M7 T\K=.N38A=67% KE][\V.TNQ'EHU*_CPXHQ'NI3#]3,YN_&XTO*QU]1C.+
M_UVP'&HA#CD:L;+DQ[CNZ$:O2*!?E^GJ2Q^2(BO<0&'PMRL4_M4(!55_ ;T(
ML8RO(4QV6!;BDV]2;;Q 96]C0Z;^+B@$B::.F(GF80\G%L+)QJ3::<4GED$0
M.'S$D.^'DCSMWF_$ N7^/N[+[BC/CYJX?267-2EOU)<=[YJ1:TK)]\L\"EVD
M__KI/IT/N02:(%0I9BJ'HYY( SW#!6'YR7;<BD*S >&]H,7<FG[H/.Y=06NS
MFO<X*?^6R6'F&A4:.HM^3E7LTI*4#",!RJJ43S/'!RAP9E\[!U#(5X09WB-7
MO0X-R)X;CF*8G*,?)%O_'K[6EPV0@^V6S\\C>*]\Z3'=Z\Q:RDR39;+\(&T[
M[E)L!L7-/I9\D2W%)V_Q/IWVK*>KL.N:@8BNC#O<+1T'>N3+Q@>%R/[PX20Y
MJ1 W5OV2EN =>/\FW!YBZHM@7KV8)3?<YU@-'IC&IH6>E)^6U2,G*G>I7D-!
M? +O+Y)&<XW.L)$9HL334*LNO?FXR?^JEZD?Y;"%$!R7Z&-E2,>]H;@'-UV%
MFC=?M).'KC6VT/0N3 #*6S\1=]-@*<Y5EE7M+8 56HNUJ +,_;PBH8KQ/=L5
M#2R4_@%30ZMDB0BY0^97LS>_-W5:IL41[SOXCZ %R;,++_H7+V<L 6  *G[!
M9#_A*->24R,B.M44Z:J60F]TF$D4#]_G3/F_PE2=W/5IT$DX4-^0;C'9UG>,
M(D-0KLOR2[']#\Q:\OY:3#$L?,LIP+>\&,WKP.*!O-YSLM;)E3"/:TP:$6<'
M5^7YOBI!W:^/NAY--O'K%2W6Q#<'B^'F0GG;D3=/>(3Z#Q0)'L?]G\25,787
M9G,V-P5H=I$:)K?S>4<%\T0/1&N6:WRS@Z\B;[;>JB7XLNKABUZE]]%$%_'F
M7A*P)Z[-["]HPGLN8L$O62J5159026IE;Q71!WU,+2J/EA6>.*.!K<JEHAH@
MI,I-?B:+:53:/P;)@8GT:EV2%8?>$MD*LJ/7J--A<=E,[3O61*R'W^J3E,^T
MS]MVNKGU(C2W7DSWI/X1(7W (A6L]1CU;3ZHJ?7EBWFB8[EPW:]VBI([1O F
MEY7C"JN"R 4[P6'WX;"&Y/&'3S=GX0Y?:C49MXJ=XR6T^2J!!Y/X9L@E&B>W
MN2]>$[^1^JJCA&9'V=9V8$QI,A:,I+6?N%LEN$O[C6RQRA9-<=)&0O1%M9_W
MLG5>O8NO<>&TW-[R?2I-:]G,^-K57_/;UNM[J7LAO>&.&KCFN*AM<";78R5!
MH.YS[48X,5RAA8&*9RRCFH4.C8P,49_9IG^'F%^6C2NP [3PGCKU%;D!,C#[
MGRD-<LA$[QIG]PCVYH,U*KHJJB%Y+K-0 !L:R6EC)K[[A>8Y=5;N\0WLDPAH
M\6(R 7@1VDDOIMM)_\S)):.$//VF$O++>2*#.*3@+3N&].+DQGLW)<(0DC!)
M1?,]G8B=#UO)X=6/Q+XX"2.G4G)/ M%UTOV69JP]QE:44Y7@U(O> ^<[B5+\
MD+PXI;3_J*6 ,,?V63_;:\GY);:%T7P^N;S>D,,KPMBO5E /B&K)Z4N^2%"S
M !0TOM&)]JDT=\,[HY1HR219828YF?Q4^<;.Z4N$=Z!<KKB+.7FN3S_*N24\
M-FE9&R80="1&"51QTE6X\[X'2E3NXCZR!)B3,*7LSW;FW? A3X$GK^J]\LG^
M'3GQ2L92[)S@9AUGMVDS;8F!UQA:Y@OK_"&&.ZQJWU9XY$TUA U[ITO2N+L,
M985(*P>2\5S-QD"BK.THU39=<VR>X DB@X4*,E;:*+%:OH(@5"A>3];933&;
MT I\,=VW^X-D:XYRFX>U_/X&<TOE'JZ?04O BAUQGH*651TD1P4/WO\L$1ES
MY:U>J2/.<]\1KB6S-CRO=^EB>JD??F2\Y%>.I[3A1'@\Y-Y<]KU)^W"J#H$S
MG;ETC97T/M(2FIF&>X+\Q64!0TQ6G?_UU^Y!$W7#-0F@CVA6L6K_#^SY1UMS
MT=;"L@$3X=N<LA$*ZIM0F<?\/6\2"91#CW0RLMFE;S56J<+"\?)RON^4%\H#
M<J**NXZ!.K(2NA$9G?JH)#!?!.:WP?[NCZ7AIHE3(!2Z G.XCC-5(U+-UF:^
MJ7.<S5![P2X@! ZKU=CV];91O6]$[=N CIQ] )UI/AGY6?'(I(PA!*C#(3G*
M%@Z#J.&D79,QSW++]\E-,8O0)W@QW<[W)ML2M7E/W2C7F!QC\GZ+!=YOP7.8
M?H>!1+1])M<(2PPI +;A5TT/<\GE:;C$6:X<V%1$2[X"6%)[X*#Z(ZF 8"N>
M>@)HN06GRKF,(XAT25BES7(;C*[CH=CL^) '2YH%]K5$!5>U+6\=8YG1QFQJ
MG:TH$$X!YIHOQ\E-P,\;QROJ ,]R_X/O@_XY2_=T+R&.0^8,1B"D0Q5U/ D-
MC(D(2:6P$IVE6#PBF6P("\KMD2X'N' 7GOL+U9S7/J'JW8>_:!+5++Q@ KZ#
M%[X??>$3"^_AXY_"XRX\_AD+_ZJBVAZ';WSV;WB;BU_2FOC!&S?^C5&P>-W9
M#<[G!#((@QR>0!Q_BS0L;?01WA,_K.'K=.&J$XY/'_"]/V>MJB!/R*[Q]VZ9
M+NKQLN7QF=,>%;K&5M_&H4MUWU, 1LA'&[K%YG'(\ EY/6'=/NJ/RWT7W7'_
MD=L-X_RG7PGH]$GO^+$)[)KUYW4L-]2KDK=B%>H]!W1[I+F<"<V#<)6S*::>
M<?S+!TUD,NN !P"0*_"EX3;"\IJ9LXT7.5)R?H?-OJ)HK;JEC<+,,5E\A'O#
MV#NB>#HW,AWGC?44!A-'.[4"(T7C'A)]I D&1$,QFB]KT.%?V6+OP1O.W+@8
M!%W4N2+*AU5?NK:*9B[:]+2<\4#VSK9?BM7S7G%B[+4)<:Q0:12ZH:RQ\WM>
M9)A+7)YK%$ZZBYI"L_$B]>$[4J$Y\0X>H-[>[%LU:HLP7AFH *\<>W?H7_=C
M]S7Y?;)X=CE[^O0"_CIWO:8K3V<O7CR=72TNX*_G%R]F+Y^^=*$9RM/9-U<7
ML^?/G\.+G^F:D?+$PJ<V^_ODF]DWSY[/GBZ>P]]^GJE+CA:AW?EBNFWY:+[A
MJ,+RH/;GBTOOO+=]AZT&KXT+T#:US2BD9[2I^9A(./P<LQ3."8SNFVG$W 0%
M9FNN>X^[U1N+V#L$HP89FZ@UG=&93A3Z:B7KX&I!E9SVOO0CH\-([SQJA$8I
M@[VV>(-*M*E1.'DC#*&K._6\IU-T+*):66$5J(N:(]GD[9 ,%.;P8Z@CC7@D
M>@@U;-(_NC@%,C).T\88LM?^:LTMV[)1B3!E45@'A\T;ZY<W/.3(!G>EQ)@S
M;&$H;7M=U+972Y?34=J6UEI2\7\:JT[5G/V@/<*I'$SRZZ-4<ZX:B&XKPN;&
M3>@6]F "&4'A*61RVE$:ZVRI2LVCI;88\=W,$#TB?-'T.%%$9L-$N:8!"")6
M4#1X+'_-;0UT^C"1N]Y+2B[J]A)405=X7M/):/-KO*O;?-WR'4ZST)[=*TMQ
M9P7;ASGG>VX4XD/>4*A<0H4F#3X 3 LX%S\[PI9O/XL=!()@\:T0Y X,&=/-
M$8;8FK:49G6SD 0>?*\^(,S":;SAC2I^AK]P1X"P&;;8:=E,P :4$JOP-9O2
M):9_(\-I7PQGLEC=5V^&^*CEH'(S9H XETVVZ1:S+NR]+NX.'5CGU6:C^U*\
M+8[</<.7",4U858Z-&ENKS+&K9R?$A0>?A)/[;<;&K3\ZXN"<#L/\V6=B1-Y
MHLGNNX-E2I,(+6H7T\UDW^'M(M1&)R0;_+U;V[08G^<XJF \J%?M8I'H1.X!
M$QFAB9Z!1EU/+CPAEEJWE]O6D!W6/JZJ3?D_1,_C=%&<#HNGR7MN/!5:TJ/=
M*L575K/1[/V=CII,UK;KYR G3!*.)1G,AWK ,I%N*])).FU 9",##3T;H\ZB
MGC1X0'3I4:5(6)?#(E].W?7\ [NXG@*79 ><A&9H#YT.@A=$P*E>F^SSM<-E
MI1HT&%SZ49V\*40Z+K!4^=H:L4M%060$4#Z^E@-YM U)N.?)1Q%&J^!^B&\^
MC*15CC[1+:4_^[XPG,=-*;R&^3P6++XZF^,L@1E2?T@=1??FL_5]SW344?&2
M9AJGX8'&B/=)L\NR]GW:IF^^!=-LF[W+BD+LK^\>8=F8_Q8]#=ANZ=7UXM$3
M>#,\_N;; _#)GU*0'+#T(MO JQ?S%\\><:A,/[35 8?$YK)@!]*?NRP%],,'
MX/=-!6N5#S@!%B31\M[\+U!+ P04    " "9BEY7;@\D*.T#  #J"   &0
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MO*WTK=C\B%M_$H.7B4K9?]ATNE'@0M8J+>JM,3&HRZ9[\\=M'/8,1L<,V-:
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M=',O<VAE970T-2YX;6R=5%%OTS 0?M^O.)D)@;0N:=JMU6@CM04$2(-I&_"
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M(:'7)X$7A!UX89.*T.*%_R<57V<;I26^JF_GDE&%&IP/92KM7A4TAJF#I:1
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MXX$^(U#9 )K/I#1MQQ;H/DQ6?P-02P,$%     @ F8I>5^Q*DQ U P  !0<
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M5@"?SR0&OMW8"[H_(</_ %!+ P04    " "9BEY7-V56XZ8"  #1!0  &0
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MRP:D+XWQNP,'&#Y-BW\ 4$L#!!0    ( )F*7E>%:Z ].0<  $83   9
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M:&5E=',O<VAE970V,2YX;6R%E=%NVS84AN_[%(0&%"F@1A(EV6YJ&W"R%LN
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M=%!L&*_ MT+'1K>H"3<$=X#R<T=O;^#P*76-YJ*\'==!"0;6,+!AX'N6&[J
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M JY?4-_?,R9W-[J!^K1L]A]02P,$%     @ F8I>5QM+",L> P  \ H  !D
M  !X;"]W;W)K<VAE971S+W-H965T-C8N>&ULK99=;]HP%(;_BI5-4RNMS7>
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M.[K^ EN@4.DE-.?Z'ZWKL8&<,:FXH,4V6+:+C-17_+1-1"O #0X$>-L [W5
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MJ0'R^8)2\=Q0$S1%;OP'4$L#!!0    ( )F*7E</7!Q#H0(  %,&   9
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ME6Y"=ECJK@_"&.C]@G-UG)@ _?](^@=02P,$%     @ F8I>5PCL3WR/!0
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MH.P'.(_[Q1Q?+$#3ZR_^!U!+ P04    " "9BEY7PEC C0 #   (#   &0
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MKZ3(SO=91_'$'I%G=M>WS97^)P)A)NCG"\[5MF,"%']9X5]02P,$%     @
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M4&K@<+[K]F[;+3O1+67D0YY5JY*$V4(L=,!0'L/^0-C7 [EE(/%.S%\3E_Y
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M-/VN&^59/=BSGKSO!LNH>J8?]7H^\XY_U(O5(T< Z6(JH^MU;*A:5&!@E(W
M[4W.RXG+O..?A6)UR!% NK[*LWJP9^U18($)-K*VW:<[\NEDTM(5J4>. -)U
M53;6@^^=M"G0>*BN%I46HM(X%DU/RL$-D;!#MBC0P"3KG&#982P01P#I25 F
MV.NX'Q,J\,"QUK)C65S487&$8>G:*W?K=;C;LTI$,-PZ.8;?O8[IQ'&.+1-J
MMQR+IF= .50/=JAGEH!@NG4*VAZ3!<QMW<"-NK^)1=,3H-RO![O?/@6>#L2)
M @\<99V;]J:F>0V*ZG^Q:'IRE/_UX/U6B_H-3+)6NWTWZ(FE*=:>*@)(?QR"
M\J<^[$_O\V7U'!6"O&_N5Q)@Z0=FV<J,2@M1:1R+IF=%&5T?WM']EJ4?'W4'
M&)46HM(X%DU/HG+3/NRF3Y5^X# +"^VW+;3OC(Y73%C=<020KJ3RSW['-K#-
M4UN0?@I\Y[?W9B\I&QWOHF/UQQ% NKS*"?NP$^Y1]H$)-JIZAH5^:Y6/U1U'
M .FB'CQH"+Z#U*;FXZ,:751:B$KC6#0]*<KR^K#EM:CYP"3KG&#MT&*!. )(
M3X)RO7['G:A0S0>.M98=Z_Y3U&%QA&'IVBO#ZW<8WK-J/C#<.CEM4^L[WG&]
M ;5/CD73Y5>6UH<M[9D%'YANK;_!YAYO&J+VR+%H^@/JE-<-.I[%U*/:TX$X
M4>V!HVP3$[2W=$TK3]1..19-SXURO &\M6M1[(%)UF)O:8=/FC0L2%_2I_&R
MBP#2%:[MJ/Z)LE4!;*ODR?S+2M134?'8%!,J^2XZ_)+$]00U3S;U*E;.5+-%
M&F=Q6<D)*GX2_Q!?UG7):/N\FT]RM%$Q7S5O%N)))/DZ%5E%]JTN2B%(ELNY
MC3"O:<;\5Z]-QS8\>/AP*N3@ZL=$UY<G>4;4AW/PZ?Y1U&^;!S ??7Y'KS@U
M?#X+V%48F"*D9O(OS;.9AZKK[3.Q/TB=8GG=3,12#L-Y/9+?T&+[F.GMFRI?
M-X]%?LBK*D^;ERL1+411-Y!_7^;RZ'=OZ@[V#_N>_@U02P,$%     @ F8I>
M5UC*V.&!&@  :'4! !D   !X;"]W;W)K<VAE971S+W-H965T-S4N>&ULO9UO
M;^1&<L;?YU,02A"<@5MKV/R_V15@K[IP%\2)<<Y=$!CW8E;BK@:69O9F1EX;
MR(</1RLNB\U2-;OGF7EC:Z7FKZFGJ!H^7:SFF\^;[2^[N[;=)[\]W*]W;R_N
M]OM/KR\O=S=W[<-R]^WF4[ON?O)ALWU8[KM_;C]>[CYMV^7MTT$/]Y=FL2@O
M'Y:K]<75FZ?O_;B]>K-YW-^OUNV/VV3W^/"PW/[^?7N_^?SV(KWHO_&7U<>[
M_>$;EU=O/BT_MC^U^[]^^G';_>OR*^5V]="N=ZO-.MFV']Y>?)>^)E,4AR.>
MAOQMU7[>L:^3P^_R?K/YY?"//]^^O5@<3JF];V_V!\:R^]^O[;OV_OZ ZD[D
M'\_4BZ^3'@[D7_=T>OKMN]_F_7+7OMO<_\_J=G_W]J*^2&[;#\O'^_U?-I__
MU#[_1D\G>+.YWSW]-_G\/'9QD=P\[O:;A^>#NS-X6*V__'_YV[,2[( T>^$
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M?FE]IQ L<E4NW/M1G1Z0EU @B@'Y]1P\<N&K]P;L83(M[(H:1QA,66,0B&)
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MA1V.!&51CA4%HAB07]G!L9:X'7)+:.,LE&:A-$+1QD$9'&P)VR=7)P6LY:!
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MV_3 2!1%\@N=,N^9^M^BPJW O/<3>:C!V0F*LU@<P7!.D)BI3<^]BVT_(RR
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M'J"<@[VOI#1'PR48_T?Y/U!+ P04    " "9BEY7G]F$H0\#   >"   &0
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M--@_--IE-[UV&RWJ=F)<ME6C719FXD=I+YCG*R'T[<8J&/Y#)%\!4$L#!!0
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M?7CRF@+B*W0<<8'N%[?H[.WYQ%5:FEG S5H9-XV,X(B,;S6[1*'W'@5>$ [
M9R^'!T_AKDY(EY6@RTI@^<(C?'V_V=ZO;4#/[^_KI51"'\0_0X:;%:+A%<SE
M',L*9S!U].V3(+;@I._>^(GW<<C^?R)[DHRP2T9XBMT>D2&##2JQ*%,LMFD0
M17KSMGWA)ZE?*3SJA$<GA=]@MM%U(N.UWJTA!PT\[COP$C\)DV<FH@.GOC?R
M1]ZHBWNB+^[TQ2?U+0HNU(4"42+"MB!5"4>$Q@="HR2,/T3/=)Y<[I7)3CHS
MR4DS/[C"]/AE&7*5'!Z@.+A*KIZ?H<.XX?2[O3)HGJ#O6*P)DXC"2B.]RRN=
M']&4]::C>&4KXY(K76=ML] O(0@3H.=7G*M]QQ3;[FU-_P%02P,$%     @
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M9BH0KXMJW9&L,'5IRZ2J<J:9JG<(N%Z@YA/&Y+&C2UW[LH5_ %!+ P04
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M"0B3H-=WG*M38)I5\V^*_P)02P,$%     @ F8I>5Z-$IZBS @  FP@  !D
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MSWY]?CXL1,/+\,/%MI%OZD:2 XUTT66:%*L<^<F2+S7UY^;ZWK'ZS%P?$P/
M4#"^HYT\TOZ&&!$97[Q"%+] Q"&.[H;,U=]O$E'=J:ICW?UTKTXUU?WNU8F!
M#+KK@[3"H_]['_S\081&[PH>Y__JNF'=3E??SG+,/LO7P8)?#,2@G//LG@]F
MO_V"/>=WG8208 P2S <"4\1V=V*[)O39GYOXAF>E6'DI3?[B+S'GA<F=&.ZC
M(%EP]"Q,:M5R[4AA1->W'>G4J7%&%4XYF][/R!2[COAW/KS?9[Y=D&+':1?T
M.Q14&!OM&!L9&:O)0&&>;_@2!7&Z28HF:SJFC*@63-4X7HNI!D_M8O7M-U@Z
M6DSAR-MQY'7AJ$C1#;=GRHAMP100#@/"\7\<1Q%CO!-C?%R,QS&W"_]&. O^
MQZV^Y5)GXK6Z:KO<F$PU??5X.86?R8Z?B=T0B-Z5/79W 2VV$]B1H7#2<0B;
MMPOBDI46+^UR=(2G#5*,]V;?J:8[TJ;VH^ !XG1D33N-8O-V,:SI0.U2U&O0
M9+P;>YJP(Q?T3M^AT((N<Q"+[R04$(,"\@& 5&GVO!:V&!AMU,#=1K:YIB"9
M3C2SM:8@=CQWW.C%YAOJP1617!'+0?)MEL;H9I.+@GF.@L7739B'U<K_R#AI
MCF2[K =%8WW0]+T:J%FJ7-+"8:-I.# \'Y1,*Q.H^P)%8WW0]#*=PGMA:;ZP
MV7V9)@<[L7KX,(-8D&@,MYV8Y^+FR 844A5">CK<P=3)J<".^Q[.SL ])!K#
M&K>(QV0\:M(/%%6E7]I%;/:+[=G%%Y07WU'.BR(27XIZ2BY3T$NT#K['/"F.
M3C,][)9!%D@TMD53O (EHS+[I\H"%%6511I'W,$YMF:1X])HY>CA*@UR0*(Q
MW':60HZFA8"*J8HA72HVVU337-%3DA[>T2 ))!K#&C?MDM9Z&"BF*HGTP+B#
M"9:S1D\5>EA3@PJ0: RWG?5H2KV)V]0!**JZ>2,]-C%[;,WTD2PMDMA;^ ZI
M&TU)??J9Z4J.1QX=>Y,&>5TP56*DPR4='&Y[ %?(T1*B\ZV:](RFG"[+S'3E
M!!FM5>!Q/)4(:5^)V;X:!\_C= "YPCD4$-L"*7W&:?>L'P^G\BW])^G@/_=&
MQN,4TXXI%4U!;;:8:0IZWG3J32>D2=-Q2)4&Z>^(V=\=2B1?IFG$%^AZ$?)R
M>*I'K>?H\R4O!S+M7J@YDNTT 8K&0-%\*#15,VD%R>B);'\34&,)BL9 T7PH
M-%5R:3^)K?WLMP-D#F,M&*CE)&W+B4>Z?7.HL*H6TG.2/IZS>V[>#&^M :C/
M)&V?66G05. 41I-(HTGZ&TT+'4#-)2@:ZX.F31]#-4M52OI/8N4_+<0!]9R@
M:(RT/><$.[JOR2E,)Y6FDYI-YZ$IXOKU6[_3BLZ,;WV\#1*-@:+Y4&BJ4M(%
M4_Q$5G2TQ_ZM07)(- :*YD.AJ9)+OT]MMZO[K>C,8:P% ]VKINT< /$(\9KC
M)%1458J]T\1]MJ*[SU5F>&L)8(\!MS,'0H+F+@Y43%4 F82@_3>9+60 S3^
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M>JT0?V-X>PMOOYG="JFJW]J=KN,X.Y*]W19H8^U^K>,*M6IMVV%YNJWOM+G
MYWYKO\QOC5+[IFR[$U#GD'YKW&?VA=_N'[1Y WF5W[K/_.9:^F]'LK>; VVL
MX*_VF_NLQ'5:]O^N-RM'Q!C$/#L(2^+K33H_+99OR\/V:7[$W#;/3^K73,Q#
MW.PCF&&HU7)Q"D1^^,T?%$^S ^>4*SR^9K<+_,$ 0C? [S/.U>9!=U#^!/'^
M E!+ P04    " "9BEY7;3J354H$  #3%   &0   'AL+W=O<FMS:&5E=',O
M<VAE970X.2YX;6S56&%OVS80_2L'+1A:8+5$VD[BS#90-\G6HL&,!-L^%/O
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MT' P,<E+WQO]1(O:]:.-T*:[.;,TOQ.0UL'L;X70QXDE:']0Z1]02P,$%
M  @ F8I>5V+ZPN.< @  L08  !D   !X;"]W;W)K<VAE971S+W-H965T.38N
M>&ULO55=3]LP%/TK5]DT@31(FM*D8VTD"F-C JVB8CR@/;C);6/AV)GMM/#O
M9SMIZ+:0ASWLI?''/>>>8S<GDZV0CRI'U/!4,*ZF7JYU>>K[*LVQ(.I8E,C-
MSDK(@F@SE6M?E1))YD %\\,@B/R"4.XE$[<VE\E$5)I1CG,)JBH*(I]GR,1V
MZ@V\W<(M7>?:+OC)I"1K7*"^*^?2S/R6):,%<D4%!XFKJ7<V.)W%MMX5?*>X
M57MCL$Z60CS:R54V]0(K"!FFVC(0\]C@.3)FB8R,GPVGU[:TP/WQCOW2>3=>
MED3AN6#W--/YU!M[D.&*5$S?BNT7;/R,+%\JF'*_L&UJ P_22FE1-&"CH*"\
M?I*GYASV &'X"B!L *'373=R*B^()LE$BBU(6VW8[,!9=6@CCG)[*0LMS2XU
M.)W<$RD)UPJN*5E21C5%!0<7J EEZA".8&'^!EG%$,0*+@F5\)VP"N&;S"@W
MMPB+G$BWV3(=O0P?;K!8HOPQ\;71:COZ::-K5NL*7]$U".%&<)TK^,0SS'XG
M\(W)UFFX<SH+>QF_5OP8AL%["(-P"'>+"SAX>]C#.VQ/<.AXA__O!!^N30^X
MTEBHSJ.K!9UT"[*O\:DJ28I3S[RG"N4&O>3=FT$4?.RQ>]+:/>EC3V:$$9YB
MEZQ>8+<LZ%$T:A6->A5=*55A!LMGT#G"8GYVWB6NYA@Y#IM4FV001=$H"";^
MIJ-YU#:/>IN["]VX"Y58(%&5?7 -!Y]-(AYV*8G^4G(4Q^/Q8-"M)&Z5Q/]Z
M,34PVNLX'L?1^,,?#?V]&"E0KEU8*DA%Q76=*.UJF\=G=0R]E-=A?D/DFG(%
M#%<&&AS'QJZL [*>:%&Z4%H*;2+.#7/S34%I"\S^2@B]F]@&[5<J^0502P,$
M%     @ F8I>5SRZ#DF3 P  01$  !D   !X;"]W;W)K<VAE971S+W-H965T
M.3<N>&ULK5AM;Z,X$/XK%GM:M=)N>0LT;9-(:0'=G;12M;F]^W"Z#RY, EJP
M6=LDN__^;$/9T%(N.3D?$MO,\XP]SS!D6!PH^\IS (&^5R7A2RL7HKZU;9[F
M4&%^16L@\LJ6L@H+.64[F]<,<*9!56E[CA/:%2Z(M5KHM4>V6M!&E 6!1X9X
M4U68_;B'DAZ6EFL]+WPN=KE0"_9J4>,=;$!\J1^9G-D]2U940'A!"6*P75IK
M]S:Y4?;:X,\"#OQHC-1)GBC]JB:_94O+41N"$E*A&+#\V<,#E*4BDMOXUG%:
MO4L%/!X_LR?Z[/(L3YC# RW_*C*1+ZVYA3+8XJ84G^GA5^C.$RB^E)9<?Z-#
M:QO.+)0V7-"J \L=5 5I?_'W+@Y' #=\ ^!U .\EX"T/?@?P3P7,.L#L5$#0
M 8)3 6$'"'7LVV#I2$=8X-6"T0-BREJRJ8&62Z-E@ NB$FLCF+Q:2)Q8;8JJ
M+@&M=PQ YHM ,E=1THB& 8J_-87X@2[>OYM[GG.W62>Q'KIWE^@B H&+DE^B
MC^C+)D(7OUPN;"$WI&CMM'-^WSKWWG#N>N@3)2+G*"899$,"6YZD/X[W?)Q[
M;Y+Q]X9<(=_Y@#S'\T<V]# -CR#MX=X(/#K=^Q@\_@\XEG G?!.>G (/QN"#
M6/I]:OB:S___J;'!6T!_KY^X8+)$_#.6 :V/V;@/539O>8U36%JR+G)@>[!6
M[]^YH7,WIIY)LL@D66R2+#%$-E!]UJL^FV*7JN\(9 A7M"%B3- 6'FJX>FSM
M5V[@J,_"WA]K->GF7*U,DL4FR1)#9 .M@EZK8%*KM19)/M]3D(_G;$RM28)S
M;S^39%'P*H_&TB@^S2QY;>8Z0[M!A,,^PN%DA+LZMRT()FE!=F,A#E^Y]AQG
M[(Z8='5N^$R2Q2;)$D-D [VN>[VN)_5ZH&0/3,@"QG,LZ=%%0=!&#T?_GTRR
MG7M[M&3!<2*$GA>^2(/(I,_8)%EBB&R@W+Q7;CZIW&/#TERV"*AF12J_@;42
M:@4C6I:8\9^KHV)..CA7S)9L?EQ0O"OWA90F/<8FR1)#9 ,I;WHI;R:E_(,*
M7*)Z(.B87I,LY^IU\ZH*^^ZU[\_"%Y*9=!J;)$L,D;62V4<M805LIYMWCE+U
MAZ'M#OO5_OW 6K?%]D_S]N7")\QV!>&HA*V$.E?7LL*QMF%O)X+6NL%\HD*V
MJWJ8 \Z *0-Y?4NI>)XH!_U;D]6_4$L#!!0    ( )F*7E>(@F)2E0,  $L.
M   9    >&PO=V]R:W-H965T<R]S:&5E=#DX+GAM;*U776_:,!1]WZ^PLFEJ
MI:WY@D I1*(ET39I6E7V\3#MP20&K"5V9CO0[=?/=M(,J)NE AZ([=QS[O6Y
MSK4]WE+VDZ\1$N ^SPB?6&LABI%M\V2-<L@O:(&(?+.D+(="=MG*Y@5#,-6@
M/+,]QPGL'&)BA6,]=LO",2U%A@FZ98"7>0[9[VN4T>W$<JV'@3N\6@LU8(?C
M J[0'(DOQ2V3/;MA27&.",>4 (:6$VOJCN)+9:\-OF*TY3MMH&:RH/2GZKQ/
M)Y:C D(92H1B@/*Q03<HRQ21#.-7S6DU+A5PM_W 'NNYR[DL($<W-/N&4[&>
M6$,+I&@)RTS<T>T[5,^GK_@2FG']#[:UK6.!I.2"YC581I!C4CWA?:W##L#U
MGP!X-< [!/2> /@UP.\*Z-6 7E= OP;TNP*"&A!H[2NQM-(S*& X9G0+F+*6
M;*JATZ714F!,U,*:"R;?8HD3X1SG18; =,40DNM% +E605R*DB$0_2JQ^ W.
M7K\<>IYS-9_&D6ZZ5^?@;(8$Q!D_!V_!7*[VM)0L= EB3"!),,S >\(%*Q4G
MES9?YC-P]NI\; L9M')M)W6 -U6 WA,!?BC)!?"=-\!S/-\ GW6'>P9XU!WN
M&N!Q=[BS#[=EHIIL>4VV/,WG/Y6M_RK]?;J0'?F]_C!)7;'WS.RJAHUX 1,T
ML621XHAMD!6^?ND&SI5)^%.21:<DBT]$MI<BOTF1W\8>3@40:P06:(4)P61E
M2D/%$&@&5?DWH3<,'/D;VYM=A5L]F><!3.*>B"<^GF=/TEXC::]=TC3%:AOB
M)BU;H=WG-JMX^KLY<9S'.8E.Y"\^GF=/RWZC9;]5RSO$Y9[+@=S4U3)-UI"L
MJG(",0-?85;JGGJGZKTA\NMV!]]=8^7I/Y+7=WV_%QRL^,=FI@\C:@WA&4DX
MGF<O"4&3A*!5(Z4LN($%%C##?Z!:VR;-@D=BO/7=@4&U5F_/J!,GXHF/Y]F3
M==#(.NA2>A%)36JV8I]1* ;=BG=T(G_Q\3Q[8@ZM@X'+1MW+_WW8GZ6Z3!<0
MD,HZ(>AN#<%515FJ.K(YK",OMI!+BR0K4Y0JT_I,^4D:,+!LCC)U>:J/F1>F
M>=@[A]T<L96^EG"0T)*(:IMN1IN;S[6^(1R.#T?1T#1^.8KT3<G^1U]=LSY"
M)G=U#C*TE*Z<BX'\-EEU=:DZ@A;ZJ+V@0A[<=7,M;WN(*0/Y?DFI>.@H!\W]
M,?P+4$L#!!0    ( )F*7E?#3_UW> (  (T&   9    >&PO=V]R:W-H965T
M<R]S:&5E=#DY+GAM;*U5:V_3,!3]*U9 :).@>;795M)(:SM@:!751@$)\<%-
M;AMKL9W9;CO^/7ZD63>Z"@%?$E_[GG//N9%OT@T7M[($4.B>5DP.O%*INN_[
M,B^!8MGA-3!]LN""8J5#L?1E+0 7%D0K/PJ"Q*>8,"]+[=Y49"E?J8HPF HD
M5Y1B\7,(%=\,O-#;;ER39:G,AI^E-5["#:A9/14Z\EN6@E!@DG"&!"P&WGG8
M'_5,ODWX0F C=];(.)ES?FN"RV+@!4805) KPX#U:PTCJ"I#I&7<-9Q>6](
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M$"9!GR\X5]O %&C_0-DO4$L#!!0    ( )F*7E<*D7M79 ,  ,@-   :
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M]*Z'>(!5V3>4$R.SXF*\E :OV<4PP58+E-V []=2FN>)-5 W;].?4$L#!!0
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MT<<9+S9/59N"XDOSM#+E2O'"?"Z 9B"T ;;/.%?/!=U!_6 X_@]02P,$%
M  @ F8I>5QBP^8#M @  40H  !H   !X;"]W;W)K<VAE971S+W-H965T,3 S
M+GAM;*V6;6^;,!#'OXK%IJF5UD* 0-(E2&NB:9W6K6K6[<6T%PY<@E6#F>T\
M]-O/-@3E@=)DZANPL>]_]_/9AP<KQA]%"B#1.J.Y&%JIE,65;8LXA0R+2U9
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M)@%A%NCW,\[5W< 0M%\YT5]02P,$%     @ F8I>5[!=?-&3!   QR   !H
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MN(1*.IMP=D!<1RLW?5'3K]6*5U[IB;*47#W-E4[.YIDRS87D5 \86CRH&2A
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M0#1^2<+WR6!J&8*P>M]ZP\5FB M)>&37HS'N:(SM^W7)N,S_HWJ#,J&PJM^
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M S0#K@/4\Q5C\NE&5]!]>YE]!U!+ P04    " "9BEY76UF%#7,#  #<#
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M82L<PT03AR@#N@$MW-\S/>-4M0>[-(MV:3;=D=FCW7+:W7*&W,,9)0M@\KV
M<[0 8*I]&+10)XA46U#[>)6/?,5MPB/?-8/16-]TX2K"@L#SK.!QW%019_NV
MY3[X/4+BMDC<021?\)Q0S G-@.WO!9;IGXIW9HXY) CJNE52&G1] Z7:Q^TN
MR[4\W[5[F!1QCNVXKMG#I(IS1HYCJ3%Y+29O$--902C/_F+9$:AP#*K?@&-'
M/I'W%(/IC7JU-WTIZA$JOT7E#Z+ZRE.@B'8/PZ1S& X5E:_(QQ\97F^3+P83
M> ,EQ7Q68-M]3*JT/,-W S6HH 45#(+Z1K@XAJ[^!U3P]#!0@E+$>88YZOP:
M:A J/]LUQ6G00Z$(' 6N^02%WFGC"J#+JG]F*";KDM>M1GNW;='/JLZT=S\2
MK7O=:3_8U'W_):;+K&0HAX6P-(Y]L4&T[J7K 2>KJEF<$RY:S^HR%7\_@,H
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M9$JP>KF^WA%T7:U'SZD0M*@V5X!38.H">7Y!J7C;40':ER:3_P!02P,$%
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ML>O$15C@<,CH!C%E+=740&=?TS)?6:'J9":8?)M)3H13(%A @B:8B0PX.HM
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MRROI&JNZ>341M-3M:DZ%;'YZF,H+$#!E(-\O*!6[B=J@N5*%_P!02P,$%
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M#*3MFX*ORF?VW/&BX,ORY4+,0)K)!N+[>RZ&5_5&;F#W)*KS_P%02P,$%
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MJ(M$:1;0^Y6@U-8#XZ#I2T?_ E!+ P04    " "9BEY7$U-.X80#  !C$@
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M],,2[S?0+@&_KY6R^\ MT-V8V1]02P,$%     @ F8I>5XC+%/&' P  1P\
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M%#?@O,A%*;._DC:73*S*1-P#.3>7XSY=OP//?WTQ'@KI6CW!<+9UX^W&#?2
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MQ)VOS*8V,?;!5U3Q%77D*[.=S0UPG@&,*@"C/[]3IU@)P/)[P"LA6VI22>(
M@I>9D<7,NK:[K2^U;A84B]&GPV+4*XOY4NLF3K$8/97%S (VUXAG%J.*Q:@'
M%C-K6"^K9R"C.W<'/][MP5Z!S$7-F!(%9/1D(#,KV%1Y'T!&%9!1=R SF]K$
MZ!G(J (RZ@QD9DN;Z/H ,JJ C+H#F=G4)L8^@"Q40!8Z IG9SB) %Z&' QSN
M/#I5/[=VR<K;)*] RF^D?/ RDEM;N7D4;',BBF7S--6T$*+(FL,%EYVVK ?(
M]V^*0OPXJ1_0:A_(F_P/4$L#!!0    ( )F*7E>Z+#XTF 0  !TC   :
M>&PO=V]R:W-H965T<R]S:&5E=#$R,2YX;6S-FMMNXS8417^%4"](T,82J5AV
M4MO 3#*#9M  08RT#X,^T#9M$Y%$EZ3C#-"/'U*21<D7(DJIPB^);MPZ9XN;
M6C TV##^+):$2/":Q*D8>DLI5]>^+Z9+DF#182N2JC-SQA,LU2Y?^&+%"9YE
M@Y+81T$0^0FFJ3<:9,<>^&C UC*F*7G@0*R3!/-O'TG,-D,/>ML#CW2QE/J
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MCM3R99UV0!C\"E" P@/#;]X^'-6'^\J5TAI46H,RO<LC>A_X0OF@#H(5$4R
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M7WWJ822K3E]-M"A<[YL+;3JI&R[-Y0C2!ICWF1!Z-['MM+ENXW]02P,$%
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M<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ F8I>5^1.0]'G!P  2%$
M  \   !X;"]W;W)K8F]O:RYX;6S%G%MOVS88AO^*X*L.6&<=+%DJF@)I#EV
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M!,0JN12/NE/99T+B"(C-\:EIB@=1EC8/<D1 +(D;L5JWI@'\K;AYV2\M)(>
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M*>IN?@)02P$"% ,4    " "9BEY7!T%-8H$   "Q    $
M@ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( )F*7E<H$&4B[0
M "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4
M Q0    ( )F*7E>97)PC$ 8  )PG   3              "  <L!  !X;"]T
M:&5M92]T:&5M93$N>&UL4$L! A0#%     @ F8I>5Y+6+@\<!P  CR$  !@
M             ("!# @  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4
M Q0    ( )F*7E?)N%<-3 8  % @   8              " @5X/  !X;"]W
M;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " "9BEY71P9/!JD"   ,
M"   &               @('@%0  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL
M4$L! A0#%     @ F8I>5[EKU:*I!@  #2   !@              ("!OQ@
M 'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( )F*7E<,W JF
M%P<  &DT   8              " @9X?  !X;"]W;W)K<VAE971S+W-H965T
M-2YX;6Q02P$"% ,4    " "9BEY7Z_1/UDP+  #@20  &
M@('K)@  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ F8I>
M5WQ5@N[=#   ;R$  !@              ("!;3(  'AL+W=O<FMS:&5E=',O
M<VAE970W+GAM;%!+ 0(4 Q0    ( )F*7E?(WT"4%0D  ! 4   8
M      " @8 _  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4
M" "9BEY7!D,%NZ8*   D'   &               @('+2   >&PO=V]R:W-H
M965T<R]S:&5E=#DN>&UL4$L! A0#%     @ F8I>5[F>=/T@*@  N84  !D
M             ("!IU,  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"
M% ,4    " "9BEY770(9DTD#  !Z!P  &0              @('^?0  >&PO
M=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( )F*7E>$@F_[V@,
M %8*   9              " @7Z!  !X;"]W;W)K<VAE971S+W-H965T,3(N
M>&UL4$L! A0#%     @ F8I>5['J0-@;!   H H  !D              ("!
MCX4  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " "9BEY7
M)M62?#H"   "!0  &0              @('AB0  >&PO=V]R:W-H965T<R]S
M:&5E=#$T+GAM;%!+ 0(4 Q0    ( )F*7E<*WHU#H0(  ,D%   9
M      " @5*,  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%
M  @ F8I>5U;_9R^% P  5 @  !D              ("!*H\  'AL+W=O<FMS
M:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " "9BEY7+"=;ZX #   >"
M&0              @('FD@  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+
M 0(4 Q0    ( )F*7E=^"#B:/@(  "0%   9              " @9V6  !X
M;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ F8I>5SPX?-Z9
M @  'P8  !D              ("!$ID  'AL+W=O<FMS:&5E=',O<VAE970Q
M.2YX;6Q02P$"% ,4    " "9BEY7, ]'9#L"   "!0  &0
M@('BFP  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( )F*
M7E<7UOWMGP4  ! -   9              " @52>  !X;"]W;W)K<VAE971S
M+W-H965T,C$N>&UL4$L! A0#%     @ F8I>5\Q\\1I;!@  # \  !D
M         ("!*J0  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4
M    " "9BEY7AKV>9W,#  "^!P  &0              @(&\J@  >&PO=V]R
M:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( )F*7E=B\S<YUP0  .P*
M   9              " @6:N  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL
M4$L! A0#%     @ F8I>5]A8XS?Y!   1@L  !D              ("!=+,
M 'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " "9BEY7#BX*
M*(\%  "@#   &0              @(&DN   >&PO=V]R:W-H965T<R]S:&5E
M=#(V+GAM;%!+ 0(4 Q0    ( )F*7E>9JR,S;@@  .,4   9
M  " @6J^  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @
MF8I>5\K.V Y6 P  :0<  !D              ("!#\<  'AL+W=O<FMS:&5E
M=',O<VAE970R."YX;6Q02P$"% ,4    " "9BEY7E (OP7,"  ",!0  &0
M            @(&<R@  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4
M Q0    ( )F*7E=@B.N)'0,  +(&   9              " @4;-  !X;"]W
M;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ F8I>5P]'I?K$ @
M0 8  !D              ("!FM   'AL+W=O<FMS:&5E=',O<VAE970S,2YX
M;6Q02P$"% ,4    " "9BEY7W&<)[AH#  #F!@  &0              @(&5
MTP  >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( )F*7E=1
M8H.ZE@,  )()   9              " @>;6  !X;"]W;W)K<VAE971S+W-H
M965T,S,N>&UL4$L! A0#%     @ F8I>5WL29_N2!@  ?A   !D
M     ("!L]H  'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )F*7E=N#R0H[0,  .H(   9              "
M@?TO 0!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ F8I>
M5]T(0B#S!   !0P  !D              ("!(30! 'AL+W=O<FMS:&5E=',O
M<VAE970T,"YX;6Q02P$"% ,4    " "9BEY77X!TU^,#  !C"@  &0
M        @(%+.0$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0
M   ( )F*7E<6>7P<) 0  * *   9              " @64] 0!X;"]W;W)K
M<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ F8I>5^F/(=0A @  V 0
M !D              ("!P$$! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q0
M2P$"% ,4    " "9BEY7C"!;&JD"  #6!0  &0              @($81 $
M>&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( )F*7E?@6 WG
M00(  $4%   9              " @?A& 0!X;"]W;W)K<VAE971S+W-H965T
M-#4N>&UL4$L! A0#%     @ F8I>5RVK:=+* @  .08  !D
M ("!<$D! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " "9
MBEY7G;_;!CX"   9!0  &0              @(%Q3 $ >&PO=V]R:W-H965T
M<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( )F*7E?>H!JV>0(  $L&   9
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M970U,BYX;6Q02P$"% ,4    " "9BEY7F:R:6B,%  "0#   &0
M    @($%7P$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    (
M )F*7E<W95;CI@(  -$%   9              " @5]D 0!X;"]W;W)K<VAE
M971S+W-H965T-30N>&UL4$L! A0#%     @ F8I>5Y^WHF@2 P  I@8  !D
M             ("!/&<! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"
M% ,4    " "9BEY7A6N@/3D'  !&$P  &0              @(&%:@$ >&PO
M=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( )F*7E>*#FVO70,
M %<'   9              " @?5Q 0!X;"]W;W)K<VAE971S+W-H965T-3<N
M>&UL4$L! A0#%     @ F8I>5S0!\ MV @  @ 4  !D              ("!
MB74! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"% ,4    " "9BEY7
MY<@%01\#  "F!@  &0              @($V> $ >&PO=V]R:W-H965T<R]S
M:&5E=#4Y+GAM;%!+ 0(4 Q0    ( )F*7E=X"##UQ (  "L&   9
M      " @8Q[ 0!X;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%
M  @ F8I>5X>"];P? P  Y 8  !D              ("!AWX! 'AL+W=O<FMS
M:&5E=',O<VAE970V,2YX;6Q02P$"% ,4    " "9BEY7V=I<$> "  #$!@
M&0              @('=@0$ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+
M 0(4 Q0    ( )F*7E?#"'2E,P8   P0   9              " @?2$ 0!X
M;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @ F8I>5Z95J79K
M!P   !,  !D              ("!7HL! 'AL+W=O<FMS:&5E=',O<VAE970V
M-"YX;6Q02P$"% ,4    " "9BEY7TVDB]R,$   Y$P  &0
M@($ DP$ >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( )F*
M7E<;2PC+'@,  / *   9              " @5J7 0!X;"]W;W)K<VAE971S
M+W-H965T-C8N>&UL4$L! A0#%     @ F8I>5P]<'$.A @  4P8  !D
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M=#<Q+GAM;%!+ 0(4 Q0    ( )F*7E?:SM/^#@4  .H9   9
M  " @;ZM 0!X;"]W;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @
MF8I>5U.G[/$M P  ?P\  !D              ("! [,! 'AL+W=O<FMS:&5E
M=',O<VAE970W,RYX;6Q02P$"% ,4    " "9BEY7JOY%#.T)  #X6P  &0
M            @(%GM@$ >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4
M Q0    ( )F*7E=8RMCA@1H  &AU 0 9              " @8O  0!X;"]W
M;W)K<VAE971S+W-H965T-S4N>&UL4$L! A0#%     @ F8I>5U,C@S(B @
MU@4  !D              ("!0]L! 'AL+W=O<FMS:&5E=',O<VAE970W-BYX
M;6Q02P$"% ,4    " "9BEY7>8 "QA\"  ";!   &0              @(&<
MW0$ >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    ( )F*7E>?
MV82A#P,  !X(   9              " @?+? 0!X;"]W;W)K<VAE971S+W-H
M965T-S@N>&UL4$L! A0#%     @ F8I>5Y.W+TQ( P  3PP  !D
M     ("!..,! 'AL+W=O<FMS:&5E=',O<VAE970W.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )F*7E<\?B]690(  .4&   9              "
M@1OQ 0!X;"]W;W)K<VAE971S+W-H965T.#0N>&UL4$L! A0#%     @ F8I>
M5\'[Y!M8 @  IP8  !D              ("!M_,! 'AL+W=O<FMS:&5E=',O
M<VAE970X-2YX;6Q02P$"% ,4    " "9BEY7HT2GJ+,"  ";"   &0
M        @(%&]@$ >&PO=V]R:W-H965T<R]S:&5E=#@V+GAM;%!+ 0(4 Q0
M   ( )F*7E<^*[=X$P@  $E*   9              " @3#Y 0!X;"]W;W)K
M<VAE971S+W-H965T.#<N>&UL4$L! A0#%     @ F8I>5YY&UR!) P  C@P
M !D              ("!>@$" 'AL+W=O<FMS:&5E=',O<VAE970X."YX;6Q0
M2P$"% ,4    " "9BEY7;3J354H$  #3%   &0              @('Z! (
M>&PO=V]R:W-H965T<R]S:&5E=#@Y+GAM;%!+ 0(4 Q0    ( )F*7E>H-.Q2
M$04  !DB   9              " @7L) @!X;"]W;W)K<VAE971S+W-H965T
M.3 N>&UL4$L! A0#%     @ F8I>5WMOLR+> P  D X  !D
M ("!PPX" 'AL+W=O<FMS:&5E=',O<VAE970Y,2YX;6Q02P$"% ,4    " "9
MBEY7<.,1_+@"  !6"P  &0              @('8$@( >&PO=V]R:W-H965T
M<R]S:&5E=#DR+GAM;%!+ 0(4 Q0    ( )F*7E?BC7!'IP(  "L)   9
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M970Y-RYX;6Q02P$"% ,4    " "9BEY7B()B4I4#  !+#@  &0
M    @($M,0( >&PO=V]R:W-H965T<R]S:&5E=#DX+GAM;%!+ 0(4 Q0    (
M )F*7E?#3_UW> (  (T&   9              " @?DT @!X;"]W;W)K<VAE
M971S+W-H965T.3DN>&UL4$L! A0#%     @ F8I>5PJ1>U=D P  R T  !H
M             ("!J#<" 'AL+W=O<FMS:&5E=',O<VAE970Q,# N>&UL4$L!
M A0#%     @ F8I>5]#B*%T@!   ZB   !H              ("!1#L" 'AL
M+W=O<FMS:&5E=',O<VAE970Q,#$N>&UL4$L! A0#%     @ F8I>5Q^>]Z3M
M!   /!0  !H              ("!G#\" 'AL+W=O<FMS:&5E=',O<VAE970Q
M,#(N>&UL4$L! A0#%     @ F8I>5QBP^8#M @  40H  !H
M ("!P40" 'AL+W=O<FMS:&5E=',O<VAE970Q,#,N>&UL4$L! A0#%     @
MF8I>5YL5.54\ P  \0P  !H              ("!YD<" 'AL+W=O<FMS:&5E
M=',O<VAE970Q,#0N>&UL4$L! A0#%     @ F8I>5[!=?-&3!   QR   !H
M             ("!6DL" 'AL+W=O<FMS:&5E=',O<VAE970Q,#4N>&UL4$L!
M A0#%     @ F8I>5ZHXV)]A!   ^Q4  !H              ("!)5 " 'AL
M+W=O<FMS:&5E=',O<VAE970Q,#8N>&UL4$L! A0#%     @ F8I>5\6/?2R]
M @  3PD  !H              ("!OE0" 'AL+W=O<FMS:&5E=',O<VAE970Q
M,#<N>&UL4$L! A0#%     @ F8I>5^GC<QTD!   AQ$  !H
M ("!LU<" 'AL+W=O<FMS:&5E=',O<VAE970Q,#@N>&UL4$L! A0#%     @
MF8I>5UM9A0US P  W P  !H              ("!#UP" 'AL+W=O<FMS:&5E
M=',O<VAE970Q,#DN>&UL4$L! A0#%     @ F8I>5YZ0,UB@!   0!D  !H
M             ("!NE\" 'AL+W=O<FMS:&5E=',O<VAE970Q,3 N>&UL4$L!
M A0#%     @ F8I>5P^VF35U P  <0L  !H              ("!DF0" 'AL
M+W=O<FMS:&5E=',O<VAE970Q,3$N>&UL4$L! A0#%     @ F8I>5[L#@1RB
M @  '0@  !H              ("!/V@" 'AL+W=O<FMS:&5E=',O<VAE970Q
M,3(N>&UL4$L! A0#%     @ F8I>5^,2/V7L @  7@D  !H
M ("!&6L" 'AL+W=O<FMS:&5E=',O<VAE970Q,3,N>&UL4$L! A0#%     @
MF8I>5[VZYJ5S"0  E4H  !H              ("!/6X" 'AL+W=O<FMS:&5E
M=',O<VAE970Q,30N>&UL4$L! A0#%     @ F8I>5T$PG(+M P  HPX  !H
M             ("!Z'<" 'AL+W=O<FMS:&5E=',O<VAE970Q,34N>&UL4$L!
M A0#%     @ F8I>5Q-33N&$ P  8Q(  !H              ("!#7P" 'AL
M+W=O<FMS:&5E=',O<VAE970Q,38N>&UL4$L! A0#%     @ F8I>5_4Y@!>.
M @  /0<  !H              ("!R7\" 'AL+W=O<FMS:&5E=',O<VAE970Q
M,3<N>&UL4$L! A0#%     @ F8I>5XC+%/&' P  1P\  !H
M ("!CX(" 'AL+W=O<FMS:&5E=',O<VAE970Q,3@N>&UL4$L! A0#%     @
MF8I>5^^#YHA* @  (@8  !H              ("!3H8" 'AL+W=O<FMS:&5E
M=',O<VAE970Q,3DN>&UL4$L! A0#%     @ F8I>5R<,R2V$!@  G#<  !H
M             ("!T(@" 'AL+W=O<FMS:&5E=',O<VAE970Q,C N>&UL4$L!
M A0#%     @ F8I>5[HL/C28!   '2,  !H              ("!C(\" 'AL
M+W=O<FMS:&5E=',O<VAE970Q,C$N>&UL4$L! A0#%     @ F8I>5R@6Z^L\
M!0  N!,  !H              ("!7)0" 'AL+W=O<FMS:&5E=',O<VAE970Q
M,C(N>&UL4$L! A0#%     @ F8I>5]<EO9MP @  >@<  !H
M ("!T)D" 'AL+W=O<FMS:&5E=',O<VAE970Q,C,N>&UL4$L! A0#%     @
MF8I>5Q6U6=J> @  >@8  !H              ("!>)P" 'AL+W=O<FMS:&5E
M=',O<VAE970Q,C0N>&UL4$L! A0#%     @ F8I>5Z<S.;0Y P  [A,   T
M             ( !3I\" 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " "9BEY7
MEXJ[',     3 @  "P              @ &RH@( 7W)E;',O+G)E;'-02P$"
M% ,4    " "9BEY7Y$Y#T><'  !(40  #P              @ &;HP( >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ F8I>5QCJ*5%F P  OT@  !H
M         ( !KZL" 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ F8I>5VX0J*>E @  LT4  !,              ( !3:\" %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&     (0 A !L)   ([("

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>465</ContextCount>
  <ElementCount>501</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>95</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - Consolidated Statements of Comprehensive Loss (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome_Parentheticals</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - Consolidated Statements of Financial Position</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Consolidated Statements of Financial Position</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - Consolidated Statements of Changes in Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>Consolidated Statements of Changes in Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ConsolidatedCashFlow</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Disclosure - General Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/GeneralInformation</Role>
      <ShortName>General Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Disclosure - Business Combination</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/BusinessCombination</Role>
      <ShortName>Business Combination</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - Accounting Standards and Basis of Preparation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparation</Role>
      <ShortName>Accounting Standards and Basis of Preparation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - Comparative Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ComparativeInformation</Role>
      <ShortName>Comparative Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - Fixed Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/FixedAssets</Role>
      <ShortName>Fixed Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/Goodwill</Role>
      <ShortName>Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - Right of Use of Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/RightofUseofAssets</Role>
      <ShortName>Right of Use of Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - Other Non-Current Receivables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/OtherNonCurrentReceivables</Role>
      <ShortName>Other Non-Current Receivables</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - Cash and Cash Equivalents</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/CashandCashEquivalents</Role>
      <ShortName>Cash and Cash Equivalents</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - Short Term Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ShortTermInvestments</Role>
      <ShortName>Short Term Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - Trade Receivable and Other Current Receivables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/TradeReceivableandOtherCurrentReceivables</Role>
      <ShortName>Trade Receivable and Other Current Receivables</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>019 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>020 - Disclosure - Share Capital and Share Premium</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ShareCapitalandSharePremium</Role>
      <ShortName>Share Capital and Share Premium</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>021 - Disclosure - Share Based Payment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ShareBasedPayment</Role>
      <ShortName>Share Based Payment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>022 - Disclosure - Accounts Payable and Other Current and Non-Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/AccountsPayableandOtherCurrentandNonCurrentLiabilities</Role>
      <ShortName>Accounts Payable and Other Current and Non-Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>023 - Disclosure - Financial Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/FinancialDebt</Role>
      <ShortName>Financial Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>024 - Disclosure - Warrants Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/WarrantsLiabilities</Role>
      <ShortName>Warrants Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>025 - Disclosure - Simple Agreement for Future Equity (???SAFE???)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFE</Role>
      <ShortName>Simple Agreement for Future Equity (???SAFE???)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>026 - Disclosure - Deferred Tax and Income Tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/DeferredTaxandIncomeTax</Role>
      <ShortName>Deferred Tax and Income Tax</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>027 - Disclosure - Financial Income / Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/FinancialIncomeExpenses</Role>
      <ShortName>Financial Income / Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>028 - Disclosure - Other Operating Expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/OtherOperatingExpense</Role>
      <ShortName>Other Operating Expense</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>029 - Disclosure - Administrative Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/AdministrativeExpenses</Role>
      <ShortName>Administrative Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>030 - Disclosure - Research and Development Expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ResearchandDevelopmentExpense</Role>
      <ShortName>Research and Development Expense</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>031 - Disclosure - Cost of sales</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/Costofsales</Role>
      <ShortName>Cost of sales</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>032 - Disclosure - Net Loss per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/NetLossperShare</Role>
      <ShortName>Net Loss per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>033 - Disclosure - Related Parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/RelatedParties</Role>
      <ShortName>Related Parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>034 - Disclosure - Financial Risk Management</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/FinancialRiskManagement</Role>
      <ShortName>Financial Risk Management</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>035 - Disclosure - Capital Risk Management</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/CapitalRiskManagement</Role>
      <ShortName>Capital Risk Management</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>036 - Disclosure - Events after the Reporting Period</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/EventsaftertheReportingPeriod</Role>
      <ShortName>Events after the Reporting Period</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>037 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparation</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>038 - Disclosure - Business Combination (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/BusinessCombinationTables</Role>
      <ShortName>Business Combination (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/BusinessCombination</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>039 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>040 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/IntangibleAssets</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>041 - Disclosure - Fixed Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/FixedAssetsTables</Role>
      <ShortName>Fixed Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/FixedAssets</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>042 - Disclosure - Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/GoodwillTables</Role>
      <ShortName>Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/Goodwill</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>043 - Disclosure - Right of Use of Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/RightofUseofAssetsTables</Role>
      <ShortName>Right of Use of Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/RightofUseofAssets</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>044 - Disclosure - Other Non-Current Receivables (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/OtherNonCurrentReceivablesTables</Role>
      <ShortName>Other Non-Current Receivables (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/OtherNonCurrentReceivables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>045 - Disclosure - Cash and Cash Equivalents (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/CashandCashEquivalentsTables</Role>
      <ShortName>Cash and Cash Equivalents (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/CashandCashEquivalents</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>046 - Disclosure - Short Term Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ShortTermInvestmentsTables</Role>
      <ShortName>Short Term Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/ShortTermInvestments</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>047 - Disclosure - Trade Receivable and Other Current Receivables (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/TradeReceivableandOtherCurrentReceivablesTables</Role>
      <ShortName>Trade Receivable and Other Current Receivables (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/TradeReceivableandOtherCurrentReceivables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>048 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/Inventories</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>049 - Disclosure - Share Capital and Share Premium (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ShareCapitalandSharePremiumTables</Role>
      <ShortName>Share Capital and Share Premium (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/ShareCapitalandSharePremium</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>050 - Disclosure - Share Based Payment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ShareBasedPaymentTables</Role>
      <ShortName>Share Based Payment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/ShareBasedPayment</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>051 - Disclosure - Accounts Payable and Other Current and Non-Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTables</Role>
      <ShortName>Accounts Payable and Other Current and Non-Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/AccountsPayableandOtherCurrentandNonCurrentLiabilities</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>052 - Disclosure - Financial Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/FinancialDebtTables</Role>
      <ShortName>Financial Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/FinancialDebt</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>053 - Disclosure - Warrants Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/WarrantsLiabilitiesTables</Role>
      <ShortName>Warrants Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/WarrantsLiabilities</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>054 - Disclosure - Simple Agreement for Future Equity (???SAFE???) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFETables</Role>
      <ShortName>Simple Agreement for Future Equity (???SAFE???) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFE</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>055 - Disclosure - Deferred Tax and Income Tax (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/DeferredTaxandIncomeTaxTables</Role>
      <ShortName>Deferred Tax and Income Tax (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/DeferredTaxandIncomeTax</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>056 - Disclosure - Financial Income / Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/FinancialIncomeExpensesTables</Role>
      <ShortName>Financial Income / Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/FinancialIncomeExpenses</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>057 - Disclosure - Other Operating Expense (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/OtherOperatingExpenseTables</Role>
      <ShortName>Other Operating Expense (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/OtherOperatingExpense</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>058 - Disclosure - Administrative Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/AdministrativeExpensesTables</Role>
      <ShortName>Administrative Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/AdministrativeExpenses</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>059 - Disclosure - Research and Development Expense (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ResearchandDevelopmentExpenseTables</Role>
      <ShortName>Research and Development Expense (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/ResearchandDevelopmentExpense</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>060 - Disclosure - Cost of sales (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/CostofsalesTables</Role>
      <ShortName>Cost of sales (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/Costofsales</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>061 - Disclosure - Net Loss per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/NetLossperShareTables</Role>
      <ShortName>Net Loss per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/NetLossperShare</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>062 - Disclosure - Related Parties (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/RelatedPartiesTables</Role>
      <ShortName>Related Parties (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/RelatedParties</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>063 - Disclosure - Financial Risk Management (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/FinancialRiskManagementTables</Role>
      <ShortName>Financial Risk Management (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/FinancialRiskManagement</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>064 - Disclosure - General Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/GeneralInformationDetails</Role>
      <ShortName>General Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/GeneralInformation</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>065 - Disclosure - Business Combination (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/BusinessCombinationDetails</Role>
      <ShortName>Business Combination (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/BusinessCombinationTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>066 - Disclosure - Business Combination (Details) - Schedule of Net Assets Acquired and Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofNetAssetsAcquiredandGoodwillTable</Role>
      <ShortName>Business Combination (Details) - Schedule of Net Assets Acquired and Goodwill</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/BusinessCombinationTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>067 - Disclosure - Business Combination (Details) - Schedule of Assets and Liabilities Recognised</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable</Role>
      <ShortName>Business Combination (Details) - Schedule of Assets and Liabilities Recognised</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/BusinessCombinationTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>068 - Disclosure - Accounting Standards and Basis of Preparation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails</Role>
      <ShortName>Accounting Standards and Basis of Preparation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>069 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>070 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Useful Lives of Property, Plant and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofUsefulLivesofPropertyPlantandEquipmentTable</Role>
      <ShortName>Summary of Significant Accounting Policies (Details) - Schedule of Useful Lives of Property, Plant and Equipment</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>071 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Consolidated Financial Statements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofConsolidatedFinancialStatementsTable</Role>
      <ShortName>Summary of Significant Accounting Policies (Details) - Schedule of Consolidated Financial Statements</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>072 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Non-Current Assets Other than Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable</Role>
      <ShortName>Summary of Significant Accounting Policies (Details) - Schedule of Non-Current Assets Other than Financial Instruments</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>073 - Disclosure - Intangible Assets (Details) - Schedule of Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable</Role>
      <ShortName>Intangible Assets (Details) - Schedule of Intangible Assets</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/IntangibleAssetsTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>074 - Disclosure - Fixed Assets (Details) - Schedule of Fixed Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofFixedAssetsTable</Role>
      <ShortName>Fixed Assets (Details) - Schedule of Fixed Assets</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/FixedAssetsTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>075 - Disclosure - Goodwill (Details) - Schedule of Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofGoodwillTable</Role>
      <ShortName>Goodwill (Details) - Schedule of Goodwill</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/GoodwillTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>076 - Disclosure - Right of Use of Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/RightofUseofAssetsDetails</Role>
      <ShortName>Right of Use of Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/RightofUseofAssetsTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>077 - Disclosure - Right of Use of Assets (Details) - Schedule of Right of Use of Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofRightofUseofAssetsTable</Role>
      <ShortName>Right of Use of Assets (Details) - Schedule of Right of Use of Assets</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/RightofUseofAssetsTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>078 - Disclosure - Other Non-Current Receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/OtherNonCurrentReceivablesDetails</Role>
      <ShortName>Other Non-Current Receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/OtherNonCurrentReceivablesTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>079 - Disclosure - Other Non-Current Receivables (Details) - Schedule of Other Non-Current Receivables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofOtherNonCurrentReceivablesTable</Role>
      <ShortName>Other Non-Current Receivables (Details) - Schedule of Other Non-Current Receivables</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/OtherNonCurrentReceivablesTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>080 - Disclosure - Cash and Cash Equivalents (Details) - Schedule of Cash and Cash Equivalents</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable</Role>
      <ShortName>Cash and Cash Equivalents (Details) - Schedule of Cash and Cash Equivalents</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/CashandCashEquivalentsTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>081 - Disclosure - Short Term Investments (Details) - Schedule of Short Term Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofShortTermInvestmentsTable</Role>
      <ShortName>Short Term Investments (Details) - Schedule of Short Term Investments</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/ShortTermInvestmentsTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>082 - Disclosure - Trade Receivable and Other Current Receivables (Details) - Schedule of Trade Receivable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofTradeReceivableTable</Role>
      <ShortName>Trade Receivable and Other Current Receivables (Details) - Schedule of Trade Receivable</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/TradeReceivableandOtherCurrentReceivablesTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>083 - Disclosure - Trade Receivable and Other Current Receivables (Details) - Schedule of Other Current Receivables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofOtherCurrentReceivablesTable</Role>
      <ShortName>Trade Receivable and Other Current Receivables (Details) - Schedule of Other Current Receivables</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/TradeReceivableandOtherCurrentReceivablesTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>084 - Disclosure - Inventories (Details) - Schedule of Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofInventoriesTable</Role>
      <ShortName>Inventories (Details) - Schedule of Inventories</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/InventoriesTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>085 - Disclosure - Share Capital and Share Premium (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ShareCapitalandSharePremiumDetails</Role>
      <ShortName>Share Capital and Share Premium (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/ShareCapitalandSharePremiumTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>086 - Disclosure - Share Capital and Share Premium (Details) - Schedule of Reconciliation of Share Capital and Share Premium</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable</Role>
      <ShortName>Share Capital and Share Premium (Details) - Schedule of Reconciliation of Share Capital and Share Premium</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/ShareCapitalandSharePremiumTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>087 - Disclosure - Share Based Payment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ShareBasedPaymentDetails</Role>
      <ShortName>Share Based Payment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/ShareBasedPaymentTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>088 - Disclosure - Share Based Payment (Details) - Schedule and the Possible Dilutive Effect of the Future Exercise of Options</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable</Role>
      <ShortName>Share Based Payment (Details) - Schedule and the Possible Dilutive Effect of the Future Exercise of Options</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/ShareBasedPaymentTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>089 - Disclosure - Share Based Payment (Details) - Schedule of Amount and Exercise Price and the Movements of the Stock Options of Executives and Managers</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable</Role>
      <ShortName>Share Based Payment (Details) - Schedule of Amount and Exercise Price and the Movements of the Stock Options of Executives and Managers</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/ShareBasedPaymentTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>090 - Disclosure - Accounts Payable and Other Current and Non-Current Liabilities (Details) - Schedule of Accounts Payable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofAccountsPayableTable</Role>
      <ShortName>Accounts Payable and Other Current and Non-Current Liabilities (Details) - Schedule of Accounts Payable</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTables</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>091 - Disclosure - Financial Debt (Details) - Schedule of Financial Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofFinancialDebtTable</Role>
      <ShortName>Financial Debt (Details) - Schedule of Financial Debt</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/FinancialDebtTables</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>092 - Disclosure - Financial Debt (Details) - Schedule of Book Value is Reasonably Approximate to the Fair Value given its Short-Term Nature</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable</Role>
      <ShortName>Financial Debt (Details) - Schedule of Book Value is Reasonably Approximate to the Fair Value given its Short-Term Nature</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/FinancialDebtTables</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>093 - Disclosure - Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable</Role>
      <ShortName>Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/FinancialDebtTables</ParentRole>
      <Position>94</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>094 - Disclosure - Warrants Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/WarrantsLiabilitiesDetails</Role>
      <ShortName>Warrants Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/WarrantsLiabilitiesTables</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>095 - Disclosure - Warrants Liabilities (Details) - Schedule of Fair Value Ordinary Share of Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofFairValueOrdinaryShareofWarrantsTable</Role>
      <ShortName>Warrants Liabilities (Details) - Schedule of Fair Value Ordinary Share of Warrants</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/WarrantsLiabilitiesTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>096 - Disclosure - Simple Agreement for Future Equity (???SAFE???) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFEDetails</Role>
      <ShortName>Simple Agreement for Future Equity (???SAFE???) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFETables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>097 - Disclosure - Simple Agreement for Future Equity (???SAFE???) (Details) - Schedule of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofFinancialInstrumentsTable</Role>
      <ShortName>Simple Agreement for Future Equity (???SAFE???) (Details) - Schedule of Financial Instruments</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFETables</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>098 - Disclosure - Deferred Tax and Income Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/DeferredTaxandIncomeTaxDetails</Role>
      <ShortName>Deferred Tax and Income Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/DeferredTaxandIncomeTaxTables</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>099 - Disclosure -  Deferred Tax and Income Tax (Details) - Schedule of Roll Forward of Net Deferred Tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofRollForwardofNetDeferredTaxTable</Role>
      <ShortName>Deferred Tax and Income Tax (Details) - Schedule of Roll Forward of Net Deferred Tax</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/DeferredTaxandIncomeTaxTables</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>100 - Disclosure -  Deferred Tax and Income Tax (Details) - Schedule of Principal Statutory Taxes Rates in the Countries</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable</Role>
      <ShortName>Deferred Tax and Income Tax (Details) - Schedule of Principal Statutory Taxes Rates in the Countries</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/DeferredTaxandIncomeTaxTables</ParentRole>
      <Position>101</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>101 - Disclosure -  Deferred Tax and Income Tax (Details) - Schedule of Income Tax for Other Jurisdictions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofIncomeTaxforOtherJurisdictionsTable</Role>
      <ShortName>Deferred Tax and Income Tax (Details) - Schedule of Income Tax for Other Jurisdictions</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/DeferredTaxandIncomeTaxTables</ParentRole>
      <Position>102</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>102 - Disclosure -  Deferred Tax and Income Tax (Details) - Schedule of Net Deferred Tax Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable</Role>
      <ShortName>Deferred Tax and Income Tax (Details) - Schedule of Net Deferred Tax Liabilities</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/DeferredTaxandIncomeTaxTables</ParentRole>
      <Position>103</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>103 - Disclosure -  Deferred Tax and Income Tax (Details) - Schedule of Accumulated Tax Loss Carryforwards</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofAccumulatedTaxLossCarryforwardsTable</Role>
      <ShortName>Deferred Tax and Income Tax (Details) - Schedule of Accumulated Tax Loss Carryforwards</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/DeferredTaxandIncomeTaxTables</ParentRole>
      <Position>104</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>104 - Disclosure -  Deferred Tax and Income Tax (Details) - Schedule of Estimated Future Taxable Profit.</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofEstimatedFutureTaxableProfitTable</Role>
      <ShortName>Deferred Tax and Income Tax (Details) - Schedule of Estimated Future Taxable Profit.</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/DeferredTaxandIncomeTaxTables</ParentRole>
      <Position>105</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>105 - Disclosure - Financial Income / Expenses (Details) - Schedule of Financial Income Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofFinancialIncomeExpensesTable</Role>
      <ShortName>Financial Income / Expenses (Details) - Schedule of Financial Income Expenses</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/FinancialIncomeExpensesTables</ParentRole>
      <Position>106</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>106 - Disclosure - Other Operating Expense (Details) - Schedule of Other Operating Expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofOtherOperatingExpenseTable</Role>
      <ShortName>Other Operating Expense (Details) - Schedule of Other Operating Expense</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/OtherOperatingExpenseTables</ParentRole>
      <Position>107</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>107 - Disclosure - Administrative Expenses (Details) - Schedule of Administrative Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable</Role>
      <ShortName>Administrative Expenses (Details) - Schedule of Administrative Expenses</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/AdministrativeExpensesTables</ParentRole>
      <Position>108</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>108 - Disclosure - Research and Development Expense (Details) - Schedule of Research and Development Expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofResearchandDevelopmentExpenseTable</Role>
      <ShortName>Research and Development Expense (Details) - Schedule of Research and Development Expense</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/ResearchandDevelopmentExpenseTables</ParentRole>
      <Position>109</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>109 - Disclosure - Cost of sales (Details) - Schedule of Cost of sales</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofCostofsalesTable</Role>
      <ShortName>Cost of sales (Details) - Schedule of Cost of sales</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/CostofsalesTables</ParentRole>
      <Position>110</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>110 - Disclosure - Net Loss per Share (Details) - Schedule of Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable</Role>
      <ShortName>Net Loss per Share (Details) - Schedule of Net Loss Per Share</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/NetLossperShareTables</ParentRole>
      <Position>111</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>111 - Disclosure - Net Loss per Share (Details) - Schedule of Net Loss Per Share (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable_Parentheticals</Role>
      <ShortName>Net Loss per Share (Details) - Schedule of Net Loss Per Share (Parentheticals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/NetLossperShareTables</ParentRole>
      <Position>112</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>112 - Disclosure - Related Parties (Details) - Schedule of Other Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofOtherRelatedPartyTransactionsTable</Role>
      <ShortName>Related Parties (Details) - Schedule of Other Related Party Transactions</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/RelatedPartiesTables</ParentRole>
      <Position>113</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>113 - Disclosure - Related Parties (Details) - Schedule of Share Based Payment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable</Role>
      <ShortName>Related Parties (Details) - Schedule of Share Based Payment</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/RelatedPartiesTables</ParentRole>
      <Position>114</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>114 - Disclosure - Related Parties (Details) - Schedule of Share Based Payment (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable_Parentheticals</Role>
      <ShortName>Related Parties (Details) - Schedule of Share Based Payment (Parentheticals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/RelatedPartiesTables</ParentRole>
      <Position>115</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>115 - Disclosure - Related Parties (Details) - Schedule of other related party balances</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable</Role>
      <ShortName>Related Parties (Details) - Schedule of other related party balances</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/RelatedPartiesTables</ParentRole>
      <Position>116</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>116 - Disclosure - Related Parties (Details) - Schedule of other related party balances (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable_Parentheticals</Role>
      <ShortName>Related Parties (Details) - Schedule of other related party balances (Parentheticals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/RelatedPartiesTables</ParentRole>
      <Position>117</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>117 - Disclosure - Financial Risk Management (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/FinancialRiskManagementDetails</Role>
      <ShortName>Financial Risk Management (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/FinancialRiskManagementTables</ParentRole>
      <Position>118</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>118 - Disclosure - Financial Risk Management (Details) - Schedule of Trade and Other Receivables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofTradeandOtherReceivablesTable</Role>
      <ShortName>Financial Risk Management (Details) - Schedule of Trade and Other Receivables</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/FinancialRiskManagementTables</ParentRole>
      <Position>119</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R120.htm</HtmlFileName>
      <LongName>119 - Disclosure - Financial Risk Management (Details) - Schedule of Contractual Maturity Date</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable</Role>
      <ShortName>Financial Risk Management (Details) - Schedule of Contractual Maturity Date</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/FinancialRiskManagementTables</ParentRole>
      <Position>120</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R121.htm</HtmlFileName>
      <LongName>120 - Disclosure - Financial Risk Management (Details) - Schedule of Foreign Currency Exchange Risk</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofForeignCurrencyExchangeRiskTable</Role>
      <ShortName>Financial Risk Management (Details) - Schedule of Foreign Currency Exchange Risk</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/FinancialRiskManagementTables</ParentRole>
      <Position>121</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R122.htm</HtmlFileName>
      <LongName>121 - Disclosure - Financial Risk Management (Details) - Schedule of Fair Value and Carrying Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable</Role>
      <ShortName>Financial Risk Management (Details) - Schedule of Fair Value and Carrying Value of Financial Instruments</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/FinancialRiskManagementTables</ParentRole>
      <Position>122</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R123.htm</HtmlFileName>
      <LongName>122 - Disclosure - Financial Risk Management (Details) - Schedule of Fixed-Rate Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/ScheduleofFixedRateInstrumentsTable</Role>
      <ShortName>Financial Risk Management (Details) - Schedule of Fixed-Rate Instruments</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/FinancialRiskManagementTables</ParentRole>
      <Position>123</Position>
    </Report>
    <Report instance="f20f2023_moolecsci.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R124.htm</HtmlFileName>
      <LongName>123 - Disclosure - Events after the Reporting Period (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.moolecscience.com/role/EventsaftertheReportingPeriodDetails</Role>
      <ShortName>Events after the Reporting Period (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.moolecscience.com/role/EventsaftertheReportingPeriod</ParentRole>
      <Position>124</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="20-F" isDefinitelyFs="true" isIfrs="true" isUsgaap="true" original="f20f2023_moolecsci.htm">f20f2023_moolecsci.htm</File>
    <File>mlec-20230630.xsd</File>
    <File>mlec-20230630_cal.xml</File>
    <File>mlec-20230630_def.xml</File>
    <File>mlec-20230630_lab.xml</File>
    <File>mlec-20230630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_001.jpg</File>
    <File>image_002.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2023</BaseTaxonomy>
    <BaseTaxonomy items="1">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="46">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="1057">https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>144
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "f20f2023_moolecsci.htm": {
   "nsprefix": "mlec",
   "nsuri": "http://www.moolecscience.com/20230630",
   "dts": {
    "inline": {
     "local": [
      "f20f2023_moolecsci.htm"
     ]
    },
    "schema": {
     "local": [
      "mlec-20230630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "mlec-20230630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mlec-20230630_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "mlec-20230630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mlec-20230630_pre.xml"
     ]
    }
   },
   "keyStandard": 298,
   "keyCustom": 203,
   "axisStandard": 18,
   "axisCustom": 0,
   "memberStandard": 24,
   "memberCustom": 69,
   "hidden": {
    "total": 724,
    "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 428,
    "http://www.moolecscience.com/20230630": 292,
    "http://xbrl.sec.gov/dei/2023": 4
   },
   "contextCount": 465,
   "entityCount": 1,
   "segmentCount": 95,
   "elementCount": 847,
   "unitCount": 4,
   "baseTaxonomies": {
    "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 1057,
    "http://xbrl.sec.gov/dei/2023": 46,
    "http://fasb.org/srt/2023": 1,
    "http://fasb.org/us-gaap/2023": 1
   },
   "report": {
    "R1": {
     "role": "http://www.moolecscience.com/role/DocumentAndEntityInformation",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
     "longName": "001 - Statement - Consolidated Statements of Comprehensive Loss",
     "shortName": "Consolidated Statements of Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:Revenue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:Revenue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome_Parentheticals",
     "longName": "002 - Statement - Consolidated Statements of Comprehensive Loss (Parentheticals)",
     "shortName": "Consolidated Statements of Comprehensive Loss (Parentheticals)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R4": {
     "role": "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
     "longName": "003 - Statement - Consolidated Statements of Financial Position",
     "shortName": "Consolidated Statements of Financial Position",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c2",
      "name": "mlec:FixedAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.moolecscience.com/role/ShareholdersEquityType2or3",
     "longName": "004 - Statement - Consolidated Statements of Changes in Equity",
     "shortName": "Consolidated Statements of Changes in Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c14",
      "name": "mlec:IssueOfShareCapital",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c14",
      "name": "mlec:IssueOfShareCapital",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.moolecscience.com/role/ConsolidatedCashFlow",
     "longName": "005 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "ifrs-full:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:AdjustmentsForIncomeTaxExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.moolecscience.com/role/GeneralInformation",
     "longName": "006 - Disclosure - General Information",
     "shortName": "General Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.moolecscience.com/role/BusinessCombination",
     "longName": "007 - Disclosure - Business Combination",
     "shortName": "Business Combination",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparation",
     "longName": "008 - Disclosure - Accounting Standards and Basis of Preparation",
     "shortName": "Accounting Standards and Basis of Preparation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.moolecscience.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "009 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.moolecscience.com/role/ComparativeInformation",
     "longName": "010 - Disclosure - Comparative Information",
     "shortName": "Comparative Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfAdditionalInformationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfAdditionalInformationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.moolecscience.com/role/IntangibleAssets",
     "longName": "011 - Disclosure - Intangible Assets",
     "shortName": "Intangible Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.moolecscience.com/role/FixedAssets",
     "longName": "012 - Disclosure - Fixed Assets",
     "shortName": "Fixed Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.moolecscience.com/role/Goodwill",
     "longName": "013 - Disclosure - Goodwill",
     "shortName": "Goodwill",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfGoodwillExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfGoodwillExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.moolecscience.com/role/RightofUseofAssets",
     "longName": "014 - Disclosure - Right of Use of Assets",
     "shortName": "Right of Use of Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.moolecscience.com/role/OtherNonCurrentReceivables",
     "longName": "015 - Disclosure - Other Non-Current Receivables",
     "shortName": "Other Non-Current Receivables",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.moolecscience.com/role/CashandCashEquivalents",
     "longName": "016 - Disclosure - Cash and Cash Equivalents",
     "shortName": "Cash and Cash Equivalents",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.moolecscience.com/role/ShortTermInvestments",
     "longName": "017 - Disclosure - Short Term Investments",
     "shortName": "Short Term Investments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.moolecscience.com/role/TradeReceivableandOtherCurrentReceivables",
     "longName": "018 - Disclosure - Trade Receivable and Other Current Receivables",
     "shortName": "Trade Receivable and Other Current Receivables",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.moolecscience.com/role/Inventories",
     "longName": "019 - Disclosure - Inventories",
     "shortName": "Inventories",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfInventoriesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfInventoriesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.moolecscience.com/role/ShareCapitalandSharePremium",
     "longName": "020 - Disclosure - Share Capital and Share Premium",
     "shortName": "Share Capital and Share Premium",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.moolecscience.com/role/ShareBasedPayment",
     "longName": "021 - Disclosure - Share Based Payment",
     "shortName": "Share Based Payment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.moolecscience.com/role/AccountsPayableandOtherCurrentandNonCurrentLiabilities",
     "longName": "022 - Disclosure - Accounts Payable and Other Current and Non-Current Liabilities",
     "shortName": "Accounts Payable and Other Current and Non-Current Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.moolecscience.com/role/FinancialDebt",
     "longName": "023 - Disclosure - Financial Debt",
     "shortName": "Financial Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfDebtSecuritiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfDebtSecuritiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.moolecscience.com/role/WarrantsLiabilities",
     "longName": "024 - Disclosure - Warrants Liabilities",
     "shortName": "Warrants Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFE",
     "longName": "025 - Disclosure - Simple Agreement for Future Equity (\u201cSAFE\u201d)",
     "shortName": "Simple Agreement for Future Equity (\u201cSAFE\u201d)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:SimpleAgreementForFutureEquitySAFETextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:SimpleAgreementForFutureEquitySAFETextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.moolecscience.com/role/DeferredTaxandIncomeTax",
     "longName": "026 - Disclosure - Deferred Tax and Income Tax",
     "shortName": "Deferred Tax and Income Tax",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.moolecscience.com/role/FinancialIncomeExpenses",
     "longName": "027 - Disclosure - Financial Income / Expenses",
     "shortName": "Financial Income / Expenses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.moolecscience.com/role/OtherOperatingExpense",
     "longName": "028 - Disclosure - Other Operating Expense",
     "shortName": "Other Operating Expense",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.moolecscience.com/role/AdministrativeExpenses",
     "longName": "029 - Disclosure - Administrative Expenses",
     "shortName": "Administrative Expenses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.moolecscience.com/role/ResearchandDevelopmentExpense",
     "longName": "030 - Disclosure - Research and Development Expense",
     "shortName": "Research and Development Expense",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.moolecscience.com/role/Costofsales",
     "longName": "031 - Disclosure - Cost of sales",
     "shortName": "Cost of sales",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfCostOfSalesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfCostOfSalesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.moolecscience.com/role/NetLossperShare",
     "longName": "032 - Disclosure - Net Loss per Share",
     "shortName": "Net Loss per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.moolecscience.com/role/RelatedParties",
     "longName": "033 - Disclosure - Related Parties",
     "shortName": "Related Parties",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.moolecscience.com/role/FinancialRiskManagement",
     "longName": "034 - Disclosure - Financial Risk Management",
     "shortName": "Financial Risk Management",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.moolecscience.com/role/CapitalRiskManagement",
     "longName": "035 - Disclosure - Capital Risk Management",
     "shortName": "Capital Risk Management",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:DisclosureOfCapitalRiskManagementTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:DisclosureOfCapitalRiskManagementTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.moolecscience.com/role/EventsaftertheReportingPeriod",
     "longName": "036 - Disclosure - Events after the Reporting Period",
     "shortName": "Events after the Reporting Period",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.moolecscience.com/role/AccountingPoliciesByPolicy",
     "longName": "037 - Disclosure - Accounting Policies, by Policy (Policies)",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfChangesInAccountingPoliciesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.moolecscience.com/role/BusinessCombinationTables",
     "longName": "038 - Disclosure - Business Combination (Tables)",
     "shortName": "Business Combination (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:ScheduleOfNetAssetsAcquiredAndGoodwill",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:ScheduleOfNetAssetsAcquiredAndGoodwill",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesTables",
     "longName": "039 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.moolecscience.com/role/IntangibleAssetsTables",
     "longName": "040 - Disclosure - Intangible Assets (Tables)",
     "shortName": "Intangible Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:DisclosureOfIntangibleAssetsExplanatoryTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:DisclosureOfIntangibleAssetsExplanatoryTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.moolecscience.com/role/FixedAssetsTables",
     "longName": "041 - Disclosure - Fixed Assets (Tables)",
     "shortName": "Fixed Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:ScheduleOfFixedAssetstextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:ScheduleOfFixedAssetstextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.moolecscience.com/role/GoodwillTables",
     "longName": "042 - Disclosure - Goodwill (Tables)",
     "shortName": "Goodwill (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfGoodwillExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfGoodwillExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.moolecscience.com/role/RightofUseofAssetsTables",
     "longName": "043 - Disclosure - Right of Use of Assets (Tables)",
     "shortName": "Right of Use of Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:ScheduleOfRightofuseOfAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:ScheduleOfRightofuseOfAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.moolecscience.com/role/OtherNonCurrentReceivablesTables",
     "longName": "044 - Disclosure - Other Non-Current Receivables (Tables)",
     "shortName": "Other Non-Current Receivables (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:ScheduleOfOtherNoncurrentReceivableTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:ScheduleOfOtherNoncurrentReceivableTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.moolecscience.com/role/CashandCashEquivalentsTables",
     "longName": "045 - Disclosure - Cash and Cash Equivalents (Tables)",
     "shortName": "Cash and Cash Equivalents (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfRestrictedCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfRestrictedCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.moolecscience.com/role/ShortTermInvestmentsTables",
     "longName": "046 - Disclosure - Short Term Investments (Tables)",
     "shortName": "Short Term Investments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:DisclosureOfShortTermInvestmentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:DisclosureOfShortTermInvestmentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.moolecscience.com/role/TradeReceivableandOtherCurrentReceivablesTables",
     "longName": "047 - Disclosure - Trade Receivable and Other Current Receivables (Tables)",
     "shortName": "Trade Receivable and Other Current Receivables (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:ScheduleOfTradeReceivableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:ScheduleOfTradeReceivableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.moolecscience.com/role/InventoriesTables",
     "longName": "048 - Disclosure - Inventories (Tables)",
     "shortName": "Inventories (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:DisclosureOfInventoriesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:DisclosureOfInventoriesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.moolecscience.com/role/ShareCapitalandSharePremiumTables",
     "longName": "049 - Disclosure - Share Capital and Share Premium (Tables)",
     "shortName": "Share Capital and Share Premium (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.moolecscience.com/role/ShareBasedPaymentTables",
     "longName": "050 - Disclosure - Share Based Payment (Tables)",
     "shortName": "Share Based Payment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.moolecscience.com/role/AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTables",
     "longName": "051 - Disclosure - Accounts Payable and Other Current and Non-Current Liabilities (Tables)",
     "shortName": "Accounts Payable and Other Current and Non-Current Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:ScheduleOfAccountsPayable",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:ScheduleOfAccountsPayable",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.moolecscience.com/role/FinancialDebtTables",
     "longName": "052 - Disclosure - Financial Debt (Tables)",
     "shortName": "Financial Debt (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFinancialAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfDebtSecuritiesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFinancialAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfDebtSecuritiesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.moolecscience.com/role/WarrantsLiabilitiesTables",
     "longName": "053 - Disclosure - Warrants Liabilities (Tables)",
     "shortName": "Warrants Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFETables",
     "longName": "054 - Disclosure - Simple Agreement for Future Equity (\u201cSAFE\u201d) (Tables)",
     "shortName": "Simple Agreement for Future Equity (\u201cSAFE\u201d) (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.moolecscience.com/role/DeferredTaxandIncomeTaxTables",
     "longName": "055 - Disclosure - Deferred Tax and Income Tax (Tables)",
     "shortName": "Deferred Tax and Income Tax (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfDeferredTaxesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.moolecscience.com/role/FinancialIncomeExpensesTables",
     "longName": "056 - Disclosure - Financial Income / Expenses (Tables)",
     "shortName": "Financial Income / Expenses (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFinanceIncomeExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfFinanceIncomeExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.moolecscience.com/role/OtherOperatingExpenseTables",
     "longName": "057 - Disclosure - Other Operating Expense (Tables)",
     "shortName": "Other Operating Expense (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:ScheduleOfOtherOperatingExpensesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:ScheduleOfOtherOperatingExpensesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.moolecscience.com/role/AdministrativeExpensesTables",
     "longName": "058 - Disclosure - Administrative Expenses (Tables)",
     "shortName": "Administrative Expenses (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.moolecscience.com/role/ResearchandDevelopmentExpenseTables",
     "longName": "059 - Disclosure - Research and Development Expense (Tables)",
     "shortName": "Research and Development Expense (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.moolecscience.com/role/CostofsalesTables",
     "longName": "060 - Disclosure - Cost of sales (Tables)",
     "shortName": "Cost of sales (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:ScheduleOfCostOfSalesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfCostOfSalesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:ScheduleOfCostOfSalesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfCostOfSalesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.moolecscience.com/role/NetLossperShareTables",
     "longName": "061 - Disclosure - Net Loss per Share (Tables)",
     "shortName": "Net Loss per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:EarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:EarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.moolecscience.com/role/RelatedPartiesTables",
     "longName": "062 - Disclosure - Related Parties (Tables)",
     "shortName": "Related Parties (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:ScheduleOfOtherRelatedPartyTransactions",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:ScheduleOfOtherRelatedPartyTransactions",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.moolecscience.com/role/FinancialRiskManagementTables",
     "longName": "063 - Disclosure - Financial Risk Management (Tables)",
     "shortName": "Financial Risk Management (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfTradingIncomeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:DisclosureOfTradingIncomeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.moolecscience.com/role/GeneralInformationDetails",
     "longName": "064 - Disclosure - General Information (Details)",
     "shortName": "General Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:ParValuePerShare",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.moolecscience.com/role/BusinessCombinationDetails",
     "longName": "065 - Disclosure - Business Combination (Details)",
     "shortName": "Business Combination (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c69",
      "name": "ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c69",
      "name": "ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.moolecscience.com/role/ScheduleofNetAssetsAcquiredandGoodwillTable",
     "longName": "066 - Disclosure - Business Combination (Details) - Schedule of Net Assets Acquired and Goodwill",
     "shortName": "Business Combination (Details) - Schedule of Net Assets Acquired and Goodwill",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "mlec:CashPaid",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c2",
      "name": "mlec:CashPaid",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable",
     "longName": "067 - Disclosure - Business Combination (Details) - Schedule of Assets and Liabilities Recognised",
     "shortName": "Business Combination (Details) - Schedule of Assets and Liabilities Recognised",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c71",
      "name": "ifrs-full:BalancesWithBanks",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c71",
      "name": "ifrs-full:BalancesWithBanks",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails",
     "longName": "068 - Disclosure - Accounting Standards and Basis of Preparation (Details)",
     "shortName": "Accounting Standards and Basis of Preparation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:CumulativeInflationRate",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:CumulativeInflationRate",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ifrs-full:DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails",
     "longName": "069 - Disclosure - Summary of Significant Accounting Policies (Details)",
     "shortName": "Summary of Significant Accounting Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:NumberOfSharesToBeIssuedOfContingentPayment",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:NumberOfSharesToBeIssuedOfContingentPayment",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.moolecscience.com/role/ScheduleofUsefulLivesofPropertyPlantandEquipmentTable",
     "longName": "070 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Useful Lives of Property, Plant and Equipment",
     "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of Useful Lives of Property, Plant and Equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c79",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c79",
      "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.moolecscience.com/role/ScheduleofConsolidatedFinancialStatementsTable",
     "longName": "071 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Consolidated Financial Statements",
     "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of Consolidated Financial Statements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c86",
      "name": "ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c86",
      "name": "ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.moolecscience.com/role/ScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable",
     "longName": "072 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of Non-Current Assets Other than Financial Instruments",
     "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of Non-Current Assets Other than Financial Instruments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "mlec:OtherNonCurrentAssetsOtherThanFinancialAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c2",
      "name": "mlec:OtherNonCurrentAssetsOtherThanFinancialAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable",
     "longName": "073 - Disclosure - Intangible Assets (Details) - Schedule of Intangible Assets",
     "shortName": "Intangible Assets (Details) - Schedule of Intangible Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:Cost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:Cost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.moolecscience.com/role/ScheduleofFixedAssetsTable",
     "longName": "074 - Disclosure - Fixed Assets (Details) - Schedule of Fixed Assets",
     "shortName": "Fixed Assets (Details) - Schedule of Fixed Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfFixedAssetstextBlock",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfFixedAssetstextBlock",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.moolecscience.com/role/ScheduleofGoodwillTable",
     "longName": "075 - Disclosure - Goodwill (Details) - Schedule of Goodwill",
     "shortName": "Goodwill (Details) - Schedule of Goodwill",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c2",
      "name": "mlec:TotalGoodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
       "ifrs-full:DisclosureOfGoodwillExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.moolecscience.com/role/RightofUseofAssetsDetails",
     "longName": "076 - Disclosure - Right of Use of Assets (Details)",
     "shortName": "Right of Use of Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:OriginalAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "link:footnote",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:OriginalAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "link:footnote",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.moolecscience.com/role/ScheduleofRightofUseofAssetsTable",
     "longName": "077 - Disclosure - Right of Use of Assets (Details) - Schedule of Right of Use of Assets",
     "shortName": "Right of Use of Assets (Details) - Schedule of Right of Use of Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:AcquisitionsThroughBusinessCombinationsi",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:AcquisitionsThroughBusinessCombinationsi",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R79": {
     "role": "http://www.moolecscience.com/role/OtherNonCurrentReceivablesDetails",
     "longName": "078 - Disclosure - Other Non-Current Receivables (Details)",
     "shortName": "Other Non-Current Receivables (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:AggregatePurchasePrice",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.moolecscience.com/role/ScheduleofOtherNonCurrentReceivablesTable",
     "longName": "079 - Disclosure - Other Non-Current Receivables (Details) - Schedule of Other Non-Current Receivables",
     "shortName": "Other Non-Current Receivables (Details) - Schedule of Other Non-Current Receivables",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:OtherNoncurrentReceivables",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfOtherNoncurrentReceivableTableTextBlock",
       "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:OtherNoncurrentReceivables",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfOtherNoncurrentReceivableTableTextBlock",
       "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable",
     "longName": "080 - Disclosure - Cash and Cash Equivalents (Details) - Schedule of Cash and Cash Equivalents",
     "shortName": "Cash and Cash Equivalents (Details) - Schedule of Cash and Cash Equivalents",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:Cash",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:Cash",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://www.moolecscience.com/role/ScheduleofShortTermInvestmentsTable",
     "longName": "081 - Disclosure - Short Term Investments (Details) - Schedule of Short Term Investments",
     "shortName": "Short Term Investments (Details) - Schedule of Short Term Investments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "mlec:MutualFunds",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfShortTermInvestmentsTableTextBlock",
       "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c2",
      "name": "mlec:MutualFunds",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfShortTermInvestmentsTableTextBlock",
       "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://www.moolecscience.com/role/ScheduleofTradeReceivableTable",
     "longName": "082 - Disclosure - Trade Receivable and Other Current Receivables (Details) - Schedule of Trade Receivable",
     "shortName": "Trade Receivable and Other Current Receivables (Details) - Schedule of Trade Receivable",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:TradeReceivables",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfTradeReceivableTextBlock",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:TradeReceivables",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfTradeReceivableTextBlock",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R84": {
     "role": "http://www.moolecscience.com/role/ScheduleofOtherCurrentReceivablesTable",
     "longName": "083 - Disclosure - Trade Receivable and Other Current Receivables (Details) - Schedule of Other Current Receivables",
     "shortName": "Trade Receivable and Other Current Receivables (Details) - Schedule of Other Current Receivables",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:CurrentValueAddedTaxReceivables",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfOtherCurrentReceivablesTextBlock",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:CurrentValueAddedTaxReceivables",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfOtherCurrentReceivablesTextBlock",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R85": {
     "role": "http://www.moolecscience.com/role/ScheduleofInventoriesTable",
     "longName": "084 - Disclosure - Inventories (Details) - Schedule of Inventories",
     "shortName": "Inventories (Details) - Schedule of Inventories",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:RawMaterials",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfInventoriesTableTextBlock",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:RawMaterials",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfInventoriesTableTextBlock",
       "ifrs-full:DisclosureOfInventoriesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R86": {
     "role": "http://www.moolecscience.com/role/ShareCapitalandSharePremiumDetails",
     "longName": "085 - Disclosure - Share Capital and Share Premium (Details)",
     "shortName": "Share Capital and Share Premium (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "mlec:ShareCapitalStockAndSharePremiumAmounts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c2",
      "name": "mlec:ShareCapitalStockAndSharePremiumAmounts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R87": {
     "role": "http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable",
     "longName": "086 - Disclosure - Share Capital and Share Premium (Details) - Schedule of Reconciliation of Share Capital and Share Premium",
     "shortName": "Share Capital and Share Premium (Details) - Schedule of Reconciliation of Share Capital and Share Premium",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "c26",
      "name": "ifrs-full:NumberOfSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "mlec:NumberOfSharesIssueOfShareCapitalinShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "unique": true
     }
    },
    "R88": {
     "role": "http://www.moolecscience.com/role/ShareBasedPaymentDetails",
     "longName": "087 - Disclosure - Share Based Payment (Details)",
     "shortName": "Share Based Payment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:ConstantValuePercentage",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:ConstantValuePercentage",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R89": {
     "role": "http://www.moolecscience.com/role/ScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable",
     "longName": "088 - Disclosure - Share Based Payment (Details) - Schedule and the Possible Dilutive Effect of the Future Exercise of Options",
     "shortName": "Share Based Payment (Details) - Schedule and the Possible Dilutive Effect of the Future Exercise of Options",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "c271",
      "name": "mlec:FairValueOfSharesinShares",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c271",
      "name": "mlec:FairValueOfSharesinShares",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
       "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R90": {
     "role": "http://www.moolecscience.com/role/ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable",
     "longName": "089 - Disclosure - Share Based Payment (Details) - Schedule of Amount and Exercise Price and the Movements of the Stock Options of Executives and Managers",
     "shortName": "Share Based Payment (Details) - Schedule of Amount and Exercise Price and the Movements of the Stock Options of Executives and Managers",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "c271",
      "name": "mlec:NumberOfOptionsGrantedDuringThePeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c271",
      "name": "mlec:NumberOfOptionsGrantedDuringThePeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R91": {
     "role": "http://www.moolecscience.com/role/ScheduleofAccountsPayableTable",
     "longName": "090 - Disclosure - Accounts Payable and Other Current and Non-Current Liabilities (Details) - Schedule of Accounts Payable",
     "shortName": "Accounts Payable and Other Current and Non-Current Liabilities (Details) - Schedule of Accounts Payable",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfAccountsPayable",
       "ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfAccountsPayable",
       "ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R92": {
     "role": "http://www.moolecscience.com/role/ScheduleofFinancialDebtTable",
     "longName": "091 - Disclosure - Financial Debt (Details) - Schedule of Financial Debt",
     "shortName": "Financial Debt (Details) - Schedule of Financial Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:CurrentFinancialAssetsAtAmortisedCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFinancialAssetsExplanatory",
       "ifrs-full:DisclosureOfDebtSecuritiesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:CurrentFinancialAssetsAtAmortisedCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFinancialAssetsExplanatory",
       "ifrs-full:DisclosureOfDebtSecuritiesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R93": {
     "role": "http://www.moolecscience.com/role/ScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable",
     "longName": "092 - Disclosure - Financial Debt (Details) - Schedule of Book Value is Reasonably Approximate to the Fair Value given its Short-Term Nature",
     "shortName": "Financial Debt (Details) - Schedule of Book Value is Reasonably Approximate to the Fair Value given its Short-Term Nature",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:NoncurrentFinancialAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfDebtSecuritiesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:NoncurrentFinancialAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfDebtSecuritiesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R94": {
     "role": "http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable",
     "longName": "093 - Disclosure - Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans",
     "shortName": "Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "c278",
      "name": "mlec:BorrowingOriginalCurrency",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfDebtSecuritiesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c278",
      "name": "mlec:BorrowingOriginalCurrency",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfDebtSecuritiesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R95": {
     "role": "http://www.moolecscience.com/role/WarrantsLiabilitiesDetails",
     "longName": "094 - Disclosure - Warrants Liabilities (Details)",
     "shortName": "Warrants Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "95",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:AggregateShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:AggregateShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R96": {
     "role": "http://www.moolecscience.com/role/ScheduleofFairValueOrdinaryShareofWarrantsTable",
     "longName": "095 - Disclosure - Warrants Liabilities (Details) - Schedule of Fair Value Ordinary Share of Warrants",
     "shortName": "Warrants Liabilities (Details) - Schedule of Fair Value Ordinary Share of Warrants",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "96",
     "firstAnchor": {
      "contextRef": "c327",
      "name": "ifrs-full:GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementEntitysOwnEquityInstruments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c327",
      "name": "ifrs-full:GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementEntitysOwnEquityInstruments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R97": {
     "role": "http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFEDetails",
     "longName": "096 - Disclosure - Simple Agreement for Future Equity (\u201cSAFE\u201d) (Details)",
     "shortName": "Simple Agreement for Future Equity (\u201cSAFE\u201d) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "97",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:NotionalAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "mlec:SimpleAgreementForFutureEquitySAFETextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:NotionalAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "mlec:SimpleAgreementForFutureEquitySAFETextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R98": {
     "role": "http://www.moolecscience.com/role/ScheduleofFinancialInstrumentsTable",
     "longName": "097 - Disclosure - Simple Agreement for Future Equity (\u201cSAFE\u201d) (Details) - Schedule of Financial Instruments",
     "shortName": "Simple Agreement for Future Equity (\u201cSAFE\u201d) (Details) - Schedule of Financial Instruments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "98",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "mlec:FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c2",
      "name": "mlec:FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R99": {
     "role": "http://www.moolecscience.com/role/DeferredTaxandIncomeTaxDetails",
     "longName": "098 - Disclosure - Deferred Tax and Income Tax (Details)",
     "shortName": "Deferred Tax and Income Tax (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "99",
     "firstAnchor": {
      "contextRef": "c332",
      "name": "mlec:IncomeTaxRate",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c332",
      "name": "mlec:IncomeTaxRate",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R100": {
     "role": "http://www.moolecscience.com/role/ScheduleofRollForwardofNetDeferredTaxTable",
     "longName": "099 - Disclosure -  Deferred Tax and Income Tax (Details) - Schedule of Roll Forward of Net Deferred Tax",
     "shortName": "Deferred Tax and Income Tax (Details) - Schedule of Roll Forward of Net Deferred Tax",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "100",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:IncorporatedThroughTheBusinessCombination",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:IncorporatedThroughTheBusinessCombination",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R101": {
     "role": "http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable",
     "longName": "100 - Disclosure -  Deferred Tax and Income Tax (Details) - Schedule of Principal Statutory Taxes Rates in the Countries",
     "shortName": "Deferred Tax and Income Tax (Details) - Schedule of Principal Statutory Taxes Rates in the Countries",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "101",
     "firstAnchor": {
      "contextRef": "c337",
      "name": "mlec:TaxJurisdiction",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c337",
      "name": "mlec:TaxJurisdiction",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R102": {
     "role": "http://www.moolecscience.com/role/ScheduleofIncomeTaxforOtherJurisdictionsTable",
     "longName": "101 - Disclosure -  Deferred Tax and Income Tax (Details) - Schedule of Income Tax for Other Jurisdictions",
     "shortName": "Deferred Tax and Income Tax (Details) - Schedule of Income Tax for Other Jurisdictions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "102",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "mlec:LossBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c2",
      "name": "mlec:LossBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R103": {
     "role": "http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable",
     "longName": "102 - Disclosure -  Deferred Tax and Income Tax (Details) - Schedule of Net Deferred Tax Liabilities",
     "shortName": "Deferred Tax and Income Tax (Details) - Schedule of Net Deferred Tax Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "103",
     "firstAnchor": {
      "contextRef": "c357",
      "name": "ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c357",
      "name": "ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R104": {
     "role": "http://www.moolecscience.com/role/ScheduleofAccumulatedTaxLossCarryforwardsTable",
     "longName": "103 - Disclosure -  Deferred Tax and Income Tax (Details) - Schedule of Accumulated Tax Loss Carryforwards",
     "shortName": "Deferred Tax and Income Tax (Details) - Schedule of Accumulated Tax Loss Carryforwards",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "104",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "mlec:TaxlossCarryForward",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c2",
      "name": "mlec:TaxlossCarryForward",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R105": {
     "role": "http://www.moolecscience.com/role/ScheduleofEstimatedFutureTaxableProfitTable",
     "longName": "104 - Disclosure -  Deferred Tax and Income Tax (Details) - Schedule of Estimated Future Taxable Profit.",
     "shortName": "Deferred Tax and Income Tax (Details) - Schedule of Estimated Future Taxable Profit.",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "105",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "mlec:DeferredTaxAssetsGrossAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c2",
      "name": "mlec:DeferredTaxAssetsGrossAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R106": {
     "role": "http://www.moolecscience.com/role/ScheduleofFinancialIncomeExpensesTable",
     "longName": "105 - Disclosure - Financial Income / Expenses (Details) - Schedule of Financial Income Expenses",
     "shortName": "Financial Income / Expenses (Details) - Schedule of Financial Income Expenses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "106",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "mlec:InterestExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFinanceIncomeExplanatory",
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c2",
      "name": "mlec:InterestExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfFinanceIncomeExplanatory",
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R107": {
     "role": "http://www.moolecscience.com/role/ScheduleofOtherOperatingExpenseTable",
     "longName": "106 - Disclosure - Other Operating Expense (Details) - Schedule of Other Operating Expense",
     "shortName": "Other Operating Expense (Details) - Schedule of Other Operating Expense",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "107",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "mlec:TaxesDutiesAndPenalties",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfOtherOperatingExpensesTableTextBlock",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c2",
      "name": "mlec:TaxesDutiesAndPenalties",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfOtherOperatingExpensesTableTextBlock",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R108": {
     "role": "http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable",
     "longName": "107 - Disclosure - Administrative Expenses (Details) - Schedule of Administrative Expenses",
     "shortName": "Administrative Expenses (Details) - Schedule of Administrative Expenses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "108",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "mlec:AuditLegalAndAccountancyFee",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock",
       "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "mlec:AuditLegalAndAccountancyFee",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock",
       "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R109": {
     "role": "http://www.moolecscience.com/role/ScheduleofResearchandDevelopmentExpenseTable",
     "longName": "108 - Disclosure - Research and Development Expense (Details) - Schedule of Research and Development Expense",
     "shortName": "Research and Development Expense (Details) - Schedule of Research and Development Expense",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "109",
     "firstAnchor": {
      "contextRef": "c4",
      "name": "ifrs-full:ProfessionalFeesExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory",
       "ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c4",
      "name": "ifrs-full:ProfessionalFeesExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory",
       "ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R110": {
     "role": "http://www.moolecscience.com/role/ScheduleofCostofsalesTable",
     "longName": "109 - Disclosure - Cost of sales (Details) - Schedule of Cost of sales",
     "shortName": "Cost of sales (Details) - Schedule of Cost of sales",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "110",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:InventoriesIncorporatedThroughTheBusinessCombination",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfCostOfSalesTableTextBlock",
       "ifrs-full:DisclosureOfCostOfSalesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:InventoriesIncorporatedThroughTheBusinessCombination",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfCostOfSalesTableTextBlock",
       "ifrs-full:DisclosureOfCostOfSalesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R111": {
     "role": "http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable",
     "longName": "110 - Disclosure - Net Loss per Share (Details) - Schedule of Net Loss Per Share",
     "shortName": "Net Loss per Share (Details) - Schedule of Net Loss Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "111",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ifrs-full:EarningsPerShareExplanatory",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "ifrs-full:AdjustedWeightedAverageShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "unique": true
     }
    },
    "R112": {
     "role": "http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable_Parentheticals",
     "longName": "111 - Disclosure - Net Loss per Share (Details) - Schedule of Net Loss Per Share (Parentheticals)",
     "shortName": "Net Loss per Share (Details) - Schedule of Net Loss Per Share (Parentheticals)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "112",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R113": {
     "role": "http://www.moolecscience.com/role/ScheduleofOtherRelatedPartyTransactionsTable",
     "longName": "112 - Disclosure - Related Parties (Details) - Schedule of Other Related Party Transactions",
     "shortName": "Related Parties (Details) - Schedule of Other Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "113",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "ifrs-full:ShorttermEmployeeBenefitsExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfOtherRelatedPartyTransactions",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "ifrs-full:ShorttermEmployeeBenefitsExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfOtherRelatedPartyTransactions",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R114": {
     "role": "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable",
     "longName": "113 - Disclosure - Related Parties (Details) - Schedule of Share Based Payment",
     "shortName": "Related Parties (Details) - Schedule of Share Based Payment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "114",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:KeyManagementPersonnelCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfShareBasedPayment",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ifrs-full:KeyManagementPersonnelCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfShareBasedPayment",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R115": {
     "role": "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable_Parentheticals",
     "longName": "114 - Disclosure - Related Parties (Details) - Schedule of Share Based Payment (Parentheticals)",
     "shortName": "Related Parties (Details) - Schedule of Share Based Payment (Parentheticals)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "115",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "mlec:SubsidiaryPercentage",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfShareBasedPayment",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:SubsidiaryPercentage",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfShareBasedPayment",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R116": {
     "role": "http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable",
     "longName": "115 - Disclosure - Related Parties (Details) - Schedule of other related party balances",
     "shortName": "Related Parties (Details) - Schedule of other related party balances",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "116",
     "firstAnchor": {
      "contextRef": "c416",
      "name": "mlec:OtherRelatedPartyBalances",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfOtherRelatedPartyBalances",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c416",
      "name": "mlec:OtherRelatedPartyBalances",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfOtherRelatedPartyBalances",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R117": {
     "role": "http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable_Parentheticals",
     "longName": "116 - Disclosure - Related Parties (Details) - Schedule of other related party balances (Parentheticals)",
     "shortName": "Related Parties (Details) - Schedule of other related party balances (Parentheticals)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "117",
     "firstAnchor": {
      "contextRef": "c418",
      "name": "mlec:SubsidiaryPercentage",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfOtherRelatedPartyBalances",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c418",
      "name": "mlec:SubsidiaryPercentage",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfOtherRelatedPartyBalances",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R118": {
     "role": "http://www.moolecscience.com/role/FinancialRiskManagementDetails",
     "longName": "117 - Disclosure - Financial Risk Management (Details)",
     "shortName": "Financial Risk Management (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "118",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:FinancialLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "mlec:PercentageOfFunctionalCurrency",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "unique": true
     }
    },
    "R119": {
     "role": "http://www.moolecscience.com/role/ScheduleofTradeandOtherReceivablesTable",
     "longName": "118 - Disclosure - Financial Risk Management (Details) - Schedule of Trade and Other Receivables",
     "shortName": "Financial Risk Management (Details) - Schedule of Trade and Other Receivables",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "119",
     "firstAnchor": {
      "contextRef": "c431",
      "name": "ifrs-full:TradeAndOtherReceivables",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c431",
      "name": "ifrs-full:TradeAndOtherReceivables",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R120": {
     "role": "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable",
     "longName": "119 - Disclosure - Financial Risk Management (Details) - Schedule of Contractual Maturity Date",
     "shortName": "Financial Risk Management (Details) - Schedule of Contractual Maturity Date",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "120",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:TradeAndOtherPayables",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "mlec:ScheduleOfAccountsPayable",
       "ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:OtherLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "unique": true
     }
    },
    "R121": {
     "role": "http://www.moolecscience.com/role/ScheduleofForeignCurrencyExchangeRiskTable",
     "longName": "120 - Disclosure - Financial Risk Management (Details) - Schedule of Foreign Currency Exchange Risk",
     "shortName": "Financial Risk Management (Details) - Schedule of Foreign Currency Exchange Risk",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "121",
     "firstAnchor": {
      "contextRef": "c443",
      "name": "mlec:ForeignCurrencyExchangeRiskAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c443",
      "name": "mlec:ForeignCurrencyExchangeRiskAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R122": {
     "role": "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable",
     "longName": "121 - Disclosure - Financial Risk Management (Details) - Schedule of Fair Value and Carrying Value of Financial Instruments",
     "shortName": "Financial Risk Management (Details) - Schedule of Fair Value and Carrying Value of Financial Instruments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "122",
     "firstAnchor": {
      "contextRef": "c461",
      "name": "ifrs-full:CashAndCashEquivalents",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c461",
      "name": "ifrs-full:CashAndCashEquivalents",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    },
    "R123": {
     "role": "http://www.moolecscience.com/role/ScheduleofFixedRateInstrumentsTable",
     "longName": "122 - Disclosure - Financial Risk Management (Details) - Schedule of Fixed-Rate Instruments",
     "shortName": "Financial Risk Management (Details) - Schedule of Fixed-Rate Instruments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "123",
     "firstAnchor": {
      "contextRef": "c2",
      "name": "ifrs-full:OtherCurrentFinancialLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R124": {
     "role": "http://www.moolecscience.com/role/EventsaftertheReportingPeriodDetails",
     "longName": "123 - Disclosure - Events after the Reporting Period (Details)",
     "shortName": "Events after the Reporting Period (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "124",
     "firstAnchor": {
      "contextRef": "c463",
      "name": "ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c463",
      "name": "ifrs-full:NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "p",
       "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "f20f2023_moolecsci.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "mlec_OtherNonCurrentReceivablesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "OtherNonCurrentReceivablesDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/OtherNonCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Non-Current Receivables (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price",
        "label": "Weighted average exercise price of share options expired in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "mlec_CommonStockExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "CommonStockExercised",
     "presentation": [
      "http://www.moolecscience.com/role/GeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock exercised",
        "label": "Common Stock Exercised"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_GeneralInformationDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "GeneralInformationDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/GeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Information (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForMeasuringInventories",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories, net",
        "label": "Description of accounting policy for measuring inventories [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "ifrs-full_RangesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RangesMember",
     "presentation": [
      "http://www.moolecscience.com/role/OtherNonCurrentReceivablesDetails",
      "http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable",
      "http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable",
      "http://www.moolecscience.com/role/ScheduleofUsefulLivesofPropertyPlantandEquipmentTable",
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ranges [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r151",
      "r162",
      "r241",
      "r242",
      "r301"
     ]
    },
    "mlec_AggregateRedemption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "AggregateRedemption",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/GeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate redemption",
        "label": "Aggregate Redemption"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "mlec_RedemptionPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "RedemptionPrice",
     "presentation": [
      "http://www.moolecscience.com/role/GeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redemption price",
        "label": "Redemption Price"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "mlec_SponsorShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SponsorShares",
     "presentation": [
      "http://www.moolecscience.com/role/GeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sponsor shares",
        "label": "Sponsor Shares"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment, net",
        "label": "Description of accounting policy for property, plant and equipment [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "ifrs-full_NumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NumberOfSharesIssued",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of shares,Opening balance (in Shares)",
        "periodEndLabel": "Number of shares, Ending balance (in Shares)",
        "label": "Number of shares issued"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity."
       }
      }
     },
     "auth_ref": [
      "r273"
     ]
    },
    "mlec_TrustAccount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "TrustAccount",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/GeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trust account",
        "label": "Trust Account"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RawMaterialsAndConsumablesUsed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RawMaterialsAndConsumablesUsed",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCostofsalesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Sub-total Production costs",
        "label": "Raw materials and consumables used"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of raw materials and consumables used in the production process or in the rendering of services. [Refer: Current raw materials]"
       }
      }
     },
     "auth_ref": [
      "r40",
      "r221"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForRecognitionOfRevenue",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Description of accounting policy for recognition of revenue [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for recognising revenue. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "mlec_ShareBasedPaymentCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ShareBasedPaymentCost",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/GeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share based payment cost",
        "label": "Share Based Payment Cost"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RawMaterials": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RawMaterials",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofInventoriesTable": {
       "parentTag": "ifrs-full_InventoriesTotal",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Raw materials",
        "label": "Current raw materials"
       }
      },
      "en": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of assets to be consumed in the production process or in the rendering of services. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r226",
      "r286"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r258"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/ResearchandDevelopmentExpense"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development expense",
        "label": "Description of accounting policy for research and development expense [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for research and development expense. [Refer: Research and development expense]"
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "mlec_NegativeWorkingCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NegativeWorkingCapital",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/GeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Negative Working Capital",
        "documentation": "Negative working capital.",
        "label": "Negative Working Capital"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForSegmentReportingExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForSegmentReportingExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment reporting",
        "label": "Description of accounting policy for segment reporting [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "ifrs-full_LiquidityRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LiquidityRiskMember",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liquidity Risk [member]",
        "label": "Liquidity risk [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities that are settled by delivering cash or another financial asset. [Refer: Financial assets; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r152",
      "r153",
      "r154",
      "r251"
     ]
    },
    "mlec_ShareEquivalent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ShareEquivalent",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/BusinessCombinationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares equivalent",
        "documentation": "Share equivalent.",
        "label": "Share Equivalent"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payment arrangements",
        "label": "Description of accounting policy for share-based payment transactions [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]"
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "mlec_CashPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "CashPayment",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/BusinessCombinationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash payment",
        "documentation": "The amount of cash payment.",
        "label": "Cash Payment"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ExpensesPaidOnBehalfOfTheCompanyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ExpensesPaidOnBehalfOfTheCompanyAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expenses Paid on Behalf of the Company",
        "label": "Expenses Paid On Behalf Of The Company Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "mlec_ExperienceDate": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ExperienceDate",
     "presentation": [
      "http://www.moolecscience.com/role/BusinessCombinationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Experience years",
        "documentation": "Experience date.",
        "label": "Experience Date"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountsPayableandOtherCurrentandNonCurrentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Payable and other current and non-current liabilities",
        "label": "Description of accounting policy for trade and other payables [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for trade and other payables. [Refer: Trade and other payables]"
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "mlec_CumulativeInflationRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "CumulativeInflationRate",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cumulative inflation rate",
        "documentation": "Cumulative inflation rate.",
        "label": "Cumulative Inflation Rate"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseInCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase in cash and cash equivalents",
        "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade receivables and other receivables",
        "label": "Description of accounting policy for trade and other receivables [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for trade and other receivables. [Refer: Trade and other receivables]"
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "ifrs-full_EarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EarningsPerShareExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/NetLossperShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Net Loss Per Share",
        "label": "Earnings per share [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of earnings per share."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Contact [Member]",
        "verboseLabel": "Business Contact",
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r262",
      "r263"
     ]
    },
    "mlec_InflationAccumulated": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "InflationAccumulated",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inflation accumulated",
        "documentation": "Inflation accumulated.",
        "label": "Inflation Accumulated"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForWarrantsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForWarrantsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/WarrantsLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants liabilities",
        "label": "Description of accounting policy for warrants [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for warrants. Warrants are financial instruments that give the holder the right to purchase ordinary shares."
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "mlec_Accumulated": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "Accumulated",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated",
        "documentation": "Accumulated.",
        "label": "Accumulated"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Description of accounting policy for determining components of cash and cash equivalents [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "ifrs-full_LoansAndReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "LoansAndReceivables",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialIncomeExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest gain (Shareholders loan)",
        "label": "Loans and receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-derivative financial assets with fixed or determinable payments that are not quoted in an active market, other than: (a) those that the entity intends to sell immediately or in the near term, which shall be classified as held for trading, and those that the entity, upon initial recognition, designates as at fair value through profit or loss; (b) those that the entity, upon initial recognition, designates as available for sale; or (c) those for which the holder may not recover substantially all of its initial investment, other than because of credit deterioration, which shall be classified as available for sale. An interest acquired in a pool of assets that are not loans or receivables (for example, an interest in a mutual fund or a similar fund) is not a loan or receivable. [Refer: Derivative financial assets]"
       }
      }
     },
     "auth_ref": [
      "r215"
     ]
    },
    "mlec_ArgentinePriceIndexes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ArgentinePriceIndexes",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Argentine price indexes",
        "documentation": "Argentine price indexes.",
        "label": "Argentine Price Indexes"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_JointArrangementParticipationPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "JointArrangementParticipationPercentage",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Participation percentage",
        "documentation": "Joint arrangement participation percentage.",
        "label": "Joint Arrangement Participation Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SummaryofSignificantAccountingPoliciesDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SummaryofSignificantAccountingPoliciesDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "mlec_IssueOfAdditionalSharesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "IssueOfAdditionalSharesAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of Additional Shares",
        "label": "Issue Of Additional Shares Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SummaryofSignificantAccountingPoliciesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SummaryofSignificantAccountingPoliciesDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OriginalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "OriginalAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/RightofUseofAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Original amount",
        "documentation": "Original amount.",
        "label": "Original Amount"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of exchange rate changes on cash and equivalents",
        "label": "Effect of exchange rate changes on cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r104",
      "r105"
     ]
    },
    "mlec_NumberOfSharesToBeIssuedOfContingentPayment": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NumberOfSharesToBeIssuedOfContingentPayment",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares to be issued of contingent payment (in Shares)",
        "documentation": "Number of shares to be issued of contingent payment.",
        "label": "Number Of Shares To Be Issued Of Contingent Payment"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFixedAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions",
        "label": "Additions other than through business combinations, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "ifrs-full_FinancialLiabilitiesAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinancialLiabilitiesAtFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Results on the change of Fair Value of the SAFE",
        "label": "Financial liabilities, at fair value"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "mlec_ProductionCostsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ProductionCostsAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCostofsalesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Production costs",
        "label": "Production Costs Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DepreciationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DepreciationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable": {
       "parentTag": "ifrs-full_AdministrativeExpense",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Depreciation",
        "label": "Depreciation expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives."
       }
      }
     },
     "auth_ref": [
      "r275"
     ]
    },
    "ifrs-full_SegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SegmentsAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable",
      "http://www.moolecscience.com/role/ScheduleofCostofsalesTable",
      "http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable",
      "http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable_Parentheticals",
      "http://www.moolecscience.com/role/ScheduleofOtherRelatedPartyTransactionsTable",
      "http://www.moolecscience.com/role/ScheduleofResearchandDevelopmentExpenseTable"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r141",
      "r198",
      "r231",
      "r247"
     ]
    },
    "ifrs-full_SegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SegmentsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable",
      "http://www.moolecscience.com/role/ScheduleofCostofsalesTable",
      "http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable",
      "http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable_Parentheticals",
      "http://www.moolecscience.com/role/ScheduleofOtherRelatedPartyTransactionsTable",
      "http://www.moolecscience.com/role/ScheduleofResearchandDevelopmentExpenseTable"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r141",
      "r204",
      "r231",
      "r247"
     ]
    },
    "ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFinancialLiabilitiesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Terms and Conditions of Outstanding Loans",
        "label": "Disclosure of financial liabilities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of financial liabilities. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "ifrs-full_DepreciationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DepreciationPropertyPlantAndEquipment",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFixedAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Depreciation",
        "label": "Depreciation, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r54",
      "r58"
     ]
    },
    "ifrs-full_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable": {
       "parentTag": "ifrs-full_AdministrativeExpense",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other office and admin expenses",
        "label": "Selling, general and administrative expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense relating to selling, general and administrative activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r281"
     ]
    },
    "mlec_FinancialAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FinancialAssetsAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Assets",
        "label": "Financial Assets Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialRiskManagementExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFinancialRiskManagementExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialRiskManagement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial risk management",
        "label": "Disclosure of financial risk management [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the entity's financial risk management practices and policies."
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherComprehensiveIncomeNetOfTaxHedgesOfNetInvestmentsInForeignOperations",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCostofsalesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation",
        "label": "Other comprehensive income, net of tax, hedges of net investments in foreign operations"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to hedges of net investments in foreign operations. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r38",
      "r95",
      "r209"
     ]
    },
    "ifrs-full_SellingGeneralAndAdministrativeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SellingGeneralAndAdministrativeExpenseAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Administrative Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfGeneralAndAdministrativeExpenseExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AdministrativeExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Administrative Expenses",
        "label": "Disclosure of general and administrative expense [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of general and administrative expenses. [Refer: Administrative expenses]"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "mlec_AmortizedCostsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "AmortizedCostsAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortized costs",
        "label": "Amortized Costs Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/GeneralInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General information",
        "label": "Disclosure of general information about financial statements [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for general information about financial statements."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total comprehensive (loss)",
        "label": "Other comprehensive income that will be reclassified to profit or loss, before tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income that will be reclassified to profit or loss, before tax. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r280",
      "r282"
     ]
    },
    "ifrs-full_DisclosureOfGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfGoodwillExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/Goodwill"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Disclosure of goodwill [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "mlec_FairValueThroughProfitOrLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FairValueThroughProfitOrLossAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value through profit or loss",
        "label": "Fair Value Through Profit Or Loss Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FinancialLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FinancialLiabilitiesAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Liabilities",
        "label": "Financial Liabilities Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherCurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofAccountsPayableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current liabilities",
        "verboseLabel": "Total Other current liabilities",
        "label": "Other current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r277"
     ]
    },
    "ifrs-full_OtherCurrentFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherCurrentFinancialLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofFixedRateInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial debts",
        "negatedLabel": "Current financial liabilities",
        "label": "Other current financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities; Current financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r16",
      "r130"
     ]
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/BusinessCombinationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pro-forma revenue",
        "label": "Business Acquisition, Pro Forma Revenue",
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r220"
     ]
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions",
        "label": "Additions other than through business combinations, intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "ifrs-full_RetainedEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RetainedEarnings",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained earnings"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r228"
     ]
    },
    "ifrs-full_FinishedGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinishedGoods",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofInventoriesTable": {
       "parentTag": "ifrs-full_InventoriesTotal",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finished goods",
        "label": "Current finished goods"
       }
      },
      "en": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r226",
      "r286"
     ]
    },
    "mlec_TransactionsExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "TransactionsExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Transaction expenses",
        "documentation": "Transaction expenses.",
        "label": "Transactions Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FairValueThroughProfitOrLossAbstract0": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FairValueThroughProfitOrLossAbstract0",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value through profit or loss",
        "label": "Fair Value Through Profit Or Loss Abstract0"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ShorttermInvestmentsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ShorttermInvestmentsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term investments",
        "documentation": "Amount of short-term investments.",
        "label": "Shortterm Investments Current"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherCurrentNonfinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherCurrentNonfinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAccountsPayableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Others",
        "label": "Other current non-financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current non-financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r277"
     ]
    },
    "mlec_FixedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FixedAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed Assets",
        "documentation": "Fixed Assets.",
        "label": "Fixed Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ShareIssueRelatedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ShareIssueRelatedCost",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares equivalent amount (in Dollars)",
        "label": "Share issue related cost"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cost related to the issuance of shares."
       }
      }
     },
     "auth_ref": [
      "r273"
     ]
    },
    "mlec_EquitySettledShareBasedPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "EquitySettledShareBasedPayments",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity settled share-based payment",
        "documentation": "Equity settled share based payment.",
        "label": "Equity Settled Share Based Payments"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained (deficit)",
        "label": "Retained earnings [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r223"
     ]
    },
    "ifrs-full_DisclosureOfIncomeTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfIncomeTaxExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/DeferredTaxandIncomeTax"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax and income tax",
        "label": "Disclosure of income tax [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for income taxes."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "ifrs-full_OtherCurrentReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherCurrentReceivables",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable",
      "http://www.moolecscience.com/role/ScheduleofOtherCurrentReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Receivable",
        "verboseLabel": "Others",
        "label": "Other current receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current other receivables. [Refer: Other receivables]"
       }
      }
     },
     "auth_ref": [
      "r225"
     ]
    },
    "ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule and the Possible Dilutive Effect of the Future Exercise of Options",
        "label": "Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options."
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "mlec_ShareToBeIssuedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ShareToBeIssuedAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Shares to be issued amount,Opening balance",
        "periodEndLabel": "Shares to be issued amount, Ending balance",
        "terseLabel": "Shares to be issued",
        "documentation": "The amount of shares to be issued.",
        "label": "Share To Be Issued Amount"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combinations",
        "label": "Description of accounting policy for business combinations [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for business combinations. [Refer: Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "mlec_PlanDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "PlanDuration",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan duration",
        "documentation": "The duration of plan.",
        "label": "Plan Duration"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_KeyManagementPersonnelCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "KeyManagementPersonnelCompensation",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Key management",
        "label": "Key management personnel compensation"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "mlec_ExercisePrice": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ExercisePrice",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price",
        "documentation": "Exercise price.",
        "label": "Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FairValueOfStockOptionsAtMeasurementDate": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FairValueOfStockOptionsAtMeasurementDate",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of stock options at measurement date",
        "documentation": "Fair value of stock options at measurement date.",
        "label": "Fair Value Of Stock Options At Measurement Date"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExercisePriceShareOptionsGranted2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ExercisePriceShareOptionsGranted2019",
     "presentation": [
      "http://www.moolecscience.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price",
        "label": "Exercise price, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The exercise price of share options granted."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "ifrs-full_NetDeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NetDeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable",
      "http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax liability",
        "terseLabel": "Deferred Tax Liability",
        "label": "Net deferred tax liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deferred tax liabilities net of deferred tax assets, when the absolute amount of deferred tax liabilities is greater than the absolute amount of deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      }
     },
     "auth_ref": [
      "r283"
     ]
    },
    "mlec_MoolecScienceSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "MoolecScienceSAMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Moolec Science S.A. [Member]",
        "label": "Moolec Science SAMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Payment (Details) - Schedule of Amount and Exercise Price and the Movements of the Stock Options of Executives and Managers [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ShareBasedPaymentDetailsScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Payment (Details) - Schedule of Amount and Exercise Price and the Movements of the Stock Options of Executives and Managers [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NumberOfOptionsAtTheBeginning": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NumberOfOptionsAtTheBeginning",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of options, At the beginning",
        "documentation": "Number of options outstanding shares.",
        "label": "Number Of Options At The Beginning"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_MoolecScienceSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "MoolecScienceSharesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of share capital (Moolec Science shares) [Member]",
        "label": "Moolec Science Shares Member"
       }
      }
     },
     "auth_ref": []
    },
    "srt_CondensedBalanceSheetStatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CondensedBalanceSheetStatementTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Balance Sheet Statement [Table]",
        "documentation": "Disclosure of information about condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r212",
      "r216",
      "r270"
     ]
    },
    "ifrs-full_CurrentReceivablesFromSaleOfProperties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentReceivablesFromSaleOfProperties",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount received",
        "label": "Current receivables from sale of properties"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current receivables from sale of properties. [Refer: Receivables from sale of properties]"
       }
      }
     },
     "auth_ref": [
      "r278"
     ]
    },
    "mlec_ExercisePriceAtTheBeginning": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ExercisePriceAtTheBeginning",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price, At the beginning",
        "documentation": "Exercise price per share balance at beginning.",
        "label": "Exercise Price At The Beginning"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other comprehensive income/(loss)",
        "label": "Other comprehensive income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r30",
      "r38",
      "r128"
     ]
    },
    "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ExpectedDividendAsPercentageShareOptionsGranted",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend rate",
        "label": "Expected dividend as percentage, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "mlec_MoreThanFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "MoreThanFiveYearsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "More than 5 years [Member]",
        "label": "More Than Five Years Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ExercisePriceGrantedDuringThePeriod": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ExercisePriceGrantedDuringThePeriod",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price, Granted during the period",
        "documentation": "Exercise price, granted during the period.",
        "label": "Exercise Price Granted During The Period"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NumberOfOptionsGrantedDuringThePeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NumberOfOptionsGrantedDuringThePeriod",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of options, Granted during the period",
        "documentation": "Number of option granted shares during the period.",
        "label": "Number Of Options Granted During The Period"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherComprehensiveIncomeAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income/loss",
        "label": "Other comprehensive income [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NumberOfOptionsForfeitedDuringThePeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NumberOfOptionsForfeitedDuringThePeriod",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of options, Forfeited during the period",
        "documentation": "Number of options shares forfeited during the period.",
        "label": "Number Of Options Forfeited During The Period"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NetBookAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NetBookAmountMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFixedAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net book amount [Member]",
        "label": "Net Book Amount Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ExercisePriceForfeitedDuringThePeriod": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ExercisePriceForfeitedDuringThePeriod",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price, Forfeited during the period",
        "documentation": "Exercise price, forfeited during the period.",
        "label": "Exercise Price Forfeited During The Period"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NumberOfOptionsExercisedDuringThePeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NumberOfOptionsExercisedDuringThePeriod",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of options, Exercised during the period",
        "documentation": "Number of options shares exercised during the period.",
        "label": "Number Of Options Exercised During The Period"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax loss carry-forward",
        "label": "Unused tax losses for which no deferred tax asset recognised"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of unused tax losses for which no deferred tax asset is recognised in the statement of financial position. [Refer: Unused tax losses [member]]"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "mlec_ExercisePriceExercisedDuringThePeriod": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ExercisePriceExercisedDuringThePeriod",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price, Exercised during the period",
        "documentation": "Exercise price, exercised during the period.",
        "label": "Exercise Price Exercised During The Period"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NumberOfOptionsExpiredDuringThePeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NumberOfOptionsExpiredDuringThePeriod",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of options, Expired during the period",
        "documentation": "Number of options shares expired during the period.",
        "label": "Number Of Options Expired During The Period"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NetDeferredTaxLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NetDeferredTaxLiabilitiesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net deferred tax liabilities [Member]",
        "label": "Net Deferred Tax Liabilities Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ExercisePriceExpiredDuringThePeriod": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ExercisePriceExpiredDuringThePeriod",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price, Expired during the period",
        "documentation": "Exercise price, expired during the period.",
        "label": "Exercise Price Expired During The Period"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NumberOfOptionsAtTheEnding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NumberOfOptionsAtTheEnding",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of options,At the ending",
        "documentation": "Number of options, at the ending.",
        "label": "Number Of Options At The Ending"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PoundSterlingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "PoundSterlingMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofForeignCurrencyExchangeRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pound sterling [Member]",
        "label": "Pound Sterling Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/ShareCapitalandSharePremium"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share capital and share premium",
        "label": "Disclosure of share capital, reserves and other equity interest [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for share capital, reserves and other equity interest."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPayment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Based Payment",
        "label": "Disclosure of share-based payment arrangements [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangements."
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "mlec_ExercisePriceAtTheEnding": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ExercisePriceAtTheEnding",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price, At the ending",
        "documentation": "Exercise price per share balance at the ending.",
        "label": "Exercise Price At The Ending"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofUsefulLivesofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment",
        "label": "Useful life measured as period of time, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "mlec_PromissoryNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "PromissoryNotesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Promissory Notes [Member]",
        "label": "Promissory Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Share based payment cost of listing shares",
        "label": "Expense from share-based payment transactions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets."
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "ifrs-full_ProceedsFromCurrentBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProceedsFromCurrentBorrowings",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from financial debts",
        "label": "Proceeds from current borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from current borrowings obtained. [Refer: Current borrowings]"
       }
      }
     },
     "auth_ref": [
      "r294"
     ]
    },
    "mlec_Wages": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "Wages",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAccountsPayableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Wages",
        "documentation": "The amount of wages.",
        "label": "Wages"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DeferredPaymentRelatedToBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DeferredPaymentRelatedToBusinessCombination",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAccountsPayableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred payment related to Business Combination",
        "documentation": "The amount of deferred payments.",
        "label": "Deferred Payment Related To Business Combination"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SAFESharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SAFESharesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of share capital (SAFE shares) [Member]",
        "label": "SAFEShares Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_Taxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "Taxes",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAccountsPayableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Taxes",
        "documentation": "The amount of taxes.",
        "label": "Taxes"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Consolidated Financial Statements",
        "label": "Disclosure of subsidiaries [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of subsidiaries. [Refer: Subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r76",
      "r134"
     ]
    },
    "mlec_PayAsYouEarnPAYE": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "PayAsYouEarnPAYE",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAccountsPayableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay As You Earn (PAYE)",
        "documentation": "Pay as you earn.",
        "label": "Pay As You Earn PAYE"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SPCTechnologyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SPCTechnologyMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SPC\u00ae technology [Member]",
        "label": "SPCTechnology Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FinancialDebtDetailsScheduleofFinancialDebtLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FinancialDebtDetailsScheduleofFinancialDebtLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialDebtTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Debt (Details) - Schedule of Financial Debt [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FinancialDebtDetailsScheduleofFinancialDebtTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FinancialDebtDetailsScheduleofFinancialDebtTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialDebtTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Debt (Details) - Schedule of Financial Debt [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SoftwareLicenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SoftwareLicenseMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Software License [Member]",
        "label": "Software License Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Debt (Details) - Schedule of Book Value is Reasonably Approximate to the Fair Value given its Short-Term Nature [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FinancialDebtDetailsScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Debt (Details) - Schedule of Book Value is Reasonably Approximate to the Fair Value given its Short-Term Nature [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_THEOISCSpMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "THEOISCSpMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "THEO I SCSp [Member]",
        "label": "THEOISCSp Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProceedsFromIssueOfOrdinaryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProceedsFromIssueOfOrdinaryShares",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from additional issue of ordinary shares",
        "label": "Proceeds from issue of ordinary shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]"
       }
      }
     },
     "auth_ref": [
      "r294"
     ]
    },
    "mlec_FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FinancialDebtDetailsScheduleofTermsandConditionsofOutstandingLoansLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Debt (Details) - Schedule of Terms and Conditions of Outstanding Loans [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BorrowingOriginalCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "BorrowingOriginalCurrency",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency of denomination",
        "documentation": "Currency of denomination.",
        "label": "Borrowing Original Currency"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_StorageMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "StorageMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFixedAssetsTable",
      "http://www.moolecscience.com/role/ScheduleofUsefulLivesofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Storage [Member]",
        "label": "Storage Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TwoThousandTwentyTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "TwoThousandTwentyTwoMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAccumulatedTaxLossCarryforwardsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2022 [Member]",
        "label": "Two Thousand Twenty Two Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TwoThousandTwentyThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "TwoThousandTwentyThreeMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAccumulatedTaxLossCarryforwardsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023 [Member]",
        "label": "Two Thousand Twenty Three Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NominalInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NominalInterestRate",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nominal interest rate",
        "documentation": "Nominal interest rate.",
        "label": "Nominal Interest Rate"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IdentifiableAssetsAcquiredLiabilitiesAssumed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IdentifiableAssetsAcquiredLiabilitiesAssumed",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net identifiable assets acquired",
        "label": "Identifiable assets acquired (liabilities assumed)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for net identifiable assets acquired or liabilities assumed in a business combination. [Refer: Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r248",
      "r250"
     ]
    },
    "ifrs-full_CostOfSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CostOfSales",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
      "http://www.moolecscience.com/role/ScheduleofCostofsalesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cost of sales",
        "negatedTerseLabel": "Cost of sales",
        "label": "Cost of sales"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r40"
     ]
    },
    "mlec_ScheduleOfAssetsAndLiabilitiesRecognisedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfAssetsAndLiabilitiesRecognisedAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Assets And Liabilities Recognised Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfAdministrativeExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfAdministrativeExpensesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Administrative Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfUsefulLivesOfPropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfUsefulLivesOfPropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Useful Lives Of Property Plant And Equipment Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfConsolidatedFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfConsolidatedFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Consolidated Financial Statements Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Non Current Assets Other Than Financial Instruments Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DisclosureOfAdditionalInformationTextBlockAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DisclosureOfAdditionalInformationTextBlockAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Additional Information Text Block Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfIntangibleAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfIntangibleAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Intangible Assets Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfFixedAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfFixedAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Fixed Assets Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AggregatedTimeBandsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AggregatedTimeBandsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregated time bands [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r142",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r157",
      "r175",
      "r233",
      "r253",
      "r254"
     ]
    },
    "ifrs-full_CounterpartiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CounterpartiesAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialDebtTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparties [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "mlec_ScheduleOfGoodwillAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfGoodwillAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Goodwill [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfResearchAndDevelopmentExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfResearchAndDevelopmentExpenseAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Research And Development Expense Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfOtherNonCurrentReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfOtherNonCurrentReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Other Non Current Receivables [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfRightOfUseOfAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfRightOfUseOfAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Right-of-Use of Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CounterpartiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CounterpartiesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialDebtTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparties [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the parties to the transaction other than the entity. It also represents the standard value for the 'Counterparties' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "mlec_ScheduleOfCashAndCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfCashAndCashEquivalentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Cash And Cash Equivalents Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfShortTermInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfShortTermInvestmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Short Term Investments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfTradeReceivableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfTradeReceivableAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Trade Receivable Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfOtherCurrentReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfOtherCurrentReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Other Current Receivables [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfInventoriesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfInventoriesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Inventories [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CountryOfIncorporation": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CountryOfIncorporation",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofConsolidatedFinancialStatementsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Country of incorporation and principal place of business",
        "label": "Country of incorporation"
       }
      },
      "en": {
       "role": {
        "documentation": "The country in which the entity is incorporated."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "mlec_ScheduleAndThePossibleDilutiveEffectOfTheFutureExerciseOfOptionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleAndThePossibleDilutiveEffectOfTheFutureExerciseOfOptionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule And The Possible Dilutive Effect Of The Future Exercise Of Options Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfReconciliationOfShareCapitalAndSharePremiumAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Reconciliation Of Share Capital And Share Premium Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfOtherOperatingExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfOtherOperatingExpenseAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Other Operating Expense [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfAmountAndExercisePriceAndTheMovementsOfTheStockOptionsOfExecutivesAndManagersAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfAmountAndExercisePriceAndTheMovementsOfTheStockOptionsOfExecutivesAndManagersAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Amount And Exercise Price And The Movements Of The Stock Options Of Executives And Managers Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfAccountsPayableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfAccountsPayableAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Accounts Payable [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfFinancialDebtAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfFinancialDebtAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Financial Debt Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CountryOfIncorporationOrResidenceOfSubsidiary",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofConsolidatedFinancialStatementsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal activities",
        "label": "Country of incorporation of subsidiary"
       }
      },
      "en": {
       "role": {
        "documentation": "The country in which a subsidiary of the entity is incorporated. [Refer: Subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r74",
      "r119",
      "r120"
     ]
    },
    "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reference risk-free interest rate",
        "label": "Risk free interest rate, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]"
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "ifrs-full_ParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ParValuePerShare",
     "presentation": [
      "http://www.moolecscience.com/role/GeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price per share",
        "label": "Par value per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value per share."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "ifrs-full_CreationDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CreationDateAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable",
      "http://www.moolecscience.com/role/ScheduleofAccumulatedTaxLossCarryforwardsTable",
      "http://www.moolecscience.com/role/ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Creation date [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r113",
      "r114"
     ]
    },
    "mlec_ScheduleOfFairValueOrdinaryShareOfWarrantsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfFairValueOrdinaryShareOfWarrantsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Fair Value Ordinary Share Of Warrants Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfTermsAndConditionsOfOutstandingLoansAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfTermsAndConditionsOfOutstandingLoansAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Terms And Conditions Of Outstanding Loans Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility",
        "label": "Expected volatility, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "mlec_ScheduleOfFinancialIncomeExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfFinancialIncomeExpensesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Financial Income Expenses Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfExpiryDateOfTemporaryDifferencesUnusedTaxLossesAndUnusedTaxCredits",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAccumulatedTaxLossCarryforwardsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration date",
        "label": "Description of expiry date of deductible temporary differences, unused tax losses and unused tax credits"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the expiry date (if any) of deductible temporary differences, unused tax losses and unused tax credits for which no deferred tax asset is recognised in the statement of financial position. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "mlec_SimpleAgreementForFutureEquitySafeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SimpleAgreementForFutureEquitySafeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Simple Agreement for Future Equity Safe [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfFinancialInstrumentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfFinancialInstrumentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Financial Instruments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfRollForwardOfNetDeferredTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfRollForwardOfNetDeferredTaxAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Roll Forward of Net Deferred Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfPrincipalStatutoryTaxesRatesInTheCountriesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfPrincipalStatutoryTaxesRatesInTheCountriesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Principal Statutory Taxes Rates In The Countries Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AmortisationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AmortisationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofResearchandDevelopmentExpenseTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofResearchandDevelopmentExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Amortization",
        "label": "Amortisation expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of amortisation expense. Amortisation is the systematic allocation of depreciable amounts of intangible assets over their useful lives."
       }
      }
     },
     "auth_ref": [
      "r275"
     ]
    },
    "mlec_ScheduleOfIncomeTaxForOtherJurisdictionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfIncomeTaxForOtherJurisdictionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Income Tax For Other Jurisdictions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfNetDeferredTaxLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfNetDeferredTaxLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Net Deferred Tax Liabilities Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfAccumulatedTaxLossCarryforwardsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfAccumulatedTaxLossCarryforwardsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Accumulated Tax Loss Carryforwards Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfEstimatedFutureTaxableProfitAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfEstimatedFutureTaxableProfitAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Estimated Future Taxable Profit Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeExpenseGainsOrLossesOfFinancialInstrumentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncomeExpenseGainsOrLossesOfFinancialInstrumentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial income / expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RepaymentsOfBorrowingsClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment of loans",
        "label": "Repayments of borrowings, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r238"
     ]
    },
    "mlec_BancoMacroLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "BancoMacroLoansMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Banco Macro - Loans [Member]",
        "label": "Banco Macro Loans Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GeographicalAreasAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "GeographicalAreasAxis",
     "presentation": [
      "http://www.moolecscience.com/role/DeferredTaxandIncomeTaxDetails",
      "http://www.moolecscience.com/role/ScheduleofEstimatedFutureTaxableProfitTable",
      "http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical areas [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r230",
      "r243",
      "r246"
     ]
    },
    "mlec_BancoNacinPreFinancingOfExportsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "BancoNacinPreFinancingOfExportsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Banco Naci\u00f3n - Pre-Financing of Exports [Member]",
        "label": "Banco Nacin Pre Financing Of Exports Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MaturityAnalysisForDerivativeFinancialLiabilities": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "MaturityAnalysisForDerivativeFinancialLiabilities",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Contractual Maturity Date",
        "label": "Disclosure of maturity analysis for derivative financial liabilities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of a maturity analysis for derivative financial liabilities, including the remaining contractual maturities for those derivative financial liabilities for which contractual maturities are essential for an understanding of the timing of the cash flows. [Refer: Derivative financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r185"
     ]
    },
    "mlec_BancoMacroPreFinancingOfExportsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "BancoMacroPreFinancingOfExportsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Banco Macro - Pre-Financing of Exports [Member]",
        "label": "Banco Macro Pre Financing Of Exports Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GeographicalAreasMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "GeographicalAreasMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofEstimatedFutureTaxableProfitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical areas [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r230",
      "r243",
      "r246"
     ]
    },
    "ifrs-full_FinanceIncomeCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinanceIncomeCost",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Financial income / expenses",
        "label": "Finance income (cost)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income or cost associated with interest and other financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r281"
     ]
    },
    "ifrs-full_AccruedIncomeOtherThanContractAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AccruedIncomeOtherThanContractAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIncomeTaxforOtherJurisdictionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax (benefit)/expense",
        "label": "Accrued income other than contract assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets representing income that has been earned but is not yet a receivable, other than contract assets. [Refer: Contract assets]"
       }
      }
     },
     "auth_ref": [
      "r277",
      "r279"
     ]
    },
    "mlec_ToDueBecomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ToDueBecomeAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTradeandOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "To due become",
        "label": "To Due Become Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MaturityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "MaturityAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable",
      "http://www.moolecscience.com/role/ScheduleofTradeandOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r142",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r157",
      "r175",
      "r186",
      "r233",
      "r253"
     ]
    },
    "mlec_BancoSantanderBankOverdraftsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "BancoSantanderBankOverdraftsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Banco Santander - Bank Overdrafts [Member]",
        "label": "Banco Santander Bank Overdrafts Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BancoSantanderLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "BancoSantanderLoansMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Banco Santander - Loans [Member]",
        "label": "Banco Santander Loans Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinanceCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Financial Cost",
        "label": "Finance costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of costs associated with financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/TradeReceivableandOtherCurrentReceivables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade Receivable and Other current receivables",
        "label": "Disclosure of trade and other receivables [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "ifrs-full_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 4.0
      },
      "http://www.moolecscience.com/role/ScheduleofResearchandDevelopmentExpenseTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
      "http://www.moolecscience.com/role/ScheduleofResearchandDevelopmentExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total Research and development expenses",
        "negatedLabel": "Research and development expense",
        "label": "Research and development expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss."
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "GainsLossesOnExchangeDifferencesOnTranslationNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign exchange differences on translation of foreign operations",
        "label": "Gains (losses) on exchange differences on translation of foreign operations, net of tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "ifrs-full_DisclosureOfTradingIncomeExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfTradingIncomeExpenseExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Trade and Other Receivables",
        "label": "Disclosure of trading income (expense) [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of trading income (expense). [Refer: Trading income (expense)]"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BetweenOneAndTwoYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "BetweenOneAndTwoYearsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Between 1 and 2 years [Member]",
        "label": "Between One And Two Years Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofGoodwillTable": {
       "parentTag": "mlec_TotalGoodwill",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofGoodwillTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r11",
      "r85",
      "r86",
      "r170"
     ]
    },
    "ifrs-full_GoodwillRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "GoodwillRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill recognized (i)",
        "label": "Goodwill recognised as of acquisition date"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r249",
      "r250"
     ]
    },
    "mlec_BetweenTwoAndFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "BetweenTwoAndFiveYearsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Between 2 and 5 years [Member]",
        "label": "Between Two And Five Years Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BioceresCropSolutionsCorpMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "BioceresCropSolutionsCorpMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bioceres Crop Solutions Corp [Member]",
        "label": "Bioceres Crop Solutions Corp Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value of Simply Agreement for Future Equity (\u201cSAFE\u201d)",
        "label": "Gains (losses) on financial assets at fair value through profit or loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The gains (losses) on financial assets at fair value through profit or loss. [Refer: Financial assets at fair value through profit or loss]"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "ifrs-full_InsuranceExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "InsuranceExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable": {
       "parentTag": "ifrs-full_AdministrativeExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Insurance",
        "label": "Insurance expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from purchased insurance."
       }
      }
     },
     "auth_ref": [
      "r275"
     ]
    },
    "ifrs-full_MeasurementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "MeasurementAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r100",
      "r135"
     ]
    },
    "mlec_BioceresLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "BioceresLLCMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable",
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bioceres LLC [Member]",
        "label": "Bioceres LLCMember"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AccrualsClassifiedAsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AccrualsClassifiedAsNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAccountsPayableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accruals",
        "label": "Accruals classified as non-current"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of accruals classified as non-current. [Refer: Accruals]"
       }
      }
     },
     "auth_ref": [
      "r279"
     ]
    },
    "mlec_BioceresSAAgralityIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "BioceresSAAgralityIncMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bioceres S.A. - Agrality Inc.[Member]",
        "label": "Bioceres SAAgrality Inc Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r268"
     ]
    },
    "mlec_BioceresSABioceresLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "BioceresSABioceresLLCMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable",
      "http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "100% Subsidiary of Bioceres S.A. - Bioceres LLC\t[Member]",
        "label": "Bioceres SABioceres LLCMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BioceresSAINMETSAIngenieriaMetabolicaSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "BioceresSAINMETSAIngenieriaMetabolicaSAMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable",
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "30% owned by Bioceres S.A. - INMET S.A.- Ingenieria Metabolica S.A [Member]",
        "label": "Bioceres SAINMETSAIngenieria Metabolica SAMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "BioceresSAINDEARSAInstitutoDeAgrobiotecnologaRosarioMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable",
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "98.6% owned by Bioceres S.A. - INDEAR S.A.- Instituto de Agrobiotecnolog\u00eda Rosario [Member]",
        "label": "Bioceres SAINDEARSAInstituto De Agrobiotecnologa Rosario Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BioceresSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "BioceresSAMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bioceres S.A. [Member]",
        "label": "Bioceres SAMember"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReserveOfExchangeDifferencesOnTranslation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ReserveOfExchangeDifferencesOnTranslation",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cumulative translation adjustment",
        "label": "Reserve of exchange differences on translation"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFixedAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r56",
      "r87",
      "r91",
      "r97",
      "r98",
      "r99",
      "r100",
      "r101",
      "r170",
      "r180",
      "r181"
     ]
    },
    "ifrs-full_GrossCarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "GrossCarryingAmountMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFixedAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost [Member]",
        "label": "Gross carrying amount [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      }
     },
     "auth_ref": [
      "r51",
      "r87",
      "r98",
      "r101",
      "r170",
      "r181",
      "r183",
      "r252"
     ]
    },
    "currency_USD": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2023",
     "localname": "USD",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofEstimatedFutureTaxableProfitTable",
      "http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States of America [Member]",
        "label": "United States of America, Dollars"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CarryingAmountMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFixedAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying amount [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      }
     },
     "auth_ref": [
      "r56",
      "r91",
      "r97",
      "r99",
      "r100",
      "r170",
      "r180",
      "r181"
     ]
    },
    "mlec_ChymosinOsmosisEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ChymosinOsmosisEquipmentMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFixedAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chymosin osmosis equipment [Member]",
        "label": "Chymosin Osmosis Equipment Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Cash",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash",
        "label": "Cash"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]"
       }
      }
     },
     "auth_ref": [
      "r298"
     ]
    },
    "mlec_FutureFoodsBVMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FutureFoodsBVMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable",
      "http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Future Foods B.V. Member",
        "verboseLabel": "Future Foods B.V [Member]",
        "label": "Future Foods BVMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_CustomerRelationshipMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "CustomerRelationshipMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer relationship [Member]",
        "label": "Customer Relationship Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r14",
      "r109",
      "r129"
     ]
    },
    "mlec_CumulativeTranslationAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "CumulativeTranslationAdjustmentMember",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cumulative translation adjustment",
        "label": "Cumulative Translation Adjustment Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r267"
     ]
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FurnitureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FurnitureMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFixedAssetsTable",
      "http://www.moolecscience.com/role/ScheduleofUsefulLivesofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture [Member]",
        "label": "Furniture Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_EquitySettledShareBasedPaymentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "EquitySettledShareBasedPaymentMember",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity settled share based payment",
        "label": "Equity Settled Share Based Payment Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForIncomeTaxExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForIncomeTaxExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income tax",
        "label": "Adjustments for income tax expense"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for income tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "mlec_IssueOfSharePremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "IssueOfSharePremium",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of share premium",
        "documentation": "Issue of share premium.",
        "label": "Issue Of Share Premium"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseInNumberOfOrdinarySharesIssued",
     "presentation": [
      "http://www.moolecscience.com/role/GeneralInformationDetails",
      "http://www.moolecscience.com/role/OtherNonCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares",
        "verboseLabel": "Ordinary shares issued",
        "label": "Increase (decrease) in number of ordinary shares issued"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the number of ordinary shares issued. [Refer: Ordinary shares [member]]"
       }
      }
     },
     "auth_ref": [
      "r275"
     ]
    },
    "mlec_ServicesProvidedByOtherCompanies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ServicesProvidedByOtherCompanies",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Services Provided by Other Companies",
        "documentation": "Services provided by other companies.",
        "label": "Services Provided By Other Companies"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ExpensesPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ExpensesPaid",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expenses Paid on Behalf of the Company",
        "documentation": "Expenses paid.",
        "label": "Expenses Paid"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties (Details) - Schedule of Share Based Payment (Parentheticals) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AtFairValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AtFairValueMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value [Member]",
        "label": "At fair value [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for measurement based on fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r100",
      "r135"
     ]
    },
    "mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "RelatedPartiesDetailsScheduleofShareBasedPaymentParentheticalsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties (Details) - Schedule of Share Based Payment (Parentheticals) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SubsidiaryPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SubsidiaryPercentage",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable_Parentheticals",
      "http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiary percentage",
        "documentation": "Subsidiary percentage.",
        "label": "Subsidiary Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "RelatedPartiesDetailsScheduleofotherrelatedpartybalancesTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties (Details) - Schedule of other related party balances [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OwnedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "OwnedPercentage",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Owned percentage",
        "documentation": "Owned percentage.",
        "label": "Owned Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Assets",
        "label": "Other intangible assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r290"
     ]
    },
    "ifrs-full_NoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current liabilities",
        "label": "Non-current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r22",
      "r125",
      "r240"
     ]
    },
    "ifrs-full_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LIABILITIES",
        "label": "Liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r135",
      "r136",
      "r138",
      "r198",
      "r202"
     ]
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Payable",
        "label": "Adjustments for increase (decrease) in trade accounts payable"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r295"
     ]
    },
    "mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "RelatedPartiesDetailsScheduleofotherrelatedpartybalancesLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties (Details) - Schedule of other related party balances [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OtherRelatedPartyBalances": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "OtherRelatedPartyBalances",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other related party balances",
        "label": "Other Related Party Balances"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties (Details) - Schedule of other related party balances (Parentheticals) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherInventories",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory",
        "label": "Other current inventories"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of inventory that the entity does not separately disclose in the same statement or note. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r286"
     ]
    },
    "ifrs-full_ClassesOfFinancialAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfFinancialAssetsAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable",
      "http://www.moolecscience.com/role/ScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial assets [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r187",
      "r188",
      "r210",
      "r211"
     ]
    },
    "mlec_RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "RelatedPartiesDetailsScheduleofotherrelatedpartybalancesParentheticalsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties (Details) - Schedule of other related party balances (Parentheticals) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClassesOfFinancialInstrumentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfFinancialInstrumentsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial instruments, class [member]",
        "label": "Financial instruments, class [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial instruments. Financial instruments are contracts that give rise to a financial asset of one entity and a financial liability or equity instrument of another entity. It also represents the standard value for the 'Classes of financial instruments' axis if no other member is used. [Refer: Financial assets; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r180",
      "r182",
      "r183",
      "r184"
     ]
    },
    "mlec_FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTradeandOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management (Details) - Schedule of Trade and Other Receivables [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FinancialRiskManagementDetailsScheduleofTradeandOtherReceivablesLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTradeandOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management (Details) - Schedule of Trade and Other Receivables [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable": {
       "parentTag": "ifrs-full_DeferredTaxLiabilityAsset",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable": {
       "parentTag": "mlec_SubtotalNonDerivatesLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable",
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable",
      "http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other tax liabilities",
        "verboseLabel": "Other liabilities",
        "negatedLabel": "Current Other Liabilities",
        "label": "Other liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r277"
     ]
    },
    "mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FinancialRiskManagementDetailsScheduleofContractualMaturityDateTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management (Details) - Schedule of Contractual Maturity Date [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScheduleOfCondensedBalanceSheetTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfCondensedBalanceSheetTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/BusinessCombinationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Assets and Liabilities Recognised",
        "label": "Condensed Balance Sheet [Table Text Block]",
        "documentation": "Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r303",
      "r304"
     ]
    },
    "mlec_FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FinancialRiskManagementDetailsScheduleofContractualMaturityDateLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management (Details) - Schedule of Contractual Maturity Date [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SubtotalNonDerivatesLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SubtotalNonDerivatesLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable": {
       "parentTag": "mlec_TotalLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Subtotal",
        "documentation": "Subtotal of non-derivates liabilities.",
        "label": "Subtotal Non Derivates Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfIntangibleAssetsAndGoodwillAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of intangible assets and goodwill [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r289"
     ]
    },
    "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForReconcileProfitLossAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile loss for the year to net cash flows",
        "label": "Adjustments to reconcile profit (loss) [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClassesOfInventoriesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfInventoriesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventories [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForSharebasedPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForSharebasedPayments",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee share-based payment",
        "label": "Adjustments for share-based payments"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r296"
     ]
    },
    "ifrs-full_NoncurrentPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentPayables",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable",
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade Payables",
        "negatedLabel": "Accounts Payable",
        "label": "Trade and other non-current payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current trade payables and non-current other payables. [Refer: Other non-current payables; Non-current trade payables]"
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "mlec_SubtotalDerivatesLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SubtotalDerivatesLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable": {
       "parentTag": "mlec_TotalLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Subtotal",
        "documentation": "Subtotal of derivates liabilities.",
        "label": "Subtotal Derivates Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TotalLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "TotalLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "documentation": "Total liabilities.",
        "label": "Total Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_GeneralInformationDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "GeneralInformationDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/GeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Information (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofForeignCurrencyExchangeRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management (Details) - Schedule of Foreign Currency Exchange Risk [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FinancialRiskManagementDetailsScheduleofForeignCurrencyExchangeRiskTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofForeignCurrencyExchangeRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management (Details) - Schedule of Foreign Currency Exchange Risk [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfIntangibleAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/IntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Assets",
        "label": "Disclosure of intangible assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for intangible assets."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "mlec_ForeignCurrencyExchangeRiskAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ForeignCurrencyExchangeRiskAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofForeignCurrencyExchangeRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency exchange risk assets",
        "documentation": "Foreign currency exchange risk assets.",
        "label": "Foreign Currency Exchange Risk Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DefaultFinancialStatementsDateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DefaultFinancialStatementsDateMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAccumulatedTaxLossCarryforwardsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Default financial statements date [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Creation date' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r113",
      "r114"
     ]
    },
    "mlec_ForeignCurrencyExchangeRiskLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ForeignCurrencyExchangeRiskLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofForeignCurrencyExchangeRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency exchange risk liabilities",
        "documentation": "Foreign currency exchange risk liabilities.",
        "label": "Foreign Currency Exchange Risk Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentPayablesToRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentPayablesToRelatedParties",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAccountsPayableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related parties",
        "label": "Non-current payables to related parties"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]"
       }
      }
     },
     "auth_ref": [
      "r279"
     ]
    },
    "ifrs-full_AdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      },
      "http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
      "http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total Administrative expenses",
        "negatedLabel": "Administrative expense",
        "label": "Administrative expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expenses that the entity classifies as being administrative."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r69",
      "r222"
     ]
    },
    "ifrs-full_BalancesWithBanks": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BalancesWithBanks",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Banks",
        "label": "Balances with banks"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash balances held at banks."
       }
      }
     },
     "auth_ref": [
      "r298"
     ]
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfPropertyPlantAndEquipmentAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFixedAssetsTable",
      "http://www.moolecscience.com/role/ScheduleofUsefulLivesofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of property, plant and equipment [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management (Details) - Schedule of Fair Value and Carrying Value of Financial Instruments [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FinancialRiskManagementDetailsScheduleofFairValueandCarryingValueofFinancialInstrumentsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management (Details) - Schedule of Fair Value and Carrying Value of Financial Instruments [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FinancialDebts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FinancialDebts",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable": {
       "parentTag": "ifrs-full_FinancialLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial debt",
        "documentation": "Amount of financial debt.",
        "label": "Financial Debts"
       }
      }
     },
     "auth_ref": []
    },
    "country_GB": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "GB",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofEstimatedFutureTaxableProfitTable",
      "http://www.moolecscience.com/role/ScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable",
      "http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United Kingdom [Member]",
        "label": "UNITED KINGDOM"
       }
      }
     },
     "auth_ref": []
    },
    "srt_CondensedBalanceSheetStatementsCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CondensedBalanceSheetStatementsCaptionsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Balance Sheet Statements, Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r216",
      "r270"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ChangesInGoodwillAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ChangesInGoodwillAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInInventories",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "label": "Adjustments for decrease (increase) in inventories"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r295"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInOtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables",
        "label": "Adjustments for decrease (increase) in other assets"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in other assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r297"
     ]
    },
    "ifrs-full_GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementEntitysOwnEquityInstruments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "GainsLossesRecognisedInProfitOrLossExcludingExchangeDifferencesFairValueMeasurementEntitysOwnEquityInstruments",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueOrdinaryShareofWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issued by the SPAC",
        "label": "Gains (losses) recognised in profit or loss excluding exchange differences, fair value measurement, entity's own equity instruments"
       }
      },
      "en": {
       "role": {
        "documentation": "The gains (losses) excluding exchange differences, recognised in profit or loss, on the fair value measurement of the entity's own equity instruments. [Refer: At fair value [member]]"
       }
      }
     },
     "auth_ref": [
      "r299"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInPrepaidExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepayment",
        "label": "Adjustments for decrease (increase) in prepaid expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for the decrease (increase) in prepaid expenses to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Current prepaid expenses; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r297"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivables from related parties",
        "label": "Adjustments for decrease (increase) in trade accounts receivable"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r295"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade receivables",
        "label": "Adjustments for decrease (increase) in trade and other receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r297"
     ]
    },
    "currency_ARS": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2023",
     "localname": "ARS",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable",
      "http://www.moolecscience.com/role/ScheduleofFinancialDebtTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Debt denominated in Argentine Pesos [Member]",
        "label": "Argentina, Pesos"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustmentsForDepreciationAndAmortisationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Adjustments for depreciation and amortisation expense"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r296"
     ]
    },
    "country_AR": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "AR",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofEstimatedFutureTaxableProfitTable",
      "http://www.moolecscience.com/role/ScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable",
      "http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Argentina [Member]",
        "label": "ARGENTINA"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DividendsPaidOrdinarySharesPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DividendsPaidOrdinarySharesPerShare",
     "presentation": [
      "http://www.moolecscience.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares per share",
        "label": "Dividends paid, ordinary shares per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of dividends paid per ordinary share."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity financing",
        "label": "Dividends paid to equity holders of parent, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for dividends paid to equity holders of the parent, classified as financing activities."
       }
      }
     },
     "auth_ref": [
      "r294"
     ]
    },
    "mlec_OtherNonCurrentReceivablesDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "OtherNonCurrentReceivablesDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/OtherNonCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Non-Current Receivables (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAccumulatedTaxLossCarryforwardsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax and Income Tax (Details) - Schedule of Accumulated Tax Loss Carryforwards [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DeferredTaxandIncomeTaxDetailsScheduleofAccumulatedTaxLossCarryforwardsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAccumulatedTaxLossCarryforwardsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax and Income Tax (Details) - Schedule of Accumulated Tax Loss Carryforwards [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DeferredTaxandIncomeTaxDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DeferredTaxandIncomeTaxDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/DeferredTaxandIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax and Income Tax (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DeferredTaxAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAccumulatedTaxLossCarryforwardsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax asset",
        "label": "Deferred tax assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      }
     },
     "auth_ref": [
      "r17",
      "r19",
      "r46"
     ]
    },
    "mlec_IssueOfShareCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "IssueOfShareCapital",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of share capital",
        "documentation": "The amount of issue of share capital.",
        "label": "Issue Of Share Capital"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AggregatePurchasePrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "AggregatePurchasePrice",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/OtherNonCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate purchase price (in Dollars)",
        "documentation": "Aggregate purchase price.",
        "label": "Aggregate Purchase Price"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TaxesDutiesAndPenalties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "TaxesDutiesAndPenalties",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherOperatingExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Taxes, duties and penalties",
        "documentation": "The amount of taxes, duties and penalties.",
        "label": "Taxes Duties And Penalties"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TypesOfRisksAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TypesOfRisksAxis",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialRiskManagementDetails",
      "http://www.moolecscience.com/role/ScheduleofForeignCurrencyExchangeRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of risks [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r153",
      "r154",
      "r156",
      "r174",
      "r178",
      "r179"
     ]
    },
    "mlec_SimplyAgreementForFutureEquitySAFE": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SimplyAgreementForFutureEquitySAFE",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable": {
       "parentTag": "ifrs-full_FinancialLiabilities",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable": {
       "parentTag": "mlec_SubtotalNonDerivatesLiabilities",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable",
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Simply Agreement for Future Equity (\u201cSAFE\u201d)",
        "documentation": "Simply Agreement for Future Equity (\u201cSAFE\u201d).",
        "label": "Simply Agreement For Future Equity SAFE"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TaxlossCarryForward": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "TaxlossCarryForward",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAccumulatedTaxLossCarryforwardsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax-loss carry forward",
        "documentation": "The amount of tax-loss carry forward.",
        "label": "Taxloss Carry Forward"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_UGVLAndTheoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "UGVLAndTheoMember",
     "presentation": [
      "http://www.moolecscience.com/role/GeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "UGVL and Theo [Member]",
        "label": "UGVLAnd Theo Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PurchasePaymentTerms": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "PurchasePaymentTerms",
     "presentation": [
      "http://www.moolecscience.com/role/OtherNonCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase payment term",
        "documentation": "Term of purchase payment.",
        "label": "Purchase Payment Terms"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_UnionGroupVenturesLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "UnionGroupVenturesLimitedMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Union Group Ventures Limited [Member]",
        "label": "Union Group Ventures Limited Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofEstimatedFutureTaxableProfitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax and Income Tax (Details) - Schedule of Estimated Future Taxable Profit. [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TypesOfRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TypesOfRisksMember",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r153",
      "r154",
      "r156",
      "r174",
      "r178",
      "r179"
     ]
    },
    "mlec_DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DeferredTaxandIncomeTaxDetailsScheduleofEstimatedFutureTaxableProfitTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofEstimatedFutureTaxableProfitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax and Income Tax (Details) - Schedule of Estimated Future Taxable Profit. [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_EquitySettledShareBasedPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "EquitySettledShareBasedPayment",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity settled share-based payment",
        "documentation": "The amount of equity settled share based payment.",
        "label": "Equity Settled Share Based Payment"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DeferredTaxExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DeferredTaxExpenseIncome",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/DeferredTaxandIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income tax assets",
        "label": "Deferred tax expense (income)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "mlec_USDollarMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "USDollarMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofForeignCurrencyExchangeRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. Dollar [Member]",
        "label": "USDollar Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DeferredTaxAssetsGrossAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DeferredTaxAssetsGrossAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofEstimatedFutureTaxableProfitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets, Gross amount",
        "documentation": "Deferred tax assets, gross amount.",
        "label": "Deferred Tax Assets Gross Amount"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_Equivalent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "Equivalent",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ShareCapitalandSharePremiumDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equivalent",
        "documentation": "The Amount Equivalent.",
        "label": "Equivalent"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ShareCapitalStockAndSharePremiumAmounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ShareCapitalStockAndSharePremiumAmounts",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ShareCapitalandSharePremiumDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share capital stock and share premium amounts",
        "label": "Share Capital Stock And Share Premium Amounts"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TypesOfSharebasedPaymentArrangementsAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of share-based payment arrangements [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "mlec_IssueOfShareCapitalSAFEShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "IssueOfShareCapitalSAFEShares",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of share capital (SAFE shares)",
        "documentation": "The amount of issue of share capital (SAFE shares).",
        "label": "Issue Of Share Capital SAFEShares"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Additions of Intangible assets",
        "label": "Purchase of intangible assets, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r236"
     ]
    },
    "mlec_SharePurchaseAgreementOverPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SharePurchaseAgreementOverPeriod",
     "presentation": [
      "http://www.moolecscience.com/role/ShareCapitalandSharePremiumDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share purchase Agreement over period",
        "documentation": "Share purchase Agreement over period.",
        "label": "Share Purchase Agreement Over Period"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DeferredTaxAssetsTaxEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DeferredTaxAssetsTaxEffect",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofEstimatedFutureTaxableProfitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets, Tax effect",
        "label": "Deferred Tax Assets Tax Effect"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_IssueOfShareCapitalBackstopShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "IssueOfShareCapitalBackstopShares",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of share capital (Backstop shares)",
        "documentation": "The amount of issue of share capital (Backstop shares).",
        "label": "Issue Of Share Capital Backstop Shares"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_UnderIssuedSharePurchaseAgreement": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "UnderIssuedSharePurchaseAgreement",
     "presentation": [
      "http://www.moolecscience.com/role/ShareCapitalandSharePremiumDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued (in Shares)",
        "documentation": "The amount of under share issued agreement.",
        "label": "Under Issued Share Purchase Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_UnionGroupVenturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "UnionGroupVenturesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Union Group Ventures [Member]",
        "label": "Union Group Ventures Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_IssueOfShareCapitalLightJumpShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "IssueOfShareCapitalLightJumpShares",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of share capital (LightJump shares)",
        "documentation": "The amount of issue of share capital (LightJump shares).",
        "label": "Issue Of Share Capital Light Jump Shares"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SharePurchaseAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SharePurchaseAgreement",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ShareCapitalandSharePremiumDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Purchase Agreement",
        "documentation": "Share Purchase Agreement.",
        "label": "Share Purchase Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofRollForwardofNetDeferredTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at beginning of year",
        "periodEndLabel": "Balance at year end",
        "terseLabel": "Deferred Tax Liability",
        "label": "Deferred tax liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]"
       }
      }
     },
     "auth_ref": [
      "r17",
      "r19",
      "r46"
     ]
    },
    "mlec_BusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "BusinessCombination",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination",
        "documentation": "Amount of business combination consideration.",
        "label": "Business Combination"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InterestExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "InterestExpenses",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialIncomeExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense",
        "documentation": "Interest expense.",
        "label": "Interest Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfInventoriesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfInventoriesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/Inventories"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "label": "Disclosure of inventories [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for inventories."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ifrs-full_DilutedEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DilutedEarningsLossPerShare",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted loss per share",
        "label": "Diluted earnings (loss) per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r77",
      "r78"
     ]
    },
    "ifrs-full_DeferredTaxLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DeferredTaxLiabilityAsset",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable": {
       "parentTag": "ifrs-full_NetDeferredTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax liability",
        "label": "Deferred tax liability (asset)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]"
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "mlec_UpToThreeMonthsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "UpToThreeMonthsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTradeandOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Up to 3 months [Member]",
        "label": "Up To Three Months Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ShareBasedPaymentDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ShareBasedPaymentDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Payment (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OtherLiabilitie": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "OtherLiabilitie",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other liabilities",
        "documentation": "Amount of other liabilities",
        "label": "Other Liabilitie"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TotalFinancialCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "TotalFinancialCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialIncomeExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Total Financial Costs",
        "label": "Total Financial Costs"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OrdinaryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "OrdinaryShares",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares",
        "documentation": "Number of ordinary shares.",
        "label": "Ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ShareBasedPaymentCostOfListingSharesnoncashItem": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ShareBasedPaymentCostOfListingSharesnoncashItem",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share based payment cost of listing shares (non-cash item)",
        "label": "Share Based Payment Cost Of Listing Sharesnoncash Item"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_Proceedsfromissuanceofsharecapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "Proceedsfromissuanceofsharecapital",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of share capital to SPAC public holders (Trust)",
        "documentation": "The amount of proceeds from issuance of share capital.",
        "label": "Proceedsfromissuanceofsharecapital"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ValoraSoySAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ValoraSoySAMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofConsolidatedFinancialStatementsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ValoraSoy S.A. [Member]",
        "label": "Valora Soy SAMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ShareBasedPaymentDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ShareBasedPaymentDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Payment (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ConstantValuePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ConstantValuePercentage",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Constant value percentage",
        "documentation": "Percentage of constant value.",
        "label": "Constant Value Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DilutedEarningsLossPerShareFromDiscontinuedOperations",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted",
        "label": "Diluted earnings (loss) per share from discontinued operations"
       }
      },
      "en": {
       "role": {
        "documentation": "Diluted earnings (loss) per share from discontinued operations. [Refer: Diluted earnings (loss) per share; Discontinued operations [member]]"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r79"
     ]
    },
    "ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/ShortTermInvestments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short term investments",
        "label": "Disclosure of investments accounted for using equity method [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of investments accounted for using the equity method. [Refer: Investments accounted for using equity method]"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of cash flows [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DeferredTaxandIncomeTaxLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DeferredTaxandIncomeTaxLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/DeferredTaxandIncomeTax"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax and Income Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ExchangeRateDifference": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ExchangeRateDifference",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialIncomeExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Exchange rate difference",
        "documentation": "Amount of exchange rate difference.",
        "label": "Exchange Rate Difference"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ProceedsFromSAFE": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ProceedsFromSAFE",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from the SAFE",
        "documentation": "The cash inflow from the SAFE.",
        "label": "Proceeds From SAFE"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Additions of fixed assets",
        "label": "Purchase of property, plant and equipment, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r236"
     ]
    },
    "mlec_WithinOneYearOrOnDemandMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "WithinOneYearOrOnDemandMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Within 1 year or on demand [Member]",
        "label": "Within One Year Or On Demand Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "StatementOfChangesInEquityLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NotionalAmount",
     "presentation": [
      "http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Signed amount",
        "label": "Notional amount"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal or face amount of a financial instrument, used to calculate payments made on that instrument."
       }
      }
     },
     "auth_ref": [
      "r275"
     ]
    },
    "mlec_InvestmentGainRelatedToMoneyMarketFunds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "InvestmentGainRelatedToMoneyMarketFunds",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialIncomeExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment gain related to money market funds",
        "label": "Investment Gain Related To Money Market Funds"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NotesAndOtherExplanatoryInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NotesAndOtherExplanatoryInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "General Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ProceedsFromIssueOfShareCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ProceedsFromIssueOfShareCapital",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issue of share capital",
        "documentation": "The cash inflow from the issuing of share capital.",
        "label": "Proceeds From Issue Of Share Capital"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ChangeInFairValueOfSimplyAgreementForFutureEquitySAFELoss",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialIncomeExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in fair value of Simply Agreement for Future Equity (\u201cSAFE\u201d) - Loss",
        "label": "Change In Fair Value Of Simply Agreement For Future Equity SAFELoss"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OptionsRecognizedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "OptionsRecognizedAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options recognized amount",
        "documentation": "The amount of options recognized.",
        "label": "Options Recognized Amount"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_WithoutAnyEstablishedTermMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "WithoutAnyEstablishedTermMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Without any established term [Member]",
        "label": "Without Any Established Term Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "StatementOfChangesInEquityTable",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to changes in equity."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "mlec_ChangeInWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ChangeInWarrants",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialIncomeExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in warrants",
        "documentation": "Amount of change in warrants.",
        "label": "Change In Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ReliefOfSAFEFinancialLiabilitiesThroughTheIssueOfShareCapitalAndSharePremium",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Relief of SAFE financial liabilities through the issue of Share Capital and Share Premium",
        "label": "Relief Of SAFEFinancial Liabilities Through The Issue Of Share Capital And Share Premium"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PricePerWarrant": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "PricePerWarrant",
     "presentation": [
      "http://www.moolecscience.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price per warrant",
        "documentation": "Price per warrant.",
        "label": "Price Per Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "IssueOfShareCapitalAndSharePremiumOfNewShareholdersThroughOtherNonCurrentRecei",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of Share Capital and Share Premium of New Shareholders through other non current receivables",
        "label": "Issue Of Share Capital And Share Premium Of New Shareholders Through Other Non Current Recei"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BusinessCombinationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "BusinessCombinationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AggregateShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "AggregateShares",
     "presentation": [
      "http://www.moolecscience.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate shares (in Shares)",
        "documentation": "Aggregate shares.",
        "label": "Aggregate Shares"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_IncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "IncomeTaxRate",
     "presentation": [
      "http://www.moolecscience.com/role/DeferredTaxandIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax rate",
        "documentation": "Income tax rate.",
        "label": "Income Tax Rate"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_CapitalizationOfTransactionExpensesThroughAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "CapitalizationOfTransactionExpensesThroughAccountsPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalization of transaction expenses through Accounts Payable",
        "documentation": "Capitalization of transaction expenses through accounts payable.",
        "label": "Capitalization Of Transaction Expenses Through Accounts Payable"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.moolecscience.com/role/OtherNonCurrentReceivablesDetails",
      "http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable",
      "http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable",
      "http://www.moolecscience.com/role/ScheduleofUsefulLivesofPropertyPlantandEquipmentTable",
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r151",
      "r162",
      "r241",
      "r242",
      "r301"
     ]
    },
    "ifrs-full_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of financial position [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_CapitalRiskManagementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "CapitalRiskManagementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Risk Management [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NetLiabilitiesAcquiredThroughIssuanceOfShareCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NetLiabilitiesAcquiredThroughIssuanceOfShareCapital",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net liabilities acquired through issuance of share capital",
        "label": "Net Liabilities Acquired Through Issuance Of Share Capital"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InflationAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "InflationAdjustment",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialIncomeExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inflation adjustment",
        "documentation": "Amount of inflation adjustment.",
        "label": "Inflation Adjustment"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DepositsFromBanks": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DepositsFromBanks",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bank accounts",
        "label": "Deposits from banks"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deposit liabilities from banks held by the entity."
       }
      }
     },
     "auth_ref": [
      "r277"
     ]
    },
    "mlec_ExercisePricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ExercisePricePerShare",
     "presentation": [
      "http://www.moolecscience.com/role/WarrantsLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price per share",
        "documentation": "Exercise price per share.",
        "label": "Exercise Price Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PurchasesFairValueMeasurementAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PurchasesFairValueMeasurementAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCostofsalesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases",
        "label": "Purchases, fair value measurement, assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in the fair value measurement of assets resulting from purchases of those assets. [Refer: At fair value [member]]"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "mlec_AcquisitionOfBusinessCombinationTroughDeferredPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "AcquisitionOfBusinessCombinationTroughDeferredPayment",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisition of Business Combination trough deferred payment",
        "documentation": "Amount of acquisition of business combination trough deferred payment.",
        "label": "Acquisition Of Business Combination Trough Deferred Payment"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "AcquisitionOfBusinessCombinationTroughDeferredPaymentInKind",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisition of Business Combination trough deferred payment in kind",
        "documentation": "Amount of acquisition of business combination trough deferred payment in kind.",
        "label": "Acquisition Of Business Combination Trough Deferred Payment In Kind"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "AcquisitionOfNoncurrentAssetsByTheIssuanceOfOrdinaryShares",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisition of non-current assets by the issuance of ordinary shares",
        "documentation": "Amount of acquisition of non-current assets by the issuance of ordinary shares.",
        "label": "Acquisition Of Noncurrent Assets By The Issuance Of Ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ChangesInWorkingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ChangesInWorkingCapitalAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in working capital",
        "label": "Changes In Working Capital Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PurchasePricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "PurchasePricePerShare",
     "presentation": [
      "http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase price per share (in Dollars per share)",
        "documentation": "The price per share of purchase.",
        "label": "Purchase Price Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OtherFinancialResults": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "OtherFinancialResults",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialIncomeExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other",
        "label": "Other Financial Results"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ComparativeInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ComparativeInformationTable",
     "presentation": [
      "http://www.moolecscience.com/role/ComparativeInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comparative Information [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ConvertedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ConvertedShares",
     "presentation": [
      "http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Converted shares (in Shares)",
        "documentation": "Number of converted shares.",
        "label": "Converted Shares"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r261",
      "r262",
      "r263"
     ]
    },
    "mlec_CostOfSalesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "CostOfSalesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Sales [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ComparativeInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ComparativeInformationLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ComparativeInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comparative Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TotalOtherFinancialResults": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "TotalOtherFinancialResults",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialIncomeExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Total Other financial results",
        "documentation": "Represents the amount of total other financial results.",
        "label": "Total Other Financial Results"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DeferredTaxandIncomeTaxTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DeferredTaxandIncomeTaxTable",
     "presentation": [
      "http://www.moolecscience.com/role/DeferredTaxandIncomeTax"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax and Income Tax [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentFinancialAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total current financial assets",
        "label": "Current financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current financial assets. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "mlec_NonCashFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NonCashFinancingActivitiesAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash financing activities",
        "label": "Non Cash Financing Activities Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "AccountsPayableandOtherCurrentandNonCurrentLiabilitiesLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/AccountsPayableandOtherCurrentandNonCurrentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Other Current and Non-Current Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DeferredTaxandIncomeTaxDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DeferredTaxandIncomeTaxDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/DeferredTaxandIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax and Income Tax (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTable",
     "presentation": [
      "http://www.moolecscience.com/role/AccountsPayableandOtherCurrentandNonCurrentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Other Current and Non-Current Liabilities [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_EventsAfterTheReportingPeriodAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "EventsAfterTheReportingPeriodAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Events After The Reporting Period Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Critical accounting judgements and estimates",
        "label": "Disclosure of accounting judgements and estimates [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "mlec_ShareCapitalAndSharePremiumAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ShareCapitalAndSharePremiumAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Capital and Share Premium [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_RightofUseOfAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "RightofUseOfAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-Use of Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NetFinancialIncomeExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NetFinancialIncomeExpenses",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialIncomeExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total net financial income / expenses",
        "documentation": "Total net financial income / expenses.",
        "label": "Net Financial Income Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PurchasePrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "PurchasePrice",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFEDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total purchase price",
        "documentation": "Purchase price.",
        "label": "Purchase Price"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SimpleAgreementForFutureEquitySAFETextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SimpleAgreementForFutureEquitySAFETextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Simple Agreement for Future Equity (\u201cSAFE\u201d)",
        "label": "Simple Agreement For Future Equity SAFEText Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DepreciationAndAmortisationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DepreciationAndAmortisationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCostofsalesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Amortization and depreciation",
        "label": "Depreciation and amortisation expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r40",
      "r132",
      "r195",
      "r203",
      "r221"
     ]
    },
    "ifrs-full_CurrentFinancialAssetsAtAmortisedCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentFinancialAssetsAtAmortisedCost",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialDebtTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Current Financial Debt",
        "label": "Current financial assets at amortised cost"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current financial assets measured at amortised cost. [Refer: Financial assets at amortised cost]"
       }
      }
     },
     "auth_ref": [
      "r190"
     ]
    },
    "mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofConsolidatedFinancialStatementsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies (Details) - Schedule of Consolidated Financial Statements [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies (Details) - Schedule of Non-Current Assets Other than Financial Instruments [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cash paid for acquisition of ValoraSoy net of the cash acquired",
        "label": "Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The aggregate cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities. [Refer: Subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "mlec_Amortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "Amortization",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Amortization (i)",
        "documentation": "Amortization.",
        "label": "Amortization"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SummaryofSignificantAccountingPoliciesDetailsScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies (Details) - Schedule of Non-Current Assets Other than Financial Instruments [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OtherNonCurrentAssetsOtherThanFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "OtherNonCurrentAssetsOtherThanFinancialAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total non-current assets other than financial instruments",
        "documentation": "Other non current assets other than financial assets.",
        "label": "Other Non Current Assets Other Than Financial Assets"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AsOfJune302021Abstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "AsOfJune302021Abstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "As of June 30, 2021",
        "label": "As Of June302021 Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "IntangibleAssetsDetailsScheduleofIntangibleAssetsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets (Details) - Schedule of Intangible Assets [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFixedAssetsTable",
      "http://www.moolecscience.com/role/ScheduleofUsefulLivesofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer equipment [Member]",
        "verboseLabel": "Computer equipment [member]",
        "label": "Computer equipment [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing computer equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r284"
     ]
    },
    "mlec_IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "IntangibleAssetsDetailsScheduleofIntangibleAssetsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets (Details) - Schedule of Intangible Assets [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_Cost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "Cost",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost",
        "documentation": "Cost.",
        "label": "Cost"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NetBookAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NetBookAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net book amount",
        "documentation": "Net book amount.",
        "label": "Net Book Amount"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfAdditionalInformationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfAdditionalInformationExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/ComparativeInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Comparative Information",
        "label": "Disclosure of additional information [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of additional information that is not presented elsewhere in the financial statements, but that is relevant to an understanding of them."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "mlec_FixedAssetsDetailsScheduleofFixedAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FixedAssetsDetailsScheduleofFixedAssetsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFixedAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed Assets (Details) - Schedule of Fixed Assets [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AcquisitionsThroughBusinessCombinationsi": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "AcquisitionsThroughBusinessCombinationsi",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseofAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisitions through business combinations (i)",
        "documentation": "Acquisitions through business combinations.",
        "label": "Acquisitions Through Business Combinationsi"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashRepaymentsOfAdvancesAndLoansFromRelatedParties",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/EventsaftertheReportingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash payment",
        "label": "Cash repayments of advances and loans from related parties"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for repayments of advances and loans from related parties. [Refer: Related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r294"
     ]
    },
    "mlec_FixedAssetsDetailsScheduleofFixedAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FixedAssetsDetailsScheduleofFixedAssetsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFixedAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed Assets (Details) - Schedule of Fixed Assets [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TotalGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "TotalGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofGoodwillTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofGoodwillTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Goodwill",
        "documentation": "The total amount of goodwill.",
        "label": "Total Goodwill"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashTransferred",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/BusinessCombinationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Combination of cash",
        "label": "Cash transferred"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "mlec_TotalMutualFunds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "TotalMutualFunds",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShortTermInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Short-term investments",
        "documentation": "The amount of total short-term investments.",
        "label": "Total Mutual Funds"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_EffectOfChangesInForeignExchangeRates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "EffectOfChangesInForeignExchangeRates",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRightofUseofAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of changes in foreign exchange rates",
        "documentation": "Effect of changes in foreign exchange rates.",
        "label": "Effect Of Changes In Foreign Exchange Rates"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents (Details) - Schedule of Cash and Cash Equivalents [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "CashandCashEquivalentsDetailsScheduleofCashandCashEquivalentsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of cash and cash equivalents [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AsOfJune302022Abstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "AsOfJune302022Abstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "As of June 30, 2022",
        "label": "As Of June302022 Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_MutualFunds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "MutualFunds",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShortTermInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mutual funds",
        "documentation": "The amount of short term mutual funds.",
        "label": "Mutual Funds"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Capital and Share Premium (Details) - Schedule of Reconciliation of Share Capital and Share Premium [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ShareCapitalandSharePremiumDetailsScheduleofReconciliationofShareCapitalandSharePremiumTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Capital and Share Premium (Details) - Schedule of Reconciliation of Share Capital and Share Premium [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SharesIssuedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SharesIssuedAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Shares issued amount,Opening balance",
        "periodEndLabel": "Shares issued amount, Ending balance",
        "documentation": "The amount of shares issued.",
        "label": "Shares Issued Amount"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CategoriesOfRelatedPartiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CategoriesOfRelatedPartiesAxis",
     "presentation": [
      "http://www.moolecscience.com/role/GeneralInformationDetails",
      "http://www.moolecscience.com/role/OtherNonCurrentReceivablesDetails",
      "http://www.moolecscience.com/role/ScheduleofConsolidatedFinancialStatementsTable",
      "http://www.moolecscience.com/role/ScheduleofForeignCurrencyExchangeRiskTable",
      "http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable",
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable",
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable_Parentheticals",
      "http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable",
      "http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Categories of related parties [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "mlec_SharesToBeIssuedAmountIssueOfShareCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SharesToBeIssuedAmountIssueOfShareCapital",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares to be issued amount, Issue of share capital",
        "documentation": "The amount of shares to be issued amount issue of share capital.",
        "label": "Shares To Be Issued Amount Issue Of Share Capital"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NumberOfSharesIssueOfShareCapitalinShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NumberOfSharesIssueOfShareCapitalinShares",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares, Issue of share capital (in Shares)",
        "documentation": "Number of shares issue of share capital.",
        "label": "Number Of Shares Issue Of Share Capitalin Shares"
       }
      }
     },
     "auth_ref": []
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "US",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialDebtTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Debt denominated in US Dollars [Member]",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SharePremiumIssueOfShareCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SharePremiumIssueOfShareCapital",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Premium, Issue of share capital",
        "documentation": "The amount of share premium issue of share capital.",
        "label": "Share Premium Issue Of Share Capital"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AsOfJune302023Abstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "AsOfJune302023Abstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "As of June 30, 2023",
        "label": "As Of June302023 Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SharesIssuedAmountFromBusinessAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SharesIssuedAmountFromBusinessAcquisition",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued amount, From business acquisition",
        "documentation": "The amount of shares issued amount from business acquisition.",
        "label": "Shares Issued Amount From Business Acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NumberOfSharesFromBusinessAcquisition": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NumberOfSharesFromBusinessAcquisition",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares, From business acquisition (in Shares)",
        "documentation": "Acquisition occurs when one company buys the shares of another company in an effort to gain control over that company. In simple terms you can say that acquisition is an act of one company taking over or acquiring another company's controlling interest.",
        "label": "Number Of Shares From Business Acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdditionsToRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdditionsToRightofuseAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use of assets",
        "label": "Additions to right-of-use assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "mlec_FairValueOfSharesinShares": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FairValueOfSharesinShares",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of shares (in Dollars per share)",
        "documentation": "Fair value of shares price per share.",
        "label": "Fair Value Of Sharesin Shares"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SharesToBeIssuedAmountFromBusinessAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SharesToBeIssuedAmountFromBusinessAcquisition",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares to be issued amount, From business acquisition",
        "documentation": "The amount of shares to be issued from business acquisition.",
        "label": "Shares To Be Issued Amount From Business Acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Borrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Borrowings",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding loans balance",
        "label": "Borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of outstanding funds that the entity is obligated to repay."
       }
      }
     },
     "auth_ref": [
      "r277"
     ]
    },
    "mlec_SharePremiumFromBusinessAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SharePremiumFromBusinessAcquisition",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Premium, From business acquisition",
        "documentation": "The amount of share premium from business acquisition.",
        "label": "Share Premium From Business Acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NetAssetsLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NetAssetsLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net assets acquired",
        "label": "Assets (liabilities)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets less the amount of liabilities."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r275"
     ]
    },
    "mlec_NumberOfShareEquitySettledShareBasedPayment": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NumberOfShareEquitySettledShareBasedPayment",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares, Equity settled share based payment (in Shares)",
        "documentation": "A share-based payment is a transaction in which the entity receives goods or services either as consideration for its equity instruments or by incurring liabilities for amounts based on the price of the entity's shares or other equity instruments of the entity.",
        "label": "Number Of Share Equity Settled Share Based Payment"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SharesIssuedAmountEquitySettledShareBasedPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SharesIssuedAmountEquitySettledShareBasedPayment",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued amount, Equity settled share based payment",
        "documentation": "The amount of shares issued amount equity settled share based payment.",
        "label": "Shares Issued Amount Equity Settled Share Based Payment"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_YearEndedJune302021Abstract0": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "YearEndedJune302021Abstract0",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFixedAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year ended June 30, 2021",
        "label": "Year Ended June302021 Abstract0"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SharesToBeIssuedAmountEquitySettledShareBasedPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SharesToBeIssuedAmountEquitySettledShareBasedPayment",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares to be issued amount, Equity settled share based payment",
        "documentation": "The amount of shares to be issued equity settled share based payment.",
        "label": "Shares To Be Issued Amount Equity Settled Share Based Payment"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SharePremiumEquitySettledShareBasedPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SharePremiumEquitySettledShareBasedPayment",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Premium, Equity settled share based payment",
        "documentation": "The amount of share premium equity settled share based payment.",
        "label": "Share Premium Equity Settled Share Based Payment"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Payment (Details) - Schedule and the Possible Dilutive Effect of the Future Exercise of Options [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ShareBasedPaymentDetailsScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Payment (Details) - Schedule and the Possible Dilutive Effect of the Future Exercise of Options [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AsOfJune302021Abstract0": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "AsOfJune302021Abstract0",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFixedAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "As of June 30, 2021",
        "label": "As Of June302021 Abstract0"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Equity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Equity",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total equity",
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "label": "Equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r24",
      "r115",
      "r117",
      "r135",
      "r136",
      "r138"
     ]
    },
    "ifrs-full_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EquityAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity",
        "label": "Equity [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EquityAndLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EquityAndLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LIABILITIES AND EQUITY",
        "label": "Equity and liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]"
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "ifrs-full_IssuedCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IssuedCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share capital",
        "label": "Issued capital"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value of capital issued."
       }
      }
     },
     "auth_ref": [
      "r227"
     ]
    },
    "ifrs-full_InterestRateRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "InterestRateRiskMember",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Rate Risk [member]",
        "label": "Interest rate risk [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the type of risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. [Refer: Financial instruments, class [member]]"
       }
      }
     },
     "auth_ref": [
      "r152",
      "r153",
      "r154",
      "r155",
      "r192"
     ]
    },
    "ifrs-full_IssueCostsNotRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IssueCostsNotRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/BusinessCombinationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash payments",
        "label": "Issue costs not recognised as expense for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of issue costs not recognised as an expense for transactions recognised separately from the acquisition of assets and assumption of liabilities in a business combination. [Refer: Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "ifrs-full_IssueOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IssueOfEquity",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of share capital (Moolec Science shares)",
        "label": "Issue of equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in equity through the issue of equity instruments."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ifrs-full_DisclosureOfBusinessCombinationsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfBusinessCombinationsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/BusinessCombination"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination",
        "label": "Disclosure of business combinations [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for business combinations."
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfCashAndCashEquivalentsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/CashandCashEquivalents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Disclosure of cash and cash equivalents [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "ifrs-full_IssuedCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IssuedCapitalMember",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital shares to be issued",
        "label": "Issued capital [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing issued capital."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ifrs-full_NoncurrentFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentFinancialAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofBookValueisReasonablyApproximatetotheFairValuegivenitsShortTermNatureTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Non-current Financial Debt",
        "label": "Non-current financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current financial assets. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "ifrs-full_DisclosureOfChangesInAccountingPoliciesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfChangesInAccountingPoliciesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of significant accounting policies",
        "label": "Disclosure of changes in accounting policies [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of changes made to accounting policies by the entity."
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "ifrs-full_EquityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EquityMember",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Book Value is Reasonably Approximate to the Fair Value given its Short-Term Nature [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r261",
      "r262",
      "r263"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r261",
      "r262",
      "r263"
     ]
    },
    "srt_ScenarioForecastMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioForecastMember",
     "presentation": [
      "http://www.moolecscience.com/role/EventsaftertheReportingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forecast [Member]",
        "label": "Forecast [Member]",
        "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r302",
      "r305"
     ]
    },
    "ifrs-full_Inventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Inventories",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofCostofsalesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Inventories at beginning",
        "periodEndLabel": "Inventories as of the end",
        "terseLabel": "Inventories",
        "label": "Current inventories"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current inventories. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r12",
      "r62",
      "r224"
     ]
    },
    "mlec_ShareBasedPaymentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ShareBasedPaymentAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Payment [Abstract]",
        "terseLabel": "Share based payment"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r261",
      "r262",
      "r263"
     ]
    },
    "ifrs-full_NoncurrentFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentFinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Non-current Financial Debt",
        "label": "Non-current financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current financial liabilities. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://www.moolecscience.com/role/EventsaftertheReportingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts."
       }
      }
     },
     "auth_ref": [
      "r217",
      "r218",
      "r269",
      "r271",
      "r305"
     ]
    },
    "ifrs-full_InventoriesTotal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "InventoriesTotal",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofInventoriesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofInventoriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Inventories",
        "label": "Inventories"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets: (a) held for sale in the ordinary course of business; (b) in the process of production for such sale; or (c) in the form of materials or supplies to be consumed in the production process or in the rendering of services. Inventories encompass goods purchased and held for resale including, for example, merchandise purchased by a retailer and held for resale, or land and other property held for resale. Inventories also encompass finished goods produced, or work in progress being produced, by the entity and include materials and supplies awaiting use in the production process. [Refer: Current finished goods; Current merchandise; Current work in progress; Land]"
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ifrs-full_OtherCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherCashAndCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total cash and cash equivalents",
        "label": "Other cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash and cash equivalents that the entity does not separately disclose in the same statement or note. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r298"
     ]
    },
    "mlec_ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfReconciliationOfShareCapitalAndSharePremiumTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/ShareCapitalandSharePremiumTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation of Share Capital and Share Premium",
        "documentation": "The entire disclosure of Reconciliation of Share Capital and Share Premium.",
        "label": "Schedule Of Reconciliation Of Share Capital And Share Premium Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of changes in foreign exchange rates",
        "label": "Increase (decrease) through net exchange differences, intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Useful Lives of Property, Plant and Equipment",
        "label": "Disclosure of detailed information about property, plant and equipment [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "ifrs-full_DisclosureOfCostOfSalesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfCostOfSalesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/Costofsales"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of sales",
        "label": "Disclosure of cost of sales [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the cost of sales. [Refer: Cost of sales]"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "ifrs-full_TopOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TopOfRangeMember",
     "presentation": [
      "http://www.moolecscience.com/role/OtherNonCurrentReceivablesDetails",
      "http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable",
      "http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable",
      "http://www.moolecscience.com/role/ScheduleofUsefulLivesofPropertyPlantandEquipmentTable",
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Top of range [member]",
        "verboseLabel": "Top of Range [Member]",
        "netLabel": "Top of range [Member]",
        "label": "Top of range [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for top of a range."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r151",
      "r162",
      "r241",
      "r242",
      "r301"
     ]
    },
    "ifrs-full_CurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentLiabilitiesAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities",
        "label": "Current liabilities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SummaryofSignificantAccountingPoliciesDetailsScheduleofConsolidatedFinancialStatementsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofConsolidatedFinancialStatementsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies (Details) - Schedule of Consolidated Financial Statements [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFixedAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of changes in foreign exchange rates",
        "label": "Increase (decrease) through net exchange differences, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "ifrs-full_PropertyPlantAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PropertyPlantAndEquipmentMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFixedAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, plant and equipment [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r57",
      "r235",
      "r244"
     ]
    },
    "mlec_ScheduleOfAccountsPayable": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfAccountsPayable",
     "presentation": [
      "http://www.moolecscience.com/role/AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accounts Payable",
        "label": "Schedule Of Accounts Payable"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Payable and Other Current and Non-Current Liabilities [Abstract]",
        "label": "Accounts Payableand Other Currentand Non Current Liabilities Tables Line Items"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDebtSecuritiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDebtSecuritiesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialDebt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial debt",
        "label": "Disclosure of debt instruments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of debt instruments. [Refer: Debt instruments issued; Debt instruments held]"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTablesTable",
     "presentation": [
      "http://www.moolecscience.com/role/AccountsPayableandOtherCurrentandNonCurrentLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Other Current and Non-Current Liabilities (Tables) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant, and Equipment",
        "label": "Property, plant and equipment recognised as of acquisition date"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r248",
      "r250"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r261",
      "r262",
      "r263"
     ]
    },
    "mlec_DisclosureOfStatutoryTaxesInCountriesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DisclosureOfStatutoryTaxesInCountriesTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/DeferredTaxandIncomeTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Principal Statutory Taxes Rates in the Countries",
        "documentation": "Disclosure of statutory taxes in countries.",
        "label": "Disclosure Of Statutory Taxes In Countries Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_VehiclesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "VehiclesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFixedAssetsTable",
      "http://www.moolecscience.com/role/ScheduleofUsefulLivesofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vehicles [Member]",
        "verboseLabel": "Vehicles [member]",
        "label": "Vehicles [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing vehicles used in the entity's operations, specifically to include aircraft, motor vehicles and ships. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r284"
     ]
    },
    "mlec_ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfIncomeTaxForOtherJurisdictionsTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/DeferredTaxandIncomeTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Income Tax for Other Jurisdictions",
        "documentation": "Schedule of income tax for other jurisdictions.",
        "label": "Schedule Of Income Tax For Other Jurisdictions Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDeferredTaxesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDeferredTaxesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/DeferredTaxandIncomeTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Net Deferred Tax Liabilities",
        "label": "Disclosure of deferred taxes [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of deferred taxes. [Refer: Deferred tax liabilities; Deferred tax assets]"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "mlec_ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfNetDeferredTaxLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/DeferredTaxandIncomeTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Net Deferred Tax Liabilities",
        "label": "Schedule Of Net Deferred Tax Liabilities Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfAccumulatedTaxLossCarryforwardsTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/DeferredTaxandIncomeTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accumulated Tax Loss Carryforwards",
        "documentation": "Schedule of accumulated tax loss carryforwards.",
        "label": "Schedule Of Accumulated Tax Loss Carryforwards Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfEstimatedFutureTaxableProfitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfEstimatedFutureTaxableProfitTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/DeferredTaxandIncomeTaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Estimated Future Taxable Profit.",
        "documentation": "Schedule of estimated future taxable profit.",
        "label": "Schedule Of Estimated Future Taxable Profit Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProfitLossFromOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProfitLossFromOperatingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Profit (loss) from operating activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r234",
      "r281"
     ]
    },
    "mlec_ScheduleOfOtherOperatingExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfOtherOperatingExpensesTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/OtherOperatingExpenseTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Operating Expense",
        "label": "Schedule Of Other Operating Expenses Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OtherOperatingExpenseTablesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "OtherOperatingExpenseTablesTable",
     "presentation": [
      "http://www.moolecscience.com/role/OtherOperatingExpenseTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Operating Expense (Tables) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OtherOperatingExpenseTablesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "OtherOperatingExpenseTablesLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/OtherOperatingExpenseTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Operating Expense [Abstract]",
        "label": "Other Operating Expense Tables Line Items"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r264"
     ]
    },
    "mlec_DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/AdministrativeExpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Administrative Expenses",
        "documentation": "The tabular disclosure of general and administrative expenses.",
        "label": "Disclosure Of General And Administrative Expenses Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WarrantLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable": {
       "parentTag": "mlec_SubtotalDerivatesLiabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable": {
       "parentTag": "ifrs-full_FinancialLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable",
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants liabilities",
        "verboseLabel": "Warrant",
        "netLabel": "Warrant liabilities",
        "label": "Warrant liability"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of warrant liabilities."
       }
      }
     },
     "auth_ref": [
      "r277"
     ]
    },
    "mlec_ResearchandDevelopmentExpenseTablesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ResearchandDevelopmentExpenseTablesTable",
     "presentation": [
      "http://www.moolecscience.com/role/ResearchandDevelopmentExpenseTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense (Tables) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeAndOtherCurrentPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TradeAndOtherCurrentPayables",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable": {
       "parentTag": "ifrs-full_FinancialLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "verboseLabel": "Trade and other payables",
        "label": "Trade and other current payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]"
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "ifrs-full_WarrantReserveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "WarrantReserveMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueOrdinaryShareofWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants [Member]",
        "label": "Warrant reserve [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity resulting from issuing share purchase warrants, other than those resulting from share-based payment arrangements. [Refer: Reserve of share-based payments [member]]"
       }
      }
     },
     "auth_ref": [
      "r274"
     ]
    },
    "mlec_ResearchandDevelopmentExpenseTablesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ResearchandDevelopmentExpenseTablesLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ResearchandDevelopmentExpenseTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Expense [Abstract]",
        "label": "Researchand Development Expense Tables Line Items"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfCostOfSalesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfCostOfSalesTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/CostofsalesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cost of Sales",
        "label": "Schedule Of Cost Of Sales Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TradeAndOtherCurrentPayablesToRelatedParties",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAccountsPayableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related parties",
        "label": "Current payables to related parties"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]"
       }
      }
     },
     "auth_ref": [
      "r279"
     ]
    },
    "mlec_NetLossperShareTablesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NetLossperShareTablesTable",
     "presentation": [
      "http://www.moolecscience.com/role/NetLossperShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Loss per Share (Tables) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Revenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Revenue",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Revenue"
       }
      },
      "en": {
       "role": {
        "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r127",
      "r172",
      "r194",
      "r199",
      "r205",
      "r206",
      "r208",
      "r221",
      "r222",
      "r240"
     ]
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFixedAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisitions through business combinations, net",
        "label": "Acquisitions through business combinations, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in property, plant and equipment resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TradeAndOtherCurrentReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable": {
       "parentTag": "ifrs-full_NetDeferredTaxLiabilities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable",
      "http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable",
      "http://www.moolecscience.com/role/ScheduleofOtherCurrentReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other receivables",
        "terseLabel": "Total Other current receivables",
        "verboseLabel": "Trade and other receivables",
        "label": "Trade and other current receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]"
       }
      }
     },
     "auth_ref": [
      "r13",
      "r23"
     ]
    },
    "ifrs-full_SalesAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SalesAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Marketing expense",
        "label": "Sales and marketing expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense relating to the marketing and selling of goods or services."
       }
      }
     },
     "auth_ref": [
      "r281"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Shell Company Report",
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r262"
     ]
    },
    "mlec_NetLossperShareTablesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NetLossperShareTablesLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/NetLossperShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss per Share [Abstract]",
        "label": "Net Lossper Share Tables Line Items"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentAccruedExpensesAndOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentAccruedExpensesAndOtherCurrentLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAccountsPayableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction expenses payable",
        "label": "Current accrued expenses and other current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current accrued expenses and other current liabilities. [Refer: Accruals; Other current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r277"
     ]
    },
    "mlec_ScheduleOfShareBasedPayment": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfShareBasedPayment",
     "presentation": [
      "http://www.moolecscience.com/role/RelatedPartiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share Based Payment",
        "label": "Schedule Of Share Based Payment"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfOtherRelatedPartyTransactions": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfOtherRelatedPartyTransactions",
     "presentation": [
      "http://www.moolecscience.com/role/RelatedPartiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Related Party Transactions",
        "label": "Schedule Of Other Related Party Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeAndOtherCurrentReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TradeAndOtherCurrentReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade Receivable and Other Current Receivables [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r261",
      "r262",
      "r263",
      "r265"
     ]
    },
    "ifrs-full_TradeAndOtherPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TradeAndOtherPayables",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable": {
       "parentTag": "mlec_SubtotalNonDerivatesLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAccountsPayableTable",
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Accounts payable",
        "verboseLabel": "Trade Payables",
        "label": "Trade and other payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of trade payables and other payables. [Refer: Trade payables; Other payables]"
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r266"
     ]
    },
    "ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CorporateInformationAndStatementOfIFRSComplianceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting standards and Basis of preparation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_RelatedPartiesTablesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "RelatedPartiesTablesTable",
     "presentation": [
      "http://www.moolecscience.com/role/RelatedPartiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties (Tables) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentPrepayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentPrepayments",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepayments",
        "label": "Current prepayments"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current prepayments. [Refer: Prepayments]"
       }
      }
     },
     "auth_ref": [
      "r225"
     ]
    },
    "ifrs-full_PropertyAmountContributedToFairValueOfPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PropertyAmountContributedToFairValueOfPlanAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/GeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contributed amount",
        "label": "Real estate, amount contributed to fair value of plan assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount real estate contributes to the fair value of defined benefit plan assets. [Refer: Plan assets, at fair value; Defined benefit plans [member]]"
       }
      }
     },
     "auth_ref": [
      "r232"
     ]
    },
    "ifrs-full_ProportionOfVotingPowerHeldInSubsidiary": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProportionOfVotingPowerHeldInSubsidiary",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofConsolidatedFinancialStatementsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "% Equity interest as of June 30, 2023",
        "label": "Proportion of voting rights held in subsidiary"
       }
      },
      "en": {
       "role": {
        "documentation": "The proportion of the voting rights in a subsidiary held by the entity. [Refer: Subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r72",
      "r75",
      "r121"
     ]
    },
    "mlec_ScheduleOfOtherRelatedPartyBalances": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfOtherRelatedPartyBalances",
     "presentation": [
      "http://www.moolecscience.com/role/RelatedPartiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of other related party balances",
        "label": "Schedule Of Other Related Party Balances"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Registration Statement",
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r257"
     ]
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisitions through business combinations",
        "label": "Acquisitions through business combinations, intangible assets and goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in intangible assets and goodwill resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Intangible assets and goodwill]"
       }
      }
     },
     "auth_ref": [
      "r288"
     ]
    },
    "ifrs-full_CurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentAssetsAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets",
        "label": "Current assets [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_RelatedPartiesTablesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "RelatedPartiesTablesLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/RelatedPartiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Parties [Abstract]",
        "label": "Related Parties Tables Line Items"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFixedAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Opening net book amount",
        "periodEndLabel": "Closing net book amount",
        "terseLabel": "Cost",
        "verboseLabel": "Accumulated Depreciation",
        "netLabel": "Net book amount",
        "label": "Property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r10",
      "r56"
     ]
    },
    "ifrs-full_TradeAndOtherPayablesToTradeSuppliers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TradeAndOtherPayablesToTradeSuppliers",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAccountsPayableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade payables",
        "label": "Trade payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of payment due to suppliers for goods and services used in the entity's business."
       }
      }
     },
     "auth_ref": [
      "r279"
     ]
    },
    "mlec_CashPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "CashPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNetAssetsAcquiredandGoodwillTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid",
        "documentation": "The amount of cash paid.",
        "label": "Cash Paid"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DisclosureOfFixedRateInstruments": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DisclosureOfFixedRateInstruments",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fixed-Rate Instruments",
        "documentation": "The disclosure of fixed rate instruments.",
        "label": "Disclosure Of Fixed Rate Instruments"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable": {
       "parentTag": "ifrs-full_CurrentAssetsLiabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "terseLabel": "Total financial assets",
        "label": "Current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]"
       }
      }
     },
     "auth_ref": [
      "r21",
      "r122",
      "r240"
     ]
    },
    "ifrs-full_TradeAndOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TradeAndOtherReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofTradeReceivableTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable",
      "http://www.moolecscience.com/role/ScheduleofTradeReceivableTable",
      "http://www.moolecscience.com/role/ScheduleofTradeandOtherReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Trade receivable",
        "terseLabel": "Accounts Receivable",
        "verboseLabel": "Up to 3 months",
        "label": "Trade and other receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of trade receivables and other receivables. [Refer: Trade receivables; Other receivables]"
       }
      }
     },
     "auth_ref": [
      "r13",
      "r23"
     ]
    },
    "mlec_DeferredPaymentAfter6Months": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DeferredPaymentAfter6Months",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNetAssetsAcquiredandGoodwillTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Payment after 6 months",
        "documentation": "The amount of deferred payment after 6 months.",
        "label": "Deferred Payment After6 Months"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InterestPaidClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "InterestPaidClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payment of loan interests",
        "label": "Interest paid, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for interest paid, classified as financing activities."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "mlec_ConsiderationPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ConsiderationPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNetAssetsAcquiredandGoodwillTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total purchase consideration",
        "documentation": "The amount of consideration paid in respect of both obtaining and losing control of subsidiaries or other businesses.",
        "label": "Consideration Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TradeReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofTradeReceivableTable": {
       "parentTag": "ifrs-full_TradeAndOtherReceivables",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTradeReceivableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable",
        "label": "Trade receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount due from customers for goods and services sold."
       }
      }
     },
     "auth_ref": [
      "r225"
     ]
    },
    "ifrs-full_CurrentAssetsLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentAssetsLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net financial asset /(liability)",
        "label": "Current assets (liabilities)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current assets less the amount of current liabilities."
       }
      }
     },
     "auth_ref": [
      "r277"
     ]
    },
    "ifrs-full_RepairsAndMaintenanceExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RepairsAndMaintenanceExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCostofsalesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Maintenance, energy and fuel related to fixed assets",
        "label": "Repairs and maintenance expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expenses incurred for the day-to-day servicing of assets, which may include the cost of labour, consumables or small parts."
       }
      }
     },
     "auth_ref": [
      "r281"
     ]
    },
    "mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofUsefulLivesofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies (Details) - Schedule of Useful Lives of Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/GoodwillTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Goodwill",
        "label": "Disclosure of detailed information about intangible assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "mlec_SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SummaryofSignificantAccountingPoliciesDetailsScheduleofUsefulLivesofPropertyPlantandEquipmentTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofUsefulLivesofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies (Details) - Schedule of Useful Lives of Property, Plant and Equipment [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentTradeReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentTradeReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade receivables",
        "label": "Current trade receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables. [Refer: Trade receivables]"
       }
      }
     },
     "auth_ref": [
      "r224",
      "r225"
     ]
    },
    "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AmortisationIntangibleAssetsOtherThanGoodwill",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accumulated Amortization",
        "label": "Amortisation, intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "mlec_Group1GrantedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "Group1GrantedMember",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Group 1 Granted [Member]",
        "label": "Group1 Granted Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "GammaLinolenicAcidGLAAssetsAndLicensingRightsToArachidonicAcidARAMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gamma Linolenic Acid (\u201cGLA\u2019) assets and licensing rights to Arachidonic Acid (\u201cARA\u201d) [Member]",
        "label": "Gamma Linolenic Acid GLAAssets And Licensing Rights To Arachidonic Acid ARAMember"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share of loss from associate",
        "label": "Share of other comprehensive income of associates and joint ventures accounted for using equity method that will be reclassified to profit or loss, net of tax"
       }
      },
      "en": {
       "role": {
        "documentation": "Share of the other comprehensive income of associates and joint ventures accounted for using the equity method that will be reclassified to profit or loss, net of tax."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "mlec_Group2GrantedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "Group2GrantedMember",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Group 2 Granted [Member]",
        "label": "Group2 Granted Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentValueAddedTaxReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentValueAddedTaxReceivables",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherCurrentReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Taxes",
        "label": "Current value added tax receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current value added tax receivables. [Refer: Value added tax receivables]"
       }
      }
     },
     "auth_ref": [
      "r278"
     ]
    },
    "mlec_Group1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "Group1Member",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable",
      "http://www.moolecscience.com/role/ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Group 1 [Member]",
        "label": "Group1 Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Share of loss from associate",
        "label": "Share of profit (loss) of associates and joint ventures accounted for using equity method"
       }
      },
      "en": {
       "role": {
        "documentation": "The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r35",
      "r196",
      "r203"
     ]
    },
    "ifrs-full_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL ASSETS",
        "label": "Assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r135",
      "r136",
      "r138",
      "r198",
      "r201"
     ]
    },
    "mlec_Group3GrantedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "Group3GrantedMember",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Group 3 Granted [Member]",
        "label": "Group3 Granted Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_Group2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "Group2Member",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable",
      "http://www.moolecscience.com/role/ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Group 2 [Member]",
        "label": "Group2 Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PaymentsForShareIssueCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PaymentsForShareIssueCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued amount, Issue of share capital",
        "label": "Payments for share issue costs"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for share issue costs."
       }
      }
     },
     "auth_ref": [
      "r294"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SharePremiumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SharePremiumMember",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Premium",
        "label": "Share premium [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the amount received or receivable from issuance of the entity's shares in excess of nominal value."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "mlec_HSBCBankBankOverdraftsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "HSBCBankBankOverdraftsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "HSBC Bank - Bank Overdrafts [Member]",
        "label": "HSBCBank Bank Overdrafts Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SharePremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SharePremium",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Share Premium,Opening balance",
        "periodEndLabel": "Share Premium, Ending balance",
        "terseLabel": "Share premium",
        "label": "Share premium"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value."
       }
      }
     },
     "auth_ref": [
      "r227"
     ]
    },
    "mlec_Group3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "Group3Member",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleandthePossibleDilutiveEffectoftheFutureExerciseofOptionsTable",
      "http://www.moolecscience.com/role/ScheduleofAmountandExercisePriceandtheMovementsoftheStockOptionsofExecutivesandManagersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Group 3 [Member]",
        "label": "Group3 Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_HSBCBankLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "HSBCBankLoansMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "HSBC Bank - Loans [Member]",
        "label": "HSBCBank Loans Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SharebasedPaymentArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SharebasedPaymentArrangementsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based payment arrangements [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "mlec_ImpactToProfitOrLossBeforeTaxAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ImpactToProfitOrLossBeforeTaxAssetsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofForeignCurrencyExchangeRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "(+10%) Impact to profit or loss before tax assets [Member]",
        "label": "Impact To Profit Or Loss Before Tax Assets Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares",
     "presentation": [
      "http://www.moolecscience.com/role/BusinessCombinationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity (in Shares)",
        "label": "Number of shares reserved for issue under options and contracts for sale of shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares reserved for issue under options and contracts for the sale of shares."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "mlec_INDEARSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "INDEARSAMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INDEAR S.A. [Member]",
        "label": "INDEARSAMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_MoolecScienceLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "MoolecScienceLimitedMember",
     "presentation": [
      "http://www.moolecscience.com/role/OtherNonCurrentReceivablesDetails",
      "http://www.moolecscience.com/role/ScheduleofConsolidatedFinancialStatementsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Moolec Science Limited [Member]",
        "label": "Moolec Science Limited Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AnalysisOfAgeOfFinancialAssetsThatArePastDueButNotImpaired": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AnalysisOfAgeOfFinancialAssetsThatArePastDueButNotImpaired",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Book Value is Reasonably Approximate to the Fair Value given its Short-Term Nature",
        "label": "Analysis of age of financial assets that are past due but not impaired [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "Analysis of the age of financial assets that are past due but not impaired. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r214"
     ]
    },
    "mlec_ImpactToProfitOrLossBeforeTaxLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ImpactToProfitOrLossBeforeTaxLiabilitiesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofForeignCurrencyExchangeRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "(-10%) Impact to profit or loss before tax liabilities [Member]",
        "label": "Impact To Profit Or Loss Before Tax Liabilities Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_LightJumpAcquisitionCorporationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "LightJumpAcquisitionCorporationMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofConsolidatedFinancialStatementsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LightJump Acquisition Corporation [Member]",
        "label": "Light Jump Acquisition Corporation Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_LightJumpSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "LightJumpSharesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of share capital (LightJump shares) [Member]",
        "label": "Light Jump Shares Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_MicrooFoodsIngredientsSLMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "MicrooFoodsIngredientsSLMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofConsolidatedFinancialStatementsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Microo Foods Ingredients S.L. [Member]",
        "label": "Microo Foods Ingredients SLMember"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_LuxMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "LuxMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lux [Member]",
        "label": "Lux Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ShorttermInvestmentsClassifiedAsCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Short-term investments, classified as cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "A classification of cash equivalents representing short-term investments. [Refer: Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r298"
     ]
    },
    "ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ShorttermDepositsClassifiedAsCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCashandCashEquivalentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term investments",
        "label": "Short-term deposits, classified as cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "A classification of cash equivalents representing short-term deposits. [Refer: Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r298"
     ]
    },
    "mlec_MoolecSAFEMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "MoolecSAFEMember",
     "presentation": [
      "http://www.moolecscience.com/role/GeneralInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Moolec SAFE [Member]",
        "label": "Moolec SAFEMember"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ShorttermEmployeeBenefitsAccruals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ShorttermEmployeeBenefitsAccruals",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherRelatedPartyTransactionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share based payment",
        "label": "Short-term employee benefits accruals"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of accruals for employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services. [Refer: Accruals classified as current]"
       }
      }
     },
     "auth_ref": [
      "r279"
     ]
    },
    "ifrs-full_PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "PercentageOfReasonablyPossibleIncreaseInUnobservableInputAssets",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount rate",
        "label": "Percentage of reasonably possible increase in unobservable input, assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The percentage of a reasonably possible increase in an unobservable input used in fair value measurement of assets."
       }
      }
     },
     "auth_ref": [
      "r300"
     ]
    },
    "ifrs-full_ShorttermEmployeeBenefitsExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ShorttermEmployeeBenefitsExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherRelatedPartyTransactionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term employee benefits",
        "label": "Short-term employee benefits expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense from employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services."
       }
      }
     },
     "auth_ref": [
      "r275"
     ]
    },
    "mlec_MoolecSAShareholdersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "MoolecSAShareholdersMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofotherrelatedpartybalancesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Moolec S.A. Shareholders [Member]",
        "label": "Moolec SAShareholders Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/FixedAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed Assets",
        "label": "Disclosure of property, plant and equipment [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for property, plant and equipment."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "mlec_ShortTermInvestmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ShortTermInvestmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Investments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contact Personnel Name",
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BorrowingMaturity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "BorrowingMaturity",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Date of maturity",
        "label": "Borrowing Maturity"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashAndCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashAndCashEquivalentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/ShareBasedPaymentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Amount and Exercise Price and the Movements of the Stock Options of Executives and Managers",
        "label": "Disclosure of number and weighted average exercise prices of share options [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ifrs-full_ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ReclassificationAdjustmentsOnExchangeDifferencesOnTranslationNetOfTax",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange differences on translation of foreign operations",
        "label": "Reclassification adjustments on exchange differences on translation of foreign operations, net of tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of reclassification adjustments related to exchange differences when the financial statements of foreign operations are translated, net of tax. Reclassification adjustments are amounts reclassified to profit (loss) in the current period that were recognised in other comprehensive income in the current or previous periods. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r39",
      "r64"
     ]
    },
    "mlec_WarrantsLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "WarrantsLiabilitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueOrdinaryShareofWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Liabilities (Details) - Schedule of Fair Value Ordinary Share of Warrants [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "WarrantsLiabilitiesDetailsScheduleofFairValueOrdinaryShareofWarrantsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueOrdinaryShareofWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants Liabilities (Details) - Schedule of Fair Value Ordinary Share of Warrants [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contact Personnel Email Address",
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents at beginning of the year/period",
        "periodEndLabel": "Cash and cash equivalents at end of the year/period",
        "label": "Cash and cash equivalents if different from statement of financial position"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash and cash equivalents in the statement of cash flows when different from the amount of cash and cash equivalents in the statement of financial position. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r298"
     ]
    },
    "mlec_WarrantAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "WarrantAndRightsOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueOrdinaryShareofWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.",
        "label": "Warrant And Rights Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DocumentAndEntityInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DocumentAndEntityInformationAbstract",
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForDerivativeFinancialInstrumentsAndHedgingExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingStandardsandBasisofPreparation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting standards and Basis of preparation",
        "label": "Description of accounting policy for derivative financial instruments and hedging [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for derivative financial instruments and hedging. [Refer: Financial instruments, class [member]; Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFinanceIncomeExpenseExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialIncomeExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial income / expenses",
        "label": "Disclosure of finance income (cost) [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of finance income (cost). [Refer: Finance income (cost)]"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "mlec_ScheduleOfNetAssetsAcquiredAndGoodwillAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfNetAssetsAcquiredAndGoodwillAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Net Assets Acquired And Goodwill Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinanceIncomeExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFinanceIncomeExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialIncomeExpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Financial Income Expenses",
        "label": "Disclosure of finance income [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of finance income. [Refer: Finance income]"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "mlec_FairValueAdjustmentOfWarrant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FairValueAdjustmentOfWarrant",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueOrdinaryShareofWarrantsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value remeasurement (Gain)",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.",
        "label": "Fair Value Adjustment Of Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFinancialAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Debt [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_Additions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "Additions",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions",
        "label": "Additions"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EmployeeBenefitsExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EmployeeBenefitsExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable": {
       "parentTag": "ifrs-full_AdministrativeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Employee Stock Option Plan",
        "label": "Employee benefits expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r40",
      "r221"
     ]
    },
    "mlec_FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FinancialInstrumentsDesignatedAsHedgingInstrumentAtFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At the beginning",
        "label": "Financial Instruments Designated As Hedging Instrument At Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company\u2019s Cash Balance in Other\u2019s Accounts",
        "label": "Cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value."
       }
      }
     },
     "auth_ref": [
      "r298"
     ]
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/RightofUseofAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use of assets",
        "label": "Disclosure of quantitative information about right-of-use assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "mlec_SAFECapitalization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "SAFECapitalization",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SAFE Capitalization",
        "documentation": "Safe capitalization.",
        "label": "SAFECapitalization"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_LossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "LossBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIncomeTaxforOtherJurisdictionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss before tax",
        "label": "Loss Before Tax"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_IncorporatedThroughTheBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "IncorporatedThroughTheBusinessCombination",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRollForwardofNetDeferredTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Incorporated through the business combination",
        "documentation": "IncorporatedThroughTheBusinessCombination.",
        "label": "Incorporated Through The Business Combination"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForExpensesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForExpensesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expenses",
        "label": "Description of accounting policy for expenses [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for expenses."
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "mlec_ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ifrs-full_FinancialInstrumentDesignatedAsHedgingInstrumentsAtFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At the end",
        "label": "ifrs-full_ Financial Instrument Designated As Hedging Instruments At Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DeferredTaxesExpenseIncomeRecognisedInProfitOrLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRollForwardofNetDeferredTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Credited to profit &amp; loss",
        "documentation": "Deferred tax expense income recognized in profit or loss.",
        "label": "Deferred Taxes Expense Income Recognised In Profit Or Loss"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ChargedToOtherComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ChargedToOtherComprehensiveIncome",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofRollForwardofNetDeferredTaxTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Charged to Other Comprehensive Income",
        "documentation": "Charged to Other Comprehensive Income.",
        "label": "Charged To Other Comprehensive Income"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFinancialAssetsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Financial Debt",
        "label": "Disclosure of financial assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of financial assets. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax and Income Tax (Details) - Schedule of Principal Statutory Taxes Rates in the Countries [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForFinancialAssetsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial assets",
        "label": "Description of accounting policy for financial assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for financial assets. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "mlec_DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DeferredTaxandIncomeTaxDetailsScheduleofPrincipalStatutoryTaxesRatesintheCountriesLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax and Income Tax (Details) - Schedule of Principal Statutory Taxes Rates in the Countries [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_TaxJurisdiction": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "TaxJurisdiction",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax rate",
        "documentation": "Income tax rate.",
        "label": "Tax Jurisdiction"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial instruments",
        "label": "Description of accounting policy for financial instruments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for financial instruments. [Refer: Financial instruments, class [member]]"
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "mlec_CorporateTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "CorporateTaxRate",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIncomeTaxforOtherJurisdictionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate tax rate",
        "label": "Corporate Tax Rate"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfOtherNoncurrentAssetsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/OtherNonCurrentReceivables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current receivables",
        "label": "Disclosure of other non-current assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of other non-current assets. [Refer: Other non-current assets]"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial liabilities and equity instruments",
        "label": "Description of accounting policy for financial liabilities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for financial liabilities. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short term investment subscriptions",
        "label": "Cash flows from (used in) decrease (increase) in short-term deposits and investments"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow (outflow) due to a decrease (increase) in short-term deposits and investments."
       }
      }
     },
     "auth_ref": [
      "r293"
     ]
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Country",
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Foreign Currency Exchange Risk",
        "label": "Description of accounting policy for functional currency [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for the currency of the primary economic environment in which the entity operates."
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfOtherOperatingIncomeExpenseExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/OtherOperatingExpense"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other operating expense",
        "label": "Disclosure of other operating income (expense) [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of other operating income or expense. [Refer: Other operating income (expense)]"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash generated from financing activities",
        "label": "Cash flows from (used in) financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r111"
     ]
    },
    "mlec_TaxLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "TaxLosses",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIncomeTaxforOtherJurisdictionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Tax losses",
        "label": "Tax Losses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForGoodwillExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Description of accounting policy for goodwill [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "mlec_EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "EffectOfDifferenceTaxRatesSubsidiariesOperatingInOtherJurisdictions",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIncomeTaxforOtherJurisdictionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of difference tax rates subsidiaries operating in other jurisdictions",
        "label": "Effect Of Difference Tax Rates Subsidiaries Operating In Other Jurisdictions"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities",
        "label": "Cash flows from (used in) financing activities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NondeductibleExpensesListingCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NondeductibleExpensesListingCost",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIncomeTaxforOtherJurisdictionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Non-deductible expenses - listing cost",
        "label": "Nondeductible Expenses Listing Cost"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NetGainOnInflationEffectOnMonetaryItems": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NetGainOnInflationEffectOnMonetaryItems",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIncomeTaxforOtherJurisdictionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net gain on inflation effect on monetary items",
        "documentation": "Net gain on inflation effect on monetary items.",
        "label": "Net Gain On Inflation Effect On Monetary Items"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_IncomeTaxInflationAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "IncomeTaxInflationAdjustment",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIncomeTaxforOtherJurisdictionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income tax inflation adjustment",
        "label": "Income Tax Inflation Adjustment"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Cash flows from (used in) investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r111"
     ]
    },
    "mlec_TaxBenefitForTheYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "TaxBenefitForTheYear",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIncomeTaxforOtherJurisdictionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Tax benefit for the year",
        "label": "Tax Benefit For The Year"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Taxes",
        "label": "Description of accounting policy for income tax [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for income tax."
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities",
        "label": "Cash flows from (used in) investing activities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_Others": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "Others",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIncomeTaxforOtherJurisdictionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Others",
        "documentation": "Others.",
        "label": "Others"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets",
        "label": "Description of accounting policy for intangible assets and goodwill [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for intangible assets and goodwill. [Refer: Intangible assets and goodwill]"
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/SimpleAgreementforFutureEquitySAFETables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Financial Instruments",
        "label": "Disclosure of financial instruments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for financial instruments."
       }
      }
     },
     "auth_ref": [
      "r193"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivities",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash (used in) / generated by operating activities",
        "label": "Cash flows from (used in) operating activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r111"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities",
        "label": "Cash flows from (used in) operating activities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax and Income Tax (Details) - Schedule of Net Deferred Tax Liabilities [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DeferredTaxandIncomeTaxDetailsScheduleofNetDeferredTaxLiabilitiesTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax and Income Tax (Details) - Schedule of Net Deferred Tax Liabilities [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EntitysTotalForRelatedPartiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "EntitysTotalForRelatedPartiesMember",
     "presentation": [
      "http://www.moolecscience.com/role/GeneralInformationDetails",
      "http://www.moolecscience.com/role/OtherNonCurrentReceivablesDetails",
      "http://www.moolecscience.com/role/ScheduleofForeignCurrencyExchangeRiskTable",
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable",
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity's total for related parties [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "mlec_CustomerRelationship": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "CustomerRelationship",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable": {
       "parentTag": "ifrs-full_DeferredTaxLiabilityAsset",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer relationship",
        "documentation": "Customer relationship.",
        "label": "Customer Relationship"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BorrowingsByNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BorrowingsByNameAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowings by name [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r301"
     ]
    },
    "ifrs-full_ProceedsFromIssuingOtherEquityInstruments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProceedsFromIssuingOtherEquityInstruments",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of share capital to UGVL and Theo (Backstop)",
        "label": "Proceeds from issuing other equity instruments"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from issuing equity instruments that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r237"
     ]
    },
    "ifrs-full_OtherNoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherNoncurrentLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAccountsPayableTable",
      "http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current liabilities",
        "negatedLabel": "Non-current Other Liabilities",
        "label": "Other non-current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r277"
     ]
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "ifrs-full_OtherNoncurrentFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherNoncurrentFinancialLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofFixedRateInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial debt",
        "negatedLabel": "Non-current financial liabilities",
        "label": "Other non-current financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r16",
      "r131"
     ]
    },
    "ifrs-full_ProceedsFromIssuingShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProceedsFromIssuingShares",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from of issue of shares",
        "label": "Proceeds from issuing shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from issuing shares."
       }
      }
     },
     "auth_ref": [
      "r237"
     ]
    },
    "ifrs-full_NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NominalOrPrincipalAmountOfFinancialInstrumentOnDiscontinuationOfMeasurementAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRisk",
     "presentation": [
      "http://www.moolecscience.com/role/EventsaftertheReportingPeriodDetails",
      "http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nominal value (equivalent in USD)",
        "verboseLabel": "Principal amount",
        "label": "Nominal or principal amount of financial instrument on discontinuation of measurement at fair value through profit or loss because credit derivative is used to manage credit risk"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal or principal amount of a financial instrument on discontinuation of its measurement at fair value through profit or loss, because a credit derivative is used to manage the credit risk of that financial instrument. [Refer: Credit risk [member]; Derivatives [member]; Financial instruments, class [member]]"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "mlec_OtherOperatingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "OtherOperatingExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherOperatingExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Total other operating expense",
        "documentation": "The amount of total other operating expense.",
        "label": "Other Operating Expense"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherNoncurrentNonfinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherNoncurrentNonfinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAccountsPayableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Others",
        "label": "Other non-current non-financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current non-financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Other financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r277"
     ]
    },
    "ifrs-full_DisclosureOfEarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfEarningsPerShareExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/NetLossperShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per share",
        "label": "Disclosure of earnings per share [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "ifrs-full_OtherNoncurrentPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherNoncurrentPayables",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current liabilities",
        "label": "Other non-current payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current payables that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r277"
     ]
    },
    "mlec_AuditLegalAndAccountancyFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "AuditLegalAndAccountancyFee",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable": {
       "parentTag": "ifrs-full_AdministrativeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Audit. legal and accountancy fees",
        "label": "Audit Legal And Accountancy Fee"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BorrowingsInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BorrowingsInterestRate",
     "presentation": [
      "http://www.moolecscience.com/role/OtherNonCurrentReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Internal rate percentage",
        "label": "Borrowings, interest rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The interest rate on borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r301"
     ]
    },
    "mlec_AmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "AmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable": {
       "parentTag": "ifrs-full_AdministrativeExpense",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Amortization",
        "documentation": "Amortization expense.",
        "label": "Amortization Expense"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherNoncurrentReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherNoncurrentReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofOtherNonCurrentReceivablesTable": {
       "parentTag": "ifrs-full_NoncurrentReceivables",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherNonCurrentReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivables with shareholders",
        "label": "Other non-current receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current other receivables. [Refer: Other receivables]"
       }
      }
     },
     "auth_ref": [
      "r225"
     ]
    },
    "mlec_PayrollExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "PayrollExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable": {
       "parentTag": "ifrs-full_AdministrativeExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payroll Expenses",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Payroll Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term investments withdrawals",
        "label": "Proceeds from sales or maturity of financial instruments, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from sales or maturity of financial instruments, classified as investing activities. [Refer: Financial instruments, class [member]]"
       }
      }
     },
     "auth_ref": [
      "r293"
     ]
    },
    "mlec_AsOfJune302022Abstract0": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "AsOfJune302022Abstract0",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFixedAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "As of June 30, 2022",
        "label": "As Of June302022 Abstract0"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/EventsaftertheReportingPeriod"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Events after the reporting period",
        "label": "Disclosure of events after reporting period [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for events after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofResearchandDevelopmentExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Research and Development Expense [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfEvidenceSupportingRecognitionOfDeferredTaxAssetsDependentOnFutureTaxableProfitsAndEntityHasSufferedALossInCurrentOrPrecedingPeriodExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAccumulatedTaxLossCarryforwardsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax jurisdiction",
        "label": "Description of evidence supporting recognition of deferred tax asset when utilisation is dependent on future taxable profits in excess of profits from reversal of taxable temporary differences and entity has suffered loss in jurisdiction to which deferred tax asset relates"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the nature of the evidence supporting the recognition of a deferred tax asset when: (a) the utilisation of the deferred tax asset is dependent on future taxable profits in excess of the profits arising from the reversal of existing taxable temporary differences; and (b) the entity has suffered a loss in either the current or preceding period in the tax jurisdiction to which the deferred tax asset relates. [Refer: Temporary differences [member]; Deferred tax asset when utilisation is dependent on future taxable profits in excess of profits from reversal of taxable temporary differences and entity has suffered loss in jurisdiction to which deferred tax asset relates]"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "mlec_ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ResearchandDevelopmentExpenseDetailsScheduleofResearchandDevelopmentExpenseTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofResearchandDevelopmentExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense (Details) - Schedule of Research and Development Expense [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_LaboratoriesRelatedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "LaboratoriesRelatedExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofResearchandDevelopmentExpenseTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofResearchandDevelopmentExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Laboratories\u2019 related expenses",
        "documentation": "Amount of labor-related expenses classified as other.",
        "label": "Laboratories Related Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherOperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherOperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other operating expense",
        "label": "Other operating income (expense)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of operating income (expense) that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r281"
     ]
    },
    "ifrs-full_NoncurrentReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.moolecscience.com/role/ScheduleofOtherNonCurrentReceivablesTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofOtherNonCurrentReceivablesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Other Non-Current receivables",
        "terseLabel": "Other Non-Current receivables",
        "label": "Trade and other non-current receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current trade receivables and non-current other receivables. [Refer: Non-current trade receivables; Other non-current receivables]"
       }
      }
     },
     "auth_ref": [
      "r13",
      "r23"
     ]
    },
    "ifrs-full_BottomOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BottomOfRangeMember",
     "presentation": [
      "http://www.moolecscience.com/role/OtherNonCurrentReceivablesDetails",
      "http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable",
      "http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable",
      "http://www.moolecscience.com/role/ScheduleofUsefulLivesofPropertyPlantandEquipmentTable",
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bottom of range [member]",
        "verboseLabel": "Bottom of Range [Member]",
        "netLabel": "Bottom of range [Member]",
        "label": "Bottom of range [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the bottom of a range."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r151",
      "r162",
      "r241",
      "r242",
      "r301"
     ]
    },
    "mlec_CostofsalesDetailsScheduleofCostofsalesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "CostofsalesDetailsScheduleofCostofsalesTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCostofsalesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of sales (Details) - Schedule of Cost of sales [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherPayables",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNetAssetsAcquiredandGoodwillTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment in kind after 12 months",
        "label": "Other payables"
       }
      },
      "en": {
       "role": {
        "documentation": "Amounts payable that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r277"
     ]
    },
    "mlec_OtherResearchAndDevelopmentExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "OtherResearchAndDevelopmentExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofResearchandDevelopmentExpenseTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofResearchandDevelopmentExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other research and development expenses",
        "documentation": "Amount of other research and development expense.",
        "label": "Other Research And Development Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_CostofsalesDetailsScheduleofCostofsalesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "CostofsalesDetailsScheduleofCostofsalesLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCostofsalesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Cost Sales [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_InventoriesIncorporatedThroughTheBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "InventoriesIncorporatedThroughTheBusinessCombination",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCostofsalesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventories incorporated through the business combination",
        "documentation": "The amount of inventories incorporated through the business combination.",
        "label": "Inventories Incorporated Through The Business Combination"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current assets",
        "label": "Non-current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      }
     },
     "auth_ref": [
      "r21",
      "r123",
      "r240"
     ]
    },
    "mlec_PayrollAndAndProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "PayrollAndAndProfessionalFees",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCostofsalesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payroll and and professional fees",
        "documentation": "The amount of fees paid payroll and and professional fees.",
        "label": "Payroll And And Professional Fees"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "NoncurrentReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Non-Current Receivables [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProfessionalFeesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProfessionalFeesExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofResearchandDevelopmentExpenseTable": {
       "parentTag": "ifrs-full_ResearchAndDevelopmentExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofResearchandDevelopmentExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Professional fees",
        "label": "Professional fees expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of fees paid or payable for professional services."
       }
      }
     },
     "auth_ref": [
      "r275"
     ]
    },
    "mlec_OtherProductionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "OtherProductionCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCostofsalesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other production costs",
        "documentation": "Amount of other production costs.",
        "label": "Other Production Costs"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AsOfJune302023Abstract0": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "AsOfJune302023Abstract0",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFixedAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "As of June 30, 2023",
        "label": "As Of June302023 Abstract0"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.moolecscience.com/role/ConsolidatedCashFlow": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedCashFlow",
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome",
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss of the year",
        "terseLabel": "Net loss of the year",
        "verboseLabel": "Loss for the year",
        "label": "Profit (loss)"
       }
      },
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r3",
      "r29",
      "r103",
      "r116",
      "r118",
      "r198",
      "r200",
      "r240",
      "r245"
     ]
    },
    "mlec_TotalOtherProductionCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "TotalOtherProductionCost",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofCostofsalesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sub-total",
        "documentation": "Other cost of sales.",
        "label": "Total Other Production Cost"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DeferredTaxAssetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DeferredTaxAssetAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax asset",
        "label": "Deferred Tax Asset Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinancialLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable": {
       "parentTag": "ifrs-full_CurrentAssetsLiabilities",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable": {
       "parentTag": "mlec_SubtotalNonDerivatesLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/FinancialRiskManagementDetails",
      "http://www.moolecscience.com/role/ScheduleofContractualMaturityDateTable",
      "http://www.moolecscience.com/role/ScheduleofFairValueandCarryingValueofFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total financial liabilities",
        "terseLabel": "Financial debts",
        "label": "Financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "ifrs-full_ProfitLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProfitLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss before Income tax",
        "label": "Profit (loss) before tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r172",
      "r221",
      "r222",
      "r255",
      "r256"
     ]
    },
    "ifrs-full_AdjustedWeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AdjustedWeightedAverageShares",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average number of ordinary shares (in Shares)",
        "label": "Weighted average number of ordinary shares used in calculating diluted earnings per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "mlec_NetLossperShareDetailsScheduleofNetLossPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NetLossperShareDetailsScheduleofNetLossPerShareLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of net loss per share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NetLossperShareDetailsScheduleofNetLossPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NetLossperShareDetailsScheduleofNetLossPerShareTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Loss per Share (Details) - Schedule of Net Loss Per Share [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_IssueOfSharesCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "IssueOfSharesCapital",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of share capital",
        "documentation": "The nominal value of capital arising from issuing ordinary shares.",
        "label": "Issue Of Shares Capital"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/WarrantsLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value Ordinary Share of Warrants",
        "label": "Disclosure of fair value measurement of liabilities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the fair value measurement of liabilities."
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "mlec_CompanySCashBalanceInOtherSAccountsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "CompanySCashBalanceInOtherSAccountsAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company\u2019s Cash Balance in Other\u2019s Accounts",
        "label": "Company SCash Balance In Other SAccounts Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Loss per Share (Details) - Schedule of Net Loss Per Share (Parentheticals) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NetLossperShareDetailsScheduleofNetLossPerShareParentheticalsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of net loss per share [Abstract]",
        "label": "Net Lossper Share Details Scheduleof Net Loss Per Share Parentheticals Line Items"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other receivables",
        "label": "Other receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount receivable by the entity that it does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": [
      "r225"
     ]
    },
    "mlec_DeferredTaxLiabilityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DeferredTaxLiabilityAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNetDeferredTaxLiabilitiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liability",
        "label": "Deferred Tax Liability Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherRelatedPartyTransactionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties (Details) - Schedule of Other Related Party Transactions [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss for the year, attributable to the owners of the Group",
        "verboseLabel": "Loss attributable to the ordinary shareholders",
        "label": "Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating diluted earnings per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) attributable to ordinary equity holders of the parent entity, adjusted for the effects of all dilutive potential ordinary shares. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "mlec_RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "RelatedPartiesDetailsScheduleofOtherRelatedPartyTransactionsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherRelatedPartyTransactionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of other related party transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProfitLossAttributableToOwnersOfParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ProfitLossAttributableToOwnersOfParent",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Parent of the Company",
        "label": "Profit (loss), attributable to owners of parent"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "RelatedPartiesDetailsScheduleofShareBasedPaymentTable",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties (Details) - Schedule of Share Based Payment [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfFairValueOfFinancialInstrumentsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialRiskManagementTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value and Carrying Value of Financial Instruments",
        "label": "Disclosure of fair value of financial instruments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the fair value of financial instruments. [Refer: Financial instruments, class [member]; At fair value [member]]"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "mlec_FinancialCostsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FinancialCostsAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialIncomeExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Costs",
        "label": "Financial Costs Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_RelatedPartiesDetailsScheduleofShareBasedPaymentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "RelatedPartiesDetailsScheduleofShareBasedPaymentLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties (Details) - Schedule of Share Based Payment [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_CFOSharesAlloted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "CFOSharesAlloted",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CFO Shares Alloted",
        "documentation": "CFO Shares Alloted.",
        "label": "CFOShares Alloted"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OtherFinancialResultsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "OtherFinancialResultsAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFinancialIncomeExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financial results",
        "label": "Other Financial Results Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_FinancialRiskManagementDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FinancialRiskManagementDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClassesOfShareCapitalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfShareCapitalAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of share capital [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "mlec_ScheduleOfCostOfSalesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfCostOfSalesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Cost Of Sales Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClassesOfShareCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ClassesOfShareCapitalMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable",
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital shares issued",
        "label": "Share capital [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "mlec_FinancialRiskManagementDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "FinancialRiskManagementDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfOtherRelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfOtherRelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Other Related Party Transactions Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PercentageOfFunctionalCurrency": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "PercentageOfFunctionalCurrency",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of functional currency",
        "documentation": "Percentage of functional currency.",
        "label": "Percentage Of Functional Currency"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfNetLossPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfNetLossPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Net Loss Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfShareBasedPaymentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfShareBasedPaymentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Share Based Payment Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PercentageOfInterestRates": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "PercentageOfInterestRates",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of interest rates",
        "documentation": "Percentage of interest rates.",
        "label": "Percentage Of Interest Rates"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfOtherRelatedPartyBalancesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfOtherRelatedPartyBalancesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Other Related Party Balances Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentFinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAssetsandLiabilitiesRecognisedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Current Financial Debt",
        "label": "Current financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current financial liabilities. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "mlec_BancoGaliciaLoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "BancoGaliciaLoansMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Banco Galicia - Loans [Member]",
        "label": "Banco Galicia Loans Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfTradeAndOtherReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfTradeAndOtherReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Trade And Other Receivables Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfContractualMaturityDateAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfContractualMaturityDateAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Contractual Maturity Date Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfForeignCurrencyExchangeRiskAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfForeignCurrencyExchangeRiskAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Foreign Currency Exchange Risk Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_IncreasedecreaseInterestPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "IncreasedecreaseInterestPayable",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest payable",
        "documentation": "Amount of increase/(decrease) interest payable.",
        "label": "Increasedecrease Interest Payable"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfFairValueAndCarryingValueOfFinancialInstrumentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfFairValueAndCarryingValueOfFinancialInstrumentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Fair Value And Carrying Value Of Financial Instruments Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfFixedRateInstrumentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfFixedRateInstrumentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Fixed Rate Instruments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ContinuingOperationsAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Continuing operations",
        "label": "Continuing Operations Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_EventsaftertheReportingPeriodDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "EventsaftertheReportingPeriodDetailsLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/EventsaftertheReportingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Events after the Reporting Period (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IntangibleAssetsAndGoodwillMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IntangibleAssetsAndGoodwillMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets and goodwill [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for intangible assets and goodwill. It also represents the standard value for the 'Classes of intangible assets and goodwill' axis if no other member is used. [Refer: Goodwill; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r289"
     ]
    },
    "ifrs-full_IntangibleAssetsAndGoodwillAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IntangibleAssetsAndGoodwillAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_EventsaftertheReportingPeriodDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "EventsaftertheReportingPeriodDetailsTable",
     "presentation": [
      "http://www.moolecscience.com/role/EventsaftertheReportingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Events after the Reporting Period (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_StrikePricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "StrikePricePerShare",
     "presentation": [
      "http://www.moolecscience.com/role/EventsaftertheReportingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Strike price per share (in Dollars per share)",
        "documentation": "Strike price per share.",
        "label": "Strike Price Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "country_LU": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "LU",
     "presentation": [
      "http://www.moolecscience.com/role/DeferredTaxandIncomeTaxDetails",
      "http://www.moolecscience.com/role/ScheduleofEstimatedFutureTaxableProfitTable",
      "http://www.moolecscience.com/role/ScheduleofPrincipalStatutoryTaxesRatesintheCountriesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Luxembourg [Member]",
        "verboseLabel": "LUXEMBOURG",
        "label": "LUXEMBOURG"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit or loss [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Opening net book amount",
        "periodEndLabel": "Closing net book amount",
        "terseLabel": "Intangible Assets",
        "label": "Intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r11",
      "r91"
     ]
    },
    "ifrs-full_IncomeTaxExpenseContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "IncomeTaxExpenseContinuingOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Income tax benefit",
        "label": "Tax expense (income)"
       }
      },
      "en": {
       "role": {
        "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]"
       }
      }
     },
     "auth_ref": [
      "r36",
      "r42",
      "r43",
      "r44",
      "r70",
      "r133",
      "r197"
     ]
    },
    "mlec_NumberOfStockInventories": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NumberOfStockInventories",
     "presentation": [
      "http://www.moolecscience.com/role/EventsaftertheReportingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Secures the supply of tons",
        "documentation": "Represents the number of soybean inventories.",
        "label": "Number Of Stock Inventories"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_CashPaidInKindInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "CashPaidInKindInterest",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/EventsaftertheReportingPeriodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and in kind",
        "documentation": "Represent the amount of cash paid in kind interest.",
        "label": "Cash Paid In Kind Interest"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NonCurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NonCurrentAssetsAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non- current assets",
        "label": "Non Current Assets Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ComponentsOfEquityAxis",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFairValueOrdinaryShareofWarrantsTable",
      "http://www.moolecscience.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of equity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "mlec_AGBiomoleculesLLCDEMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "AGBiomoleculesLLCDEMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofConsolidatedFinancialStatementsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AG Biomolecules LLC (DE) [Member]",
        "label": "AGBiomolecules LLCDEMember"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TaxRateEffectOfForeignTaxRates": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TaxRateEffectOfForeignTaxRates",
     "presentation": [
      "http://www.moolecscience.com/role/FinancialRiskManagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of exchange rate",
        "label": "Tax rate effect of foreign tax rates"
       }
      },
      "en": {
       "role": {
        "documentation": "The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from the application of foreign tax rates. [Refer: Average effective tax rate; Applicable tax rate]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "mlec_ArgentinePesosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ArgentinePesosMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofForeignCurrencyExchangeRiskTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Argentine pesos [Member]",
        "label": "Argentine Pesos Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_AsociacinMutualAMALoansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "AsociacinMutualAMALoansMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asociaci\u00f3n Mutual AMA \u2013 Loans [Member]",
        "label": "Asociacin Mutual AMALoans Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "ComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total comprehensive loss for the year",
        "label": "Comprehensive income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r31",
      "r116",
      "r118",
      "r126",
      "r240"
     ]
    },
    "mlec_NonCurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NonCurrentLiabilitiesAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current liabilities",
        "label": "Non Current Liabilities Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BGFarmingTechnologiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "BGFarmingTechnologiesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BG Farming Technologies [Member]",
        "label": "BGFarming Technologies Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_PurchaseConsiderationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "PurchaseConsiderationAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNetAssetsAcquiredandGoodwillTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase consideration:",
        "label": "Purchase Consideration Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_BackstopSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "BackstopSharesMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofReconciliationofShareCapitalandSharePremiumTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issue of share capital (Backstop shares) [Member]",
        "label": "Backstop Shares Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherFinanceIncomeCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "OtherFinanceIncomeCost",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financial results",
        "label": "Other finance income (cost)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of finance income or cost that the entity does not separately disclose in the same statement or note. [Refer: Finance income (cost)]"
       }
      }
     },
     "auth_ref": [
      "r281"
     ]
    },
    "mlec_BancoGaliciaBankOverdraftsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "BancoGaliciaBankOverdraftsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Banco Galicia - Bank Overdrafts [Member]",
        "label": "Banco Galicia Bank Overdrafts Member"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "CurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r124",
      "r240"
     ]
    },
    "mlec_BancoCrdobaPreFinancingOfExportsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "BancoCrdobaPreFinancingOfExportsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofTermsandConditionsofOutstandingLoansTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Banco C\u00f3rdoba - Pre-Financing of Exports [Member]",
        "label": "Banco Crdoba Pre Financing Of Exports Member"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_YearEndedJune302021Abstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "YearEndedJune302021Abstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year ended June 30, 2021",
        "label": "Year Ended June302021 Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TravelExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "TravelExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable": {
       "parentTag": "ifrs-full_AdministrativeExpense",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofAdministrativeExpensesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Travel Expenses",
        "label": "Travel expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from travel."
       }
      }
     },
     "auth_ref": [
      "r275"
     ]
    },
    "ifrs-full_MachineryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "MachineryMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFixedAssetsTable",
      "http://www.moolecscience.com/role/ScheduleofUsefulLivesofPropertyPlantandEquipmentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Machinery and equipment [Member]",
        "verboseLabel": "Machinery [member]",
        "label": "Machinery [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing long-lived, depreciable machinery used in operations. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r229"
     ]
    },
    "mlec_DisclosureOfInventoriesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DisclosureOfInventoriesTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/InventoriesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Inventories",
        "documentation": "The table disclosue of inventories.",
        "label": "Disclosure Of Inventories Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_OtherOperatingExpenseTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "OtherOperatingExpenseTable",
     "presentation": [
      "http://www.moolecscience.com/role/OtherOperatingExpense"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Operating Expense [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferred",
     "crdr": "credit",
     "presentation": [
      "http://www.moolecscience.com/role/BusinessCombinationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total aggregate amount",
        "label": "Consideration transferred, acquisition-date fair value"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "mlec_OtherOperatingExpenseLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "OtherOperatingExpenseLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/OtherOperatingExpense"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Operating Expense [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ResearchandDevelopmentExpenseLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ResearchandDevelopmentExpenseLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/ResearchandDevelopmentExpense"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ConsolidatedStatementsOfChangesInEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ConsolidatedStatementsOfChangesInEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Statements Of Changes In Equity Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ResearchandDevelopmentExpenseTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ResearchandDevelopmentExpenseTable",
     "presentation": [
      "http://www.moolecscience.com/role/ResearchandDevelopmentExpense"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NetLossperShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NetLossperShareTable",
     "presentation": [
      "http://www.moolecscience.com/role/NetLossperShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Loss per Share [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ServicesProvidedByOtherCompaniesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ServicesProvidedByOtherCompaniesAbstract",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofShareBasedPaymentTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Services Provided by Other Companies",
        "label": "Services Provided By Other Companies Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_NetLossperShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "NetLossperShareLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/NetLossperShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Loss per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://www.moolecscience.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Accounting Standard",
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r262"
     ]
    },
    "mlec_RelatedPartiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "RelatedPartiesTable",
     "presentation": [
      "http://www.moolecscience.com/role/RelatedParties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BasicEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BasicEarningsLossPerShare",
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic and diluted loss per share (in Dollars per share)",
        "label": "Basic earnings (loss) per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r78"
     ]
    },
    "mlec_RelatedPartiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "RelatedPartiesLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/RelatedParties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfOtherCurrentReceivablesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfOtherCurrentReceivablesTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/TradeReceivableandOtherCurrentReceivablesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Current Receivables",
        "documentation": "Schedule of Other Current Receivables Text Block.",
        "label": "Schedule Of Other Current Receivables Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_EventsaftertheReportingPeriodTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "EventsaftertheReportingPeriodTable",
     "presentation": [
      "http://www.moolecscience.com/role/EventsaftertheReportingPeriod"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Events after the Reporting Period [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DisclosureOfCapitalRiskManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DisclosureOfCapitalRiskManagementTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/CapitalRiskManagement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital Risk Management",
        "documentation": "The entire disclosure of capital risk management.",
        "label": "Disclosure Of Capital Risk Management Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfTradeReceivableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfTradeReceivableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/TradeReceivableandOtherCurrentReceivablesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Trade Receivable",
        "documentation": "Schedule of Trade Receivable Text Block.",
        "label": "Schedule Of Trade Receivable Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "BasicEarningsLossPerShareFromDiscontinuedOperations",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNetLossPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in Dollars per share)",
        "label": "Basic earnings (loss) per share from discontinued operations"
       }
      },
      "en": {
       "role": {
        "documentation": "Basic earnings (loss) per share from discontinued operations. [Refer: Basic earnings (loss) per share; Discontinued operations [member]]"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r79"
     ]
    },
    "mlec_EventsaftertheReportingPeriodLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "EventsaftertheReportingPeriodLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/EventsaftertheReportingPeriod"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Events after the Reporting Period [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DescriptionOfAccountingPolicyForBasisOfConsolidationOfSubsidiaryTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of consolidation of subsidiary",
        "documentation": "The description of accounting policy for basis of consolidation of subsidiary.",
        "label": "Description Of Accounting Policy For Basis Of Consolidation Of Subsidiary Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DescriptionOfAccountingPolicyForForeignCurrencyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency",
        "documentation": "The description of accounting policy for foreign currency.",
        "label": "Description Of Accounting Policy For Foreign Currency Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DescriptionOfAccountingPolicyForRightofuseOfAssetsTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use of assets",
        "documentation": "The description of accounting policy for right-of-use of assets.",
        "label": "Description Of Accounting Policy For Rightofuse Of Assets Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DescriptionOfAccountingPolicyForShareCapitalAndReservesTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share capital and reserves",
        "documentation": "The description of accounting policy for share capital and reserves.",
        "label": "Description Of Accounting Policy For Share Capital And Reserves Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfRelatedPartyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfRelatedPartyExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/RelatedParties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related parties",
        "label": "Disclosure of related party [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for related parties."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "mlec_DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DescriptionOfAccountingPolicyForAccountsPayableAndOtherLiabilitiesTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and other liabilities",
        "documentation": "The description of accounting policy for accounts payable and other liabilities.",
        "label": "Description Of Accounting Policy For Accounts Payable And Other Liabilities Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MiscellaneousOtherOperatingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "MiscellaneousOtherOperatingExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofOtherOperatingExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Miscellaneous expenses",
        "label": "Miscellaneous other operating expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of miscellaneous other operating expenses. [Refer: Other operating income (expense)]"
       }
      }
     },
     "auth_ref": [
      "r275"
     ]
    },
    "ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfResearchAndDevelopmentExpenseExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/ResearchandDevelopmentExpenseTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Research and Development Expense",
        "label": "Disclosure of research and development expense [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of research and development expense. [Refer: Research and development expense]"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "mlec_DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DescriptionOfAccountingPolicyForSubsidiariesAndJointArrangementsTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiaries and joint arrangements",
        "documentation": "The description of accounting policy for subsidiaries and joint arrangements.",
        "label": "Description Of Accounting Policy For Subsidiaries And Joint Arrangements Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DescriptionOfAccountingPolicyForNewStandardsAmendmentsAndInterpretationsOfIFRSTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New standards, amendments and interpretations of IFRS",
        "documentation": "The description of accounting policy for new standards, amendments and interpretations of IFRS.",
        "label": "Description Of Accounting Policy For New Standards Amendments And Interpretations Of IFRSText Block"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DescriptionOfAccountingPolicyForLossPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DescriptionOfAccountingPolicyForLossPerShareTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss per share",
        "documentation": "The description of accounting policy for loss per share.",
        "label": "Description Of Accounting Policy For Loss Per Share Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfNetAssetsAcquiredAndGoodwill": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfNetAssetsAcquiredAndGoodwill",
     "presentation": [
      "http://www.moolecscience.com/role/BusinessCombinationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Net Assets Acquired and Goodwill",
        "label": "Schedule Of Net Assets Acquired And Goodwill"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AccumulatedDepreciationAndAmortisationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "AccumulatedDepreciationAndAmortisationMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofFixedAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Depreciation [Member]",
        "label": "Accumulated depreciation and amortisation [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for accumulated depreciation and amortisation. [Refer: Depreciation and amortisation expense]"
       }
      }
     },
     "auth_ref": [
      "r59",
      "r285",
      "r287",
      "r291",
      "r292"
     ]
    },
    "mlec_ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfNonCurrentAssetsOtherThanFinancialInstrumentsTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Non-Current Assets Other than Financial Instruments",
        "label": "Schedule Of Non Current Assets Other Than Financial Instruments Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfRestrictedCashAndCashEquivalentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfRestrictedCashAndCashEquivalentsExplanatory",
     "presentation": [
      "http://www.moolecscience.com/role/CashandCashEquivalentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash and Cash Equivalents",
        "label": "Disclosure of restricted cash and cash equivalents [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "mlec_DisclosureOfIntangibleAssetsExplanatoryTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DisclosureOfIntangibleAssetsExplanatoryTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/IntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Intangible Assets",
        "label": "Disclosure Of Intangible Assets Explanatory Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "FinancialAssetsMember",
     "presentation": [
      "http://www.moolecscience.com/role/ScheduleofNonCurrentAssetsOtherthanFinancialInstrumentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial assets, class [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial assets. It also represents the standard value for the 'Classes of financial assets' axis if no other member is used. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r158",
      "r187",
      "r188",
      "r210",
      "r211"
     ]
    },
    "mlec_ScheduleOfFixedAssetstextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfFixedAssetstextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/FixedAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fixed Assets",
        "label": "Schedule Of Fixed Assetstext Block"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfOtherNoncurrentReceivableTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfOtherNoncurrentReceivableTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/OtherNonCurrentReceivablesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Non-Current Receivables",
        "documentation": "The tabular disclosure of schedule of other non-current receivables.",
        "label": "Schedule Of Other Noncurrent Receivable Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Risk Management [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_ScheduleOfRightofuseOfAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "ScheduleOfRightofuseOfAssetsTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/RightofUseofAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Right of Use of Assets",
        "documentation": "The entire disclosure of Schedule of Right-of-use of Assets Table Text Block.",
        "label": "Schedule Of Rightofuse Of Assets Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_DisclosureOfShortTermInvestmentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "DisclosureOfShortTermInvestmentsTableTextBlock",
     "presentation": [
      "http://www.moolecscience.com/role/ShortTermInvestmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Short Term Investments",
        "documentation": "The disclosure of Short-Term Investments Table Text Block.",
        "label": "Disclosure Of Short Term Investments Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full",
     "localname": "RightofuseAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.moolecscience.com/role/ConsolidatedBalanceSheet",
      "http://www.moolecscience.com/role/ScheduleofRightofUseofAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "As of June 30, 2022",
        "periodEndLabel": "As of June 30, 2023",
        "terseLabel": "Right-of-use of assets",
        "label": "Right-of-use assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r145"
     ]
    },
    "mlec_CashandCashEquivalentsTablesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "CashandCashEquivalentsTablesTable",
     "presentation": [
      "http://www.moolecscience.com/role/CashandCashEquivalentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents (Tables) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "mlec_CashandCashEquivalentsTablesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.moolecscience.com/20230630",
     "localname": "CashandCashEquivalentsTablesLineItems",
     "presentation": [
      "http://www.moolecscience.com/role/CashandCashEquivalentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Abstract]",
        "label": "Cashand Cash Equivalents Tables Line Items"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "104",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_104&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_iii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "106",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "138",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_138_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "51",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_51&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_g&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_h&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "k",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_k&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "m",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_m&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "o",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_o&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "56",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_56&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "61",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_61&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "69",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_69&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_vii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "81A",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "81A",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_a_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "82",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "82",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "82",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "82",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "82A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82A&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "91",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "92",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_92&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "99",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI",
   "URIDate": "2023-03-23"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "81",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "82",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_82&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI",
   "URIDate": "2023-03-23"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_iii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_vii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_viii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "75",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_75_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "75",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_75_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI",
   "URIDate": "2023-03-23"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "36",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_36_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "36",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_36_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS02_g36-39_TI",
   "URIDate": "2023-03-23"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2023-01-01",
   "Paragraph": "48",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2023-en-r&anchor=para_48&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2023-01-01",
   "Paragraph": "52",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2023-en-r&anchor=para_52_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Paragraph": "19",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2023-01-01",
   "Section": "Disclosures",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI",
   "URIDate": "2023-03-23"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2023-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_vi&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2023-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_viii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2023-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2023-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b_iii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2023-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b_iii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Paragraph": "67",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_67&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Paragraph": "68",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_68&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Paragraph": "70",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI",
   "URIDate": "2023-03-23"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "34",
   "IssueDate": "2023-01-01",
   "Paragraph": "16A",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=34&code=ifrs-tx-2023-en-r&anchor=para_16A_f&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2023-01-01",
   "Paragraph": "130",
   "Subparagraph": "d",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_130_d_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2023-01-01",
   "Paragraph": "134",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_134_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2023-01-01",
   "Paragraph": "135",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_135_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_vi&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_vii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "126",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS38_g118-128_TI",
   "URIDate": "2023-03-23"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "39",
   "IssueDate": "2023-01-01",
   "Paragraph": "102",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=39&code=ifrs-tx-2023-en-r&anchor=para_102_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2023-01-01",
   "Paragraph": "32A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_32A&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2023-01-01",
   "Paragraph": "76",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_76&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2023-01-01",
   "Paragraph": "50",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "39",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_39&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "46",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_46&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "f",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_f_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "29",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2023-en-r&anchor=para_29_c_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "49",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2023-en-r&anchor=para_49_b_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "12",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_12_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "19B",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_19B_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "19B",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_19B_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ix",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B13",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_b&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B13",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_c&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B13",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_d&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B13",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B4",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "93",
   "Subparagraph": "e",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e_iii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "93",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "14",
   "IssueDate": "2023-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2023-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "115",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_115&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "120",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_120_b_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_h&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "Subparagraph": "j",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_j&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "94",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "97",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_97&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "109",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_109&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "109A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_109A&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "120",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_120&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "124",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_124&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "125",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_125&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "127",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "128",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_128_a_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "128",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_128_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "132",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_132_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "C32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_C32&doctype=Appendix&subtype=C",
   "URIDate": "2023-03-23"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "44",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_44&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_v&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "51",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_51_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_f_i&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B64",
   "Subparagraph": "m",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_m&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Section": "Disclosures",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS03_g59-63_TI",
   "URIDate": "2023-03-23"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2023-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2023-en-r&anchor=para_33_b_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "20",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_a_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "21C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_21C&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "23B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_23B_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "24G",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_24G_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35H",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35I&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35K",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35K&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35M",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "36",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_36&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "39",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_39_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "42E",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_42E_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "42I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_42I&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_6&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "8",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_8_f&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "B52",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B52&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Section": "Defined terms",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&doctype=Appendix&subtype=A&dita_xref=IFRS07_APPA_TI",
   "URIDate": "2023-03-23"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Section": "Scope",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI",
   "URIDate": "2023-03-23"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "23",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "23",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "23",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_g&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "23",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_h&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "33",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2023-01-01",
   "Paragraph": "6.5.13",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_6.5.13_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2023-01-01",
   "Paragraph": "7.2.34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_7.2.34&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2023-01-01",
   "Paragraph": "7.2.42",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_7.2.42&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expired 2023-01-01",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "37",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_a&doctype=Standard&book=b",
   "URIDate": "2023-03-23"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expired 2023-01-01",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "8",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_8_c&doctype=Standard&book=b",
   "URIDate": "2023-03-23"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "102",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_102&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "68",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_68&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "78",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "IG6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_IG6&doctype=Implementation%20Guidance",
   "URIDate": "2023-03-23"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "37",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "138",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_138_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "138",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_138_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "142",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_142_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2023-01-01",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "32",
   "IssueDate": "2023-01-01",
   "Paragraph": "IE33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2023-en-r&anchor=para_IE33&doctype=Illustrative%20Examples",
   "URIDate": "2023-03-23"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2023-01-01",
   "Paragraph": "127",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "IG63",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_IG63&doctype=Implementation%20Guidance",
   "URIDate": "2023-03-23"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "B6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "IE63",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_IE63&doctype=Illustrative%20Examples",
   "URIDate": "2023-03-23"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2023-01-01",
   "Paragraph": "B89",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "96",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_96_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2023-01-01",
   "Paragraph": "96",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_96_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B64",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "B64",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2023-01-01",
   "Paragraph": "IE72",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_IE72&doctype=Illustrative%20Examples",
   "URIDate": "2023-03-23"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "35N",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35N&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "B11",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B11&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "B35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35&doctype=Appendix&subtype=B",
   "URIDate": "2023-03-23"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2023-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-11"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3"
  },
  "r272": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r273": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r274": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r275": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r276": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r277": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r278": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r279": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "78",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r280": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "82A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82A&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r281": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "85",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r282": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2023-01-01",
   "Paragraph": "IG6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_IG6&doctype=Implementation%20Guidance",
   "URIDate": "2023-03-23"
  },
  "r283": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2023-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r284": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r285": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2023-01-01",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r286": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2023-01-01",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r287": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r288": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r289": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "118",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r290": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2023-01-01",
   "Paragraph": "119",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r291": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2023-01-01",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r292": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2023-01-01",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r293": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "16",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r294": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r295": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "20",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_a&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r296": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "20",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_b&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r297": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r298": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r299": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "93",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e_i&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r300": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2023-01-01",
   "Paragraph": "93",
   "Subparagraph": "h",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_h_ii&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r301": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2023-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2023-03-23"
  },
  "r302": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "11",
   "Subsection": "03",
   "Publisher": "SEC"
  },
  "r303": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r304": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r305": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>145
<FILENAME>0001213900-23-081591-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-23-081591-xbrl.zip
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M9/U]TWZ_=?#/OS7W&^_,W.=6\')N"0^V<6K"H]**!GPLP^G;;XWAKAY>6:P
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MJK""1Q/H%34\.#6TAXF@[&8/SO4X0^"O8V#\Q<21/\Q*#]>8;NK!*9G@2/A
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MWQHXQ*]RK(,T^V;!5J_J(-\<GH!=!GR=U]]6K++R2\I91?=[O:W(<4%5-B_
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MEEF+,J9U]!.6]$5G]<-C5T+W Z=F>L#*9>!QD*T?! A.K&'BGM+TDI<,)2
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M7F%V1%>I3"1KOCN5.?*\S!&N/&Y+&0>&H">&H"41=,T6,N9=H;%449<I<B?
M107*CE]2(.5D(?PY@>>S<*@S>O"&AG)_]&TDVB-]82HK3<I/GEEHLHB$3M)S
MFJ?A=4ZD7SM7^SB&G<I_66>7(ZDC"92I2Q:..Q"_XC)$RL8R+IO]8"YZ9HR?
M*FQ0L?J:LKJ!U")>(GS\A>R.5YVHXF:@@]T^A44\VDD98#S/_;)%*)'.B(\4
MSLJT5U0Z<.>5,00^MMOG-]0ZFS>;VZ= #@:$FD=>DOZQ<WM;<6?%G>O+G:A=
MXV0(&NR_(M"YL3J>C9K4J*./"3+24>:/IOB18ZH2"%TID8F/XRS*BR&Y4L)<
M:6'T(8Q] S,YCW1<\W2QUV*NF\89W3_U";D /K"MI/[,@J'F6?BPG^C&.!+(
M!^=BZZN'\"-%?&_"'&.!%H2RT_P0\\3.RBO-JF+NBKG7E+D+-B7.ZF2("<DQ
MVJ:PJV+D:P^SSZ,OB.OC6TC*I%172<8PEL&@ITKV-QF_WQK$M 2@ IJY6V./
MK.JB:9LVJBG8KV_8J+>;ED5W>%O%HQ6/KBF/4IF,;M)FDY_<9'C*;B+NTZQ'
M'6ML3[<RMW!5_BEE&)=;"?AQ,HDUA$C9MLZORFP;5'L[!AIQ42;O'- >U:PQ
M-*#A$U//$PTKF)^*.=>9.:,XVG:4*):S!51]7;#8XDOC?JF$Q>+2R0B<1D$0
ML"Y$G36&;S2RG^W5UXI&J^=C^62C7/*O:[ZP2KX]+_D&WG]?A'1S?RT(,A C
M6M@YB+,)>.Y4G&OB=<Y-OBVW1[><*'\@ @(U<P3<)$NPQK[H*@8?$OE,!4??
MG:R+7[)(L)U&S6LU6CNUW&< Z>F'^'J",Z-;K_/C[N%<@[+2D$5BJ_NQ*IDY
M5B;3I&^(N'M&D#MR^Z8UND*\DM&K)<H<&:UO=O >]8/;M^$L1U5?\Z5^WWG)
ME..EU>HMXWW?(J[-P"KFB%&$NLU&4A%:/_!M&"LE2NB)&&.TR4B$(R CBA>6
M&M34V?N7_8.UW[!'+0:_8?XSU="M%N;O/'0Y>"12>[0V*\UJ#>!EJS08*@VM
MK3[W_K[7K+UZ_;KV^G6CSMHDU$O/U9! 1AP;I@!]^-E8-[MC@1A(7U*T&@=Y
M7=N'9YNMG;KWNRG8BX26'T,1H;PH%:RR!.@LRHRV,&17(K7:+'$Z]7]YTARI
MO46$ZAG/(,+5&^V&_9J QL.P3B+-?&K:Q>LIZR0[K &F?E U3+>;\=@1C]?.
M?@Y%8Y EA.U[\4\^GKP[JMEN@1BHPP%A(]1(3C3C!3)!E4JU)%C7BR"ELI\!
MBYIN%7$<F-Z=\#.\%,?UY =\+0R8'&[0(,RP'7<Z4Q5,H0\/20!TX#:1 G7%
MT5##>($OXP"_TO_2 B.12J..W-Q,PST3-L1Y&LP16?S2-A\5"5W<@ZHGTH")
M$;YQ1#@CI0K/G% *>#Q+)C5[3H,,PZJ4R)P@\ DP0-%9%4XX'\,>$05_0 S!
M"]%P0J(4 >8-\)3(AH-A>B6HHX^E(#B/8JUU]H%F8BAA7H;"[$V"*%Z>4DG#
MXJK506;B/V$<#06<B$C&GL\G*";IP(LZ")PEQJF2.!MJK'>?JQ'K\Y"3WTN1
MI!RNC+X;A$"7'(86FKRMJ:?@UZ:>HF2'4JF&C"R-S,;/:NS#1W;,$VQAQ"Z%
M/XJHJ1/\ZB0-ZC2!SQ&>]D>8XX1U2UTB?H8Q"#?F1 .M&3#"$D3,#%OIVRDO
M'<DD(%:9TGXAV2_>.7;+SI',,J=Q/2.-*.-%E&Z_]4!ZVVQ6O8=MZ-VF,89V
MYE V3(J]EAQTA89(6>,8_T6R(,5\?J5AL*RP,2PB!@-*[)\3*V:YYGO=7D"7
MT^"S0O>EP[[ !HT@O[>O;YA2VR@+30>;<_3!@H&-4*GEN1-?,+:5.O>X>.I8
MM8N2S77D2OW40'X1G&YQAU2J;40$&* \KY #E3GW4)3_:!C*,Q8]V@0@_HPX
MGLY:^#>2EE9*:&4@!2$&9E^("(;S,U1NDT3"DF&>J.:L\6(O)[")G?(E]A0'
M:BPJDPB+A'IZZ;;C1@O70&**$,N$L"U>C1$PBKX1T0"!KO+6%H.5@W1!F<E0
MRU$R;7+<SE3P<=TKI_Z2A>3LAM-B#+4->CS#$2P*N2(SC<O0%.97<5)G7;1"
M0.N$JI2%D4U (<( 9AM<M9GWA_9@])(UBZQ5TOLS%JL$X9SH1$:T4)1.7"YZ
MCC)4-YK-OTX28FA8C0(+D>JM))5UH3D*JGP<!Q3?J7DWO"P1U&W" L#1[\%F
M!NF O153&)3!'Q/=-2:AK)5XQJ0RF(UT-P4K#"3239U]BA.!/::T-BL:P'D3
MGHZN^30/-,W]5C$#\)%%MH>&;HRH+]&"VU+3]+Y+C5'LGK$5<]@] !LQAE./
MWE#8BD^K#Y<.>;7417U74<RKJBAFKBCF=5444['5X^(#WFP0H-Q$0_,>=J81
M\-K6K+/?A4ZC .+%_$50C\;A(]UD'1=T8O(G:J8%A Z#F)>C<SE(B LP=%&
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MI-MY$Y\W\7D3_P<W<:1[ <N.X$J)#H,[EY7'N+>820.1)^1DW]T\F.W[J[W
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M500/:,^Z1^%_=?UEU=;##M">GX+S,9!.;5B;]8Z]4N2IR8])^5_\:=5MC/.
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MJ\K"!&GHMV>.CO! =+2:4U$#D_ "+$?'(47O4>U&J! \U[7')N>'#;O[ZC@
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M72NR!<I5EK66\2;G I*S"E6EQ6,S=1$$8G#I)'I5B*,MHD*"FM@!"U>!_&@
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MF )4:FMXJDR<*T0\IKU8.V33B"3ML=5 #+!L"G[P:^YYJH=A#/L^&'=G>?@
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M#C&*FGQ@G:\>33W%\^_^Y\57CYY\%A?]A[29(G^+4&K/9%"#5=] PO+1+@0
MM#D6PK+$NG#I._M"<435!4NSD6C=P&!'DQ/F=!,6BR1K@ (<J>LT[M<A)X1S
MXI$L2;5>%,\@ZHU-62ZH7'#7\'5'ZR0Z8NJIB7_'*$73%)Q7@JBV(J<'"4]:
M8J%L'$!OU.W(5*W-?)M:D,%O1DQI[AAR!NVFRM3C)).S%$S;%?"V-K1.;Z
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MK((P\^9H0'&6MR-Q-U.8=7ED1 ?0H?!5AD50JM%PRV]I['RJ1E$(MJE[CYS
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M[%;K:A\NQS7&U&1@"91SN0QKE$,L2H"CB8A74DI.?1X$C,[IV+HV5W/N^7S
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M?PVF<M/M2O=E7_V[;LKB6_]3O>[*XAD!A\-[A4O04/S_OFIPV/ZEVM.8_)D
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M0D(Q"L8A^%J/B+@T>4A1;Z[?+$E3J4%Q:J_>5<TC(,SK-F'C#?"!OP)R7"=
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M:/@DYK_^D/Y(BE4\\Y]^>GE557*1K,MGKC#RW<&#AX_[UC[I#IY&_QKM@2_
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M[!IY0T[BO5KPZ\(7VGA6@74&?>L!(S&FNE*^9H$T(/ES5:/!+\LN>4#^K&E
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M13W-3LN*E2C==?V52K)!G?47/Z+EP:WY#_'$_6'3F1J-#V8(!$<PCWL@^9\
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MW*VS'UE 8TT3=&%A@05:GA6M#F/?^H 3OA62[0'^C/;F;AW@EJW-UC[03GW
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M^N192:(>BF<UI-L-X]F-WM$@^D+WKN+TR)%)?_AIGQ1EXXI.(ZA5LCATB2K
ME];<"D"7SP7=C4-QK>&DE]()I!UA+Z&* -!Q*V-:-[KX^Y%SKIZL]^"2_8[?
MR^9*JW)RK"LG<C[VJRH_7BK^D/;''Z)+)U&@1E^[RH.IL1462TE;L11#F$!0
M.W5\NO^Y)/OKX0,)/K'U,LDG''(7&ZQ8^;G4W<GHXY(-C]N[&^?G]K0;/][=
M9D?7LZ-[V^SHG;M& *EPZ(Z"1_$_;I6^5U?L5EXF5WSG!61]ZR>$I"F?,PO+
M/[[Z*JVK\3^^(M?ZR/V_!P]VA_]>''G:0*7>>_K@P>(C&H)0&/]=^O#;1XN/
M7WUS*W3:!\:XA[,^<N@U1NTZ[@(E #"O7H U6J%R^@$UFL)?JR'J6JE/IN;I
M2D&:II97Y/H'_.F8\HCOJ@ CP[>5$7 G\8LB[]9PDA%T-=0E\92UIIXQ9)%7
M1@R&K4KRR37X$S]'B$QF6F,K4Q@(E#;W;@G#)]O(-BN4ZOIXZ"V]&6^(WS*B
MKO17TKB<S;)%31K9_O45=.@YQ)9RP+Y231LX(R^ZX\+['WUMW[[NPU_)*7UP
ML380^DQ5A7*'@.>P,R==_G ?83IA(E_WW\&<"#Q3C8$YA9WN><?EU^WIY=_W
M$CAX9;6ZQ;.R46 GF#)V-R(YC9AD]=<ZND>/+S^\5ZX>5_E"$N*W=ATZFD&G
MVUZ=!]$*[%UA8&\9@$G87<'@>?[)IN.T?JP[ QGN]A'1]NR:0M$>OG^Y)Q&<
MGL4YUU"XX/-R@#NAMW.W^5-F<,Y@>G;H@H=RD<[[*/ ^/E[-RQIP&2_U7P(:
M"#B["/C"W,7QC*2(8;D:M^"2Y6,'QS.$A7O8+,DRJ,/CI;XUID X] C/@EM-
M[FHAY5@YRK3F^0X9"!-N'0_-B&3"9P"PY:%%&4A7_+Z:.R.-_7/VH;O$O6>G
M7W(&BK!X3Q?24KGW_\H3\\-/^X?OTAL\,S&3"=?_<]#B#AR=_0B.'&W]' 9!
MXEH0*=EX1;3QWI+3^$\>?,TA(ZXLP.<10*&GW1\F_:=$LN!"P%LTH?0 SY0D
MDJ"6RN.;8V3C&C94F*?.OL4LFC%FN72;<(K/,->U+:!.]/&6FZ3K HXJ1LO)
M.)"H2*??O.+RDGR&*"[^V1IF#3M^Y>&3T!6Z]S4_XMG.[M[7@RCC-5O=A>/Y
M*G>,@EA[ 05G:"2Y(\:A.%)DJ(5K)!/Y=_K"\WN[=(+QC[_R'/_OZ]?[NW_Z
M,4;U[-V[%/<+KM%"H-;S\DIBHRB!-<L)<]P[\ZPV1NV(WH13H4ZSS>OG>NIY
M(IUUXOMO=T"!6WPY0?0D&ZM$P)F!9BI7+M,;L=\+TM4CA0C.IX[7)!5,(:@@
M;HRTXK<8!:W%.W%L;+: QZX!3#G!08A*R(052@R!Y21W$16G\!396@($BWE8
M,&B8'+P4-:@Q5ZE09$8HPG=!+?S<NS^*,(;8AV?0&(#X6SJ!XOG6?ZDQ_.[=
M_]ZD2G@+X.A?@J3?@9//2R)6;XLKVF/4"QIVI_*%KW(MWUR4 .B*"C8!YJ>]
M=9OL8>Y4+XY136L:@>MNRIDC=S'6*6WJ-CZ@+13R%NYVAQMSM-(ZU$SR2S%]
MA#)MHJ27?S2T^S6VDW70<X^E']G]=^#H?@@3^29>M&]2].QQ^EH(![0(MBB+
MG=9Z_M4G]R;]V#MZ<O?^T,GM8;:C@ZLDL?V'=DZB,/.&N295[:@R?)]C]K1P
MV1LGQ9+]NXV7W_;@\<%;.W2R?KQ:]**_^@@^W![![A%\>'-'T..2*.Q,KV&-
M'O"Y@O-IM4-\2E%; =$29./.X?R\3L_MN[7>W[ +VCTRZ1TX,[PFUVYP+LA!
MW1J;M^?4ONUHFL$:5>D:*?,WJ,<?1QPSG:/[#6=E-V6+6QG)]?3C)>H?+GS"
MN35,ORQG;B<N<NE][*8Z"4LM/?[ZJW;-CF2O^,L]J2O..-7Y[RB4BBMR>'#K
M-3AK8[R>5?@SLN67*ZNZ2+M'<JU/YPE!RM;_,GS(6CQ_#CB1^KL=J84VB;PI
M<;S3BZEE%1S^;2]J?_GY6O>NRC(/8+_^0^V]#)A/QD'BFS2+ @74I)3*BNEG
MN(=O[\'.&X%V?O-J7SH0#.I8BZ=WHJNG;B7K)$V FZR@@427%7= K<?/D][X
M^4!-LTE.VVNJCTV[X^4\LQX>/SH@?;>&N*P]EF9K4$5W1.61D@,UB><<Z'L
M:6J&;*8/-L8=6Y*M!;<-*<IAZGL0]7\N>2CN3%7;!5T35ZIEW=O6LJ[7LC[\
M_&M9[[R81WU2_&W?H?A>>OAO9?GJC1=\ GZ_B LX&4.6@>^C#D'X*,V43F.9
M3K@(:@079\0@:6BIA/'?:I,-U9_VA*C,DK%,^=1K>ZEVM8-BLVS5EA;@XN1B
ME;D N'F,1$\%)Z"YA<,66O-_ZR&@%"U]YZV5DD8CC$86<]7%K91)N]@4R3'
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MC3:14RL(^%(!DS>"J\3EH_(=M$(6QR6[=K1-<P 1166C=2#,.RJSF0<R4HW
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ME*^%YI(MAY&KE1>5=1M\#8'_;I:3E8[D.#M%8YH1?GM;HY5=26K'1?Y:UZH
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M9\\ /M_\?51]\UP!P,U+D-_]6-9W22@VM5/T('!=TP*>7W;]1ILP/KGVNHL
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M^)0V9C:#.&C-M4-E[10DM(_;(#*D;R$%4OL-"NAB,DC.P!R(=LV2#H'3IJZ
M%-,B_FOU</C'SIW3XC!)L$;U75J%SE^8H'K%SOTP_;$\ Q@:J 5GV:JFU5AI
M*T6VSC[<4W'>Y7L_:-P\?3ADLLV#PMM^2@/_:IC^DM<GZ1MI_C5R>/I5G?X2
MRHJ!E/("B)[6!?/.LQ;J5PY$]RJR!1]95Y!X..[0D [5=%(R?Z.>.D:5,?R7
M=,7M9NB(*3IHGTQ@C&6@[R8CYXNIF^S$K:'UJ/"P9@<=#HUCCM6ON/4_+K\6
MXD5YPDCGQASO6MA].\OC;I9J'LC6V4SA2-]:4\^72GK_R54_^W42XU])D^1X
MR13>\W+FQLM95J73K)I+RQ2+-N"0^/EY)NH#--L>^25PG/)Q8/-@Y(RPE ^I
MWCN.W@FY_N31^W<F@=7;+(:E_#1"*TL7;2L=5="<?$N7]".-;'Q"!TV85,>N
M*J+GS!1ULD2+*6EFTEO[Z/?W71&&","Z1Y]\QC>V6@""4<"CJ+W,AD:T!FWH
MUF.P9%.([@$QK>DEIG5)"=0EZ8<9MV?(_<((EA5WP,4]<@=%$CU,=9+T5$PF
M.@:R2*3[3&%]^\;I '[<>'02]Y$M"7^U!/OA#NB?:X6U>TE7+6V>A":^-#P]
M0T.HW+@\*L@,G@BI6T(.!IGI52V8/;)"=%5OFUL^73^3UYA(W]%8J6F#(R=0
M(^M:FI')"]AXTA;([0%E=8*_ 3 IIS=G59N\0']'ED< -XR@[10Q:9@8Y("-
M9L#:@KNDHAWG5_[/BK11SKHN5"#\YJH3&'[TIW-'7I ZC;'$HO'#GTIL\*J!
M2"=];%1-Y9724TK;/_W_M^7OOV>#].=R- )*RQL&)-1.A..M=/XQZ12JM1[Q
M[(JA79>Z9?680P[*(\#7:P1\_,E#BB&[$GFQH.<$FC>5.P&X"S^P[\:*S4Y#
MQ!WG.>;X"?K$$%]Q==0XCRF/&<>95T(Q'G",VMWB:$340%IP((#PLJR4&T,,
M!1+C87K)@Z?O))&G_9Y*_<]O=';J07(P7Y1UG<,EX1,P2-_3)5_R.W[(BY,R
M?9&7.&?UG;K7;W0,;P2_4_!,:/VK(.A)CZ#K3AA\P3H8JDJ[,L34%@=4>0K0
MJE7TT'EV(AVKT<,B/H:$_<N.A+<$,QK?+",)F*Z$>#66&FD<+\L:N$\(##I\
MAGXIS;4<SYOE)TZ,9' A!W/?[$Y =:G)N:S5#.A R0C]HFH"-QF2X)UFRPD=
MEA_09CX@,=>9\3RE:J 62?A;-E]\G[ZILB/&0Z+=?77XEJ7WQXS&6VA89>22
M@M9@PJA<[F.&F AZU^8EK@]<F5N#Y*K=MH^VW;;KW;:/M]VV=\YO@WIA%"90
M2KP7 J'5E^?!?;)U]0X1#HNN"IAJ7DO$2&+CO["6?N5)*CKHW'H]'+P7:)ZL
MD7P(4!CH=QZW1S,^?(.H+1*!3'SRZ#TJ10?[N\H6^00P$F,.46$H?!6+[\-H
M7;.9S]G-L@:QZ:V5U.I99TOTW\LJKR?YV"QF-<#/&##R1/<[6MOVM3Q@4P-2
M\VN1-VXB4SML,L::?ID5V82\N!=5]CO8W/?)Y$';.OUJ'SAL--(,]L,$__/R
MF/_P(SU<GO(_]*]!\L]L@6F_S9"OP.>P%O^?HQ\1LWOK/N;C4@-_RP+Y,S:-
M7B^A*+9&P_,/)5/S##QRC"&)NTDB(%Y+<'JO;7.J*5\ @H]S!M=,7<[1"S)
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MAU#P8C()<$*KBBU<=&[<^HFK8A1)UDW\OB_B^\(T\14MO]YL@:MQXCD3$:?
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M4/..CUO>R=$, OA.+%^E=Y=:^X:[?I_$^LCYG-7 -&,YXZ\/'*[1:'O']2T
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MX\Q_5VK;3N6763-8WZ&84B^=MFZGOJ:LVTXVA'4JQYG-VQ-O9A6IX*X/-%#
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MJ#X;*O';=0QBL#SP5PU!?"W'66A-_WH>N.:M!2I&"6'/2LNYQG/RQ%L7Y,V
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MK%V66=^:RTHJU"V&TNI*)#)"(1-$^$/\5P8$:%?<JRA&'.9FQ:V!1WA<JYZ
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MV>,6MR5<T(D\98F=LEDINNA&B9R*^WF, I98V(_ZB9JUS@'L>S;&4HIODQ,
M7JO]6AQYCP5/ZMNN$LZWF!''.T)_LV_%'8L:Z8(<],=X)TC6[@B[KSDY)8(D
MFLI0.<T*2 F[A(H(K(H]\Y*FM[J7X/.MC%$SJC^=9QAW<\\C/-JWE=\K[H']
MJS>[E[I:O:5V 2L9<[J&:-P9QI*LA]=IEEV4%XK#[Y)LS&SH*/5G.EAZT;CK
M<P07HP4N59A(#-B S>%/T5=H^BJII8V5@O2:,^RI@HF,1%K/<%#-^GUI1%5N
M;>'_Y^_!BX( JT3-6KC0,$MTW_ @"P+0Q?#*%.U&D&=*+L*G G$'+P3!"W\/
M?-'U S3$<('ZMR( ^^QO+#"# XFE &, ]#P6,O:R& D!2YD(GYXV\L?XXX@#
M)].D1FNV%PA_#':LLF<3L/OH 7&$=B@J [9A8=D4/\2R53@!2L(JDU5HV_:>
MJ( 2_ ZK_.']MWZ<LG1&H%^UDJ[$Q^(/XI:#Y5))=E%*3[*[K?V3%$]XCV1!
M\KZ=F?VRU91$0<95>ZA:H@$=J\T8J.V2K/LG6J%P0DKQJ0PG:AY/-7%3' M>
MCZLGK6A_A%@BC)QI#M3<H%B'*GR1\&4[-5N$O^>'#U_(B'@F%Z!M^ /_#5*9
MF8#HU$NQD'40BZSO.7T_&2$>0GKO%?Z2!<AVP W]K >>"#QY&$=PLT(YA$M+
MP78E^_%4M?U9LN"?8 732YB(>_*&Q@+N"74!.0(C*TD&JAF>K$S4*&9G:N2#
M3\;,0Q1$_P 4/P;]LI@N'Y,$5Z!(F\HYBX%_PWI@0>!;4:@&8XM(;E-TZ,#U
MVE;]/Q6].7ZVZ,WI&J(W%\JI([_S#*17K%(3&%I/Y+JBD[M8.O2*RV27+8AM
M[@MB9PMB6_N"V&\U@*=$\<FSE+X>Z]+7\XM/G4^G%YU+]^+3^>?KCQVL;]V^
M\M9F]465MV(O&%YY8?*,REH$I<71HW/P0D**J5I>\ZXILM6[N#E9<JJ]3N\6
MDPX#0XW$4,,ACT.FF&  -XR,Y.EJX1I<_W)*[H,HEW*(8SJ,BYJXKY._SN-H
M[*;P) HLP/]2/&0L[AWVT8V+CLYP0$2;6$03L4\@8LI3-M4<RO-241(==ZFX
M7 Y"KB F@MB;IE?J1+ORX]C!I1<Z^0M?*[>^P_92"5I#96E?,:\B/XDPQ$!$
M".(/>&- N';@]P=2@)??^AX#'$' <;I[*3!:A!&OJ$=Z6 70L$XROL7__2OS
M8PZ<Y2X3QM 2]P _J(0J"XQK_I82GF\P#B12_7",-*JG%S[-\9L>K(YN6==Z
MJ4C *< 88TC_#C N))*21^B(%7R_QI@"5N:WM,;3P1#54,TC&DM)M7F8X["C
M/TPI"G#!2T;1G:+-6/BD4?1[9@GNBD&*X2:S=;=LZYZC8U?<@"XI>8ZD5M^#
M->&7L,E><M0QCQ;ERT!Q8$XL4C]3-"RAD",\L"?B^)Y$$>E$;*/5*PJ!F9P\
M,Y6K4V(.3&UC* WA$KM9RH_PX+M#0CCG,"<^'6.P^LF&"N9[Q#5JB8FKZR3A
M@W+L9V.U%,<FODI[%RO8& <C(+I$>3TFO(_J@B,J,*) 9[YBL#)?IHN_;/:1
MJS,08$%S-,8#G3L,0MYC*:%+840L$A@#_91,U70N'(T5S%79A+ZONOX'+M5@
MP'$WV[7#AN;6VDFMY5YBZ)W*%F/]*?Y&DD3 <O@$OIB\5+Y^:,99MYD@'+2&
MM**AZCW3Z]\??2>\+]XV#^GM@^^& M_15U G%LKOK,;E&,02P57-9V0I@TSS
MAY%%R3QV<.:Q@XL)+)$HP ##E>K4E9"PBZ[]1 D)7EHL>Q)33M9WJ0(;U^3&
M(A6NZ/7(,$.1XEA)%-CY!',YM];>X%.<W# /4^\B%@S$!#-&V43%]N7?$U]W
M=^'J!_"L0Y*JV(?0BWU&IE#9]@'9FHJS'9,24.^QY1DO(0LILR3[YD.8K$JS
MF'0-73'8&:K%;;T#4]&-VHNJIKS)FP95J?#.E5&N-01O=U7J F L%HQZ.LG*
M93%8/%?H@21G"FM-V.KBEB!,IYU'\=BM5P_/58^EK27P.HRQT0#E 6J1K$_E
M[3T[!E462=B1NU-_E@#JB0Z@?OEPYGX^/S^[)LB RXN;+Q>?WF]A +7QH@*H
MG[&UB#3H)6@'U&#O9"K\8"]H=BW7-\6FSX?ZM Y-B,A;7!2>FS![#MUM#ETE
M5LWSUTY\%/%7N;9^UUUD2IIA)Y*^^,M]'T1=3)#( +PAATFU(USZ?'! [];A
M4<B (E][0*"7(T>?KX/P;"WXCL%>N[\ KGR^RLAUH(Z>Z5)N%5.[P/[Y/8ON
M&(MN,6IH:U\D.5LDV=X726Y$5C]/Z62MJD-_G7?O+K!<<MN+)ULOJWB2T^&G
M7,VP5V;?/JV^DS@*BH<WD>/Q6 VS.31/^7P6"X^'XK(,U4/Y.OT(:@NMU;P:
MSWG1LYKNU(06]\D;L+& '$J+6L42(ZGA?=((IVSV1I13#>5T@86@*@ S1V82
M^SU*H"!: DBF*F8K.1]:<14 C,C2410#CU+"E;9,J4YWE(5]:AOSP7&-0O>@
M5:4]Z_][,XM/1$E0[H<S2>4$: ;*H'^OD8^XG)-J O)7J\(>531 (R2P^4KV
M\YE@6VG73$FIEY4$_2C'$;!U/QO3=>A82?Y.GN3?-?&U^@I&/0B!Z@$^90C\
M\3J+&+&@.[:)$1(Q'-.X?)G]+<?=*(N'B":!4W_#OFJ@]Q6H\]%/:K $"(F#
MGWU-7)0(^,DQ8O:Z,L64LGL#/,@HE"G_#Y5_>RY\+7\3_NH-SNY[6V\?-YO5
M'7&15L^FGZFJYQ7W&A@!1@4"7#]'E=U,&,(SRK67'N*%)4D)EE/YR4A-)A*]
MOS(_\;DE7%4669.(! %1^J:ETP]MQH?/_4!MV?@^"4O'CGV^  0*3/HQ%5^Q
M!AV+O<#P )6H"F=%'\$Z]/WRX!;<RB":&(#T<8Z7KB$_S#I(Y6,EF.[2#R(1
M<L..JIW@8G=$@>/R#5@#M9!C]PZW06.YQS 3- U>E8(R+N2]^J8[^\T<*(IA
MEDRUG]FW.[UO^A[\P[%+9H<$7VMP$E5=O5!02V9W9*+YA.:#:P+;(Z #3'$X
M&I=(!I@,R;C<'UMM[S48J.JZYCV,HUL&"(H=?ZQ_$$DB^4CQ@_8VS0+ _X^C
MN[*/Y%8E?"CLP_&&42JG7MN775PXG'&F.JH,"SC&SC3U?EP;B*.[3$6:PBC%
MVCMABJ0'(AEI1 A<))44J[)1;&D@P>J+ &G4SS#5BUQL]^<@I9CK'', ^"2<
MV.5FB1QD@6Z5P-*U\00OC&%,FU$U2BM?NU<KCPW,VNN4R)9(#*S*8BVD'919
MX+^D12P2;2-,HCMVAT!BY#@,!!PA [\K=>5FC,B]D@4!583JCS$  H.LV:A(
M!I4.&/D>(3BD(_##@\#G+VMYZAY081M<$"YKLQ?_QL-2?0;RP+<RR(E!10E%
MJJ9HF:)G?*#>@,9N4!*$I+A>KC.UW-QAXNE<W.P!CQVC,TA()3XW%>#0 BR8
M \FOB$.-&? "HA"C?X3:V_431D4.^P*6@D7G*2R+K_-0.@,%MU'$B)GZC>IZ
M,@TA6-AZQX1*<C1A)%VL?%O5#Y+D3WFUTN%S$3SX=<J()X=3KK(XR7#B!S!5
M4=!X?.=P%&_(P9'I,)#B5^),N#V@_2:H^#6&(%\O!">*A>D)?*07R;%*ZD/9
MDTF"7_HKBV+E6Q/\.%I1ZN5<O4J5XDN]"'_6ABN!1)OKCQTZ!IGL-,>(<D]!
M:I#]2ALD:&H=UK("-$\^"1W9(6%CGD=V-_>)P-H._#?,:VBLP9_)8,0M*-B<
M.Q"<20061&Q!#;ELG*,QA2(D9  F_!#&D;(>4AGC6"@M>R,.6QP(]2*6J[G1
MY"BK' 0D/"#)S2C[A<;Z.F -H;HJ5%PKD:"%P,H,"+PG\,.O+/)FHF33IA]W
M<\2VS>>H9Q(L%B@37E;JHP6ZP-=MK^&@J[8<P@G-K(6A"KD1#(W!8JN)H]&%
M=)N.3^T<(X:5(M.6^]-RJ@&1J;$AP9KN+*$_WPD"Z2Q^*@?@M!O+"DX$<!,P
M^T\.@BCQ'OHR13"PD,O#)X'H<0A!%XKKJRTU^J'%!_3[Q+,^0^%1_@4^EG58
ML1N*GV'QB0+; H(@1Z _$JH^O!+JXB<)<4ES-W@1DKEC[*>JN4;RA $J7)\Q
MX\T:[#ONAXYNJN&-S#VF&>'FS6-BS;WDBZ2IZ(T6X%ZGG/V69U@/*:G:C<;B
M;W^,8M'T?S+VV6RPF*2$_KRC82\'%+YFBF.[3E+LS6$3KC"[*7:U..#AQA8H
M&C6E]D ,H?<H8*U]Q#Z'PR:Y$%/;:Q0S4AW%!IS9=2XHQF?0R[C7#QF+4=SX
M;?.(06BB]M^$W;-K1"TSS,RI4L8A!<&MB*J(B>8;(RYS<VF!KEL>FM_BDH/V
MON1@MN3@:%]RL(T782/F^@488/V^"JA2!R:ASI-DQ%9(%+QJ:$K,L;S^O!9D
MS(^2Z:_U":MVI4>-!6Q0C(PA_.3%>\Z,Z+:3JD;ZJB5H\QS[_!5P@\*M5VU
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M)_@$LF=#S%O8H0M]-MKI4#;6;GL0,IKB>05B<FW :%#>KZLM2)13[WA!, !
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MFR8+7..%QR9M%9O<GS(V:<T0F[3'A"6-N,.C5Y:WD"L(+G@QA P\F=H;+'$
M4?=+#W!-5.'"2D1]72(*)].9.#P2^RR('G_[Z"^\/F(6M?/ZBB^_&[5$928J
MFVV3?8K$KI"JD@MQ*-J7B=3938-H_SB*!Y'9.70$],=0KI90KIE@VFG2B:-'
M^YJS]+DO F(F@X:05LJ6CD_(CR HZ9$6[?H)=SS)4+=XV\3-$4:6H2!S'5!=
M0\N0 7XG7$H=5Y'&):D8L3G%)'E#V*C$,BY&,G"?\#F@U9 @IC.$:]'J%D,<
M(D%)()Y/M5.6+'@ZA4Y>7WRB.S<2;+JU@R-A@&"EW4OX4$DE!?.E9\K<MG1W
M3;6>V^J&,'T6WE(VFO@Y1#LV]BDPF6)1''+)E9=E9Y3[-V1>SY1^*1"2>DUU
M3CBV&AO8K>) #+VGA&NXK)[G,>31&PX#@S,7-2QRU+M/^ 3H?%$H$E&/.W:3
M>_O,\SCYB;0PY(8XM?JNL[M[5#G87Q-UNFC6NB01?Z"E$#^GS">+W./&85YT
M,]ZE=3G2Z,[BSTQH5\&@5#-IVDIH%Y#NA44P7"!5SUA6<PF;E<VS@G<*MP6N
M1ZX%-^#"PM&49%RMZ^:Q#!5@[%C^_$YW@[DFX]7;._>S.(1%8Y&%O)8V%XI@
M_FD/"SS@E>ZNV.=T[+H:Z#ZN[M[ ZU#YH0+L2*ZU\6@=/.:SWJ$^1PP,B'!/
MIG-V2@0&306"97*SMI+LJGA?\@Y4?7I_(!PW5TY &U"-3Y+F6X]QJJ*"B@5+
M:$)NV  <^>:4&>O.@#XI75LPU<1"Z/ 5M/C-OL!64[$(JG.;(UIC'63E^BEX
M5%WC;K0K>1='"3#D1@1OW4)7T,HTPX2J4.>P@14;VQF*T=L8Z).:1$MF;Y'1
M:30R5VQ2FIF]Z[G=0(S:X3  R'*N0VB=9Y];Z713Y8XCNZ#ATI.U8WCSI>-B
MYK1^/T+4,]P$;3HDF=IFXF$FDC 7@UM]6<Q=2OW,RA#HI>L \QMW S:N,+@0
MI7%'M]\!VGHAV(,@30QP&5IALODHVG9?%">!E3'1X49:3'SH6":FJ@0^16@?
MQ-R.QCYE9,[E@"?(&CQSZ ]3%%UR":P9 @_B?>KJ?0C[K/LEB<EA2,"3@6N;
MJA-J+H$];V-47!?_IXT4N&*^0Q^L 4P^CP$;R#V&Z_-O8^6@Z-RQ*)R2V4/[
M- .,P,_!V)2;.J\B8:]3K1E&N%09A%Y7AHACA$S>FX9T M,BY=3_N8/S(:D]
M9YH4IR3.8U$Y!YZ G$MW [64BLLQ,0LX<A*).DKH$*"N@)_A3*,<C H8^AH-
M4-%?509CGC@$0_7&P*B'-0XLZSKY21:SWH)L$&$I,C1V>8=KNOCTZ.646"*%
MQQ C['D^WBZW_:CZ(816Z'PBRLR$=N)Y=@%-0AD7JD?@4S,K*&10HYHRI*I$
M>NS%"<Z:F-BK!(6H;: 012A$?0.%>!$*RL:K45">+(&"4F4?CJGWZ]HQ4+X4
MIZRJEN FN8D%;2\AIDE)H\Y3OOTE*/[1S0@HD(PE95"O#>%5LU>:="'@O'_@
MJKY,L>"J'ANYW;+[:KOE= F[Y=;]Z1+KZ&:3&%U#-0D@UBYA-$88G"RP?<ER
M:T@_[(KOE5;%'KH_=8%3A\F.,<F#-G7T&.I^I)#4D4SRJF1C5??!0@1B5)ED
MR8P*T<R2""Y+DZ]L.+)$$F531\**%V#EICIF.=335\ASR5"^3+D9H(!"!UN$
M<W$('4*7W<A++&3WAV[*\9!#=ZXJ.Q=?<8.GQ$]DO*=D0%#7X$E')RJM.99C
MTP^_CB,%X)8M=^/$2N[QZ.D012.[D="D'I[K=A_\!"LV$@U<P: 2)!+9L\0K
M\0RDPN@V>)6!]^"&1J86-_$]\;T4=S% +HRR=57UD=,'A#'OY',>ZOFJX;L:
M(M3VP50*-^S!%V(F?B8>/A46A3ZF+I5!8E[$XK_+[N#H_DKP/U&49BJZD3)
M16;A;GB@ Y8?2TTXVT)..KY %W-"B-;AOJ#"C'!I8>CJUU)ENZM!MG5+X6T*
M;;8]L8_1]H)R&P#+6!C]!]Z=CEY88S,73I*2[9+?PG)#. :-OB&E9D8A'T:!
MRW[(C%EIB0. &A(06:@CI3=!L>E&:7MHJUZX8M_!T-7S<CO3A0!0S\,F-6Y@
M;L]W+B[7 ;8S BWZB WD[SD]P%T;.A[$C;'7"=)J:L5AE+3<>Q@>5?(&$&<.
MHQJKZ8="+DGAN$DBUD+6QP'*!$SUX(EZM,1>SXO1[6;[G]' H.6D'+IP'\#
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M8( LP;X#N'.H@S22/1! GD(HSKQVK$E8:@V@D:@>. :Y@C#J\65E<LTXP>3
MY3/L\F=\DVW5:C5HR\.W5_</31@;566K)CCFZ[ TJH?-O2KM)ZMDE%E"C=H!
MS$2M2CT5'M1<@#:)P181<R&&X>8'B7..42E*A(U='"L'AS(ABY,F]8\TX%FM
MXZ+5]D' *$Q&XF.<\UF]AXT(&,#%II4UE6E5,"WLG&EA/$0#=]ZT&EEJJ7IC
M ]DH0C9V-Y"--?6[ ;KP@PX1QDYNO.P93(DRT\% [+N90!]:'/?XYQ'1/'L6
M4UD5\D'5W;@ '9P0[I R0V#^4I#.."+X,##N/?>47/ZXM9!>7HQK;&@NZ^6R
M2>9G3"@U;TCQ:LQC"7(_:QW)I#%UG[6FMHGBSKW)W57=1:K\S,VR=M*TYI;!
MR;:']A;>^4&\3&I@&1X\L9X!S*9IWF0J#09$]R6F@,FLQ,_CGDW$P-HP86MR
M3SQ"/<&:QE8=\6(C;=6'.6Q5:0^7V*CZMC/;J!/>H&!C6LK&?#!7>BHK<V8#
M\4T;8G.AI[=>;ALO?Q<;SUC*-D8H__-\H1'#GUV4K=CK0[#2.%@DM$:<"FN2
MV5A%,^-6G._&3)+WF% !(&)$=2Q0-YSW8^SVDPXC(*03ZXV9<S&@&)!%7;B?
M(H++ OCM,\QX<X0P _JR$F(!+ =].9S" QL#FD-"J']()=M>5P\R!_!B!6C@
MO.:>**IK2>X!_M=VPS]S.#$9!$1P%?&%,L2J!"9&W'7FM$. 4;40!:RQ.\RC
MQ&#F@.N!R-<7NBR\"!R7[\%3. > L<A.-% !Q<R@%#)-O$+QG6) .204FU#8
MY\9>$:56 E)CI:DPG<5Y7:_#;?'.%8$&;Z$Z]WUZ5I<12#OT@\6(MT.4F [3
M:*I.$[*!*?0MY7IX+&G&QIDI)2H8A"^YD;-[H_V41;:-X+?%IX_C?]#N22C[
M@W/;!O&-Q.-1&<.0!-:2I(*+^M,V-WA7[Z8Q1>-SFR69#<?6Z /%8%)DLYGD
M 2J["FAIA4<9^]C25-&&9JNUN6TMFQ6# 9W]" I4)"J()6>@M.*QCV)YU]+#
M93U4P8I: ;%GB4.(E6H8S7]0&EN'4E%N%Y<78MUZ@S&M!HBHP5"=)3&R)$&Q
MV;]VDCA",Y/,[9%9@UM^:%J/";<8<O4.;"]K\E,K]IBW[KM/0&O$+DA6SQCC
MQ,8E5(G,7+5,, !&M]_Q$J'98/BT55(Q73TG7U]=F'!.+G 62=X)]ZRZ&]@5
ML41'VA(=R1\6,@E6!IR+A_N8 0"5%1H51.W 7$;TSMA0VQC5>IWHRSW9,I@V
ML3E]I)>P"M:Y*:?3[ Z-B1'FX3V=*#(^%D(!!.;M/>[TUO6X625P9>,JJKA9
M#E?8PVVG!IHCX_A!W)A&),X,P!5NE$F+<4G1$"J1 &@+3%LP=J<T-%F2O=*L
M]RAM- 9M6'+6WL/VI:7O4<+B4[$S:V3=^3TL65:FQ.@5&K<ZPM1X=-$DP!L:
M1S/^[B<CS]2W>?8M-=FVNTFV%9-M>YMDVQHS?"))ZID']E-@,FFL =7GXAWD
MKX0XM=^G=WP[EFE7FI8@,#36'DN- 2+),VOFX)\ST"#*LPY:11K/I*/8VL*Z
M]!X6I6-Q_38S<O* D8M.L>V-\$BQXP[TQ):ENQ1\@_-\[$NJ$]VZ):1P)\4X
M.I?Y*_NU Q%KZJV#UBMU QQS9Y=;3##/9Y;PU)$^!G=[A)$PM2@1[*G  ! B
M#R'L0*RT;>AS*8Y_GZD#$%TI.VJ.6)PHGG)M"(F;!FYL450?6@T;Z,6,0&A7
MRLP&R/@?XKECY$XP$@1Z=KAR7[L'W2Y4MF+\TG/L(.JX@6-!8E;/L:(\5%RN
M6Q(;Q]:;N$)98G!!7I#<((GT,^6,4E256X'EY1Z6PRHNH,)^XW(!%>X6%;D'
MR&\E?T90YI-*D(OIWZ8Z]IA0SJ/7XB&B]^'85AC%%@Y\:+X/BVO9"QA,P"-D
M4'.A"I,@D45L\$Y&DD4"$N,TD&N.6+JQ>PJF7N$6?UU1RQ31"C8T@QE =YKP
M[J\?JA_P=^&$=N3O<PYTK&GV26S=[O >[E?]11Q5PU@^1J@8:-@3R%<3=QEQ
MP%B_#;OR6WPW%03Z..Q^'O5Q]G:!U\,9.MH_./J4_U[I<W5:QL@NHA.C/U%1
M!IGGH5N+B1_&,#J8^$5)Q 0;>+/XBUS\N4."/C2/QP &AWA4]FKN6WY2P:*-
M:+UOT9)P+2E;L3=D<I5G)'NI*V)BFS;'3A=(CR'T(C_>".&;$D)NR0-9IODE
M!QK "\5F82 Q&<:8SG*)DXK(@:+>1F[>E-S,+2PL<%Y7ZBZS^F7>FQH\0MBT
M55AD[!X9=Q]"\]>-_MK((8H,T9\G%'O D +G?2@9J)V]#F </3+XA9?72X,,
MH)SKZ:4O^CV$OIOT3>P'NA&XC<"AP&F)D@X!"]:S"H''2&3@$P5@.X[<[D8*
M-U)HJCT6!]1^SW 9$*O4+0WHF5V/"3\1=WPBB<!6(D^>9Q'19$1-X9TRF)F\
ME#DI_1#R@<AJ$[BA]E4>X<X0"A>&@-A2& 7<B/Q&Y$%*N\(<!/8'2#_$;C[:
MZR(;KYBU'6;E[7O#^ZB+YSD (<CM!46:!_*4"/U&Y#8B9VI9Q?-85G2>8/*)
M\$A,Y T@SVXW\!RF\\:TAO!;J 8+"#(<^][KWN$] 6##3?\<6SE30^\NQOJ
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M,[_O^SQ"YS ]WMO1VK2S['&&DZUVACL9QOYD;_'Q"Z:FRN),G\SUZ=S,V*;
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MN8-?5$&/I((W@]L,;C.XS> V@]L,;C.XS> V@YLXN'*/R3);V:"/:<;V"G%
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MT6\?,U_^K  ,\TU&>7_29]UK%$8S TU[>?%A5,Y\KS9)+.JY(W)JY-H\PUG
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MS8.WZEOF/<2M&S**4-^KV#=>XKEQAV+77>_!"Z(!&@VKO7?>;/BZ(<,(]7V
M<R18II*X*QO_?!\[1@80Z@<5<9,A5H! H2.%W%9T9=YL9+HA@P+U0U!@ >*B
M!VZ\PI[G>XA.-V14H'YD6LNQG_QIB[NY=][JQD%W7S4.NM3-(D,#C2IDJ2E;
ML!YK\JI^Y4MM&NGZ-X3K?_I E?@],0/<+Q(J51%HZT%5_>HOE/7;,KBTU[/0
M?#;FD<-/]M4 T+K)KS"<EM>!7Z9OVK1X8A*:I1!0Q,&<XC%E[Z:SG7FZ-]4V
MS9N6M5/P']?VNV(@5#1/JJ=LC.THZ"Y]H*4U^];$FOV).N!%!K\2/$BW5$S8
MCMRX"_/8]6.A8J(XL11VX%Y,AA=C!0YQV-@OR6$SB<?I)1N031[+;_[GJX$?
M0F_E*,29+6/5H8Y&KS[>EQ% U6=@Y#A^>/:]^^#9+G?W@&F#:J+^P V?Q)ZU
M9FJ7,T).*6DBOI2D[<3O^BZ@ENPM>!:GO8[I@3+SQ=1'&8HC*TMQ1,88>9HS
M=3AR2FO>"71@E%@G(TF7K +IDN)<\MS.O>PL+EF7D,YV">RW%GSB0.HC2(%\
M)3,C(58K;T%3.K!:'KS@27PFTU@1S*\Q^YU)Y<QR70!V9D<I1/1QHSEP%VOB
MUP$!E6#>T_7CX D&C3W8^^*"&#U2+QF(<29XOQ%R1777*"9CQ<.0CB0-2 I
M]C@)(<:JQ'&*Q2XR;$U<[*51'<.TB;F&(C*0V$=_> _%3%X<XGN)^=(^_HWT
M4T#UR8).(>])DHHW:S_AJ+-?-@YJ_9TO<#@M_:"9K*=615_2.?,%RV)!"/C$
M>:E397TFZO9>;'F[7#58AFH 6![OUH&XV$? RE-NPX/^J1U\2HP(2<6^$GHH
M]RT?&1J\GZ!O8)M+/24-@MSMIM!<A!B,2.OA(9E4;'%HPK!=>T FKE%^VP-:
MJE@;P;A)X=%L#4L-9FRVJP=AX4&1CX6;S=[Z'N)1C#9+LFUO(<O5-BH,>&P,
M)Q;K\;9G^P9C%CZ-E:GFJJ G@LX5#XV[+AS+:ES?*ZV*W?.Z2)20>)TT1KR0
M%;B/B5*E[F @!H_@O#@-//I O&4:L$;EY6JI[^,5IS_IG(4Q](7J@960M\27
MVB@6TQ 3TMA-.[#T6M@LFMF16\F4U1$KK"OZ>95HZNW;^R@Q/V6Y$I>X0I+$
MF1:XM%SB<(,SQT))@%&!:$7MH2L>*!SV1)P>"-L49TN,CW;;42IN<>]A]A^^
M-GGP(-F]V,,2-V47@-#(2QQY0ZN;>KC-XU@H8/&_7BQ&M1$E-8XK)3UL'7IJ
M#<$@&,11Q^NF0DV0)9B KD05["=_)B/G7TK/Q*54"V67+I1CRE1^/"!ZI-.[
MI+] 1'%<P'T@["WC8O5NWD\7$ WAG0.*VA6S)<PI9*YP;._![Z(?(K25D')I
M)[M]@AQCCMU/.L(Q@'M:?CC=.]+IPY/L!DEDC.;!#5)"NTAG2E(SQ.(B?P#Z
M,X53!;U\7[,XB&'[,/6)U8<R'&&DZ>/. >OMT1-&L_AO[A'1 RCO0%K9KFDQ
M3_$F0O.TO<#W'GCK&\I'S#;,GYA38Y^WE?%C> *O'8M8T5[@9I9DRE:?C\74
M$S]M=P2;)G2D-E]AIR?V0_#TZZ27P&L3_]\>O?.'SQ^3C_9U[(O=\@,TP'T$
M)<?_Z?;%.(\CL0$K-Y4+L=#PO&+2@P>Y7S[(?&/NQ4S,,B=#CKC\;5_J#2?G
M$)8M$"U/;/BA+^[8_+=[%[NO/2,E[SLC]RMD+18Y2R-G*$\KNSHSMK!WOW;C
M8>C%ZR\4%U$'#\Y%3LY-E+BQ'SEV,[[SP 9X5Z)QU1E&&+[B"-IS9"23PEXI
M ^-%!R&C]8D7/X !F5AE01*7)%K8EF#X;NCYYQC:;$"!HPTF8#0FH+[!!+SD
MYLGA!.KC< ++SK+/D[*>*_T/VV>> 9H\OM9D@OE71B^=&3FJZ?*1V1Z<R\A"
M+NEXV:T<\)(>5&KKVM;D/+2_MT[L__.7__OJ0WGA\,C(B$BNXXG0NF/,6-+F
M'U@W:X,QUVVD4JL+C9C3DCOJS_)J=3; 85L.G#3MSN+C9KM!?M"S.?+RAK^U
MB7B<<HMSCHMM\T</DDRD8<N'*E8)3/2_?JA_F'[8A7N/ *4:RHO[4I$*BT+^
M56HA_I5<AB6]\KN:QOIF&@O3".=;OD.:."+E'*J#4L]BC7[D0Y!^*<YU;3/7
M,\ZUMC+T+%9+YEJ9'33^1O;ZI<TZ0NA?X)B:,)D4&(%&:7Z80N)'PYGDNX\[
M?2:?=M.*Q?AH3?8^F]O.(D'3U;P\3\K&9Y)NO <O3+W\9BIO:)8?B+RJ-J)7
M6;DJ4_>>6E69H4G\608_C,YKN9O)STNBG>W/?RFSK<;<_6B:N\?PD0I"G\4N
MEHX4HM!=K^.+[R9H91,Y_%\_^#^'OX9I?Z<;#7?X AFO]GMQLM-+@^!77BHA
MD4*.//Q^&OITYS014W=4W7.JNK>='$+A3<<MP*1$W@*6<=;'CUJP48M3O(]<
M&B/$M)-XG1W_Y\Z]WQ4;YE>;_KO3$U.V4_OP>8>=I<W,S31S]<W,S3ESC:7,
MW'/.(:Z'?=[A4V;/9.@4YK-C)"O_]-\<)U4ER[:U/#4.$W#5:\'KCU;E-:'(
M#YW&WNY$95Y\R>TES\VT(KT[4J1GL:5>8>![ZSKP_3D'ODKF:IF).HD=9TXE
MLK>^2D3.23/LGN@9.:4)&:=6&GLUIUX[6$&U,GZV&J\P6T>'>TYM[W#MYFKW
M%>9JOUISCG;K:S=7>Z^Q"P^.G.I^;?ZY6D&S[IL;_^EE^?Z6%J)::<V,AIT0
M"#4A$\6AOK?O[-:?(0[KJ))GGZ8:1#?VJVLW3<_2QK-/TV'5J:^A,#U+#\\C
M3,Y1XQDG^VI;S.5TGW/;R;OKJXVS,S%1+':=P^JAL[^WMW;[YUG*>,99JCM[
M]880WW>FBV><I<.ZT#&[^VLW1\_2Q#/.4:U^X!P>/F..5LX2'@$^^O!Y)"UV
M]DU'?'LFE3UR#%.B:Q8(:AHGF;/=:?EG!:[0E5R@<^27+Y%@*-_\ZX>=0K!
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M.D"B*&$, AP E,SY]6]FU@4%$B!!$B!!BB?.3EL2"51E9>4]GUPB,CM-JUD
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M^G][7TH>1<B@@J][GK#5R-[#GZ.)/90_K[U4H<-@#9X]B4 HRW^],9]<)W[
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M'FYC7?<X,<9N'X(PAM^'TK<G;)T(M/4P="<D5 Y7?F3$B!8K*HD"2( /;!*
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M\+,4).N@@:,T^/-V^,"<*5H07Y@8#",G+X.=\2M((]1DJV"_N6HO]*@7;S_
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M;%)+YHCCFT0"ET+J,WPF;U"6*"A\31%-;C)R45]X6S1V _+A1CA<CYZ+P';
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MI$:T:\ 78HP(5H_[\Y;;7((8$^-L";H=SA6DW'(@V[VXT9"Y<RS\HF&L<90
M$'I,/.[<O)XW(M<;)R]2?H>7R-[Z-NREZW;AL)*#,G@YV"(+1&+@)G#G%,$
M/"\8TBFJWEI1R.!G,9R:D</';HD;(IB".(Q:'H '4,?:!G4[U)<'2@M(_"[1
MH*_]1SB/('195%Y$(NOI>PU)=''^D5J*91Q@B7*A&[_B6/?1D:G6P8',.68L
MW'>A[T /X43K4<IRYV6U(562AXSJ0U'H4]WLN?D>_TI%?@HC7B U/3&L[4/[
M&?7$O2SPXR5560\SYC#)DR) *I$B5!D1N1# M<DG=.1F J%E'LW-I7K7='DP
M-OI'#PD(CQQR(GYP?8-F@E-,14XDB<7W28*%]E,R],,R'3=D-(9A$(26$&WB
M=_PKLK9+:Z46?T\FF<@J7W!C9(FD(=IYA'^-F[&QO"*>O:(:;%@9_A+>*N<;
M\KWFGK+>M(:2^XD#^:*L#P:@D(&=F8!XP6E=FIJFYG3Q;>:YDM)$C:G/SY$3
M=,2%N)NLX=1U5F776>O4=;:DZ^SBU'5V>%UG%]MWG77*[#J["SY(W889UL!'
M!05+ O/XRG?P/YBG PV&OR_);%OKG7LUYGI@ J 7BX.XR)UER<)J9-1MZ;]M
MR@.[/YE/$G1/Q B$PC?2;G82HH0/N8G5E.XF4G,V+/YO&@(P=\8*A)_^ ,]Y
MX'UCY.P/;/\[MW^BAR",SY"$Q@.8A=[,]%QXB$.6@L#MYZ:+!/$7X$K8->3"
MQX&@5#TA0/N_^\&3K[N5:H&$ZX1V3S0=T+@=^+3KZ[,_0C?ZCH7U/)Q+#BAO
M EL=GEBDVZ[<TY5@9#EN2VE.ZEUH.PR8_2L:N-_8D+D$,YPI?[?V60N\;*]2
MKP\N!2X18R9R;13 X^:_]MM#D8'5,4/1)/QZ#+:'!.O\@2=35PPEB)[DF$P,
MB$4T"\5S$Y]88%VA+XMR.I@?4J;)%ZH+$O'DD&%7*+A:$]OE#O2,2@,D=#+F
MJCAX-PYBIB<M.(_:V$WQLF,&WEJ'F8IF_-=C^CHP*(+;R+&-""_(L69P#JJ.
M$J?@WX8A<UP%37,8;%'ZR>TCF7ZGB0:MT1%4BB81>)Y&=5;C8A&Q?XH@@AAI
MBZ0\T>:CJ29%_F4X:1>G+,F.203A0]DQPO&#:?F3=!SBU*D8[";JA#=DZ V-
MJ$C ;C[9H<.GU3_Y\*0'=Y+NK<0*%)]KQHD=QC,P]%(2"!C1I;\FB_&I*3X&
MJ1>E%R!C?\:*!?#9Q%QD$&6(7@%?O'Q/*&<Y6:GE) <@4ETQG^%&N3@^%C'9
M'<_;41HM$$W.B +*YW*A)I"Z 8@]MG%0XB-9L!-[D0Y+=[R"Y :5@^D[FSO,
M]!Y3M%$;SF4"VXL"G2XV;^.*<=PL2105AC0TV&^>+N02J<XS(8L:R6./#5<*
MFV]X&8/1-&+P9TIQW<$#WWG!\/LJ QF?O](V7O+\O=K$E^<F+>TL&)W!XH@?
M:7DU,H'7AI\I[<2%%5PB!^W^K#],649IEZ&7=EG)G+T$%B913]AV;Z,2&#(/
MI9='N08[(KV@E(:6?++O0T;N][EYE5?,&F9R'4>(5@@NN;#+?(:AC1-R0^>,
M]!/]Q=ZE=U^F;5P:B[5+9ME]5<7.6R5&FO\P>_F (Y[!1]-FHF,&$2V1-'<_
M/00TG(:B,=PD"$C[2S[E0U)T3?N$TRWAV0CY -J9LI6DS=-<JZ,6S4$CFTAL
MD?$<C40*<33U1J[GT3OAZSC?.1@ 63A'P ,\=P06GS^<C@<A9?HLM"L<E\"8
M2:?3E)?4BXVY%^-F"-1)N*.XSB?F/5*54OP0\4(=A,R@>G$QXE>YN\($ $:!
MER>VZ!&@G)=V*3HE7[)]N2\Z.\N;940/:+LB6!<AN"0P0$ZB2=PQ1M7]Q!/)
M="0XBBZO)9(^1:)I>)0$[Z7M4X$=@?E+0 D#L:H.A,E*Y85]%,YF\8*<H9 J
M1B"Q@KK70S1>O][1]SV[%+<XU>T]AV>[\IUO#(?\L9+]BE4OV:MST6R<F[1
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M@ D-C=/4]$KL]4&NX*)L#E%%%AS@A\7L*,]3M1D3-N1SW^4SE'CE1A.7L6@
M1?BQ$Y>E/,+RV7?W7/9/60>M1?%!^K!PZ,+"T[6NE O@;"62 ++S0LHOW?"5
M?U.&+UJ[7),OE+2F,@(R'V&D\Q$)\7C>@D_UXK7V6 HALQCPWH.2B=7PTCZ@
M</!H-7 ZK;0Q*>NB FC1Z^B08J.-$AR3\->IHF'D_N"3?P7 DC (^2\(T"Z0
M@,*?0L46Z:B* ])M#"^D,1H:NO!K?SH^<P(:+XT?2*7WOTR1?;^.B.+17?".
M72/;.U]'[]52Q1F\,*.AC?2%QZ._12_F-^/%VW:_8UU<]&6@02[RK;PZ2>\G
M;N6OQ?=R=E%H,TEPAW9"F_C&4:D0:T2MO:NM?1HY+]XVSWN+BQZ[GN>J^8/&
MDYU"*N%JPL;^JJFO4"S5F:,W(89**4?S)<H&X9TR._3/@FDL7539=" &_2'8
M5VSB*SE:!Y;DBVR!,4P-&L3OR4%7<YE(A0R2Z$U592>=!:XK)<K)(E]B>>V,
MA!&PJ#A&?)J!5:^PV3/$DI8:EY;8:K0Z2!WX;U<V@<AF6E["]^"R1R:+#Z53
M\O'=]=V'*S-&J#,2= O>27+-;F^NSLW;*1R*MDY[&@<X_V9(-;M _Q%SQ2AL
M'>$%[Q6);JH,KHVXW+(%MU!63OPJNN$G*IN:/HN6$[?LJJ UWK??(&KKW)1K
M-22[)QVY7K+>@PRE5L8;ZQ0,;<9[^VJ$3 Y?L .O0)P#1]2J2*E^U/38/9\I
M:&OS9Q_U8!#W?C%T.?6X\0=OB&*3/5),E4K*N=0-@P&W 1\XP!:B.]HS W4.
M"+%IC$UZA"C%HF :HGH!&S1PJ,QU<8QA;G!* DQIOQ+H"<KW#QG> &]&2B*2
MD(U1 KFEWQ"M@9EC:0G=IX>B$[)E]3(GJ7)2+<GP7]'"7!N178,;N$XMUV8W
MO$8-K0ECZ/R&%Y%?'(J5\A\U#PX-K&;OC=[AP/U\QXV&#VAM. A1X@^9A\9"
MR&.[O-M5V$6+0SB-.!L2-5WJD?1RIB:0JGF=*3L.>9NCR4E[*YJ+L1TLOFF%
M[+^'JL.46M""E ;B+ A?7!F8::[C6(&/+L[$KO$!EI:TOZ8IXG?VCTH2]%E/
MWZ\=V09Y8?^HE9E8/KSWTD,MFF1?P1E[J=I,#9^B;SM8]4<T>LV;B, =??'V
M/57<8<P&]V#$]@\U2JE&]9PE1HN7'E;17/$*MMG]B:>/D6JR9;.1[Z1,#$)6
MUS)A%,7@.E_AG_!PD$ VE]&:(.1J71BX\ IA=$_CAR"DAW,+ U^.2.\"\!5^
M\NRGR)#5IT,^G4U_,64J'H)(. CX(_-M6@J\58% /")LO/Q#YNR4I'<*'AN*
MEE/-1.<H0 *B2B+21[07'A5"ZM57EU7%]D53PRON3BW8GH#[$7X#X>YB-DX9
MGBK'X"9E$?.6J0Q4 X=@=<3J;CPU]P?X_W=M. &%$7D$SV"\DQY]QT#.)8KM
M[P@]X\OK)*IZ(IXR%B#)Y.RZ\5187?!IX4,BGM:0.]7TU?NII_D#*<R_F(43
M1%3AD7P<RAMA2@;!GR/-AA.W!9X<!N#+JH;D$V1Q-277G5/)]9*2Z]ZIY/KP
M((M[V]=:=U^L7-\V6JIHA<D*?5EKF_X#$\!7S]R:+UKGL8)A]H OI!V@B)]3
MO-G@&#UH+R3A.#Y-@F<&QV ,8XNGWM$EHGS*RL BA,C4X('F'00>T7/#Q:DU
ME >6$4$C,;T5QG+V0,-GQWB],AAO'P4@*<;3F&(^841P?HC&)QRG3,ZCX1QL
M$K]^=N??+^/\>W#^O')JR#QO8CM8.4JE*O@SSA^7/V](Q*5VVQOP0ISX 9_7
M^ E7DCN['9Z2>0XOWAKZU'3^M,9YZ\+U7RP,ZD[].?TX/K=[<9AZ!)S(M_OB
M[5F!^=]J61O/9<=2.X,7JF=<$X%$K'7""M U>7%DQ88:$8:72!L[ESR("JCT
M>CD*B[B\7#\9=6S,S>NTI/R-8=DR@Z,]!O[.^_03G%$J89%\*9,RB#DJ;W8Z
M3T.Y*9W6!@U1SY^@KE_R%-<M\MSNKN=E&=>S?SC7<_.;2#>KRBMU[:M !_+K
M,G6"S O7@Z8R4H1$FYA ]5S30>0ZKDVSU!(4VD@4(@C(6OKHOP)WKJW02FH@
M8ASK="^O3XA#(R-;55QG+LT050;(&&'@>2(OFE/\D+,]$@EXP?DK52P3'=B(
M,7H$+\([3TF[XA?PR+1LLU'&/;[<MYF5H'0:&1:6P%]98F2I[#U^YTDT'DY]
M'FZ'Y_,":V[7<PQ%]2<!<&YFK&?>XE/%X#$5O)(^RF+OM-J0M9SVH^UZO!+M
M'H&=]?FP*W=HJ!J#@KM<V*&L IK&+H$T/U_+M-DL):?9>![*KRY&I[E@='*C
M4>8ZY.U,KI*1=96*&JA;&:7Z$'EC/T;I(=JDS7**#9JGB[FKBYDV75=I,2.Q
M7LUUK-=BQNNB;%A <PMX.9=12(LO-U)7&J@R\;_4%# 638'L=\XI[WI8O_1+
MEZ;7(UM2U&+_VKV4^I7FO@IE%VM0C2S&IHS]H\N>>!4(LVDP5*H,A/=TXVCV
M)9:K'PC([CGNCZ9P58<N?9KSL)%KSB+H.4X0YDVY80J^/T-A\\(:Q<GF'[Y>
MG)![B<_PIRCB\ZGS]EO(8,?2_@&C8HGTIL7%35]:<=_Y#O4M&?-;4K5"U07[
M^?^>+\0':V1<EU)'T]Q'(4VF1^H[QJK*L:36*ZG<TJK(L$IE)O6$Z(!@VLP@
M?I?%Y!PQ+D>S.".)'V(9<ACX_!NIP'V ^:W-*L8.)#E5 EOM(VF=8JNEE5G!
M-,;^@3G3?JXZ*_M#<_$+_N@Y:4A3W$.^ @X]@\VG&IB^[M@(/P2^\_7]-;YE
ML6RLOFQ3+MZZ9I5>^<YO:'I>:99GR<#K1=^VW\+X#K;K)BNE\-2B45ZGLOEJ
MP)#7YHVU,-DWX+R]@&^(^F+9Y/40> Z.*Y2I ([VDXS+PSYVV"EB:$=3,.3X
M#VG\+-Y6J3Q"WJNHWB"Q/2(UR8\:XNEIZNDXA ;,-H/:VE4S5X"&'/54>J)\
M51M%\=I\Z;Y*[\46$#3!$Z/&1BX'42(.[6G$-\Y_YR;HP!H\'O4(B5HO.=I'
M[OZE._<V%^$!L(Q$V:Z/</IDC<K"6,0%2XCVAIX/S\E8MEHR#RYICR/3PI!/
M$D\^-]\+6G*#1)C;9*V@LVN.[*$(+@_=<#@=HWF!OBEX@.[0CN<[6SF:@L!B
MHU.?"?( U13QP;\11UA?=;)S(;$6HO\&(F@?1M 9LD\R>9/]<*.8\/JTRNZG
M15$BKQ^!> QQ#*4PC).KR U:CSTBG%EZLG$B"S#>!*83R299/S:V_X5-&S-Y
M+1\#,HGYA#H<,J#@0?#7L#@RB1QF9FUE8:(FM8)&Y!2KU>5<(4N R<!K7AM2
M G%#[9%)H,S4=%#5!)M:\T+5_" 0T&T8&N2(AR[\,8R$K$KFL/+.VX#H(QYJ
M\(>^X6)*\R= LJ!#C5'S].OEY#2=$OA2'*:FO\D2$HO_DN@HAM?JUH.4;8^O
MC >@<(#FW,2.X41X$X!X-_[&)Z2Z<_-*S;-&F"="KU,BYY-JX[U5K0N6$%<\
M$N+,,RDI%=(WQ$15M +(,O)#ZP18N>XU&P$N3HT 2QH!^L?<"* >O(=B_?[V
MQ?J]5<7Z%:GQM>:K;&""[!<H O&?^(!P#)78B\ZEBJ)Q\6WGJ1%NE<(?:90X
M?TQ*OB\Q'RA&ESS*2$&=4+PY-CV&<"\T*S36AIK_EGH1+E#:TPDH:V13"!IT
MOSM!Z %[P9U)3NUD'<^WKU1VK?;1U[(.1H,FJF[A!> N#X%UKY-<ZK6O;WLS
MJ(;-7\+OL<Z[%$5?C [-F;06_JSRH*[692'0E2(MT*W %T5<_;W>FIIMZ>%]
ME9$):?FG;>NT,6O3 G^;PLUN-RQ$OVM3J,".1! A>CT?U\J[HT;IUW0-LW%U
MOJ<$AFIEZ-'-F7,_"K5;J5RYJ*XJ11C$0YP4-8G P)/_FJM% ?ML23D*M_M>
M""LNJ1A9;6Y3Q<@3PVN#C_&<K.8%M&GGBU$ROB@(DUBA^**$G;'<ONSU\;OT
MXNT-U\1H/B@KH-XK?B\@'D!.8?=_. D2#-%?!N'/;Z5U@5-RX2TDZ6216KE;
M Y;#BI3_?M%Z4?HV?S(_<CP"OB<52B8)S7\GQ33]9)"PGM]?YF8RUI#:']76
M%+DW6:(XO!^\;#4Z5JO=MUH7%Z\6[Y:XGNW&3UE7YO<@ %EDWF(=!IS=9W=,
M^*<OW5<YI6'-GY;RG?A4J_]3-IV7F2%](1W='W\V_\0HR:+-(+CQZ^A:Y\6O
MX3>&H3#8 :@$%<_'VC&I$^9KOQ;5ZAYWVUIKMR_>_N'3(?T/L)H3C$O=2C.3
M2W1N7?C*Y=Q7R+91>\\&:L;-)TC-K15 S8),[1PRW80!E1J@'OU'P'7H$PO_
MSCQ'LP1F"LGYK*5!.4_ CGCQ%I37 I9S+AVS*/33]E?YG]RJFC^8Q7=]1@+_
M-AU/S*L$.AS,4\4A<N7+SGMM=NWMX3;N9P-PP6ZOMEW2LHNS]FWIK7-;]G0]
M*KD3J]7;XFLUR._SJW/*+%3"3WTEF#K[TE85[>=B37TD9\[:M;HT_0U43'>_
M*F:_>N7J5_.=&XS1()QBK/#SY_?FRP\?J[D]EX=^70IOH'[JY/*D3HJKD]_=
M81@$YB>")[_V[[$!DD*+M^>?SWF2N0K^NFPHH=2K0KUD5=)5?VNT7?775#*W
M$]OUZW2-+AL;*)C+ZA3,10F7*K?#)SOD?.01YW:)$>?6GB+.O4HCSMW#Z8-<
M%SPGR\O/"(ME-SO"28^"(/:QE#D):8G?O#!_C+W7P"% &>:?_7&;&X;C$T(&
M< +#!S/ =BDJ<U3VMF7D?/'V_.,Y75GYSF(P,CMLXBWA2G5*O)[M/5W/?J77
M\XBQK;*OYQ;WL[7L?B:V")9-/X!NNG\0#?1)! [^_]4D=#VSU>&YW+I=P=)N
M2R?CME3(Q@>$ 542&V_!Q^UE?/R!C_7^P(8T?!2YM)6N*J9IA-0:0(6TF-@C
MO'<CLSY*CFU>:BCWUHK$:(U,\ZQQHU8$[[AA(=J+]CU;TRC^"3.4$_U1LCC#
M9T\X.3UD=,V'@B*X(,?4W,"T%QB ZG5LAZM>V['+O_1[;^0M;;:+JIJYID%G
M=-TK&?.RXD7[;6R[.$_*APPW6:!YR+ULI9U]48"6XKRT^\-.JL.6]'C/#P9,
M&DF$..(UH!Q&(.)%G[)E2R]$U28+\':4A*4.L:*SM(,O"M)1G#%KRD@"7LJ;
MI6 #1K8;FC@.@YV;VA!L/A,\@1%0/=?I(>+!HG4;\KGFJ7&+1@ZX]<M 0$S9
MOI@XX[ (]FS'\XM3UG2ZV?P5KX-TQ/1'; XGY!]MIK'V$-E=-9HG5Y":Q"K0
M)[7)&X2:E0'/E46RHI0R4O,H,Q>R+C46VNS'8)+@^A%K*/,;S_KF%\4'*2Y)
M]MNH0$-H\+(;#RX+[7#X0(I =#+/3#[T!NG)0>HC4PZ!$@)!XT?=WD @('=1
M6GQFC\R+S"8^@-<CRZ':$AU$H#.CJX ?XA75&A>[_F0JNIZ# 8YS5=.1J;S:
M-J/$\309;QT.?-$F,<2:/D=[G)6NAWZ^?%UTJ$;Q>W*T?O4&T.?%()CI<IC-
MU^;_FP8HOD&/8(/ZRZEO._@AYKRB3G0^Q!EV_9WQB0X&YN1$?W&63GBS-M#W
M\3)ZT8DBQ2_.B=$W8_36:^J9%7 ^;/C@N_^>,E(P*2&>B'F#"W]+POLHL^FE
M>\[.29;S._/_L_>N36XJR;KP=_T*3N]9.^PWZ+9 =]O;$7+;7MMSUK+]NGOM
MB?W)@:12BS$"#:!N]_SZDUD7!!(@K@(D)F*66Q*7JJRLK+P\F?F2JI3F_N\+
MH.NC4//XE3)>ZIUR[&#Q*E7]*[ 1L:"SHZ]U0[/]MO4;5KRT@3NLT(UPQO&Z
MDC="+^%&X*H/VE>TMC=6[?58U:<,L9,!:Z-I>'CX?F%/>'G3%&XMWCLXI>=C
MN8[!@W=4[1-4_%Y!IB'4R!]8AA(0O<RI?8!Q'%-)#[E;7F5J+@(,G0.7P+GV
MBDNP**E=<W&L<OKU_;RDMJQP)O$&L1U_&(V;J\PK98.0>K+LG[Q>[K^VH/+P
M].2M:U#+&DR&SY^^WTF3@&%_P#/>2<(K!9VW.1R]ZJD]/'&\V*I$?FCD9#B:
MQ&(CO??>'WI<L0H%K="$D6':R<#K5["V%J!&/:$SN&/1KLEH(,/UM!B28: /
MR!_6F&O.2EK23639[#XI<)\V7^GD<0^/P9_$@[H1S^.-3CJ.9@3=V7R;93,6
M3MGC( %?IW86Q>VV=HLD;9'G;:#DK1'N]P)Z6 _.D1Z0S;&1"-T@.^;U(C?8
M::"ST9Z]0A>[1&Q_,X-0.Z+M-9Y4E4M78FS8EAB+*3$V.><28^?::WR2OWS9
M.'>O\02'5&J?<=S1>?IU??^,439M:[@R:W*!ZOVAT8B"'U/=Z-YQ(T/^%QD5
MCE[0I(VB$[%9!;%@6UO0R"C1J8N0=3$4W<(76\*<Y7-XD+7&$G3H!'^@"6L.
MUEI%ESBQ'ZE_?$-LA%_NREK!,02SMK&>[!:[#?G*M]""V,^4YQZ(26R*,:&O
MHT_$EA&T9AU7]GM=::$].UZ7%%HX#V4U9>A@W>WYUK81H"2%SBW84D"@6WAC
M":]KC5<!EW)-1_1)VYKP_8)",31#AH\&FA\NS@174*/U@'<.6[[%S <*^+3,
M8)O2Y_WA["-K/)P6K?M%S0KW8$H>3G9GP-#A,UN%EPJ.-U8X)?EVIR]:!R4!
MJH5KS"'[-P6O.JZOC3V+L5/#252V85"!2Y4(25N')Q(NE7@8?\>N7@QXQ9IO
MZF8'602>P'?7_+E6+D88LUACO6!(:?3B).U!G8AEZB#Y%\2TUCJ%CG6H@T6L
MM12 W 6K(_)2WM(29".3B[O;=,<K02X.!91Q>YS$"HI;)IK<N\X!(>_HA+V#
M2VYBTG:R>YVUX$32K86T$U8NRMZ-3;#[%W[G;+!;,S81DC[^XL7^ PVK]SIR
M,=6GLP^AXZ>2[QSBYY8?'$5;=KVBS95,IYDE40N)FB3M^9QH"U8B'S^0O7:K
M^Z#55C@F[E*<C&.J 4DR[6M!/ F Q5?WW=*T*Z?7$\VO:?%*K +&BU=[C0]\
M6A@(!-TF,G-%8W%8E[6RHA6?0Z#'%*CM]3-@ZBLHP13AJ#L_'1X*P@[;U'=G
M/8%^[:STC5<36G3]T\Q T>?/_MR A4587V Q%AR?39B.ZW]YA[:(B'\QE_"4
MQ;A7GA6*]CH)\^Y?=&BR;Q@[TDLZ;9[*54PVDIVI06_LL ;IN]ZK"U\KNB5O
M3B=L&];U<*/IB[V9LT<[4E82:QW_C/86SS^W $6\B48M.8S L?STT.#P06\Q
MF5,CG3>NP,ZN\$Q^L)?9S;'FQTR1@?XJ(OU_@<&XDSTBU'\H?_Q>FJ"1)O/N
M3E[S\!EQGX@05 >=6GVR@1N&L 76XH>@02RXBV\$H4/N-?MKM*>H,.:IJA<O
MK_./4N/($1;L1:";+(E6IU@ A-^+%EG.KK<TI02Q6>:8SOI?H[*]=7Q/1];3
MYUO#?=ZY&GBS&MHR%&8Q1UW::\'->]#R=FF^41_(48?VZ(('L':^(*O_R9L&
MH:L%I#[RNZ\= L5-(_R?_N Y32B-Q*'<$:]'AIV3!3I#8 ]I/WD'.$OTM)<,
M\H #6:#?ZR#QYT::FL_>5!J^)8I'X/VQPZ67"\,+?U'56#S5C\4+I-O!#F&=
M2:7+2]P]PA2IS_*C3%8'Y)[F=!9D1H4 6_A+,1N/K$YJ"-]1[JFB8^#,C=C2
MG3U7D>8_,OT2P>.+J-.+6RA>F[A@$R%,H?-Z>-(T.]T5J=S+ Q'T'#[:^IY,
M)V#$U%# HXQ=B=CY>,""K:#)AF,[RB^G7]^I>;AI.]18<UQ>M>'9DPM,?R>/
MK(8GNA!L+.BYI?[I78=CSQ ,=B&5)6WI$I$N3VU'1!,LJ6?&)[AN>,.+0 $2
MFN!/O10:MTQX18H]%_N29FY17[DP,F7))-0\X!U36:T FCE_T>(I-2SEZ':H
MQE"UR69KSU<:0PB00]X)%"T)VE/L;./E&[Q\/UULBAOIBR4]H,]2Q&J2F&/
MZ+:.,:..5Q!"C%"6$-DKBWH5V$;;1*2JR,5@P:A#-=X_A1N)U\IBGCZL,"4]
M$\W&(!:,*=BSB]K*XNT=CSZ!A[N6]9-UR+GH_9 :BG-T?U5R7'\*4P;;$SL;
MMN(HRU19>,>WO@=&@<O;",)92#;,7$Q2S07^#?$#QZ)U^,7,L>N'[K1([G*0
MW*,6R1V-Y%:[+9*[>4CN':@C#QJ\,"CW$:F?&KEU]%2J1%'X!ZV7ZM963:A
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MQ4)JJ /_7:_$;9102&:/1)$DLXGV\WI&,+G\-1S!2'W_>(<AXT7"^8GD8X4
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MRREMJG&^*]9!9^PKT=$:Y)=GD.]9ARV,IJW.<4(3E[MG'9]DO0!;J;30U9Y
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MK.GG?@:[PU$ =]'OOK$AL/;@,9;*<"A/)O#_L1K6(_ST%'^K>\NMEU,9^N@
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MW)69.=5]WLPED"?A OE/KE%=O>N.7BFC5TPI"<KCZ]@GXYK'/UE17ZGA3V[
MKBY1TGNDBLT!ZX%&DC@8<JZR-;%?,;KT:7X*51Z:2*E&?M'F^G_^A]KOO3%3
M*)/I%[PH&356DRJ-?]U]."9*\DVCT-*=XYQ!CJ;I@W6%-9>WP+TT:D]V->?(
M*/JG&4580O*QTRF%MRI$SPI=S?K)*9_&TWTU3*3PU(F)<TFI)+H,R(5A@D;
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M$T$W+[/W4G4"AB%CF@\]'1,[2$)>>6B?7;T3FGM"/_+!4T^)%SPR);8 TYT
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MM"2=U?"*T'@"OBUI-G5EZ&B.0&7': "'+CT8^0)HH'::!KW!,="@WVT:5#,
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M;=UQ]Q>=Y8F1A<5G^>)JK8B5 _/1MB&\\C5_1)_PMXU/F!N,;]%>O/7-Q;1
M:LRGO//\"_$CC]-Z/XX6.REI(RZ'BC4D#=W4QG^9CPW.7[\96WYIXW*KZ6C$
M2LE12TWLC/*A5;H/C&WG CW=.]C&-JYW.O3ZCL5MOZOOAL^^V8-&@)"  ?FE
M8L"QYQP%"_B.'=#?G@G_T$$M.RM!VJ! @N^!S'YX3$"1=!PHPG+"J^4#J#)!
MEGC3ZEZ(&"'!4>_[Z=.1D]FGDMS.J4%A3OIF\HMSBGX%&";K,R_M/:7\</_S
M[MV'#]?7B1$;M?=3\W;"=K8'Q4[%O+MQE^8>9BOH/L[RK22/<74GL[98%1#F
M\YHNMV$2SKM(#DX1#V95Y'TQ-"H5ZBI#HV2/Z8'2:+]S4@H(4Y2(YR\4+W+S
M>"FEQ)[W-[AL2FV]N[X1_.)HX<HT;5X15=X2J@Z^GY^,7TI9YWL" AU47N@0
M-'Y\&RC?D*VWO#U *9]0 9WVQ$PU5>R1S>:*X[$,;O<?7*6.@]O^MM27N:U^
MW=NJYV;0PD7SH^LN&;]VP])X_G0SD+0-WS=S,D.)MYY6JO7>VQ&38<W8_L"T
MB;[ ?.[N,G1#>KY E@W7ZQR=00C'?><C<T_663^A0TT7E87V,G7@X&5N:WA2
M[07$W\)A<V,Y/XF_"L3?K8_+O=GCFM03->50).#H18H*I?<RMU6+;^VEF7]!
M270P-2XLF.9CD %_;PU[PM";],ZQ%\*=C>W/L43XG>TL#D1&[N>16OR,[6_K
M8+TP-48TM%))X(GC _C4Q7!>P!Y=MZ?):A<YJ':'U\LP'_>+SS\L9$._B<6_
MX'M+[BYZ 6*S=K]A.]MZF3=<Y6!ON#5J@X'4IC:0"VN#([ Y?Q>N=6<.  GW
M;/)H >@/Q@N1F[4[9=K9ULN\%ZL'>R^N4V[6,X2KVW*S,^;F;^/+0%QR:3EX
M U=QW7T4@MYNV%:-%_>L_WHUF<!&O%.0\GA7>ED6P]MKTCK8]5C=75Q==)?C
M<VBAVMV8[6SK97K>U)/GC; 91F5L!E1P.)SS"4P"R]O3;$$Y;M.@XF;S?DWJ
M<NP:4T-W5K?,08FH/VRZNYS+$0HLE@[#+CJ[Z/])V+R%2_"HA-Z5VY\^O7L1
M8OME9@RJ!^OYJU&^#4NUY,DLW_H="R#4B=%2]2?=UA@=,:GA*AFTZW*%6]W@
MG;O?LD?=G,4<<Z>KX]&N]#(LH\CED78M"^?57QLKK)EIIF1FO]H_V,A8G4HJ
MERLTJ 521[NU0*$<1C&\Q_>I]<6A=!SJ/U>J1H#9?J\H9ON]D:C)U$S6EX?9
M01',2H5Y5E7%GCPZ3@-K/R&&>:[D(2&T74+4?T4_K_QR?G#*L3%&R'HBY<(G
M4AF*DIRM!\*AR[I<;L<0LT2M;C;,2GU-'&A'H9]'1:J@^VI1S*I]192'\E%@
M-E=:4HC9?F'+1Q.'FG*L'O/Q)?SIR<"9:+>._61@Z[7QRH^@!]X/XU3?>\0K
MO7PS="07,$,UXCZ &3S3;!8H4>[UDV#C\WCZXK;GQR^?/]SS7^!GZX'!D70,
M7?C,/'ULFT *_%O7C-*#MTI'N4(:H1X:$->30,*& O;MBHO7M73=8ZD.LW6!
M.G2-GRO4$6)Z6"FF^\=A6^4:+1-BFO#7%<>TI*IBOT/EKG5BNXAW5"-\>"6P
MK?5$N*L<JWF[GSQ;+E8E(WD(_U,.Q3\:7NR*]+VJ__V'JZ]KW>]ZAK?T; !;
MN *<CPW;8Q,>P_G?_Y&5P1L=$./JCF%WSAHX?'.@B$->(YQ499344)0'^5W)
MAXCM(DYZC7!<%<=V?R#V5&KFW,M#=A'_JT;XLDKH*7DD:B-J+-K+PW81GZQ&
M^+=*"!*QKQYGRL]-DJ(%=0I[\%:@9">=RWYX.G#EJ?:*>,NU2N_2W6HS5B>N
MB_C/M4IOT\.^J"K=$>;[\WH.MC1\_[9.S<\R;?,:H0*5H%M3P5XPA\\# _T0
MR?[<U!G>WH"FN%YB$POAVK:GKO#VXE]=TQ:'KRR*.*FT2IU4(,"&P^/0%D5\
M5(-*?50C51SVC^&BI?:*^! &1*BI.+*5OCCJ'T.>G]HKXD(85.JPD0;BL)<_
MT>@E7+0^VS;@3KB;&'Q2*[]E\9:8C[8Y94XEO4PJ'<IPZ Y*M5?$BS.HU(NC
MC12Q)W='E.^WD%]FRY;^P;9LV;^M;K<R[<Q]YO[O'VZ$C\+=N[L7T9VT?[ ]
M$FJ4]%*!TM"REHS8M=+;_6QSL#TH]F^KN9:DO_*V5)<AN8,9X)?-CR(/@0L'
MDB?/JL\\@CR84Y]C9'EMP\<C$\9#/)U[]H+C:OU!.'67?Y8\LSU9;\$;03-%
MN#!8%L>:^V3?_=.%TC>LH+ID^QL$_7R)-;-MS[(]%AJ74N];^-$KX<?<?&WJ
MB"=@YS_N7FU*KQ=8>AT-R7SZ] Y+L<=4*?8%Y\CPM9<;IMWBV"B35,<W2DZ^
MD8^:;\HPCK2/<>XC'3.YF<*F@F%YM@!25']P&)^Y"1CR'K-DSHI7Z['1@)#)
MHV# L_;2G)XY;,*,)R8 2S+=@;^X8:J\80GLQ^01@&*H>\.QRVWRIIJ3-Y7C
MYLTRS"E7QIP9<[N,=5H7X 7>""QZQEE4."@6[>=D4?6H6?2I!(<J%7%H-"E"
MY&R$FGB!MP<7^0!G!@4,UR9C:3D9JW_,C%6&K]2*^&HGA-I=WAKDY"WMJ'FK
MC%KM[V.N8**SP4>5.<SD87K@+7]DV1@I$:HX03<=ID]7PA-SX5O5,$\N'A@<
M-P^480*M(@GC1D)-@5VO3R;.$G +7S;P81Q?B^D>*&D<!@+)2F>5IIT?OXW7
M_@^LP%T0S$I\,C6>D(=_Q7^W?VD<?@1Y"X*_G)\+UP8SIZ^%6_V!O8%E_K/$
M$"% @\-'_J6;2_Q9.#\/GN1>JO5>P@V,;0=HNV;UMR: ($@7?8#2A9O==/MT
M2#)Q/#3N:8VAQ$)7JID),[O^\DQ'\M7E]7D4#2$"W@CWJP5L_<K1Q\;DC?!%
MGS,?25]LQ(8RBC[U:_@81Q3GC VY$U &8O'[^9B!KH47+SCVH_!J!+R(N"B2
M(MP0=<TE+!Z%%S>R(6IK#+ESH+; H<3^M_>&.S%M%RR6F]E77_7<ZHZW^O!C
M >))]VQGM>7R:6%/?KU^ )S H3L+&N*[X4[/FO?=[F#;UZP;?_).BU[F3O0%
M:@P0U=NAB[7>Y7N-TB'<:'U:-Q VL#E37[AP>,*?MA3RJTS1P]T08;HHXW[\
M9X;A GR-&7[$7_!:P '+*#&BQ,%XXZO+CY;PQ]U[X>>_[JADXI5AJ')]]A$$
M,@2(^\<X B^7+[,+*N08D/.WL?/KI6 O/=?3+83+_T!W05_[/_YC:3%!Z8G\
MMS-![LE*?)?DE@A(MG;YTK$D5X.E,N%RYV'\L]Q316S%)/?[O^P>BN!<#;2?
M=ODZD0@I8=-<_<8:[2^6(P38WT3Q8DW)2+M<^BD7R^X^O"M4Z*,2/#**/1+$
M.'].(4V!P91^Z6VB,HB$LEV !-"ZDZTD*Z)&=N;+ATD*1SOR]K#(D2MULB)R
M*,.^V.]1J:F5D:.,R/J3SJO,+)O"A,C=1,@,PG@O=V1E"2KU8"\;R+FJMO*R
M02SC7AQH2<F#F;155BPTB]_(]6N_6->X6.>7D"KV6Z]RSLSTU/17X9,QAZ,T
M;94P*0)0+C#.H+P^&@P2,JP*,L2.$NHH[P^ZP_MEI7PDIMMI_LY58E41?P]D
M41VIQ\?>P^ZP=X6B/1[#ZS2[MW&]& Q%1:G0G#D4=A_5P^X)":F)X8]Z/,S^
MD<B0K+H;A/E-Y^[DV;>>@@D(O^J7&Z?S'H_H5MAZRQ=];5C BX9N?C7<[Y]U
M2W_@ 3#*+2W1GM7-O*!\[]UU<J-[J&;<?L$XH3RZ$-;P 6^ZW\_F:PA;\G)O
M92@WO3C&1+E]O:Y21SGS9'@&<\\P-NXNQ_]F$X\'RQEH"D#;; N![FN$X#OS
M^&_"SX8U,9=X3GE"QCJ)C(=*\1LB_YR'4)GK;3[G)?0+8&'_UU]$8>*PJ>&=
MK?]H&O]9&E/,)\*/+HZ57#/;-.UG1##H(,"B>_:H/S%AS!C76ZXQY9'M\4K8
M'#[,YYLR^/+<L$+2Z(N%8P/"@0 6<]TP4?K!QB_ BR;,L3 UPN!_6CALH3M^
M6"OXICZ9^-%T?. =K(P>:%1U9YLC=N?!!PB!VPEZU13@*95)X<> _O;*CP$5
M2:O8DU4A\ZR*W\:7^B]^$"U+9L7X\AT_>OR<;1Z+IC*T3<BF%X\@1( #@>S/
MM0<<A8TX! WHHJ#T0J$J&/Y)X1/$F;- $Q"_H$<>,BP7="H_I#/=,/D+Y@S$
MJ>&Y7'NCY;>$+]IC )8?0#>JQ#;/@R!@YKK[B ^ ]ZA[ LKQ!:@_L 1TTUQ%
M93H_Y[A&>+ GD8WRYQRP:AT#GIK@F'24PW[6,+*!ZPMSD\LA@:^N@]K ?.*E
MR>>%_4L'+.IW]DJXFH#T=@U<YR(JF<;,-$"QN#ZH'%L1$"+P@9#AN3GP\D4(
M?0B2/N<SVB.@G1GXVQQVW0G!TWCHO*A5>._H*!<_6B#;65!C4]HD3'EI7*_Y
M4MIEP-%PTP*2@^KB1R-4/ \\ZPJX8LK\SCL\?R'"EZ]W[?SV>2 U.R0[[H\I
M58'445=@J'J'$VX_ZER#UE,(=ADQ*YO=V\)TB;8UGL@0Z*P()-^X3;P]OU;Y
MY@[F6ORQ0 6N"'.@Q.-.%+-4N#N=<?<&Q/\:!R;S^Q*BY?N=BTJN?HMQ+8LJ
M@UU9T\#3N%: ^T9!]<0!.:JQ?)Q\;R[!"R%F5D>FUDMT9)9%+>73C%4@G.[9
M+=VSQZGW;)^>\-5/6_ZLTST;%]_&27#5]EV Z_NA?[-]-DQ38%9PM1:FQFQF
M3.#6N4)?%UZ@0S]7Y-XLZ/ ET^!9SOPNB7?LR/W=T,?P9_1];B[.< WQ3.Y/
M.YO"5168A?O'\.9I.W#[\.\>FY?H+CQQ(1".5?2WZ9-'?L''^R^^9^/3-/C-
M'TQ^N J(F($YTQW\9V&[K@&L(/H@8>TN[EPWG_65*W#7G[O$O1MXF]Z\+^I&
MB&[L^9%9:-2( G8N=5#S/X9E"WB7<CVX8&,]%$B4*;^N VD16?82W8B3I<,1
ML+3TR80M.)>>H>,#7@WX0$KAGZ?Z'&]I46=(@ @![^6+I:?[GH#? :/6SI>B
M5 $$<##\K-1U0BHWH@$IM@??0:A@^V<Q,KC"7U,B>[F:GL65[SM_U;4OYHJO
MN4?UBGU9%4>#W5E!N#?N3'7\NC1_5S1G @YJW=5Z.Y\VB^[I[".)(VQW2HSM
M%#:A%8']0)^-2Q[B,5SB45UX]MG"[RSDNX'T!6:F"Q9C4Q\KWQE;1![V>=WW
M__C/"["!&;X2F=Y]M!WO''W>VZZS#'QV%N,S.<9G\>.>SF>YFO:7Y3-)[ TE
M<4@D0U;,9Z5VE9//1%D>B,IP-P%$# KT<%\@?MCT#%GD[NKZ0Z2J#P#G:A[Y
M!/3#S,\^^  ,Y*V.TD$8+88,;$=[Z9JK,[B0&9[MN(&K]\E@SRX_3X$;&C_&
M$C#0@*A&N2*<F?:S_X!_Y-U8K Y]TG/=L#S=#S_!G>4_2PS\K1VX_ ?X$*XO
M)KJRQ3-X9.D!6_R7ZW$\Q::M6_XJ^#H?3*YKV!,S[05W@2-QH\+##TUV(_C4
M:1_P9QU.!-#KRM+-E6NXU[;S'AY[ JGYQ*BCFMT3G/O5/G?Z=X@QD/89B Z/
M_I>Y9U1?=5I\\<I>AYGL28?S/P]@$!!3"^ :-ZCZMGU^<=@\X,T%@&:#1O'5
MU-A/V %E@K948,Y$HC)GZQ=CY/."<CNWR'0[X!"EO9DJ:P>GRMKDREJU]Y(J
M:^M)? K)D#OU:6\;CJ+Y3$$'O^+I4 FEOF6$Z(&&=+8;U/8N)/2$Q)O4KC_.
MX.XB6L?FRP$,66U_\&#7O2ZIU8<^/D>U0^&]E$9&YIA/2R"]R#T5CTZ]G#-5
M0S3Q3\-[!"-?"J*)*Z8[Z'BRK>"#*5AR5K;JH")[/%B\O67>,Z8(AHC#>Y3,
MT9>MAO HD25'D-4_(2M!R8'9BHX]2_"Q=4+4'M&%7G2XO 9\Q5PT^@RX74Z#
M3]#3<<)<''/WZ*>L#RU-J>J4W?J1P:T 1YG,$"HF7T'"R>FU+;ZVWDR>?-P<
MW![E(9EYP3-3A%M]Q?-1$E,@FFU<D9**4V P1D(J3KCOY(#&0%0'(U&3TBM:
MBV.A<?1F3HZ1LB3'O)C=RD>U6R5<8/]_CP@C:C:,9/_OX>-NGR NT#VC2V*X
MA@82^13S+GA^@\=(>&ROD9+1,*&^UX">Y7O)F#,P&&BBJJ0GN^:QP9I#4X$N
M&X70-.R)TBB]U4!;2,HL9ON):K;SH"?W;VH)]/0O=N6<E-(6>83)J*^)FM(O
M>4ZZ=(/+G'V^*3>=LK%70=.Y=,]05G;)]Z8&]%.^O#99[ ^&(M7RLX"[J]K&
M==VF42GEF(]& UD<*M0<[A.!]A"HWV!R:&\(DCG=S#LZ"F6V/RKNH7<4.*NX
M,=LAXZPV^RRO,AWT1V)?2V_*W)7.D)78:YG"2G?+L9<CBI8QZ%=5H*]PM6;*
M>VNS]\+.[ARG7VPKR/-C;M:JF:&BBE)_MQ2H*'U*BI<CHWC1!J:%*2[WL3UU
M81/E1.Y2Y"Y@BY8\X.4LTA.Y4\B=V4C+W4[TA/J*4#](;H!P0GWU0JYHR_GB
M(DX6I5%?'$K-2;DN^4Y/?OD3,"=@F@&F]8OW+GA_ZHZC6U[-R*HS3A'L()3U
MJSW#=88#41NF.U6R;C2?5BYA%51MT21GK54)Y*%@(SFK[1BQH9RP$<&&6B4V
M#BZKH&G1VB6[^.2C[J:/.M_E+BM?GF[R-3M1DG/:3JBO&?6Y9RJ>4%\5ZG.G
M(YQ07Q7J<V<UG%#?HM>VVUJ]=;]-F8WDJ3D^(HXM;HERA&8-+0QD21RJA9,N
M3T*IE?2(["0^Y4,<8CY$CB-\2H#HACUW2H!H"_7#4P+$(9C2.60:J*RA(O9[
MA<<RGS(>CC!Z?0+F!,S!93SD;E4E=Q"+)V!.P!PT,-U6_W2+KW92H4J-O,G9
M,P9GD6BB+"D'WS)CF)S1U'G0D]./.@]Z<JY0YT%/3NSI8A:/=H!2H773;Q>\
MCK6/*B7K\W1\D0;I 8C.G]C#[8HT[%Q7I.R@)V<P=![TY R %R?BFQ4&7;+F
M,S= N#/F"W,E7*U'Z0&"A>OH_#SA9QS%)??>X,P]_J/TYI=,#M&2SNBL+%5'
M=YL".LA/W.#H7&/SVG9\7/JH1 SN:V\QU'IB[]0KJH1PRQT..^%LE#N.=<+9
M*/EB?<)9$LZ2;_1'A[.*+9ZNJY[6[[RGJI5Z$HT*FTE%NQ*H8F](SXDN2IY3
M#D9!<9[LY3RAOF;4)WMI3ZBO&?6G@JW64'\JV&I2N1<V0P]'M1^ P^Y4RM*&
M>9H]9_1DCW9&/9R*2EM#_:FHM#74G^H_*D9]N:V?D%F_A=DU[;QM3/Z*(Y_9
M)5\1MVM82YTO>79V]MLB7 ]?#*OT *'WQIRYPA?V+'RUY[HE^A^(PAU8S[,W
MPEQW'@SKW+,78$0B3,$'(:2]I*'(NS;KL^]*#?EI 2#]QJ&%9TPS0 %'(_[N
M+O1)^'L]4"=!Z(^>_=LKJ=?["=";;)[#Z\'NCI Q&.+7>[5#X/ O%VANPY_'
MEY-??OMUG"'$#U_]K#O?F0=,[7[?/(,$#ZE=AK0<&4*O#!&K7?O?2]<S9JL]
MBT?P(1BNX#TR_O.9]ZA[PN11MQY@:</"1?!["\>8P ?G[.+A D\YG"=+8#_\
M+PH.WA!%^#ILF+F>_[N@6U.!^?D'X>//AFD*^FS&)AY?\G< ;8$)"=+@#2XW
ML>=,L)TS_-N3;B[AEYE@>*[P" <7.-G%WV?K45>&Y7K.$D,E_&%SB=\!"36?
MV]/(L@A("/-DZ3C,FJQBP%\(]["D/?XW0&8\\67]G9]Q# 'V]0<_N0*190<?
M\#>CA'!L,\04_S[[L;#=)> "SH'W"&C4)Q.V\ _J0G= $ *F &- #/C$7GC&
MW/@OPL[IP+RE8UW4PAAX'MIAR925?\.AVULG&/2&[7"Y^QJ^SAS3L.![[];$
M]8\R/G99"\"IYQ>DRF_&&F7&I2]76CG-'RW..1:J7Q,X<NFX["PX.N.E"YAS
M827\"N /,+9"-N9,RJ;(SIQI@5V7IH=<.'/LN3 SEQ//5WQ<$N#3V]( %@C/
MFA$>H?#]4QN^8-G>&;,>\*3@"QS=<GWE#4 ^LND#KA5 &3NT'")^!+I"U5UK
M "U\)+9ONF_]TC3,"-\6 '\Y/Q>N#69.7PNW@/XWL,I_EB#W& "C#-\(_T+A
M"C\+Y^?!D]PL76\ENQ49-1,DF; 3- SDQS$2<&H6Q%"8R&";O+J\/H^B(43
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MYHOS&#4 X=P_MW40:]+B_#2B K\%KOUH_1-T6NC33U;2RAXE'=41"<J:R[=
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MIW(\P^6_%@6T /8(/WG+8)+8)$3U-I@[K37J*(XA,4@(\!9 (X*V$E5X&O3
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MV[E_9/_'=*<1CWM?WK&VJP"DT(F0=XSN2D!)A86Z'%)5IW]82]>_&MHNZ$B
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M:!L,:!L,:!&E0&$@12VD+;_9O3;<Y5--'<1^W^93J:2NP&4WF!YL,#W8\,B
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M&Z00^@A9>"]!%G[QR,*W:5=0^7B?C.P6D2I*>)^,_C8Q*QIXGXST%N$NV/2
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M:CQ<?N$-ZT@'7';R*C27=U[ECF!JT.T&YT_64*;F^B@\S,D-T]1<&P7>F#:
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M3$3D-OY&B>E1)$.A1-)1<M:7DRR?N4E'JMD>$U.:<Q-Y@P"F]%0N)3E$WGH
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M8X]S2E?-Q%Q#9CB#^6PA6)1\^J;3WW_K19^S:*B_2_[7_:%RPW,,F;S05LO
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MB BWD!=>VFVLUUDG6#(E;X7*GO:L3:AO3,V=X]AC_.V<;H]>[71KGU)[>5X
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M:FET&7*E FAGVU+]<O^H?&2_R^7CGI.OM"3%8C3I,]WTNUWZO/??4$L#!!0
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M>96OG/)J^C,W_^[5G\=_ 5!+ P04    " "9BEY7MC'I?H'D 0 F20( #0
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M(6 $9]ORJ9%"*(>Y!+_V^F,3JZ5<UK\-B&I)=B/EN?7#9HJ+BGNLX/,#/PH
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MNKK_C:2$!H?&.\CV%VHK'9C[EB2 %/U4C>REL>^2>^S!-J*#PG>C.#H0CI.
M1*I >#RQUV\XPUDH^J29J.<4F=,%&\-?"I<D3I+P4?)B?VYC6U$;_:Z4>,H=
M1A,/")V%L:",@@C0&$QES[HLP1AATIP]9M$,JL\')VBNW/CFNWAKI,9!U&)
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M)!W(CJ$#(8K@N#(UGZA&0"F%BP=ZCBTVBGE%59J_/;B?M [A10_4"M(@[^G
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MP(4537HAFO58(EX)]O/I^K38;3:37_ITX!(O;1].SOUGB]_I_W>[PVJTC>G
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M.-4@@F]Q[.OO!E#5$(\]Y'*8R(7$=N8'SD1)5/&L14@MNL/7AI%KP\2D^L$
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M4C"]!/?3LX1VO#( 2ZD5:F)CHGJC9!J5<['(R3";&0]W6KX #F[MG DOQ9T
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M1Y:_3RF^7U_\ZFI;_"]/V@600,B[QN3R=PC4+_LZ;1;"332A+H7=BY"YFF,
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M7L@(A"8C=A>!F5U'!V>*@5AB,F)/0V/V7=,ZV<#8>*7V#<6*HCO)4$*K+B%
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MB2&?:=(;?SBHT?$O'<[E*GE!J"053JOI+9:^[13V@CMXZ=OF<*(3!;WCJER
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ML+^H=U>89((FDLK:B L.-$.:>L[53S3"LQ9X%[')R/)O]GSWU63?9,7IQ2U
M[P!9JL?"B&&>/[FSSH0$ZCX-^3V'Q9(9I7^7ZAMHU$@:-P"VV!"@_[J*AA#]
MTJ+_?4PR &X,N@8XLC;(&HP&T:_:@L"]<0$#/X0I_]O1A -V$KD'E-L2O)<3
MBEK.0D/Q*E7 RD#F #UCTQ0.\)"*,F@8D<%<B 1:](_^3P(2Z$+_)'IEO! J
M+'H0C6P)\8](P<VUYK"_)M?PQ@9L]#ROV@ESW44<*!.#RK*E^TS[B^^O9!<
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MK)]O&)%X-V.)J[-2<\VD,IT$XF L1AN@"&?F@.9W3T>:-Z.&4NO73P!R  T
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M?*S ]2W4EN;VX_MHX\]RY4UG=N@]:+^VRT6Y;(6Y//I\^RF;*D=YD*2.<9A
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MY(S4@V^:C/&2ZGS?8A:/(IU""37/1BX=F^V.=61OF7=S[>H3_2%J22E\+[]
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M0,]/B[*)6*X!H!.T:$&TLX%BE-5?CLZ5<:QA5F\?6K<JB"&L /DA,R2!SNB
M<3D' Y7$2%<2J*4K '6(]F/^&9(R$!O=<0QT)BJ1/*?=!C8X.Q2\TQX6Q?O_
M^V3F.3/-BW Y7"?-(D<S\9+N"\T+1'D,H<!X]Z)<R_4$*/_6U(*V<>+>]]]6
MLT%W-)[:QXQ!&<L3#)E[^-IKI*U=4T(;+Y\&_7P1HE>&/?^ULT% E_NP;/F.
M_]D+F9#K6N[9"8O:'Y%#=H5<^RM=7N4EHWFCV9N[R@/.R#Z%%8UXZVMMC^""
M\6J0'S^FZ+-LL<@S;<_:Y[_CS[NX?N.,C?A\WM#%7D,7>L[\[I.P!R[,[;1A
M1J+7[[C$1-$-+< Z.QF=51I/-6VWF84\N"WK43P!Q;E-]/L78\=D2VL_PX+O
MX>?;:,#HOENWF98V2V]8OKX5"ZB+\Y=+V!%JJ39YEHY:ULK36%6*M(F=;M>"
M?-% DX*+)AKEGCIIG5N'!C7V?H01E"SIYV$R XV<HX%]^YJBF>J DH"7](:5
M]:61F,S.)5_%JA\R4 \SDU]%,O8O(LGJ)W-''D69!4F Z]T &([2 TD,KX/@
MG"  WO/&_Y#(-Q L;"O;B7!Y@00*321'[+3@)7Z2=C3 W@(''/^DB+^QVWI=
M%_$%H#TSG8 2TQ*/# !#6VR!>^?L20+)PIH1?V@ X/8 7>SW#""!+LX!;E=?
M[7=,_>%1?H_JYA]1<0(+B568W"*J+[JX.9=\ 4EW8>#?BJSH'R,3J,39*>!O
M8W@MW@+=IOTLVXNTAJN#>L\V50BP6R[''/^<MOIL1".W29-T0RS:MD&R69:-
M96@=KBSH@I=_8^628=;\[-))W&=/O@=,Q =^BB#J[SS[!D_&U$\8>OS%'#Q_
M6H,2$IET]#$6Z6->T0WL*;F_!Q<F3,K."<15>W4%%%M%-XM;$](%?/LBIP53
MD\L>CRFC@\.>1'AEFKNVZL-AQ2>-C9TMAY? C5J:9]<IO3C8PQ:GC#HD70[>
M$LD9BR=J>W&<&FVE'I[Y$FW+&V<*/;D_CJQA]A:3F)/QIJ:M'(@FHTYM:^L3
M_3],+6T?\',#7"RC:12 ':.Z!=G13#5D/0/&<RGP1+^U)(OPF$4\7@1P4V4
MF[H_E#.@L3^U,>E8X>F3F/+\)#&^"M]UHU6$XD%#Z;O%O<>)3)CGA;+3=&'!
M/'@^.:G/-]0TRB5YQ=*+)?XU3P;\#E78+\A<^)=F\'=A_>=R04MV1(Y.Y)-
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M([5.X8/<UDOAB<:,5L_<^_A2N>A8;P?.E)]O,)QV)<1O$J_Y]2'!>%6>"+S
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M;SF--[]D:>QG.;GY4;\_#)QC#_?=XC1T-*IMBGR5"8$R>M"5VS$X-_0)VE5
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M7Y5Q8E=4Q>GIJ/.@-*8^0[K,F$6>EVQB?<900'1VBMD/JDX$;<U<_PJF,Z+
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M1-0;##8ZY]P$8NS VAK3$A0]B3"P)Y,VE)67]GEN4&U1Z_34Y@.VJ$_0"K#
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M -F9U:@1Z#'_&-AQ@,.&7*_^Q$N 5"K?J$PY/(4?PSS5]BYS&%],Z\C/ RQ
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MUC'F0Q:1>=>/1CKM9,63+TBO"&MI/_Z9J!MC8-4-?D?\N?94_ZUNBIHZ!?Z
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MMA>UM5:Q/_,F$<N2!-_-: )Q&*(G]6@-X5]<M_7D-@M'HGK??$U%Z_:)9H1
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M@U8"&<9,!0QI*5Y787>'?]>#:@!?Y7!0#! ;R[10:$2Z(D@#72M'-V(+\ZG
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MX.1QV-IRO)7EF]D"-UM%F,K_?"K]3_J[XO)_5?M/U?X;;[? _OD]WWOKXL9
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M!=(]2=^H0$!7"Q4@9Z?_U<'LY3G'+HGUH;'P>!KG?&O!&))TJ(!A5%:F'J=
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M:G!0>P6D ^?&(=C_X31Q*)AGD(+H<6(4CHEFD"S@#<>WS<.K8R3T)]?U#;*
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MC^5AXQ;X_P&XORT)F QFT%(83?B@\R.P93L/ZB'_)PD8_X&E]%_+S&EC^PY
M(<*P>3KU"#9KD<@<Q!]O@:%TE) (A:]-.4),/BQ[[0E93'B6"T[J_N+A?*CY
M?;"58U:'<5.AM<<*!]!_O"5+>F]I0IQP&!O6>B+XM:'X,I<@ ?M:L]:!C3/
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M?U995-3F60RZ5'O;V03_YBP9#S"'HU- %34N9R1;8,P%7P*@V^&@XQ1Y4GY
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M&=1Y/.^2^&ON-[V,U]9O;73(YN<"F&2[KKB("9Z,LPD]4J%_4>++=L5W-9(
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MEPJSSP4R<9<MX2@>^.]='T<^;<30FY(,CB:/(0 D@3-U_TXD+@(@I!W>!B(
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MZR?-EM#HW8#[H[/,6ANR_:D%=W7ZK&-OB@H\R?R#R$,GT,H*)%94P(BS'<Z
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MS7,%V&0C128JHFV!#_, -:6(<5\2G#GI23$/*W!HO8^.Z8(S^0BV)7N;WVA
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M#+='3F\N7D,3 "'WYK"0OW53^!.=<,SI/6"UZZ[87I O$!QVN^.,$44:<W0
MG^J:PB=JF_J H\MS$(>;Q\PJ1'+)H"0 *B$L!$!IL).B$HVA!?KS?T]0_]%J
MD3?VCP>K/%#*M=-$RF@0"'=?I1$_B-@WDZ>"SVB@,O'I_+\ZRT&3!,!7^+%M
MN3,N%;[:"/W=])"\#,+)F$R%F<-+__1*; ^:'K9*$9&;CX^]M(6&[RNO91[K
MH>GPA5+6Q40!GN\K_.?DZL*!\8%S"W'A@*>='J"IT_&*(E5ZV29ZJQ<\/3#W
M>AOEJT(R[Z6/"QS0N*.S<4U).@>I!_F#3.Z\8CM>&5&\H/O',EP3Z=+=N=PR
MX@[<^OG&&8EL,F[N$:8_1KPA26I="_QEC1Z,)*&></(M8ZV:K$7-W%_RC!.'
M.W#%\>WIW-WT$@=)(BP"MD4O2N#BMN;OZY/\_/CB1TEH%QQ!.<.TTHQ@)@#L
M]H(SZ3AK;B?#Y%"UJ:6.(UG7/LN<^<Z^;.*HMCZ-@+@7..R#GY>$E[*DSS>3
MW3:RB0(-38L4--H.]5/'OU;[JN,#N-4C]YK/_R+D/)L >&L>"6L'5WWK2V^]
MU:A8D_C:YVC'7))!1V]Y./*MHA6/^GO(SX,>6NO"-K-N+35YV]6LU3U8J=EA
MR^$X :" L%OP_$ ,QA[V?M;)>57BI?)VX-<2DB>&E+DO0T+(9^.1CEM^:+&6
M;KY$Z?5'+WEXDR3.=\.YRE- $W?^Y4F'I@K^42LK 5#>1 #@Q,TFYRT=0?NT
MJ!-<P"(!L%FT^UK\WVZ]^=>,ZO]O4_W?M*D".#^R4[D^'NNZ@&M+SWX^U^O_
MNH@AT3G;._V#P 6ER\$\E(.M-W ?Y&DP+DA0#SP:806FPY0?1R(PO"L(!GL\
M?XS*9#4Y-1A#G:6Y!+]JOBDAPK_3+.)PO.E;6A(T,R!> )7F,_S208ZDS/YA
M\W!_ILWFT;?N^>$&GB"P-:F^8/4WA'"<N,,UJKF^36P;;!98FX:_@JL N2 N
M8W6(D R&32"JQ B :UAN%#NLAP @QU/ZW(4Z+.W18<Z[X3=V/2.<;^%'#Y8,
M.\F!^JUHP>AX!=1.4GRY3W:;B*G)+YD$(B_,[IL9R;W7D^<XP,:,E4+PU\51
M=\N<L-K+VJ'PV[*7T)S:F!8BI:TT VD\UE&2H5"%V^GGFC[QVFC#+O#5*+H5
MRD"HR[*S25N=Y+$\Z[BL:.Y6*WV\(2JI(;^L*=<G4VW<^4[$TS9,!0%PV1_#
MA'8$WIJ%+-Z&21MS=I:_@=W$9;;RR<9"N="P<N0.25M28U1N2&@V&A[>"OPE
MSX\"1Y>N3QQ)'^&TE[M+EU.UJ4U*K@N\9?57;CA] U^JQK-AE&=).K0C%DD\
M!K61P#9$"+!J$U?L$:'-JK"T%P9"U>%Y?4@5T8:A6."Y')1Q%,KK3M=%#FD;
MQD2O[)F-W9^2%6=<E&_(\8'ZQ.M]::H<QI5I8WCRHYT^86+1ACJX.%C7.3>4
M!5?N"9\!KH"Z==&0#B J:;H:1$4$W#L9SDXSDJ7:\F46]17X%8>SXXH\1.BN
M(%1/UHJUA,,,J-I:$[ZSD^+E+>ZXU3.[>($ L$)<QP\AZ/!24%T49R<BS##%
MKD<%M782@Z?"1)\HMJ"NE'=J7\6P=8 H=%?DTWTM\F<P\<J3-=IDF <=8_-M
MLLF-ZC]Z^'[QIY46\ :\X1O.;A+M8'IB59\,?8_+4EM771;DCIKA=$BZ(*;;
M.70<>MOD]2#-K48XR)R,B)DTJ!Y&\IS_.>:D)P[+A^E'FA  ,01 G6T8Q [M
M?QQ)C/_:7*@7,<"EY)TKR'FVME9&C$/.@@]O5SFR>,Z%K#V#>I2=\7YLEF(
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MA4CW@9%PR_/R4+^%:OP=S/**M*QPV2]BP&\PNH;R#K) 7\UUJJ/ZH90_B"Q
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M5O&?JV?C+T/Y.X(/]G^WR*T^&D?\W %A2W_O0X7^_K?K9;+W#\D:I @ 'P)
M\51OP00^U%6'PT>'1"71N8OQ7:X@8R_HX:M<0KEW4Q[LJ$WD<O3OW"W64/.&
M.7:/WU7VW&B;S$O84J9K\7QI\XP3OWVVOYTZ]7C7WWM[X0;4&Z-"?9$9JH9*
M=>Y!$0".<P>Q^R?,=O(3*X9@L8^FL<&F2T>&KAWY5MU^K!,[BU6OU 1[]H(T
MUY7NNH3)4X5>B;WN'6!PU>!96NC$O5?[$FQ:DE_X&M 2:@R9)Q6?%K9O&5 U
MAM%_N\3^6B:]).?MIT@DP]4L@31?FYV[_KT(7^/]H)=)R1LI^XBL,\8C^_[
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ME6Y^0+@ F,.;/[P\K?FW6XC_7S]_W6JOFN]OV_&IP5J"<=$]8220)\ V38O
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MAV$S.F-/4$#^C% -@QYM<!/VP"002P8=8F\$>K(,(<H\8>D[2B2>$B8^P)%
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ML;O+_P(-Y6'&$@DT+T)@0ZW15\H!F-HM).K#+6%_K?Y7KZ(#PH;%@A21_A5
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MZ*N;H;VX<'7@;E4GVEFG1%"['Q,5/CN&^?DFHK#=W:@PVJ)0KSXPP\C_6KJ
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MHN3W:2O@X71!OZU9&;YVFK)JR?%<0=L9]'1I$D:\NM+T@-4HX6%[<0JRC"/
M(7^F!T>;0+3 #GL.]X_%!\+73"64KI.XUC[9JERD[Y/BW&Y<.?.Y96/WLF5
M62Z)HQB+1\-=\IF5W<L)O"^.*CN XVYOFC$TU--3AOV<@G5SSVRS2Q73],:*
M(AVN )X:G*U^PCX,(48://25V1C>.Q9=G\&W1>Z23_9#Y32+'?LI6"[(-2.
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M D0MX>D1\$T'VSY!-C(P>&R2%%8$CB&(KZ!!R)((I4 N!33VUA-GR$".YFK
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M,()VH#T92#,!_^Q^\[5H==NMIBRPQ]]S]X=4,EZ2 9;NL8 =)BZ0Q#$#)Z[
M[V()D8CQR!W>R,8$HL!S*8CDQ> _^+YHZUQNPN=8A5W>P1%8R0 4TF@GO#(I
MB@X:56A74:1KL$[<CQD(^P&DZ<Y10\T_0+H#-E80(-XZM]]V]Y\-H*ZFDO!A
MZ2\R,.%'G*1$$?2.71=\5ND7$B49> 7_N[6"0!#DS<=CLA*&=2?.9#$GC\/I
M189'Y71<Z7S#;LN-C1%?C,$^[H^!_UJ(/PTUOB>A;342*%(77G!YUG*IK]J?
MO!#3IPV_FG]90=X![7WU>I'RR<V5'OA8:,X^_$Q8W6&"&&YR*<'S6-T1S?%
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MIDW 3?@/X T#^G_._ENO/T;^NS8V\>H T>V;C#;;;]ET"-@LNFF+Z"9>(X
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M=U>ARMY3LS K=Z3K)E1Y@&=E<M)4P_CQST,FM=(UVMV/<TU,$KG;N$G5KWC
M6]]3.9Q*'I 3MS[I=I65J0%7O#%D'&%@//$IVJ2^3Q:IJ7TXUM3?26V=M7M4
M_F,KF@>8%335\X!L'QFT28'.#V;<1(<P$TUW1=8]>I;.4'+H0+9Q0VJMN9_
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M^CMJ=[$:6NY&'#)Y=6CXQL=G \29)X+5[O"F9<D9GP3K%8ACJ9:G]BAA6RA
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M#A\>04M*(ES9NEH-XG8R*'\;VTV*,\W''PD3(WSN/;U(K/RQLL]A4=B)=:Q
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MO3CJ+=I*S$E'K9U\4]QV%^"C#RR=-UQ#]8"E"D6Z%A8V(L,)$Y46ESSN4)F
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M(OP$:-/I+5G2P)[WA\1S2?MA&"O<H\5"]B3$.9=NVI68-JJ@=6FVCK2OX9I
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M&&;X05@$![]% FN0?S,!>5!*,A/ 93@'9 (4?N^B/1&'>M@8$$FL]0@3L,-
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M70L(UNI#LDH2+7$;"D@\*FQ?R5JONFXX.-[LV4NYP;EIAWC!J5S*S\1F&;&
M8J>JU_%; V76IJ-U5EF.4&SY$U9S*M#V[/CA.M!4KDY.XS1Y$'\8,*$F=BNY
M>V V 6<).F1OR'$;4BK8)"LSL@?.<Y3)Y&;*5:^(JIZ1.TVT3:Z2%6N/!9D^
M(C?CV\.1CH=O3)]IE)YVX)XG._GX@:_UZ9=[]I=BA"5YU=OU*1 FM) :48YH
MEGK'TZ.S=/X &DZ ;IIO*KW&!TRW:LOV!HB[%HXVZ5>-O=3[8&7SPQU1YIVG
M$,O[G6DO6::DVV E3_VKRNT,(;\Q@R-KNREGE'H-KCBTXN*W=6-[_<KA"BI
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M$GF5(7K=![+D=,%I3#@7%L"CV#=:/-'];MNK7C794@SB54;1+I:>,25CAD'
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MTVW=;,)PW'+9=A>&'(17H/ *&&J$7B%TCF!3V4Z39$GCB?K_-2);UAG**BM
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MK=I<&.FU('72I+JR5!AI!7&Z&9>-VDP8J31!="/04'X((Z$VJ';55"F$@Y%
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M*1>\87I#?/G26@FSGQ(4%#F#A<\,P$)EXVQSE2\?JUS/%O ->\J>E:DU6X7
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M5W$UT)[.YM%R.$F(:BAVQSQ7199R97AYL:4KL)W9S&O3!-V5/I',O2#=+65
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M[1!!.Z9:Q1B#U[D!"(BH9-GB5K>FF"(]3,! -JB;#I[7C_R#A+L_'6S\9-\
MV9B_L+#'T(A:$Q'$(&4\"F8V*E>O?0.X!:NP@0BL/9??<A9]%%X$-.AQ =?)
ML; JTGPOWER$ME  L X(,.5JIY"ML6!C"O2P3&MXVV>_'9T@-">^=8IGH#-B
M7."N32TBD\85J#DO0=$%19G0.AKH!2;X> R=.+K 79M:1.+H"M0HCBLC<#2^
M7,0JK8P?%>]4O[[%:L$'[6J5GD4Y$U7V%1=1=6C@=:DPB^59BF3_+3J*HU5[
M]:$ZNMN0&[UE,O$D]\>B=3HE=V0NTS['D\QU@U7SN(/>A&Q$*J@;7,BC*,!_
M0G<.T*$"<B,6MXW2.5S)G%IG$Q4+8$*2KW43VL0&O9-1CYNH,'1^IM+<R18N
M8EUC  Q<'KT[I6S&1-^%#(*]/CN_N"%RHJJR%[*93[7.Z]VM*S,PXV:^>MM!
M..-(R-!A,E/ F;!F AK?+&3\Z/!F>,W\& LI(#C(R7'Z[M)/9D(K/I!@&K.(
M3<2ZPT$4!,VT0YWZP2>>LGGF6D!"APZ34<Y.A;)A9TG('OW;A.16=#P9C2^>
MY?Z%AB8GE&;EI@9XY\L7/K[X]R=Y\Q4F8J_&1""$SRR!JXZ(-(0)EH5#-WZ0
M,&QDM$ !9L*J _;59 4)2MP'J?VQDV@%"9)X[\LJ2"%)T.H+&"&X#=>Z8UMP
M6F#F'8RDGPF)1S$9QN'#9_8;\1,LU #0C+*7]1&M19]+^D3PT:/'!JAVR@)Y
M^CA+A%7"(O49?L:2.1*J+/ @=9]W%8<27+2L !GE+&]Y/QQ.$K%1I\NK.,!%
MA Z:G1RT/-%!LY-S]>'\8G@G_AMG'V/G\M$/>Z0L)8$ZIOAWC/L",#9J.R.W
M:Q YZ,W%@QQ3'*:I .[?D-1_E$_W_?LAOAFP@S7O:^4PV,BRZ\6SZ7+&.(U'
M7/Z'RX>4JF08#DHLZ,Q/&\J0-%5ZH%F'& EQ3B!->N=,-&.S/,VGW >G%,DN
M#2"#0C.SRN8D3:/\ 4CU%1X.RIPP0G>TBR2FLHP[#G*:<,PI)U7M^4O&0G[Z
M"Q;L;4C0.>J=/YOYUU1L9D+!!\. AN^NAUD6)V$A7]. Q$+/3.[H9)KR!S84
M^*<T9'G;X1T2U;XM,J L*O+S@W?R%1P)D5"M@00R6[7'A-VBS%6C8WQS?MQQ
MSH\Q87>9\Q-\<W[2<<Y/,&&WS/E?[T_/I L,HZ,.Q&8^\!3=$+GF=) @,2J.
M?SC0-]" P&=S >:!R=JF-!TELH[=*1DS61#R.=L5D=#D#!1Z304-4DG)N <D
MM]$"=%]+8^;]8C8?!L+^YE1^^2POZBO^B8-<-Y FO5CVQG0]K0<%,6KQC 1Y
M"032'C<T2!A31XBK>"+C=^2KL/MK'#18T!G/:C=,OK^Y'UXB>1/4P@,(4-%6
M"=R412'!<I\"(+/3$ZC\3M=T1M%8F@ R5WJPV MZ4,Y4(%*X9F# :A?[Z=2/
MD5T_FF !KU!)>LK8IRSJ$0<1.DC0?B+:5T)MT!ED-GA07(*8@? ^)6+4>(*#
M&ATD..*4S2CG+%E^8"D6ENA!0>_-Q3:*26.U\$#8;\_*]YI+)/ UD, ,%&R<
M?A;49GY6)%Y\/2@P:$$<2B98T-? F/>'A[]>C*[NS^Z1W'$UX9B3*G]F#U.V
MX+Y\5B3^O'R8)@3)W(/8 %:TNGU&\J(!0 :LAX_O?KF6K[ZF! D9;4#&G#_W
MYTQ\(T&"NXX&TJ0?XV*L7\0?%_*E#:;CD0T>)$VMKEA)<F'3_(%E2H'%Z10+
M)5I0 $M^\2.QR=RS)98C:QN0:8'_2M,IE<]2Y2EJE(SB<S(3V@T'&3 X2*YD
M3[9(A_'R@J?BTY1/Q:F$)#,\A$'PH'>F"TYCPOD9FSW2.'O2DR/^^G&O$#@@
M-526/+ >KH^'*!B>^8F8JF;%K^)Z:G]$=%D &A^&,9Z.QO=^1#@B8C2@C*S)
MPK.',CS[H16>C8<F-YB RXO%,O2WC'D9!BE]4AX9/#0Z8#2R43U"8N./G(S&
M^1,E-'0!V,""&,4B;.1014.7"T@P0ZJ08;G1R5C[[!DJ)MK,X,RK+$_HQBL.
M3SPD0>#,))VS0-6Q$PR^B%,5=%%6$\-#FQ-*N=A^/!04\F JC$=%\O\!4$L#
M!!0    ( )F*7E<50E<U)!$  "7A   5    ;6QE8RTR,#(S,#8S,%]C86PN
M>&UL[5UM=]JX$OZ^OX*;^^7>LX="DF;3]#1W#X$F2YJ$-B1]V3U[>H0M0%MC
M4<GF);_^2K8!&TNVL17+=/=3FP0THWE&,Z/1:/3FU\7$JLT@H0C;YP>'+YH'
M-6@;V$3VZ/S@L5]O]=O=[L&O_ZO5?GKSKWJ]=@5M2( #S=I@66OCR;1OH-H#
M 38=8C*I_<>9_+=6KXT=9_JZT9C/YR\,]AEJ( (I=HD!*?]%K5YG ZZ&;!/(
M!WQ=N\5VK6<XM>-F[>CP=?/D]>%9[?&A73MJ'AW[7_GIC87L;P- 88WQ;=/S
M@Q"EQ8!8+S 9-8Z:S>/&ZH,'_B=?+_@O(I^?'WN?/CP[.VMX?UU_E"+1!]FP
MAXW/MS=]8PPGH(YLZ@#;X 0H>DV]7]Y@ SB>)%/YJDD_P7^JKSY6Y[^J'Q[5
MCP]?+*AYX,NM5GM#L 7OX;#F<?[:64[A^0%%DZG%&?)^-R9P>'XPL:!1YQ)L
M_G+<Y$/\F__F*_G:QC;%%C*Y[#F0!(ZA3=$,=AG^$S8*I_!XWXW,98+9+PV&
M)U,2R*%L\$\UTL9J/ _;%\#B"/3'$#JY^8T,XC/Z# (&='QIX7E^J:X&X!PJ
M88^KL>E:$ ^O,#;GR+(>P,#:#7?9&)X8%7/9<\:0W&&[[1(";><>&A#-.#5:
MA.^T415J[H8HLY<FW) JPK]PJ&?0D:X]8^+!!!43=VR89Y'O'70Z< @9HN8#
M6-P@,$ 6<@JRGC+H,\B\94Z0C:C#_"TSI6\74V93B\TA:40V <7\WT,* 3'&
MP#8[< 8M/)TP\ .J1::186"5AGQ#F%ED)CO#<8%U"QR7(&?98=:YR%P2AWP.
M.WH)$/D(+!<RZ;4!(4L6ZGD_LS\AF[E"!*PNBVV(RX5:2-URD0KTT "6X5I>
M-'7#YA>9.5PXT#:AN9H[)ZLB3/$H,]H6-B+T+![68;(B9X$!M,X/T)#0^M"U
MK*_O"1XBYP93>DGPI#?E$3*;:LM@J\PS$5&0.*.4<>J%?7P4+_9SP +;>+)L
M</CJ+.@[.FYXH_-/;/Y7-S#YNOF(A_$NG*Q4*L<T[]E:LUU8VF16]!HK7$(Z
MT2)1WIDY6/'%_AM3B&B$'7RB0=W)Q!NMCAPX67U_R"27"UT'"Z6%B0D)VUL=
MU.80C<8._^_&/.7 P8M9UGSXNAL8O]*P2>)A/_%*E&J X9$R#-N8.KUA'U@E
M&H<PS77<M6\P1007P'*\@:5>$)=5:-$2A18E6KXD+B(3W"OP4J0;P/DR#F<^
M,#TM8;1N ?D&.7]EXRAE8'\AE,LT0.]$%7K"S4IIT(FI[ZW9E @SP.P7=09T
MP]\%'&+"-C(+#='OAG:E5EI,)%&0,F K"R9S&L@Q(+#G)\$$&Z+>L$4I9KLT
MQUORUQC9SD=FL%W"?C8,[-IL(W6)R2/E=N"[R_:NM] 98_-A#)Q/R+(N>&K*
M I2B(8+F _8GV"-\BG>0^?$RM:,2DZU,;)RBBI40EBSL+K!M\O,.P2QX+%GN
MCBE.?E\40B:]> A> *)@?#YR>=NB"-%]@2,J*6G@O L,7J;0.\H%!F>4KO+#
MF5*,PB]6*5P2"C1ASO)P-J^W#<;FOMTSK_Q\UWP/EGP/%.:A:W\:(V/,C]1H
MC_0AF2$#4O^0!YH=9-YAYX,++#1<,A/+?H]'-O+D2IE5AB4NG?)FM%'F2NJ1
M%I"?,WC7$+-7"..T\#RD _+L;CX(?-_*A@X4B9\/(=ME852P'V"Z4QHXF9BI
MDI$7 Y=-IO%@,X<3W0J8A(4U90:<\FJ<G-.Z LBF7-20]NRW"WX(.X(=-!Q"
MP@_;V"\]*^?K0.E[O'S<A9)4>A0X35>BZIP3 K6I YV:G:K4>E#,#&#87J7Y
MCXI/I9@NQL[3^,E_8^OHOYQZ@$@98 '_?8=MPZ\E*SD6CQ$N%H4X#$@TL* _
MF&>@'ABXJSJ_$D.0-$ZT6V\9Y-M!2*I(U<22WI[V$BV@*=) R?8]_'G-.9 D
M<<;GEF!)\D0W9:OWOFEQ3%FW$W_Y3][Y('CH4EBRX8P1UN]^LV$1EU@\#UAD
M,6RX")5%:_!G8>K[@HU$=O&D8J$87$N@T8Y'&3G9!Y17@O!_^!'1#%B\"K2\
M>8C):_9^0DRW2J D<E-4:.CYV/X8$\>!9,(K]JGCU><&K&6*)Y*^K]W5266<
M/G7UA8#^R%OW.$I?S3'ZU04I@^R4'DIZ@;H.:&*$]3N_#*#$Q26+2@HNF?<$
M3OUSE=)72YCT'BV4B,0DH4C>?,'Z7E>)F8$-S;U8&1$AQ0_OBBV*DH/ RFR5
ML@7A6QLD20Z\>C-H"]D71!\Y*Q*\RJSRR@5\<H42DY2Z_#;T%#F@Q"1DA*IV
MBQ^%;<O(1 6D^GC:JVE@?F2"W$EIXH\0U;P_2Y)]5#C2Q9IC,\;&?< 7T >W
M->'UE1FW8:)O5DZ$2;.4Y1EWEJ)/M@\=QX*F1^PB5)N3+4V>-D8U)9LZ<[5Y
M0W[+A\Q@;YAV'EA>BC<S1_H#FB0#LX-DU68:[Z$#D W-MX#8R!Z5F)S?)EQU
M@+;E)(OS"VU]0]TGRM[ZADD7R/UZ.9N6;?J5+\'V%"S+3; D,J$]RI-C'=6Y
M9%%* L B-6T^B74'!QW*F,I(-;+XJ=BE"U1YPCE,4C=T$F.R/YB)H%*3=?X$
M"'/G:P+E;=)CA/5[W*S(Q&6F)O7L;T]XNYUE:T0@Y%'S)2:7+K_O%@37K<NW
MV79DZ</H3D@EBSNS,-1&H)M<G@ZC):9>))&R:CQG5,6;IO"B6RD3\1<8Z#31
MJH^+-A1+#V1E]+7[U/RHQ2)894EO<1>_TK"2D*],T64J4#+Y20L"\\&D QN9
M<=>#22H2"4%HQ>X3I$Y%HG]JJWO]Z(1ME77HEI"X;J^:))&M>ZU!UBO1;U9]
M$EET2]\5E'6/YT+U9,$@7@N91PK-KJVS(65&=@KXB;_WG>7=X,YQ#2UO[ZZ_
MW*!TDNT-M^_?EE>EDLS&/H.7)F$EI\\R<ATX)9!W_^'RLOE1+7$0]7[4"W$&
MQK3OB=2AG@4&I4G)*/E8?XL2R\_2&-&=_U>&L4C(\JQFSMJ2<#F WV#U!E'.
MJ_=7:K/@G$VH&YIP>M7)#F/NX9+,)SM92E29638(9.PP;Q#\&SD;U%'#GIM!
M_7M6E78Z.R[*ZX)3./$X*+MX> >>]M VY!1^@/SI,WAJF0+ZG1HW^E<9#9"P
M5X4F'\]N%>*@!)KQ2DT6+(T+[Y8(,L7=_S3JQ#9?/TR(EP&"0 /.2@L<=%SH
MV86G']HMB"X*'3:?8_6O:&YX"-N@X Q.7[HF V^-T$N2?WRZ_7CRYQ^?C:F[
M^&*?G)E/I[/1EZ7]V''G5Z?D[/3=T5^/#TMJG<Z,IZ9U[32</KQ^.CW^MC@T
M;ISF[Y>71_UWC=GBHOVE.3/[9- VW 5Z.S_M@'?VM'G\H3TXZQ]2>C-^-_XP
M?M\]:]Q<79\</HR>*&UW#WL=9]XFHV]W3?#S[X^?[=O+5]W&.Z/56<X&D^[9
MV6]GS9?T>_?R\,OMR>#&N/NY,YC"C_V3V>WR[O/WTRO#:+;HO=MRND]CTIFV
MS&^_?6KV!_>#V[-KYVVG<?<.-EM/3ZVI:33?H<FKQM4(=!\[%YUA]^C[U?5U
MLSEO6B^-Z^'\PR,\^GUH.'?@U9/=N#C%D_GY^9^U=O^>OZ/Y8ZR;C+J[6C_J
MWM\)>F-OTJ>YNV&7MK(4LKSG,9A*\%:J%6\9J:2[XKIPQ=\AM)SU>VH/8X+=
MT3C<-+TT52K XEX[[2+0K!1%\%!1H4;I&MK85ZZ#?1%,Y?WL#Q7T4O=V]YLC
MYTRIT^WO[&,:3#SYE6 5-E07L.;W;*G,6;>(G8(=D[8HQ'</Z_XU'3C%%#G<
MJX5:V>@4Q^[,5M%E).A8O%%3<;B45JHROV1 :'H<>4]Y]<CJV=F>\%'6]OJ1
MEA;5N;B4,U[!P__,BJ4>1<7E N]=_CPS]0-MYBV<Y7L+V Y3;1Y!>Z_^54:Q
MBK-:22>=79D48*7^(<[UC(*08\ OUC*JWGO9V.H-^^Z (A,!GB7K$2_<N'#9
M'@WR"+TJRO6\L_@QG./S *SD2231(MGNXUP55<O/8?4V<#ELU\ZPR-YW4A:9
M!WZX*EL1$3O%RF[7(0AOV,(?4^%+U,^0A4(/+1%B,D>5]-<)ZB(/_E(DK["A
M_(HJGPEB5'G>! \ISZ8:HFY<DOQ&AF$J&)BG8)-90&JOLX05(;@*=($)P?-2
M.[0D<U'-TX)<:TT@8F6]J2(;NJQ7R6-?JIXCWV7A;.:NNF&LP&+ZQ9DZ?5/
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M@03->$M0Z4F&[.V3E#%RFYE(TKST%V;%U'5I^BYH)1P]Q-Z8572N_<\I97Z
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M9/Z&_=:;/EAO<KVP0/;O=QY&4;)&2>A[&Z)S%4W0AA9UYFV8_BW6""7*Y->
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M9,/CEH'*W/-TFVZRY\4JY8JSX+_2O,F7)Z>N]UM!D,;)=AE6:.UA I0'2X@
M!&B,%X<$&PR^ZM$L#[5\2'6@'Z.\^GG66UA[JJM5B<;)A1(:9;5:^V0RVZ%N
MWX'.*-YW8XEU0KC;O7BMY5F $U'#E3 QS08QQ50O32%SRR=0'>MHRGWDSJ$&
MZ[1?X5U[DE6"93_#.LS$$-R^RL%3/M%Q5%VZD;&A')PW;*+@S^EV-XSG33#3
M8GR+";KK.+H0GWG^%Y+$ YG?@.(ZAB'-_B87C-5D'-]']1N.XAA?,=%#[6BU
M0;M8C!1RGZ6$WI.$G,?;QS#B]-UV;%/>=R,^%+G+-#=KY%M^6*U_/W">4S/Q
MR&37RR:0]Z3M/TNIAUK7IZ&R.:Y)6) 0C[L':#RROMK$7[\;,HZEPN "G/VN
M82$10]YF*H&QYVT_4[E=1\4KF-%JYB?ADZ,F:3FR1A2_Z-*0]MA:&;8;RI5^
MPY>FFN+WWJKZWT6LF*[%L]&1'V[0$;?US0FGR'4GIP892[#?7*M&G8CF \:.
M!-\BP^E^EMXF(C&W.6QI>U\@:HWY8>ZS1FP6%TY"DOWH5M@ PMQ&I;7*'R*&
MWMVN0Q^R^-5C]Y T:_+G$.(R(ZU5VCPF0YY[&%( -5\>:9TO9X3$3-WH910%
M/\>4);]2,E),?_9]-HX/!93.SX3>6V4N/EG'@35=T$BR:W=YH.;H%)ZI%&7M
M!>=#XTXQ2CNY\D+\J[=)J9^/XW2UKKKUUA1J (F3OF:&B$;KH/GCY,]JVOP\
M)M2'O0D)LY#SW$E$%TC-:!9' D6I96%.4)QJO#,8=LT5J0C?,3JL[>,VY@E;
M!1PV0B81*E3;EG':WV+\A6I+D;24&DG2!V-R<H!QQMPTP:8'X&-$=S=5AN+_
MM>EX+IZV42;0211&1M'%KAA<$.8:M/IHRFBQ_?Z$!$W.1J$8T8 :MZWXX5U:
MF!OX1R4<C? [R'/C?9D^"]I2T-LB Z<G>QDJ#(H@T7C.@B9=CJ;L&-&!%L\A
M53N&Y._BU2X9FE[6/<![^4OW.VRMQ$"&^TA+]00JIG:YR\< :)NT,0ADO^Y'
MX#+R,Z/C.,X&Y*0UOYD$\_FK!7C")BM01E9Y,K&#%,KC7N]:FXCS!X1'5V0D
M(NLE%!D)V6[(D[I+L;^FAW66-:%:E^SO-EZ44 ^>I4-V6>ST4&8X(QP2[14G
M#2=U?"4O@*W6*&O2(#!SH9C#"HMS[)%U'K.#,(X2RJ?Y<I$^DC (/686SG%V
MD96UZ(B,1=/,KL+Q2P<:=-"PE(T?===10N_ID)JC>9QJ+'JG3J'3YT^TGFK2
MLC%8#,)96=O/7:QCG"0(;R_0CHW?9(4&.:&6GV[70>P+.IL&R<S0(]CTRO81
M"C+:%MZ&'8ZW7I+B,-E7IKA>1W2!:4;):$XFW82/K;Q<_L32+DI ^YU)#V]D
MGMW+/(I$@M<]AX>#OM#+L3GV(K)>@F,O9+NA%\.JYQ/K0:78,SL\KW*LG$M.
M[A Q1>-STP$;I_MZZ&&_D=$?)7ZVMI#B9[53\9*PRC=?8A(4 ,S8;G*@J,!<
M,C6\MJHAQ>LF9S'&\5>K3T2+J7!=#ZY[)W+X;*H8X1[MBGZ%^?*(KVH$<E9B
M3>QJU(W.))-6!D6I&'('KR/J@U)[\,X+@[%HA@Q-T]<'*0GHK_&O.9'01T);
M'XTL^*=R 1\9H+L\0&B2\>9PV;6 QS _S9"]VQCOI:LXH:4WJE-.^V"\D&TE
MFH-JH%*?@WJ. TH[WCO>;6U*IG]_ ;BM]<E>6>I'%E5Z 1*'\KWWF6!5D[59
MY,<(FD79,"<6W'CR-E:C2F""1C/ &A9&A#/:8$4U'^7ULAS.F&1VF^ A0JO[
M?QBE;J<$2FZK]IDP4$S]04C%QP H!3Y%68[UO*=$%%62<]='APIMCD/3P_1$
M21@F'B9@#SJS8Q":CNJPX %@)G'J@WFB>T)KUX1FJ@?5MXWFRT_H:_4IUF($
M0ODN>A%6S7J\0(+3C-)AXQQ<DT43L0?QVTC^Z!YM0K2D5,ZN+@_71>6]X(*B
MAS7J7PY();0B=-1!IZ ,>OFL-U>5MS3DJ,(_L@%;\V4VBINNY#AMJZ2Q:/0A
MW$:KKD$)RM"=]7@H"'D #S7/QL]7@)**ALU\>MMC%!047!=I4(6 F@K<Z>Q4
M):[IG2*5T9%ASLWV^9(SQ_TA(^@"4<L?R[U#I 9Y6I>O(O>,&%Y*M%Q'OX11
M8$Z>!7P'=K-5D99LU#[XJ4T279*?&VQY1?O9OKC-\P-#%!V'"%8._(1WJR0?
M(=.A;$^__X@BA%E5\#+&V_S5#>7(RJ<X'VJ8EY4][S9>Q'Y_7P%NO;93AJ8!
M!<T7(6'"3-FPQS9+9X]QFAQLZ8,/3BKT6&/(<$J=!C 4=*P><=(@*8A[:WTC
M\][/4;+%.8"D0F"B[S7M, X*YWNICR9GWB% GMT[I)?3H"B]U8U0.*RLW"/Q
MHL## :'_._-(2.)E-OP''W>':A8JQKN8@D'5HR,**M'5ZZO[!7LL9Q,R6\!^
M2X,J@4,*+2X0\7&XRVVCHQCNXDWH[[.)/#A\RIY*YW4C4?)^0L&*C3UVL94-
MT.XXM3]01QN'@@G90IZIL7IV+-+MEAKL\7(1KJ+L-4!JVM<7RTH9)"WDE+Q>
M>=[N]S8DP+FP],ACI@0%E$S+WZ!-0LJ_R>[@3)T!B)3++*JWPF&H3!N1ZVL8
M2)H#&Q:N!=W7,93QH]M8[)C)[MTG5'<UY:/_7$@WS;?KQ#'^'A@JA=-\F _P
MO(/@>V,7B;?9<"Q&((N/R031TMNJ&$<)5:/+378+_?@=0:LB'JRUS*.Z;69!
MD+&LYNJY/JEZB7(Y?!6N :H<!R4&K9Y1S3D?WPVI4VL"HQ;0QS@.OH:;CKGM
M9AMH>FG1L]&:F%SO,1$]KCL))32D>Y\)&3XZ*^ J?&:M3(,W5^><,>M;JY\2
M32&O3D2NMQB(,+>>,%A=NO<9C/VP5__LYG>*(T4]JW/P.9S=7]T4Z+FU2K"N
MMQ*/#M>#)_J$+TBN\+@ZPAUR'Z[62;S\3%"\/-Y-\N6)!S#S HQ4UD3PN9:0
MS3]3>G"%2=.DS_)=!>Z4C,1J4Z754>56O^2[-XFR6$:9@^15 Q>/[0PQ]XYE
M%A6(#BH)1%0,:FJJ:D3)PUIAB>L=V4N4:V<*I"+=V["?Z:/<;ZQXR6LWR QI
MH&WWVS@9QR8@0X_-QT?B>I_U4^5\+$._@@C2%_U,'U\]03:9]0'A;74<JUIY
M+0>4E)$H^EY3G*&R2.%SQ*YWB@J=SDIP '(7A?@4)#*^;92]O'.\G+VBA$^S
MJ5A[[+$-V_I=!J5'F_G8]=JEZ_T*H<OE>!M)Q>G>KB !C# ,4GT<;=" !C:S
M#)'\W"H VC<A141HO"D+T*XW5P<IKITRB"J([ST>?X'-Q99MQ&.+G==H@56H
M)1%TU$K:B_UP!A5\5L15Q76/",)/E3K]8L1P/MG0]6Y1H]15^YF$+G3O)47A
MC,^*S!9RYI%C(Z3J]JH"D=]4W*^U;J7'*@:,61IF%#U#8.(<1>-[A=NS2T!\
M'^,=U&C4;SA8],=C8+[2-:[6(Z2&ZT:J2',H#O5.616\\$+/(?!-74+\.E!-
M4J[TS@[@[. Z4C,]+35WKUB8FS-Z**$.RTTU*II.R0'FC#DHH2NZ:R[08Z)>
MU%.]]@X@164+EJR++EKT)'T8SQ;(9T]BC<!K[Z;&92!,0C.Z+2D!H\=H.OWF
M,4,O(8/M(@X@*=]"]/V0L%7/45BB'>.]Q:/-25$<5,!RMQ"7]:,L-EB$V]T&
MS58890;7,L97:4)W>QX_R)Y*4-HS#;A7#;C>LJ-[NLL]AX-3FU76@X#RX8&R
M^(Q"^**#X!H\AS::O)@.=K\4Q\87<RKG-#UXSQY[E)7^ Z)_5JH2[8 EYQGW
M E%3[ ZP<,]6","@ZO*]5RBK#VHJ7O_P/D8]2:>"*M?&*Y<01R$_&4G+L!7R
MZKL;YR^GMYS4J>X&UN!\I$PF<WP3YTD[[AP'^ZV+B@3JVG Y$E2CP_7>ZZ/)
M;;?54)WJWJ6]LAA=PV,66YKO$&NESF:?,)(5RBNR8XX+3,YRZ &A.#64"Q5N
M-@@^-W2A\ T&&'\/YH)HU3J,!5V]! <21W6& 4ESE76'Z\(PSH]O"L(LV%*0
M[$AF/4D5$T--'1=H0_]A54Q:G$4!%[YUNT*2+%W61 \^UYM2@CS7M65J>M4[
M"A0DF?&%*%A-#V4?:P:Z0$]H$Y>]Z0=[0[Z?5012SNH @E)-V O!P\T0 !B[
MZ7<Y"53>[^AGQTB3Z27I,Q[I8TQ.@ EVU9HLK4(FA#4^(^<\)DF\))Y:NTDQ
M(HLD\^7"Z^PJZ9SSUOY.4TOC$;)K0Z*#%*<3S3K%)>A7[.#H*/-S[#68F!#J
M<V1UC(HMB@TH<A=]Y\=*S\HTH,%O<NZ'YG+&_-N[CY&U5WS:R]0001A^HEQZ
M.*)'/KDK:'-]K(CH<?F,"$#4"@R&E)\Y\#0V7L(*I+%ZE4P=AJPOP?]6W7FH
MPI/Q%MK?V78/A%RLON?77J$K!Z"B^Q6Z]JX/EBY:7(4? ;*59.HH#Y-#.N@^
M)%]N*:UYKX6>LM8ZS 6+YZ#5OF#00\SFT:.C6^.TZE615+TYSI887&]* %F.
MI^/I4[>^I*=8.&.LJ2V[#5L[6\G9Y@&3<[N%$)3\D_ID&PYXN3I "7#.!IF
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M3SS_41:H:AD/$!&\>$<*H-V2'55)'<=:2C'+57F.A_$^C%9Y4&[F^^DVS3K
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MA/(AR_&2_M-5RMX;OGQ&V _9,/OY+A^+?>A)4E/.*G\:\E$EJ26J?ITV2L6
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MJLN,J<6#_(R)A/[NK1?1&PNK/[?7)S_-=.I-W!DC;DC]G#UZ]>7YC!!F]=E
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M"%Z$RR5B@4]$#HNMA'TNHX2J(9E_C7*%/(:+[!DKEI?ERFTUIH_N%,1(E.]
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MWN*U/CQ4[7C=8>2'W8PVVI[<QCT*1TYE6W 9V1M-51/:@KJ,U&OY2 T'G-N
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M3A;.1M*?PD_FPD\V"WM.L:A3+.H4BSK%HDZQ*!>QJ&^DOF"PS:189^#.FWG
M7H"\*"B<,1^%3^P:'_(FUE4849Z%WN8^)%^.@RQ:S.Y"+>>VZ,.F6GLSE *X
MMZ('DRD;@^^E:->&8RA'#]\'>R9J5LNMEZ28GOQ6O9 :4J=/96G=-'4SI<Y9
M<WGNV6J%T8I=%0]TH6>42-L>13<%KOT(GG;7I23@7K_(- O,HGL@%IECIV"
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M]NZS5!:%]YT#7U[ID#J^M<=;O'[G/4/S3I''[UX"CYN+[]5D-1Z_5^3Q^Y?
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MQGAUC%;YQQL&_M$CB*W]_P%02P,$%     @ F8I>5_X@W:+-&@$ B_D- !4
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M:H@AXZNG2 A1[;E.LY0A@&?R'=$(,$,XB=<DVU!RH%XR&X0, :/$PZ1";=B
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M!+97@]-P?34K,D>^1 F8P:WC9#TN6K]Y4'%VG&@-ZG;-E#.A/*X6;6#+!.G
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M3ROX4*.A[$+R/F7D-K9IJM14&R#PI*V\VP71E_JQ0/[$: J8](GBK!9]1@9
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MFZR?VV5-P@$ &;3-3B'<:MV"IC%^PRHWQ(/MIM4G@%8D4\:-SOY5YH@XX)V
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M+0Q<(=S*MH"F81G>WR?WO:4^OT?7Y_?SU^?W&OK\?HP^_[R/Z+MCIJ]3HZ.
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M<>GF_9VWW?W<\?2Z=[!8*[=VM-C)R&9[XYW/Z#I.*!M,"V7M'E/Z-C01U&(
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M&"J_C@F:$0*46NE'_4R$A3-O]3G-8G,H2#NZWA1D3!ABH20!0\$U$%0JJ7
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M;W 7UO^/NS=MCANY$D7_2KZX$1/=<26WI+YCCV/>_5#<9'9+(H>DNL?3X7"
MA:PBK"J@#*!(5?_ZFR<7( 'DBD)E0OY@-T5F'IPEEY-GG63Q=$_#X]DV[@BC
M ("_SP2>XS'6GQ/:@]C[OLEH5"'<C(MJVU:SN6LIZI$TQH<(=V=)B_-=D"O2
M29J]*6$]A]V/Z[9_,XCE,L<S^ZG9VTA108V_GW!?O5XGR>[O0E61-)SJMBS(
MUM\F=_@9YWM3!% 3C<K!21&I_#=M5*K/%P/N=0^T]&V?7Z]@&"K9N"@K9X1
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MFOH[3FO'#B6XR=6*DMFFQ0VK:A-JC'9LCF*2&K*YT#\^/W7<0C&MCMA'B_%
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MF^&,9^*8FFD?"T+G\GYQ=?D10S4N)W/)8%+0.B_]KVL6$!N&8!SZC8W\6\1
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M"ONH9\4EP:<^5 ]%G6QHRUW9AABZ*K8#+F'+S#I@I$MIH3/_+=D5U7]6J 8
M:%64J.1FYITP,\_& .BQ$GK5MQV9-,8O,7(;D>=Y1?Z6 B)764Y>Z%FR:9_G
M)]<MG;X?RK%^0AI.=]G(7T?-YR6#4O0PI !+\]C;Q%F$XT(,3H-5$"W1&8>
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MHAS)P3%GG->G_,Z]D:"#G87C\)MTK<[!OG+<"ABW9B<Y7&FPP:>"&V5J*>S
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MLLOJ9,-OF)N5U'>27S?B)<!3,"KRR!>V?*48.@!A1T@-/L6=V[Z>$@X5#"@
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M!& &W2;P#WVKY9B"J5S4@VJ@'P252[^<Q&U2UMDRV[&V#-9^"#_U2W2@G0P
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M1]$#%/%P+)P'0^.I-Q13%1>CI?S3;U_L85M *1N<)QO38:'@YBN4TNFL)(P
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M\D8-V'"AWARSX<Z_V?5K$"6679(/7=HU8%&S>DY5H_QYH'-6CV1F2'>F*H_
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MMS=E:OB'I,)XG:X7L^AW,2'3AN:7J042;"EU$EO(L4Z-L&[I.G"/,=MT1(^
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MFRQA5GFZ9\^375:3MUW.BF??EGB;[;=NP:/RH=8%WAYS'#[U@[#?\$_,J3;
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MSJDB0/ L9WUA/+@J:#BR;=,DQLY]%]%X'JE[-M(VJ>A)K;<^6 35B9R6T+.
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MDF;H.X',0);;?DT -KOQOO''_ZUE162[QCWY$O>R[4[;?F+LQ&%?F'TRF<C
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M[#*4D[AP\G1-RY(]L\KH[H9P%0U)G7RQX.Y&PF/M3-Y^NSEH1.:S'_#UD6[
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M]XF/,YA:&WMGV(7R6+P\SOPBK&A(6$NBFL8T01CS-D16!V71WD(H0<0.J0!
MD\'Y@P]%+091=5O_(M,4OIE4)<]PHOO/21#7\$+5EB53A*3KTXT(SMH0V2AB
M_J ^5],R9Q""90.]+=B?5X^KC#^3 2'SH@.1/1R!\]C,=5)A<+J'7MR06E$'
M39;H: NA.1/PEZ)T7%/QI*T=%U]*=-%BOU3\E*-')BB .Y $:L;QC,U%2(17
M.R:,9^L,W!4"4^<D4- 9FJ>P_KCHI(:4T4079-6,"GZ>3(VK!5W&EZM&\\2^
MXJ]D,6*.KJ85:#'X_EL1LG:;N#%(6]>3%>++9SU4&;=D$!<P@S7Y1;TL+@6R
M1"K,.?Z$5V>PIGBQE@6YI")./96YUJ0_.3C:"S>& \:RCF<C.A3S@_0&6S,C
M6^SE!]TG'@UJ^:'C]7:1@B<9BPBNQ5H&9[TORC6%^H#7QY)=KLLM%=8)IX%<
M!,X!.I.,AFM&(&((PL8@8I!X+I- *LWK;0AWT(61$]E(KUMEC4GHB(1FJ:X)
MB(/^2ET>>K$=6;JN>TT_UX]TQ;9$/<9@EK+NFO_(:36+;A1PTMEO#NAA$5K)
M)3TL=5:S\WO#0=7<*/(R])=W(+.:7V:B3US8#P<AQ@7FIQCIQM+PV(7QNPDU
MAR*T1Z=NI)#G)9I<TXN(;C&>\SY2NL$/_62C&C;E1 :@JBKF[Z:)KNHFR'XI
M]3$ $WFN8"IL64M)V@V+H)I)"UI4O+G3*9OA)C:2\,HM[.%T_9\ $NS=V$UK
M'I9I+Z&#'C1HI<!@LX_0]CH9@S\AK6P<CO$^*>L7#E:?<!?T6/3:L#'Q-)Z!
M,PN GA"!O@H7G(]$]*$L>RM>_N:@);:D;H8S#35.V(K:]]U@A,+O(D8,VTDP
M3[^/5+QC]!$2OGXY[H/@DWAC JV= $K8[+;.WV"VATI$44&>N8HRXK9, ;ZF
M3W17\ J3JH:42WQ0=Y/HR^%QM-Y$=8^W[0-H,U8EF!_(=203IL9#E(\.Q#//
M]3C FR^KW3'E2;9&:9@F?E"+*A3Z0[5XSH7QM8U&=&I-?!8B#8Q6W^B90EG>
M#3*E:CK6NCP7>IBJ%L!Z(</6_B,Y%-5_5:1XS@D5%G'-CA%=-\!=#KN^$6-+
M1-OTB[ROX-$=K1?K9?(E<.\6>4B]*!Z)790TV^1::N,%R6DM@S!C6]%&\:AW
M0PUE-Z*(G>T/NY?9IJ1\Q[XO2A$D*1U(L_?.=&+1DS1=P9V@\%&4TXUUC^==
MZZ7,%)T#F8'N/K@K8(^HD'>GPUJVDFD/D8/43N=L/R(VNM"9^W>HG@1!_;#F
M][2LBCRGNZMB#^*)MU@>ZRGS.O@!.*B^9*5UCOZX]M-G7YQ0OL1UIC4&V\&1
M5BMI+YULQ)5)6H"SS<4/1!WHQ),QU$W=<>1,TD<=1*#?P=/KG\:+P8'7C2D.
M?>$UI&T7%9;U=,KV>)@N27A U;1^IC1?/A?L/+[/GCA&>1]@M>A#6">N]$,W
M#M(^A2@S'T$&[_NI1\Z4"4.&/ ^D9F1Q*XQ4AZMM )OP5)-?BBRO9P#:+460
MI*PSR/P$T8/=EBOV.R:=N"XMWIUH_<G) *0=(>;Y"B32.&J#F!,M]MIJ%?$C
M-39=W2:MB> W!A!I/V[!W$%[MDY$DS#);#I!-7Y!"S%*4ZL4PPT&?7YM:269
M4(S&Z;SMN]=&&_H%<V);Z\+%>-/[P^V9+62$N'""P"!B@WF-YDN #7,$GR-F
M1BM,?D#=KR'+F^U;Y7<:%O9YD"-=\+(%M4 #4*---2\TA'S[FH]CHK[2X?$L
M^K=FJ:BB"T >ZZ+<<U&F09<>%-(R8EA$^\CPV3DB6[1M"F55FJ&(-I8&2SZ%
M(LSC%[QYWD>R#\NF\BEG4^#5R__!SLFQ-^""MR>\ U$])J#XN\@PEL-/[VNK
MM;,[!VQC[$&!Y,+K;'<$,)Z;]9JNP&&VI=)#(T6^)O]C5 3<JS^&'QKWVBGW
MQ<R!08J;7.47B/H$$=_@5>#9WY7C3^D(6IK1!&Z=<^\F(]CN+,O0GA7)JH_L
M6_)W[#?LA\],:P3AXO\!4$L#!!0    ( )F*7E<UMK,)?G,  &V@!P 5
M;6QE8RTR,#(S,#8S,%]P<F4N>&UL[;UKD]PVLB#Z?7^%UOOEWMC02);.C$<3
M,[M1_9+;[E;U=)7L,V=CP\$F4548L<@R0;:Z_.L7X*.*#Y $P"PDV>H(1U@M
M-1.)S$0B,Y&/O__OIZW_ZI%$C(;!/[[[_D]OOWM% C?T:+#^QW>?%Z]GB_/K
MZ^_^]_]Z]>J__?V_OW[]ZB,)2.3$Q'OUL']U'FYW"Y>^6D9.P%9AM'WU_\7;
M___5ZU>;.-[][<V;KU^__LGEO\-<&A$6)I%+F/B+5Z]?<X %R/.("(!_>W4;
M!J_F;OSJ_=M7[[[_V]L__^W[#Z\^+\]?O7O[[GWVR7_[NT^#+P\.(Z\XW@'[
MQW>EE9X>(O]/8;1^\^[MV_=OBE_\+OO-OSV)OZC\_M?WZ6]__^'#AS?IOQY^
ME5'9+W*PW[_YS]N;A;LA6^<U#5CL!*Y8@-&_L?0O;T+7B5-*]N+UJO4WQ$^O
MBU][+?[J]??O7K___D]/S/LNH]NK5W^/0I_<D]6K%/._Q?L=^<=WC&YWOD H
M_;M-1%;_^&[K$_>UH.#;O[Q_*T#\#_$WOT6_G8<!"WWJ"=H+1D9D0P)&'\DU
MY_^60Q$K?+Z_KNQE&_*_=#D_N9 0P<HWXK?>],%Z8PWMW^Z<B 3QAL34=7P&
MN8LZZ!-MZLSQA5@M-H3$QNA7@&2(PF"ZV' B;$+?XRKC\O>$QOLE!_(NC-YK
MX=H!YE2RXK#-E1]^-9>( H! $ 2]3)?ZUX%0G:G>T$).\GE*.Q#<SA)& \(8
M/P</--!'3O8]I!S.7#=,@IA?4PNNA3TG\AC_WYG#* M7=Q'9.9$^TLI P41@
MD6RW3K0/5PNZ#NB**Y8@/F)QQV6/XZBGQ11!PHF*4)4I882B-!/E%A <1Q ,
MKP/.SC5]\,F,,1+KT;/Q,:""NJ)/Q#/ J?P=(#H?P]#[2GU?3PT5'\%)U#U=
M;^)P]9F1<&5 '<GG<+C-N0$0?0J#\R02UL ]<0E]=+ATZ.'8 0;R N1W%M=@
MXG_BEGUT?+Z6IE$D!P%U-!>;,(J7)-I>!X^$Q5MM_*0 P/0S]VP\<F0.)T3*
MN(',5X<** N"/D$<1KKW2?D[0'12"_#<V=%8F*I>^B._8K<TV>I;DBUPX(24
M ^5F /'NG+V0,'T,*U]#X95?ZXS#E<@1__&H8&ZH\T!]&NMRWW )2%/OBMN/
M@4L=_X(\Z%&^^B7<'?"K$T7<JF*F1)5]#^JDI;\\6T>$"'GC!M55$B<1R3RM
MQ>SJ4D^ ^\%!8G]!5H0+E+=TGKA\9;XW_[,6RFTPX&3@(%L9\,NG'0F8IART
MP0"V5N8[$;+CQG^^@+ZATH  >!',O"T-*(LS\]^(CBT@H-3L/6'$B5QA!EV0
M1^*'.W$,3(C9#0GR$)V'C)O S-$U3<K? 3+Y$XEO0L:X&*6WH19*]6_!C+M[
MXHO SIT3:6OPVJ<GN>[N*?MRZP3.FFB;'&TP )W^S.(:@*,< J#,70J[E3FK
MF$1<A]V3'7<41 2$1#3TM%#MAG2:L%81J#G;IW_:&P:R&F  "2R)\2WUG:%V
M*):C; :X:P&&E)-Z4,H ]Q804)=F*41E@%SS:RB\BG"5 5*U3R'YV0Q9&>#7
M"@02T_; E0'&O<"@N"Z/8AE@W D([GJ51;5,]%,[&,![0#F<9; #7=AP3P:'
MJ)>1;JU_#1J*DH>[C.2C#QJD2-?"8*;X2F# 86D6[S+8RJ"%P"RC2H3,Z)YN
M?@]YVT@B9098MD.!,S%[8V0FXJX*%&P;+7$S ]R[(9W$8:Y&T89(LQ02N!55
MCZJ9&E M<,!>&:31-1.5UP4(\/6X*\AF8E8KP ,[@*7XFXEUVO@:2@AJ03@#
MW.00 ,W0:DS.B-$2 /!7;37B-41-22&!/B2Y&^(E/O<G.?<REW+F\LN'ZW5^
M&BK^L-[%I@$7T (]K)HMR9<J603<EPC77#V)*\M\/RJ0X8R.P[+<YU\E_@U7
MJVFF6LA/6;R_XS:]L"2%N; [2(CAQG16. 7+RJF8AP.PB/F/1Z_6<&M*H"%3
M'X[2?[#Q,[E)K_.8WS0E2X3?E\G@+1HL= (IE88<#7<DAW42+M6#D888-\"<
M!%D(I7QZ!=P2JC3$MPW:*3#O"5D:[J /ZDE$I2.6::I).R""1< .J[5&-PVQ
M;X=W EU8"VP.P5L*Z@0H=T5>A\A]I]"#7T'5R*SQ[5,#<Y(#*@Q'?CG[-'T5
M%0+:':XU59^ZR\ SAB_#)>&.^X?B1K^@?I*&"%8KXG+%SO\I#WP]D<BE0LW/
M=P+7 3P<MN)IG*S95H2$A3V=KWH743?']#9\S,S1%+E%'+I?<HS"%?]U-T5?
M.!Z90Q@-$N\3( *O_FL1]$'[E8$Z@09MALN-;<D&H%-HR[,P_/*+XR>$<B?6
M86' 5]K/=KLH?*);[A_%H3@H#HW27UISQ@<T9H=[]),CCM"0?0(B<)HC*U81
MPLY]2(_FIV">Q*(T6-10WX3.$"6E _\TKD]!VGG$EW.B?7H9A*OB1660#"O!
MAM<;T+ZU51?Z/O3]JS#ZZD1>&CPK/;,,,@'ZP,*S@5\IG&J[+-*2<%MJSQ<C
M[)Z?:D9%F?6Y4,E##37=5>#W>7CZ6H51:N[^E$24>=0=:,"H03Z!"%;%H_ZF
M:AX'[@)Z@FWP.S_9)FG$7ZS(#<%SKGCVJ^P4##.?5$"?1%]?LCB]%[W,>A6/
MKWRMNRA<T4'V1C_<4Y@?7>^QPY5U$^3)XD72%]HA+K,<X$E$JN/5UO1X=$"$
MU[_]S[?&;G,OX-/8G/577N-GCQJ8TSQQ9,^^=^5G7_,[H@GJ-!=<8YTA?67T
M()\J<%=ZW=ZG#9N<X1:( N#3' %Y(J!QW%<*[!0!:]E",**E!AM^3\(!YU9;
M*@([(0(/6>NA07+5 _0$1Z1[11@6Z:UQJC>'(M,4*(+?#?-4%R!WV;B621S_
M5D1X:+R_X$0=F /0#O(DMFT8$;K.'_S<_>63,"361*3T#+)O^\">()Y2Q''2
MES_NYW"S-/WY!*$6DZ5.$4%Z(IX((8!%D-K@G;#7V 6)':JIR]JA@"$J*0<T
MP;0##&3MNF+#,),=Z,(&$W.EFD:3'>E!ABOS;F2'F"#?#@4,T?8D$!.$^Z$!
MU_;(7XR-!*4?''A/R[+I;(RS#,B)RV%,<.T  QD#Z*U>,:*S,E3 K;04LYC@
MWP/JU.GF)BCW@ )#N;/-@@GB2@ AQ.0B=%.K;19XE_PRB_>FC3 [ >4W_"XB
M3)0(BK^[X5A5\"5/,0D\XA48"Z@0'9PS'O/5_="M+.B+EM=A5*SG.P_$_\=W
M=!6QUZO$]W_+OC]D4\\>6.IG52DJ\&,<P;01MO@V[88=.T]A$&[W;P2M7[]]
M__K=^S<I3/$;QS^]=L/HM^.OI SI7[^X_)2W)#Q$&B1<?O+@.Z>8?#<M MX)
MX'A+U#@\BZK(.9%;K,;_V&!OM95X_AMO=FEHX;6[H?Y!,E91N-5@5!SVD2",
M/!+]X[NWHH<\WT&FYFXRXK5BF*+'SR<CZ6\>3Z.!J-T3?MX38DVTBO6R<VF7
M;RK2*%@FH0X<G\S8)-X=YJM%UIK*$JO*:Y9%;-0<JQ JY]KW&ES[D'$M(&NA
MU2'.5_;@-9/W0;-VZKJPP-*C)N>QDYHYO]\!\-N,VZG<S40:9_2%5+H'6F)T
M*P+3X7$[#7/VOD=CK_01WAIOY:M/1C.W$"]GZG\@ZNAJ=D@ER<4:<[MPF(:M
MU$G%G,M_QK*?LJPKD4=PQ;=WP'+F<EG,>Q%;8G0_)J5MCIKA"C3-V?X7 [:'
ML>,//]IIA'&>ETPU7?2Y"$N'+A69K?S*^2FD0?P+)U#"Z9Y'V8EW%4:?F;B'
MTFC9+8DWH;?<./&OU/?/1 V9[S!&5Y1XRS"CR3P25/E$N"6:-F&V=?F/8;,8
MRDK+(1\9O4R<%%#5F$4JB7"<[&G!RJ(3$IDJL0#]C6'&2XY6MA6!G%V[I;G\
MA%C:1D #;P/@7):3 8]]W14BI=(/D9P#+4[(=PSI%I@=K!P78=ND%\5#.4^P
MA/-U\.N&NAO1_X'-HP6)'JF;]J\A_";Q+JCW*8S_F3@^7>WY99'WM4F9P(HY
M39;.JKT='5WLL4H="I\-O"!@H3[:[&=D%4;$IGDJ6WL23S@]Y -T<@:]%W)D
M<EF6^7*6'P][D)G"Q:1+WUP.?D",9!WE$^%43TKKERF5,^ZO0P^P&<]$=J)[
MZ40!%R=6KG2QQL)V#*;$T0XZY@S^,-24'^"A2>(+UM,Z>A&9FM?62=0BKH*7
M6W'4,;^]Q=+'J.=75?+;5+,@&UCFA1D//SHT2+4)8?.@J RYH"N.AT@&XW^9
M^@A^2ECK$5\S[' >&(:*A2$GL,.K;9M%U_HC\+W,!*&=H@;Q6-CG)DP^/R<6
M=W'7)" KX>[?W]1S@O.4;(Q4X7H=ZTOF\!%DVF:0>*@>4A<.$S*:.TD)FN**
M=[K.LOKPQ8:0^+LA0;4#3>?'.MF[D&4A7=OG2@D9_9NKWN)<*S>_]6/DJ($.
MX\3Y:"<"=M9WO5][>IDNN>%;-!NWJ-?[,,%Q*OH$N!['[:4G8$&&%M-+C>Z5
M#E_Y]S%N(!7"5_:$[8=9/S*3.AF- V#B0PTZ $=<\JKQA!'+[^.-A9$":'JL
M:Y(+)W/EB!''WVT4T%OCHGSU2;"RA7 &N3 GXJ?E ]E8&#VBK6M;=A%QP(T(
ME#>@8/N?,F#5ZCQ,E,7=7@3BC2IFR\P:(V;L,5J^/&[@1$,MMY$/RE?086K:
MIC^NSMO)MZ+D-W1]C_TNU,N2SLU#.1B#5&EMK)#%,]:R_NAYJD!", 4ZX 4/
M@Z>-A='O1@UN-JD&YY8,M'?21G!I?J_U\UE>>GI'LT(X,*_$-#9ZF"9F,0IZ
M7'-*9[%"*[A27!"W \?=0#]\0%X&X*NX84L$NTR<?AR@QC<3]0GD_6<EJ];=
M_MJR^"DJYKRL4Q"[R\$U8PGQ\B:@]F[%RJK8BE4NU;7[L$HGK#>_D@B6NK7:
MRRDH+XH;C%%A6I5&<,^)FN$7,8(D/".9"&4S/Q4#+[(OQTKVEGW"A3)UB)ZW
MJ25Q[!.OT3-8[;V\#\98&=&[=^S'/M&2+7HD\U5?2K:]9UQEC-#-2!6]IT%@
M[(?">]$>.#@F&%ID>6WAB7"V3BYL S+#VK(K@,^LH1[ &&K \[! J3T]UH.N
M#(4)L[B+L 8EW\">0_I:,LM'215AVFPBNSWUVXD$MD/8?S"J_.ZF*'(Y8AFI
M@QR7MF;W;:H+D5&\[BLSO9^NN,_+9?RPV5WC\J0.=RL=D=^8\^DR!4KV3+#&
MPN@WM2Y+FZ3#>FA.Q^SL#V-VKIIC=M0B1?U@D"MLU%BD0@YLCQ51I8Y0FT(:
MR7!M=0PKVGH]H=ZRMC9'9D(<ZB$'5&.<0>;L,3,:WZ+MP06%^THB+3%S^N@Z
M!E?FB*-UI[5M?>QR+5,F-WQ4B+<QTYK]X\ ^C*/<LCQNG:0R7]N(!UA',+0.
M"(.I\M71W16(BB!IH,%$+P.T(\1@[3-AJ)2-@\N[!B5W!1X&/Z6+3\QR[B-E
MP5^(9E/V.Z:DF02;T.=[8-G^EAS>NS!ZK]M[J-Q[Y4!C-E^=IV_5[#KH2C-L
MG_JI!7. !U(2BQKTI;"F["5C]> Q: A.*VPN3^2:_YL]U:"""XJF,)3C6HY:
MGS29F^;^P/JT<+L+@VQ+^4Z>J,U9HM+E<1^)%,]^LS6=C)!XG!43A@C')M7I
M>5+K+=D^D,@>>SMP0'X([)3[&FN[*(D<+:FD+%OFKFQM_+1]'<Y*J8>40ES2
M/Z6,9LLLE2R-_?B@PT\9Y7!RD\^3;>*G$TU+F9@S[]])5IXN8VN;T:L$:?Q<
M4J0(V",M7":Y!K.4 (W]YE.C!M03+4Q*L64]V;+\V#G;3S^P3.,AX2G+S*PL
M.AT65FE5RC0>4ZA4W8%2BD:87^;^8+/L)0F^+TK4F0-OX"'M2$1#$76)8N/'
MQ]3$K[IN2C>Y[+OQA*I5."'=.9AS V=> 1A6DSLE?13!<5IJCG%Q!=D-*!Q6
MQ79IC!5?C7A0'LU K2<2*].?U0ICNR%@#X"3B6>+SBOO&ZNB7X+6C6C/^U.R
MW0WC21W,A!C3H !6?I($MS/'_<+B<"!S:E#P8Z,Z[*F3 #W-Z)ZX(A!/5]2M
MQ8[&.((-!ML1BPPX8[#*,\X2QN]SQKCO_4 #24^"E@,O^VZLZE>Z1[@BBY>Y
MQ*<Y69)IQ(,C<T,*#9L3RI8;)_Z5^OX9.6H!XBW##/-YA#-2'@9;?.5K[((
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MZJF^,:M42C]UF[3C<\W*32DD/5NT!P1ZU;&A*=K%(@@[S#I%^F6N==O@KW-
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MJ1O 9T?@>HUE]$!JQF3N$I$5PLAY&##JI7G/;='T%ORZ(>!T(#?B@I#['G*
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M>] 8Z>N"OF;O3@G7B=\!RT$JFT<\T0Z\'(7G<?1;R%MP7R>0!ZWE6^=OV-,
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M4,H;SK8U3:$3CA?Q1FK>FF$WB0!0SWU>R\HSXQ+@/&?4P39YDPQ.LGB_C)R
M.>D;/!O>2*\3_)!9-[TP#1KI'2!2R7NV J%4MC%\%9-6>>9KZAG","LA-\/3
MDMFL\]1@R7GI?H?0@@+HO+^TNWNQB2V(&) 6QVMHM]B$4<P-GRWV6)E>1*8F
M*SW6;3_A 0?; <O&S'6C1 1<T87C@ E6TSS[\G$DOKE],JK(?NK1G3E,T&@O
M;HJA,]8:  U]FG8XX.9^"PT S/L6R :VJ>Y"H%Y*!W3L\0^]XJ9@*+3Q'ZW5
MTCG'=IWF\XM&Y&7<K3HD/6B@.*6#CG(MR[Z'RFCLSS)56%H$<A5&5=PLNSPJ
MN* (@NYIJ<T>5"%QU5?2U=AG-'0)I\=Y%.X6H4@VXG;'>1CM9!QLT<M],##,
M<A/"]]("T)K2X='G@"/R,0J3W2]\MTDD/UXMS&G]>#+GH7W[8*]$6B?FXY43
M;6FP7A)W$X1^N&[1=VVGI>-['#O%Z*QT40$XGTA;F2UF!MKK\-'4U-5QMT@%
MR@4B-S?G!G0_?C4AZ6_N&*L(^2@%UY]N+Y?\?\&:!%2T4KCE=N=#Z%/7,3P0
M*A"1DI^&'1@E4AF4M +DUY:1O+B<W0LL&3<#DSB\(+-U%#[0,"9NJG*=^Y Y
M$0T-F:L)'O\AP8S5NE0TF*<XN*/,$5^.G.-G)0!&;&U^/SVU*J6"P1!$$ 5[
ME0B;\RH,/7;VBP9+9-]-QN:6;CKGP >KYO9M&AM>9+%AK7M,_N54K+N6?1<N
M*,23CUX7FA\OY]>+\X5.8*#^S81LA<9V"\+#.?]3BD<.".R#-/G6>N49]K:C
M]*(S8MY)'PT[: +XAFP82?Z9[&^=P%FG[83O.- P"(@O>G:1@$DZ=I\PD*R
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MCW_5KJT2U#YK/^^6X9)SD-R&_&+3ZJHM_1+W$4,FGNF3A7R7L,7#4Q9(P L
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MHMXY7 <B,#%CET\[$C!R%48IQGQ/?'O'7U@03A<NK/[^BM.B),'S5=X3(>!
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M;&5C+FAT;5!+ 0(4 Q0    ( )F*7E?->0$5S ,  .$.   9
M  "  ?&Y P!F,C!F,C R,V5X,3,M,5]M;V]L96,N:'1M4$L! A0#%     @
MF8I>5YDTC.KR P  )0\  !D              ( !]+T# &8R,&8R,#(S97@Q
M,RTR7VUO;VQE8RYH=&U02P$"% ,4    " "9BEY7MC'I?H'D 0 F20( #0
M            @ $=P@, :6UA9V5?,# Q+FIP9U!+ 0(4 Q0    ( )F*7E<O
M-_#>6ZT  #F]   -              "  <FF!0!I;6%G95\P,#(N:G!G4$L!
M A0#%     @ F8I>5WXBGQ@?,@  [;4" !$              ( !3U0& &UL
M96,M,C R,S V,S N>'-D4$L! A0#%     @ F8I>5Q5"5S4D$0  )>$  !4
M             ( !G88& &UL96,M,C R,S V,S!?8V%L+GAM;%!+ 0(4 Q0
M   ( )F*7E?>3K$M<7   #8B!P 5              "  ?27!@!M;&5C+3(P
M,C,P-C,P7V1E9BYX;6Q02P$"% ,4    " "9BEY7_B#=HLT: 0"+^0T %0
M            @ &8" < ;6QE8RTR,#(S,#8S,%]L86(N>&UL4$L! A0#%
M  @ F8I>5S6VLPE^<P  ;: ' !4              ( !F",( &UL96,M,C R
C,S V,S!?<')E+GAM;%!+!08     #  , "$#  !)EP@    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
